Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,GO_Biological_Process_2021__protein targeting to ER (GO:0045047),-0.8320754257193483,-2.086452487032961,0.0,0.0,0.0,59/97,11.28%,RPL19;RPS13;RPL12;RPL23;RPS14;RPS21;RPS23;RPL41;RPS4X;RPS27;RPL27A;RPL10;RPL39;RPLP1;RPL34;RPL8;RPL29;RPL15;RPL38;SRPRA;RPL35;RPS27A;RPL7A;RPL24;RPL11;RPL35A;RPS8;RPL27;RPS7;RPL9;RPL23A;RPS25;RPLP2;RPS6;RPL30;RPS15;RPS12;RPL3;RPL18A;RPS9;RPL18;RPL13;RPS24;RPL21;RPL7;RPL5;RPL32;RPS26;RPS16;RPS3A;RPS28;RPS18;RPS11;RPL13A;RPS20;RPL14;RPL10A;RPL6;SPCS1
prerank,PanglaoDB_Augmented_2021__Immature Neurons,0.6805457132489622,2.083181800839775,0.0,0.0,0.0,59/121,22.18%,EPHA7;FEZF2;PCDH8;ANK2;SOX5;CADM2;FUT9;SNAP91;LHX6;LSAMP;CAMKV;ASCL1;ADGRB3;AMER2;ATP2B3;ADGRL3;STIM2;RBFOX1;CACNA1B;NOL4;UNC79;SLC35F1;KIF5A;CTNNA2;NRXN1;NPAS3;ROBO1;LRRC4C;PPFIA2;ASTN1;HIVEP2;ADGRA1;CELF3;NF1;PAK3;SLITRK1;GPM6B;KIF1B;OLFM3;MAPK4;KCNQ2;PURG;BCL2;ELAVL3;CSRNP3;PCLO;CTNND2;OPCML;ERC2;NOVA1;FAT3;GRIA2;DPYSL5;NOVA2;POU3F2;UNC13A;CLVS2;NTRK3;ABI2
prerank,GO_Biological_Process_2021__SRP-dependent cotranslational protein targeting to membrane (GO:0006614),-0.843218867985867,-2.07385751547637,0.0,0.0,0.0,57/85,10.95%,RPL19;RPS13;RPL12;RPL23;RPS14;RPS21;RPS23;RPL41;RPS4X;RPS27;RPL27A;RPL10;RPL39;RPLP1;RPL34;RPL8;RPL29;RPL15;RPL38;RPL35;RPS27A;RPL7A;RPL24;RPL11;RPL35A;RPS8;RPL27;RPS7;RPL9;RPL23A;RPS25;RPLP2;RPS6;RPL30;RPS15;RPS12;RPL3;RPL18A;RPS9;RPL18;RPL13;RPS24;RPL21;RPL7;RPL5;RPL32;RPS26;RPS16;RPS3A;RPS28;RPS18;RPS11;RPL13A;RPS20;RPL14;RPL10A;RPL6
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",-0.8143847035639964,-2.0722555087575665,0.0,0.0,0.0,58/105,10.95%,RPL19;RPS13;RPL12;RPL23;RPS14;RPS21;RPS23;RPL41;RPS4X;RPS27;RPL27A;RPL10;RPL39;RPLP1;RPL34;RPL8;RPL29;RPL15;RPL38;RPL35;RPS27A;RPL7A;RPL24;RPL11;RPL35A;RPS8;RPL27;RPS7;RPL9;RPL23A;RPS25;RPLP2;RPS6;RPL30;RPS15;RPS12;RPL3;RPL18A;RPS9;RPL18;RPL13;RPS24;RPL21;RPL7;RPL5;RPL32;RPS26;RPS16;RPS3A;RPS28;RPS18;HELZ2;RPS11;RPL13A;RPS20;RPL14;RPL10A;RPL6
prerank,GO_Biological_Process_2021__cotranslational protein targeting to membrane (GO:0006613),-0.8331451588522636,-2.0475156173633264,0.0,0.0,0.0,58/88,10.95%,RPL19;RPS13;RPL12;RPL23;RPS14;RPS21;RPS23;RPL41;RPS4X;RPS27;RPL27A;RPL10;RPL39;RPLP1;RPL34;RPL8;RPL29;RPL15;RPL38;SRPRA;RPL35;RPS27A;RPL7A;RPL24;RPL11;RPL35A;RPS8;RPL27;RPS7;RPL9;RPL23A;RPS25;RPLP2;RPS6;RPL30;RPS15;RPS12;RPL3;RPL18A;RPS9;RPL18;RPL13;RPS24;RPL21;RPL7;RPL5;RPL32;RPS26;RPS16;RPS3A;RPS28;RPS18;RPS11;RPL13A;RPS20;RPL14;RPL10A;RPL6
prerank,GO_Biological_Process_2021__cytoplasmic translation (GO:0002181),-0.8344718648353866,-2.0471089110018785,0.0,0.0,0.0,58/87,10.95%,RPL19;RPS13;RPL12;RPL23;RPS14;RPS21;RPS23;RPL41;RPS4X;RPS27;RPL27A;RPL10;RPL39;RPLP1;RPL34;RPL8;RPL29;RPL15;RPL38;RPL35;RPS27A;RPL7A;RPL24;RPL11;RPL35A;RPS8;RPL27;RPS7;RPL9;RPL23A;RPS25;RPS6;RPL30;RPS15;RPS12;RPL3;TMA7;RPL18A;RPS9;RPL18;RPL13;RPS24;RPL21;RPL7;RPL5;RPL32;RPS26;RPS16;RPS3A;RPS28;RPS18;RPS11;RPL13A;RPS20;RPL14;RPL22L1;RPL10A;RPL6
prerank,PanglaoDB_Augmented_2021__Neuroblasts,0.6610000185388527,2.006531872937804,0.0,0.04907559337080501,0.06,34/111,11.45%,POU6F2;SPSB4;EPHA7;SEMA5B;PCDH8;EFNA2;CSPG5;ERBB4;SNAP91;EGFR;CAMKV;TSHZ1;EPHA4;ASCL1;CNR1;CCKBR;ADGRL3;RHBDL3;CACNA1B;PPM1E;MPP2;NOL4;SALL3;SLC35F1;CDK5R2;KIF5A;PBX1;ASTN1;FBLL1;UNC5D;CELF3;LRP8;KIF5C;IGDCC3
prerank,MSigDB_Hallmark_2020__Interferon Alpha Response,-0.7780404669545132,-1.992034922805965,0.0,0.0,0.0,33/81,10.61%,IFI44L;GBP2;SAMD9;WARS1;IFI44;IFITM3;IRF1;IL7;BST2;HERC6;PARP14;MX1;EPSTI1;USP18;ISG15;IFIT3;HLA-C;B2M;CMPK2;SAMD9L;IFIT2;DDX60;PSMB9;IFI35;TRIM21;SP110;CASP8;RSAD2;PROCR;HELZ2;STAT2;PSME1;LPAR6
prerank,PanglaoDB_Augmented_2021__Glutaminergic Neurons,0.6714951026070813,1.9852867400117893,0.0,0.049075593370805005,0.09,42/101,23.76%,GABRG1;FUT9;SNAP91;GLS;LSAMP;PSD2;AMER2;ATP2B3;RBFOX1;GRIN1;CACNA1B;NOL4;UNC79;KCTD16;CTNNA2;NRXN1;CACNG3;CAMK2A;PPFIA2;ASTN1;ADGRA1;CELF3;SLITRK1;MEIS2;GRM1;TRPM3;TMEM196;OLFM3;MAGI2;ELAVL3;CA10;CSRNP3;KCNC2;OPCML;GRIA2;UNC13A;CLVS2;SLC6A1;NTRK3;GRIN2B;GRM5;CNTN2
prerank,GO_Biological_Process_2021__translation (GO:0006412),-0.7370137968016636,-1.956481336533417,0.0,0.0,0.0,79/191,15.51%,RPL19;RPS13;RPL12;RPL23;RPS14;WARS1;RPS21;RPS23;RPL41;RPS4X;RPS27;RPL27A;RPL10;RPL39;RPLP1;RPL34;RPL8;RPL29;RPL15;RPL38;RPL35;RPS27A;RPL7A;RPL24;RPL11;RPL35A;RPS8;RPL27;RPS7;RPL9;RPL23A;RPS25;RPLP2;RPS6;RPL30;RPS15;RPS12;RPL3;TMA7;RPL18A;GARS1;EEF1B2;RPS9;RPL18;RPL13;RPS24;RPL21;RPL7;RPL5;RPL32;RPS26;RPS16;RPS3A;RPS28;MRPL51;TRMT112;RPS18;RPS11;RPL13A;RPS20;RPL14;RPL22L1;RPL10A;RPL6;NARS1;RPL26L1;ZC3H15;MRPL27;DRG1;RPS19;RPL36;RPL31;MRPS33;MRPL36;RPS2;GTPBP2;RPL37A;RPL4;MRPL34
prerank,PanglaoDB_Augmented_2021__Radial Glia Cells,0.6342378446502189,1.9520621727342133,0.0,0.04089632780900417,0.1,55/109,24.22%,MAPK10;PCDH19;SEMA5B;ANK2;PDZRN3;SNAP91;ADGRB3;ADGRL3;OLIG2;PCDH17;CACNA2D1;MEGF10;SLC35F1;NTRK2;NPAS3;LRRC4C;PPFIA2;CDH4;ASTN1;SHC3;GLI3;GUCY1A2;ADGRA1;RUNX1T1;GPM6B;SLIT2;ZNF423;RGS7BP;MAPK4;LY6H;ASXL3;PTPRZ1;PURG;TMEM178A;CSRNP3;PLPPR4;LRCH2;OPCML;LRP4;FAM13C;NOVA1;BRINP1;FAT3;TCEAL7;GRIA2;MARK1;ARNT2;CLVS2;SLC6A1;NLGN1;CNTFR;CNTN2;TMEM47;FAIM2;FBXL7
prerank,GO_Biological_Process_2021__peptide biosynthetic process (GO:0043043),-0.7599702496428296,-1.9407080717440306,0.0,0.0,0.0,56/142,8.74%,RPL19;RPS13;RPL12;RPL23;RPS14;WARS1;RPS21;RPS23;RPL41;RPS4X;RPS27;RPL27A;RPL10;RPL39;RPLP1;RPL34;RPL8;RPL29;RPL15;RPL38;RPL35;RPS27A;RPL7A;RPL24;RPL11;RPL35A;RPS8;RPL27;RPS7;RPL9;RPL23A;RPS25;RPLP2;RPS6;RPL30;RPS15;RPS12;RPL3;RPL18A;RPS9;RPL18;RPL13;RPS24;RPL21;RPL7;RPL5;RPL32;PCSK1;RPS26;RPS16;RPS3A;RPS28;MRPL51;RPS18;RPS11;RPL13A
prerank,PanglaoDB_Augmented_2021__Motor Neurons,0.6765198681640125,1.9254834256107245,0.0,0.06870583071912702,0.19,16/61,9.77%,SPSB4;MEX3A;TENM3;EFNA2;CSPG5;MEIS3;MPP2;PCGF2;CDK5R2;ZIC2;LYPD6;MID1;CSNK1E;RBFOX2;HSPA12A;CBARP
prerank,GO_Biological_Process_2021__sphingolipid biosynthetic process (GO:0030148),0.6910885655874892,1.9225639577388616,0.0,0.057254858932605845,0.19,18/65,12.01%,VAPB;CERS3;SGMS1;ST6GALNAC5;ELOVL7;VAPA;HACD2;ACER3;PLPP1;ELOVL6;SPNS2;B4GALT6;LARGE1;PRKD1;PPM1L;PLPP3;PLPP2;ELOVL5
prerank,GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process (GO:0000956),-0.7250291228964978,-1.9093317964300067,0.0,0.0,0.0,55/161,8.74%,RPL19;RPS13;RPL12;RPL23;RPS14;RPS21;RPS23;RPL41;RPS4X;RPS27;RPL27A;RPL10;RPL39;RPLP1;RPL34;PATL2;RPL8;RPL29;RPL15;RPL38;RPL35;RPS27A;RPL7A;RPL24;RPL11;RPL35A;RPS8;RPL27;RPS7;RPL9;RPL23A;RPS25;RPLP2;RPS6;RPL30;RPS15;RPS12;RPL3;RPL18A;RPS9;RPL18;RPL13;RPS24;RPL21;RPL7;RPL5;RPL32;RPS26;RPS16;RPS3A;RPS28;RPS18;HELZ2;RPS11;RPL13A
prerank,MSigDB_Hallmark_2020__Interferon Gamma Response,-0.6917076783550575,-1.8943908732798973,0.0,0.0006193022846103084,0.01,54/147,14.85%,IFI44L;IFIT1;WARS1;IFI44;IFITM3;SELP;IRF1;IL7;BST2;HLA-B;HLA-A;HERC6;PARP14;MX1;EPSTI1;STAT1;USP18;ISG15;P2RY14;IFIT3;B2M;CMPK2;SAMD9L;GPR18;IFIT2;C1R;DDX60;PSMB9;IFI35;TRIM21;PNP;SP110;CASP8;RSAD2;RNF213;HELZ2;VAMP5;CIITA;TNFAIP2;STAT2;VAMP8;MT2A;PSME1;APOL6;EIF2AK2;OAS3;LY6E;IL15RA;BPGM;PSMA3;RIPK2;CCL2;C1S;BTG1
prerank,PanglaoDB_Augmented_2021__Parathyroid Chief Cells,0.6439542713887279,1.873584491796954,0.0,0.07945572260035096,0.24,15/70,10.04%,STARD13;SOWAHA;ABCC8;ANK2;NPNT;PDZRN3;SPRED2;CYS1;NOL4;PCGF2;CDK5R2;CEP170B;NTRK2;GLIS3;FOXP4
prerank,GO_Biological_Process_2021__cellular macromolecule biosynthetic process (GO:0034645),-0.6768614669591434,-1.8698698999823316,0.0,0.0011260041538369242,0.02,86/271,15.51%,PIF1;RPL19;RPS13;RPL12;RPL23;RPS14;WARS1;RPS21;RPS23;RPL41;RPS4X;RPS27;RPL27A;RPL10;RPL39;RPLP1;RPL34;GCNT1;RPL8;RPL29;RPL15;RPL38;RPL35;RPS27A;RPL7A;RPL24;RPL11;RPL35A;RPS8;RPL27;RPS7;RPL9;RPL23A;RPS25;RPLP2;RPS6;RPL30;RPS15;RPS12;RPL3;RPA3;RPL18A;EEF1B2;RPS9;RPL18;RPL13;RPS24;RPL21;TYMS;RPL7;RPL5;RPL32;RPS26;RPS16;RPS3A;RPS28;MRPL51;RPS18;RPS11;RPL13A;RPS20;INHA;RPL14;RPL10A;BLM;RPL6;RRAGC;APOE;BRCA1;MRPL27;PTMA;POLR2I;DRG1;POLE3;RPS19;RPL36;RPL31;MRPS33;POLR2L;MRPL36;POLR2J;RPS2;GTPBP2;RPL37A;RPL4;MRPL34
prerank,GO_Biological_Process_2021__type I interferon signaling pathway (GO:0060337),-0.8324082104529814,-1.8648574358869814,0.0,0.0009527727455543206,0.02,15/38,6.21%,GBP2;IFI6;IFIT1;IFITM3;IRF1;BST2;HLA-B;HLA-A;MX1;STAT1;ISG15;IFIT3;HLA-C;IFIT2;IFI35
prerank,GO_Biological_Process_2021__cellular response to type I interferon (GO:0071357),-0.8324082104529814,-1.8648574358869814,0.0,0.0009527727455543206,0.02,15/38,6.21%,GBP2;IFI6;IFIT1;IFITM3;IRF1;BST2;HLA-B;HLA-A;MX1;STAT1;ISG15;IFIT3;HLA-C;IFIT2;IFI35
prerank,GO_Biological_Process_2021__rRNA metabolic process (GO:0016072),-0.72548256945303,-1.8611121054167399,0.0,0.0008847175494432976,0.02,47/149,10.95%,RPL19;RPL12;RPL23;RPS14;RPL41;RPS27;RPL27A;RPL10;RPL39;RPLP1;RPL34;RPL8;RPL29;RPL15;RPL38;RPL35;RPL7A;RPL24;RPL11;RPL35A;RPL27;RPS7;RPL9;RPL23A;RPS25;RPLP2;RPS6;RPL30;RPS15;RPL3;RPL18A;RPS9;RPL18;RPL13;RPS24;RPL21;RPL7;RPL5;EMG1;RPL32;RPS16;RPS28;RPL13A;POP5;RPL14;RPL10A;RPL6
prerank,PanglaoDB_Augmented_2021__Oligodendrocyte Progenitor Cells,0.5831033016722648,1.856961937307327,0.0,0.0940615539607096,0.32,50/118,25.26%,CHRNA4;ETV5;ANK2;CSPG5;SNAP91;ASCL1;ADGRB3;PSD2;ADGRL3;OLIG2;PDGFRA;MEGF10;SLC35F1;LRRC4C;ASTN1;VSTM2B;SHC3;ADGRA1;HAPLN2;CLIP3;MAPK4;LY6H;OLIG1;ELAVL3;CA10;TMEM178A;VCAN;PLPPR4;CTNND2;OPCML;NRXN2;FYN;BRINP1;TCEAL7;GRIA2;ARNT2;CLVS2;SLC6A1;CNTFR;CHST1;CDO1;ATP2B2;TMEM59L;CNP;CNTN2;FAIM2;LHFPL3;CACNG7;PCDH15;SLCO1C1
prerank,PanglaoDB_Augmented_2021__Kidney Progenitor Cells,0.6131383192023597,1.8527110865368348,0.0,0.08906311389516465,0.34,33/88,18.90%,MEX3A;ADAMTS3;TENM3;MPDZ;SALL1;MEIS3;CDH2;SOX9;CACNA2D1;PCGF2;LYPD6;MID1;RBFOX2;HSPA12A;GLI3;DZIP1;ZFHX4;GPR161;SLIT2;GLRB;NCKAP1;ENAH;ADGRL2;PTPRG;IGDCC4;YAP1;DDAH1;SMO;BCAR1;LIFR;LRCH2;CHST3;LRP4
prerank,GO_Biological_Process_2021__protein phosphorylation (GO:0006468),0.5167513174245777,1.8510429737391367,0.0,0.08342850873036851,0.36,142/408,22.18%,PDK4;CDKL1;MAPK10;CDK18;MAP3K11;PRKX;BMP2;ERBB4;CSF1R;EGFR;RPS6KA4;CAMKV;PASK;STK32C;EPHA4;PRKACB;FLT1;STK38L;CDKL5;CILK1;PDGFRA;MAP4K5;GRK3;DAPK2;RPS6KB2;CSNK1G3;SMAD2;CDK8;RPS6KA3;PRKG1;TNIK;AKT1;NTRK2;PRKAR1B;CSNK2A1;COPS2;TEC;CAMK2B;SMAD7;UHMK1;DYRK1A;CDK12;TTBK2;ABL2;CSNK1E;PKDCC;CAMK2A;NLK;BMPR1B;MAP3K7;RPS6KB1;RPS6KA2;EIF2AK4;MORC3;CCNA2;LMTK3;PIK3R4;PRKCE;BRAF;MAP3K20;NEK4;MAST2;PRKD1;MAP3K5;MAP4K2;PAK3;MAP4K4;CAMK2D;SMG1;SIK2;INCENP;TGFBR2;PTK2;SIK3;OXSR1;GRK4;PPP4R1;ACVR1;CDK19;MAPKAPK2;SGK3;MERTK;HIPK2;ABI1;TGFBR1;PRKAB1;FER;MAPKAPK5;ACVR2A;CDC42BPA;MAP4K3;BMPR1A;MAPK1;MAP3K10;DYRK2;TAOK2;TP53RK;GSK3B;CDK13;ROCK2;LATS1;PDK2;VRK3;MAPK8;PPP3CB;STK11;MAST4;AKT2;TRIB2;EEF2K;MAML1;PRKG2;CSK;SBK1;MAP3K1;CSNK2A2;WNK3;CDK14;SRPK2;TBCK;PAK4;CAB39;WNK1;FYN;YWHAZ;CDK5R1;MAPK9;ROCK1;PLK1;FAM20B;CDK9;AKT3;MARK1;PRKCB;AURKA;PNCK;PRKCA;MAPK6;CTBP1;STK4;CAMK4;ABI2
prerank,GO_Biological_Process_2021__central nervous system development (GO:0007417),0.5293519564957093,1.8376942326010057,0.0,0.0996383259346647,0.41,55/211,16.66%,POU6F2;EPHA7;CHST8;IL1RAPL2;LIG4;SOX4;SOX8;MEIS3;KLHL17;NR4A2;SMG9;CDH2;ZIC5;ADGRL3;SOX9;PSPN;NFIB;MYRF;GRIN1;RPS6KA3;CHD7;PCDH18;RAB18;PBX1;ZIC2;HAPLN1;ADAM23;MBP;SOX6;PKD2;NPAS2;PRKN;UGP2;PBX2;PBX3;POMK;NF1;MEIS2;TGFBR2;HAPLN2;ZBTB16;RAB3GAP1;NIPBL;NCKAP1;SCYL2;PDGFC;PTPRZ1;ADGRL2;SYNJ1;PTPN11;SMO;CNTN4;CA10;TBC1D23;VCAN
prerank,GO_Biological_Process_2021__regulation of cilium assembly (GO:1902017),0.6364355105168522,1.8179185387072132,0.0,0.11587292879217848,0.46,17/56,16.58%,CDKL1;TBC1D1;USP6NL;TBC1D5;CDKL5;EVI5L;ARHGAP35;TESK1;KCTD17;CEP97;TBC1D24;TBC1D22B;ODAD3;TAPT1;YAP1;TBC1D10A;CEP120
prerank,GO_Biological_Process_2021__insulin receptor signaling pathway (GO:0008286),0.6493466239424418,1.8124493398401413,0.041666666666666664,0.11828476350911976,0.48,21/60,18.14%,PDK4;ATP6V0D2;FOXO1;AP3S1;ATP6V1A;RHOQ;AKT1;PIK3CA;PIK3R1;IRS1;ATP6V1C1;SOS1;FER;ATP6V1B2;GAB1;GSK3B;PDK2;PHIP;AKT2;BCAR1;IDE
prerank,GO_Biological_Process_2021__visual system development (GO:0150063),0.7201897736328613,1.8121582490424593,0.0,0.1121727848475543,0.48,13/28,14.82%,MEIS3;SMG9;RAB18;PBX1;FREM2;ATF6;BMPR1B;PBX2;PBX3;MEIS2;HIPK2;ZDHHC16;SH3PXD2B
prerank,PanglaoDB_Augmented_2021__Epiblast Cells,0.6156752241259514,1.8039658267804022,0.0,0.11778142408993202,0.52,11/59,5.95%,SPSB4;PLEKHG4B;EPHA7;MEX3A;SEMA5B;CAMKV;CCKBR;CXCL12;CACNA1B;SALL3;PHC1
prerank,GO_Biological_Process_2021__transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),0.5383219179082758,1.7967743531163671,0.0,0.12575620801268783,0.55,85/309,15.85%,VEGFD;PDK4;EPHA7;EPHA6;ATP6V0D2;NCK2;CASS4;EFNA5;HNRNPH1;EFNA2;FOXO1;AP3S1;ERBB4;CSF1R;EPHA2;EGFR;EPHA4;AP2B1;SORT1;GIT1;FLT1;ATP6V1A;SPRED2;ANKS1B;FLRT2;RHOQ;PDGFRA;FGF17;GRIN1;NCSTN;CBL;MUC20;AKT1;NTRK2;EFNB1;EPHA5;RAPGEF2;ADRB2;PIK3CA;NRP2;WASL;PIK3R1;PDGFA;IRS1;SPRED1;ROR1;CYFIP2;ATP6V1C1;SHOC2;PLCB1;RBFOX2;MAPK11;SHC3;ITSN1;VEGFC;EFNB2;PTPRJ;MTSS1;PRKD1;PAK3;SOS1;ANKS1A;PTK2;MAPKAPK2;MERTK;NCKAP1;ABI1;PDGFC;FER;SIRT2;NCK1;MAPK1;TIAL1;ATP6V1B2;GAB1;GSK3B;CYFIP1;PTPRG;ROCK2;PTPN11;PDK2;PHIP;ARHGEF7;PXN;NRP1
prerank,GO_Biological_Process_2021__rRNA processing (GO:0006364),-0.696362558981867,-1.794064739888313,0.0,0.014450386640907196,0.23,47/161,10.95%,RPL19;RPL12;RPL23;RPS14;RPL41;RPS27;RPL27A;RPL10;RPL39;RPLP1;RPL34;RPL8;RPL29;RPL15;RPL38;RPL35;RPL7A;RPL24;RPL11;RPL35A;RPL27;RPS7;RPL9;RPL23A;RPS25;RPLP2;RPS6;RPL30;RPS15;RPL3;RPL18A;RPS9;RPL18;RPL13;RPS24;RPL21;RPL7;RPL5;EMG1;RPL32;RPS16;RPS28;RPL13A;POP5;RPL14;RPL10A;RPL6
prerank,GO_Biological_Process_2021__vascular endothelial growth factor receptor signaling pathway (GO:0048010),0.6797082940196015,1.7868061781508102,0.0,0.13279278206217826,0.59,19/52,15.85%,VEGFD;NCK2;FLT1;PIK3CA;NRP2;PIK3R1;CYFIP2;MAPK11;VEGFC;PRKD1;PTK2;MAPKAPK2;NCKAP1;ABI1;NCK1;CYFIP1;ROCK2;PXN;NRP1
prerank,GO_Biological_Process_2021__regulation of axonogenesis (GO:0050770),0.6541667660391454,1.786334075490487,0.0,0.12632421256559068,0.59,20/50,19.22%,TIAM2;PLXNA2;EPHA4;CDH2;KIF13B;ARHGAP35;NTRK2;PLXNA1;ROBO1;LRRC4C;CHODL;PAK3;SLITRK1;SLIT2;GSK3B;RUFY3;PTEN;LRP4;PLXNA4;ARHGDIA
prerank,PanglaoDB_Augmented_2021__Cajal-Retzius Cells,0.5812363544883965,1.784299406071379,0.0,0.12484142173274959,0.61,69/155,22.18%,EPHA7;GNL3L;PCDH19;PCDH8;DNM3;ANK2;CADM2;FUT9;SNAP91;CAMKV;ADGRB3;CNR1;DACH1;ADGRL3;CACNA1B;NOL4;MEGF10;SLC35F1;KIF5A;FAM171B;ZIC2;PPFIA2;TMEM170B;ABCC5;CDH4;ASTN1;ISOC1;CELF3;LINGO2;SLITRK1;KIF5C;GPM6B;KIF1B;OLFM3;MAPK4;NBEA;KCNH7;KCNQ2;CLSTN2;PURG;ELAVL3;LZTFL1;MAPK8;TRIM44;CSRNP3;ADAM12;B3GALT1;NDNF;RALGPS2;CCM2;AATF;TBCK;LRCH2;RAB11FIP2;OPCML;ERC2;NOVA1;BRINP1;FAT3;TCEAL7;NRG1;GRIA2;DPYSL5;ZDBF2;CNTNAP2;CLVS2;NLGN1;HOMER2;ABI2
prerank,GO_Biological_Process_2021__positive regulation of stem cell differentiation (GO:2000738),0.8724622281829097,1.7825542620366654,0.0,0.12023520375847227,0.63,5/10,9.01%,NUDT21;SOX5;SOX9;RBM24;SOX6
prerank,GO_Biological_Process_2021__peptidyl-serine phosphorylation (GO:0018105),0.5895210779155071,1.78056971604326,0.0,0.118404606227974,0.65,61/146,23.09%,PRKX;RPS6KA4;CAMKV;STK32C;STK38L;RPS6KB2;CSNK1G3;RPS6KA3;AKT1;CSNK2A1;UHMK1;DYRK1A;TTBK2;CSNK1E;CAMK2A;NLK;RPS6KB1;RPS6KA2;MORC3;PRKCE;MAST2;PRKD1;CAMK2D;SMG1;TGFBR2;PIKFYVE;MAPKAPK2;SGK3;HIPK2;TGFBR1;MAPKAPK5;MAPK1;MAP3K10;DYRK2;GSK3B;ROCK2;LATS1;VRK3;MAPK8;MAST4;AKT2;SBK1;CSNK2A2;SRPK2;CAB39;WNK1;MAP2K2;CDK5R1;MAPK9;ROCK1;PLK1;AKT3;MARK1;PRKCB;AURKA;PNCK;PRKCA;STK4;CAMK4;MARK3;TAF1
prerank,GO_Biological_Process_2021__peptidyl-tyrosine phosphorylation (GO:0018108),0.6466611760243836,1.7802084733248287,0.0,0.113022578672157,0.65,13/48,13.58%,ERBB4;CSF1R;EGFR;EPHA4;FLT1;PDGFRA;TEC;DYRK1A;ABL2;PKDCC;PTK2;ABI1;FER
prerank,GO_Biological_Process_2021__limb development (GO:0060173),0.7568374343027826,1.775815109356446,0.0,0.11379847738157683,0.66,8/22,10.51%,PCSK5;KAT2B;SALL1;CHD7;BMPR1B;GLI3;KAT2A;MAP3K20
prerank,GO_Biological_Process_2021__positive regulation of neuron differentiation (GO:0045666),0.7121591232048526,1.7726889071787582,0.0,0.11791774518262871,0.67,13/32,19.80%,BRINP3;BMP2;ASCL1;ZEB1;MMD;KCTD11;TCF4;ZC4H2;NBL1;IMPACT;CPNE1;BRINP1;REST
prerank,GO_Biological_Process_2021__retina homeostasis (GO:0001895),-0.8999913346359276,-1.7591143922251316,0.0,0.03135217815839686,0.39,3/17,3.99%,SLC28A2;RPE65;B2M
prerank,GO_Biological_Process_2021__ephrin receptor signaling pathway (GO:0048013),0.6552787403565866,1.7570158718184288,0.0,0.1400290264180303,0.73,20/71,11.91%,EPHA7;EPHA6;NCK2;EFNA5;EFNA2;EPHA2;EPHA4;AP2B1;GIT1;ANKS1B;GRIN1;NCSTN;EFNB1;EPHA5;WASL;ITSN1;EFNB2;PAK3;ANKS1A;PTK2
prerank,PanglaoDB_Augmented_2021__Bergmann Glia,0.5712396964518784,1.7501014878810688,0.0,0.15729356849616988,0.81,52/128,24.00%,MAPK10;GABRG1;CADM2;LSAMP;EGFR;ADGRB3;PSD2;AMER2;ZEB2;RBFOX1;CHL1;CTNNA2;NTRK2;CDH20;SLITRK2;NRXN1;NPAS3;LRRC4C;CAMK2A;PPFIA2;ASTN1;FAM107A;ADGRA1;KCNA2;GDF10;GPM6B;TRPM3;KIF1B;BICD2;RGS7BP;MAGI2;SLC4A4;PTPRZ1;ELAVL3;CA10;RUFY3;ACSBG1;PLPPR4;OPCML;SLC39A12;GRIA2;CLVS2;SLC6A1;NTRK3;RFX4;ATP2B2;GRIN2B;GRM5;CNTN2;TTC21B;P2RY1;FAIM2
prerank,GO_Biological_Process_2021__clathrin-dependent endocytosis (GO:0072583),0.7585327901611983,1.7446336717600222,0.0,0.16419118275911304,0.83,6/26,10.66%,SNAP91;PICALM;AP2B1;ITSN1;PIP5K1C;SGIP1
prerank,GO_Biological_Process_2021__defense response to symbiont (GO:0140546),-0.6926476114903342,-1.7440352726236423,0.0,0.044079750845792534,0.49,21/77,12.56%,IFI44L;IFI6;IFIT1;IFITM3;IRF1;BST2;MX1;STAT1;ISG15;IFIT3;IFIT2;PQBP1;APOBEC3G;NLRP1;RSAD2;STAT2;SKP2;TLR3;EIF2AK2;OAS3;NLRP9
prerank,GO_Biological_Process_2021__ncRNA processing (GO:0034470),-0.6658332410999114,-1.7422969712871166,0.0,0.04369521674750509,0.53,47/188,10.95%,RPL19;RPL12;RPL23;RPS14;RPL41;RPS27;RPL27A;RPL10;RPL39;RPLP1;RPL34;RPL8;RPL29;RPL15;RPL38;RPL35;RPL7A;RPL24;RPL11;RPL35A;RPL27;RPS7;RPL9;RPL23A;RPS25;RPLP2;RPS6;RPL30;RPS15;RPL3;RPL18A;RPS9;RPL18;RPL13;RPS24;RPL21;RPL7;RPL5;EMG1;RPL32;RPS16;RPS28;RPL13A;POP5;RPL14;RPL10A;RPL6
prerank,GO_Biological_Process_2021__positive regulation of phosphatase activity (GO:0010922),0.8543684739101512,1.7420175259477895,0.0,0.1635853112360167,0.84,4/15,4.01%,ITGA1;BMP2;PPP1R15B;PLEK
prerank,GO_Biological_Process_2021__membrane lipid biosynthetic process (GO:0046467),0.6909931008957628,1.7393324522078246,0.0,0.16527757307638932,0.86,15/53,12.01%,VAPB;CERS3;SGMS1;ELOVL7;VAPA;HACD2;ACER3;PLPP1;ELOVL6;SPNS2;PRKD1;PPM1L;PLPP3;PLPP2;ELOVL5
prerank,GO_Biological_Process_2021__calcium ion homeostasis (GO:0055074),0.5967634468519927,1.734623068370364,0.0,0.172855145539391,0.88,17/60,11.69%,VAPB;SLC24A3;ATP13A5;SNCA;ANK2;NPTN;ATP2B3;HTR2C;STIM2;CXCL12;GRIN1;ATP2C1;CALCB;ATP13A4;SLC10A7;TMTC2;STIM1
prerank,GO_Biological_Process_2021__ribosome biogenesis (GO:0042254),-0.6602623458868552,-1.729330497239858,0.0,0.053129617048147504,0.6,57/179,13.83%,RPL19;RPL12;RPL23;RPS14;RPL41;RPS27;RPL27A;RPL10;RPL39;RPLP1;RPL34;RPL8;RPL29;RPL15;RPL38;RPL35;RPL7A;RPL24;RPL11;RPL35A;RPL27;RPS7;RPL9;RPL23A;RPS25;RPLP2;RPS6;RPL30;RPS15;RPL3;RPL18A;RPS9;RPL18;RPL13;RPS24;RPL21;RPL7;RPL5;EMG1;RPL32;RPS16;RPS28;RPL13A;POP5;RPL14;RPL10A;RPL6;RPL26L1;IMP3;RBIS;GTF3A;RPF2;WDR12;RPS19;RPL36;RPL31;EBNA1BP2
prerank,GO_Biological_Process_2021__cellular protein metabolic process (GO:0044267),-0.631591105713555,-1.7291307403763498,0.0,0.05078278733804529,0.61,78/326,11.83%,RPL19;RPS13;RPL12;PRSS23;RPL23;RPS14;WARS1;RPS21;RPS23;CP;RPL41;RPS4X;RPS27;RPL27A;RPL10;USP6;RPL39;RPLP1;RPL34;RPL8;RPL29;RPL15;RPL38;TMEM208;RPL35;RPS27A;RPL7A;RPL24;RPL11;RPL35A;RPS8;RPL27;RPS7;RPL9;RPL23A;RPS25;RPLP2;RPS6;RPL30;RPS15;RPS12;TIMP1;RPL3;RPL18A;GPC3;GGCX;RPS9;RPL18;RPL13;RPS24;RPL21;RPL7;RPL5;RPL32;RPS26;RPS16;RPS3A;CCN1;RPS28;ST3GAL6;MRPL51;SEC11C;IGFBP5;RPS18;PHEX;UBL5;RPS11;RPL13A;RPS20;CTSH;RPL14;RPL10A;CST3;RPL6;F5;SPCS1;APOE;LAMB1
prerank,GO_Biological_Process_2021__peptidyl-serine modification (GO:0018209),0.5498275201713632,1.7274070344712653,0.0,0.18258231512148962,0.9,66/156,25.39%,PRKX;RPS6KA4;CAMKV;STK32C;STK38L;RPS6KB2;CSNK1G3;RPS6KA3;AKT1;CSNK2A1;UHMK1;DYRK1A;TTBK2;CSNK1E;CAMK2A;RPS6KB1;RPS6KA2;MORC3;PRKCE;MAST2;PRKD1;CAMK2D;SMG1;TGFBR2;MAPKAPK2;SGK3;HIPK2;TGFBR1;MAPKAPK5;MAPK1;MAP3K10;DYRK2;GSK3B;ROCK2;LATS1;VRK3;MAPK8;MAST4;AKT2;NDNF;SBK1;CSNK2A2;SRPK2;CAB39;WNK1;CDK5R1;MAPK9;ROCK1;PLK1;AKT3;MARK1;PRKCB;AURKA;PNCK;PRKCA;STK4;GALNT1;CAMK4;MARK3;TAF1;MGAT5B;CSNK1D;GALNT2;GAS6;POGLUT1;TNKS
prerank,GO_Biological_Process_2021__regulation of fatty acid oxidation (GO:0046320),0.8131575595011299,1.7270515464330864,0.03125,0.1773878218715556,0.9,3/16,4.24%,PDK4;PPARGC1A;SOX9
prerank,GO_Biological_Process_2021__phosphorylation (GO:0016310),0.5356177654334204,1.7197588921536877,0.0,0.19035381671100124,0.91,118/337,22.18%,PDK4;DGKB;EPHA7;LIMD1;CDKL1;MAPK10;CDK18;MAP3K11;BMP2;RPS6KA4;PASK;PRKACB;STK38L;CDKL5;CILK1;MAP4K5;GRK3;DAPK2;CDK8;PRKG1;TNIK;AKT1;PRKAR1B;CSNK2A1;COPS2;TEC;PIK3CA;CAMK2B;DYRK1A;CDK12;CSNK1E;CAMK2A;DGKH;NLK;BMPR1B;PANK2;EIF2AK4;MORC3;LMTK3;PIK3R4;PRKCE;BRAF;POMK;MAP3K20;NEK4;MAST2;PRKD1;DGKZ;MAP3K5;MAP4K2;PAK3;MAP4K4;CAMK2D;SIK2;TGFBR2;SIK3;OXSR1;GRK4;PPP4R1;ACVR1;GK;CDK19;MAPKAPK2;SGK3;MERTK;HIPK2;TGFBR1;PRKAB1;FER;ACVR2A;CDC42BPA;MAP4K3;BMPR1A;MAPK1;DGKG;DYRK2;TAOK2;TP53RK;GSK3B;CDK13;ROCK2;LATS1;PDK2;MAPK8;PPP3CB;STK11;TRIB2;MAML1;PRKG2;CSK;MAP3K1;WNK3;CDK14;SRPK2;TBCK;AGK;PAK4;WNK1;FYN;YWHAZ;MAPK9;FGGY;PANK3;ROCK1;PLK1;FAM20B;CDK9;DGKE;AKT3;MARK1;PRKCB;AURKA;PRKCA;MAPK6;CTBP1;GK5;STK4;CAMK4
prerank,PanglaoDB_Augmented_2021__Purkinje Neurons,0.55468598167588,1.719150365455789,0.0,0.18523630831137183,0.91,42/143,15.11%,CHRNA4;SLC24A3;DLGAP1;CACNG2;PCDH8;CADM2;SNAP91;TSHZ1;ADGRB3;PSD2;AMER2;ATP2B3;RBFOX1;GRIN1;CACNA1B;PPM1E;PDE1B;PRKG1;KIF5A;CTNNA2;NRIP3;KCNMA1;NRXN1;PKP4;GNG4;CAMK2A;ASTN1;VSTM2B;MRPS35;HIVEP2;ADGRA1;KCNA2;CELF3;SLITRK1;SLC32A1;TMEM196;OLFM3;LY6H;KCNQ2;SEZ6L;ELAVL3;SLC22A15
prerank,PanglaoDB_Augmented_2021__His Bundle Cells,0.6010091185147401,1.712721190086333,0.0,0.20004146631147182,0.91,38/93,19.04%,RNF150;AMOTL1;TENM3;MPDZ;ANK2;RASSF8;PARVA;FLRT2;CDH11;LIMCH1;CACNA2D1;PCDH18;PDE10A;PPFIBP1;ITSN1;GUCY1A2;DZIP1;RUNX1T1;GPR161;SLIT2;ALDH7A1;NCKAP1;APBB2;ENAH;FARP1;TJP1;BMPR1A;ADGRL2;PTPN14;PYGO1;PTPRG;EML1;FBLN1;ZNF462;LIFR;LRCH2;CHST3;RBMS3
prerank,GO_Biological_Process_2021__leukotriene metabolic process (GO:0006691),0.8395540708278003,1.7113469110312278,0.0,0.1985743916948314,0.94,1/16,0.01%,CPA1
prerank,GO_Biological_Process_2021__folic acid metabolic process (GO:0046655),0.7557084949227275,1.7089909111995134,0.0,0.19939723072282034,0.94,2/17,1.47%,MTHFS;SLC19A1
prerank,PanglaoDB_Augmented_2021__Retinal Progenitor Cells,0.5910539706410793,1.7088057482484225,0.0,0.19414993517748297,0.94,40/95,21.65%,PCDH19;SEMA5B;PCDH8;ANK2;CSPG5;CADM2;SNAP91;CAMKV;ADGRL3;SOX9;RHBDL3;CACNA1B;NOL4;SALL3;MEGF10;SLC35F1;CDK5R2;NR2E1;LRRC4C;ASTN1;UNC5D;CELF3;ZNF423;MAPK4;KCNQ2;PTPRZ1;PURG;ELAVL3;IGDCC4;CSRNP3;PCLO;CTNND2;OPCML;LRP4;ERC2;GRIA2;DPYSL5;NOVA2;UNC13A;CLVS2
prerank,GO_Biological_Process_2021__dendrite morphogenesis (GO:0048813),0.7173704867929689,1.7039610711802238,0.0,0.19965796961113833,0.94,16/34,21.53%,WNT7A;SHANK1;BTBD3;CTNNA2;WASL;PAK3;DVL1;SHANK3;FARP1;TAOK2;TMEM106B;CTNND2;PTEN;LRP4;SDC2;PHACTR1
prerank,GO_Biological_Process_2021__regulation of kinase activity (GO:0043549),0.5625627342954073,1.7037762952054236,0.0,0.19466652037085985,0.94,13/75,8.04%,EPHA7;EPHA6;ERBB4;CSF1R;EPHA2;EGFR;EPHA4;FLT1;PDGFRA;HNRNPU;NTRK2;EPHA5;ROR1
prerank,GO_Biological_Process_2021__purine ribonucleoside bisphosphate metabolic process (GO:0034035),-0.9176467967231412,-1.7011550426033255,0.0,0.08050929699934009,0.81,2/12,1.44%,SULT1C3;SULT1C2
prerank,GO_Biological_Process_2021__histone H3 deacetylation (GO:0070932),0.8030180097156386,1.7001329583239064,0.0,0.201888213379084,0.95,7/14,13.72%,HDAC9;SMARCAD1;HDAC2;ELK4;HDAC4;SIRT1;SIRT2
prerank,GO_Biological_Process_2021__regulation of mRNA processing (GO:0050684),0.6858151750026058,1.6982062787345584,0.030303030303030304,0.20214470602736348,0.95,11/33,20.61%,PAPOLA;IWS1;QKI;SAFB2;SLTM;KHDRBS3;DHX9;JMJD6;SRPK2;KHDRBS2;PTCD2
prerank,PanglaoDB_Augmented_2021__Chromaffin Cells,0.5262370115000521,1.697354160304627,0.0,0.1993458211341227,0.95,50/116,21.65%,MAPK10;CNTN1;SERPINE1;ANK2;SNAP91;LSAMP;ADGRB3;PNMT;PCDH17;RBFOX1;CACNA1B;KCTD16;CACNA2D1;SLC12A2;FAM171B;RAPGEF2;NRXN1;DOC2B;ASTN1;SHC3;ITSN1;GUCY1A2;ADGRA1;UNC5D;CELF3;KIF1B;TMEM196;RGS7BP;MAPK4;ASXL3;CDC42BPA;PSD3;STX1A;CSRNP3;PCLO;NPY;PLPPR4;LIFR;LRCH2;OPCML;LRP4;FAM13C;ERC2;BRINP1;TCEAL7;GRIA2;NOVA2;ARNT2;UNC13A;CLVS2
prerank,PanglaoDB_Augmented_2021__Enteric Neurons,0.5706061283549938,1.6934296499739987,0.0,0.2041098542467572,0.96,45/146,13.78%,TAFA1;MAPK10;TUB;CNTN1;EFNA5;ANK2;CADM2;SNAP91;TAFA5;LSAMP;RGS3;TSHZ1;ADGRB3;PARVA;ATP2B3;NMNAT2;STXBP5;ADGRL3;PCDH17;TOX;RBFOX1;CACNA1B;KCTD16;CACNA2D1;CDK5R2;CYTH3;NTRK2;PIK3CA;NRXN1;ARHGAP26;TTBK2;LRRC4C;PPFIA2;ASTN1;SHC3;GUCY1A2;ADGRA1;CELF3;KIF1B;TMEM196;RGS7BP;OLFM3;MAPK4;LY6H;ASXL3
prerank,GO_Biological_Process_2021__cellular response to insulin stimulus (GO:0032869),0.559828166811182,1.6912705124655782,0.0,0.2057539692435232,0.97,31/107,18.35%,PDK4;ATP6V0D2;LPIN3;TBC1D4;HDAC9;KAT2B;PDE3B;FOXO1;AP3S1;ATP6V1A;RHOQ;DENND4C;RAB31;AKT1;RAB8B;PIK3R1;IRS1;ATP6V1C1;RPS6KB1;SOS1;FER;ATP6V1B2;GAB1;GSK3B;PDK2;PHIP;AKT2;MYO5A;BCAR1;IDE;INSIG2
prerank,PanglaoDB_Augmented_2021__Anterior Pituitary Gland Cells,0.5217724839906929,1.6892762596255406,0.0,0.20519287952865572,0.97,52/110,21.65%,RNF150;MAPK10;RCN3;PDZRN4;CADM2;PDZRN3;SNAP91;LSAMP;RAB27A;ADGRB3;RBFOX1;PDGFRA;CDH11;KCTD16;CACNA2D1;PRKG1;PCDH18;FRZB;NRXN1;ASTN1;CPEB4;UNC5D;CELF3;SGIP1;RUNX1T1;PAK3;ZNF423;TRPM3;SGCD;TMEM196;MEST;OLFM3;MAGI2;ASXL3;GMPPA;CNTN4;CSRNP3;HEPH;NDNF;PLPPR4;LRCH2;OPCML;INTS6L;FGF14;FAM13C;NOVA1;TCEAL7;FMN2;GRIA2;COL11A1;CLVS2;GNB3
prerank,GO_Biological_Process_2021__membrane depolarization during cardiac muscle cell action potential (GO:0086012),0.8180315369103099,1.6891964674749613,0.0,0.20082707358123753,0.97,4/14,6.66%,CACNA1G;ANK2;CACNA2D1;TRPM4
prerank,GO_Biological_Process_2021__embryonic limb morphogenesis (GO:0030326),0.7197590150818697,1.6856737717158112,0.0,0.20857127182592128,0.98,7/26,12.75%,WNT7A;SALL1;HDAC2;GLI3;MAP3K20;MBNL1;NIPBL
prerank,GO_Biological_Process_2021__adherens junction organization (GO:0034332),0.6356690883154814,1.6844840566382893,0.0,0.20798703857150694,0.98,25/43,23.95%,CADM2;CDH2;CDH11;NECTIN3;CDH20;SMAD7;CDH4;CADM1;PIP5K1C;CDH9;AFDN;TJP1;CDH13;CSK;ZNF703;CDH18;CDH6;CDH10;DCHS1;NECTIN2;CDH8;NECTIN1;CDH19;CTNNB1;TBCD
prerank,GO_Biological_Process_2021__response to fatty acid (GO:0070542),0.8589682538707368,1.6813465386599364,0.0,0.21266090460682172,0.98,6/12,7.80%,PDK4;PID1;FOXO1;SOX9;FOXO3;IRS1
prerank,PanglaoDB_Augmented_2021__Purkinje Fiber Cells,0.5571964622422368,1.6810844150660167,0.0,0.20849108294786442,0.98,43/96,22.18%,SEMA5B;CNTN1;ANK2;SNAP91;LSAMP;ADGRB3;ADGRL3;PCDH17;RBFOX1;CACNA1B;SLC35F1;CTNNA2;NRXN1;ASTN1;CPT1C;GUCY1A2;UNC5D;RGMA;RUNX1T1;PAK3;GPM6B;ZNF423;TRPM3;MAPK4;MAGI2;ASXL3;KCNQ2;PURG;ELAVL3;CSRNP3;LRCH2;OPCML;NOVA1;BRINP1;FAT3;TCEAL7;FMN2;GRIA2;NOVA2;UNC13A;CLVS2;NTRK3;ABI2
prerank,GO_Biological_Process_2021__interferon-gamma-mediated signaling pathway (GO:0060333),-0.7412635609030918,-1.6777949154726872,0.0,0.12611246522973552,0.96,13/43,9.72%,GBP2;GBP1;TRIM22;IRF1;HLA-B;HLA-A;STAT1;HLA-C;B2M;IFNGR2;TRIM21;CIITA;MT2A
prerank,GO_Biological_Process_2021__sulfate transport (GO:0008272),0.8145913523274707,1.6774504521340579,0.0,0.21675053738772213,0.98,1/12,0.26%,SLC26A7
prerank,GO_Biological_Process_2021__defense response to Gram-positive bacterium (GO:0050830),-0.8210340958279214,-1.6768405157001163,0.0,0.12224488574481739,0.96,6/25,5.79%,GBP2;GBP7;RPL39;HLA-A;STAB2;IL12A
prerank,PanglaoDB_Augmented_2021__Mast Cells,0.508369419386604,1.6749652466232496,0.0,0.21667337450506363,0.98,25/164,8.04%,CPA1;PDK4;POSTN;PID1;DCN;STARD13;TIAM2;MITF;DNM3;PCDH7;ABCA1;ESYT3;LSAMP;PLEK;ACER3;CXCL12;RBFOX1;PDGFRA;PDE1C;GPM6A;LTC4S;LRRC66;RAPGEF2;SPRED1;ROR1
prerank,GO_Biological_Process_2021__sensory organ development (GO:0007423),0.698403558879236,1.6728410989895244,0.02857142857142857,0.21781081255314072,0.99,15/35,14.82%,MEIS3;SMG9;ASCL1;CHD7;RAB18;PBX1;FREM2;ATF6;BMPR1B;PBX2;PBX3;MEIS2;HIPK2;ZDHHC16;SH3PXD2B
prerank,GO_Biological_Process_2021__stress-activated MAPK cascade (GO:0051403),0.59977974009908,1.6719560959392237,0.0,0.2165274665087639,0.99,24/58,15.86%,MAPK10;MAP3K11;BTRC;ARHGEF6;IRAK2;TAB3;MAP2K4;NFKB1;TNFRSF19;UBE2N;MAP3K7;MAPK11;TAB1;MAP3K20;MAP3K5;MAP4K2;CRKL;GPS1;MAP4K3;MAPK1;MAP3K10;TAOK2;CUL1;MAPK8
prerank,GO_Biological_Process_2021__tight junction assembly (GO:0120192),0.6287140947107105,1.669807803086858,0.0,0.21762688726934362,0.99,8/31,15.65%,CLDN12;PARD3;MARVELD3;STRN;AFDN;OCLN;DLG1;PARD6G
prerank,GO_Biological_Process_2021__chordate embryonic development (GO:0043009),0.6494683392697471,1.6693872378425203,0.0,0.21438285525141132,0.99,11/38,13.12%,LIG4;PCSK5;SOX8;BMP2;CHD7;ZNF568;PKD2;FUT8;MBNL1;DVL1;TGFBR1
prerank,GO_Biological_Process_2021__glutamate metabolic process (GO:0006536),0.7598751936907088,1.6691376355719318,0.0,0.21068659912638704,0.99,3/16,3.18%,PRODH;MTHFS;GLS
prerank,GO_Biological_Process_2021__defense response to virus (GO:0051607),-0.672453670429773,-1.667103203539152,0.0,0.13676258785144307,0.97,21/84,12.56%,IFI44L;IFI6;IFIT1;IFITM3;IRF1;BST2;MX1;STAT1;ISG15;IFIT3;IFIT2;PQBP1;APOBEC3G;NLRP1;RSAD2;STAT2;SKP2;TLR3;EIF2AK2;OAS3;NLRP9
prerank,GO_Biological_Process_2021__peptidyl-threonine phosphorylation (GO:0018107),0.6114182233239741,1.6657347148676875,0.0,0.2168198531975679,1.0,30/53,26.28%,AKT1;CSNK2A1;DYRK1A;CAMK2A;NLK;PRKD1;CAMK2D;TGFBR2;OXSR1;ACVR1;HIPK2;TGFBR1;CDC42BPA;MAPK1;MAP3K10;DYRK2;GSK3B;ROCK2;MAPK8;SBK1;CSNK2A2;WNK3;WNK1;CDK5R1;ROCK1;PRKCA;TAF1;TNKS;DYRK3;MARK2
prerank,GO_Biological_Process_2021__histone deacetylation (GO:0016575),0.6347025365485889,1.6655863200697696,0.0,0.2134788311630018,1.0,10/41,15.70%,HDAC9;RCOR1;SMARCAD1;HDAC2;ELK4;TBL1XR1;HDAC4;SIRT1;SIRT2;MIER3
prerank,GO_Biological_Process_2021__neuron migration (GO:0001764),0.6138645013691805,1.6647886851250682,0.03571428571428571,0.21078369611722808,1.0,17/48,18.03%,LRP12;NR4A2;ASTN2;CDKL5;ADGRL3;GPM6A;SH3RF1;NTRK2;RAPGEF2;ASTN1;AUTS2;DNAAF4;KIAA0319;USP9X;NRP1;NDNF;PEX13
prerank,PanglaoDB_Augmented_2021__Serotonergic Neurons,-0.7416757431813158,-1.6643846612195559,0.0,0.1369896653558002,0.97,11/31,12.26%,SLC28A2;SLC3A1;ADH4;SLC18A2;VIL1;ALDOB;FMO5;ADH6;ABCC6;ACSM3;GLOD5
prerank,GO_Biological_Process_2021__embryonic digit morphogenesis (GO:0042733),0.825332106930087,1.6628877561585471,0.0,0.21213321005444746,1.0,5/12,10.51%,WNT7A;SALL1;HDAC2;GLI3;MAP3K20
prerank,GO_Biological_Process_2021__regulation of microtubule cytoskeleton organization (GO:0070507),0.6387895593892675,1.6614102624096139,0.0,0.21343988227937416,1.0,16/32,26.28%,EFNA5;FAM107A;BICD2;MAPRE1;CLASP1;GSK3B;SKA2;CDK2AP2;ROCK1;TRIM36;PRKAA1;GAS2L1;TAOK1;CLASP2;CYLD;MARK2
prerank,GO_Biological_Process_2021__ribosomal large subunit biogenesis (GO:0042273),-0.7136814529177451,-1.66114682908122,0.0,0.13981940041009655,0.98,25/49,20.40%,RPL10;RPL7A;RPL24;RPL11;RPL35A;RPL23A;MRPL20;RPL3;RPL7;RPL5;RPL14;RPL10A;RPL6;RPL26L1;GTF3A;RPF2;WDR12;EBNA1BP2;NIP7;RPLP0;LAS1L;SNU13;NOP16;RRP15;NPM1
prerank,GO_Biological_Process_2021__defense response to protozoan (GO:0042832),-0.9393855193963974,-1.6564531246369216,0.01639344262295082,0.14381575275950495,0.98,2/7,0.41%,GBP2;GBP7
prerank,GO_Biological_Process_2021__regulation of cellular metabolic process (GO:0031323),0.6220382152320357,1.6559894815753886,0.03333333333333333,0.2279970275351983,1.0,11/41,16.82%,PDK4;PID1;ACACB;BCO2;PANK2;MKLN1;PRKN;SSH1;ABCA2;PDK2;RNF41
prerank,GO_Biological_Process_2021__regulation of presynapse organization (GO:0099174),0.8231711218338713,1.6548902265933265,0.0,0.22307087895820457,1.0,6/16,11.25%,IL1RAPL2;WNT7A;SNCA;SLITRK2;LRFN5;SLITRK1
prerank,GO_Biological_Process_2021__regulation of presynapse assembly (GO:1905606),0.8231711218338713,1.6548902265933265,0.0,0.22307087895820457,1.0,6/16,11.25%,IL1RAPL2;WNT7A;SNCA;SLITRK2;LRFN5;SLITRK1
prerank,GO_Biological_Process_2021__gene expression (GO:0010467),-0.5939130265587453,-1.6547395258688955,0.0,0.14354542239717505,0.98,83/320,15.51%,RPL19;RPS13;RPL12;RPL23;RPS14;WARS1;RPS21;RPS23;RPL41;RPS4X;RPS27;RPL27A;RPL10;RPL39;RPLP1;RPL34;RPL8;RPL29;RPL15;RPL38;RPL35;RPS27A;FIP1L1;RPL7A;RPL24;RPL11;RPL35A;RPS8;RPL27;RPS7;RPL9;RPL23A;RPS25;RPLP2;RPS6;RPL30;RPS15;RPS12;RPL3;RPL18A;RPS9;RPL18;RPL13;RPS24;RPL21;RPL7;RPL5;RPL32;RPS26;RPS16;RPS3A;RPS28;MRPL51;TSPAN32;RPS18;RPS11;RPL13A;RPS20;RPL14;RPL10A;CPSF3;RPL6;RRAGC;SLU7;MCM3AP;MRPL27;PTMA;POLR2I;DRG1;RPS19;RPL36;RPL31;MRPS33;PRPF4;NXF5;RBM8A;POLR2L;MRPL36;POLR2J;RPS2;RPL37A;RPL4;MRPL34
prerank,GO_Biological_Process_2021__peptidyl-tyrosine modification (GO:0018212),0.6506694737032462,1.6522000461073496,0.0,0.2273103354637784,1.0,13/41,13.58%,ERBB4;CSF1R;EGFR;EPHA4;FLT1;PDGFRA;TEC;DYRK1A;ABL2;PKDCC;PTK2;ABI1;FER
prerank,PanglaoDB_Augmented_2021__Gamma (PP) Cells,0.5737143479445049,1.6489389801537515,0.0,0.2333496351454944,1.0,43/105,19.56%,PPARGC1A;MAPK10;PCDH19;PDZRN4;SOWAHA;ABCC8;CNTN1;ANK2;ERBB4;SNAP91;ETV1;ESRRG;PLEKHA6;PCDH17;NFIB;LONRF2;CADPS2;NOL4;LIMCH1;THSD7A;NTRK2;FRZB;PBX1;NRXN1;LMO3;PPFIA2;ATP9A;GUCY1A2;ADGRA1;TMEM196;RGS7BP;MAPK4;ASXL3;ADGRL2;CNTN4;CSRNP3;PCLO;PLPPR4;LIFR;CXXC4;FGF14;FAM13C;NOVA1
prerank,GO_Biological_Process_2021__membrane depolarization (GO:0051899),0.679942695462688,1.6463505950726598,0.03225806451612903,0.2396880429849462,1.0,7/26,6.86%,CHRNA4;CACNA1G;CACNG2;CACNB4;CACNA1I;CACNA1B;KCNH2
prerank,GO_Biological_Process_2021__regulation of lipid storage (GO:0010883),0.7681007309645006,1.6430123837326347,0.022222222222222223,0.2458453534575565,1.0,6/14,13.01%,FTO;NFKB1;PLIN5;FBXW7;MEST;SIRT1
prerank,GO_Biological_Process_2021__kidney development (GO:0001822),0.6301243208643943,1.6415138990155242,0.0,0.24814278901576056,1.0,14/38,16.20%,PCSK5;SOX4;PRKX;SALL1;MME;PYGO2;CEP290;C1GALT1;NF1;ZBTB16;NIPBL;TGFBR1;PYGO1;BMP7
prerank,PanglaoDB_Augmented_2021__Ciliated Cells,-0.6745789915207151,-1.6414349369593437,0.013513513513513514,0.17255042964314798,0.99,26/57,17.46%,RSPH4A;CCDC39;DCDC2B;CCDC181;CFAP52;TEKT1;DNAAF1;ECT2L;CFAP73;ANKUB1;CFAP77;VWA3A;CXCL17;CFAP126;APOBEC4;FAM161A;EFHB;CFAP100;C1ORF87;DRC1;TEKT2;ATP5MK;TMEM212;RSPH10B;ARMC3;CFAP70
prerank,GO_Biological_Process_2021__positive regulation of excitatory postsynaptic potential (GO:2000463),0.7268665881358286,1.6414293539413165,0.023809523809523808,0.2449235632117028,1.0,6/18,11.56%,WNT7A;SHANK1;GRIN1;NRXN1;NLGN3;SHANK3
prerank,GO_Biological_Process_2021__regulation of cartilage development (GO:0061035),0.8278555095224552,1.6403932320038914,0.0,0.2440334300493455,1.0,9/14,12.81%,TRPS1;SOX5;BMP2;SOX9;BMPR1B;SOX6;KAT2A;ZBTB16;TAPT1
prerank,GO_Biological_Process_2021__positive regulation of mRNA metabolic process (GO:1903313),0.8319225600993391,1.6388829849819873,0.0,0.244935844391225,1.0,1/12,0.60%,NUDT21
prerank,GO_Biological_Process_2021__positive regulation of cartilage development (GO:0061036),0.8237910963880632,1.6386625334781588,0.023809523809523808,0.24254248812593407,1.0,9/13,12.81%,SOX5;BMP2;LOXL2;SOX9;PKDCC;BMPR1B;SOX6;ZBTB16;TAPT1
prerank,PanglaoDB_Augmented_2021__Ependymal Cells,-0.6376734331756706,-1.6370127148372327,0.0,0.17897836025237912,0.99,28/90,17.46%,SPAG17;RSPH4A;USP18;CFAP52;TEKT1;AQP1;ANGPTL2;DNAAF1;ENKUR;ZBBX;CFAP77;VWA3A;DYNLRB2;RGS22;CXCL17;CFAP126;APOBEC4;LRRIQ1;CFAP99;AK7;CFAP100;C1ORF87;DRC1;S100B;TEKT2;TMEM212;ARMC3;CFAP70
prerank,GO_Biological_Process_2021__positive regulation of neurogenesis (GO:0050769),0.5753386409618291,1.6349372168526357,0.0,0.2511895502795151,1.0,24/64,19.41%,LIG4;TIAM2;SOX8;NPTN;PLXNA2;CDKL5;MME;NTRK2;PLXNA1;SPEN;ROBO1;CAPRIN2;CHODL;NAP1L1;SLITRK1;SHANK3;SLIT2;CAPRIN1;FZD3;KDM1A;PLXNA4;ARHGDIA;DRD2;SS18L1
prerank,PanglaoDB_Augmented_2021__GABAergic Neurons,0.5672837505939284,1.6347917841348094,0.0,0.24835224524013444,1.0,44/105,24.00%,ABCC8;ANK2;CADM2;SNAP91;ADGRB3;PSD2;ATP2B3;RBFOX1;KCTD16;CDK5R2;NTRK2;MYBPC1;CAMK2B;CAMK2A;PPFIA2;ASTN1;VSTM2B;ADGRA1;LRFN5;CELF3;SEMA3C;SLITRK1;NKAIN2;SLC32A1;TMEM196;RGS7BP;OLFM3;MAPK4;LY6H;ELAVL3;CA10;KCNC2;PLPPR4;CTNND2;OPCML;BRINP1;GRIA2;CLVS2;SLC6A1;CHST1;TMEM59L;GRM5;CNTN2;FAIM2
prerank,GO_Biological_Process_2021__negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),0.7781940595244228,1.6340028804239985,0.0,0.24768493919196885,1.0,5/18,11.84%,SNCA;PLEK;GRK3;MRAP;ADA
prerank,GO_Biological_Process_2021__diacylglycerol metabolic process (GO:0046339),0.7400750313936593,1.633006383907271,0.021739130434782608,0.24827694705314432,1.0,5/18,14.38%,DGKB;DGKH;GPAM;DGKZ;DGKG
prerank,PanglaoDB_Augmented_2021__Glycinergic Neurons,0.5609906930501404,1.6319360716660891,0.0,0.24885415471779038,1.0,38/94,24.75%,SHISA7;PCDH8;CSPG5;SNAP91;CAMKV;PSD2;GRIN1;MPP2;CDK5R2;KIF5A;ASTN1;VSTM2B;FBLL1;ADGRA1;CELF3;SLITRK1;CLIP3;SLC32A1;LY6H;KCNQ2;ELAVL3;NCDN;ADGRB2;NGB;OPCML;BRINP1;PIANP;GRIA2;SLC6A9;PNCK;CLVS2;TMEM198;TMEM59L;GRM5;CNTN2;FAIM2;CACNG7;B4GALNT4
prerank,GO_Biological_Process_2021__brain development (GO:0007420),0.540321648854235,1.6300990124608659,0.0,0.25002298186443045,1.0,41/118,21.51%,EPHA7;MEIS3;KLHL17;SMG9;CDH2;ADGRL3;NFIB;GRIN1;PCDH18;CTNNA2;RAB18;PBX1;ZIC2;RAPGEF2;SOX6;UGP2;PBX2;PBX3;POMK;NF1;MEIS2;SHANK3;TGFBR2;RAB3GAP1;NIPBL;SCYL2;ADGRL2;SYNJ1;PTPN11;MKKS;CNTN4;CA10;TBC1D23;EML1;BBS2;PTEN;FBXW11;CDK5R1;PITPNM1;CNTNAP2;ARNT2
prerank,GO_Biological_Process_2021__cellular response to interferon-gamma (GO:0071346),-0.6922500014865942,-1.6264300904500693,0.0,0.2073663778791936,0.99,16/62,9.72%,GBP2;GBP7;GBP1;GBP3;TRIM22;IRF1;HLA-B;HLA-A;STAT1;HLA-C;B2M;IFNGR2;TRIM21;RPL13A;CIITA;MT2A
prerank,GO_Biological_Process_2021__positive regulation of glucose import (GO:0046326),0.7687498755184766,1.625837885208352,0.0,0.25774661233772383,1.0,10/18,17.75%,RHOQ;AKT1;PIK3R1;IRS1;OCLN;OSBPL8;PTPN11;ARPP19;AKT2;IGF1
prerank,GO_Biological_Process_2021__peptidyl-threonine modification (GO:0018210),0.5704798367776491,1.6253022466941884,0.03571428571428571,0.2564150480940454,1.0,31/59,26.28%,AKT1;CSNK2A1;DYRK1A;NLK;PRKD1;CAMK2D;TGFBR2;OXSR1;ACVR1;HIPK2;TGFBR1;CDC42BPA;MAPK1;MAP3K10;DYRK2;GSK3B;ROCK2;MAPK8;SBK1;CSNK2A2;WNK3;WNK1;CDK5R1;ROCK1;PRKCA;GALNT1;TAF1;GALNT2;TNKS;DYRK3;MARK2
prerank,GO_Biological_Process_2021__positive regulation of metabolic process (GO:0009893),0.56154390913786,1.624674636880777,0.0,0.2547256989246546,1.0,16/78,14.49%,PPARGC1A;LEPR;ACACB;PLAC8;HADH;ESRRG;ADIPOR2;ELOVL6;ADRB2;ZNF516;ADRB1;PRKAB1;PDGFC;OGT;ALMS1;ADIPOR1
prerank,GO_Biological_Process_2021__positive regulation of glucose transmembrane transport (GO:0010828),0.716503406134695,1.6226331325251224,0.0,0.25769497852356044,1.0,12/23,17.75%,RHOQ;AKT1;PIK3R1;IRS1;BRAF;CLIP3;OCLN;OSBPL8;PTPN11;ARPP19;AKT2;IGF1
prerank,GO_Biological_Process_2021__positive regulation of stress-activated MAPK cascade (GO:0032874),0.5602611080734983,1.6218599461481538,0.0,0.2571713265012728,1.0,21/75,15.15%,WNT7A;MAP3K11;SASH1;TPD52L1;BMP2;SH3RF3;PRMT1;MBIP;SH3RF1;TNFRSF19;MID1;PLCB1;HMGB1;MAP3K5;DUSP19;MAP4K2;MAP3K4;HIPK2;MAP3K10;TAOK2;DUSP22
prerank,GO_Biological_Process_2021__small nucleolar ribonucleoprotein complex assembly (GO:0000491),0.8953737956001568,1.6217023027648898,0.0,0.2545913924293869,1.0,1/9,0.41%,NAF1
prerank,GO_Biological_Process_2021__regulation of sprouting angiogenesis (GO:1903670),-0.7494458569876248,-1.6210811493171586,0.014492753623188406,0.2165622676496672,0.99,8/28,10.93%,EPN1;KLF2;ITGA5;CEACAM1;THBS1;PIK3CB;FGF1;KLF4
prerank,GO_Biological_Process_2021__mRNA transcription (GO:0009299),0.8943847323113551,1.620822500125912,0.023809523809523808,0.25411490961322136,1.0,1/10,2.47%,ZBTB1
prerank,GO_Biological_Process_2021__phenol-containing compound biosynthetic process (GO:0046189),0.9319590423364684,1.615819502661214,0.0,0.2700076653996725,1.0,1/5,0.16%,TYR
prerank,PanglaoDB_Augmented_2021__Photoreceptor Cells,0.5259102104493436,1.6147663868152073,0.0,0.2711880937379299,1.0,39/123,16.04%,CADM2;SNAP91;GLS;LSAMP;ADGRB3;AMER2;ATP2B3;RBFOX1;CACNA1B;UNC79;KCNA4;CTNNA2;CDH20;KCNMA1;NRXN1;CACNG3;PPFIA2;NLK;ASTN1;VSTM2B;HSPA12A;CELF3;SGIP1;PAK3;SYNE1;SLITRK1;GRM1;CACNA2D3;TRPM3;KIF1B;TMEM196;OLFM3;NAPB;MAGI2;SEZ6L;ELAVL3;VWC2L;CNTN4;CA10
prerank,GO_Biological_Process_2021__regulation of retinoic acid receptor signaling pathway (GO:0048385),-0.8609310344650988,-1.6105233727963546,0.0,0.24321689722877562,0.99,2/11,2.37%,PRAME;KLF2
prerank,GO_Biological_Process_2021__establishment of protein localization to extracellular region (GO:0035592),0.6378354612268413,1.6060408727772801,0.029411764705882353,0.30470011268686625,1.0,8/34,10.72%,RCN3;ABCA1;TVP23B;TMEM167A;TANGO6;RAB8B;GOLPH3;MTTP
prerank,GO_Biological_Process_2021__dendritic spine organization (GO:0097061),0.73626757164,1.604550298032403,0.0,0.308144939534801,1.0,9/24,19.12%,WNT7A;SHANK1;WASL;PAK3;SHANK3;MTMR2;CTNND2;PTEN;FYN
prerank,GO_Biological_Process_2021__ribosome assembly (GO:0042255),-0.7087576130332289,-1.603463440229944,0.0,0.26411420961321974,1.0,14/41,13.67%,RPS14;RPS27;RPL10;RPL24;RPL11;RPL23A;RPS15;MRPL20;RPL3;RPL5;RPS28;RPL6;RPF2;RPS19
prerank,GO_Biological_Process_2021__central nervous system neuron development (GO:0021954),0.7751587359463038,1.6029411654034105,0.0,0.31081209134843174,1.0,8/13,18.44%,LHX6;ARHGAP35;NTRK2;RAPGEF2;B4GALT6;B4GALT5;NPY;PTEN
prerank,GO_Biological_Process_2021__positive regulation of JUN kinase activity (GO:0043507),0.8022934512531033,1.60181659381829,0.0,0.3122043067632064,1.0,7/15,14.32%,MAP3K11;SASH1;MAP3K7;MAP3K5;DUSP19;MAP3K4;MAP3K10
prerank,GO_Biological_Process_2021__DNA duplex unwinding (GO:0032508),-0.6862831244904608,-1.6016774159521705,0.0,0.26258416867477075,1.0,7/45,10.79%,PIF1;CETN2;RPS27A;ANXA1;DDX11;UBC;BLM
prerank,GO_Biological_Process_2021__transcription by RNA polymerase II (GO:0006366),0.48541501523732616,1.6007912849102532,0.0,0.3128784321219393,1.0,69/278,19.08%,NUDT21;PPARGC1A;RARB;SNRPF;WDR33;HDAC9;PAPOLA;NR2F6;KAT2B;EAF2;TRIM24;ZBTB1;CSTF3;SOX5;INTS13;NR4A2;MLLT3;ESRRG;SNAPC1;RORA;NOTCH2;IWS1;NFKB1;INTS7;MAML2;RNGTT;THRB;PIR;COPS2;NRBF2;NR2E1;NR1D2;CDK12;PRRX1;INTS6;TAF4;TRIP11;PKNOX1;NR3C1;GLIS3;NR1D1;INTS8;NELFA;TBL1XR1;SNAPC3;RREB1;TAF8;HNF4G;CDK13;DTX1;POU2F1;YAP1;CCNT2;NR3C2;SETD2;PCID2;ZNF141;MAML1;SCAF8;MAF;CBFB;TAF2;SNAPC5;RPRD1B;TAF4B;RBPJ;RORB;MED27;TAF3
prerank,GO_Biological_Process_2021__negative regulation of osteoblast differentiation (GO:0045668),0.7162141628666815,1.5997717844297907,0.06896551724137931,0.31268650637301104,1.0,10/25,19.44%,LIMD1;RANBP3L;SOX9;TRPM4;MEN1;GDF10;SEMA4D;SUFU;RORB;CRIM1
prerank,GO_Biological_Process_2021__cellular response to peptide hormone stimulus (GO:0071375),0.5502822896212534,1.5967536331422758,0.0,0.32042483644168224,1.0,19/83,8.84%,LPIN3;TBC1D4;HDAC9;KAT2B;PDE3B;FOXO1;NR4A2;PRKACB;ADCY1;RHOQ;NFKB1;DENND4C;RAB31;AKT1;PRKAR1B;RAB8B;PIK3R1;IRS1;RPS6KB1
prerank,PanglaoDB_Augmented_2021__Cholinergic Neurons,0.5549283380734122,1.5963789341082302,0.0,0.31832366176233046,1.0,35/73,24.45%,SPSB4;MEX3A;PCDH8;EFNA2;CSPG5;SNAP91;CAMKV;RHBDL3;CACNA1B;PPM1E;MPP2;CDK5R2;KIF5A;ASTN1;FBLL1;CELF3;IGDCC3;KCNQ2;PURG;GRM8;MYT1;LRCH2;DRD2;LIN28B;DPYSL5;POU3F2;UNC13A;CLVS2;VGF;CNTFR;CACNG4;TMEM59L;OGDHL;CACNG7;KLHL23
prerank,GO_Biological_Process_2021__drug transport (GO:0015893),0.9398473096945685,1.596276069109875,0.0,0.3152735089275958,1.0,2/5,3.70%,SLC19A1;ABCC2
prerank,GO_Biological_Process_2021__3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),-0.8673068592161037,-1.5944132475835677,0.0,0.2871154202818346,1.0,2/17,1.44%,SULT1C3;SULT1C2
prerank,GO_Biological_Process_2021__organelle organization (GO:0006996),0.4778602090952839,1.5937082359026435,0.0,0.3224266484461889,1.0,99/352,20.71%,VAPB;FMNL3;PPARGC1A;LIMD1;LIG4;MICAL1;WTIP;CSPG5;VAPA;MTX2;USP6NL;SORT1;RHOT1;TRAPPC12;EPS15;TRAPPC8;AFG1L;PLIN5;GABPB1;CHMP1A;BRWD1;BIN1;TMCC1;RAB31;TNIK;RAB18;GABPA;PEX11A;NRF1;WASL;FMNL2;PEX14;FGD4;TRIP11;HPS3;ZMYM3;TFB1M;PYROXD2;PKD2;BRWD3;PRKN;GOLPH3;MAST2;PRKD1;DYM;ZRANB1;SYNE1;KIF5C;PEX16;RAB30;TTC17;PEX2;PIKFYVE;CHMP2B;RAB3GAP1;MTERF1;TJAP1;NDP;OPA1;CLASP1;ABCD3;TMED3;PEX7;TRAPPC11;PHIP;HACE1;ARHGEF7;AGTPBP1;MAST4;RAB1A;WASF3;ARFGEF1;TMED5;PEX6;PRPF40A;TMEM135;ATAD3C;PCLO;TTC29;WDR81;STRIP1;LARP4;TOR1B;SEC23IP;YTHDF2;PAK4;TOR1AIP2;MIEF2;NSFL1C;PDZD8;UBXN2B;CHMP6;STX7;ARMC2;SIRT5;NECTIN2;ATXN7;PTCD2;PLAAT3
prerank,GO_Biological_Process_2021__regulation of dendrite development (GO:0050773),0.7014254213214224,1.5936914445844128,0.0,0.3193962710469554,1.0,17/34,21.21%,ADGRB3;CDKL5;CSMD3;NEDD4L;TNIK;SARM1;LRP8;CAMSAP2;KIAA0319;DCC;GSK3B;BMP7;SEMA4D;RAP2A;RTN4IP1;SDC2;MARK1
prerank,GO_Biological_Process_2021__positive regulation of gene silencing by miRNA (GO:2000637),0.6793147834910835,1.5915014125879177,0.0,0.3242838228619861,1.0,11/22,21.70%,LIMD1;WTIP;EGFR;PUM2;TNRC6B;DHX9;PUM1;FXR1;MAP2K2;DDX6;FMR1
prerank,GO_Biological_Process_2021__regulation of dopamine secretion (GO:0014059),0.7167620701023096,1.5887817838519072,0.0,0.33241170525920677,1.0,6/17,14.24%,CHRNA4;SYT3;SNCA;PRKN;KCNA2;SYT9
prerank,GO_Biological_Process_2021__hippo signaling (GO:0035329),0.6957250905258324,1.5883553069273693,0.05,0.33078837454744525,1.0,15/25,23.76%,AMOTL1;FAT4;AMOT;TJP1;LATS1;YAP1;MOB1A;DCHS1;CASP3;NPHP4;STK4;TJP2;MOB1B;TEAD2;TEAD1
prerank,GO_Biological_Process_2021__cortical actin cytoskeleton organization (GO:0030866),0.7456203224638339,1.5880570588041982,0.02631578947368421,0.32888437335164883,1.0,10/16,19.93%,FMNL3;PLEK;RHOQ;FMNL2;NCKAP1;DLG1;ROCK2;STRIP1;ARF6;ROCK1
prerank,GO_Biological_Process_2021__embryonic axis specification (GO:0000578),0.8147638408222964,1.5872319186211814,0.0,0.32886820589052035,1.0,4/11,6.32%,WNT7A;FZD5;SMAD2;TASOR
prerank,GO_Biological_Process_2021__positive regulation of cold-induced thermogenesis (GO:0120162),0.5614858487587039,1.586373229672688,0.0,0.3296167579671514,1.0,15/68,14.49%,PPARGC1A;LEPR;PLAC8;HADH;ESRRG;ADIPOR2;ELOVL6;ADRB2;ZNF516;ADRB1;PRKAB1;PDGFC;OGT;ALMS1;ADIPOR1
prerank,GO_Biological_Process_2021__negative regulation of viral genome replication (GO:0045071),-0.695859867453943,-1.585927060165408,0.03125,0.314170375192851,1.0,9/36,12.07%,IFIT1;IFITM3;BST2;MX1;ISG15;APOBEC3G;RSAD2;EIF2AK2;OAS3
prerank,GO_Biological_Process_2021__regulation of phosphoprotein phosphatase activity (GO:0043666),0.6880593531747908,1.5857200320120441,0.05263157894736842,0.3297455764451929,1.0,8/29,16.61%,ITGA1;PPP1R15B;PPP1R1B;PPP6R3;PPP4R4;MAGI2;GSK3B;PPP1R12A
prerank,GO_Biological_Process_2021__ribosomal large subunit assembly (GO:0000027),-0.8150866083877274,-1.5848611090242128,0.016129032258064516,0.31176980801566306,1.0,9/18,13.15%,RPL10;RPL24;RPL11;RPL23A;MRPL20;RPL3;RPL5;RPL6;RPF2
prerank,GO_Biological_Process_2021__cytoplasmic sequestering of transcription factor (GO:0042994),0.7606505195940576,1.582350824389667,0.07692307692307693,0.3379762577096418,1.0,5/12,17.02%,KEAP1;PSMD10;PKD2;FAF1;SUFU
prerank,GO_Biological_Process_2021__chromatin remodeling (GO:0006338),0.5642295475797944,1.5810518658618014,0.0,0.33891902209716546,1.0,27/89,20.00%,KAT2B;ZBTB1;DR1;SOX9;SMARCAD1;HNRNPC;ARID1B;BAHD1;MBD2;SMARCA2;HDAC2;KDM5A;KAT2A;MBD3;HDAC4;SIRT1;SMARCD2;BAZ2B;RSF1;RBBP4;SMARCC1;SATB2;JARID2;ATRX;NPM2;KDM4C;BAZ1A
prerank,GO_Biological_Process_2021__regulation of JNK cascade (GO:0046328),0.5671655498167735,1.5801721761193914,0.0,0.3396974255847013,1.0,23/85,15.15%,WNT7A;MAP3K11;TPD52L1;SH3RF3;EGFR;MARVELD3;MBIP;DUSP10;SH3RF1;TNFRSF19;PLCB1;ITCH;MEN1;HMGB1;PRKN;MAP3K5;DUSP19;MAP4K2;MAP4K4;HIPK2;MAP3K10;TAOK2;DUSP22
prerank,PanglaoDB_Augmented_2021__T Memory Cells,-0.6689549562009377,-1.5786907339427738,0.0,0.33569359735030563,1.0,14/44,11.13%,P2RY10;ARHGAP15;TAGAP;CD5;EPSTI1;DPEP2;THEMIS;ARHGAP9;GPR171;GMFG;TRAF3IP3;TMC8;RHOH;ARHGAP30
prerank,GO_Biological_Process_2021__nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),0.7061898953760042,1.5751851714635354,0.02564102564102564,0.356966518447165,1.0,7/21,16.98%,PNLDC1;CNOT9;CNOT6L;CNOT2;CNOT4;PAN3;CNOT8
prerank,GO_Biological_Process_2021__production of miRNAs involved in gene silencing by miRNA (GO:0035196),0.6252656772636506,1.5747571487687342,0.0,0.35539994609240794,1.0,13/26,26.27%,DROSHA;SMAD2;PUS10;PUM2;PRKRA;AGO3;PUM1;ZC3H7A;LIN28B;ZC3H7B;SMAD3;SMAD1;DICER1
prerank,GO_Biological_Process_2021__regulation of small molecule metabolic process (GO:0062012),0.6217030092961127,1.5732905215835038,0.03333333333333333,0.3585962217357945,1.0,10/25,15.44%,PDK4;RORA;PANK2;PRKN;SIRT1;TTC39B;ACADVL;ARV1;ADIPOR1;PDK2
prerank,GO_Biological_Process_2021__negative regulation of response to wounding (GO:1903035),0.7578066290084291,1.5714116658984998,0.0,0.3630171428472301,1.0,5/15,9.87%,SERPINE1;AJAP1;EPHA4;GIT1;RTN4RL1
prerank,GO_Biological_Process_2021__histone H4 deacetylation (GO:0070933),0.7969696455206099,1.5712704235513335,0.025,0.35988768471923677,1.0,6/9,13.72%,HDAC9;RCOR1;SMARCAD1;HDAC2;HDAC4;SIRT2
prerank,GO_Biological_Process_2021__regulation of microtubule-based process (GO:0032886),0.6123430176350684,1.567792944942448,0.0,0.3724711701989304,1.0,17/35,26.28%,EFNA5;KLHL42;FAM107A;MEMO1;BICD2;CLASP1;GSK3B;CDK2AP2;ROCK1;AURKA;TRIM36;MACF1;PRKAA1;TAOK1;CLASP2;CYLD;MARK2
prerank,GO_Biological_Process_2021__glutamine family amino acid metabolic process (GO:0009064),0.6151856487440264,1.5677182794436575,0.0,0.36931463485826144,1.0,6/30,10.15%,PRODH;MTHFS;GLS;KYAT1;ALDH4A1;GCLC
prerank,GO_Biological_Process_2021__cAMP-mediated signaling (GO:0019933),0.7314775308556326,1.5668950000400155,0.0,0.3706100832708412,1.0,8/21,11.60%,PDE3A;ADCY1;SOX9;PDE7B;PDE7A;EPHA5;RAPGEF2;AHR
prerank,GO_Biological_Process_2021__outflow tract septum morphogenesis (GO:0003148),0.740639905789548,1.5668792071073594,0.0,0.36752166591025087,1.0,10/19,15.85%,ZFPM2;PARVA;NRP2;ROBO1;SEMA3C;TGFBR2;ACVR1;BMPR1A;SMAD4;NRP1
prerank,GO_Biological_Process_2021__mitotic metaphase plate congression (GO:0007080),-0.6924885239863676,-1.5667044290232661,0.015384615384615385,0.3878380557372056,1.0,8/39,8.99%,ANKRD53;CENPE;KIF2C;RAB11A;NUF2;SPDL1;MIS12;CHMP2A
prerank,GO_Biological_Process_2021__regulation of chondrocyte differentiation (GO:0032330),0.7898115777055357,1.5665576760130167,0.02857142857142857,0.3657010470193597,1.0,10/17,15.44%,TRPS1;SOX5;LOXL2;SOX9;PKDCC;BMPR1B;SOX6;ZBTB16;TGFBR1;PTPN11
prerank,PanglaoDB_Augmented_2021__T Regulatory Cells,-0.7120115986279025,-1.564601326721404,0.015873015873015872,0.38910309394052545,1.0,10/35,11.13%,GBP2;P2RY10;TAGAP;IL1R1;GPR183;CD5;GPR171;TRAF3IP3;SP140;ARHGAP30
prerank,GO_Biological_Process_2021__central nervous system neuron differentiation (GO:0021953),0.632308279563731,1.5638662340856873,0.0,0.37544169791872684,1.0,11/26,17.96%,SOX4;NR4A2;TOX;NTRK2;CHD5;CEND1;MDGA2;ZC4H2;OPHN1;AGTPBP1;NPY
prerank,GO_Biological_Process_2021__response to cholesterol (GO:0070723),0.7441081393729928,1.5608338374672845,0.0,0.38688591088257934,1.0,7/15,15.98%,GRAMD1C;SMAD2;TGFBR2;TGFBR1;OSBPL7;ABCA2;SMO
prerank,GO_Biological_Process_2021__negative regulation of BMP signaling pathway (GO:0030514),0.594284199299893,1.5595206611395303,0.029411764705882353,0.3887789614617268,1.0,16/42,20.83%,RBPMS2;BMP2;SMAD7;UBE2D1;SMAD5;BMPR1B;SMURF1;HIPK2;NBL1;ACVR2A;BMPR1A;SMAD4;VWC2L;LEMD3;CRIM1;UBE2D3
prerank,GO_Biological_Process_2021__regulation of neuron differentiation (GO:0045664),0.5366488566092452,1.558657001762237,0.03571428571428571,0.38867869949677564,1.0,22/61,19.93%,BRINP3;MOSMO;BMP2;ASCL1;ZEB1;MMD;BIN1;KCTD11;TCF4;EIF2AK4;ZC4H2;NBL1;DTX1;CNTN4;BMP7;IMPACT;YWHAG;CPNE1;CDK5R1;BRINP1;REST;ROCK1
prerank,GO_Biological_Process_2021__negative regulation of transcription regulatory region DNA binding (GO:2000678),-0.7840675612179296,-1.5572737252009865,0.03278688524590164,0.42230517693426745,1.0,5/13,16.00%,GATA1;ZNF593;DDIT3;HEY2;MSX2
prerank,GO_Biological_Process_2021__in utero embryonic development (GO:0001701),0.7527185444235069,1.5570315068089262,0.02857142857142857,0.3936433838631767,1.0,8/19,13.12%,LIG4;SOX8;BMP2;CHD7;ZNF568;FUT8;MBNL1;TGFBR1
prerank,GO_Biological_Process_2021__cardiac muscle cell contraction (GO:0086003),0.6846423785758676,1.5554999651368537,0.023809523809523808,0.3968553889119429,1.0,4/17,11.24%,CACNA1G;CACNA2D1;PIK3CA;CAMK2D
prerank,GO_Biological_Process_2021__regulation of Golgi organization (GO:1903358),0.7033100933590758,1.5547745657598493,0.08333333333333333,0.3965665787229374,1.0,8/17,19.29%,USP6NL;RAB33B;PDE4DIP;STX18;CAMSAP2;MAPK1;MYO5A;MAP2K2
prerank,GO_Biological_Process_2021__response to organophosphorus (GO:0046683),-0.8499415532885632,-1.5538588912008418,0.0,0.43135124242043565,1.0,4/14,6.59%,AKR1C1;DUOX1;STAT1;TYMS
prerank,PanglaoDB_Augmented_2021__T Cells Naive,-0.7239260964965519,-1.55312022219499,0.058823529411764705,0.4259110711888166,1.0,9/25,11.13%,P2RY10;TAGAP;CD5;DPEP2;ARHGAP9;GPR171;GMFG;TRAF3IP3;ARHGAP30
prerank,PanglaoDB_Augmented_2021__Transient Cells,0.5376047547127799,1.5518274534912035,0.0,0.40604664075792674,1.0,19/103,15.17%,NR2F6;SDC4;MYO5B;NPNT;ARHGEF16;HID1;PLEKHA6;CADPS2;CEP170B;SEC23B;LGR4;MAOA;WASL;GCLC;PIP4K2C;ARHGEF10L;TMEM117;MYH14;MTUS1
prerank,GO_Biological_Process_2021__calcium ion import (GO:0070509),0.6458671541075416,1.5510900294515189,0.04878048780487805,0.40669825070369686,1.0,5/23,5.41%,CACNA1G;MAIP1;MCU;CACNA1I;CACNA1B
prerank,GO_Biological_Process_2021__peptidyl-L-cysteine S-palmitoylation (GO:0018230),0.6521402669513693,1.5493802222110433,0.029411764705882353,0.4085914932917781,1.0,5/21,12.16%,ZDHHC18;ZDHHC11;ZDHHC21;CLIP3;GOLGA7
prerank,GO_Biological_Process_2021__peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),0.6521402669513693,1.5493802222110433,0.029411764705882353,0.4085914932917781,1.0,5/21,12.16%,ZDHHC18;ZDHHC11;ZDHHC21;CLIP3;GOLGA7
prerank,GO_Biological_Process_2021__regulation of intracellular estrogen receptor signaling pathway (GO:0033146),0.6316394130187668,1.547100461662805,0.0,0.4172040418891494,1.0,10/26,18.50%,CNOT9;CNOT2;STRN3;DNAAF4;GPAM;LATS1;YAP1;CBFB;RUNX1;AXIN1
prerank,PanglaoDB_Augmented_2021__Pyramidal Cells,0.5281447445617138,1.5469344129337543,0.0,0.41494512902329905,1.0,41/121,19.77%,SHISA7;FEZF2;KCNQ3;GABRG1;CADM2;SNAP91;NR4A2;ADGRB3;PSD2;AMER2;ATP2B3;RBFOX1;CACNA1B;CTNNA2;CDH20;ADRB2;NRXN1;CACNG3;CAMK2A;ASTN1;VSTM2B;ADGRA1;CELF3;SLITRK1;GRM1;SLC32A1;TMEM196;OLFM3;LY6H;KCNQ2;SEZ6L;POU3F1;ELAVL3;CA10;SATB2;KCNC2;CCM2;NGB;OPCML;YWHAZ;BRINP1
prerank,GO_Biological_Process_2021__defense response to bacterium (GO:0042742),-0.6557081749774053,-1.5451413874964932,0.014285714285714285,0.46433909072781787,1.0,17/62,13.90%,GBP2;GBP7;RPL39;SELP;HLA-A;ISG15;RPL30;AQP1;STAB2;IL12A;NLRP1;SLC11A1;TLR3;OAS3;PGLYRP1;RPS19;DEFB109B
prerank,GO_Biological_Process_2021__mRNA pseudouridine synthesis (GO:1990481),0.8361186269516973,1.5451170594236654,0.0,0.41902074537344125,1.0,2/7,11.50%,TRUB1;DKC1
prerank,GO_Biological_Process_2021__positive regulation of CREB transcription factor activity (GO:0032793),0.7412630857182907,1.5438963399875896,0.047619047619047616,0.4225552929206813,1.0,6/16,13.89%,RPS6KA4;ADCY1;EPHA5;LRP8;PRKD1;CRTC2
prerank,GO_Biological_Process_2021__icosanoid metabolic process (GO:0006690),0.6290641661333707,1.5428402925834166,0.03125,0.42496359320363747,1.0,4/38,7.18%,CPA1;MGLL;LTC4S;PON2
prerank,GO_Biological_Process_2021__folic acid-containing compound metabolic process (GO:0006760),0.6946979298163709,1.5423210640532816,0.05555555555555555,0.42401786832697946,1.0,2/18,1.47%,MTHFS;SLC19A1
prerank,GO_Biological_Process_2021__DNA packaging (GO:0006323),-0.8322674426767236,-1.5403529690118631,0.0,0.48588303155621804,1.0,2/14,1.35%,H1-4;H1-2
prerank,GO_Biological_Process_2021__endoplasmic reticulum membrane organization (GO:0090158),0.8173379732333349,1.5392969509918848,0.043478260869565216,0.4350898529780962,1.0,1/11,0.04%,VAPB
prerank,GO_Biological_Process_2021__regulation of monooxygenase activity (GO:0032768),0.7145537997822308,1.5390755701730476,0.06060606060606061,0.4335010747754442,1.0,7/14,18.91%,SNCA;EGFR;AKT1;WASL;ZDHHC21;DDAH1;DNM2
prerank,GO_Biological_Process_2021__nucleosome positioning (GO:0016584),-0.8630879808323776,-1.5383490484102922,0.0,0.4917523672692917,1.0,2/9,1.35%,H1-4;H1-2
prerank,GO_Biological_Process_2021__dendritic spine morphogenesis (GO:0060997),0.7678022270119454,1.5380080269434018,0.047619047619047616,0.43634351458060916,1.0,7/14,18.44%,WNT7A;SHANK1;WASL;PAK3;SHANK3;CTNND2;PTEN
prerank,GO_Biological_Process_2021__regulation of G protein-coupled receptor signaling pathway (GO:0008277),0.5724765549879018,1.5369024548704293,0.0,0.43776350894145316,1.0,17/59,12.61%,KCTD8;RGS5;RGS3;MGLL;RGS16;RGS6;GIT1;PLEK;GNG4;CAMKMT;CAMK2A;PLCB1;RIC8B;MRAP;PPEF1;GRK4;RGS12
prerank,GO_Biological_Process_2021__axon guidance (GO:0007411),0.5002784554438483,1.5365462931348732,0.0,0.43664694614536764,1.0,53/175,17.24%,EPHA7;EPHA6;SEMA5B;SLIT1;EFNA5;EFNA2;NPTN;EPHA2;EMB;PLXNA2;EPHA4;PSPN;NOTCH2;NFIB;CXCL12;ARHGAP35;ALCAM;KIF5A;EFNB1;EPHA5;PIK3CA;NRP2;NRXN1;PLXNA1;PIK3R1;ROBO1;GFRA1;SHC3;EFNB2;UNC5D;SEMA3C;KIF5C;SHANK3;SOS1;PTK2;SLIT2;DCC;BSG;ENAH;OPHN1;MAPK1;SEMA6C;VASP;GAB1;CYFIP1;PTPN11;NRP1;SMO;CNTN4;SEMA4D;SEMA3D;PTPRO;LYPLA2
prerank,GO_Biological_Process_2021__positive regulation of positive chemotaxis (GO:0050927),0.8274083737491765,1.5334333130256275,0.020833333333333332,0.44679238131337057,1.0,3/9,9.39%,VEGFD;CXCL12;VEGFC
prerank,GO_Biological_Process_2021__purine nucleobase transport (GO:0006863),-0.9892396682183713,-1.5332295188124954,0.0,0.5153111093194941,1.0,1/5,0.04%,SLC28A2
prerank,GO_Biological_Process_2021__tRNA transport (GO:0051031),0.6052709584392796,1.53174426959738,0.0,0.45251081611562965,1.0,10/35,24.56%,NUP42;NUP37;NUP188;NUP153;NDC1;NUP205;NUP214;RANBP2;NUP54;NUP98
prerank,GO_Biological_Process_2021__GDP-mannose metabolic process (GO:0019673),-0.8569240822876942,-1.531679531464629,0.10638297872340426,0.5160431077681407,1.0,1/6,1.92%,GMPPB
prerank,GO_Biological_Process_2021__response to interferon-gamma (GO:0034341),-0.7036728921812484,-1.5315712301641045,0.015384615384615385,0.5064654083543102,1.0,11/37,10.16%,GBP2;GBP7;GBP1;GBP3;IFITM3;BST2;STAT1;TRIM21;RPL13A;CIITA;SLC11A1
prerank,GO_Biological_Process_2021__positive regulation of mRNA catabolic process (GO:0061014),0.6016863619641051,1.530380111765436,0.0,0.4543413952479779,1.0,13/41,22.79%,RIDA;CPEB3;FTO;RBM24;TNRC6B;ROCK2;CNOT8;PUM1;CELF1;YTHDF2;ROCK1;YTHDF3;GIGYF2
prerank,GO_Biological_Process_2021__lens fiber cell development (GO:0070307),0.9083794942400583,1.5299635111719168,0.02,0.4532537229008817,1.0,2/7,3.06%,WNT7A;EPHA2
prerank,GO_Biological_Process_2021__cellular metal ion homeostasis (GO:0006875),0.5564087382567893,1.5294185634265867,0.0,0.45240181006014624,1.0,15/69,7.11%,VAPB;SLC24A3;ATP13A5;ANK2;NPTN;ATP2B3;HTR2C;STIM2;CXCL12;NEDD4L;ATP2C1;SLC12A2;CALCB;KCNMA1;ATP13A4
prerank,GO_Biological_Process_2021__contractile actin filament bundle assembly (GO:0030038),0.7328510994384635,1.528905123257554,0.05714285714285714,0.44865998028331516,1.0,7/14,21.53%,KCTD13;FHDC1;ARRB1;FAM171A1;CUL3;TNFAIP1;PHACTR1
prerank,GO_Biological_Process_2021__stress fiber assembly (GO:0043149),0.7328510994384635,1.528905123257554,0.05714285714285714,0.44865998028331516,1.0,7/14,21.53%,KCTD13;FHDC1;ARRB1;FAM171A1;CUL3;TNFAIP1;PHACTR1
prerank,GO_Biological_Process_2021__regulation of glucose metabolic process (GO:0010906),0.6201463533898399,1.5288816574627448,0.027777777777777776,0.44579705677894615,1.0,11/29,16.90%,PDK4;RORA;AKT1;IRS1;PRKN;SIRT1;OGT;RUBCNL;ADIPOR1;PDK2;AKT2
prerank,GO_Biological_Process_2021__regulation by virus of viral protein levels in host cell (GO:0046719),-0.8433934263726801,-1.528178645522368,0.0,0.5196067599700999,1.0,2/7,3.14%,IFIT1;STAT1
prerank,GO_Biological_Process_2021__positive regulation of protein dephosphorylation (GO:0035307),0.6699409637379513,1.5270321367741782,0.0,0.4516891784589224,1.0,7/27,17.95%,ITGA1;PPP1R15B;PPP2R5A;CAMTA1;MAGI2;SPPL3;PTBP1
prerank,GO_Biological_Process_2021__nervous system development (GO:0007399),0.4585950701796478,1.5265555595756473,0.0,0.4509822501918421,1.0,86/354,16.19%,POU6F2;CHST8;IL1RAPL2;LIG4;EFNA5;PCDHB2;DNM3;SOX8;CSPG5;ERBB4;FAT4;LSAMP;ASCL1;FBXL17;CDH2;BTBD3;ZIC5;ATXN10;DOC2A;ADGRL3;SCD5;PSPN;NOTCH2;ZEB2;RBFOX1;FGF17;FZD5;BTBD1;RPS6KA3;GPM6A;RBM45;CHD7;ZIC2;MOBP;IGF2BP2;HAPLN1;DPF1;NRXN1;NR2E1;DYRK1A;ARHGAP26;ADAM23;ROBO1;MBP;TRAK1;GFRA1;RBFOX2;SOX6;PKD2;SDK1;NPAS2;PRKN;PCDHB13;NF1;TRAK2;NAV3;EP300;SLITRK1;MBNL1;DVL1;NLGN3;SHANK3;GPM6B;HAPLN2;GLRB;ZBTB16;ZC4H2;MERTK;HDAC4;NCKAP1;TGFBR1;LY6H;NBL1;PDGFC;FARP1;NDP;OPHN1;KCNQ2;PTPRZ1;POU3F1;TENM1;YAP1;SMO;TMOD2;CNTN4;DPF3
prerank,GO_Biological_Process_2021__ribosomal small subunit biogenesis (GO:0042274),-0.6857751705924806,-1.526363770396501,0.041666666666666664,0.5235486236820992,1.0,10/38,7.88%,RPS14;RPS27;RPS7;RPS25;RPS6;RPS15;RPS24;EMG1;RPS16;RPS28
prerank,PanglaoDB_Augmented_2021__Beta Cells,0.5095515846734203,1.5258586154431701,0.0,0.45028450281134724,1.0,33/114,16.55%,MAPK10;ABCC8;CNTN1;EFNA5;CADM2;SNAP91;LSAMP;RGS16;ADGRB3;STXBP5;PCDH17;RBFOX1;CACNA1B;NOL4;UNC79;PIR;CAMK2B;NRXN1;LRRC4C;ASTN1;ADGRA1;UNC5D;CELF3;PAK3;TMEM196;MAPK4;LY6H;ASXL3;SEZ6L;ELAVL3;CNTN4;CA10;CSRNP3
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell proliferation (GO:0060043),0.6775233856712384,1.5258543832423113,0.08333333333333333,0.44737944150288694,1.0,9/17,23.54%,ZFPM2;ERBB4;TGFBR1;BMPR1A;VGLL4;RUNX1;RBPJ;FGF2;FGFR2
prerank,GO_Biological_Process_2021__gene silencing by miRNA (GO:0035195),0.6347074889414577,1.5257861008877076,0.0,0.44514079884416086,1.0,9/28,19.35%,LIMD1;WTIP;PUM2;TNRC6B;PRKRA;AGO3;CNOT8;PUM1;ZC3H7A
prerank,PanglaoDB_Augmented_2021__Neuroendocrine Cells,0.526510323399908,1.525509326045719,0.0,0.4436600351865982,1.0,38/117,21.67%,GABRG1;CADM2;SNAP91;LSAMP;ADGRB3;PSD2;AMER2;ATP2B3;RBFOX1;PDE10A;DPF1;NRXN1;LRRC4C;CAMK2A;PPFIA2;PPP1R1B;ASTN1;VSTM2B;ADGRA1;CELF3;SLITRK1;TMEM196;RGS7BP;OLFM3;GABRB1;LY6H;ELAVL3;CA10;CSRNP3;KCNC2;NPY;PLPPR4;OPCML;ABHD2;BRINP1;GRIA2;CLVS2;SLC6A1
prerank,GO_Biological_Process_2021__RNA destabilization (GO:0050779),0.7026033777045811,1.5253251442105376,0.04878048780487805,0.44168034033724507,1.0,11/18,22.79%,RIDA;FTO;RBM24;ROCK2;PUM1;CELF1;YTHDF2;ROCK1;LIN28B;YTHDF3;GIGYF2
prerank,GO_Biological_Process_2021__mesenchyme morphogenesis (GO:0072132),0.758220157585514,1.5246069872851928,0.023255813953488372,0.4409601534324324,1.0,6/13,14.40%,BMP2;SOX9;SMAD2;ACVR1;BMPR1A;MDM4
prerank,GO_Biological_Process_2021__regulation of glucose import (GO:0046324),0.6333018257104169,1.5243778826367043,0.0,0.43902207902965984,1.0,11/26,17.75%,PID1;RHOQ;AKT1;PIK3R1;IRS1;OCLN;OSBPL8;PTPN11;ARPP19;AKT2;IGF1
prerank,GO_Biological_Process_2021__energy derivation by oxidation of organic compounds (GO:0015980),0.7189583872743736,1.5238812609533299,0.044444444444444446,0.43914019575283486,1.0,5/19,2.94%,PPARGC1A;PID1;LEPR;SDHAF4;COX10
prerank,GO_Biological_Process_2021__maintenance of blood-brain barrier (GO:0035633),0.6575793325926629,1.5228700842026939,0.075,0.4423871904475241,1.0,7/23,17.96%,CLDN12;SLC12A2;MBP;JAM2;OCLN;TJP1;WNK3
prerank,GO_Biological_Process_2021__positive regulation of dendritic spine development (GO:0060999),0.6744590537870472,1.5220546312323926,0.045454545454545456,0.44288464937701943,1.0,9/21,12.88%,SHANK1;CPEB3;LLPH;CAMK2B;CAPRIN2;LRP8;SHANK3;CAPRIN1;DLG5
prerank,GO_Biological_Process_2021__regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),0.6015684134576291,1.5214782733935917,0.0,0.44247831746522565,1.0,13/31,19.63%,RNF6;NCOA2;RNF14;SAFB2;DNAAF4;EP300;GPAM;LATS1;CBFB;RUNX1;KDM1A;AXIN1;KDM4C
prerank,GO_Biological_Process_2021__cilium movement (GO:0003341),-0.6356123563457541,-1.521471221982183,0.013888888888888888,0.5486083445746033,1.0,7/43,7.21%,SPAG17;RSPH4A;CCDC39;TEKT1;DNAAF1;CFAP73;ZBBX
prerank,GO_Biological_Process_2021__modification-dependent protein catabolic process (GO:0019941),0.4441063677131119,1.5213549375829487,0.0,0.4402923437570607,1.0,52/176,17.58%,SPSB4;RNF150;BTRC;SPSB2;KEAP1;ANAPC1;UBE2G1;KLHL8;RNF11;RNF217;RNF146;ARRB1;NEDD4L;CBL;CDC27;RNF144A;FEM1C;RNF6;UBE2D1;UBR3;PSMD11;RNF14;ITCH;KLHL15;CNOT4;UBE3C;PRKN;FBXO11;PSMF1;KCTD10;FBXL14;FBXO21;PSMD14;SMURF1;BUB3;TRIP12;MIB1;UBE2E1;UBQLN1;FBXO45;ARIH1;CDC34;ANAPC16;HACE1;UBQLN4;WDR91;RNF166;UBQLN2;BFAR;WDR81;CUL3;NDFIP1
prerank,GO_Biological_Process_2021__regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),0.8548296023218606,1.521209751002544,0.0,0.4383297978179531,1.0,3/9,5.26%,DLGAP1;DLGAP4;NPTXR
prerank,GO_Biological_Process_2021__L-methionine salvage (GO:0071267),-0.9620663186945695,-1.521158804744969,0.0,0.5405132717348857,1.0,2/6,3.28%,APIP;BHMT
prerank,GO_Biological_Process_2021__regulation of cellular carbohydrate metabolic process (GO:0010675),0.7482873932473784,1.52091275903464,0.027777777777777776,0.43619484487064814,1.0,6/14,15.44%,PDK4;RORA;PRKN;SIRT1;ADIPOR1;PDK2
prerank,GO_Biological_Process_2021__mRNA transcription by RNA polymerase II (GO:0042789),0.9465314731248275,1.5199960437508855,0.0,0.43759070755634466,1.0,1/6,2.47%,ZBTB1
prerank,GO_Biological_Process_2021__regulation of transcription regulatory region DNA binding (GO:2000677),-0.7809265476964611,-1.5199267014710731,0.015625,0.539243389272503,1.0,2/19,0.97%,POU4F1;GATA1
prerank,GO_Biological_Process_2021__regulation of cellular biosynthetic process (GO:0031326),0.7483081502228538,1.5195086895124135,0.05263157894736842,0.4372277223982766,1.0,3/20,4.77%,PDK4;MITF;ADIPOR2
prerank,GO_Biological_Process_2021__positive regulation of protein localization to Cajal body (GO:1904871),0.7329449128819852,1.518783623030961,0.025,0.4357491770058808,1.0,3/11,15.88%,CCT4;DKC1;CCT3
prerank,GO_Biological_Process_2021__regulation of protein localization to Cajal body (GO:1904869),0.7329449128819852,1.518783623030961,0.025,0.4357491770058808,1.0,3/11,15.88%,CCT4;DKC1;CCT3
prerank,GO_Biological_Process_2021__negative regulation of lipid catabolic process (GO:0050995),0.829816162477578,1.5181346853596922,0.0625,0.435878768252712,1.0,3/9,6.29%,PDE3B;PLIN5;AKT1
prerank,GO_Biological_Process_2021__positive regulation of JNK cascade (GO:0046330),0.5804146858583822,1.5177431524937401,0.0,0.4351558394844791,1.0,16/56,15.15%,WNT7A;MAP3K11;TPD52L1;SH3RF3;MBIP;SH3RF1;TNFRSF19;PLCB1;HMGB1;MAP3K5;DUSP19;MAP4K2;HIPK2;MAP3K10;TAOK2;DUSP22
prerank,GO_Biological_Process_2021__modulation of chemical synaptic transmission (GO:0050804),0.5019494055040371,1.5174286056517627,0.0,0.43340706022875686,1.0,37/93,23.57%,DLGAP1;KCTD13;USP46;NRG3;CDH2;DLGAP4;BAIAP3;NPTXR;CACNA1B;SLC12A2;EIF4EBP2;LRRC4C;HOMER1;CAMK2A;BTBD9;LRP8;DGKZ;NLGN3;GRM1;NLGN4X;RIMS3;IQSEC2;OPHN1;CLSTN2;GRM8;GRID1;PTEN;DRD2;GRIK2;NPTX2;UNC13A;FMR1;NLGN1;RIMS2;HCRT;GRIK1;GRM5
prerank,GO_Biological_Process_2021__dicarboxylic acid transport (GO:0006835),0.6140661459275081,1.517027025387201,0.03333333333333333,0.43233260826661557,1.0,4/23,5.19%,SLC26A7;SLC19A1;ABCC2;SLC25A18
prerank,GO_Biological_Process_2021__regulation of transmembrane transporter activity (GO:0022898),0.8995590068161139,1.5166680139922373,0.025,0.43154920458456,1.0,2/7,2.09%,ACE2;SNCA
prerank,GO_Biological_Process_2021__ethanol oxidation (GO:0006069),-0.8909900273763128,-1.5166667861320535,0.02127659574468085,0.552395519933659,1.0,2/7,7.98%,ADH4;ADH6
prerank,PanglaoDB_Augmented_2021__Plasma Cells,-0.6753881419431823,-1.5162726670826703,0.015873015873015872,0.5453119590279188,1.0,5/39,3.03%,CD24;P2RY10;IGHG1;TAGAP;CD9
prerank,GO_Biological_Process_2021__heparan sulfate proteoglycan biosynthetic process (GO:0015012),0.7052029309020622,1.515248727684737,0.0,0.4363199177091722,1.0,7/18,14.19%,HS3ST5;CSGALNACT1;UGDH;EXT1;EXT2;EXTL3;HS2ST1
prerank,GO_Biological_Process_2021__negative regulation of signal transduction in absence of ligand (GO:1901099),-0.7738837132287602,-1.5149276763388309,0.015384615384615385,0.5355390264545412,1.0,2/15,0.97%,IFI6;GATA1
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),-0.7738837132287602,-1.5149276763388309,0.015384615384615385,0.5355390264545412,1.0,2/15,0.97%,IFI6;GATA1
prerank,"GO_Biological_Process_2021__regulation of mRNA splicing, via spliceosome (GO:0048024)",0.5031730882676639,1.5131776897641867,0.0,0.4443454942843488,1.0,30/79,24.56%,RBFOX1;RBM24;PRDX6;HNRNPU;MBNL2;QKI;NSRP1;RBM15B;RBFOX2;CELF2;CELF3;MBNL1;KHDRBS3;U2AF2;JMJD6;FXR1;PTBP1;CELF1;SRPK2;TRA2A;SMU1;KHDRBS2;NOVA1;REST;PCBP4;NOVA2;FMR1;WTAP;MAGOH;NUP98
prerank,GO_Biological_Process_2021__post-transcriptional gene silencing by RNA (GO:0035194),0.6701000146172933,1.5129539747871197,0.09302325581395349,0.4427770016416206,1.0,7/18,17.97%,LIMD1;WTIP;HELZ;TNRC6B;AGO3;CNOT8;CELF1
prerank,GO_Biological_Process_2021__tRNA export from nucleus (GO:0006409),0.615123836272894,1.5127422837338687,0.06666666666666667,0.43842670983752324,1.0,10/33,24.56%,NUP42;NUP37;NUP188;NUP153;NDC1;NUP205;NUP214;RANBP2;NUP54;NUP98
prerank,GO_Biological_Process_2021__tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),0.615123836272894,1.5127422837338687,0.06666666666666667,0.43842670983752324,1.0,10/33,24.56%,NUP42;NUP37;NUP188;NUP153;NDC1;NUP205;NUP214;RANBP2;NUP54;NUP98
prerank,GO_Biological_Process_2021__positive regulation of cell projection organization (GO:0031346),0.4910611805889584,1.5126379643249102,0.0,0.4367368281845083,1.0,28/107,13.90%,TENM3;TIAM2;ZNF804A;NPTN;FUT9;PLXNA2;CDKL5;TOX;ARHGAP35;NTRK2;CARMIL1;RAPGEF2;CAMK2B;PLXNA1;ABL2;ROBO1;ROR1;CAPRIN2;CHODL;EP300;PRKD1;SLITRK1;DVL1;SLIT2;CAPRIN1;GRIP1;MAGI2;RAP1A
prerank,GO_Biological_Process_2021__neuron cell-cell adhesion (GO:0007158),0.7061334088797936,1.5123746731766339,0.045454545454545456,0.4354229787052663,1.0,10/15,22.01%,ASTN2;NCAM2;NRXN1;ASTN1;NLGN3;NLGN4X;CNTN4;NRXN2;CDK5R1;NLGN1
prerank,GO_Biological_Process_2021__forebrain neuron differentiation (GO:0021879),0.8847321115909885,1.511921815920323,0.05,0.435190270924077,1.0,6/6,11.56%,ZSWIM6;SALL1;ERBB4;LHX6;RAPGEF2;SHANK3
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-lysine acetylation (GO:2000758),0.7524301272748005,1.5117703401175693,0.024390243902439025,0.4331915890514842,1.0,4/18,5.26%,PPARGC1A;SOX4;RPS6KA4;ARRB1
prerank,GO_Biological_Process_2021__regulation of PERK-mediated unfolded protein response (GO:1903897),0.8268314189962088,1.5101393973625183,0.03125,0.4395695621277481,1.0,4/8,13.73%,PPP1R15B;TMEM33;BOK;NCK1
prerank,GO_Biological_Process_2021__regulation of neurotransmitter receptor activity (GO:0099601),0.6037158547674503,1.5089740222253527,0.0,0.44273008564998956,1.0,11/53,8.03%,SHISA7;DLGAP1;CACNG2;SHANK1;DLGAP4;GRIN1;NPTXR;CAMK2B;DLG3;CACNG3;CAMK2A
prerank,GO_Biological_Process_2021__regulation of ERBB signaling pathway (GO:1901184),-0.7828134844681295,-1.5085376604474388,0.01694915254237288,0.5722353109799249,1.0,2/16,4.51%,IFI6;CEACAM1
prerank,GO_Biological_Process_2021__regulation of AMPA receptor activity (GO:2000311),0.7137193149267265,1.5085367585340836,0.0625,0.4418543672640919,1.0,7/23,11.56%,SHISA7;CACNG2;SHANK1;ADRB2;CACNG3;NLGN3;SHANK3
prerank,GO_Biological_Process_2021__negative regulation of viral process (GO:0048525),-0.647988369777991,-1.5073803630845033,0.029411764705882353,0.5713825012765271,1.0,12/50,12.07%,IFIT1;IFITM3;BST2;MX1;STAT1;ISG15;TRIM21;APOBEC3G;HEXIM1;RSAD2;EIF2AK2;OAS3
prerank,GO_Biological_Process_2021__negative regulation of hippo signaling (GO:0035331),0.7807405532626307,1.5069401885613245,0.07692307692307693,0.4470466309703843,1.0,4/12,14.59%,LIMD1;WTIP;DLG5;VGLL4
prerank,GO_Biological_Process_2021__proline metabolic process (GO:0006560),0.9004597194772874,1.5067597898255174,0.046511627906976744,0.4459852169487192,1.0,2/5,8.89%,PRODH;ALDH4A1
prerank,GO_Biological_Process_2021__epithelial cell development (GO:0002064),0.712780485062354,1.506552969831462,0.06382978723404255,0.4440784496119092,1.0,2/15,3.55%,WNT7A;ACTA2
prerank,GO_Biological_Process_2021__positive regulation of mitochondrion organization (GO:0010822),0.5826001880419456,1.5042047028375214,0.0,0.4519044222894961,1.0,8/47,10.08%,PLD6;PPARGC1A;DCN;MCU;BOK;MFF;SPIRE1;PRKN
prerank,GO_Biological_Process_2021__tRNA processing (GO:0008033),0.5230986441509743,1.5039322256330314,0.0,0.45083433702817244,1.0,12/60,10.94%,LCMT2;TSEN15;TRUB1;RPP40;TRMT1;FARS2;ZBTB8OS;CTU1;THUMPD1;TRIT1;CDKAL1;NSUN6
prerank,GO_Biological_Process_2021__axon extension involved in axon guidance (GO:0048846),0.8340970156399572,1.5038462789356484,0.04081632653061224,0.4463781749163307,1.0,5/7,15.85%,SLIT1;ALCAM;NRP2;SLIT2;NRP1
prerank,GO_Biological_Process_2021__neuron projection extension involved in neuron projection guidance (GO:1902284),0.8340970156399572,1.5038462789356484,0.04081632653061224,0.4463781749163307,1.0,5/7,15.85%,SLIT1;ALCAM;NRP2;SLIT2;NRP1
prerank,PanglaoDB_Augmented_2021__NK Cells,-0.6384227093707512,-1.5035607608056385,0.013513513513513514,0.5905346946155069,1.0,16/46,14.07%,P2RY10;TAGAP;HSD11B1;SPON2;CD5;DPEP2;THEMIS;ARHGAP9;GPR171;GMFG;TRAF3IP3;KLRD1;FHL2;ARHGAP30;MYO1F;ITGA2
prerank,GO_Biological_Process_2021__embryonic digestive tract development (GO:0048566),0.7761883954503195,1.502845348553028,0.027777777777777776,0.44869113939021726,1.0,8/13,12.75%,RARB;PCSK5;RBPMS2;SALL1;PDGFRA;PKDCC;GLI3;NIPBL
prerank,GO_Biological_Process_2021__regulation of fatty acid metabolic process (GO:0019217),0.7463061702039242,1.5024690030819874,0.06976744186046512,0.44915378095208847,1.0,3/12,8.55%,PDK4;ADIPOR2;PANK2
prerank,GO_Biological_Process_2021__regulation of osteoblast differentiation (GO:0045667),0.5902361422752667,1.5018456029129137,0.05,0.4502727001193389,1.0,24/66,19.80%,LIMD1;NPNT;BMP2;RANBP3L;SOX9;TRPM4;ZHX3;BMPR1B;MEN1;GDF10;PRKD1;PTK2;ACVR1;ACVR2A;BMPR1A;YAP1;HGF;BMP7;SEMA4D;SUFU;IGF1;RORB;CRIM1;REST
prerank,GO_Biological_Process_2021__regulation of myoblast differentiation (GO:0045661),0.6597564819591863,1.5018150203702703,0.04878048780487805,0.448174430582293,1.0,6/24,8.66%,ANKRD2;SOX8;RANBP3L;SOX9;RBM24;PLCB1
prerank,GO_Biological_Process_2021__pyrimidine nucleoside transport (GO:0015864),-0.9779848819751217,-1.501603850972853,0.0,0.5779519474532508,1.0,1/5,0.04%,SLC28A2
prerank,GO_Biological_Process_2021__nucleoside transport (GO:0015858),-0.9779848819751217,-1.501603850972853,0.0,0.5779519474532508,1.0,1/5,0.04%,SLC28A2
prerank,GO_Biological_Process_2021__uridine transport (GO:0015862),-0.9779848819751217,-1.501603850972853,0.0,0.5779519474532508,1.0,1/5,0.04%,SLC28A2
prerank,GO_Biological_Process_2021__purine ribonucleoside triphosphate metabolic process (GO:0009205),0.7739998941027707,1.5009181684340505,0.05555555555555555,0.44928705730971985,1.0,6/12,13.68%,AK3;RHOQ;RAB23;EFL1;GNAI3;OPA1
prerank,PanglaoDB_Augmented_2021__Thymocytes,-0.6720983737300653,-1.5008760537769708,0.04477611940298507,0.5740744510978585,1.0,9/32,7.84%,P2RY10;TAGAP;CD5;DPEP2;ARHGAP9;GMFG;TSHR;TRAF3IP3;TMC8
prerank,GO_Biological_Process_2021__interleukin-27-mediated signaling pathway (GO:0070106),-0.8035958845593802,-1.5003721480520618,0.028985507246376812,0.5695732354878686,1.0,2/10,3.14%,MX1;STAT1
prerank,GO_Biological_Process_2021__ribonucleoside bisphosphate metabolic process (GO:0033875),-0.7476130869397768,-1.4999552640900633,0.0,0.5555769770634505,1.0,7/23,12.00%,ACOT2;ACOT1;ACOT6;GLYAT;ACSM6;ACSM5;ACSM3
prerank,GO_Biological_Process_2021__purine nucleoside bisphosphate metabolic process (GO:0034032),-0.7476130869397768,-1.4999552640900633,0.0,0.5555769770634505,1.0,7/23,12.00%,ACOT2;ACOT1;ACOT6;GLYAT;ACSM6;ACSM5;ACSM3
prerank,GO_Biological_Process_2021__cellular response to starvation (GO:0009267),0.4908396929203626,1.4989598087554679,0.0,0.4553531424704047,1.0,30/129,18.61%,PDK4;ATP6V0D2;FOXO1;ATP6V1A;RHEB;FOXO3;SESN1;ATP6V1C1;KPTN;EIF2AK4;CPEB4;ATG7;PIK3C3;PIK3R4;RALB;PRKD1;MAP3K5;SIK2;VPS41;TFEB;SIRT1;RPTOR;MAPK1;SESN3;ATP6V1B2;MAPK8;IMPACT;ATF2;FAS;ATG5
prerank,MSigDB_Hallmark_2020__Xenobiotic Metabolism,0.45967199776042367,1.498934549387904,0.0,0.4534228503022067,1.0,27/150,12.67%,GSTT2;PDK4;TYR;SERPINE1;EPHA2;ABCC2;AHCY;MPP2;MARCHF6;UGDH;LEAP2;PGD;MAOA;SMOX;CA2;CYFIP2;GSR;ETS2;NDRG2;ASL;GCLC;SLC35D1;ELOVL5;KYNU;ABHD6;ABCC3;PDLIM5
prerank,GO_Biological_Process_2021__positive regulation of phosphoprotein phosphatase activity (GO:0032516),0.7569253266312732,1.4987889909057834,0.07894736842105263,0.452156246968123,1.0,4/12,16.61%,ITGA1;PPP1R15B;MAGI2;PPP1R12A
prerank,GO_Biological_Process_2021__fat cell differentiation (GO:0045444),0.5707828595752286,1.4972506754816766,0.05714285714285714,0.4573171715583349,1.0,14/46,17.73%,PPARGC1A;PID1;FOXO1;SOX8;NR4A2;ZNF516;EP300;CLIP3;SIRT1;BBS9;OSBPL8;MKKS;AKT2;BBS2
prerank,PanglaoDB_Augmented_2021__Tanycytes,0.49884147930417927,1.496628225570368,0.0,0.4575600851840584,1.0,46/112,20.08%,MAPK10;PCDH19;SEMA5B;MPDZ;ANK2;PDZRN3;RGCC;ADGRL3;PRDX6;CDH11;CACNA2D1;COL25A1;PRKG1;MEGF10;PCDH18;FRZB;PBX1;GFRA1;ASTN1;PRICKLE2;COL23A1;GUCY1A2;LRFN5;RUNX1T1;PLPP3;SLIT2;ZNF423;MEST;RGS7BP;MAPK4;ASXL3;ADGRL2;LHX2;TMEM178A;WASF3;CSRNP3;VCAN;PLPPR4;LIFR;LRCH2;OPCML;LRP4;FAM13C;DRD2;BRINP1;TCEAL7
prerank,GO_Biological_Process_2021__formation of translation preinitiation complex (GO:0001731),-0.8395273815014948,-1.4964847124968688,0.0,0.5723237827348693,1.0,2/10,8.10%,EIF2S3B;EIF2S2
prerank,GO_Biological_Process_2021__glucose homeostasis (GO:0042593),0.5561072430893333,1.4960821577626697,0.0,0.45748299904402534,1.0,17/60,16.28%,PDK4;PPARGC1A;LEPR;FOXO1;SOX4;MCU;ADIPOR2;PIK3R1;IRS1;NR1D1;SIRT1;CRTC2;ADIPOR1;MLXIPL;PDK2;HECTD4;STK11
prerank,GO_Biological_Process_2021__ethanol metabolic process (GO:0006067),-0.8297291863658682,-1.4958567018623188,0.06,0.5691475221242622,1.0,2/9,7.98%,ADH4;ADH6
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, preincision complex assembly (GO:0006294)",-0.6930940637947242,-1.495765691823623,0.03571428571428571,0.5620168232838548,1.0,4/26,9.49%,CETN2;RPS27A;RPA3;UBC
prerank,GO_Biological_Process_2021__ceramide biosynthetic process (GO:0046513),0.5870727027013959,1.4952412151156982,0.030303030303030304,0.45867108522407773,1.0,4/33,8.26%,CERS3;SGMS1;ST6GALNAC5;B4GALT6
prerank,GO_Biological_Process_2021__regulation of water loss via skin (GO:0033561),-0.8540993954050462,-1.4950946124687192,0.046875,0.5504258278218916,1.0,4/12,8.09%,FLG2;ABCA12;FLG;HRNR
prerank,GO_Biological_Process_2021__establishment of skin barrier (GO:0061436),-0.8540993954050462,-1.4950946124687192,0.046875,0.5504258278218916,1.0,4/12,8.09%,FLG2;ABCA12;FLG;HRNR
prerank,GO_Biological_Process_2021__positive regulation of IRE1-mediated unfolded protein response (GO:1903896),0.8854058025431509,1.4898107391632935,0.0,0.4849360716736918,1.0,1/6,3.64%,TMEM33
prerank,GO_Biological_Process_2021__endocardial cushion morphogenesis (GO:0003203),0.7504279105670347,1.4891124729902667,0.05128205128205128,0.48504218838736624,1.0,6/13,14.40%,BMP2;SOX9;TGFBR2;ACVR1;BMPR1A;MDM4
prerank,GO_Biological_Process_2021__cellular response to virus (GO:0098586),-0.7481649460415735,-1.4880179015348487,0.0,0.5950256350535843,1.0,4/23,12.29%,IFI6;IL12A;LGALS8;VWCE
prerank,GO_Biological_Process_2021__pathway-restricted SMAD protein phosphorylation (GO:0060389),0.7559745949552983,1.4876411836293808,0.06818181818181818,0.4898211605009871,1.0,5/9,13.12%,BMP2;SMAD7;TGFBR2;ACVR1;TGFBR1
prerank,GO_Biological_Process_2021__protein autophosphorylation (GO:0046777),0.5150761991914512,1.487389854268826,0.0,0.48912783345404237,1.0,34/134,15.08%,MAP3K11;PRKX;ERBB4;CSF1R;EGFR;PASK;EPHA4;FLT1;CDKL5;PDGFRA;DAPK2;TNIK;AKT1;NTRK2;TEC;CAMK2B;UHMK1;DYRK1A;CDK12;CAMK2A;EIF2AK4;PRKD1;CAMK2D;SMG1;SIK2;PTK2;OXSR1;PIKFYVE;MAPKAPK2;FER;MAPKAPK5;MAP3K10;TAOK2;GSK3B
prerank,"GO_Biological_Process_2021__mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",-0.6862974158502464,-1.4871163914429002,0.015151515151515152,0.5929004503716584,1.0,11/30,20.93%,NDUFS5;NDUFA6;NDUFA2;NDUFC1;NDUFB10;NDUFB3;NDUFA1;NDUFB9;NDUFA12;NDUFB7;NDUFB11
prerank,GO_Biological_Process_2021__negative regulation of microtubule polymerization or depolymerization (GO:0031111),0.5962346948202665,1.4868435830519595,0.037037037037037035,0.48998430488146505,1.0,18/31,27.19%,SNCA;DYRK1A;TTBK2;NAV3;CAMSAP2;CLIP3;MAPRE1;CLASP1;HDGFL3;KATNB1;ATXN7;CIB1;TRIM54;TBCD;FKBP4;TAOK1;CLASP2;ARHGEF2
prerank,GO_Biological_Process_2021__positive regulation of establishment of protein localization to telomere (GO:1904851),0.7326318920537519,1.484677130707581,0.024390243902439025,0.49897359957765275,1.0,3/10,15.88%,CCT4;DKC1;CCT3
prerank,GO_Biological_Process_2021__histone modification (GO:0016570),0.48795787444047223,1.4845427920570369,0.0,0.4973299228511798,1.0,25/99,17.03%,HDAC9;PRMT1;RPS6KA4;EYA2;PRMT6;RCOR1;PHC1;UBE2N;HDAC2;CCNA2;KAT2A;SUPT3H;EP300;USP3;INCENP;TBL1XR1;HDAC4;SIRT1;SIRT2;EYA3;USP22;PADI2;MIER3;NAA50;KAT6B
prerank,GO_Biological_Process_2021__regulation of dendritic spine development (GO:0060998),0.6394868291588102,1.484133086125126,0.02127659574468085,0.4979080356876713,1.0,11/21,22.01%,SHANK1;CPEB3;LLPH;CAMK2B;PPFIA2;SHANK3;DLG5;TANC2;ARF6;FMR1;NLGN1
prerank,GO_Biological_Process_2021__regulation of fertilization (GO:0080154),0.9106638160264682,1.4841236762106411,0.0,0.49560290589282097,1.0,3/5,8.66%,INTS13;LHFPL2;PLCB1
prerank,GO_Biological_Process_2021__sno(s)RNA 3'-end processing (GO:0031126),0.7358469591327668,1.48345984503557,0.02631578947368421,0.4971636532725945,1.0,4/11,12.22%,EXOSC6;FBLL1;DKC1;TENT4B
prerank,GO_Biological_Process_2021__proteoglycan biosynthetic process (GO:0030166),0.648403919765643,1.4831890545500093,0.02564102564102564,0.4963088295940433,1.0,9/28,11.32%,CHST8;CHST11;CSGALNACT1;UGDH;BMPR1B;EXT1;EXT2;CANT1;EXTL3
prerank,MSigDB_Hallmark_2020__Allograft Rejection,-0.5906921998712807,-1.4831258256918118,0.01282051282051282,0.6123854019510243,1.0,23/108,14.31%,GBP2;WARS1;RPL39;GCNT1;IL7;HLA-A;STAT1;RPL9;IGSF6;B2M;TIMP1;IFNGR2;IL12A;RPS9;RPS3A;KLRD1;TLR3;IL18;BRCA1;SPI1;RPS19;RIPK2;CCL2
prerank,GO_Biological_Process_2021__regulation of angiotensin levels in blood (GO:0002002),0.8916131385445647,1.482800460972518,0.0392156862745098,0.49320971337659036,1.0,2/7,5.00%,ACE2;MME
prerank,GO_Biological_Process_2021__angiotensin maturation (GO:0002003),0.8916131385445647,1.482800460972518,0.0392156862745098,0.49320971337659036,1.0,2/7,5.00%,ACE2;MME
prerank,GO_Biological_Process_2021__odontogenesis of dentin-containing tooth (GO:0042475),0.7811151248098811,1.4825327747564685,0.0,0.491866241250376,1.0,2/8,8.82%,BMP2;HDAC2
prerank,GO_Biological_Process_2021__ATP-dependent chromatin remodeling (GO:0043044),0.5772387134714653,1.482517234423163,0.0,0.48979800170531657,1.0,24/39,35.33%,SMARCAD1;HNRNPC;ARID1B;MBD2;SMARCA2;HDAC2;MBD3;SMARCD2;RBBP4;SMARCC1;SPTY2D1;VPS72;ARID1A;ERCC6;PBRM1;CHD3;MTA2;INO80;NASP;CHD8;GATAD2B;ACTR6;CECR2;SRCAP
prerank,GO_Biological_Process_2021__negative regulation of PERK-mediated unfolded protein response (GO:1903898),0.8440369454749709,1.4805028239217135,0.027777777777777776,0.49750474475455836,1.0,2/5,13.73%,PPP1R15B;NCK1
prerank,GO_Biological_Process_2021__alcohol catabolic process (GO:0046164),-0.8424725625034414,-1.479915683422213,0.03571428571428571,0.628591818879463,1.0,4/8,13.24%,ADH4;MT3;APOE;SCARF1
prerank,GO_Biological_Process_2021__phospholipid dephosphorylation (GO:0046839),0.6168476435437217,1.4793493879350452,0.03125,0.5011991031307065,1.0,19/37,27.53%,PLPP1;PIP4P2;PLPP3;PLPP2;SYNJ1;MTMR10;MTMR2;PLPPR4;PTEN;MTM1;MTMR12;SACM1L;OCRL;TPTE2;MTMR6;SYNJ2;PLPPR2;MTMR9;SGPP1
prerank,GO_Biological_Process_2021__positive regulation of cell aging (GO:0090343),-0.8081789210999661,-1.4785225151227106,0.05172413793103448,0.6312179741369877,1.0,2/9,3.99%,ARG2;B2M
prerank,GO_Biological_Process_2021__regulation of translational initiation (GO:0006446),0.5558418138815802,1.4778957913818171,0.034482758620689655,0.5060238960900784,1.0,17/60,22.38%,NCK2;PPP1R15B;C8ORF88;RPS6KB2;UHMK1;EIF4EBP2;RPS6KB1;EIF2AK4;EIF3H;NCK1;EIF4G3;IMPACT;EIF3E;YTHDF2;DNAJC3;FMR1;YTHDF3
prerank,GO_Biological_Process_2021__response to insulin (GO:0032868),0.5248466312250123,1.4777140989000361,0.0,0.5045810639939258,1.0,15/70,8.84%,LPIN3;TBC1D4;HDAC9;KAT2B;PDE3B;FOXO1;SORT1;RHOQ;DENND4C;RAB31;AKT1;RAB8B;PIK3R1;IRS1;RPS6KB1
prerank,GO_Biological_Process_2021__postsynapse organization (GO:0099173),0.8471619236710651,1.4770747695717303,0.0,0.5057452485702049,1.0,1/8,0.52%,WNT7A
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",0.53679125288069,1.4767245870952392,0.06451612903225806,0.5051055224129638,1.0,16/47,22.28%,SOX4;CRADD;PRMT1;RGCC;CNOT9;CNOT6L;CNOT2;CNOT4;EP300;MDM4;TFDP2;CNOT8;MDM2;PCBP4;AURKA;E2F4
prerank,GO_Biological_Process_2021__protein deacetylation (GO:0006476),0.5812476002765031,1.4761164711991213,0.0,0.5059000760582839,1.0,8/40,15.70%,HDAC9;RCOR1;HDAC2;TBL1XR1;HDAC4;SIRT1;SIRT2;MIER3
prerank,GO_Biological_Process_2021__regulation of DNA repair (GO:0006282),0.5335316331310771,1.4758479320555884,0.034482758620689655,0.5052652395742011,1.0,17/41,20.95%,EGFR;EYA2;UBE2N;UBR5;RAD52;NPAS2;TRIP12;SIRT1;DHX9;EYA3;KAT7;TRIM28;UIMC1;BRCC3;WRNIP1;H2AX;CDK9
prerank,GO_Biological_Process_2021__cytoplasmic translational initiation (GO:0002183),-0.7481326928092147,-1.4747494804321548,0.027777777777777776,0.6479450152735351,1.0,2/18,8.10%,EIF2S3B;EIF2S2
prerank,GO_Biological_Process_2021__regulation of mast cell chemotaxis (GO:0060753),0.9028894406394581,1.4747380815358657,0.0,0.5083891555685559,1.0,3/5,9.39%,VEGFD;RIN3;VEGFC
prerank,GO_Biological_Process_2021__vitamin D metabolic process (GO:0042359),-0.8269540237659356,-1.4745915707439574,0.03636363636363636,0.6408631789634079,1.0,1/8,0.25%,GC
prerank,PanglaoDB_Augmented_2021__Crypt Cells,0.5374773360210073,1.4738519019294902,0.0,0.5109925648825057,1.0,29/84,16.57%,LRRN1;CAPN13;PCDH19;SPON1;CLIC5;MYO5B;NPNT;PDZRN3;HID1;PRIMA1;SLC12A2;AHCYL2;TNFRSF19;FRZB;PBX1;AMOT;DLG3;ZBTB7C;PPP1R1B;NDRG2;ARHGAP32;ZNF423;ASXL3;MYH14;NEBL;MCF2L;NEO1;BMP7;HEPH
prerank,PanglaoDB_Augmented_2021__Endothelial Cells (Blood Brain Barrier),0.5031112346293778,1.4734012089669029,0.0,0.5109759206762787,1.0,32/106,22.13%,MTCL1;SLC19A1;MPDZ;SALL1;MEIS3;EGFR;SOX9;ALCAM;CEP170B;TNFRSF19;FMNL2;RBFOX2;HSPA12A;SHC3;CAMK2N1;DZIP1;FARP1;TJP1;PSD3;SH3PXD2B;YAP1;DDAH1;BCAR1;LIFR;ADGRB2;CHST3;LRP4;CASKIN2;LEF1;ARNT2;SDC3;DOCK1
prerank,PanglaoDB_Augmented_2021__B Cells Memory,-0.6313880159026287,-1.4728378902682808,0.0136986301369863,0.6471708874177723,1.0,14/54,12.02%,P2RY10;TAGAP;IL7;GPR18;DPEP2;ARHGAP9;GMFG;TRAF3IP3;TMC8;ZBTB32;SP140;RHOH;ARHGAP30;RCSD1
prerank,GO_Biological_Process_2021__histone H4 acetylation (GO:0043967),0.5321088414334609,1.4723492847663835,0.037037037037037035,0.5138955653401533,1.0,18/46,26.70%,MSL2;CHD5;ZZZ3;KANSL2;EP300;OGT;KAT7;TRIM16;EP400;ATF2;APBB1;LEF1;BEND3;EPC1;KANSL3;ING3;HAT1;HCFC1
prerank,"GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",-0.58606863159283,-1.4715477554105858,0.0273972602739726,0.6492227925776257,1.0,13/59,13.44%,PSMB6;HLA-B;HLA-A;HLA-C;B2M;PSMA8;PSMB9;PSMA7;PSMC3;VAMP8;PSME1;PSMC4;PSMA3
prerank,GO_Biological_Process_2021__positive regulation of phosphorylation (GO:0042327),0.4315813324217563,1.4710715377314456,0.0,0.5172776373595065,1.0,53/194,19.09%,VEGFD;EPHA7;EPHA6;LEPR;EFNA5;NPTN;BMP2;ERBB4;CSF1R;EPHA2;EGFR;EPHA4;FLT1;ZBTB20;SOX9;PDGFRA;FGF17;ARRB1;TESK1;LIMCH1;TNIK;AKT1;NTRK2;EPHA5;ROR1;VEGFC;RALB;CRKL;PTK2;CLIP3;MERTK;SIRT1;SLC4A4;ACVR2A;WDFY2;NIBAN1;MLXIPL;ROCK2;NRP1;PTGES3;HGF;SEMA4D;TFRC;AKT2;FXR1;HIF1A;ITGA6;RAP2A;IGF1;FAS;AXIN1;BCL10;CCND3
prerank,GO_Biological_Process_2021__response to purine-containing compound (GO:0014074),-0.7528847028619547,-1.4709984617669372,0.04918032786885246,0.6465810757181435,1.0,3/15,11.33%,DUOX1;STAT1;P2RY6
prerank,GO_Biological_Process_2021__extracellular transport (GO:0006858),-0.8129694403480874,-1.4707945897678725,0.0196078431372549,0.6402857031947519,1.0,1/10,0.24%,SPAG17
prerank,GO_Biological_Process_2021__axon extension (GO:0048675),0.6281438099561083,1.4705657300109731,0.0,0.5168879940199054,1.0,11/23,16.09%,SEMA5B;SLIT1;ALCAM;NRP2;AUTS2;NLGN3;SLIT2;CYFIP1;USP9X;NRP1;PPP3CB
prerank,GO_Biological_Process_2021__negative regulation of ubiquitin protein ligase activity (GO:1904667),-0.9000911347361131,-1.4699944287853524,0.038461538461538464,0.6391775672326856,1.0,4/8,6.86%,RPL23;RPL11;RPS7;RPL5
prerank,GO_Biological_Process_2021__mitochondrial DNA metabolic process (GO:0032042),0.7919042450116939,1.469647554851347,0.06521739130434782,0.5188484323042775,1.0,2/7,14.52%,DNA2;PRIMPOL
prerank,PanglaoDB_Augmented_2021__Dopaminergic Neurons,0.5040565503489468,1.4680569354785133,0.0,0.5256037290007646,1.0,27/104,14.99%,CHRNA4;PCDH8;ABCC8;SNAP91;NR4A2;CAMKV;ADCY1;LONRF2;CADPS2;CACNA1B;NOL4;CDK5R2;KIF5A;CHD5;NRXN1;ASTN1;SRCIN1;ADGRA1;CELF3;SLITRK1;TMEM196;OLFM3;MAPK4;LY6H;KCNQ2;TENM1;ELAVL3
prerank,GO_Biological_Process_2021__protein deacylation (GO:0035601),0.6042158241403122,1.4679126787933696,0.06666666666666667,0.5238836703767664,1.0,11/23,25.83%,ABHD17B;ABHD17A;HDAC4;SIRT1;SIRT2;LYPLA2;SIRT5;LYPLAL1;HDAC10;ABHD17C;ABHD10
prerank,GO_Biological_Process_2021__regulation of autophagosome assembly (GO:2000785),0.5914476566054213,1.4676800902833609,0.03225806451612903,0.52279139049177,1.0,16/33,28.70%,TBC1D12;SMCR8;SEC22B;RALB;PIP4K2C;PIKFYVE;RAB3GAP1;UBQLN2;MTM1;LRSAM1;SCFD1;SH3GLB1;RAB5A;PIP4K2B;IFT20;RAB1B
prerank,GO_Biological_Process_2021__metaphase/anaphase transition of cell cycle (GO:0044784),0.8553446464670071,1.4671007140625674,0.020833333333333332,0.5213098844017194,1.0,2/6,5.89%,ANAPC1;CDC27
prerank,GO_Biological_Process_2021__metaphase/anaphase transition of mitotic cell cycle (GO:0007091),0.8553446464670071,1.4671007140625674,0.020833333333333332,0.5213098844017194,1.0,2/6,5.89%,ANAPC1;CDC27
prerank,GO_Biological_Process_2021__homologous chromosome segregation (GO:0045143),-0.7926145620048284,-1.4667538030589968,0.06666666666666667,0.6573146317346652,1.0,5/13,14.95%,RNF212B;MEIOB;IHO1;MEI4;RNF212
prerank,GO_Biological_Process_2021__COPII-coated vesicle budding (GO:0090114),0.5143720435163062,1.466100934917641,0.0,0.5234056768971316,1.0,20/63,19.03%,VAPB;BET1;VAPA;TRAPPC6B;SEC23B;SEC22B;PPP6R3;COL7A1;TRAPPC10;PEF1;SEC24B;NSF;TFG;RAB1A;TRAPPC9;CUL3;SEC23IP;SEC23A;CNIH1;CD59
prerank,GO_Biological_Process_2021__regulation of chromatin silencing (GO:0031935),-0.8294023924794638,-1.465983437977163,0.034482758620689655,0.6558974196100084,1.0,3/10,8.55%,H1-4;H1-2;ATAD2
prerank,GO_Biological_Process_2021__antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),-0.800070767156013,-1.4657825224482355,0.0,0.6504065678935452,1.0,7/12,15.81%,RPL39;RPL30;CXCL2;PGLYRP1;RPS19;ROMO1;CXCL14
prerank,MSigDB_Hallmark_2020__Apical Junction,0.44788709860537057,1.4657473006277255,0.0,0.5230707369931977,1.0,52/157,21.98%,CERCAM;ARHGEF6;AMH;CNTN1;CADM2;EGFR;HADH;RSU1;PARVA;ITGA10;COL9A1;CDH11;CDK8;NECTIN3;KCNH2;WASL;ADAM23;IRS1;CDH4;MAPK11;PBX2;MAP3K20;NF1;MAP4K2;NLGN3;PTK2;SLIT2;EXOC4;PPP2R2C;TJP1;TIAL1;VASP;TAOK2;DLG1;TUBG1;GNAI1;PARD6G;CRAT;VCAN;AKT2;PTEN;MPZL1;NRXN2;CDH6;TMEM8B;ADAM9;NECTIN2;AKT3;PTPRC;CDH8;ADAM15;SDC3
prerank,GO_Biological_Process_2021__retinol metabolic process (GO:0042572),-0.7811434196712402,-1.4651590835095158,0.06779661016949153,0.6477901897023826,1.0,8/11,16.34%,ADH4;CYP2D6;ADH6;RDH11;RETSAT;RDH12;LRAT;CYP3A4
prerank,GO_Biological_Process_2021__regulation of acyl-CoA biosynthetic process (GO:0050812),0.8220753426863798,1.465134570825985,0.0,0.5222095321692842,1.0,2/8,0.74%,PDK4;PDP1
prerank,GO_Biological_Process_2021__regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510),0.8220753426863798,1.465134570825985,0.0,0.5222095321692842,1.0,2/8,0.74%,PDK4;PDP1
prerank,GO_Biological_Process_2021__histone arginine methylation (GO:0034969),0.7819259164271055,1.4645178679632067,0.02631578947368421,0.5226120206329586,1.0,2/7,4.84%,PRMT1;PRMT6
prerank,GO_Biological_Process_2021__induction of positive chemotaxis (GO:0050930),0.8909448282086447,1.4642934706347404,0.018518518518518517,0.5215601032028968,1.0,3/6,9.39%,VEGFD;CXCL12;VEGFC
prerank,GO_Biological_Process_2021__lipid phosphorylation (GO:0046834),0.7981985281186783,1.4640493724678292,0.06521739130434782,0.5210422102059633,1.0,4/9,14.38%,DGKB;DGKH;DGKZ;DGKG
prerank,GO_Biological_Process_2021__cellular response to sterol (GO:0036315),0.680177557203707,1.4638583902366444,0.021739130434782608,0.5199395532325555,1.0,5/12,18.35%,GRAMD1C;RORA;OSBPL7;SMO;INSIG2
prerank,GO_Biological_Process_2021__regulation of B cell activation (GO:0050864),0.7245981774295721,1.4632763852905766,0.0,0.5209312321551719,1.0,4/13,13.60%,TNFSF4;CD22;AHR;SAMSN1
prerank,GO_Biological_Process_2021__activation of GTPase activity (GO:0090630),0.5100217975487196,1.4627720747144068,0.0,0.5209413185194579,1.0,23/76,18.09%,TBC1D4;TIAM2;ARHGEF16;TBC1D1;EPHA2;USP6NL;TBC1D5;TBC1D12;EVI5L;ARHGEF26;ARHGAP24;RANGAP1;MTSS2;TBC1D22B;DOCK7;TBC1D8B;SCRIB;TBC1D10A;GARNL3;RALGAPB;RABGAP1L;RALGAPA1;TBCK
prerank,GO_Biological_Process_2021__positive regulation of dendritic spine morphogenesis (GO:0061003),0.7700511448111562,1.462753639594091,0.020833333333333332,0.5190762366018743,1.0,4/9,12.74%,CAMK2B;CAPRIN2;LRP8;CAPRIN1
prerank,GO_Biological_Process_2021__protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),0.6353159625474377,1.462580504397484,0.08108108108108109,0.5181274916904545,1.0,11/23,29.73%,FBXL17;KLHL15;UGGT1;VCP;ZYG11B;CUL3;DERL1;RNF185;BAG6;AUP1;UGGT2
prerank,GO_Biological_Process_2021__peptidyl-tyrosine autophosphorylation (GO:0038083),0.7947642386116672,1.4623220861491668,0.07142857142857142,0.5173144901204858,1.0,3/10,7.40%,EGFR;TEC;DYRK1A
prerank,GO_Biological_Process_2021__antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),-0.705058627655156,-1.4622587759657957,0.0,0.6615645613952535,1.0,6/27,6.58%,HLA-B;HLA-A;HLA-C;B2M;ERAP2;ERAP1
prerank,GO_Biological_Process_2021__ribosomal small subunit assembly (GO:0000028),-0.7669950467632529,-1.4620142495953297,0.0,0.6555180051668678,1.0,4/16,7.88%,RPS14;RPS27;RPS15;RPS28
prerank,"GO_Biological_Process_2021__regulation of synaptic transmission, glutamatergic (GO:0051966)",0.5719474416706206,1.4618683816195839,0.0,0.5178497508815154,1.0,20/38,24.31%,CACNG2;CDH2;NRXN1;CACNG3;TSHZ3;HOMER1;DGKZ;NLGN3;SHANK3;GRM1;OPHN1;GRM8;DRD2;UNC13A;CACNG8;NLGN1;CACNG4;GRIK1;GRM5;CACNG7
prerank,GO_Biological_Process_2021__telomere maintenance via telomerase (GO:0007004),-0.7213363450497869,-1.4616786816483294,0.04477611940298507,0.6511996818499146,1.0,2/26,3.75%,PIF1;NOP10
prerank,GO_Biological_Process_2021__cell-cell junction organization (GO:0045216),0.5607216381468288,1.4616057314133686,0.0,0.5176170237242365,1.0,29/63,23.30%,CADM2;CSF1R;MARVELD3;CDH2;CDH11;NECTIN3;CDH20;PKP4;CDH4;CADM1;TLN2;SDK1;CDH9;NLGN4X;AFDN;OCLN;TJP1;CDH13;CSK;CDH18;CTNND2;CDH6;CDH10;DCHS1;NECTIN2;CDH8;TJP2;NECTIN1;CDH19
prerank,GO_Biological_Process_2021__regulation of triglyceride catabolic process (GO:0010896),0.8800189866438387,1.4610345232976083,0.06521739130434782,0.5176397212910233,1.0,2/6,6.31%,PLIN5;ABHD5
prerank,GO_Biological_Process_2021__actin crosslink formation (GO:0051764),0.7733339017901028,1.4608922265548205,0.021739130434782608,0.516209555494967,1.0,2/9,2.91%,GAS2;EPS8
prerank,GO_Biological_Process_2021__regulation of establishment of protein localization to telomere (GO:0070203),0.7295712079013101,1.4603137841775686,0.0,0.5177475100619928,1.0,3/11,15.88%,CCT4;DKC1;CCT3
prerank,MSigDB_Hallmark_2020__Inflammatory Response,-0.5511766078662839,-1.460043689341327,0.0,0.6559333559127905,1.0,29/118,14.31%,SLC28A2;IL1R1;GPR183;IRF1;BST2;ITGA5;BEST1;APLNR;ADM;TIMP1;RASGRP1;IFNGR2;GPC3;SELENOS;PDPN;TACR1;EMP3;TLR3;EIF2AK2;IL18;CX3CL1;LY6E;CD14;CALCRL;IL15RA;CLEC5A;SCARF1;RIPK2;CCL2
prerank,GO_Biological_Process_2021__endocytic recycling (GO:0032456),0.592659589714272,1.4594284757413458,0.06896551724137931,0.5199004431811335,1.0,7/47,8.20%,ANKRD50;ACAP2;EPS15;CMTM6;EHD4;SNX27;DENND1A
prerank,GO_Biological_Process_2021__regulation of cilium beat frequency (GO:0003356),-0.9183770652054241,-1.459325838415989,0.0,0.6544395405476722,1.0,2/6,5.19%,CCDC39;DNAAF1
prerank,GO_Biological_Process_2021__lung epithelium development (GO:0060428),0.9088766971976054,1.4592979885110093,0.0,0.51822827605303,1.0,2/6,3.61%,RCN3;ASCL1
prerank,GO_Biological_Process_2021__serine family amino acid biosynthetic process (GO:0009070),0.7546518824753458,1.4585850380965615,0.05405405405405406,0.5192434137635997,1.0,1/11,1.65%,SERINC5
prerank,GO_Biological_Process_2021__basic amino acid transport (GO:0015802),-0.8061920962248651,-1.4583729026801278,0.037037037037037035,0.6540090168103443,1.0,1/8,0.76%,SLC3A1
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),-0.584589597264794,-1.4580340668179839,0.028169014084507043,0.6493735604919016,1.0,14/61,13.44%,PSMB6;HLA-B;HLA-A;HLA-C;B2M;PSMA8;PSMB9;PSMA7;PSMC3;VAMP8;PSME1;PSMC4;MFSD6;PSMA3
prerank,GO_Biological_Process_2021__modulation of excitatory postsynaptic potential (GO:0098815),0.6006102632932163,1.4575928407306116,0.023255813953488372,0.5222337132943745,1.0,8/26,15.54%,WNT7A;SHANK1;GRIN1;NRXN1;NLGN3;SHANK3;NLGN4X;MTMR2
prerank,GO_Biological_Process_2021__positive regulation of GTPase activity (GO:0043547),0.4524542880043004,1.4574675081165989,0.0,0.5208185927918011,1.0,47/145,18.88%,TBC1D4;TIAM2;ARHGEF16;TBC1D1;EPHA2;PICALM;RSU1;RGS16;SNX18;RGS6;USP6NL;TBC1D5;CDKL5;ARAP1;TBC1D12;EVI5L;DOCK9;ARHGEF26;ARHGAP24;RANGAP1;RAPGEF2;PKP4;MTSS2;TBC1D22B;DOCK7;NF1;ADRB1;MAP4K4;AFDN;RAB3GAP1;RAP1GDS1;TBC1D8B;RAP1A;GSK3B;SCRIB;SNX13;ARHGEF7;TBC1D10A;SEMA4D;GARNL3;RALGAPB;RABGAP1L;RALGAPA1;ITGA6;TBCK;RAB11FIP2;ALS2
prerank,GO_Biological_Process_2021__microtubule-based transport (GO:0099111),-0.807462417973041,-1.4562729939937415,0.07142857142857142,0.6563972275762523,1.0,1/11,0.24%,SPAG17
prerank,GO_Biological_Process_2021__negative regulation of myoblast differentiation (GO:0045662),0.8207681094987855,1.4558450476094724,0.02564102564102564,0.5259944236848311,1.0,3/10,4.24%,ANKRD2;SOX8;SOX9
prerank,GO_Biological_Process_2021__axo-dendritic protein transport (GO:0099640),0.8312797522170323,1.4556435232826153,0.0,0.5205540015540159,1.0,2/8,11.36%,KIF5A;KIF5C
prerank,GO_Biological_Process_2021__protein localization to presynapse (GO:1905383),0.8312797522170323,1.4556435232826153,0.0,0.5205540015540159,1.0,2/8,11.36%,KIF5A;KIF5C
prerank,GO_Biological_Process_2021__anterograde axonal protein transport (GO:0099641),0.8312797522170323,1.4556435232826153,0.0,0.5205540015540159,1.0,2/8,11.36%,KIF5A;KIF5C
prerank,GO_Biological_Process_2021__positive regulation of developmental process (GO:0051094),0.49114491765611396,1.4555079875097503,0.0,0.5189895466843404,1.0,37/141,14.10%,PLD6;ELAPOR2;DCN;SOX8;SOX5;SHANK1;BMP2;VHL;CPEB3;SOX9;MCU;RPS6KA3;MFF;LLPH;TRPM4;CAMK2B;NRXN1;SPIRE1;BMPR1B;PLCB1;SOX6;NCOA3;ZNF268;PRKN;LRP8;DVL1;SHANK3;ZBTB16;ACVR1;TAPT1;DLG5;SIRT1;GRIP1;RREB1;B4GALT5;CLASP1;BMPR1A
prerank,GO_Biological_Process_2021__regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),0.7910848633643232,1.4550091277630994,0.021739130434782608,0.5193682722784825,1.0,3/9,9.71%,FUT9;NFAT5;ZDHHC21
prerank,GO_Biological_Process_2021__C-terminal protein amino acid modification (GO:0018410),0.6701710620060605,1.454570549594729,0.05555555555555555,0.5189623715645544,1.0,4/11,18.61%,ATG7;AGTPBP1;TTL;ATG5
prerank,GO_Biological_Process_2021__mitotic G1 DNA damage checkpoint signaling (GO:0031571),0.5381781543937355,1.4540785733379618,0.07692307692307693,0.5188590512793657,1.0,20/56,22.28%,SOX4;CRADD;PRMT1;RGCC;CNOT9;SDE2;CNOT6L;CNOT2;RFWD3;CNOT4;EP300;MDM4;TFDP2;CNOT8;MDM2;WAC;PCBP4;FBXO31;AURKA;E2F4
prerank,GO_Biological_Process_2021__termination of RNA polymerase II transcription (GO:0006369),0.5940350846851474,1.4538952331801587,0.027777777777777776,0.5179803504684967,1.0,5/31,2.47%,NUDT21;SNRPF;WDR33;PAPOLA;CSTF3
prerank,GO_Biological_Process_2021__snRNA 3'-end processing (GO:0034472),0.6496685686068633,1.4530484046090444,0.05263157894736842,0.5210340876786437,1.0,7/18,18.82%,EXOSC6;INTS7;TOE1;INTS6;INTS8;USB1;INTS6L
prerank,GO_Biological_Process_2021__negative regulation of transforming growth factor beta production (GO:0071635),-0.9033218570585032,-1.4524557486385579,0.0,0.6798562857722051,1.0,1/6,0.14%,CD24
prerank,GO_Biological_Process_2021__fat-soluble vitamin metabolic process (GO:0006775),-0.7553619351423018,-1.4522192656302408,0.014925373134328358,0.674977559996775,1.0,3/19,5.40%,GC;RPE65;RBP2
prerank,GO_Biological_Process_2021__maturation of LSU-rRNA (GO:0000470),-0.6987977601515871,-1.4521065174055372,0.0625,0.6690917356106619,1.0,11/24,20.05%,RPL35;RPL7A;RPL7;DDX18;RPL10A;RPF2;WDR12;NIFK;LAS1L;SNU13;RRP15
prerank,GO_Biological_Process_2021__camera-type eye photoreceptor cell differentiation (GO:0060219),0.8905320561563814,1.4512624633978985,0.02702702702702703,0.5275033586958509,1.0,2/5,4.24%,SOX8;SOX9
prerank,GO_Biological_Process_2021__regulation of type B pancreatic cell development (GO:2000074),0.8470426749924411,1.4508269920352648,0.05454545454545454,0.5274297525808177,1.0,6/7,15.08%,FOXO1;RHEB;AKT1;RFX3;CLOCK;GSK3B
prerank,GO_Biological_Process_2021__regulation of amyloid fibril formation (GO:1905906),-0.7325065144443853,-1.4504477794990736,0.016129032258064516,0.6734608765585824,1.0,6/12,21.00%,PFDN6;CLU;APOE;VBP1;CRYAB;PFDN1
prerank,GO_Biological_Process_2021__anoikis (GO:0043276),0.7916298340002147,1.4502787805301511,0.09302325581395349,0.5271801450947746,1.0,5/8,16.28%,DAPK2;AKT1;PIK3CA;MAP3K7;STK11
prerank,GO_Biological_Process_2021__positive regulation of synaptic transmission (GO:0050806),0.5190087410955505,1.450204851514482,0.038461538461538464,0.5258183050769167,1.0,15/62,12.25%,SHISA7;CACNG2;KCTD13;NPTN;ADCY1;BAIAP3;MPP2;NRXN1;CACNG3;TSHZ3;ADRA1A;EIF2AK4;NLGN3;SHANK3;RIMS3
prerank,GO_Biological_Process_2021__positive regulation of oxidoreductase activity (GO:0051353),0.6907720399781047,1.4498814562927023,0.029411764705882353,0.5247583091149649,1.0,2/9,7.84%,PDP1;ABL2
prerank,GO_Biological_Process_2021__homologous chromosome pairing at meiosis (GO:0007129),-0.7482873752244465,-1.4497394873578675,0.03076923076923077,0.6727546856800719,1.0,10/20,15.53%,RNF212B;SYCE2;MEIOB;IHO1;MEI4;STAG3;RAD21L1;REC8;RNF212;TEX11
prerank,GO_Biological_Process_2021__endoplasmic reticulum organization (GO:0007029),0.5350211050162926,1.449622489279093,0.0,0.5241715809142684,1.0,6/64,6.48%,VAPB;VAPA;TRAM1;TMEM33;TMCC1;RAB18
prerank,GO_Biological_Process_2021__regulation of bicellular tight junction assembly (GO:2000810),0.7384688210179228,1.4495890434695395,0.030303030303030304,0.5226608702966349,1.0,8/13,20.29%,EPHA2;OCLN;TJP1;ROCK2;CBFB;RUNX1;ROCK1;NPHP4
prerank,PanglaoDB_Augmented_2021__Granulosa Cells,0.49928676685845197,1.4495121011306566,0.037037037037037035,0.5211030320822229,1.0,24/93,19.15%,MTCL1;AMOTL1;TENM3;MPDZ;AMH;MEIS3;EPHA2;EGFR;PARVA;BOK;PCGF2;MID1;RBFOX2;GPR176;NCKAP1;B4GALT2;ENAH;TJP1;YAP1;DDAH1;BCAR1;CHST3;LRP4;CASKIN2
prerank,GO_Biological_Process_2021__immune response-regulating cell surface receptor signaling pathway (GO:0002768),-0.9560570803914341,-1.4494401346360581,0.0,0.668786919082536,1.0,1/5,0.14%,CD24
prerank,GO_Biological_Process_2021__RNA-dependent DNA biosynthetic process (GO:0006278),-0.719767420797091,-1.4488237332728027,0.03125,0.6673129569600981,1.0,2/27,3.75%,PIF1;NOP10
prerank,GO_Biological_Process_2021__negative regulation of sprouting angiogenesis (GO:1903671),-0.8567447162946016,-1.4488202264824832,0.06557377049180328,0.6610175517057574,1.0,4/9,8.27%,EPN1;KLF2;THBS1;PIK3CB
prerank,GO_Biological_Process_2021__positive regulation of axonogenesis (GO:0050772),0.5542893000303317,1.4487545503289134,0.0,0.5227817904148195,1.0,13/40,19.22%,TIAM2;PLXNA2;CDKL5;NTRK2;PLXNA1;ROBO1;CHODL;SLITRK1;SLIT2;SEMA4D;RUFY3;PLXNA4;ARHGDIA
prerank,GO_Biological_Process_2021__response to light stimulus (GO:0009416),0.5990542458134513,1.4484592655652024,0.0,0.5226694189877783,1.0,7/42,15.86%,TYR;MAPK10;MEN1;CLOCK;MAP4K3;PRIMPOL;MAPK8
prerank,GO_Biological_Process_2021__attachment of mitotic spindle microtubules to kinetochore (GO:0051315),-0.851223698374098,-1.4483550001112084,0.03571428571428571,0.6579073896416238,1.0,4/9,8.70%,CENPE;KIF2C;NUF2;MIS12
prerank,GO_Biological_Process_2021__positive regulation of cellular senescence (GO:2000774),-0.8228625178439698,-1.4479377855951403,0.03571428571428571,0.6555429368208375,1.0,2/8,3.99%,ARG2;B2M
prerank,GO_Biological_Process_2021__regulation of synapse organization (GO:0050807),0.6265046775025995,1.4478374061745847,0.06451612903225806,0.5233586006327108,1.0,8/21,12.67%,EPHA4;CDKL5;ABHD17B;CTNNA2;CAMK2B;SLITRK2;ABHD17A;PDLIM5
prerank,GO_Biological_Process_2021__JNK cascade (GO:0007254),0.5895268052573847,1.4476019188267117,0.058823529411764705,0.522675018827273,1.0,17/38,15.86%,MAPK10;MAP3K11;ARHGEF6;IRAK2;TAB3;MAP2K4;TNFRSF19;UBE2N;MAP3K7;TAB1;MAP3K5;MAP4K2;CRKL;GPS1;MAP4K3;MAP3K10;MAPK8
prerank,GO_Biological_Process_2021__regulation of protein autophosphorylation (GO:0031952),0.6654876541454735,1.4473630238962245,0.05714285714285714,0.5219961841177061,1.0,10/32,17.59%,EPHA7;TESK1;PPP2R5A;PDGFA;PDGFC;RAP2C;TAOK2;IMPACT;PPP2R5E;RAP2A
prerank,GO_Biological_Process_2021__regulation of sequestering of triglyceride (GO:0010889),0.729420373943459,1.4463709250728765,0.06896551724137931,0.5252843212007734,1.0,3/11,14.87%,PLIN5;ABHD5;OSBPL8
prerank,GO_Biological_Process_2021__positive regulation of mRNA 3'-end processing (GO:0031442),0.7365381693508186,1.446050893986485,0.08108108108108109,0.5249396228835764,1.0,2/10,3.84%,NUDT21;CPEB3
prerank,GO_Biological_Process_2021__determination of heart left/right asymmetry (GO:0061371),-0.6575164757020662,-1.4452606232985399,0.030303030303030304,0.6686760172090568,1.0,5/27,8.69%,CCDC39;MMP21;APLNR;DNAAF1;SRF
prerank,"GO_Biological_Process_2021__positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",0.6789562319465186,1.4452080994480199,0.09090909090909091,0.5266772443196703,1.0,4/12,15.88%,GNL3L;CCT4;DKC1;CCT3
prerank,GO_Biological_Process_2021__regulation of glycogen metabolic process (GO:0070873),0.7361816408723602,1.4449400288640122,0.08333333333333333,0.5259940024640277,1.0,5/9,15.88%,PPP1R3D;AKT1;PPP1R3F;RUBCNL;PPP1R3G
prerank,GO_Biological_Process_2021__response to interferon-beta (GO:0035456),-0.755940913314247,-1.4447669516700776,0.05084745762711865,0.6659751567868488,1.0,4/17,3.14%,IFITM3;IRF1;BST2;STAT1
prerank,GO_Biological_Process_2021__mRNA destabilization (GO:0061157),0.5491031103628424,1.4445183026934985,0.05555555555555555,0.526097060674739,1.0,14/35,22.79%,PDE12;RIDA;CPEB3;FTO;RBM24;ROCK2;ZC3H12D;PUM1;CELF1;YTHDF2;ROCK1;YTHDF3;DIS3L2;GIGYF2
prerank,GO_Biological_Process_2021__regulation of JUN kinase activity (GO:0043506),0.6296359010967288,1.4441433925834786,0.02631578947368421,0.5258655702352361,1.0,8/24,14.32%,MAP3K11;SASH1;DUSP10;MAP3K7;MAP3K5;DUSP19;MAP3K4;MAP3K10
prerank,GO_Biological_Process_2021__mRNA metabolic process (GO:0016071),0.4799854320037577,1.443799596461161,0.0,0.5255247439266882,1.0,14/85,18.07%,NUDT21;PPARGC1A;SNRPF;CSTF3;RIDA;DHX15;CPSF6;U2AF1;U2AF2;AGO3;ZC3H12D;PTBP1;CELF1;YTHDF2
prerank,GO_Biological_Process_2021__eye development (GO:0001654),0.5829240025018818,1.4436639350054965,0.03225806451612903,0.5244125061887035,1.0,16/39,14.82%,MEIS3;SMG9;RAB18;PBX1;FREM2;ATF6;CEP290;BMPR1B;PBX2;PBX3;MEIS2;RAB3GAP1;NIPBL;HIPK2;ZDHHC16;SH3PXD2B
prerank,GO_Biological_Process_2021__positive regulation of kinase activity (GO:0033674),0.48600851623042085,1.4425694886848186,0.0,0.5279894927637899,1.0,15/86,8.04%,EPHA7;EPHA6;ERBB4;CSF1R;EPHA2;EGFR;EPHA4;FLT1;MMD;PDGFRA;AGAP2;NTRK2;EPHA5;RAPGEF2;ROR1
prerank,GO_Biological_Process_2021__positive regulation of glucose metabolic process (GO:0010907),0.7391292595513793,1.4422625014006494,0.044444444444444446,0.5273704983370512,1.0,6/12,16.90%,PPARGC1A;AKT1;IRS1;SIRT1;ARPP19;AKT2
prerank,GO_Biological_Process_2021__clathrin coat assembly (GO:0048268),0.6584596302872023,1.4420014320886283,0.12121212121212122,0.5271933307927281,1.0,4/15,14.97%,PICALM;EPS15;SGIP1;HIP1
prerank,GO_Biological_Process_2021__epithelial cilium movement involved in extracellular fluid movement (GO:0003351),-0.7500860045822797,-1.4417012155740498,0.0625,0.6852496089715142,1.0,3/16,5.19%,SPAG17;CCDC39;DNAAF1
prerank,GO_Biological_Process_2021__regulation of mRNA metabolic process (GO:1903311),0.7002839598860641,1.440944588102571,0.044444444444444446,0.5316522615170542,1.0,6/12,20.61%,IWS1;SAFB2;SLTM;DHX9;SRPK2;PTCD2
prerank,GO_Biological_Process_2021__release of cytochrome c from mitochondria (GO:0001836),-0.7178611930426357,-1.4409093538287285,0.04918032786885246,0.684937267809633,1.0,1/17,0.05%,IFI6
prerank,GO_Biological_Process_2021__regulation of B cell apoptotic process (GO:0002902),0.8330899753915397,1.4398176179091797,0.046511627906976744,0.535646786558864,1.0,1/6,2.08%,FOXP1
prerank,GO_Biological_Process_2021__regulation of purine nucleotide metabolic process (GO:1900542),0.6107650096461883,1.4396560395755527,0.07407407407407407,0.5345231295619247,1.0,13/39,24.56%,NUP42;NUP37;NUP188;EP300;NUP153;OGT;NDC1;NUP205;HIF1A;NUP214;RANBP2;NUP54;NUP98
prerank,GO_Biological_Process_2021__ncRNA 3'-end processing (GO:0043628),0.6799412636241473,1.4396076999327285,0.02857142857142857,0.5328670039272226,1.0,5/14,12.23%,INTS7;ERI1;TOE1;INTS6;INTS8
prerank,GO_Biological_Process_2021__bicellular tight junction assembly (GO:0070830),0.5585631239589733,1.4389623172411476,0.08108108108108109,0.5342889984415822,1.0,7/28,15.65%,PARD3;MARVELD3;STRN;AFDN;OCLN;DLG1;PARD6G
prerank,GO_Biological_Process_2021__oligodendrocyte development (GO:0014003),0.6875700043206464,1.4388102701149743,0.03225806451612903,0.533556287270785,1.0,4/15,13.91%,MYRF;B4GALT6;PRDM8;B4GALT5
prerank,GO_Biological_Process_2021__monovalent inorganic cation homeostasis (GO:0055067),0.6875610360836756,1.4385605540140782,0.03333333333333333,0.5328283650618884,1.0,8/17,19.42%,PDK4;SLC12A2;KCNH2;PDK2;SLC12A8;SLC12A9;CYP4F12;CLCN3
prerank,GO_Biological_Process_2021__regulation of mitochondrion organization (GO:0010821),0.6116919320527766,1.4385119463262859,0.06060606060606061,0.5313059082522222,1.0,12/39,11.30%,PPARGC1A;PID1;RHOT1;PRMT6;FZD5;MFF;INF2;PRKN;GOLPH3;EP300;FBXW7;STOX1
prerank,GO_Biological_Process_2021__mitochondrial fusion (GO:0008053),0.6774014577082745,1.4383291749544507,0.05714285714285714,0.5305369071222632,1.0,9/18,18.68%,PLD6;GDAP1;CHCHD3;MFF;MIGA2;OPA1;MIGA1;THG1L;MIEF2
prerank,GO_Biological_Process_2021__vascular endothelial growth factor signaling pathway (GO:0038084),0.821160183907565,1.438240441915507,0.019230769230769232,0.5293493615045084,1.0,5/10,15.85%,VEGFD;PIK3CA;VEGFC;GAB1;NRP1
prerank,GO_Biological_Process_2021__chondrocyte differentiation (GO:0002062),0.6438782890918188,1.4381689165925962,0.027777777777777776,0.5279583996504346,1.0,7/25,9.01%,WNT7A;SOX5;BMP2;SOX9;NFIB;BMPR1B;SOX6
prerank,GO_Biological_Process_2021__positive regulation of DNA metabolic process (GO:0051054),0.5460432760786782,1.4380871528864607,0.08,0.5266815824457348,1.0,20/52,18.41%,EGFR;PPP1R10;RGCC;TOX;EYA2;UBE2N;HMGB1;NPAS2;SIRT1;DHX9;EYA3;TRIM28;OTUD4;USP9X;UIMC1;APLF;HGF;BRCC3;POT1;ATRX
prerank,GO_Biological_Process_2021__negative regulation of Ras protein signal transduction (GO:0046580),0.6081258352702309,1.4379348347808683,0.02857142857142857,0.5259372618616934,1.0,10/32,17.56%,KCTD13;KANK1;ARHGAP35;SPRY4;ARHGAP24;ABL2;SPRY3;KCTD10;SYNGAP1;CUL3
prerank,GO_Biological_Process_2021__regulation of nuclear division (GO:0051783),-0.7393479452967199,-1.4375189219100895,0.03508771929824561,0.7044152446102915,1.0,5/15,16.11%,FBXO43;KIF20B;CAV2;BORA;OBSL1
prerank,GO_Biological_Process_2021__plasma membrane invagination (GO:0099024),0.6260313069324986,1.4373384596786893,0.05555555555555555,0.526713343973347,1.0,3/20,7.93%,SPIRE2;SNX18;SPIRE1
prerank,GO_Biological_Process_2021__chondroitin sulfate biosynthetic process (GO:0030206),0.6781100345757022,1.4370418634028064,0.027777777777777776,0.5264946354621607,1.0,6/20,10.22%,CHST11;DCN;CSPG5;CSGALNACT1;UGDH;CHPF2
prerank,GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885),-0.8670757882748961,-1.4365321767007668,0.0,0.7060046044557515,1.0,4/7,6.58%,HLA-A;B2M;ERAP2;ERAP1
prerank,GO_Biological_Process_2021__regulation of glucocorticoid receptor signaling pathway (GO:2000322),0.8654107870679366,1.436168253686417,0.10638297872340426,0.5283026575250787,1.0,2/5,9.52%,LMO3;CLOCK
prerank,GO_Biological_Process_2021__organelle fusion (GO:0048284),0.6743914964138339,1.4360802696937969,0.08571428571428572,0.5268896511899297,1.0,9/21,18.68%,PLD6;GDAP1;CHCHD3;MFF;MIGA2;OPA1;MIGA1;THG1L;MIEF2
prerank,GO_Biological_Process_2021__axon ensheathment in central nervous system (GO:0032291),0.7971641735231849,1.435716570077678,0.024390243902439025,0.5266208521020663,1.0,3/7,13.91%,MYRF;B4GALT6;B4GALT5
prerank,GO_Biological_Process_2021__adrenergic receptor signaling pathway (GO:0071875),0.7519531486417067,1.435640222727359,0.1,0.5250676955301957,1.0,9/12,22.67%,RAPGEF2;ADRB2;ADRA1A;ZDHHC21;ADRB1;PDE4D;LMBRD2;DRD2;ADCY9
prerank,GO_Biological_Process_2021__positive regulation of nuclear division (GO:0051785),0.7391532012204128,1.4353886625343768,0.10526315789473684,0.5241909252208661,1.0,6/12,21.35%,RGCC;SIRT2;PHIP;IGF1;NPM2;AURKA
prerank,GO_Biological_Process_2021__protein modification by small protein conjugation (GO:0032446),0.4225790442086477,1.4350048975958065,0.0,0.5242909225114335,1.0,109/341,20.83%,SPSB4;UHRF2;BTRC;KCTD13;SPSB2;NUP42;TRIM24;PDZRN3;KEAP1;DCUN1D1;NUP37;MSL2;FBXL17;UBE2G1;KLHL8;UBE2T;NUP188;VHL;ARRB1;NEDD4L;MARCHF6;SDE2;TSPAN17;DTX4;CBL;RAD18;CDC27;RANGAP1;RNF144A;TRPM4;UBE2E3;FBXL3;RNF6;RNF182;UBE2D1;UBE2N;LMO7;UBE2Z;UBR3;PEX14;RNF14;ITCH;TMEM129;RNF26;ATG7;RFWD3;CNOT4;PRKN;ZNF451;FBXO11;FBXW7;KCTD10;PCNP;NUP153;PIAS1;SMURF1;RNF25;DCUN1D5;PEX5;MKRN3;PEX2;NSMCE2;VCPIP1;SIRT1;COMMD1;NDC1;CUL2;MIB1;UBE2E1;TRIM28;HIF3A;FBXO45;ARIH1;CUL1;VCP;DCUN1D4;PIAS4;CDC34;DTX1;STX1A;ANAPC16;MARCHF3;USP9X;HACE1;TRIM35;NUP205;KLHL24;TRIM44;RNF41;UBR1;HIF1A;ANKRD9;CUL3;PEX13;DCUN1D2;NUP214;MDM2;KLHL2;BCL10;FBXW11;OTULIN;MIB2;PLK1;WAC;NFE2L2;UBA3;TNFAIP1;MKRN1;UBE2D3
prerank,GO_Biological_Process_2021__regulation of ATP biosynthetic process (GO:2001169),0.7330704624757793,1.4349836440647628,0.047619047619047616,0.5226576174568808,1.0,2/13,0.70%,PPARGC1A;PID1
prerank,GO_Biological_Process_2021__cytoplasmic sequestering of protein (GO:0051220),0.7721799083210218,1.4347491322590995,0.0975609756097561,0.5224569381214893,1.0,4/11,17.02%,KEAP1;PKD2;LATS1;SUFU
prerank,GO_Biological_Process_2021__retinoid metabolic process (GO:0001523),-0.6220716087426855,-1.4345306376713562,0.0273972602739726,0.7135977889887997,1.0,19/50,16.34%,RPE65;ADH4;AKR1C1;RBP2;GPC3;PLB1;CYP2D6;ADH6;APOM;BCO1;APOE;RDH13;RDH11;RBP1;SCPEP1;RETSAT;RDH12;LRAT;CYP3A4
prerank,PanglaoDB_Augmented_2021__Airway Epithelial Cells,-0.645971257980708,-1.4338426771321433,0.07462686567164178,0.7126781204537074,1.0,18/34,15.25%,FMO6P;CP;CFTR;DUOX1;TEKT1;AQP1;TMC4;FMO2;CXCL17;TRIM29;CLCA4;PPL;C1ORF87;ERBB3;IL20RA;POF1B;FUT2;DUOXA1
prerank,GO_Biological_Process_2021__protein dephosphorylation (GO:0006470),0.48049252567723555,1.4331817739456822,0.0,0.5281323918170843,1.0,53/120,21.25%,PDP1;PTPRK;PTPN4;BTRC;PPP1R15B;EYA2;PPM1E;DUSP10;PPP2R1B;PTPN13;PPP2R5A;PPM1A;PPP2R2B;TAB1;PTPRJ;PTPN9;PPM1L;PPEF1;PPP4R1;SSH1;PTPRB;PPP2R2C;NCK1;EYA3;PPTC7;PTPRZ1;PTPN14;DUSP6;DUSP22;PTPRG;PTPN11;MTMR2;PPP2R2A;PPP3CB;STK11;PPP1R12A;PTPRO;PPP2R5E;LHPP;PPP1CC;RPRD1B;PTEN;PPM1D;MTM1;FBXW11;PPP1CB;PPM1F;DUSP18;SSH2;PTPRE;PPP2R1A;DUSP12;PTPRC
prerank,GO_Biological_Process_2021__erythrocyte development (GO:0048821),-0.8682923524539522,-1.4327671839686058,0.0,0.7141561046121607,1.0,1/9,0.97%,GATA1
prerank,GO_Biological_Process_2021__positive regulation of immune system process (GO:0002684),-0.8139014452723391,-1.4322953608727569,0.06153846153846154,0.7113054121460601,1.0,5/11,14.75%,ANXA1;RSAD2;PIK3CB;MADCAM1;ZP3
prerank,GO_Biological_Process_2021__phosphatidylinositol metabolic process (GO:0046488),0.4998656705784802,1.4319095374971151,0.0,0.5319047079850111,1.0,38/95,24.63%,PIP5K1B;CSF1R;PLEK;PGAP1;PLEKHA2;PIK3CA;PTPN13;PLBD1;PIK3R1;PLCB1;PIK3C3;PLEKHA8;PIP5K1C;PIK3R4;PIP4P2;PIP4K2C;PIKFYVE;SYNJ1;MTMR10;MTMR2;PITPNM3;PI4KB;RAB4A;PTEN;PLEKHA3;MTM1;MTMR12;PLAAT3;PLEKHA1;PLCB3;PITPNM1;SACM1L;PIK3C2B;FGF2;OCRL;TPTE2;MTMR6;SYNJ2
prerank,GO_Biological_Process_2021__negative regulation of fatty acid oxidation (GO:0046322),0.8432891435661493,1.4316838647427375,0.029411764705882353,0.531375424836501,1.0,4/8,13.42%,SOX9;PLIN5;AKT1;ACADVL
prerank,GO_Biological_Process_2021__filopodium assembly (GO:0046847),0.7614412778883876,1.4313906630768278,0.05555555555555555,0.5312508251704627,1.0,2/10,8.84%,DNM3;FGD4
prerank,GO_Biological_Process_2021__regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),0.8022453746906939,1.4311148367281175,0.0,0.5307768049584517,1.0,4/9,12.17%,SNCA;CBL;PTPRJ;CBLB
prerank,GO_Biological_Process_2021__positive regulation of Notch signaling pathway (GO:0045747),0.5741599473648534,1.4310257218412792,0.0,0.5295575715561053,1.0,17/33,30.46%,KAT2B;TSPAN14;MAML2;ROBO1;EP300;YAP1;MAML1;RBPJ;CREBBP;TSPAN5;MESP1;POGLUT1;JAG1;MAML3;TGFB2;ROBO2;IL6ST
prerank,GO_Biological_Process_2021__negative regulation of nucleic acid-templated transcription (GO:1903507),0.42863376894471666,1.4306822524651828,0.0,0.5298871312590364,1.0,112/362,20.50%,ZNF93;LIMD1;ZFPM2;PTPRK;TNFSF4;BTRC;YAF2;ZNF706;HDAC9;FOXP1;FOXO1;SOX8;KCTD1;SALL1;EED;BMP2;SPINDOC;LOXL2;ASCL1;DACH1;PSPC1;SOX9;ZEB1;PHF10;PRMT6;TLE2;RCOR1;SMAD2;ZNF746;PHC1;CHMP1A;ZIC2;RFX3;COPS2;HIC2;BAHD1;DPF1;NR1D2;SPEN;TSHZ3;SP3;MBD2;PEX14;ZHX3;SMARCA2;ZNF568;PLCB1;RBM15B;HDAC2;RBFOX2;NR3C1;SFMBT2;MEN1;CLOCK;GLI3;NR1D1;SCMH1;GCLC;ZNF148;RUNX1T1;AHR;ZHX2;ZNF423;ZBTB16;ZNF24;NIPBL;HDAC4;SIRT1;ZNF91;SIRT2;KAT7;TRIM28;FOXN3;MAP3K10;SMAD4;VGLL4;MLXIPL;SOX13;PIAS4;SAMD1;ZBTB38;PHC3;POU2F1;ZNF282;USP47;TFDP2;UIMC1;PHC2;RSF1;DPF3;BMP7;KAT6B;ZNF703;KDM1A;MTERF3;ZBTB21;JARID2;ZBTB18;MDM2;RBPJ;RORB;FBXW11;PPM1F;CDK5R1;MBTD1;REST;LEF1;TCEAL7;ZNF639;HMBOX1;NRG1;ATOH8
prerank,GO_Biological_Process_2021__negative regulation of chromatin silencing (GO:0031936),-0.8371454603381991,-1.4306152179489613,0.03571428571428571,0.7062605144907145,1.0,3/8,8.55%,H1-4;H1-2;ATAD2
prerank,GO_Biological_Process_2021__negative regulation of gene silencing (GO:0060969),-0.8371454603381991,-1.4306152179489613,0.03571428571428571,0.7062605144907145,1.0,3/8,8.55%,H1-4;H1-2;ATAD2
prerank,GO_Biological_Process_2021__negative regulation of chromatin organization (GO:1905268),-0.8371454603381991,-1.4306152179489613,0.03571428571428571,0.7062605144907145,1.0,3/8,8.55%,H1-4;H1-2;ATAD2
prerank,GO_Biological_Process_2021__cardiac conduction system development (GO:0003161),0.6263136775668293,1.430497503514934,0.08823529411764706,0.5288762683566854,1.0,6/13,17.14%,CACNA1G;NOTCH2;SMAD5;BMPR1A;SMAD4;MAML1
prerank,GO_Biological_Process_2021__neuron differentiation (GO:0030182),0.4549204405236213,1.4302324581656194,0.0,0.5283657288290798,1.0,40/107,23.69%,WNT7A;TENM3;SOX4;FUT9;LHX6;NR4A2;ASCL1;OLIG2;ADNP2;FZD5;NTRK2;UGDH;PBX1;EPHA5;DTNB;TENM2;PBX2;PBX3;NLGN4X;TGFBR1;OLIG1;OPHN1;TENM1;LHX2;FZD3;RUNX1;RORB;WNK1;CDK5R1;ACSL3;CASP3;ATOH8;POU3F2;TDP2;MYEF2;THOC2;FZD7;ATP2B2;CTNNB1;MYT1L
prerank,GO_Biological_Process_2021__regulation of cardiac conduction (GO:1903779),0.5838596451724494,1.4301698140981187,0.05405405405405406,0.5271191745791887,1.0,10/39,17.84%,ACE2;ANK2;ATP2B3;CASQ1;TMEM65;STIM1;ASPH;ATP2B4;CORIN;ATP1A4
prerank,GO_Biological_Process_2021__positive regulation of protein polyubiquitination (GO:1902916),0.797791837286658,1.4301453606902552,0.10869565217391304,0.5256344835511647,1.0,3/7,10.08%,SPSB4;MARCHF7;PRKN
prerank,GO_Biological_Process_2021__cellular response to transforming growth factor beta stimulus (GO:0071560),0.4844280863944197,1.4291485088515998,0.0,0.528125871574242,1.0,29/87,15.78%,WNT7A;PTPRK;PDE3A;SOX5;PARD3;SOX9;SMAD2;CBL;SMAD7;NLK;SMAD5;MAP3K7;SOX6;NR3C1;TGFBRAP1;GDF10;SMURF1;CRKL;TGFBR2;PTK2;ACVR1;WWOX;SIRT1;TGFBR1;BMPR1A;SMAD4;DUSP22;USP9X;PXN
prerank,GO_Biological_Process_2021__regulation of BMP signaling pathway (GO:0030510),0.4998050904298642,1.429063589383849,0.03571428571428571,0.526695870743784,1.0,19/57,19.44%,ELAPOR2;RBPMS2;BMP2;SMAD2;SMAD7;UBE2D1;SMAD5;BMPR1B;SMURF1;ZNF423;HIPK2;NBL1;ACVR2A;BMPR1A;SMAD4;VWC2L;LEMD3;RBPJ;CRIM1
prerank,GO_Biological_Process_2021__negative regulation of G0 to G1 transition (GO:0070317),0.6060685712887492,1.4288749995164822,0.0,0.526199417809187,1.0,8/34,16.24%,YAF2;EED;PHC1;PCGF2;MGA;PHC3;TFDP2;RBBP4
prerank,GO_Biological_Process_2021__histone H3-K4 demethylation (GO:0034720),0.75101021246194,1.428336841025295,0.10256410256410256,0.5275019516919268,1.0,3/8,17.94%,KDM5A;KDM1A;KDM1B
prerank,GO_Biological_Process_2021__cellular response to calcium ion (GO:0071277),0.5385040686520213,1.4278738832322604,0.0,0.527732021809919,1.0,12/55,18.89%,CPNE2;SYT3;ADCY1;ITPKB;PKD2;BRAF;SLC25A24;CAMK2D;SYT9;CPNE3;CPNE1;ADD1
prerank,GO_Biological_Process_2021__regulation of protein catabolic process (GO:0042176),0.5036716795784763,1.4278655634427682,0.0,0.5262235454362131,1.0,26/81,20.35%,FOXO1;EGFR;NEDD4L;AGAP2;CSNK2A1;SEC22B;ITCH;ATG7;PRKN;SMURF1;SIRT2;MDM4;VCP;GSK3B;NSF;FAF1;HACE1;WDR91;SF3B3;RNF41;IDE;MDM2;AXIN1;CHMP6;ADGRB1;FMN2
prerank,GO_Biological_Process_2021__regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),-0.855741322598788,-1.4278341551138085,0.03571428571428571,0.7216394490180446,1.0,3/9,5.79%,APLNR;THBS1;IL12A
prerank,PanglaoDB_Augmented_2021__Keratinocytes,-0.6992285518238646,-1.427809852111455,0.03076923076923077,0.7159738607446003,1.0,10/24,19.88%,CD24;FLG;GPR87;TRIM29;B3GNT3;CCL2;DUOXA1;ICAM1;DMKN;KRT10
prerank,GO_Biological_Process_2021__positive regulation of transferase activity (GO:0051347),0.4727077612261895,1.427755216467265,0.0,0.5251088490676137,1.0,25/119,14.70%,EPHA7;NAF1;EPHA6;SERINC5;ERBB4;CSF1R;EPHA2;DCUN1D1;EGFR;EPHA4;FLT1;PDGFRA;CCT4;NTRK2;EPHA5;UBE2N;ROR1;FBXW7;DKC1;DCUN1D5;MAP3K4;MERTK;MAPKAPK5;MAPK1;DCUN1D4
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte migration (GO:2000402),0.7837792766804978,1.4277520470760787,0.07142857142857142,0.5235689404193214,1.0,5/9,15.69%,LRCH1;AKT1;WASL;CD200R1;PADI2
prerank,GO_Biological_Process_2021__autonomic nervous system development (GO:0048483),0.7085588148803236,1.4272666448939415,0.09090909090909091,0.5243339712775482,1.0,5/12,15.85%,SOX4;SOX8;ASCL1;NF1;NRP1
prerank,GO_Biological_Process_2021__regulation of catabolic process (GO:0009894),0.660000572541265,1.4269282061448094,0.08333333333333333,0.5242360761242845,1.0,7/16,26.29%,NEDD4L;FAP;FAF1;MDM2;CHMP6;ZDHHC2;FURIN
prerank,GO_Biological_Process_2021__dermatan sulfate proteoglycan biosynthetic process (GO:0050651),0.702453355771824,1.4265858557892823,0.10869565217391304,0.5239960885202524,1.0,3/15,3.27%,DCN;CSPG5;CSGALNACT1
prerank,GO_Biological_Process_2021__regulation of protein modification by small protein conjugation or removal (GO:1903320),0.696300202515473,1.4264692131165613,0.07692307692307693,0.5231410837295573,1.0,10/19,21.28%,DCUN1D1;ITCH;DNAJB2;PRKN;DCUN1D5;TGFBR1;UBQLN1;HIF1A;DCUN1D2;HSPA1A
prerank,GO_Biological_Process_2021__positive regulation of chondrocyte differentiation (GO:0032332),0.8783050253895991,1.4258693723551585,0.024390243902439025,0.5238512278887472,1.0,7/7,12.21%,SOX5;LOXL2;SOX9;PKDCC;BMPR1B;SOX6;ZBTB16
prerank,GO_Biological_Process_2021__regulation of organelle assembly (GO:1902115),0.4993798203655755,1.4258323173019756,0.0,0.5226244266174297,1.0,15/64,16.48%,CDKL1;TBC1D1;USP6NL;TBC1D5;TRAPPC12;CDKL5;TBC1D12;TBC1D24;TBC1D22B;STX18;ODAD3;PIKFYVE;ALMS1;TBC1D10A;UBQLN2
prerank,GO_Biological_Process_2021__regulation of cytoplasmic translational elongation (GO:1900247),0.7559094423383701,1.4256633724317656,0.17777777777777778,0.5216867195681936,1.0,5/8,19.91%,CPEB3;DPH5;DPH3;DPH1;CPEB2
prerank,GO_Biological_Process_2021__import into nucleus (GO:0051170),0.5082636530501139,1.4252855727977165,0.041666666666666664,0.522113691076788,1.0,9/67,11.83%,RANBP17;SNRPF;PPP1R10;NUP188;AKT1;IPO8;SPRN;NUP153;NXT2
prerank,GO_Biological_Process_2021__positive regulation of ATP biosynthetic process (GO:2001171),0.862864819378611,1.4252358827249256,0.06,0.5209023696358303,1.0,2/7,0.70%,PPARGC1A;PID1
prerank,"GO_Biological_Process_2021__positive regulation of phagocytosis, engulfment (GO:0060100)",0.7893069892770472,1.4246302806826099,0.10204081632653061,0.5213757483753044,1.0,1/5,6.22%,RAB31
prerank,GO_Biological_Process_2021__regulation of nervous system process (GO:0031644),0.6698429329061757,1.4246035260672354,0.04878048780487805,0.5200339865713145,1.0,4/17,5.26%,DLGAP1;DLGAP4;HTR2C;NPTXR
prerank,GO_Biological_Process_2021__glutamine family amino acid biosynthetic process (GO:0009084),0.8393918820685983,1.4240032103857556,0.02564102564102564,0.5211095821102005,1.0,1/6,3.18%,GLS
prerank,GO_Biological_Process_2021__negative regulation of interferon-gamma-mediated signaling pathway (GO:0060336),-0.8693018504964951,-1.4234538676801967,0.06779661016949153,0.734987951375514,1.0,1/6,2.96%,PARP14
prerank,GO_Biological_Process_2021__negative regulation of response to interferon-gamma (GO:0060331),-0.8693018504964951,-1.4234538676801967,0.06779661016949153,0.734987951375514,1.0,1/6,2.96%,PARP14
prerank,GO_Biological_Process_2021__dicarboxylic acid metabolic process (GO:0043648),0.5068733513558367,1.4227559996654788,0.05,0.5251827859314491,1.0,4/46,10.15%,MTHFS;SLC19A1;ME2;GCLC
prerank,GO_Biological_Process_2021__regulation of neuron projection development (GO:0010975),0.46174579706221763,1.422521966610637,0.0,0.5247632462973967,1.0,43/145,18.44%,TENM3;ZNF804A;NPTN;FUT9;EPHA4;CDH2;CDKL5;TOX;KIF13B;KANK1;ARHGAP35;CSMD3;AKT1;CTNNA2;NTRK2;RAPGEF2;CAMK2B;ABL2;LRRC4C;ROR1;PPFIA2;HDAC2;SRCIN1;RTN4RL1;EFNB2;PTPN9;EP300;PRKD1;PAK3;SHANK3;CAMSAP2;DCC;PDLIM5;MAGI2;RAP1A;TANC2;GSK3B;RUFY3;PTPRO;NDNF;ITGA6;RETREG3;PTEN
prerank,GO_Biological_Process_2021__cerebral cortex neuron differentiation (GO:0021895),0.8445950737160502,1.422301557131731,0.075,0.5244379654878254,1.0,4/5,14.05%,ASCL1;TOX;CHD5;OPHN1
prerank,GO_Biological_Process_2021__snRNA processing (GO:0016180),0.6710087269631678,1.4221703997007045,0.02702702702702703,0.523793751467481,1.0,6/15,23.14%,INTS7;TOE1;INTS6;INTS8;INTS6L;INTS14
prerank,GO_Biological_Process_2021__primary alcohol metabolic process (GO:0034308),-0.6955317950406117,-1.4218789101820395,0.07936507936507936,0.7408526457088236,1.0,8/21,16.34%,ADH4;CYP2D6;ADH6;RDH11;RETSAT;RDH12;LRAT;CYP3A4
prerank,GO_Biological_Process_2021__positive regulation of lipid transport (GO:0032370),-0.7765321263901603,-1.421776734870211,0.08620689655172414,0.7357993836602317,1.0,4/8,21.14%,ABCA12;APOE;PRELID1;DBI
prerank,GO_Biological_Process_2021__stem cell development (GO:0048864),0.744572303352134,1.4216740742051306,0.06521739130434782,0.5246153514806446,1.0,5/10,14.16%,WNT7A;SOX8;CDH2;TAPT1;PEF1
prerank,GO_Biological_Process_2021__mitotic recombination (GO:0006312),0.7407307303757068,1.421577328728578,0.043478260869565216,0.5235641298333794,1.0,4/13,13.49%,RAD54B;RAD52;NSMCE2;SMC6
prerank,GO_Biological_Process_2021__positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),0.7425476388376433,1.4215747403224597,0.1388888888888889,0.5221097850282866,1.0,4/11,7.77%,TMEM33;BOK;ATF6;PIK3R1
prerank,GO_Biological_Process_2021__negative regulation of viral life cycle (GO:1903901),-0.7848860561852207,-1.4214500529448901,0.018867924528301886,0.7324701005246452,1.0,4/11,12.39%,IFITM3;BST2;CIITA;LY6E
prerank,GO_Biological_Process_2021__GTP metabolic process (GO:0046039),0.7256705415558673,1.4207444060977987,0.125,0.5237901973897832,1.0,6/14,13.68%,AK3;RHOQ;RAB23;EFL1;GNAI3;OPA1
prerank,GO_Biological_Process_2021__removal of superoxide radicals (GO:0019430),-0.8045013896942752,-1.4207172371875674,0.061224489795918366,0.7314968147757572,1.0,3/6,14.42%,MT3;SOD3;CCS
prerank,"GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (GO:0002480)",-0.8719468523160354,-1.4199152160539292,0.05555555555555555,0.7323011322330508,1.0,4/7,3.99%,HLA-B;HLA-A;HLA-C;B2M
prerank,GO_Biological_Process_2021__membrane lipid catabolic process (GO:0046466),-0.8342848627251627,-1.4196349166202367,0.03508771929824561,0.7289329714814003,1.0,2/9,2.49%,ENPP2;PDXDC1
prerank,GO_Biological_Process_2021__regulation of lipoprotein lipase activity (GO:0051004),0.7044564437069409,1.4193627682087153,0.05405405405405406,0.5280371165173633,1.0,3/12,3.91%,HDAC9;PCSK5;SORT1
prerank,GO_Biological_Process_2021__positive regulation of proteasomal protein catabolic process (GO:1901800),0.4925337167201321,1.4181381420387542,0.0,0.5328915441779332,1.0,35/75,25.44%,USP13;KEAP1;RNF217;RNF144A;SMAD7;CSNK1E;RNF14;DNAJB2;PSMD10;PRKN;FBXW7;COP1;DVL1;PIAS1;OSBPL7;SIRT2;ARIH1;VCP;GSK3B;ZYG11B;TRIB2;MDM2;PLK1;BAG2;RNFT1;HECTD1;HSPA1A;FMR1;TAF1;RNF185;CSNK1D;RCHY1;SUMO2;PSMC2;BAG6
prerank,GO_Biological_Process_2021__chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),0.629635203897537,1.4175507185519367,0.0,0.5335397843390083,1.0,6/26,10.22%,CHST11;DCN;CSPG5;CSGALNACT1;UGDH;CHPF2
prerank,GO_Biological_Process_2021__regulation of glial cell proliferation (GO:0060251),-0.8831308271638607,-1.4172572729652761,0.1,0.7432096583721132,1.0,1/5,7.41%,HES1
prerank,GO_Biological_Process_2021__axonogenesis (GO:0007409),0.444429817928605,1.4165412525044343,0.0,0.5361116419192415,1.0,60/211,16.40%,EPHA7;WNT7A;EPHA6;SEMA5B;SLIT1;EFNA5;EFNA2;NPTN;PARD3;EPHA2;EMB;EPHA4;PSPN;NOTCH2;CXCL12;ARHGAP35;KIF5A;CTNNA2;EFNB1;EPHA5;PIK3CA;SLITRK2;NRP2;NRXN1;PIK3R1;ROBO1;B4GALT6;GFRA1;SHC3;AUTS2;EFNB2;DOCK7;UNC5D;SEMA3C;PAK3;SLITRK1;KIF5C;NLGN3;SHANK3;SOS1;PTK2;SLIT2;DCC;BSG;ENAH;B4GALT5;OPHN1;MAPK1;SEMA6C;VASP;TAOK2;GAB1;CYFIP1;PTPN11;USP9X;NRP1;CNTN4;PPP3CB;SEMA4D;SEMA3D
prerank,GO_Biological_Process_2021__platelet-derived growth factor receptor signaling pathway (GO:0048008),0.7032680559028018,1.41615333101256,0.08823529411764706,0.5363452827410383,1.0,7/15,18.12%,PDGFRA;PDGFA;PTPRJ;PDGFC;FER;NRP1;BCAR1
prerank,GO_Biological_Process_2021__regulation of natural killer cell mediated cytotoxicity directed against tumor cell target (GO:0002858),-0.8593238569350423,-1.4160795768566046,0.07272727272727272,0.7458634582622495,1.0,2/5,5.79%,CEACAM1;IL12A
prerank,"GO_Biological_Process_2021__regulation of DNA-templated transcription, elongation (GO:0032784)",0.5740820402771247,1.4160184116456698,0.05405405405405406,0.5354633089586563,1.0,7/23,25.93%,EAF2;KAT7;CCNT2;SCAF8;SETD5;ZMYND11;ERCC6
prerank,GO_Biological_Process_2021__response to calcium ion (GO:0051592),0.4592998068247658,1.415740521547238,0.0,0.535075106344547,1.0,15/81,15.78%,ANXA11;CPNE2;SYT3;ADCY1;ITPKB;KCNMA1;HOMER1;PKD2;BRAF;SLC25A24;CAMK2D;STIM1;PEF1;SYT9;CPNE3
prerank,GO_Biological_Process_2021__cellular response to hepatocyte growth factor stimulus (GO:0035729),0.7994066380159652,1.415638823213637,0.06818181818181818,0.5326249309352143,1.0,4/7,18.12%,SIRT2;NRP1;HGF;BCAR1
prerank,GO_Biological_Process_2021__response to hepatocyte growth factor (GO:0035728),0.7994066380159652,1.415638823213637,0.06818181818181818,0.5326249309352143,1.0,4/7,18.12%,SIRT2;NRP1;HGF;BCAR1
prerank,GO_Biological_Process_2021__inorganic anion transport (GO:0015698),0.5417023618764565,1.415544534471413,0.03225806451612903,0.5319829595855907,1.0,3/35,1.79%,SLC26A7;CLIC5;ANO5
prerank,GO_Biological_Process_2021__regulation of B cell differentiation (GO:0045577),-0.7700570109004149,-1.4147689063714772,0.057692307692307696,0.7506498288537783,1.0,5/11,18.44%,INHA;SFRP1;ID2;XBP1;MMP14
prerank,GO_Biological_Process_2021__proteasomal ubiquitin-independent protein catabolic process (GO:0010499),-0.6921877673194373,-1.4144287986945216,0.03508771929824561,0.7472914234297721,1.0,4/18,6.91%,PSMB6;PSMA8;PSMB9;PSMA7
prerank,GO_Biological_Process_2021__positive regulation of fatty acid metabolic process (GO:0045923),0.7393201885507713,1.4136384166368448,0.05,0.5381165197836387,1.0,3/13,14.71%,PPARGC1A;ELOVL5;MLXIPL
prerank,GO_Biological_Process_2021__cardiac muscle tissue development (GO:0048738),0.5662882932240809,1.413559106481337,0.11428571428571428,0.5370685580150832,1.0,10/32,17.14%,TCAP;CACNA1G;BMP2;NOTCH2;SMAD5;SGCD;BMPR1A;SMAD4;BMP7;MAML1
prerank,GO_Biological_Process_2021__protein localization to endoplasmic reticulum (GO:0070972),0.7095538847089782,1.4134835326977968,0.06060606060606061,0.5362886366483425,1.0,3/14,12.81%,ANK2;VAPA;TAPT1
prerank,GO_Biological_Process_2021__antibacterial humoral response (GO:0019731),-0.8573080284153726,-1.413449672711083,0.017857142857142856,0.7493557643784731,1.0,2/9,2.89%,RPL39;HLA-A
prerank,GO_Biological_Process_2021__cell differentiation in spinal cord (GO:0021515),0.8310137042914812,1.4132979869295106,0.045454545454545456,0.5353820066132354,1.0,5/7,15.10%,SOX4;SOX6;MDGA2;ZC4H2;SOX13
prerank,GO_Biological_Process_2021__primary miRNA processing (GO:0031053),0.7484260171953787,1.412481825251305,0.06521739130434782,0.5372211231761527,1.0,3/10,6.07%,DROSHA;SMAD2;PUS10
prerank,GO_Biological_Process_2021__response to interleukin-1 (GO:0070555),-0.6264637287019712,-1.412472648490039,0.04878048780487805,0.7506666962218089,1.0,5/47,4.63%,GBP2;GBP1;GBP3;IL1R1;ANXA1
prerank,GO_Biological_Process_2021__regulation of cellular catabolic process (GO:0031329),0.4705094916668918,1.412199333915736,0.0,0.5370544820074744,1.0,23/60,27.00%,USP13;KEAP1;SMCR8;DAPK2;BOK;ABL2;PRKN;EP300;PIP4K2C;DRAM2;OSBPL7;RPTOR;WDR91;ROCK1;RRAGD;IFI16;TPCN2;GPR137B;USP33;RAB39B;DCAF12;DAPK1;WDR24
prerank,GO_Biological_Process_2021__ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),0.6000094078900802,1.412046746542399,0.044444444444444446,0.536282851015005,1.0,6/22,21.73%,VPS37B;VPS37A;UBAP1L;PTPN23;MVB12B;TSG101
prerank,GO_Biological_Process_2021__regulation of histone acetylation (GO:0035065),0.6078012357677998,1.4118334550742355,0.08333333333333333,0.5358174284126415,1.0,5/29,5.26%,PPARGC1A;SNCA;RPS6KA4;IWS1;ARRB1
prerank,GO_Biological_Process_2021__positive regulation of mitophagy in response to mitochondrial depolarization (GO:0098779),-0.8411802653190043,-1.411829155857148,0.03636363636363636,0.7498942881042212,1.0,1/7,0.29%,TOMM7
prerank,GO_Biological_Process_2021__phosphatidylcholine biosynthetic process (GO:0006656),0.6232610628022313,1.411165744635823,0.08,0.5375929912408886,1.0,8/26,23.44%,LPIN3;CSNK2A1;SLC44A5;CSNK2A2;PCYT1B;SLC44A1;CEPT1;CHPT1
prerank,GO_Biological_Process_2021__negative regulation of lipid storage (GO:0010888),0.7325902290909445,1.4105798085146124,0.10256410256410256,0.5397885913016278,1.0,4/14,14.87%,ABCA1;ABHD5;TTC39B;OSBPL8
prerank,GO_Biological_Process_2021__regulation of dendrite morphogenesis (GO:0048814),0.5762624931648668,1.4095408574956299,0.0,0.5433858676109464,1.0,13/29,20.45%,ADGRB3;CDKL5;NEDD4L;TNIK;RAPGEF2;CAPRIN2;SARM1;CAPRIN1;GSK3B;SEMA4D;RAP2A;SS18L1;SDC2
prerank,GO_Biological_Process_2021__positive regulation of organelle organization (GO:0010638),0.5796015798704904,1.409047729751105,0.05128205128205128,0.5438891261826205,1.0,12/31,16.90%,PPARGC1A;LIG4;SMCR8;ADRB2;DOC2B;STX18;KATNBL1;RAB3GAP1;FYCO1;SYNJ1;GSK3B;AKT2
prerank,GO_Biological_Process_2021__sulfation (GO:0051923),-0.8172439183424652,-1.4087694101092085,0.058823529411764705,0.766330884553763,1.0,2/9,1.44%,SULT1C3;SULT1C2
prerank,PanglaoDB_Augmented_2021__Delta Cells,0.4928234083051399,1.4084839362335966,0.0,0.5446879660061743,1.0,28/100,16.55%,PPARGC1A;LEPR;MAPK10;SOWAHA;ABCC8;CNTN1;SNAP91;ETV1;PLEKHA6;PCDH17;BAIAP3;NOL4;FRZB;NRXN1;LCORL;ASTN1;ADGRA1;UNC5D;CELF3;TMEM196;RGS7BP;MAPK4;LY6H;ASXL3;EHF;POU3F1;CNTN4;CSRNP3
prerank,"GO_Biological_Process_2021__synaptic transmission, cholinergic (GO:0007271)",0.6872903272760112,1.4084169012388916,0.10638297872340426,0.5433581714509563,1.0,1/12,0.48%,CHRNA4
prerank,GO_Biological_Process_2021__positive regulation of heart rate by epinephrine-norepinephrine (GO:0001996),0.7946218291900339,1.4083156740375844,0.047619047619047616,0.5425014427803756,1.0,3/6,16.88%,ADRA1A;ADRB1;PDE4D
prerank,GO_Biological_Process_2021__kinetochore assembly (GO:0051382),-0.8174270581685086,-1.4071702004404505,0.0392156862745098,0.7722699489090545,1.0,2/6,8.70%,CENPE;MIS12
prerank,GO_Biological_Process_2021__regulation of protein ubiquitination (GO:0031396),0.4706532535796612,1.4071549959092073,0.0,0.5461297729119732,1.0,32/97,22.76%,GNL3L;SASH1;SOX4;DCUN1D1;ARRB1;AKT1;SMAD7;UBE2D1;UBE2N;FAM107A;DNAJB2;PSMD10;PRKN;FBXW7;TGFBR1;U2AF2;OGT;COMMD1;SPOPL;UBQLN1;BIRC2;CUL3;NDFIP1;AXIN1;BCL10;ADGRB1;PRMT3;BAG2;N4BP1;HSPA1A;DERL1;NDFIP2
prerank,PanglaoDB_Augmented_2021__Astrocytes,0.4578650933053066,1.4066305391120189,0.0,0.5472940528749312,1.0,45/141,24.00%,GABRG1;SLIT1;TMEM235;CADM2;ADGRB3;PSD2;AMER2;SOX9;RBFOX1;HMG20A;NTRK2;CDH20;NRXN1;CAMK2A;ASTN1;VSTM2B;FAM107A;LUZP2;ADGRA1;SYNE1;GPM6B;RGS7BP;MAPK4;LY6H;SLC4A4;PTPRZ1;CA10;TMEM178A;ACSBG1;PLPPR4;NFATC3;OPCML;SLC6A11;S1PR1;BRINP1;TCEAL7;SLC39A12;GRIA2;SLC6A1;CNTFR;ATP2B2;GRM5;CNTN2;TEAD1;FAIM2
prerank,GO_Biological_Process_2021__cellular macromolecule catabolic process (GO:0044265),0.6105633939518237,1.4064160306704354,0.08695652173913043,0.5467281828738955,1.0,8/40,18.98%,DNASE1L2;STT3B;UBE2G1;DFFB;PRKN;IDE;PPP1R8;HNRNPD
prerank,GO_Biological_Process_2021__regulation of macroautophagy (GO:0016241),0.4950074827465198,1.4063726172566922,0.0,0.5456199303995142,1.0,24/103,16.48%,ATP6V0D2;DCN;QSOX1;ATP6V1A;SMCR8;RHEB;SESN1;AKT1;EXOC8;PIK3CA;ATP6V1C1;MAP3K7;GNAI3;SMG1;SIRT1;EXOC4;PRKAB1;RPTOR;UBQLN1;SNX5;SESN3;ATP6V1B2;MAPK8;UBQLN2
prerank,GO_Biological_Process_2021__macromolecule biosynthetic process (GO:0009059),-0.8782391307003179,-1.4045184256353176,0.044444444444444446,0.787040967229228,1.0,3/5,10.16%,RPS23;COL5A1;SLC11A1
prerank,GO_Biological_Process_2021__nucleosome assembly (GO:0006334),0.5445166460661276,1.4040853934297814,0.03225806451612903,0.5543073628045998,1.0,14/32,25.71%,SOX9;H2BC18;NAP1L1;ANP32B;RSF1;RBBP4;KAT6B;ATRX;ASF1A;SPTY2D1;H2AX;MACROH2A1;NAP1L3;HAT1
prerank,GO_Biological_Process_2021__negative regulation of telomerase activity (GO:0051974),-0.8477737860355835,-1.403073424102578,0.017543859649122806,0.7932302783445274,1.0,1/9,0.16%,PIF1
prerank,GO_Biological_Process_2021__RNA localization to Cajal body (GO:0090670),0.8542235704913961,1.4026820254972303,0.06666666666666667,0.5580215476921221,1.0,2/5,11.50%,CCT4;DKC1
prerank,GO_Biological_Process_2021__scaRNA localization to Cajal body (GO:0090666),0.8542235704913961,1.4026820254972303,0.06666666666666667,0.5580215476921221,1.0,2/5,11.50%,CCT4;DKC1
prerank,GO_Biological_Process_2021__negative regulation of small molecule metabolic process (GO:0062014),-0.7958114891160025,-1.402416055495351,0.07936507936507936,0.7918407672597816,1.0,3/9,9.32%,ACMSD;MST1;PGP
prerank,GO_Biological_Process_2021__response to cAMP (GO:0051591),-0.6269471559404884,-1.4023336169465617,0.03389830508474576,0.7872880293108545,1.0,6/29,8.35%,CFTR;DUOX1;STAT1;AQP1;KCNQ1;IGFBP5
prerank,GO_Biological_Process_2021__negative regulation of ubiquitin-protein transferase activity (GO:0051444),-0.7505369409225204,-1.4020092851658343,0.05,0.7846773498524542,1.0,4/14,6.86%,RPL23;RPL11;RPS7;RPL5
prerank,GO_Biological_Process_2021__response to type I interferon (GO:0034340),-0.8271673763544607,-1.4018542854545972,0.12903225806451613,0.7803208786089886,1.0,3/9,3.26%,IFIT1;MX1;ISG15
prerank,GO_Biological_Process_2021__regulation of actin filament length (GO:0030832),0.8676476073822477,1.4015162053329868,0.06666666666666667,0.5614629857473741,1.0,3/6,5.05%,EPS8;CXCL12;ARHGAP35
prerank,GO_Biological_Process_2021__dense core granule cytoskeletal transport (GO:0099519),0.8204520823322371,1.4006704864273234,0.06666666666666667,0.5640587187429235,1.0,3/7,14.84%,KIF5A;PPFIA2;TANC2
prerank,GO_Biological_Process_2021__cellular response to vascular endothelial growth factor stimulus (GO:0035924),0.5781695721717415,1.4006302965448656,0.03571428571428571,0.5627582563051151,1.0,8/27,15.85%,VEGFD;FLT1;PIK3CA;VEGFC;PRKD1;MAPKAPK2;GAB1;NRP1
prerank,GO_Biological_Process_2021__negative regulation of signaling receptor activity (GO:2000272),0.6613809172581052,1.3997207113347367,0.07692307692307693,0.5646783640247791,1.0,2/17,5.82%,ACE2;CBL
prerank,GO_Biological_Process_2021__microvillus organization (GO:0032528),0.7277999965230051,1.3989497441654626,0.06818181818181818,0.5646768149507915,1.0,7/11,17.59%,RAP2B;TNIK;RAPGEF2;MAP4K4;RAP2C;RAP1A;RAP2A
prerank,GO_Biological_Process_2021__microvillus assembly (GO:0030033),0.7277999965230051,1.3989497441654626,0.06818181818181818,0.5646768149507915,1.0,7/11,17.59%,RAP2B;TNIK;RAPGEF2;MAP4K4;RAP2C;RAP1A;RAP2A
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),-0.7318725222941591,-1.3986663502097143,0.047619047619047616,0.7986471707045997,1.0,2/18,0.97%,IFI6;GATA1
prerank,GO_Biological_Process_2021__actin filament network formation (GO:0051639),0.7676707999885405,1.3984987331818197,0.08823529411764706,0.5653099393038648,1.0,3/10,7.93%,SPIRE2;CARMIL1;SPIRE1
prerank,GO_Biological_Process_2021__regulation of axon guidance (GO:1902667),0.7731209317652284,1.3984498374835288,0.06521739130434782,0.5643081322513264,1.0,4/9,19.55%,ZSWIM6;ZSWIM5;NRP1;ZSWIM4
prerank,GO_Biological_Process_2021__double-strand break repair via classical nonhomologous end joining (GO:0097680),0.8522080228383994,1.397712050031396,0.06,0.5655901096690039,1.0,1/6,1.18%,LIG4
prerank,GO_Biological_Process_2021__T cell proliferation (GO:0042098),-0.7789259139370945,-1.397650987837359,0.12903225806451613,0.8009084950973853,1.0,4/11,10.16%,DOCK8;RASGRP1;BTN3A1;SLC11A1
prerank,PanglaoDB_Augmented_2021__Pancreatic Progenitor Cells,0.4579536229726925,1.3976036777618928,0.0,0.5645925791518006,1.0,39/94,27.09%,SOWAHA;ABCC8;EFNA2;NPNT;ARHGEF16;RGS16;SOX9;CADPS2;PRIMA1;PCGF2;LYPD6;EFNB2;MAPK4;ENAH;HNF4G;MYH14;JPH1;YAP1;DDAH1;BMP7;PCLO;BCAR1;SHROOM3;LRP4;CXXC4;TSPAN12;MARK1;CNTFR;CACNG4;CTNNB1;TEAD1;CPE;PRR36;C2CD4C;EPB41L4B;NR2F1;MMP15;HS6ST2;MYO6
prerank,GO_Biological_Process_2021__small GTPase mediated signal transduction (GO:0007264),0.4816379093359699,1.397200919268351,0.0,0.5649362035556695,1.0,24/95,14.11%,CCDC88C;TIAM2;RRAD;RHEB;RAB18;RAPGEF2;G3BP1;SHOC2;MAPK11;CCNA2;SHC3;ARHGAP32;RALB;NF1;PRKD1;RUNDC3A;MRAS;CRKL;SOS1;NRAS;RRAS2;RREB1;MAPKAPK5;TRIM28
prerank,GO_Biological_Process_2021__regulation of generation of precursor metabolites and energy (GO:0043467),0.5884517256409951,1.3969936530960791,0.08333333333333333,0.5643895194816941,1.0,14/44,24.56%,NUP42;NUP37;NUP188;EP300;NUP153;OGT;NDC1;RUBCNL;NUP205;HIF1A;NUP214;RANBP2;NUP54;NUP98
prerank,GO_Biological_Process_2021__regulation of carbohydrate catabolic process (GO:0043470),0.6084493618980111,1.3969795530996671,0.04,0.5629993975125274,1.0,13/40,24.56%,NUP42;NUP37;NUP188;EP300;NUP153;OGT;NDC1;NUP205;HIF1A;NUP214;RANBP2;NUP54;NUP98
prerank,GO_Biological_Process_2021__endoplasmic reticulum localization (GO:0051643),0.8288112806193959,1.3967846480866628,0.05,0.5628218951444574,1.0,1/6,0.04%,VAPB
prerank,PanglaoDB_Augmented_2021__Trigeminal Neurons,0.4679500491341025,1.3967038521573194,0.0,0.5618433741054661,1.0,50/133,21.83%,MAPK10;GDAP1;ANK2;PRKX;CADM2;SNAP91;LSAMP;ADGRB3;AMER2;ATP2B3;RBFOX1;CACNA1B;KCTD16;KIF5A;CALCB;NRXN1;PPFIA2;DGKH;ASTN1;TLN2;ADGRA1;LRFN5;DGKZ;SLITRK1;NKAIN2;KIF1B;TMEM196;RGS7BP;OLFM3;MAPK4;LY6H;MAGI2;ASXL3;ELAVL3;CPNE3;CA10;CSRNP3;CCDC92;RUFY3;PLPPR4;OPCML;FAM13C;ERC2;NOVA1;BRINP1;TCEAL7;GRIA2;CLVS2;SLC6A1;ZDHHC2
prerank,GO_Biological_Process_2021__pteridine-containing compound metabolic process (GO:0042558),0.7174618062135301,1.3961987754063536,0.09090909090909091,0.5627894656239587,1.0,4/11,17.21%,QDPR;AKT1;FTCD;PRKG2
prerank,GO_Biological_Process_2021__cellular response to zinc ion (GO:0071294),-0.7790149408920701,-1.3960372354619708,0.06349206349206349,0.8080024438137178,1.0,9/14,20.26%,MT1H;MT1G;MT2A;MT3;MT1E;MT1F;MT1A;MT1M;GLRA1
prerank,GO_Biological_Process_2021__detection of visible light (GO:0009584),-0.8034373741724786,-1.3957348946330927,0.09230769230769231,0.8050103963554529,1.0,2/10,4.52%,RPE65;PDE6B
prerank,GO_Biological_Process_2021__pteridine-containing compound biosynthetic process (GO:0042559),0.9122340459742856,1.395562289462182,0.03773584905660377,0.5646486157590508,1.0,2/5,5.79%,MTHFS;QDPR
prerank,PanglaoDB_Augmented_2021__T Cells,-0.5740612436497353,-1.3955149954235422,0.0273972602739726,0.8009096035675565,1.0,19/55,17.73%,P2RY10;TAGAP;CD163L1;CD5;IFIT3;THEMIS;ARHGAP9;GPR171;GMFG;TRAF3IP3;RHOH;ARHGAP30;CD160;SKAP1;GIMAP2;CXCR4;PTPN22;SEPTIN1;CD6
prerank,GO_Biological_Process_2021__fatty acid elongation (GO:0030497),0.709343336857704,1.3949757349681597,0.1111111111111111,0.565384269125941,1.0,5/12,15.01%,ELOVL7;HACD2;ELOVL6;ELOVL5;HACD1
prerank,GO_Biological_Process_2021__neurotransmitter transport (GO:0006836),-0.5720332490980463,-1.3946746612764567,0.029411764705882353,0.8023224071411968,1.0,5/60,8.17%,SLC28A2;SLC18A2;SYN3;GAD1;SNAPIN
prerank,GO_Biological_Process_2021__negative regulation of cAMP-dependent protein kinase activity (GO:2000480),0.7353600384713894,1.3945695007561458,0.08695652173913043,0.5654016582526402,1.0,3/8,13.01%,PRKAR1B;PKIA;SIRT1
prerank,GO_Biological_Process_2021__glomerular visceral epithelial cell differentiation (GO:0072112),-0.7388644921938863,-1.393593665035019,0.06349206349206349,0.8046477199848575,1.0,1/11,0.14%,CD24
prerank,GO_Biological_Process_2021__protein export from nucleus (GO:0006611),0.651708451478352,1.3933259762883825,0.12121212121212122,0.5693798665902519,1.0,9/24,11.67%,RANBP17;NUP42;XPO1;RANBP3L;XPO6;RANBP3;STYX;SMURF1;XPO7
prerank,PanglaoDB_Augmented_2021__Neutrophils,-0.6168161687427984,-1.3926844601812802,0.031746031746031744,0.8064602607516314,1.0,11/41,5.11%,CD24;DOCK8;TAGAP;ARG2;CLEC12A;IGSF6;CEACAM1;NR1I3;CXCL2;P2RY13;DPEP2
prerank,GO_Biological_Process_2021__generation of neurons (GO:0048699),0.4720340660760852,1.3923342028839965,0.0,0.5725881026862604,1.0,49/138,24.02%,TAFA1;WNT7A;LRP12;FUT9;LHX6;NR4A2;ASTN2;ASCL1;CDKL5;ADGRL3;OLIG2;ADNP2;FZD5;GPM6A;SH3RF1;NTRK2;RAPGEF2;DTNB;ASTN1;AUTS2;DNAAF4;DOCK7;NLGN4X;KIAA0319;OLIG1;OPHN1;YAP1;USP9X;NRP1;LHX2;FZD3;EML1;NDNF;RUNX1;PEX13;YTHDF2;CDK5R1;ACSL3;CASP3;ATOH8;MARK1;POU3F2;MYEF2;THOC2;FZD7;ATP2B2;CTNNB1;MYT1L;ELP3
prerank,GO_Biological_Process_2021__negative regulation of RNA catabolic process (GO:1902369),0.7710600954424194,1.391960848020954,0.14634146341463414,0.5727850982097732,1.0,1/7,0.41%,NAF1
prerank,GO_Biological_Process_2021__negative regulation of regulated secretory pathway (GO:1903306),0.7552944711756293,1.391895265849919,0.047619047619047616,0.5716834746993295,1.0,5/7,23.66%,CBARP;RAP1A;REST;FMR1;RAP1B
prerank,GO_Biological_Process_2021__pancreas development (GO:0031016),-0.8330272578111309,-1.3918729194532558,0.03389830508474576,0.8069708543402838,1.0,2/8,5.19%,CCDC39;DNAAF1
prerank,GO_Biological_Process_2021__inhibition of cysteine-type endopeptidase activity (GO:0097340),0.8190984656190113,1.3918445055346207,0.08695652173913043,0.5705479056634597,1.0,1/5,1.74%,CARD18
prerank,GO_Biological_Process_2021__vascular process in circulatory system (GO:0003018),0.7414881046575247,1.391519610304822,0.05263157894736842,0.5688005726485745,1.0,1/8,0.08%,ACE2
prerank,GO_Biological_Process_2021__regulation of tube diameter (GO:0035296),0.7414881046575247,1.391519610304822,0.05263157894736842,0.5688005726485745,1.0,1/8,0.08%,ACE2
prerank,GO_Biological_Process_2021__mesonephric tubule development (GO:0072164),0.7687970430606806,1.3911719301486611,0.10204081632653061,0.5686926498469238,1.0,5/8,16.20%,NPNT;SALL1;PKD2;SLIT2;BMP7
prerank,GO_Biological_Process_2021__innate immune response (GO:0045087),-0.5439387195162128,-1.391058519906515,0.012048192771084338,0.8074749018572867,1.0,28/140,16.25%,IFI6;IFIT1;IFITM3;TRIM22;RPL39;BST2;MX1;ISG15;B2M;TRIM21;APOBEC3G;NLRP1;MASP2;KLRD1;CIITA;SLC11A1;SKP2;TLR3;FES;NLRP9;PGLYRP1;CLEC5A;RIPK2;TRIM61;SHFL;S100B;CD74;SP100
prerank,GO_Biological_Process_2021__regulation of lipid biosynthetic process (GO:0046890),0.599663883947291,1.3909159890515685,0.03333333333333333,0.5682355324264865,1.0,7/24,14.71%,PDK4;ZBTB20;ADIPOR2;AKT1;ASXL3;ADIPOR1;MLXIPL
prerank,GO_Biological_Process_2021__proteoglycan metabolic process (GO:0006029),0.6114813119786583,1.3905631778751164,0.09090909090909091,0.5686721601498496,1.0,5/22,9.11%,CHST8;CHST11;CSGALNACT1;BMPR1B;CANT1
prerank,GO_Biological_Process_2021__positive regulation of nucleic acid-templated transcription (GO:1903508),0.41694090849341253,1.390272651394649,0.0,0.5685653063337867,1.0,123/385,21.61%,WNT7A;PPARGC1A;FLI1;BTRC;YAF2;MITF;FOXO1;SOX4;SOX8;SALL1;BMP2;ERBB4;PICALM;EGFR;ZXDA;MLLT3;ACTA2;ESRRG;VHL;SOX9;RORA;NFIB;MSANTD1;NFKB1;MYRF;FOXO3;ZXDC;SMAD2;AKT1;ZIC2;RFX3;KCNH2;RNF6;ARID1B;DYRK1A;NR1D2;NPAS3;CEP290;PPM1A;SP3;SMARCA2;SMAD5;TCF4;ZNF516;PLCB1;RNF14;HDAC2;KDM5A;ETS2;TFE3;CLOCK;GLI3;ELF1;NR1D1;KAT2A;NPAS2;SUPT3H;MED13;EP300;NEK4;MAP3K5;AHR;ZNF423;ZBTB16;ACVR1;TBL1XR1;SETD3;TFEB;HDAC4;HIPK2;TGFBR1;RREB1;NDP;TRIM28;EHF;SMAD4;SNX5;MLXIPL;TRIM16;TRIP4;POU3F1;USP22;JMJD6;PHIP;YAP1;LHX2;PPP3CB;RSF1;BMP7;TRIM44;SMARCC1;KAT6B;PCID2;HIF1A;CXXC1;RUNX1;IGF1;RORB;AXIN1;BCL10;APBB1;DNM2;HNRNPD;FBXW11;MAP2K2;SS18L1;REST;MAP3K2;LEF1;WAC;HIVEP3;ESRRB;ATOH8;MED4;RNF10;NFATC2;NFIL3;CREBBP;ZNF318;NAT14;MLLT11;ARNT2;NAA16
prerank,GO_Biological_Process_2021__mitochondrial DNA repair (GO:0043504),0.8160581959079658,1.3902381659938736,0.05660377358490566,0.5674172576292683,1.0,2/5,14.52%,DNA2;PRIMPOL
prerank,GO_Biological_Process_2021__sympathetic nervous system development (GO:0048485),0.7909766725054562,1.3901500594149183,0.07692307692307693,0.566428574152758,1.0,6/8,16.26%,SOX4;ASCL1;NRP2;NF1;NRP1;FZD3
prerank,GO_Biological_Process_2021__limb morphogenesis (GO:0035108),0.6779653283236872,1.3899043610074289,0.10810810810810811,0.5663661397699554,1.0,6/15,17.14%,PCSK5;BMPR1B;GLI3;MBNL1;NIPBL;ZNF141
prerank,GO_Biological_Process_2021__endocardial cushion development (GO:0003197),0.7280010149433807,1.3889931112802072,0.05263157894736842,0.568717551592194,1.0,5/13,14.40%,BMP2;SOX9;ACVR1;BMPR1A;MDM4
prerank,GO_Biological_Process_2021__phosphatidylcholine catabolic process (GO:0034638),-0.8908095894663923,-1.3883170873002386,0.02127659574468085,0.8219758602999749,1.0,1/6,2.28%,ENPP2
prerank,GO_Biological_Process_2021__erythrocyte differentiation (GO:0030218),-0.6191972253401197,-1.3879094854159182,0.09333333333333334,0.8197524038189866,1.0,7/35,13.67%,RPS14;GATA1;INHA;ATP5IF1;ID2;ZFPM1;RPS19
prerank,MSigDB_Hallmark_2020__Protein Secretion,0.46787789778227024,1.3876870565587054,0.08333333333333333,0.5729307979971706,1.0,23/90,19.71%,BET1;SGMS1;ARFIP1;TMX1;AP3S1;ABCA1;EGFR;AP2B1;RPS6KA3;SEC22B;AP3B1;RAB9A;KIF1B;DOP1A;MAPK1;AP1G1;RAB22A;SCRN1;ARFGEF1;SCAMP1;CLCN3;STX12;STX7
prerank,PanglaoDB_Augmented_2021__Oxyphil Cells,0.48181980424545695,1.3873696405372935,0.05,0.5729680388420482,1.0,12/62,10.60%,ACACB;ANO5;CADM2;LRP1B;SYCP2L;NT5C1A;RBFOX1;KBTBD12;COL9A1;SLC35F1;ADRA1A;RGMA
prerank,GO_Biological_Process_2021__regulation of pH (GO:0006885),0.8018328038508765,1.387119549617707,0.10869565217391304,0.5728909771867849,1.0,1/8,0.07%,PDK4
prerank,GO_Biological_Process_2021__DNA topological change (GO:0006265),0.8041858250470111,1.3870799225146986,0.0425531914893617,0.5719413120685697,1.0,3/8,9.68%,TOP3B;TOP1MT;HMGB1
prerank,GO_Biological_Process_2021__regulation of muscle contraction (GO:0006937),-0.7836965155870399,-1.3866573084276173,0.07936507936507936,0.8241004866531387,1.0,2/14,5.61%,TNNT1;CHRM2
prerank,GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway (GO:0002484),-0.8546401861289705,-1.3864388888697419,0.1,0.8155557166650782,1.0,3/6,3.97%,HLA-B;HLA-A;HLA-C
prerank,"GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent (GO:0002486)",-0.8546401861289705,-1.3864388888697419,0.1,0.8155557166650782,1.0,3/6,3.97%,HLA-B;HLA-A;HLA-C
prerank,GO_Biological_Process_2021__transcription initiation from RNA polymerase II promoter (GO:0006367),0.4679047069350652,1.3860691272287617,0.0,0.5755400799713467,1.0,36/119,21.52%,PPARGC1A;RARB;HDAC9;NR2F6;KAT2B;NR4A2;ESRRG;DR1;RORA;NOTCH2;MAML2;THRB;NRBF2;NR2E1;NR1D2;TAF4;NR3C1;NR1D1;TBL1XR1;TAF8;HNF4G;YAP1;NR3C2;MAML1;TAF2;TAF4B;RBPJ;RORB;MED27;TAF3;GTF2F2;ESRRB;CDK9;CREBBP;NR4A1;NR6A1
prerank,GO_Biological_Process_2021__positive regulation of lipid localization (GO:1905954),0.8052494442779135,1.3859151074684781,0.17391304347826086,0.5749664784528725,1.0,2/7,5.57%,NFKB1;PLIN5
prerank,GO_Biological_Process_2021__low-density lipoprotein particle receptor catabolic process (GO:0032802),0.7215267683659312,1.3854792665133076,0.13636363636363635,0.5744288802598058,1.0,1/9,3.77%,AP2B1
prerank,GO_Biological_Process_2021__low-density lipoprotein receptor particle metabolic process (GO:0032799),0.7215267683659312,1.3854792665133076,0.13636363636363635,0.5744288802598058,1.0,1/9,3.77%,AP2B1
prerank,GO_Biological_Process_2021__N-terminal protein amino acid acetylation (GO:0006474),0.7346516582334967,1.3851437184687208,0.09523809523809523,0.574874802467488,1.0,7/12,21.61%,KAT2B;NAA25;EP300;NAA30;NAA50;CREBBP;NAA16
prerank,GO_Biological_Process_2021__carnitine shuttle (GO:0006853),0.765993878836141,1.3850638314975547,0.10638297872340426,0.5740085040029931,1.0,1/9,0.90%,ACACB
prerank,GO_Biological_Process_2021__vesicle transport along microtubule (GO:0047496),0.6172130103941001,1.3840721210867375,0.09090909090909091,0.5772918163870114,1.0,8/22,19.18%,BICDL1;KIF5A;TRAK1;TRAK2;FYCO1;KIF13A;RAB1A;FBXW11
prerank,PanglaoDB_Augmented_2021__Choroid Plexus Cells,0.46027924472059123,1.3839176436709322,0.0,0.5765730115614776,1.0,26/105,16.06%,MPDZ;PDZRN3;EGFR;SOX9;HTR2C;PLEKHA6;CADPS2;CHMP1A;CEP170B;CGNL1;FRZB;LGR4;PRICKLE2;ATP9A;PLPP3;NCKAP1;ARHGEF10L;FARP1;SLC4A10;TJP1;ADGRL2;MYH14;NEO1;DDAH1;PARD3B;TMEM178A
prerank,GO_Biological_Process_2021__cellular response to cholesterol (GO:0071397),0.7252260390004153,1.383833943708408,0.07142857142857142,0.5754856892323414,1.0,3/9,15.98%,GRAMD1C;OSBPL7;SMO
prerank,PanglaoDB_Augmented_2021__Melanocytes,0.4701150894447306,1.383039771286063,0.041666666666666664,0.5773337378860235,1.0,23/115,11.74%,TYR;POSTN;STARD13;HMCN1;SASH1;MITF;RASSF8;EPS8;EGFR;LOXL2;PARVA;SOX9;NRP2;PRRX1;PPFIBP1;RASAL2;PRICKLE2;MEN1;GLI3;FAP;PRKN;AHR;PLPP3
prerank,GO_Biological_Process_2021__carbohydrate derivative catabolic process (GO:1901136),0.6788271081946491,1.3826720296772836,0.1,0.5772488912552382,1.0,2/17,3.46%,SAMHD1;STT3B
prerank,GO_Biological_Process_2021__purine ribonucleotide metabolic process (GO:0009150),-0.5731858709486198,-1.3825578830030947,0.05128205128205128,0.8379312824921821,1.0,9/58,9.81%,SULT1C3;ACOT2;SULT1C2;ACOT1;ACOT6;GLYAT;ACSM6;HINT1;ACSM5
prerank,GO_Biological_Process_2021__regulation of telomere maintenance via telomere lengthening (GO:1904356),0.6655417521259487,1.3824972494131293,0.175,0.5768690140246169,1.0,1/16,0.41%,NAF1
prerank,GO_Biological_Process_2021__regulation of neuronal synaptic plasticity (GO:0048168),0.5804002589121301,1.382393906981899,0.05714285714285714,0.5759381948741921,1.0,12/27,23.49%,SHISA7;CAMK2B;CAMK2A;RAB3GAP1;SLC4A10;NCDN;SHISA9;DRD2;GRIK2;SYNGR1;ZDHHC2;NETO1
prerank,GO_Biological_Process_2021__negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),0.618330353809827,1.3821774871728754,0.04878048780487805,0.5755262095979948,1.0,7/21,15.63%,EVI5L;KANK1;TESK1;ARHGAP24;CEP97;SLIT2;YAP1
prerank,GO_Biological_Process_2021__negative regulation of cell motility (GO:2000146),0.4289156065146821,1.3821311030267514,0.0,0.5743458270504003,1.0,31/84,19.38%,PTPRK;MITF;SERPINE1;ZMYND8;RAP2B;EPHA4;DACH1;KANK1;FOXO3;LIMCH1;DUSP10;SMAD7;ROBO1;PTPRJ;ADARB1;NF1;NAV3;SLIT2;AFDN;DLG5;MAGI2;RAP2C;DUSP22;ARID2;SRGAP2B;RNF41;RAP2A;FBLN1;PTEN;DRD2;FRMD5
prerank,GO_Biological_Process_2021__lipid modification (GO:0030258),0.5879782255109146,1.3821034822623262,0.08333333333333333,0.5730975333234947,1.0,7/33,14.38%,DGKB;PLPP1;DGKH;DGKZ;PLPP3;PLPP2;DGKG
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle cell proliferation (GO:0060045),0.6901294854462023,1.3811953258887855,0.17142857142857143,0.5759809596957427,1.0,2/13,2.79%,ZFPM2;ERBB4
prerank,GO_Biological_Process_2021__self proteolysis (GO:0097264),-0.901623800726812,-1.381110615730321,0.057692307692307696,0.8449106874333765,1.0,2/6,7.92%,CASP8;NLRP1
prerank,"GO_Biological_Process_2021__regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",0.5326754316507305,1.3810600500903187,0.0,0.5752082168806751,1.0,22/47,23.92%,RBFOX1;RBM24;HNRNPU;MBNL2;NSRP1;RBM15B;RBFOX2;CELF2;CELF3;MBNL1;KHDRBS3;FXR1;PTBP1;CELF1;SMU1;KHDRBS2;NOVA1;REST;NOVA2;FMR1;WTAP;MAGOH
prerank,GO_Biological_Process_2021__endoplasmic reticulum tubular network organization (GO:0071786),0.725510982626165,1.3803204248427405,0.13157894736842105,0.5765109890871086,1.0,4/13,20.55%,TMEM33;RAB18;REEP4;RAB10
prerank,GO_Biological_Process_2021__regulation of plasma membrane bounded cell projection organization (GO:0120035),0.613426629935733,1.380265359745891,0.10256410256410256,0.5754865960245323,1.0,7/23,21.21%,ZNF804A;AKT1;CTNNA2;HOMER1;GSK3B;PTEN;MARK1
prerank,GO_Biological_Process_2021__protein acylation (GO:0043543),0.5282854316979853,1.3799257098823754,0.0,0.57591439329618,1.0,14/35,22.94%,KAT2B;FOXO1;ZDHHC18;CLOCK;ZDHHC21;KAT2A;EP300;ZDHHC5;ZDHHC16;CREBBP;ZDHHC2;ZDHHC13;ZDHHC14;PORCN
prerank,GO_Biological_Process_2021__negative regulation of cellular response to growth factor stimulus (GO:0090288),0.4624826770777317,1.379923029438252,0.0,0.5747152821901116,1.0,18/64,17.36%,RBPMS2;BMP2;SPRY4;SMAD7;UBE2D1;SMAD5;BMPR1B;SPRY3;SMURF1;SLIT2;HIPK2;NBL1;ACVR2A;BMPR1A;SMAD4;ATP2B4;VWC2L;LEMD3
prerank,GO_Biological_Process_2021__histone H3 acetylation (GO:0043966),0.5308606924878578,1.3796656298293755,0.09090909090909091,0.5741700296356665,1.0,12/38,19.94%,KAT2B;DR1;PHF14;MBIP;MAP3K7;KAT2A;SUPT3H;KAT7;TRIM16;KAT6B;KAT14;LEF1
prerank,GO_Biological_Process_2021__oligodendrocyte differentiation (GO:0048709),0.5985418667340799,1.379553897813555,0.0967741935483871,0.5731957400078712,1.0,7/18,15.10%,SOX8;SOX9;MYRF;SOX6;PRDM8;PTPRZ1;SOX13
prerank,GO_Biological_Process_2021__positive regulation of chromosome segregation (GO:0051984),0.7658974207331939,1.3793052155283112,0.12,0.5733019427330663,1.0,4/7,13.72%,RCC2;RAD18;SMC6;SIRT2
prerank,GO_Biological_Process_2021__negative regulation of fat cell differentiation (GO:0045599),0.5906775391621746,1.3792375975344422,0.10810810810810811,0.5722980210156312,1.0,9/25,16.90%,ZFPM2;FOXO1;RORA;ANKRD26;RUNX1T1;SIRT1;SIRT2;YAP1;TRIB2
prerank,GO_Biological_Process_2021__regulation of mesenchymal stem cell differentiation (GO:2000739),0.7644172838158995,1.3791092262935338,0.0975609756097561,0.5717628083550557,1.0,4/7,9.01%,SOX5;SOX9;PDGFRA;SOX6
prerank,GO_Biological_Process_2021__establishment of epithelial cell polarity (GO:0090162),0.6501470320254799,1.3789861192187174,0.10526315789473684,0.5708735327622038,1.0,8/17,21.13%,PARD3;CYTH3;GOLPH3;CLASP1;OPHN1;FERMT1;RAP2A;SIPA1L3
prerank,GO_Biological_Process_2021__RNA interference (GO:0016246),0.6568182979736801,1.37881391679057,0.05405405405405406,0.5701659337058816,1.0,9/14,31.12%,DROSHA;DHX9;PRKRA;AGO3;CELF1;TSN;DICER1;AGO1;AGO2
prerank,GO_Biological_Process_2021__positive regulation of transcription by RNA polymerase II (GO:0045944),0.36651947499444937,1.3780214436367901,0.0,0.5724066497935326,1.0,181/669,18.63%,ZNF300;WNT7A;PPARGC1A;PID1;LPIN3;ZFPM2;MEOX2;RARB;NCK2;ETV5;ZGLP1;NRIP1;DCN;MITF;VEZF1;SERPINE1;KAT2B;EAF2;UBP1;FOXO1;SOX4;SOX8;SALL1;MEIS3;BMP2;PLAC8;ETV1;TFAP2C;NR4A2;EGFR;RPS6KA4;ASCL1;RGCC;DR1;SOX9;RORA;MLLT10;NFIB;RHOQ;PHF10;CCDC62;NFKB1;ZEB2;GRIN1;ARRB1;FZD5;HCLS1;FOXO3;HNRNPU;ZNF407;SMAD2;ZNF746;GABPB1;CDK8;MAML2;RPS6KA3;THRB;PBX1;GABPA;RFX3;NFAT5;SMAD7;DPF1;NR1D2;CDK12;NRF1;WASL;ATF6;PIK3R1;LMO7;NCOA2;SP3;SMARCA2;SMAD5;BMPR1B;TCF4;HDAC2;NCOA3;NR3C1;TFE3;MEN1;PKD2;CLOCK;MRTFA;GLI3;GLIS3;ZNF268;AUTS2;HMGB1;ELF1;NR1D1;KAT2A;NPAS2;PRKN;FOXJ3;CAPRIN2;PBX2;ZNF451;TCF12;RGMA;MED13;EP300;PRKD1;AKIRIN2;MEIS2;SS18;DVL1;AHR;ELK4;ZNF24;ACVR1;WWOX;TBL1XR1;SETD3;TFEB;HDAC4;SIRT1;HIPK2;METTL23;RREB1;SLC30A9;OGT;DHX9;MAP2K5;SMARCD2;SIRT2;NCK1;ASXL3;ACVR2A;EPCAM;CRTC2;KAT7;HNF4G;BMPR1A;KMT2C;EHF;SMAD4;BCL9;MLXIPL;CDK13;ZBTB38;POU2F1;JMJD6;PHIP;YAP1;HSF2;CCNT2;TFDP2;THAP3;PPP3CB;HGF;RSF1;DPF3;CSRNP3;PPP1R12A;ATAD2B;SATB2;KAT6B;MAML1;POGZ;ATF2;CDH13;HIF1A;ITGA6;RUNX1;IGF1;KDM1A;YY1;KDM1B;ABHD14B;AATF;DCAF6;ZNF462;RPRD1B;ZBTB18;RBPJ;ATRX;RORB;NFATC3;SSBP2;LMO1
prerank,GO_Biological_Process_2021__regulation of mRNA polyadenylation (GO:1900363),0.6383014235437694,1.3776005375215579,0.05714285714285714,0.5731859346945105,1.0,4/18,6.26%,NUDT21;CPEB3;ZC3H14;CPSF6
prerank,GO_Biological_Process_2021__positive regulation of protein ubiquitination (GO:0031398),0.5044471143702878,1.3773830801360554,0.06060606060606061,0.5725132577253595,1.0,21/67,18.83%,SPSB4;DCUN1D1;SMAD7;UBE2D1;UBE2N;FAM107A;MARCHF7;PSMD10;FBXW7;DCUN1D5;COMMD1;PEF1;UBQLN1;DCUN1D4;BIRC2;CUL3;NDFIP1;KDM1A;DCUN1D2;AXIN1;BCL10
prerank,GO_Biological_Process_2021__cartilage development (GO:0051216),0.5566904781081863,1.3773610285435316,0.06060606060606061,0.5713851593108024,1.0,8/35,9.01%,WNT7A;SOX5;BMP2;ITGB8;SOX9;NFIB;TRIP11;SOX6
prerank,GO_Biological_Process_2021__ribonucleoprotein complex biogenesis (GO:0022613),-0.5789954353800303,-1.3767003283627903,0.043478260869565216,0.8740092303235114,1.0,22/56,14.89%,RPL38;RPL11;RPL35A;RPS7;RPS25;RPS6;RPS15;RPS24;RPL7;RPL5;EMG1;RPS16;RPS28;RPL14;RPL26L1;RBIS;GTF3A;RPF2;WDR12;RPS19;EBNA1BP2;MRPL36
prerank,GO_Biological_Process_2021__positive regulation of phospholipase activity (GO:0010518),0.6043220570695013,1.3765950953829809,0.0975609756097561,0.5737095173412818,1.0,7/19,23.54%,FLT1;PDGFRA;ABL2;GNA13;NTRK3;FGF2;FGFR2
prerank,GO_Biological_Process_2021__organonitrogen compound biosynthetic process (GO:1901566),0.45912579634414535,1.3764273011665673,0.05555555555555555,0.5729698390545632,1.0,26/134,12.01%,VAPB;LPIN3;CERS3;LCMT2;SGMS1;PCSK5;ELOVL7;VAPA;HACD2;ACER3;PLPP1;GPHN;ELOVL6;CSNK2A1;SPNS2;SLC44A5;LARGE1;GSTM2;ASL;GOLPH3;PRKD1;PPM1L;ESD;PLPP3;PLPP2;ELOVL5
prerank,GO_Biological_Process_2021__regulation of bone remodeling (GO:0046850),0.751791094144216,1.3763918571675977,0.06666666666666667,0.5719530967583899,1.0,1/6,0.74%,LEPR
prerank,GO_Biological_Process_2021__regulation of systemic arterial blood pressure by hormone (GO:0001990),0.8938086733913166,1.3763658934221514,0.04,0.570765928883102,1.0,1/5,0.08%,ACE2
prerank,PanglaoDB_Augmented_2021__Cardiac Stem And Precursor Cells,0.4705672763588279,1.3761312424321719,0.045454545454545456,0.5704906930866288,1.0,32/92,23.76%,TENM3;MPDZ;EPHA2;EGFR;PARVA;CACNA2D1;PCGF2;MID1;PKDCC;RBFOX2;PLOD2;SLIT2;NCKAP1;ENAH;TJP1;ADGRL2;PTPRG;YAP1;DDAH1;BCAR1;LIFR;CHST3;LRP4;CASKIN2;SNX7;TSPAN12;DOCK1;ADCY6;PLS3;FZD7;MESP1;TEAD1
prerank,GO_Biological_Process_2021__cleavage furrow formation (GO:0036089),0.9032202210521046,1.3756309795143193,0.024390243902439025,0.5717480654625631,1.0,3/6,7.93%,SPIRE2;SNX18;SPIRE1
prerank,GO_Biological_Process_2021__toll-like receptor 9 signaling pathway (GO:0034162),0.7138729551552505,1.3754536891975713,0.11627906976744186,0.5712982557369933,1.0,3/11,9.92%,IRAK2;PIK3C3;PIK3R4
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",-0.6904798026880088,-1.375428796115287,0.05555555555555555,0.8776827044440879,1.0,5/20,17.91%,CETN2;RPS27A;UBC;RBX1;UBA52
prerank,GO_Biological_Process_2021__sodium ion transmembrane transport (GO:0035725),0.48480544280102794,1.3748353040031214,0.03571428571428571,0.5723406418965212,1.0,16/61,21.67%,ASIC4;SLC24A3;SLC6A13;SLC12A2;TRPM4;PKD2;SLC4A4;ASIC3;SLC24A4;SLC6A6;ATP1A4;SLC6A11;SLC9A9;SLC6A9;SLC6A12;SLC6A1
prerank,GO_Biological_Process_2021__cellular response to superoxide (GO:0071451),-0.8000264106183489,-1.374549952278898,0.1320754716981132,0.8794092441466379,1.0,3/7,14.42%,MT3;SOD3;CCS
prerank,GO_Biological_Process_2021__negative regulation of catalytic activity (GO:0043086),-0.6341046484011721,-1.374366593635059,0.078125,0.8752929235722818,1.0,7/22,13.86%,IFIT1;PLN;TIMP1;MT3;ATP5IF1;NOS1;CLN3
prerank,PanglaoDB_Augmented_2021__Tuft Cells,-0.6308662158637962,-1.3733708961454505,0.09230769230769231,0.878082167822473,1.0,11/33,18.42%,CD24;IGHG1;P2RY13;POU2F3;CD14;SPI1;TUBB;GFI1B;IRAG2;CDHR2;NFAM1
prerank,PanglaoDB_Augmented_2021__Oligodendrocytes,0.45934216968969555,1.37258936873178,0.05555555555555555,0.5812293320576103,1.0,37/160,16.25%,GABRG1;SOWAHA;SOX8;TMEM235;ELOVL7;PSD2;AMER2;OLIG2;KIF13B;MYRF;NTRK2;PEX5L;MOBP;ADAMTS4;NRXN1;MBP;CAMK2A;PPP1R1B;ASTN1;VSTM2B;FAM107A;SRCIN1;NDRG2;ADGRA1;ANLN;GPM6B;HAPLN2;KIF1B;SGK3;RGS7BP;MAPK4;LY6H;OLIG1;POU3F1;CA10;TMEM178A;SEMA4D
prerank,GO_Biological_Process_2021__energy reserve metabolic process (GO:0006112),0.6567469081598714,1.3725804773005028,0.058823529411764705,0.5800031098380795,1.0,2/16,0.74%,PID1;LEPR
prerank,GO_Biological_Process_2021__regulation of cytokine-mediated signaling pathway (GO:0001959),-0.5578912649930925,-1.3721414676137864,0.08823529411764706,0.8814613700601395,1.0,8/62,7.86%,CD24;IL7;AGPAT2;STAT1;USP18;IFNGR2;SIGIRR;CASP8
prerank,"GO_Biological_Process_2021__RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503)",0.8434421565835702,1.3720951637220777,0.0851063829787234,0.580607318342738,1.0,2/5,7.58%,PDE12;TOE1
prerank,GO_Biological_Process_2021__regulation of extracellular matrix constituent secretion (GO:0003330),0.890756091534775,1.3718921980712155,0.02040816326530612,0.5800405216473719,1.0,2/5,4.09%,BMP2;RGCC
prerank,GO_Biological_Process_2021__protein secretion (GO:0009306),0.5248002194758022,1.3715277884322095,0.07407407407407407,0.5799219314467594,1.0,9/47,10.72%,RCN3;PCSK5;ABCA1;TVP23B;TMEM167A;TANGO6;RAB8B;GOLPH3;MTTP
prerank,GO_Biological_Process_2021__regulation of brown fat cell differentiation (GO:0090335),0.7408647086421725,1.3713734571309402,0.08823529411764706,0.5791878258071855,1.0,7/13,16.20%,FTO;HNRNPU;TFE3;SIRT1;RREB1;SOX13;BMP7
prerank,GO_Biological_Process_2021__positive regulation of cell development (GO:0010720),0.6316786197248615,1.3712113599069515,0.05,0.5789007538124675,1.0,6/21,11.20%,LIG4;PDE3A;MME;RFX3;SPEN;NAP1L1
prerank,GO_Biological_Process_2021__establishment of protein localization to membrane (GO:0090150),0.4957800299013985,1.3705231965536129,0.041666666666666664,0.5799780888780276,1.0,16/60,16.16%,VPS37B;PARD3;ZDHHC18;EGFR;ZDHHC11;NECTIN3;RAB3IP;VPS37A;ZDHHC21;BRAF;GOLGA7;AFDN;PIKFYVE;RAB3GAP1;TAOK2;CHM
prerank,GO_Biological_Process_2021__positive regulation of apoptotic process (GO:0043065),0.40972724002481525,1.370522497997227,0.0,0.5787723132254745,1.0,71/246,18.91%,EPHA7;KLF11;MAP3K11;TIAM2;ARHGEF6;SNCA;PAWR;TPD52L1;AIFM2;FOXO1;SOX4;BMP2;PHLDA1;ARHGEF16;CRADD;ARHGEF12;DAPK2;BOK;NCSTN;FOXO3;ARHGEF26;BIN1;FRZB;KCNMA1;ATF6;UBE2Z;CTNNBL1;FGD4;RPS6KA2;ATG7;ITSN1;ZNF268;HMGB1;C3ORF38;FAP;ADAMTSL4;TRADD;MAP3K20;NF1;TP53BP2;GNA13;MAP3K5;SOS1;SLIT2;CLIP3;SIRT1;TGFBR1;TNFRSF10B;SIRT2;IP6K2;MAP3K10;MCF2L;JMY;DUSP6;FAF1;SCRIB;LATS1;ARHGEF7;TRIM35;MAPK8;CCAR1;CSRNP3;ITGA6;TNFRSF8;PNMA3;SRPK2;FAS;AIFM1;BCL10;APBB1;DNM2
prerank,GO_Biological_Process_2021__branched-chain amino acid catabolic process (GO:0009083),0.6544084162579674,1.3698342316463294,0.11764705882352941,0.5790852280566074,1.0,6/19,23.24%,ACAD8;AUH;BCKDHB;HIBCH;ACADSB;ACAT1
prerank,GO_Biological_Process_2021__branched-chain amino acid metabolic process (GO:0009081),0.6544084162579674,1.3698342316463294,0.11764705882352941,0.5790852280566074,1.0,6/19,23.24%,ACAD8;AUH;BCKDHB;HIBCH;ACADSB;ACAT1
prerank,GO_Biological_Process_2021__interleukin-9-mediated signaling pathway (GO:0038113),-0.8622558692899627,-1.3697873949149644,0.03773584905660377,0.8887168866697285,1.0,1/6,3.14%,STAT1
prerank,GO_Biological_Process_2021__cellular response to interleukin-9 (GO:0071355),-0.8622558692899627,-1.3697873949149644,0.03773584905660377,0.8887168866697285,1.0,1/6,3.14%,STAT1
prerank,GO_Biological_Process_2021__regulation of metaphase/anaphase transition of cell cycle (GO:1902099),-0.8554584542340358,-1.3693013090694148,0.11538461538461539,0.8872585405446056,1.0,1/6,1.66%,CENPE
prerank,GO_Biological_Process_2021__positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),0.4888893592895791,1.3692839803023733,0.043478260869565216,0.5803898687076195,1.0,28/68,21.28%,KEAP1;RNF217;RNF144A;SMAD7;CSNK1E;RNF14;DNAJB2;PSMD10;PRKN;FBXW7;COP1;DVL1;PIAS1;SMURF1;PTK2;SIRT2;ARIH1;VCP;GSK3B;ZYG11B;TRIB2;MDM2;PTEN;AXIN1;PLK1;BAG2;HECTD1;HSPA1A
prerank,GO_Biological_Process_2021__sensory perception (GO:0007600),0.6184622607159717,1.369250060262535,0.08888888888888889,0.5792269174961062,1.0,7/29,14.52%,CHRNA4;MME;KCNA2;TTC8;OR3A2;ASIC3;WHRN
prerank,GO_Biological_Process_2021__Roundabout signaling pathway (GO:0035385),0.8422214410578894,1.3691239090829683,0.09615384615384616,0.5784390069117176,1.0,2/5,12.05%,ROBO1;SLIT2
prerank,GO_Biological_Process_2021__negative regulation of systemic arterial blood pressure (GO:0003085),0.8494239872028777,1.3689601515775223,0.1346153846153846,0.578225369120491,1.0,3/6,11.00%,ADRB2;PRCP;ADRB1
prerank,GO_Biological_Process_2021__cellular modified amino acid catabolic process (GO:0042219),0.7106996276375022,1.3688796125799718,0.13513513513513514,0.5773086537103852,1.0,2/10,8.89%,PRODH;ALDH4A1
prerank,GO_Biological_Process_2021__regulation of cell projection organization (GO:0031344),0.6794807722301347,1.3688607190165651,0.10416666666666667,0.576295328560912,1.0,3/11,23.89%,FAM110C;SEMA4D;MACF1
prerank,GO_Biological_Process_2021__regulation of insulin receptor signaling pathway (GO:0046626),0.5886314907662298,1.3688307091772989,0.07894736842105263,0.5752193699176669,1.0,11/32,15.44%,PID1;KANK1;IRS1;RPS6KB1;SIK2;PIP4K2C;SIRT1;OGT;NCK1;SNX5;PTPN11
prerank,PanglaoDB_Augmented_2021__Peri-islet Schwann Cells,0.46427042463777496,1.3687876429588173,0.0,0.5742810610540163,1.0,40/107,19.31%,TENM3;MPDZ;ANK2;PCDH7;MEIS3;PDZRN3;PARVA;ADGRL3;INSC;CDH11;OLFML2A;CACNA2D1;PCDH18;FRZB;PBX1;SLITRK2;GFRA1;PRICKLE2;RBFOX2;HSPA12A;ITSN1;DZIP1;RUNX1T1;SLIT2;ALDH7A1;ZNF423;NCKAP1;ENAH;FARP1;TJP1;ADGRL2;PTPRG;YAP1;CSRNP3;EML1;FBLN1;LIFR;CHST3;LRP4;FAM13C
prerank,GO_Biological_Process_2021__catecholamine biosynthetic process (GO:0042423),0.8032433533428107,1.368674541269069,0.1111111111111111,0.5734795626420358,1.0,2/7,3.91%,SNCA;PNMT
prerank,GO_Biological_Process_2021__protein complex oligomerization (GO:0051259),0.4772170895530142,1.3683833208570284,0.03571428571428571,0.5738426719098728,1.0,12/72,9.50%,NUDT21;SNCA;ZBTB1;PRMT1;MCU;BOK;MPP2;CPSF6;UGDH;EHD4;HOMER1;PKD2
prerank,GO_Biological_Process_2021__BMP signaling pathway (GO:0030509),0.5136486520554121,1.3682230681080854,0.0,0.5732771069064618,1.0,14/45,16.20%,AMH;BMP2;SMAD2;SMAD7;SMAD5;BMPR1B;RGMA;SMURF1;ACVR1;ACVR2A;BMPR1A;SMAD4;USP9X;BMP7
prerank,GO_Biological_Process_2021__erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221),0.8547631359158918,1.3681478100688822,0.0625,0.5724824942508117,1.0,2/5,5.79%,KYAT1;QDPR
prerank,GO_Biological_Process_2021__Fc receptor mediated stimulatory signaling pathway (GO:0002431),0.5007059485292168,1.36813964723475,0.08333333333333333,0.5713612765832164,1.0,21/58,26.49%,CD247;PIK3CA;WASL;PIK3R1;CYFIP2;PRKCE;WIPF2;PTK2;NCKAP1;ABI1;NCK1;MAPK1;CYFIP1;FYN;WIPF3;DOCK1;CRK;ACTR3;ELMO2;ELMO1;MYO10
prerank,GO_Biological_Process_2021__positive regulation of cell junction assembly (GO:1901890),0.5151397304547977,1.3677128798562177,0.1111111111111111,0.5721207001819804,1.0,11/47,15.85%,ACE2;WNT7A;EPHA2;SLITRK2;NRXN1;PTPRJ;MAP4K4;NLGN3;DLG5;CLSTN2;NRP1
prerank,GO_Biological_Process_2021__regulation of execution phase of apoptosis (GO:1900117),0.6594037998868694,1.3674298520303156,0.13636363636363635,0.5722529532214151,1.0,5/10,16.26%,BOK;FAP;TP53BP2;SIRT2;FZD3
prerank,GO_Biological_Process_2021__cellular response to angiotensin (GO:1904385),0.8335888164346479,1.3673664705172406,0.07317073170731707,0.5713356321084767,1.0,3/7,8.03%,NFKB1;CA2;CAMK2A
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion (GO:0022407),0.5327143668392449,1.3668813664395623,0.027777777777777776,0.5723850040148224,1.0,9/35,12.34%,EPHA7;TENM3;EFNA5;FUT9;MEGF10;SMAD7;ADA;PTK2;AFDN
prerank,GO_Biological_Process_2021__protein-containing complex subunit organization (GO:0043933),0.503334300266091,1.3665704218553314,0.03571428571428571,0.5725812410847883,1.0,30/96,24.56%,TCAP;PPARGC1A;MITF;PARD3;SHANK1;PICALM;SOX9;CD247;WASL;PEX14;OCLN;NDC1;MDM4;YAP1;NUP205;WASF3;WASF1;FAS;MDM2;SLC7A9;LIN7A;PPP2R1A;CREBBP;REPS2;TEAD2;CAPZA1;TEAD1;NUP54;VAMP3;NUP98
prerank,GO_Biological_Process_2021__basement membrane organization (GO:0071711),0.6765777188671339,1.3663127281332739,0.16666666666666666,0.5728418697645293,1.0,2/13,4.53%,LAMB4;FLRT2
prerank,GO_Biological_Process_2021__maintenance of DNA methylation (GO:0010216),0.8156998110077935,1.3661497194026901,0.1320754716981132,0.5721583261580997,1.0,2/6,9.75%,UHRF2;HELLS
prerank,GO_Biological_Process_2021__kinetochore organization (GO:0051383),-0.7854534244411134,-1.3661028576426202,0.09433962264150944,0.9070809589445435,1.0,4/8,14.74%,CENPE;NUF2;MIS12;CENPH
prerank,GO_Biological_Process_2021__coronary vasculature morphogenesis (GO:0060977),0.7971110316289237,1.366068870007274,0.1320754716981132,0.5713152080111836,1.0,3/7,15.85%,SPRED1;TGFBR1;NRP1
prerank,GO_Biological_Process_2021__regulation of macrophage migration (GO:1905521),-0.7644629518782412,-1.3657715540551214,0.09090909090909091,0.9044660722136296,1.0,2/9,3.42%,MST1;P2RY12
prerank,GO_Biological_Process_2021__Fc-gamma receptor signaling pathway (GO:0038094),0.5050259504673337,1.3656774941082148,0.08333333333333333,0.5706735007782938,1.0,21/57,26.49%,CD247;PIK3CA;WASL;PIK3R1;CYFIP2;PRKCE;WIPF2;PTK2;NCKAP1;ABI1;NCK1;MAPK1;CYFIP1;FYN;WIPF3;DOCK1;CRK;ACTR3;ELMO2;ELMO1;MYO10
prerank,GO_Biological_Process_2021__Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),0.5050259504673337,1.3656774941082148,0.08333333333333333,0.5706735007782938,1.0,21/57,26.49%,CD247;PIK3CA;WASL;PIK3R1;CYFIP2;PRKCE;WIPF2;PTK2;NCKAP1;ABI1;NCK1;MAPK1;CYFIP1;FYN;WIPF3;DOCK1;CRK;ACTR3;ELMO2;ELMO1;MYO10
prerank,GO_Biological_Process_2021__ERBB signaling pathway (GO:0038127),0.5388499395646347,1.3647602681908781,0.08333333333333333,0.5727099160629776,1.0,17/56,15.78%,NCK2;ERBB4;EGFR;SOX9;CBL;AKT1;PIK3CA;PIK3R1;SHC3;BRAF;SOS1;PTK2;NRG2;MAPK1;GAB1;PTPN11;CPNE3
prerank,GO_Biological_Process_2021__positive regulation of immunoglobulin mediated immune response (GO:0002891),0.6907022026683163,1.3646655683792779,0.11363636363636363,0.571904552667649,1.0,3/13,20.46%,TNFSF4;TFRC;NECTIN2
prerank,GO_Biological_Process_2021__regulation of protein phosphorylation (GO:0001932),0.41827536369125556,1.3646048987165968,0.0,0.5709737994929416,1.0,56/207,19.12%,VEGFD;EPHA7;PID1;LEPR;CCDC88C;EFNA5;NPTN;BMP2;ERBB4;PPP1R15B;CSF1R;EGFR;SOX9;FGF17;ARRB1;TESK1;LIMCH1;TNIK;AKT1;NTRK2;BST1;PTPN13;PPP2R5A;PDGFA;VEGFC;MEN1;PRKN;RALB;CRKL;PLPP3;PTK2;SLIT2;CLIP3;OCLN;SIRT1;FER;ACVR2A;WDFY2;NIBAN1;ROCK2;PHIP;HGF;BMP7;IMPACT;SEMA4D;TFRC;AKT2;PPP2R5E;FXR1;RAP2A;FBLN1;FAS;PTEN;AXIN1;CCND3;FYN
prerank,GO_Biological_Process_2021__axoneme assembly (GO:0035082),-0.6603062120128528,-1.364413873334494,0.09375,0.9097019730395765,1.0,4/24,5.19%,SPAG17;RSPH4A;CCDC39;DNAAF1
prerank,GO_Biological_Process_2021__cellular response to amino acid starvation (GO:0034198),0.48511579463996046,1.3642497079675675,0.0,0.5711051895210347,1.0,18/65,18.23%,ATP6V0D2;ATP6V1A;RHEB;SESN1;ATP6V1C1;KPTN;EIF2AK4;PRKD1;MAP3K5;TFEB;RPTOR;MAPK1;SESN3;ATP6V1B2;MAPK8;IMPACT;ATF2;FAS
prerank,GO_Biological_Process_2021__pyruvate metabolic process (GO:0006090),-0.6031027925106995,-1.364134964817769,0.11940298507462686,0.9066796572473758,1.0,14/43,20.22%,LDHC;GAPDHS;ENO4;SLC16A3;ALDOB;PDHX;LDHA;HK2;GPI;PCK2;PGAM1;SDS;GAPDH;ENO1
prerank,GO_Biological_Process_2021__ncRNA export from nucleus (GO:0097064),0.5264292688867315,1.3629910104391771,0.13333333333333333,0.5746294200952055,1.0,10/37,24.56%,NUP42;NUP37;NUP188;NUP153;NDC1;NUP205;NUP214;RANBP2;NUP54;NUP98
prerank,GO_Biological_Process_2021__synaptic vesicle recycling (GO:0036465),0.5667222972113639,1.3628348949982187,0.1,0.5743058534116016,1.0,9/29,15.35%,WNT7A;SNCA;TBC1D24;PIP5K1C;NLGN3;NLGN4X;OPHN1;SYNJ1;STX1A
prerank,GO_Biological_Process_2021__phosphatidylinositol dephosphorylation (GO:0046856),0.6116977395768337,1.3620688369808955,0.10810810810810811,0.5764389222638351,1.0,13/24,27.22%,PIP4P2;SYNJ1;MTMR10;MTMR2;PTEN;MTM1;MTMR12;SACM1L;OCRL;TPTE2;MTMR6;SYNJ2;MTMR9
prerank,GO_Biological_Process_2021__protein import (GO:0017038),0.46791794251290836,1.3620210997496918,0.045454545454545456,0.5756357051217577,1.0,21/79,18.33%,GDAP1;RANBP17;PPP1R10;NUP188;AKT1;RAB8B;IPO8;PEX14;SPRN;TOMM22;NUP153;PEX16;SAMM50;NXT2;PEX5;PEX2;ABCD3;HSPA4;TNPO1;PEX13;NUP214
prerank,GO_Biological_Process_2021__histone H2A-K119 monoubiquitination (GO:0036353),0.764632169206859,1.361843294518292,0.08333333333333333,0.5750897203743849,1.0,1/8,6.10%,PCGF2
prerank,GO_Biological_Process_2021__glycosphingolipid biosynthetic process (GO:0006688),0.6644349972053374,1.3611446597899404,0.12244897959183673,0.5763528988896868,1.0,3/14,9.17%,ST6GALNAC5;B4GALT6;LARGE1
prerank,GO_Biological_Process_2021__tyrosine metabolic process (GO:0006570),0.8206700608036842,1.3611384817528864,0.09523809523809523,0.5752697376367543,1.0,1/7,0.16%,TYR
prerank,GO_Biological_Process_2021__histone acetylation (GO:0016573),0.4846728200739055,1.361093085306805,0.06666666666666667,0.5743170791772586,1.0,24/66,24.66%,KAT2B;DR1;MBIP;CHD5;ZZZ3;MAP3K7;KAT2A;SUPT3H;EP300;KAT7;TRIM16;NAA50;KAT6B;EP400;ATF2;APBB1;PHF20L1;KAT14;LEF1;CREBBP;BEND3;EPC1;TAF12;ING3
prerank,GO_Biological_Process_2021__endosome organization (GO:0007032),0.5617363557629174,1.3608865009963316,0.09090909090909091,0.5740615170600332,1.0,12/37,19.42%,RAB27A;ALS2CL;TMCC1;EXOC8;RNF26;DNAJC13;HOOK1;CHMP2B;RAB22A;ALS2;PHETA1;CLCN3
prerank,GO_Biological_Process_2021__cellular modified amino acid biosynthetic process (GO:0042398),0.619963814940305,1.3603095163495798,0.05263157894736842,0.5750023689945987,1.0,4/18,12.62%,MTHFS;PLOD2;GCLC;GGCT
prerank,GO_Biological_Process_2021__sensory perception of pain (GO:0019233),0.7322093979905867,1.3600307277447208,0.07692307692307693,0.5747778709187182,1.0,3/11,10.20%,CHRNA4;MME;KCNA2
prerank,GO_Biological_Process_2021__regulation of interferon-gamma-mediated signaling pathway (GO:0060334),-0.6505164997926884,-1.3596789806482417,0.14285714285714285,0.9354963380579557,1.0,7/19,21.24%,PARP14;STAT1;IFNGR2;CDC37;SOCS3;NLRC5;PARP9
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),0.7114112934430155,1.3595308824869352,0.06451612903225806,0.575776422095658,1.0,3/13,11.24%,ANK2;GSTM2;CAMK2D
prerank,GO_Biological_Process_2021__Rap protein signal transduction (GO:0032486),0.7609368897119061,1.3591030966397133,0.07317073170731707,0.5760517546909597,1.0,5/9,17.59%,RAP2B;RAPGEF2;RAP2C;RAP1A;RAP2A
prerank,GO_Biological_Process_2021__calcium ion transport (GO:0006816),0.4542845908969753,1.3584892335267904,0.0,0.5777308720865887,1.0,15/81,12.49%,CHRNA4;SLC24A3;CACNA1G;ANK2;STIM2;CACNA1I;CACNA1B;CACNA2D1;ATP2C1;TRPM4;CACNG3;CAMK2A;PKD2;STIM1;TRPM3
prerank,GO_Biological_Process_2021__CD40 signaling pathway (GO:0023035),-0.8741666825389798,-1.3584227804504871,0.08620689655172414,0.9397390285013724,1.0,1/5,3.13%,ITGA5
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),0.6478345637167446,1.3584177999939406,0.14285714285714285,0.5768485460785481,1.0,3/16,11.24%,ANK2;GSTM2;CAMK2D
prerank,GO_Biological_Process_2021__glucose import (GO:0046323),0.6803652651358215,1.3583875570848647,0.0967741935483871,0.5759073751841363,1.0,1/8,3.91%,SORT1
prerank,GO_Biological_Process_2021__regulation of phosphate metabolic process (GO:0019220),-0.7507631068235484,-1.3582555365268647,0.11864406779661017,0.9358384076214654,1.0,1/14,0.14%,CD24
prerank,GO_Biological_Process_2021__positive regulation of rRNA processing (GO:2000234),-0.7493817198296766,-1.3579257307608665,0.11666666666666667,0.933322948590213,1.0,2/10,8.13%,BUD23;TRMT112
prerank,GO_Biological_Process_2021__very long-chain fatty acid biosynthetic process (GO:0042761),0.7167692714631757,1.3577229658996002,0.15555555555555556,0.5774530445775368,1.0,5/11,15.01%,ELOVL7;HACD2;ELOVL6;ELOVL5;HACD1
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transport (GO:0051928),0.658330742558295,1.357675094250359,0.09375,0.5765142938408709,1.0,5/23,8.03%,ANK2;STIM2;CXCL12;GRIN1;CAMK2A
prerank,GO_Biological_Process_2021__lens fiber cell differentiation (GO:0070306),0.8572837502248309,1.3571468276448213,0.0625,0.577434502213637,1.0,1/6,0.52%,WNT7A
prerank,GO_Biological_Process_2021__regulation of humoral immune response (GO:0002920),-0.6215452154629494,-1.356921601610999,0.09836065573770492,0.9357965460824275,1.0,17/25,30.90%,C1R;CLU;CPB2;C1S;ZP3;SUSD4;C1QB;CR1;C2;C6;C3;CR1L;PHB2;C5;SERPING1;CD46;C1QBP
prerank,GO_Biological_Process_2021__positive regulation of programmed cell death (GO:0043068),0.41375257512296143,1.356757321774371,0.0,0.578320372948914,1.0,64/226,18.91%,KLF11;MAP3K11;TIAM2;ARHGEF6;SNCA;PAWR;AIFM2;FOXO1;SOX4;BMP2;PHLDA1;ARHGEF16;CRADD;ARHGEF12;DAPK2;BOK;NCSTN;FOXO3;ARHGEF26;BIN1;FRZB;KCNMA1;ATF6;UBE2Z;CTNNBL1;FGD4;RPS6KA2;ATG7;ITSN1;ZNF268;HMGB1;C3ORF38;ADAMTSL4;TRADD;MAP3K20;NF1;GNA13;MAP3K5;SOS1;SLIT2;CLIP3;SIRT1;TNFRSF10B;IP6K2;MAP3K10;MCF2L;JMY;DUSP6;FAF1;SCRIB;LATS1;ARHGEF7;TRIM35;MAPK8;CCAR1;CSRNP3;ITGA6;TNFRSF8;PNMA3;FAS;AIFM1;BCL10;APBB1;DNM2
prerank,GO_Biological_Process_2021__negative regulation of macroautophagy (GO:0016242),0.5953640415862019,1.3558955017430874,0.10256410256410256,0.5804351881351771,1.0,8/25,18.71%,QSOX1;SMCR8;AKT1;SEC22B;PIK3CA;SMG1;UBQLN4;MTM1
prerank,GO_Biological_Process_2021__negative regulation of organelle assembly (GO:1902116),0.5260664195835467,1.355430585747303,0.09090909090909091,0.5812813390236202,1.0,9/32,15.63%,KAT2B;SMCR8;EVI5L;TESK1;CEP97;SEC22B;KAT2A;SMAD4;YAP1
prerank,GO_Biological_Process_2021__negative regulation of sodium ion transmembrane transport (GO:1902306),0.7645317779610614,1.3550045502763115,0.10638297872340426,0.5823698462858193,1.0,4/8,13.37%,NEDD4L;PRKCE;CAMK2D;COMMD1
prerank,GO_Biological_Process_2021__regulation of metallopeptidase activity (GO:1905048),-0.7976587174752952,-1.354362037590239,0.14285714285714285,0.9510373380534894,1.0,2/6,7.75%,TIMP1;SVBP
prerank,GO_Biological_Process_2021__positive regulation of cell adhesion mediated by integrin (GO:0033630),-0.7521372381645121,-1.3543530172620277,0.1,0.9458404127089348,1.0,4/11,15.28%,SFRP2;P2RY12;PODXL;SKAP1
prerank,GO_Biological_Process_2021__hepaticobiliary system development (GO:0061008),0.6830516198275937,1.3535918297274867,0.1320754716981132,0.5876204944062308,1.0,5/16,12.75%,PRKCSH;PHF2;PKD2;NF1;NIPBL
prerank,GO_Biological_Process_2021__regulation of autophagy (GO:0010506),0.41474230990570643,1.3530911275148303,0.0,0.5888153903685932,1.0,45/202,16.48%,ATP6V0D2;LEPR;USP13;DCN;FOXO1;KEAP1;TAB3;ATP6V1A;SMCR8;RHEB;DAPK2;BOK;FZD5;FOXO3;AKT1;EXOC8;ATF6;ABL2;ATP6V1C1;TICAM1;HMGB1;PRKN;EIF4E;EP300;PRKD1;FBXW7;PIP4K2C;TFEB;EXOC4;PRKAB1;DRAM2;OSBPL7;SIRT2;RPTOR;UBQLN1;EIF4G3;SNX5;TPCN1;ATP6V1B2;BCL2;GSK3B;MAPK8;HGF;STK11;UBQLN2
prerank,GO_Biological_Process_2021__forelimb morphogenesis (GO:0035136),0.8289795781717448,1.3526869856617678,0.125,0.5882978641694515,1.0,2/5,12.75%,WNT7A;NIPBL
prerank,GO_Biological_Process_2021__embryonic forelimb morphogenesis (GO:0035115),0.8289795781717448,1.3526869856617678,0.125,0.5882978641694515,1.0,2/5,12.75%,WNT7A;NIPBL
prerank,"GO_Biological_Process_2021__heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process (GO:0015014)",0.7879458422274798,1.3526802442489627,0.07142857142857142,0.5873259984823231,1.0,5/7,18.66%,CSGALNACT1;EXT1;EXT2;HS2ST1;NDST1
prerank,GO_Biological_Process_2021__central nervous system neuron axonogenesis (GO:0021955),0.6917696164285089,1.3521278475959506,0.11627906976744186,0.5881180261839576,1.0,4/11,18.44%,ARHGAP35;B4GALT6;B4GALT5;PTEN
prerank,PanglaoDB_Augmented_2021__Gamma Delta T Cells,-0.6718016078786164,-1.3520190182391696,0.078125,0.9582356545030153,1.0,6/20,15.18%,P2RY10;SPON2;TYMS;KLRD1;TUBB;S100B
prerank,GO_Biological_Process_2021__negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),-0.5941948826569903,-1.3518987428701372,0.0821917808219178,0.9542276552873967,1.0,7/42,10.93%,IFI6;DHCR24;AQP1;THBS1;BEX3;MT3;KLF4
prerank,GO_Biological_Process_2021__postsynaptic neurotransmitter receptor diffusion trapping (GO:0098970),0.7687991170064125,1.3517276524923316,0.18604651162790697,0.5878185675467956,1.0,3/7,7.54%,CACNG2;GPHN;CACNG3
prerank,GO_Biological_Process_2021__neurotransmitter receptor diffusion trapping (GO:0099628),0.7687991170064125,1.3517276524923316,0.18604651162790697,0.5878185675467956,1.0,3/7,7.54%,CACNG2;GPHN;CACNG3
prerank,GO_Biological_Process_2021__regulation of glucan biosynthetic process (GO:0010962),0.759223539801656,1.351706813618186,0.11363636363636363,0.5867943950277927,1.0,4/7,15.88%,PPP1R3D;AKT1;PPP1R3F;PPP1R3G
prerank,GO_Biological_Process_2021__intracellular cholesterol transport (GO:0032367),0.6610362936749666,1.3517016400184672,0.15151515151515152,0.5857438685749304,1.0,3/13,11.17%,ABCA1;STARD4;RELCH
prerank,GO_Biological_Process_2021__oxoacid metabolic process (GO:0043436),-0.6982964354647816,-1.3515585725369204,0.09230769230769231,0.951661177351174,1.0,2/21,1.44%,SULT1C3;SULT1C2
prerank,GO_Biological_Process_2021__dephosphorylation (GO:0016311),0.4364934001302201,1.3511771032281734,0.0,0.5868923748884812,1.0,48/128,21.25%,PDP1;PTPRK;PTPN4;BTRC;PLPP1;PPM1E;DUSP10;PPP2R1B;PTPN13;PPP2R5A;PPM1A;TAB1;PTPRJ;PTPN9;ACP6;PPM1L;PPEF1;PLPP3;PLPP2;PPP4R1;SSH1;PTPRB;PTPRZ1;PTPN14;DUSP6;PTPRG;MTMR2;PPP2R2A;PPP3CB;STK11;PPP1R12A;PTPRO;PPP2R5E;LHPP;PPP1CC;PLPPR4;PTEN;PPM1D;MTM1;FBXW11;PPP1CB;PPM1F;DUSP18;SSH2;PTPRE;PPP2R1A;DUSP12;PTPRC
prerank,GO_Biological_Process_2021__actin filament bundle organization (GO:0061572),0.5302406682708504,1.351023160242424,0.05555555555555555,0.5865959151349494,1.0,4/26,8.77%,MICAL1;PAWR;EPS8;FAM107A
prerank,GO_Biological_Process_2021__regulation of T cell mediated cytotoxicity (GO:0001914),-0.7007504174294585,-1.3508800309125952,0.09722222222222222,0.951605981069123,1.0,5/16,8.78%,HLA-B;HLA-A;CEACAM1;IL12A;KLRD1
prerank,GO_Biological_Process_2021__regulation of mitochondrial depolarization (GO:0051900),-0.8030872838249516,-1.3508250717551145,0.05172413793103448,0.9468736632361013,1.0,1/9,0.05%,IFI6
prerank,GO_Biological_Process_2021__activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO:0008635),0.8470725067693994,1.3508248573648,0.046511627906976744,0.5861806985957265,1.0,1/5,5.15%,BOK
prerank,GO_Biological_Process_2021__aromatic amino acid family metabolic process (GO:0009072),0.7479198599792447,1.3505860695350258,0.12,0.5861856829135581,1.0,4/7,18.87%,KYAT1;QDPR;KYNU;THAP4
prerank,GO_Biological_Process_2021__interleukin-35-mediated signaling pathway (GO:0070757),-0.7931740252888213,-1.350407871169264,0.06666666666666667,0.9446489715889196,1.0,2/10,5.79%,STAT1;IL12A
prerank,GO_Biological_Process_2021__positive regulation of triglyceride metabolic process (GO:0090208),0.662210764638216,1.3503112943359077,0.12195121951219512,0.5861309463721145,1.0,2/13,6.31%,PLIN5;ABHD5
prerank,GO_Biological_Process_2021__positive regulation of neuron projection development (GO:0010976),0.44603893547505635,1.3502580425762545,0.0,0.5852718913110819,1.0,22/78,18.20%,TENM3;ZNF804A;NPTN;FUT9;TOX;ARHGAP35;NTRK2;RAPGEF2;CAMK2B;ABL2;ROR1;CAPRIN2;LRP8;EP300;PRKD1;CAPRIN1;MAGI2;RAP1A;BMP7;NDNF;ITGA6;RETREG3
prerank,GO_Biological_Process_2021__peptidyl-lysine deacetylation (GO:0034983),0.7147735400628263,1.3499000553554905,0.11627906976744186,0.586022070415134,1.0,4/8,13.72%,HDAC9;HDAC4;SIRT1;SIRT2
prerank,GO_Biological_Process_2021__response to amino acid starvation (GO:1990928),0.4809546346660233,1.3495441402411479,0.038461538461538464,0.586561704916512,1.0,18/66,18.23%,ATP6V0D2;ATP6V1A;RHEB;SESN1;ATP6V1C1;KPTN;EIF2AK4;PRKD1;MAP3K5;TFEB;RPTOR;MAPK1;SESN3;ATP6V1B2;MAPK8;IMPACT;ATF2;FAS
prerank,GO_Biological_Process_2021__negative regulation of biosynthetic process (GO:0009890),-0.724716345374123,-1.349477897329866,0.125,0.946196106313297,1.0,4/14,9.42%,SLC18A2;CEACAM1;GSTP1;CIITA
prerank,GO_Biological_Process_2021__positive regulation of muscle cell differentiation (GO:0051149),0.5633784057682739,1.3492059656226219,0.14285714285714285,0.5868326690390584,1.0,7/22,23.61%,CDH2;CTNNA2;MAPK11;OLFM2;NRG1;MESP1;CTNNB1
prerank,GO_Biological_Process_2021__peptidyl-diphthamide biosynthetic process from peptidyl-histidine (GO:0017183),0.74545480667495,1.3491753233765607,0.1111111111111111,0.5848617797205384,1.0,3/6,16.98%,DPH5;DPH3;DPH1
prerank,GO_Biological_Process_2021__peptidyl-diphthamide metabolic process (GO:0017182),0.74545480667495,1.3491753233765607,0.1111111111111111,0.5848617797205384,1.0,3/6,16.98%,DPH5;DPH3;DPH1
prerank,GO_Biological_Process_2021__striated muscle cell development (GO:0055002),-0.8640427186782004,-1.3490342993947493,0.03508771929824561,0.9449385591831527,1.0,1/6,0.81%,LMOD1
prerank,GO_Biological_Process_2021__respiratory system development (GO:0060541),-0.6346636715116756,-1.3490115071832458,0.06451612903225806,0.9402750468059946,1.0,5/24,10.67%,CCDC39;DNAAF1;FGF7;PDPN;FGF1
prerank,GO_Biological_Process_2021__regulation of cytoplasmic mRNA processing body assembly (GO:0010603),0.836670239605015,1.3486819026839838,0.020833333333333332,0.5857827883792064,1.0,2/6,7.08%,CNOT6L;CNOT2
prerank,GO_Biological_Process_2021__diterpenoid metabolic process (GO:0016101),-0.6084325852686274,-1.3485311381920686,0.11940298507462686,0.9388365929082073,1.0,13/40,15.83%,RPE65;ADH4;AKR1C1;RBP2;GPC3;PLB1;APOM;BCO1;APOE;RDH11;RBP1;RDH12;LRAT
prerank,GO_Biological_Process_2021__intracellular sterol transport (GO:0032366),0.7117825962993918,1.3483272817251952,0.07692307692307693,0.5862885785971411,1.0,4/11,13.58%,ABCA1;STARD4;RELCH;ARV1
prerank,GO_Biological_Process_2021__triglyceride catabolic process (GO:0019433),-0.7521084190968856,-1.3482536538288639,0.16666666666666666,0.9361999021013666,1.0,3/11,8.80%,LIPI;PNPLA3;FABP3
prerank,GO_Biological_Process_2021__snRNA metabolic process (GO:0016073),0.662940949989561,1.3478281924503956,0.1111111111111111,0.5871156116551542,1.0,3/15,12.23%,INTS7;INTS6;INTS8
prerank,GO_Biological_Process_2021__mammary gland duct morphogenesis (GO:0060603),0.8384793846788672,1.347720760306375,0.13636363636363635,0.5864738622359343,1.0,3/5,15.37%,CSF1R;EPHA2;SCRIB
prerank,GO_Biological_Process_2021__glial cell development (GO:0021782),0.6028021833149506,1.347243555922255,0.025,0.5872683409453279,1.0,5/22,13.84%,SOX4;CSPG5;MYRF;NF1;PRDM8
prerank,GO_Biological_Process_2021__detection of light stimulus involved in visual perception (GO:0050908),-0.9009907760226803,-1.3470691954471747,0.10714285714285714,0.9362523466983698,1.0,1/5,0.30%,RPE65
prerank,GO_Biological_Process_2021__detection of light stimulus involved in sensory perception (GO:0050962),-0.9009907760226803,-1.3470691954471747,0.10714285714285714,0.9362523466983698,1.0,1/5,0.30%,RPE65
prerank,GO_Biological_Process_2021__glial cell differentiation (GO:0010001),0.5637351069358147,1.3466306463335862,0.05405405405405406,0.5889655437751015,1.0,6/21,4.89%,SOX4;SOX8;CDH2;SOX9;NFIB;MYRF
prerank,GO_Biological_Process_2021__renal filtration cell differentiation (GO:0061318),-0.8938211991006445,-1.3465810356490429,0.0,0.9303609321077586,1.0,1/5,0.14%,CD24
prerank,GO_Biological_Process_2021__glomerular epithelial cell differentiation (GO:0072311),-0.8938211991006445,-1.3465810356490429,0.0,0.9303609321077586,1.0,1/5,0.14%,CD24
prerank,GO_Biological_Process_2021__response to glucagon (GO:0033762),0.6233906732852252,1.3465684923212096,0.08333333333333333,0.5881198114651017,1.0,3/16,6.50%,PRKACB;ADCY1;PRKAR1B
prerank,GO_Biological_Process_2021__negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.39843192086009777,1.3462430320579213,0.0,0.5884413971436501,1.0,125/429,20.50%,ZNF93;LIMD1;ZFPM2;PTPRK;TNFSF4;BTRC;YAF2;ZNF706;HDAC9;FOXP1;FOXO1;SOX8;KCTD1;SALL1;EED;BMP2;SPINDOC;LOXL2;PASK;ASCL1;RIDA;DACH1;PSPC1;CPEB3;SOX9;ZEB1;PHF10;PRMT6;TLE2;RCOR1;CNOT9;SMAD2;ZNF746;PHC1;CHMP1A;ZIC2;RFX3;HIC2;BAHD1;IGF2BP2;DPF1;NR1D2;SPEN;TSHZ3;SP3;MBD2;PEX14;ZHX3;SMARCA2;ZNF568;PLCB1;RBM15B;HDAC2;RBFOX2;NR3C1;SFMBT2;MEN1;CLOCK;GLI3;SYNCRIP;NR1D1;SCMH1;GCLC;ZNF148;RUNX1T1;AHR;ZHX2;ZNF423;ZBTB16;ZNF24;CAPRIN1;NIPBL;HDAC4;SIRT1;ZNF91;SIRT2;KAT7;TRIM28;FOXN3;MAP3K10;SMAD4;PDS5A;VGLL4;MLXIPL;GSK3B;SOX13;PIAS4;SAMD1;ZBTB38;PHC3;POU2F1;ZNF282;USP47;TFDP2;UIMC1;PHC2;RSF1;DPF3;BMP7;CNOT8;KAT6B;FXR1;ZNF703;KDM1A;MTERF3;ZBTB21;JARID2;ZBTB18;MDM2;RBPJ;RORB;LSM14A;FBXW11;PPM1F;CDK5R1;MBTD1;REST;LEF1;DDX6;TCEAL7;ZNF639;WAPL;HMBOX1;NRG1;ATOH8
prerank,GO_Biological_Process_2021__positive regulation of cell differentiation (GO:0045597),0.4101666461363709,1.3452616020163972,0.0,0.591638384971185,1.0,49/182,16.23%,NUDT21;BRINP3;NPNT;SOX5;BMP2;RANBP3L;LOXL2;ASCL1;CDH2;VHL;RGCC;SOX9;ZEB1;MMD;NFKB1;RBM24;SMAD2;RPS6KA3;AKT1;KCTD11;CTNNA2;FRZB;TRPM4;RAPGEF2;LMO3;PKDCC;ZHX3;BMPR1B;TCF4;PLCB1;SOX6;MAPK11;ZNF268;PRKD1;TGFBR2;ZBTB16;ACVR1;ZC4H2;TGFBR1;NBL1;ACVR2A;WDFY2;RAP1A;BMPR1A;SMAD4;YAP1;HGF;BMP7;IMPACT
prerank,GO_Biological_Process_2021__activin receptor signaling pathway (GO:0032924),0.6966526198818287,1.345167128331283,0.14705882352941177,0.5909084301083987,1.0,4/10,13.83%,SMAD2;ACVR1;TGFBR1;ACVR2A
prerank,GO_Biological_Process_2021__antiviral innate immune response (GO:0140374),-0.7230099013365742,-1.3451084123896848,0.07017543859649122,0.9357688641179579,1.0,3/10,7.92%,IFIT1;MX1;NLRP1
prerank,GO_Biological_Process_2021__adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),0.7437747553965167,1.3449263516477412,0.13513513513513514,0.5906443095955294,1.0,6/9,22.67%,RAPGEF2;ADRB2;ADRA1A;ADRB1;DRD2;ADCY9
prerank,GO_Biological_Process_2021__cellular calcium ion homeostasis (GO:0006874),0.4533241208106514,1.344841382341996,0.045454545454545456,0.5898897883970143,1.0,15/98,7.11%,VAPB;SLC24A3;ATP13A5;ANK2;NPTN;MAIP1;ATP2B3;HTR2C;MCU;STIM2;CXCL12;ATP2C1;KCTD17;CALCB;ATP13A4
prerank,GO_Biological_Process_2021__presynapse assembly (GO:0099054),0.6277986635811793,1.3446680945914733,0.047619047619047616,0.5893687368482098,1.0,8/17,22.01%,WNT7A;DVL1;NLGN3;NLGN4X;PCLO;PTEN;LRP4;NLGN1
prerank,GO_Biological_Process_2021__chromatin maintenance (GO:0070827),0.812612730988971,1.3446041580646404,0.1276595744680851,0.5885039172177404,1.0,3/5,16.73%,HDAC2;SIRT1;MTHFR
prerank,GO_Biological_Process_2021__regulation of synapse assembly (GO:0051963),0.5280929087982463,1.3445433484987477,0.047619047619047616,0.5876421373750759,1.0,12/42,14.31%,IL1RAPL2;WNT7A;SLIT1;SNCA;SLITRK2;NRXN1;LRFN5;SLITRK1;NLGN3;PDLIM5;DLG5;CLSTN2
prerank,GO_Biological_Process_2021__cardiac right ventricle morphogenesis (GO:0003215),0.7455224490367396,1.3444698200233467,0.16279069767441862,0.5870129747406115,1.0,2/7,2.46%,ZFPM2;SOX4
prerank,GO_Biological_Process_2021__regulation of cilium movement (GO:0003352),-0.8354948769141661,-1.3440445448050657,0.0847457627118644,0.938955158811919,1.0,3/7,13.80%,CCDC39;DNAAF1;DRC1
prerank,GO_Biological_Process_2021__protein K48-linked ubiquitination (GO:0070936),0.537675903675811,1.3439337972489636,0.12121212121212122,0.5884487377912054,1.0,25/54,23.91%,UBE2G1;UBE2T;KBTBD7;RNF146;NEDD4L;MARCHF6;KBTBD6;UBE2E3;RNF6;UBE2D1;UBR5;ITCH;PRKN;UBE2E2;UBE2E1;CDC34;HACE1;BFAR;CUL3;FBXO38;UBE2D3;UBE2H;PELI1;UBE2G2;AMFR
prerank,GO_Biological_Process_2021__negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),0.7735032514632035,1.343890294436611,0.023809523809523808,0.5876201730710551,1.0,2/8,10.46%,SNCA;PTPRJ
prerank,GO_Biological_Process_2021__histone H4-K16 acetylation (GO:0043984),0.6167066390939753,1.3437533225761316,0.13953488372093023,0.5870228917338527,1.0,4/19,13.97%,MSL2;KANSL2;OGT;KAT7
prerank,GO_Biological_Process_2021__skeletal system development (GO:0001501),0.47881761225537844,1.3435211659790574,0.0625,0.5870261743622773,1.0,29/100,13.12%,TRPS1;PCSK5;SOX4;SOX5;BMP2;ITGB8;RAB33B;SOX9;MMP16;CDH11;RPS6KA3;CHD7;FRZB;ADAMTS4;HAPLN1;PKDCC;BMPR1B;SLC10A7;TRIP11;EXT1;SOX6;ETS2;GDF10;ANKH;DYM;HAPLN2;ZBTB16;WWOX;TGFBR1
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway (GO:0097193),-0.5354301178781953,-1.343519442635913,0.05194805194805195,0.9386897215391868,1.0,5/82,5.41%,IFI6;CD24;POU4F1;BCL2L2;SELENOK
prerank,GO_Biological_Process_2021__focal adhesion assembly (GO:0048041),0.5904430762951538,1.3433882984345686,0.125,0.5865458020439924,1.0,4/19,15.72%,PTPRK;RCC2;TAOK2;ARHGEF7
prerank,GO_Biological_Process_2021__nuclear export (GO:0051168),0.48246497600419647,1.3431660323251553,0.07142857142857142,0.5863795001892426,1.0,14/70,15.13%,RANBP17;NUP42;XPO1;RANBP3L;NUP188;XPO6;RANBP3;EIF4E;NUP153;SMURF1;XPO7;U2AF1;U2AF2;THOC7
prerank,GO_Biological_Process_2021__glial cell migration (GO:0008347),-0.825348182656509,-1.3429867929203894,0.15789473684210525,0.9376604491347362,1.0,3/5,14.31%,CD9;P2RY12;CCL2
prerank,GO_Biological_Process_2021__RNA processing (GO:0006396),0.4081486184070602,1.3426569101676438,0.0,0.587716378149502,1.0,39/162,20.97%,NUDT21;PPARGC1A;SNRPF;HNRNPH1;CSTF3;DROSHA;SNRPN;HNRNPU;DHX15;RNGTT;HNRNPC;CPSF6;CDK12;CELF2;SYNCRIP;CELF3;ADARB1;HNRNPH3;MBNL1;DKC1;TENT4B;ZMAT5;U2AF1;U2AF2;ADARB2;MTPAP;SF3B3;RBM6;PTBP1;CELF1;SRPK2;TSEN2;USB1;SMU1;HNRNPD;NOVA1;PPP2R1A;ALKBH5;LIN28B
prerank,GO_Biological_Process_2021__regulation of nucleic acid-templated transcription (GO:1903506),0.38635209617630617,1.3425321612612535,0.0,0.587180701075024,1.0,100/339,21.53%,POU6F2;PPARGC1A;LIMD1;BACH1;USP13;YAF2;MITF;WTIP;SOX4;BMP2;RPS6KA4;ESRRG;PSPC1;VHL;RORA;HCLS1;NFXL1;CHD7;ZNF212;HMG20A;RFX3;RNF6;COPS2;NFYC;NR1D2;NCOA2;GPBP1L1;SP3;SMARCA2;NLK;ZNF117;ZNF280D;ZNF516;RNF14;SOX6;MAGED1;ZNF33A;NR3C1;CLOCK;TGFBRAP1;ZNF268;SUPT3H;ZNF737;CREM;EP300;ZNF736;FOXN2;HP1BP3;DVL1;AHR;ZNF423;ZNF519;TFEB;TGFBR1;APBB2;RREB1;PRDM8;KAT7;ZNF680;FOXN3;MLXIPL;TRIP4;SOX13;ZBTB38;ZNF282;ZFAT;CCAR1;DMTF1;SUFU;KAT6B;ZNF141;MYT1;ATF2;HIF1A;CXXC1;ZNF703;UTP4;ATRX;RORB;SSBP2;SOX21;APBB1;DNM2;HNRNPD;ASCC1;SPIN3;NSD2;RALY;REST;ZNF646;PRDM2;ESRRB;SPTY2D1;NFIA;PPP2R1A;NFATC2;NFIL3;CREBBP;ARNT2;ZNF195
prerank,GO_Biological_Process_2021__ureteric bud morphogenesis (GO:0060675),0.8069030261954602,1.3424135349798074,0.0975609756097561,0.5865621151245152,1.0,4/6,9.50%,NPNT;SALL1;BMP2;PKD2
prerank,GO_Biological_Process_2021__fatty acid catabolic process (GO:0009062),0.46358411444469405,1.3423957570830676,0.0,0.5856354142249398,1.0,20/63,24.84%,LPIN3;HADH;ECHDC1;BDH2;AUH;NUDT19;PEX2;HSD17B4;ACADVL;ABCD3;ACADM;PEX13;ABHD2;ACOX1;PCCA;AIG1;SCP2;ACAT1;ECHDC2;FAAH
prerank,GO_Biological_Process_2021__regulation of T cell mediated immunity (GO:0002709),0.873869586171883,1.342287524681328,0.05,0.5847963708041424,1.0,3/5,9.68%,ZBTB1;TRPM4;HMGB1
prerank,GO_Biological_Process_2021__positive regulation of hydrolase activity (GO:0051345),0.4452125022087866,1.3421513870041106,0.038461538461538464,0.5843256074373799,1.0,28/100,16.25%,RCN3;MTCL1;BMP2;PICALM;RSU1;RGS16;SNX18;RGS6;USP6NL;CDKL5;ARAP1;EVI5L;DOCK9;PLIN5;RAPGEF2;PKP4;NF1;ADRB1;MAP4K4;AFDN;RAB3GAP1;RAP1GDS1;RAP1A;GSK3B;SNX13;ARHGEF7;MAPK8;SEMA4D
prerank,PanglaoDB_Augmented_2021__Trophoblast Cells,-0.5862319902175075,-1.3415075901552294,0.05970149253731343,0.9441766702662282,1.0,10/41,12.13%,IL1R1;IER3;TMEM40;S100A10;GPR87;TRIM29;B3GNT3;KLF4;LTBR;IL18
prerank,GO_Biological_Process_2021__regulation of heart rate by cardiac conduction (GO:0086091),0.574826126754962,1.3413467642323664,0.058823529411764705,0.5861292566739542,1.0,7/26,11.24%,CACNA1G;ANK2;CACNA2D1;BIN1;TRPM4;KCNH2;CAMK2D
prerank,GO_Biological_Process_2021__cellular nitrogen compound catabolic process (GO:0044270),-0.7844791441765723,-1.3405630162595839,0.14285714285714285,0.9453467226845589,1.0,5/7,18.65%,PM20D1;NIT1;CYP2D6;CYP3A4;CYP3A5
prerank,GO_Biological_Process_2021__regulation of complement activation (GO:0030449),-0.6153568101970371,-1.3399293449391105,0.11290322580645161,0.9450854961828724,1.0,16/23,30.90%,C1R;CLU;CPB2;C1S;SUSD4;C1QB;CR1;C2;C6;C3;CR1L;PHB2;C5;SERPING1;CD46;C1QBP
prerank,GO_Biological_Process_2021__actin filament bundle assembly (GO:0051017),0.532598927346549,1.3398992958830958,0.05555555555555555,0.5910359703904028,1.0,4/26,8.77%,MICAL1;PAWR;EPS8;FAM107A
prerank,GO_Biological_Process_2021__regulation of cellular component size (GO:0032535),0.5575275748091443,1.3395736245085654,0.05714285714285714,0.591116221233873,1.0,10/30,22.14%,EPS8;PICALM;PEX11A;RIN3;HP1BP3;RPTOR;RAB22A;PTEN;NEB;RAP1GAP2
prerank,GO_Biological_Process_2021__regulation of catecholamine secretion (GO:0050433),0.5619231880182178,1.3395596694514382,0.16129032258064516,0.5901633216451586,1.0,7/22,15.35%,CHRNA4;SYT3;SNCA;PRKN;KCNA2;SYT9;STX1A
prerank,GO_Biological_Process_2021__proteasome assembly (GO:0043248),0.6969219943655436,1.338831817942174,0.1276595744680851,0.5917496590776113,1.0,6/10,23.37%,PSMD11;PSMD10;PSMG2;OTUD6B;PSMD13;PSMG1
prerank,"GO_Biological_Process_2021__regulation of retrograde transport, endosome to Golgi (GO:1905279)",0.7995077571865077,1.3387407000522091,0.14285714285714285,0.5911884122049923,1.0,3/6,10.08%,ARFIP1;ATP9A;PRKN
prerank,GO_Biological_Process_2021__positive regulation of posttranscriptional gene silencing (GO:0060148),0.7424289209303023,1.3383679646495692,0.11627906976744186,0.591378952826571,1.0,6/10,17.11%,LIMD1;WTIP;PUM2;DHX9;PUM1;FXR1
prerank,GO_Biological_Process_2021__polyol biosynthetic process (GO:0046173),0.6491195867367261,1.3381326298335354,0.09523809523809523,0.5915688475477376,1.0,7/14,25.86%,ACER3;ISYNA1;ITPKB;IP6K2;IPPK;FGF2;IPMK
prerank,GO_Biological_Process_2021__sterol catabolic process (GO:0016127),-0.7981564856927883,-1.3379372421856806,0.08928571428571429,0.9514816694425912,1.0,3/7,13.24%,MT3;APOE;SCARF1
prerank,GO_Biological_Process_2021__cholesterol catabolic process (GO:0006707),-0.7981564856927883,-1.3379372421856806,0.08928571428571429,0.9514816694425912,1.0,3/7,13.24%,MT3;APOE;SCARF1
prerank,GO_Biological_Process_2021__dermatan sulfate biosynthetic process (GO:0030208),0.6665580190962208,1.3377651958194527,0.17391304347826086,0.5919518555149668,1.0,5/12,20.82%,DCN;CSPG5;VCAN;CHST14;DSEL
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),0.5594695315514443,1.337653278782162,0.09523809523809523,0.5913664266489854,1.0,7/19,16.03%,CDIP1;AEN;EP300;SIRT1;HIPK2;DYRK2;MSH2
prerank,GO_Biological_Process_2021__prostanoid metabolic process (GO:0006692),-0.7492140016487594,-1.3373725223488,0.16071428571428573,0.951075619101302,1.0,3/8,15.34%,AKR1C1;GSTP1;PTGR1
prerank,GO_Biological_Process_2021__regulation of Rab protein signal transduction (GO:0032483),0.7982586505314961,1.337040261246944,0.13333333333333333,0.5932933033310306,1.0,2/6,8.20%,DENND4C;DENND1A
prerank,GO_Biological_Process_2021__regulation of lymphocyte activation (GO:0051249),0.8221591734475102,1.3364967845907756,0.061224489795918366,0.5945252018456446,1.0,2/5,9.83%,PAG1;KAT2A
prerank,GO_Biological_Process_2021__positive regulation of cell morphogenesis involved in differentiation (GO:0010770),0.5031636969713044,1.3364011382508552,0.06451612903225806,0.5939109064404089,1.0,20/42,26.66%,CASS4;CSPG5;CDKL5;TESK1;CARMIL1;CAPRIN2;CRKL;CAPRIN1;RREB1;ARHGEF7;NRP1;SS18L1;CIB1;DOCK1;CRK;TRIOBP;CUX1;NEDD9;DOCK5;IL1RAPL1
prerank,PanglaoDB_Augmented_2021__Decidual Cells,-0.7751624473734502,-1.3363648317247152,0.12727272727272726,0.95280693596385,1.0,3/8,6.27%,P2RY10;CD5;GPR171
prerank,GO_Biological_Process_2021__global genome nucleotide-excision repair (GO:0070911),-0.6601332118628327,-1.3360303631456087,0.07407407407407407,0.9505995162918419,1.0,8/24,23.00%,CETN2;RPS27A;UBC;RBX1;UBA52;RNF111;UBB;USP45
prerank,GO_Biological_Process_2021__water transport (GO:0006833),-0.8433736659484561,-1.335619283193234,0.06779661016949153,0.9493522462426741,1.0,4/6,13.39%,CFTR;AQP1;PDPN;AQP11
prerank,GO_Biological_Process_2021__positive regulation of nervous system development (GO:0051962),0.5159329352012597,1.3356013624099883,0.07407407407407407,0.5961806284156911,1.0,10/39,14.31%,WNT7A;LIG4;MME;SLITRK2;NRXN1;SPEN;NAP1L1;NLGN3;DLG5;CLSTN2
prerank,GO_Biological_Process_2021__negative regulation of sodium ion transmembrane transporter activity (GO:2000650),0.7371792628720337,1.3351824293542485,0.1,0.5968260743771658,1.0,3/8,11.24%,NEDD4L;PRKCE;CAMK2D
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-threonine phosphorylation (GO:0010801),0.6892987919870693,1.3347031273696461,0.17777777777777778,0.5975514278661453,1.0,5/15,13.72%,PARD3;SPRED2;SMAD7;SPRED1;SIRT2
prerank,GO_Biological_Process_2021__tRNA pseudouridine synthesis (GO:0031119),0.8351722990743067,1.3347006891226643,0.09090909090909091,0.5965538461835641,1.0,1/6,6.07%,PUS10
prerank,GO_Biological_Process_2021__negative regulation of nervous system development (GO:0051961),0.6961146116090726,1.3345869899410876,0.11627906976744186,0.5962411952367416,1.0,3/14,1.99%,WNT7A;ELAPOR2;SLIT1
prerank,"GO_Biological_Process_2021__positive regulation of synaptic transmission, glutamatergic (GO:0051968)",0.6432976625756152,1.3345648198228568,0.23684210526315788,0.5953035510886724,1.0,11/14,25.94%,CACNG2;NRXN1;CACNG3;TSHZ3;NLGN3;SHANK3;CACNG8;NLGN1;CACNG4;CACNG7;NLGN2
prerank,GO_Biological_Process_2021__protein import into peroxisome matrix (GO:0016558),0.7390872392617241,1.334469860293457,0.16279069767441862,0.5945048902361417,1.0,8/11,18.03%,PEX5L;PEX14;PEX16;PEX5;PEX2;PEX7;PEX6;PEX13
prerank,GO_Biological_Process_2021__L-serine biosynthetic process (GO:0006564),0.8048339531997223,1.3343013533766988,0.14285714285714285,0.5941700641279002,1.0,1/6,1.65%,SERINC5
prerank,GO_Biological_Process_2021__heparan sulfate proteoglycan metabolic process (GO:0030201),0.5888485593683537,1.3342796501748382,0.12195121951219512,0.5932675898385672,1.0,7/20,17.68%,HS3ST5;UGDH;EXT1;EXT2;EXTL3;HS2ST1;HS3ST4
prerank,GO_Biological_Process_2021__RNA modification (GO:0009451),0.5011189766288358,1.3342700386071382,0.030303030303030304,0.5923410600408955,1.0,14/52,12.09%,LCMT2;TRUB1;TRMT1;APOBEC3F;RBM15B;CTU1;TFB1M;THUMPD1;TRIT1;ADARB1;CDKAL1;NSUN6;NSUN3;PUS7L
prerank,PanglaoDB_Augmented_2021__Epithelial Cells,-0.523449394573142,-1.334215755045261,0.0821917808219178,0.9544266152258488,1.0,17/74,10.96%,CD24;IL1R1;OVOL2;CRYBA1;KIF20B;ITGA5;CEACAM1;PGR;FMO5;ST6GAL1;TMC4;GPX2;EMILIN2;CXCL17;TRIM29;B3GNT3;F5
prerank,GO_Biological_Process_2021__telomere maintenance via telomere lengthening (GO:0010833),-0.6585712410681769,-1.3341712196167572,0.057971014492753624,0.950091115221176,1.0,2/31,3.75%,PIF1;NOP10
prerank,GO_Biological_Process_2021__protein insertion into membrane (GO:0051205),0.5701405189432833,1.3338945931417394,0.125,0.5924973591286024,1.0,4/23,3.28%,VAPA;TRAM1;MAIP1;EGFR
prerank,GO_Biological_Process_2021__humoral immune response mediated by circulating immunoglobulin (GO:0002455),-0.8092596765756095,-1.3333745515065085,0.2,0.9516129450860172,1.0,4/5,18.13%,C1R;C1S;ZP3;C1QB
prerank,GO_Biological_Process_2021__negative regulation of viral entry into host cell (GO:0046597),-0.7646209790727467,-1.3333009690586974,0.1320754716981132,0.9478781525428567,1.0,4/9,17.47%,IFITM3;CIITA;LY6E;TRIM5
prerank,GO_Biological_Process_2021__regulation of synaptic vesicle priming (GO:0010807),0.8448873333146121,1.3329956226986872,0.10909090909090909,0.5951055754058848,1.0,1/5,13.06%,NAPB
prerank,GO_Biological_Process_2021__positive regulation of glycogen metabolic process (GO:0070875),0.6829477882015706,1.3328647254010568,0.13513513513513514,0.5949339477057239,1.0,8/12,26.87%,AKT1;IRS1;DYRK2;AKT2;IGF1;IRS2;EPM2AIP1;GCK
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell apoptotic process (GO:0034393),-0.8257163633129774,-1.3324221167152441,0.13333333333333333,0.9502276072479092,1.0,1/7,5.79%,IL12A
prerank,GO_Biological_Process_2021__positive regulation of neuron death (GO:1901216),0.5603902613274883,1.3323853110439738,0.10526315789473684,0.5956761678111505,1.0,14/34,19.80%,EPHA7;SNCA;PICALM;FOXO3;ZNF746;EFNB2;SARM1;NF1;MAP3K5;GSK3B;SRPK2;FYN;CDK5R1;REST
prerank,GO_Biological_Process_2021__positive regulation of insulin receptor signaling pathway (GO:0046628),0.722662330880445,1.3321955688926226,0.16666666666666666,0.5955041674273749,1.0,4/9,15.44%,IRS1;SIRT1;SNX5;PTPN11
prerank,GO_Biological_Process_2021__tryptophan metabolic process (GO:0006568),-0.7971128925008573,-1.331781631057672,0.07547169811320754,0.9462825275398794,1.0,2/8,1.59%,KMO;ACMSD
prerank,GO_Biological_Process_2021__indolalkylamine catabolic process (GO:0046218),-0.7971128925008573,-1.331781631057672,0.07547169811320754,0.9462825275398794,1.0,2/8,1.59%,KMO;ACMSD
prerank,GO_Biological_Process_2021__cellular response to increased oxygen levels (GO:0036295),0.779670931224357,1.3315634354060526,0.1509433962264151,0.5969123590846142,1.0,3/8,9.15%,FOXO1;ATP6V1A;ATG7
prerank,GO_Biological_Process_2021__spinal cord development (GO:0021510),0.6991091997104459,1.3313779546171658,0.2222222222222222,0.5967923601252524,1.0,3/10,10.68%,SOX4;PKD2;NF1
prerank,GO_Biological_Process_2021__regulation of gene silencing by miRNA (GO:0060964),0.47756504488336377,1.3312473654646961,0.13043478260869565,0.5962724623584922,1.0,14/60,18.33%,LIMD1;NUP42;WTIP;NUP37;NUP188;PUM2;IPO8;NUP153;DHX9;NDC1;NUP205;PUM1;FXR1;NUP214
prerank,GO_Biological_Process_2021__cilium movement involved in cell motility (GO:0060294),-0.7640273359503869,-1.3309559934363886,0.10344827586206896,0.9477304459557021,1.0,3/7,21.49%,TEKT1;TEKT2;TEKT3
prerank,GO_Biological_Process_2021__transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),0.4377064295755354,1.3307967724110368,0.05555555555555555,0.5967666753054622,1.0,27/98,16.20%,PTPRK;AMH;PARD3;BMP2;SMAD2;CBL;SMAD7;NLK;SMAD5;BMPR1B;MAP3K7;TGFBRAP1;RGMA;GDF10;SMURF1;TGFBR2;PTK2;ACVR1;SIRT1;TGFBR1;ACVR2A;BMPR1A;SMAD4;DUSP22;USP9X;PXN;BMP7
prerank,GO_Biological_Process_2021__sphingomyelin metabolic process (GO:0006684),0.7004861827682699,1.3307187069128,0.09523809523809523,0.5961687123142833,1.0,2/10,13.55%,SGMS1;ABCA2
prerank,PanglaoDB_Augmented_2021__Interneurons,0.404236073987496,1.3307145003867191,0.0,0.5952009059631237,1.0,64/265,14.26%,VEGFD;PDP1;DLGAP1;CACNG2;PCDH8;PTPN4;DNM3;CADM2;SNAP91;ETV1;LHX6;CAMKV;ADGRB3;ADCY1;TRIM9;PSD2;AMER2;ATP2B3;CDKL5;RORA;ILDR2;CACNA1I;RBFOX1;NPTXR;CACNA1B;NOL4;SLC35F1;CDK5R2;KIF5A;CTNNA2;NRIP3;KCNMA1;NRXN1;GNG4;LMO3;CAMK2A;PPFIA2;ABCC5;CDH4;ASTN1;VSTM2B;GABRA4;HSPA12A;HIVEP2;ADGRA1;KCNA2;CELF3;ADARB1;FBXO11;RGMA;SLITRK1;TMEM132D;OXR1;GRM1;TMEM196;GABRA5;RGS7BP;OLFM3;MAPK4;LY6H;NBEA;KCNQ2;PSD3;ADGRL2
prerank,GO_Biological_Process_2021__activation of protein kinase A activity (GO:0034199),0.6354196493681108,1.3306875560775655,0.08108108108108109,0.5943157757968477,1.0,4/15,9.51%,PRKACB;ADCY1;PRKAR1B;PRRC1
prerank,GO_Biological_Process_2021__carbohydrate homeostasis (GO:0033500),0.516626226942008,1.33054265072244,0.08333333333333333,0.5938305618557926,1.0,13/48,16.28%,PDK4;LEPR;SOX4;MCU;ADIPOR2;IRS1;TENT4B;CRTC2;ADIPOR1;MLXIPL;PDK2;HECTD4;STK11
prerank,GO_Biological_Process_2021__production of small RNA involved in gene silencing by RNA (GO:0070918),0.6537744867534668,1.3299978784975466,0.10810810810810811,0.594562573859112,1.0,11/15,31.12%,DROSHA;PUM2;PRKRA;AGO3;PUM1;ZC3H7A;ZC3H7B;TSN;DICER1;AGO1;AGO2
prerank,PanglaoDB_Augmented_2021__T Helper Cells,-0.6068952111525924,-1.3295633846088846,0.07246376811594203,0.9537536684037208,1.0,11/37,11.57%,P2RY10;TAGAP;IL5;CD5;THEMIS;GPR171;GMFG;TRAF3IP3;KLRD1;ARHGAP30;LTBR
prerank,GO_Biological_Process_2021__neuron projection extension (GO:1990138),0.5571810080482078,1.329179264132241,0.1111111111111111,0.5969808471009861,1.0,13/30,18.48%,SEMA5B;ALCAM;LLPH;NRP2;EIF2AK4;AUTS2;NLGN3;CYFIP1;USP9X;NRP1;PPP3CB;IMPACT;CPNE1
prerank,GO_Biological_Process_2021__positive regulation of execution phase of apoptosis (GO:1900119),0.7200649817938733,1.3286991567327657,0.1956521739130435,0.5978634820954324,1.0,4/7,13.72%,BOK;FAP;TP53BP2;SIRT2
prerank,GO_Biological_Process_2021__regulation of filopodium assembly (GO:0051489),0.5102636140733875,1.3283405122257779,0.09090909090909091,0.5980331820250456,1.0,22/38,31.20%,ARAP1;RHOQ;GPM6A;TENM2;WASL;PIK3R1;TENM1;NRP1;FXR1;ARF6;FMR1;NLGN1;ARHGAP44;CAPZB;TRPM2;MYO10;RAB5A;BCAS3;RALA;RIPOR2;FXR2;PPP1R16B
prerank,GO_Biological_Process_2021__fatty acid transmembrane transport (GO:1902001),0.621140980501596,1.3281864001263377,0.1,0.5976509260101085,1.0,3/17,16.87%,ACACB;ABCD3;CPT1A
prerank,GO_Biological_Process_2021__bone resorption (GO:0045453),-0.8039868629910458,-1.3279094559886728,0.08771929824561403,0.9618240866370867,1.0,1/6,2.51%,IL7
prerank,GO_Biological_Process_2021__regulation of osteoclast differentiation (GO:0045670),-0.6767156626624329,-1.3278742360293114,0.14516129032258066,0.9577705106993567,1.0,2/18,10.28%,POU4F1;TLR3
prerank,GO_Biological_Process_2021__urea cycle (GO:0000050),-0.7536214477468187,-1.3278533153203962,0.125,0.9535311184795936,1.0,1/7,2.79%,ARG2
prerank,GO_Biological_Process_2021__interleukin-21-mediated signaling pathway (GO:0038114),-0.8744406887817835,-1.327568236190345,0.04,0.9472022009019796,1.0,1/5,3.14%,STAT1
prerank,GO_Biological_Process_2021__cellular response to interleukin-21 (GO:0098757),-0.8744406887817835,-1.327568236190345,0.04,0.9472022009019796,1.0,1/5,3.14%,STAT1
prerank,GO_Biological_Process_2021__regulation of postsynapse organization (GO:0099175),0.5756359167936111,1.327027677024245,0.13513513513513514,0.6009925096291159,1.0,10/25,14.84%,EPHA4;CDKL5;ABHD17B;HOMER1;PPFIA2;SRCIN1;ABHD17A;SHANK3;PDLIM5;TANC2
prerank,GO_Biological_Process_2021__positive regulation of cell communication (GO:0010647),0.5989061119823295,1.3269924461243987,0.08333333333333333,0.6001356162129002,1.0,9/19,23.27%,KCTD13;HOMER1;RIMS3;CLSTN2;CDKN2AIP;PTPN23;GRIK2;RIMS2;HCRT
prerank,GO_Biological_Process_2021__sulfur compound transport (GO:0072348),0.5692370943702573,1.3268936690834707,0.08571428571428572,0.5994905151861756,1.0,2/24,1.84%,SLC26A7;SLC6A13
prerank,GO_Biological_Process_2021__basement membrane assembly (GO:0070831),0.782414080895582,1.3265536982392623,0.10526315789473684,0.5995779964138596,1.0,1/7,0.37%,LAMB4
prerank,GO_Biological_Process_2021__negative regulation of TORC1 signaling (GO:1904262),0.6841783498540202,1.3262642631004637,0.17647058823529413,0.5997693935046631,1.0,4/11,16.28%,SESN1;KPTN;SESN3;STK11
prerank,GO_Biological_Process_2021__positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),0.5186153486800763,1.3260528400762943,0.16666666666666666,0.5997781315938023,1.0,14/29,26.46%,CASS4;CSPG5;TESK1;CARMIL1;CRKL;RREB1;ARHGEF7;NRP1;CIB1;DOCK1;CRK;TRIOBP;NEDD9;DOCK5
prerank,GO_Biological_Process_2021__positive regulation of cell death (GO:0010942),0.5252423894533464,1.3260261132884557,0.03333333333333333,0.59890400058075,1.0,13/46,19.12%,PRODH;SLC6A13;SNCA;PICALM;ZNF746;EFNB2;SARM1;MAP3K5;GSK3B;FAF1;SLC6A6;CELF1;FYN
prerank,PanglaoDB_Augmented_2021__Proximal Tubule Cells,-0.5507772579568527,-1.325776272742492,0.078125,0.9567398214550578,1.0,17/59,18.96%,GC;HSD11B1;BHMT;PDZK1;AQP1;ALDOB;GLYAT;ADH6;APOE;SOD3;C3P1;SORD;GSTZ1;CYP3A4;SLC22A1;ABCC6P1;F11
prerank,GO_Biological_Process_2021__megakaryocyte differentiation (GO:0030219),-0.7729362353138062,-1.3256715718471554,0.11320754716981132,0.9531253134425434,1.0,4/9,18.79%,GATA1;ZNF385A;ZFPM1;THPO
prerank,GO_Biological_Process_2021__DNA replication checkpoint signaling (GO:0000076),0.7096765905108418,1.3256271614881332,0.18421052631578946,0.5992511044723496,1.0,1/12,2.95%,DNA2
prerank,GO_Biological_Process_2021__glandular epithelial cell development (GO:0002068),0.8325015820681688,1.325107989500093,0.10204081632653061,0.600192436224803,1.0,1/5,3.72%,CDH2
prerank,GO_Biological_Process_2021__Golgi to plasma membrane transport (GO:0006893),0.500363740732278,1.324907813079377,0.041666666666666664,0.6000195507547923,1.0,18/44,20.55%,STXBP6;EXOC2;RAB31;EXOC8;EXOC5;ARFRP1;EXOC6;GOLPH3;EXOC6B;GGA2;GOLGA7;EXOC4;COMMD1;KIF13A;NSF;BBS2;GGA1;RAB10
prerank,GO_Biological_Process_2021__mitochondrial respiratory chain complex I assembly (GO:0032981),-0.5667127293145552,-1.3248864587260696,0.07575757575757576,0.9504532223855584,1.0,20/50,25.55%,NDUFS5;NDUFA6;NDUFA2;NDUFC1;NDUFB10;TMEM126A;DMAC1;NDUFB3;NDUFA1;NDUFB9;NDUFA12;NDUFB7;TMEM126B;NDUFB11;NDUFAF3;OXA1L;NDUFAF8;NDUFB2;FOXRED1;NDUFA3
prerank,GO_Biological_Process_2021__NADH dehydrogenase complex assembly (GO:0010257),-0.5667127293145552,-1.3248864587260696,0.07575757575757576,0.9504532223855584,1.0,20/50,25.55%,NDUFS5;NDUFA6;NDUFA2;NDUFC1;NDUFB10;TMEM126A;DMAC1;NDUFB3;NDUFA1;NDUFB9;NDUFA12;NDUFB7;TMEM126B;NDUFB11;NDUFAF3;OXA1L;NDUFAF8;NDUFB2;FOXRED1;NDUFA3
prerank,GO_Biological_Process_2021__ventricular cardiac muscle tissue morphogenesis (GO:0055010),0.6005908197324296,1.324347097265323,0.175,0.6012405240412714,1.0,7/19,20.43%,ZFPM2;SMAD7;TGFBR1;BMPR1A;SMAD4;RBPJ;NRG1
prerank,GO_Biological_Process_2021__positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),0.4753956568305638,1.3240103050111607,0.03571428571428571,0.601556000420823,1.0,30/67,25.01%,KEAP1;RNF217;RNF144A;SMAD7;CSNK1E;RNF14;DNAJB2;PSMD10;PRKN;COP1;DVL1;PIAS1;SIRT2;UBQLN1;ARIH1;VCP;GSK3B;ZYG11B;UBQLN2;TRIB2;MDM2;PLK1;NFE2L2;BAG2;HECTD1;HSPA1A;TAF1;CSNK1D;RCHY1;SUMO2
prerank,GO_Biological_Process_2021__cardiac muscle cell differentiation (GO:0055007),0.6294551227049381,1.3239729107456446,0.18181818181818182,0.6007387624572965,1.0,2/17,2.72%,TCAP;BMP2
prerank,GO_Biological_Process_2021__negative regulation of appetite (GO:0032099),0.7483662415199154,1.3238230346623867,0.25,0.6002836185466076,1.0,3/6,17.73%,SPX;MKKS;BBS2
prerank,GO_Biological_Process_2021__vacuolar acidification (GO:0007035),0.5912758282643904,1.323635625776862,0.15,0.5998555417502525,1.0,1/16,0.67%,ATP6V0D2
prerank,GO_Biological_Process_2021__regulation of long-term synaptic potentiation (GO:1900271),0.5692387741371586,1.3235214937561153,0.09523809523809523,0.5995312056081807,1.0,6/25,11.56%,SHISA7;EPHA4;ADCY1;FAM107A;EIF2AK4;SHANK3
prerank,GO_Biological_Process_2021__regulation of cell-substrate junction assembly (GO:0090109),0.6090896442861384,1.32326021156419,0.10526315789473684,0.5996935269092849,1.0,9/21,25.82%,EFNA5;LIMCH1;GPM6B;PTK2;CLASP1;ROCK2;ROCK1;MACF1;DUSP3
prerank,GO_Biological_Process_2021__actin filament reorganization (GO:0090527),0.720329440028165,1.3232130833163067,0.17391304347826086,0.5988600489023974,1.0,2/8,4.36%,CASS4;MCU
prerank,PanglaoDB_Augmented_2021__Neurons,0.39865298425023965,1.32314791887779,0.0,0.5980801285563526,1.0,68/259,18.26%,DGKB;GNL3L;DLGAP1;CACNG2;TMEM191C;CACNB4;DNM3;CADM2;SNAP91;ADGRB3;PSD2;AMER2;ATP2B3;RORA;RBFOX1;ZCCHC7;CACNA1B;NOL4;UNC79;NWD2;CACNA2D1;CDK5R2;KIF5A;CTNNA2;KCNMA1;NRXN1;PPFIA2;PPP1R1B;ASTN1;VSTM2B;CTTNBP2;TRIP11;LUZP2;SAFB2;CBARP;ADGRA1;CAMK2N1;CELF3;CHODL;SGIP1;FBXW7;SYNE1;SLITRK1;SACS;RIMS3;SLC32A1;TMEM196;RGS7BP;OLFM3;LY6H;SLC30A9;NBEA;KCNQ2;KMT2C;ELAVL3;GNAI1;STX1A;PTPN11;CA10;CSRNP3;ADAM12;CACNB3;PCLO;MYO5A;IGF1;GPR162;NPY;RERE
prerank,GO_Biological_Process_2021__epithelial to mesenchymal transition (GO:0001837),0.5352388796144781,1.3231376582127024,0.03333333333333333,0.5971754293379502,1.0,15/37,19.94%,BMP2;LOXL2;SOX9;TASOR;DLG5;TGFBR1;TRIM28;GSK3B;ROCK2;HGF;BMP7;HIF1A;RBPJ;ROCK1;LEF1
prerank,GO_Biological_Process_2021__regulation of organelle organization (GO:0033043),0.4828763982384806,1.322630950080616,0.1111111111111111,0.5982040496286014,1.0,17/70,14.21%,TMEM33;USP6NL;RHOT1;RAB33B;PRMT6;ZEB2;PDE4DIP;MFF;PRKN;GOLPH3;EP300;STX18;STOX1;CAMSAP2;PTK2;TJP1;MAPK1
prerank,GO_Biological_Process_2021__protein deubiquitination involved in ubiquitin-dependent protein catabolic process (GO:0071947),0.7880166006524623,1.3225402293964585,0.12,0.5976063083184902,1.0,3/5,20.60%,ZRANB1;USP9X;OTUD7A
prerank,GO_Biological_Process_2021__negative regulation of cholesterol storage (GO:0010887),0.7518906806976491,1.3224079743382473,0.11904761904761904,0.5972636456366393,1.0,2/8,13.33%,ABCA1;TTC39B
prerank,GO_Biological_Process_2021__positive regulation of leukocyte chemotaxis (GO:0002690),0.5544702302931502,1.3223301720824139,0.13636363636363635,0.596669205542312,1.0,7/31,11.91%,VEGFD;SERPINE1;CSF1R;CXCL12;VEGFC;HMGB1;PTK2
prerank,GO_Biological_Process_2021__organelle transport along microtubule (GO:0072384),0.5890979253083657,1.3220948635702372,0.07692307692307693,0.596606737722343,1.0,8/30,19.18%,BICDL1;RHOT1;TRAK1;PEX14;TRAK2;BICD2;RAB1A;FBXW11
prerank,GO_Biological_Process_2021__neural tube development (GO:0021915),0.7229776911329094,1.3219836981174438,0.09375,0.5961915819207246,1.0,3/12,11.43%,SOX4;PKD2;DVL1
prerank,GO_Biological_Process_2021__macromolecule depalmitoylation (GO:0098734),0.6959508586436214,1.3216322641412561,0.14285714285714285,0.595666636382454,1.0,6/8,25.83%,ABHD17B;ABHD17A;LYPLA2;LYPLAL1;ABHD17C;ABHD10
prerank,GO_Biological_Process_2021__protein depalmitoylation (GO:0002084),0.6959508586436214,1.3216322641412561,0.14285714285714285,0.595666636382454,1.0,6/8,25.83%,ABHD17B;ABHD17A;LYPLA2;LYPLAL1;ABHD17C;ABHD10
prerank,GO_Biological_Process_2021__calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),0.7756232532214594,1.3215339029820308,0.1,0.5951042940501656,1.0,1/7,0.62%,CLDN12
prerank,GO_Biological_Process_2021__myelination (GO:0042552),0.5012463124231061,1.320870248675934,0.12121212121212122,0.5967231414459292,1.0,11/43,13.91%,PARD3;ACER3;MYRF;MBP;B4GALT6;GAL3ST1;NF1;ZNF24;SBF2;SIRT2;B4GALT5
prerank,GO_Biological_Process_2021__replicative senescence (GO:0090399),0.7206503492564793,1.3207926122072373,0.11627906976744186,0.5960358381411378,1.0,2/10,5.00%,SERPINE1;MME
prerank,GO_Biological_Process_2021__positive regulation of cyclin-dependent protein kinase activity (GO:1904031),0.6136515678036327,1.3205211593741704,0.17142857142857143,0.5961997785994183,1.0,6/19,11.30%,EGFR;RGCC;AKT1;PSMD10;PKD2;STOX1
prerank,GO_Biological_Process_2021__L-serine metabolic process (GO:0006563),0.6760821932827709,1.3203321461174207,0.08333333333333333,0.5961886617424828,1.0,1/10,1.65%,SERINC5
prerank,GO_Biological_Process_2021__negative chemotaxis (GO:0050919),0.5598796349971712,1.320264879804082,0.16666666666666666,0.5956547033027743,1.0,9/28,16.40%,EPHA7;SLIT1;PDGFA;ROBO1;SEMA3C;SLIT2;SEMA6C;SEMA4D;SEMA3D
prerank,GO_Biological_Process_2021__cardiac myofibril assembly (GO:0055003),0.6601227421864468,1.319699134147145,0.21951219512195122,0.5967631931473169,1.0,2/12,4.93%,TCAP;PDGFRA
prerank,GO_Biological_Process_2021__negative regulation of ATPase activity (GO:0032780),-0.6955184195789138,-1.3189550175611993,0.09259259259259259,0.9905066887684697,1.0,3/12,11.24%,IFIT1;PLN;ATP5IF1
prerank,PanglaoDB_Augmented_2021__Monocytes,-0.5624162632158625,-1.318412103657023,0.08571428571428572,0.9897040319772357,1.0,10/62,5.11%,IFIT1;GBP1;IFITM3;TAGAP;MX1;CLEC12A;IFIT3;IGSF6;P2RY13;DPEP2
prerank,MSigDB_Hallmark_2020__Coagulation,-0.5356630992949,-1.3181946789662828,0.08333333333333333,0.9869329339057035,1.0,15/85,11.40%,PRSS23;F8;SPARC;MST1;CD9;ANXA1;TIMP1;C1R;THBS1;MASP2;VWF;CTSH;A2M;CLU;CPB2
prerank,GO_Biological_Process_2021__regulation of myeloid leukocyte differentiation (GO:0002761),0.7182149429467285,1.3176138798283965,0.18,0.6032797904353435,1.0,1/7,2.08%,FOXP1
prerank,GO_Biological_Process_2021__DNA conformation change (GO:0071103),0.6560141278815985,1.317559282042843,0.17142857142857143,0.602663157985416,1.0,4/13,12.90%,TOP3B;TOP1MT;HMGB1;MTERF1
prerank,GO_Biological_Process_2021__cellular response to glucagon stimulus (GO:0071377),0.6288186767066191,1.3174138715861348,0.10526315789473684,0.6022711246958702,1.0,3/14,6.50%,PRKACB;ADCY1;PRKAR1B
prerank,GO_Biological_Process_2021__negative regulation of amyloid fibril formation (GO:1905907),-0.7438405403604593,-1.3172851018819196,0.14545454545454545,0.989155988058911,1.0,6/9,21.00%,PFDN6;CLU;APOE;VBP1;CRYAB;PFDN1
prerank,GO_Biological_Process_2021__regulation of chemokine-mediated signaling pathway (GO:0070099),0.8107452352240163,1.3171330341888772,0.14285714285714285,0.6026463097317183,1.0,4/6,17.47%,ROBO1;SLIT2;PADI2;HIF1A
prerank,GO_Biological_Process_2021__regulation of amyloid-beta clearance (GO:1900221),-0.7370835884597414,-1.3170899544611845,0.109375,0.9862785871063141,1.0,4/11,11.67%,LRPAP1;SRF;CLU;APOE
prerank,GO_Biological_Process_2021__regulation of epidermis development (GO:0045682),0.8009449496638855,1.3168593506638255,0.1111111111111111,0.6028229749801448,1.0,1/7,1.01%,ELAPOR2
prerank,GO_Biological_Process_2021__inositol phosphate-mediated signaling (GO:0048016),0.6367092930645615,1.3166762937013603,0.13513513513513514,0.6028020173679001,1.0,9/12,23.42%,INPP5A;NFAT5;HRH1;PPP3CB;ADGRB2;NFATC3;NFATC2;PPP3CA;NFATC1
prerank,GO_Biological_Process_2021__positive regulation of megakaryocyte differentiation (GO:0045654),-0.712813693939309,-1.316304464182508,0.17857142857142858,0.9879584403300362,1.0,2/8,18.79%,RAB7B;THPO
prerank,GO_Biological_Process_2021__regulation of ubiquitin protein ligase activity (GO:1904666),-0.6539805416585023,-1.3162055205727816,0.11940298507462686,0.9843232498191808,1.0,4/18,6.86%,RPL23;RPL11;RPS7;RPL5
prerank,GO_Biological_Process_2021__cardiac muscle cell action potential involved in contraction (GO:0086002),0.5618733190381515,1.3158842582032966,0.08108108108108109,0.6049458607392665,1.0,5/25,6.86%,CACNA1G;ANK2;NEDD4L;CACNA2D1;KCNH2
prerank,GO_Biological_Process_2021__regulation of fatty acid biosynthetic process (GO:0042304),0.5953003138659279,1.3158728782796123,0.18421052631578946,0.6040375336210394,1.0,6/22,14.71%,PDK4;ADIPOR2;ELOVL5;ACADVL;ADIPOR1;MLXIPL
prerank,GO_Biological_Process_2021__cardiac muscle cell development (GO:0055013),0.598675686071309,1.3157815513662527,0.11428571428571428,0.6034017109954601,1.0,2/16,4.93%,TCAP;PDGFRA
prerank,GO_Biological_Process_2021__beta-catenin-TCF complex assembly (GO:1904837),0.5826633381372849,1.3156106697828809,0.034482758620689655,0.6031596131351933,1.0,18/27,31.45%,TLE2;PYGO2;MEN1;EP300;BCL9;PYGO1;ASH2L;LEF1;CREBBP;CDC73;CTNNB1;BCL9L;TCF7L2;TLE1;TRRAP;TLE3;TLE4;TCF7L1
prerank,PanglaoDB_Augmented_2021__Osteoclast Precursor Cells,-0.5818135065013615,-1.3155084940362145,0.15151515151515152,0.9847690252246447,1.0,8/38,10.72%,GBP2;GPR183;IRF1;IGSF6;SAMD9L;FPR3;CIITA;APOL6
prerank,GO_Biological_Process_2021__presynapse organization (GO:0099172),0.7137463107852784,1.315407324857757,0.13333333333333333,0.6033583788862051,1.0,4/11,12.25%,WNT7A;DVL1;NLGN3;NLGN4X
prerank,GO_Biological_Process_2021__enzyme linked receptor protein signaling pathway (GO:0007167),0.47777892471693406,1.315372966883427,0.0,0.6026775854551994,1.0,20/100,13.83%,EPHA7;EPHA6;CASS4;ERBB4;CSF1R;EPHA2;EGFR;EPHA4;FLT1;PDGFRA;NTRK2;EPHA5;ROR1;SHC3;MTSS1;PTK2;MERTK;ABI1;FER;ACVR2A
prerank,GO_Biological_Process_2021__response to hexose (GO:0009746),-0.6629911757135495,-1.3149999640710863,0.16666666666666666,0.9850289068875304,1.0,2/18,5.73%,SELENOS;THBS1
prerank,GO_Biological_Process_2021__epidermal growth factor receptor signaling pathway (GO:0007173),0.5986346359249446,1.314706259505,0.08695652173913043,0.6043148576629481,1.0,13/37,15.44%,NCK2;EGFR;SOX9;CBL;AKT1;PIK3CA;PIK3R1;SHC3;BRAF;SOS1;PTK2;GAB1;PTPN11
prerank,GO_Biological_Process_2021__positive regulation of myeloid leukocyte differentiation (GO:0002763),-0.6238981549746766,-1.3143316016518882,0.13114754098360656,0.98549391164432,1.0,6/22,15.74%,POU4F1;CASP8;FES;ID2;IL34;CD74
prerank,GO_Biological_Process_2021__hyperosmotic response (GO:0006972),-0.8252276374723265,-1.3142633039744132,0.16071428571428573,0.9818005552022089,1.0,3/5,12.02%,AQP1;TLR3;RCSD1
prerank,GO_Biological_Process_2021__histone lysine demethylation (GO:0070076),0.5697028149516161,1.3142192160208743,0.07692307692307693,0.6052899946255291,1.0,10/24,32.04%,PHF2;KDM5A;KDM1A;KDM1B;KDM4C;JMJD1C;KDM7A;KDM3A;KDM6A;PHF8
prerank,GO_Biological_Process_2021__regulation of plasma membrane bounded cell projection assembly (GO:0120032),0.48750419945064016,1.3137428928999344,0.0,0.6057274823182075,1.0,28/58,29.58%,CDKL1;TBC1D1;EPHA2;USP6NL;TBC1D5;CDKL5;TBC1D24;TBC1D22B;ODAD3;FER;TBC1D10A;FXR1;ATG5;ARF6;FMR1;CAPZB;RABGAP1;TRPM2;TBC1D17;CYLD;MYO10;RAB5A;TBC1D15;ATG3;TBC1D10B;IFT20;SDCCAG8;TWF1
prerank,GO_Biological_Process_2021__cellular response to oxygen levels (GO:0071453),0.7441974749604897,1.3134952077038147,0.12,0.6061394010101308,1.0,2/8,9.12%,ATP6V1A;CPEB4
prerank,GO_Biological_Process_2021__positive regulation of DNA replication (GO:0045740),0.577040068092196,1.3126700565681,0.17857142857142858,0.6090220550164592,1.0,7/15,19.11%,DNA2;EGFR;STN1;DHX9;KAT7;FAF1;NPM2
prerank,GO_Biological_Process_2021__DNA ligation (GO:0006266),0.8116386678984407,1.3124208232178391,0.10869565217391304,0.6091858912803971,1.0,1/6,1.18%,LIG4
prerank,GO_Biological_Process_2021__ion transport (GO:0006811),0.43768095995361933,1.3124144686862456,0.04,0.6082860598309431,1.0,9/85,6.40%,SLC26A7;CHRNA4;SLC24A3;SLC15A3;SLC15A2;SLC26A3;GRIN1;SLC25A18;SLC12A2
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance via telomere lengthening (GO:1904358),0.49594324427322767,1.3121133347180483,0.16666666666666666,0.6084504983406888,1.0,11/31,25.39%,NAF1;CCT4;MAP3K4;MAPKAPK5;MAPK1;CCT3;POT1;HMBOX1;TNKS2;CTNNB1;TNKS
prerank,GO_Biological_Process_2021__mitotic cytokinesis (GO:0000281),0.4887666964550648,1.3119898912818992,0.08333333333333333,0.6080121501713334,1.0,12/42,26.92%,SNX18;SEPTIN6;ANLN;INCENP;ROCK2;ESPL1;ROCK1;PLK1;TRIM36;ARL3;EFHC2;SPTBN1
prerank,GO_Biological_Process_2021__regulation of protein deacetylation (GO:0090311),0.7714828497519935,1.3119187358244784,0.1590909090909091,0.6073345246271291,1.0,4/8,10.77%,SPRED2;DYRK1A;SPRED1;EP300
prerank,GO_Biological_Process_2021__regulation of mitochondrial fusion (GO:0010635),0.7740455041004911,1.311766353647655,0.19047619047619047,0.6069471452276701,1.0,5/10,16.74%,PLD6;PID1;PRKN;VAT1;TFRC
prerank,GO_Biological_Process_2021__tryptophan catabolic process (GO:0006569),-0.76556860940974,-1.3117360819459134,0.09090909090909091,0.9953549664769994,1.0,2/9,1.59%,KMO;ACMSD
prerank,GO_Biological_Process_2021__somatic recombination of immunoglobulin genes involved in immune response (GO:0002204),0.7992266303919398,1.3114113533029352,0.12962962962962962,0.6075203464788609,1.0,2/6,3.32%,LIG4;EXOSC6
prerank,MSigDB_Hallmark_2020__Spermatogenesis,-0.5232455343964818,-1.3109995339434741,0.10526315789473684,0.9965136761456781,1.0,21/85,15.88%,LDHC;GAPDHS;CFTR;ZC2HC1C;KIF2C;NEFH;CCNB2;GAD1;MEP1B;RPL39L;CDKN3;ART3;GSTM3;PARP2;GSG1;PCSK1N;NOS1;SCG3;CCT6B;CLGN;TEKT2
prerank,GO_Biological_Process_2021__cardiac cell development (GO:0055006),0.7179644319422777,1.3106848875183497,0.13513513513513514,0.6097684390567716,1.0,1/10,0.19%,TCAP
prerank,GO_Biological_Process_2021__single strand break repair (GO:0000012),0.7723861921890051,1.3103872370004352,0.1590909090909091,0.6099531838835336,1.0,4/7,16.13%,LIG4;APTX;SIRT1;APLF
prerank,GO_Biological_Process_2021__ganglioside biosynthetic process (GO:0001574),0.6666158279716693,1.310135452318025,0.06818181818181818,0.6100896271746743,1.0,4/13,13.91%,ST6GALNAC5;B4GALT6;ST3GAL1;B4GALT5
prerank,GO_Biological_Process_2021__signal complex assembly (GO:0007172),0.7918352873209673,1.3100183297474945,0.13043478260869565,0.6095341312687789,1.0,3/5,15.78%,NCK2;NCK1;PXN
prerank,GO_Biological_Process_2021__regulation of cellular response to heat (GO:1900034),0.4809955326691764,1.3100096001489931,0.16666666666666666,0.6086468909030309,1.0,25/76,21.80%,NUP42;NUP37;NUP188;HSPH1;CHORDC1;CAMK2B;CAMK2A;EP300;CAMK2D;NUP153;MAPKAPK2;SIRT1;NDC1;RPTOR;MAPK1;DNAJB6;GSK3B;PTGES3;NUP205;NUP214;BAG2;BAG3;CREBBP;HSPA1A;RANBP2
prerank,GO_Biological_Process_2021__negative regulation of cilium assembly (GO:1902018),0.6462299153253359,1.3098443653604326,0.17777777777777778,0.6084755377675731,1.0,4/11,15.63%,EVI5L;TESK1;CEP97;YAP1
prerank,GO_Biological_Process_2021__regulation of protein-containing complex disassembly (GO:0043244),-0.6959789443793227,-1.3094952350428342,0.19696969696969696,1.0,1.0,3/15,14.71%,OGFOD1;CLN3;SHFL
prerank,GO_Biological_Process_2021__protein destabilization (GO:0031648),0.5356921928805588,1.3094633056374383,0.19047619047619047,0.6093256063223704,1.0,16/31,23.22%,CCDC88C;BTRC;SNCA;FBXL3;NR1D1;PRKN;EP300;PEX2;SIRT1;CUL3;MDM2;FBXW11;PLK1;CREBBP;DERL1;CDC73
prerank,GO_Biological_Process_2021__protein K48-linked deubiquitination (GO:0071108),0.5538807147319037,1.309437135189777,0.15625,0.6085847738302245,1.0,7/23,25.03%,OTUB2;VCPIP1;USP25;OTUD4;USP34;OTUD7A;USP33
prerank,GO_Biological_Process_2021__regulation of long-term neuronal synaptic plasticity (GO:0048169),0.6863235316628368,1.3093994470165229,0.1282051282051282,0.6078224118646496,1.0,7/11,26.56%,NPTN;CAMK2B;SHANK3;DRD2;SYNGR1;NETO1;RAB5A
prerank,PanglaoDB_Augmented_2021__Enterocytes,-0.5162982907022979,-1.3093837341544683,0.1267605633802817,0.9997924710280597,1.0,18/88,12.30%,SLC28A2;SPON2;PDZK1;CEACAM1;NR1I3;AQP1;SLC51B;VIL1;ALDOB;RBP2;TMC4;SLC51A;ADH6;GPX2;ABCG2;ART3;CA1;GSTM3
prerank,GO_Biological_Process_2021__vesicle tethering to Golgi (GO:0099041),0.7963934784649926,1.3091780509558626,0.1,0.6078659961160309,1.0,3/5,16.32%,TRIP11;FAM91A1;TBC1D23
prerank,GO_Biological_Process_2021__purinergic nucleotide receptor signaling pathway (GO:0035590),0.6874413046015578,1.309000137192051,0.08333333333333333,0.6076970061269862,1.0,1/14,0.44%,TXNIP
prerank,GO_Biological_Process_2021__regulation of spindle organization (GO:0090224),-0.6939711206966264,-1.308997910898972,0.0847457627118644,0.9988966686100226,1.0,3/17,14.22%,ANKRD53;BORA;TPX2
prerank,GO_Biological_Process_2021__positive regulation of purine nucleotide biosynthetic process (GO:1900373),0.7979235378143636,1.3088669334986158,0.17391304347826086,0.607363503547326,1.0,2/8,0.70%,PPARGC1A;PID1
prerank,GO_Biological_Process_2021__ubiquitin-dependent protein catabolic process (GO:0006511),0.3945922377195186,1.308607797911774,0.0,0.607595859603818,1.0,104/312,21.51%,SPSB4;RNF150;VPS37B;FEM1B;BTRC;KCTD13;SPSB2;KEAP1;ANAPC1;FBXL17;UBE2G1;KLHL8;TRIM9;RNF11;KBTBD7;RNF217;RNF146;ARRB1;NEDD4L;MARCHF6;CBL;CDC27;KCTD17;PSMA1;RNF144A;KBTBD6;FEM1C;RNF6;ATE1;KLHL42;VPS37A;UBE2D1;UBR3;PSMD11;RNF14;ITCH;KLHL15;PSMD10;CLOCK;CNOT4;UBE3C;PRKN;RMND5A;FBXO11;PSMF1;FBXW7;COP1;ZRANB1;KCTD10;FBXL14;FBXO21;PSMD14;PCNP;SMURF1;TBL1XR1;BUB3;TRIP12;SIRT1;AGAP3;SIRT2;MIB1;UBE2E1;SPOPL;UBQLN1;FBXO45;ARIH1;VCP;KCTD5;UBAP1L;CDC34;FAF1;ANAPC16;USP9X;HACE1;BIRC2;UBQLN4;WDR91;RNF166;UBQLN2;PSME4;BFAR;ANKRD9;WDR81;CUL3;NDFIP1;MDM2;RAD23B;FBXW11;NSFL1C;UBXN2B;PTPN23;PLK1;NFE2L2;GID8;OTUD7A;FBXO8;TNFAIP1;MVB12B;UBE2D3;UBE3B;RBBP6;AURKA;PSMD1;UBA6
prerank,"GO_Biological_Process_2021__maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",-0.6275452498170514,-1.3072701708804533,0.13513513513513514,1.0,1.0,4/27,7.57%,RPS14;RPS21;RPS8;RPS16
prerank,GO_Biological_Process_2021__cardiac muscle cell action potential (GO:0086001),0.5729919391932708,1.3071402429312127,0.0967741935483871,0.6122227280281269,1.0,4/26,6.86%,CACNA1G;ANK2;CACNA2D1;KCNH2
prerank,GO_Biological_Process_2021__glyceraldehyde-3-phosphate metabolic process (GO:0019682),-0.7271218690397563,-1.306956214516999,0.11864406779661017,1.0,1.0,2/7,7.29%,ALDOB;GLYCTK
prerank,GO_Biological_Process_2021__ether lipid metabolic process (GO:0046485),0.6828643665434567,1.306956031383813,0.16216216216216217,0.6122127465697985,1.0,6/12,20.71%,AGMO;PEX7;FAR1;AGPS;TMEM86B;PLAAT3
prerank,GO_Biological_Process_2021__regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902108),0.767153049104644,1.3068933967578227,0.15,0.6115934501454287,1.0,3/6,20.01%,CAMK2A;ATF2;NAIF1
prerank,GO_Biological_Process_2021__ubiquinone metabolic process (GO:0006743),0.6515335384659341,1.3068572214282195,0.14285714285714285,0.6107653008065184,1.0,6/14,22.15%,AIFM2;COQ3;COQ9;COQ2;FDXR;PDSS2
prerank,GO_Biological_Process_2021__histidine metabolic process (GO:0006547),0.8243055762407021,1.3066167784990574,0.1276595744680851,0.6100728661402546,1.0,4/5,13.67%,CARNMT1;CARNS1;FTCD;AMDHD1
prerank,GO_Biological_Process_2021__histidine catabolic process (GO:0006548),0.8243055762407021,1.3066167784990574,0.1276595744680851,0.6100728661402546,1.0,4/5,13.67%,CARNMT1;CARNS1;FTCD;AMDHD1
prerank,GO_Biological_Process_2021__maintenance of protein location in nucleus (GO:0051457),0.6068615475637513,1.3062272073056016,0.034482758620689655,0.6104854677722459,1.0,7/18,19.08%,HNRNPU;RANGAP1;MORC3;SYNE1;TAF8;ARL2BP;TAF3
prerank,GO_Biological_Process_2021__negative regulation of cell division (GO:0051782),0.7711806488280415,1.3062225809439696,0.13953488372093023,0.6096170673913465,1.0,2/6,5.88%,TXNIP;ZFYVE19
prerank,GO_Biological_Process_2021__postsynaptic density assembly (GO:0097107),0.7408228771520281,1.3061929653681346,0.29545454545454547,0.6088673168064412,1.0,5/5,25.94%,NRXN1;SHANK3;PTEN;NRXN2;NLGN2
prerank,"GO_Biological_Process_2021__maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",-0.714114633976545,-1.3059956506052486,0.18867924528301888,1.0,1.0,6/14,17.22%,RPL35;RPL7;DDX18;RPF2;WDR12;NIFK
prerank,GO_Biological_Process_2021__protein oxidation (GO:0018158),0.689272818287509,1.3053037042754332,0.09523809523809523,0.6112057706763002,1.0,2/8,9.45%,LOXL2;LOXL1
prerank,GO_Biological_Process_2021__apical junction assembly (GO:0043297),0.506704610334435,1.3052898340614967,0.06451612903225806,0.6103632108469054,1.0,7/35,15.65%,PARD3;MARVELD3;STRN;AFDN;OCLN;DLG1;PARD6G
prerank,GO_Biological_Process_2021__postsynapse assembly (GO:0099068),0.6664615722217756,1.3052099556098498,0.14285714285714285,0.6098238278552272,1.0,7/11,22.01%,WNT7A;NRXN1;NLGN3;NLGN4X;LRP4;NRXN2;NLGN1
prerank,GO_Biological_Process_2021__retinal rod cell differentiation (GO:0060221),0.7235792583144431,1.305158351467417,0.1794871794871795,0.6091242316546762,1.0,5/8,23.31%,SOX8;SOX9;RORB;RPGRIP1L;RP1
prerank,GO_Biological_Process_2021__phosphatidylethanolamine biosynthetic process (GO:0006646),0.7069730276114827,1.3050704283033394,0.14583333333333334,0.6084958269714342,1.0,1/13,0.75%,LPIN3
prerank,GO_Biological_Process_2021__positive regulation of histone acetylation (GO:0035066),0.6560657143506303,1.3046049687759849,0.14705882352941177,0.6096432866626763,1.0,5/19,14.34%,PPARGC1A;RPS6KA4;ARRB1;KAT7;SMAD4
prerank,GO_Biological_Process_2021__regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),0.5942094756577153,1.3043036109987485,0.08333333333333333,0.6103963863701157,1.0,5/18,16.88%,ANK2;CASQ1;GSTM2;CAMK2D;PDE4D
prerank,GO_Biological_Process_2021__peptidyl-lysine acetylation (GO:0018394),0.7079846803061556,1.3042094314138162,0.1,0.6097458672602033,1.0,5/9,13.97%,KAT2B;KAT2A;EP300;SIRT1;KAT7
prerank,GO_Biological_Process_2021__positive regulation of transcription regulatory region DNA binding (GO:2000679),-0.735904901859118,-1.3027940442342478,0.16393442622950818,1.0,1.0,1/13,0.33%,POU4F1
prerank,GO_Biological_Process_2021__cellular response to iron ion (GO:0071281),-0.8067303277752504,-1.3016572050179926,0.19642857142857142,1.0,1.0,2/5,17.35%,B2M;TFR2
prerank,GO_Biological_Process_2021__semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),0.6846261681431333,1.3014409000192066,0.08,0.6196051774529968,1.0,5/12,19.21%,PLXNA2;NRP2;PLXNA1;NRP1;PLXNA4
prerank,GO_Biological_Process_2021__positive regulation of circadian rhythm (GO:0042753),0.7763911211741008,1.3013668441873867,0.1276595744680851,0.618920671950946,1.0,2/6,4.25%,BTRC;RORA
prerank,GO_Biological_Process_2021__negative regulation of B cell apoptotic process (GO:0002903),0.7183419693622671,1.3012895844036052,0.23076923076923078,0.6184211136656687,1.0,1/6,2.08%,FOXP1
prerank,GO_Biological_Process_2021__regulation of neutrophil chemotaxis (GO:0090022),0.6142913831163651,1.3012753613222867,0.11627906976744186,0.6175573970264708,1.0,4/16,12.05%,MCU;DAPK2;BST1;SLIT2
prerank,GO_Biological_Process_2021__negative regulation of RNA splicing (GO:0033119),-0.6958101498397997,-1.3011173488859427,0.12698412698412698,1.0,1.0,2/18,7.23%,RPS13;RPS26
prerank,GO_Biological_Process_2021__intra-Golgi vesicle-mediated transport (GO:0006891),0.5246342804587855,1.3009959590209281,0.13157894736842105,0.6175630689730126,1.0,12/27,34.45%,RAB33B;VTI1A;TRAPPC10;NSF;GOLGA5;COG5;COG3;COPA;COG1;COG6;COPB1;COG2
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell differentiation (GO:0030857),0.7538301631257007,1.3008214984671775,0.14634146341463414,0.6175003747116659,1.0,3/8,7.82%,SPRED2;ZEB1;SPRED1
prerank,GO_Biological_Process_2021__alpha-beta T cell activation (GO:0046631),-0.8375050908662947,-1.3007737693298111,0.15625,1.0,1.0,3/6,8.15%,HLA-A;ANXA1;RSAD2
prerank,GO_Biological_Process_2021__negative regulation of microtubule depolymerization (GO:0007026),0.5455259077906711,1.3006682199311117,0.10810810810810811,0.6172558405887528,1.0,13/21,29.08%,TTBK2;NAV3;CAMSAP2;CLASP1;HDGFL3;KATNB1;ATXN7;CIB1;TRIM54;TAOK1;CLASP2;ARHGEF2;FGF13
prerank,GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen (GO:0002483),-0.749257284716722,-1.3005329558813794,0.07936507936507936,1.0,1.0,4/12,6.58%,HLA-A;B2M;ERAP2;ERAP1
prerank,GO_Biological_Process_2021__steroid metabolic process (GO:0008202),-0.566713355746048,-1.3000987442302692,0.05405405405405406,1.0,1.0,5/52,7.19%,GC;AKR1C1;HSD11B1;DHCR24;CYP2D6
prerank,GO_Biological_Process_2021__embryonic skeletal system development (GO:0048706),0.6626770887503248,1.299622089014266,0.1,0.620147370859316,1.0,2/13,4.93%,PCSK5;PDGFRA
prerank,GO_Biological_Process_2021__negative regulation of phospholipase activity (GO:0010519),-0.8396995594800736,-1.299155252486148,0.13636363636363635,1.0,1.0,2/6,7.43%,ANXA1;ANGPTL3
prerank,GO_Biological_Process_2021__negative regulation of small GTPase mediated signal transduction (GO:0051058),0.5815620565723743,1.299082024548692,0.14705882352941177,0.6214199846661943,1.0,6/19,17.00%,SPRY4;CGNL1;SPRY3;SLIT2;SYNGAP1;CYRIB
prerank,GO_Biological_Process_2021__phosphatidylserine metabolic process (GO:0006658),0.5773417970991314,1.2990434298360887,0.09090909090909091,0.6207405501292451,1.0,8/20,29.81%,SERINC5;OSBPL8;PLAAT3;PTDSS2;OSBPL5;SERINC1;SLC27A1;ABHD12
prerank,GO_Biological_Process_2021__carbohydrate catabolic process (GO:0016052),-0.6023352574534596,-1.2989793066530486,0.11764705882352941,1.0,1.0,11/33,20.22%,GAPDHS;ENO4;ENOSF1;ALDOB;LDHA;HK2;GPI;NEU1;PGAM1;GAPDH;ENO1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell differentiation (GO:2000725),0.708115869401419,1.2989498471305772,0.1111111111111111,0.620176124616766,1.0,3/9,9.93%,BMP2;SOX6;EFNB2
prerank,PanglaoDB_Augmented_2021__Reticulocytes,0.4438391277645234,1.2983777928272835,0.0,0.6213078575093904,1.0,21/92,17.95%,XPO1;RCC2;STT3B;NUP188;DHX15;UBAP2L;RFWD3;TTI1;NUP153;INCENP;ZDHHC5;DHX9;NDC1;UGGT1;DCAF1;NUP205;NEU3;SF3B3;TFRC;STIP1;PTBP1
prerank,GO_Biological_Process_2021__internal protein amino acid acetylation (GO:0006475),0.7628643234718135,1.2983569966560353,0.18604651162790697,0.62047344464541,1.0,4/7,13.97%,KAT2B;KAT2A;EP300;KAT7
prerank,GO_Biological_Process_2021__cellular response to interleukin-1 (GO:0071347),-0.5110351476299196,-1.298187424796437,0.0625,1.0,1.0,19/111,14.31%,GBP2;GBP1;GBP3;PSMB6;IL1R1;RPS27A;PSMA8;PSMB9;PSMA7;HYAL1;PSMC3;UBC;PSME1;SFRP1;CX3CL1;PSMC4;PSMA3;RIPK2;CCL2
prerank,PanglaoDB_Augmented_2021__Erythroid-like And Erythroid Precursor Cells,-0.5546918550795816,-1.2981473665012233,0.08974358974358974,1.0,1.0,15/60,13.63%,GATA1;CLEC12A;CEACAM1;NR1I3;AQP1;DPEP2;THBS1;GMFG;RSAD2;TSPAN32;VAMP5;RHD;CA1;BPGM;MYO1F
prerank,GO_Biological_Process_2021__positive regulation of ERAD pathway (GO:1904294),0.6659587148232758,1.297733099487755,0.12195121951219512,0.6218945716410552,1.0,7/12,25.44%,USP13;UBQLN1;UBQLN2;NFE2L2;RNFT1;RNF185;BAG6
prerank,GO_Biological_Process_2021__proteolysis (GO:0006508),0.42161143128493983,1.2976129964996197,0.07142857142857142,0.6213766670952684,1.0,14/189,6.16%,CPA1;LVRN;CAPN13;CPO;ADAMTS3;PCSK5;VHL;MMP16;MME;CTSK;NCSTN;SDE2;ATG4C;KLKB1
prerank,GO_Biological_Process_2021__positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903589),-0.866581528416126,-1.2975456543519117,0.08333333333333333,1.0,1.0,1/5,3.87%,APLNR
prerank,GO_Biological_Process_2021__establishment of centrosome localization (GO:0051660),0.8069052121827051,1.297189079400387,0.1590909090909091,0.6225679441078404,1.0,3/5,16.00%,PARD3;DLG1;PARD3B
prerank,GO_Biological_Process_2021__positive regulation of biosynthetic process (GO:0009891),0.5577932161365217,1.2971395323698742,0.1724137931034483,0.6219607779874725,1.0,6/28,8.82%,RAB27A;ZBTB20;RGCC;GRIN1;AKT1;HDAC2
prerank,GO_Biological_Process_2021__vitamin A metabolic process (GO:0006776),-0.8069345863683974,-1.2969642011577556,0.21428571428571427,1.0,1.0,5/7,15.83%,RPE65;RBP2;BCO1;RBP1;LRAT
prerank,GO_Biological_Process_2021__negative regulation of signal transduction by p53 class mediator (GO:1901797),0.6538340936716025,1.296914496842287,0.11363636363636363,0.6223636779394373,1.0,7/14,18.39%,DYRK1A;MARCHF7;PSMD10;PRKN;SIRT1;KDM1A;MDM2
prerank,GO_Biological_Process_2021__dicarboxylic acid biosynthetic process (GO:0043650),0.7963418252462009,1.296682607848024,0.046511627906976744,0.6222731531518353,1.0,2/7,12.26%,GLS;KYNU
prerank,GO_Biological_Process_2021__isotype switching (GO:0045190),0.7533999176534572,1.2966006267566226,0.19148936170212766,0.6217359212974345,1.0,2/7,3.32%,LIG4;EXOSC6
prerank,GO_Biological_Process_2021__actin cytoskeleton reorganization (GO:0031532),0.48992905277835924,1.2963093386302018,0.15789473684210525,0.6221597962670768,1.0,16/51,19.03%,CASS4;PARVA;PLEK;MCU;ATP2C1;THSD7A;TNIK;MKLN1;AUTS2;FER;CDC42BPA;GAB1;NRP1;RAP2A;BCAR1;S1PR1
prerank,GO_Biological_Process_2021__positive regulation of brown fat cell differentiation (GO:0090336),0.6934204827376708,1.2960619970274256,0.08108108108108109,0.6222036402026041,1.0,5/11,16.20%,HNRNPU;TFE3;RREB1;SOX13;BMP7
prerank,GO_Biological_Process_2021__regulation of peroxisome proliferator activated receptor signaling pathway (GO:0035358),0.7004227357517492,1.295778388791385,0.25,0.6228037774581571,1.0,4/8,19.81%,PLIN5;LMO3;SIRT1;ASXL2
prerank,GO_Biological_Process_2021__positive regulation of viral genome replication (GO:0045070),0.5469571200464803,1.2957214972259588,0.13043478260869565,0.622135386794476,1.0,2/25,2.63%,VAPB;PDE12
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),0.7019814151427877,1.2956155111398944,0.18604651162790697,0.6216241826968634,1.0,3/11,11.05%,PRODH;GSKIP;MAP3K5
prerank,GO_Biological_Process_2021__protein O-linked mannosylation (GO:0035269),0.5394668019012127,1.2951422978337415,0.18421052631578946,0.6225994880755064,1.0,5/17,13.70%,LARGE1;CRPPA;TMTC2;TMTC4;FKRP
prerank,GO_Biological_Process_2021__poly-N-acetyllactosamine biosynthetic process (GO:0030311),-0.7251719833596764,-1.2949027797747867,0.10714285714285714,1.0,1.0,2/8,9.68%,B3GALT2;B3GNT3
prerank,GO_Biological_Process_2021__poly-N-acetyllactosamine metabolic process (GO:0030309),-0.7251719833596764,-1.2949027797747867,0.10714285714285714,1.0,1.0,2/8,9.68%,B3GALT2;B3GNT3
prerank,GO_Biological_Process_2021__positive regulation of protein localization to nucleus (GO:1900182),0.4933381035273816,1.2948707641075892,0.0,0.6225760322750974,1.0,16/55,21.04%,HCLS1;TESK1;CCT4;AKT1;PIK3R1;UBR5;DKC1;KAT7;TRIM28;YAP1;CCT3;TFRC;IPO5;PLK1;BAG3;ZPR1
prerank,GO_Biological_Process_2021__cellular response to oxidative stress (GO:0034599),0.4168783668656293,1.2944437637477348,0.0,0.6232600358092236,1.0,25/104,15.86%,PPARGC1A;ANKRD2;PTPRK;ETV5;SNCA;FOXO1;KEAP1;EGFR;PDGFRA;ADNP2;PRDX6;FOXO3;AKT1;GSR;RAD52;PKD2;SLC25A24;PRKD1;AGAP3;FER;SIRT2;MAPK1;PDK2;PXN;MAPK8
prerank,GO_Biological_Process_2021__phosphatidylinositol biosynthetic process (GO:0006661),0.4422688152280807,1.2943886930828974,0.1111111111111111,0.6224851580191583,1.0,52/110,29.19%,PIP5K1B;SOCS6;ITPKB;PLEKHA2;PIK3CA;PTPN13;EFR3A;PIK3R1;SOCS7;PIK3C3;PLEKHA8;PIP5K1C;PIK3R4;SMG1;TTC7B;PIP4K2C;PIKFYVE;IP6K2;SYNJ1;MTMR2;PIGP;PITPNM3;PI4KB;RAB4A;PTEN;PLEKHA3;MTM1;MTMR12;PLEKHA1;PITPNM1;SACM1L;TTC7A;PIK3C2B;FGF2;OCRL;TPTE2;PIGQ;MTMR6;PIGU;SYNJ2;SOCS4;DPM1;FIG4;RAB5A;MTMR9;PI4KA;PIP4K2B;PGAP4;CDS1;RUFY1;PIGZ;SLC27A1
prerank,GO_Biological_Process_2021__brain morphogenesis (GO:0048854),0.6926555738494724,1.2936223999351983,0.21951219512195122,0.6241374880177402,1.0,6/10,19.18%,CTNNA2;SHANK3;MKKS;BBS2;PTEN;FBXW11
prerank,GO_Biological_Process_2021__calcium import into the mitochondrion (GO:0036444),0.6923440869758638,1.2935843392538855,0.11363636363636363,0.623495616270896,1.0,2/10,4.36%,MAIP1;MCU
prerank,GO_Biological_Process_2021__regulation of vesicle size (GO:0097494),0.7550513921116653,1.2932691476240226,0.1568627450980392,0.623647011814298,1.0,4/7,18.88%,PICALM;RIN3;RAB22A;ALS2
prerank,GO_Biological_Process_2021__regulation of ossification (GO:0030278),0.5456200237124306,1.2932260343260726,0.125,0.6230075215704028,1.0,10/29,19.03%,BMP2;SOX9;ANKH;ZBTB16;ACVR1;ECM1;PTPN11;RBPJ;LRP4;S1PR1
prerank,"GO_Biological_Process_2021__establishment of mitochondrion localization, microtubule-mediated (GO:0034643)",0.7797509960492742,1.293080841388483,0.14285714285714285,0.622742527317914,1.0,1/6,3.99%,RHOT1
prerank,GO_Biological_Process_2021__polyol transport (GO:0015791),-0.8296966636531036,-1.292885403886821,0.11864406779661017,1.0,1.0,2/5,13.39%,AQP1;AQP11
prerank,GO_Biological_Process_2021__embryonic heart tube morphogenesis (GO:0003143),-0.5938621476463013,-1.292573492554823,0.13636363636363635,1.0,1.0,5/29,8.69%,CCDC39;APLNR;DNAAF1;HES1;SRF
prerank,GO_Biological_Process_2021__response to thyroid hormone (GO:0097066),-0.6816215812659977,-1.2920986795925962,0.12903225806451613,1.0,1.0,5/13,11.34%,GATA1;CTSL;RDX;CTSH;BRD8
prerank,GO_Biological_Process_2021__histone phosphorylation (GO:0016572),0.7598998297356047,1.291861589742737,0.20833333333333334,0.6262010675761577,1.0,3/9,11.65%,RPS6KA4;CCNA2;INCENP
prerank,GO_Biological_Process_2021__positive regulation of T cell migration (GO:2000406),-0.6759250506591117,-1.291640290437388,0.1896551724137931,1.0,1.0,1/12,0.34%,DOCK8
prerank,GO_Biological_Process_2021__positive regulation of BMP signaling pathway (GO:0030513),0.5680371105231676,1.2916367746564383,0.08888888888888889,0.6259762518059501,1.0,7/20,14.34%,ELAPOR2;SMAD2;BMPR1B;ZNF423;ACVR2A;BMPR1A;SMAD4
prerank,GO_Biological_Process_2021__positive regulation of macroautophagy (GO:0016239),0.4986329577306489,1.2914775902139144,0.16,0.6255991528764302,1.0,19/49,24.62%,DCN;SMCR8;SESN1;ADRB2;MAP3K7;GNAI3;RALB;PIP4K2C;RAB3GAP1;SIRT1;FYCO1;SESN3;WAC;BAG3;PAFAH1B2;LRSAM1;CALCOCO2;SESN2;SH3GLB1
prerank,GO_Biological_Process_2021__negative regulation of DNA repair (GO:0045738),0.799647811077374,1.2914241631200358,0.1590909090909091,0.6249177002964151,1.0,3/6,12.76%,OTUB2;UBR5;TRIP12
prerank,GO_Biological_Process_2021__regulation of cellular amino acid metabolic process (GO:0006521),-0.5570045941794776,-1.2913994013103443,0.109375,1.0,1.0,9/46,13.44%,PSMB6;BHMT;PSMA8;PSMB9;PSMA7;PSMC3;PSME1;PSMC4;PSMA3
prerank,MSigDB_Hallmark_2020__Hedgehog Signaling,0.5064001390502784,1.2913700531841772,0.09523809523809523,0.6244341034890666,1.0,7/33,15.85%,SLIT1;AMOT;NRP2;ETS2;NF1;OPHN1;NRP1
prerank,GO_Biological_Process_2021__negative regulation of axon regeneration (GO:0048681),0.7754524610822358,1.2911354936875268,0.21739130434782608,0.6242345865995658,1.0,2/6,9.87%,EPHA4;RTN4RL1
prerank,PanglaoDB_Augmented_2021__Ionocytes,-0.5367975381731483,-1.290972638613145,0.06493506493506493,1.0,1.0,19/59,16.27%,FMO6P;SPAG17;MROH9;CFTR;CFAP52;TEKT1;ZBBX;CHST9;CXCL17;ATP12A;APOBEC4;LRRIQ1;AK7;C1ORF87;IL20RA;SLC9A7;FUT2;CAPN9;PTPN3
prerank,GO_Biological_Process_2021__cellular response to thyroid hormone stimulus (GO:0097067),-0.6861379507895535,-1.2905089662557392,0.19696969696969696,1.0,1.0,5/12,11.34%,GATA1;CTSL;RDX;CTSH;BRD8
prerank,GO_Biological_Process_2021__positive regulation of autophagosome assembly (GO:2000786),0.6735198811579727,1.2900176634290121,0.10869565217391304,0.6272508222201209,1.0,6/9,27.98%,RALB;PIP4K2C;RAB3GAP1;LRSAM1;SH3GLB1;PIP4K2B
prerank,GO_Biological_Process_2021__regulation of dendritic cell apoptotic process (GO:2000668),0.7957771782226217,1.2898506892839516,0.13333333333333333,0.6270264031872836,1.0,2/5,6.98%,CXCL12;RAPGEF2
prerank,GO_Biological_Process_2021__negative regulation of ATP metabolic process (GO:1903579),0.6929753331197268,1.2895833259324303,0.20588235294117646,0.6271275825715585,1.0,5/14,14.71%,PID1;PDE12;GIT1;HDAC4;MLXIPL
prerank,GO_Biological_Process_2021__negative regulation of actin filament bundle assembly (GO:0032232),0.5420071875555662,1.2889856267172832,0.14705882352941177,0.6286133434811536,1.0,8/24,14.04%,SHANK1;ARAP1;CGNL1;PIK3R1;PRKN;SHANK3;CLASP1;TJP1
prerank,GO_Biological_Process_2021__cellular response to dopamine (GO:1903351),0.7342621967209465,1.2884440152534644,0.11627906976744186,0.6286812271261745,1.0,3/7,14.21%,GABPA;PRKN;MAPK1
prerank,GO_Biological_Process_2021__response to dopamine (GO:1903350),0.7342621967209465,1.2884440152534644,0.11627906976744186,0.6286812271261745,1.0,3/7,14.21%,GABPA;PRKN;MAPK1
prerank,GO_Biological_Process_2021__positive regulation of sequestering of triglyceride (GO:0010890),0.7453901247663689,1.2883619402164188,0.125,0.6281762162430754,1.0,1/6,5.57%,PLIN5
prerank,"GO_Biological_Process_2021__negative regulation of gene expression, epigenetic (GO:0045814)",0.5355005213713832,1.287664837340631,0.125,0.6298464970247789,1.0,9/27,24.34%,EED;AEBP2;TASOR;RBBP4;PPHLN1;JARID2;PPM1D;EPC1;MACROH2A1
prerank,GO_Biological_Process_2021__positive regulation of glycogen biosynthetic process (GO:0045725),0.688782485291528,1.2873231061551607,0.1794871794871795,0.630201126084928,1.0,8/11,26.87%,AKT1;IRS1;DYRK2;AKT2;IGF1;IRS2;EPM2AIP1;GCK
prerank,GO_Biological_Process_2021__regulation of podosome assembly (GO:0071801),-0.8059889519017485,-1.2871739597329916,0.2777777777777778,1.0,1.0,3/6,14.53%,IL5;KIF9;FSCN1
prerank,GO_Biological_Process_2021__dendrite arborization (GO:0140059),0.7485971942977052,1.2869949273096446,0.19148936170212766,0.6306621638032103,1.0,3/6,21.53%,TAOK2;NRP1;PHACTR1
prerank,GO_Biological_Process_2021__monocarboxylic acid biosynthetic process (GO:0072330),-0.5624107127384033,-1.286973935952001,0.1232876712328767,1.0,1.0,14/47,23.44%,LIPI;ACMSD;HSD17B8;ACSM6;ACSM5;ACSM3;XBP1;OXSM;SDS;PARK7;CBR4;ALOX5;ACOT8;ACOX2
prerank,GO_Biological_Process_2021__negative regulation of cytoplasmic translation (GO:2000766),0.7828742621697035,1.2869573680356143,0.18181818181818182,0.6300928849168145,1.0,6/7,21.70%,CPEB3;RBM24;CPEB4;CPEB1;CPEB2;FMR1
prerank,GO_Biological_Process_2021__positive regulation of membrane depolarization (GO:1904181),0.8322172387792459,1.2867085209204774,0.075,0.6301246236079496,1.0,2/5,6.66%,DCN;TRPM4
prerank,GO_Biological_Process_2021__regulation of helicase activity (GO:0051095),-0.735468266896836,-1.2865360636320704,0.13725490196078433,1.0,1.0,1/9,0.63%,IFIT1
prerank,GO_Biological_Process_2021__peroxisome organization (GO:0007031),0.5541158023951007,1.2864871664131758,0.09523809523809523,0.6301776630229295,1.0,10/23,20.71%,MFF;PEX11A;PEX14;PEX16;PEX2;ABCD3;PEX7;PEX6;TMEM135;PLAAT3
prerank,GO_Biological_Process_2021__regulation of lipase activity (GO:0060191),0.687511111709538,1.2864666047515654,0.16279069767441862,0.6295258230568277,1.0,3/10,5.57%,SNCA;PCSK5;PLIN5
prerank,GO_Biological_Process_2021__connective tissue development (GO:0061448),0.5542021550578811,1.2860229644666827,0.18518518518518517,0.6301553592932659,1.0,9/31,14.82%,SOX8;SOX5;ITGB8;SOX9;ZNF516;TRIP11;SOX6;ZBTB16;SH3PXD2B
prerank,GO_Biological_Process_2021__protein K11-linked deubiquitination (GO:0035871),0.6756685827929458,1.2858165012723535,0.07142857142857142,0.6297821480879303,1.0,4/9,27.18%,OTUB2;VCPIP1;OTUD7A;USP30
prerank,GO_Biological_Process_2021__negative regulation of TOR signaling (GO:0032007),0.5353899050605073,1.28525753310744,0.12195121951219512,0.6308777081048826,1.0,11/29,26.63%,SESN1;KPTN;SIRT1;MAPKAPK5;SESN3;STK11;UBR1;SESN2;PRKAA1;SH3BP4;UBR2
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection assembly (GO:0120031),0.3861382606382773,1.2852216053234824,0.07142857142857142,0.6301646106341204,1.0,52/241,17.73%,SPAG16;MACIR;ARHGEF6;DNM3;RAP2B;FHDC1;PARVA;CILK1;EXOC2;SEPTIN6;CYS1;TNIK;EXOC8;EHD4;RFX3;RAB3IP;CARMIL1;RAPGEF2;RAB23;RAB8B;EXOC5;SSX2IP;TTBK2;CEP290;FGD4;DZIP1;EXOC6;GOLPH3;MTSS1;MAP4K4;TTC8;DYNLL2;SEPTIN7;EXOC4;BBS9;RAP2C;RAP1A;CEP20;OPHN1;KIAA0586;RP2;CYFIP1;CDC14A;LZTFL1;ARHGEF7;NRP1;MKKS;RAB1A;PTPRO;CDH13;RAP2A;BBS2
prerank,MSigDB_Hallmark_2020__UV Response Dn,0.40162567595298393,1.2847606162560603,0.0,0.6309385733106911,1.0,58/132,25.34%,SERPINE1;MGLL;ANXA4;NOTCH2;NFIB;MMP16;NFKB1;ATP2C1;KCNMA1;SMAD7;DYRK1A;NR1D2;IRS1;PEX14;CELF2;NR3C1;PRKCE;SYNE1;TGFBR2;PLPP3;BCKDHB;RASA2;PDLIM5;NIPBL;APBB2;MAGI2;MAP2K5;ACVR2A;CDC42BPA;TJP1;BMPR1A;ADGRL2;DLG1;CDK13;TOGARAM1;ATP2B4;DDAH1;NRP1;SCAF8;RUNX1;ATRX;PTEN;DMAC2L;FYN;PRDM2;SDC2;AKT3;COL11A1;PRKCA;PHF3;MIOS;ADD3;RBPMS;SYNJ2;SMAD3;PMP22;SFMBT1;ATP2B1
prerank,PanglaoDB_Augmented_2021__Meningeal Cells,0.4050062122065013,1.2842529932351432,0.037037037037037035,0.6317952901312273,1.0,31/98,19.31%,POSTN;DCN;MPDZ;ANK2;PDZRN3;FAT4;CXCL12;PDGFRA;CDH11;CACNA2D1;PRKG1;PCDH18;FRZB;PRRX1;PKDCC;GFRA1;GUCY1A2;RUNX1T1;PLPP3;SLIT2;ZNF423;TJP1;ADGRL2;SLC47A1;PARD3B;BMP7;EML1;FBLN1;LIFR;LRP4;FAM13C
prerank,GO_Biological_Process_2021__regulation of feeding behavior (GO:0060259),0.7705514024584105,1.2840726502496638,0.13953488372093023,0.6317398073761411,1.0,4/8,14.90%,LEPR;EIF2AK4;SGIP1;UCN
prerank,GO_Biological_Process_2021__DNA recombination (GO:0006310),0.5264955490028511,1.2838497510665634,0.08571428571428572,0.631663332934216,1.0,5/33,9.68%,RAD54B;LIG4;RAD52;RAD51B;HMGB1
prerank,"GO_Biological_Process_2021__DNA-templated transcription, initiation (GO:0006352)",0.43547020194797503,1.2838324000814727,0.0,0.6308693912544603,1.0,47/147,24.16%,PPARGC1A;RARB;HDAC9;NR2F6;KAT2B;NR4A2;ESRRG;RORA;NOTCH2;MAML2;THRB;NRBF2;NR2E1;NR1D2;TAF4;TAF1B;NR3C1;TFB1M;NR1D1;TBL1XR1;TAF8;UBTF;HNF4G;YAP1;RSF1;NR3C2;MAML1;TAF2;TAF4B;RBPJ;RORB;MED27;TAF3;RRN3;GTF2F2;ESRRB;CDK9;CREBBP;NR4A1;NAT14;NR6A1;TEAD2;TAF1;HDAC10;TEAD1;NCOA6;TAF12
prerank,GO_Biological_Process_2021__negative regulation of chemokine-mediated signaling pathway (GO:0070100),0.8255276802325417,1.2835497532709221,0.16666666666666666,0.6313423306968382,1.0,3/5,15.69%,ROBO1;SLIT2;PADI2
prerank,GO_Biological_Process_2021__regulation of response to oxidative stress (GO:1902882),0.6296505481646089,1.2834143367734512,0.06060606060606061,0.6309087544156644,1.0,3/12,11.30%,AIFM2;PRKN;STOX1
prerank,GO_Biological_Process_2021__aerobic electron transport chain (GO:0019646),-0.5358159970150747,-1.283297436474093,0.09333333333333334,1.0,1.0,15/52,16.26%,NDUFS5;COX7C;COX4I1;NDUFA6;NDUFA2;NDUFC1;NDUFB10;UQCRQ;UQCRFS1;UQCR10;COX5B;NDUFB3;NDUFA1;NDUFB9;NDUFA12
prerank,GO_Biological_Process_2021__cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),0.4391747176373521,1.2832316542055515,0.05,0.6307916885707584,1.0,31/126,12.43%,CLDN12;TENM3;HMCN1;PCDHB2;NPTN;FAT4;IGSF11;EMB;CDH2;ADGRL3;ALCAM;CDH11;ATP2C1;CRB1;NECTIN3;CDH20;SLITRK2;TENM2;ROBO1;LRRC4C;CDH4;CADM1;SDK1;UNC5D;LRFN5;PCDHB13;SLITRK1;TGFBR2;CDH9;ACVR1;BSG
prerank,"GO_Biological_Process_2021__heparan sulfate proteoglycan biosynthetic process, enzymatic modification (GO:0015015)",0.7754831571618539,1.2831310583386992,0.09523809523809523,0.6303599323084403,1.0,2/6,14.19%,HS3ST5;HS2ST1
prerank,GO_Biological_Process_2021__regulation of cellular component organization (GO:0051128),0.40215100683254434,1.2828543337223863,0.0,0.6305794298632454,1.0,33/118,18.32%,NRG3;PICALM;MLLT3;STK38L;RAB33B;CD22;HNRNPU;RAPGEF2;SLITRK2;ABL2;ITCH;FAM107A;CAMK2D;BBS10;DCUN1D5;CAMSAP2;SGK3;RAP1A;TJP1;OPHN1;RPTOR;TAOK2;HIP1;ROCK2;LATS1;PTPN11;SEMA4D;STK11;TFRC;CDH13;RAB4A;BCAR1;PAK4
prerank,GO_Biological_Process_2021__tetrahydrobiopterin metabolic process (GO:0046146),0.6951231393154063,1.2826381641055233,0.10526315789473684,0.6303794528756925,1.0,3/9,17.21%,QDPR;AKT1;PRKG2
prerank,GO_Biological_Process_2021__negative regulation of sequestering of triglyceride (GO:0010891),0.7964192537264437,1.2825618268372245,0.2,0.6298662047719262,1.0,2/5,14.87%,ABHD5;OSBPL8
prerank,GO_Biological_Process_2021__transforming growth factor beta receptor signaling pathway (GO:0007179),0.4476746487596451,1.2825514574449273,0.16666666666666666,0.6291244543103667,1.0,21/69,15.78%,PTPRK;PARD3;SMAD2;CBL;SMAD7;NLK;SMAD5;MAP3K7;TGFBRAP1;GDF10;SMURF1;TGFBR2;PTK2;ACVR1;SIRT1;TGFBR1;BMPR1A;SMAD4;DUSP22;USP9X;PXN
prerank,GO_Biological_Process_2021__positive regulation of autophagosome maturation (GO:1901098),0.736833324519443,1.2824985599048626,0.21739130434782608,0.6284680579628601,1.0,3/6,13.50%,SMCR8;ADRB2;FYCO1
prerank,GO_Biological_Process_2021__regulation of non-canonical Wnt signaling pathway (GO:2000050),-0.7148541331866307,-1.2824005723776497,0.21311475409836064,1.0,1.0,5/12,11.83%,SFRP4;RSPO3;GPC3;RNF213;SFRP1
prerank,GO_Biological_Process_2021__negative regulation of wound healing (GO:0061045),0.5884670656573228,1.282010988353752,0.125,0.6291887009107073,1.0,8/15,22.98%,SERPINE1;AJAP1;SLC12A2;CLASP1;PTEN;SERPINE2;CRK;FGF2
prerank,PanglaoDB_Augmented_2021__Megakaryocytes,-0.5359533942114292,-1.281804143411763,0.14754098360655737,1.0,1.0,17/53,13.63%,GATA1;TAGAP;SELP;SPON2;CD9;CLEC12A;F13A1;PDE6B;DPEP2;ARHGAP9;GMFG;TSPAN32;VWF;SLC11A1;PLK3;SPI1;MYO1F
prerank,GO_Biological_Process_2021__positive regulation of signaling receptor activity (GO:2000273),0.5507922939528849,1.2816326975029781,0.125,0.6297201987364068,1.0,8/23,17.47%,ADRB2;HDAC2;NCOA3;FBXW7;NLGN3;SHANK3;NRP1;HIF1A
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle cell differentiation (GO:0051151),0.7637648081739736,1.2814547034516945,0.17647058823529413,0.6296059818728013,1.0,4/6,23.42%,RBPMS2;NFATC3;NFATC2;NFATC1
prerank,GO_Biological_Process_2021__cellular response to BMP stimulus (GO:0071773),0.4912980277771374,1.2811186239325232,0.0,0.6299695247167719,1.0,15/49,16.20%,AMH;BMP2;SOX9;SMAD2;SMAD7;SMAD5;BMPR1B;RGMA;SMURF1;ACVR1;ACVR2A;BMPR1A;SMAD4;USP9X;BMP7
prerank,GO_Biological_Process_2021__maturation of SSU-rRNA (GO:0030490),-0.5676779971495471,-1.2810418133525447,0.16,1.0,1.0,4/34,7.88%,RPS14;RPS8;RPS16;RPS28
prerank,GO_Biological_Process_2021__protein acetylation (GO:0006473),0.5878233560778814,1.2805396605239996,0.15789473684210525,0.6311407426280842,1.0,8/24,21.61%,KAT2B;FOXO1;CLOCK;EP300;SIRT1;NAA50;CREBBP;NAA16
prerank,GO_Biological_Process_2021__growth hormone receptor signaling pathway (GO:0060396),0.646482667837677,1.2805074627902544,0.2,0.6305074863070218,1.0,3/13,15.78%,PIK3R1;PTK2;PXN
prerank,GO_Biological_Process_2021__negative regulation of Rho protein signal transduction (GO:0035024),0.6645913206683487,1.2804299548507052,0.225,0.6301033201945584,1.0,5/16,11.13%,KCTD13;KANK1;ARHGAP35;ABL2;KCTD10
prerank,GO_Biological_Process_2021__positive regulation of insulin-like growth factor receptor signaling pathway (GO:0043568),0.7818255975597905,1.280049564164647,0.16326530612244897,0.6302991613230159,1.0,3/5,17.75%,MYORG;PHIP;IGF1
prerank,GO_Biological_Process_2021__cellular response to misfolded protein (GO:0071218),0.619200288830072,1.279926509168664,0.1388888888888889,0.6299787919087911,1.0,10/19,29.73%,KLHL15;UGGT1;VCP;CUL3;DERL1;RNF185;BAG6;DNAJB14;AUP1;UGGT2
prerank,"GO_Biological_Process_2021__regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",0.7787440723641155,1.27980917243583,0.19047619047619047,0.6296180241023515,1.0,6/8,19.32%,TNFSF4;SH3RF1;HMGB1;CBFB;RUNX1;HLA-DRA
prerank,GO_Biological_Process_2021__heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),0.5288417662990414,1.2796917752240908,0.1388888888888889,0.6292581638878776,1.0,8/29,9.35%,TENM3;HMCN1;FAT4;ALCAM;CRB1;NECTIN3;TENM2;CADM1
prerank,GO_Biological_Process_2021__mitochondrial ribosome assembly (GO:0061668),0.8028973140518558,1.279559535641257,0.1702127659574468,0.628755351415318,1.0,2/5,17.82%,MRPS2;MTERF3
prerank,GO_Biological_Process_2021__cellular response to exogenous dsRNA (GO:0071360),-0.7117055603916436,-1.2794327054747117,0.15873015873015872,1.0,1.0,2/11,5.97%,IFIT1;PQBP1
prerank,GO_Biological_Process_2021__negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),-0.5939662526638454,-1.279040585783299,0.15517241379310345,1.0,1.0,6/23,17.40%,ARG2;SELENOS;GSTP1;CX3CL1;CD274;PTPN22
prerank,GO_Biological_Process_2021__regulation of transmembrane transport (GO:0034762),0.5942341976529437,1.2783887285092785,0.19444444444444445,0.6320304252058547,1.0,3/24,5.40%,ACE2;SNCA;NEDD4L
prerank,PanglaoDB_Augmented_2021__Acinar Cells,0.6243659023723342,1.278310965960142,0.1794871794871795,0.6314844000783828,1.0,2/19,0.08%,CPA1;ACE2
prerank,GO_Biological_Process_2021__regulation of histone deacetylase activity (GO:1901725),0.7562862354190236,1.278209154965301,0.18181818181818182,0.6311649530392894,1.0,3/7,11.24%,KDM5A;PRKD1;CAMK2D
prerank,GO_Biological_Process_2021__pre-replicative complex assembly (GO:0036388),-0.5341823854080073,-1.2774625964598487,0.109375,1.0,1.0,10/54,13.44%,PSMB6;RPS27A;PSMA8;PSMB9;PSMA7;PSMC3;UBC;PSME1;PSMC4;PSMA3
prerank,GO_Biological_Process_2021__regulation of lamellipodium assembly (GO:0010591),0.5508184667868202,1.2770006233032383,0.14634146341463414,0.6352835561850709,1.0,9/29,15.21%,EPHA2;PIK3CA;PIK3R1;AUTS2;SLIT2;OCLN;NCKAP1;FER;CYFIP1
prerank,GO_Biological_Process_2021__aromatic amino acid transport (GO:0015801),0.7874012729450373,1.2767727628312433,0.20454545454545456,0.6352256580131166,1.0,1/5,15.93%,SLC16A10
prerank,GO_Biological_Process_2021__positive regulation of filopodium assembly (GO:0051491),0.5405272642391504,1.2767161644596947,0.15384615384615385,0.6345559890963192,1.0,8/24,15.85%,ARAP1;RHOQ;GPM6A;TENM2;WASL;PIK3R1;TENM1;NRP1
prerank,GO_Biological_Process_2021__pore complex assembly (GO:0046931),0.5718673044414284,1.2766035302475784,0.16666666666666666,0.6342343081831766,1.0,9/18,29.97%,NUP153;AFDN;NDC1;TSPAN33;NUP205;NUP98;AHCTF1;ADAM10;GSDMD
prerank,GO_Biological_Process_2021__modification-dependent macromolecule catabolic process (GO:0043632),-0.7677070424437166,-1.27656219627021,0.14285714285714285,1.0,1.0,3/9,9.49%,RPS27A;ISG15;UBC
prerank,GO_Biological_Process_2021__regulation of endothelial cell chemotaxis (GO:2001026),-0.6748599060607516,-1.2763422312008132,0.19672131147540983,1.0,1.0,3/12,10.67%,SEMA5A;THBS1;FGF1
prerank,GO_Biological_Process_2021__natural killer cell differentiation (GO:0001779),0.7383675180983738,1.2763248540930734,0.2571428571428571,0.6345645132871752,1.0,5/8,21.25%,TOX;PBX1;KAT7;NFIL3;PTPRC
prerank,GO_Biological_Process_2021__nucleobase biosynthetic process (GO:0046112),0.7375712743254688,1.2761159662653607,0.06818181818181818,0.6345484383423425,1.0,1/7,7.91%,GMPS
prerank,GO_Biological_Process_2021__heart looping (GO:0001947),-0.5985620543773963,-1.276063124609735,0.12121212121212122,1.0,1.0,4/25,8.69%,CCDC39;APLNR;DNAAF1;SRF
prerank,GO_Biological_Process_2021__glomerular visceral epithelial cell migration (GO:0090521),0.7955249171644487,1.2759692481492835,0.10526315789473684,0.6342279641208791,1.0,3/5,10.09%,KANK1;TESK1;ANLN
prerank,GO_Biological_Process_2021__estrogen metabolic process (GO:0008210),-0.6880702302016858,-1.2759577559532618,0.11864406779661017,1.0,1.0,6/12,18.65%,HSD17B8;CYP2D6;HSD17B14;HSD17B7;CYP3A4;CYP3A5
prerank,GO_Biological_Process_2021__regulation of skeletal muscle contraction (GO:0014819),-0.7652938276920549,-1.2759493346534894,0.21153846153846154,1.0,1.0,3/6,13.27%,SLC8A3;CAV3;C12ORF57
prerank,"GO_Biological_Process_2021__regulation of wound healing, spreading of epidermal cells (GO:1903689)",0.6789548810263893,1.2757388567186392,0.19047619047619047,0.6343745124078244,1.0,6/8,30.75%,RREB1;CLASP1;FERMT1;PTEN;CLASP2;MTOR
prerank,GO_Biological_Process_2021__venous blood vessel development (GO:0060841),-0.8327077262248206,-1.2753618234880795,0.1702127659574468,1.0,1.0,2/6,5.31%,APLNR;CCBE1
prerank,GO_Biological_Process_2021__positive regulation of myelination (GO:0031643),0.7439618724729704,1.2752925941712372,0.17391304347826086,0.6352900348112585,1.0,2/7,4.89%,PARD3;MYRF
prerank,GO_Biological_Process_2021__early endosome to late endosome transport (GO:0045022),0.5620966740197665,1.2752882089741935,0.19444444444444445,0.6345249773283318,1.0,10/20,26.88%,PIK3C3;HOOK1;STX8;WDR91;SNX16;WDR81;PTPN23;KIF16B;RAB5A;HOOK3
prerank,GO_Biological_Process_2021__negative regulation of autophagy (GO:0010507),0.5212063075881863,1.2751752322438286,0.1111111111111111,0.634307093247014,1.0,14/49,16.14%,LEPR;SNCA;TAB3;QSOX1;SMCR8;AKT1;PIK3CA;ATG7;EIF4E;SMG1;SIRT2;EIF4G3;BCL2;HGF
prerank,GO_Biological_Process_2021__regulation of organ growth (GO:0046620),0.6570210006955803,1.2751746754659448,0.1836734693877551,0.6335249636622458,1.0,3/9,18.44%,DUSP6;LATS1;PTEN
prerank,GO_Biological_Process_2021__phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),-0.568149578397109,-1.2750783878779257,0.17567567567567569,1.0,1.0,10/43,11.33%,P2RY10;P2RY12;GPR18;HTR2B;CHRM2;TACR1;LPAR4;FPR3;LPAR6;P2RY6
prerank,GO_Biological_Process_2021__establishment of protein localization to organelle (GO:0072594),0.44882725165090226,1.275025077559273,0.10714285714285714,0.6332081179136997,1.0,13/64,19.59%,RANBP17;PPP1R10;NUP188;TSPAN17;AKT1;IPO8;SPRN;NUP153;NXT2;TNPO1;NUP214;TSPAN10;IPO5
prerank,GO_Biological_Process_2021__negative regulation of cell volume (GO:0045794),0.7935749019337652,1.2748392916626397,0.20454545454545456,0.6330530211694413,1.0,3/5,19.42%,KCNMA1;SHANK3;CLCN3
prerank,GO_Biological_Process_2021__embryonic cranial skeleton morphogenesis (GO:0048701),0.7478675726341415,1.2744268153574236,0.16666666666666666,0.6338026468994464,1.0,4/8,13.12%,PDGFRA;TGFBR2;NIPBL;TGFBR1
prerank,GO_Biological_Process_2021__regulation of protein transport (GO:0051223),0.5970942934205303,1.2743519977103204,0.14285714285714285,0.6333059803826747,1.0,9/24,26.48%,ARFIP1;STXBP5;DISP1;GAPVD1;NDFIP1;PPM1F;NDFIP2;SCFD1;LLGL1
prerank,PanglaoDB_Augmented_2021__Adrenergic Neurons,0.46116498342984263,1.274261207467763,0.125,0.6329308145028822,1.0,14/80,10.51%,CHRNA4;SEMA5B;EBF4;ABCC8;EFNA2;HID1;PNMT;PLEKHA6;KCNH2;TMEM74B;GAL3ST1;FBLL1;FTCD;CELF3
prerank,GO_Biological_Process_2021__genetic imprinting (GO:0071514),0.7278012592462173,1.273861063279307,0.2391304347826087,0.6336578145270771,1.0,2/6,23.86%,KDM1B;MECP2
prerank,GO_Biological_Process_2021__positive regulation of protein autophosphorylation (GO:0031954),0.613172579224988,1.2736313220207063,0.13636363636363635,0.6336231052814124,1.0,5/18,17.59%,PDGFA;PDGFC;RAP2C;TAOK2;RAP2A
prerank,GO_Biological_Process_2021__commissural neuron axon guidance (GO:0071679),0.7418060399299609,1.27360437754407,0.2682926829268293,0.6329892672015391,1.0,3/7,15.98%,NFIB;NRP1;SMO
prerank,GO_Biological_Process_2021__regulation of nitric-oxide synthase biosynthetic process (GO:0051769),-0.7671967634454578,-1.2734778310552637,0.21052631578947367,1.0,1.0,3/7,14.31%,SELENOS;GSTP1;CCL2
prerank,GO_Biological_Process_2021__negative regulation of protein K63-linked ubiquitination (GO:1900045),0.7580067255585915,1.273264321742423,0.16666666666666666,0.6331948510525817,1.0,3/7,12.76%,OTUB2;UBR5;TRIP12
prerank,GO_Biological_Process_2021__left/right pattern formation (GO:0060972),-0.8067959903871005,-1.2728762514084593,0.18867924528301888,1.0,1.0,1/6,5.19%,DNAAF1
prerank,GO_Biological_Process_2021__arachidonic acid secretion (GO:0050482),-0.7729667347786148,-1.2727863689083718,0.21875,1.0,1.0,1/5,4.63%,ANXA1
prerank,GO_Biological_Process_2021__arachidonate transport (GO:1903963),-0.7729667347786148,-1.2727863689083718,0.21875,1.0,1.0,1/5,4.63%,ANXA1
prerank,GO_Biological_Process_2021__cellular response to growth hormone stimulus (GO:0071378),0.7295688464576356,1.2721721263844983,0.23255813953488372,0.6363887034795539,1.0,3/6,15.78%,PIK3R1;PTK2;PXN
prerank,GO_Biological_Process_2021__positive regulation of protein localization to synapse (GO:1902474),0.7606611733957113,1.2720758824586698,0.18181818181818182,0.6360125257654328,1.0,2/5,11.43%,WNT7A;DVL1
prerank,GO_Biological_Process_2021__pericardium development (GO:0060039),0.7298534331517254,1.271845062867826,0.14583333333333334,0.6359552895499824,1.0,2/6,16.20%,BMP2;BMP7
prerank,GO_Biological_Process_2021__regulation of viral entry into host cell (GO:0046596),-0.6267291572042677,-1.271725812547119,0.08771929824561403,1.0,1.0,7/24,17.47%,IFITM3;TRIM22;TRIM21;CIITA;LY6E;CD74;TRIM5
prerank,GO_Biological_Process_2021__dendritic cell differentiation (GO:0097028),0.6765552629859701,1.2715243804441183,0.2702702702702703,0.6362753913973708,1.0,5/8,31.86%,TGFBR2;CAMK4;TRPM2;GAS6;AXL
prerank,GO_Biological_Process_2021__establishment of endothelial intestinal barrier (GO:0090557),0.6873764747687492,1.2713739056791815,0.1590909090909091,0.636019690085633,1.0,6/10,16.38%,RAP2B;RAPGEF2;AFDN;RAP2C;TJP1;RAB1A
prerank,GO_Biological_Process_2021__regulation of cation channel activity (GO:2001257),0.44175957543646854,1.271281847573184,0.08,0.6356061717686102,1.0,27/73,23.49%,SHISA7;CACNG2;CACNB4;ANK2;SHANK1;GRIN1;CAMK2B;DLG3;CACNG3;HOMER1;CAMK2A;CAMK2D;DLG1;JPH1;PDE4D;CACNB3;SHISA9;FGF14;CTSS;GRIA2;SLMAP;CACNG8;NLGN1;CACNG4;STAC;GRIN2B;NETO1
prerank,GO_Biological_Process_2021__beta-catenin destruction complex disassembly (GO:1904886),0.5898560013574168,1.2712428013496346,0.16216216216216217,0.6349958477991061,1.0,6/17,23.61%,FZD5;FRAT2;DVL1;GSK3B;AXIN1;CTNNB1
prerank,GO_Biological_Process_2021__osteoblast development (GO:0002076),0.7419512237809139,1.2709391762069684,0.25,0.6352167786063296,1.0,2/6,9.49%,LIMD1;MEN1
prerank,GO_Biological_Process_2021__protein palmitoylation (GO:0018345),0.4647940132653672,1.2707746615221953,0.05263157894736842,0.6350425194448117,1.0,12/29,25.09%,ZDHHC18;ZDHHC11;ZDHHC21;CLIP3;GOLGA7;ZDHHC5;ZDHHC16;ZDHHC2;ZDHHC13;ZDHHC14;PORCN;ZDHHC17
prerank,GO_Biological_Process_2021__zinc ion homeostasis (GO:0055069),-0.6104383851161297,-1.2707217959263273,0.19672131147540983,1.0,1.0,11/23,18.34%,MT1H;MT1G;TMC8;MT2A;SLC39A7;MT3;MT1E;MT1F;MT1A;SLC39A6;MT1M
prerank,GO_Biological_Process_2021__angiotensin-activated signaling pathway (GO:0038166),0.7657528111816034,1.2706697632485717,0.1111111111111111,0.6345533350066016,1.0,2/5,8.03%,CA2;CAMK2A
prerank,GO_Biological_Process_2021__retinal ganglion cell axon guidance (GO:0031290),0.7126104512730553,1.269771587330651,0.23255813953488372,0.6367425363706615,1.0,3/6,15.85%,ALCAM;SLIT2;NRP1
prerank,GO_Biological_Process_2021__intestinal lipid absorption (GO:0098856),-0.7458755281301257,-1.2695211038071312,0.25,1.0,1.0,1/7,1.27%,AKR1C1
prerank,PanglaoDB_Augmented_2021__Noradrenergic Neurons,-0.6262681809815158,-1.2695066766937915,0.16666666666666666,1.0,1.0,9/23,18.96%,GC;SLC18A2;ALDOB;ADH6;SEMA4G;C3P1;CDHR2;F10;F11
prerank,GO_Biological_Process_2021__positive regulation of osteoblast differentiation (GO:0045669),0.5135901133326801,1.2688486740384048,0.10344827586206896,0.6394376793290547,1.0,12/35,17.75%,NPNT;BMP2;ZHX3;BMPR1B;PRKD1;ACVR1;ACVR2A;BMPR1A;YAP1;HGF;BMP7;IGF1
prerank,GO_Biological_Process_2021__inositol metabolic process (GO:0006020),0.7107459962821177,1.2688279335029589,0.19148936170212766,0.6387682375238793,1.0,4/7,23.73%,ISYNA1;ITPK1;IPPK;IMPA2
prerank,GO_Biological_Process_2021__regulation of multicellular organismal development (GO:2000026),-0.660172669764114,-1.2687953752197265,0.14285714285714285,1.0,1.0,1/19,0.14%,CD24
prerank,GO_Biological_Process_2021__vascular associated smooth muscle cell development (GO:0097084),-0.8007402367630576,-1.2686729955480716,0.17647058823529413,1.0,1.0,3/6,18.33%,HES1;HEY2;ENG
prerank,GO_Biological_Process_2021__regulation of DNA topoisomerase (ATP-hydrolyzing) activity (GO:2000371),0.8026903326526241,1.2682894263909559,0.07317073170731707,0.6394716340185415,1.0,2/5,13.28%,HNRNPU;DHX9
prerank,GO_Biological_Process_2021__positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity (GO:2000373),0.8026903326526241,1.2682894263909559,0.07317073170731707,0.6394716340185415,1.0,2/5,13.28%,HNRNPU;DHX9
prerank,GO_Biological_Process_2021__regulation of hippo signaling (GO:0035330),0.6296768216492848,1.2678410621583538,0.14583333333333334,0.6399786111585122,1.0,6/16,14.59%,LIMD1;WTIP;IQCJ-SCHIP1;MOB3B;DLG5;VGLL4
prerank,GO_Biological_Process_2021__regulation of T cell apoptotic process (GO:0070232),-0.7940064311829301,-1.2678173709284042,0.11538461538461539,1.0,1.0,3/6,19.02%,PRKCQ;CD274;PRELID1
prerank,GO_Biological_Process_2021__bundle of His cell to Purkinje myocyte communication (GO:0086069),-0.705631747884447,-1.267643361473647,0.30612244897959184,1.0,1.0,5/5,29.46%,CTNNA3;PKP2;TBX5;JUP;DSC2
prerank,GO_Biological_Process_2021__inositol phosphate catabolic process (GO:0071545),0.6544785507680683,1.267633399274857,0.17647058823529413,0.64001531505924,1.0,7/12,27.82%,INPP5A;SYNJ1;PTEN;OCRL;IMPA2;SYNJ2;NUDT3
prerank,GO_Biological_Process_2021__piecemeal microautophagy of the nucleus (GO:0034727),0.7429337393330151,1.267604317325309,0.2,0.6386651316861697,1.0,3/7,22.32%,ATG7;ATG2B;RB1CC1
prerank,GO_Biological_Process_2021__lysosomal microautophagy (GO:0016237),0.7429337393330151,1.267604317325309,0.2,0.6386651316861697,1.0,3/7,22.32%,ATG7;ATG2B;RB1CC1
prerank,GO_Biological_Process_2021__negative regulation of double-strand break repair (GO:2000780),0.5288583336417608,1.267500043641276,0.1388888888888889,0.6383332537731137,1.0,6/29,15.92%,OTUB2;CYREN;UBR5;KLHL15;TRIP12;UBQLN4
prerank,GO_Biological_Process_2021__mitochondrial ATP synthesis coupled electron transport (GO:0042775),-0.533862099441227,-1.2674734235734684,0.0945945945945946,1.0,1.0,15/53,16.26%,NDUFS5;COX7C;COX4I1;NDUFA6;NDUFA2;NDUFC1;NDUFB10;UQCRQ;UQCRFS1;UQCR10;COX5B;NDUFB3;NDUFA1;NDUFB9;NDUFA12
prerank,GO_Biological_Process_2021__regulation of endoplasmic reticulum tubular network organization (GO:1903371),0.8196579993794479,1.2674211855508275,0.09803921568627451,0.6378076522507714,1.0,2/5,12.74%,TMEM33;RAB3GAP1
prerank,GO_Biological_Process_2021__T cell apoptotic process (GO:0070231),0.777663951087916,1.2672343802626171,0.18604651162790697,0.637535865583122,1.0,3/5,18.23%,AKT1;GLI3;FAS
prerank,GO_Biological_Process_2021__error-prone translesion synthesis (GO:0042276),-0.6204353291904955,-1.267188946265013,0.2833333333333333,1.0,1.0,3/21,9.49%,RPS27A;RPA3;UBC
prerank,GO_Biological_Process_2021__pre-miRNA processing (GO:0031054),0.6210929084805212,1.2671732789624186,0.18421052631578946,0.6370706723461955,1.0,7/13,31.12%,DROSHA;PRKRA;AGO3;LIN28B;DICER1;AGO1;AGO2
prerank,GO_Biological_Process_2021__C-terminal protein lipidation (GO:0006501),0.7759537663241265,1.267161483610043,0.1702127659574468,0.6363739957123384,1.0,2/5,18.61%,ATG7;ATG5
prerank,GO_Biological_Process_2021__protein-containing complex assembly (GO:0065003),0.4039283254211707,1.2666189399155918,0.0,0.637711684902441,1.0,58/231,19.94%,TCAP;BET1;PPARGC1A;MITF;PARD3;SHANK1;PICALM;SOX9;MCU;CXCL12;PDE4DIP;BOK;TLE2;TRAPPC6B;PYGO2;CD247;SEC22B;WASL;PEX14;PPP6R3;MEN1;TRADD;EP300;COL7A1;SAMM50;AFDN;OCLN;TRAPPC10;DHX9;OPA1;TSPAN33;PEF1;MDM4;SEC24B;CUL1;BCL9;PYGO1;SH3PXD2B;GSK3B;NSF;YAP1;TFG;RAB1A;WASF3;TRAPPC9;WASF1;CUL3;ASH2L;SEC23IP;SEC23A;FAS;MDM2;AXIN1;CNIH1;CD59;SLC7A9;LIN7A;LEF1
prerank,GO_Biological_Process_2021__neuron fate specification (GO:0048665),-0.7516097121489765,-1.2665081194495909,0.32608695652173914,1.0,1.0,1/5,0.33%,POU4F1
prerank,GO_Biological_Process_2021__DNA integrity checkpoint signaling (GO:0031570),0.5568882557156333,1.266432044450275,0.1,0.6375379783407454,1.0,4/31,10.51%,DNA2;INTS7;CLOCK;MAP3K20
prerank,GO_Biological_Process_2021__negative regulation of cell migration (GO:0030336),0.4097022188816996,1.2663809912336514,0.058823529411764705,0.6369397850357255,1.0,37/107,19.96%,PTPRK;MACIR;MITF;SERPINE1;ZMYND8;RAP2B;MARVELD3;EPHA4;DACH1;KANK1;FOXO3;LIMCH1;DUSP10;SMAD7;ROBO1;PTPRJ;ADARB1;NF1;NAV3;SLIT2;AFDN;DLG5;MAGI2;RAP2C;CLASP1;BMPR1A;ADIPOR1;DUSP22;PTPRG;ARID2;SRGAP2B;RNF41;RAP2A;PTEN;DRD2;PTPN23;MCC
prerank,GO_Biological_Process_2021__negative regulation of nitrogen compound metabolic process (GO:0051172),-0.7646541451882074,-1.2661757475208346,0.20754716981132076,1.0,1.0,1/7,1.59%,ACMSD
prerank,GO_Biological_Process_2021__peptidyl-threonine dephosphorylation (GO:0035970),0.6289228039872519,1.2660665015029595,0.10344827586206896,0.6373268293178679,1.0,8/16,19.92%,PDP1;PPM1E;DUSP10;PPM1A;DUSP6;PPM1D;PPM1F;DUSP18
prerank,GO_Biological_Process_2021__positive regulation of cellular carbohydrate metabolic process (GO:0010676),0.7154055833565147,1.2660162736783966,0.17073170731707318,0.6367688298854982,1.0,5/9,16.90%,SNCA;AKT1;IRS1;PRKCE;AKT2
prerank,GO_Biological_Process_2021__positive regulation of synapse maturation (GO:0090129),0.7315446844960156,1.2657733989727953,0.13636363636363635,0.6369242206301143,1.0,2/8,7.38%,CAMK2B;NRXN1
prerank,GO_Biological_Process_2021__somatic recombination of immunoglobulin gene segments (GO:0016447),0.7732256884071934,1.2656897164248568,0.13559322033898305,0.6364641192743258,1.0,3/7,18.51%,LIG4;MSH2;XRCC4
prerank,GO_Biological_Process_2021__nuclear pore organization (GO:0006999),0.6723871366437977,1.2656483579894355,0.15384615384615385,0.6358898970452626,1.0,6/13,24.70%,NUP153;NDC1;NUP205;NUP54;NUP98;AHCTF1
prerank,GO_Biological_Process_2021__cytoskeleton-dependent intracellular transport (GO:0030705),0.5970690295653623,1.2648550238160625,0.07692307692307693,0.6376375162117607,1.0,5/21,12.56%,CCDC88C;KIF5A;KIF5C;HOOK1;KIF1B
prerank,GO_Biological_Process_2021__insulin-like growth factor receptor signaling pathway (GO:0048009),0.6827948442426938,1.2646755224797055,0.26666666666666666,0.6373889029717161,1.0,4/11,8.66%,AKT1;PIK3R1;IRS1;PLCB1
prerank,GO_Biological_Process_2021__DNA catabolic process (GO:0006308),0.6593453523297134,1.264440870396447,0.19047619047619047,0.6376191909066073,1.0,2/9,6.36%,DNASE1L2;DFFB
prerank,GO_Biological_Process_2021__negative regulation of macrophage derived foam cell differentiation (GO:0010745),0.6885544309636525,1.263982998559456,0.2,0.6383458120580217,1.0,1/9,2.78%,ABCA1
prerank,GO_Biological_Process_2021__carbohydrate transport (GO:0008643),-0.7654082806780427,-1.2638911655773526,0.16923076923076924,1.0,1.0,2/6,13.39%,AQP1;AQP11
prerank,GO_Biological_Process_2021__regulation of DNA recombination (GO:0000018),-0.6022175583644651,-1.2637214357958357,0.1774193548387097,1.0,1.0,5/30,15.68%,H1-4;H1-2;BLM;USP51;RAD51AP1
prerank,GO_Biological_Process_2021__plasma membrane raft assembly (GO:0044854),-0.8211557714217341,-1.2635748148581956,0.15,1.0,1.0,4/5,17.83%,CAV2;CAV3;EMP2;FLOT1
prerank,GO_Biological_Process_2021__chondroitin sulfate metabolic process (GO:0030204),0.5400955628759317,1.2633934088090333,0.058823529411764705,0.6391852662834603,1.0,10/27,18.62%,CHST11;DCN;CSPG5;CSGALNACT1;UGDH;CHPF2;HEXB;VCAN;NDNF;CHST3
prerank,GO_Biological_Process_2021__fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate (GO:0061624),-0.7970410729701153,-1.2633852420612581,0.16666666666666666,1.0,1.0,2/5,7.29%,ALDOB;GLYCTK
prerank,GO_Biological_Process_2021__fructose catabolic process (GO:0006001),-0.7970410729701153,-1.2633852420612581,0.16666666666666666,1.0,1.0,2/5,7.29%,ALDOB;GLYCTK
prerank,GO_Biological_Process_2021__regulation of chromosome separation (GO:1905818),0.7958341314330815,1.263374453167874,0.18421052631578946,0.6384974927719071,1.0,2/5,17.92%,CSNK2A1;CSNK2A2
prerank,GO_Biological_Process_2021__tRNA aminoacylation for mitochondrial protein translation (GO:0070127),-0.8182782426591525,-1.2633672228309654,0.06896551724137931,1.0,1.0,1/7,5.71%,GARS1
prerank,GO_Biological_Process_2021__regulation of epidermal growth factor-activated receptor activity (GO:0007176),0.6613711691387169,1.263284677943364,0.28205128205128205,0.6380779322786932,1.0,8/16,25.02%,NCK2;CBL;FBXW7;CBLB;CHMP6;TSG101;SOCS4;ERRFI1
prerank,GO_Biological_Process_2021__positive regulation of gluconeogenesis (GO:0045722),0.7637264239337557,1.2626395301716826,0.1346153846153846,0.6396566100284615,1.0,3/6,16.81%,PPARGC1A;SIRT1;ARPP19
prerank,GO_Biological_Process_2021__regulation of dopamine uptake involved in synaptic transmission (GO:0051584),0.8053537641982405,1.2624853594685972,0.2,0.6393886735221451,1.0,1/5,2.09%,SNCA
prerank,GO_Biological_Process_2021__mammary gland epithelium development (GO:0061180),0.6255293089362045,1.2624158475260814,0.18421052631578946,0.6389505619495877,1.0,8/12,17.57%,ERBB4;CSF1R;EPHA2;AKT1;SCRIB;LATS1;AKT2;ZNF703
prerank,GO_Biological_Process_2021__lymphocyte differentiation (GO:0030098),0.5107941172902556,1.2621910135912393,0.16666666666666666,0.63894944045697,1.0,11/44,16.03%,LEPR;HDAC9;SOX4;TOX;CHD7;PBX1;PTPRJ;HDAC4;DCAF1;KAT7;MSH2
prerank,GO_Biological_Process_2021__regulation of striated muscle cell differentiation (GO:0051153),0.7609901039481117,1.262112147119065,0.13953488372093023,0.6384371174627874,1.0,2/6,5.01%,HDAC9;RBM24
prerank,MSigDB_Hallmark_2020__PI3K/AKT/mTOR  Signaling,0.4844440420514317,1.2617151042655455,0.12,0.6391552328142954,1.0,28/93,22.18%,MAPK10;EGFR;FGF17;SMAD2;RPS6KA3;AKT1;PPP2R1B;UBE2N;PLCB1;MAP3K7;EIF4E;RALB;PIKFYVE;NCK1;RPTOR;MAPK1;GSK3B;PTPN11;MAPK8;PAK4;PTEN;CAB39;ARHGDIA;MAPK9;UBE2D3;PRKCB;MYD88;CAMK4
prerank,GO_Biological_Process_2021__regulation of mitotic nuclear division (GO:0007088),-0.5663124102620725,-1.261626265157779,0.1095890410958904,1.0,1.0,10/37,18.52%,FBXO43;KIF20B;ANAPC15;CAV2;DUSP1;BORA;OBSL1;AURKAIP1;TOM1L1;CCNB1
prerank,GO_Biological_Process_2021__positive regulation of p38MAPK cascade (GO:1900745),0.6225718141472572,1.2612403889185897,0.2,0.6401928156004436,1.0,3/17,3.27%,SASH1;BMP2;PRMT1
prerank,GO_Biological_Process_2021__protein localization to condensed chromosome (GO:1903083),-0.7062004445220518,-1.2612142474909136,0.20754716981132076,1.0,1.0,4/9,8.70%,ZWILCH;SPDL1;MTBP;MIS12
prerank,GO_Biological_Process_2021__venous blood vessel morphogenesis (GO:0048845),-0.7792243701902375,-1.2612118129283367,0.14814814814814814,1.0,1.0,2/6,18.33%,CCBE1;ENG
prerank,GO_Biological_Process_2021__high-density lipoprotein particle remodeling (GO:0034375),-0.7433848872703052,-1.261177293457819,0.23214285714285715,1.0,1.0,3/8,15.65%,APOM;APOE;ABCA5
prerank,GO_Biological_Process_2021__nucleotide-sugar metabolic process (GO:0009225),0.6592248345192415,1.2610124563064231,0.2727272727272727,0.64020913443475,1.0,3/10,11.23%,CSGALNACT1;UGP2;FUT8
prerank,GO_Biological_Process_2021__lung development (GO:0030324),-0.5970079813979119,-1.2607881769412506,0.15873015873015872,1.0,1.0,5/23,10.67%,CCDC39;DNAAF1;FGF7;PDPN;FGF1
prerank,GO_Biological_Process_2021__error-free translesion synthesis (GO:0070987),-0.6434705786518247,-1.2604023238565376,0.15789473684210525,1.0,1.0,3/22,9.49%,RPS27A;RPA3;UBC
prerank,PanglaoDB_Augmented_2021__Podocytes,0.4146814712617309,1.2603171015320376,0.07142857142857142,0.6418838842612319,1.0,49/163,18.62%,CLIC5;STARD13;MPDZ;RASSF8;FAT4;EGFR;LOXL2;DACH1;ADCY1;PARVA;ILDR2;NFIB;KANK1;CADPS2;LIMCH1;QKI;THSD7A;ARHGAP24;EHD4;EFNB1;LGR4;MID1;RASAL2;PRICKLE2;RBFOX2;HSPA12A;PLOD2;PLPP3;MERTK;NCKAP1;WSB2;APBB2;MAGI2;ENAH;CDC42BPA;TJP1;ADGRL2;NEBL;PTPRG;YAP1;DDAH1;PARD3B;PTPRO;TRIB2;CDH13;GOLIM4;BCAR1;LIFR;CHST3
prerank,GO_Biological_Process_2021__negative regulation of translational initiation (GO:0045947),0.6273783712160854,1.2601128565082065,0.1702127659574468,0.6417476231699706,1.0,5/13,21.70%,C8ORF88;EIF4EBP2;EIF2AK4;EIF3E;FMR1
prerank,"GO_Biological_Process_2021__DNA-templated transcription, termination (GO:0006353)",0.4240128465436408,1.2600746643726595,0.09375,0.6411227996798231,1.0,5/66,2.47%,NUDT21;SNRPF;WDR33;PAPOLA;CSTF3
prerank,GO_Biological_Process_2021__regulation of cAMP-mediated signaling (GO:0043949),0.5716176115107079,1.2599574172028367,0.0967741935483871,0.6407811307405761,1.0,8/18,16.88%,PDE3A;PDE3B;PRKAR1B;PEX5L;RAPGEF2;GNAI1;CDC34;PDE4D
prerank,GO_Biological_Process_2021__peptidyl-lysine hydroxylation (GO:0017185),0.7419838917239303,1.2595238091560377,0.13953488372093023,0.641847229200582,1.0,4/7,21.11%,PLOD2;JMJD6;PLOD1;P3H4
prerank,GO_Biological_Process_2021__mitochondrion transport along microtubule (GO:0047497),0.6255949160351937,1.2593295557862831,0.15555555555555556,0.6416928961371583,1.0,3/12,17.47%,RHOT1;OPA1;HIF1A
prerank,GO_Biological_Process_2021__cell-substrate junction assembly (GO:0007044),0.5400021446268366,1.2593233828683332,0.17857142857142858,0.640958693738832,1.0,5/27,17.49%,PTPRK;RCC2;TAOK2;ARHGEF7;ITGA6
prerank,GO_Biological_Process_2021__negative regulation of microtubule polymerization (GO:0031115),0.725341830871115,1.2591995616883416,0.17857142857142858,0.6406748606568063,1.0,5/11,15.72%,SNCA;DYRK1A;CLIP3;MAPRE1;ARHGEF7
prerank,GO_Biological_Process_2021__negative regulation of cell adhesion mediated by integrin (GO:0033629),0.6832234386053653,1.2589721438517734,0.22916666666666666,0.6407838321635476,1.0,2/7,2.44%,SERPINE1;PDE3B
prerank,GO_Biological_Process_2021__cyclic nucleotide transport (GO:0070729),0.8227399310540732,1.2588668163069687,0.17647058823529413,0.640332970287482,1.0,2/5,8.28%,SLC19A1;ABCC5
prerank,GO_Biological_Process_2021__positive regulation of attachment of spindle microtubules to kinetochore (GO:0051987),0.7590219333450993,1.25885399641311,0.22,0.6396595564185563,1.0,3/5,13.72%,RCC2;HNRNPU;SIRT2
prerank,GO_Biological_Process_2021__ribonucleoprotein complex assembly (GO:0022618),-0.4938956832464038,-1.2586436662470089,0.09523809523809523,1.0,1.0,20/120,14.44%,EIF2S3B;RPS14;RPS27;RPL10;RPL38;RPL24;RPL11;RPL23A;RPS15;MRPL20;RPL3;RPL5;RPS28;EIF2S2;SNRPD2;RPL6;SNRNP200;RPF2;RPS19;DDX23
prerank,GO_Biological_Process_2021__pyrimidine ribonucleotide metabolic process (GO:0009218),0.7922663782610376,1.2586228254927332,0.21568627450980393,0.6396576487477963,1.0,2/5,12.96%,AK3;ENTPD4
prerank,GO_Biological_Process_2021__regulation of lipid kinase activity (GO:0043550),0.6959813737317184,1.2585642302348559,0.16279069767441862,0.6390608897354297,1.0,4/9,17.54%,PPP2R5A;PIK3R1;WDR91;WDR81
prerank,GO_Biological_Process_2021__ERBB2 signaling pathway (GO:0038128),0.5277720931149624,1.2585521177805954,0.13333333333333333,0.6383540766155525,1.0,8/27,15.78%,ERBB4;EGFR;PIK3CA;PIK3R1;SOS1;NRG2;GAB1;CPNE3
prerank,GO_Biological_Process_2021__regulation of platelet aggregation (GO:0090330),-0.6590974513903463,-1.2583954052082857,0.14035087719298245,1.0,1.0,7/16,17.43%,CD9;CEACAM1;PDPN;PRKCQ;CELA2A;ALOX12;C1QTNF1
prerank,GO_Biological_Process_2021__positive regulation of focal adhesion disassembly (GO:0120183),0.7348492153474195,1.2580938872932241,0.24489795918367346,0.6386311267189091,1.0,4/6,25.82%,PIK3R1;MAP4K4;ARF6;DUSP3
prerank,GO_Biological_Process_2021__regulation of focal adhesion disassembly (GO:0120182),0.7348492153474195,1.2580938872932241,0.24489795918367346,0.6386311267189091,1.0,4/6,25.82%,PIK3R1;MAP4K4;ARF6;DUSP3
prerank,GO_Biological_Process_2021__positive regulation of intracellular steroid hormone receptor signaling pathway (GO:0033145),0.7657428676738662,1.2580934919092397,0.2127659574468085,0.6379086933176433,1.0,2/5,15.63%,LMO3;YAP1
prerank,GO_Biological_Process_2021__cellular zinc ion homeostasis (GO:0006882),-0.6340886354108257,-1.2579816630676186,0.18333333333333332,1.0,1.0,10/21,18.34%,MT1H;MT1G;MT2A;SLC39A7;MT3;MT1E;MT1F;MT1A;SLC39A6;MT1M
prerank,GO_Biological_Process_2021__negative regulation of fibroblast migration (GO:0010764),0.7815780184330956,1.2578707754241985,0.2391304347826087,0.6381675559800538,1.0,1/5,1.78%,MACIR
prerank,MSigDB_Hallmark_2020__Adipogenesis,0.3773643915520854,1.2574290826779382,0.0,0.6391274417320489,1.0,40/178,20.48%,MTARC2;SLC19A1;SOWAHC;ABCA1;PPP1R15B;HADH;MGLL;RNF11;ADIPOR2;QDPR;GPHN;ELOVL6;LTC4S;CCNG2;DNAJC15;PEX14;MIGA2;ITSN1;MRAP;GPAM;SAMM50;SDHC;DRAM2;RREB1;MAP4K3;UBQLN1;ACADM;COL15A1;CRAT;GPD2;COQ3;YWHAG;PGM1;LIFR;AIFM1;DLAT;APLP2;PTCD3;COQ9;SQOR
prerank,GO_Biological_Process_2021__regulation of TOR signaling (GO:0032006),0.44912866746790636,1.2566700985700654,0.1388888888888889,0.6407675370444379,1.0,20/57,27.13%,SMCR8;RHEB;PIK3CA;TTI1;GOLPH3;SIRT1;MAPKAPK5;RPTOR;UBR1;TBCK;RRAGD;MIOS;GNA12;PRKAA1;GAS6;SH3BP4;DYRK3;UBR2;WDR24;RICTOR
prerank,GO_Biological_Process_2021__cyclic-nucleotide-mediated signaling (GO:0019935),0.5221917936544569,1.2565690332780353,0.13333333333333333,0.6403591220580154,1.0,9/30,6.98%,PDE3A;ADCY1;SOX9;HTR2C;PDE7B;PDE7A;GUCY1B1;EPHA5;RAPGEF2
prerank,GO_Biological_Process_2021__negative regulation of cysteine-type endopeptidase activity (GO:2000117),-0.5703786317434333,-1.2563172259508175,0.13846153846153847,1.0,1.0,7/38,10.93%,IFI6;DHCR24;AQP1;THBS1;BEX3;MT3;KLF4
prerank,GO_Biological_Process_2021__positive regulation of neuron apoptotic process (GO:0043525),0.5992238393213136,1.2560726314961796,0.16216216216216217,0.641386907586344,1.0,4/18,10.97%,EPHA7;FOXO3;NF1;FBXW7
prerank,GO_Biological_Process_2021__positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),0.4604795002505681,1.2559335916201328,0.125,0.6411625181849405,1.0,19/71,16.58%,EPS8;ARAP1;RHOQ;ARHGAP35;GPM6A;KCTD17;PIK3CA;TENM2;WASL;PIK3R1;AUTS2;ANLN;OCLN;TAPT1;NCKAP1;TENM1;CYFIP1;NRP1;CEP120
prerank,GO_Biological_Process_2021__icosanoid secretion (GO:0032309),-0.7662479494246053,-1.2557026746300566,0.19672131147540983,1.0,1.0,1/6,4.63%,ANXA1
prerank,GO_Biological_Process_2021__phosphatidylinositol phosphate biosynthetic process (GO:0046854),0.52755058040634,1.2556147967413211,0.13513513513513514,0.6415995832159191,1.0,11/32,14.08%,SOCS6;ITPKB;PIK3CA;EFR3A;PIK3R1;SOCS7;PIK3C3;SMG1;TTC7B;PIP4K2C;IP6K2
prerank,GO_Biological_Process_2021__regulation of gene expression by genetic imprinting (GO:0006349),0.7253499161335448,1.2555921111763684,0.21951219512195122,0.6409536578137649,1.0,2/7,23.86%,KDM1B;MECP2
prerank,PanglaoDB_Augmented_2021__B Cells Naive,-0.5349139330983194,-1.255313798260007,0.19718309859154928,1.0,1.0,15/57,12.02%,P2RY10;DOCK8;TAGAP;P2RY14;GPR18;DPEP2;ARHGAP9;GMFG;TRAF3IP3;TMC8;SP140;RHOH;STAG3;ARHGAP30;RCSD1
prerank,GO_Biological_Process_2021__negative regulation of cell cycle phase transition (GO:1901988),0.6752655605537067,1.2551017660430825,0.13513513513513514,0.6421410414409102,1.0,3/6,24.34%,RGCC;PTEN;MACROH2A1
prerank,GO_Biological_Process_2021__late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),0.6205548819293766,1.2550850610110191,0.1282051282051282,0.6414227628710658,1.0,6/13,35.51%,LEPROTL1;VTA1;CHMP6;STAM;CHMP5;CHMP7
prerank,GO_Biological_Process_2021__membrane depolarization during action potential (GO:0086010),0.5331985837240887,1.254670935577397,0.15789473684210525,0.642351081349561,1.0,3/21,6.86%,CACNA1G;CACNA1I;KCNH2
prerank,GO_Biological_Process_2021__positive regulation of granulocyte chemotaxis (GO:0071624),0.6349430399477776,1.2542437027899966,0.16279069767441862,0.6422501567222743,1.0,2/12,5.06%,MCU;DAPK2
prerank,GO_Biological_Process_2021__positive regulation of neutrophil chemotaxis (GO:0090023),0.6349430399477776,1.2542437027899966,0.16279069767441862,0.6422501567222743,1.0,2/12,5.06%,MCU;DAPK2
prerank,GO_Biological_Process_2021__sphingosine metabolic process (GO:0006670),0.5782215057793378,1.2542046365660409,0.1935483870967742,0.6416624724919211,1.0,5/18,13.55%,ACER3;PLPP1;PLPP3;PLPP2;ABCA2
prerank,GO_Biological_Process_2021__negative regulation of neuron projection regeneration (GO:0070571),0.7611442135424957,1.2539041875699757,0.2391304347826087,0.6418039502342097,1.0,2/7,9.87%,EPHA4;RTN4RL1
prerank,GO_Biological_Process_2021__detection of bacterium (GO:0016045),-0.7096381740179134,-1.2529862547363815,0.24561403508771928,1.0,1.0,4/9,17.69%,HLA-B;HLA-A;PGLYRP1;PGLYRP2
prerank,GO_Biological_Process_2021__secondary palate development (GO:0062009),0.7246657287220343,1.2528746950921348,0.14285714285714285,0.6444897739785199,1.0,5/11,14.34%,WNT7A;SMAD2;CHD7;TGFBR2;SMAD4
prerank,GO_Biological_Process_2021__positive regulation of protein modification process (GO:0031401),0.40044103605937836,1.2526699752411135,0.06666666666666667,0.6444643959637789,1.0,42/164,18.50%,VEGFD;LEPR;EFNA5;NPTN;BMP2;ERBB4;CSF1R;EGFR;SOX9;FGF17;ARRB1;TESK1;LIMCH1;TNIK;AKT1;NTRK2;DYRK1A;PPP2R5A;UBE2N;ATG7;VEGFC;RALB;CAMTA1;CRKL;PTK2;CLIP3;RAB3GAP1;SIRT1;ACVR2A;WDFY2;NIBAN1;ROCK2;HGF;SPPL3;SEMA4D;TFRC;AKT2;FXR1;RAP2A;PTBP1;FAS;AXIN1
prerank,GO_Biological_Process_2021__DNA geometric change (GO:0032392),-0.5809701686697812,-1.2526461500076662,0.1267605633802817,1.0,1.0,3/24,5.54%,PIF1;ANXA1;DDX11
prerank,PanglaoDB_Augmented_2021__Sebocytes,-0.543416155304415,-1.252639699900566,0.09722222222222222,1.0,1.0,11/39,17.70%,TNFAIP2;VAMP8;TRIM29;B3GNT3;KLF4;CEBPD;LTBR;IL18;RBM47;RDH12;CDH1
prerank,GO_Biological_Process_2021__regulation of mitotic spindle checkpoint (GO:1903504),-0.7604684908614079,-1.2521624306650063,0.13725490196078433,1.0,1.0,3/6,18.52%,ANAPC15;DUSP1;CCNB1
prerank,GO_Biological_Process_2021__regulation of mitotic sister chromatid segregation (GO:0033047),-0.7604684908614079,-1.2521624306650063,0.13725490196078433,1.0,1.0,3/6,18.52%,ANAPC15;DUSP1;CCNB1
prerank,GO_Biological_Process_2021__mesenchymal cell development (GO:0014031),0.6092707548015844,1.2521316839189927,0.17391304347826086,0.6458173983497288,1.0,6/12,23.51%,SOX8;CDH2;TAPT1;PEF1;NRG1;TCOF1
prerank,GO_Biological_Process_2021__positive regulation of long-term synaptic potentiation (GO:1900273),0.6658959721336982,1.2520332484687933,0.21428571428571427,0.6454826383887609,1.0,4/13,11.56%,SHISA7;ADCY1;EIF2AK4;SHANK3
prerank,"GO_Biological_Process_2021__protein localization to chromosome, centromeric region (GO:0071459)",-0.6873489006674617,-1.2518583753707426,0.11290322580645161,1.0,1.0,4/13,8.70%,ZWILCH;SPDL1;MTBP;MIS12
prerank,GO_Biological_Process_2021__negative regulation of DNA recombination (GO:0045910),-0.5696223773729887,-1.2517425000586928,0.15942028985507245,1.0,1.0,7/46,14.89%,H1-4;H1-2;BLM;POLQ;POLR2I;POLR2L;POLR2J
prerank,GO_Biological_Process_2021__cellular response to ionizing radiation (GO:0071479),0.48200407801741735,1.251722194070912,0.06060606060606061,0.6458000649768765,1.0,12/45,22.69%,LIG4;INTS7;EEF1D;CLOCK;MAP3K20;NIPBL;SIRT1;YAP1;KDM1A;MDM2;IFI16;TANK
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance via telomerase (GO:0032212),0.49700903377918143,1.2516821641483227,0.12121212121212122,0.645213003819847,1.0,11/29,25.39%,NAF1;CCT4;MAP3K4;MAPKAPK5;MAPK1;CCT3;POT1;HMBOX1;TNKS2;CTNNB1;TNKS
prerank,GO_Biological_Process_2021__regulation of short-term neuronal synaptic plasticity (GO:0048172),0.6654323811919907,1.2516402691153221,0.1702127659574468,0.6445550155080931,1.0,6/13,21.77%,SHISA7;RAB3GAP1;SLC4A10;SHISA9;GRIK2;SYNGR1
prerank,GO_Biological_Process_2021__modulation by symbiont of host defense response (GO:0052031),-0.7926865846512277,-1.2515867640538203,0.2037037037037037,1.0,1.0,3/7,9.49%,RPS27A;B2M;UBC
prerank,GO_Biological_Process_2021__response to host defenses (GO:0052200),-0.7926865846512277,-1.2515867640538203,0.2037037037037037,1.0,1.0,3/7,9.49%,RPS27A;B2M;UBC
prerank,GO_Biological_Process_2021__positive regulation of Rho protein signal transduction (GO:0035025),-0.6384130230446774,-1.2515097009846126,0.203125,1.0,1.0,4/19,10.61%,P2RY10;GPR18;LPAR4;LPAR6
prerank,GO_Biological_Process_2021__respiratory tube development (GO:0030323),-0.6139827391971622,-1.2514898400140235,0.14285714285714285,1.0,1.0,5/21,10.67%,CCDC39;DNAAF1;FGF7;PDPN;FGF1
prerank,GO_Biological_Process_2021__neuron development (GO:0048666),0.3991976201527778,1.2504816121481532,0.058823529411764705,0.6480286915887629,1.0,47/119,23.95%,BICDL1;TENM3;LRP12;VAPA;ETV1;PRMT1;ASCL1;ATXN10;GPM6A;NTRK2;UGDH;PBX1;EPHA5;RAPGEF2;UHMK1;TENM2;B4GALT6;TBC1D24;HMGB1;DOCK7;PBX2;PBX3;GPRIN1;GPM6B;B4GALT5;OPHN1;TENM1;GSK3B;HDGFL3;CNTN4;TBC1D23;NCDN;RUNX1;NPY;WNK1;SAMD14;CDK5R1;ROCK1;POU3F2;CNTNAP2;TDP2;NLGN1;THOC2;FRYL;RP1;MYT1L;TBCD
prerank,GO_Biological_Process_2021__regulation of glycoprotein biosynthetic process (GO:0010559),-0.7106132768276123,-1.2504178367942764,0.22033898305084745,1.0,1.0,2/8,10.41%,GATA1;MT3
prerank,GO_Biological_Process_2021__negative regulation of nuclear division (GO:0051784),-0.7137537936006374,-1.250362193277411,0.10714285714285714,1.0,1.0,3/9,17.09%,FBXO43;AURKAIP1;TOM1L1
prerank,GO_Biological_Process_2021__positive regulation of response to DNA damage stimulus (GO:2001022),0.47259725632790806,1.2502214262646554,0.11538461538461539,0.6481977877709961,1.0,16/46,21.70%,EGFR;SPRED2;EYA2;UBE2N;SPRED1;NPAS2;SIRT1;DHX9;EYA3;TRIM28;UIMC1;BRCC3;FXR1;H2AX;SPRED3;FMR1
prerank,GO_Biological_Process_2021__negative regulation of reactive oxygen species biosynthetic process (GO:1903427),-0.7252417411926664,-1.2500934334459735,0.1694915254237288,1.0,1.0,1/9,2.61%,SLC18A2
prerank,GO_Biological_Process_2021__negative regulation of alcohol biosynthetic process (GO:1902931),0.6719439388375177,1.2500808872089155,0.23636363636363636,0.6478626187565018,1.0,3/10,4.81%,BMP2;PLEK;NFKB1
prerank,GO_Biological_Process_2021__neutral lipid catabolic process (GO:0046461),0.7572534454120388,1.2499421896632865,0.2,0.6476360448241728,1.0,4/5,19.52%,MGLL;ABHD6;LYPLA2;ABHD2
prerank,"GO_Biological_Process_2021__regulation of CD8-positive, alpha-beta T cell proliferation (GO:2000564)",-0.733921243012978,-1.2497370503280405,0.2692307692307692,1.0,1.0,2/7,2.89%,IRF1;HLA-A
prerank,GO_Biological_Process_2021__negative regulation of reproductive process (GO:2000242),-0.7065214799078423,-1.248103659720124,0.25806451612903225,1.0,1.0,6/12,18.33%,TIMP1;SPINK13;NODAL;DUSP1;ZP3;WEE2
prerank,GO_Biological_Process_2021__presynaptic membrane organization (GO:0097090),0.6556673753634051,1.24791746519771,0.15,0.6537666313370906,1.0,9/11,28.72%,NLGN3;NLGN4X;PTEN;LRP4;NLGN1;CNTN2;NLGN2;IL1RAPL1;CEL
prerank,PanglaoDB_Augmented_2021__T Cytotoxic Cells,-0.6335529008338319,-1.2475522920897948,0.15873015873015872,1.0,1.0,6/17,7.73%,P2RY10;TAGAP;CD5;THEMIS;GPR171;TRAF3IP3
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle tissue growth (GO:0055023),0.6598099945265159,1.2470631961585257,0.20588235294117646,0.6562784394192301,1.0,7/15,23.54%,ZFPM2;ERBB4;BMPR1A;IGF1;RBPJ;FGF2;FGFR2
prerank,GO_Biological_Process_2021__sulfur amino acid catabolic process (GO:0000098),0.7132619156729106,1.2469017111796672,0.19047619047619047,0.6561508962512779,1.0,2/8,14.72%,ADO;BLMH
prerank,GO_Biological_Process_2021__internal peptidyl-lysine acetylation (GO:0018393),0.5221803415418701,1.2465649147486637,0.17142857142857143,0.6564531778462385,1.0,9/24,21.25%,KAT2B;KAT2A;EP300;KAT7;NAA50;KAT6B;ATAT1;PHF20L1;CREBBP
prerank,GO_Biological_Process_2021__regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),0.42372862459927757,1.2462913582944304,0.038461538461538464,0.6565938951315792,1.0,38/89,25.44%,XPO1;KEAP1;RNF217;RNF144A;SMAD7;CSNK1E;RNF14;DNAJB2;PSMD10;PRKN;COP1;DVL1;PIAS1;OGT;COMMD1;EIF3H;SIRT2;ARIH1;VCP;GSK3B;UBQLN4;ZYG11B;TRIB2;MDM2;RAD23B;FHIT;PLK1;WAC;BAG2;N4BP1;HECTD1;HSPA1A;TAF1;GNA12;CSNK1D;RCHY1;SUMO2;BAG6
prerank,GO_Biological_Process_2021__negative regulation of amyloid-beta clearance (GO:1900222),-0.7953303706657597,-1.246151060760462,0.20689655172413793,1.0,1.0,2/5,8.69%,LRPAP1;SRF
prerank,GO_Biological_Process_2021__regulation of memory T cell differentiation (GO:0043380),0.7717835420990474,1.2458567805772391,0.2549019607843137,0.6565533036783379,1.0,1/5,1.31%,TNFSF4
prerank,GO_Biological_Process_2021__positive regulation of memory T cell differentiation (GO:0043382),0.7717835420990474,1.2458567805772391,0.2549019607843137,0.6565533036783379,1.0,1/5,1.31%,TNFSF4
prerank,GO_Biological_Process_2021__response to sterol (GO:0036314),0.7419644976037272,1.2454032574217717,0.2631578947368421,0.6571567655513969,1.0,5/8,13.55%,RORA;SMAD2;TGFBR2;TGFBR1;ABCA2
prerank,GO_Biological_Process_2021__histone H3-K36 methylation (GO:0010452),0.6999558168587855,1.2453261672756106,0.23076923076923078,0.6567086928651102,1.0,3/5,20.76%,SETD3;SETD2;SETD5
prerank,GO_Biological_Process_2021__positive regulation of interferon-gamma production (GO:0032729),-0.5823662676619366,-1.2449141625620703,0.13924050632911392,1.0,1.0,12/30,14.75%,IL1R1;HLA-A;ISG15;RASGRP1;IL12A;BTN3A1;SLC11A1;TLR3;IL18;CD14;ZFPM1;ZP3
prerank,GO_Biological_Process_2021__cytoskeleton organization (GO:0007010),0.4487419658591878,1.2441213903987791,0.21052631578947367,0.6606179422121443,1.0,28/101,21.21%,FMNL3;LIMD1;MICAL1;WTIP;CSPG5;BRWD1;RHOBTB3;BIN1;TNIK;FMNL2;FGD4;ZMYM3;BRWD3;MAST2;ZRANB1;PHIP;MAST4;WASF3;PRPF40A;LRCH3;PCLO;STRIP1;LARP4;PAK4;PDZD8;NECTIN2;SIPA1L3;MARK1
prerank,GO_Biological_Process_2021__positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),-0.6569716517310089,-1.2440676728582023,0.22388059701492538,1.0,1.0,4/14,10.61%,P2RY10;GPR18;LPAR4;LPAR6
prerank,GO_Biological_Process_2021__cell part morphogenesis (GO:0032990),0.6557344436939392,1.244058905111064,0.2,0.6601315610638215,1.0,7/13,19.35%,PID1;CSPG5;MFF;MYH14;WASF1;MTM1;NUBPL
prerank,GO_Biological_Process_2021__N-terminal peptidyl-methionine acetylation (GO:0017196),0.7538247568567105,1.243935794678647,0.2,0.6598236593878768,1.0,3/5,21.61%,NAA25;NAA30;NAA16
prerank,GO_Biological_Process_2021__calcium ion transmembrane transport (GO:0070588),0.44003694212967853,1.2436982663504608,0.22727272727272727,0.659658210639712,1.0,9/72,6.66%,SLC24A3;CACNA1G;MAIP1;ATP2B3;MCU;GRIN1;CACNA2D1;ATP2C1;TRPM4
prerank,GO_Biological_Process_2021__glycosaminoglycan biosynthetic process (GO:0006024),0.45598985694348276,1.2434522658879594,0.06666666666666667,0.6597763846139215,1.0,19/78,14.19%,CHST11;B4GALT3;DCN;SDC4;CSPG5;HS3ST5;CSGALNACT1;GPC5;UGDH;B4GALT6;ABCC5;SLC10A7;EXT1;EXT2;CHPF2;ST3GAL1;B4GALT2;B4GALT5;HS2ST1
prerank,GO_Biological_Process_2021__protein localization to synapse (GO:0035418),0.6979641807907275,1.2431308815683317,0.2222222222222222,0.6600711520619554,1.0,6/10,25.94%,SHANK1;NRXN1;PCLO;NRXN2;NLGN1;NLGN2
prerank,GO_Biological_Process_2021__regulation of cellular macromolecule biosynthetic process (GO:2000112),0.3456276469594747,1.2431253281062735,0.0,0.659358332243314,1.0,107/375,21.53%,POU6F2;PPARGC1A;LIMD1;BACH1;USP13;YAF2;MITF;WTIP;SOX4;BMP2;RPS6KA4;ESRRG;PSPC1;VHL;RORA;HCLS1;FOXO3;NFXL1;CHD7;ZNF212;HMG20A;RFX3;RNF6;NFYC;NR1D2;PDGFA;NCOA2;GPBP1L1;SP3;SMARCA2;NLK;ZNF117;ZNF280D;ZNF516;RNF14;SOX6;MAGED1;CCNA2;ZNF33A;NR3C1;CLOCK;TGFBRAP1;ZNF268;EIF4E;SUPT3H;ZNF737;CREM;EP300;ZNF736;FOXN2;ANKRD17;HP1BP3;DVL1;AHR;ZNF423;ZNF519;TFEB;TGFBR1;APBB2;RREB1;MAPKAPK5;PRDM8;KAT7;ZNF680;FOXN3;MLXIPL;TRIP4;SOX13;CYFIP1;ZBTB38;ZNF282;ZFAT;CCAR1;DMTF1;SUFU;KAT6B;ZNF141;MYT1;ATF2;HIF1A;CXXC1;ZNF703;ORC5;UTP4;ATRX;RORB;SSBP2;SOX21;APBB1;DNM2;HNRNPD;ASCC1;SPIN3;NSD2;REST;ZNF646;PRDM2;ESRRB;SPTY2D1;NFIA;PPP2R1A;NFATC2;NFIL3;RBBP6;CREBBP;ARNT2;ZNF195
prerank,GO_Biological_Process_2021__positive regulation of leukocyte mediated cytotoxicity (GO:0001912),-0.6066017640466658,-1.2429113171063837,0.19718309859154928,1.0,1.0,7/23,13.30%,HLA-B;HLA-A;RASGRP1;IL12A;KLRD1;SPI1;CD160
prerank,GO_Biological_Process_2021__stress-activated protein kinase signaling cascade (GO:0031098),0.5086170054767679,1.242864833237789,0.125,0.6594764472708933,1.0,14/27,19.18%,CCDC88C;BTRC;NFKB1;MAP3K7;MAPK11;MAP3K20;MAP3K5;KAT7;MAPK1;TAOK2;CUL1;MAPK8;CCM2;FBXW11
prerank,GO_Biological_Process_2021__smooth muscle cell migration (GO:0014909),0.7300968058774587,1.2424555104004353,0.28888888888888886,0.6601583950203476,1.0,1/5,3.98%,PARVA
prerank,GO_Biological_Process_2021__vesicle fusion with endoplasmic reticulum-Golgi intermediate compartment (ERGIC) membrane (GO:1990668),0.7344021224722382,1.2422754793771207,0.2727272727272727,0.6601169157821092,1.0,1/5,7.05%,SEC22B
prerank,GO_Biological_Process_2021__regulation of protein import into nucleus (GO:0042306),0.492774129553348,1.2421671902829374,0.05405405405405406,0.6597237293782842,1.0,11/31,25.38%,HCLS1;RAB23;PIK3R1;UBR5;TRIM28;SUFU;IPO5;BAG3;ZPR1;SMAD3;CABP1
prerank,GO_Biological_Process_2021__regulation of hematopoietic progenitor cell differentiation (GO:1901532),-0.5033536500427692,-1.24207749904263,0.1791044776119403,1.0,1.0,11/62,13.44%,PSMB6;GATA1;PSMA8;PSMB9;PSMA7;PSMC3;PSME1;EIF2AK2;PSMC4;SPI1;PSMA3
prerank,GO_Biological_Process_2021__response to zinc ion (GO:0010043),-0.618904579780633,-1.2420127839485016,0.23809523809523808,1.0,1.0,9/22,20.26%,MT1H;MT1G;MT2A;MT3;MT1E;MT1F;MT1A;MT1M;GLRA1
prerank,GO_Biological_Process_2021__melanocyte differentiation (GO:0030318),0.7004571119738002,1.2419560714144104,0.20754716981132076,0.6597355189021181,1.0,3/8,5.42%,USP13;MITF;LRMDA
prerank,GO_Biological_Process_2021__regulation of histone phosphorylation (GO:0033127),0.697681295946566,1.2417820332205252,0.225,0.6595542103343133,1.0,5/8,28.54%,RPS6KA4;CDK9;FMR1;MACROH2A1;MAPK3
prerank,GO_Biological_Process_2021__regulation of DNA demethylation (GO:1901535),0.7751400908459207,1.2416871590273377,0.2727272727272727,0.6583345480449032,1.0,3/5,15.64%,TOX;OTUD4;USP9X
prerank,GO_Biological_Process_2021__positive regulation of DNA demethylation (GO:1901537),0.7751400908459207,1.2416871590273377,0.2727272727272727,0.6583345480449032,1.0,3/5,15.64%,TOX;OTUD4;USP9X
prerank,GO_Biological_Process_2021__positive regulation of synapse assembly (GO:0051965),0.5004219333257653,1.2416326105406181,0.1724137931034483,0.6579103790073981,1.0,7/26,16.25%,WNT7A;SLITRK2;NRXN1;NLGN3;DLG5;CLSTN2;SEMA4D
prerank,GO_Biological_Process_2021__regulation of interferon-gamma production (GO:0032649),-0.5468342727034965,-1.2416316435621313,0.11392405063291139,1.0,1.0,17/46,17.40%,IL1R1;HLA-A;ISG15;RASGRP1;IL12A;BTN3A1;INHA;SLC11A1;TLR3;DDIT3;PDCD1LG2;IL18;CD14;ZFPM1;ZP3;CD274;PTPN22
prerank,GO_Biological_Process_2021__positive regulation of isomerase activity (GO:0010912),0.7553088657187071,1.2416149701592976,0.2,0.6572424374296628,1.0,2/6,13.28%,HNRNPU;DHX9
prerank,GO_Biological_Process_2021__regulation of neuroblast proliferation (GO:1902692),0.6399000615106711,1.2414857883858914,0.20588235294117646,0.6570298402407954,1.0,5/15,19.34%,TAFA1;NF1;FZD3;KDM1A;DRD2
prerank,GO_Biological_Process_2021__positive regulation of autophagy of mitochondrion in response to mitochondrial depolarization (GO:1904925),-0.7366303656626249,-1.2410100338533423,0.2,1.0,1.0,3/6,14.11%,TOMM7;ATP5IF1;HK2
prerank,GO_Biological_Process_2021__autophagy of peroxisome (GO:0030242),0.6528876850754171,1.2404556909145725,0.21951219512195122,0.6603579754746026,1.0,4/12,11.91%,TRAPPC8;PIK3C3;PIK3R4;PEX5
prerank,GO_Biological_Process_2021__ruffle organization (GO:0031529),0.6625500582639051,1.2403306613413299,0.2558139534883721,0.6600031433627789,1.0,6/14,20.81%,CSF1R;PLEK;CARMIL1;CYFIP1;ARF6;PLEKHA1
prerank,GO_Biological_Process_2021__regulation of activated T cell proliferation (GO:0046006),-0.6650295362425012,-1.240303178045175,0.16666666666666666,1.0,1.0,6/18,16.12%,CD24;HHLA2;PDCD1LG2;IL18;CD274;BTN2A2
prerank,GO_Biological_Process_2021__phosphorylated carbohydrate dephosphorylation (GO:0046838),0.6823867840856176,1.2401643138711425,0.28125,0.6591740522260661,1.0,6/11,24.63%,INPP5A;SYNJ1;PTEN;OCRL;IMPA2;SYNJ2
prerank,GO_Biological_Process_2021__inositol phosphate dephosphorylation (GO:0046855),0.6823867840856176,1.2401643138711425,0.28125,0.6591740522260661,1.0,6/11,24.63%,INPP5A;SYNJ1;PTEN;OCRL;IMPA2;SYNJ2
prerank,GO_Biological_Process_2021__negative regulation of phagocytosis (GO:0050765),0.6206039126449753,1.239778939841946,0.15,0.6596898941861786,1.0,2/12,10.76%,HMGB1;PIP4P2
prerank,GO_Biological_Process_2021__regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),0.643862747669792,1.2392564324851487,0.21052631578947367,0.6608464932699953,1.0,1/10,3.28%,EGFR
prerank,GO_Biological_Process_2021__histone H2A monoubiquitination (GO:0035518),0.5559713523681531,1.2392284187685014,0.1702127659574468,0.6601464440186501,1.0,1/17,6.10%,PCGF2
prerank,GO_Biological_Process_2021__cytoskeleton-dependent cytokinesis (GO:0061640),0.44654607405700114,1.2387190252239608,0.047619047619047616,0.6612828015372565,1.0,20/62,27.10%,SPIRE2;SNX18;SEPTIN6;SEPTIN8;SPIRE1;SEPTIN11;ANLN;INCENP;SEPTIN7;ROCK2;ESPL1;ROCK1;PLK1;TRIM36;BIN3;IST1;ARL3;EFHC2;SPTBN1;DCTN3
prerank,GO_Biological_Process_2021__cellular transition metal ion homeostasis (GO:0046916),-0.5189053608437731,-1.2385980232063487,0.14705882352941177,1.0,1.0,17/71,18.34%,FTH1;CP;MT1H;FTL;MT1G;MT2A;ABCG2;SLC39A7;SLC11A1;MT3;MT1E;NUBP1;MT1F;MT1A;TFR2;SLC39A6;MT1M
prerank,GO_Biological_Process_2021__modulation by symbiont of host process (GO:0044003),-0.7365567065424271,-1.238510100340047,0.19642857142857142,1.0,1.0,6/10,22.54%,RPS27A;B2M;UBC;UBA52;ENO1;UBB
prerank,"GO_Biological_Process_2021__regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",0.6393205214390737,1.238132042089901,0.19444444444444445,0.6617863631217568,1.0,2/13,10.89%,CPEB3;TNRC6B
prerank,"GO_Biological_Process_2021__positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",0.6393205214390737,1.238132042089901,0.19444444444444445,0.6617863631217568,1.0,2/13,10.89%,CPEB3;TNRC6B
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),-0.5750025595222423,-1.2380800501336493,0.11594202898550725,1.0,1.0,3/24,4.80%,SFRP2;PARP14;SH3BP5
prerank,GO_Biological_Process_2021__cellular hyperosmotic response (GO:0071474),-0.7552750504740794,-1.238022588997986,0.21153846153846154,1.0,1.0,2/5,12.02%,AQP1;RCSD1
prerank,GO_Biological_Process_2021__regulation of B cell receptor signaling pathway (GO:0050855),0.5864520354767343,1.2378263035117412,0.16666666666666666,0.662227161319052,1.0,6/15,21.27%,FOXP1;CD22;ELF1;CBFB;RUNX1;PRKCB
prerank,GO_Biological_Process_2021__protein import into nucleus (GO:0006606),0.41392118213421797,1.2378231105252917,0.1,0.6615293455537,1.0,11/67,12.17%,RANBP17;RGPD3;PPP1R10;NUP188;AKT1;IPO8;SPRN;KPNA4;NUP153;NXT2;CBLB
prerank,GO_Biological_Process_2021__regulation of pattern recognition receptor signaling pathway (GO:0062207),0.6962471789128588,1.2372652237735664,0.29545454545454547,0.6626410470509889,1.0,3/7,15.89%,SLC15A2;ZDHHC5;BIRC2
prerank,GO_Biological_Process_2021__negative regulation of protein polymerization (GO:0032272),0.5371859108997283,1.2371889002785883,0.19444444444444445,0.6622882916097913,1.0,9/25,17.00%,SNCA;KANK1;DYRK1A;SLIT2;CLIP3;SSH1;MAPRE1;ARFGEF1;CYRIB
prerank,GO_Biological_Process_2021__positive regulation of leukocyte differentiation (GO:1902107),0.704556011119257,1.2366460915006954,0.20833333333333334,0.6634827770425501,1.0,1/6,9.68%,HMGB1
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction by p53 class mediator (GO:0030330)",0.44114799396014825,1.2363403790017784,0.14814814814814814,0.6638679865742861,1.0,18/64,22.28%,SOX4;CRADD;PRMT1;RGCC;CNOT9;CNOT6L;CNOT2;CNOT4;EP300;HIPK2;MDM4;TFDP2;CNOT8;MDM2;ATRX;PCBP4;AURKA;E2F4
prerank,GO_Biological_Process_2021__adherens junction assembly (GO:0034333),0.6338429956486963,1.2363289061589915,0.21052631578947367,0.663189255488908,1.0,5/9,23.95%,SMAD7;PIP5K1C;ZNF703;CTNNB1;TBCD
prerank,GO_Biological_Process_2021__negative regulation of tumor necrosis factor production (GO:0032720),-0.5841878813540113,-1.2361931853264416,0.23214285714285715,1.0,1.0,4/22,12.24%,ARG2;SELENOS;GSTP1;CX3CL1
prerank,GO_Biological_Process_2021__negative regulation of chemokine production (GO:0032682),-0.7112461894334674,-1.2356191905646832,0.23333333333333334,1.0,1.0,4/8,12.07%,SIGIRR;GSTP1;KLF4;OAS3
prerank,GO_Biological_Process_2021__meiosis I (GO:0007127),-0.6476741014235008,-1.2356181566057531,0.16393442622950818,1.0,1.0,5/19,12.51%,MEIOB;SYCP3;BTBD18;MOV10L1;BRDT
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte migration (GO:2000403),-0.7580012596682584,-1.2350963681627345,0.28,1.0,1.0,1/6,0.34%,DOCK8
prerank,GO_Biological_Process_2021__fluid transport (GO:0042044),-0.8045535286844184,-1.2347986098375674,0.16666666666666666,1.0,1.0,4/7,15.92%,AQP1;PDPN;AQP11;SLC4A11
prerank,GO_Biological_Process_2021__negative regulation of catabolic process (GO:0009895),0.5303165387521205,1.2347879696217179,0.16666666666666666,0.6674965872507957,1.0,10/33,20.35%,PDE3B;EGFR;GIT1;AGAP2;HDAC4;SIRT2;MDM4;SF3B3;ADGRB1;FMN2
prerank,GO_Biological_Process_2021__plasma membrane phospholipid scrambling (GO:0017121),0.7324306389916985,1.2345377337752916,0.21739130434782608,0.667551272169402,1.0,1/6,14.44%,PLSCR2
prerank,GO_Biological_Process_2021__negative regulation of cation transmembrane transport (GO:1904063),0.6458584740853519,1.234475379888694,0.21951219512195122,0.6670417555238328,1.0,7/13,13.37%,SLC43A1;NEDD4L;BIN1;KCNH2;CBARP;CAMK2D;COMMD1
prerank,GO_Biological_Process_2021__negative regulation of interleukin-12 production (GO:0032695),-0.7632685959340932,-1.2342290228288477,0.25,1.0,1.0,1/6,5.73%,THBS1
prerank,GO_Biological_Process_2021__presynaptic active zone organization (GO:1990709),0.7440841445762942,1.2340838867626205,0.24444444444444444,0.6674895424024941,1.0,3/6,22.55%,PCLO;ERC2;ERC1
prerank,GO_Biological_Process_2021__cellular protein modification process (GO:0006464),0.3432888655158734,1.2339386904884755,0.0,0.6673052529252319,1.0,235/835,21.27%,PDK4;SPSB4;PDP1;CDKL1;MAPK10;EGLN3;PTPRK;CDK18;MAP3K11;FEM1B;PTPN4;BTRC;SPSB2;BMP2;FUT9;HS3ST5;KEAP1;DCUN1D1;RPS6KA4;PRKCSH;LOXL2;STT3B;PASK;PRKACB;CDH2;RHBDD1;VHL;QSOX1;STK38L;SOCS6;CDKL5;CILK1;PGAP1;MGAT4A;KBTBD7;MAP4K5;GRK3;DAPK2;CSNK1G3;PPM1E;BTBD1;CDK8;DUSP10;PRKG1;TNIK;AKT1;PPP2R1B;COPS7B;PRKAR1B;PSMA1;CD247;KBTBD6;FEM1C;CSNK2A1;FBXL3;COPS2;FBXO30;TEC;ATE1;CAMK2B;KLHL42;PTPN13;DYRK1A;DCAF17;CDK12;PPP2R5A;ABL2;LMO7;CSNK1E;PPM1A;CAMK2A;NLK;BMPR1B;PSMD11;EIF2AK4;ASB3;MORC3;ATG7;LARGE1;LMTK3;LOXL1;PSMD10;MEN1;PIK3C3;PGGT1B;PIK3R4;PLOD2;PTAR1;TAB1;PRKCE;ST3GAL1;PTPRJ;BRAF;MAP3K20;FBXO11;PSMF1;DCAF5;PTPN9;NEK4;MAST2;PRKD1;FBXW7;TGM1;COP1;MAP3K5;MAP4K2;FBXL14;PAK3;FBXO21;MAP4K4;CAMK2D;PSMD14;PPM1L;SIK2;PPEF1;TGFBR2;SIK3;OXSR1;GRK4;PPP4R1;ZBTB16;ACVR1;SSH1;CDK19;MAPKAPK2;SGK3;PTPRB;MERTK;SETD3;TULP4;NTAQ1;GPS1;SIRT1;HIPK2;TGFBR1;WSB2;PRKAB1;COMMD1;FER;CUL2;SIRT2;UBE2E2;ACVR2A;UBE2E1;B4GALT5;CDC42BPA;MAP4K3;ENGASE;BMPR1A;PTPRZ1;HIF3A;MAPK1;PTPN14;DYRK2;TAOK2;CUL1;USP25;PTP4A2;TP53RK;GSK3B;CDK13;DUSP6;CDC34;PTPRG;ROCK2;LATS1;PARP8;PDK2;MTMR2;PPP2R2A;MAPK8;PPP3CB;CHM;STK11;RAB1A;PPP1R12A;VCAN;PTPRO;AKT2;TRIB2;PPP2R5E;B3GALT1;MAML1;PRKG2;PSME4;CSK;HIF1A;ANKRD9;FBXW2;CUL3;LHPP;MAP3K1;WNK3;PPP1CC;CDK14;SRPK2;TBCK;DCAF6;DCAF7;PAK4;PTEN;PPM1D;ATG5;UBXN7;MTM1;KLHL2;WNK1;FYN;FBXW11;PPP1CB;PPM1F;YWHAZ;MACROD1;APLP2;MAPK9;ALG5;ROCK1;PLK1;SIRT5;SSH2;FBXO31;PTPRE;UBA3;SDC2;FAM20B;PPP2R1A;UBE2D3;NEURL2;CDK9;DNAJC3;DUSP12;AKT3;MARK1;PTPRC;PRKCB
prerank,GO_Biological_Process_2021__regulation of TORC1 signaling (GO:1903432),0.5166475961001786,1.233687406055407,0.14285714285714285,0.6676495916185802,1.0,10/31,25.98%,SMCR8;SESN1;KPTN;SIK3;SESN3;STK11;RRAGD;SESN2;GPR137B;DYRK3
prerank,GO_Biological_Process_2021__protein targeting to membrane (GO:0006612),0.43937995237139177,1.233678025515149,0.17647058823529413,0.6670059142010488,1.0,18/74,14.50%,VPS37B;GDAP1;PARD3;TRAM1;ZDHHC18;ZDHHC11;RAB3IP;RAB8B;VPS37A;PEX14;ZDHHC21;PEX16;PEX5;GOLGA7;PEX2;PIKFYVE;ABCD3;TAOK2
prerank,PanglaoDB_Augmented_2021__B Cells,-0.5093186339413391,-1.233025036890948,0.1232876712328767,1.0,1.0,15/71,12.42%,CD24;P2RY10;IGHG1;TAGAP;CD5;IFIT3;ARHGAP9;GMFG;TRAF3IP3;TMC8;SP140;RHOH;ARHGAP30;RCSD1;CD14
prerank,GO_Biological_Process_2021__long-chain fatty acid import into cell (GO:0044539),0.638343992574428,1.2329387500225475,0.2702702702702703,0.6688122532457145,1.0,3/9,20.19%,SPX;RPS6KB1;ACSL3
prerank,GO_Biological_Process_2021__response to increased oxygen levels (GO:0036296),0.8248934028274654,1.232541479221907,0.24,0.6694087601119117,1.0,1/5,4.08%,ATP6V1A
prerank,GO_Biological_Process_2021__aldehyde biosynthetic process (GO:0046184),-0.763822747915073,-1.23253352690066,0.23076923076923078,1.0,1.0,1/5,4.56%,CACNA1H
prerank,GO_Biological_Process_2021__DNA ligation involved in DNA repair (GO:0051103),0.8000824132136226,1.232523279685598,0.19148936170212766,0.6687991998375405,1.0,1/5,1.18%,LIG4
prerank,GO_Biological_Process_2021__cell surface receptor signaling pathway involved in heart development (GO:0061311),0.6129177922185355,1.2324670925517622,0.24390243902439024,0.6682417584376973,1.0,5/12,18.40%,BMP2;NOTCH2;ACVR1;BMPR1A;RBPJ
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial fission (GO:0090141),0.6045773320620909,1.2324476028740128,0.1794871794871795,0.6675838653774586,1.0,5/18,10.08%,DCN;MCU;MFF;SPIRE1;PRKN
prerank,GO_Biological_Process_2021__organic acid catabolic process (GO:0016054),0.7064631216175701,1.2324151450321794,0.1590909090909091,0.666995000146191,1.0,1/8,4.50%,ADO
prerank,GO_Biological_Process_2021__negative regulation of osteoblast proliferation (GO:0033689),-0.7520294754227862,-1.2322416238773441,0.2830188679245283,1.0,1.0,2/7,11.86%,SFRP1;EIF2AK2
prerank,GO_Biological_Process_2021__cellular response to caffeine (GO:0071313),0.7116139749798938,1.2322408123948165,0.28,0.666107907682096,1.0,1/6,9.40%,GSTM2
prerank,GO_Biological_Process_2021__response to caffeine (GO:0031000),0.7116139749798938,1.2322408123948165,0.28,0.666107907682096,1.0,1/6,9.40%,GSTM2
prerank,GO_Biological_Process_2021__adiponectin-activated signaling pathway (GO:0033211),0.7578131335646578,1.2320075895484406,0.21428571428571427,0.6660957771019538,1.0,2/5,14.49%,ADIPOR2;ADIPOR1
prerank,GO_Biological_Process_2021__positive regulation of neurotransmitter transport (GO:0051590),0.7143694577391997,1.23197326559806,0.24489795918367346,0.6654771760179089,1.0,2/5,10.08%,BAIAP3;PRKN
prerank,GO_Biological_Process_2021__determination of left/right symmetry (GO:0007368),-0.5807036438948413,-1.2319721387561848,0.18032786885245902,1.0,1.0,4/30,5.22%,CCDC39;MMP21;DNAAF1;ENKUR
prerank,GO_Biological_Process_2021__positive regulation of DNA biosynthetic process (GO:2000573),0.4609247161914992,1.2318369080680256,0.1875,0.6653310811824535,1.0,16/51,23.61%,NAF1;RGCC;CCT4;DKC1;MAP3K4;MAPKAPK5;MAPK1;CCT3;PTGES3;HGF;POT1;HMBOX1;POLG2;TNKS2;FGF2;CTNNB1
prerank,GO_Biological_Process_2021__ATP synthesis coupled proton transport (GO:0015986),-0.6473028605798217,-1.2317864619249348,0.1724137931034483,1.0,1.0,4/15,13.05%,ATP5ME;ATP5F1E;ATP5MC3;ATP5PD
prerank,GO_Biological_Process_2021__response to leptin (GO:0044321),0.7170710332146518,1.2314263565526395,0.23076923076923078,0.6659082227580833,1.0,3/8,13.01%,LEPR;NR1D1;SIRT1
prerank,GO_Biological_Process_2021__regulation of Fc-gamma receptor signaling pathway involved in phagocytosis (GO:1905449),0.7423902639289852,1.2313148617582939,0.2608695652173913,0.665526852468008,1.0,2/5,21.25%,PTPRJ;PTPRC
prerank,GO_Biological_Process_2021__response to tumor necrosis factor (GO:0034612),-0.5260384694602221,-1.231123729380736,0.16666666666666666,1.0,1.0,3/63,0.80%,GBP2;GBP1;GBP3
prerank,GO_Biological_Process_2021__regulation of cellular senescence (GO:2000772),-0.5914053157297243,-1.2309273738989026,0.1896551724137931,1.0,1.0,2/24,3.99%,ARG2;B2M
prerank,GO_Biological_Process_2021__response to UV-C (GO:0010225),0.7609915930844029,1.2307748479605218,0.2222222222222222,0.6667066166754457,1.0,3/6,17.91%,MAP3K4;IMPACT;YY1
prerank,GO_Biological_Process_2021__RNA metabolic process (GO:0016070),0.3912579126431126,1.230570148680974,0.0625,0.6666436648669394,1.0,25/114,19.83%,PAPOLA;HNRNPH1;FTO;FASTKD1;DROSHA;HNRNPU;RNGTT;HNRNPC;LSM8;RBFOX2;CELF2;SYNCRIP;ADARB1;HNRNPH3;DKC1;DHX9;ADARB2;AGO3;TP53RK;RBM6;PTBP1;PPP1R8;HNRNPD;NOVA1;GTF2F2
prerank,GO_Biological_Process_2021__heart contraction (GO:0060047),0.5366561328824523,1.230211047756597,0.18181818181818182,0.6673175618537815,1.0,3/23,7.14%,TCAP;KCNH2;PIK3CA
prerank,GO_Biological_Process_2021__negative regulation of necroptotic process (GO:0060546),-0.6526306409811902,-1.230183929144839,0.296875,1.0,1.0,3/9,12.07%,CASP8;SLC25A4;FZD9
prerank,GO_Biological_Process_2021__negative regulation of viral transcription (GO:0032897),-0.6471921750125624,-1.2301149960839628,0.23333333333333334,1.0,1.0,3/13,7.91%,IFITM3;TRIM21;HEXIM1
prerank,GO_Biological_Process_2021__lipid biosynthetic process (GO:0008610),-0.5259514373053944,-1.2301071191034747,0.16883116883116883,1.0,1.0,9/56,13.88%,LIPI;HSD17B8;AGPAT4;ACSM6;MVK;ACSM5;ACSM3;FADS1;XBP1
prerank,GO_Biological_Process_2021__semaphorin-plexin signaling pathway involved in axon guidance (GO:1902287),0.652875269063107,1.23008796097967,0.3,0.6672373875783173,1.0,2/9,7.59%,PLXNA2;PLXNA1
prerank,GO_Biological_Process_2021__positive regulation of hormone secretion (GO:0046887),-0.7784398149842864,-1.2298562502547343,0.2537313432835821,1.0,1.0,2/7,17.35%,VAMP8;TFR2
prerank,GO_Biological_Process_2021__acyl-CoA metabolic process (GO:0006637),-0.5992712877087938,-1.2297276877234293,0.2,1.0,1.0,7/28,12.00%,ACOT2;ACOT1;ACOT6;GLYAT;ACSM6;ACSM5;ACSM3
prerank,GO_Biological_Process_2021__gamma-aminobutyric acid transport (GO:0015812),0.7834840968777355,1.2297195978086986,0.20408163265306123,0.6677756259689654,1.0,5/5,21.67%,SLC6A13;SLC6A6;SLC6A11;SLC6A12;SLC6A1
prerank,GO_Biological_Process_2021__tRNA modification (GO:0006400),0.4526836323190696,1.229696099070735,0.12,0.6671943765411824,1.0,10/61,10.94%,LCMT2;TRUB1;TRMT1;TYW3;PUS10;CTU1;THUMPD1;TRIT1;CDKAL1;NSUN6
prerank,GO_Biological_Process_2021__regulation of response to endoplasmic reticulum stress (GO:1905897),-0.6987922440410969,-1.2295055533040986,0.15254237288135594,1.0,1.0,5/12,22.86%,CLU;USP19;AQP11;NUPR1;ALOX5
prerank,GO_Biological_Process_2021__positive regulation of response to cytokine stimulus (GO:0060760),-0.6634443274675195,-1.2294295444922019,0.24528301886792453,1.0,1.0,2/11,2.63%,IL7;AGPAT2
prerank,GO_Biological_Process_2021__negative regulation of leukocyte migration (GO:0002686),0.7389841584477529,1.2293237595527051,0.24444444444444444,0.6679149904431614,1.0,2/5,14.96%,SLIT2;CD200R1
prerank,GO_Biological_Process_2021__negative regulation of keratinocyte proliferation (GO:0010839),0.7595257075957855,1.229107976168753,0.18604651162790697,0.6677345840717407,1.0,2/5,15.32%,PTPRK;KLF9
prerank,GO_Biological_Process_2021__muscle tissue morphogenesis (GO:0060415),0.6857135338430131,1.2291058397319725,0.2,0.6670553016871306,1.0,2/11,2.72%,TCAP;BMP2
prerank,GO_Biological_Process_2021__cardiac muscle cell myoblast differentiation (GO:0060379),0.7714414909617238,1.2288314402385683,0.2,0.6674247449382482,1.0,3/5,20.43%,RBPJ;REST;NRG1
prerank,GO_Biological_Process_2021__regulation of glycogen biosynthetic process (GO:0005979),0.5796070127343936,1.228397109334102,0.1875,0.6680757680295679,1.0,10/20,17.75%,PPP1R3D;PASK;AKT1;IRS1;PPP1R3F;DYRK2;GSK3B;PPP1R3G;AKT2;IGF1
prerank,GO_Biological_Process_2021__oogenesis (GO:0048477),-0.6863619993471517,-1.2283104601388364,0.23636363636363636,1.0,1.0,2/10,9.99%,IHO1;MEI4
prerank,GO_Biological_Process_2021__mRNA 3'-splice site recognition (GO:0000389),-0.7932203492925574,-1.227602381501906,0.22,1.0,1.0,1/5,12.95%,SLU7
prerank,GO_Biological_Process_2021__peptidyl-lysine modification (GO:0018205),0.42757592729985194,1.227572903691629,0.043478260869565216,0.6701688703922575,1.0,26/90,17.21%,HDAC9;NUP42;KAT2B;NUP37;LOXL2;NUP188;RANGAP1;TRPM4;LOXL1;PLOD2;ZNF451;EP300;NUP153;PIAS1;NSMCE2;HDAC4;SIRT1;NDC1;SIRT2;TRIM28;PIAS4;STX1A;VCPKMT;NUP205;ATPSCKMT;PLOD1
prerank,GO_Biological_Process_2021__regulation of mitophagy (GO:1901524),-0.7469192542651661,-1.2270617904081287,0.2830188679245283,1.0,1.0,2/5,16.83%,SLC25A4;SLC25A5
prerank,GO_Biological_Process_2021__centromere complex assembly (GO:0034508),-0.5516390186708526,-1.2266562698992172,0.2222222222222222,1.0,1.0,9/29,20.40%,CENPE;MIS12;CENPV;OIP5;ITGB3BP;CENPH;CENPN;CENPU;NPM1
prerank,GO_Biological_Process_2021__glycolytic process (GO:0006096),-0.6093550988717877,-1.2265047630621364,0.16393442622950818,1.0,1.0,9/23,20.22%,GAPDHS;ENO4;ALDOB;LDHA;HK2;GPI;PGAM1;GAPDH;ENO1
prerank,GO_Biological_Process_2021__cellular divalent inorganic cation homeostasis (GO:0072503),0.42950282090192343,1.2264521125804633,0.06666666666666667,0.6730698570713919,1.0,12/73,7.11%,VAPB;SLC24A3;ATP13A5;ANK2;NPTN;ATP2B3;HTR2C;STIM2;CXCL12;ATP2C1;CALCB;ATP13A4
prerank,"GO_Biological_Process_2021__negative regulation of transcription, DNA-templated (GO:0045892)",0.35380715190881906,1.2259831978363085,0.0,0.6738622046553283,1.0,175/735,18.48%,ZNF93;LIMD1;ZFPM2;ANKRD2;TRPS1;BACH1;RARB;PTPRK;TNFSF4;ETV5;KLF11;ZGLP1;NRIP1;BTRC;YAF2;ZNF706;MCPH1;HDAC9;NR2F6;MITF;FOXP1;SNCA;FOXO1;ZBTB1;SOX8;KCTD1;SALL1;EED;BMP2;TFAP2C;LCOR;SPINDOC;NR4A2;LOXL2;ASCL1;DACH1;PSPC1;VHL;CPEB3;DR1;SOX9;ZEB1;PHF10;NFKB1;PRMT6;ZEB2;TLE2;RCOR1;NEDD4L;FOXO3;HNRNPU;SMAD2;ZNF746;THRB;PHC1;CHMP1A;PCGF2;ZIC2;RFX3;ZNF582;HIC2;JDP2;CNOT2;BAHD1;SMAD7;ZNF254;DPF1;NR2E1;TENM2;NR1D2;UBE2D1;SPEN;TSHZ3;PPM1A;SP3;KLF12;MBD2;PEX14;ZHX3;SMARCA2;ZNF568;PLCB1;RBM15B;HDAC2;PHF21A;RBFOX2;ETS2;NR3C1;PSMD10;SFMBT2;MEN1;CLOCK;GLI3;GLIS3;ZNF268;HMGB1;NR1D1;FOXP4;PRKN;SCMH1;GCLC;ZNF589;CREM;EP300;ZNF148;RUNX1T1;MEIS2;AHR;ZHX2;ELK4;JAZF1;ZNF556;ZNF423;ZBTB16;PEX2;ZNF24;WWOX;TBL1XR1;NIPBL;HDAC4;SIRT1;RREB1;MAP2K5;ZNF91;SIRT2;DCAF1;KAT7;TRIM28;FOXN3;MAP3K10;SMAD4;MDM4;VGLL4;MLXIPL;DLG1;SOX13;DUSP22;PIAS4;SAMD1;ZBTB38;PHC3;POU2F1;ZNF282;YAP1;USP9X;MIER3;USP47;TFDP2;ZNF140;UIMC1;PHC2;RSF1;DPF3;BMP7;IMPACT;SEMA4D;USP2;ZNF555;SUFU;KAT6B;ZNF614;ZNF141;CBFB;RUNX1;ZNF703;KDM1A;MTERF3;YY1;KDM1B;ZBTB21;JARID2;ZBTB18;MDM2;RBPJ;RORB
prerank,GO_Biological_Process_2021__dendrite extension (GO:0097484),0.805344230790042,1.225885040596118,0.1702127659574468,0.6734620356203899,1.0,2/5,9.67%,LLPH;AUTS2
prerank,GO_Biological_Process_2021__carbohydrate derivative transport (GO:1901264),0.6230113276805427,1.2254799414574173,0.275,0.6741532437493177,1.0,3/16,8.81%,SLC15A3;SLC15A2;SLC10A7
prerank,GO_Biological_Process_2021__phospholipid metabolic process (GO:0006644),-0.5119643477406209,-1.2253889743651554,0.16,1.0,1.0,8/52,9.32%,ENPP2;AGPAT2;AGPAT4;PNPLA3;PLB1;ANGPTL3;PLAAT4;PGP
prerank,GO_Biological_Process_2021__heart development (GO:0007507),0.4144323586133883,1.2250490403567378,0.14285714285714285,0.6751071704269032,1.0,30/106,16.20%,TCAP;ZFPM2;HDAC9;PCSK5;KAT2B;SOX4;SALL1;BMP2;ERBB4;SMG9;SOX9;FLRT2;TBX19;CHD7;PKD2;DNAAF4;KAT2A;NF1;TGFBR2;PTK2;ACVR1;SGCD;PDLIM5;NIPBL;TGFBR1;ZDHHC16;SH3PXD2B;PTPN11;MKKS;BMP7
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell apoptotic process (GO:0010665),0.6682916505881473,1.2249639518388937,0.22727272727272727,0.674624504300952,1.0,4/7,14.10%,PPP1R10;CAMK2A;CAMK2D;BMPR1A
prerank,PanglaoDB_Augmented_2021__Enteric Glia Cells,0.40905565378289493,1.2249235942721668,0.047619047619047616,0.674159284160273,1.0,22/97,14.12%,CNTN1;ACKR1;ANK2;RGS16;ADGRL3;PCDH17;CHL1;PRIMA1;MEGF10;NTRK2;FRZB;NRXN1;INTS6;PPP1R1B;ASTN1;FAM107A;NDRG2;GPM6B;ZNF423;RGS7BP;MAPK4;PTPRZ1
prerank,GO_Biological_Process_2021__phagosome maturation (GO:0090382),0.5587152190212479,1.2247297387294143,0.17647058823529413,0.6741887183193823,1.0,6/28,14.68%,ATP6V0D2;ATP6V1A;RAB31;ATP6V1C1;PIKFYVE;ATP6V1B2
prerank,GO_Biological_Process_2021__protein geranylgeranylation (GO:0018344),0.7346507325955334,1.2246824584062357,0.3409090909090909,0.6736426675964371,1.0,2/5,16.16%,PGGT1B;CHM
prerank,GO_Biological_Process_2021__vitamin transport (GO:0051180),-0.5768646331625732,-1.224381678363619,0.23880597014925373,1.0,1.0,4/20,9.85%,GC;PDPN;AMN;ABCG2
prerank,GO_Biological_Process_2021__protein localization to cell junction (GO:1902414),0.583619542669543,1.224093372148969,0.11764705882352941,0.6747401361644616,1.0,8/20,22.72%,SHANK1;MARVELD3;CGNL1;TJP1;PCLO;NLGN1;TJP2;NECTIN1
prerank,GO_Biological_Process_2021__nuclear pore complex assembly (GO:0051292),0.6888984695931922,1.223956088830293,0.2222222222222222,0.6744079285590767,1.0,5/9,24.70%,NUP153;NDC1;NUP205;NUP98;AHCTF1
prerank,GO_Biological_Process_2021__cellular iron ion homeostasis (GO:0006879),-0.5411209623693942,-1.2235334537524678,0.14285714285714285,1.0,1.0,5/42,10.16%,FTH1;CP;FTL;ABCG2;SLC11A1
prerank,GO_Biological_Process_2021__positive regulation of monocyte differentiation (GO:0045657),-0.71023628195087,-1.223527661186304,0.17647058823529413,1.0,1.0,3/9,15.74%,FES;IL34;CD74
prerank,"GO_Biological_Process_2021__fatty acid elongation, monounsaturated fatty acid (GO:0034625)",0.7787521150439588,1.2234666992966603,0.20930232558139536,0.6733308684861499,1.0,3/6,12.01%,ELOVL7;ELOVL6;ELOVL5
prerank,"GO_Biological_Process_2021__fatty acid elongation, unsaturated fatty acid (GO:0019368)",0.7787521150439588,1.2234666992966603,0.20930232558139536,0.6733308684861499,1.0,3/6,12.01%,ELOVL7;ELOVL6;ELOVL5
prerank,"GO_Biological_Process_2021__fatty acid elongation, polyunsaturated fatty acid (GO:0034626)",0.7787521150439588,1.2234666992966603,0.20930232558139536,0.6733308684861499,1.0,3/6,12.01%,ELOVL7;ELOVL6;ELOVL5
prerank,"GO_Biological_Process_2021__fatty acid elongation, saturated fatty acid (GO:0019367)",0.7787521150439588,1.2234666992966603,0.20930232558139536,0.6733308684861499,1.0,3/6,12.01%,ELOVL7;ELOVL6;ELOVL5
prerank,GO_Biological_Process_2021__glycerophospholipid biosynthetic process (GO:0046474),0.3897601492683962,1.2231594243106685,0.05555555555555555,0.673573130835886,1.0,45/153,21.37%,DGKB;PLD6;LPIN3;PIP5K1B;ABHD5;CSNK2A1;PLEKHA2;PIK3CA;PTPN13;PIK3R1;DGKH;SLC44A5;PIK3C3;PLEKHA8;PIP5K1C;PIK3R4;ACP6;GPAM;DGKZ;PIP4K2C;PIKFYVE;ETNK1;DGKG;SYNJ1;MTMR2;CPNE3;PITPNM3;PI4KB;RAB4A;CSNK2A2;AGK;PTEN;CPNE1;PLEKHA3;MTM1;MTMR12;PCYT1B;SLC44A1;FAR1;PLEKHA1;PITPNM1;PTDSS2;DGKE;CEPT1;SACM1L
prerank,MSigDB_Hallmark_2020__KRAS Signaling Up,0.3932187586558381,1.222895567985495,0.09090909090909091,0.6734724084614993,1.0,22/137,11.36%,WNT7A;SPON1;ETV5;CSF2RA;WDR33;HDAC9;BMP2;SNAP91;ETV1;RGS16;BTBD3;SOX9;MMD;CBL;ZNF277;PRRX1;STRN;CA2;USP12;TMEM158;ANKH;KIF5C
prerank,GO_Biological_Process_2021__positive regulation of nervous system process (GO:0031646),0.6366916008025846,1.2228389501413044,0.24444444444444444,0.6729808461446647,1.0,8/13,26.27%,PARD3;MYRF;ATPSCKMT;RNF10;RIMS2;HCRT;NLGN2;DICER1
prerank,GO_Biological_Process_2021__positive regulation of DNA repair (GO:0045739),0.4834600821248019,1.222675867814442,0.16666666666666666,0.6729297449870052,1.0,14/43,16.64%,SPIRE2;EGFR;FAM168A;EYA2;UBE2N;SPIRE1;HMGB1;NPAS2;SIRT1;DHX9;EYA3;TRIM28;UIMC1;BRCC3
prerank,GO_Biological_Process_2021__regulation of immune effector process (GO:0002697),-0.5683129387281167,-1.2226637291136988,0.19672131147540983,1.0,1.0,16/25,30.90%,C1R;CLU;CPB2;C1S;SUSD4;C1QB;CR1;C2;C6;C3;CR1L;PHB2;C5;SERPING1;CD46;C1QBP
prerank,GO_Biological_Process_2021__embryonic skeletal system morphogenesis (GO:0048704),0.6856668792380445,1.2226010449229119,0.30952380952380953,0.672521004184809,1.0,3/9,13.12%,PDGFRA;TGFBR2;TGFBR1
prerank,GO_Biological_Process_2021__plasma membrane repair (GO:0001778),-0.6878406850754759,-1.2221989697315445,0.27419354838709675,1.0,1.0,1/12,2.50%,MYOF
prerank,GO_Biological_Process_2021__leukocyte adhesion to vascular endothelial cell (GO:0061756),-0.6790896590980546,-1.2219364458588027,0.26865671641791045,1.0,1.0,2/10,1.97%,GCNT1;SELP
prerank,GO_Biological_Process_2021__steroid catabolic process (GO:0006706),-0.6922098862092132,-1.2219322801401944,0.26666666666666666,1.0,1.0,3/8,16.34%,HSD11B1;HSD17B14;CYP3A4
prerank,GO_Biological_Process_2021__sodium ion transport (GO:0006814),0.4551920431179074,1.2218878245522933,0.1111111111111111,0.674582287426696,1.0,5/60,6.40%,ASIC4;SLC24A3;SLC6A13;NEDD4L;SLC12A2
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061419),0.7800272145137357,1.2216705963329924,0.24390243902439024,0.6745946644304308,1.0,3/5,20.13%,HIF1A;RBPJ;NFE2L2
prerank,GO_Biological_Process_2021__regulation of epidermal growth factor receptor signaling pathway (GO:0042058),-0.5201438735163351,-1.2214186418119932,0.07936507936507936,1.0,1.0,4/56,6.53%,IFI6;EPN1;CEACAM1;DOK1
prerank,GO_Biological_Process_2021__lipid catabolic process (GO:0016042),-0.6296963421320576,-1.221211488250238,0.18333333333333332,1.0,1.0,5/18,16.34%,LIPI;HSD11B1;MT3;HSD17B14;CYP3A4
prerank,GO_Biological_Process_2021__postsynaptic membrane assembly (GO:0097104),0.6864085900407499,1.2211900402508695,0.225,0.6755473487197565,1.0,8/9,28.72%,NRXN1;NLGN3;NLGN4X;LRP4;NRXN2;NLGN1;NLGN2;CEL
prerank,GO_Biological_Process_2021__regulation of myosin-light-chain-phosphatase activity (GO:0035507),0.7172834212049606,1.2211809585826094,0.21951219512195122,0.6748784899586479,1.0,4/5,28.28%,ROCK2;PPP1R12A;ROCK1;IKBKB
prerank,GO_Biological_Process_2021__aspartate family amino acid biosynthetic process (GO:0009067),0.73500184239721,1.2210190420930371,0.22448979591836735,0.6747610928945963,1.0,2/6,16.73%,PLOD2;MTHFR
prerank,GO_Biological_Process_2021__protein-DNA complex disassembly (GO:0032986),-0.6975425846851481,-1.220296247708089,0.19672131147540983,1.0,1.0,1/13,0.62%,RPL23
prerank,GO_Biological_Process_2021__endothelial tube morphogenesis (GO:0061154),0.6770682059944629,1.2193335393332607,0.23809523809523808,0.6795902821131041,1.0,4/7,23.61%,STARD13;CCM2;RBPJ;CTNNB1
prerank,GO_Biological_Process_2021__smooth muscle contraction (GO:0006939),0.5981890628898269,1.219276384029308,0.25,0.6791131963197874,1.0,5/11,22.51%,ACTA2;ADRA1A;ROCK2;ROCK1;TPCN2
prerank,GO_Biological_Process_2021__motor neuron axon guidance (GO:0008045),0.6440771280304354,1.2190983800940502,0.1794871794871795,0.678927439650545,1.0,3/10,12.05%,SLIT1;EPHA4;SLIT2
prerank,"GO_Biological_Process_2021__fructose 1,6-bisphosphate metabolic process (GO:0030388)",-0.7518527064620314,-1.2189927588575407,0.2708333333333333,1.0,1.0,1/5,4.93%,ALDOB
prerank,GO_Biological_Process_2021__SNARE complex assembly (GO:0035493),0.6306026750173501,1.218841734661725,0.2727272727272727,0.6792739027255562,1.0,2/8,4.41%,SNCA;STXBP6
prerank,GO_Biological_Process_2021__regulation of DNA damage checkpoint (GO:2000001),0.6629980039531891,1.2187839909046252,0.17391304347826086,0.6787985370471681,1.0,2/9,9.53%,FEM1B;RFWD3
prerank,GO_Biological_Process_2021__circulatory system development (GO:0072359),0.41949973551914865,1.218316015705948,0.125,0.679755678744746,1.0,25/86,16.28%,ZFPM2;HDAC9;PCSK5;KAT2B;SOX4;SALL1;BMP2;ERBB4;SMG9;SOX9;PIK3CA;PKD2;DNAAF4;KAT2A;NF1;FBXW7;TGFBR2;ACVR1;PDLIM5;TGFBR1;ZDHHC16;SH3PXD2B;PTPN11;MKKS;STK11
prerank,GO_Biological_Process_2021__positive regulation of dendrite morphogenesis (GO:0050775),0.5288948438828505,1.218315612722234,0.20512820512820512,0.6790879423216175,1.0,5/18,12.74%,CDKL5;CAMK2B;CAPRIN2;LRP8;CAPRIN1
prerank,GO_Biological_Process_2021__regulation of translational termination (GO:0006449),-0.7184884071512176,-1.2182693095556982,0.22033898305084745,1.0,1.0,4/8,27.48%,OGFOD1;SHFL;JMJD4;GLE1
prerank,GO_Biological_Process_2021__protein localization to organelle (GO:0033365),-0.4908792065212916,-1.2182648242972474,0.14814814814814814,1.0,1.0,8/118,6.53%,GBP2;GBP1;FSIP2;RPL11;ISG15;PAQR3;RAB11A;TRAM1L1
prerank,GO_Biological_Process_2021__intracellular protein transport (GO:0006886),0.36468463611271046,1.2181074017003026,0.08333333333333333,0.6792081386736635,1.0,61/276,18.33%,RANBP17;TBC1D4;ARFIP1;NUP42;XPO1;ARL5A;TBC1D1;MAIP1;RANBP3L;PPP1R10;USP6NL;TBC1D5;NUP188;TBC1D12;EVI5L;KIF13B;RAB31;AKT1;RAB18;RAB23;IPO8;CACNG3;TRAK1;SNX27;XPO6;SPRN;RANBP3;TBC1D22B;AP1S3;AP3B1;ARFRP1;FAM91A1;TRAK2;SCFD2;NUP153;SMURF1;XPO7;NXT2;GGA2;RAB21;CLIP3;NAPB;TBC1D8B;KIF13A;RAB22A;TMED3;NSF;STX1A;SNX13;STX8;TBC1D10A;RAB1A;TMED5;RABGAP1L;RAB28;TNPO1;AKT2;KATNB1;SEC23IP;TBCK;NUP214
prerank,GO_Biological_Process_2021__positive regulation of actin nucleation (GO:0051127),0.6760538352690667,1.2180839108126738,0.2,0.6785743238928532,1.0,8/10,30.20%,NCKAP1;CYFIP1;WASF3;WASF1;ABI2;WHAMM;FCHSD2;GSN
prerank,GO_Biological_Process_2021__positive regulation of cellular response to insulin stimulus (GO:1900078),0.6233346379749225,1.2179210540281653,0.19607843137254902,0.6784544568353699,1.0,4/10,15.44%,IRS1;SIRT1;SNX5;PTPN11
prerank,GO_Biological_Process_2021__regulation of cell migration (GO:0030334),0.365394283338459,1.2178466737404405,0.0,0.6780787221028743,1.0,82/304,17.75%,SEMA5B;PTPRK;AMOTL1;CASS4;SASH1;FAM110C;MITF;SERPINE1;ZMYND8;RAP2B;PRKX;RCC2;BMP2;ERBB4;CSF1R;EGFR;PLXNA2;EPHA4;DACH1;FLT1;CXCL12;PDGFRA;FGF17;KANK1;FOXO3;LIMCH1;DUSP10;AKT1;CTNNA2;CARMIL1;AMOT;CAMK2B;SMAD7;PLXNA1;TTBK2;PDGFA;ROBO1;CAMK2A;FAM107A;SRCIN1;ZNF268;TRADD;PTPRJ;ADARB1;SEMA3C;NF1;NAV3;MAP4K4;PTK2;SLIT2;ACVR1;AFDN;SGK3;DLG5;TGFBR1;MAGI2;PDGFC;FER;RAP2C;MAPRE1;TJP1;SEMA6C;DUSP22;ROCK2;HACE1;CPNE3;SMO;HGF;SEMA4D;SEMA3D;CCAR1;ARID2;SRGAP2B;RUFY3;RNF41;AKT2;CYRIB;CDH13;ITGA6;ZNF703;RAP2A;IGF1
prerank,GO_Biological_Process_2021__nuclear DNA replication (GO:0033260),-0.7121513330870227,-1.2172761629908266,0.23728813559322035,1.0,1.0,6/9,27.37%,MCMDC2;DONSON;ORC3;MCM5;MCM3;MCM4
prerank,GO_Biological_Process_2021__nuclear transport (GO:0051169),0.6208263174405336,1.2171791184707452,0.16666666666666666,0.6796066204819853,1.0,7/15,24.97%,XPO1;RBM15B;NXT2;NUP205;NXT1;NUP98;ANP32A
prerank,GO_Biological_Process_2021__COPII-coated vesicle cargo loading (GO:0090110),0.6057723819698646,1.2168229683872644,0.3055555555555556,0.6801410767454502,1.0,5/14,21.90%,SEC23B;SEC24B;RAB1A;SEC23A;SAR1A
prerank,GO_Biological_Process_2021__regulation of cell cycle checkpoint (GO:1901976),0.7143988383530153,1.2167388872659968,0.16666666666666666,0.6798286344117661,1.0,2/6,9.53%,FEM1B;RFWD3
prerank,GO_Biological_Process_2021__maintenance of protein localization in organelle (GO:0072595),0.6027185591700028,1.2161885190965054,0.28125,0.6810155359477564,1.0,7/17,19.08%,HNRNPU;AKT1;MORC3;TAPT1;TAF8;ARL2BP;TAF3
prerank,GO_Biological_Process_2021__negative regulation of ceramide biosynthetic process (GO:1900060),-0.7731550253855682,-1.2161100189940033,0.25,1.0,1.0,2/5,11.77%,ORMDL2;ORMDL1
prerank,GO_Biological_Process_2021__regulation of DNA biosynthetic process (GO:2000278),0.5695441410458247,1.2157209619679081,0.2222222222222222,0.681642629896212,1.0,8/21,25.39%,DACH1;RGCC;PDGFA;HGF;POT1;HMBOX1;FGF2;TNKS
prerank,GO_Biological_Process_2021__response to interferon-alpha (GO:0035455),-0.636993649421711,-1.215704824607427,0.25,1.0,1.0,2/12,2.71%,IFITM3;BST2
prerank,GO_Biological_Process_2021__positive regulation of transporter activity (GO:0032411),-0.6777339856925159,-1.2156940243875367,0.24193548387096775,1.0,1.0,1/11,3.29%,PDZK1
prerank,GO_Biological_Process_2021__negative regulation of cardiocyte differentiation (GO:1905208),0.712436516648559,1.215675744175823,0.18604651162790697,0.6810750312161006,1.0,3/6,9.01%,BMP2;EGFR;SOX6
prerank,GO_Biological_Process_2021__ventricular septum development (GO:0003281),0.5355388373133012,1.2156397823333842,0.23076923076923078,0.680413150719292,1.0,12/29,14.40%,ZFPM2;SOX4;SALL1;SMAD7;ROBO1;TGFBR2;SLIT2;ACVR1;TGFBR1;BMPR1A;SMAD4;MDM4
prerank,GO_Biological_Process_2021__regulation of extracellular exosome assembly (GO:1903551),0.7642008091097218,1.2155657744307706,0.2222222222222222,0.6800701968083723,1.0,1/5,2.25%,SDC4
prerank,GO_Biological_Process_2021__synaptic membrane adhesion (GO:0099560),0.5927994315623571,1.2151113655685708,0.18181818181818182,0.6809020413561998,1.0,4/13,11.25%,SLITRK2;LRRC4C;LRFN5;SLITRK1
prerank,PanglaoDB_Augmented_2021__Platelets,-0.4633961384344494,-1.2150870455637726,0.13157894736842105,1.0,1.0,25/91,17.61%,SELP;SPARC;HLA-A;CD9;CLEC12A;P2RY12;F13A1;P2RY13;DPEP2;THBS1;GMFG;LGALS8;VWF;F5;LTBR;SPI1;MYO1F;ITGA2;CRLF2;ARHGAP10;CXCL14;ALOX12;CTSA;CXCR4;ILK
prerank,GO_Biological_Process_2021__positive regulation by symbiont of host autophagy (GO:0075044),0.7442542456583269,1.214865030753758,0.2,0.6809555605996164,1.0,3/7,18.61%,EIF2AK4;ATG7;ATG5
prerank,GO_Biological_Process_2021__renal system development (GO:0072001),0.4791480579952493,1.2147967126525372,0.15384615384615385,0.6804547181510553,1.0,8/30,14.78%,PCSK5;SALL1;MME;PYGO2;CEP290;C1GALT1;TGFBR1;PYGO1
prerank,GO_Biological_Process_2021__inositol phosphate metabolic process (GO:0043647),0.4728606269481157,1.214764406134996,0.1388888888888889,0.6799232031905502,1.0,14/41,23.73%,ISYNA1;ITPKB;INPP5A;PLCB1;MINPP1;IP6K2;SYNJ1;ITPK1;IPPK;PTEN;PLCB3;FGF2;OCRL;IMPA2
prerank,GO_Biological_Process_2021__cell-cell junction maintenance (GO:0045217),0.692515020360983,1.2146060367669327,0.2857142857142857,0.679851070290437,1.0,4/7,28.00%,CSF1R;TJP1;NLGN2;PARD6A
prerank,GO_Biological_Process_2021__ketone body metabolic process (GO:1902224),0.6792533319608806,1.2139695053394857,0.175,0.6815633565821839,1.0,4/9,25.96%,BDH2;OXCT1;ACAT1;HMGCLL1
prerank,GO_Biological_Process_2021__regulation of cholesterol transport (GO:0032374),0.5827655047215929,1.2138077783162526,0.2,0.681395131999975,1.0,5/17,13.58%,NFKB1;YJEFN3;TTC39B;ABCA2;ARV1
prerank,GO_Biological_Process_2021__regulation of mRNA export from nucleus (GO:0010793),0.7592280124636127,1.2134199858696382,0.21818181818181817,0.6814060332034232,1.0,2/6,16.70%,IWS1;SETD2
prerank,GO_Biological_Process_2021__regulation of ribonucleoprotein complex localization (GO:2000197),0.7592280124636127,1.2134199858696382,0.21818181818181817,0.6814060332034232,1.0,2/6,16.70%,IWS1;SETD2
prerank,GO_Biological_Process_2021__positive regulation of cation transmembrane transport (GO:1904064),0.519432494518827,1.213375196759929,0.2,0.6808452112356714,1.0,4/33,7.05%,ACE2;ANK2;KCNH2;KCNMA1
prerank,GO_Biological_Process_2021__vascular associated smooth muscle cell differentiation (GO:0035886),-0.76072941937743,-1.2133204457661066,0.23214285714285715,1.0,1.0,4/6,18.33%,APLNR;HES1;HEY2;ENG
prerank,GO_Biological_Process_2021__camera-type eye morphogenesis (GO:0048593),0.6408321720650942,1.2131628174374314,0.17391304347826086,0.6808511796275596,1.0,2/10,10.68%,TENM3;NF1
prerank,GO_Biological_Process_2021__imitative learning (GO:0098596),0.7194185867644222,1.2131157152733747,0.36363636363636365,0.6796710893971988,1.0,4/5,21.40%,NRXN1;SHANK3;NRXN2;CNTNAP2
prerank,GO_Biological_Process_2021__vocal learning (GO:0042297),0.7194185867644222,1.2131157152733747,0.36363636363636365,0.6796710893971988,1.0,4/5,21.40%,NRXN1;SHANK3;NRXN2;CNTNAP2
prerank,GO_Biological_Process_2021__glutathione metabolic process (GO:0006749),0.5077895848910391,1.2126604260843754,0.125,0.6805399652876127,1.0,5/31,12.62%,GSTT2;GSR;GSTM2;GCLC;GGCT
prerank,GO_Biological_Process_2021__mRNA export from nucleus (GO:0006406),0.3928892431141964,1.2125155146003983,0.0,0.6803270455806015,1.0,27/93,24.86%,WDR33;NUP42;NUP37;NUP188;IWS1;AGFG1;RBM15B;FYTTD1;EIF4E;SMG1;NUP153;U2AF1;U2AF2;NDC1;THOC7;SMG7;NUP205;PCID2;NUP214;ALKBH5;RANBP2;THOC2;NXT1;MAGOH;NUP54;NUP98;CPSF2
prerank,GO_Biological_Process_2021__mycotoxin metabolic process (GO:0043385),-0.7088749754402159,-1.2122062712156878,0.24,1.0,1.0,4/8,24.57%,CYP3A4;AKR7A2;CYP3A5;MGST1
prerank,GO_Biological_Process_2021__aflatoxin metabolic process (GO:0046222),-0.7088749754402159,-1.2122062712156878,0.24,1.0,1.0,4/8,24.57%,CYP3A4;AKR7A2;CYP3A5;MGST1
prerank,GO_Biological_Process_2021__organic heteropentacyclic compound metabolic process (GO:1901376),-0.7088749754402159,-1.2122062712156878,0.24,1.0,1.0,4/8,24.57%,CYP3A4;AKR7A2;CYP3A5;MGST1
prerank,GO_Biological_Process_2021__amino acid import (GO:0043090),0.5738366850594577,1.2117799748644418,0.25,0.6820694243725044,1.0,7/18,25.60%,SLC6A13;SFXN1;SLC47A1;SLC6A6;SLC6A1;SLC22A2;SH3BP4
prerank,GO_Biological_Process_2021__anterograde trans-synaptic signaling (GO:0098916),0.35665287725715644,1.2116568514215993,0.1,0.6819179473635099,1.0,35/178,15.02%,CHRNA4;DLGAP1;KCNQ3;GABRG1;SNCA;CACNB4;PCDHB2;PRKACB;DOC2A;HTR2C;PDE7B;GRIN1;CACNA1B;RPS6KA3;KIF5A;PRKAR1B;NRXN1;MBP;HOMER1;GABRA4;RPS6KA2;GPR176;PCDHB13;LPAR3;NLGN3;GRM1;GLRB;NLGN4X;GABRA5;GABRB1;EXOC4;KCNQ2;MAPK1;DLG1;APBA3
prerank,GO_Biological_Process_2021__protein retention in Golgi apparatus (GO:0045053),0.7472218854393273,1.2115483251217367,0.2653061224489796,0.6815794480076974,1.0,1/5,10.61%,GOLPH3
prerank,GO_Biological_Process_2021__mitochondrial DNA replication (GO:0006264),0.6956957551622196,1.211489818720889,0.2641509433962264,0.6810388667587532,1.0,3/7,22.21%,DNA2;PRIMPOL;POLG2
prerank,GO_Biological_Process_2021__positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),0.6184103276105987,1.2113789030749988,0.25,0.6807485880435952,1.0,5/16,9.50%,EGFR;RGCC;AKT1;PSMD10;PKD2
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle contraction (GO:0003056),0.7356288298803619,1.2112408557622083,0.25925925925925924,0.6805211206337889,1.0,5/5,26.46%,ZDHHC21;DOCK4;CHRM3;ATP2B1;DOCK5
prerank,GO_Biological_Process_2021__diol metabolic process (GO:0034311),0.5276894937522494,1.2112066275431816,0.22580645161290322,0.6799986369154952,1.0,5/17,17.21%,PLPP1;AKT1;PLPP3;PLPP2;PRKG2
prerank,PanglaoDB_Augmented_2021__Nuocytes,-0.607491802578111,-1.211157427492047,0.24285714285714285,1.0,1.0,7/21,7.73%,P2RY10;TAGAP;IL5;CD5;THEMIS;GPR171;TRAF3IP3
prerank,MSigDB_Hallmark_2020__heme Metabolism,0.39440915420152056,1.2109364357661139,0.1111111111111111,0.6802383687646214,1.0,35/163,14.49%,TYR;BACH1;BTRC;SNCA;ACKR1;VEZF1;KAT2B;PICALM;DCUN1D1;ARHGEF12;FOXO3;RCL1;EPOR;CDC27;YPEL5;SLC7A11;SMOX;GMPS;CA2;NR3C1;FBXO34;GCLC;FTCD;TRAK2;TNRC6B;CDR2;SEC14L1;XPO7;BSG;NNT;MINPP1;SLC30A1;ARL2BP;SYNJ1;ADIPOR1
prerank,GO_Biological_Process_2021__positive regulation of stem cell proliferation (GO:2000648),0.6014832054766792,1.2107050665767205,0.21052631578947367,0.6802137984384159,1.0,6/13,21.25%,HNRNPU;EPCAM;KAT7;KDM1A;N4BP2L2;PTPRC
prerank,GO_Biological_Process_2021__positive regulation of ion transmembrane transport (GO:0034767),-0.756887506595594,-1.2105678388830672,0.16666666666666666,1.0,1.0,1/6,3.29%,PDZK1
prerank,GO_Biological_Process_2021__positive regulation of translation in response to stress (GO:0032056),0.7856709303306261,1.2103118342940005,0.2222222222222222,0.680840514792631,1.0,3/5,16.23%,EIF2AK4;NCK1;IMPACT
prerank,GO_Biological_Process_2021__cellular response to leucine starvation (GO:1990253),0.705028485229718,1.2101572580648923,0.2,0.6807999297538316,1.0,6/10,24.21%,SESN1;EIF2AK4;SESN3;IMPACT;RRAGD;SESN2
prerank,GO_Biological_Process_2021__regulation of 3'-UTR-mediated mRNA stabilization (GO:1905868),0.7040948628461273,1.2097442330401416,0.2916666666666667,0.6816260986535367,1.0,4/6,27.02%,RBM24;TENT4B;LARP4B;TENT4A
prerank,GO_Biological_Process_2021__positive regulation of stress fiber assembly (GO:0051496),0.48970345277995825,1.2094398724311257,0.20588235294117646,0.6818476975611626,1.0,10/35,15.85%,RGCC;TESK1;PPM1E;LIMCH1;CARMIL1;ARHGEF10L;TGFBR1;ROCK2;PXN;NRP1
prerank,GO_Biological_Process_2021__aromatic amino acid family catabolic process (GO:0009074),-0.6707933835479103,-1.2090471833808298,0.21052631578947367,1.0,1.0,2/12,1.59%,KMO;ACMSD
prerank,GO_Biological_Process_2021__positive regulation of cholesterol efflux (GO:0010875),-0.6330874486613922,-1.2088377703856725,0.20634920634920634,1.0,1.0,2/18,11.67%,ABCA12;APOE
prerank,GO_Biological_Process_2021__synaptic vesicle endocytosis (GO:0048488),0.4728826882190129,1.2087736408255516,0.22857142857142856,0.6833200970572648,1.0,11/33,15.35%,SNCA;DNM3;SNAP91;PICALM;ITSN1;PIP5K1C;NLGN3;NLGN4X;OPHN1;SYNJ1;STX1A
prerank,GO_Biological_Process_2021__regulation of protein tyrosine kinase activity (GO:0061097),0.5037600596671842,1.2086550837286911,0.12195121951219512,0.6830458372930283,1.0,9/32,10.71%,NCK2;CASS4;RAP2B;CSF1R;EPHA4;SH3BP5L;DLG3;SRCIN1;LRP8
prerank,"GO_Biological_Process_2021__energy coupled proton transport, down electrochemical gradient (GO:0015985)",-0.6920385963052593,-1.2083756804716672,0.25,1.0,1.0,2/9,13.05%,ATP5MC3;ATP5PD
prerank,GO_Biological_Process_2021__intracellular lipid transport (GO:0032365),0.5372393839970661,1.2083710580307705,0.225,0.6831575452928053,1.0,5/19,16.87%,ACACB;PLEKHA8;ARV1;ABCD3;CPT1A
prerank,GO_Biological_Process_2021__regulation of stress fiber assembly (GO:0051492),0.4479172535075188,1.2082892502940699,0.13636363636363635,0.6828377445473277,1.0,16/62,15.85%,RGCC;ARAP1;TESK1;PPM1E;LIMCH1;CGNL1;CARMIL1;PIK3R1;ARHGEF10L;TGFBR1;CLASP1;TJP1;ALMS1;ROCK2;PXN;NRP1
prerank,GO_Biological_Process_2021__sphingolipid catabolic process (GO:0030149),-0.6342584075194735,-1.208189485697576,0.25675675675675674,1.0,1.0,2/16,2.49%,ENPP2;PDXDC1
prerank,GO_Biological_Process_2021__vesicle organization (GO:0016050),0.4898964123908701,1.2079658003792335,0.15384615384615385,0.6832110515177984,1.0,12/39,19.07%,SORT1;EPS15;ALS2CL;EXOC8;WASL;RNF26;DNAJC13;HOOK1;CHMP2B;RAB22A;ALS2;PHETA1
prerank,GO_Biological_Process_2021__positive regulation of cholesterol storage (GO:0010886),-0.7308956238801043,-1.2079117259526926,0.27906976744186046,1.0,1.0,3/5,23.35%,MSR1;EHD1;SREBF2
prerank,GO_Biological_Process_2021__AMP metabolic process (GO:0046033),0.6501255264763718,1.207643487943664,0.32608695652173914,0.6836144059020908,1.0,2/10,4.71%,AK3;NT5C1A
prerank,GO_Biological_Process_2021__leukocyte tethering or rolling (GO:0050901),-0.6984806090175797,-1.207456050339427,0.265625,1.0,1.0,2/9,1.97%,GCNT1;SELP
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell migration (GO:0014910),0.5799573956806661,1.207237008041043,0.21621621621621623,0.6840784433058441,1.0,6/13,17.75%,SERPINE1;PDGFA;SLIT2;BMPR1A;NRP1;IGF1
prerank,GO_Biological_Process_2021__delamination (GO:0060232),-0.7646676614785626,-1.2070066327285098,0.2857142857142857,1.0,1.0,3/5,12.68%,ABCA12;AKNA;SPI1
prerank,GO_Biological_Process_2021__positive regulation of protein localization to cell periphery (GO:1904377),0.42877811599343607,1.2069830511118878,0.06896551724137931,0.6842500415293385,1.0,15/47,20.59%,ARHGEF16;EPHA2;EGFR;AKT1;PIK3R1;PRKCE;PTPN9;CLIP3;ZDHHC5;DLG1;GNAI1;ATP2B4;WNK3;ARF6;CIB1
prerank,GO_Biological_Process_2021__regulation of peptidyl-threonine phosphorylation (GO:0010799),0.5217191777497057,1.2068062128352453,0.2222222222222222,0.6840686974732736,1.0,14/34,21.11%,PARD3;SPRED2;SMAD7;SPRED1;STOX1;SIRT2;RPTOR;MAPK1;BMP7;WNK3;AXIN1;CAB39;PLK1;SPRED3
prerank,GO_Biological_Process_2021__DNA metabolic process (GO:0006259),0.3889232122552007,1.206800754463713,0.09090909090909091,0.6834741346417169,1.0,25/239,9.75%,CHRNA4;UHRF2;DNASE1L2;BACH1;LIG4;SAMHD1;TOP3B;ZBTB1;DNA2;UBE2T;LTO1;POLD3;SMARCAD1;RAD18;DFFB;PDS5B;TOP1MT;STN1;UBE2N;CSNK1E;RAD52;MEN1;RAD51B;HMGB1;HELLS
prerank,GO_Biological_Process_2021__positive regulation of phospholipid transport (GO:2001140),-0.6964005356708733,-1.2064810797783292,0.2982456140350877,1.0,1.0,3/7,21.14%,APOE;PRELID1;DBI
prerank,PanglaoDB_Augmented_2021__Plasmacytoid Dendritic Cells,-0.5021247513803229,-1.2060434929573205,0.1506849315068493,1.0,1.0,19/59,18.42%,P2RY10;DOCK8;TAGAP;GPR183;BST2;DPEP2;ARHGAP9;GMFG;TRAF3IP3;ARHGAP30;IL3RA;SPI1;MYO1F;SERPINF1;BLNK;CXCR4;CDH1;NFAM1;WDFY4
prerank,PanglaoDB_Augmented_2021__Myoepithelial Cells,0.4468476859918362,1.206008896849874,0.15384615384615385,0.6858493979688524,1.0,7/61,5.00%,POSTN;SDC4;EPHA2;EGFR;ACTA2;PARVA;MME
prerank,GO_Biological_Process_2021__positive regulation of macrophage activation (GO:0043032),-0.6718183033011216,-1.2058461080977336,0.24193548387096775,1.0,1.0,5/8,28.30%,THBS1;WNT5A;HSPD1;TNIP2;IL33
prerank,GO_Biological_Process_2021__piRNA metabolic process (GO:0034587),0.5994611782695032,1.20574398001792,0.18518518518518517,0.685926969524778,1.0,2/13,3.00%,PLD6;PIWIL4
prerank,GO_Biological_Process_2021__response to gamma radiation (GO:0010332),0.5876248270807132,1.2057070525153608,0.23076923076923078,0.6854087074141002,1.0,6/21,18.39%,LIG4;MEN1;MAP3K20;YAP1;KDM1A;MDM2
prerank,GO_Biological_Process_2021__camera-type eye development (GO:0043010),0.561843557940299,1.2056265790106104,0.21951219512195122,0.6849524515055826,1.0,4/17,12.74%,TENM3;CEP290;NF1;RAB3GAP1
prerank,GO_Biological_Process_2021__beta-catenin destruction complex assembly (GO:1904885),0.750683089969113,1.2055916262209625,0.2641509433962264,0.6844055724144698,1.0,2/5,18.50%,GSK3B;AXIN1
prerank,GO_Biological_Process_2021__sympathetic ganglion development (GO:0061549),0.758124177450821,1.2055601117557804,0.21153846153846154,0.6838597117201748,1.0,4/6,16.26%,ASCL1;NRP2;NRP1;FZD3
prerank,GO_Biological_Process_2021__constitutive secretory pathway (GO:0045054),0.7943941767074787,1.2054936362065745,0.20454545454545456,0.6833909527719324,1.0,3/5,15.38%,TMEM167A;TMEM167B;TRAPPC11
prerank,GO_Biological_Process_2021__negative regulation of epithelial to mesenchymal transition (GO:0010719),-0.600959636863384,-1.2053750635838032,0.2,1.0,1.0,3/22,3.19%,SFRP2;OVOL2;EFNA1
prerank,GO_Biological_Process_2021__Ras protein signal transduction (GO:0007265),0.3854040389125687,1.2053294276138558,0.043478260869565216,0.6832727363271652,1.0,32/123,17.75%,RAP2B;EPS8;ARHGAP5;RAPGEF2;G3BP1;SHOC2;MAPK11;CCNA2;SHC3;RALB;NF1;PRKD1;GNA13;MRAS;CRKL;SOS1;NRAS;RRAS2;NCKAP1;RREB1;RAP2C;MAPKAPK5;RAP1A;TRIM28;CYFIP1;ROCK2;HACE1;CNKSR1;WASF1;CDH13;RAP2A;IGF1
prerank,GO_Biological_Process_2021__negative regulation of transcription by RNA polymerase II (GO:0000122),0.3372371528785551,1.205044260209043,0.0,0.6837015426802989,1.0,119/531,18.52%,ZFPM2;ANKRD2;TRPS1;BACH1;RARB;ETV5;KLF11;ZGLP1;NRIP1;MCPH1;HDAC9;NR2F6;MITF;FOXP1;SNCA;ZBTB1;SOX8;KCTD1;SALL1;EED;BMP2;TFAP2C;LCOR;NR4A2;LOXL2;ASCL1;DACH1;VHL;CPEB3;DR1;SOX9;ZEB1;NFIB;NFKB1;ZEB2;NEDD4L;FOXO3;HNRNPU;SMAD2;ZNF746;THRB;PCGF2;ZNF582;JDP2;CNOT2;SMAD7;ZNF254;NR2E1;TENM2;NR1D2;UBE2D1;SPEN;PPM1A;KLF12;MBD2;SMARCA2;ZNF568;HDAC2;PHF21A;ETS2;NR3C1;PSMD10;MEN1;GLI3;GLIS3;ZNF268;HMGB1;NR1D1;FOXP4;PRKN;ZNF451;ZNF589;CREM;EP300;ZNF148;MEIS2;ZHX2;ELK4;JAZF1;ZNF556;ZBTB16;PEX2;WWOX;TBL1XR1;NIPBL;HDAC4;SIRT1;RREB1;MAP2K5;SIRT2;DCAF1;SMAD4;MDM4;DLG1;SOX13;DUSP22;ZNF282;YAP1;USP9X;MIER3;ZNF140;IMPACT;SEMA4D;USP2;ZNF555;SUFU;ZNF614;ZNF141;CBFB;RUNX1;KDM1A;YY1;KDM1B;ZBTB21;ZBTB18;MDM2;RBPJ;ATRX;NFATC3
prerank,PanglaoDB_Augmented_2021__Principal Cells,0.4422498119854523,1.2042727802117366,0.13636363636363635,0.6852980199831645,1.0,9/61,7.69%,ACE2;CAPN13;FAM110C;MYO5B;NPNT;ARHGEF16;PLEKHA6;MAOA;ZBTB7C
prerank,GO_Biological_Process_2021__dermatan sulfate metabolic process (GO:0030205),0.604886810823057,1.2042247514205227,0.25,0.684799344135277,1.0,2/13,2.57%,DCN;CSPG5
prerank,GO_Biological_Process_2021__phosphatidylglycerol biosynthetic process (GO:0006655),0.6609057189077365,1.2041940402838731,0.22950819672131148,0.684241004608872,1.0,4/6,29.19%,GPAM;TAMM41;CDS2;SLC27A1
prerank,GO_Biological_Process_2021__negative regulation of cellular response to insulin stimulus (GO:1900077),0.5628728982641158,1.2041713588611063,0.25,0.6836836980880664,1.0,6/23,13.73%,PID1;KANK1;IRS1;RPS6KB1;PIP4K2C;NCK1
prerank,GO_Biological_Process_2021__cytokine-mediated signaling pathway (GO:0019221),-0.4428039999505011,-1.2040409287318385,0.05555555555555555,1.0,1.0,66/376,15.21%,GBP2;IFI6;IFIT1;GBP1;PSMB6;IFITM3;TRIM22;IL1R1;DUOX1;IRF1;IL5;RPS27A;IL7;BST2;HLA-B;HLA-A;MX1;STAT1;ISG15;F13A1;IFIT3;HLA-C;B2M;CEACAM1;CXCL2;ANXA1;IFIT2;TIMP1;PSMA8;IFNGR2;IL12A;PSMB9;IFI35;TRIM21;INPP5D;PSMA7;RSAD2;PIK3CB;PSMC3;CIITA;UBC;STAT2;MT2A;PSME1;MT3;CEBPD;LTBR;CA1;TXNDC17;OAS3;IL3RA;IL18;CX3CL1;PSMC4;SPI1;IL15RA;PSMA3;CTR9;IL20RA;RIPK2;AIM2;CCL2;FSCN1;IL34;CRLF2;GREM2
prerank,GO_Biological_Process_2021__monocarboxylic acid catabolic process (GO:0072329),0.5559640816929292,1.2034785265889618,0.23076923076923078,0.6852440523531627,1.0,8/17,28.72%,LPIN3;NUDT19;CYP4F12;ACOX1;FAAH;FAH;PPARD;CEL
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",-0.5360122267405755,-1.2034338593249587,0.16417910447761194,1.0,1.0,6/33,17.91%,RPS27A;RPA3;UBC;POLD2;RBX1;UBA52
prerank,PanglaoDB_Augmented_2021__Retinal Ganglion Cells,0.3789076900875522,1.2033808348735744,0.0,0.6848832116402095,1.0,32/144,15.29%,POU6F2;CHRNA4;PCDH8;KCTD8;RBPMS2;SNAP91;GALNT14;CAMKV;ADGRB3;PSD2;ATP2B3;RBFOX1;CACNA1B;SLC35F1;CDK5R2;KIF5A;GPHN;ASTN1;VSTM2B;FBLL1;ADGRA1;CELF3;SLITRK1;TMEM196;OLFM3;GRIP1;MAPK4;LY6H;KCNQ2;PURG;ELAVL3;DTX1
prerank,GO_Biological_Process_2021__RNA secondary structure unwinding (GO:0010501),0.681430528000885,1.2033060469073429,0.358974358974359,0.6844475822056768,1.0,4/7,31.12%,DHX9;AGO3;AGO1;AGO2
prerank,GO_Biological_Process_2021__positive regulation of protein-containing complex disassembly (GO:0043243),0.6331398864516553,1.203257115585011,0.32558139534883723,0.6839373708386567,1.0,3/11,13.50%,SMCR8;ADRB2;FYCO1
prerank,GO_Biological_Process_2021__regulation of hair cycle (GO:0042634),0.7413664597617293,1.203031322445085,0.2978723404255319,0.6839101184207058,1.0,2/5,12.75%,CLOCK;NIPBL
prerank,GO_Biological_Process_2021__negative regulation of phosphoprotein phosphatase activity (GO:0032515),0.5456441569802484,1.2028419113308961,0.21428571428571427,0.6837625221718876,1.0,7/17,28.28%,PPP1R1B;PPP4R4;GSK3B;ROCK2;ROCK1;STYXL1;IKBKB
prerank,GO_Biological_Process_2021__regulation of Notch signaling pathway (GO:0008593),0.43960984364173106,1.2028166195905117,0.16666666666666666,0.683179170215269,1.0,22/63,26.93%,KAT2B;EGFR;TSPAN14;ARRB1;MAML2;AKT1;YJEFN3;EP300;FBXW7;DTX1;YAP1;MAML1;YTHDF2;RBPJ;CREBBP;TSPAN5;MESP1;POFUT1;RFNG;POGLUT1;LLGL1;JAG1
prerank,PanglaoDB_Augmented_2021__Neural Stem/Precursor Cells,0.3820744836120856,1.2027145431374413,0.1,0.6829123433803297,1.0,26/114,14.12%,PCDH19;SEMA5B;PCDH8;CSPG5;MEIS3;SNAP91;CAMKV;ASCL1;ADGRL3;SOX9;RHBDL3;SALL3;MEGF10;SLC35F1;CDK5R2;NPAS3;ASTN1;ADGRA1;CELF3;SLITRK1;GPM6B;MAPK4;LY6H;TMTC4;KCNQ2;PTPRZ1
prerank,GO_Biological_Process_2021__regulation of branching involved in ureteric bud morphogenesis (GO:0090189),0.6793586160283859,1.2026915172442738,0.23684210526315788,0.6816904298839838,1.0,2/7,4.24%,SOX8;SOX9
prerank,GO_Biological_Process_2021__positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),0.6793586160283859,1.2026915172442738,0.23684210526315788,0.6816904298839838,1.0,2/7,4.24%,SOX8;SOX9
prerank,GO_Biological_Process_2021__regulation of Ras protein signal transduction (GO:0046578),0.4319844130870834,1.202069037057269,0.08695652173913043,0.682953694070513,1.0,21/70,19.22%,STARD13;EPS8;NOTCH2;KBTBD7;KANK1;EPOR;SPRY4;DENND4C;KBTBD6;DENND1A;SHOC2;SPRY3;CRKL;OGT;OPHN1;SYNGAP1;RALGPS1;IGF1;ARHGAP17;ARF6;ARHGDIA
prerank,GO_Biological_Process_2021__negative regulation of transcription by competitive promoter binding (GO:0010944),0.7970959277225774,1.2020140287626764,0.23076923076923078,0.6826431501176539,1.0,2/6,7.25%,DACH1;SMAD7
prerank,GO_Biological_Process_2021__regulation of smoothened signaling pathway (GO:0008589),0.45587408809144947,1.2019239836561546,0.09090909090909091,0.6824677504682849,1.0,10/44,17.02%,MOSMO;BTRC;FBXL17;RORA;GLI3;HERC4;DLG5;VCP;SMO;SUFU
prerank,GO_Biological_Process_2021__negative regulation of cation channel activity (GO:2001258),0.5789867766465947,1.2007179584573002,0.1794871794871795,0.6857735275779095,1.0,8/17,22.43%,GSTM2;PKD2;CBARP;UBQLN1;DRD2;SLC6A9;FMR1;GPR35
prerank,GO_Biological_Process_2021__cellular amide metabolic process (GO:0043603),-0.463173373202003,-1.2002478275867288,0.1875,1.0,1.0,15/89,12.00%,ACOT2;ACOT1;ORMDL2;ABCA12;ACOT6;PM20D1;GLYAT;ST6GAL1;ACSM6;NIT1;GNE;PLAAT4;ACSM5;ORMDL1;ACSM3
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell membrane potential (GO:0086036),-0.7586457072812836,-1.2002203547606936,0.22448979591836735,1.0,1.0,3/6,18.80%,PLN;SLC8B1;TRDN
prerank,GO_Biological_Process_2021__regulation of dendrite extension (GO:1903859),0.5253239956402233,1.199780743104847,0.22857142857142856,0.687909070215034,1.0,4/18,12.50%,SYT3;NEDD4L;SMURF1;RASAL1
prerank,GO_Biological_Process_2021__positive regulation of activated T cell proliferation (GO:0042104),-0.7280238220660944,-1.199458431032436,0.2727272727272727,1.0,1.0,3/10,12.13%,CD24;HHLA2;IL18
prerank,GO_Biological_Process_2021__positive regulation of signaling (GO:0023056),0.5323886291450651,1.1993926814422733,0.15151515151515152,0.6882810962087135,1.0,13/28,24.54%,KCTD13;SNCA;HOMER1;RIMS3;CLSTN2;NSF;SCRIB;CDKN2AIP;PTPN23;GRIK2;RIMS2;HCRT;VAMP3
prerank,PanglaoDB_Augmented_2021__Natural Killer T Cells,-0.5463080896504394,-1.1992518164382906,0.18421052631578946,1.0,1.0,9/39,7.73%,P2RY10;TAGAP;CD5;DPEP2;THEMIS;ARHGAP9;GPR171;GMFG;TRAF3IP3
prerank,GO_Biological_Process_2021__microtubule bundle formation (GO:0001578),0.469417643565869,1.1992387172855983,0.16666666666666666,0.688220388637209,1.0,4/35,2.53%,MTCL1;SPAG16;NCKAP5;ZNF207
prerank,GO_Biological_Process_2021__neurotransmitter-gated ion channel clustering (GO:0072578),0.7271515137861564,1.1992327473646662,0.30952380952380953,0.6875941644437266,1.0,3/6,11.56%,SHISA7;GPHN;SHANK3
prerank,GO_Biological_Process_2021__NLS-bearing protein import into nucleus (GO:0006607),0.5695292429629004,1.1990941006415108,0.21621621621621623,0.6872665066782978,1.0,6/17,24.37%,RGPD3;KPNA4;CBLB;IPO5;RANBP2;NUP54
prerank,"GO_Biological_Process_2021__synaptic transmission, glutamatergic (GO:0035249)",0.5512726988755221,1.1986037434537533,0.21951219512195122,0.6884103747046649,1.0,9/16,32.03%,NAPB;GRID1;GRIK2;GRIA2;UNC13A;CDH8;GRIK1;GRID2;GRIK5
prerank,"GO_Biological_Process_2021__chemical synaptic transmission, postsynaptic (GO:0099565)",0.5360064030605629,1.1985356983812803,0.21875,0.687948971317782,1.0,8/21,16.77%,CHRNA4;GRIN1;MPP2;AKT1;NLGN3;RAB3GAP1;GSK3B;INSYN1
prerank,GO_Biological_Process_2021__regulation of gene expression (GO:0010468),0.32158841221058804,1.198496020265217,0.0,0.687384587957108,1.0,214/776,21.35%,ACE2;POU6F2;NUDT21;PPARGC1A;SLC24A3;PID1;LIMD1;FEZF2;CAVIN4;BACH1;USP13;YAF2;ZNF804A;AMH;MITF;FOXP1;BTN3A3;WTIP;ANK2;HNRNPH1;SOX4;BMP2;TFAP2C;PICALM;RPS6KA4;SERPINB9;RAB27A;ACTA2;ASCL1;ESRRG;ABCC2;ITGB8;PSPC1;VHL;SORT1;RGCC;SOX9;RORA;SMCR8;NOTCH2;NFKB1;RBM12B;FGF17;ADNP2;HCLS1;MBNL2;ZNF407;NFXL1;MBIP;CHD7;ZNF212;HMG20A;C1D;AKT1;NTRK2;GABPA;RFX3;RNF6;PUM2;NFYC;IGF2BP2;NR1D2;NCOA2;ROBO1;GPBP1L1;ADNP;SP3;SMARCA2;UBR5;NLK;ZNF117;ZNF280D;ZNF516;RNF14;TICAM1;SOX6;MAGED1;MAPK11;ZNF33A;NR3C1;SFMBT2;CLOCK;TGFBRAP1;ZNF268;PRKN;CAMK2N1;ZNF451;SUPT3H;ZNF737;BRAF;CREM;EP300;ZNF736;TNRC6B;HNRNPLL;ZNF148;HNRNPH3;FOXN2;FBXW7;STOX1;MBNL1;HP1BP3;DVL1;AHR;CRKL;FUBP1;ZNF423;ZNF519;AFDN;OCLN;TFEB;HDAC4;SIRT1;TGFBR1;PRKAB1;APBB2;RREB1;HAVCR2;PRDM8;KAT7;ZNF680;BMPR1A;FOXN3;MAPK1;CLK1;ZUP1;AGO3;MLXIPL;TRIP4;POU3F1;GSK3B;SOX13;ZBTB38;PTBP2;ROCK2;AFF1;ATP2B4;ZNF282;YAP1;ZFAT;MAPK8;SMO;BMP7;CCAR1;DMTF1;TRIM44;TFRC;SUFU;KAT6B;PUM1;ZNF141;POGZ;MYT1;ATF2;HIF1A;CXXC1;RUNX1;ZNF703;NDFIP1;RBM20;ALPK2;IGF1;LARP4;TOB2;YY1;PTBP1;CELF1;YTHDF2;SRPK2;ZNF462;UTP4;CIAO3;RBPJ;ATRX;RORB;CPNE1;SSBP2;SOX21;APBB1;DNM2;RBM38;HNRNPD;RBMS3;ASCC1;PPM1F;MAP2K2;ZC3H7A;SPIN3;NOVA1;NSD2;REST;MAPK9;ROCK1;LEF1;NFE2L2;PCBP4;ZNF646;PRDM2;ESRRB;SPTY2D1;ATOH8;NFIA;UBAP2;PPP2R1A;IFI16;ZPR1;NFATC2;NFIL3;CREBBP;PTPRC;MYD88;HSPA1A;NOVA2;AURKA
prerank,GO_Biological_Process_2021__regulation of actin cytoskeleton organization (GO:0032956),0.4334540659710429,1.1983792036938716,0.07142857142857142,0.6870583071912701,1.0,17/72,11.65%,EFNA5;EPS8;CSF1R;NOTCH2;RHOQ;PDGFRA;ARHGAP35;TESK1;RHOBTB3;EPHA5;PIK3CA;BST1;PDGFA;ABL2;FAM107A;PAK3;GPM6B
prerank,GO_Biological_Process_2021__negative regulation of insulin receptor signaling pathway (GO:0046627),0.5628891934380991,1.1982443046452804,0.2777777777777778,0.6868214415822406,1.0,6/22,13.73%,PID1;KANK1;IRS1;RPS6KB1;PIP4K2C;NCK1
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",0.4651115937990027,1.1979355196116566,0.11428571428571428,0.6871470514830799,1.0,9/51,9.59%,PNLDC1;PDE12;EXOSC6;DCP1B;CNOT9;CNOT6L;CNOT2;EXOSC1;CNOT4
prerank,GO_Biological_Process_2021__arginine catabolic process (GO:0006527),-0.7373512847860234,-1.1978660319580356,0.3137254901960784,1.0,1.0,2/5,13.85%,ARG2;NOS1
prerank,GO_Biological_Process_2021__hematopoietic stem cell proliferation (GO:0071425),-0.6732295213769669,-1.1978393328698496,0.24074074074074073,1.0,1.0,3/9,8.97%,SFRP2;ARIH2;WNT2B
prerank,GO_Biological_Process_2021__organic hydroxy compound catabolic process (GO:1901616),-0.7708296042010229,-1.197592947744222,0.20754716981132076,1.0,1.0,1/7,0.78%,ADH4
prerank,"GO_Biological_Process_2021__tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",0.5637890553627103,1.197531844402575,0.21739130434782608,0.68793017109036,1.0,2/15,8.40%,TSEN15;ZBTB8OS
prerank,GO_Biological_Process_2021__positive regulation of interferon-beta production (GO:0032728),-0.5609651671169757,-1.1972706614068085,0.21666666666666667,1.0,1.0,7/27,17.83%,IRF1;ISG15;TLR3;OAS3;RIPK2;POLR3G;FLOT1
prerank,GO_Biological_Process_2021__cellular response to growth factor stimulus (GO:0071363),0.40613332223713516,1.1968394224698744,0.058823529411764705,0.6897748863670307,1.0,37/126,16.20%,WNT7A;PDE3A;ACAP2;SOX5;BMP2;EGFR;FLT1;SOX9;AKT1;NTRK2;RAPGEF2;SMAD7;MTSS2;BMPR1B;RPS6KB1;SOX6;NR3C1;PRKD1;CRKL;TGFBR2;ACVR1;WWOX;MAPKAPK2;TGFBR1;MAGI2;MAP2K5;SIRT2;ACVR2A;RAP1A;BMPR1A;SMAD4;DUSP22;PTPN11;CPNE3;NRP1;HGF;BMP7
prerank,GO_Biological_Process_2021__anterograde axonal transport (GO:0008089),0.49690409347770115,1.1959361691485375,0.21428571428571427,0.6917932832874614,1.0,8/32,12.56%,AP3S1;KIF5A;TRAK1;AP3B1;TRAK2;KIF5C;RAB21;KIF1B
prerank,GO_Biological_Process_2021__positive regulation of integrin-mediated signaling pathway (GO:2001046),-0.7956200279482868,-1.1958417292526322,0.23636363636363636,1.0,1.0,2/6,17.03%,CD63;EMP2
prerank,GO_Biological_Process_2021__proteasomal protein catabolic process (GO:0010498),0.3869533030084967,1.1952634335037997,0.13636363636363635,0.6932185468396174,1.0,53/186,17.56%,SPSB4;RCN3;FEM1B;BTRC;KCTD13;SPSB2;FBXL17;UBE2G1;RHBDD1;TRIM9;SOCS6;KBTBD7;ARRB1;NEDD4L;MARCHF6;KCTD17;PSMA1;KBTBD6;FEM1C;ATE1;KLHL42;PSMD11;ITCH;PSMD10;CLOCK;NR1D1;PRKN;RMND5A;PSMF1;FBXW7;COP1;KCTD10;PSMD14;PCNP;SMURF1;TBL1XR1;UBXN6;SIRT1;AGAP3;SIRT2;SPOPL;FBXO45;VCP;KCTD5;CDC34;FAF1;HACE1;BIRC2;RNF41;PSME4;BFAR;ANKRD9;CUL3
prerank,GO_Biological_Process_2021__negative regulation of execution phase of apoptosis (GO:1900118),0.678950924419913,1.1951808770032624,0.32,0.6928890707600786,1.0,3/6,29.95%,FZD3;BCL2L1;PAK2
prerank,GO_Biological_Process_2021__anaphase-promoting complex-dependent catabolic process (GO:0031145),-0.4746202011279375,-1.19510880193999,0.11764705882352941,1.0,1.0,14/69,13.44%,PSMB6;RPS27A;ANAPC15;ANAPC11;PSMA8;PSMB9;PSMA7;PSMC3;UBC;PSME1;SKP2;CDC26;PSMC4;PSMA3
prerank,GO_Biological_Process_2021__bile acid biosynthetic process (GO:0006699),0.4610597030346698,1.1950189038579575,0.16216216216216217,0.6925896090819843,1.0,7/20,29.52%,HSD17B4;OSBPL7;OSBPL1A;SCP2;CYP39A1;CYP7B1;HSD3B7
prerank,GO_Biological_Process_2021__protein K63-linked deubiquitination (GO:0070536),0.5152488233753091,1.1948253304549672,0.25,0.6927316162781616,1.0,9/30,16.64%,USP13;OTUB2;ZRANB1;PSMD14;USP25;OTUD4;UIMC1;ABRAXAS2;BRCC3
prerank,GO_Biological_Process_2021__positive regulation of receptor binding (GO:1900122),-0.7803346496657211,-1.1945150693964164,0.21666666666666667,1.0,1.0,2/5,5.93%,B2M;BDNF
prerank,GO_Biological_Process_2021__C4-dicarboxylate transport (GO:0015740),0.5686636257411696,1.1943926259976563,0.3142857142857143,0.6936369624366683,1.0,7/13,33.07%,SLC25A18;SLC25A14;SLC25A13;SLC25A12;SLC1A2;LRRC8D;SLC13A5
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle contraction (GO:0045986),0.793166245169181,1.1942331208517523,0.2765957446808511,0.693469677685453,1.0,3/5,11.94%,KCNMA1;ADRB2;DOCK4
prerank,GO_Biological_Process_2021__phosphatidylethanolamine metabolic process (GO:0046337),0.5218294538615507,1.1942006199930446,0.22916666666666666,0.6930095290874907,1.0,1/23,0.75%,LPIN3
prerank,GO_Biological_Process_2021__mesenchymal cell differentiation (GO:0048762),0.47751139532262027,1.1939909973230256,0.2,0.6930774265214404,1.0,16/41,19.94%,BMP2;RANBP3L;LOXL2;FBXL17;SOX9;DLG5;TGFBR1;TRIM28;GSK3B;ROCK2;HGF;BMP7;HIF1A;RBPJ;ROCK1;LEF1
prerank,GO_Biological_Process_2021__anion transport (GO:0006820),0.5264405013692037,1.193662062390818,0.17073170731707318,0.6935110014895781,1.0,3/25,4.80%,SLC26A7;SLC19A1;SLC26A3
prerank,GO_Biological_Process_2021__sphingolipid metabolic process (GO:0006665),0.4246353789553582,1.1933528653264125,0.1,0.694104609248085,1.0,21/99,13.58%,VAPB;CERS3;SGMS1;ELOVL7;ESYT3;VAPA;HACD2;ACER3;PLPP1;ESYT2;ELOVL6;SPNS2;GAL3ST1;PRKD1;PPM1L;PLPP3;PLPP2;ELOVL5;HEXB;ABCA2;ARV1
prerank,GO_Biological_Process_2021__positive regulation of protein targeting to mitochondrion (GO:1903955),-0.5583931763355906,-1.1932859653669672,0.18055555555555555,1.0,1.0,3/26,8.72%,TOMM7;UBL5;ARIH2
prerank,GO_Biological_Process_2021__acetyl-CoA metabolic process (GO:0006084),0.5917308761138168,1.193123813728114,0.2,0.694142135401044,1.0,1/14,0.90%,ACACB
prerank,GO_Biological_Process_2021__response to estrogen (GO:0043627),-0.5457405317984529,-1.1931067470965198,0.25806451612903225,1.0,1.0,5/25,12.61%,CD24;SFRP1;GSTM3;BRCA1;SFR1
prerank,GO_Biological_Process_2021__lactation (GO:0007595),0.6408772977025736,1.193048179307562,0.25,0.693785588946828,1.0,1/8,2.79%,ERBB4
prerank,GO_Biological_Process_2021__regulation of homotypic cell-cell adhesion (GO:0034110),-0.6717349702068165,-1.193026458404476,0.32727272727272727,1.0,1.0,3/10,10.51%,RDX;PRKCQ;CELA2A
prerank,GO_Biological_Process_2021__cell cycle checkpoint signaling (GO:0000075),-0.6453576277594143,-1.1929449895347188,0.25396825396825395,1.0,1.0,3/9,18.33%,ZWILCH;WEE1;WEE2
prerank,GO_Biological_Process_2021__regulation of myelination (GO:0031641),0.5438666368109639,1.1927557151993258,0.17647058823529413,0.6938233325400679,1.0,7/21,21.04%,PARD3;MYRF;JAM2;SIRT2;PTPRZ1;RNF10;ZPR1
prerank,GO_Biological_Process_2021__regulation of sensory perception (GO:0051931),0.6688862021043074,1.192532771230285,0.18421052631578946,0.6940212438583062,1.0,2/8,6.35%,MGLL;SPX
prerank,GO_Biological_Process_2021__extracellular matrix assembly (GO:0085029),0.5945467543281184,1.1925243101002867,0.18181818181818182,0.6934183410889693,1.0,2/17,3.89%,LAMB4;QSOX1
prerank,GO_Biological_Process_2021__ER-associated misfolded protein catabolic process (GO:0071712),0.6411564379579199,1.192515561932896,0.2564102564102564,0.6928310510633321,1.0,8/11,33.89%,UGGT1;VCP;DERL1;RNF185;BAG6;AUP1;UGGT2;POMT2
prerank,GO_Biological_Process_2021__regulation of leukocyte cell-cell adhesion (GO:1903037),0.657914802033885,1.192353978551149,0.21621621621621623,0.692927620311994,1.0,2/8,6.29%,FUT9;AKT1
prerank,GO_Biological_Process_2021__negative regulation of B cell activation (GO:0050869),-0.6675593804431627,-1.192270937012613,0.2631578947368421,1.0,1.0,5/12,17.56%,INHA;SFRP1;ID2;TNFRSF21;BANK1
prerank,GO_Biological_Process_2021__negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),-0.5674575986056243,-1.1921679336295143,0.22058823529411764,1.0,1.0,5/23,6.86%,RPL23;RPL11;RPS7;EFNA1;RPL5
prerank,GO_Biological_Process_2021__regulation of trophoblast cell migration (GO:1901163),-0.6491879226655899,-1.1919968486371304,0.27692307692307694,1.0,1.0,2/12,9.68%,TIMP1;NODAL
prerank,GO_Biological_Process_2021__calcium-ion regulated exocytosis (GO:0017156),0.5359385441576998,1.1918031878252109,0.25806451612903225,0.6937352586702912,1.0,6/20,18.14%,SYT3;DOC2B;RIMS3;SYT9;PPP3CB;ARHGAP17
prerank,GO_Biological_Process_2021__regulation of gene silencing by RNA (GO:0060966),0.46280580375295577,1.191787591569175,0.15,0.6925787680930348,1.0,14/50,24.56%,NUP42;NUP37;NUP188;PUM2;IPO8;NUP153;NDC1;NUP205;PUM1;NUP214;FMR1;RANBP2;NUP54;NUP98
prerank,GO_Biological_Process_2021__regulation of posttranscriptional gene silencing (GO:0060147),0.46280580375295577,1.191787591569175,0.15,0.6925787680930348,1.0,14/50,24.56%,NUP42;NUP37;NUP188;PUM2;IPO8;NUP153;NDC1;NUP205;PUM1;NUP214;FMR1;RANBP2;NUP54;NUP98
prerank,GO_Biological_Process_2021__regulation of microtubule depolymerization (GO:0031114),0.5107597684217231,1.1916114792843626,0.21875,0.6924870232721114,1.0,13/24,29.08%,TTBK2;NAV3;CAMSAP2;CLASP1;HDGFL3;KATNB1;ATXN7;CIB1;TRIM54;TAOK1;CLASP2;ARHGEF2;FGF13
prerank,GO_Biological_Process_2021__regulation of RNA export from nucleus (GO:0046831),0.6663535515821176,1.1915339272445538,0.3684210526315789,0.6921206289359745,1.0,5/12,16.70%,IWS1;CPSF6;NUP153;DHX9;SETD2
prerank,GO_Biological_Process_2021__positive regulation of morphogenesis of an epithelium (GO:1905332),0.5706170621261746,1.1913831529329468,0.2222222222222222,0.6919138429311378,1.0,2/14,4.24%,SOX8;SOX9
prerank,GO_Biological_Process_2021__regulation of gap junction assembly (GO:1903596),0.7113011832532448,1.1912844009383992,0.26,0.691534163015027,1.0,1/5,0.08%,ACE2
prerank,GO_Biological_Process_2021__positive regulation of reactive oxygen species metabolic process (GO:2000379),0.5099149800096264,1.1912576532904027,0.12903225806451613,0.6910253231163058,1.0,4/31,4.99%,ACE2;PID1;RAB27A;GRIN1
prerank,GO_Biological_Process_2021__glycolipid transport (GO:0046836),-0.7325825556207272,-1.1912385125459044,0.2222222222222222,1.0,1.0,2/6,18.22%,CLN3;CPTP
prerank,GO_Biological_Process_2021__mitochondrial RNA metabolic process (GO:0000959),0.6021224128516985,1.1912357745934272,0.21052631578947367,0.6904885542462633,1.0,4/12,12.90%,FASTKD1;FOXO3;TFB1M;MTERF1
prerank,GO_Biological_Process_2021__negative regulation of myeloid leukocyte differentiation (GO:0002762),-0.6142348038019656,-1.1910144754558438,0.2542372881355932,1.0,1.0,4/16,13.47%,CEACAM1;INHA;TLR3;ZFPM1
prerank,GO_Biological_Process_2021__regulation of macromolecule metabolic process (GO:0060255),0.37691780318841234,1.190743820439504,0.10526315789473684,0.6910759393950421,1.0,38/136,21.65%,FEZF2;CAVIN4;FOXP1;ASCL1;SORT1;ADNP2;ZNF407;HMG20A;C1D;IGF2BP2;ADNP;MKLN1;ZNF451;STOX1;AHR;FUBP1;TFEB;ZUP1;ROCK2;AFF1;MTMR2;TRIM44;POGZ;HIF1A;ALPK2;IGF1;TOB2;ZNF462;CIAO3;HNRNPD;NOVA1;REST;PCBP4;PRDM2;UBAP2;PTPRC;NOVA2;GNB3
prerank,GO_Biological_Process_2021__regulation of microvillus assembly (GO:0032534),-0.7848375004212879,-1.1906089813160494,0.265625,1.0,1.0,3/5,20.15%,PODXL;FSCN1;ATP8B1
prerank,GO_Biological_Process_2021__UV-damage excision repair (GO:0070914),0.6402334701552886,1.190284022591378,0.32558139534883723,0.6917917783783106,1.0,2/11,13.01%,POLD3;SIRT1
prerank,GO_Biological_Process_2021__amino acid import across plasma membrane (GO:0089718),0.5128855761251623,1.190208410682941,0.20512820512820512,0.6914713731446496,1.0,5/18,23.66%,SLC6A13;SLC47A1;SLC6A6;SLC6A9;SLC22A2
prerank,GO_Biological_Process_2021__protein localization to vacuole (GO:0072665),-0.6549472466210278,-1.190176255191722,0.3148148148148148,1.0,1.0,1/14,0.79%,GBP1
prerank,GO_Biological_Process_2021__membrane biogenesis (GO:0044091),-0.7081220683264999,-1.1899324835987137,0.22413793103448276,1.0,1.0,1/7,0.47%,TLCD1
prerank,GO_Biological_Process_2021__positive regulation of vascular permeability (GO:0043117),0.6296343062753951,1.1898472749366684,0.26666666666666666,0.691927088623141,1.0,3/11,14.04%,PDE3A;OCLN;TJP1
prerank,GO_Biological_Process_2021__regulation of response to interferon-gamma (GO:0060330),-0.6076872654583385,-1.1897458477401746,0.2807017543859649,1.0,1.0,5/12,21.24%,STAT1;IFNGR2;CDC37;SOCS3;PARP9
prerank,GO_Biological_Process_2021__regulation of aldosterone biosynthetic process (GO:0032347),0.7314833642785722,1.1895656563752626,0.23529411764705882,0.6921237120041047,1.0,1/5,2.72%,BMP2
prerank,GO_Biological_Process_2021__regulation of histone H3-K27 methylation (GO:0061085),0.674067508761208,1.1894310167081426,0.325,0.6919472284122589,1.0,2/6,24.34%,OGT;MACROH2A1
prerank,GO_Biological_Process_2021__response to muscle stretch (GO:0035994),0.6193798050965927,1.1893847090832896,0.21739130434782608,0.6914559158208199,1.0,4/12,11.91%,TCAP;CDH2;PIK3CA;PTK2
prerank,GO_Biological_Process_2021__positive regulation of multicellular organismal process (GO:0051240),0.36009213068770207,1.1891375693836026,0.14285714285714285,0.6917096830575611,1.0,47/222,14.90%,PPARGC1A;LEPR;TNFSF4;SERPINE1;SOX8;SOX5;BMP2;ABCA1;PLAC8;HADH;LOXL2;ESRRG;RGCC;SOX9;ADIPOR2;SMAD2;ELOVL6;TRPM4;RFX3;ADRB2;BMPR1B;ZNF516;PLCB1;ADRA1A;SOX6;NCOA3;CADM1;KAT2A;ADRB1;TGFBR2;LURAP1;ZBTB16;ACVR1;TAPT1;SIRT1;TGFBR1;PRKAB1;RREB1;PDGFC;OGT;B4GALT5;BMPR1A;ALMS1;SMAD4;ADIPOR1;TRIM16;UCN
prerank,GO_Biological_Process_2021__cardiac muscle tissue morphogenesis (GO:0055008),0.6134420680651651,1.188910168401349,0.2608695652173913,0.6916484195082948,1.0,3/16,7.25%,TCAP;BMP2;SMAD7
prerank,GO_Biological_Process_2021__negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),0.6084945501426986,1.1888016660685286,0.3333333333333333,0.6913872459951578,1.0,2/14,5.99%,TAFA5;PRKG1
prerank,GO_Biological_Process_2021__negative regulation of intracellular estrogen receptor signaling pathway (GO:0033147),0.67931523867462,1.1885879928859568,0.25,0.6912407239619641,1.0,3/8,9.68%,CNOT9;CNOT2;STRN3
prerank,GO_Biological_Process_2021__UDP-N-acetylglucosamine biosynthetic process (GO:0006048),-0.6675576021469714,-1.188433562558811,0.29508196721311475,1.0,1.0,4/11,23.31%,UAP1;GNPDA1;UAP1L1;GFPT2
prerank,GO_Biological_Process_2021__UDP-N-acetylglucosamine metabolic process (GO:0006047),-0.6675576021469714,-1.188433562558811,0.29508196721311475,1.0,1.0,4/11,23.31%,UAP1;GNPDA1;UAP1L1;GFPT2
prerank,GO_Biological_Process_2021__response to organonitrogen compound (GO:0010243),0.48776511253272753,1.1880924161502495,0.2962962962962963,0.6922354186105094,1.0,9/32,14.67%,RCN3;RHBDD1;MARCHF6;PRKN;GLRB;KYNU;UBXN6;KAT7;VCP
prerank,GO_Biological_Process_2021__protein transport (GO:0015031),0.3588906281714607,1.188063876625102,0.0,0.691732173226585,1.0,65/293,19.71%,TXNIP;ATP6V0D2;RCN3;TBC1D4;ARFIP1;ARL5A;ABCA1;TBC1D1;TVP23B;LRP1B;USP6NL;TBC1D5;ATP6V1A;TBC1D12;EVI5L;TMEM167A;CMTM6;CHMP1A;RAB31;RAB18;TANGO6;RAB23;RAB8B;CEP290;SNX27;ATP6V1C1;SLC10A7;TBC1D22B;AP3B1;ARFRP1;GOLPH3;FAM91A1;MTTP;SCFD2;GGA2;RAB21;GOLGA7;CHMP2B;NAPB;NDC1;TBC1D8B;KIF13A;RAB22A;ATP6V1B2;TMED3;NSF;STX1A;SNX13;STX8;TBC1D10A;RAB1A;TMED5;TFRC;RABGAP1L;RAB28;BBS2;SEC23IP;TBCK;MIA2;DNM2;ARF6;OLFM2;SCAMP1;STX12;STX7
prerank,GO_Biological_Process_2021__late endosome to Golgi transport (GO:0034499),-0.7779128264456628,-1.1879650768474888,0.3389830508474576,1.0,1.0,2/5,17.72%,RAB7B;GCC2
prerank,GO_Biological_Process_2021__negative regulation of dendritic spine development (GO:0061000),-0.7087237773110973,-1.1879466818499238,0.32653061224489793,1.0,1.0,1/7,3.19%,EFNA1
prerank,GO_Biological_Process_2021__dopamine metabolic process (GO:0042417),0.5830469135887067,1.1879070825769917,0.2391304347826087,0.6916711566987088,1.0,3/13,10.08%,SNCA;MAOA;PRKN
prerank,GO_Biological_Process_2021__negative regulation of cytoskeleton organization (GO:0051494),0.5296136726387893,1.1878201036131941,0.24324324324324326,0.6912404012350432,1.0,13/27,17.00%,SHANK1;IQCJ-SCHIP1;KANK1;PIK3CA;PRKN;SHANK3;SLIT2;SSH1;CLASP1;TJP1;SMAD4;ARFGEF1;CYRIB
prerank,GO_Biological_Process_2021__carboxylic acid biosynthetic process (GO:0046394),0.6594870049807218,1.187750561369587,0.2826086956521739,0.6909240938686113,1.0,4/10,11.14%,CARNS1;UGDH;UGP2;SLC35D1
prerank,GO_Biological_Process_2021__protein K27-linked ubiquitination (GO:0044314),0.7172212325547668,1.1874341174860068,0.2727272727272727,0.6912899411103963,1.0,3/6,10.08%,UBE2T;RNF6;PRKN
prerank,GO_Biological_Process_2021__polarized epithelial cell differentiation (GO:0030859),0.6091745030596746,1.1873479888533387,0.3333333333333333,0.6909173882542534,1.0,9/11,38.62%,OPHN1;SCRIB;RAP2A;RAB10;CAMSAP3;ZDHHC7;CDC42;EZR;RHOA
prerank,GO_Biological_Process_2021__dendrite self-avoidance (GO:0070593),0.5977278690912806,1.187346038603261,0.25,0.6903328485167052,1.0,4/14,16.04%,NPTN;EMB;BSG;CNTN4
prerank,GO_Biological_Process_2021__histone H3-K14 acetylation (GO:0044154),0.7130247216461345,1.1872151011568628,0.2857142857142857,0.6900892384990197,1.0,2/7,13.97%,PHF14;KAT7
prerank,GO_Biological_Process_2021__snRNA transcription by RNA polymerase III (GO:0042796),0.6954122805765843,1.1871574811881713,0.358974358974359,0.6896054833177826,1.0,3/8,18.17%,SNAPC1;SNAPC3;SNAPC5
prerank,GO_Biological_Process_2021__calcineurin-mediated signaling (GO:0097720),0.6108314183382462,1.1865518203464078,0.3055555555555556,0.6903215374931285,1.0,7/9,23.42%,NFAT5;PPP3CB;ADGRB2;NFATC3;NFATC2;PPP3CA;NFATC1
prerank,GO_Biological_Process_2021__calcineurin-NFAT signaling cascade (GO:0033173),0.6108314183382462,1.1865518203464078,0.3055555555555556,0.6903215374931285,1.0,7/9,23.42%,NFAT5;PPP3CB;ADGRB2;NFATC3;NFATC2;PPP3CA;NFATC1
prerank,GO_Biological_Process_2021__positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),0.43909123088244967,1.1861879856975976,0.16666666666666666,0.6908974102677323,1.0,18/53,16.25%,DCN;FLT1;SOX9;PDGFRA;HCLS1;EPOR;CBL;NTRK2;PIK3CA;PIK3R1;PDGFA;ROR1;PTK2;SIRT1;PDGFC;GAB1;HGF;SEMA4D
prerank,GO_Biological_Process_2021__RNA catabolic process (GO:0006401),0.4541645885964381,1.185847319985888,0.2,0.691204348700183,1.0,10/38,22.46%,DNA2;RIDA;AGO3;ZC3H12D;YTHDF2;PPP1R8;HNRNPD;ZPR1;HSPA1A;DIS3L2
prerank,GO_Biological_Process_2021__heart morphogenesis (GO:0003007),0.5107224688394097,1.1855903646407917,0.1875,0.6914403082071532,1.0,12/35,14.40%,TCAP;BMP2;SOX9;FLRT2;TBX19;CHD7;PTK2;ACVR1;NIPBL;TGFBR1;BMPR1A;MDM4
prerank,GO_Biological_Process_2021__presynaptic membrane assembly (GO:0097105),0.653298307063631,1.185546343477151,0.21052631578947367,0.6910423556490837,1.0,10/10,34.71%,NLGN3;NLGN4X;PTEN;LRP4;NLGN1;NLGN2;IL1RAPL1;CEL;NLGN4Y;PTPRD
prerank,PanglaoDB_Augmented_2021__Osteocytes,0.4271020776827244,1.1853965188479842,0.12903225806451613,0.6908842061298941,1.0,20/80,15.63%,TENM3;EFNA5;EPHA2;PARVA;CDH11;PCDH18;NRP2;MID1;ROR1;VEGFC;LOXL1;GLI3;EFNB2;GPR161;FBLIM1;SLIT2;ENAH;ADGRL2;PTPN14;YAP1
prerank,GO_Biological_Process_2021__negative regulation of metallopeptidase activity (GO:1905049),-0.7777256800017631,-1.1853885407400315,0.16666666666666666,1.0,1.0,1/5,5.04%,TIMP1
prerank,GO_Biological_Process_2021__negative regulation of transferase activity (GO:0051348),-0.5463677141866923,-1.1853446432786425,0.25,1.0,1.0,1/27,0.16%,PIF1
prerank,GO_Biological_Process_2021__endoderm formation (GO:0001706),-0.6273596418336764,-1.1847353845207953,0.18461538461538463,1.0,1.0,7/20,18.44%,COL8A1;ITGA5;NODAL;DUSP1;LAMB1;COL4A2;MMP14
prerank,GO_Biological_Process_2021__positive regulation of protein modification by small protein conjugation or removal (GO:1903322),0.4330364047793829,1.1847001893007696,0.2,0.6922722376438958,1.0,25/64,24.89%,DCUN1D1;SMAD7;UBE2D1;FAM107A;PSMD10;FBXW7;PIAS1;DCUN1D5;HDAC4;COMMD1;UBQLN1;DCUN1D4;PIAS4;BIRC2;CUL3;NDFIP1;DCUN1D2;AXIN1;BCL10;WDR48;DERL1;TANK;NDFIP2;HUWE1;RCHY1
prerank,GO_Biological_Process_2021__regulation of histone exchange (GO:1900049),0.6364311378292419,1.184692742353072,0.29545454545454547,0.6910848067045409,1.0,6/9,31.95%,POT1;ATRX;DAXX;TERF2IP;H3-3A;TERF2
prerank,GO_Biological_Process_2021__positive regulation of histone exchange (GO:1900051),0.6364311378292419,1.184692742353072,0.29545454545454547,0.6910848067045409,1.0,6/9,31.95%,POT1;ATRX;DAXX;TERF2IP;H3-3A;TERF2
prerank,GO_Biological_Process_2021__positive regulation of neutrophil migration (GO:1902624),0.569480513165179,1.1846847865592252,0.18604651162790697,0.6904926174957109,1.0,2/15,5.06%,MCU;DAPK2
prerank,GO_Biological_Process_2021__excitatory synapse assembly (GO:1904861),0.5935032112891571,1.184537242735606,0.2926829268292683,0.6902935988775304,1.0,1/8,0.52%,WNT7A
prerank,GO_Biological_Process_2021__positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),0.4307537280806157,1.1845026565651149,0.2631578947368421,0.6898850165898737,1.0,18/62,16.28%,ELAPOR2;BMP2;ZEB2;SMAD2;BMPR1B;MEN1;GDF10;EP300;ZNF423;ACVR1;KIAA0319;HIPK2;TGFBR1;ACVR2A;BMPR1A;SMAD4;BMP7;STK11
prerank,GO_Biological_Process_2021__gland development (GO:0048732),0.4705394294291632,1.1844497578891435,0.15151515151515152,0.689449169432412,1.0,9/41,13.12%,ZBTB1;SALL1;PRKCSH;SOX9;ARHGAP35;PHF2;PKD2;NF1;TGFBR1
prerank,GO_Biological_Process_2021__negative regulation of gluconeogenesis (GO:0045721),-0.7141615856360424,-1.184260813066688,0.3709677419354839,1.0,1.0,2/6,9.32%,MST1;PGP
prerank,"GO_Biological_Process_2021__regulation of DNA-templated transcription, initiation (GO:2000142)",0.4279474517801343,1.1835829120243724,0.21875,0.691472735743839,1.0,21/52,26.91%,MITF;CSF1R;SOX9;NFKB1;CDK8;MED13;TNRC6B;TRIM28;AGO3;CBFB;PTEN;PPM1D;MED27;LEF1;MED4;CTNNB1;MECP2;RELA;SETX;TCF7L2;MED23
prerank,GO_Biological_Process_2021__modulation by host of viral process (GO:0044788),-0.717894327690231,-1.1834664651649407,0.28,1.0,1.0,3/8,11.67%,PPIB;CAV2;APOE
prerank,GO_Biological_Process_2021__regulation of lymphocyte migration (GO:2000401),0.7131318502526398,1.1834339581219873,0.2127659574468085,0.6914131380023313,1.0,3/7,11.68%,AKT1;WASL;JAM2
prerank,GO_Biological_Process_2021__protein ubiquitination (GO:0016567),0.3402661068943547,1.1833345965145963,0.0,0.6910747240400317,1.0,109/445,17.56%,SPSB4;UHRF2;BTRC;KCTD13;SPSB2;SASH1;TRIM24;PDZRN3;SH3RF3;KEAP1;MSL2;FBXL17;UBE2G1;KLHL8;UBE2T;VHL;RNF11;RNF217;RNF146;ARRB1;NEDD4L;MARCHF6;SDE2;TSPAN17;DTX4;CBL;RAD18;CDC27;PHC1;SH3RF1;PSMA1;RNF144A;UBE2E3;FBXL3;RNF6;FBXO30;KLHL42;RNF182;UBE2D1;UBE2N;LMO7;UBE2Z;UBR3;PEX14;UBR5;PSMD11;RNF14;ITCH;TMEM129;RUSC1;RNF26;MARCHF7;PSMD10;RFWD3;CNOT4;UBE3C;PRKN;RMND5A;FBXO11;PSMF1;FBXW7;KCTD10;FBXL14;FBXO21;PSMD14;PCNP;SMURF1;RNF25;PEX5;MKRN3;PEX2;TRIP12;VCPIP1;SIRT1;COMMD1;FBXO28;CUL2;UBE2E2;MIB1;UBE2E1;RNF208;HIF3A;FBXO45;ARIH1;CUL1;VCP;BLMH;BCL2;USP22;CDC34;DTX1;ANAPC16;MARCHF3;USP9X;HACE1;TRIM35;BIRC2;RNF166;KLHL24;TRIM44;RNF41;PSME4;UBR1;CBFB;BFAR;HIF1A;ANKRD9;FBXW2;CUL3
prerank,GO_Biological_Process_2021__glutamine family amino acid catabolic process (GO:0009065),0.6316015447350471,1.1832645081865703,0.325,0.6906811505406197,1.0,3/10,8.89%,PRODH;GLS;ALDH4A1
prerank,GO_Biological_Process_2021__positive regulation of catabolic process (GO:0009896),0.4603581941923722,1.1828080574378583,0.2,0.6916943845224697,1.0,15/48,18.50%,FOXO1;NEDD4L;CSNK2A1;SEC22B;ITCH;ATG7;PRKN;SMURF1;VCP;GSK3B;NSF;HACE1;RNF41;IDE;AXIN1
prerank,GO_Biological_Process_2021__RNA methylation (GO:0001510),0.4477066585881193,1.1824299936729161,0.21875,0.6921216620628611,1.0,9/55,11.06%,LCMT2;ZCCHC4;TYW3;METTL8;RBM15B;TFB1M;FBLL1;NSUN6;NSUN3
prerank,GO_Biological_Process_2021__negative regulation of cardiac muscle cell differentiation (GO:2000726),0.7460526989399385,1.1822295725449157,0.2222222222222222,0.6919644766786376,1.0,3/5,14.34%,BMP2;SOX6;SMAD4
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor-mediated signaling pathway (GO:1903265),0.7047432730034171,1.1821996237656236,0.2826086956521739,0.6914603906939711,1.0,4/6,25.40%,PRKN;CPNE1;HSPA1A;UBE2K
prerank,GO_Biological_Process_2021__mitochondrial ATP synthesis coupled proton transport (GO:0042776),-0.6480942571115015,-1.1821371834276189,0.22807017543859648,1.0,1.0,4/14,13.05%,ATP5ME;ATP5F1E;ATP5MC3;ATP5PD
prerank,GO_Biological_Process_2021__regulation of telomerase RNA localization to Cajal body (GO:1904872),0.5388451411424008,1.1821008080027962,0.21212121212121213,0.6910542842596309,1.0,4/18,15.88%,NAF1;CCT4;DKC1;CCT3
prerank,GO_Biological_Process_2021__negative regulation of T cell migration (GO:2000405),0.7248704553236525,1.1819970762824388,0.2857142857142857,0.6907320451130959,1.0,2/5,14.96%,LRCH1;CD200R1
prerank,GO_Biological_Process_2021__positive regulation of dendrite extension (GO:1903861),0.5295459061924096,1.181949014739186,0.2571428571428571,0.6902856888608715,1.0,4/17,12.50%,SYT3;NEDD4L;SMURF1;RASAL1
prerank,GO_Biological_Process_2021__glycosphingolipid metabolic process (GO:0006687),0.45020694336601075,1.1818911604963769,0.15151515151515152,0.6898262481597307,1.0,9/42,16.63%,ST6GALNAC5;ESYT3;ESYT2;B4GALT6;LARGE1;HEXB;ABCA2;STS;NEU3
prerank,GO_Biological_Process_2021__intestinal cholesterol absorption (GO:0030299),-0.748193748121737,-1.1817319706783889,0.2619047619047619,1.0,1.0,1/6,1.27%,AKR1C1
prerank,GO_Biological_Process_2021__central nervous system projection neuron axonogenesis (GO:0021952),0.6414336561185704,1.181418067012748,0.24444444444444444,0.6905429647087238,1.0,2/11,4.62%,EPHA4;NFIB
prerank,GO_Biological_Process_2021__phagosome acidification (GO:0090383),0.5629331548472166,1.181391794627282,0.2702702702702703,0.6900702664690954,1.0,3/21,8.36%,ATP6V0D2;ATP6V1A;ATP6V1C1
prerank,GO_Biological_Process_2021__positive regulation of secretion (GO:0051047),-0.7295176324065242,-1.181312285420591,0.2857142857142857,1.0,1.0,2/5,13.88%,AQP1;XBP1
prerank,GO_Biological_Process_2021__photoreceptor cell development (GO:0042461),0.6375168135051786,1.1810630403680624,0.2857142857142857,0.6905232787625984,1.0,5/9,28.59%,CEP290;RORB;RP1;ARL3;CDHR1
prerank,GO_Biological_Process_2021__contact inhibition (GO:0060242),0.6723877510800345,1.1808369694115655,0.2,0.690644494452768,1.0,4/6,15.98%,FAP;PTPRJ;YAP1;SMO
prerank,GO_Biological_Process_2021__modified amino acid transport (GO:0072337),0.6199135608843791,1.1808025811134633,0.30434782608695654,0.6901315611428819,1.0,2/10,1.84%,SLC19A1;SLC6A13
prerank,GO_Biological_Process_2021__lipid import into cell (GO:0140354),0.6506757149924112,1.1807496594580298,0.2894736842105263,0.6897571894305176,1.0,3/7,20.19%,SPX;RPS6KB1;ACSL3
prerank,GO_Biological_Process_2021__positive regulation of histone phosphorylation (GO:0033129),0.7030628291164547,1.180610928876878,0.2553191489361702,0.6895760626123123,1.0,4/5,28.54%,RPS6KA4;CDK9;FMR1;MAPK3
prerank,GO_Biological_Process_2021__polyol metabolic process (GO:0019751),0.4661362515982065,1.1805176264082697,0.1388888888888889,0.6891752935719716,1.0,13/40,23.73%,ISYNA1;ITPKB;INPP5A;PLCB1;MINPP1;IP6K2;SYNJ1;ITPK1;IPPK;PTEN;PLCB3;OCRL;IMPA2
prerank,GO_Biological_Process_2021__response to alcohol (GO:0097305),0.5381301781287708,1.1804821169110689,0.24444444444444444,0.688720257036741,1.0,6/18,13.55%,GRIN1;SMAD2;TGFBR2;SLIT2;TGFBR1;ABCA2
prerank,GO_Biological_Process_2021__chromatin organization (GO:0006325),0.4057380871930434,1.1802483852691643,0.14285714285714285,0.6889109931826177,1.0,31/115,20.76%,KAT2B;ZBTB1;LOXL2;DR1;SOX9;SMARCAD1;HMGN4;BRWD1;HMG20A;SMARCA2;HDAC2;KDM5A;KAT2A;HP1BP3;HDAC4;SIRT1;SMARCD2;BAZ2B;PADI2;RSF1;RBBP4;SETD2;SMARCC1;SATB2;JARID2;CHD1;ATRX;NPM2;KDM4C;BAZ1A;SETD5
prerank,GO_Biological_Process_2021__negative regulation of protein depolymerization (GO:1901880),0.4885343509780966,1.1801111924045788,0.20588235294117646,0.6887448950606775,1.0,14/24,29.08%,PIK3CA;TTBK2;NAV3;CAMSAP2;CLASP1;HDGFL3;KATNB1;ATXN7;CIB1;TRIM54;TAOK1;CLASP2;ARHGEF2;FGF13
prerank,GO_Biological_Process_2021__heterochromatin organization (GO:0070828),0.594104558337594,1.1800585078856862,0.2653061224489796,0.6883461647504147,1.0,4/13,13.01%,LOXL2;BAHD1;HP1BP3;SIRT1
prerank,GO_Biological_Process_2021__positive regulation of T cell mediated cytotoxicity (GO:0001916),-0.652876259263224,-1.1797074665970397,0.208955223880597,1.0,1.0,3/15,5.79%,HLA-B;HLA-A;IL12A
prerank,GO_Biological_Process_2021__regulation of cellular amine metabolic process (GO:0033238),-0.5191706280402948,-1.1796039470449091,0.23728813559322035,1.0,1.0,8/43,13.44%,PSMB6;PSMA8;PSMB9;PSMA7;PSMC3;PSME1;PSMC4;PSMA3
prerank,GO_Biological_Process_2021__ganglion development (GO:0061548),0.7191381529940416,1.1794506000199294,0.3,0.6893991513938944,1.0,4/7,16.26%,ASCL1;NRP2;NRP1;FZD3
prerank,GO_Biological_Process_2021__negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),0.5362079137460856,1.1794182164102223,0.2631578947368421,0.6889731854164409,1.0,6/24,13.01%,FOXP1;CNOT9;CNOT2;CLOCK;STRN3;SIRT1
prerank,GO_Biological_Process_2021__protein processing involved in protein targeting to mitochondrion (GO:0006627),0.6962671489970215,1.1792082358785192,0.35135135135135137,0.6891629135346575,1.0,2/5,20.88%,IMMP2L;MIPEP
prerank,GO_Biological_Process_2021__regulation of mitotic metaphase/anaphase transition (GO:0030071),-0.5866854578111615,-1.178746096263884,0.16666666666666666,1.0,1.0,4/23,10.30%,CENPE;ANAPC15;ANAPC11;DUSP1
prerank,GO_Biological_Process_2021__positive regulation of type I interferon production (GO:0032481),-0.47011956900173046,-1.1785243732056514,0.19736842105263158,1.0,1.0,20/66,22.60%,IRF1;STAT1;ISG15;PQBP1;TLR3;OAS3;CD14;RIPK2;POLR2L;DDX41;POLR1C;POLR3G;PTPN22;FLOT1;GAPDH;POLR2K;RIOK3;HSPD1;NFKB2;DHX58
prerank,GO_Biological_Process_2021__regulation of ER to Golgi vesicle-mediated transport (GO:0060628),0.6326760939731757,1.1782917191212203,0.2553191489361702,0.6916053780294666,1.0,2/9,10.83%,PGAP1;STX18
prerank,GO_Biological_Process_2021__osteoclast differentiation (GO:0030316),0.5614495076248014,1.17788868906499,0.2,0.6922291856698731,1.0,4/15,3.06%,FOXP1;EFNA2;CSF1R;EPHA2
prerank,GO_Biological_Process_2021__rRNA-containing ribonucleoprotein complex export from nucleus (GO:0071428),0.7045284937370705,1.17777832513371,0.3269230769230769,0.6920476591839686,1.0,1/6,2.20%,XPO1
prerank,GO_Biological_Process_2021__regulation of telomere maintenance (GO:0032204),-0.5940135823032355,-1.1776314658078864,0.2807017543859649,1.0,1.0,1/22,0.16%,PIF1
prerank,GO_Biological_Process_2021__endosome to melanosome transport (GO:0035646),-0.7359816335547718,-1.177499823522208,0.32142857142857145,1.0,1.0,1/5,2.99%,CD63
prerank,GO_Biological_Process_2021__endosome to pigment granule transport (GO:0043485),-0.7359816335547718,-1.177499823522208,0.32142857142857145,1.0,1.0,1/5,2.99%,CD63
prerank,GO_Biological_Process_2021__cardiac muscle contraction (GO:0060048),0.5580307692470223,1.1771899156706955,0.20512820512820512,0.6931467863022194,1.0,4/19,11.24%,TCAP;KCNH2;PIK3CA;CAMK2D
prerank,GO_Biological_Process_2021__neuron projection morphogenesis (GO:0048812),0.36450554469120616,1.1770741836778016,0.1,0.6928695324739472,1.0,40/124,20.65%,WNT7A;PARD3;SHANK1;BTBD3;ALCAM;GPM6A;TNIK;CTNNA2;SLITRK2;WASL;EIF2AK4;DOCK7;PAK3;MAP4K4;SLITRK1;DVL1;SHANK3;DCC;NCKAP1;NBL1;FARP1;TAOK2;TMEM106B;CNTN4;BMP7;IMPACT;PLPPR4;CTNND2;PTEN;CPNE1;ALS2;APBB1;LRP4;DNM2;DRD2;ROCK1;ADGRB1;SDC2;RAB10;TRIO
prerank,GO_Biological_Process_2021__very long-chain fatty acid catabolic process (GO:0042760),0.6638999063383738,1.1769586863165786,0.2978723404255319,0.6926471320389844,1.0,3/6,27.71%,ABCD3;ACOX1;ABCD2
prerank,GO_Biological_Process_2021__polyadenylation-dependent snoRNA 3'-end processing (GO:0071051),0.7029897881121211,1.1768341998903327,0.275,0.6923571669406096,1.0,1/6,3.32%,EXOSC6
prerank,GO_Biological_Process_2021__response to unfolded protein (GO:0006986),0.4890206377469722,1.1762051875332866,0.2692307692307692,0.6938460794417273,1.0,11/43,22.32%,STT3B;RHBDD1;HSPH1;ERP44;DNAJB2;PRKN;HSPA4;TOR1B;BAG3;HSPA1A;DERL1
prerank,GO_Biological_Process_2021__mRNA modification (GO:0016556),0.5783015276597703,1.1758916194412283,0.2702702702702703,0.6941524297266297,1.0,4/22,14.05%,TRUB1;METTL8;DKC1;ZC3H13
prerank,GO_Biological_Process_2021__positive regulation of chromatin organization (GO:1905269),0.6157730808409634,1.1757020225992423,0.2894736842105263,0.6942820827412948,1.0,7/12,31.95%,UBE2N;POT1;ATRX;DAXX;TERF2IP;H3-3A;TERF2
prerank,GO_Biological_Process_2021__response to angiotensin (GO:1990776),0.6957377587705371,1.175620298625156,0.40425531914893614,0.693896931543438,1.0,4/6,26.72%,NFKB1;ROCK2;ROCK1;RELA
prerank,GO_Biological_Process_2021__positive regulation of 3'-UTR-mediated mRNA stabilization (GO:1905870),0.710966334340533,1.175591046919283,0.2857142857142857,0.6933906418197611,1.0,4/5,27.02%,RBM24;TENT4B;LARP4B;TENT4A
prerank,GO_Biological_Process_2021__negative regulation of transposition (GO:0010529),0.5896942338651364,1.1755371928122902,0.23255813953488372,0.6928851889386026,1.0,4/18,13.46%,ZNF93;PIWIL4;APOBEC3F;ZNF91
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 4 signaling pathway (GO:0034143),-0.633676004136426,-1.1752886289694282,0.22580645161290322,1.0,1.0,4/14,17.83%,RAB7B;IFI35;PTPN22;FLOT1
prerank,GO_Biological_Process_2021__cytoplasmic microtubule organization (GO:0031122),0.42051647861010644,1.1752410752239542,0.12903225806451613,0.6930424767104738,1.0,12/51,20.86%,CCDC88C;CRIPT;CAMSAP2;CLIP3;HOOK1;KATNAL1;CLASP1;DLG1;SLAIN2;KATNAL2;CIB1;PCM1
prerank,GO_Biological_Process_2021__membrane protein intracellular domain proteolysis (GO:0031293),0.5751744458787512,1.1751239967518299,0.3181818181818182,0.692754099381171,1.0,3/17,5.23%,RHBDD1;NFKB1;NCSTN
prerank,GO_Biological_Process_2021__nose development (GO:0043584),0.7793039441563434,1.1750969085571932,0.21739130434782608,0.6921964773133578,1.0,2/6,9.57%,CHD7;GLI3
prerank,GO_Biological_Process_2021__positive regulation of Arp2/3 complex-mediated actin nucleation (GO:2000601),0.6909130208535096,1.174963153068742,0.30434782608695654,0.6918957970375411,1.0,5/8,22.18%,NCKAP1;CYFIP1;WASF3;WASF1;ABI2
prerank,GO_Biological_Process_2021__catecholamine metabolic process (GO:0006584),0.5944714275956928,1.1748593779620713,0.25,0.691757177448173,1.0,3/9,19.34%,PNMT;PRKN;DRD2
prerank,GO_Biological_Process_2021__cellular biogenic amine metabolic process (GO:0006576),0.6574557711600096,1.1748549528996868,0.37777777777777777,0.6912017509298141,1.0,2/9,12.79%,MAOA;SMS
prerank,GO_Biological_Process_2021__triglyceride biosynthetic process (GO:0019432),0.6063351221072264,1.1747633348883755,0.34285714285714286,0.6908623041575638,1.0,4/13,12.35%,LPIN3;AGMO;GPAM;GK
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, preincision complex stabilization (GO:0006293)",-0.5597968925207408,-1.174721608277158,0.2711864406779661,1.0,1.0,2/18,17.14%,RPA3;RBX1
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",-0.5597968925207408,-1.174721608277158,0.2711864406779661,1.0,1.0,2/18,17.14%,RPA3;RBX1
prerank,GO_Biological_Process_2021__glycoside metabolic process (GO:0016137),-0.6780420593455304,-1.174541461493336,0.2692307692307692,1.0,1.0,5/6,31.93%,FUCA2;FUCA1;GBA3;GBA2;NAGA
prerank,GO_Biological_Process_2021__glycosyl compound catabolic process (GO:1901658),-0.6780420593455304,-1.174541461493336,0.2692307692307692,1.0,1.0,5/6,31.93%,FUCA2;FUCA1;GBA3;GBA2;NAGA
prerank,GO_Biological_Process_2021__regulation of protein dephosphorylation (GO:0035304),0.48819790825602827,1.174273814335614,0.23076923076923078,0.6916515893294243,1.0,9/34,25.19%,PPP2R5A;PPP6R3;CAMTA1;SPPL3;ARPP19;PTBP1;PPP1R8;PPP6R1;ENSA
prerank,GO_Biological_Process_2021__nucleoside metabolic process (GO:0009116),0.6126066168911362,1.1741697680194423,0.22727272727272727,0.6914331071472128,1.0,5/10,23.52%,NT5C1A;MACROD1;ERH;NT5C3A;NME4
prerank,GO_Biological_Process_2021__positive regulation of protein metabolic process (GO:0051247),0.3944477674981154,1.174133234330903,0.041666666666666664,0.6910406709156224,1.0,25/83,18.83%,WNT7A;FOXO1;PRMT1;NEDD4L;IL17D;AKT1;CSNK2A1;SEC22B;ITCH;ATG7;PRKN;SMURF1;MAP2K5;ABCA2;VCP;GSK3B;NSF;ROCK2;HACE1;MAPK8;RAB1A;RNF41;IDE;AXIN1;BCL10
prerank,GO_Biological_Process_2021__regulation of ceramide biosynthetic process (GO:2000303),-0.6608511400817215,-1.1739852356607698,0.34545454545454546,1.0,1.0,2/14,11.77%,ORMDL2;ORMDL1
prerank,GO_Biological_Process_2021__positive regulation of translational initiation (GO:0045948),0.5552453741616237,1.1739428970909387,0.25,0.6910374093564705,1.0,5/15,22.38%,RPS6KB2;UHMK1;RPS6KB1;YTHDF2;YTHDF3
prerank,GO_Biological_Process_2021__production of siRNA involved in RNA interference (GO:0030422),0.6500244069233901,1.173658176529972,0.21428571428571427,0.691234953435594,1.0,5/7,31.12%,DROSHA;PRKRA;TSN;DICER1;AGO2
prerank,GO_Biological_Process_2021__regulation of neuron death (GO:1901214),0.41464553444123775,1.1730844024198697,0.15625,0.6923149733659025,1.0,15/67,15.08%,PPARGC1A;EGLN3;SNCA;PICALM;ZNF746;INPP5A;AKT1;EFNB2;PRKN;SARM1;MAP3K5;DCC;RRAS2;CD200R1;GSK3B
prerank,GO_Biological_Process_2021__response to cytokine (GO:0034097),-0.4476890742602413,-1.17294302618935,0.2111111111111111,1.0,1.0,17/117,10.16%,POU4F1;IFITM3;IL1R1;SELP;BST2;MX1;STAT1;ISG15;PTPN7;ANXA1;TIMP1;TRIM21;SIGIRR;CASP8;SRF;CIITA;SLC11A1
prerank,GO_Biological_Process_2021__positive regulation of cilium assembly (GO:0045724),0.5435827685019697,1.172689859383658,0.2727272727272727,0.6927249879072891,1.0,6/19,16.58%,ZMYND10;ARHGAP35;KCTD17;TAPT1;SEPTIN7;CEP120
prerank,GO_Biological_Process_2021__regulation of cell adhesion (GO:0030155),0.41128071927598325,1.172616209277983,0.15,0.6923464527626548,1.0,30/97,21.83%,EPHA7;EFNA5;PDE3B;PRKX;EPHA2;RSU1;PLXNA2;EPHA4;CXCL12;PKP4;PLXNA1;ABL2;TFE3;PTPRJ;PTK2;ROCK2;PTPN11;SEMA4D;PPP1R12A;CDH13;FBLN1;YTHDF2;PLXNA4;ARHGDIA;PPP1CB;FRMD5;ROCK1;PPP2R1A;PRKCA;ZDHHC2
prerank,GO_Biological_Process_2021__prostaglandin metabolic process (GO:0006693),-0.586153740346715,-1.1725710208845805,0.2909090909090909,1.0,1.0,4/16,15.74%,AKR1C1;GSTP1;PTGR1;CD74
prerank,GO_Biological_Process_2021__negative regulation of protein localization to nucleus (GO:1900181),0.5560062966086906,1.1724831287712802,0.2631578947368421,0.692182023301762,1.0,8/16,31.55%,RAB23;GSK3B;LATS1;SUFU;CABP1;UFM1;POLR1A;ILRUN
prerank,GO_Biological_Process_2021__peptidyl-serine dephosphorylation (GO:0070262),0.54809145211835,1.1724108822800654,0.3157894736842105,0.6918712083612948,1.0,11/13,30.07%,PPP1R15B;PPP2R2B;PPP2R2C;NCK1;PPTC7;PPP2R2A;PPM1F;PPP3CA;PPP2R2D;PPP2CB;PPP5C
prerank,GO_Biological_Process_2021__negative regulation of natural killer cell mediated cytotoxicity (GO:0045953),-0.6755962159274638,-1.1722455813052919,0.3275862068965517,1.0,1.0,4/9,8.78%,HLA-B;HLA-A;CEACAM1;KLRD1
prerank,GO_Biological_Process_2021__regulation of growth hormone secretion (GO:0060123),0.7079742352574311,1.1718906722831886,0.3111111111111111,0.6927598147815809,1.0,2/5,19.34%,CHD7;DRD2
prerank,GO_Biological_Process_2021__iron ion homeostasis (GO:0055072),-0.5087585279552848,-1.1718318122871079,0.21212121212121213,1.0,1.0,6/45,10.16%,FTH1;CP;FTL;B2M;ABCG2;SLC11A1
prerank,GO_Biological_Process_2021__regulation of response to wounding (GO:1903034),-0.76779685358565,-1.1718086420460017,0.38,1.0,1.0,4/5,22.86%,VIL1;TNFRSF12A;CADM4;ALOX5
prerank,GO_Biological_Process_2021__regulation of GTPase activity (GO:0043087),0.38177665426296564,1.1713433491543686,0.17647058823529413,0.6938067004212669,1.0,36/136,16.53%,ADAP1;EFNA5;RCC2;PICALM;RSU1;PLXNA2;EPHA4;RGS16;SNX18;RGS6;USP6NL;LRCH1;CDKL5;ARAP1;EVI5L;DOCK9;PRKG1;NTRK2;EPHA5;RAPGEF2;PKP4;PLXNA1;FGD4;NF1;ADRB1;MAP4K4;PTK2;AFDN;RAB3GAP1;RAP1GDS1;RAP1A;GSK3B;SNX13;ARHGEF7;SEMA4D;ARFGEF1
prerank,GO_Biological_Process_2021__cellular response to lipid (GO:0071396),0.38599155797884516,1.1711923739478232,0.08695652173913043,0.693841112779105,1.0,22/129,9.81%,PDK4;PID1;BRINP3;TNFSF4;NRIP1;SERPINE1;LCOR;EGFR;ADCY1;GIT1;SOX9;RORA;CCDC62;NFKB1;ADNP2;IRS1;ABL2;TICAM1;NCOA3;NR3C1;HMGB1;NR1D1
prerank,GO_Biological_Process_2021__long-term memory (GO:0007616),0.5646037619560412,1.171141102343898,0.325,0.69342364952125,1.0,4/15,9.83%,SHANK1;CPEB3;EIF2AK4;KAT2A
prerank,GO_Biological_Process_2021__inner ear receptor cell development (GO:0060119),0.6853253093690668,1.170979262468813,0.3125,0.6932458684766585,1.0,2/7,14.52%,SLC4A7;WHRN
prerank,GO_Biological_Process_2021__myelination in peripheral nervous system (GO:0022011),0.6442254997037378,1.1706403405062256,0.3,0.6935857989291551,1.0,3/9,13.72%,PARD3;NF1;SIRT2
prerank,GO_Biological_Process_2021__epidermis development (GO:0008544),-0.5311665251455784,-1.1703197124116445,0.2318840579710145,1.0,1.0,5/35,6.05%,FLG2;OVOL2;OVOL3;RBP2;FGF7
prerank,GO_Biological_Process_2021__leptin-mediated signaling pathway (GO:0033210),0.641910853642925,1.1703136885724341,0.27906976744186046,0.6939782044737013,1.0,4/8,17.73%,LEPR;SIRT1;MKKS;BBS2
prerank,GO_Biological_Process_2021__regulation of respiratory system process (GO:0044065),0.7047887102230785,1.1699847736077742,0.2857142857142857,0.6941712879308443,1.0,2/6,11.44%,TSHZ3;NLGN3
prerank,GO_Biological_Process_2021__positive regulation of protein import into nucleus (GO:0042307),0.47601153682047065,1.1699766355173284,0.1891891891891892,0.6936228957327802,1.0,7/24,21.04%,HCLS1;PIK3R1;UBR5;TRIM28;IPO5;BAG3;ZPR1
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),-0.4845423183578908,-1.1697126469719594,0.2077922077922078,1.0,1.0,5/62,8.49%,IFI6;GATA1;THBS1;CASP8;GSTP1
prerank,GO_Biological_Process_2021__positive regulation of transmembrane transport (GO:0034764),0.5397808288957645,1.1695952417052524,0.1875,0.6941465631995567,1.0,3/13,12.15%,CA2;BRAF;CLIP3
prerank,GO_Biological_Process_2021__response to metal ion (GO:0010038),0.42391503338061853,1.1695549648925492,0.1111111111111111,0.6937179999911856,1.0,11/50,14.73%,ANXA11;SNCA;LOXL2;SLC30A4;NEDD4L;GPHN;KCNMA1;HOMER1;ATP7B;PEF1;BCL2
prerank,GO_Biological_Process_2021__anion transmembrane transport (GO:0098656),0.43864539995031876,1.1693030029786036,0.23076923076923078,0.6938974670960528,1.0,6/54,9.09%,SLC19A1;SLC6A13;SLC25A41;SLC25A18;ABCC5;SFXN1
prerank,GO_Biological_Process_2021__negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),0.39097394800516366,1.1691584240390689,0.09523809523809523,0.693760028006423,1.0,35/86,24.90%,RBPMS2;BMP2;SPRED2;SMAD2;SMAD7;UBE2D1;SPRED1;PPM1A;SMAD5;BMPR1B;ZNF451;SMURF1;TGFBR2;ACVR1;SIRT1;HIPK2;TGFBR1;MAGI2;NBL1;ACVR2A;BMPR1A;SMAD4;VWC2L;LEMD3;CRIM1;UBE2D3;SNX25;SPRED3;HSPA1A;PMEPA1;SKIL;WFIKKN1;TRIM33;SMAD3;SLC2A10
prerank,GO_Biological_Process_2021__transition metal ion homeostasis (GO:0055076),-0.5475304888259276,-1.1688489739095307,0.26229508196721313,1.0,1.0,7/28,10.41%,CP;FTL;B2M;TMC8;CUTC;SLC11A1;MT3
prerank,GO_Biological_Process_2021__regulation of neuron projection arborization (GO:0150011),0.5659980330872687,1.1688407764922593,0.2558139534883721,0.6940709893490107,1.0,3/15,13.03%,SPRY3;DVL1;GRIP1
prerank,GO_Biological_Process_2021__synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),-0.6916945921827307,-1.1684213096635074,0.22641509433962265,1.0,1.0,1/10,2.85%,STX19
prerank,GO_Biological_Process_2021__regulation of hematopoietic stem cell differentiation (GO:1902036),-0.49165031467306475,-1.168220954433391,0.19672131147540983,1.0,1.0,10/58,13.44%,PSMB6;GATA1;PSMA8;PSMB9;PSMA7;PSMC3;PSME1;EIF2AK2;PSMC4;PSMA3
prerank,GO_Biological_Process_2021__natural killer cell mediated immunity (GO:0002228),-0.6743826656875916,-1.1677783111487705,0.25862068965517243,1.0,1.0,3/9,16.54%,KLRD1;TUBB;MICA
prerank,GO_Biological_Process_2021__regulation of anatomical structure morphogenesis (GO:0022603),0.4094491528784042,1.1676512186876014,0.19230769230769232,0.69705518732236,1.0,44/105,23.61%,PID1;EFNA5;WTIP;EPHA2;EPHA4;ADGRB3;CDH2;KIF13B;ARHGAP35;NEDD4L;TNIK;LRRC4C;PPFIA2;FMNL2;SRCIN1;INF2;ZMYM3;SARM1;NF1;ZRANB1;PAK3;SHANK3;PDLIM5;CLASP1;TANC2;GSK3B;PHIP;SEMA4D;RUFY3;CYRIB;RAP2A;STRIP1;LARP4;PDZD8;CDK5R1;SDC2;TSPAN12;VASH1;ABI2;ARHGAP44;FGF2;CAPZB;FGFR2;CTNNB1
prerank,GO_Biological_Process_2021__positive regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902043),-0.7256566171674801,-1.16764987746679,0.3793103448275862,1.0,1.0,2/5,11.83%,THBS1;SFRP1
prerank,GO_Biological_Process_2021__regulation of microtubule-based movement (GO:0060632),-0.6701900161533296,-1.1675559558028588,0.29310344827586204,1.0,1.0,3/8,15.18%,NEFH;DRC1;HAP1
prerank,GO_Biological_Process_2021__Golgi organization (GO:0007030),0.3911671945474478,1.1674311097721979,0.07692307692307693,0.6972050710660062,1.0,38/111,26.20%,BET1;FHDC1;USP6NL;TRAPPC12;VTI1A;TRAPPC8;SEC22B;TRIP11;GOLPH3;PRKD1;DYM;SYNE1;RAB30;VCPIP1;TJAP1;CLASP1;TMED3;TRAPPC11;HACE1;ARHGEF7;RAB1A;ARFGEF1;TMED5;SEC23IP;NSFL1C;UBXN2B;YWHAZ;GORASP2;GOLGA5;STX17;CSNK1D;VMP1;HUWE1;STK25;VPS51;CLASP2;BAG5;COG3
prerank,GO_Biological_Process_2021__regulation of protein glycosylation (GO:0060049),-0.6638164837544653,-1.1674143404835382,0.3392857142857143,1.0,1.0,2/8,10.41%,SLC51B;MT3
prerank,GO_Biological_Process_2021__mRNA 3'-end processing (GO:0031124),0.3825331750392357,1.1672235072604153,0.14285714285714285,0.6972495142819384,1.0,19/70,23.92%,NUDT21;WDR33;PAPOLA;CSTF3;CPSF6;TENT4B;U2AF1;U2AF2;THOC7;MTPAP;SCAF8;RPRD1B;PAPOLG;THOC2;CPSF7;CDC73;RPRD2;GRSF1;MAGOH
prerank,GO_Biological_Process_2021__dopamine transport (GO:0015872),-0.7662278683304096,-1.1671690185415724,0.32608695652173914,1.0,1.0,1/5,2.61%,SLC18A2
prerank,GO_Biological_Process_2021__cognition (GO:0050890),0.470836243124454,1.167037685528511,0.27586206896551724,0.6972150498085746,1.0,9/37,15.21%,CHRNA4;CHD7;FAM107A;NF1;TTC8;CHMP2B;NIPBL;METTL23;CYFIP1
prerank,GO_Biological_Process_2021__regulation of cortisol biosynthetic process (GO:2000064),0.7226328038219392,1.16665901315147,0.3125,0.6976926653053289,1.0,1/5,2.72%,BMP2
prerank,GO_Biological_Process_2021__cellular response to copper ion (GO:0071280),-0.6490934203418282,-1.1666121502121567,0.26153846153846155,1.0,1.0,9/13,18.34%,MT1H;AQP1;MT1G;MT2A;MT3;MT1E;MT1F;MT1A;MT1M
prerank,GO_Biological_Process_2021__protein mannosylation (GO:0035268),0.46448731091133943,1.1663842224513625,0.26666666666666666,0.6980645683081119,1.0,10/21,29.85%,LARGE1;CRPPA;TMTC2;TMTC4;FKRP;TMTC1;DPM1;DPY19L3;TMTC3;DPY19L4
prerank,GO_Biological_Process_2021__cellular response to interferon-alpha (GO:0035457),0.672791947207751,1.1663082000622267,0.3333333333333333,0.697701838659511,1.0,1/7,2.63%,PDE12
prerank,GO_Biological_Process_2021__protein maturation by iron-sulfur cluster transfer (GO:0097428),0.5744633120484678,1.166263468966457,0.24390243902439024,0.6973265925402723,1.0,2/13,3.87%,YAE1;LTO1
prerank,GO_Biological_Process_2021__regulation of mitochondrial fission (GO:0090140),0.5271399318361258,1.1660128310107658,0.3,0.6973183779119931,1.0,6/24,10.08%,DCN;MCU;MFF;SPIRE1;INF2;PRKN
prerank,GO_Biological_Process_2021__positive regulation of mast cell degranulation (GO:0043306),-0.7441601558226054,-1.1659468597480205,0.2727272727272727,1.0,1.0,1/6,9.62%,VAMP8
prerank,GO_Biological_Process_2021__negative regulation of leukocyte cell-cell adhesion (GO:1903038),0.5899917901519621,1.1658539902331686,0.2926829268292683,0.697297100052805,1.0,4/12,18.82%,PAG1;AKT1;FGL1;WNK1
prerank,GO_Biological_Process_2021__regulation of nucleotide-binding oligomerization domain containing signaling pathway (GO:0070424),0.7305043685977763,1.1658511230520892,0.37209302325581395,0.6967662853261232,1.0,2/5,15.89%,SLC15A2;BIRC2
prerank,GO_Biological_Process_2021__lipid oxidation (GO:0034440),0.7117759858684984,1.1657212794520428,0.3404255319148936,0.6965104831956498,1.0,2/6,4.77%,PPARGC1A;ADIPOR2
prerank,GO_Biological_Process_2021__sterol biosynthetic process (GO:0016126),-0.5454908575899718,-1.1656453212116924,0.2916666666666667,1.0,1.0,11/28,21.38%,DHCR24;MVK;SQLE;DHCR7;HSD17B7;FDPS;ACAT2;TM7SF2;INSIG1;MSMO1;HMGCR
prerank,GO_Biological_Process_2021__epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287),-0.7036653384484013,-1.1656365914947255,0.3181818181818182,1.0,1.0,2/7,5.19%,CCDC39;DNAAF1
prerank,GO_Biological_Process_2021__superoxide anion generation (GO:0042554),-0.7156883189755016,-1.1655821181600277,0.32653061224489793,1.0,1.0,3/6,15.84%,DUOX1;NOX1;ALOX12
prerank,GO_Biological_Process_2021__regulation of glycolytic process (GO:0006110),0.42597551208777945,1.1654602387751802,0.21875,0.6966725316235624,1.0,16/64,18.33%,NUP42;NUP37;NUP188;GIT1;ZBTB20;EP300;NUP153;HDAC4;OGT;NDC1;SLC4A4;MLXIPL;NUP205;HIF1A;IGF1;NUP214
prerank,GO_Biological_Process_2021__mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),0.37529285275987695,1.1653630092720104,0.1111111111111111,0.6963390037331063,1.0,25/88,24.86%,WDR33;NUP42;NUP37;NUP188;AGFG1;RBM15B;FYTTD1;EIF4E;SMG1;NUP153;U2AF1;U2AF2;NDC1;THOC7;SMG7;NUP205;NUP214;ALKBH5;RANBP2;THOC2;NXT1;MAGOH;NUP54;NUP98;CPSF2
prerank,PanglaoDB_Augmented_2021__Goblet Cells,0.4899403589077836,1.1650554126908292,0.27586206896551724,0.6969046842051577,1.0,3/27,4.80%,ACE2;CAPN13;SLC26A3
prerank,GO_Biological_Process_2021__transferrin transport (GO:0033572),0.4798459622697432,1.1649900903884582,0.23684210526315788,0.6965845162465417,1.0,6/30,18.91%,ATP6V0D2;ATP6V1A;ATP6V1C1;ATP6V1B2;TFRC;DNM2
prerank,GO_Biological_Process_2021__tetrahydrofolate metabolic process (GO:0046653),0.5957403400996224,1.1647191835567523,0.26666666666666666,0.6969150373913418,1.0,1/11,0.50%,MTHFS
prerank,GO_Biological_Process_2021__positive regulation of T cell apoptotic process (GO:0070234),-0.7549797594763734,-1.1646748354087626,0.3125,1.0,1.0,3/6,20.29%,CD274;PRELID1;ADAM8
prerank,GO_Biological_Process_2021__cytosolic transport (GO:0016482),0.40923778750099854,1.1646541116920484,0.2222222222222222,0.6965953698161499,1.0,38/105,27.77%,TBC1D5;SORT1;EPS15;VTI1A;BAIAP3;RHOBTB3;PIK3C3;ARFRP1;RAB9A;HOOK1;PIKFYVE;SNX5;AP1G1;CCDC91;STX8;TBC1D10A;WDR91;TBC1D23;SNX16;WDR81;PHETA1;PTPN23;GGA1;ERC1;MON2;VAMP3;KIF16B;VPS50;SNX1;TBC1D17;VPS54;VPS51;RIC1;VPS26B;RAB5A;HOOK3;TBC1D10B;STX5
prerank,GO_Biological_Process_2021__DNA-dependent DNA replication (GO:0006261),-0.44122969460859784,-1.164627805300061,0.18666666666666668,1.0,1.0,21/112,17.91%,PSMB6;RPS27A;RPA3;PSMA8;PSMB9;PSMA7;POLE4;PSMC3;UBC;PSME1;BLM;WDHD1;PNKP;PSMC4;PSMA3;POLE3;DDX23;POLD2;GINS3;MCMDC2;UBA52
prerank,GO_Biological_Process_2021__modulation by symbiont of host autophagy (GO:0075071),0.7715225091908201,1.1644280905253164,0.20454545454545456,0.696990272516314,1.0,2/5,18.61%,ATG7;ATG5
prerank,GO_Biological_Process_2021__double-strand break repair via break-induced replication (GO:0000727),-0.6917547056639397,-1.1641185825160936,0.26229508196721313,1.0,1.0,5/9,27.37%,MCMDC2;MUS81;MCM5;MCM3;MCM4
prerank,GO_Biological_Process_2021__membrane raft assembly (GO:0001765),-0.7505421731048758,-1.1640539945237465,0.3333333333333333,1.0,1.0,5/6,22.08%,S100A10;EMP2;FLOT1;RFTN1;ANXA2
prerank,GO_Biological_Process_2021__negative regulation of endocytosis (GO:0045806),0.5670352190318606,1.1637024601218229,0.20588235294117646,0.6985261434428672,1.0,5/19,22.99%,PICALM;PRKD1;MTMR2;ARF6;LRSAM1
prerank,GO_Biological_Process_2021__fructose metabolic process (GO:0006000),-0.6982217433380016,-1.163684586236232,0.35714285714285715,1.0,1.0,4/5,24.37%,ALDOB;SORD;FBP1;KHK
prerank,GO_Biological_Process_2021__positive regulation of cholesterol transport (GO:0032376),-0.5762357823663199,-1.163637154167477,0.2318840579710145,1.0,1.0,3/23,15.65%,ABCA12;APOE;ABCA5
prerank,GO_Biological_Process_2021__positive regulation of myoblast differentiation (GO:0045663),0.5913276469749142,1.1635188097827907,0.23404255319148937,0.6984133573214405,1.0,3/12,8.66%,RANBP3L;RBM24;PLCB1
prerank,GO_Biological_Process_2021__positive regulation of signal transduction by p53 class mediator (GO:1901798),-0.6143457107180597,-1.1629106842247505,0.25757575757575757,1.0,1.0,6/18,13.08%,RPL23;RPS7;RPS15;HEXIM1;RPS20;HIC1
prerank,GO_Biological_Process_2021__positive regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045899),-0.7107463618505319,-1.1628853910267676,0.28,1.0,1.0,2/7,12.58%,PSMC3;PSMC4
prerank,GO_Biological_Process_2021__canonical glycolysis (GO:0061621),-0.5791681253213755,-1.1628117509580613,0.2549019607843137,1.0,1.0,7/20,20.22%,GAPDHS;ALDOB;HK2;GPI;PGAM1;GAPDH;ENO1
prerank,GO_Biological_Process_2021__glucose catabolic process to pyruvate (GO:0061718),-0.5791681253213755,-1.1628117509580613,0.2549019607843137,1.0,1.0,7/20,20.22%,GAPDHS;ALDOB;HK2;GPI;PGAM1;GAPDH;ENO1
prerank,GO_Biological_Process_2021__glycolytic process through glucose-6-phosphate (GO:0061620),-0.5790879378650371,-1.1626218892950608,0.22,1.0,1.0,7/21,20.22%,GAPDHS;ALDOB;HK2;GPI;PGAM1;GAPDH;ENO1
prerank,GO_Biological_Process_2021__nucleoside triphosphate metabolic process (GO:0009141),0.5461516468497586,1.1624539651816639,0.2727272727272727,0.7010465998385305,1.0,2/13,2.37%,AK3;AK1
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),-0.7390811887820444,-1.1623732644775413,0.3684210526315789,1.0,1.0,2/5,17.40%,IFI35;PTPN22
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA incision (GO:0033683)",-0.5232524820596864,-1.1621922340478847,0.16923076923076924,1.0,1.0,6/35,17.91%,RPS27A;RPA3;UBC;POLD2;RBX1;UBA52
prerank,GO_Biological_Process_2021__peptide cross-linking (GO:0018149),-0.6989992167928676,-1.1620991775674363,0.3389830508474576,1.0,1.0,4/10,5.73%,F13A1;FLG;ANXA1;THBS1
prerank,GO_Biological_Process_2021__regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),0.5315853165066817,1.1619826523259418,0.2564102564102564,0.7017214525734227,1.0,3/15,12.22%,CPEB3;TNRC6B;TENT4B
prerank,GO_Biological_Process_2021__negative regulation of natural killer cell mediated immunity (GO:0002716),-0.7541161931154036,-1.1616847531005925,0.3442622950819672,1.0,1.0,4/5,23.11%,KLRD1;MICA;HLA-F;HLA-E
prerank,GO_Biological_Process_2021__positive regulation of nucleocytoplasmic transport (GO:0046824),0.4250193497627907,1.161593333470073,0.15625,0.7022012636701142,1.0,11/40,21.04%,HCLS1;CPSF6;PIK3R1;UBR5;ANP32B;DHX9;TRIM28;GSK3B;IPO5;BAG3;ZPR1
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell proliferation (GO:0001937),-0.5692950798102181,-1.1614915920409719,0.2835820895522388,1.0,1.0,8/25,14.31%,SPARC;STAT1;THBS1;IL12A;CAV2;ATP5IF1;APOE;CCL2
prerank,GO_Biological_Process_2021__positive regulation of protein glycosylation (GO:0060050),-0.68669308194428,-1.1611023175300907,0.2982456140350877,1.0,1.0,1/6,4.61%,SLC51B
prerank,GO_Biological_Process_2021__positive regulation of protein localization to plasma membrane (GO:1903078),0.42409459899593965,1.1610831600035303,0.16129032258064516,0.7030679596890129,1.0,17/47,21.83%,ARHGEF16;EPHA2;EGFR;ATP2C1;AKT1;PIK3R1;PRKCE;PTPN9;CLIP3;ZDHHC5;DLG1;ATP2B4;WNK3;ARF6;ACSL3;CIB1;ZDHHC2
prerank,GO_Biological_Process_2021__regulation of synapse maturation (GO:0090128),0.6353191216395058,1.1610074410920572,0.29545454545454547,0.7027970991720676,1.0,3/9,19.50%,CAMK2B;NRXN1;YWHAZ
prerank,GO_Biological_Process_2021__motile cilium assembly (GO:0044458),-0.7288874360297279,-1.1604488491634781,0.29411764705882354,1.0,1.0,3/8,5.19%,CCDC39;BBOF1;DNAAF1
prerank,PanglaoDB_Augmented_2021__Spermatozoa,-0.4637894143866674,-1.1601844182233638,0.2236842105263158,1.0,1.0,19/77,19.22%,LDHC;CP;IL1R1;TEKT1;FMO5;FPR3;ANKUB1;ST3GAL6;FMO2;APOL6;APOBEC4;CD14;C1ORF87;CD74;FAM20A;OMG;C1QB;ASAH1;HLA-DPB1
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),0.39735466023907107,1.1601384394996443,0.047619047619047616,0.7046295369943818,1.0,25/78,16.25%,DCN;PIP5K1B;EGFR;FLT1;SOX9;PDGFRA;HCLS1;EPOR;CBL;NTRK2;PIK3CA;PTPN13;PIK3R1;PDGFA;ROR1;DIPK2A;PIP5K1C;PTK2;PIP4K2C;SIRT1;PDGFC;MAPK1;GAB1;HGF;SEMA4D
prerank,GO_Biological_Process_2021__granulocyte differentiation (GO:0030851),-0.5856955560472056,-1.1601157510183648,0.3220338983050847,1.0,1.0,1/16,0.97%,GATA1
prerank,GO_Biological_Process_2021__positive regulation of deacetylase activity (GO:0090045),0.6307929075774962,1.1600599021796083,0.27906976744186046,0.70419029132308,1.0,2/6,15.86%,PRKD1;MAPK8
prerank,GO_Biological_Process_2021__eye photoreceptor cell differentiation (GO:0001754),0.6011369247505136,1.1597988552873297,0.34285714285714286,0.7046920308985226,1.0,4/9,26.68%,CEP290;AGTPBP1;RORB;SDK2
prerank,GO_Biological_Process_2021__late endosome to lysosome transport (GO:1902774),0.6635976717818692,1.1594377222895502,0.38461538461538464,0.7050900161638632,1.0,3/5,29.89%,VPS41;VPS39;ARL8B
prerank,GO_Biological_Process_2021__cellular response to nutrient levels (GO:0031669),0.4390160651110569,1.1594324524566146,0.20689655172413793,0.7045357001134199,1.0,10/54,15.44%,PDK4;FOXO1;FAM107A;ATG7;RALB;VPS41;TFEB;SIRT1;RPTOR;PDK2
prerank,GO_Biological_Process_2021__macrophage activation involved in immune response (GO:0002281),-0.6939450156736843,-1.1587398816381178,0.32727272727272727,1.0,1.0,1/8,6.21%,IFI35
prerank,GO_Biological_Process_2021__negative regulation of interferon-beta production (GO:0032688),0.6419264747545059,1.158723316221374,0.38461538461538464,0.7061539688170927,1.0,4/7,33.38%,YY1;SIRPA;PTPRS;RELB
prerank,GO_Biological_Process_2021__superoxide metabolic process (GO:0006801),-0.6007573756536293,-1.1585474132049207,0.24074074074074073,1.0,1.0,6/16,15.84%,DUOX1;MT3;NOX1;SOD3;CCS;ALOX12
prerank,GO_Biological_Process_2021__regulation of membrane tubulation (GO:1903525),0.6759061537977713,1.1585317936814128,0.32727272727272727,0.7060619383238687,1.0,4/6,24.62%,WASL;DNM2;ATP10A;SH3GLB1
prerank,GO_Biological_Process_2021__regulation of T cell migration (GO:2000404),-0.6412595483907728,-1.158429232062196,0.2903225806451613,1.0,1.0,1/10,0.34%,DOCK8
prerank,GO_Biological_Process_2021__positive regulation of RNA splicing (GO:0033120),0.5180067679575651,1.1582206169777578,0.22580645161290322,0.7063549588068755,1.0,14/28,28.35%,PRDX6;DYRK1A;PIK3R1;CELF3;HNRNPLL;U2AF2;RBM20;TRA2A;ZPR1;HSPA1A;NUP98;SETX;ERN1;SLC38A2
prerank,GO_Biological_Process_2021__keratinocyte differentiation (GO:0030216),0.5267958046705048,1.1579676281217934,0.30303030303030304,0.7066346998446711,1.0,3/22,3.06%,TXNIP;CERS3;EPHA2
prerank,GO_Biological_Process_2021__regulation of synapse structural plasticity (GO:0051823),0.7585133081029445,1.157881558555885,0.28888888888888886,0.7063119268300903,1.0,3/5,11.56%,CTNNA2;CAMK2B;SHANK3
prerank,GO_Biological_Process_2021__positive regulation of B cell differentiation (GO:0045579),-0.7238683623037755,-1.157675910764417,0.28,1.0,1.0,2/5,18.44%,XBP1;MMP14
prerank,GO_Biological_Process_2021__cellular response to topologically incorrect protein (GO:0035967),0.5033104182560639,1.1576674512474157,0.3333333333333333,0.7063736620156167,1.0,7/30,27.73%,RHBDD1;PRKN;BAG3;HSPA1A;ERN1;DNAJB14;DAXX
prerank,GO_Biological_Process_2021__regulation of microtubule polymerization or depolymerization (GO:0031110),0.49294622872071847,1.1574302840623805,0.25,0.706716682747936,1.0,12/23,35.73%,CAMSAP2;MAPRE1;CLASP1;SKA2;GAS2L1;FKBP4;CLASP2;CAMSAP3;PRUNE1;MAP2;ABL1;MAPRE3
prerank,GO_Biological_Process_2021__RNA 3'-end processing (GO:0031123),0.3955805217849087,1.1574243258005406,0.16,0.7061773404419796,1.0,4/60,2.47%,NUDT21;WDR33;PAPOLA;CSTF3
prerank,GO_Biological_Process_2021__glycerolipid catabolic process (GO:0046503),0.5387020959398107,1.157002339466567,0.2653061224489796,0.7069286229042476,1.0,5/15,19.52%,MGLL;PRDX6;ABHD6;LYPLA2;ABHD2
prerank,GO_Biological_Process_2021__receptor catabolic process (GO:0032801),0.513075373344333,1.1569895079712877,0.2647058823529412,0.7064154770153759,1.0,6/21,24.64%,AP2B1;PIK3R4;SMURF1;SNX25;SH3GLB1;KIF16B
prerank,GO_Biological_Process_2021__positive regulation of cell activation (GO:0050867),-0.7883270863894363,-1.1569736195518496,0.2708333333333333,1.0,1.0,2/6,1.97%,SOX15;SELP
prerank,GO_Biological_Process_2021__regulation of postsynaptic membrane potential (GO:0060078),0.46972908873145947,1.1569520027100384,0.2,0.7059158812612677,1.0,11/31,16.77%,CHRNA4;GABRG1;GRIN1;MPP2;AKT1;GABRA4;NLGN3;RAB3GAP1;GABRA5;GSK3B;INSYN1
prerank,GO_Biological_Process_2021__positive regulation of cellular metabolic process (GO:0031325),0.4133916252360954,1.1566372635158326,0.058823529411764705,0.706092299012657,1.0,8/77,6.29%,ACE2;WNT7A;PID1;ACACB;SNCA;TBC1D5;ARRB1;AKT1
prerank,GO_Biological_Process_2021__regulation of heart contraction (GO:0008016),0.42835466829375973,1.1565921567407276,0.2,0.7056064627142955,1.0,16/59,17.84%,ACE2;ANK2;ATP2B3;CASQ1;TMEM65;SMAD7;CELF2;ASB3;CAMK2D;STIM1;ASPH;CYP2J2;ATP2B4;CORIN;PDE4D;ATP1A4
prerank,GO_Biological_Process_2021__parallel actin filament bundle assembly (GO:0030046),0.7474197327551456,1.1565826575215175,0.35555555555555557,0.7050832205677425,1.0,2/5,7.93%,SPIRE2;SPIRE1
prerank,GO_Biological_Process_2021__cardiac left ventricle morphogenesis (GO:0003214),-0.6556240870444763,-1.1564566169665171,0.2,1.0,1.0,1/9,0.66%,SFRP2
prerank,GO_Biological_Process_2021__positive regulation of organelle assembly (GO:1902117),0.48329374760007127,1.1558443368760054,0.2,0.7066453285288538,1.0,11/40,12.81%,SDC4;ARHGAP35;KCTD17;CNOT6L;CNOT2;G3BP1;RALB;STX18;PIP4K2C;RAB3GAP1;TAPT1
prerank,GO_Biological_Process_2021__epithelial cell migration (GO:0010631),0.4672390794104877,1.1557299530124132,0.2647058823529412,0.7063888074786316,1.0,13/32,17.44%,STARD13;PRKX;LOXL2;ZEB2;KANK1;TESK1;PIK3CA;FAP;ANLN;FERMT1;PXN;NRP1;CDH13
prerank,GO_Biological_Process_2021__axon choice point recognition (GO:0016198),0.7293948198675516,1.1555837892982062,0.3076923076923077,0.7062215205323396,1.0,1/5,7.91%,ROBO1
prerank,GO_Biological_Process_2021__regulation of nitrogen compound metabolic process (GO:0051171),-0.6856861598761045,-1.1555801172662725,0.36923076923076925,1.0,1.0,2/6,11.67%,SELENOS;APOE
prerank,PanglaoDB_Augmented_2021__Mller Cells,0.3625791588532709,1.1553537041429953,0.1,0.7062320273919568,1.0,23/127,8.77%,POSTN;MAPK10;MPDZ;ANK2;PDZRN3;ANXA4;PCDH17;CXCL12;PDGFRA;PRDX6;COL9A1;CDH11;CACNA2D1;CRB1;MEGF10;PCDH18;NTRK2;FRZB;SLITRK2;PRRX1;CA2;PRICKLE2;FAM107A
prerank,GO_Biological_Process_2021__regulation of cytokinesis (GO:0032465),-0.48381850220644995,-1.1552368333709748,0.21052631578947367,1.0,1.0,9/61,13.87%,ANKRD53;CETN2;KIF20B;SVIL;RAB11A;DCDC1;CENPV;PLK3;GIPC1
prerank,GO_Biological_Process_2021__positive regulation of dendrite development (GO:1900006),0.6086701835751779,1.155094908700268,0.21951219512195122,0.7065846406238573,1.0,2/9,16.20%,LRP8;BMP7
prerank,GO_Biological_Process_2021__cellular response to acetylcholine (GO:1905145),0.710854953344472,1.1549456000375655,0.2608695652173913,0.7063416221303144,1.0,5/6,28.70%,LY6H;ROCK2;ATP2B4;CHRM3;LYPD1
prerank,GO_Biological_Process_2021__V(D)J recombination (GO:0033151),0.6147745604321887,1.154912391035286,0.26666666666666666,0.7058965537829506,1.0,4/10,18.51%,LIG4;HMGB1;DCAF1;XRCC4
prerank,GO_Biological_Process_2021__positive regulation of dephosphorylation (GO:0035306),0.5517615050773409,1.1548778436639875,0.2702702702702703,0.7054521733310232,1.0,5/22,17.95%,BMP2;PPP2R5A;CAMTA1;SPPL3;PTBP1
prerank,GO_Biological_Process_2021__pre-replicative complex assembly involved in nuclear cell cycle DNA replication (GO:0006267),-0.7085490525876973,-1.154867393921254,0.35714285714285715,1.0,1.0,5/7,27.37%,MCMDC2;ORC3;MCM5;MCM3;MCM4
prerank,GO_Biological_Process_2021__Schwann cell development (GO:0014044),0.7055057330677759,1.1547631715066304,0.3333333333333333,0.7046159590376667,1.0,3/6,13.72%,PARD3;NF1;SIRT2
prerank,GO_Biological_Process_2021__peripheral nervous system axon ensheathment (GO:0032292),0.7055057330677759,1.1547631715066304,0.3333333333333333,0.7046159590376667,1.0,3/6,13.72%,PARD3;NF1;SIRT2
prerank,GO_Biological_Process_2021__positive regulation of B cell receptor signaling pathway (GO:0050861),0.6825850980722429,1.1543720363259329,0.3673469387755102,0.7052078263021897,1.0,1/6,2.08%,FOXP1
prerank,GO_Biological_Process_2021__tRNA aminoacylation for protein translation (GO:0006418),-0.5348889454608561,-1.1543376960847298,0.2608695652173913,1.0,1.0,4/39,11.56%,WARS1;PARS2;GARS1;NARS1
prerank,GO_Biological_Process_2021__regulation of receptor binding (GO:1900120),-0.7257651223112976,-1.154170360123018,0.3148148148148148,1.0,1.0,4/7,20.08%,B2M;BDNF;GREM2;PTPRF
prerank,GO_Biological_Process_2021__negative regulation of smoothened signaling pathway (GO:0045879),0.48832688536642077,1.1539962948174716,0.26666666666666666,0.7058113844731803,1.0,7/23,17.02%,MOSMO;BTRC;GLI3;GPR161;HERC4;VCP;SUFU
prerank,GO_Biological_Process_2021__negative regulation of transporter activity (GO:0032410),0.7247007493223301,1.1539889188249857,0.3469387755102041,0.7052806278501242,1.0,3/6,22.76%,SNCA;NDFIP1;NDFIP2
prerank,GO_Biological_Process_2021__monoacylglycerol catabolic process (GO:0052651),0.6905643902982704,1.1538318043458735,0.34,0.705216276738468,1.0,2/5,12.36%,MGLL;ABHD6
prerank,GO_Biological_Process_2021__amino sugar biosynthetic process (GO:0046349),-0.6235485853980939,-1.1536815811166314,0.3064516129032258,1.0,1.0,4/12,23.31%,UAP1;GNPDA1;UAP1L1;GFPT2
prerank,GO_Biological_Process_2021__regulation of neural precursor cell proliferation (GO:2000177),0.5432544433394401,1.1533819808440897,0.3157894736842105,0.705956748604624,1.0,5/18,17.81%,TAFA1;TOX;NAP1L1;PTPRZ1;KDM1A
prerank,GO_Biological_Process_2021__endodermal cell differentiation (GO:0035987),-0.5856342375906498,-1.1530285581495543,0.3382352941176471,1.0,1.0,7/23,18.44%,COL8A1;ITGA5;NODAL;LAMB1;CTR9;COL4A2;MMP14
prerank,GO_Biological_Process_2021__regulation of biomineral tissue development (GO:0070167),0.5038449487696238,1.1528656799158334,0.23076923076923078,0.7068845453733311,1.0,9/21,25.15%,SOX9;ANKH;ECM1;ROCK2;S1PR1;ROCK1;DDR2;SGMS2;GAS6
prerank,PanglaoDB_Augmented_2021__Follicular Cells,-0.503330648466203,-1.1526478107855835,0.2537313432835821,1.0,1.0,10/42,11.43%,SLC3A1;ADH4;BHMT;PDZK1;ALDOB;FMO5;TSHR;ANGPTL3;ABCC6;SLC10A1
prerank,GO_Biological_Process_2021__heart trabecula morphogenesis (GO:0061384),0.590656078343861,1.1524101916532428,0.2972972972972973,0.7075096097241536,1.0,6/12,20.43%,TGFBR1;BMPR1A;BMP7;RBPJ;S1PR1;NRG1
prerank,GO_Biological_Process_2021__mRNA transport (GO:0051028),0.3797378775659529,1.1523087014358369,0.16666666666666666,0.7072179387216595,1.0,27/92,24.86%,WDR33;NUP42;NUP37;NUP188;AGFG1;RBM15B;FYTTD1;EIF4E;KIF5C;SMG1;NUP153;U2AF1;U2AF2;NDC1;THOC7;SMG7;NUP205;NUP214;ALKBH5;FMR1;RANBP2;THOC2;NXT1;MAGOH;NUP54;NUP98;CPSF2
prerank,GO_Biological_Process_2021__cell differentiation in hindbrain (GO:0021533),0.6610979170103455,1.152023164894093,0.358974358974359,0.7075033372775492,1.0,5/7,29.12%,CEND1;OPHN1;AGTPBP1;FAIM2;GRID2
prerank,GO_Biological_Process_2021__rRNA base methylation (GO:0070475),-0.7336277948626505,-1.1519494804567167,0.2982456140350877,1.0,1.0,3/6,8.13%,BUD23;EMG1;TRMT112
prerank,GO_Biological_Process_2021__cellular response to cold (GO:0070417),0.7115975918525604,1.1517902903543074,0.2909090909090909,0.707637990679844,1.0,2/6,8.98%,FOXO1;EIF2AK4
prerank,GO_Biological_Process_2021__cellular component maintenance (GO:0043954),0.6170473415120573,1.151575905926856,0.35555555555555557,0.7077724380325561,1.0,3/10,26.37%,MTMR2;FYN;PICK1
prerank,GO_Biological_Process_2021__gamma-aminobutyric acid metabolic process (GO:0009448),-0.7156675962517731,-1.151572735584894,0.3125,1.0,1.0,1/5,8.14%,GAD1
prerank,GO_Biological_Process_2021__plus-end-directed organelle transport along microtubule (GO:0072386),0.7051543461858614,1.1515346640627655,0.30952380952380953,0.7073814058731147,1.0,2/6,14.54%,FYCO1;KIF13A
prerank,GO_Biological_Process_2021__mitochondrial RNA processing (GO:0000963),-0.6905738151351138,-1.1514606288064986,0.37735849056603776,1.0,1.0,3/7,19.66%,TRMT10B;TRMT10C;TRMT10A
prerank,GO_Biological_Process_2021__regulation of macrophage differentiation (GO:0045649),-0.6708365085074618,-1.151392790050001,0.3076923076923077,1.0,1.0,4/10,14.90%,CASP8;INHA;ID2;IL34
prerank,GO_Biological_Process_2021__mesodermal cell differentiation (GO:0048333),-0.6716337607154952,-1.15134102561327,0.2807017543859649,1.0,1.0,2/7,27.08%,ITGA2;ITGB4
prerank,GO_Biological_Process_2021__negative regulation of excitatory postsynaptic potential (GO:0090394),0.7039955768095447,1.1511805992029815,0.39215686274509803,0.7077407892459384,1.0,3/5,18.44%,NLGN4X;MTMR2;PTEN
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA damage recognition (GO:0000715)",-0.5535401224487628,-1.1509732146935823,0.2459016393442623,1.0,1.0,7/23,17.91%,CETN2;RPS27A;UBC;COPS6;COPS5;RBX1;UBA52
prerank,GO_Biological_Process_2021__glycerol ether metabolic process (GO:0006662),0.72300029053644,1.1507051182977246,0.3137254901960784,0.7085241965053702,1.0,1/5,1.34%,AGMO
prerank,GO_Biological_Process_2021__cAMP metabolic process (GO:0046058),0.5821819858580626,1.1506022719239255,0.2708333333333333,0.7082208310552124,1.0,5/11,22.67%,EPHA2;ADCY1;PDE4D;ADCY6;ADCY9
prerank,GO_Biological_Process_2021__embryonic organ development (GO:0048568),0.46078804555587644,1.1502497096511493,0.16666666666666666,0.7087657787508664,1.0,11/41,14.10%,RARB;PCSK5;SALL1;PBX1;PDGFA;PKDCC;GLI3;PBX2;PBX3;TGFBR2;BMPR1A
prerank,GO_Biological_Process_2021__negative regulation of biomineral tissue development (GO:0070168),0.49785388498625477,1.1501637735017982,0.24390243902439024,0.7085249858858365,1.0,5/16,19.93%,SOX9;TRPM4;ECM1;ROCK2;ROCK1
prerank,GO_Biological_Process_2021__response to UV (GO:0009411),0.39381995565483835,1.1501276034746244,0.14285714285714285,0.7080853688866758,1.0,18/81,17.91%,CDC25A;PTPRK;ZBTB1;EGFR;RHBDD1;SDE2;AKT1;EIF2AK4;MEN1;EP300;MAP3K4;MAP4K3;PRIMPOL;USP47;MAPK8;MSH2;KDM1A;YY1
prerank,GO_Biological_Process_2021__negative regulation of bone mineralization (GO:0030502),0.6154578559508936,1.149592936167987,0.23684210526315788,0.7092138539069618,1.0,2/8,15.40%,TRPM4;ECM1
prerank,GO_Biological_Process_2021__RNA export from nucleus (GO:0006405),0.3638401540672427,1.1495758779930312,0.11538461538461539,0.7086997985941504,1.0,16/91,16.17%,WDR33;NUP42;NUP37;NUP188;AGFG1;RBM15B;FYTTD1;EIF4E;SMG1;NUP153;U2AF1;U2AF2;NDC1;THOC7;SMG7;NUP205
prerank,GO_Biological_Process_2021__negative regulation of leukocyte mediated cytotoxicity (GO:0001911),-0.697501677770904,-1.1494817198925744,0.3220338983050847,1.0,1.0,5/7,23.11%,CEACAM1;KLRD1;MICA;HLA-F;HLA-E
prerank,GO_Biological_Process_2021__galactose metabolic process (GO:0006012),0.660991933159794,1.1490960920178637,0.2553191489361702,0.7093913663865896,1.0,4/9,28.26%,PGM2;GALK2;CHST1;GALE
prerank,GO_Biological_Process_2021__positive regulation of lipid storage (GO:0010884),0.5768763013209817,1.1490429375169782,0.2608695652173913,0.7089772495010429,1.0,2/14,5.57%,NFKB1;PLIN5
prerank,GO_Biological_Process_2021__chondrocyte development (GO:0002063),0.754757442841133,1.148980936107574,0.34782608695652173,0.7086257716521824,1.0,2/6,8.44%,SOX9;BMPR1B
prerank,GO_Biological_Process_2021__cellular response to fatty acid (GO:0071398),0.6727367197973866,1.1489303272380016,0.2653061224489796,0.7082500406922995,1.0,2/7,0.70%,PDK4;PID1
prerank,GO_Biological_Process_2021__regulation of establishment of endothelial barrier (GO:1903140),0.6215742907244628,1.1487442072971699,0.3333333333333333,0.7081720812758582,1.0,5/10,19.93%,ZDHHC21;ROCK2;PPP1R12A;ADD1;ROCK1
prerank,GO_Biological_Process_2021__protein insertion into mitochondrial inner membrane (GO:0045039),-0.678450094123234,-1.148739914310412,0.32,1.0,1.0,3/10,14.94%,TIMM10;TIMM8B;ROMO1
prerank,PanglaoDB_Augmented_2021__Basal Cells,-0.4741400339375064,-1.148673920019199,0.2676056338028169,1.0,1.0,19/67,17.61%,ADIRF;MYOF;CD9;SLC16A3;TRIM29;B3GNT3;RRAS;LTBR;MT1L;TAX1BP3;MT1E;EPS8L2;ITGA2;SRPX2;RARRES1;S100A16;DUOXA1;TNFRSF12A;ILK
prerank,"GO_Biological_Process_2021__RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",0.5391438028861031,1.1482836675810921,0.2765957446808511,0.7086758214673156,1.0,2/16,8.40%,TSEN15;ZBTB8OS
prerank,GO_Biological_Process_2021__negative regulation of double-strand break repair via nonhomologous end joining (GO:2001033),0.6553485470735145,1.1479870732098723,0.34782608695652173,0.7091664354218066,1.0,1/7,5.55%,CYREN
prerank,GO_Biological_Process_2021__membrane fission (GO:0090148),0.6736660104033408,1.1479491791100187,0.30434782608695654,0.7087543650863188,1.0,3/7,30.37%,TMCC1;SH3GLB1;SLC25A46
prerank,GO_Biological_Process_2021__cellular response to leucine (GO:0071233),0.6705937072150425,1.147916698478888,0.3488372093023256,0.7077963847318239,1.0,7/10,26.63%,SESN1;RPTOR;SESN3;UBR1;RRAGD;SESN2;UBR2
prerank,GO_Biological_Process_2021__response to leucine (GO:0043201),0.6705937072150425,1.147916698478888,0.3488372093023256,0.7077963847318239,1.0,7/10,26.63%,SESN1;RPTOR;SESN3;UBR1;RRAGD;SESN2;UBR2
prerank,GO_Biological_Process_2021__positive regulation of sprouting angiogenesis (GO:1903672),-0.5968478658595311,-1.1474430797150659,0.3793103448275862,1.0,1.0,3/14,10.93%,ITGA5;FGF1;KLF4
prerank,"GO_Biological_Process_2021__regulation of CD8-positive, alpha-beta T cell activation (GO:2001185)",-0.7247908838473933,-1.147267654689277,0.36,1.0,1.0,2/7,2.89%,IRF1;HLA-A
prerank,GO_Biological_Process_2021__negative regulation of trophoblast cell migration (GO:1901164),-0.7846816927960383,-1.1472464545232848,0.3050847457627119,1.0,1.0,2/5,9.68%,TIMP1;NODAL
prerank,PanglaoDB_Augmented_2021__Hepatocytes,-0.4324111784137286,-1.147224174011428,0.2692307692307692,1.0,1.0,15/94,11.43%,GC;CP;AKR1C1;HSD11B1;NR1I3;ALDOB;GPC3;CYP2D6;ADH6;RPP25L;MASP2;APOM;SAT2;CPB2;SLC10A1
prerank,GO_Biological_Process_2021__negative regulation of voltage-gated calcium channel activity (GO:1901386),0.6944935363521045,1.147214884390626,0.30952380952380953,0.7091491043076937,1.0,4/8,22.43%,CBARP;DRD2;FMR1;GPR35
prerank,GO_Biological_Process_2021__regulation of insulin secretion (GO:0050796),0.40194401020829773,1.1471431676195862,0.18181818181818182,0.7087506063694798,1.0,12/72,10.08%,ABCC8;EFNA5;SOX4;HADH;MCU;RFX3;EPHA5;IRS1;DOC2B;CLOCK;NR1D1;PRKN
prerank,GO_Biological_Process_2021__negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),0.6187596772600644,1.1469802400433287,0.4,0.7087219751954378,1.0,6/10,21.28%,VHL;SIRT2;NCK1;IMPACT;BAG3;HSPA1A
prerank,GO_Biological_Process_2021__synaptonemal complex assembly (GO:0007130),-0.6577984313123961,-1.1469703888896803,0.3389830508474576,1.0,1.0,5/10,15.53%,SYCE2;STAG3;RAD21L1;REC8;TEX11
prerank,GO_Biological_Process_2021__synaptonemal complex organization (GO:0070193),-0.6577984313123961,-1.1469703888896803,0.3389830508474576,1.0,1.0,5/10,15.53%,SYCE2;STAG3;RAD21L1;REC8;TEX11
prerank,GO_Biological_Process_2021__macromolecule catabolic process (GO:0009057),0.5099316641166366,1.146743029378307,0.3170731707317073,0.7087548853130996,1.0,12/21,31.79%,TRIM24;PIK3R4;SMURF1;IDE;SNX25;LRSAM1;SH3GLB1;KIF16B;NEDD4;CLN6;MTOR;UVRAG
prerank,GO_Biological_Process_2021__protein targeting to lysosome (GO:0006622),-0.5730590435155211,-1.1464061196579727,0.29411764705882354,1.0,1.0,5/19,17.72%,M6PR;CLU;GNPTAB;AP4M1;GCC2
prerank,GO_Biological_Process_2021__regulation of canonical Wnt signaling pathway (GO:0060828),0.351437875350792,1.1463868916669662,0.1111111111111111,0.7091441677691154,1.0,62/206,20.29%,LIMD1;CCDC88C;BTRC;SOX4;BMP2;EGFR;MLLT3;AMER2;SOX9;NFKB1;GPC5;ZEB2;KANK1;CSNK1G3;RNF146;TLE2;INVS;FRZB;PSMA1;GSKIP;TRPM4;LYPD6;LGR4;CSNK1E;PPM1A;TMEM170B;UBR5;PSMD11;PSMD10;GLI3;DACT3;PRKN;CAPRIN2;PSMF1;PSMD14;DVL1;TBL1XR1;SCYL2;TMEM131L;VCP;GSK3B;SOX13;BICC1;LATS1;GNAQ;USP47;STK11;PTPRO;PSME4;CUL3;ZNF703;CDK14;CTNND2;AXIN1;WNK1;LRP4;RBMS3;USP34;OTULIN;MCC;GID8;NPHP4
prerank,GO_Biological_Process_2021__positive regulation of monocyte chemotaxis (GO:0090026),0.583883150302707,1.1462709148435233,0.3055555555555556,0.708869682022739,1.0,3/8,9.68%,SERPINE1;CXCL12;HMGB1
prerank,GO_Biological_Process_2021__negative regulation of alpha-beta T cell differentiation (GO:0046639),0.7672214969953602,1.1461239639695482,0.34615384615384615,0.7087305997376171,1.0,4/5,17.52%,GLI3;HMGB1;CBFB;RUNX1
prerank,GO_Biological_Process_2021__ventricular septum morphogenesis (GO:0060412),0.5175951105545935,1.1458011052112833,0.2926829268292683,0.7089963972813178,1.0,10/24,14.34%,ZFPM2;SOX4;SMAD7;ROBO1;TGFBR2;SLIT2;ACVR1;TGFBR1;BMPR1A;SMAD4
prerank,GO_Biological_Process_2021__apoptotic mitochondrial changes (GO:0008637),-0.5424674182827902,-1.1455311373458064,0.26865671641791045,1.0,1.0,6/30,14.11%,IFI6;IFIT2;CLU;FZD9;FIS1;HK2
prerank,GO_Biological_Process_2021__establishment or maintenance of apical/basal cell polarity (GO:0035088),0.5410634577835739,1.1454433771062698,0.3181818181818182,0.7095313754165028,1.0,7/17,16.00%,MTCL1;PARD3;CRB1;DLG3;DLG1;SCRIB;PARD3B
prerank,GO_Biological_Process_2021__cellular response to brain-derived neurotrophic factor stimulus (GO:1990416),0.7223903589262037,1.1453047739868745,0.26785714285714285,0.7093921101624149,1.0,2/5,17.42%,NTRK2;WASF1
prerank,GO_Biological_Process_2021__negative regulation of leukocyte proliferation (GO:0070664),-0.7081657603110778,-1.1449226353949866,0.375,1.0,1.0,1/6,8.49%,GSTP1
prerank,GO_Biological_Process_2021__long-chain fatty acid transport (GO:0015909),0.44425094649937713,1.1448902496888838,0.25925925925925924,0.7098403453005793,1.0,6/27,20.19%,ACACB;SPX;RPS6KB1;ABCD3;CPT1A;ACSL3
prerank,GO_Biological_Process_2021__histone deubiquitination (GO:0016578),0.5385472346594377,1.1447106233448352,0.2682926829268293,0.7097255095105209,1.0,7/19,16.64%,USP49;KAT2A;SUPT3H;USP3;USP22;UIMC1;BRCC3
prerank,GO_Biological_Process_2021__monocyte differentiation (GO:0030224),0.5820425464255855,1.1447094646846974,0.2702702702702703,0.7091954680545758,1.0,3/9,6.81%,CSF1R;PDE1B;PIR
prerank,GO_Biological_Process_2021__positive regulation of cytokine-mediated signaling pathway (GO:0001961),-0.5653469515788303,-1.1446743909995387,0.265625,1.0,1.0,3/25,2.96%,IL7;AGPAT2;PARP14
prerank,GO_Biological_Process_2021__organophosphate catabolic process (GO:0046434),-0.6972347965682397,-1.1444217537682924,0.3018867924528302,1.0,1.0,2/7,7.43%,ENPP2;ANGPTL3
prerank,GO_Biological_Process_2021__cellular response to catecholamine stimulus (GO:0071870),0.5083439464065179,1.1441605960367225,0.2222222222222222,0.7100701214957397,1.0,6/20,15.57%,SNCA;GABPA;PRKN;SIRT2;MAPK1;ATP2B4
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta production (GO:0071634),0.57363614337892,1.1441074770249153,0.3617021276595745,0.7097357936631385,1.0,5/11,25.06%,ITGB8;SMAD4;HIF1A;SMAD3;SERPINF2
prerank,GO_Biological_Process_2021__regulation of cytoplasmic translation (GO:2000765),0.5832342228098837,1.1437730164280107,0.3076923076923077,0.710194292342236,1.0,7/13,21.70%,CPEB3;RBM24;CPEB4;DHX9;CPEB1;CPEB2;FMR1
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta2 production (GO:0032909),0.667494288758875,1.1431775270352842,0.38461538461538464,0.7111271511974033,1.0,5/6,29.52%,BMPR1A;SMAD4;HIF1A;SMAD3;TGFB2
prerank,GO_Biological_Process_2021__rRNA catabolic process (GO:0016075),0.5320041415969334,1.1429402162057112,0.2571428571428571,0.7112796441971982,1.0,1/13,3.32%,EXOSC6
prerank,GO_Biological_Process_2021__monocarboxylic acid metabolic process (GO:0032787),-0.4572011351208916,-1.142925351062075,0.20512820512820512,1.0,1.0,11/101,8.75%,ACOT2;LDHC;AKR1C1;ACOT1;SLC16A3;ACOT6;GLYAT;PDHX;ANGPTL3;ADH6;ACSBG2
prerank,GO_Biological_Process_2021__regulation of lens fiber cell differentiation (GO:1902746),0.6798640882868616,1.142894335401088,0.30434782608695654,0.7108237866080118,1.0,4/6,22.98%,SPRED2;SPRED1;SPRED3;FGF2
prerank,GO_Biological_Process_2021__hematopoietic progenitor cell differentiation (GO:0002244),0.5654669437838564,1.1423860888645987,0.25806451612903225,0.7117662520458631,1.0,4/18,4.03%,CSF1R;MLLT3;PLEK;FLT1
prerank,GO_Biological_Process_2021__adipose tissue development (GO:0060612),0.564933172058947,1.142373161093386,0.3157894736842105,0.7112864212162037,1.0,3/10,14.82%,SOX8;ZNF516;SH3PXD2B
prerank,GO_Biological_Process_2021__regulation of RNA biosynthetic process (GO:2001141),0.7601548196063487,1.1422779459185133,0.3617021276595745,0.7110257396609388,1.0,1/5,2.08%,MITF
prerank,GO_Biological_Process_2021__histone mRNA catabolic process (GO:0071044),0.582600867053202,1.1422256031116498,0.3142857142857143,0.7106805596959226,1.0,3/14,16.52%,ERI1;TENT4B;MTPAP
prerank,GO_Biological_Process_2021__response to exogenous dsRNA (GO:0043330),-0.6109094899072617,-1.1419150985040947,0.3442622950819672,1.0,1.0,3/16,10.28%,IFIT1;PQBP1;TLR3
prerank,GO_Biological_Process_2021__adenosine to inosine editing (GO:0006382),0.6776986497916546,1.1418634617258607,0.3673469387755102,0.7109781149231144,1.0,2/6,13.84%,ADARB1;ADARB2
prerank,GO_Biological_Process_2021__peptidyl-methionine modification (GO:0018206),0.6393014064848002,1.1418391359525317,0.3404255319148936,0.710524505057695,1.0,3/8,21.61%,NAA25;NAA30;NAA16
prerank,GO_Biological_Process_2021__progesterone receptor signaling pathway (GO:0050847),0.6346749651415801,1.1414403651363767,0.3584905660377358,0.711160521686991,1.0,4/7,32.33%,UBR5;YAP1;NEDD4;SRC
prerank,GO_Biological_Process_2021__elastic fiber assembly (GO:0048251),-0.7501710827189099,-1.1414356594491368,0.37037037037037035,1.0,1.0,1/6,10.75%,FBLN5
prerank,GO_Biological_Process_2021__mitochondrion morphogenesis (GO:0070584),0.620537019749036,1.1411420731023427,0.42857142857142855,0.7116263302830356,1.0,6/11,19.35%,PID1;MFF;MYH14;WASF1;MTM1;NUBPL
prerank,MSigDB_Hallmark_2020__IL-6/JAK/STAT3 Signaling,-0.4834273196319574,-1.1410506500224338,0.24242424242424243,1.0,1.0,16/54,17.99%,IL1R1;IRF1;IL7;CD9;STAT1;IFNGR2;STAT2;A2M;LTBR;IL3RA;CD14;IL15RA;CRLF2;TNFRSF21;TNFRSF12A;SOCS3
prerank,GO_Biological_Process_2021__endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),0.37504194321026696,1.140895791446034,0.1875,0.7116806753078878,1.0,27/153,19.03%,VAPB;BET1;ANK2;VAPA;TRAPPC12;PGAP1;VTI1A;TRAPPC8;TRAPPC6B;SEC22B;TRIP11;DCTN5;COL7A1;DYNLL2;PEF1;SEC24B;TMED3;NSF;TRAPPC11;TFG;RAB1A;TMED5;CUL3;SEC23A;MIA2;CNIH1;CD59
prerank,GO_Biological_Process_2021__positive regulation of ubiquitin protein ligase activity (GO:1904668),0.5808282865697538,1.1407039466366098,0.24242424242424243,0.7116625038185027,1.0,4/10,20.03%,BTRC;RAB1A;PTEN;PLK1
prerank,GO_Biological_Process_2021__regulation of muscle cell differentiation (GO:0051147),0.5087879125171555,1.1406382396670294,0.2777777777777778,0.7113427637929001,1.0,5/27,9.14%,HDAC9;CDH2;MEGF10;CTNNA2;MAPK11
prerank,GO_Biological_Process_2021__cellular response to DNA damage stimulus (GO:0006974),0.351709798011126,1.1406188111940851,0.07692307692307693,0.7108185613140549,1.0,70/302,22.69%,CHRNA4;BACH1;SAMHD1;FOXP1;FOXO1;ZBTB1;EPHA2;UBE2T;RBM24;BOK;RAD18;PDS5B;CSNK1E;UBR5;APTX;RAD52;MEN1;RFWD3;RAD51B;NEK4;USP3;DCUN1D5;MAPKAPK2;NIPBL;TRIP12;VCPIP1;SIRT1;SMC6;UBE2E2;ZDHHC16;TRIM28;FBXO45;DYRK2;TAOK2;PDS5A;VCP;BCL2;ZBTB38;YAP1;USP47;UBQLN4;MSH2;APLF;STK11;PSME4;ATF2;CDKN2AIP;ASH2L;YY1;AATF;ASF1A;APBB1;MACROD1;WAC;FBXO31;FMN2;H2AX;CIB1;WDR48;NFATC2;TICRR;RBBP6;UBA6;FMR1;ETAA1;ZBTB40;SHPRH;XRCC2;HERC2;TANK
prerank,GO_Biological_Process_2021__stem cell differentiation (GO:0048863),0.48149327969699784,1.1402825540886143,0.22580645161290322,0.7111504001568102,1.0,10/30,18.84%,WNT7A;MLLT3;FBXL17;GPM6A;PSMD11;EPCAM;SETD2;PUM1;JARID2;SOX21
prerank,GO_Biological_Process_2021__ncRNA metabolic process (GO:0034660),0.5084635556906397,1.1399670152717012,0.23076923076923078,0.7116382340156959,1.0,5/30,13.54%,PLD6;PIWIL4;DROSHA;TENT4B;PRKRA
prerank,GO_Biological_Process_2021__positive regulation of cellular biosynthetic process (GO:0031328),0.3602652802812796,1.139777074336418,0.125,0.7115479905498385,1.0,36/138,17.88%,PPARGC1A;SNCA;SOX4;DNA2;PRMT1;EGFR;PASK;ZCCHC4;CPEB3;RGCC;ZEB2;PLIN5;AKT1;STN1;IRS1;RPS6KB1;PKD2;NR1D1;STARD4;ELOVL5;SIRT1;DHX9;KAT7;NIBAN1;DYRK2;MLXIPL;FAF1;DDAH1;HGF;ARPP19;EIF3E;AKT2;FXR1;HIF1A;IGF1;LARP4
prerank,GO_Biological_Process_2021__cytoplasmic sequestering of NF-kappaB (GO:0007253),0.6622927875206772,1.13966344532102,0.3090909090909091,0.7114218212159142,1.0,2/7,15.37%,PSMD10;FAF1
prerank,GO_Biological_Process_2021__negative regulation of gene silencing by miRNA (GO:0060965),-0.726070587087071,-1.1389545443481979,0.3157894736842105,1.0,1.0,1/7,5.12%,DND1
prerank,"GO_Biological_Process_2021__regulation of gene expression, epigenetic (GO:0040029)",0.412454690535327,1.138953268611114,0.1724137931034483,0.7130734161587601,1.0,15/75,18.47%,KAT2B;EED;TFAP2C;AEBP2;PHF2;TASOR;TAF1B;KAT2A;EP300;HDAC4;RBBP4;KDM1B;PPHLN1;JARID2;PPM1D
prerank,GO_Biological_Process_2021__negative regulation of lipase activity (GO:0060192),0.6858358028983664,1.1388868368443932,0.2926829268292683,0.7126222626522177,1.0,3/7,5.57%,HDAC9;SORT1;PLIN5
prerank,GO_Biological_Process_2021__carboxylic acid transmembrane transport (GO:1905039),0.4328840660515718,1.1388821174863162,0.23529411764705882,0.7121118053710385,1.0,8/33,19.22%,SLC19A1;SLC7A11;ABCC5;SLC38A6;SLC38A10;SLC13A3;SLC25A14;SLC7A9
prerank,GO_Biological_Process_2021__long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),0.5569913653950178,1.138349459343454,0.3103448275862069,0.7131001299982932,1.0,7/16,20.19%,ELOVL7;HACD2;ELOVL6;ELOVL5;HACD1;ACSBG1;ACSL3
prerank,GO_Biological_Process_2021__negative regulation of protein phosphorylation (GO:0001933),0.3857043632548969,1.138174881214112,0.1111111111111111,0.7131050167035935,1.0,45/128,21.25%,PID1;NCK2;SNCA;PARD3;PPP1R15B;SMCR8;SPRED2;TESK1;PPM1E;AKT1;GSKIP;SMAD7;PTPN13;SPRED1;MEN1;PRKN;TAB1;CAMK2N1;NF1;DUSP19;DVL1;CRKL;PLPP3;SLIT2;OCLN;SAMSN1;SIRT2;NCK1;NIBAN1;MLXIPL;GNAQ;IMPACT;SEMA4D;YWHAG;PDE4D;TRIB2;FBLN1;PTEN;PPM1F;FKBP8;CIB1;DNAJC3;SNX25;SPRED3;PTPRC
prerank,GO_Biological_Process_2021__positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),0.5102084596554147,1.1379963779349265,0.2682926829268293,0.7132056301649861,1.0,5/17,21.27%,FOXP1;BCL10;NECTIN2;PTPRC;PRKCB
prerank,GO_Biological_Process_2021__positive regulation of cytosolic calcium ion concentration (GO:0007204),-0.4701415996824046,-1.1379174649633697,0.25,1.0,1.0,11/74,12.15%,CD24;P2RY10;ACKR4;JPH3;GPR18;TACR1;LPAR4;FPR3;CAV3;LPAR6;FIS1
prerank,GO_Biological_Process_2021__regulation of glucokinase activity (GO:0033131),0.7003763844808457,1.1378197394163583,0.36538461538461536,0.7131745586342132,1.0,2/5,21.06%,PRKN;DUSP12
prerank,GO_Biological_Process_2021__negative regulation of platelet aggregation (GO:0090331),-0.6212244435031369,-1.1375316074205415,0.3448275862068966,1.0,1.0,4/9,17.43%,CD9;CEACAM1;ALOX12;C1QTNF1
prerank,GO_Biological_Process_2021__enteric nervous system development (GO:0048484),0.6760440859941257,1.1372308031662623,0.3617021276595745,0.7141950670025918,1.0,1/6,2.50%,SOX8
prerank,GO_Biological_Process_2021__regulation of autophagosome maturation (GO:1901096),0.562118822505929,1.137190466706855,0.3076923076923077,0.7137573404703748,1.0,4/13,15.92%,SMCR8;ADRB2;FYCO1;UBQLN4
prerank,GO_Biological_Process_2021__positive regulation of extracellular matrix assembly (GO:1901203),0.6150235535015781,1.1370185646673818,0.3684210526315789,0.7136543435694672,1.0,4/9,25.72%,RGCC;CLASP1;SMAD3;CLASP2
prerank,GO_Biological_Process_2021__tetrahydrofolate interconversion (GO:0035999),0.6285226949572552,1.1366792595265605,0.32558139534883723,0.7142311150853579,1.0,1/9,0.50%,MTHFS
prerank,GO_Biological_Process_2021__cardiac muscle cell-cardiac muscle cell adhesion (GO:0086042),-0.6897724897071593,-1.1366552020051082,0.3541666666666667,1.0,1.0,4/5,29.46%,CTNNA3;PKP2;JUP;DSC2
prerank,GO_Biological_Process_2021__cholesterol biosynthetic process (GO:0006695),-0.5456739552976352,-1.136587761272607,0.3188405797101449,1.0,1.0,11/26,21.38%,DHCR24;MVK;SQLE;DHCR7;HSD17B7;FDPS;ACAT2;TM7SF2;INSIG1;MSMO1;HMGCR
prerank,GO_Biological_Process_2021__positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),0.6564952115088725,1.1362646238435339,0.2571428571428571,0.7148189608824514,1.0,1/7,3.28%,EGFR
prerank,GO_Biological_Process_2021__regulation of hyaluronan biosynthetic process (GO:1900125),0.7009331909502224,1.1358117875399456,0.3673469387755102,0.7158464645834599,1.0,1/5,4.81%,NFKB1
prerank,GO_Biological_Process_2021__response to vitamin D (GO:0033280),-0.7352515578336968,-1.1356922165984937,0.3728813559322034,1.0,1.0,2/5,11.83%,FES;SFRP1
prerank,GO_Biological_Process_2021__negative regulation of phosphate metabolic process (GO:0045936),0.5215583201246936,1.135659201388259,0.3157894736842105,0.7157541450604537,1.0,5/18,19.93%,PLEK;TESK1;SIRT1;BMP7;ROCK1
prerank,GO_Biological_Process_2021__positive regulation of DNA ligation (GO:0051106),0.7163069669739506,1.1351290023750529,0.3333333333333333,0.7165179293746168,1.0,2/5,16.13%,HMGB1;APLF
prerank,GO_Biological_Process_2021__negative regulation of lens fiber cell differentiation (GO:1902747),0.7140500038058624,1.1350124750463553,0.38,0.7162826983053298,1.0,2/5,7.82%,SPRED2;SPRED1
prerank,GO_Biological_Process_2021__cellular response to glucose starvation (GO:0042149),0.4836406474910136,1.1349427299094104,0.24390243902439024,0.7159647101564154,1.0,14/34,26.37%,FOXO3;SESN1;KPTN;CPEB4;PIK3C3;PIK3R4;SIK2;SESN3;IMPACT;IFI16;SESN2;PRKAA1;SH3GLB1;PICK1
prerank,GO_Biological_Process_2021__regulation of steroid biosynthetic process (GO:0050810),0.7046198593278972,1.1343598188932285,0.3953488372093023,0.7170351078796976,1.0,2/6,13.01%,BMP2;SIRT1
prerank,GO_Biological_Process_2021__T cell activation (GO:0042110),0.47244638323287586,1.1343559910543877,0.18181818181818182,0.7165273712298743,1.0,11/40,16.09%,LEPR;NCK2;TNFSF4;SOX4;KIF13B;CHD7;EIF2AK4;ADA;NCK1;SCRIB;PPP3CB
prerank,GO_Biological_Process_2021__regulation of nucleobase-containing compound metabolic process (GO:0019219),0.5412192909764044,1.134330626493818,0.3191489361702128,0.7161388241416266,1.0,6/10,24.67%,IGF2BP2;NOVA1;PCBP4;NOVA2;ZNF445;PCBP2
prerank,GO_Biological_Process_2021__positive regulation of homotypic cell-cell adhesion (GO:0034112),-0.748542069698621,-1.1339773721140596,0.3,1.0,1.0,1/5,6.08%,PDPN
prerank,GO_Biological_Process_2021__synaptic vesicle membrane organization (GO:0048499),-0.6037651269674837,-1.133783581715251,0.288135593220339,1.0,1.0,1/15,2.85%,STX19
prerank,GO_Biological_Process_2021__regulation of barbed-end actin filament capping (GO:2000812),0.7220703284626289,1.1334415126569506,0.3191489361702128,0.7180116783115439,1.0,1/5,6.96%,CARMIL1
prerank,GO_Biological_Process_2021__regulation of cellular extravasation (GO:0002691),0.6374316446840794,1.1332706482144046,0.3877551020408163,0.7179301555156378,1.0,2/7,7.28%,FUT9;BST1
prerank,GO_Biological_Process_2021__inositol phosphate biosynthetic process (GO:0032958),0.5863305522462333,1.1331590109453615,0.37209302325581395,0.717671454308415,1.0,5/10,25.86%,ITPKB;IP6K2;IPPK;FGF2;IPMK
prerank,GO_Biological_Process_2021__positive regulation of DNA methylation-dependent heterochromatin assembly (GO:0090309),0.5739850166108096,1.1331564335230733,0.32608695652173914,0.7171769024007895,1.0,4/11,25.89%,TASOR;TRIM28;PPHLN1;ZNF304
prerank,GO_Biological_Process_2021__regulation of lymphocyte differentiation (GO:0045619),-0.6134838578798253,-1.1330344543787447,0.2898550724637681,1.0,1.0,4/10,26.58%,SPINK5;PRELID1;PRDM1;METTL3
prerank,GO_Biological_Process_2021__positive regulation of TOR signaling (GO:0032008),0.4488139996114179,1.1326965238439093,0.2571428571428571,0.7180521764052513,1.0,12/34,27.13%,SMCR8;RHEB;PIK3CA;GOLPH3;SIK3;RPTOR;RRAGD;MIOS;GPR137B;GAS6;WDR24;RICTOR
prerank,GO_Biological_Process_2021__endosome to lysosome transport via multivesicular body sorting pathway (GO:0032510),0.7050559745222806,1.132644872744017,0.32608695652173914,0.717687799136471,1.0,3/7,14.67%,CHMP2B;UBXN6;VCP
prerank,GO_Biological_Process_2021__epithelial cell morphogenesis (GO:0003382),0.5865583206238109,1.1325727080083954,0.3488372093023256,0.7173121612217352,1.0,1/11,1.21%,CCDC88C
prerank,GO_Biological_Process_2021__stress granule disassembly (GO:0035617),0.7394709030762068,1.1324674701976274,0.3829787234042553,0.7171254993860542,1.0,4/5,25.98%,VCP;KLC1;ZFAND1;DYRK3
prerank,GO_Biological_Process_2021__ketone body biosynthetic process (GO:0046951),0.6542821888019269,1.132210639800223,0.325,0.7172333243142303,1.0,3/8,25.96%,BDH2;ACAT1;HMGCLL1
prerank,GO_Biological_Process_2021__regulation of RNA metabolic process (GO:0051252),0.4171378844801941,1.1319276937799505,0.25,0.7173409942101588,1.0,18/54,21.30%,MITF;HNRNPH1;RBM12B;MBNL2;IGF2BP2;HNRNPLL;HNRNPH3;MBNL1;CLK1;PTBP2;RBM20;PTBP1;CELF1;YTHDF2;RBM38;NOVA1;PCBP4;NOVA2
prerank,GO_Biological_Process_2021__mitochondrial respirasome assembly (GO:0097250),-0.6854109023118294,-1.13183893961275,0.3076923076923077,1.0,1.0,3/6,17.53%,COX7A1;COX7A2;HIGD1B
prerank,GO_Biological_Process_2021__tricarboxylic acid metabolic process (GO:0072350),0.5743038875728859,1.1317098181253906,0.35294117647058826,0.7174837648629689,1.0,1/12,3.48%,IREB2
prerank,GO_Biological_Process_2021__response to muramyl dipeptide (GO:0032495),-0.6332547336484801,-1.1316484584157798,0.26229508196721313,1.0,1.0,3/10,17.40%,NLRP1;RIPK2;PTPN22
prerank,GO_Biological_Process_2021__negative regulation of receptor signaling pathway via STAT (GO:1904893),0.6018225718998973,1.1313420731467743,0.3111111111111111,0.7179081717007472,1.0,2/8,14.49%,VHL;ADIPOR1
prerank,GO_Biological_Process_2021__cellular response to tumor necrosis factor (GO:0071356),-0.4246071685822814,-1.1310179723166627,0.2222222222222222,1.0,1.0,20/127,14.31%,GBP2;GBP1;GBP3;PSMB6;STAT1;PSMA8;PSMB9;PSMA7;HYAL1;PSMC3;PSME1;LTBR;SFRP1;TXNDC17;CX3CL1;BRCA1;PSMC4;PSMA3;AIM2;CCL2
prerank,GO_Biological_Process_2021__cobalamin metabolic process (GO:0009235),-0.611179935528702,-1.131008531551544,0.26666666666666666,1.0,1.0,4/15,18.30%,PRSS3;AMN;MMAB;MMACHC
prerank,GO_Biological_Process_2021__tetrapyrrole metabolic process (GO:0033013),-0.611179935528702,-1.131008531551544,0.26666666666666666,1.0,1.0,4/15,18.30%,PRSS3;AMN;MMAB;MMACHC
prerank,GO_Biological_Process_2021__regulation of sensory perception of pain (GO:0051930),0.5990291254692041,1.1309678702456887,0.3170731707317073,0.7183789094645076,1.0,3/9,16.35%,MGLL;SPX;ATPSCKMT
prerank,GO_Biological_Process_2021__radial glial cell differentiation (GO:0060019),-0.7061417909773116,-1.1308344052106376,0.42105263157894735,1.0,1.0,3/5,26.58%,HES1;GPR157;METTL3
prerank,GO_Biological_Process_2021__negative regulation of cellular protein localization (GO:1903828),0.4751804861849443,1.13066206049828,0.2,0.7188255192441999,1.0,12/30,19.45%,PICALM;NEDD4L;TTBK2;GPM6B;LEPROTL1;COMMD1;GSK3B;ROCK2;LATS1;LZTFL1;NSFL1C;UBXN2B
prerank,GO_Biological_Process_2021__cellular response to unfolded protein (GO:0034620),0.4862090576607793,1.1305870444492472,0.2903225806451613,0.7185684004515602,1.0,7/26,27.73%,RHBDD1;PRKN;BAG3;ABCB10;HSPA1A;ERN1;DAXX
prerank,GO_Biological_Process_2021__positive regulation of lamellipodium morphogenesis (GO:2000394),-0.7420056051704906,-1.130554821234219,0.39622641509433965,1.0,1.0,2/7,4.89%,ENPP2;VIL1
prerank,GO_Biological_Process_2021__protein K29-linked ubiquitination (GO:0035519),0.7412843399278636,1.130407849634025,0.3392857142857143,0.7183936180622494,1.0,3/5,10.08%,UBE2T;ITCH;PRKN
prerank,GO_Biological_Process_2021__protein poly-ADP-ribosylation (GO:0070212),-0.6515241321296623,-1.1301943011845772,0.36363636363636365,1.0,1.0,2/9,12.43%,PARP14;PARP2
prerank,GO_Biological_Process_2021__response to molecule of bacterial origin (GO:0002237),-0.4988921895385172,-1.1298053588726371,0.31343283582089554,1.0,1.0,8/43,13.85%,CD24;SELP;CXCL2;IL12A;LY96;SLC11A1;CD14;NOS1
prerank,GO_Biological_Process_2021__regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),0.5189585859055428,1.1298036790460775,0.2972972972972973,0.7196232514809578,1.0,3/24,1.42%,BACH1;CDK18;KLF11
prerank,GO_Biological_Process_2021__glycerol ether biosynthetic process (GO:0046504),0.6965333582038182,1.1291485134866521,0.3469387755102041,0.7200207474053275,1.0,3/5,19.92%,PEX7;FAR1;AGPS
prerank,GO_Biological_Process_2021__cellular lipid biosynthetic process (GO:0097384),0.6965333582038182,1.1291485134866521,0.3469387755102041,0.7200207474053275,1.0,3/5,19.92%,PEX7;FAR1;AGPS
prerank,GO_Biological_Process_2021__G protein-coupled receptor internalization (GO:0002031),-0.7066578521108703,-1.128803123157581,0.4482758620689655,1.0,1.0,2/5,5.70%,ADM;ARR3
prerank,GO_Biological_Process_2021__positive regulation of myeloid cell apoptotic process (GO:0033034),-0.7481518408759048,-1.1287295906835104,0.36065573770491804,1.0,1.0,2/6,8.27%,ANXA1;PIK3CB
prerank,GO_Biological_Process_2021__negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),0.6236336013110426,1.1285514843701034,0.33962264150943394,0.7210130598732356,1.0,6/9,25.02%,CBL;CBLB;CHMP6;TSG101;SOCS4;ERRFI1
prerank,GO_Biological_Process_2021__negative regulation of immune system process (GO:0002683),0.6256101049873257,1.1282601689056204,0.3902439024390244,0.7213505489689201,1.0,2/8,5.76%,SOX9;IL17D
prerank,PanglaoDB_Augmented_2021__Intercalated Cells,-0.4514456304616318,-1.128201716971778,0.2054794520547945,1.0,1.0,8/71,8.93%,FMO6P;SPAG17;CYP4Z1;P2RY14;DNAAF1;RGS22;FMO2;DCDC1
prerank,GO_Biological_Process_2021__regulation of leukocyte migration (GO:0002685),-0.6525004357579459,-1.1280722907803928,0.3050847457627119,1.0,1.0,4/12,14.75%,ANXA1;RHOH;MADCAM1;ZP3
prerank,GO_Biological_Process_2021__regulation of protein autoubiquitination (GO:1902498),0.6748814155116954,1.1280523052429938,0.36538461538461536,0.7214543633670542,1.0,2/6,9.44%,SASH1;MARCHF7
prerank,GO_Biological_Process_2021__dopamine uptake (GO:0090494),0.7054794014243103,1.1280225850109749,0.3269230769230769,0.7209754611092221,1.0,1/5,2.09%,SNCA
prerank,PanglaoDB_Augmented_2021__Epsilon Cells,-0.4720104248561829,-1.1276104831347509,0.3287671232876712,1.0,1.0,8/68,10.09%,THSD4;GC;BHMT;ALDOB;S100A6;GRAMD2A;ADH6;A2M
prerank,GO_Biological_Process_2021__regulation of microtubule binding (GO:1904526),0.659177122847972,1.1275900755552983,0.36585365853658536,0.7214170440921588,1.0,5/5,34.10%,TTBK2;MARK2;PPP2CB;MAP2;ABL1
prerank,GO_Biological_Process_2021__endocrine system development (GO:0035270),0.6032657871420176,1.1274252903025612,0.3181818181818182,0.7213344328599263,1.0,3/11,13.12%,SALL1;NF1;TGFBR1
prerank,GO_Biological_Process_2021__PML body organization (GO:0030578),0.7039441846913475,1.1269925038600663,0.4772727272727273,0.7218216391454769,1.0,1/5,13.07%,HIPK2
prerank,GO_Biological_Process_2021__positive regulation of heterochromatin assembly (GO:0031453),0.5678105050989227,1.1268340100187992,0.3404255319148936,0.7216110568799005,1.0,4/13,25.89%,TASOR;TRIM28;PPHLN1;ZNF304
prerank,GO_Biological_Process_2021__neuron projection arborization (GO:0140058),0.7124753228014424,1.126573741081023,0.34146341463414637,0.7216561941666662,1.0,3/6,22.01%,ROCK1;PHACTR1;NLGN1
prerank,GO_Biological_Process_2021__serine transport (GO:0032329),0.6576437383760512,1.1264060401509985,0.36585365853658536,0.7215852494776804,1.0,1/6,9.09%,SFXN1
prerank,GO_Biological_Process_2021__negative regulation of RNA metabolic process (GO:0051253),-0.6386874526113361,-1.12618396321892,0.3157894736842105,1.0,1.0,2/14,7.23%,RPS13;RPS26
prerank,GO_Biological_Process_2021__attachment of GPI anchor to protein (GO:0016255),0.7301840172218144,1.1260131279171615,0.3877551020408163,0.7223607361575118,1.0,1/5,4.51%,PGAP1
prerank,GO_Biological_Process_2021__myeloid cell activation involved in immune response (GO:0002275),-0.6421774545370541,-1.125669315613407,0.3389830508474576,1.0,1.0,3/11,20.75%,IFI35;DOCK2;SBNO2
prerank,PanglaoDB_Augmented_2021__Spermatocytes,0.5411007291801644,1.1252052155748165,0.2972972972972973,0.7239460997532727,1.0,2/17,3.00%,PRNT;GCNA
prerank,GO_Biological_Process_2021__cellular response to oxygen-containing compound (GO:1901701),0.3469616286962909,1.1247749589885834,0.1111111111111111,0.7246725093289784,1.0,48/215,16.23%,PDK4;PID1;PTPRK;BRINP3;TNFSF4;NRIP1;PDE3A;SERPINE1;FOXO1;LCOR;EGFR;CPEB3;GIT1;SOX9;RORA;CCDC62;SLC26A3;NFKB1;PDGFRA;ADNP2;GUCY1B1;AKT1;RAPGEF2;IRS1;ABL2;TICAM1;CPEB4;NCOA3;PKD2;HMGB1;NR1D1;PRKD1;AHR;SLIT2;SSH1;AGAP3;FER;RAP1A;IP6K2;RPTOR;MAPK1;VCP;ROCK2;PDK2;ATP2B4;PXN;MAPK8;IMPACT
prerank,GO_Biological_Process_2021__regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547),-0.717957408361505,-1.1243618022892201,0.35185185185185186,1.0,1.0,1/5,2.99%,CD63
prerank,GO_Biological_Process_2021__cellular response to laminar fluid shear stress (GO:0071499),-0.6565088402643218,-1.1243578767632916,0.3559322033898305,1.0,1.0,2/7,10.93%,KLF2;KLF4
prerank,GO_Biological_Process_2021__regulation of vasoconstriction (GO:0019229),0.5392608834286738,1.1239871956461778,0.2857142857142857,0.7266473407874263,1.0,4/18,9.71%,ACE2;TRPM4;ADRA1A;ZDHHC21
prerank,GO_Biological_Process_2021__cation homeostasis (GO:0055080),-0.6140365779105174,-1.123929223785793,0.3157894736842105,1.0,1.0,1/7,15.92%,SLC4A11
prerank,GO_Biological_Process_2021__positive regulation of cell division (GO:0051781),-0.5439296731292113,-1.1238816319058182,0.3230769230769231,1.0,1.0,6/25,13.87%,KIF20B;SVIL;HTR2B;FGF1;CENPV;GIPC1
prerank,GO_Biological_Process_2021__positive regulation of telomerase RNA localization to Cajal body (GO:1904874),0.5518361507389249,1.1237144236310594,0.2777777777777778,0.7269199434557073,1.0,4/15,15.88%,NAF1;CCT4;DKC1;CCT3
prerank,GO_Biological_Process_2021__secondary alcohol biosynthetic process (GO:1902653),-0.5505631993998891,-1.1235503297936347,0.3382352941176471,1.0,1.0,11/25,21.38%,DHCR24;MVK;SQLE;DHCR7;HSD17B7;FDPS;ACAT2;TM7SF2;INSIG1;MSMO1;HMGCR
prerank,GO_Biological_Process_2021__small RNA loading onto RISC (GO:0070922),0.5972807929299649,1.123144902316093,0.39473684210526316,0.727746687570737,1.0,5/9,31.12%,DHX9;AGO3;DICER1;AGO1;AGO2
prerank,GO_Biological_Process_2021__regulation of cellular response to stress (GO:0080135),0.3677730817955172,1.1231371605407143,0.17647058823529413,0.7272446493516495,1.0,25/112,16.17%,NUP42;AIFM2;NUP37;NUP188;HSPH1;CHORDC1;CAMK2B;CAMK2A;NPAS2;PRKN;EP300;NEK4;CAMK2D;SMG1;NUP153;MAPKAPK2;SIRT1;NDC1;RPTOR;MAPK1;DNAJB6;GSK3B;ROCK2;PTGES3;NUP205
prerank,GO_Biological_Process_2021__negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),-0.6457511700435633,-1.1230530525636855,0.3220338983050847,1.0,1.0,1/8,2.96%,PARP14
prerank,"GO_Biological_Process_2021__negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",0.6311189453156117,1.1229153189632664,0.4186046511627907,0.7274354996684252,1.0,6/10,18.39%,DYRK1A;MARCHF7;PSMD10;SIRT1;KDM1A;MDM2
prerank,GO_Biological_Process_2021__regulation of axon regeneration (GO:0048679),0.5814915853865577,1.1226505370556572,0.42105263157894735,0.7274992706737188,1.0,2/10,9.87%,EPHA4;RTN4RL1
prerank,GO_Biological_Process_2021__negative regulation of establishment of protein localization (GO:1904950),0.6299509633005452,1.122526194261001,0.39473684210526316,0.7274016705679273,1.0,6/10,33.72%,NDFIP1;PPM1F;NDFIP2;CORO2B;DNAJA1;SNX3
prerank,GO_Biological_Process_2021__negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),-0.5056941684139643,-1.1219896159730578,0.2753623188405797,1.0,1.0,4/34,6.86%,RPL23;RPL11;RPS7;RPL5
prerank,GO_Biological_Process_2021__establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),0.47093472595262004,1.1219391530446918,0.3333333333333333,0.7285820381995961,1.0,11/28,19.58%,MTCL1;PARD3;CRB1;DLG3;OPHN1;DLG1;SCRIB;PARD3B;LIN7C;RAP2A;LIN7A
prerank,GO_Biological_Process_2021__negative regulation of protein dephosphorylation (GO:0035308),0.5062630982962806,1.1215384499600969,0.28125,0.7289554734023511,1.0,7/19,27.47%,PPP1R1B;PPP4R4;GSK3B;ARPP19;PPP1R8;ENSA;STYXL1
prerank,GO_Biological_Process_2021__regulation of dendritic spine morphogenesis (GO:0061001),0.4750940977779835,1.1214477050466065,0.2702702702702703,0.7287420976720711,1.0,15/29,22.42%,EPHA4;CAMK2B;PPFIA2;SRCIN1;CAPRIN2;LRP8;SHANK3;PDLIM5;CAPRIN1;TANC2;PTEN;CDK5R1;NLGN1;ABI2;ARHGAP44
prerank,GO_Biological_Process_2021__positive regulation of chemotaxis (GO:0050921),-0.5551200520265636,-1.1214188913657712,0.34285714285714286,1.0,1.0,3/29,5.73%,P2RY12;SEMA5A;THBS1
prerank,GO_Biological_Process_2021__chemical synaptic transmission (GO:0007268),0.32777757456180995,1.121347773474161,0.0,0.7285519970918665,1.0,73/229,23.72%,CHRNA4;DLGAP1;KCNQ3;GABRG1;SNCA;CACNB4;PCDHB2;PRKACB;DOC2A;HTR2C;PDE7B;GRIN1;CACNA1B;RPS6KA3;KIF5A;PRKAR1B;NRXN1;MBP;HOMER1;TBC1D24;GABRA4;RPS6KA2;GPR176;PCDHB13;LPAR3;DVL1;NLGN3;GRM1;GLRB;NLGN4X;SLC32A1;KIF1B;GABRA5;GABRB1;NAPB;EXOC4;KCNQ2;MAPK1;DLG1;APBA3;STX1A;HRH1;LIN7C;CACNB3;GRID1;NPY;APBA1;PTEN;CAMKK1;NRXN2;DRD2;ERC2;NOVA1;LIN7A;GRIK2;GABRG3;GRIA2;NPTX2;DNAJC5;UNC13A;CDH8;SLC6A1;NLGN1;CAMK4;KCNC4;ERC1;PTPRN2;HCRT;GRIN2B;GRIK1;GRM5;CNP;GABRB3
prerank,GO_Biological_Process_2021__Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),-0.6813825801318387,-1.1211338861028135,0.3793103448275862,1.0,1.0,3/7,17.22%,WNT9B;WNT3;WNT5A
prerank,GO_Biological_Process_2021__regulation of dendritic cell differentiation (GO:2001198),-0.6680576473513327,-1.12090155715769,0.3389830508474576,1.0,1.0,1/7,2.78%,HLA-B
prerank,GO_Biological_Process_2021__pinocytosis (GO:0006907),0.6136508039184003,1.1200734264987142,0.40476190476190477,0.7319093816473485,1.0,3/8,14.46%,CARMIL1;MAPKAPK2;SNX5
prerank,GO_Biological_Process_2021__negative regulation of T cell receptor signaling pathway (GO:0050860),-0.6183068840731818,-1.119802611926966,0.2833333333333333,1.0,1.0,5/14,17.72%,GBP1;CEACAM1;CD160;PTPN22;PHPT1
prerank,GO_Biological_Process_2021__amyloid-beta metabolic process (GO:0050435),0.6081293128327926,1.119797705622711,0.40425531914893614,0.7321647197985645,1.0,3/12,7.40%,MME;NCSTN;DYRK1A
prerank,GO_Biological_Process_2021__positive regulation of cell migration by vascular endothelial growth factor signaling pathway (GO:0038089),0.6577281851428243,1.119649407553914,0.4146341463414634,0.7321331105395545,1.0,2/7,14.92%,PRKD1;GAB1
prerank,GO_Biological_Process_2021__plus-end-directed vesicle transport along microtubule (GO:0072383),0.7051833576280107,1.1191990945109835,0.40476190476190477,0.7331325454119465,1.0,2/5,14.54%,FYCO1;KIF13A
prerank,GO_Biological_Process_2021__cell junction maintenance (GO:0034331),0.617848204509398,1.1189671056530002,0.37209302325581395,0.7333178063308603,1.0,1/8,3.05%,CSF1R
prerank,GO_Biological_Process_2021__positive regulation of leukocyte activation (GO:0002696),-0.6184697708245891,-1.118436092250451,0.3275862068965517,1.0,1.0,4/10,21.11%,THBS1;CRLF2;WNT5A;HSPD1
prerank,GO_Biological_Process_2021__multivesicular body organization (GO:0036257),0.4678396172015422,1.1183203164993432,0.19444444444444445,0.7345209265142235,1.0,9/28,21.73%,VPS37B;RAB27A;CHMP1A;VPS37A;CHMP2B;VTA1;CHMP6;STAM2;TSG101
prerank,GO_Biological_Process_2021__protein neddylation (GO:0045116),0.6519461098564389,1.117755449424841,0.37209302325581395,0.7356995021115532,1.0,5/8,20.38%,DCUN1D1;DCUN1D5;DCUN1D4;DCUN1D2;UBA3
prerank,GO_Biological_Process_2021__negative regulation of programmed cell death (GO:0043069),-0.409688021947611,-1.117392093331459,0.13636363636363635,1.0,1.0,32/275,14.02%,IFI6;APIP;PRAME;POU4F1;GATA1;RPL10;RPS27A;IL7;DHCR24;PRDX5;IFIT3;BCL2L2;AQP1;ANXA1;HTR2B;THBS1;PDPN;RPS3A;GSTP1;UBC;CTSH;FHL2;MT3;NAA38;SFRP1;PLK3;CX3CL1;PTMA;CLEC5A;CLN3;XBP1;RIPK2
prerank,GO_Biological_Process_2021__response to growth factor (GO:0070848),0.4629413363277912,1.1173557847143347,0.25,0.736419489443423,1.0,11/33,15.78%,EPHA2;AKT1;BMPR1B;RPS6KB1;TGFBR2;ACVR1;TGFBR1;MAP2K5;ACVR2A;BMPR1A;CPNE3
prerank,GO_Biological_Process_2021__regulation of cell death (GO:0010941),0.3796222136271031,1.1172668793753695,0.12,0.7361110693951197,1.0,18/76,16.23%,PRODH;SNCA;SOX4;PDE12;ACER3;ADNP2;RAD18;NPAS2;PRKN;SARM1;SLC25A24;PRKD1;DCC;RRAS2;NCK1;FAF1;BMP7;IMPACT
prerank,GO_Biological_Process_2021__protein mono-ADP-ribosylation (GO:0140289),-0.6060516787422909,-1.116980882357023,0.3709677419354839,1.0,1.0,1/11,2.96%,PARP14
prerank,GO_Biological_Process_2021__cellular cation homeostasis (GO:0030003),-0.6876577060766198,-1.1168821774423265,0.34146341463414637,1.0,1.0,3/6,15.92%,MT3;LETM2;SLC4A11
prerank,PanglaoDB_Augmented_2021__Distal Tubule Cells,0.3778801919956201,1.1166761844699942,0.17857142857142858,0.7372404399755963,1.0,13/84,9.12%,ACE2;PPARGC1A;TFCP2L1;MYO5B;ESRRG;ITGB8;LPP;CDKL5;THRB;MUC20;ZBTB7C;FGD4;CPEB4
prerank,GO_Biological_Process_2021__amyloid-beta formation (GO:0034205),0.6716282831312195,1.1165536327175325,0.3829787234042553,0.7370686737691381,1.0,2/7,7.40%,NCSTN;DYRK1A
prerank,GO_Biological_Process_2021__macrophage migration (GO:1905517),-0.6643002713859436,-1.1165301637065896,0.32075471698113206,1.0,1.0,5/8,22.74%,P2RY12;CXCL17;CCL2;EDNRB;SFTPD
prerank,GO_Biological_Process_2021__adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),0.41281581201014234,1.1163553993064772,0.2,0.7370908062823973,1.0,14/58,11.41%,ABCA1;ADGRB3;CNR1;ADCY1;ADGRL3;CALCB;RAPGEF2;ADRB2;LGR4;ADRA1A;ADRB1;GNA13;LPAR3;GPR161
prerank,GO_Biological_Process_2021__regulation of cell development (GO:0060284),0.5189184535587475,1.116245359033134,0.2777777777777778,0.7370218375332935,1.0,8/29,9.98%,HDAC9;FOXO1;ASCL1;NOTCH2;RHEB;AKT1;CLOCK;DOCK7
prerank,GO_Biological_Process_2021__response to DNA damage checkpoint signaling (GO:0072423),-0.741488934165738,-1.116164914098524,0.40350877192982454,1.0,1.0,2/5,19.15%,SLX4;MUS81
prerank,GO_Biological_Process_2021__negative regulation of ossification (GO:0030279),0.5136798474155663,1.1161097568837617,0.2903225806451613,0.7368619575800937,1.0,5/17,18.90%,SOX9;TRPM4;ECM1;RBPJ;LRP4
prerank,GO_Biological_Process_2021__lymphocyte migration (GO:0072676),-0.6743450380006957,-1.1157583673849687,0.38333333333333336,1.0,1.0,4/6,20.29%,MSMP;CX3CL1;CCL2;ADAM8
prerank,GO_Biological_Process_2021__positive regulation of ubiquitin-protein transferase activity (GO:0051443),0.4571094858725886,1.1157156295372819,0.24390243902439024,0.7375207947921512,1.0,11/25,20.03%,BTRC;DCUN1D1;UBE2N;FBXW7;DCUN1D5;DCUN1D4;RAB1A;DCUN1D2;PTEN;AXIN1;PLK1
prerank,GO_Biological_Process_2021__positive regulation of locomotion (GO:0040017),-0.5995434051774502,-1.115702193732267,0.3181818181818182,1.0,1.0,3/18,5.73%,DUOX1;P2RY12;THBS1
prerank,GO_Biological_Process_2021__negative regulation of DNA-binding transcription factor activity (GO:0043433),0.3713333964179424,1.1154667093904902,0.16129032258064516,0.7375993523085645,1.0,28/108,20.44%,TNFSF4;BTRC;IRAK2;KEAP1;ANXA4;ARRB1;SMAD7;PEX14;ITCH;HDAC2;EIF2AK4;PSMD10;MEN1;PKD2;HDAC4;SIRT1;HAVCR2;MAP2K5;COMMD1;MAP3K10;BMP7;SUFU;KDM1A;TAX1BP1;TAF3;OTULIN;TCEAL7;NFKBIL1
prerank,GO_Biological_Process_2021__positive regulation of amyloid-beta clearance (GO:1900223),-0.729642554011956,-1.1154171089129656,0.375,1.0,1.0,2/5,11.67%,LRPAP1;APOE
prerank,GO_Biological_Process_2021__positive regulation of fatty acid biosynthetic process (GO:0045723),0.5938210972748166,1.1152405150421287,0.3181818181818182,0.7378026750764191,1.0,4/9,30.51%,ELOVL5;MLXIPL;ABCD2;SLC45A3
prerank,GO_Biological_Process_2021__regulation of protein targeting to mitochondrion (GO:1903214),-0.5106847403444694,-1.115081392766732,0.323943661971831,1.0,1.0,4/32,11.24%,TOMM7;UBL5;ARIH2;ATP5IF1
prerank,GO_Biological_Process_2021__acetyl-CoA biosynthetic process from pyruvate (GO:0006086),-0.732588141685967,-1.1141803921143087,0.3076923076923077,1.0,1.0,1/5,6.52%,PDHX
prerank,GO_Biological_Process_2021__double-strand break repair (GO:0006302),0.35766546815507083,1.114080466890054,0.2222222222222222,0.7405695355616093,1.0,34/146,20.59%,RAD54B;SEM1;LIG4;SAMHD1;DNA2;CYREN;SMARCAD1;UBE2N;APTX;RAD52;RFWD3;RAD51B;HMGB1;PSMD14;NSMCE2;EXD2;SMC6;REV3L;EYA3;VCP;PIAS4;MAPK8;UIMC1;DCLRE1C;APLF;BRCC3;PALB2;AP5S1;YY1;XRCC4;APBB1;NSD2;H2AX;CIB1
prerank,GO_Biological_Process_2021__positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),0.5175178846617827,1.1138752911107817,0.375,0.7406004710836961,1.0,4/17,11.30%,CDC25A;RCC2;RAD51B;STOX1
prerank,GO_Biological_Process_2021__regulation of T cell receptor signaling pathway (GO:0050856),-0.5220220464113644,-1.1137317743929922,0.3235294117647059,1.0,1.0,2/26,4.51%,GBP1;CEACAM1
prerank,GO_Biological_Process_2021__nucleic acid metabolic process (GO:0090304),0.41093338480548375,1.1136466134921947,0.25925925925925924,0.7406653496267848,1.0,8/63,8.96%,DNASE1L2;HNRNPH1;PDE12;DNA2;HNRNPU;HNRNPC;LSM8;RBFOX2
prerank,GO_Biological_Process_2021__response to interleukin-6 (GO:0070741),0.6327724307035707,1.1135286268561924,0.3181818181818182,0.7403452317579089,1.0,2/8,4.81%,PID1;NFKB1
prerank,GO_Biological_Process_2021__cellular defense response (GO:0006968),0.5173846459319345,1.1134094241242007,0.2727272727272727,0.7401047473285925,1.0,4/15,12.99%,VEZF1;RAB23;ZNF148;KLRG1
prerank,GO_Biological_Process_2021__cellular response to interferon-beta (GO:0035458),-0.6562495319047321,-1.1133211979079953,0.35185185185185186,1.0,1.0,4/11,16.67%,IRF1;STAT1;AIM2;HTRA2
prerank,PanglaoDB_Augmented_2021__Taste Receptor Cells,0.39094937891514153,1.1131115746537734,0.30434782608695654,0.7404524623376217,1.0,18/97,14.32%,CACNG2;CACNB4;AMER2;C4ORF50;PDE1B;CTNNA2;KCNH2;MOBP;KCNT1;NRXN1;CACNG3;NR3C1;KCNA2;CELF3;RUNDC3A;NAPB;SLC4A10;SEZ6L
prerank,GO_Biological_Process_2021__negative regulation of protein ubiquitination (GO:0031397),0.40949674007758274,1.1130121207719494,0.25,0.7401670467023554,1.0,14/48,21.28%,GNL3L;SOX4;ARRB1;AKT1;SMAD7;MARCHF7;U2AF2;OGT;SPOPL;ADGRB1;PRMT3;BAG2;N4BP1;HSPA1A
prerank,GO_Biological_Process_2021__negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),0.5856627609423771,1.1126256710235118,0.3,0.7406497131565821,1.0,3/13,17.46%,PPP1R15B;NCK1;BFAR
prerank,GO_Biological_Process_2021__positive regulation of actin filament polymerization (GO:0030838),0.4794844888065592,1.1121179023784378,0.32432432432432434,0.7416619559072922,1.0,11/32,14.98%,SPIRE2;NCK2;BIN1;CARMIL1;SPIRE1;PRKCE;NCKAP1;FER;NCK1;VASP;TENM1
prerank,GO_Biological_Process_2021__peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity (GO:1990264),0.6293936249045071,1.1120280205336137,0.37209302325581395,0.7413650228510835,1.0,3/7,16.88%,DUSP10;PTPRB;PTPRO
prerank,GO_Biological_Process_2021__regulation of protein localization to plasma membrane (GO:1903076),0.3651294181072785,1.1116551992018673,0.23076923076923078,0.7420035938922379,1.0,17/70,15.76%,PID1;ARHGEF16;EPHA2;PICALM;EGFR;RHOQ;AKT1;PPP2R5A;PIK3R1;MRAP;PRKCE;PTPN9;CLIP3;ZDHHC5;DLG1;ATP2B4;STX8
prerank,GO_Biological_Process_2021__defense response to tumor cell (GO:0002357),-0.6597386158859854,-1.1116029040905628,0.40350877192982454,1.0,1.0,3/6,12.81%,KLF4;SPI1;DLEC1
prerank,GO_Biological_Process_2021__negative regulation of JNK cascade (GO:0046329),0.49009359225738247,1.1112222994557293,0.3333333333333333,0.7427763873913421,1.0,6/27,11.06%,MARVELD3;DUSP10;ITCH;MEN1;PRKN;DUSP19
prerank,GO_Biological_Process_2021__inositol lipid-mediated signaling (GO:0048017),0.46659120554490746,1.1110539948414735,0.2727272727272727,0.7427380668409982,1.0,16/44,24.99%,CSF1R;PDGFRA;PIK3CA;PIK3R1;IRS1;PLCB1;RPS6KB1;PIK3C3;OGT;PI4KB;IGF1;PLCB3;PLCL1;PIK3C2B;IRS2;ADAP2
prerank,GO_Biological_Process_2021__regulation of metal ion transport (GO:0010959),0.532296002525146,1.110641919613014,0.3142857142857143,0.7434081064981373,1.0,6/13,14.81%,ANK2;CACNA2D1;CAMK2B;STIM1;BCL2;DLG1
prerank,GO_Biological_Process_2021__sterol homeostasis (GO:0055092),-0.48150103968195795,-1.110640839033719,0.2535211267605634,1.0,1.0,10/47,13.88%,CD24;AKR1C1;ANGPTL3;FABP3;APOM;CAV3;APOE;ACSM3;IL18;XBP1
prerank,GO_Biological_Process_2021__cellular response to hormone stimulus (GO:0032870),-0.457132481144767,-1.1106229096670133,0.2537313432835821,1.0,1.0,11/56,13.88%,GATA1;AKR1C1;CACNA1H;CTSL;RDX;CTSH;BRD8;SFRP1;SFR1;RAMP3;XBP1
prerank,GO_Biological_Process_2021__organelle fission (GO:0048285),0.5064189750445437,1.1105632221546924,0.23684210526315788,0.7430548175759066,1.0,7/22,13.68%,GDAP1;DNM3;MFF;TMCC1;PEX11A;PRKN;OPA1
prerank,GO_Biological_Process_2021__phosphate ion transport (GO:0006817),0.5640049757544792,1.1105049918022152,0.3333333333333333,0.7422262753220996,1.0,4/12,22.96%,SLC37A1;SLC37A2;SLC25A14;SLC37A3
prerank,GO_Biological_Process_2021__phosphate ion transmembrane transport (GO:0035435),0.5640049757544792,1.1105049918022152,0.3333333333333333,0.7422262753220996,1.0,4/12,22.96%,SLC37A1;SLC37A2;SLC25A14;SLC37A3
prerank,GO_Biological_Process_2021__organic cyclic compound catabolic process (GO:1901361),-0.7091225950079655,-1.1104662068384816,0.36538461538461536,1.0,1.0,3/6,16.34%,HSD11B1;HSD17B14;CYP3A4
prerank,GO_Biological_Process_2021__mitochondrial RNA 3'-end processing (GO:0000965),-0.7350488663727358,-1.1104367050861215,0.3584905660377358,1.0,1.0,2/5,19.92%,TRMT10C;TRNT1
prerank,GO_Biological_Process_2021__endosome transport via multivesicular body sorting pathway (GO:0032509),0.4997210755296654,1.110426587034464,0.3793103448275862,0.7419754322381522,1.0,8/21,19.53%,SORT1;CHMP1A;LEPROTL1;CHMP2B;UBXN6;VCP;VTA1;CHMP6
prerank,GO_Biological_Process_2021__zymogen activation (GO:0031638),-0.5419804837289549,-1.1101226785859113,0.2982456140350877,1.0,1.0,10/25,18.96%,C1R;PRSS3;CTSL;CASP8;CTSH;C1RL;RIPK2;PLAT;MMP14;F11
prerank,GO_Biological_Process_2021__positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),0.4797163949464808,1.1101082073048416,0.34146341463414637,0.7423972011772075,1.0,8/22,16.63%,ARAP1;CNOT9;CBL;AKT1;FBXW7;HIP1;SHKBP1;NEU3
prerank,PanglaoDB_Augmented_2021__Luteal Cells,0.3523743144450739,1.1099034411688316,0.2222222222222222,0.7424936854205322,1.0,14/120,9.42%,CLDN12;MPDZ;NR2F6;EGFR;RORA;BOK;PLIN5;CEP170B;AKT1;LGR4;PKDCC;ALDH4A1;RBFOX2;FKBP5
prerank,GO_Biological_Process_2021__negative regulation of programmed necrotic cell death (GO:0062099),-0.6009058789814405,-1.1098081894807337,0.32786885245901637,1.0,1.0,3/10,12.07%,CASP8;SLC25A4;FZD9
prerank,GO_Biological_Process_2021__negative regulation of interleukin-2 production (GO:0032703),-0.5919171268431735,-1.109628770664225,0.3114754098360656,1.0,1.0,1/15,0.79%,GBP1
prerank,GO_Biological_Process_2021__branching involved in ureteric bud morphogenesis (GO:0001658),0.6944165544508872,1.1093558136505444,0.35135135135135137,0.7437872762724332,1.0,4/7,9.50%,NPNT;SALL1;BMP2;PKD2
prerank,GO_Biological_Process_2021__peptidyl-serine autophosphorylation (GO:0036289),0.6174250603584203,1.1092842005505383,0.4,0.7435807780250407,1.0,5/8,26.79%,DYRK1A;PIKFYVE;MAP2K2;MARK3;ERN1
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell proliferation (GO:0050679),0.39180131441961596,1.1091464775059876,0.2222222222222222,0.7435198220598215,1.0,22/84,17.75%,VEGFD;WNT7A;BMP2;EGFR;SOX9;NOTCH2;AKT1;NRP2;VEGFC;PRKD1;TGM1;NRAS;SIRT1;TGFBR1;RREB1;ECM1;YAP1;NRP1;CDH13;HIF1A;ZNF703;IGF1
prerank,GO_Biological_Process_2021__cholesterol homeostasis (GO:0042632),-0.48250400136659616,-1.1090418757146354,0.22857142857142856,1.0,1.0,10/46,13.88%,CD24;AKR1C1;ANGPTL3;FABP3;APOM;CAV3;APOE;ACSM3;IL18;XBP1
prerank,GO_Biological_Process_2021__positive regulation of T cell activation (GO:0050870),-0.5064845429392144,-1.108675153305794,0.2676056338028169,1.0,1.0,12/37,16.07%,DOCK8;IL7;HLA-A;ANXA1;PNP;PRKCQ;RHOH;PDCD1LG2;XBP1;CCL2;ZP3;CD274
prerank,GO_Biological_Process_2021__positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),0.6142249521585396,1.108622664207942,0.4722222222222222,0.7439337731783082,1.0,5/8,20.59%,CAMTA1;SPPL3;IGF1;PTBP1;CIB1
prerank,GO_Biological_Process_2021__positive regulation of calcineurin-mediated signaling (GO:0106058),0.6142249521585396,1.108622664207942,0.4722222222222222,0.7439337731783082,1.0,5/8,20.59%,CAMTA1;SPPL3;IGF1;PTBP1;CIB1
prerank,GO_Biological_Process_2021__apoptotic cell clearance (GO:0043277),-0.5520866646203324,-1.1082941165376239,0.265625,1.0,1.0,4/20,10.33%,ANXA1;RHOBTB2;THBS1;RHOH
prerank,GO_Biological_Process_2021__adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathway (GO:0007197),-0.7166411377722087,-1.1082131990622142,0.4528301886792453,1.0,1.0,3/6,20.50%,CHRM2;CHRM5;OPRM1
prerank,GO_Biological_Process_2021__secretory granule organization (GO:0033363),0.6822950582675374,1.107766359549368,0.4634146341463415,0.7460136950920759,1.0,1/6,2.78%,ABCA1
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor signaling pathway (GO:0034123),-0.59832175435397,-1.107603883659452,0.36065573770491804,1.0,1.0,5/16,17.83%,IFI35;RSAD2;TLR3;PTPN22;FLOT1
prerank,GO_Biological_Process_2021__regulation of protein localization to cell periphery (GO:1904375),-0.5492467690251904,-1.1070852943360847,0.3333333333333333,1.0,1.0,6/18,20.33%,GBP1;VAMP8;CLN3;CDK5;MMP14;AR
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell proliferation (GO:0048660),-0.5077975263434358,-1.1068516776107173,0.323943661971831,1.0,1.0,10/34,12.68%,STAT1;THBS1;IL12A;ELN;IGFBP5;NOX1;IL18;CX3CL1;OGN;ID2
prerank,GO_Biological_Process_2021__ureteric bud development (GO:0001657),0.6054187751404757,1.106623543897375,0.3488372093023256,0.7487816749662222,1.0,6/10,16.20%,NPNT;SALL1;BMP2;PKD2;SLIT2;BMP7
prerank,GO_Biological_Process_2021__cell-cell junction assembly (GO:0007043),0.43850241650447536,1.1063966844161666,0.3,0.7489401025989314,1.0,21/53,23.95%,CLDN12;CDH2;CDH11;CDH20;SMAD7;PKP4;TLN2;PIP5K1C;CDH9;TJP1;ZNF703;CDH18;CTNND2;CDH6;CDH10;DCHS1;CDH8;PRKCA;CDH19;CTNNB1;TBCD
prerank,GO_Biological_Process_2021__positive regulation of vacuole organization (GO:0044090),0.5910951437790514,1.1063264942707192,0.2857142857142857,0.7485196455556592,1.0,6/11,27.98%,RALB;PIP4K2C;RAB3GAP1;LRSAM1;SH3GLB1;PIP4K2B
prerank,GO_Biological_Process_2021__cellular response to cAMP (GO:0071320),-0.5257654928947277,-1.1062838496254281,0.31666666666666665,1.0,1.0,4/24,8.35%,CFTR;AQP1;KCNQ1;IGFBP5
prerank,GO_Biological_Process_2021__negative regulation of supramolecular fiber organization (GO:1902904),0.37861262638260657,1.1058805478637215,0.25925925925925924,0.7491006220373434,1.0,23/65,20.59%,SNCA;SHANK1;KANK1;PIK3CA;DYRK1A;TTBK2;PRKN;NAV3;SHANK3;CAMSAP2;SLIT2;CLIP3;SSH1;MAPRE1;CLASP1;SMAD4;HDGFL3;ARFGEF1;CYRIB;KATNB1;SSH2;ATXN7;CIB1
prerank,GO_Biological_Process_2021__negative regulation of defense response to virus (GO:0050687),0.6624552445400843,1.1058736283929118,0.41025641025641024,0.7486028352907986,1.0,2/9,8.91%,ITCH;RNF26
prerank,GO_Biological_Process_2021__glucuronate catabolic process (GO:0006064),-0.7309440115577032,-1.1058349573553805,0.41509433962264153,1.0,1.0,4/5,24.97%,AKR1A1;SORD;XYLB;DCXR
prerank,GO_Biological_Process_2021__glucuronate catabolic process to xylulose 5-phosphate (GO:0019640),-0.7309440115577032,-1.1058349573553805,0.41509433962264153,1.0,1.0,4/5,24.97%,AKR1A1;SORD;XYLB;DCXR
prerank,GO_Biological_Process_2021__xylulose 5-phosphate biosynthetic process (GO:1901159),-0.7309440115577032,-1.1058349573553805,0.41509433962264153,1.0,1.0,4/5,24.97%,AKR1A1;SORD;XYLB;DCXR
prerank,GO_Biological_Process_2021__mitochondrial respiratory chain complex assembly (GO:0033108),-0.4434692403802515,-1.1056891098338726,0.29577464788732394,1.0,1.0,20/74,21.59%,NDUFS5;NDUFA6;NDUFA2;NDUFC1;COX20;NDUFB10;UQCRFS1;SLC25A33;SURF1;TMEM126A;DMAC1;NDUFB3;NDUFA1;NDUFB9;NDUFA12;NDUFB7;TMEM126B;NDUFB11;NDUFAF3;OXA1L
prerank,GO_Biological_Process_2021__regulation of stem cell population maintenance (GO:2000036),0.5418979926229642,1.1055804810910637,0.2972972972972973,0.748949749113763,1.0,8/18,20.47%,ZNF706;LOXL2;CNOT2;NCOA3;KAT2A;ZC3H13;REST;ESRRB
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell mediated immunity (GO:0002717),-0.5797302282927168,-1.1053700893557168,0.3548387096774194,1.0,1.0,4/12,13.30%,RASGRP1;IL12A;KLRD1;CD160
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),-0.5797302282927168,-1.1053700893557168,0.3548387096774194,1.0,1.0,4/12,13.30%,RASGRP1;IL12A;KLRD1;CD160
prerank,GO_Biological_Process_2021__cellular glucose homeostasis (GO:0001678),0.46491256522137187,1.1051529825751887,0.26666666666666666,0.7497623104805167,1.0,6/34,9.81%,PPARGC1A;FOXO1;SOX4;ZBTB20;PIK3R1;NR1D1
prerank,MSigDB_Hallmark_2020__KRAS Signaling Dn,-0.43810812183811476,-1.1049618460184847,0.2962962962962963,1.0,1.0,7/108,4.52%,IFI44L;MYOT;PLAG1;IL5;MX1;ZC2HC1C;PDE6B
prerank,GO_Biological_Process_2021__telomere capping (GO:0016233),0.5507787526405047,1.1047987106462875,0.2727272727272727,0.7504295931846666,1.0,6/15,31.95%,STN1;DCLRE1C;POT1;DCLRE1A;TERF2IP;TERF2
prerank,PanglaoDB_Augmented_2021__Pulmonary Alveolar Type II Cells,-0.47734227721275924,-1.104635929168727,0.273972602739726,1.0,1.0,13/54,12.96%,PPP1R14C;IL1R1;CXCL2;NRN1;FPR3;FMO2;CXCL17;TNFAIP2;CTSH;KLF4;CEBPD;CD14;RBM47
prerank,GO_Biological_Process_2021__protein localization to chromatin (GO:0071168),0.5327199908857465,1.1044142553032976,0.35,0.7508853944140492,1.0,9/18,30.57%,TASOR;NIPBL;MSH2;PPHLN1;PLK1;WAPL;MACROH2A1;RAD21;LEMD2
prerank,GO_Biological_Process_2021__homocysteine metabolic process (GO:0050667),0.5798173233092949,1.1044048280524648,0.37209302325581395,0.750410235442456,1.0,5/10,35.89%,BLMH;MTHFR;TST;NOX4;CBS
prerank,GO_Biological_Process_2021__cortical cytoskeleton organization (GO:0030865),0.434361808174386,1.104384116428818,0.2857142857142857,0.7499246514281155,1.0,11/35,19.93%,FMNL3;PLEK;RHOQ;RHOBTB3;FMNL2;NCKAP1;DLG1;ROCK2;STRIP1;ARF6;ROCK1
prerank,GO_Biological_Process_2021__regulation of natural killer cell mediated cytotoxicity (GO:0042269),-0.5789468062295543,-1.1042332212031816,0.29310344827586204,1.0,1.0,6/15,19.17%,RASGRP1;IL12A;KLRD1;CD160;MICA;HLA-F
prerank,GO_Biological_Process_2021__negative regulation of chondrocyte differentiation (GO:0032331),0.6251752848033817,1.103647893557766,0.35135135135135137,0.751353196590524,1.0,3/9,15.44%,SOX9;TGFBR1;PTPN11
prerank,GO_Biological_Process_2021__regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),-0.6049761865841327,-1.1032639627917682,0.4,1.0,1.0,2/11,10.30%,ANAPC15;DUSP1
prerank,GO_Biological_Process_2021__regulation of Rac protein signal transduction (GO:0035020),0.5701620668361975,1.1032314357065514,0.3076923076923077,0.7518292479914767,1.0,9/13,22.42%,KBTBD7;ARHGAP24;KBTBD6;AUTS2;OGT;ARHGAP17;ALS2;ARF6;ARHGAP44
prerank,GO_Biological_Process_2021__amino acid transmembrane transport (GO:0003333),0.42409138684355807,1.1031062631801258,0.30303030303030304,0.7516087838194458,1.0,9/36,19.22%,SLC6A13;SLC25A18;SLC7A11;SFXN1;SLC38A6;SLC38A10;SLC47A1;SLC6A6;SLC7A9
prerank,GO_Biological_Process_2021__negative regulation of protein localization to membrane (GO:1905476),0.46450777499670215,1.1029608692880648,0.3684210526315789,0.7515210749118058,1.0,5/21,9.43%,PID1;PICALM;RHOQ;PPP2R5A;MRAP
prerank,GO_Biological_Process_2021__negative regulation of lipid localization (GO:1905953),0.7018044658553434,1.1028906274593486,0.42857142857142855,0.7512459623552877,1.0,1/5,25.37%,PTPN2
prerank,GO_Biological_Process_2021__negative regulation of nitric oxide metabolic process (GO:1904406),0.6608478481743842,1.1028486347101698,0.3953488372093023,0.7503112942025298,1.0,5/6,33.76%,ROCK2;ATP2B4;SIRPA;PTGIS;KHSRP
prerank,GO_Biological_Process_2021__negative regulation of nitric oxide biosynthetic process (GO:0045019),0.6608478481743842,1.1028486347101698,0.3953488372093023,0.7503112942025298,1.0,5/6,33.76%,ROCK2;ATP2B4;SIRPA;PTGIS;KHSRP
prerank,GO_Biological_Process_2021__protein localization to nucleolus (GO:1902570),-0.7128488634649818,-1.1020555125574363,0.4444444444444444,1.0,1.0,2/5,20.05%,RPF2;RAN
prerank,GO_Biological_Process_2021__branching involved in blood vessel morphogenesis (GO:0001569),-0.6426353162134921,-1.1012518299447789,0.3584905660377358,1.0,1.0,2/10,8.07%,SFRP2;NRARP
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway (GO:1903376),0.6730992532565224,1.1011211669126955,0.4,0.7541987387678828,1.0,3/6,17.47%,PRKN;FBXW7;HIF1A
prerank,GO_Biological_Process_2021__kynurenine metabolic process (GO:0070189),-0.6372189832161657,-1.1011160694866877,0.3220338983050847,1.0,1.0,1/8,0.82%,KMO
prerank,GO_Biological_Process_2021__positive regulation of cell cycle (GO:0045787),0.41811642754366096,1.101038765661772,0.23076923076923078,0.7538565593651163,1.0,17/57,19.09%,EGFR;RGCC;AKT1;RPS6KB1;PSMD10;PKD2;EIF4E;TGM1;ANKRD17;MEIS2;CCPG1;USP22;USP2;TTL;SRPK2;MDM2;CCND3
prerank,GO_Biological_Process_2021__T cell differentiation in thymus (GO:0033077),0.591312466441374,1.100940840773467,0.3235294117647059,0.753613782609472,1.0,2/10,9.57%,LIG4;GLI3
prerank,GO_Biological_Process_2021__negative regulation of autophagosome assembly (GO:1902902),0.5720215875659966,1.100878408684148,0.4411764705882353,0.7532065381484264,1.0,4/12,23.77%,SMCR8;SEC22B;MTM1;SCFD1
prerank,GO_Biological_Process_2021__long-chain fatty acid metabolic process (GO:0001676),-0.4696247659885205,-1.100872013899191,0.34782608695652173,1.0,1.0,8/63,8.75%,ACOT2;ACOT1;CYP4Z1;AWAT1;PNPLA3;CYP2D6;GSTP1;ACSBG2
prerank,GO_Biological_Process_2021__regulation of guanyl-nucleotide exchange factor activity (GO:1905097),0.6342254485360829,1.100580441558055,0.3076923076923077,0.7533487843216774,1.0,1/5,14.39%,CCPG1
prerank,GO_Biological_Process_2021__protein modification by small protein conjugation or removal (GO:0070647),0.5767001167537695,1.100423457865166,0.3333333333333333,0.7531507226765662,1.0,9/13,34.85%,ATG7;UBA3;UBA6;UBA1;SAE1;DESI2;SENP6;DESI1;UBA2
prerank,GO_Biological_Process_2021__dicarboxylic acid catabolic process (GO:0043649),0.5560088696117845,1.1004197158355842,0.3333333333333333,0.7526459299669975,1.0,2/13,8.83%,MTHFS;DDO
prerank,GO_Biological_Process_2021__positive regulation of muscle hypertrophy (GO:0014742),0.528167824821068,1.1002370416835345,0.3055555555555556,0.7526348703357818,1.0,6/13,24.50%,CAMK2D;ROCK2;IGF1;ROCK1;PRKCA;PDE9A
prerank,GO_Biological_Process_2021__male meiosis I (GO:0007141),-0.6031538324361192,-1.1000488328769231,0.3389830508474576,1.0,1.0,4/13,12.51%,SYCP3;BTBD18;MOV10L1;BRDT
prerank,GO_Biological_Process_2021__DNA damage checkpoint signaling (GO:0000077),0.48390955341572406,1.09990392629578,0.28205128205128205,0.7531275018363922,1.0,6/28,25.93%,INTS7;CLOCK;MAP3K20;H2AX;CDC5L;ERCC6
prerank,GO_Biological_Process_2021__regulation of keratinocyte proliferation (GO:0010837),0.5167314545005609,1.0999011343195715,0.30303030303030304,0.7526346797824037,1.0,5/15,15.32%,PTPRK;NOTCH2;PRKD1;TGM1;KLF9
prerank,GO_Biological_Process_2021__homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),0.4073824832023973,1.0996497778760042,0.2619047619047619,0.7528860861779559,1.0,11/52,9.86%,TENM3;HMCN1;NPTN;IGSF11;EMB;CDH2;NECTIN3;ROBO1;CDH4;CADM1;SDK1
prerank,GO_Biological_Process_2021__negative regulation of fibroblast proliferation (GO:0048147),-0.5872712962478002,-1.0993315500532626,0.30434782608695654,1.0,1.0,4/16,15.99%,FTH1;GSTP1;SFRP1;EMD
prerank,GO_Biological_Process_2021__response to peptide (GO:1901652),-0.5085731300037422,-1.0993062226012995,0.35384615384615387,1.0,1.0,5/25,13.14%,STAT1;ANXA1;NLRP1;STAT2;RAMP3
prerank,GO_Biological_Process_2021__regulation of endothelial cell differentiation (GO:0045601),0.5771662909785139,1.0992125185920223,0.3333333333333333,0.7534431278832407,1.0,3/8,4.47%,APOLD1;VEZF1;ZEB1
prerank,GO_Biological_Process_2021__signal transduction in response to DNA damage (GO:0042770),0.4335298763832227,1.0992056454929175,0.27586206896551724,0.7529401618432653,1.0,12/46,29.35%,INTS7;CLOCK;MAP3K20;MDM4;ATRX;H2AX;CDC5L;SESN2;ERCC6;MYO6;BID;GRB2
prerank,GO_Biological_Process_2021__negative regulation of homotypic cell-cell adhesion (GO:0034111),-0.6203814587441854,-1.0991291944876083,0.3220338983050847,1.0,1.0,5/11,17.43%,CD9;CEACAM1;RDX;ALOX12;C1QTNF1
prerank,PanglaoDB_Augmented_2021__Dendritic Cells,-0.45663928834209533,-1.0990703683869547,0.275,1.0,1.0,24/78,15.74%,P2RY10;KMO;TAGAP;FTL;HLA-B;HLA-A;CLEC12A;HLA-C;IGSF6;ANXA1;RAB7B;PDPN;SLC11A1;TLR3;PDCD1LG2;ARHGAP30;GPR68;CD14;PPL;SPI1;MYO1F;SCIMP;S100B;CD74
prerank,GO_Biological_Process_2021__regulation of regulated secretory pathway (GO:1903305),0.47938552631778014,1.0989513180290424,0.3333333333333333,0.7530817316727845,1.0,6/29,15.08%,SYT3;RAB27A;DOC2A;RIMS3;SYT9;GSK3B
prerank,GO_Biological_Process_2021__protein-DNA complex subunit organization (GO:0071824),-0.7125040797307618,-1.098354593014839,0.4117647058823529,1.0,1.0,1/5,0.62%,RPL23
prerank,GO_Biological_Process_2021__hydrogen peroxide metabolic process (GO:0042743),-0.6001297851211699,-1.0980604039166508,0.3220338983050847,1.0,1.0,5/14,15.37%,DUOX1;PRDX5;PRDX4;NOX1;MAOB
prerank,GO_Biological_Process_2021__skeletal myofibril assembly (GO:0014866),0.7272405921339774,1.0980256838423907,0.4166666666666667,0.7550116454787115,1.0,1/5,0.19%,TCAP
prerank,GO_Biological_Process_2021__regulation of miRNA metabolic process (GO:2000628),0.6876513727313301,1.0980124651617813,0.37254901960784315,0.7545195381406999,1.0,1/5,4.81%,NFKB1
prerank,GO_Biological_Process_2021__intestinal absorption (GO:0050892),-0.666929226046411,-1.0979748298627325,0.43137254901960786,1.0,1.0,1/7,6.80%,KCNQ1
prerank,GO_Biological_Process_2021__positive regulation of ion transport (GO:0043270),0.43530103642204804,1.0979470424606168,0.3,0.754224127057616,1.0,6/33,19.34%,ANK2;STIM2;CAMK2A;DLG1;WNK3;DRD2
prerank,GO_Biological_Process_2021__cerebral cortex cell migration (GO:0021795),0.6980642436507689,1.0978880123264507,0.37209302325581395,0.7538964573110558,1.0,4/5,29.08%,LHX6;PEX13;RELN;FGF13
prerank,GO_Biological_Process_2021__detection of calcium ion (GO:0005513),0.5722033993771163,1.0978462713229333,0.38636363636363635,0.753493086515046,1.0,2/9,25.32%,STIM1;KCNIP2
prerank,GO_Biological_Process_2021__negative regulation of long-term synaptic potentiation (GO:1900272),0.5901670884534845,1.0977327041441607,0.3783783783783784,0.7532532935984024,1.0,2/7,8.77%,EPHA4;FAM107A
prerank,GO_Biological_Process_2021__glycosylceramide metabolic process (GO:0006677),0.7091435912699513,1.0977116948710621,0.37209302325581395,0.7528074366010715,1.0,1/5,8.62%,GAL3ST1
prerank,GO_Biological_Process_2021__negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),-0.5816869347694185,-1.0976808167932328,0.3148148148148148,1.0,1.0,1/10,8.49%,GSTP1
prerank,GO_Biological_Process_2021__response to mitochondrial depolarisation (GO:0098780),-0.7380383156593165,-1.097605854273776,0.4117647058823529,1.0,1.0,2/5,20.07%,ATG14;SQSTM1
prerank,GO_Biological_Process_2021__positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),0.5181212535562181,1.0968120854356669,0.358974358974359,0.7545657425314684,1.0,2/13,10.89%,CPEB3;TNRC6B
prerank,GO_Biological_Process_2021__organophosphate ester transport (GO:0015748),0.49343826500601257,1.0964159467436259,0.2972972972972973,0.7553020202539876,1.0,8/23,28.15%,PRELID2;MTTP;OSBPL8;PITPNM1;SCP2;OSBPL5;TNFAIP8L3;PRELID3B
prerank,"GO_Biological_Process_2021__regulation of CD4-positive, alpha-beta T cell activation (GO:2000514)",0.6119600441337755,1.0960260300475948,0.40425531914893614,0.7558313499004344,1.0,2/7,19.32%,SH3RF1;HLA-DRA
prerank,GO_Biological_Process_2021__deadenylation-dependent decapping of nuclear-transcribed mRNA (GO:0000290),-0.6573643419701807,-1.0960162879380915,0.38333333333333336,1.0,1.0,1/7,1.81%,PATL2
prerank,GO_Biological_Process_2021__regulation of skeletal muscle satellite cell proliferation (GO:0014842),0.674069440925981,1.095930520210278,0.4,0.755558302088312,1.0,3/6,25.30%,CFLAR;FGF2;AKIRIN1
prerank,GO_Biological_Process_2021__MyD88-independent toll-like receptor signaling pathway (GO:0002756),-0.5260893259238595,-1.0958046422081962,0.3235294117647059,1.0,1.0,6/26,12.42%,RPS27A;CASP8;UBC;LY96;TLR3;CD14
prerank,GO_Biological_Process_2021__TRIF-dependent toll-like receptor signaling pathway (GO:0035666),-0.5260893259238595,-1.0958046422081962,0.3235294117647059,1.0,1.0,6/26,12.42%,RPS27A;CASP8;UBC;LY96;TLR3;CD14
prerank,GO_Biological_Process_2021__neuron fate commitment (GO:0048663),-0.6475421010162162,-1.0953797633365758,0.41509433962264153,1.0,1.0,1/9,0.33%,POU4F1
prerank,GO_Biological_Process_2021__myeloid cell differentiation (GO:0030099),-0.5022115870635059,-1.0952369978568195,0.3230769230769231,1.0,1.0,7/39,13.67%,RPS14;GATA1;INHA;ATP5IF1;SPI1;ZFPM1;RPS19
prerank,GO_Biological_Process_2021__pyroptosis (GO:0070269),-0.5974600225843013,-1.0951537646205745,0.4,1.0,1.0,5/11,14.21%,APIP;CASP8;NLRP1;NLRP9;AIM2
prerank,GO_Biological_Process_2021__regulation of lamellipodium morphogenesis (GO:2000392),-0.6533928928621097,-1.0951508359833946,0.4406779661016949,1.0,1.0,3/10,6.08%,ENPP2;VIL1;PDPN
prerank,GO_Biological_Process_2021__negative regulation of mononuclear cell migration (GO:0071676),0.6508934101775263,1.095031147441737,0.3829787234042553,0.7574617009019131,1.0,5/8,13.21%,AKT1;WASL;PLCB1;SLIT2;NBL1
prerank,GO_Biological_Process_2021__histone-threonine phosphorylation (GO:0035405),0.7034693708152938,1.0946260780232293,0.36363636363636365,0.7580534667369541,1.0,4/5,29.61%,DCAF1;PRKCB;PRKCA;PKN1
prerank,GO_Biological_Process_2021__positive regulation of macromolecule biosynthetic process (GO:0010557),0.35419063580263455,1.0945042469784876,0.15789473684210525,0.7577470556949765,1.0,28/103,19.11%,SOX4;DNA2;PRMT1;EGFR;PASK;ZCCHC4;CPEB3;RGCC;HSPH1;NFKB1;AKT1;STN1;IRS1;RPS6KB1;SIRT1;DHX9;KAT7;NIBAN1;DYRK2;FAF1;HGF;EIF3E;AKT2;FXR1;IGF1;LARP4;HNRNPD;NPM2
prerank,GO_Biological_Process_2021__metal ion homeostasis (GO:0055065),0.4504711824969575,1.0940801343015567,0.29411764705882354,0.7583702658542628,1.0,9/29,19.82%,SNCA;GRIN1;SLC12A2;KCNH2;TMTC2;SLC12A8;SLC12A9;CYP4F12;LETM1
prerank,MSigDB_Hallmark_2020__Unfolded Protein Response,-0.42270653191566815,-1.0940126984163947,0.29333333333333333,1.0,1.0,4/105,2.33%,IFIT1;RPS14;SRPRA;KDELR3
prerank,"GO_Biological_Process_2021__base-excision repair, AP site formation (GO:0006285)",0.4978187834620707,1.0938938736713113,0.3409090909090909,0.7584203746472987,1.0,6/15,31.95%,NEIL2;POT1;SMUG1;TDG;TERF2IP;TERF2
prerank,GO_Biological_Process_2021__myoblast differentiation (GO:0045445),-0.5779270328721957,-1.093884210042578,0.375,1.0,1.0,1/14,1.48%,SOX15
prerank,GO_Biological_Process_2021__T cell migration (GO:0072678),-0.6571959612383811,-1.0938430393882612,0.3050847457627119,1.0,1.0,1/8,1.79%,GPR183
prerank,GO_Biological_Process_2021__negative regulation of receptor-mediated endocytosis (GO:0048261),0.5112826359802604,1.093690679314134,0.3333333333333333,0.7583301396921864,1.0,7/19,19.13%,PICALM;RIN3;ABCA2;MTMR2;UBQLN2;NEU3;ARF6
prerank,GO_Biological_Process_2021__response to histamine (GO:0034776),0.6460459262993391,1.0934558349555636,0.425,0.7583370749743993,1.0,4/8,23.72%,GABRB1;HRH1;DRD2;GABRB3
prerank,GO_Biological_Process_2021__negative regulation of mitochondrial fusion (GO:0010637),0.6933484954008722,1.0932546745044627,0.46511627906976744,0.7584302120869314,1.0,5/7,27.60%,PRKN;VAT1;TFRC;HUWE1;ADCK1
prerank,GO_Biological_Process_2021__regulation of chromosome organization (GO:0033044),-0.548785552968787,-1.0931326025043104,0.41818181818181815,1.0,1.0,1/18,0.16%,PIF1
prerank,GO_Biological_Process_2021__cellular response to prostaglandin stimulus (GO:0071379),0.6648099896654334,1.093074384170252,0.41304347826086957,0.7584693801870586,1.0,1/6,1.31%,TNFSF4
prerank,GO_Biological_Process_2021__transport along microtubule (GO:0010970),0.5630751331619009,1.0926333464494915,0.38636363636363635,0.7592726123487485,1.0,7/13,34.77%,CLIP3;APBA1;BAG3;BORCS5;DYNC1I1;CAMSAP3;CDC42
prerank,GO_Biological_Process_2021__membrane raft organization (GO:0031579),-0.5761397573313178,-1.0926263989163172,0.3333333333333333,1.0,1.0,9/15,24.18%,S100A10;CAV3;CLN3;EMP2;FLOT1;RFTN1;NAXE;ANXA2;NPC1
prerank,GO_Biological_Process_2021__protein localization to nuclear envelope (GO:0090435),0.6879315893757096,1.0923706462794849,0.32558139534883723,0.7596230734575031,1.0,5/6,28.87%,INTS13;TOR1AIP2;PLK1;NUP54;NUTF2
prerank,GO_Biological_Process_2021__positive regulation of protein import (GO:1904591),0.4353645340867855,1.0922401147893583,0.2571428571428571,0.7594679157193283,1.0,7/25,21.04%,HCLS1;PIK3R1;UBR5;TRIM28;IPO5;BAG3;ZPR1
prerank,GO_Biological_Process_2021__ornithine metabolic process (GO:0006591),-0.662602813128754,-1.0921317833006892,0.36363636363636365,1.0,1.0,1/7,2.79%,ARG2
prerank,GO_Biological_Process_2021__positive regulation of fatty acid oxidation (GO:0046321),0.5908755844734072,1.0920852199238618,0.38636363636363635,0.7595170405857657,1.0,3/11,7.80%,PPARGC1A;PLIN5;IRS1
prerank,GO_Biological_Process_2021__miRNA metabolic process (GO:0010586),0.5226281734696443,1.091892706719982,0.34375,0.7594587615408064,1.0,12/18,34.73%,DROSHA;TENT4B;PRKRA;LIN28B;DIS3L2;DICER1;DDX17;PARN;AGO2;XPO5;KHSRP;SND1
prerank,GO_Biological_Process_2021__female gonad development (GO:0008585),-0.5741800479516579,-1.09184269511599,0.3125,1.0,1.0,4/13,24.75%,INHA;FSHR;EIF2B4;COL9A3
prerank,GO_Biological_Process_2021__ER overload response (GO:0006983),-0.6380375873098593,-1.0917913525984384,0.3958333333333333,1.0,1.0,3/8,17.89%,SELENOS;DDIT3;TMCO1
prerank,GO_Biological_Process_2021__cellular response to nerve growth factor stimulus (GO:1990090),0.5201819922005203,1.091724391766551,0.32432432432432434,0.7593791051160718,1.0,9/19,22.16%,ACAP2;AKT1;NTRK2;RAPGEF2;MAGI2;RAP1A;WASF1;CIB1;NTRK3
prerank,GO_Biological_Process_2021__regulation of monocyte chemotaxis (GO:0090025),0.5026521501727899,1.0915696467107154,0.3333333333333333,0.75935315247146,1.0,5/13,13.21%,SERPINE1;CXCL12;HMGB1;SLIT2;NBL1
prerank,GO_Biological_Process_2021__methionine metabolic process (GO:0006555),0.6558689585432946,1.0914838276961727,0.40425531914893614,0.7590486995623266,1.0,3/7,27.42%,SMS;MTHFR;MSRA
prerank,PanglaoDB_Augmented_2021__T Follicular Helper Cells,-0.5041444112624197,-1.0913366560832232,0.36764705882352944,1.0,1.0,9/32,7.73%,P2RY10;TAGAP;GPR183;CD5;DPEP2;ARHGAP9;GPR171;GMFG;TRAF3IP3
prerank,GO_Biological_Process_2021__positive chemotaxis (GO:0050918),-0.547457693845101,-1.0912836351398625,0.3076923076923077,1.0,1.0,3/14,12.24%,SEMA5A;FGF7;CX3CL1
prerank,GO_Biological_Process_2021__negative regulation of exocytosis (GO:0045920),0.6238396849552915,1.0911314374231702,0.3870967741935484,0.7594619367651694,1.0,5/9,10.08%,SNCA;RAB33B;STXBP6;ATP9A;PRKN
prerank,GO_Biological_Process_2021__neuronal ion channel clustering (GO:0045161),0.6023385783042796,1.0904761610415754,0.40476190476190477,0.7606877455121508,1.0,6/8,30.69%,CNTNAP2;CNTN2;KCNIP2;PICK1;SPTBN4;NRCAM
prerank,GO_Biological_Process_2021__neurotrophin signaling pathway (GO:0038179),0.4539339490181335,1.0904040324790363,0.3235294117647059,0.7604471683889185,1.0,8/17,20.20%,SORT1;NTRK2;RAPGEF2;SOS1;MAGI2;RAP1A;BCAR1;CASP3
prerank,GO_Biological_Process_2021__negative regulation of intracellular signal transduction (GO:1902532),0.3389819352052653,1.0900125921315946,0.1875,0.7611685435552813,1.0,43/158,20.81%,LIMD1;PDE3A;WTIP;PDE3B;EPHA2;PLEK;CD22;RORA;MAPKBP1;PDE10A;AKT1;CGNL1;SPRED1;PPM1A;SPRY3;PSMD10;NR1D1;PTPRJ;NF1;SLIT2;DLG5;SIRT1;MAGI2;MAPKAPK5;DGKG;ADIPOR1;VGLL4;BCL2;CDC34;ATP2B4;BMP7;PDE4D;CYRIB;UBR1;PHLPP2;MDM2;PTEN;CPNE1;DRD2;PHLPP1;CIB1;OTUD7A;PLEKHA1
prerank,GO_Biological_Process_2021__neuronal action potential (GO:0019228),0.49904962307300876,1.0897437551461384,0.3055555555555556,0.7614084718215823,1.0,4/17,14.29%,CACNA1G;CACNA1I;KCNA2;MYH14
prerank,GO_Biological_Process_2021__positive regulation of exocytosis (GO:0045921),0.4553937947141074,1.089621492945565,0.3055555555555556,0.7611678953539665,1.0,5/32,5.08%,SNCA;SDC4;RAB27A;STXBP5;CADPS2
prerank,GO_Biological_Process_2021__positive regulation of reactive oxygen species biosynthetic process (GO:1903428),0.6634985304255101,1.0894964225689703,0.49019607843137253,0.7609596244576062,1.0,2/7,4.99%,RAB27A;GRIN1
prerank,GO_Biological_Process_2021__regulation of viral life cycle (GO:1903900),-0.5384936718224352,-1.08906996660893,0.3770491803278688,1.0,1.0,2/18,6.55%,TRIM22;TRIM21
prerank,GO_Biological_Process_2021__granulocyte chemotaxis (GO:0071621),-0.5496838861603104,-1.0889485841583886,0.359375,1.0,1.0,5/20,14.31%,CXCL2;ANXA1;PPIB;CX3CL1;CCL2
prerank,GO_Biological_Process_2021__negative regulation of cell cycle process (GO:0010948),0.4156926742847369,1.0889223240270431,0.29411764705882354,0.7621583520303716,1.0,12/53,16.25%,YAF2;EED;PPP1R10;ZFYVE19;PHC1;PCGF2;MGA;PHC3;TFDP2;BMP7;RBBP4;ESPL1
prerank,GO_Biological_Process_2021__negative regulation of sodium ion transport (GO:0010766),0.6333256989521198,1.0886170956177788,0.3877551020408163,0.76253546218669,1.0,5/8,18.82%,NEDD4L;CAMK2D;COMMD1;WNK3;WNK1
prerank,GO_Biological_Process_2021__positive regulation of DNA binding (GO:0043388),-0.5459534988769517,-1.0885045188403508,0.3225806451612903,1.0,1.0,2/23,7.41%,POU4F1;HES1
prerank,GO_Biological_Process_2021__regulation of trans-synaptic signaling (GO:0099177),0.4563044228247449,1.0884267315139027,0.3548387096774194,0.7624757122282522,1.0,9/31,12.41%,NRG3;CACNA1B;EIF4EBP2;LRRC4C;BTBD9;LRP8;NLGN3;NLGN4X;IQSEC2
prerank,GO_Biological_Process_2021__bile acid metabolic process (GO:0008206),-0.5112062452607823,-1.0880891834030453,0.36363636363636365,1.0,1.0,1/24,1.27%,AKR1C1
prerank,GO_Biological_Process_2021__positive regulation of tau-protein kinase activity (GO:1902949),-0.6670674675163726,-1.0876095950450715,0.4444444444444444,1.0,1.0,1/5,11.22%,CLU
prerank,GO_Biological_Process_2021__regulation of interferon-beta production (GO:0032648),-0.4778667009118597,-1.08718322760471,0.3880597014925373,1.0,1.0,7/37,17.83%,IRF1;ISG15;TLR3;OAS3;RIPK2;POLR3G;FLOT1
prerank,GO_Biological_Process_2021__regulation of maintenance of mitotic sister chromatid cohesion (GO:0034182),0.6859619500105836,1.0871757947374474,0.35555555555555557,0.7640390052774658,1.0,2/5,24.34%,NSMCE2;MACROH2A1
prerank,GO_Biological_Process_2021__positive regulation of maintenance of sister chromatid cohesion (GO:0034093),0.6859619500105836,1.0871757947374474,0.35555555555555557,0.7640390052774658,1.0,2/5,24.34%,NSMCE2;MACROH2A1
prerank,GO_Biological_Process_2021__positive regulation of maintenance of mitotic sister chromatid cohesion (GO:0034184),0.6859619500105836,1.0871757947374474,0.35555555555555557,0.7640390052774658,1.0,2/5,24.34%,NSMCE2;MACROH2A1
prerank,GO_Biological_Process_2021__positive regulation of ERBB signaling pathway (GO:1901186),0.4576047029937249,1.0871014072430627,0.32558139534883723,0.7637448930685566,1.0,8/20,18.40%,ARAP1;CNOT9;CBL;AKT1;HIP1;SHKBP1;NEU3;RBPJ
prerank,GO_Biological_Process_2021__negative regulation of cytokine-mediated signaling pathway (GO:0001960),-0.4791423992966222,-1.0870327500996462,0.3582089552238806,1.0,1.0,7/37,12.07%,PARP14;USP18;ISG15;SIGIRR;GSTP1;STAT2;OAS3
prerank,GO_Biological_Process_2021__regulation of viral genome replication (GO:0045069),-0.4501850414847176,-1.0870205645297273,0.296875,1.0,1.0,9/49,12.07%,IFIT1;IFITM3;BST2;MX1;ISG15;APOBEC3G;RSAD2;EIF2AK2;OAS3
prerank,GO_Biological_Process_2021__peptide metabolic process (GO:0006518),0.4282617910379779,1.086954274989033,0.2916666666666667,0.7636527265897164,1.0,5/62,5.00%,GSTT2;LVRN;PCSK5;CARNMT1;MME
prerank,GO_Biological_Process_2021__protein localization to kinetochore (GO:0034501),-0.5671321954867228,-1.0869457574692176,0.3584905660377358,1.0,1.0,4/11,8.70%,ZWILCH;SPDL1;MTBP;MIS12
prerank,GO_Biological_Process_2021__establishment of protein localization to plasma membrane (GO:0061951),0.4355683088982148,1.0869447711077478,0.3333333333333333,0.7631684140845537,1.0,13/32,21.80%,NECTIN3;RAB31;ARFRP1;GOLPH3;GGA2;GOLGA7;AFDN;KIF13A;NSF;BBS2;GGA1;RAB10;GORASP2
prerank,GO_Biological_Process_2021__negative regulation of pathway-restricted SMAD protein phosphorylation (GO:0060394),0.6753305399713567,1.0867119441582787,0.4634146341463415,0.7633416129489982,1.0,3/7,22.23%,SMAD7;SNX25;PMEPA1
prerank,GO_Biological_Process_2021__protein localization to nucleus (GO:0034504),-0.4248819134173509,-1.0866337045041607,0.345679012345679,1.0,1.0,2/91,2.60%,GBP2;RPL11
prerank,GO_Biological_Process_2021__aspartate metabolic process (GO:0006531),0.7199490724503579,1.0866314890125293,0.4,0.7631228299045093,1.0,1/5,8.83%,DDO
prerank,GO_Biological_Process_2021__regulation of endocytosis (GO:0030100),0.38011938756389924,1.086609664451336,0.3157894736842105,0.7626821247464973,1.0,12/53,17.69%,SNCA;PICALM;CD22;NEDD4L;ABL2;PRKD1;CLIP3;OPHN1;HIP1;MTMR2;CDH13;RAB4A
prerank,GO_Biological_Process_2021__regulation of interleukin-2 production (GO:0032663),-0.5051992939106622,-1.0865896289383883,0.3246753246753247,1.0,1.0,3/32,7.28%,GBP1;ANXA1;PNP
prerank,GO_Biological_Process_2021__forebrain neuron development (GO:0021884),0.6559590441273664,1.0865018024457265,0.44,0.7624006047062424,1.0,3/6,13.24%,LHX6;RAPGEF2;SCYL2
prerank,GO_Biological_Process_2021__regulation of actin cytoskeleton reorganization (GO:2000249),0.4653265378898273,1.086336090844424,0.43333333333333335,0.7623202313917167,1.0,7/28,15.85%,CSF1R;NOTCH2;PDGFRA;HCLS1;ABL2;TJP1;NRP1
prerank,GO_Biological_Process_2021__cytosolic calcium ion transport (GO:0060401),0.4445206565255537,1.086190098802545,0.34210526315789475,0.7622822046692654,1.0,5/27,8.71%,MAIP1;ATP2B3;MCU;CACNA2D1;ADRA1A
prerank,GO_Biological_Process_2021__regulation of immunoglobulin production (GO:0002637),0.5398981603672354,1.0858680572159667,0.3409090909090909,0.7626980443285948,1.0,2/13,4.22%,TNFSF4;CD22
prerank,GO_Biological_Process_2021__protein maturation (GO:0051604),0.3829959284694998,1.0858063333901247,0.2,0.7623961458862326,1.0,8/76,5.72%,ADAMTS3;PCSK5;MMP16;MME;TSPAN14;NCSTN;SDE2;TSPAN17
prerank,GO_Biological_Process_2021__aspartate transmembrane transport (GO:0015810),0.6495729078692809,1.0856617047853594,0.3404255319148936,0.7622105796856515,1.0,4/6,32.93%,SLC25A18;SLC25A13;SLC25A12;LRRC8D
prerank,GO_Biological_Process_2021__snRNA modification (GO:0040031),-0.6737923315687248,-1.085483773242976,0.40384615384615385,1.0,1.0,1/6,3.75%,NOP10
prerank,GO_Biological_Process_2021__regulation of ubiquitin-protein transferase activity (GO:0051438),0.4398542557366636,1.084894638869738,0.3023255813953488,0.7637000795385501,1.0,10/25,20.03%,FEM1B;DCUN1D1;SMAD7;UBE2N;FBXW7;DCUN1D5;DCUN1D4;DCUN1D2;AXIN1;PLK1
prerank,GO_Biological_Process_2021__U4 snRNA 3'-end processing (GO:0034475),0.6322496566439553,1.084500856754808,0.3953488372093023,0.7636541046902693,1.0,1/7,3.32%,EXOSC6
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' (GO:0034427)",0.6322496566439553,1.084500856754808,0.3953488372093023,0.7636541046902693,1.0,1/7,3.32%,EXOSC6
prerank,GO_Biological_Process_2021__regulation of blood-brain barrier permeability (GO:1905603),0.6489639684985182,1.0844559444771327,0.4090909090909091,0.7633105091446654,1.0,3/7,22.08%,OCLN;TJP1;TJP2
prerank,GO_Biological_Process_2021__cell proliferation in forebrain (GO:0021846),0.5785479255470765,1.0843080460829793,0.3469387755102041,0.7631354580364851,1.0,2/10,9.98%,WNT7A;DOCK7
prerank,GO_Biological_Process_2021__DNA repair (GO:0006281),0.3396046987296338,1.0842305015726137,0.25,0.7629081331456338,1.0,58/258,21.42%,CHRNA4;BACH1;LIG4;WDR33;ZBTB1;DNA2;UBE2T;FTO;POLD3;PRMT6;RAD18;FAAP100;NEIL2;PDS5B;UBE2N;CSNK1E;ASCC3;APTX;RAD52;MEN1;RFWD3;RAD51B;USP3;VCPIP1;SIRT1;EXD2;SLC30A9;COMMD1;EYA3;TRIM28;PRIMPOL;PDS5A;VCP;PIAS4;USP47;MAPK8;UIMC1;DCLRE1C;MSH2;APLF;BRCC3;APEX2;SETD2;PSME4;WRNIP1;RAD23B;ASF1A;XRCC4;APBB1;ASCC1;NSD2;H2AX;CIB1;WDR48;ALKBH5;TICRR;SMUG1;TDP2
prerank,GO_Biological_Process_2021__regulation of protein localization to nucleus (GO:1900180),0.4296325951222489,1.0838076723462207,0.3076923076923077,0.7635939877657093,1.0,13/32,29.70%,TESK1;AKT1;KAT7;GSK3B;LATS1;YAP1;TFRC;PLK1;SESN2;NVL;GLUL;SUMO3;EIF2AK3
prerank,"GO_Biological_Process_2021__transcription, DNA-templated (GO:0006351)",0.33434508911919075,1.0836589322161088,0.15789473684210525,0.7634190915772108,1.0,45/191,24.16%,EAF2;TRIM24;SOX5;NR4A2;MLLT3;IWS1;NFKB1;FOXO3;RNGTT;THRB;PIR;COPS2;TAF4;TRIP11;TAF1B;PKNOX1;GLIS3;NELFA;SNAPC3;MTERF1;RREB1;UBTF;GTF3C3;DTX1;CCNT2;RSF1;ZNF141;MAF;CBFB;TAF2;TAF4B;TAF3;TSC22D1;GTF2F2;MED4;CDK9;NAT14;EPC1;TAF1;CDC73;TCEA1;RO60;NCOA6;THAP1;TAF12
prerank,GO_Biological_Process_2021__negative regulation of sphingolipid biosynthetic process (GO:0090155),-0.7061505366248418,-1.0834290392911563,0.43636363636363634,1.0,1.0,2/5,11.77%,ORMDL2;ORMDL1
prerank,GO_Biological_Process_2021__negative regulation of cartilage development (GO:0061037),0.6556401586916217,1.0831369696021882,0.2972972972972973,0.7644390847804277,1.0,3/8,15.44%,SOX9;TGFBR1;PTPN11
prerank,GO_Biological_Process_2021__regulation of cholesterol storage (GO:0010885),0.553051257429942,1.0830186995079052,0.35555555555555557,0.7643057627403649,1.0,2/13,13.33%,ABCA1;TTC39B
prerank,GO_Biological_Process_2021__positive regulation of interleukin-13 production (GO:0032736),0.6719078945887076,1.0828563967460592,0.47368421052631576,0.7641412129656312,1.0,1/6,1.31%,TNFSF4
prerank,GO_Biological_Process_2021__negative regulation of cell cycle G2/M phase transition (GO:1902750),-0.46283020338247705,-1.082536881554358,0.3064516129032258,1.0,1.0,8/50,13.44%,PSMB6;PSMA8;PSMB9;PSMA7;PSMC3;PSME1;PSMC4;PSMA3
prerank,GO_Biological_Process_2021__negative regulation of lipoprotein lipase activity (GO:0051005),0.6457453779852269,1.0823933796977814,0.34146341463414637,0.7649705184059178,1.0,2/5,3.91%,HDAC9;SORT1
prerank,GO_Biological_Process_2021__RNA stabilization (GO:0043489),0.4749632386019063,1.0823414937339204,0.275,0.7645757939725034,1.0,3/29,5.51%,NAF1;RBM24;HNRNPU
prerank,GO_Biological_Process_2021__tRNA wobble uridine modification (GO:0002098),0.5402660453584028,1.082261402696231,0.35135135135135137,0.7643800488112571,1.0,8/13,26.76%,CTU1;DPH3;TRMT9B;ELP3;ALKBH8;ELP1;ELP4;MTO1
prerank,GO_Biological_Process_2021__regulation of peptide hormone secretion (GO:0090276),0.4420474946951078,1.0821779504221123,0.3333333333333333,0.7641636746953684,1.0,11/42,17.44%,ABCC8;HADH;PASK;HTR2C;CHD7;RFX3;CLOCK;RAP1A;STX1A;PPP3CB;KCNC2
prerank,GO_Biological_Process_2021__cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),0.7102822476310515,1.0821596754585554,0.45454545454545453,0.763749354569839,1.0,3/5,21.27%,AKT1;TICAM1;MYD88
prerank,GO_Biological_Process_2021__regulation of reactive oxygen species metabolic process (GO:2000377),0.44746561985018035,1.0819502572592696,0.22727272727272727,0.7638464408594196,1.0,10/43,13.72%,ACE2;PID1;SNCA;BCO2;PLIN5;BST1;PRKN;TGFBR2;PIKFYVE;SIRT2
prerank,GO_Biological_Process_2021__galactose catabolic process (GO:0019388),0.6501838361579633,1.0816120546268075,0.45098039215686275,0.7640892757242557,1.0,1/6,9.18%,PGM2
prerank,GO_Biological_Process_2021__negative regulation of centriole replication (GO:0046600),0.6176416202255892,1.081456460213838,0.4230769230769231,0.7640194170159296,1.0,2/6,9.83%,KAT2B;KAT2A
prerank,GO_Biological_Process_2021__mesoderm morphogenesis (GO:0048332),0.6635431906632739,1.081384788115175,0.47058823529411764,0.7637727419515702,1.0,2/6,5.76%,SMAD2;TBX19
prerank,GO_Biological_Process_2021__stress-induced premature senescence (GO:0090400),0.6794700887927838,1.0813431056705503,0.4523809523809524,0.7633599873272304,1.0,2/6,13.82%,SIRT1;MAPKAPK5
prerank,GO_Biological_Process_2021__positive regulation of basement membrane assembly involved in embryonic body morphogenesis (GO:1904261),0.6918012292503725,1.081187078367819,0.3953488372093023,0.7629307324978798,1.0,2/5,25.72%,CLASP1;CLASP2
prerank,GO_Biological_Process_2021__regulation of basement membrane assembly involved in embryonic body morphogenesis (GO:1904259),0.6918012292503725,1.081187078367819,0.3953488372093023,0.7629307324978798,1.0,2/5,25.72%,CLASP1;CLASP2
prerank,GO_Biological_Process_2021__regulation of cell cycle process (GO:0010564),-0.43595124518521916,-1.0809697634759439,0.31645569620253167,1.0,1.0,12/86,13.34%,CETN2;FBXO43;KIF20B;KNSTRN;RAB11A;IHO1;CAV2;SFRP1;PLK3;USP19;BORA;USP51
prerank,GO_Biological_Process_2021__negative regulation of cell junction assembly (GO:1901889),0.4564009488911134,1.0804560338318139,0.2727272727272727,0.7646990513565878,1.0,7/21,19.93%,SLIT1;RCC2;FAM107A;DUSP22;ROCK2;PTEN;ROCK1
prerank,GO_Biological_Process_2021__pulmonary valve development (GO:0003177),0.5366257933799246,1.0803312638092948,0.34782608695652173,0.7646290717710376,1.0,3/14,12.05%,NOTCH2;ROBO1;SLIT2
prerank,GO_Biological_Process_2021__positive regulation of myeloid cell differentiation (GO:0045639),-0.49086575222523343,-1.080306433143142,0.36507936507936506,1.0,1.0,3/30,4.91%,GATA1;STAT1;RAB7B
prerank,GO_Biological_Process_2021__ectoderm development (GO:0007398),0.5678157516018155,1.0802994309164606,0.45,0.7641859824508369,1.0,3/8,17.49%,AMER2;SMURF1;ITGA6
prerank,GO_Biological_Process_2021__regulation of transferase activity (GO:0051338),0.5614546947828541,1.0801710928224442,0.4,0.7639195753394658,1.0,2/16,9.05%,FEM1B;PPP1R3F
prerank,GO_Biological_Process_2021__positive regulation of muscle contraction (GO:0045933),-0.6860237036960437,-1.0800130192292672,0.3709677419354839,1.0,1.0,3/6,25.04%,SRF;ENO1;SPHK1
prerank,GO_Biological_Process_2021__translational readthrough (GO:0006451),0.6344548836084005,1.079920315384839,0.42105263157894735,0.7635222825254994,1.0,4/7,34.31%,EEFSEC;SEPSECS;SECISBP2L;SELENOT
prerank,GO_Biological_Process_2021__selenocysteine incorporation (GO:0001514),0.6344548836084005,1.079920315384839,0.42105263157894735,0.7635222825254994,1.0,4/7,34.31%,EEFSEC;SEPSECS;SECISBP2L;SELENOT
prerank,GO_Biological_Process_2021__sarcoplasmic reticulum calcium ion transport (GO:0070296),0.6666219390308241,1.079858459130693,0.5,0.7631430556157083,1.0,1/6,2.35%,ANK2
prerank,GO_Biological_Process_2021__regulation of response to cytokine stimulus (GO:0060759),-0.5496356716313939,-1.0796741179168463,0.46875,1.0,1.0,1/17,0.14%,CD24
prerank,GO_Biological_Process_2021__positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),-0.6444683265435689,-1.0796566869764597,0.4166666666666667,1.0,1.0,1/10,1.97%,SELP
prerank,GO_Biological_Process_2021__histone H4-K20 trimethylation (GO:0034773),0.6733591484736238,1.0792201755047237,0.3898305084745763,0.7640693972093874,1.0,3/5,31.72%,BEND3;KMT5B;SETD4
prerank,GO_Biological_Process_2021__histone H4-K20 methylation (GO:0034770),0.6733591484736238,1.0792201755047237,0.3898305084745763,0.7640693972093874,1.0,3/5,31.72%,BEND3;KMT5B;SETD4
prerank,GO_Biological_Process_2021__positive regulation of protein catabolic process (GO:0045732),0.37186993405641416,1.079031427463625,0.21428571428571427,0.7640827348098438,1.0,17/67,18.50%,FOXO1;NEDD4L;CSNK2A1;SEC22B;ITCH;ATG7;PRKN;SMURF1;VGLL4;VCP;GSK3B;NSF;FAF1;HACE1;RNF41;IDE;AXIN1
prerank,GO_Biological_Process_2021__mononuclear cell differentiation (GO:1903131),0.5130685705235255,1.07833863595261,0.3611111111111111,0.7652925181449389,1.0,3/15,6.81%,CSF1R;PDE1B;PIR
prerank,GO_Biological_Process_2021__muscle contraction (GO:0006936),-0.4265673462404763,-1.07807429221783,0.2987012987012987,1.0,1.0,7/77,6.42%,TNNT1;MYOT;UTS2;LMOD1;MYOF;CACNA1H;TTN
prerank,GO_Biological_Process_2021__glycerophospholipid metabolic process (GO:0006650),0.4207424149287377,1.077845444609391,0.26666666666666666,0.7661709262042776,1.0,16/59,20.86%,SERINC5;CSF1R;PLEK;PRDX6;DGKH;PLCB1;PIGX;ACP6;ABHD6;SYNJ1;CPNE3;PIGP;AGK;CPNE1;FAR1;PLCB3
prerank,GO_Biological_Process_2021__oxidative RNA demethylation (GO:0035513),0.7164449286101807,1.0773983709917796,0.4444444444444444,0.7668318997738717,1.0,3/5,20.82%,FTO;JMJD6;ALKBH5
prerank,GO_Biological_Process_2021__regulation of focal adhesion assembly (GO:0051893),0.41503703761985283,1.0772351424596402,0.2222222222222222,0.7668949395786401,1.0,15/50,19.93%,EFNA5;RCC2;LIMCH1;FAM107A;PTPRJ;MAP4K4;GPM6B;PTK2;CLASP1;DUSP22;ROCK2;NRP1;PTEN;PPM1F;ROCK1
prerank,GO_Biological_Process_2021__monoubiquitinated protein deubiquitination (GO:0035520),0.6390806346532713,1.0771636279482377,0.42857142857142855,0.7666492485574227,1.0,3/6,28.84%,USP47;USP15;USP7
prerank,GO_Biological_Process_2021__phosphatidylglycerol metabolic process (GO:0046471),0.5173734346049937,1.0771517281093594,0.3111111111111111,0.7662496376211759,1.0,5/14,29.19%,GPAM;SERAC1;LPCAT1;CDS2;SLC27A1
prerank,GO_Biological_Process_2021__sprouting angiogenesis (GO:0002040),0.41366771185697776,1.077134509535241,0.2972972972972973,0.7657991514124759,1.0,8/40,9.93%,VEGFD;LOXL2;PARVA;AKT1;YJEFN3;ROBO1;VEGFC;EFNB2
prerank,GO_Biological_Process_2021__regulation of mitochondrial gene expression (GO:0062125),0.5910214201413139,1.0771320230755272,0.39473684210526316,0.7653286927682268,1.0,1/8,11.06%,NSUN3
prerank,GO_Biological_Process_2021__regulation of SMAD protein signal transduction (GO:0060390),-0.5621264468850931,-1.0770996941136826,0.38028169014084506,1.0,1.0,3/17,9.68%,OVOL2;VEPH1;NODAL
prerank,GO_Biological_Process_2021__plasma membrane organization (GO:0007009),-0.47057856878090426,-1.0770565350804875,0.3125,1.0,1.0,9/54,19.35%,TLCD1;MYOF;COL5A1;CAV3;CLN3;TLCD2;CXCR4;EHD2;DMKN
prerank,GO_Biological_Process_2021__mammary gland development (GO:0030879),0.49060877418448673,1.0770141665112827,0.3409090909090909,0.7651769639747431,1.0,2/16,5.05%,ERBB4;ARHGAP35
prerank,GO_Biological_Process_2021__hexose catabolic process (GO:0019320),0.6471778610480456,1.076987852240878,0.4878048780487805,0.7647485098629208,1.0,1/6,9.18%,PGM2
prerank,GO_Biological_Process_2021__positive regulation of fibroblast apoptotic process (GO:2000271),-0.6324054600817063,-1.0768923735868623,0.46296296296296297,1.0,1.0,2/6,14.85%,SFRP1;BTG1
prerank,GO_Biological_Process_2021__regulation of long-term synaptic depression (GO:1900452),-0.6179468856428749,-1.076875952854462,0.3620689655172414,1.0,1.0,1/7,3.26%,KCNB1
prerank,GO_Biological_Process_2021__regulation of innate immune response (GO:0045088),-0.4547348849127656,-1.0767275288473377,0.38333333333333336,1.0,1.0,6/48,7.86%,IRF1;USP18;IFI35;TRIM21;ERAP1;CASP8
prerank,GO_Biological_Process_2021__regulation of chromatin organization (GO:1902275),0.5135965203004698,1.076655269949161,0.38235294117647056,0.7649560744465163,1.0,2/12,5.51%,MLLT3;HNRNPU
prerank,GO_Biological_Process_2021__regulation of DNA-dependent DNA replication initiation (GO:0030174),0.6899351548743409,1.07628804212105,0.425531914893617,0.7655218941711004,1.0,3/5,21.18%,KAT7;WRNIP1;TICRR
prerank,GO_Biological_Process_2021__endomembrane system organization (GO:0010256),0.3392008497725867,1.0762786773117057,0.2777777777777778,0.765042844174748,1.0,37/170,19.45%,VAPB;VAPA;USP6NL;TRAPPC12;TRAPPC8;ALS2CL;TMCC1;EXOC8;TRIP11;RNF26;DNAJC13;GOLPH3;PRKD1;DYM;SYNE1;RAB30;HOOK1;CHMP2B;TJAP1;REEP4;CLASP1;RAB22A;TMED3;TRAPPC11;HACE1;ARHGEF7;RAB1A;ARFGEF1;TMED5;LEMD3;TOR1B;SEC23IP;TOR1AIP2;ALS2;PHETA1;NSFL1C;UBXN2B
prerank,GO_Biological_Process_2021__regulation of cardiac muscle hypertrophy in response to stress (GO:1903242),0.7180657953275279,1.0758622328931784,0.37254901960784315,0.7655567495373587,1.0,2/5,15.57%,FOXO1;ATP2B4
prerank,GO_Biological_Process_2021__mRNA cleavage involved in gene silencing by miRNA (GO:0035279),0.6782310828915974,1.0757779891215227,0.4782608695652174,0.7652009655523249,1.0,3/5,31.12%,AGO3;AGO1;AGO2
prerank,GO_Biological_Process_2021__negative regulation of innate immune response (GO:0045824),-0.47341895791237393,-1.0757039483166193,0.3939393939393939,1.0,1.0,7/32,13.67%,USP18;ISG15;TRIM21;STAT2;A2M;OAS3;RPS19
prerank,GO_Biological_Process_2021__response to prostaglandin E (GO:0034695),0.6633125133881723,1.0754910728453821,0.3953488372093023,0.7654791231648135,1.0,1/6,1.31%,TNFSF4
prerank,GO_Biological_Process_2021__mitochondrial outer membrane permeabilization (GO:0097345),0.6053321583607193,1.0754395078324008,0.4473684210526316,0.7651136204926504,1.0,1/10,3.99%,RHOT1
prerank,GO_Biological_Process_2021__regulation of endothelial cell development (GO:1901550),0.6656738953847963,1.0752461404350069,0.40540540540540543,0.7651873865938243,1.0,4/7,19.93%,ZDHHC21;ROCK2;PPP1R12A;ROCK1
prerank,GO_Biological_Process_2021__purine deoxyribonucleotide catabolic process (GO:0009155),0.6316382599128174,1.0751461220332161,0.46808510638297873,0.7649449045671717,1.0,2/5,4.71%,SAMHD1;NT5C1A
prerank,GO_Biological_Process_2021__histone H3-K9 demethylation (GO:0033169),0.5355991278741377,1.0751069871435093,0.35294117647058826,0.7646109946177406,1.0,7/10,35.69%,KDM1A;KDM4C;JMJD1C;KDM7A;KDM3A;PHF8;KDM3B
prerank,GO_Biological_Process_2021__regulation of apoptotic signaling pathway (GO:2001233),0.45746789364197016,1.0750477147803952,0.3684210526315789,0.7642876863812751,1.0,6/29,6.78%,SGMS1;TPD52L1;CRADD;NR4A2;DAPK2;CSNK2A1
prerank,GO_Biological_Process_2021__positive regulation of B cell activation (GO:0050871),0.42292592178163335,1.0750345932068577,0.3142857142857143,0.7638935236946587,1.0,2/35,1.31%,TNFSF13B;TNFSF4
prerank,GO_Biological_Process_2021__T cell differentiation (GO:0030217),0.44820922305846134,1.0750202210569928,0.23529411764705882,0.7634693316125214,1.0,5/28,9.57%,LEPR;LIG4;SOX4;CHD7;GLI3
prerank,GO_Biological_Process_2021__positive regulation of peroxisome proliferator activated receptor signaling pathway (GO:0035360),0.6567226347964512,1.0749203091984174,0.5,0.7632388377749539,1.0,3/5,28.07%,LMO3;ASXL2;PTGIS
prerank,GO_Biological_Process_2021__regulation of inclusion body assembly (GO:0090083),0.5594859274993625,1.0748108253850877,0.37777777777777777,0.7630695937351609,1.0,6/10,26.18%,DNAJB2;SACS;DNAJB6;HSPA1A;DNAJA4;BAG5
prerank,GO_Biological_Process_2021__ether lipid biosynthetic process (GO:0008611),0.5610695822945659,1.0747915857952413,0.41025641025641024,0.7626365487511504,1.0,4/9,23.44%,PEX7;FAR1;AGPS;CHPT1
prerank,PanglaoDB_Augmented_2021__Satellite Glial Cells,0.35523259446297106,1.0747893458064162,0.20833333333333334,0.7621837450994732,1.0,13/92,10.20%,PDK4;PID1;TDRD6;CSF1R;CHL1;EPOR;NTRK2;CDH20;NRXN1;FAM107A;NDRG2;LYVE1;KCNA2
prerank,GO_Biological_Process_2021__protein polymerization (GO:0051258),0.4117616498295002,1.07467725471357,0.3333333333333333,0.7620357533145108,1.0,12/47,17.42%,SPIRE2;ZNF207;CASQ1;WASL;SPIRE1;FAM107A;PRKN;TTC17;CKAP5;HDGFL3;WASF3;WASF1
prerank,GO_Biological_Process_2021__epiboly involved in wound healing (GO:0090505),-0.579405271429669,-1.074614552077352,0.41935483870967744,1.0,1.0,3/15,7.71%,CEACAM1;PDPN;CCN1
prerank,GO_Biological_Process_2021__ubiquinone biosynthetic process (GO:0006744),0.5413428627063082,1.0744965587285638,0.35135135135135137,0.761578253616247,1.0,5/13,22.15%,COQ3;COQ9;COQ2;FDXR;PDSS2
prerank,GO_Biological_Process_2021__quinone biosynthetic process (GO:1901663),0.5413428627063082,1.0744965587285638,0.35135135135135137,0.761578253616247,1.0,5/13,22.15%,COQ3;COQ9;COQ2;FDXR;PDSS2
prerank,GO_Biological_Process_2021__protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),0.5562539774219181,1.0742433169362964,0.46,0.7617447197097932,1.0,3/10,8.16%,PARD3;PLPP1;DGKH
prerank,GO_Biological_Process_2021__cilium organization (GO:0044782),0.33106378184273294,1.0742028148744156,0.15789473684210525,0.7614658498097552,1.0,34/197,16.38%,SPAG16;MACIR;FHDC1;PARVA;CILK1;EXOC2;SEPTIN6;CYS1;EXOC8;EHD4;RFX3;RAB3IP;RAB23;RAB8B;EXOC5;SSX2IP;TTBK2;CEP290;PKD2;DZIP1;EXOC6;TTC8;DYNLL2;TTC17;SEPTIN7;EXOC4;BBS9;CEP20;KIAA0586;RP2;CDC14A;LZTFL1;MKKS;RAB1A
prerank,GO_Biological_Process_2021__positive regulation of histone H3-K27 methylation (GO:0061087),0.6784173361884287,1.0741941365315801,0.4523809523809524,0.7610255591691871,1.0,2/5,25.89%,OGT;ZNF304
prerank,GO_Biological_Process_2021__chromatin silencing at telomere (GO:0006348),0.6332551443997079,1.074082106534446,0.35555555555555557,0.760878831211674,1.0,1/6,13.72%,SIRT2
prerank,GO_Biological_Process_2021__regulation of glial cell differentiation (GO:0045685),0.6629996371722773,1.0740592078867393,0.38461538461538464,0.7604697400731122,1.0,2/5,10.68%,EPHA4;NF1
prerank,PanglaoDB_Augmented_2021__Red Pulp Macrophages,-0.49261749230165575,-1.0736589535317989,0.4067796610169492,1.0,1.0,8/29,13.63%,CLEC12A;IGSF6;P2RY13;SLC11A1;CD14;SPI1;CLEC5A;MYO1F
prerank,GO_Biological_Process_2021__protein K11-linked ubiquitination (GO:0070979),0.44025494707189905,1.0733123894089343,0.37777777777777777,0.7620592962786282,1.0,11/26,23.00%,ANAPC1;UBE2T;CDC27;UBE2E3;RNF26;PRKN;UBE2E2;UBE2D3;ANAPC13;UBE2L5;UBE2H
prerank,GO_Biological_Process_2021__phosphatidylinositol acyl-chain remodeling (GO:0036149),0.5649166225351221,1.0733028816843104,0.43902439024390244,0.7615995547464736,1.0,2/9,20.71%,PLBD1;PLAAT3
prerank,GO_Biological_Process_2021__mitochondrial genome maintenance (GO:0000002),-0.556323196863396,-1.0730200334441884,0.4074074074074074,1.0,1.0,2/12,10.62%,SLC25A4;SLC25A33
prerank,GO_Biological_Process_2021__regulation of actomyosin structure organization (GO:0110020),0.535058042318671,1.0729081453866618,0.37777777777777777,0.7622793286179117,1.0,3/12,19.93%,ALMS1;ROCK2;ROCK1
prerank,GO_Biological_Process_2021__actin filament polymerization (GO:0030041),0.49165579354910843,1.072773935354755,0.3235294117647059,0.762182645319239,1.0,8/27,19.77%,SPIRE2;WASL;SPIRE1;FAM107A;TTC17;WASF3;WASF1;MSRB1
prerank,GO_Biological_Process_2021__eye photoreceptor cell development (GO:0042462),0.5723421643646722,1.0727179296633724,0.35,0.7618142777290338,1.0,4/11,23.31%,CEP290;RORB;RPGRIP1L;RP1
prerank,GO_Biological_Process_2021__glycerolipid metabolic process (GO:0046486),0.5609636524424854,1.0724504384300844,0.3888888888888889,0.7622713322097486,1.0,4/10,14.38%,DGKB;GAL3ST1;DGKZ;DGKG
prerank,GO_Biological_Process_2021__heparin metabolic process (GO:0030202),0.7143220691637164,1.072330043441809,0.47058823529411764,0.7620541791340758,1.0,2/5,8.81%,CSGALNACT1;SLC10A7
prerank,GO_Biological_Process_2021__positive regulation of viral release from host cell (GO:1902188),0.5482893855719018,1.0722065267374037,0.4444444444444444,0.7618071481178504,1.0,2/11,2.99%,VPS37B;VAPA
prerank,GO_Biological_Process_2021__transition metal ion transport (GO:0000041),-0.5131761023342528,-1.0721589411124974,0.4411764705882353,1.0,1.0,5/32,10.41%,FTH1;CP;CUTC;SLC11A1;MT3
prerank,GO_Biological_Process_2021__regulation of macrophage derived foam cell differentiation (GO:0010743),0.4648459070580919,1.0721160799028062,0.2777777777777778,0.7616005886710093,1.0,2/19,4.81%,ABCA1;NFKB1
prerank,GO_Biological_Process_2021__T cell mediated cytotoxicity (GO:0001913),-0.6872888120423922,-1.0720578117970339,0.43636363636363634,1.0,1.0,4/5,17.03%,HLA-A;CTSH;MICA;EMP2
prerank,GO_Biological_Process_2021__regulation of stem cell division (GO:2000035),-0.6178190987956169,-1.0716710651162489,0.38181818181818183,1.0,1.0,1/7,0.66%,SFRP2
prerank,GO_Biological_Process_2021__regulation of vascular wound healing (GO:0061043),0.7035873556019319,1.0713854089242272,0.5094339622641509,0.7628996689710602,1.0,2/5,6.40%,SERPINE1;SLC12A2
prerank,GO_Biological_Process_2021__skin development (GO:0043588),-0.47271907853676887,-1.0708882348991937,0.38571428571428573,1.0,1.0,7/44,8.09%,FLG2;DHCR24;ABCA12;COL5A1;FLG;ANXA1;HRNR
prerank,GO_Biological_Process_2021__establishment of protein localization to peroxisome (GO:0072663),0.6166875152951028,1.0704111216169199,0.43478260869565216,0.7647889118558396,1.0,3/7,16.73%,PEX16;ZFAND6;PEX6
prerank,GO_Biological_Process_2021__bleb assembly (GO:0032060),-0.6232753861107897,-1.0702302486784008,0.42857142857142855,1.0,1.0,2/7,17.03%,EMP3;EMP2
prerank,GO_Biological_Process_2021__retinal metabolic process (GO:0042574),-0.6051418960356942,-1.0699357059985877,0.3870967741935484,1.0,1.0,4/11,11.82%,AKR1C1;BCO1;RDH13;RDH11
prerank,GO_Biological_Process_2021__cellular response to cytokine stimulus (GO:0071345),-0.39827649729007764,-1.069708674908206,0.3076923076923077,1.0,1.0,46/290,15.21%,GBP2;POU4F1;DOCK8;GBP7;IFIT1;GBP1;GBP3;IL1R1;DUOX1;IRF1;IL5;RPS27A;IL7;STAT1;PTPN7;F13A1;CXCL2;ANXA1;TIMP1;IFNGR2;IL12A;INPP5D;SIGIRR;ST3GAL6;PIK3CB;HYAL1;RPL13A;UBC;STAT2;MT2A;DUSP1;CEBPD;SFRP1;IL3RA;IL18;CX3CL1;BRCA1;IL20RA;XBP1;AIM2;DPYSL3;CCL2;FSCN1;IL34;CRLF2;GREM2
prerank,GO_Biological_Process_2021__protein-DNA complex assembly (GO:0065004),-0.4181348221543544,-1.0695585368510385,0.30434782608695654,1.0,1.0,13/106,13.44%,PSMB6;CETN2;RPS27A;RPA3;PSMA8;PSMB9;PSMA7;PSMC3;UBC;PSME1;CENPV;PSMC4;PSMA3
prerank,GO_Biological_Process_2021__positive regulation of mitotic nuclear division (GO:0045840),0.4508199411605429,1.0695283568826326,0.3333333333333333,0.7668261936383425,1.0,8/21,21.35%,RGCC;CDC27;NSMCE2;PHIP;ESPL1;CUL3;IGF1;AURKA
prerank,GO_Biological_Process_2021__acute-phase response (GO:0006953),-0.7171541089581723,-1.06938894832742,0.4745762711864407,1.0,1.0,1/6,7.64%,SIGIRR
prerank,GO_Biological_Process_2021__mitochondrial fragmentation involved in apoptotic process (GO:0043653),0.5884718135616069,1.0693470004240386,0.43478260869565216,0.766757311244776,1.0,2/9,5.86%,ERBB4;MFF
prerank,GO_Biological_Process_2021__ganglioside metabolic process (GO:0001573),0.5151520816410482,1.069174631502925,0.42857142857142855,0.7665883997530153,1.0,4/16,16.63%,ST6GALNAC5;HEXB;ABCA2;NEU3
prerank,GO_Biological_Process_2021__protein hydroxylation (GO:0018126),0.5716641793081072,1.0691387420706846,0.4,0.7661495539998764,1.0,5/13,21.11%,EGLN3;PLOD2;ASPH;PLOD1;P3H4
prerank,GO_Biological_Process_2021__activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),0.38324005143876416,1.069001124277293,0.3448275862068966,0.7660912106148322,1.0,12/60,14.97%,EGLN3;SNCA;CRADD;BOK;CASP10;ROBO1;TRADD;CFLAR;ANP32B;TNFRSF10B;VCP;HIP1
prerank,GO_Biological_Process_2021__positive regulation of establishment of protein localization to mitochondrion (GO:1903749),-0.45302081031824704,-1.068863536434653,0.3382352941176471,1.0,1.0,7/44,16.67%,TOMM7;CASP8;UBL5;ARIH2;NMT1;PPP3CC;HTRA2
prerank,GO_Biological_Process_2021__L-phenylalanine metabolic process (GO:0006558),0.6453581940038127,1.0684749240088953,0.40425531914893614,0.7669922659314593,1.0,2/7,5.79%,KYAT1;QDPR
prerank,GO_Biological_Process_2021__mast cell mediated immunity (GO:0002448),0.6729638194353769,1.0684165419122666,0.5,0.7666738200834267,1.0,1/6,3.35%,SERPINB9
prerank,GO_Biological_Process_2021__cysteine metabolic process (GO:0006534),0.6141576218972802,1.0680180740324807,0.36585365853658536,0.7672939580165501,1.0,4/6,35.89%,GCLC;CDO1;TST;CBS
prerank,GO_Biological_Process_2021__central nervous system myelination (GO:0022010),0.562381135405511,1.0679292545660355,0.35,0.767105387841821,1.0,5/11,18.44%,MYRF;B4GALT6;ABCA2;B4GALT5;PTEN
prerank,GO_Biological_Process_2021__acylglycerol acyl-chain remodeling (GO:0036155),-0.679962842443017,-1.0676750414449743,0.46296296296296297,1.0,1.0,2/5,5.75%,DGAT2L6;PNPLA3
prerank,GO_Biological_Process_2021__negative regulation of cell size (GO:0045792),-0.7032314925213956,-1.067269601507514,0.4666666666666667,1.0,1.0,2/5,10.23%,RDX;CAV3
prerank,GO_Biological_Process_2021__cellular response to leptin stimulus (GO:0044320),0.6360372475253497,1.0670458226316855,0.3902439024390244,0.7688509628092786,1.0,1/7,0.74%,LEPR
prerank,GO_Biological_Process_2021__negative regulation of DNA replication (GO:0008156),0.5941181626452463,1.0670178557283665,0.47058823529411764,0.7685122356118348,1.0,4/10,33.48%,PDS5A;WAPL;GMNN;CDAN1
prerank,GO_Biological_Process_2021__positive regulation of cellular protein metabolic process (GO:0032270),0.3546585441380236,1.066982133018574,0.17391304347826086,0.768154007740105,1.0,22/89,19.18%,WNT7A;BTRC;SOX4;PASK;ZCCHC4;CPEB3;AKT1;CYFIP2;HDAC2;RPS6KB1;ATG7;ASPH;OGT;NIBAN1;VGLL4;FAF1;TBC1D10A;EIF3E;FXR1;LARP4;HNRNPD;FBXW11
prerank,GO_Biological_Process_2021__regulation of calcium ion-dependent exocytosis (GO:0017158),0.4884166560688269,1.0668920676308302,0.35294117647058826,0.7679156210053742,1.0,9/24,15.35%,CACNA1G;SYT3;DOC2A;CACNA1I;DOC2B;CBARP;RAB3GAP1;SYT9;STX1A
prerank,GO_Biological_Process_2021__negative regulation of phosphorylation (GO:0042326),0.3796103575347436,1.066731043394643,0.35,0.7679161896022156,1.0,22/74,20.59%,PID1;PPP1R15B;GIT1;TESK1;HNRNPU;PTPN13;MEN1;PRKN;CRKL;PLPP3;SLIT2;OCLN;HDAC4;SIRT1;NIBAN1;BMP7;IMPACT;FBLN1;PTEN;ROCK1;FKBP8;CIB1
prerank,GO_Biological_Process_2021__positive regulation of T cell cytokine production (GO:0002726),-0.5639325781546841,-1.0665736104088934,0.43283582089552236,1.0,1.0,5/15,12.13%,IL1R1;HLA-A;B2M;RSAD2;IL18
prerank,GO_Biological_Process_2021__mRNA catabolic process (GO:0006402),0.3913823418269746,1.0665418511765417,0.2903225806451613,0.7679167575081737,1.0,8/42,22.46%,PDE12;RIDA;AGO3;ZC3H12D;YTHDF2;NBAS;HSPA1A;DIS3L2
prerank,GO_Biological_Process_2021__N-glycan processing (GO:0006491),0.4858716890463514,1.066454676897447,0.3611111111111111,0.7677882045638473,1.0,4/18,11.23%,PRKCSH;MGAT4A;MAN1A2;FUT8
prerank,GO_Biological_Process_2021__autophagosome membrane docking (GO:0016240),-0.6754076148213131,-1.0663616109673093,0.42857142857142855,1.0,1.0,2/7,9.62%,ATG14;VAMP8
prerank,GO_Biological_Process_2021__retinoic acid receptor signaling pathway (GO:0048384),0.6001172985331504,1.0661959939048935,0.4375,0.7680072278908888,1.0,1/9,1.15%,RARB
prerank,GO_Biological_Process_2021__regulation of blood vessel endothelial cell migration (GO:0043535),0.4535733930304243,1.0659525013418831,0.3793103448275862,0.7683251883098541,1.0,15/42,23.86%,EPHA2;RGCC;AKT1;HMGB1;PRCP;NF1;PRKD1;SIRT1;ATP2B4;HIF1A;AKT3;PRKCA;VASH1;FGF2;MECP2
prerank,GO_Biological_Process_2021__cell projection organization (GO:0030030),0.4738198424363162,1.0657852197560467,0.38235294117647056,0.7682065358256215,1.0,6/25,7.78%,QRICH2;CSPG5;PARVA;PLEK;RHOQ;PDGFA
prerank,GO_Biological_Process_2021__response to granulocyte macrophage colony-stimulating factor (GO:0097012),0.6617925266413841,1.0657782650791532,0.39215686274509803,0.7672864059584739,1.0,1/5,5.96%,PDE1B
prerank,GO_Biological_Process_2021__cellular response to granulocyte macrophage colony-stimulating factor stimulus (GO:0097011),0.6617925266413841,1.0657782650791532,0.39215686274509803,0.7672864059584739,1.0,1/5,5.96%,PDE1B
prerank,GO_Biological_Process_2021__positive regulation by symbiont of entry into host (GO:0075294),-0.6630176822037397,-1.065643271044319,0.5333333333333333,1.0,1.0,1/6,15.74%,CD74
prerank,GO_Biological_Process_2021__positive regulation of viral entry into host cell (GO:0046598),-0.6630176822037397,-1.065643271044319,0.5333333333333333,1.0,1.0,1/6,15.74%,CD74
prerank,GO_Biological_Process_2021__regulation of macrophage proliferation (GO:0120040),0.6204884671434244,1.0656394866345686,0.425,0.767188389773123,1.0,3/6,14.21%,CSF1R;PTK2;MAPK1
prerank,GO_Biological_Process_2021__positive regulation of telomerase activity (GO:0051973),0.47123032280580024,1.0656274922524795,0.42857142857142855,0.7668036738476185,1.0,8/29,16.86%,NAF1;CCT4;DKC1;MAP3K4;MAPKAPK5;MAPK1;PTGES3;POT1
prerank,GO_Biological_Process_2021__protein autoubiquitination (GO:0051865),0.39137626707368856,1.0656048001474208,0.28125,0.7664095385267833,1.0,20/62,21.00%,UHRF2;SH3RF3;UBE2T;RNF11;RNF146;RAD18;SH3RF1;ITCH;MARCHF7;CNOT4;PRKN;RNF208;KLHL24;RNF41;BFAR;CUL3;MDM2;RNFT1;UBE2D3;RNF10
prerank,GO_Biological_Process_2021__muscle cell development (GO:0055001),0.4333215170272227,1.0655574234334073,0.3333333333333333,0.7661047842752439,1.0,4/27,6.19%,TCAP;ANK2;MEGF10;BIN1
prerank,PanglaoDB_Augmented_2021__Enteroendocrine Cells,0.36798000066066877,1.0653095078166726,0.3888888888888889,0.76635325105655,1.0,24/103,18.72%,SOWAHA;ABCC8;SNAP91;ALCAM;CACNA1B;NOL4;UNC79;VWA5B2;CDK5R2;NRXN1;ASTN1;ADGRA1;UNC5D;CELF3;TMEM196;OLFM3;LY6H;ASXL3;ELAVL3;CA10;CSRNP3;NPY;CTNND2;OPCML
prerank,GO_Biological_Process_2021__tRNA 3'-end processing (GO:0042780),-0.6573035553221678,-1.06520713227748,0.47058823529411764,1.0,1.0,2/6,19.92%,TRMT10C;TRNT1
prerank,GO_Biological_Process_2021__cellular amino acid biosynthetic process (GO:0008652),-0.6656198752355524,-1.0651829077060688,0.38596491228070173,1.0,1.0,1/6,8.14%,GAD1
prerank,GO_Biological_Process_2021__negative regulation of centrosome duplication (GO:0010826),0.536074692036614,1.065145906276403,0.38636363636363635,0.7661870283078476,1.0,2/10,9.83%,KAT2B;KAT2A
prerank,GO_Biological_Process_2021__regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway (GO:0070432),0.6185356527814819,1.0650729081932355,0.44680851063829785,0.765922401179556,1.0,1/6,2.23%,SLC15A3
prerank,GO_Biological_Process_2021__mitochondrion-endoplasmic reticulum membrane tethering (GO:1990456),0.6154164501920754,1.0646313359234196,0.40425531914893614,0.7666435465612743,1.0,3/6,26.67%,PDZD8;VMP1;PACS2
prerank,GO_Biological_Process_2021__cellular amino acid catabolic process (GO:0009063),0.3970585042313152,1.0645037301871294,0.23809523809523808,0.7664085090352549,1.0,17/72,15.68%,PRODH;GLS;CARNMT1;KYAT1;ACAD8;CARNS1;QDPR;DDO;ALDH4A1;AUH;FTCD;BCKDHB;ALDH7A1;KYNU;AMDHD1;BLMH;DDAH1
prerank,GO_Biological_Process_2021__cell morphogenesis involved in differentiation (GO:0000904),0.39238347515761474,1.0643562672407416,0.2727272727272727,0.7663706079096709,1.0,14/61,22.23%,LAMB4;EPHA2;PARVA;PIK3R1;SRCIN1;FER;OPHN1;PXN;NRP1;YTHDF2;TMEFF2;SIPA1L3;ABI2;NTN4
prerank,GO_Biological_Process_2021__arginine metabolic process (GO:0006525),-0.6339318716532836,-1.0642311478687512,0.45454545454545453,1.0,1.0,2/7,13.85%,ART4;NOS1
prerank,GO_Biological_Process_2021__positive regulation of axon extension involved in axon guidance (GO:0048842),-0.6947108261661334,-1.0641787702639836,0.3559322033898305,1.0,1.0,1/5,5.50%,SEMA5A
prerank,GO_Biological_Process_2021__positive regulation of establishment of protein localization (GO:1904951),0.5179464906109329,1.0639694543303524,0.3870967741935484,0.766913121178882,1.0,4/16,16.58%,CCT4;DKC1;CCT3;CEP120
prerank,GO_Biological_Process_2021__citrulline metabolic process (GO:0000052),0.6156706150892797,1.0639063682895022,0.5208333333333334,0.7666685145463942,1.0,1/6,15.68%,DDAH1
prerank,GO_Biological_Process_2021__astrocyte differentiation (GO:0048708),-0.6946480850232861,-1.0635842826174804,0.46,1.0,1.0,1/6,10.41%,MT3
prerank,GO_Biological_Process_2021__regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),0.4154111535341126,1.063542287949128,0.25925925925925924,0.7670726480144606,1.0,9/35,16.20%,BMP2;SMAD7;GDF10;ACVR1;TGFBR1;ACVR2A;BMPR1A;SMAD4;BMP7
prerank,GO_Biological_Process_2021__acylglycerol homeostasis (GO:0055090),-0.5964020106937249,-1.0632304689065386,0.42105263157894735,1.0,1.0,4/12,12.13%,MTLN;ANGPTL3;APOE;IL18
prerank,GO_Biological_Process_2021__regulation of cytokine production (GO:0001817),0.3753119677456405,1.0631593387226594,0.3333333333333333,0.7674959344208888,1.0,18/84,12.58%,ACE2;TNFSF4;HDAC9;FOXP1;ACKR1;BTN3A3;NPTN;RPS6KA4;RGCC;DTX4;LGR4;IGF2BP2;RNF26;CADM1;KAT2A;MAST2;LURAP1;MAPKAPK2
prerank,GO_Biological_Process_2021__N-acetylneuraminate metabolic process (GO:0006054),-0.5850267328465741,-1.063135953970941,0.4098360655737705,1.0,1.0,2/10,8.53%,ST6GAL1;GNE
prerank,GO_Biological_Process_2021__cellular response to prostaglandin E stimulus (GO:0071380),0.6651069723980623,1.063059341803953,0.5,0.7672416052182344,1.0,1/5,1.31%,TNFSF4
prerank,GO_Biological_Process_2021__regulation of clathrin-dependent endocytosis (GO:2000369),0.5168328214637625,1.0627998204734492,0.27906976744186046,0.7675662100651587,1.0,5/13,16.63%,SNAP91;WASL;SCYL2;UBQLN2;NEU3
prerank,GO_Biological_Process_2021__N-acylphosphatidylethanolamine metabolic process (GO:0070292),-0.6345623022262774,-1.0627801076746803,0.46153846153846156,1.0,1.0,1/7,9.14%,PLAAT4
prerank,PanglaoDB_Augmented_2021__Microfold Cells,-0.4258701386201593,-1.062535593107912,0.3375,1.0,1.0,16/83,13.02%,GBP3;IL1R1;IER3;HLA-C;HELZ2;TNFAIP2;B3GNT3;CTSH;KLF4;CEBPD;LTBR;OAS3;CD14;DTX3L;RBM47;PGLYRP1
prerank,GO_Biological_Process_2021__regulation of cellular localization (GO:0060341),0.4194788110298144,1.0625215338868992,0.3333333333333333,0.7678512203439656,1.0,12/41,19.25%,EFNA5;EPHA5;CSNK1E;NR1D1;PRKN;CAMK2D;DVL1;FER;PARD6G;KDM1A;TTL;PPM1F
prerank,GO_Biological_Process_2021__regulation of integrin-mediated signaling pathway (GO:2001044),-0.5758343966988967,-1.062278741415493,0.42857142857142855,1.0,1.0,2/12,5.04%,CD63;TIMP1
prerank,GO_Biological_Process_2021__positive regulation of striated muscle cell differentiation (GO:0051155),0.502465351326129,1.0622627119170807,0.425,0.7679791608511942,1.0,7/18,23.03%,RBM24;EFNB2;MAML1;IGF1;ATP11A;NRG1;MESP1
prerank,GO_Biological_Process_2021__positive regulation of erythrocyte differentiation (GO:0045648),-0.4964844127427511,-1.0621568930950698,0.4461538461538462,1.0,1.0,2/23,3.14%,GATA1;STAT1
prerank,GO_Biological_Process_2021__pulmonary valve morphogenesis (GO:0003184),0.5368699324173455,1.062047013283035,0.38461538461538464,0.7680677895657787,1.0,3/13,12.05%,NOTCH2;ROBO1;SLIT2
prerank,GO_Biological_Process_2021__regulation of actin filament organization (GO:0110053),0.6062594297008471,1.061970278982181,0.40476190476190477,0.7677258246040067,1.0,3/7,7.14%,CXCL12;ARHGAP35;PIK3CA
prerank,GO_Biological_Process_2021__positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),0.46101736682484407,1.061941432635604,0.3611111111111111,0.7673451565970641,1.0,7/19,11.91%,FLT1;PDGFRA;AGAP2;IRS1;PIK3R4;PRKD1;PTK2
prerank,GO_Biological_Process_2021__actin polymerization or depolymerization (GO:0008154),0.4200849168080897,1.061907398364005,0.3225806451612903,0.7669942597546283,1.0,10/45,17.42%,SPIRE2;MICAL1;WASL;SPIRE1;FAM107A;TTC17;ABI1;ENAH;WASF3;WASF1
prerank,GO_Biological_Process_2021__nuclear migration (GO:0007097),0.5675012913283166,1.0618910716711536,0.4222222222222222,0.7665558853083554,1.0,7/13,31.02%,DOCK7;CEP120;FBXW11;PCM1;HOOK3;SUN2;PAFAH1B1
prerank,GO_Biological_Process_2021__positive regulation of T-helper 17 type immune response (GO:2000318),-0.6812285404081131,-1.061763843794262,0.46,1.0,1.0,3/5,26.17%,PRKCQ;IL12RB1;NFKBID
prerank,GO_Biological_Process_2021__regulation of protein neddylation (GO:2000434),-0.6270934052490128,-1.0615360067064918,0.3404255319148936,1.0,1.0,3/9,6.86%,COPS9;RPL11;RPL5
prerank,GO_Biological_Process_2021__negative regulation of protein kinase B signaling (GO:0051898),0.41248686324769773,1.0614667653302499,0.3684210526315789,0.7672307264330746,1.0,11/33,20.81%,EPHA2;AKT1;PTPRJ;SIRT1;MAGI2;PHLPP2;PTEN;DRD2;PHLPP1;CIB1;PLEKHA1
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance (GO:0032206),0.45030352875189245,1.0612561118977284,0.39473684210526316,0.7671731647453194,1.0,7/26,18.98%,NAF1;PPP1R10;MAP3K4;MAPKAPK5;MAPK1;ATRX;HNRNPD
prerank,GO_Biological_Process_2021__ncRNA catabolic process (GO:0034661),0.4656407046683806,1.0612233858598021,0.2972972972972973,0.7668232068654709,1.0,10/24,31.41%,EXOSC6;TENT4B;LIN28B;DIS3L2;ZCCHC8;DIS3;POP1;PARN;EXOSC9;NUDT16L1
prerank,GO_Biological_Process_2021__Golgi localization (GO:0051645),0.5194194489519445,1.061112181679042,0.375,0.7666685262567551,1.0,8/11,39.85%,YWHAZ;STK25;HOOK3;TBCCD1;UVRAG;CDC42;COPG1;PDCD10
prerank,GO_Biological_Process_2021__positive regulation of epithelial to mesenchymal transition (GO:0010718),0.4682791778126303,1.0608647276767407,0.42857142857142855,0.7668840441860835,1.0,14/32,26.93%,BMP2;LOXL2;RGCC;SMAD2;TGFBR2;TGFBR1;SMAD4;ZNF703;LEF1;CTNNB1;SMAD3;BCL9L;TCF7L2;JAG1
prerank,GO_Biological_Process_2021__positive regulation of lipase activity (GO:0060193),0.6391422723203313,1.0608148864738711,0.3902439024390244,0.7666030028511869,1.0,1/8,5.57%,PLIN5
prerank,GO_Biological_Process_2021__regulation of hemopoiesis (GO:1903706),0.5419742245454658,1.060668864333597,0.41025641025641024,0.7664876316184133,1.0,5/11,21.27%,IL17D;CBFB;RUNX1;CREBBP;PRKCB
prerank,GO_Biological_Process_2021__dendritic spine maintenance (GO:0097062),0.6597248690123724,1.0604967909104037,0.43478260869565216,0.7664501563995758,1.0,3/7,26.37%,MTMR2;FYN;PICK1
prerank,GO_Biological_Process_2021__male gonad development (GO:0008584),-0.5166582972545435,-1.0603593702561065,0.4117647058823529,1.0,1.0,4/24,4.02%,GATA1;SOX15;ADAM21;MEA1
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell proliferation (GO:0001938),0.41820401535512625,1.0597402513902587,0.4166666666666667,0.7678504113213147,1.0,14/57,17.47%,VEGFD;BMP2;AKT1;NRP2;VEGFC;HMGB1;PRKD1;NRAS;SIRT1;TGFBR1;ECM1;NRP1;CDH13;HIF1A
prerank,GO_Biological_Process_2021__G2/M transition of mitotic cell cycle (GO:0000086),0.3517679002249837,1.0593641282790571,0.2857142857142857,0.7684820463803783,1.0,34/121,21.35%,BACH1;CDC25A;BTRC;CEP152;TPD52L1;PHLDA1;FBXL17;FBXL3;NEDD1;CEP290;CSNK1E;PLCB1;CCNA2;CKAP5;MAPRE1;CLASP1;ALMS1;CUL1;TUBG1;LATS1;PPP2R2A;FBXL6;PPP1R12A;YWHAG;ARPP19;TAF2;CDK14;DNM2;FBXW11;PPP1CB;PLK1;PPP2R1A;PCM1;AURKA
prerank,GO_Biological_Process_2021__regulation of cytoskeleton organization (GO:0051493),0.36129516068780176,1.059323124710202,0.3125,0.7681232701436378,1.0,21/92,15.41%,EFNA5;IQCJ-SCHIP1;RHOQ;ARHGAP35;TESK1;RHOBTB3;EPHA5;BST1;PDGFA;FAM107A;PAK3;KATNBL1;GPM6B;PTK2;BICD2;CLASP1;TJP1;MAPK1;TAOK2;GSK3B;ROCK2
prerank,GO_Biological_Process_2021__positive regulation of protein depolymerization (GO:1901881),-0.5845839850095658,-1.058783021092991,0.3508771929824561,1.0,1.0,2/8,5.50%,VIL1;SEMA5A
prerank,GO_Biological_Process_2021__regulation of signal transduction by p53 class mediator (GO:1901796),-0.3948154407396822,-1.058756764345127,0.2857142857142857,1.0,1.0,17/139,15.23%,POU4F1;RPL23;RPL11;RPS15;RPA3;SETD9;RPL5;HEXIM1;RPS20;ZNF385A;BLM;PLK3;BRCA1;RPF2;TPX2;MAP2K6;CDK5
prerank,GO_Biological_Process_2021__positive regulation of superoxide anion generation (GO:0032930),-0.6249207920063569,-1.058727738738745,0.39622641509433965,1.0,1.0,2/7,22.39%,GSTP1;TGFB1
prerank,GO_Biological_Process_2021__negative regulation of receptor binding (GO:1900121),-0.7154915229039293,-1.0583291416329892,0.45614035087719296,1.0,1.0,1/5,3.99%,B2M
prerank,GO_Biological_Process_2021__protein localization to ciliary transition zone (GO:1904491),0.63340943563274,1.057935049296114,0.4727272727272727,0.7713624385419476,1.0,3/5,32.46%,TCTN1;NPHP4;SPATA7
prerank,GO_Biological_Process_2021__negative regulation of autophagosome maturation (GO:1901097),0.657281510514697,1.0578958446767133,0.42857142857142855,0.7710411452938365,1.0,1/5,15.92%,UBQLN4
prerank,GO_Biological_Process_2021__negative regulation of nucleocytoplasmic transport (GO:0046823),0.5186666752602643,1.0578914880689343,0.41025641025641024,0.7706040084773496,1.0,4/13,17.02%,RANGAP1;RAB23;NUP153;SUFU
prerank,GO_Biological_Process_2021__blood circulation (GO:0008015),0.41019603086681633,1.05737309747805,0.35135135135135137,0.7713289414883565,1.0,4/28,5.24%,ACE2;MEOX2;CXCL12;GUCY1B1
prerank,PanglaoDB_Augmented_2021__Pericytes,-0.4060989660992051,-1.0570694843993158,0.3974358974358974,1.0,1.0,32/111,18.67%,LMOD1;PDE5A;SPARC;HSD11B1;COX7A1;P2RY14;APLNR;ADM;AQP1;ANGPTL2;C1R;COL6A2;ECM2;ELN;IGFBP5;SOD3;PAMR1;ADGRL4;C1S;KCNJ8;TNS2;EDNRA;COL4A2;ICAM1;CRYAB;C1QTNF1;HIGD1B;COL14A1;GLI1;TAGLN;LAMA4;BGN
prerank,GO_Biological_Process_2021__blood vessel diameter maintenance (GO:0097746),0.4207895114811068,1.0569978983763333,0.2727272727272727,0.7717628006970396,1.0,1/22,0.08%,ACE2
prerank,GO_Biological_Process_2021__protein transmembrane import into intracellular organelle (GO:0044743),0.46100343495205337,1.0569975721581855,0.3939393939393939,0.7713066761103392,1.0,8/28,18.37%,DNAJC15;PEX14;PEX16;PEX5;PEX2;PEX7;PEX6;AIFM1
prerank,GO_Biological_Process_2021__vacuole organization (GO:0007033),0.622938506832643,1.0568641701746846,0.5111111111111111,0.7712086010810794,1.0,1/6,13.40%,NDP
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),-0.45399943185342834,-1.0568078633072608,0.391304347826087,1.0,1.0,9/61,12.15%,IFI6;DHCR24;AQP1;THBS1;BEX3;NODAL;MT3;KLF4;FIS1
prerank,GO_Biological_Process_2021__positive regulation of epidermal cell differentiation (GO:0045606),-0.5784877674208568,-1.0565626051963446,0.41818181818181815,1.0,1.0,4/11,17.51%,SFRP4;PLAAT4;ETV4;MACROH2A2
prerank,GO_Biological_Process_2021__negative regulation of collateral sprouting (GO:0048671),0.6950202323570746,1.0564566115369642,0.5238095238095238,0.7719121519274494,1.0,3/5,29.08%,DCC;PTPRS;FGF13
prerank,GO_Biological_Process_2021__ribosomal large subunit export from nucleus (GO:0000055),0.6869546873982136,1.0564304123514392,0.4489795918367347,0.7715339549345654,1.0,1/6,2.20%,XPO1
prerank,GO_Biological_Process_2021__import into cell (GO:0098657),0.45436124122864746,1.056205600406693,0.41379310344827586,0.7717445709089722,1.0,2/31,1.84%,SLC19A1;SLC6A13
prerank,GO_Biological_Process_2021__neuron projection development (GO:0031175),0.34262052694383416,1.0561717821241694,0.3125,0.771357278715075,1.0,41/145,19.93%,WNT7A;BICDL1;LRP12;SHANK1;VAPA;PRMT1;EPHA4;ATXN10;GPM6A;TNIK;RAPGEF2;UHMK1;WASL;TBC1D24;HMGB1;DOCK7;PAK3;MAP4K4;GPRIN1;SHANK3;GPM6B;CAMSAP2;NCKAP1;NBL1;OPHN1;TAOK2;WHRN;GSK3B;HDGFL3;CNTN4;BMP7;TBC1D23;NCDN;NPY;CTNND2;PTEN;ALS2;DNM2;SAMD14;CDK5R1;ROCK1
prerank,GO_Biological_Process_2021__cellular response to decreased oxygen levels (GO:0036294),0.39541308847007306,1.0557532571455515,0.34285714285714286,0.7718953066461796,1.0,18/52,21.55%,EGLN3;RGCC;RORA;CPEB4;HP1BP3;SIRT1;HIPK2;SIRT2;UBQLN1;MDM4;BMP7;NDNF;HIF1A;MDM2;CPEB1;CPEB2;FMN2;AK4
prerank,GO_Biological_Process_2021__regulation of macrophage apoptotic process (GO:2000109),-0.6794669855052724,-1.0553714621063337,0.5166666666666667,1.0,1.0,1/5,5.71%,SELENOS
prerank,GO_Biological_Process_2021__organic hydroxy compound transport (GO:0015850),-0.4924339325967352,-1.0553539636848484,0.43548387096774194,1.0,1.0,5/25,11.43%,AKR1C1;CEACAM1;SLC51B;SLC51A;SLC10A1
prerank,GO_Biological_Process_2021__response to manganese ion (GO:0010042),0.6611000304760705,1.0553472227635394,0.47058823529411764,0.7725674978379485,1.0,3/5,30.18%,PRKN;ADAM9;D2HGDH
prerank,GO_Biological_Process_2021__cellular response to histamine (GO:0071420),0.6565783710066536,1.0551633246373489,0.5227272727272727,0.7725268209794054,1.0,3/6,23.72%,GABRB1;HRH1;GABRB3
prerank,GO_Biological_Process_2021__cell projection assembly (GO:0030031),0.5254292953314343,1.0550944891492198,0.42857142857142855,0.7722361497319756,1.0,6/17,15.21%,QRICH2;PARVA;RHOQ;PDGFA;NCKAP1;CYFIP1
prerank,GO_Biological_Process_2021__nuclear membrane reassembly (GO:0031468),0.3976408332510678,1.0550472777189452,0.4,0.7719073746173309,1.0,17/50,24.73%,NUP37;NUP188;RANGAP1;CHMP2B;NDC1;SIRT2;REEP4;LBR;PPP2R2A;NUP205;NSFL1C;UBXN2B;CHMP6;PPP2R1A;NUP98;AHCTF1;IST1
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced cell death (GO:1903201),0.5974512206385368,1.054946537563599,0.43478260869565216,0.7717038598989495,1.0,5/8,22.48%,PRKN;UBQLN1;FYN;REST;LANCL1
prerank,"GO_Biological_Process_2021__DNA catabolic process, endonucleolytic (GO:0000737)",0.46980554454688517,1.0548515825901827,0.3684210526315789,0.7714717838167569,1.0,3/20,9.68%,DNASE1L2;DFFB;HMGB1
prerank,GO_Biological_Process_2021__inclusion body assembly (GO:0070841),0.6783774240515213,1.0548120196168402,0.4791666666666667,0.7710768743756572,1.0,2/5,20.43%,PRKN;BAG3
prerank,GO_Biological_Process_2021__positive regulation of miRNA metabolic process (GO:2000630),0.6760364115738788,1.0547895461000751,0.43902439024390244,0.7707111943672964,1.0,3/6,26.72%,NFKB1;LIN28B;RELA
prerank,GO_Biological_Process_2021__synapse assembly (GO:0007416),0.3961044789642121,1.0544183595379766,0.4583333333333333,0.7712371808817898,1.0,16/61,13.39%,WNT7A;PCDHB2;DNM3;CDH2;ADGRL3;FZD5;GPM6A;NRXN1;SDK1;PCDHB13;SLITRK1;DVL1;NLGN3;SHANK3;NLGN4X;FARP1
prerank,GO_Biological_Process_2021__regulation of protein kinase B signaling (GO:0051896),0.35975976751618943,1.0543073841337613,0.2727272727272727,0.7710729646949199,1.0,39/140,20.81%,RCN3;CASS4;FAM110C;ERBB4;EPHA2;EGFR;PDGFRA;FGF17;HCLS1;AKT1;NTRK2;MYORG;PIK3CA;STRN;PIK3R1;PDGFA;IRS1;PTPRJ;PTK2;NRG2;SIRT1;TGFBR1;MAGI2;OSBPL8;GAB1;HIP1;PTPN11;HGF;RNF41;AKT2;PHLPP2;PTEN;CPNE1;FYN;DRD2;PHLPP1;NRG1;CIB1;PLEKHA1
prerank,GO_Biological_Process_2021__negative regulation of phosphatase activity (GO:0010923),0.43880256060382977,1.0542668694901083,0.2857142857142857,0.7707749328244008,1.0,6/23,16.25%,PPP1R36;PPP1R1B;PPP4R4;GPATCH2;GSK3B;SEMA4D
prerank,GO_Biological_Process_2021__nucleobase-containing compound catabolic process (GO:0034655),0.4292976794467845,1.053814062185727,0.35135135135135137,0.7716921813728513,1.0,6/29,18.98%,DNASE1L2;DFFB;ENTPD6;ENTPD4;PPP1R8;HNRNPD
prerank,GO_Biological_Process_2021__regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),0.5174714046806482,1.0535928488043265,0.44680851063829785,0.7717574464221219,1.0,3/12,18.18%,TASOR;TRIM28;PPHLN1
prerank,GO_Biological_Process_2021__endosomal vesicle fusion (GO:0034058),-0.6065929759051805,-1.0535697281546716,0.39285714285714285,1.0,1.0,1/8,0.78%,SAMD9
prerank,PanglaoDB_Augmented_2021__Stromal Cells,-0.41090804440976614,-1.05337730896061,0.373134328358209,1.0,1.0,29/89,18.67%,LMOD1;SPARC;COL5A1;SNED1;AQP1;ANGPTL2;C1R;COL6A2;ELN;TLR3;FBLN5;MMRN2;MADCAM1;SOD3;PAMR1;ADGRL4;TNC;C1S;SRPX2;EDNRA;COL4A2;B4GALNT1;ICAM1;AEBP1;COL14A1;MMP14;TAGLN;LAMA4;BGN
prerank,GO_Biological_Process_2021__phagosome-lysosome fusion (GO:0090385),-0.5851486994570748,-1.0531152971368225,0.3548387096774194,1.0,1.0,2/10,13.86%,RAB7B;CLN3
prerank,GO_Biological_Process_2021__vesicle cytoskeletal trafficking (GO:0099518),0.45796513722570603,1.0528776465965544,0.43333333333333335,0.7731699207928462,1.0,10/33,19.18%,BICDL1;MYO5B;WASL;TRAK1;PPFIA2;TRAK2;TANC2;RAB1A;MYO5A;FBXW11
prerank,GO_Biological_Process_2021__nucleoside phosphate catabolic process (GO:1901292),-0.5572476485433719,-1.052859168773824,0.4262295081967213,1.0,1.0,1/13,3.34%,ENTPD3
prerank,PanglaoDB_Augmented_2021__Airway Smooth Muscle Cells,0.37549820218478863,1.0528426924372587,0.4,0.7727472154061434,1.0,12/63,9.45%,POSTN;DCN;LOXL2;ACTA2;CXCL12;PDGFRA;CDH11;MSRB3;PCDH18;GLT8D2;VEGFC;LOXL1
prerank,GO_Biological_Process_2021__nuclear RNA surveillance (GO:0071027),0.5739967509484506,1.052756838221756,0.3888888888888889,0.7724777083325973,1.0,1/9,3.32%,EXOSC6
prerank,GO_Biological_Process_2021__protein heterooligomerization (GO:0051291),0.48074012294803764,1.0526462096919083,0.37142857142857144,0.7722943620720308,1.0,4/16,9.50%,NUDT21;GRIN1;CPSF6;PKD2
prerank,GO_Biological_Process_2021__regulation of mRNA 3'-end processing (GO:0031440),0.5483655851402094,1.052056403398187,0.41025641025641024,0.7731026556304477,1.0,1/11,1.95%,PAPOLA
prerank,GO_Biological_Process_2021__regulation of triglyceride biosynthetic process (GO:0010866),0.5333725864390187,1.0519952836598623,0.42857142857142855,0.7728238850448882,1.0,2/13,10.97%,PLIN5;FBXW7
prerank,GO_Biological_Process_2021__response to misfolded protein (GO:0051788),-0.6202685469127303,-1.0518799279432673,0.4339622641509434,1.0,1.0,1/7,11.22%,CLU
prerank,GO_Biological_Process_2021__transcription preinitiation complex assembly (GO:0070897),0.5557055785833085,1.0516537641186283,0.45454545454545453,0.773326230346003,1.0,5/11,26.77%,DR1;TAF1B;TAF1;TAF12;GTF2B
prerank,GO_Biological_Process_2021__methylguanosine-cap decapping (GO:0110156),-0.5853472064992308,-1.0514483369638625,0.423728813559322,1.0,1.0,1/10,1.81%,PATL2
prerank,GO_Biological_Process_2021__negative regulation of glucose import (GO:0046325),0.6426398917362166,1.0513775070032163,0.40816326530612246,0.773456855225697,1.0,1/6,0.70%,PID1
prerank,GO_Biological_Process_2021__protein repair (GO:0030091),0.6241355120004466,1.0511940017987558,0.47619047619047616,0.7734827097029958,1.0,4/6,29.50%,MSRB3;MSRB1;MSRA;FN3K
prerank,GO_Biological_Process_2021__mammary gland epithelial cell differentiation (GO:0060644),0.622755243601645,1.0509972635086546,0.40476190476190477,0.7735085341344179,1.0,5/7,17.57%,ERBB4;AKT1;LATS1;AKT2;ZNF703
prerank,GO_Biological_Process_2021__negative regulation of striated muscle cell apoptotic process (GO:0010664),0.6326134939288887,1.0508003479808132,0.48,0.7735818272108775,1.0,3/5,20.43%,PPP1R10;BMP7;BAG3
prerank,GO_Biological_Process_2021__regulation of membrane protein ectodomain proteolysis (GO:0051043),-0.5553681527752262,-1.0502665939514124,0.4375,1.0,1.0,5/15,21.32%,TIMP1;APOE;PTPN3;ADAM8;TIMP2
prerank,GO_Biological_Process_2021__multi-ciliated epithelial cell differentiation (GO:1903251),0.680925209769498,1.0501761137758832,0.4523809523809524,0.7745474913491281,1.0,1/5,2.15%,CEP152
prerank,GO_Biological_Process_2021__tRNA methylation (GO:0030488),0.429356962786144,1.0498533310288272,0.38235294117647056,0.7749237353841654,1.0,5/31,10.94%,LCMT2;TRMT1;TYW3;TRMT1L;NSUN6
prerank,GO_Biological_Process_2021__establishment of epithelial cell apical/basal polarity (GO:0045198),0.6056247077868079,1.04966769727023,0.4222222222222222,0.7750340134136775,1.0,6/8,38.62%,OPHN1;RAP2A;CAMSAP3;CDC42;EZR;RHOA
prerank,GO_Biological_Process_2021__rRNA pseudouridine synthesis (GO:0031118),0.5480984468549301,1.0493229583091976,0.41025641025641024,0.775371628749625,1.0,1/10,0.41%,NAF1
prerank,GO_Biological_Process_2021__liver development (GO:0001889),-0.5005218081897915,-1.0492264113568837,0.43333333333333335,1.0,1.0,3/23,5.19%,CCDC39;ANXA1;DNAAF1
prerank,GO_Biological_Process_2021__phosphorylation of RNA polymerase II C-terminal domain (GO:0070816),0.5669223436016873,1.049208720617799,0.4074074074074074,0.7752068252203594,1.0,3/8,20.95%,CDK12;CDK13;CDK9
prerank,GO_Biological_Process_2021__positive regulation of macrophage differentiation (GO:0045651),-0.6099239537936467,-1.0491259975626397,0.40350877192982454,1.0,1.0,3/9,14.90%,CASP8;ID2;IL34
prerank,GO_Biological_Process_2021__regulation of stem cell proliferation (GO:0072091),0.5462139859673785,1.0491050491172385,0.47619047619047616,0.7750138122082743,1.0,7/12,21.25%,HNRNPU;EPCAM;AGO3;YAP1;KDM1A;FBLN1;PTPRC
prerank,GO_Biological_Process_2021__lymphocyte chemotaxis (GO:0048247),-0.5896890207030614,-1.0486616475626895,0.4,1.0,1.0,4/12,14.31%,GPR183;MSMP;CX3CL1;CCL2
prerank,GO_Biological_Process_2021__defense response to Gram-negative bacterium (GO:0050829),-0.5421961968394962,-1.0484766557937901,0.3898305084745763,1.0,1.0,6/18,14.94%,SELP;RPL30;AQP1;SLC11A1;RPS19;ROMO1
prerank,GO_Biological_Process_2021__sequestering of actin monomers (GO:0042989),-0.6445382240286345,-1.0482383533166537,0.5,1.0,1.0,2/6,14.82%,PFN4;TMSB10
prerank,GO_Biological_Process_2021__purine ribonucleotide transport (GO:0015868),0.5524068199135286,1.048175108711908,0.5789473684210527,0.7769687301337725,1.0,4/12,10.73%,SLC19A1;SLC25A41;ABCC5;SLC25A24
prerank,GO_Biological_Process_2021__aminophospholipid transport (GO:0015917),0.608793292278873,1.0479968371750432,0.43902439024390244,0.7768978471943565,1.0,3/5,34.88%,ATP8A1;TMEM30A;ATP11B
prerank,GO_Biological_Process_2021__neurogenesis (GO:0022008),0.45405616516537983,1.0478805350471665,0.3103448275862069,0.7767419931317554,1.0,6/34,10.69%,FAT4;ASCL1;BTBD3;BTBD1;TRAK1;TRAK2
prerank,GO_Biological_Process_2021__axonal transport of mitochondrion (GO:0019896),0.5609201742315412,1.047696767122595,0.40816326530612246,0.7767279922302276,1.0,4/10,17.47%,TRAK1;TRAK2;OPA1;HIF1A
prerank,GO_Biological_Process_2021__negative regulation of inclusion body assembly (GO:0090084),0.5899700752019326,1.0476066973830103,0.4634146341463415,0.7764969006108465,1.0,5/9,24.32%,DNAJB2;SACS;DNAJB6;HSPA1A;DNAJA4
prerank,GO_Biological_Process_2021__negative regulation of glycolytic process (GO:0045820),0.6291720599712824,1.0472735743469068,0.5,0.7764692297532959,1.0,2/8,12.84%,GIT1;HDAC4
prerank,GO_Biological_Process_2021__negative regulation of purine nucleotide metabolic process (GO:1900543),0.6291720599712824,1.0472735743469068,0.5,0.7764692297532959,1.0,2/8,12.84%,GIT1;HDAC4
prerank,GO_Biological_Process_2021__positive regulation of microtubule polymerization or depolymerization (GO:0031112),-0.49977607178622746,-1.0472462161589322,0.38095238095238093,1.0,1.0,4/24,13.54%,ANKRD53;CAV3;FES;DRG1
prerank,GO_Biological_Process_2021__positive regulation of phagocytosis (GO:0050766),0.43460060380258597,1.0471859152950327,0.3448275862068966,0.7761821478404778,1.0,5/26,12.81%,TUB;RAB27A;RAB31;PTPRJ;MERTK
prerank,GO_Biological_Process_2021__cell migration involved in sprouting angiogenesis (GO:0002042),0.5003758228778512,1.047072273536772,0.34285714285714286,0.7759707380133332,1.0,7/14,22.98%,AKT1;ROBO1;EFNB2;SLIT2;NRP1;NR4A1;FGF2
prerank,GO_Biological_Process_2021__CENP-A containing chromatin organization (GO:0061641),-0.4884257272576866,-1.0469790655024045,0.36065573770491804,1.0,1.0,10/24,27.40%,OIP5;ITGB3BP;CENPH;CENPN;CENPU;NPM1;KNL1;SMARCA5;CENPX;MIS18A
prerank,GO_Biological_Process_2021__CENP-A containing nucleosome assembly (GO:0034080),-0.4884257272576866,-1.0469790655024045,0.36065573770491804,1.0,1.0,10/24,27.40%,OIP5;ITGB3BP;CENPH;CENPN;CENPU;NPM1;KNL1;SMARCA5;CENPX;MIS18A
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),0.39158393859608986,1.0467415684389514,0.40625,0.7762678342278043,1.0,10/41,16.03%,EPHA2;CDIP1;AEN;BOK;EP300;SIRT1;HIPK2;DYRK2;BCL2;MSH2
prerank,GO_Biological_Process_2021__late nucleophagy (GO:0044805),0.5960433817450779,1.046650566565845,0.5135135135135135,0.7760378045450069,1.0,2/6,16.30%,ATG7;ATG2B
prerank,GO_Biological_Process_2021__regulation of protein ADP-ribosylation (GO:0010835),-0.6031313673235671,-1.046500548752311,0.4807692307692308,1.0,1.0,1/7,0.88%,WARS1
prerank,GO_Biological_Process_2021__regulation of positive chemotaxis (GO:0050926),0.6135411794355647,1.0462989045016284,0.5116279069767442,0.7765131483642987,1.0,2/5,22.16%,CDH13;NTRK3
prerank,GO_Biological_Process_2021__RNA polyadenylation (GO:0043631),0.4313268722135093,1.045962388130428,0.40625,0.7763916634362888,1.0,3/24,2.47%,WDR33;PAPOLA;CSTF3
prerank,GO_Biological_Process_2021__mRNA polyadenylation (GO:0006378),0.4313268722135093,1.045962388130428,0.40625,0.7763916634362888,1.0,3/24,2.47%,WDR33;PAPOLA;CSTF3
prerank,GO_Biological_Process_2021__diol biosynthetic process (GO:0034312),0.5202756113182948,1.0459206963832448,0.43243243243243246,0.7760963936913328,1.0,3/15,13.55%,ACER3;QDPR;ABCA2
prerank,GO_Biological_Process_2021__regulation of glucose transmembrane transport (GO:0010827),0.5048368918678104,1.0457735851599512,0.4722222222222222,0.7760078201758541,1.0,4/13,21.27%,BRAF;CLIP3;OCLN;PRKCB
prerank,GO_Biological_Process_2021__dephosphorylation of RNA polymerase II C-terminal domain (GO:0070940),0.6704279625412362,1.0457255883809145,0.49019607843137253,0.7756287381687994,1.0,1/5,18.24%,RPRD1B
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle cell migration (GO:0014912),0.5742584138530731,1.0457214916437998,0.47368421052631576,0.775184506359997,1.0,4/11,14.10%,SERPINE1;PRKG1;SLIT2;BMPR1A
prerank,GO_Biological_Process_2021__cellular response to dsRNA (GO:0071359),-0.5471669037207028,-1.0455966689017837,0.42424242424242425,1.0,1.0,2/14,5.97%,IFIT1;PQBP1
prerank,GO_Biological_Process_2021__chondroitin sulfate catabolic process (GO:0030207),0.5163675269468828,1.0455064601732227,0.3902439024390244,0.7753213377413958,1.0,2/11,2.57%,DCN;CSPG5
prerank,GO_Biological_Process_2021__negative regulation of toll-like receptor 4 signaling pathway (GO:0034144),-0.6597191570286673,-1.0454501989817686,0.5245901639344263,1.0,1.0,1/6,4.91%,RAB7B
prerank,GO_Biological_Process_2021__actin-mediated cell contraction (GO:0070252),0.5820724265174853,1.0454436400908458,0.4418604651162791,0.7749713743395047,1.0,4/8,11.24%,CCDC88C;PARVA;PIK3CA;CAMK2D
prerank,GO_Biological_Process_2021__protein sumoylation (GO:0016925),0.38768497559049475,1.0452484423909298,0.36666666666666664,0.7750146403452726,1.0,14/50,16.17%,NUP42;NUP37;NUP188;RANGAP1;TRPM4;ZNF451;NUP153;PIAS1;NSMCE2;NDC1;TRIM28;PIAS4;STX1A;NUP205
prerank,GO_Biological_Process_2021__regulation of viral transcription (GO:0046782),-0.45442113640949844,-1.045189970025473,0.4084507042253521,1.0,1.0,12/39,22.57%,IFITM3;TRIM21;HEXIM1;POLR2I;GTF2F1;POLR2L;POLR2J;POLR2G;POLR2K;ZFP36;NELFE;NELFCD
prerank,GO_Biological_Process_2021__detection of virus (GO:0009597),0.6319423385367127,1.0449708122641297,0.4634146341463415,0.7752074206173065,1.0,1/5,1.65%,SERINC5
prerank,GO_Biological_Process_2021__regulation of phospholipid metabolic process (GO:1903725),0.5751120107746052,1.0448237565775114,0.43478260869565216,0.7750636545266943,1.0,4/10,32.01%,MTMR2;GNB3;MTMR9;MTMR3
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),-0.42878253400331723,-1.0445802536246271,0.42105263157894735,1.0,1.0,13/54,21.43%,SFRP2;BCL2L2;SELENOS;CLU;CREB3;XBP1;CREB3L1;HTRA2;DDIAS;NOL3;ENO1;PARK7;TPT1
prerank,GO_Biological_Process_2021__regulation of antigen receptor-mediated signaling pathway (GO:0050854),0.5571714019375866,1.0435741487250456,0.3888888888888889,0.7778799009351476,1.0,4/8,21.25%,ELF1;CBFB;RUNX1;PTPRC
prerank,GO_Biological_Process_2021__hormone transport (GO:0009914),0.6356923027244481,1.0434472316482941,0.45652173913043476,0.777254062320319,1.0,2/6,25.26%,SLC16A10;SLCO1C1
prerank,GO_Biological_Process_2021__thyroid hormone transport (GO:0070327),0.6356923027244481,1.0434472316482941,0.45652173913043476,0.777254062320319,1.0,2/6,25.26%,SLC16A10;SLCO1C1
prerank,GO_Biological_Process_2021__negative regulation of translation (GO:0017148),0.37069070221879286,1.0433747759320031,0.32,0.777006925620191,1.0,28/81,22.90%,C8ORF88;RIDA;CPEB3;FTO;RBM24;CNOT9;IGF2BP2;EIF4EBP2;EIF2AK4;CPEB4;SYNCRIP;CAPRIN1;ROCK2;EIF3E;CNOT8;PUM1;FXR1;CELF1;YTHDF2;LSM14A;CPEB1;CPEB2;ROCK1;DDX6;FMR1;YTHDF3;GIGYF2;MRPL13
prerank,GO_Biological_Process_2021__positive regulation of signal transduction (GO:0009967),0.3135344154536986,1.0431175863882867,0.3,0.7771979126308884,1.0,46/195,18.44%,WNT7A;ADAMTS3;SASH1;KAT2B;TPD52L1;NPTN;SALL1;SHANK1;BMP2;CRADD;KANK1;GRIN1;TSPAN14;MAML2;CSNK2A1;MYORG;NRXN1;LMO3;PIK3R1;IRS1;ROBO1;HOMER1;PKD2;EP300;ZRANB1;NLGN3;SHANK3;ZDHHC5;DLG5;SIRT1;TGFBR1;SNX5;TRIM16;PTPN11;PHIP;YAP1;NRP1;SMO;TRIM44;MAML1;CDKN2AIP;HIF1A;IGF1;FAS;RBPJ;PTEN
prerank,GO_Biological_Process_2021__cellular response to UV (GO:0034644),0.3706032762059197,1.0430129249106106,0.3888888888888889,0.7770441941062446,1.0,14/58,17.91%,CDC25A;PTPRK;ZBTB1;RHBDD1;MME;SDE2;EIF2AK4;EP300;SIRT1;USP47;IMPACT;STK11;KDM1A;YY1
prerank,"GO_Biological_Process_2021__endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000447)",-0.6683672274525481,-1.0428666354847989,0.5166666666666667,1.0,1.0,1/6,1.02%,RPS21
prerank,GO_Biological_Process_2021__ammonium transmembrane transport (GO:0072488),-0.6569469425705436,-1.0426078437076807,0.5409836065573771,1.0,1.0,4/6,24.95%,RHD;RHCE;RHCG;SLC12A7
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),-0.6183390725688749,-1.0424890997219651,0.5166666666666667,1.0,1.0,2/7,10.41%,ITGA5;MT3
prerank,GO_Biological_Process_2021__intracellular pH reduction (GO:0051452),0.4571437097517745,1.0424363931434715,0.3783783783783784,0.7780165789393965,1.0,3/28,8.36%,ATP6V0D2;ATP6V1A;ATP6V1C1
prerank,GO_Biological_Process_2021__positive regulation of interferon-alpha production (GO:0032727),-0.5598431959578164,-1.0419666648650698,0.5161290322580645,1.0,1.0,3/14,14.02%,STAT1;TLR3;RIPK2
prerank,GO_Biological_Process_2021__benzene-containing compound metabolic process (GO:0042537),-0.6587479622553993,-1.0419227311365116,0.4727272727272727,1.0,1.0,1/7,0.82%,KMO
prerank,GO_Biological_Process_2021__tRNA wobble base modification (GO:0002097),0.512228511141448,1.0417811647869186,0.34210526315789475,0.7792761551853772,1.0,7/13,26.76%,CTU1;DPH3;TRMT9B;ELP3;ALKBH8;ELP4;MTO1
prerank,GO_Biological_Process_2021__negative regulation of DNA metabolic process (GO:0051053),-0.47144225389724836,-1.0413971784248535,0.4126984126984127,1.0,1.0,2/24,1.35%,H1-4;H1-2
prerank,GO_Biological_Process_2021__cellular component assembly (GO:0022607),0.3398771957455509,1.041324827063354,0.3181818181818182,0.7799115605576228,1.0,51/209,19.71%,TCAP;WNT7A;PPARGC1A;SPAG16;MICAL1;QRICH2;MITF;PAWR;PARD3;SHANK1;EPS8;PICALM;QSOX1;PARVA;SOX9;RHOQ;CD247;WASL;CEP290;PDGFA;PEX14;FAM107A;DVL1;NLGN3;FBLIM1;GPM6B;NLGN4X;SYCE1;OCLN;VCPIP1;NCKAP1;DNAJB13;OPHN1;MDM4;VASP;CYFIP1;TOGARAM1;YAP1;RBBP4;WASF3;POT1;PCLO;WASF1;YTHDF2;FAS;MDM2;ADD1;SLC7A9;YWHAZ;LIN7A;STX7
prerank,GO_Biological_Process_2021__positive regulation of macrophage proliferation (GO:0120041),0.643485355615941,1.0413166357271522,0.48717948717948717,0.7794779699673706,1.0,3/5,14.21%,CSF1R;PTK2;MAPK1
prerank,GO_Biological_Process_2021__purine ribonucleoside bisphosphate biosynthetic process (GO:0034036),0.6435366209512691,1.0411222234308304,0.46808510638297873,0.7789184649471729,1.0,5/5,35.67%,PAPSS2;PAPSS1;SLC26A2;SLC35B2;SLC35B3
prerank,GO_Biological_Process_2021__3'-phosphoadenosine 5'-phosphosulfate biosynthetic process (GO:0050428),0.6435366209512691,1.0411222234308304,0.46808510638297873,0.7789184649471729,1.0,5/5,35.67%,PAPSS2;PAPSS1;SLC26A2;SLC35B2;SLC35B3
prerank,"GO_Biological_Process_2021__Wnt signaling pathway, calcium modulating pathway (GO:0007223)",0.4683019280747428,1.0410865751236587,0.2916666666666667,0.7785139953664173,1.0,14/30,23.61%,FZD5;CAMK2A;NLK;PLCB1;MAP3K7;TNRC6B;AGO3;PPP3CB;FZD3;LEF1;PLCB3;PPP3CA;NFATC1;CTNNB1
prerank,GO_Biological_Process_2021__negative regulation of cell cycle (GO:0045786),0.3865475988074487,1.0410807523051724,0.4074074074074074,0.7781007158185445,1.0,18/58,20.03%,PTPRK;BRINP3;BMP2;CHMP1A;RPS6KA2;MEN1;CAMK2N1;TP53BP2;HECA;ANGEL2;SCRIB;LATS1;TRIM35;BMP7;PTEN;IPO5;BRINP1;PLK1
prerank,GO_Biological_Process_2021__miRNA catabolic process (GO:0010587),0.6342188468592725,1.0409472750033906,0.4642857142857143,0.7779287433874945,1.0,5/6,34.73%,TENT4B;LIN28B;DIS3L2;PARN;SND1
prerank,GO_Biological_Process_2021__inhibitory postsynaptic potential (GO:0060080),0.6464402800558277,1.039911345985814,0.4857142857142857,0.7803121181748806,1.0,3/6,16.77%,CHRNA4;NLGN3;INSYN1
prerank,GO_Biological_Process_2021__negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665),-0.6473231828294402,-1.039697126243131,0.5,1.0,1.0,1/5,7.64%,SIGIRR
prerank,GO_Biological_Process_2021__detection of muscle stretch (GO:0035995),0.6509118508626175,1.0394362541310411,0.4583333333333333,0.7810828509005688,1.0,2/6,3.72%,TCAP;CDH2
prerank,GO_Biological_Process_2021__positive regulation of viral life cycle (GO:1903902),0.4739165704267175,1.0393877486455,0.4782608695652174,0.7807337850217309,1.0,1/18,0.82%,VPS37B
prerank,GO_Biological_Process_2021__positive regulation of RNA metabolic process (GO:0051254),0.3886215664335776,1.0391352318182618,0.3870967741935484,0.7809766084782984,1.0,16/40,26.79%,EGFR;NFKB1;DYRK1A;PIK3R1;HNRNPLL;U2AF2;RBM20;MAP2K2;LIN28B;ZPR1;HSPA1A;GRSF1;UTP15;RELA;SETX;ERN1
prerank,GO_Biological_Process_2021__signal transduction by p53 class mediator (GO:0072331),-0.4666711190714271,-1.038822158037391,0.38333333333333336,1.0,1.0,2/28,8.28%,POU4F1;HINT1
prerank,GO_Biological_Process_2021__positive regulation of glial cell migration (GO:1903977),-0.6780077957428302,-1.0388202552966077,0.5208333333333334,1.0,1.0,2/5,12.24%,P2RY12;CX3CL1
prerank,GO_Biological_Process_2021__mitochondrion organization (GO:0007005),0.32162836880889384,1.0385372432152227,0.35,0.7821613204315879,1.0,38/155,19.35%,PLD6;PPARGC1A;PID1;GDAP1;DNM3;AIFM2;MTX2;RHOT1;AFG1L;GABPB1;CHCHD3;MFF;GABPA;NRF1;TRAK1;MIGA2;TFB1M;PYROXD2;PRKN;TOMM22;TRAK2;SAMM50;MTERF1;OPA1;MYH14;MIGA1;IMMP2L;AGTPBP1;ATAD3C;WASF1;WDR81;THG1L;AIFM1;COX7A2L;MIEF2;MTM1;DNM2;NUBPL
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902253),-0.5937593859241089,-1.0385236177593844,0.4915254237288136,1.0,1.0,1/8,2.98%,RPS7
prerank,GO_Biological_Process_2021__cell junction assembly (GO:0034329),0.3600066640351493,1.0384680786450473,0.37037037037037035,0.7819230170254297,1.0,31/85,20.08%,PCDHB2;DNM3;CDH2;ADGRL3;FZD5;CDH11;GPM6A;CDH20;NRXN1;PKP4;TLN2;SDK1;PCDHB13;SLITRK1;NLGN3;SHANK3;FBLIM1;CDH9;FARP1;TJP1;OPHN1;VASP;ITGA6;CDH18;CTNND2;PTEN;NRXN2;DRD2;CDH6;CDH10;DCHS1
prerank,GO_Biological_Process_2021__regulation of striated muscle tissue development (GO:0016202),-0.649947713938893,-1.038028475480606,0.5555555555555556,1.0,1.0,1/6,1.48%,SOX15
prerank,GO_Biological_Process_2021__negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),-0.43435917385429856,-1.0377755459348093,0.4032258064516129,1.0,1.0,8/55,13.44%,PSMB6;PSMA8;PSMB9;PSMA7;PSMC3;PSME1;PSMC4;PSMA3
prerank,PanglaoDB_Augmented_2021__Merkel Cells,0.42910156601068583,1.0377434459424988,0.4166666666666667,0.7833826528936962,1.0,5/29,4.80%,ACE2;FLI1;EFNA2;ARHGEF16;SLC26A3
prerank,GO_Biological_Process_2021__regulation of triglyceride metabolic process (GO:0090207),0.621154998340963,1.037458361281414,0.5510204081632653,0.7835773293281014,1.0,3/5,29.22%,PANK2;GNB3;FITM2
prerank,GO_Biological_Process_2021__positive regulation of cytokine production involved in inflammatory response (GO:1900017),0.5906798322672653,1.0373910735159322,0.45652173913043476,0.7833201987890276,1.0,4/8,21.27%,IL17D;TICAM1;HIF1A;MYD88
prerank,GO_Biological_Process_2021__aromatic compound catabolic process (GO:0019439),0.5945685945928657,1.0373786962212332,0.3333333333333333,0.7829620380803132,1.0,1/6,7.18%,PON2
prerank,GO_Biological_Process_2021__DNA methylation or demethylation (GO:0044728),0.5137462232337398,1.0372780740289382,0.38461538461538464,0.7823021284463457,1.0,5/18,23.61%,HELLS;ATRX;PPM1D;BEND3;EHMT1
prerank,GO_Biological_Process_2021__DNA alkylation (GO:0006305),0.5137462232337398,1.0372780740289382,0.38461538461538464,0.7823021284463457,1.0,5/18,23.61%,HELLS;ATRX;PPM1D;BEND3;EHMT1
prerank,GO_Biological_Process_2021__positive regulation of granulocyte differentiation (GO:0030854),0.6785848840377016,1.0371432213871616,0.5636363636363636,0.782110660324868,1.0,3/5,19.94%,HCLS1;RUNX1;LEF1
prerank,GO_Biological_Process_2021__G1/S transition of mitotic cell cycle (GO:0000082),0.3750523407267425,1.036961539596002,0.5,0.7822226834749191,1.0,15/70,18.02%,BACH1;CDC25A;CDK18;KLF11;CAMK2A;RPS6KB1;EIF4E;ACVR1;CUL2;CUL1;CDC34;LATS1;TFDP2;CUL3;CDK14
prerank,GO_Biological_Process_2021__positive regulation of microtubule nucleation (GO:0090063),0.6249723652341972,1.0369323232945868,0.46153846153846156,0.7818018493248755,1.0,4/7,23.86%,GIT1;CKAP5;HSPA1A;MECP2
prerank,GO_Biological_Process_2021__positive regulation of triglyceride biosynthetic process (GO:0010867),0.5505144247045934,1.0369282925150893,0.4772727272727273,0.7813906673630606,1.0,1/10,5.57%,PLIN5
prerank,PanglaoDB_Augmented_2021__Germ Cells,-0.43178350348553196,-1.0366723433950182,0.3902439024390244,1.0,1.0,22/83,18.78%,LDHC;TSKS;GAPDHS;BCL2L14;WDR87;TEKT1;DNAAF1;SPATA12;MOV10L1;DEPDC4;BRCA1;GSG1;AQP11;GGNBP1;SORD;CREB3L4;SMC1B;TSACC;SPATA24;SPATA18;DNAH6;MS4A5
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),-0.5034566032048321,-1.0365770529057912,0.42857142857142855,1.0,1.0,4/23,15.71%,KLF2;MT3;DDIT3;CREB3L1
prerank,GO_Biological_Process_2021__mature B cell differentiation involved in immune response (GO:0002313),-0.6243976724915778,-1.0365485234093121,0.45,1.0,1.0,2/7,12.58%,GPR183;LFNG
prerank,GO_Biological_Process_2021__C21-steroid hormone metabolic process (GO:0008207),-0.5499299944536541,-1.0364303466092735,0.423728813559322,1.0,1.0,1/12,1.27%,AKR1C1
prerank,"GO_Biological_Process_2021__phototransduction, visible light (GO:0007603)",-0.6416830367630919,-1.036413169098138,0.44642857142857145,1.0,1.0,1/7,4.52%,PDE6B
prerank,GO_Biological_Process_2021__taurine metabolic process (GO:0019530),0.5974283585366361,1.035991947246953,0.4897959183673469,0.7832461032091276,1.0,4/5,38.64%,CSAD;CDO1;STAT5B;GHR
prerank,GO_Biological_Process_2021__Notch signaling pathway (GO:0007219),0.4093565133099301,1.0356517606253068,0.4375,0.7837056827757777,1.0,15/49,18.40%,KAT2B;BMP2;ASCL1;NOTCH2;NCSTN;MAML2;DTX4;PBX1;ITCH;EP300;ZNF423;MIB1;DTX1;MAML1;RBPJ
prerank,GO_Biological_Process_2021__positive regulation of secretion by cell (GO:1903532),0.39375040234506925,1.035622734593015,0.3870967741935484,0.7833216186323413,1.0,16/57,19.13%,SNCA;BMP2;RAB27A;RGCC;STXBP5;BAIAP3;CADPS2;SLC12A2;GOLPH3;RAB9A;CLASP1;STX1A;SYTL4;IGF1;APBB1;ARF6
prerank,GO_Biological_Process_2021__phosphatidylserine acyl-chain remodeling (GO:0036150),0.5430920653885991,1.0356121837319818,0.4,0.7829105066361141,1.0,3/11,22.96%,OSBPL8;PLAAT3;OSBPL5
prerank,GO_Biological_Process_2021__positive regulation of leukocyte migration (GO:0002687),-0.5376011081595231,-1.0355617948008118,0.4444444444444444,1.0,1.0,5/17,23.21%,MADCAM1;ZP3;ICAM1;ADAM8;PLVAP
prerank,GO_Biological_Process_2021__calcium ion export (GO:1901660),0.5846810628614505,1.0355424281989263,0.47058823529411764,0.7825913966181907,1.0,5/7,25.34%,ATP2B3;ATP2B4;LETM1;SLC35G1;ATP2B1
prerank,GO_Biological_Process_2021__cellular response to arsenic-containing substance (GO:0071243),0.5228783912604817,1.0354406944594416,0.4827586206896552,0.782400730479331,1.0,5/13,27.73%,VCP;CPEB2;ZFAND1;GSTO2;DAXX
prerank,GO_Biological_Process_2021__negative regulation of circadian rhythm (GO:0042754),-0.5782994117523479,-1.0354357774198804,0.4482758620689655,1.0,1.0,1/8,11.45%,SUV39H1
prerank,GO_Biological_Process_2021__negative regulation of angiogenesis (GO:0016525),-0.4426211056413894,-1.0350329038955195,0.4246575342465753,1.0,1.0,13/61,16.62%,EPN1;SPARC;KLF2;STAT1;THBS1;ISM1;PIK3CB;KLF4;CD160;SERPINF1;CREB3L1;SPINK5;COL4A2
prerank,GO_Biological_Process_2021__regulation of nitric oxide metabolic process (GO:0080164),-0.6271430818211523,-1.0348668093091264,0.5,1.0,1.0,2/7,17.06%,SELENOS;NOS1AP
prerank,"GO_Biological_Process_2021__vesicle targeting, rough ER to cis-Golgi (GO:0048207)",0.3728184039206934,1.0345736774039676,0.3103448275862069,0.7832274720156152,1.0,17/56,19.03%,BET1;TRAPPC6B;SEC22B;PPP6R3;COL7A1;TRAPPC10;PEF1;SEC24B;NSF;TFG;RAB1A;TRAPPC9;CUL3;SEC23IP;SEC23A;CNIH1;CD59
prerank,GO_Biological_Process_2021__COPII vesicle coating (GO:0048208),0.3728184039206934,1.0345736774039676,0.3103448275862069,0.7832274720156152,1.0,17/56,19.03%,BET1;TRAPPC6B;SEC22B;PPP6R3;COL7A1;TRAPPC10;PEF1;SEC24B;NSF;TFG;RAB1A;TRAPPC9;CUL3;SEC23IP;SEC23A;CNIH1;CD59
prerank,GO_Biological_Process_2021__vesicle coating (GO:0006901),0.3728184039206934,1.0345736774039676,0.3103448275862069,0.7832274720156152,1.0,17/56,19.03%,BET1;TRAPPC6B;SEC22B;PPP6R3;COL7A1;TRAPPC10;PEF1;SEC24B;NSF;TFG;RAB1A;TRAPPC9;CUL3;SEC23IP;SEC23A;CNIH1;CD59
prerank,GO_Biological_Process_2021__positive regulation of lamellipodium assembly (GO:0010592),0.5098172033460309,1.0343747206687834,0.36585365853658536,0.7832011921208307,1.0,9/21,25.30%,PIK3CA;PIK3R1;AUTS2;OCLN;NCKAP1;CYFIP1;ABI2;ACTR3;AKIRIN1
prerank,GO_Biological_Process_2021__regulation of ketone biosynthetic process (GO:0010566),0.6052842176048634,1.0341939754303127,0.5238095238095238,0.783202312199923,1.0,2/7,20.20%,PPTC7;SIRT5
prerank,GO_Biological_Process_2021__histone H4-K8 acetylation (GO:0043982),0.5266844956240622,1.0340438640488268,0.38461538461538464,0.7827853327747308,1.0,7/15,33.00%,KANSL2;OGT;KAT7;KANSL3;HCFC1;KAT8;JADE1
prerank,GO_Biological_Process_2021__histone H4-K5 acetylation (GO:0043981),0.5266844956240622,1.0340438640488268,0.38461538461538464,0.7827853327747308,1.0,7/15,33.00%,KANSL2;OGT;KAT7;KANSL3;HCFC1;KAT8;JADE1
prerank,GO_Biological_Process_2021__cellular response to chemical stress (GO:0062197),0.3747571936621817,1.0340236634043847,0.3888888888888889,0.782404133361572,1.0,16/82,11.30%,PPARGC1A;ETV5;SNCA;FOXO1;KEAP1;ADNP2;PRDX6;FOXO3;PIK3CA;ATG7;GSR;RAD52;PKD2;SLC25A24;PRKD1;STOX1
prerank,PanglaoDB_Augmented_2021__Hemangioblasts,-0.45481812008078254,-1.0340178257321802,0.4262295081967213,1.0,1.0,8/40,15.79%,GATA1;DOK1;GMFG;EMP3;FES;BLVRB;CCS;GFI1B
prerank,GO_Biological_Process_2021__negative regulation of kinase activity (GO:0033673),0.3732947073463199,1.0340078713219534,0.32,0.7820142549654988,1.0,13/56,11.43%,SNCA;SMCR8;PPM1E;HNRNPU;AKT1;GSKIP;PPP2R5A;SPRED1;TAB1;CAMK2N1;NF1;DUSP19;DVL1
prerank,"GO_Biological_Process_2021__regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",0.5214535267015239,1.0339140487698164,0.5,0.7817794793424474,1.0,9/21,21.11%,SPRED2;DYRK1A;SPRED1;MARCHF7;PSMD10;SIRT1;KDM1A;MDM2;SPRED3
prerank,"GO_Biological_Process_2021__negative regulation of mRNA splicing, via spliceosome (GO:0048025)",0.5177948441111927,1.0339104265543855,0.40540540540540543,0.7813540091099747,1.0,4/13,27.41%,U2AF2;PTBP1;PCBP4;SFSWAP
prerank,GO_Biological_Process_2021__negative regulation of cellular component movement (GO:0051271),-0.5320374330053798,-1.0338749333418782,0.43636363636363634,1.0,1.0,3/13,16.25%,CD9;SPINT2;SP100
prerank,GO_Biological_Process_2021__positive regulation of cholesterol metabolic process (GO:0090205),-0.6030111600053454,-1.0338747194076026,0.43137254901960786,1.0,1.0,1/5,10.67%,FGF1
prerank,GO_Biological_Process_2021__protein K63-linked ubiquitination (GO:0070534),0.4112229210841167,1.0337848258653164,0.40540540540540543,0.781147125370519,1.0,8/39,13.76%,UBE2G1;UBE2T;UBE2E3;UBE2N;TRAF3IP2;ITCH;PRKN;UBE2E2
prerank,GO_Biological_Process_2021__positive regulation of behavior (GO:0048520),0.6297322240411307,1.0336897364374127,0.5116279069767442,0.78094047137425,1.0,3/7,22.01%,NPAS2;SGIP1;NLGN1
prerank,GO_Biological_Process_2021__regulation of hormone secretion (GO:0046883),-0.6932350647944003,-1.033563189836109,0.5230769230769231,1.0,1.0,1/5,4.63%,ANXA1
prerank,GO_Biological_Process_2021__regulation of phosphatase activity (GO:0010921),0.48165032994387896,1.033328801134646,0.3488372093023256,0.781414895703321,1.0,4/20,14.63%,BMP2;PPP1R36;PPP6R3;GPATCH2
prerank,PanglaoDB_Augmented_2021__Erythroblasts,-0.4086108052585195,-1.0331358445462724,0.352112676056338,1.0,1.0,19/65,22.98%,GATA1;PTPN7;GMFG;PNP;TMC8;TSPAN32;BPGM;DOCK2;GFI1B;TFR2;CDH1;ADCY7;ENG;LMO2;TALDO1;GAB3;TUBB1;IGBP1;USE1
prerank,GO_Biological_Process_2021__peroxisomal transport (GO:0043574),0.5966505722239411,1.0330801418169973,0.5217391304347826,0.781562167525954,1.0,3/8,16.73%,PEX16;ZFAND6;PEX6
prerank,GO_Biological_Process_2021__modulation by host of symbiont process (GO:0051851),-0.4775536230259755,-1.0329397836883518,0.4090909090909091,1.0,1.0,7/27,21.85%,AQP1;LRRC19;POU2F3;SNW1;SAP30;SAP30BP;TFAP4
prerank,GO_Biological_Process_2021__riboflavin metabolic process (GO:0006771),-0.6570444189393677,-1.0327676274339028,0.5,1.0,1.0,2/5,27.54%,SLC52A2;RFK
prerank,GO_Biological_Process_2021__flavin-containing compound metabolic process (GO:0042726),-0.6570444189393677,-1.0327676274339028,0.5,1.0,1.0,2/5,27.54%,SLC52A2;RFK
prerank,GO_Biological_Process_2021__negative regulation of stress-activated MAPK cascade (GO:0032873),0.42241047013159555,1.0324001322771479,0.2413793103448276,0.7827430191736674,1.0,7/31,11.06%,FOXO1;MARVELD3;DUSP10;ITCH;MEN1;PRKN;DUSP19
prerank,GO_Biological_Process_2021__epoxygenase P450 pathway (GO:0019373),0.6025994051102743,1.0323210132964176,0.5116279069767442,0.7825268760865721,1.0,2/6,19.39%,CYP2J2;CYP4F12
prerank,GO_Biological_Process_2021__glucose transmembrane transport (GO:1904659),0.5539533316534435,1.0320690715382748,0.42857142857142855,0.7827729242361753,1.0,5/12,28.55%,SORT1;SLC2A8;SLC2A9;SLC2A10;PPARD
prerank,GO_Biological_Process_2021__negative regulation of developmental growth (GO:0048640),0.4387381159368925,1.032001818721855,0.37037037037037035,0.7825479509609161,1.0,10/28,29.08%,DUSP10;RNF6;KIAA0319;DCC;BBS2;PTEN;PTPRS;TRIM46;CDKN1B;FGF13
prerank,GO_Biological_Process_2021__pseudouridine synthesis (GO:0001522),0.49892182153205994,1.0315996292174332,0.4,0.7831646775424299,1.0,4/13,12.09%,TRUB1;PUS10;DKC1;PUS7L
prerank,GO_Biological_Process_2021__negative regulation of protein activation cascade (GO:2000258),-0.6414509168006405,-1.0313884020818607,0.5,1.0,1.0,2/7,10.09%,F8;A2M
prerank,MSigDB_Hallmark_2020__Wnt-beta Catenin Signaling,0.4248876002058298,1.0311674884858675,0.45652173913043476,0.7838982794425969,1.0,10/35,19.94%,NCSTN;CSNK1E;HDAC2;KAT2A;CUL1;GNAI1;MAML1;RBPJ;AXIN1;LEF1
prerank,GO_Biological_Process_2021__establishment of endothelial barrier (GO:0061028),0.4506122869126968,1.0311257062234647,0.36666666666666664,0.7835826786830191,1.0,8/25,16.88%,RAP2B;RAPGEF2;AFDN;RAP2C;RAP1A;TJP1;RAB1A;PDE4D
prerank,GO_Biological_Process_2021__action potential (GO:0001508),0.3950851179345754,1.0308599601134067,0.37142857142857144,0.7838906946263944,1.0,5/36,10.20%,CHRNA4;CACNA1G;CACNA1I;KCNH2;KCNA2
prerank,GO_Biological_Process_2021__negative regulation of calcium ion transport (GO:0051926),-0.569894495809149,-1.030729589685653,0.43859649122807015,1.0,1.0,3/10,13.85%,PLN;CAV3;NOS1
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),-0.5474178233219674,-1.030710350990775,0.4426229508196721,1.0,1.0,3/15,21.24%,PNKP;DTX3L;PARP9
prerank,GO_Biological_Process_2021__deadenylation-independent decapping of nuclear-transcribed mRNA (GO:0031087),0.640227020369722,1.0304759697940755,0.46,0.7843247610133917,1.0,3/5,24.81%,DCP1B;EDC3;DCP1A
prerank,MSigDB_Hallmark_2020__Mitotic Spindle,0.33499215113808994,1.0304569325730377,0.2727272727272727,0.7839733556185209,1.0,56/185,20.86%,NCK2;MAP3K11;ARHGEF12;STK38L;NOTCH2;CDC27;BIN1;ARHGAP5;MID1;WASL;RASAL2;KPTN;FGD4;ITSN1;PKD2;ANLN;NF1;STAU1;INCENP;SOS1;DOCK4;RASA2;DYNLL2;CKAP5;KIF1B;PDLIM5;RAB3GAP1;ABI1;FARP1;NCK1;MAPRE1;CLASP1;CDC42BPA;OPHN1;ALMS1;TAOK2;DLG1;LATS1;ARHGEF7;PXN;ESPL1;KIF15;ARFGEF1;WASF1;KLC1;KATNB1;BCAR1;ALS2;ARF6;ARHGDIA;ROCK1;PLK1;SSH2;TRIO;MARCKS;PCM1
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection organization (GO:0120036),0.3318096591493796,1.0301670822387767,0.35714285714285715,0.7843527902632317,1.0,31/106,19.93%,BICDL1;LRP12;VAPA;CSF1R;PRMT1;ATXN10;PLEK;GPM6A;CARMIL1;RAPGEF2;UHMK1;TBC1D24;PKD2;HMGB1;DOCK7;GPRIN1;GPM6B;TTC17;OPHN1;GSK3B;CYFIP1;HDGFL3;CNTN4;TBC1D23;NCDN;TTC29;NPY;SAMD14;CDK5R1;ARMC2;ROCK1
prerank,GO_Biological_Process_2021__protein catabolic process (GO:0030163),0.38131920566295424,1.0298409175057535,0.4482758620689655,0.7847588456925606,1.0,8/50,10.08%,TRIM24;STT3B;UBE2G1;SOCS6;MARCHF6;ATE1;NR1D1;PRKN
prerank,GO_Biological_Process_2021__medium-chain fatty acid catabolic process (GO:0051793),0.6637811293450104,1.029809806972027,0.4864864864864865,0.7843627417711958,1.0,2/5,19.52%,ACADM;ABHD2
prerank,GO_Biological_Process_2021__negative regulation of protein kinase activity (GO:0006469),0.3435103922566205,1.0297009631339205,0.4782608695652174,0.7842821803909258,1.0,21/78,16.90%,SNCA;SMCR8;TESK1;PPM1E;DUSP10;AKT1;GSKIP;SH3BP5L;SPRED1;SRCIN1;TAB1;CAMK2N1;ADARB1;NF1;DUSP19;DVL1;PTPRB;GNAQ;YWHAG;PTPRO;TRIB2
prerank,GO_Biological_Process_2021__epithelial structure maintenance (GO:0010669),0.6203601098770529,1.0296772953214584,0.5277777777777778,0.7839407629711486,1.0,1/7,3.00%,PIWIL4
prerank,GO_Biological_Process_2021__dermatan sulfate proteoglycan metabolic process (GO:0050655),0.667255316304923,1.0296544443155347,0.49056603773584906,0.7835277757799866,1.0,5/6,31.50%,CSGALNACT1;CHST14;DSEL;DSE;CSGALNACT2
prerank,GO_Biological_Process_2021__regulation of T cell mediated immune response to tumor cell (GO:0002840),0.652595921660414,1.029642883324216,0.5476190476190477,0.7831062542169884,1.0,3/5,19.96%,HMGB1;AHR;FBXO38
prerank,GO_Biological_Process_2021__protein-DNA covalent cross-linking repair (GO:0106300),0.5638728699403264,1.0296272044636312,0.4897959183673469,0.7826851956101277,1.0,2/6,14.67%,VCPIP1;VCP
prerank,GO_Biological_Process_2021__positive regulation of lipid biosynthetic process (GO:0046889),0.4385380165222609,1.0295395708067243,0.36666666666666664,0.7824711009621346,1.0,5/26,14.71%,ZBTB20;PLIN5;AKT1;ELOVL5;MLXIPL
prerank,GO_Biological_Process_2021__ISG15-protein conjugation (GO:0032020),-0.6261361683546471,-1.0294003622114782,0.5094339622641509,1.0,1.0,2/6,11.58%,ISG15;HERC5
prerank,GO_Biological_Process_2021__cellular response to estrogen stimulus (GO:0071391),0.5513831655479915,1.0293868500826973,0.42857142857142855,0.7824367094473108,1.0,2/13,3.35%,TRIM24;SERPINB9
prerank,GO_Biological_Process_2021__positive regulation of NLRP3 inflammasome complex assembly (GO:1900227),0.6148050291544684,1.0292930165244945,0.43902439024390244,0.7823575131777785,1.0,1/6,2.98%,STMP1
prerank,GO_Biological_Process_2021__maintenance of DNA repeat elements (GO:0043570),0.5801899907391768,1.029258498339003,0.40425531914893614,0.7819826056016491,1.0,3/6,32.14%,MSH2;TCF7L2;MSH3
prerank,GO_Biological_Process_2021__regulation of cytosolic calcium ion concentration (GO:0051480),-0.4139346557618938,-1.0288258097914917,0.375,1.0,1.0,18/82,17.91%,CD24;ACKR4;PLN;TACR1;FPR3;CAV2;CAV3;CALB1;FZD9;FIS1;CLN3;SLC8B1;EDNRA;TRPC5;WNT5A;CXCR4;C1QTNF1;GPER1
prerank,GO_Biological_Process_2021__positive regulation of response to endoplasmic reticulum stress (GO:1905898),0.5281473385671139,1.0281178149220027,0.42857142857142855,0.7842777922697615,1.0,4/15,13.73%,USP13;BOK;PIK3R1;NCK1
prerank,GO_Biological_Process_2021__thyroid hormone generation (GO:0006590),-0.6585919650175227,-1.0279940096217377,0.4909090909090909,1.0,1.0,1/6,1.99%,DUOX1
prerank,GO_Biological_Process_2021__negative regulation of protein import into nucleus (GO:0042308),0.582442173663843,1.027723942686657,0.4222222222222222,0.7842698627687782,1.0,4/7,31.36%,RAB23;SUFU;CABP1;UFM1
prerank,GO_Biological_Process_2021__negative regulation of protein import (GO:1904590),0.582442173663843,1.027723942686657,0.4222222222222222,0.7842698627687782,1.0,4/7,31.36%,RAB23;SUFU;CABP1;UFM1
prerank,GO_Biological_Process_2021__recombinational repair (GO:0000725),0.3501093871284527,1.0275782489383478,0.36363636363636365,0.7840914969998838,1.0,15/69,17.91%,RAD54B;SEM1;SAMHD1;UBE2N;RAD52;RFWD3;RAD51B;PSMD14;NSMCE2;EXD2;SMC6;REV3L;PALB2;AP5S1;YY1
prerank,GO_Biological_Process_2021__positive regulation of T cell differentiation (GO:0045582),0.4383656235153052,1.027271415721167,0.36666666666666664,0.7843870978326771,1.0,6/25,9.57%,TNFSF4;SOX4;ZBTB1;SART1;DUSP10;GLI3
prerank,GO_Biological_Process_2021__positive regulation of ERK1 and ERK2 cascade (GO:0070374),0.3357056940841435,1.0272409016579638,0.36,0.7839944419215149,1.0,22/103,15.85%,NPNT;BMP2;ERBB4;CSF1R;EGFR;HTR2C;NOTCH2;PDGFRA;ARRB1;NTRK2;RAPGEF2;PDGFA;ROR1;ADRA1A;HMGB1;BRAF;FBXW7;CRKL;PDGFC;RAP1A;PTPN11;NRP1
prerank,GO_Biological_Process_2021__cellular response to chemokine (GO:1990869),-0.5319697030122987,-1.0271624747824162,0.5079365079365079,1.0,1.0,5/18,14.31%,DOCK8;CXCL2;DUSP1;CX3CL1;CCL2
prerank,GO_Biological_Process_2021__nucleobase-containing small molecule catabolic process (GO:0034656),-0.5648186165707205,-1.0270406038080908,0.4406779661016949,1.0,1.0,1/12,3.34%,ENTPD3
prerank,GO_Biological_Process_2021__regulation of cholesterol biosynthetic process (GO:0045540),-0.5062858118506259,-1.0268336356841152,0.46938775510204084,1.0,1.0,7/17,23.84%,FGF1;APOE;SREBF1;RAN;SEC14L2;SREBF2;ERLIN2
prerank,GO_Biological_Process_2021__tyrosine phosphorylation of STAT protein (GO:0007260),0.6504275009730837,1.026765857941128,0.4418604651162791,0.7847540981428671,1.0,2/5,28.65%,FER;JAK2
prerank,GO_Biological_Process_2021__ionotropic glutamate receptor signaling pathway (GO:0035235),0.5760211924643747,1.026625406312547,0.5106382978723404,0.78461155526115,1.0,4/8,20.47%,GRIN1;CPEB4;CDK5R1;GRIA2
prerank,GO_Biological_Process_2021__succinate transmembrane transport (GO:0071422),0.6365684988121845,1.0265941942789376,0.4166666666666667,0.7843086151741648,1.0,2/5,18.73%,SLC13A3;SLC25A14
prerank,GO_Biological_Process_2021__phagolysosome assembly (GO:0001845),-0.5658155777854066,-1.0261222618676877,0.4,1.0,1.0,2/11,13.86%,RAB7B;CLN3
prerank,GO_Biological_Process_2021__myoblast fusion (GO:0007520),-0.5433373851916008,-1.0260730882503326,0.4067796610169492,1.0,1.0,4/10,13.85%,CD9;CACNA1H;ERVW-1;NOS1
prerank,GO_Biological_Process_2021__choline catabolic process (GO:0042426),-0.6412552444261888,-1.0260378783657478,0.49122807017543857,1.0,1.0,1/6,3.28%,BHMT
prerank,GO_Biological_Process_2021__presynaptic endocytosis (GO:0140238),0.448635246287838,1.026006449501631,0.4375,0.7853967032808887,1.0,7/23,15.35%,SNCA;PIP5K1C;NLGN3;NLGN4X;OPHN1;SYNJ1;STX1A
prerank,GO_Biological_Process_2021__cell cycle G1/S phase transition (GO:0044843),0.3789560614870321,1.0259625679967996,0.3939393939393939,0.7850491161767663,1.0,11/55,15.41%,CDC25A;MAP3K11;CAMK2A;RPS6KB1;CCNA2;EIF4E;ACVR1;CUL2;CUL1;CDC34;LATS1
prerank,GO_Biological_Process_2021__multivesicular body assembly (GO:0036258),0.4246575743666201,1.025920128734981,0.5142857142857142,0.7847375276021502,1.0,8/27,21.73%,VPS37B;CHMP1A;VPS37A;CHMP2B;VTA1;CHMP6;STAM2;TSG101
prerank,GO_Biological_Process_2021__nucleoside triphosphate biosynthetic process (GO:0009142),0.5589938762728646,1.0257962932023164,0.4444444444444444,0.7845864813220791,1.0,2/8,2.37%,AK3;AK1
prerank,GO_Biological_Process_2021__ruffle assembly (GO:0097178),0.6579050567256173,1.025574145807909,0.5094339622641509,0.7847825175903391,1.0,2/5,33.63%,ARF6;AIF1L
prerank,GO_Biological_Process_2021__neutrophil degranulation (GO:0043312),-0.3674347425461721,-1.02550942175639,0.3763440860215054,1.0,1.0,39/335,13.41%,FTH1;FLG2;FTL;AGPAT2;BST2;HLA-B;MMP25;CD63;CLEC12A;HLA-C;B2M;DSC1;LRRC7;CEACAM1;PRSS3;ARHGAP9;TMC6;PRDX4;GMFG;PNP;GLIPR1;HRNR;GSTP1;PSMC3;ALDH3B1;SVIP;VAMP8;AGA;CTSH;CSTB;NIT2;SLC11A1;CST3;CD14;PGLYRP1;RHOF;CLEC5A;LAMTOR2;ATP6V1D
prerank,GO_Biological_Process_2021__positive regulation of myotube differentiation (GO:0010831),0.594988789052131,1.025470100617076,0.4782608695652174,0.784596049015745,1.0,3/6,19.68%,RBM24;MAML1;ATP11A
prerank,GO_Biological_Process_2021__negative regulation of membrane protein ectodomain proteolysis (GO:0051045),-0.6494873345352421,-1.0252255706527096,0.509090909090909,1.0,1.0,3/5,21.32%,TIMP1;PTPN3;TIMP2
prerank,GO_Biological_Process_2021__postsynaptic density organization (GO:0097106),0.5312373130716104,1.0251227701562162,0.4358974358974359,0.7850317803954158,1.0,7/8,28.67%,NRXN1;SHANK3;PTEN;NRXN2;NLGN1;NLGN2;TMEM108
prerank,GO_Biological_Process_2021__neutrophil activation involved in immune response (GO:0002283),-0.3668270752871067,-1.0250600878289378,0.3763440860215054,1.0,1.0,39/337,13.41%,FTH1;FLG2;FTL;AGPAT2;BST2;HLA-B;MMP25;CD63;CLEC12A;HLA-C;B2M;DSC1;LRRC7;CEACAM1;PRSS3;ARHGAP9;TMC6;PRDX4;GMFG;PNP;GLIPR1;HRNR;GSTP1;PSMC3;ALDH3B1;SVIP;VAMP8;AGA;CTSH;CSTB;NIT2;SLC11A1;CST3;CD14;PGLYRP1;RHOF;CLEC5A;LAMTOR2;ATP6V1D
prerank,GO_Biological_Process_2021__negative regulation of cold-induced thermogenesis (GO:0120163),0.42564626791892624,1.0249825830104087,0.46875,0.7848631406680481,1.0,14/35,21.30%,RHEB;LGR4;TFE3;NR1D1;DOCK7;ZNF423;ABHD6;STK11;RBPJ;LNPEP;NOVA1;PGAM5;PLCL1;NOVA2
prerank,PanglaoDB_Augmented_2021__Foveolar Cells,0.45164374611640135,1.0249717119418835,0.42105263157894735,0.7844994111928432,1.0,2/19,4.17%,ACE2;ANXA4
prerank,GO_Biological_Process_2021__positive regulation of regulatory T cell differentiation (GO:0045591),0.5430168039693468,1.024879641685335,0.45454545454545453,0.7843667279585079,1.0,3/8,27.21%,DUSP10;HLA-DRA;SOX12
prerank,GO_Biological_Process_2021__inorganic cation transmembrane transport (GO:0098662),0.31447322015248524,1.0247752539024746,0.3157894736842105,0.7841721236665055,1.0,14/186,6.86%,ASIC4;SLC24A3;CACNA1G;KCNQ3;SLC6A13;ABCC8;SLC39A11;ATP6V1A;SLC30A4;KCNA4;ATP2C1;SLC12A2;TRPM4;KCNH2
prerank,GO_Biological_Process_2021__rRNA 3'-end processing (GO:0031125),-0.5930935074930614,-1.024710804193983,0.4262295081967213,1.0,1.0,2/9,9.71%,RPS21;ERI2
prerank,GO_Biological_Process_2021__negative regulation of cytosolic calcium ion concentration (GO:0051481),0.6229333878346095,1.024693558782138,0.46153846153846156,0.7839068373374471,1.0,4/5,34.01%,DRD2;SMAD3;ATP2B1;ATP1A2
prerank,GO_Biological_Process_2021__neutrophil mediated immunity (GO:0002446),-0.36714405385318866,-1.0246651898289212,0.3723404255319149,1.0,1.0,39/338,13.41%,FTH1;FLG2;FTL;AGPAT2;BST2;HLA-B;MMP25;CD63;CLEC12A;HLA-C;B2M;DSC1;LRRC7;CEACAM1;PRSS3;ARHGAP9;TMC6;PRDX4;GMFG;PNP;GLIPR1;HRNR;GSTP1;PSMC3;ALDH3B1;SVIP;VAMP8;AGA;CTSH;CSTB;NIT2;SLC11A1;CST3;CD14;PGLYRP1;RHOF;CLEC5A;LAMTOR2;ATP6V1D
prerank,GO_Biological_Process_2021__androgen receptor signaling pathway (GO:0030521),0.5640466700485796,1.0238047541426079,0.5853658536585366,0.7855460527757047,1.0,7/11,30.45%,PLPP1;RNF14;PMEPA1;ARID1A;DAXX;DDX17;KDM3A
prerank,PanglaoDB_Augmented_2021__Pancreatic Stellate Cells,-0.41636108940703753,-1.0233671143478333,0.4657534246575342,1.0,1.0,33/83,21.39%,SFRP2;LMOD1;SPARC;SPON2;COL5A1;ANGPTL2;TIMP1;C1R;COL6A2;IGFBP5;MGP;SOD3;PAMR1;ADGRL4;TNC;C1S;SRPX2;EDNRA;COL4A2;CALD1;CRYAB;C1QTNF1;COL14A1;MMP14;TAGLN;LAMA4;BGN;EHD2;KRT10;COL4A1;OLFML2B;NID2;THBS2
prerank,GO_Biological_Process_2021__translocation of molecules into host (GO:0044417),0.6186576777012895,1.0232156837550603,0.54,0.786306550644252,1.0,4/6,33.43%,THOC7;THOC2;THOC3;THOC1
prerank,GO_Biological_Process_2021__viral mRNA export from host cell nucleus (GO:0046784),0.6186576777012895,1.0232156837550603,0.54,0.786306550644252,1.0,4/6,33.43%,THOC7;THOC2;THOC3;THOC1
prerank,GO_Biological_Process_2021__regulation of acrosome reaction (GO:0060046),-0.6295779297191842,-1.0229436205087725,0.42105263157894735,1.0,1.0,4/7,20.26%,CACNA1H;SPINK13;ZP3;GLRA1
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),-0.5721072340256035,-1.0226137896099292,0.55,1.0,1.0,1/14,0.66%,SFRP2
prerank,GO_Biological_Process_2021__negative regulation by host of viral process (GO:0044793),0.6378538508217475,1.0224849963422526,0.4807692307692308,0.7874554760439044,1.0,3/5,10.08%,VAPA;EIF2AK4;PRKN
prerank,GO_Biological_Process_2021__telomere maintenance (GO:0000723),0.38644037029045475,1.0223274126312552,0.3333333333333333,0.7874454249832699,1.0,8/44,16.86%,DNA2;LTO1;POLD3;STN1;NSMCE2;SMC6;PTGES3;POT1
prerank,GO_Biological_Process_2021__regulation of substrate adhesion-dependent cell spreading (GO:1900024),0.40464410679717444,1.022109257279608,0.43333333333333335,0.7876208756805818,1.0,13/43,15.85%,CASS4;EFNA5;CSPG5;RCC2;KANK1;TESK1;SPRY4;CARMIL1;CRKL;PTK2;RREB1;ARHGEF7;NRP1
prerank,GO_Biological_Process_2021__alpha-amino acid biosynthetic process (GO:1901607),-0.5849401822604038,-1.0221046559358262,0.43636363636363634,1.0,1.0,3/7,25.15%,SDS;PAH;SDSL
prerank,GO_Biological_Process_2021__tRNA aminoacylation (GO:0043039),-0.47486373759915085,-1.0217327844924091,0.4393939393939394,1.0,1.0,3/35,11.56%,WARS1;GARS1;NARS1
prerank,GO_Biological_Process_2021__regulation of epidermal cell differentiation (GO:0045604),-0.519209223975499,-1.0217196031661933,0.48214285714285715,1.0,1.0,3/18,5.85%,ABCA12;SFRP4;CTSL
prerank,GO_Biological_Process_2021__double-strand break repair via synthesis-dependent strand annealing (GO:0045003),-0.6332707081990598,-1.0214217661583485,0.48936170212765956,1.0,1.0,4/5,35.62%,XRCC3;RAD51;FANCM;RAD54L
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),-0.5291240696992197,-1.0213392340310354,0.4264705882352941,1.0,1.0,7/18,25.52%,ITGA5;MT3;MMRN2;TMEM204;CADM4;PRKD2;NIBAN2
prerank,GO_Biological_Process_2021__positive regulation of interleukin-12 production (GO:0032735),0.5054420579172629,1.0213194917383444,0.5142857142857142,0.7890409038128818,1.0,4/16,9.68%,TNFSF4;PLCB1;MAPK11;HMGB1
prerank,GO_Biological_Process_2021__cellular protein localization (GO:0034613),0.3248747181788522,1.0211073967288733,0.3333333333333333,0.7891270709657169,1.0,56/263,18.09%,PTPRK;TBC1D4;ARFIP1;ANK2;ARL5A;TBC1D1;EGFR;USP6NL;TBC1D5;TBC1D12;EVI5L;SEPTIN6;TRAPPC8;SEPTIN8;RAB31;RAB18;AMOT;RAB23;SNX27;TBC1D22B;AP3B1;ITSN1;SEPTIN11;CNTLN;ARFRP1;FAM91A1;SCFD2;ABHD17A;SMURF1;GGA2;RAB21;OCLN;NIPBL;BICD2;SEPTIN7;NAPB;TBC1D8B;TM9SF3;KIF13A;RAB22A;SH3PXD2B;TMED3;TM9SF4;NSF;STX1A;SNX13;STX8;TBC1D10A;RAB1A;TMED5;RABGAP1L;RAB28;RAP2A;BBS2;SEC23IP;TBCK
prerank,GO_Biological_Process_2021__positive regulation of viral process (GO:0048524),0.376142770721521,1.0210661175249132,0.4117647058823529,0.7888163075337175,1.0,2/57,2.63%,VAPB;PDE12
prerank,GO_Biological_Process_2021__regulation of cellular component biogenesis (GO:0044087),0.398279016491314,1.0207448628258655,0.37037037037037035,0.7890258969374705,1.0,11/34,20.67%,FAM110C;RAPGEF2;BBS10;RAP1A;TJP1;ROCK2;LATS1;PTPN11;ROCK1;SPTY2D1;NCLN
prerank,GO_Biological_Process_2021__regulation of DNA replication (GO:0006275),0.4081527708280312,1.0205455187035388,0.4117647058823529,0.7890678873804502,1.0,15/42,21.20%,DNA2;EGFR;STN1;CCNA2;ANKRD17;DHX9;KAT7;PDS5A;ZBTB38;FAF1;ORC5;NPM2;WAPL;PPP2R1A;RBBP6
prerank,GO_Biological_Process_2021__regulation of chloride transport (GO:2001225),-0.6605959998333316,-1.0205065177896517,0.5079365079365079,1.0,1.0,2/5,20.15%,GABRE;ATP8B1
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 9 signaling pathway (GO:0034163),-0.591080580518545,-1.0196415948117517,0.4915254237288136,1.0,1.0,2/8,8.15%,RAB7B;RSAD2
prerank,GO_Biological_Process_2021__regulation of vasculogenesis (GO:2001212),-0.5518261913203382,-1.0195009867794236,0.4727272727272727,1.0,1.0,5/11,17.03%,CEACAM1;RRAS;HEY2;ASB4;EMP2
prerank,GO_Biological_Process_2021__nucleocytoplasmic transport (GO:0006913),0.3892246767136494,1.0194431095882035,0.4642857142857143,0.7913901660796877,1.0,4/36,11.83%,SNRPF;XPO1;RBM15B;NXT2
prerank,GO_Biological_Process_2021__protein targeting to peroxisome (GO:0006625),0.4468925767231699,1.0193928112510324,0.39473684210526316,0.7911316517845122,1.0,11/27,18.03%,GDAP1;RAB8B;PEX14;PEX16;PEX5;PEX2;ABCD3;ZFAND6;PEX7;PEX6;PEX13
prerank,GO_Biological_Process_2021__cilium-dependent cell motility (GO:0060285),-0.4844678838355017,-1.019290928423263,0.453125,1.0,1.0,2/20,4.38%,CCDC39;TEKT1
prerank,GO_Biological_Process_2021__regulation of cyclic-nucleotide phosphodiesterase activity (GO:0051342),-0.6443648555049732,-1.0191732226526022,0.5370370370370371,1.0,1.0,4/5,34.24%,SLC39A14;MAPK7;RACK1;CALM1
prerank,GO_Biological_Process_2021__negative regulation of amino acid transport (GO:0051956),0.6417316270762471,1.0191505110166104,0.5128205128205128,0.7913923151048652,1.0,1/5,3.12%,SLC43A1
prerank,GO_Biological_Process_2021__negative regulation of protein localization to plasma membrane (GO:1903077),0.5003180506874845,1.0191265380155483,0.4117647058823529,0.790993434545094,1.0,6/17,9.43%,PID1;PICALM;RHOQ;PPP2R5A;PKDCC;MRAP
prerank,GO_Biological_Process_2021__DNA replication-dependent nucleosome assembly (GO:0006335),0.6117045067052337,1.0191179289338705,0.5,0.7901442735847665,1.0,4/5,32.24%,RBBP4;ASF1A;HAT1;NASP
prerank,GO_Biological_Process_2021__DNA replication-dependent nucleosome organization (GO:0034723),0.6117045067052337,1.0191179289338705,0.5,0.7901442735847665,1.0,4/5,32.24%,RBBP4;ASF1A;HAT1;NASP
prerank,GO_Biological_Process_2021__positive regulation of cellular protein localization (GO:1903829),0.37529597041960067,1.019049724067285,0.35714285714285715,0.7899397773425484,1.0,12/56,20.03%,GNL3L;TRAPPC12;TESK1;AKT1;PRKN;KAT7;GSK3B;TM9SF4;YAP1;TFRC;FYN;PLK1
prerank,GO_Biological_Process_2021__response to copper ion (GO:0046688),-0.5312305152614555,-1.018846476241851,0.47058823529411764,1.0,1.0,9/16,18.34%,MT1H;AQP1;MT1G;MT2A;MT3;MT1E;MT1F;MT1A;MT1M
prerank,GO_Biological_Process_2021__negative regulation of glucose transmembrane transport (GO:0010829),0.6085627246869978,1.0186781758169332,0.5,0.7903582648548931,1.0,1/8,0.70%,PID1
prerank,GO_Biological_Process_2021__phosphatidylinositol-mediated signaling (GO:0048015),0.38147140177534666,1.0185933272863648,0.36363636363636365,0.7902327727827322,1.0,18/59,20.94%,CSF1R;PDGFRA;AKT1;PIK3CA;PIK3R1;IRS1;PLCB1;RPS6KB1;PIK3C3;NF1;OGT;SIRT2;PI4KB;IGF1;PTEN;PLEKHA1;PLCB3;PLCL1
prerank,GO_Biological_Process_2021__bile acid and bile salt transport (GO:0015721),-0.5108431854498663,-1.0185687105407346,0.4406779661016949,1.0,1.0,5/19,11.43%,AKR1C1;CEACAM1;SLC51B;SLC51A;SLC10A1
prerank,GO_Biological_Process_2021__positive regulation of interleukin-17 production (GO:0032740),-0.6044439271254607,-1.0185197037686542,0.4727272727272727,1.0,1.0,5/9,25.04%,PRKCQ;IL18;RFTN1;TGFB1;SPHK1
prerank,GO_Biological_Process_2021__response to fructose (GO:0009750),-0.6700736972193471,-1.0184750973789232,0.543859649122807,1.0,1.0,4/5,32.95%,XBP1;KHK;SLC2A5;GCKR
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol dephosphorylation (GO:0060304),0.6768172401779785,1.0179996788373669,0.5769230769230769,0.7912114188496809,1.0,3/5,32.01%,MTMR2;MTMR9;MTMR3
prerank,GO_Biological_Process_2021__megakaryocyte development (GO:0035855),-0.6886259253549756,-1.0177645151902357,0.49056603773584906,1.0,1.0,2/5,18.79%,ZNF385A;THPO
prerank,GO_Biological_Process_2021__fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),-0.5665628139474522,-1.0176985196493147,0.5,1.0,1.0,1/9,3.17%,ETFB
prerank,GO_Biological_Process_2021__protein ADP-ribosylation (GO:0006471),-0.48502044369903163,-1.0174649112089886,0.45,1.0,1.0,4/26,12.43%,PARP14;ART4;ART3;PARP2
prerank,GO_Biological_Process_2021__negative regulation of cholesterol biosynthetic process (GO:0045541),-0.6210719206865274,-1.0174564318539119,0.5106382978723404,1.0,1.0,2/5,23.84%,APOE;ERLIN2
prerank,GO_Biological_Process_2021__negative regulation of sterol biosynthetic process (GO:0106119),-0.6210719206865274,-1.0174564318539119,0.5106382978723404,1.0,1.0,2/5,23.84%,APOE;ERLIN2
prerank,GO_Biological_Process_2021__negative regulation of cholesterol metabolic process (GO:0090206),-0.6210719206865274,-1.0174564318539119,0.5106382978723404,1.0,1.0,2/5,23.84%,APOE;ERLIN2
prerank,GO_Biological_Process_2021__regulation of aerobic respiration (GO:1903715),-0.5532675746006418,-1.0170525129139505,0.4915254237288136,1.0,1.0,3/13,13.93%,COX7A1;SLC25A33;COX7A2
prerank,GO_Biological_Process_2021__synaptic vesicle transport (GO:0048489),0.5171904116928123,1.0166818358615768,0.45652173913043476,0.7939754948187074,1.0,6/11,18.91%,RAB27A;KIF5A;KIF5C;SYNJ1;TMEM230;DNM2
prerank,GO_Biological_Process_2021__isoprenoid biosynthetic process (GO:0008299),-0.6382005765787406,-1.0164101435051283,0.5344827586206896,1.0,1.0,4/7,24.39%,MVK;DHDDS;HMGCR;IDI1
prerank,GO_Biological_Process_2021__nucleoside diphosphate catabolic process (GO:0009134),-0.5925965883145752,-1.016222380002311,0.48214285714285715,1.0,1.0,1/8,3.34%,ENTPD3
prerank,GO_Biological_Process_2021__regulation of telomere maintenance via telomerase (GO:0032210),0.3698718380521643,1.01599550165751,0.2222222222222222,0.7951611525136908,1.0,12/47,16.86%,NAF1;GNL3L;HNRNPU;CCT4;HNRNPC;STN1;TENT4B;MAP3K4;MAPKAPK5;MAPK1;CCT3;POT1
prerank,GO_Biological_Process_2021__organic substance transport (GO:0071702),0.3454650353270006,1.015570007443884,0.2727272727272727,0.7959081482452678,1.0,19/98,14.83%,TXNIP;RCN3;SLC19A1;ABCA1;LRP1B;CMTM6;CHMP1A;SPNS2;CEP290;ABCA9;PLEKHA8;SLC22A5;DISP1;CHMP2B;ATP8A1;NDC1;ABCA2;ABCD3;SLC47A1
prerank,GO_Biological_Process_2021__regulation of small GTPase mediated signal transduction (GO:0051056),0.34096880193542706,1.0155536186437473,0.4090909090909091,0.7955089860032184,1.0,21/118,12.05%,STARD13;TIAM2;ARHGEF6;ARAP2;ARHGEF16;ARHGEF12;RHOT1;ARAP1;RHOQ;ARHGAP35;ARHGEF26;ARHGAP24;CGNL1;ARHGAP5;ARHGAP26;FGD4;ITSN1;ARHGAP32;GNA13;SOS1;SLIT2
prerank,GO_Biological_Process_2021__regulation of dephosphorylation (GO:0035303),0.5165079783621371,1.0155482042420199,0.42105263157894735,0.7950927731533896,1.0,6/13,32.33%,SMG7;MTMR2;MTMR9;PPP1R16B;MTMR3;SRC
prerank,GO_Biological_Process_2021__protein deneddylation (GO:0000338),0.5474065317901223,1.015259282147797,0.46511627906976744,0.7954717865491279,1.0,3/10,12.98%,COPS7B;COPS2;GPS1
prerank,GO_Biological_Process_2021__cyclic purine nucleotide metabolic process (GO:0052652),0.5018749889006994,1.0151464972875768,0.39473684210526316,0.7953353723231567,1.0,2/14,5.24%,ADCY1;GUCY1B1
prerank,GO_Biological_Process_2021__diacylglycerol biosynthetic process (GO:0006651),0.6315691359383464,1.0151209753340662,0.5,0.7949460916576478,1.0,1/5,10.81%,GPAM
prerank,PanglaoDB_Augmented_2021__Endothelial Cells,-0.3839090743631482,-1.0149614084827046,0.38961038961038963,1.0,1.0,32/147,13.81%,LMOD1;F8;ADIRF;SPARC;CD9;COX7A1;APLNR;AQP1;ANGPTL2;STAB2;C1R;PDPN;S100A10;HEXIM1;MEOX1;PROCR;FMO2;MGP;VWF;ABCG2;FHL2;A2M;USHBP1;PODXL;ELK3;MMRN2;CALCRL;MADCAM1;RAMP3;SCARF1;SOD3;ADGRL4
prerank,GO_Biological_Process_2021__response to amyloid-beta (GO:1904645),0.4596907538305058,1.014649120622748,0.46875,0.7956210537205031,1.0,5/27,7.11%,EPHA4;GRIN1;CACNA1B;CACNA2D1;ADRB2
prerank,GO_Biological_Process_2021__positive regulation of blood-brain barrier permeability (GO:1905605),0.6507569116851618,1.0146120294847787,0.5531914893617021,0.7953191881808173,1.0,3/5,22.08%,OCLN;TJP1;TJP2
prerank,GO_Biological_Process_2021__lamellipodium organization (GO:0097581),0.4303536745081117,1.0143278441009302,0.4186046511627907,0.7955228596678878,1.0,9/28,19.03%,ARHGEF6;CARMIL1;GOLPH3;CYFIP1;ARHGEF7;PTPRO;WASF1;CDH13;S1PR1
prerank,GO_Biological_Process_2021__negative regulation of cell differentiation (GO:0045596),0.3477125890066567,1.0143108424028835,0.3888888888888889,0.7951430138967064,1.0,40/135,18.48%,LIMD1;ZFPM2;ANKRD2;FOXO1;SOX8;ABCA1;RANBP3L;EGFR;ASCL1;SOX9;RORA;SPRED2;HNRNPU;TRPM4;SMAD7;SPRED1;ANKRD26;EIF2AK4;MEN1;GDF10;RUNX1T1;MEIS2;ANP32B;ZBTB16;SIRT1;TGFBR1;SIRT2;ADIPOR1;DTX1;PTPN11;YAP1;CNTN4;BMP7;SEMA4D;TRIB2;SUFU;PTBP1;YTHDF2;PTEN;RORB
prerank,GO_Biological_Process_2021__mesoderm formation (GO:0001707),0.5017209496814625,1.0142406617393835,0.47619047619047616,0.7948766897192214,1.0,2/14,5.76%,SMAD2;TBX19
prerank,GO_Biological_Process_2021__protein stabilization (GO:0050821),0.32351149695189557,1.014188048100742,0.26666666666666666,0.7946280421555599,1.0,41/152,20.67%,PPARGC1A;USP13;ANK2;SOX4;ZNF207;EPHA4;VHL;PARVA;CCT4;SMAD7;PIK3R1;NLK;MORC3;MARCHF7;MFSD1;PRKN;EP300;FBXW7;DVL1;PLPP3;RAB21;GOLGA7;PRKRA;MDM4;HIP1;GNAQ;USP9X;CCT3;PTGES3;USP2;TRIM44;PEX6;CRTAP;WDR81;IGF1;PTEN;STX12;SUGT1;BAG2;BAG3;NCLN
prerank,GO_Biological_Process_2021__negative regulation of chromosome organization (GO:2001251),0.5585439170169733,1.0139996804416216,0.46153846153846156,0.7947186507071736,1.0,5/7,35.82%,ESPL1;WAPL;TERF2IP;TERF2;ERCC4
prerank,GO_Biological_Process_2021__phospholipid translocation (GO:0045332),0.44675790479977995,1.0139698325763322,0.36,0.7943747888534324,1.0,5/27,14.44%,ABCA1;ATP11C;ATP9A;ATP8A1;PLSCR2
prerank,GO_Biological_Process_2021__regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),0.49918126551539127,1.0138262391650275,0.4090909090909091,0.794300461070041,1.0,6/17,17.42%,ARFIP1;CTNNA2;NCKAP1;CYFIP1;WASF3;WASF1
prerank,GO_Biological_Process_2021__regulation of MAP kinase activity (GO:0043405),-0.43050351316225305,-1.0138055376162767,0.43037974683544306,1.0,1.0,10/70,11.67%,CD24;PAQR3;HTR2B;RASGRP1;PIK3CB;GSTP1;CAV3;DUSP1;FGF1;APOE
prerank,GO_Biological_Process_2021__semaphorin-plexin signaling pathway (GO:0071526),0.4335424088040444,1.0137650331679144,0.37142857142857144,0.7939571859077291,1.0,10/32,19.22%,SEMA5B;PLXNA2;NRP2;SEMA3C;SEMA6C;NRP1;SEMA4D;SEMA3D;PLXNA4;ARHGDIA
prerank,GO_Biological_Process_2021__drug catabolic process (GO:0042737),-0.5611887334911034,-1.0137558787520942,0.4915254237288136,1.0,1.0,4/10,18.65%,CYP2D6;NOS1;CYP3A4;CYP3A5
prerank,GO_Biological_Process_2021__positive regulation of ion transmembrane transporter activity (GO:0032414),-0.49717432091525426,-1.013746390872319,0.42857142857142855,1.0,1.0,3/23,8.75%,CFTR;PDZK1;GLRX
prerank,MSigDB_Hallmark_2020__TGF-beta Signaling,0.3925783558266734,1.0136602706051883,0.4375,0.793753053400933,1.0,23/51,26.92%,SERPINE1;BMP2;RAB31;SMAD7;PPM1A;MAP3K7;SMURF1;ACVR1;HIPK2;TGFBR1;TJP1;BMPR1A;UBE2D3;CDK9;PMEPA1;SKIL;CTNNB1;TRIM33;SMAD3;ARID4B;SMAD1;FURIN;SPTBN1
prerank,GO_Biological_Process_2021__protein localization to cytoplasmic stress granule (GO:1903608),0.6177980191982066,1.013612444310144,0.5576923076923077,0.7935231300471006,1.0,2/6,24.81%,DHX9;DCP1A
prerank,GO_Biological_Process_2021__TORC1 signaling (GO:0038202),0.5655818736473428,1.013466521262396,0.46153846153846156,0.7934667397807574,1.0,4/8,30.75%,SMG1;RPTOR;LARP1;MTOR
prerank,GO_Biological_Process_2021__regulation of histone H4 acetylation (GO:0090239),0.5609302417127826,1.0133790067528583,0.5,0.7932631910980201,1.0,3/8,13.97%,IWS1;ARRB1;KAT7
prerank,GO_Biological_Process_2021__regulation of tau-protein kinase activity (GO:1902947),-0.5765555731571648,-1.0132557866656278,0.46296296296296297,1.0,1.0,1/8,11.22%,CLU
prerank,GO_Biological_Process_2021__mitotic nuclear membrane organization (GO:0101024),0.3803037105560206,1.0131302457453932,0.36,0.7930297541844591,1.0,15/47,24.73%,NUP37;NUP188;RANGAP1;CHMP2B;NDC1;SIRT2;REEP4;LBR;PPP2R2A;NUP205;CHMP6;PPP2R1A;NUP98;AHCTF1;IST1
prerank,GO_Biological_Process_2021__mitotic nuclear membrane reassembly (GO:0007084),0.3803037105560206,1.0131302457453932,0.36,0.7930297541844591,1.0,15/47,24.73%,NUP37;NUP188;RANGAP1;CHMP2B;NDC1;SIRT2;REEP4;LBR;PPP2R2A;NUP205;CHMP6;PPP2R1A;NUP98;AHCTF1;IST1
prerank,GO_Biological_Process_2021__negative regulation of protein secretion (GO:0050709),-0.47920853216560355,-1.0129865058525902,0.46153846153846156,1.0,1.0,6/29,14.15%,KCNB1;IL12A;RSAD2;APOE;SFRP1;ERP29
prerank,GO_Biological_Process_2021__regulation of exosomal secretion (GO:1903541),0.47985419289304265,1.012672058968481,0.3684210526315789,0.7937346058186473,1.0,3/17,10.08%,SDC4;ATP9A;PRKN
prerank,GO_Biological_Process_2021__regulation of cell migration involved in sprouting angiogenesis (GO:0090049),0.45909870115760365,1.012392907077284,0.59375,0.7940757659523282,1.0,3/24,1.86%,MEOX2;STARD13;HDAC9
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced cell death (GO:1903202),0.43218414653967413,1.0123588482232928,0.43243243243243246,0.7937342406166156,1.0,6/24,20.13%,AKT1;PRKN;SIRT1;FYN;REST;NFE2L2
prerank,GO_Biological_Process_2021__response to lead ion (GO:0010288),0.6271225708706429,1.0123037269136588,0.4782608695652174,0.793496665372805,1.0,2/5,30.07%,PPP2CB;PPP5C
prerank,GO_Biological_Process_2021__positive regulation of cytokinesis (GO:0032467),-0.5049706082903577,-1.0120264909456025,0.4375,1.0,1.0,4/21,13.87%,KIF20B;SVIL;CENPV;GIPC1
prerank,PanglaoDB_Augmented_2021__Kupffer Cells,0.38560485674140815,1.0114364346420146,0.46153846153846156,0.7950021800221672,1.0,5/42,4.01%,C1ORF162;NR2F6;SLC15A3;CSF1R;PLEK
prerank,GO_Biological_Process_2021__response to hydroperoxide (GO:0033194),0.5635797637790698,1.0114300649124002,0.4222222222222222,0.794600342848854,1.0,2/6,26.61%,PRKD1;DAPK1
prerank,GO_Biological_Process_2021__negative regulation of neurotransmitter secretion (GO:0046929),0.5458797463065491,1.0107476769741561,0.425531914893617,0.7958020306825675,1.0,5/7,23.66%,PRKN;RAP1A;SLC30A1;FMR1;RAP1B
prerank,GO_Biological_Process_2021__regulation of meiotic nuclear division (GO:0040020),-0.6467393633535842,-1.0107261125455889,0.46,1.0,1.0,1/6,2.74%,FBXO43
prerank,PanglaoDB_Augmented_2021__Trophoblast Progenitor Cells,-0.4278088502024021,-1.0104317926250215,0.45,1.0,1.0,22/65,23.90%,IRF1;MMP25;HLA-C;IFI35;TMC6;SIGIRR;HELZ2;VAMP8;DEF6;ARRDC2;HLA-F;ADAM8;SBNO2;ZFP36;RHBDF2;PARP12;IL4R;NFKB2;JUNB;HLA-E;ANO9;PRKD2
prerank,GO_Biological_Process_2021__myelin assembly (GO:0032288),-0.5725156825012404,-1.0102336365148963,0.41379310344827586,1.0,1.0,1/10,3.03%,CD9
prerank,GO_Biological_Process_2021__glutathione derivative biosynthetic process (GO:1901687),-0.5151189339935233,-1.0101777929367677,0.5,1.0,1.0,8/17,22.05%,GSTT2B;GSTP1;GSTM5;GSTM3;AKR1A1;GSTZ1;GSTK1;GSTO1
prerank,GO_Biological_Process_2021__glutathione derivative metabolic process (GO:1901685),-0.5151189339935233,-1.0101777929367677,0.5,1.0,1.0,8/17,22.05%,GSTT2B;GSTP1;GSTM5;GSTM3;AKR1A1;GSTZ1;GSTK1;GSTO1
prerank,GO_Biological_Process_2021__histone mRNA metabolic process (GO:0008334),0.43126280380182486,1.0100347455742686,0.47058823529411764,0.797200581517953,1.0,4/26,16.52%,SNRPF;ERI1;TENT4B;MTPAP
prerank,GO_Biological_Process_2021__regulation of androgen receptor signaling pathway (GO:0060765),0.47948317333309753,1.0099854278689262,0.4444444444444444,0.7969359778225357,1.0,9/27,19.63%,FOXP1;RNF6;NCOA2;RNF14;SAFB2;EP300;SIRT1;KDM1A;KDM4C
prerank,GO_Biological_Process_2021__T cell homeostasis (GO:0043029),0.6264628760163552,1.0098958740436166,0.5625,0.7966372316141758,1.0,2/7,18.23%,AKT1;FAS
prerank,GO_Biological_Process_2021__bone morphogenesis (GO:0060349),-0.5910638303060811,-1.0094675070824968,0.5192307692307693,1.0,1.0,1/8,3.94%,SFRP4
prerank,GO_Biological_Process_2021__regulation of chemokine (C-C motif) ligand 5 production (GO:0071649),-0.6328234636959988,-1.009172959589923,0.509090909090909,1.0,1.0,1/5,12.07%,OAS3
prerank,GO_Biological_Process_2021__RNA phosphodiester bond hydrolysis (GO:0090501),0.4494181053780856,1.008987913743487,0.5135135135135135,0.7985233773079251,1.0,3/22,7.58%,CSTF3;PDE12;TOE1
prerank,GO_Biological_Process_2021__regulation of protein K63-linked ubiquitination (GO:1900044),0.6086411614017133,1.0084651253291914,0.4878048780487805,0.7993158258161331,1.0,2/7,15.89%,SASH1;BIRC2
prerank,GO_Biological_Process_2021__synaptic vesicle localization (GO:0097479),0.49858382769576487,1.0080353714011117,0.4,0.7999098336138059,1.0,7/13,22.01%,RAB27A;KIF5A;KIF5C;SYNJ1;TMEM230;DNM2;NLGN1
prerank,GO_Biological_Process_2021__synaptic vesicle budding (GO:0070142),0.5928964646231396,1.0079453902272508,0.45652173913043476,0.7997046123248169,1.0,3/7,3.12%,DNM3;SNAP91;PICALM
prerank,GO_Biological_Process_2021__positive regulation of protein secretion (GO:0050714),0.37006223112843134,1.0079115026710193,0.37142857142857144,0.7993193707257454,1.0,17/52,26.88%,SOX4;MCU;DOC2B;GOLPH3;SYTL4;IGF1;APBB1;ARF6;PTPN23;ADAM9;MYOM1;FRMD4A;IRS2;LRRC8A;NLGN2;GCK;TCF7L2
prerank,MSigDB_Hallmark_2020__Hypoxia,-0.37915423920977503,-1.0074584036905005,0.4125,1.0,1.0,27/162,15.33%,LDHC;CP;GAPDHS;LXN;KDELR3;IER3;EFNA1;PRDX5;COL5A1;ADM;ALDOB;GPC3;CCN1;GLRX;TMEM45A;MT2A;INHA;DUSP1;DDIT3;PHKG1;LDHA;MT1E;HK2;GYS1;BTG1;GPI;SLC25A1
prerank,GO_Biological_Process_2021__amino acid transport (GO:0006865),-0.44029704481188164,-1.0074579046140393,0.5205479452054794,1.0,1.0,5/37,11.61%,SLC3A1;SLC38A4;PDPN;SLC25A45;SLC38A1
prerank,GO_Biological_Process_2021__mRNA processing (GO:0006397),0.30822508188738285,1.007175484825936,0.375,0.8007445227031175,1.0,48/274,19.83%,NUDT21;PPARGC1A;USP49;SNRPF;WDR33;PAPOLA;HNRNPH1;CSTF3;RAVER2;PSPC1;SART1;SNRPN;HNRNPU;DHX15;RNGTT;HNRNPC;CPSF6;SPEN;LSM8;RBM15B;CTNNBL1;SYNCRIP;HNRNPH3;ZMAT5;U2AF1;U2AF2;DHX9;SMNDC1;PRPF40B;PRCC;THOC7;RBM17;CMTR2;RBM41;CCAR1;SF3B3;PRPF40A;RBM6;PTBP1;CELF1;RPRD1B;CWC27;TRA2A;SMU1;HNRNPD;NOVA1;RALY;GTF2F2
prerank,GO_Biological_Process_2021__regulation of hepatocyte proliferation (GO:2000345),-0.6157428204983773,-1.0071128235665896,0.5263157894736842,1.0,1.0,2/6,13.88%,CEACAM1;XBP1
prerank,GO_Biological_Process_2021__regulation of cell population proliferation (GO:0042127),0.28403182883809724,1.0070113710736557,0.3333333333333333,0.8006849387327235,1.0,119/523,18.47%,VEGFD;ACE2;ITGA1;EGLN3;NCK2;PTPRK;TNFSF4;KLF11;KAT2B;SOX4;MEIS3;BMP2;ERBB4;CSF1R;TFAP2C;PRMT1;EGFR;VHL;FLT1;CCKBR;RGCC;RAB33B;ACER3;SOX9;PLPP1;PDGFRA;FGF17;BOK;HCLS1;AKT1;NTRK2;FRZB;CHD5;PDS5B;TRPM4;CNOT6L;CSNK2A1;RAPGEF2;BST1;DLG3;STRN;ZBTB7C;PDGFA;IRS1;SMARCA2;ADRA1A;HDAC2;RBFOX2;RPS6KA2;DNAJB2;VEGFC;MARCHF7;MEN1;PKD2;ZNF268;EFNB2;CAMK2N1;PTPRJ;ADARB1;NAP1L1;MEIS2;STOX1;HP1BP3;PIAS1;DERL2;CRKL;TGFBR2;PTK2;SGK3;HDAC4;DLG5;SIRT1;ABI1;TGFBR1;MAGI2;PDGFC;PRKRA;FER;SIRT2;EPCAM;TJP1;BMPR1A;DNAJA2;CCPG1;MDM4;AGO3;PTPN14;MLXIPL;BCL2;TENM1;CDK13;DUSP22;PHIP;YAP1;DDAH1;BIRC2;VIPR1;RBBP4;STK11;CCAR1;ARID2;TFRC;RNF41;AKT2;CNOT8;CDH13;RUNX1;CUL3;ZNF703;ASH2L;TNFRSF8;IGF1;CELF1;SRPK2;RPRD1B;LIFR;MDM2;PTEN;PPM1D
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell chemotaxis (GO:2001028),-0.5356775366571844,-1.006944692610213,0.4852941176470588,1.0,1.0,1/11,5.50%,SEMA5A
prerank,GO_Biological_Process_2021__ovarian follicle development (GO:0001541),-0.57500085190149,-1.006721969200992,0.5,1.0,1.0,2/10,22.70%,INHA;EIF2B4
prerank,GO_Biological_Process_2021__regulation of astrocyte differentiation (GO:0048710),0.568825558836535,1.006711370642331,0.4897959183673469,0.8009938911721018,1.0,3/8,6.19%,BMP2;EPHA4;BIN1
prerank,GO_Biological_Process_2021__3'-UTR-mediated mRNA stabilization (GO:0070935),0.5066153947018719,1.0065616608295065,0.3488372093023256,0.8010284504696825,1.0,7/12,33.02%,HNRNPC;MAPKAPK2;ANGEL2;MYD88;ELAVL1;TIRAP;HNRNPA0
prerank,GO_Biological_Process_2021__cation transmembrane transport (GO:0098655),0.43840117523911165,1.0064411487280953,0.52,0.8009174502969875,1.0,6/33,12.49%,ABCC8;TRPM4;SFXN1;PKD2;SLC22A5;TRPM3
prerank,GO_Biological_Process_2021__protein K6-linked ubiquitination (GO:0085020),0.5676426894806995,1.0063400934619826,0.5,0.8006867861936519,1.0,3/8,10.08%,UBE2T;RNF6;PRKN
prerank,GO_Biological_Process_2021__regulation of neurogenesis (GO:0050767),0.38227240169901516,1.0063390302165767,0.4594594594594595,0.8002682358610885,1.0,7/46,11.20%,WNT7A;LIG4;ASCL1;MME;SPEN;DOCK7;NAP1L1
prerank,GO_Biological_Process_2021__positive regulation of mitotic cell cycle phase transition (GO:1901992),0.38738582780032654,1.0062827105080292,0.3793103448275862,0.7999612309858251,1.0,13/50,14.11%,CDC25A;RCC2;EGFR;RGCC;CDC27;AKT1;PLCB1;RAD51B;ANKRD17;STOX1;NSMCE2;UBE2E2;RPTOR
prerank,"GO_Biological_Process_2021__positive regulation of CD8-positive, alpha-beta T cell activation (GO:2001187)",-0.6144354887466238,-1.0062156805478524,0.5272727272727272,1.0,1.0,1/5,2.89%,HLA-A
prerank,GO_Biological_Process_2021__regulation of tumor necrosis factor production (GO:0032680),-0.4113825785773026,-1.0058585801911057,0.4305555555555556,1.0,1.0,11/68,12.42%,ARG2;RASGRP1;SELENOS;THBS1;GSTP1;LY96;TLR3;CLU;OAS3;CX3CL1;CD14
prerank,GO_Biological_Process_2021__protein hexamerization (GO:0034214),0.6025866511712874,1.005669918395719,0.5319148936170213,0.8010384015945167,1.0,3/7,25.88%,UGDH;LETM1;LRRC8A
prerank,GO_Biological_Process_2021__embryonic digestive tract morphogenesis (GO:0048557),0.6532154692813423,1.005512360645824,0.5306122448979592,0.8011496701373501,1.0,3/5,12.75%,RBPMS2;PDGFRA;NIPBL
prerank,GO_Biological_Process_2021__dolichyl diphosphate metabolic process (GO:0046465),-0.6396385083526546,-1.0053339921500624,0.47540983606557374,1.0,1.0,3/6,25.34%,DOLK;DHDDS;DPAGT1
prerank,GO_Biological_Process_2021__dolichyl diphosphate biosynthetic process (GO:0006489),-0.6396385083526546,-1.0053339921500624,0.47540983606557374,1.0,1.0,3/6,25.34%,DOLK;DHDDS;DPAGT1
prerank,GO_Biological_Process_2021__cellular response to light stimulus (GO:0071482),0.3632026697170797,1.0049100004317288,0.43478260869565216,0.8020800291605069,1.0,7/47,10.77%,CDC25A;PTPRK;ZBTB1;RHBDD1;SDE2;EIF2AK4;EP300
prerank,MSigDB_Hallmark_2020__Cholesterol Homeostasis,-0.41579979286616836,-1.0049019507163335,0.43037974683544306,1.0,1.0,14/67,18.47%,ADH4;CD9;MVK;SQLE;CLU;DHCR7;HSD17B7;FDPS;ACAT2;TNFRSF12A;FASN;TM7SF2;PDK3;SEMA3B
prerank,GO_Biological_Process_2021__detection of mechanical stimulus involved in sensory perception (GO:0050974),-0.5168933573231199,-1.004715931223993,0.5079365079365079,1.0,1.0,1/13,2.75%,LHFPL5
prerank,GO_Biological_Process_2021__cellular response to hydroxyurea (GO:0072711),-0.5810555408195618,-1.0045189376479828,0.53125,1.0,1.0,2/8,10.79%,DDX11;BLM
prerank,GO_Biological_Process_2021__positive regulation of autophagy (GO:0010508),0.3473664084327603,1.0044976042760385,0.3333333333333333,0.8024635650814965,1.0,18/77,16.28%,DCN;FOXO1;FOXO3;SESN1;ATF6;TICAM1;MAP3K7;EIF2AK4;HMGB1;PRKN;GNAI3;PRKD1;TFEB;SIRT1;TPCN1;SESN3;GSK3B;STK11
prerank,GO_Biological_Process_2021__positive regulation of chromatin binding (GO:0035563),-0.5761930683677673,-1.0044607505503464,0.49019607843137253,1.0,1.0,2/8,12.71%,DDX11;DTX3L
prerank,GO_Biological_Process_2021__axon regeneration (GO:0031103),0.56872173955574,1.004237722959698,0.5106382978723404,0.8025909660334658,1.0,1/7,9.87%,RTN4RL1
prerank,GO_Biological_Process_2021__regulation of double-strand break repair (GO:2000779),0.4154977566208891,1.0040904695431034,0.41379310344827586,0.8025307927736521,1.0,8/37,17.81%,SPIRE2;OTUB2;SPIRE1;UBR5;TRIP12;SETD2;POT1;KDM1A
prerank,GO_Biological_Process_2021__DNA replication initiation (GO:0006270),-0.4619302732744405,-1.0040778486418787,0.4918032786885246,1.0,1.0,3/29,13.61%,RPA3;POLE4;POLE3
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation (GO:0003256),-0.5986427826859922,-1.0039233090934956,0.5084745762711864,1.0,1.0,1/6,8.69%,SRF
prerank,PanglaoDB_Augmented_2021__Loop Of Henle Cells,0.33396815877208663,1.003714713075425,0.4,0.8030582608433794,1.0,17/107,8.44%,POSTN;DCN;SASH1;RGS5;PLXNA2;DACH1;PARVA;CXCL12;PDGFRA;CDH11;CGNL1;FRZB;LRRC66;KCNT1;RNF182;PPP1R1B;PRICKLE2
prerank,GO_Biological_Process_2021__regulation of keratinocyte apoptotic process (GO:1902172),-0.6515844633030796,-1.0036702479824973,0.4888888888888889,1.0,1.0,1/5,3.94%,SFRP4
prerank,GO_Biological_Process_2021__negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067),-0.618142584024884,-1.0036194247244004,0.49056603773584906,1.0,1.0,1/7,7.78%,PIK3IP1
prerank,GO_Biological_Process_2021__telomeric D-loop disassembly (GO:0061820),-0.6098918781455424,-1.0035455044302397,0.5185185185185185,1.0,1.0,2/7,11.65%,BLM;SLX4
prerank,GO_Biological_Process_2021__ethanolamine-containing compound metabolic process (GO:0042439),0.5879562762854778,1.003415958828235,0.4878048780487805,0.8028950821835135,1.0,1/5,31.71%,GDE1
prerank,GO_Biological_Process_2021__N-acylethanolamine metabolic process (GO:0070291),0.5879562762854778,1.003415958828235,0.4878048780487805,0.8028950821835135,1.0,1/5,31.71%,GDE1
prerank,GO_Biological_Process_2021__fatty acid transport (GO:0015908),-0.5478964581463914,-1.0032929797271788,0.47058823529411764,1.0,1.0,2/15,11.67%,FABP3;APOE
prerank,GO_Biological_Process_2021__ERAD pathway (GO:0036503),0.34902975172146916,1.0031537199001637,0.3888888888888889,0.8032259842919821,1.0,14/83,14.67%,USP13;RCN3;STT3B;RHBDD1;MARCHF6;TMEM129;ECPAS;DNAJB2;PRKN;DERL2;UBXN6;UGGT1;UBQLN1;VCP
prerank,GO_Biological_Process_2021__L-arginine transmembrane transport (GO:1903400),0.6633295719731099,1.0030240407023967,0.5,0.8030636621877825,1.0,3/5,28.61%,SLC47A1;SLC22A2;SLC7A2
prerank,GO_Biological_Process_2021__synaptic vesicle budding from presynaptic endocytic zone membrane (GO:0016185),0.6007493035240976,1.002778785835435,0.45652173913043476,0.8033346784696227,1.0,3/6,3.12%,DNM3;SNAP91;PICALM
prerank,GO_Biological_Process_2021__negative regulation of protein localization to cell periphery (GO:1904376),0.472893218739569,1.00241386354386,0.5,0.8038600870198302,1.0,5/16,9.43%,PID1;PICALM;RHOQ;PPP2R5A;MRAP
prerank,GO_Biological_Process_2021__monocarboxylic acid transport (GO:0015718),-0.4555988631059715,-1.0020057916464786,0.49206349206349204,1.0,1.0,8/41,11.43%,AKR1C1;SLC16A3;CEACAM1;SLC51B;SLC51A;SLC16A4;ABCG2;SLC10A1
prerank,GO_Biological_Process_2021__negative regulation of release of cytochrome c from mitochondria (GO:0090201),0.4932789900364117,1.0019181940576343,0.5128205128205128,0.8046564614304399,1.0,6/14,17.75%,AKT1;PSMD10;PRKN;OPA1;HGF;IGF1
prerank,GO_Biological_Process_2021__positive regulation of peptide hormone secretion (GO:0090277),0.4223142099993785,1.001752688515689,0.47058823529411764,0.8046887816420107,1.0,10/27,26.88%,SOX4;MCU;DOC2B;UCN;DRD2;IRS2;LRRC8A;NLGN2;GCK;TCF7L2
prerank,GO_Biological_Process_2021__proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),0.3004276118281892,1.0017120481462096,0.36363636363636365,0.8043142240637601,1.0,78/291,20.33%,SPSB4;FEM1B;BTRC;KCTD13;SPSB2;ANAPC1;STT3B;FBXL17;UBE2G1;TRIM9;KBTBD7;ARRB1;NEDD4L;MARCHF6;CDC27;KCTD17;PSMA1;KBTBD6;FEM1C;FBXL3;KLHL42;UBE2D1;UBR3;PSMD11;ITCH;TMEM129;ECPAS;KLHL15;DNAJB2;PSMD10;CLOCK;PRKN;RMND5A;PSMF1;FBXW7;COP1;KCTD10;FBXL14;PSMD14;PCNP;SMURF1;DERL2;TBL1XR1;BUB3;SIRT1;AGAP3;CUL2;SIRT2;UBE2E1;SPOPL;UBQLN1;FBXO45;CUL1;VCP;KCTD5;CDC34;FAF1;ANAPC16;HACE1;BIRC2;FBXL6;UBQLN2;PSME4;UBR1;BFAR;ANKRD9;CUL3;MDM2;RAD23B;EDEM1;FBXW11;NSFL1C;UBXN2B;FBXO38;PLK1;NFE2L2;GID8;FBXO31
prerank,GO_Biological_Process_2021__regulation of protein localization to cell cortex (GO:1904776),0.6121832298365062,1.0016977632933721,0.5121951219512195,0.8039569974940042,1.0,4/6,33.69%,GNAI1;PLK1;EPB41;EPB41L2
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell apoptotic process (GO:1904037),-0.5404434588006873,-1.0015234805367261,0.4915254237288136,1.0,1.0,5/15,17.91%,SFRP4;THBS1;CD160;CCL2;GPER1
prerank,GO_Biological_Process_2021__cellular response to amyloid-beta (GO:1904646),0.45705677244734083,1.001478798606387,0.5151515151515151,0.8041166367895067,1.0,7/24,19.12%,EPHA4;GRIN1;CACNA2D1;ADRB2;GSK3B;IGF1;FYN
prerank,GO_Biological_Process_2021__cellular polysaccharide biosynthetic process (GO:0033692),0.4871122225507685,1.0014512217273561,0.4166666666666667,0.8037768075827415,1.0,7/17,18.66%,FUT9;CSGALNACT1;EXT1;EXT2;HS2ST1;B3GALT1;NDST1
prerank,GO_Biological_Process_2021__double-strand break repair via nonhomologous end joining (GO:0006303),0.3740610065045953,1.0013758860667805,0.30303030303030304,0.8035895808675164,1.0,13/56,20.56%,LIG4;CYREN;UBE2N;HMGB1;PSMD14;NSMCE2;PIAS4;UIMC1;DCLRE1C;BRCC3;XRCC4;NSD2;H2AX
prerank,GO_Biological_Process_2021__regulation of lipid metabolic process (GO:0019216),0.34580477274248883,1.0012982916565312,0.5,0.8033940936470233,1.0,14/75,14.49%,ACACB;RORA;PLPP1;ELOVL6;NFYC;NR1D2;NCOA2;PANK2;NR1D1;GPAM;TBL1XR1;CHD9;RUBCNL;ADIPOR1
prerank,GO_Biological_Process_2021__negative regulation of apoptotic process (GO:0043066),-0.35959060404582466,-1.0012929882885415,0.4891304347826087,1.0,1.0,43/345,14.31%,IFI6;APIP;PRAME;POU4F1;GATA1;PTRH2;RPL10;RPS27A;IL7;DHCR24;ITGA5;PRDX5;IFIT3;BCL2L2;AQP1;ANXA1;HTR2B;THBS1;BDNF;PDPN;RPS3A;RNF213;GSTP1;BEX3;UBC;CTSH;FHL2;MT3;NAA38;KLF4;APOE;SFRP1;PLK3;UNC5B;FZD9;CX3CL1;PTMA;CLEC5A;ERBB3;CLN3;XBP1;RIPK2;CCL2
prerank,GO_Biological_Process_2021__isocitrate metabolic process (GO:0006102),-0.6396640383451178,-1.0011694735829106,0.48148148148148145,1.0,1.0,2/5,22.96%,IDH2;IDH3G
prerank,PanglaoDB_Augmented_2021__Luminal Epithelial Cells,-0.4319170742207062,-1.0009500339839312,0.47368421052631576,1.0,1.0,17/44,18.27%,OVOL2;CD9;ANXA1;PGR;TMC4;TRIM29;B3GNT3;CEBPD;PPL;ERBB3;EPS8L2;IL20RA;BTG1;CD74;WNT5A;CDH1;SYTL2
prerank,GO_Biological_Process_2021__regulation of protein sumoylation (GO:0033233),0.47637326331753077,1.0008723247104923,0.48484848484848486,0.8038578814276058,1.0,4/14,15.18%,GNL3L;PIAS1;HDAC4;PIAS4
prerank,GO_Biological_Process_2021__nucleosome disassembly (GO:0006337),0.5111273603156634,1.000533263166785,0.46153846153846156,0.8040074551363172,1.0,4/12,24.72%,SMARCD2;ARID2;SMARCC1;ARID1A
prerank,GO_Biological_Process_2021__chromatin disassembly (GO:0031498),0.5111273603156634,1.000533263166785,0.46153846153846156,0.8040074551363172,1.0,4/12,24.72%,SMARCD2;ARID2;SMARCC1;ARID1A
prerank,GO_Biological_Process_2021__anterior/posterior pattern specification (GO:0009952),0.4357369418485222,1.0004952775030231,0.425,0.8036771703792772,1.0,3/24,5.65%,PCSK5;BMP2;SMAD2
prerank,GO_Biological_Process_2021__retinal rod cell development (GO:0046548),0.6071303074074017,1.000361300567214,0.525,0.8036339220282769,1.0,3/6,23.31%,RORB;RPGRIP1L;RP1
prerank,GO_Biological_Process_2021__regulation of RNA polymerase II regulatory region sequence-specific DNA binding (GO:1903025),-0.5884943289155868,-1.0002735252499175,0.49019607843137253,1.0,1.0,2/8,11.06%,ZNF593;DDIT3
prerank,GO_Biological_Process_2021__DNA replication-independent nucleosome organization (GO:0034724),0.5438977684064136,1.0002461679194774,0.4883720930232558,0.8034053046983907,1.0,6/10,32.24%,RBBP4;ATRX;ASF1A;HAT1;H3-3A;NASP
prerank,GO_Biological_Process_2021__positive regulation of cytoplasmic translation (GO:2000767),0.6372714036874649,1.000204688055871,0.52,0.8030842637806056,1.0,1/5,13.28%,DHX9
prerank,"GO_Biological_Process_2021__substrate-dependent cell migration, cell extension (GO:0006930)",-0.6127555908679048,-1.0000504039999578,0.5074626865671642,1.0,1.0,1/7,3.42%,P2RY12
prerank,"GO_Biological_Process_2021__positive regulation of transcription, DNA-templated (GO:0045893)",0.3700295294061812,1.0,1.0,0.802274511747681,1.0,269/886,21.42%,ZNF300;WNT7A;PPARGC1A;PID1;LPIN3;ZFPM2;MEOX2;RARB;NCK2;ETV5;ZGLP1;NRIP1;FLI1;BTRC;DCN;YAF2;MITF;VEZF1;SERPINE1;KAT2B;EAF2;UBP1;FOXO1;SOX4;SOX8;SALL1;MEIS3;BMP2;ERBB4;PLAC8;ETV1;TFAP2C;PICALM;NR4A2;EGFR;ZXDA;RPS6KA4;MLLT3;ACTA2;ASCL1;ESRRG;VHL;RGCC;DR1;SOX9;RORA;MLLT10;NFIB;MSANTD1;RHOQ;PHF10;CCDC62;NFKB1;ZEB2;MYRF;GRIN1;ARRB1;FZD5;HCLS1;FOXO3;ZXDC;HNRNPU;ZNF407;SMAD2;ZNF746;GABPB1;CDK8;MAML2;RPS6KA3;THRB;AKT1;PBX1;ZIC2;GABPA;RFX3;KCNH2;RNF6;NFAT5;ARID1B;SMAD7;DPF1;DYRK1A;NR1D2;NRF1;NPAS3;WASL;ATF6;CEP290;PIK3R1;LMO7;NCOA2;PPM1A;SP3;SMARCA2;SMAD5;BMPR1B;TCF4;ZNF516;PLCB1;RNF14;HDAC2;KDM5A;ETS2;NCOA3;NR3C1;TFE3;MEN1;PKD2;CLOCK;MRTFA;GLI3;GLIS3;ZNF268;AUTS2;HMGB1;ELF1;NR1D1;KAT2A;NPAS2;PRKN;FOXJ3;CAPRIN2;PBX2;ZNF451;TCF12;SUPT3H;RGMA;MED13;EP300;NEK4;PRKD1;AKIRIN2;MAP3K5;MEIS2;SS18;DVL1;AHR;ELK4;ZNF423;ZBTB16;ZNF24;ACVR1;WWOX;TBL1XR1;SETD3;TFEB;HDAC4;SIRT1;HIPK2;TGFBR1;METTL23;RREB1;SLC30A9;OGT;DHX9;MAP2K5;NDP;SMARCD2;SIRT2;NCK1;ASXL3;UBTF;ACVR2A;EPCAM;CRTC2;KAT7;HNF4G;BMPR1A;TRIM28;RPTOR;KMT2C;EHF;SMAD4;SNX5;BCL9;MLXIPL;TRIM16;TRIP4;POU3F1;USP22;SERTAD2;ZBTB38;POU2F1;JMJD6;PHIP;YAP1;PADI2;HSF2;CCNT2;TFDP2;LHX2;THAP3;PPP3CB;HGF;RSF1;DPF3;BMP7;TRIM44;CSRNP3;PPP1R12A;SMARCC1;ATAD2B;SATB2;KAT6B;PCID2;MAML1;SCAF8;POGZ;ATF2;CDH13;HIF1A;ITGA6;CXXC1;RUNX1;IGF1;KDM1A;YY1;KDM1B;ABHD14B;AATF;DCAF6;ZNF462;RPRD1B;ZBTB18;RBPJ;ATRX;ASF1A;RORB;AXIN1;NFATC3;SSBP2;LMO1;BCL10;APBB1;DNM2;HNRNPD;RFXAP;FBXW11;MAP2K2;SS18L1;REST;ASXL2;MAP3K2;ARNT;LEF1;ZNF639;WAC;KLF15;NFE2L2;HIVEP3;GRHL1;PRDM2;ESRRB;ATOH8;MED4;NFIA;CDK9;IFI16;RNF10;ZPR1;MTF1;NFATC2;NFIL3;CREBBP;POU3F2;ZNF318;NR4A1;NAT14;MLLT11
prerank,"GO_Biological_Process_2021__regulation of transcription, DNA-templated (GO:0006355)",0.3861055163190906,1.0,1.0,0.802274511747681,1.0,463/1648,21.61%,POU6F2;ZNF93;ZNF300;WNT7A;PPARGC1A;LIMD1;ZFPM2;MEOX2;ANKRD2;TRPS1;BACH1;USP13;PTPRK;TNFSF4;ZNF696;CDK18;ETV5;KLF11;ETV3;ZGLP1;FLI1;BTRC;YAF2;EBF4;ZNF706;HDAC9;NR2F6;TFCP2L1;MITF;FOXP1;VEZF1;ZSCAN23;WTIP;ZNF283;UBP1;ZSCAN25;FOXO1;SOX4;ZBTB1;SOX8;KCTD1;ZNF287;SOX5;ZSCAN20;ZNF510;SALL1;MEIS3;ZNF189;EED;BMP2;ERBB4;MAMLD1;ETV1;LHX6;TFAP2C;KLF16;LCOR;SPINDOC;PICALM;ZSCAN22;NR4A2;EGFR;ZXDA;RPS6KA4;LOXL2;ZBTB37;EBF1;MLLT3;ACTA2;TSHZ1;ZNF805;CHD2;ASCL1;ESRRG;ZNF384;ZNF697;DACH1;ZNF41;PSPC1;VHL;AEBP2;ZIC5;ZBTB43;ZBTB20;ANXA4;OLIG2;SOX9;RORA;ZBTB34;ZEB1;NFIB;MSANTD1;PHF10;TOX;NFKB1;PRMT6;ZEB2;MYRF;ZNF595;ARRB1;ZNF577;HCLS1;TLE2;RCOR1;FOXO3;ZXDC;PHF14;ZNF484;NFXL1;SMAD2;ZNF746;TBX19;RPS6KA3;SALL3;PHF2;PHC1;ZNF783;CHD7;CHMP1A;BRWD1;ZBTB10;ZNF212;HMG20A;AKT1;ZNF521;PBX1;CHD5;ZIC2;GABPA;RFX3;ZNF582;KCNH2;RNF6;HIC2;JDP2;NFAT5;CNOT2;ARID1B;BAHD1;NFYC;SMAD7;ZNF254;DPF1;NR2E1;DYRK1A;NR1D2;ZNF211;NRF1;PRRX1;NPAS3;ZBTB7C;ATF6;CEP290;LCORL;SPEN;NCOA2;TSHZ3;PPM1A;GPBP1L1;TRAK1;SP3;KLF12;MBD2;PEX14;ZNF319;ZHX3;SMARCA2;NLK;ZNF117;SMAD5;ZNF280D;TCF4;ZNF568;ZNF516;PLCB1;ZNF415;RNF14;RBM15B;HDAC2;RBFOX2;KDM5A;SOX6;MAGED1;ZNF33A;ETS2;PKNOX1;NR3C1;TFE3;SAFB2;ZNF587;SFMBT2;MEN1;BBX;CLOCK;HIVEP2;GLI3;GLIS3;TGFBRAP1;ZNF268;HMGB1;BRWD3;ELF1;NR1D1;KAT2A;MGA;FOXP4;NPAS2;MXD3;SCMH1;GCLC;FOXJ3;PBX2;PBX3;TCF12;SUPT3H;ZFHX4;ZNF737;ZNF589;CREM;MED13;ZNF382;EP300;ZNF736;NEK4;ZNF615;ZNF148;RUNX1T1;FOXN2;MAP3K5;CAMK2D;MEIS2;ZNF717;IKZF2;CAMTA1;ZNF316;HP1BP3;DVL1;ZNF644;PIAS1;AHR;ZHX2;ELK4;ZNF556;ZNF276;ZNF423;ZIK1;ZBTB16;ZNF519;ZNF24;ACVR1;ZNF667;HSF5;SLTM;ZNF787;TBL1XR1;ZNF43;NIPBL;SETD3;TFEB;HDAC4;SIRT1;HIPK2;TGFBR1;APBB2;RREB1;ZNF561;OGT;DHX9;ZNF782;NDP;ZNF91;SMARCD2;ABCA2;SIRT2;OLIG1;PRDM8;KAT7;ZNF680;BAZ2B;HNF4G;TRIM28;HIF3A;FOXN3;ZNF652;EHF;MAP3K10;SMAD4;TIAL1;MDM4;PURG;SNX5;JMY;VGLL4;MLXIPL;TRIM16;ZBTB9;TRIP4;POU3F1;TENM1;SOX13;USP22;ZNF292;PIAS4;ZNF530;HDGFL3;SAMD1;KLF9;ZBTB38;PHC3;ZBTB26;ZNF471;POU2F1;JMJD6;ATP2B4;ZNF81;ZNF282;PHIP;YAP1;HSF2;CCNT2;USP47;TFDP2;ZFAT;ZNF140;UIMC1;LHX2;PPP3CB;ZNF438;PHC2;RFX7;RSF1;PKNOX2;DPF3;BMP7;ZNF160;ZFP92;ZNF44;CCAR1;ZNF347;DMTF1;TRIM44;CSRNP3;NR3C2;SMARCC1;ZNF426;ZNF230;ZNF555;SATB2;SUFU;KAT6B;ZNF57;MED13L;ZNF614;PCID2;ZNF141;ZNF774;MYT1;ZNF613;MAF;ATF2;CBFB;HIF1A;CXXC1;RUNX1;ZNF703;IGF1;KDM1A;MTERF3;YY1;AATF;CDK14;ZBTB21;ZNF264;JARID2;CHD1;ZBTB18;UTP4;ZNF654;MDM2;RBPJ;ATRX;RORB;AXIN1;NFATC3;SSBP2;ZNF771;ZNF493;BCL10;SOX21;APBB1;ZNF14;DNM2;MED27;HNRNPD;ZNF689;RFXAP;ASCC1;FBXW11;PPM1F;ZNF557;ZNF311;MAP2K2;PHF20L1;SS18L1;SPIN3;POU3F4;KDM4C;NSD2;CDK5R1;ZKSCAN4;MBTD1;ZNF786;REST;MAP3K2;ARNT;LEF1;BAZ1A;TCEAL7;ZNF639;WAC;KLF15;NFE2L2;HIVEP3;ZNF624;GRHL1;HMBOX1;ZNF646;PRDM2;NRG1;ESRRB;SPTY2D1;ATOH8;MED4;ZNF354B;ZNF792;NFIA;ZNF586;MYNN;SETD5;PPP2R1A;ZNF567;IFI16;RNF10;MTF1;NFATC2;ARID3B;NFIL3;CREBBP;PRKCB;ZNF30;POU3F2;ZNF318;ZNF518A;NR4A1;NAT14;MLLT11;IFRD1;ZNF526;ARNT2;NR6A1;ZNF195;PLAGL2;NAA16
prerank,GO_Biological_Process_2021__regulation of transcription by RNA polymerase II (GO:0006357),0.3786121803919594,1.0,1.0,0.802274511747681,1.0,430/1616,20.54%,POU6F2;ZNF93;ZNF300;WNT7A;PPARGC1A;PID1;LPIN3;ZFPM2;MEOX2;ANKRD2;TRPS1;BACH1;RARB;NCK2;ZNF696;ETV5;KLF11;ETV3;ZGLP1;NRIP1;FLI1;DCN;EBF4;MCPH1;HDAC9;NR2F6;TFCP2L1;MITF;FOXP1;SNCA;VEZF1;SERPINE1;ZSCAN23;KAT2B;EAF2;ZNF283;UBP1;ZSCAN25;FOXO1;SOX4;ZBTB1;SOX8;KCTD1;ZNF287;SOX5;ZSCAN20;ZNF510;SALL1;MEIS3;ZNF189;EED;BMP2;PLAC8;MAMLD1;ETV1;LHX6;CSF1R;TFAP2C;KLF16;LCOR;ZSCAN22;NR4A2;EGFR;ZXDA;RPS6KA4;LOXL2;ZBTB37;EBF1;TSHZ1;ZNF805;CHD2;ASCL1;ESRRG;ZNF384;ZNF697;DACH1;ZNF41;VHL;CPEB3;AEBP2;ZIC5;ZBTB43;ZBTB20;RGCC;DR1;ANXA4;OLIG2;SOX9;RORA;ZBTB34;MLLT10;ZEB1;NFIB;RHOQ;PHF10;CCDC62;TOX;NFKB1;ZEB2;GRIN1;ZNF595;ARRB1;ZNF577;FZD5;HCLS1;RCOR1;NEDD4L;FOXO3;ZXDC;HNRNPU;ZNF407;PHF14;ZNF484;SMAD2;ZNF746;GABPB1;CDK8;TBX19;MAML2;RPS6KA3;SALL3;PHF2;THRB;ZNF783;PCGF2;BRWD1;ZBTB10;ZNF212;ZNF521;PBX1;CHD5;ZIC2;GABPA;RFX3;ZNF582;HIC2;JDP2;NFAT5;CNOT2;ARID1B;NFYC;SMAD7;ZNF254;DPF1;NR2E1;TENM2;NR1D2;ZNF211;CDK12;NRF1;PRRX1;NPAS3;WASL;ZBTB7C;ATF6;UBE2D1;PIK3R1;LCORL;SPEN;LMO7;NCOA2;TSHZ3;PPM1A;TRAK1;SP3;KLF12;MBD2;ZNF319;ZHX3;SMARCA2;SMAD5;BMPR1B;TCF4;ZNF568;ZNF415;RNF14;HDAC2;PHF21A;SOX6;ZNF33A;ETS2;PKNOX1;NCOA3;NR3C1;TFE3;SAFB2;PSMD10;ZNF587;MEN1;PKD2;BBX;CLOCK;MRTFA;HIVEP2;GLI3;GLIS3;ZNF268;AUTS2;HMGB1;BRWD3;ELF1;NR1D1;KAT2A;MGA;FOXP4;NPAS2;PRKN;MXD3;FOXJ3;CAPRIN2;PBX2;PBX3;ZNF451;TCF12;SUPT3H;ZFHX4;ZNF589;CREM;RGMA;MED13;ZNF382;EP300;ZNF615;PRKD1;TNRC6B;ZNF148;AKIRIN2;CAMK2D;MEIS2;ZNF717;IKZF2;CAMTA1;SS18;ZNF316;DVL1;ZNF644;PIAS1;AHR;ZHX2;ELK4;JAZF1;ZNF556;ZNF276;ZIK1;ZBTB16;PEX2;ZNF24;ACVR1;ZNF667;HSF5;SLTM;ZNF787;WWOX;TBL1XR1;ZNF43;NIPBL;SETD3;TFEB;HDAC4;SIRT1;HIPK2;METTL23;RREB1;SLC30A9;ZNF561;OGT;DHX9;ZNF782;MAP2K5;ZNF91;SMARCD2;ABCA2;SIRT2;NCK1;OLIG1;DCAF1;ASXL3;ACVR2A;EPCAM;CRTC2;KAT7;BAZ2B;HNF4G;BMPR1A;TRIM28;HIF3A;ZNF652;KMT2C;EHF;SMAD4;TIAL1;MDM4;PURG;AGO3;JMY;BCL9;MLXIPL;DLG1;ZBTB9;POU3F1;CDK13;SOX13;ZNF292;DUSP22;PIAS4;ZNF530;HDGFL3;KLF9;ZBTB38;ZBTB26;ZNF471;POU2F1;JMJD6;ATP2B4;ZNF81;ZNF282;PHIP;YAP1;USP9X;MIER3;HSF2;CCNT2;TFDP2;ZNF140;LHX2;THAP3;PPP3CB;ZNF438;RFX7;HGF;RSF1;PKNOX2;DPF3;IMPACT;ZNF160;SEMA4D;ZFP92;ZNF44;ZNF347;DMTF1;USP2;CSRNP3;PPP1R12A;NR3C2;SMARCC1;ZNF426;ZNF230;ATAD2B;ZNF555;SATB2;SUFU;KAT6B;ZNF57;MED13L;ZNF614;ZNF141;MAML1;ZNF774;POGZ;MYT1;ZNF613;MAF;ATF2;CBFB;CDH13;HIF1A;ITGA6;RUNX1;IGF1;KDM1A;YY1;KDM1B;ABHD14B;AATF;ZBTB21;ZNF264;DCAF6;ZNF462;RPRD1B;CHD1;ZBTB18;ZNF654;MDM2;RBPJ;ATRX;PTEN;PPM1D;RORB;NFATC3;SSBP2;LMO1;ZNF771;ZNF493;SOX21;APBB1;ZNF14;MED27;ZNF689;RFXAP;TAF3;ZNF557;ZNF311;PHF20L1;SS18L1;NCOA5;POU3F4;KDM4C;ZKSCAN4;ZNF786;REST;ASXL2;ARNT;LEF1;BAZ1A;PLK1;N4BP2L2;ZNF639;KLF15;NFE2L2;HIVEP3;ZNF624;GRHL1;HMBOX1;PRDM2;ESRRB;ATOH8;MED4;ZNF354B;ZNF792;NFIA
prerank,GO_Biological_Process_2021__neuropeptide signaling pathway (GO:0007218),0.46386519718387204,0.9999939386783988,0.45714285714285713,0.8018706494760346,1.0,7/23,26.98%,SORT1;RAPGEF2;GLRB;NPY;CPE;PNOC;SORCS2
prerank,GO_Biological_Process_2021__regulation of phagocytosis (GO:0050764),0.42347816263216065,0.999733008118326,0.5151515151515151,0.8021225515352479,1.0,4/31,12.81%,TUB;RAB27A;PIP4P2;MERTK
prerank,GO_Biological_Process_2021__purine ribonucleotide biosynthetic process (GO:0009152),0.3709174239248885,0.9995256060578057,0.391304347826087,0.8022482309194242,1.0,16/38,29.13%,ADCY1;GUCY1B1;GMPS;PANK2;SLC25A16;PANK3;PAPSS2;PANK1;ADCY6;ADCY9;PAPSS1;ACAT1;ACOT7;ADCY2;SLC26A2;AMPD2
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle hypertrophy (GO:0010613),0.47403575861757974,0.9993607187766319,0.42424242424242425,0.8023234215680899,1.0,6/15,24.50%,CAMK2D;ROCK2;IGF1;ROCK1;PRKCA;PDE9A
prerank,GO_Biological_Process_2021__platelet aggregation (GO:0070527),-0.47169279595017255,-0.9991373745823564,0.47368421052631576,1.0,1.0,7/29,17.61%,GATA1;P2RY12;PIK3CB;MYL12A;TLN1;CLIC1;ILK
prerank,GO_Biological_Process_2021__positive regulation of Ras protein signal transduction (GO:0046579),-0.4459279940676067,-0.9990636893930929,0.4444444444444444,1.0,1.0,6/44,10.61%,P2RY10;GPR18;RASGRP1;LPAR4;PIK3CB;LPAR6
prerank,GO_Biological_Process_2021__positive regulation of alpha-beta T cell differentiation (GO:0046638),0.5704623948712427,0.9989624271598566,0.4782608695652174,0.80287670754637,1.0,5/8,17.52%,TNFSF4;GLI3;TGFBR2;CBFB;RUNX1
prerank,GO_Biological_Process_2021__metal ion transport (GO:0030001),0.36042690851785897,0.998593840619755,0.5,0.8034378110331928,1.0,20/63,24.55%,CHRNA4;CACNA1B;CACNA2D1;ATP2C1;CACNG3;CAMK2A;PKD2;SLC30A9;SLC30A1;MMGT1;CACNB3;NDFIP1;FYN;CACNG8;NDFIP2;SLC39A8;ATP2B2;RAMP1;CACNG7;TRPM2
prerank,GO_Biological_Process_2021__cellular monovalent inorganic cation homeostasis (GO:0030004),0.5054199296434922,0.9981192899178934,0.4146341463414634,0.804300033840444,1.0,3/15,7.05%,NEDD4L;SLC12A2;KCNMA1
prerank,GO_Biological_Process_2021__negative regulation of neurogenesis (GO:0050768),0.44956495563071963,0.9981150553178879,0.42857142857142855,0.8039049580741392,1.0,9/29,20.86%,WNT7A;RAPGEF2;NF1;RUFY3;PTEN;LRP4;ARHGDIA;REST;PCM1
prerank,GO_Biological_Process_2021__positive regulation of chromosome organization (GO:2001252),0.513025423097797,0.9981102372992222,0.45098039215686275,0.8034935430495364,1.0,2/12,3.61%,LIG4;PPP1R10
prerank,GO_Biological_Process_2021__mitotic sister chromatid segregation (GO:0000070),-0.40933498125832685,-0.9978432792609441,0.4153846153846154,1.0,1.0,10/77,8.99%,ANKRD53;CENPE;KIF2C;KNSTRN;RAB11A;TTN;SPDL1;TEX14;MIS12;CHMP2A
prerank,GO_Biological_Process_2021__positive regulation of intracellular signal transduction (GO:1902533),0.2933558915444031,0.9978226321153483,0.25,0.8037184815775895,1.0,84/391,17.75%,CASS4;DCN;SASH1;FAM110C;BMP2;ERBB4;C18ORF32;VAPA;TAB3;EGFR;FLT1;SOX9;SMCR8;IQCJ-SCHIP1;RHEB;PDGFRA;FGF17;BOK;EEF1D;HCLS1;EPOR;CBL;ATP2C1;NTRK2;TNFRSF19;CHD5;MYORG;RAPGEF2;NFAT5;ADRB2;PIK3CA;PUM2;CASP10;STRN;UBE2N;PIK3R1;PDGFA;IRS1;PPM1A;ROR1;TRAF3IP2;ADRA1A;TICAM1;MAP3K7;CANT1;HMGB1;PRKN;TRADD;PTPRJ;GOLPH3;CFLAR;EP300;PRKD1;RUNDC3A;DUSP19;ANKRD17;PTK2;LURAP1;NRG2;DLG5;SIRT1;TGFBR1;PDGFC;TNFRSF10B;RPTOR;BCL2;OSBPL8;GAB1;HIP1;ECM1;ROCK2;PTPN11;BIRC2;HGF;SEMA4D;TFG;TRIM44;NR3C2;TFRC;AKT2;PUM1;CDH13;NDFIP1;IGF1
prerank,GO_Biological_Process_2021__regulation of mitochondrial membrane potential (GO:0051881),0.3973179614368049,0.9977935654356167,0.4666666666666667,0.8033828518733641,1.0,8/36,16.90%,PID1;BCO2;AKT1;STOX1;PPA2;VCP;BCL2;AKT2
prerank,GO_Biological_Process_2021__cellular response to reactive oxygen species (GO:0034614),0.34946162297943456,0.9977750319969804,0.7058823529411765,0.8030141292385886,1.0,14/54,16.23%,PTPRK;EGFR;PDGFRA;AKT1;PKD2;MAP3K5;SIRT1;AGAP3;FER;MAPK1;PDK2;PXN;MAPK8;IMPACT
prerank,GO_Biological_Process_2021__cell cycle G2/M phase transition (GO:0044839),0.3272702847871252,0.9976605690488338,0.4090909090909091,0.8028462963853434,1.0,33/122,21.35%,CDC25A;BTRC;CEP152;TPD52L1;PHLDA1;FBXL17;FBXL3;NEDD1;CEP290;CSNK1E;PLCB1;CCNA2;CKAP5;MAPRE1;CLASP1;ALMS1;CUL1;TUBG1;LATS1;PPP2R2A;FBXL6;PPP1R12A;YWHAG;ARPP19;TAF2;CDK14;DNM2;FBXW11;PPP1CB;PLK1;PPP2R1A;PCM1;AURKA
prerank,GO_Biological_Process_2021__mitochondrial transcription (GO:0006390),0.5373296457864787,0.9971654285947597,0.5454545454545454,0.803572133004243,1.0,3/9,12.90%,FOXO3;TFB1M;MTERF1
prerank,GO_Biological_Process_2021__positive regulation of developmental growth (GO:0048639),0.3455727562724859,0.9967657599780115,0.43333333333333335,0.8041970747013464,1.0,8/44,16.80%,SYT3;CDKL5;NEDD4L;PLCB1;SMURF1;RASAL1;SEMA4D;RUFY3
prerank,GO_Biological_Process_2021__DNA double-strand break processing (GO:0000729),0.48366187042985076,0.9965261376127074,0.4857142857142857,0.8042708114328443,1.0,5/17,13.20%,DNA2;SMARCAD1;UBE2N;RAD52;EXD2
prerank,GO_Biological_Process_2021__negative regulation of Notch signaling pathway (GO:0045746),0.42855734490502473,0.9964580844517811,0.40476190476190477,0.8040860048726529,1.0,4/22,10.97%,EGFR;ARRB1;AKT1;FBXW7
prerank,GO_Biological_Process_2021__negative regulation of interleukin-10 production (GO:0032693),-0.5896421325116923,-0.996399704273556,0.5102040816326531,1.0,1.0,3/8,16.27%,PDCD1LG2;CD274;TNFRSF21
prerank,GO_Biological_Process_2021__positive regulation of cell-substrate adhesion (GO:0010811),0.3753678672589189,0.9962562442563972,0.3939393939393939,0.8041013890206056,1.0,17/51,20.59%,CASS4;NPNT;CSPG5;RSU1;TESK1;PLEKHA2;CARMIL1;CRKL;RREB1;GSK3B;ARHGEF7;NRP1;NDNF;CDH13;PPM1F;UTRN;CIB1
prerank,GO_Biological_Process_2021__acute inflammatory response (GO:0002526),0.4940007450346267,0.9962488116715611,0.46875,0.8037002979524299,1.0,1/13,1.31%,TNFSF4
prerank,GO_Biological_Process_2021__amino-acid betaine metabolic process (GO:0006577),-0.5984386946142812,-0.99612212134971,0.44642857142857145,1.0,1.0,1/6,3.28%,BHMT
prerank,GO_Biological_Process_2021__regulation of cytoplasmic transport (GO:1903649),0.5271508891830116,0.9958659965412248,0.46153846153846156,0.804140435294239,1.0,6/11,28.84%,ATP9A;DNAJC13;MAPK1;MAP2K2;MAPK3;USP7
prerank,GO_Biological_Process_2021__regulation of microtubule nucleation (GO:0010968),0.5670940912790483,0.9957723059599015,0.4888888888888889,0.8039810332079795,1.0,5/10,23.86%,GIT1;CKAP5;ARHGEF7;HSPA1A;MECP2
prerank,GO_Biological_Process_2021__negative regulation of mRNA processing (GO:0050686),0.5021730866418789,0.9957692837717372,0.45454545454545453,0.803588931545061,1.0,4/14,27.41%,U2AF2;PTBP1;PCBP4;SFSWAP
prerank,GO_Biological_Process_2021__cochlea morphogenesis (GO:0090103),-0.6173764734704872,-0.9956917428883216,0.6415094339622641,1.0,1.0,2/5,6.10%,MYO3A;MYO3B
prerank,GO_Biological_Process_2021__regulation of fat cell differentiation (GO:0045598),0.3598336945476836,0.9955387995303198,0.4166666666666667,0.8036294659704317,1.0,17/61,13.86%,ZFPM2;FOXO1;BMP2;FTO;RORA;AKT1;FRZB;TRPM4;LMO3;ANKRD26;NR1D1;RUNX1T1;ZBTB16;SIRT1;TAF8;SIRT2;WDFY2
prerank,GO_Biological_Process_2021__negative regulation of macrophage cytokine production (GO:0010936),-0.6641850878619386,-0.9955054666101986,0.5686274509803921,1.0,1.0,2/5,22.39%,CUEDC2;TGFB1
prerank,GO_Biological_Process_2021__epithelial tube morphogenesis (GO:0060562),0.46657724760981173,0.9951717930138833,0.5161290322580645,0.8039856647502188,1.0,8/25,17.98%,PRKX;CSF1R;PKD2;MTSS1;SLIT2;ACVR1;SCRIB;CCM2
prerank,GO_Biological_Process_2021__insulin metabolic process (GO:1901142),-0.6903801443651846,-0.9949192331295682,0.5686274509803921,1.0,1.0,3/5,16.88%,CEACAM1;CELA2A;PCSK2
prerank,GO_Biological_Process_2021__G protein-coupled glutamate receptor signaling pathway (GO:0007216),0.5012195188487405,0.9948160753796481,0.391304347826087,0.80435810955269,1.0,5/13,23.57%,HOMER1;GRM1;GRM8;HOMER2;GRM5
prerank,GO_Biological_Process_2021__positive regulation of supramolecular fiber organization (GO:1902905),-0.40790371539050935,-0.9947846207555611,0.4647887323943662,1.0,1.0,11/70,14.19%,ANKRD53;LMOD1;VIL1;SEMA5A;CAV3;FES;CLU;APOE;CX3CL1;DRG1;PFN1
prerank,GO_Biological_Process_2021__isoprenoid metabolic process (GO:0006720),-0.6218004453831691,-0.9946793745973292,0.5087719298245614,1.0,1.0,2/6,21.38%,MVK;HMGCR
prerank,GO_Biological_Process_2021__lamellipodium assembly (GO:0030032),0.4295830997398962,0.9944694398925287,0.46153846153846156,0.8046471803313962,1.0,8/25,19.03%,ARHGEF6;CARMIL1;GOLPH3;CYFIP1;ARHGEF7;PTPRO;CDH13;S1PR1
prerank,GO_Biological_Process_2021__B cell chemotaxis (GO:0035754),0.6221794747120811,0.9943805702723171,0.5714285714285714,0.804396756858281,1.0,3/5,29.52%,GAS6;CYP7B1;HSD3B7
prerank,GO_Biological_Process_2021__anterograde dendritic transport of neurotransmitter receptor complex (GO:0098971),0.6292995914432411,0.9942860989088851,0.4791666666666667,0.8038303751054906,1.0,2/5,11.36%,KIF5A;KIF5C
prerank,GO_Biological_Process_2021__anterograde dendritic transport (GO:0098937),0.6292995914432411,0.9942860989088851,0.4791666666666667,0.8038303751054906,1.0,2/5,11.36%,KIF5A;KIF5C
prerank,MSigDB_Hallmark_2020__G2-M Checkpoint,0.32140566599207104,0.9941030543400787,0.47058823529411764,0.8037712500078125,1.0,40/165,20.74%,CDC25A;XPO1;EFNA5;DR1;NOTCH2;HNRNPU;CDC27;CHMP1A;HMMR;SLC12A2;PDS5B;G3BP1;RASAL2;CCNA2;SYNCRIP;CKS1B;MAP3K20;MEIS2;SS18;DKC1;INCENP;BUB3;FOXN3;CUL1;LBR;ESPL1;KIF15;SMARCC1;UCK2;HIF1A;CUL3;ORC5;EWSR1;ATRX;RAD23B;HNRNPD;NSD2;PLK1;H2AX;MARCKS
prerank,GO_Biological_Process_2021__peroxisome fission (GO:0016559),0.5636217664516479,0.9939310915692843,0.5111111111111111,0.8037535777976917,1.0,2/7,7.04%,MFF;PEX11A
prerank,GO_Biological_Process_2021__positive regulation of defense response (GO:0031349),0.34414515239662036,0.993485579156766,0.4827586206896552,0.8042903096997114,1.0,7/56,13.28%,TNFSF4;SNCA;SERPINE1;NPAS2;TRADD;AKIRIN2;DHX9
prerank,GO_Biological_Process_2021__gliogenesis (GO:0042063),-0.5506483602263518,-0.9930081740477263,0.5081967213114754,1.0,1.0,3/13,7.74%,CD9;ANXA1;MMP24
prerank,GO_Biological_Process_2021__response to ionizing radiation (GO:0010212),0.37623043068979034,0.9928430794232181,0.47619047619047616,0.8054881179546554,1.0,18/67,21.18%,LIG4;AEN;INTS7;EEF1D;MEN1;CLOCK;RFWD3;COP1;SIRT1;EYA3;UIMC1;MSH2;STK11;BRCC3;XRCC4;H2AX;IFI16;TICRR
prerank,GO_Biological_Process_2021__regulation of G0 to G1 transition (GO:0070316),0.4062472271537349,0.9925295463580569,0.5227272727272727,0.8058746418909418,1.0,8/36,16.24%,YAF2;EED;PHC1;PCGF2;MGA;PHC3;TFDP2;RBBP4
prerank,GO_Biological_Process_2021__positive regulation of protein tyrosine kinase activity (GO:0061098),0.44579280542093014,0.9923361411180088,0.5,0.8059963950980226,1.0,8/29,10.97%,CASS4;CSF1R;EPHA4;NTRK2;DLG3;SRCIN1;LRP8;FBXW7
prerank,GO_Biological_Process_2021__negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),0.4784261049024313,0.9923156872114727,0.4117647058823529,0.8056308202673914,1.0,2/10,4.62%,SOX9;NFIB
prerank,GO_Biological_Process_2021__positive regulation of cytokine production (GO:0001819),-0.37590444646698745,-0.9921843498317734,0.5172413793103449,1.0,1.0,50/210,19.82%,IL1R1;IRF1;IL7;AGPAT2;HLA-A;ISG15;ANXA1;HTR2B;RAB7B;RASGRP1;CCBE1;IL12A;BTN3A1;PQBP1;PNP;HHLA2;PRKCQ;CXCL17;NODAL;SLC11A1;TLR3;DDIT3;NOX1;EIF2AK2;IL18;CD14;BRCA1;NLRP9;ZFPM1;XBP1;RIPK2;SCIMP;POLR2L;ZP3;CRLF2;DDX41;CD74;CD274;POLR1C;WNT5A;POLR3G;PTPN22;CD6;FLOT1;C1QTNF4;NFAM1;HLA-DPB1;AGT;GAPDH;S100A13
prerank,GO_Biological_Process_2021__regulation of synaptic vesicle recycling (GO:1903421),0.6389906227473803,0.9917512904600748,0.47619047619047616,0.8065614212874501,1.0,1/5,2.09%,SNCA
prerank,GO_Biological_Process_2021__sulfur compound biosynthetic process (GO:0044272),0.3825283555943116,0.991655630238939,0.4642857142857143,0.8063939154787243,1.0,17/89,13.91%,CHST11;B4GALT3;DCN;CSPG5;CSGALNACT1;TPK1;UGDH;B4GALT6;SLC10A7;GSTM2;GCLC;CHPF2;ST3GAL1;ESD;GGCT;B4GALT2;B4GALT5
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043619),0.5710793048154538,0.9915524164759915,0.5227272727272727,0.8061935976171373,1.0,1/8,1.00%,ANKRD2
prerank,MSigDB_Hallmark_2020__Reactive Oxygen Species Pathway,-0.4530736835458242,-0.9911822634916112,0.4626865671641791,1.0,1.0,8/41,14.78%,FTL;NDUFA6;SELENOS;PRDX4;GLRX;FES;GPX4;TXNRD2
prerank,GO_Biological_Process_2021__nucleus organization (GO:0006997),0.378162550431643,0.9908871866431757,0.47058823529411764,0.8074851159112656,1.0,12/39,24.56%,CHMP1A;BIN1;SYNE1;CHMP2B;NDC1;REEP4;NUP205;LEMD3;CHMP6;ATXN7;NUP54;NUP98
prerank,GO_Biological_Process_2021__long-chain fatty-acyl-CoA metabolic process (GO:0035336),0.4413350288570985,0.9908478714835532,0.48148148148148145,0.8071856072449493,1.0,8/20,20.19%,ELOVL7;HACD2;ELOVL6;ELOVL5;HACD1;ACSBG1;FAR1;ACSL3
prerank,GO_Biological_Process_2021__sulfur amino acid biosynthetic process (GO:0000097),0.578569199147305,0.9907540105576652,0.475,0.807075753955168,1.0,2/7,22.75%,MTHFR;CDO1
prerank,GO_Biological_Process_2021__neural crest cell differentiation (GO:0014033),0.5258823353863429,0.990611530944367,0.5555555555555556,0.8069413252696166,1.0,5/13,14.16%,SOX8;FBXL17;CDH2;TAPT1;PEF1
prerank,GO_Biological_Process_2021__protein prenylation (GO:0018342),0.5464281283388593,0.990585248307768,0.525,0.8066096437486727,1.0,3/9,16.16%,PGGT1B;PTAR1;CHM
prerank,GO_Biological_Process_2021__positive regulation of protein localization to endosome (GO:1905668),-0.5892868513347241,-0.9900691652477499,0.559322033898305,1.0,1.0,2/8,12.71%,RDX;DTX3L
prerank,GO_Biological_Process_2021__positive regulation of protein localization to early endosome (GO:1902966),-0.5892868513347241,-0.9900691652477499,0.559322033898305,1.0,1.0,2/8,12.71%,RDX;DTX3L
prerank,GO_Biological_Process_2021__regulation of protein localization to early endosome (GO:1902965),-0.5892868513347241,-0.9900691652477499,0.559322033898305,1.0,1.0,2/8,12.71%,RDX;DTX3L
prerank,GO_Biological_Process_2021__development of primary male sexual characteristics (GO:0046546),-0.4823563367045124,-0.9900133838300816,0.5076923076923077,1.0,1.0,4/24,4.02%,GATA1;SOX15;ADAM21;MEA1
prerank,GO_Biological_Process_2021__DNA replication (GO:0006260),-0.3926993075374052,-0.9898049287830868,0.45454545454545453,1.0,1.0,7/90,13.61%,PIF1;RPA3;BLM;WDHD1;PNKP;BRCA1;POLE3
prerank,GO_Biological_Process_2021__protein heterotetramerization (GO:0051290),0.5211840361036305,0.9897821192490275,0.5588235294117647,0.8083580485278863,1.0,4/12,9.50%,NUDT21;GRIN1;CPSF6;PKD2
prerank,GO_Biological_Process_2021__postsynaptic membrane organization (GO:0001941),0.44345361152954543,0.9896650161938468,0.5,0.8082724757831814,1.0,6/19,12.25%,SHISA7;GPHN;NRXN1;NLGN3;SHANK3;NLGN4X
prerank,GO_Biological_Process_2021__genitalia development (GO:0048806),0.6113613564618708,0.9893798272218869,0.5,0.8084251402614052,1.0,2/5,15.44%,CHD7;PTPN11
prerank,GO_Biological_Process_2021__regulation of actin filament-based process (GO:0032970),0.344073501061181,0.9892882748528293,0.2631578947368421,0.8082657477844591,1.0,13/56,15.41%,EFNA5;RHOQ;ARHGAP35;TESK1;RHOBTB3;EPHA5;BST1;PDGFA;FAM107A;PAK3;GPM6B;TAOK2;ROCK2
prerank,GO_Biological_Process_2021__regulation of peptidyl-tyrosine phosphorylation (GO:0050730),-0.40160423981279836,-0.9892173105833176,0.4430379746835443,1.0,1.0,7/65,6.05%,SFRP2;GATA1;ENPP2;IL5;ITGA5;EFNA1;FGF7
prerank,GO_Biological_Process_2021__regulation of T cell proliferation (GO:0042129),0.3911267800281738,0.9889718205355982,0.4411764705882353,0.8086151555655962,1.0,3/33,2.25%,NCK2;TNFSF4;SDC4
prerank,GO_Biological_Process_2021__regulation of proteasomal protein catabolic process (GO:0061136),0.3459212849013214,0.9888948928544974,0.3870967741935484,0.808373829985098,1.0,14/49,21.70%,XPO1;MARCHF7;DNAAF4;PRKN;PSMF1;FBXW7;PSMD14;OSBPL7;COMMD1;OPHN1;UBQLN4;RAD23B;BAG2;FMR1
prerank,GO_Biological_Process_2021__negative regulation of protein-containing complex disassembly (GO:0043242),0.5920272410516219,0.988721235721356,0.5208333333333334,0.808386811576941,1.0,1/7,15.92%,UBQLN4
prerank,MSigDB_Hallmark_2020__Bile Acid Metabolism,-0.41394735947764516,-0.9882985109863618,0.5,1.0,1.0,4/86,3.25%,GC;PXMP2;DHCR24;PRDX5
prerank,GO_Biological_Process_2021__RNA splicing (GO:0008380),0.3248280161092041,0.9882932212132063,0.4074074074074074,0.809022338187417,1.0,19/90,19.56%,PPARGC1A;SNRPF;SNRPN;DHX15;HNRNPC;CDK12;SYNCRIP;CELF3;HNRNPH3;MBNL1;ZMAT5;U2AF1;SMNDC1;SF3B3;PTBP1;SRPK2;USB1;SMU1;NOVA1
prerank,GO_Biological_Process_2021__regulation of epithelial cell differentiation (GO:0030856),-0.5516040301680544,-0.9876495622607495,0.5918367346938775,1.0,1.0,2/11,4.51%,CD24;CEACAM1
prerank,GO_Biological_Process_2021__regulation of Golgi to plasma membrane protein transport (GO:0042996),0.5532962371292375,0.9875734857997464,0.5581395348837209,0.8102057879871124,1.0,4/7,20.19%,ATP2C1;PKDCC;CSK;ACSL3
prerank,GO_Biological_Process_2021__regulation of DNA metabolic process (GO:0051052),-0.4553696911389268,-0.9875719362311879,0.5147058823529411,1.0,1.0,1/37,0.16%,PIF1
prerank,GO_Biological_Process_2021__mitochondrial protein catabolic process (GO:0035694),0.6064054838191137,0.9874475806899523,0.5,0.8101114500154813,1.0,1/6,5.53%,AFG1L
prerank,GO_Biological_Process_2021__mitochondrion localization (GO:0051646),0.4468074103965853,0.9874365685604207,0.4,0.8097472906182827,1.0,6/17,26.28%,TRAK1;TRAK2;MTM1;NECTIN2;MARK1;MARK2
prerank,GO_Biological_Process_2021__xenobiotic transport (GO:0042908),0.48115450918893077,0.9869927353834709,0.45161290322580644,0.8103481661992844,1.0,5/18,14.83%,ABCC2;SLC15A2;ABCC5;ABCC3;SLC47A1
prerank,GO_Biological_Process_2021__high-density lipoprotein particle assembly (GO:0034380),0.5653582357399912,0.9868984569041445,0.5405405405405406,0.8101640164361167,1.0,2/8,3.66%,ABCA1;PRKACB
prerank,PanglaoDB_Augmented_2021__Smooth Muscle Cells,0.3249727624751916,0.9866468512348066,0.5,0.8104292363740593,1.0,19/127,7.86%,POSTN;ITGA1;DCN;KAT2B;RGS5;RBPMS2;RRAD;ACTA2;CXCL12;PDE4DIP;PDGFRA;CDH11;MSRB3;ZBTB44;PRKG1;PCDH18;NRP2;PRRX1;LMO7
prerank,GO_Biological_Process_2021__positive regulation of histone H4 acetylation (GO:0090240),0.6044835469424876,0.9866374445310881,0.4883720930232558,0.8100656452658976,1.0,3/6,13.97%,ARRB1;AUTS2;KAT7
prerank,GO_Biological_Process_2021__monocyte chemotaxis (GO:0002548),-0.5631832050264093,-0.9865136547880594,0.5217391304347826,1.0,1.0,5/9,14.31%,ANXA1;MSMP;CX3CL1;RPS19;CCL2
prerank,GO_Biological_Process_2021__positive regulation of synaptic plasticity (GO:0031915),-0.6220206753083152,-0.9865099553914821,0.52,1.0,1.0,4/6,36.55%,ADCY8;NEUROD2;ANAPC2;CPLX2
prerank,GO_Biological_Process_2021__regulation of flagellated sperm motility (GO:1901317),-0.635295863843357,-0.9862147508807759,0.5531914893617021,1.0,1.0,1/5,6.51%,TACR1
prerank,GO_Biological_Process_2021__positive regulation of cilium-dependent cell motility (GO:2000155),-0.635295863843357,-0.9862147508807759,0.5531914893617021,1.0,1.0,1/5,6.51%,TACR1
prerank,GO_Biological_Process_2021__positive regulation of cilium movement (GO:0003353),-0.635295863843357,-0.9862147508807759,0.5531914893617021,1.0,1.0,1/5,6.51%,TACR1
prerank,GO_Biological_Process_2021__positive regulation of flagellated sperm motility (GO:1902093),-0.635295863843357,-0.9862147508807759,0.5531914893617021,1.0,1.0,1/5,6.51%,TACR1
prerank,GO_Biological_Process_2021__positive regulation of ER-associated ubiquitin-dependent protein catabolic process (GO:1903071),0.5582868501880787,0.9860642847950842,0.5,0.8109507237059291,1.0,3/6,20.13%,UBQLN1;UBQLN2;NFE2L2
prerank,GO_Biological_Process_2021__myeloid leukocyte differentiation (GO:0002573),0.3776862298266029,0.9860248032924803,0.5172413793103449,0.8106361639445402,1.0,9/47,13.01%,FOXP1;EFNA2;CSF1R;EPHA2;PDE1B;PIR;EP300;TGFBR2;SIRT1
prerank,GO_Biological_Process_2021__purine ribonucleoside monophosphate metabolic process (GO:0009167),0.4580925591837364,0.9858629593715929,0.39473684210526316,0.8106723993788849,1.0,6/18,23.93%,AK3;GMPS;ATIC;LHPP;AK4;NT5C2
prerank,GO_Biological_Process_2021__cranial nerve development (GO:0021545),-0.6066332949151927,-0.9854220804639363,0.52,1.0,1.0,3/5,13.38%,POU4F1;TMEM126A;ERBB3
prerank,GO_Biological_Process_2021__TRAIL-activated apoptotic signaling pathway (GO:0036462),-0.6374815116306259,-0.9850313104723842,0.5384615384615384,1.0,1.0,3/6,15.13%,CASP8;SPI1;TNFRSF10A
prerank,GO_Biological_Process_2021__regulation of phospholipase C activity (GO:1900274),0.46864591267426947,0.9844429966430607,0.5,0.8132910959164733,1.0,3/14,7.84%,FLT1;PDGFRA;ABL2
prerank,GO_Biological_Process_2021__exogenous drug catabolic process (GO:0042738),-0.5572239369070884,-0.9839829870696132,0.5,1.0,1.0,3/9,16.34%,CYP2D6;NOS1;CYP3A4
prerank,GO_Biological_Process_2021__cardiac muscle hypertrophy (GO:0003300),0.5941431617823375,0.9838634927279122,0.55,0.8140588098965041,1.0,1/7,0.19%,TCAP
prerank,GO_Biological_Process_2021__negative regulation of protein autophosphorylation (GO:0031953),0.5125218076329993,0.9837796474989854,0.5238095238095238,0.8138247155401356,1.0,3/8,25.02%,TESK1;IMPACT;ERRFI1
prerank,GO_Biological_Process_2021__regulation of T-helper 17 cell differentiation (GO:2000319),0.6145931743869852,0.9835478896967579,0.5384615384615384,0.8139569076528246,1.0,1/6,7.25%,SMAD7
prerank,GO_Biological_Process_2021__cellular response to heat (GO:0034605),-0.4451742302437094,-0.983494674154094,0.4857142857142857,1.0,1.0,4/30,16.67%,THBS1;FGF1;SLU7;HTRA2
prerank,GO_Biological_Process_2021__substrate adhesion-dependent cell spreading (GO:0034446),0.4307193123502773,0.9833170020447132,0.5357142857142857,0.8141621427058153,1.0,7/41,15.85%,LAMB4;PARVA;PIK3R1;SRCIN1;FER;PXN;NRP1
prerank,GO_Biological_Process_2021__regulation of interleukin-13 production (GO:0032656),0.5409448026567284,0.9833133367754895,0.5,0.8137576905733235,1.0,1/8,1.31%,TNFSF4
prerank,GO_Biological_Process_2021__intracellular pH elevation (GO:0051454),-0.605737118397178,-0.9831795198721069,0.5555555555555556,1.0,1.0,3/6,13.86%,CFTR;NOX1;CLN3
prerank,GO_Biological_Process_2021__regulation of T cell differentiation in thymus (GO:0033081),0.5553266490104217,0.9831763829007737,0.5384615384615384,0.8136541692034129,1.0,1/9,4.75%,TOX
prerank,GO_Biological_Process_2021__positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation (GO:1905007),0.6374991603978782,0.9827777679334685,0.5625,0.8140865635143447,1.0,3/5,13.12%,TGFBR2;ACVR1;TGFBR1
prerank,GO_Biological_Process_2021__positive regulation of T cell proliferation (GO:0042102),-0.4744125763619668,-0.9824818567697254,0.5857142857142857,1.0,1.0,9/31,17.73%,CD24;ANXA1;PNP;HHLA2;PDCD1LG2;IL18;ZP3;CD274;CD6
prerank,GO_Biological_Process_2021__negative regulation of vascular endothelial cell proliferation (GO:1905563),0.6038262081852972,0.982270947656902,0.5714285714285714,0.8148999033481871,1.0,1/5,4.03%,FLT1
prerank,GO_Biological_Process_2021__positive regulation of alcohol biosynthetic process (GO:1902932),0.537130632611623,0.982017072793623,0.5208333333333334,0.8149743968697258,1.0,1/7,2.09%,SNCA
prerank,GO_Biological_Process_2021__mitotic chromosome condensation (GO:0007076),0.43726887770418754,0.9819228173236069,0.4146341463414634,0.8147650957548087,1.0,4/21,7.43%,MCPH1;CHMP1A;CSNK2A1;PHF13
prerank,GO_Biological_Process_2021__smooth muscle cell differentiation (GO:0051145),-0.6014085151525218,-0.9818948392964186,0.5660377358490566,1.0,1.0,4/9,20.54%,APLNR;HEY2;TMEM204;EDNRB
prerank,GO_Biological_Process_2021__lipid translocation (GO:0034204),0.4438900980050226,0.9814272325078094,0.4444444444444444,0.8153905382297677,1.0,4/22,12.75%,ABCA1;ATP11C;ATP9A;ATP8A1
prerank,GO_Biological_Process_2021__melanosome organization (GO:0032438),-0.5139175730563945,-0.9811661618909809,0.4915254237288136,1.0,1.0,3/20,9.09%,ASIP;SNAPIN;PMEL
prerank,GO_Biological_Process_2021__negative regulation of monooxygenase activity (GO:0032769),0.6350884670604386,0.9808909685580389,0.5531914893617021,0.816460767005147,1.0,2/6,4.81%,SNCA;NFKB1
prerank,"GO_Biological_Process_2021__regulation of complement activation, classical pathway (GO:0030450)",-0.6143535061161011,-0.9805968433240437,0.5789473684210527,1.0,1.0,4/6,30.51%,SUSD4;CR1;CR1L;CD46
prerank,"GO_Biological_Process_2021__negative regulation of complement activation, classical pathway (GO:0045959)",-0.6143535061161011,-0.9805968433240437,0.5789473684210527,1.0,1.0,4/6,30.51%,SUSD4;CR1;CR1L;CD46
prerank,PanglaoDB_Augmented_2021__Alpha Cells,0.3403879466375025,0.9803336736678525,0.35294117647058826,0.8174247110887112,1.0,27/101,20.08%,MAPK10;SOWAHA;ABCC8;PDZRN3;GLS;PLEKHA6;PCDH17;NOL4;CACNA2D1;FRZB;PKDCC;FAP;CAMK2N1;CELF3;RUNX1T1;TMEM196;RGS7BP;ASXL3;PRRG2;DDAH1;CNTN4;CSRNP3;PLPPR4;FGF14;FAM13C;POU3F4;TCEAL7
prerank,PanglaoDB_Augmented_2021__Parietal Cells,0.33271221125899725,0.9800730417320659,0.42857142857142855,0.8175948550049759,1.0,22/101,15.47%,CAPN13;EBF4;SOWAHA;FAM110C;MYO5B;HID1;PLEKHA6;BAIAP3;ZSWIM5;DLG3;ZBTB7C;PPP1R1B;SRCIN1;ATP9A;NDRG2;HOOK1;MAPK4;MYH14;NEBL;MCF2L;MTUS1;NEO1
prerank,GO_Biological_Process_2021__regulation of histone H3-K9 trimethylation (GO:1900112),0.6322828809459613,0.9799947441332477,0.5555555555555556,0.817400948407946,1.0,2/5,25.89%,ATRX;ZNF304
prerank,GO_Biological_Process_2021__protein homotetramerization (GO:0051289),-0.4372975898849577,-0.9799073518702107,0.5138888888888888,1.0,1.0,2/35,3.99%,APIP;B2M
prerank,GO_Biological_Process_2021__chromatin-mediated maintenance of transcription (GO:0048096),0.5268961960032281,0.9798031859516241,0.4883720930232558,0.8175143599907041,1.0,7/10,35.56%,ARID1B;SERTAD2;PADI2;ARID1A;SERTAD1;ELOF1;ZMIZ1
prerank,GO_Biological_Process_2021__negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),-0.5480101246122632,-0.9797352788596148,0.47619047619047616,1.0,1.0,3/10,25.52%,MMRN2;CADM4;NIBAN2
prerank,GO_Biological_Process_2021__glycoprotein metabolic process (GO:0009100),0.37212701662604347,0.9797030811283397,0.4782608695652174,0.8173368412309363,1.0,10/48,14.01%,PRKCSH;STT3B;MGAT4A;MAN1A2;ERP44;LARGE1;GOLPH3;FUT8;B4GALT5;ENGASE
prerank,GO_Biological_Process_2021__succinate transport (GO:0015744),0.5636071164040997,0.9797013239146963,0.5675675675675675,0.8169334173211482,1.0,2/6,18.73%,SLC13A3;SLC25A14
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 3 signaling pathway (GO:0034139),-0.6104970986510454,-0.9796052251049711,0.5614035087719298,1.0,1.0,2/5,17.83%,PTPN22;FLOT1
prerank,GO_Biological_Process_2021__positive regulation of neuron projection arborization (GO:0150012),0.530703768093961,0.9795137737150853,0.5714285714285714,0.8169258369598927,1.0,2/8,13.03%,DVL1;GRIP1
prerank,GO_Biological_Process_2021__intraciliary retrograde transport (GO:0035721),0.5173994980358039,0.9791340108961774,0.4772727272727273,0.8173941779482503,1.0,1/12,4.45%,CILK1
prerank,GO_Biological_Process_2021__vascular associated smooth muscle contraction (GO:0014829),0.6040680767937361,0.9789878331838043,0.6037735849056604,0.8173380038035319,1.0,1/5,3.55%,ACTA2
prerank,GO_Biological_Process_2021__negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),0.5341463367047153,0.978749465714728,0.5348837209302325,0.8174994615251323,1.0,2/11,1.73%,MEOX2;STARD13
prerank,GO_Biological_Process_2021__regulation of exocytosis (GO:0017157),0.37267282517788103,0.9786673208613712,0.39285714285714285,0.8172983112624858,1.0,11/46,16.03%,SNCA;RAB27A;STXBP5;STXBP6;CADPS2;RAB8B;RAB9A;RAB21;CLASP1;NSF;SYTL4
prerank,GO_Biological_Process_2021__atrial septum morphogenesis (GO:0060413),0.5778355532603615,0.978617175745491,0.5227272727272727,0.8170249048583101,1.0,3/8,12.28%,SOX4;NOTCH2;ACVR1
prerank,GO_Biological_Process_2021__positive regulation of mitotic cell cycle (GO:0045931),0.4595204671821346,0.9786032387359347,0.4722222222222222,0.8166471629441501,1.0,9/22,18.39%,PPP1R10;RPS6KB1;EIF4E;MEIS2;USP22;USP2;CUL3;TTL;MDM2
prerank,GO_Biological_Process_2021__protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),-0.5641538453612446,-0.978572227822648,0.5483870967741935,1.0,1.0,2/10,11.89%,EMC6;EMC4
prerank,GO_Biological_Process_2021__foam cell differentiation (GO:0090077),-0.6631045550354019,-0.9785636808183226,0.6101694915254238,1.0,1.0,1/5,3.14%,STAT1
prerank,GO_Biological_Process_2021__macrophage derived foam cell differentiation (GO:0010742),-0.6631045550354019,-0.9785636808183226,0.6101694915254238,1.0,1.0,1/5,3.14%,STAT1
prerank,GO_Biological_Process_2021__negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),-0.5168647781622865,-0.978560422219415,0.5294117647058824,1.0,1.0,2/17,4.51%,GBP1;CEACAM1
prerank,GO_Biological_Process_2021__triglyceride homeostasis (GO:0070328),-0.5379055788780394,-0.9785384004218032,0.5535714285714286,1.0,1.0,5/15,13.88%,MTLN;ANGPTL3;APOE;IL18;XBP1
prerank,GO_Biological_Process_2021__hydrogen peroxide catabolic process (GO:0042744),-0.5764555310057984,-0.9784288682355132,0.5833333333333334,1.0,1.0,2/8,6.62%,PRDX5;PRDX4
prerank,GO_Biological_Process_2021__protein N-linked glycosylation (GO:0006487),0.3239102155843902,0.9783636416968043,0.4375,0.8168086427945472,1.0,9/61,14.60%,OSTC;STT3B;MGAT4A;GAL3ST1;ST3GAL1;ALG6;FUT8;UGGT1;ALG10
prerank,GO_Biological_Process_2021__neural crest cell development (GO:0014032),0.41259987176720087,0.9779765770223744,0.46875,0.8174844337172834,1.0,10/34,16.40%,SEMA5B;SOX8;ERBB4;CDH2;SEMA3C;TAPT1;PEF1;SEMA6C;SEMA4D;SEMA3D
prerank,GO_Biological_Process_2021__fatty acid oxidation (GO:0019395),0.37427037432821997,0.9779245279302536,0.42857142857142855,0.8172436116095992,1.0,12/49,14.49%,PPARGC1A;HADH;ADIPOR2;ECHDC1;BDH2;AUH;PEX2;HSD17B4;ACADVL;ABCD3;ACADM;ADIPOR1
prerank,GO_Biological_Process_2021__positive regulation of helicase activity (GO:0051096),0.5609926126651802,0.977710404210681,0.5961538461538461,0.8172921310653242,1.0,4/7,34.27%,MSH2;POT1;MSH3;SSBP1
prerank,GO_Biological_Process_2021__associative learning (GO:0008306),0.5169196629634311,0.9776674676970785,0.5813953488372093,0.8170115058620803,1.0,3/8,21.67%,SHANK1;DRD2;SLC6A1
prerank,GO_Biological_Process_2021__Golgi to plasma membrane protein transport (GO:0043001),0.4091562102669084,0.9772982174105408,0.4782608695652174,0.817421118484749,1.0,10/26,20.55%,RAB31;ARFRP1;GOLPH3;GGA2;GOLGA7;KIF13A;NSF;BBS2;GGA1;RAB10
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial growth factor signaling pathway (GO:1900748),0.6130622561522754,0.9772204092407184,0.5531914893617021,0.8172048562775717,1.0,2/5,7.91%,ADAMTS3;ROBO1
prerank,GO_Biological_Process_2021__ear morphogenesis (GO:0042471),0.5495600015581665,0.9767080588051715,0.5087719298245614,0.8178864813855621,1.0,5/9,27.09%,CHD7;NIPBL;FGFR2;TMIE;MYO6
prerank,GO_Biological_Process_2021__ion homeostasis (GO:0050801),0.43608018657236874,0.9763577875722528,0.5833333333333334,0.8183511409741828,1.0,8/24,18.82%,SLC30A4;NEDD4L;CAMK2D;SLC4A7;SLC4A4;SLC4A10;WNK3;WNK1
prerank,GO_Biological_Process_2021__negative regulation of protein localization to cell surface (GO:2000009),0.5466606320817418,0.9762378854230773,0.5,0.818238833573045,1.0,5/10,13.37%,PICALM;NEDD4L;GPM6B;LEPROTL1;COMMD1
prerank,GO_Biological_Process_2021__positive regulation of DNA-dependent DNA replication (GO:2000105),0.5329209844008709,0.9760290565157849,0.5306122448979592,0.8183507255291788,1.0,4/9,40.34%,ATRX;INO80;SSBP1;WIZ
prerank,GO_Biological_Process_2021__regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),0.4452959496853597,0.9758757458198297,0.4418604651162791,0.818334519547958,1.0,8/19,24.64%,SMAD2;SMAD7;SMAD4;BCL9;LATS1;ZNF703;TRIM33;SMAD3
prerank,GO_Biological_Process_2021__mismatch repair (GO:0006298),0.43252316408698294,0.9757154844791412,0.41025641025641024,0.8183503108963841,1.0,2/22,4.20%,MSH4;POLD3
prerank,GO_Biological_Process_2021__positive regulation of protein kinase B signaling (GO:0051897),0.33184471188329195,0.9755829452585282,0.5263157894736842,0.8182861721549549,1.0,23/105,16.90%,CASS4;FAM110C;ERBB4;EGFR;PDGFRA;FGF17;HCLS1;MYORG;PIK3CA;STRN;PIK3R1;PDGFA;IRS1;PTPRJ;PTK2;NRG2;TGFBR1;OSBPL8;GAB1;HIP1;PTPN11;HGF;AKT2
prerank,GO_Biological_Process_2021__regulation of protein kinase C signaling (GO:0090036),0.50127118206863,0.9755052113723839,0.4634146341463415,0.8180383820764362,1.0,2/11,14.38%,ADRA1A;DGKG
prerank,GO_Biological_Process_2021__negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),0.5425142302801896,0.9754859798372176,0.5641025641025641,0.8173041340202586,1.0,2/8,9.50%,GSTM2;PKD2
prerank,GO_Biological_Process_2021__negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),0.5425142302801896,0.9754859798372176,0.5641025641025641,0.8173041340202586,1.0,2/8,9.50%,GSTM2;PKD2
prerank,GO_Biological_Process_2021__receptor recycling (GO:0001881),0.5629265346888108,0.975378806530386,0.6388888888888888,0.817208726925513,1.0,7/8,43.43%,PHETA1;RAB11B;LMTK2;PLEKHJ1;ARFGEF2;SORL1;EHD3
prerank,GO_Biological_Process_2021__Rac protein signal transduction (GO:0016601),0.48785996627380257,0.975073111437111,0.5116279069767442,0.8175439004812859,1.0,6/17,17.44%,EPS8;NCKAP1;CYFIP1;HACE1;WASF1;CDH13
prerank,GO_Biological_Process_2021__positive regulation of protein targeting to membrane (GO:0090314),-0.46190313455117105,-0.9744697429439436,0.4794520547945205,1.0,1.0,5/22,12.15%,KCNB1;PDZK1;SLC51B;CEMIP;FIS1
prerank,GO_Biological_Process_2021__microtubule cytoskeleton organization involved in mitosis (GO:1902850),-0.3782274165693163,-0.9736594306872748,0.4675324675324675,1.0,1.0,16/103,16.21%,RPS27;ERCC6L;CENPE;SPC24;ZWILCH;KIF2C;NUF2;SPDL1;MIS12;KIF4A;ITGB3BP;CENPH;CENPN;TBCE;DCTN2;DSN1
prerank,GO_Biological_Process_2021__negative regulation of myotube differentiation (GO:0010832),-0.5746961972325825,-0.9736029968744982,0.4807692307692308,1.0,1.0,2/8,13.88%,BDNF;XBP1
prerank,GO_Biological_Process_2021__intracellular steroid hormone receptor signaling pathway (GO:0030518),0.3984862220174398,0.973187146497225,0.5454545454545454,0.8215361102955203,1.0,9/35,16.66%,PLPP1;UBR5;RNF14;RBFOX2;NR3C1;TRIP4;YAP1;PADI2;NR3C2
prerank,GO_Biological_Process_2021__positive regulation of protein phosphorylation (GO:0001934),0.3045514726703513,0.973167514206768,0.5,0.8211600340944858,1.0,74/273,19.09%,VEGFD;LEPR;SNCA;EFNA5;NPTN;BMP2;ERBB4;CSF1R;EGFR;RPS6KA4;SOX9;MMD;FGF17;ARRB1;HCLS1;TESK1;CNOT9;LIMCH1;TNIK;AKT1;AGAP2;NTRK2;TEC;RAPGEF2;PDGFA;VEGFC;DOCK7;CAPRIN2;PTPRJ;BRAF;RALB;GDF10;LRP8;PRKD1;DUSP19;STOX1;CRKL;PTK2;CLIP3;ACVR1;SIRT1;TGFBR1;PDGFC;RAP2C;ACVR2A;WDFY2;RAP1A;NIBAN1;BMPR1A;RPTOR;MAPK1;SMAD4;TAOK2;TENM1;ROCK2;LATS1;PTPN11;ATP2B4;NRP1;HGF;BMP7;SEMA4D;TFRC;AKT2;FXR1;RAP2A;IGF1;WNK3;FAS;AXIN1;CAB39;CAMKK1;ALS2;CCND3
prerank,"GO_Biological_Process_2021__positive regulation of DNA-templated transcription, elongation (GO:0032786)",0.4279314526409265,0.9730859288825775,0.5428571428571428,0.8209833327988003,1.0,8/21,25.93%,CDK12;KAT7;CDK13;CCNT2;SCAF8;CDC73;BRD4;ERCC6
prerank,GO_Biological_Process_2021__regulation of dopamine receptor signaling pathway (GO:0060159),-0.5732224337176253,-0.9726841576672034,0.5740740740740741,1.0,1.0,2/6,19.17%,CAV2;VPS35
prerank,GO_Biological_Process_2021__positive regulation of ATP metabolic process (GO:1903580),0.43991647017542157,0.9726157853961203,0.4444444444444444,0.8217854509247075,1.0,3/28,4.08%,PPARGC1A;PID1;ZBTB20
prerank,GO_Biological_Process_2021__fatty acid biosynthetic process (GO:0006633),-0.4047679970599886,-0.9724542782112281,0.48717948717948717,1.0,1.0,16/56,20.27%,LIPI;HSD17B8;ACSM6;CYP2D6;ACSBG2;ACSM5;ACSM3;FADS1;XBP1;GPX4;ALOX12;CYP3A4;OXSM;ASAH2;FADS3;TECR
prerank,GO_Biological_Process_2021__Golgi to endosome transport (GO:0006895),0.516576386299525,0.972372781226463,0.4878048780487805,0.8219187694149148,1.0,2/15,4.67%,SORT1;EPS15
prerank,GO_Biological_Process_2021__pyrimidine deoxyribonucleotide biosynthetic process (GO:0009221),-0.6322568981412795,-0.9721934896687338,0.5636363636363636,1.0,1.0,2/5,6.59%,CMPK2;TYMS
prerank,GO_Biological_Process_2021__negative regulation of protein modification by small protein conjugation or removal (GO:1903321),-0.42096600883145896,-0.9720867016641555,0.4647887323943662,1.0,1.0,7/48,9.40%,COPS9;RPL11;ISG15;TRIM21;RPL5;SVBP;PIAS3
prerank,GO_Biological_Process_2021__positive regulation of histone modification (GO:0031058),0.44251754345966304,0.9720782657403154,0.5675675675675675,0.8220599070956679,1.0,4/30,7.77%,PPARGC1A;RPS6KA4;ARRB1;UBE2N
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),-0.3872230475001146,-0.9717830732443453,0.4625,1.0,1.0,9/87,7.41%,GATA1;ENPP2;IL5;PARP14;ITGA5;EFNA1;IL12A;FGF7;HES1
prerank,GO_Biological_Process_2021__monovalent inorganic anion homeostasis (GO:0055083),0.5661407523005768,0.9716661282339657,0.4358974358974359,0.8221988327550824,1.0,5/9,25.41%,SLC12A2;CA12;SLC12A8;SLC12A9;SLC12A6
prerank,GO_Biological_Process_2021__chloride ion homeostasis (GO:0055064),0.5661407523005768,0.9716661282339657,0.4358974358974359,0.8221988327550824,1.0,5/9,25.41%,SLC12A2;CA12;SLC12A8;SLC12A9;SLC12A6
prerank,GO_Biological_Process_2021__positive regulation of DNA-binding transcription factor activity (GO:0051091),0.2957336632882567,0.9716531501250358,0.6470588235294118,0.8218395866720465,1.0,31/184,14.58%,PPARGC1A;IRAK2;TAB3;RPS6KA4;ADCY1;RGCC;NFKB1;HCLS1;AKT1;ZIC2;EPHA5;UBE2N;CAMK2A;ROR1;TICAM1;MAP3K7;CLOCK;TAB1;TRADD;LRP8;CFLAR;EP300;PRKD1;RNF25;PLPP3;HDAC4;HIPK2;DHX9;FER;CRTC2;JMY
prerank,GO_Biological_Process_2021__spermatid development (GO:0007286),0.4255936018987684,0.9715630920683945,0.5882352941176471,0.8215758890204601,1.0,7/22,25.18%,PLD6;JAM2;MKKS;NECTIN2;CIB1;YTHDC2;RFX2
prerank,GO_Biological_Process_2021__negative regulation of establishment of protein localization to mitochondrion (GO:1903748),0.5790326453690404,0.9715313830374457,0.5849056603773585,0.8212172931729554,1.0,3/5,40.29%,DNAJA1;BAG4;LRRK2
prerank,GO_Biological_Process_2021__DNA methylation (GO:0006306),0.4711937952363253,0.9709671176501424,0.43243243243243246,0.8221509249246958,1.0,6/20,26.37%,HELLS;ATRX;PPM1D;BEND3;EHMT1;PICK1
prerank,PanglaoDB_Augmented_2021__Juxtaglomerular Cells,-0.3842346732785302,-0.9709659861332152,0.4861111111111111,1.0,1.0,24/69,19.18%,LMOD1;AQP1;ANGPTL2;C1R;SEMA5A;ELN;IGFBP5;MGP;SOD3;PAMR1;ADGRL4;MATN2;C1S;SRPX2;CREB3L1;TNS2;EDNRA;COL4A2;CALD1;CRYAB;COL14A1;TAGLN;BGN;CPXM2
prerank,GO_Biological_Process_2021__peptidyl-tyrosine dephosphorylation (GO:0035335),0.41210397702470924,0.9708804465441662,0.5,0.8219983648955951,1.0,16/28,25.82%,DUSP10;PTPN13;PTPRJ;PTPN9;PTPRB;PTPRZ1;DUSP6;DUSP22;PTPN11;PTPRO;DUSP18;UBASH3B;PTPN2;PTPRS;DUSP8;DUSP3
prerank,GO_Biological_Process_2021__regulation of defense response to virus (GO:0050688),0.4794005865573552,0.970857707262429,0.4878048780487805,0.8216559212135861,1.0,4/14,13.47%,ITCH;RNF26;DHX9;ELMOD2
prerank,GO_Biological_Process_2021__selective autophagy (GO:0061912),-0.4182055561744177,-0.9708392301363605,0.5068493150684932,1.0,1.0,5/54,9.49%,CFTR;RPS27A;ATG14;LGALS8;UBC
prerank,GO_Biological_Process_2021__negative regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002924),-0.6141035894058331,-0.9707910028604152,0.5833333333333334,1.0,1.0,4/7,30.51%,SUSD4;CR1;CR1L;CD46
prerank,GO_Biological_Process_2021__negative regulation of muscle cell apoptotic process (GO:0010656),0.5852159685330859,0.9706458548417607,0.5714285714285714,0.8217411725330472,1.0,4/6,20.43%,DIPK2A;BMP7;IGF1;BAG3
prerank,GO_Biological_Process_2021__histone-serine phosphorylation (GO:0035404),-0.5953778975187191,-0.9705893841797644,0.5576923076923077,1.0,1.0,1/5,2.92%,MST1
prerank,GO_Biological_Process_2021__autophagy of nucleus (GO:0044804),0.4504908617012242,0.9705853951974388,0.4857142857142857,0.8215415700695835,1.0,5/15,27.63%,ATG7;ATG2B;ATG5;RB1CC1;ATG3
prerank,PanglaoDB_Augmented_2021__Alveolar Macrophages,-0.4497374259639776,-0.970499321891489,0.5636363636363636,1.0,1.0,10/35,13.63%,CLEC12A;IGSF6;CXCL2;TNFAIP2;SLC11A1;PLET1;CD14;SPI1;CLEC5A;MYO1F
prerank,GO_Biological_Process_2021__aromatic compound biosynthetic process (GO:0019438),-0.6643665884676834,-0.9704979536334322,0.6346153846153846,1.0,1.0,1/6,1.59%,ACMSD
prerank,GO_Biological_Process_2021__regulation of nucleocytoplasmic transport (GO:0046822),0.5047264805795785,0.9700960163285763,0.5416666666666666,0.8224411628845671,1.0,3/11,18.33%,UHMK1;PTPN14;NUP214
prerank,GO_Biological_Process_2021__nonribosomal peptide biosynthetic process (GO:0019184),0.511529782784266,0.9697211391180504,0.5128205128205128,0.823015876974093,1.0,3/10,12.62%,BDH2;GCLC;GGCT
prerank,GO_Biological_Process_2021__macroautophagy (GO:0016236),0.3265310341283957,0.9694794884115129,0.5789473684210527,0.8230450149768453,1.0,31/107,23.51%,VPS37B;TBC1D5;CSNK2A1;VPS37A;ATG7;PIK3C3;PIK3R4;TMEM74;PRKN;TOMM22;VPS16;DYNLL2;VPS41;CHMP2B;UBXN6;PRKAB1;RUBCNL;UBQLN1;VCP;VTA1;MTERF3;CSNK2A2;ATG5;CHMP6;PGAM5;STAM2;VPS39;TSG101;RB1CC1;STX17;HDAC10
prerank,GO_Biological_Process_2021__protein deubiquitination (GO:0016579),0.314300478161066,0.9680795456795651,0.3333333333333333,0.8260268713020986,1.0,64/223,20.74%,USP13;CDC25A;USP49;USP46;KAT2B;KEAP1;RHOT1;OTUB2;USP31;SMAD2;PSMA1;USP38;ADRB2;SMAD7;UBE2D1;USP12;PSMD11;MAP3K7;CCNA2;INO80D;PSMD10;USP24;KAT2A;PRKN;TAB1;SUPT3H;PSMF1;EP300;USP3;ZRANB1;PSMD14;VCPIP1;TGFBR1;OGT;USP40;SMAD4;MDM4;VCP;USP25;OTUD4;USP35;USP22;USP9X;USP47;BIRC2;UIMC1;ABRAXAS2;USP2;BRCC3;PSME4;HIF1A;YY1;KDM1B;MDM2;RAD23B;PTEN;USP34;OTULIN;ASXL2;STAM2;MBD5;ATXN7;OTUD7A;WDR48
prerank,GO_Biological_Process_2021__negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901029),-0.6216796287236481,-0.9679219533910667,0.6071428571428571,1.0,1.0,2/5,16.83%,FZD9;SLC25A5
prerank,GO_Biological_Process_2021__negative regulation of response to external stimulus (GO:0032102),0.3625332330334747,0.9676225155335259,0.45,0.826622697664989,1.0,13/79,11.64%,MACIR;SERPINE1;AJAP1;EPHA4;RORA;MAPKBP1;CTNNA2;ITCH;RNF26;NR1D1;RTN4RL1;LRFN5;TNFAIP6
prerank,GO_Biological_Process_2021__MAPK cascade (GO:0000165),0.2950001298946556,0.9675876991035506,0.5454545454545454,0.8262951200769694,1.0,70/238,19.40%,BTRC;CSF2RA;ERBB4;EGFR;SOX9;PSPN;KBTBD7;NFKB1;PDGFRA;FGF17;GRIN1;TNIK;ABHD17B;PSMA1;RAPGEF2;PIK3CA;CAMK2B;DLG3;PIK3R1;PDGFA;IRS1;SPRED1;MBP;CAMK2A;RASAL2;GFRA1;SHOC2;PSMD11;MAP3K7;MAPK11;SHC3;PSMD10;MEN1;BRAF;MAP3K20;PSMF1;NF1;MAP3K5;MAP4K4;MRAS;ABHD17A;PSMD14;SHANK3;SOS1;PTK2;RASA2;GOLGA7;NRAS;RASAL1;MAPKAPK2;NRG2;MAPK1;TAOK2;CUL1;DLG1;DUSP6;MAPK8;HGF;SYNGAP1;PRKG2;PSME4;CUL3;IGF1;CCM2;PPP1CC;FYN;FBXW11;PPP1CB;MAP2K2;RGL3
prerank,GO_Biological_Process_2021__positive regulation of TORC1 signaling (GO:1904263),0.4947593786870853,0.9674306182628076,0.5238095238095238,0.8262122507395561,1.0,3/15,24.58%,SIK3;RRAGD;GPR137B
prerank,GO_Biological_Process_2021__chromatin remodeling at centromere (GO:0031055),-0.43655096049016384,-0.9673558696423971,0.45454545454545453,1.0,1.0,11/26,27.40%,CENPV;OIP5;ITGB3BP;CENPH;CENPN;CENPU;NPM1;KNL1;SMARCA5;CENPX;MIS18A
prerank,GO_Biological_Process_2021__regulation of amyloid precursor protein catabolic process (GO:1902991),0.5132772286928766,0.967349582151711,0.5,0.8259639847668242,1.0,4/11,19.93%,PICALM;ABCA2;ROCK2;ROCK1
prerank,GO_Biological_Process_2021__negative regulation of proteolysis (GO:0045861),-0.47825181364288083,-0.9672467504138842,0.5,1.0,1.0,9/26,18.13%,EFNA1;TIMP1;TRIM21;CSTB;CST3;CLN3;CDK5;PTPN3;PLAT
prerank,GO_Biological_Process_2021__regulation of lipid transport (GO:0032368),0.6076432040231461,0.9672024558334595,0.5952380952380952,0.8258734786180778,1.0,1/7,10.08%,PRKN
prerank,GO_Biological_Process_2021__negative regulation of ERBB signaling pathway (GO:1901185),-0.43145729084052714,-0.9670726692881099,0.4857142857142857,1.0,1.0,1/33,0.10%,EPN1
prerank,GO_Biological_Process_2021__adenosine metabolic process (GO:0046085),0.5801087268348837,0.9669841871208555,0.5531914893617021,0.8259562490318995,1.0,2/5,11.84%,NT5C1A;ADA
prerank,GO_Biological_Process_2021__negative regulation of stress fiber assembly (GO:0051497),0.4133389266388873,0.9668875889778185,0.4722222222222222,0.8257714121349806,1.0,5/21,14.04%,ARAP1;CGNL1;PIK3R1;CLASP1;TJP1
prerank,GO_Biological_Process_2021__cell morphogenesis involved in neuron differentiation (GO:0048667),0.3401066649656538,0.9668739347368268,0.5517241379310345,0.8254215947189258,1.0,22/70,20.55%,WNT7A;PARD3;BTBD3;CTNNA2;SLITRK2;DOCK7;PAK3;SLITRK1;DVL1;DCC;FARP1;OPHN1;TAOK2;TMEM106B;CNTN4;PLPPR4;APBB1;LRP4;DRD2;ADGRB1;SDC2;RAB10
prerank,GO_Biological_Process_2021__regulation of blood circulation (GO:1903522),0.4194291063293225,0.9668346912266168,0.5,0.8250721135041363,1.0,1/20,0.08%,ACE2
prerank,GO_Biological_Process_2021__negative regulation of potassium ion transmembrane transport (GO:1901380),0.5958876802916431,0.9667099696515351,0.5,0.8249901102051161,1.0,3/7,6.86%,NEDD4L;BIN1;KCNH2
prerank,GO_Biological_Process_2021__macropinocytosis (GO:0044351),0.5860522714957626,0.9665503467889276,0.5454545454545454,0.8249160389933364,1.0,2/6,12.58%,CARMIL1;MAPKAPK2
prerank,GO_Biological_Process_2021__negative regulation of interleukin-1 beta production (GO:0032691),0.5073928489543003,0.9661151971144804,0.475,0.8255014038452829,1.0,2/11,3.96%,CARD18;GIT1
prerank,GO_Biological_Process_2021__sensory perception of light stimulus (GO:0050953),0.3550153622706697,0.9659614166124981,0.4411764705882353,0.8254820791882507,1.0,15/59,15.09%,POU6F2;TYR;RGS16;CRYGS;ZIC2;ATF6;CRYBB3;DRAM2;SLC4A10;OPA1;EYA3;WHRN;RP2;CRYBB2;GRM8
prerank,PanglaoDB_Augmented_2021__Mesothelial Cells,-0.3745918044662708,-0.9659433444143117,0.44155844155844154,1.0,1.0,22/98,19.25%,GBP2;C1R;IGFBP5;FMO2;CAV2;FGF1;SOD3;ADGRL4;MATN2;LURAP1L;C1S;SRPX2;S100A16;TNS2;EDNRA;COL4A2;CRYAB;C1QTNF1;CDH1;BGN;EHD2;AMOTL2
prerank,GO_Biological_Process_2021__regulation of interleukin-1 beta production (GO:0032651),0.38531587680214546,0.9658433708403703,0.4827586206896552,0.8253765104310047,1.0,5/42,5.31%,CARD18;FOXP1;STMP1;GIT1;FZD5
prerank,GO_Biological_Process_2021__engulfment of apoptotic cell (GO:0043652),-0.5492719293581977,-0.9657299135304914,0.5645161290322581,1.0,1.0,3/11,10.33%,RHOBTB2;THBS1;RHOH
prerank,GO_Biological_Process_2021__negative regulation of mitotic cell cycle phase transition (GO:1901991),-0.375135215240852,-0.9656211178129838,0.4927536231884058,1.0,1.0,13/80,17.14%,PSMB6;PSMA8;PSMB9;PSMA7;PSMC3;PSME1;WEE1;KLF4;PSMC4;PSMA3;CCL2;GFI1B;RBX1
prerank,MSigDB_Hallmark_2020__Apoptosis,-0.3785783746467176,-0.9656126939574685,0.5555555555555556,1.0,1.0,28/123,21.70%,IFITM3;IRF1;IER3;BCL2L2;ANXA1;TIMP1;NEFH;CASP8;WEE1;DDIT3;CLU;IL18;CD14;BRCA1;ERBB3;GPX4;RETSAT;CCND1;TNFRSF12A;BTG3;PLAT;BGN;SQSTM1;GADD45A;GADD45B;TIMP2;TSPO;BCAP31
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance via telomerase (GO:0032211),-0.5166423773983353,-0.9654406374094413,0.49230769230769234,1.0,1.0,1/18,0.16%,PIF1
prerank,GO_Biological_Process_2021__positive regulation of nitric oxide biosynthetic process (GO:0045429),-0.4812890632351647,-0.9653114065744691,0.5205479452054794,1.0,1.0,3/15,11.22%,KLF2;KLF4;CLU
prerank,GO_Biological_Process_2021__miRNA loading onto RISC involved in gene silencing by miRNA (GO:0035280),0.5514675584301699,0.9643601161462674,0.5641025641025641,0.8281398604704779,1.0,4/7,31.12%,AGO3;DICER1;AGO1;AGO2
prerank,"GO_Biological_Process_2021__wound healing, spreading of cells (GO:0044319)",-0.48691601541750434,-0.9643193433311329,0.5,1.0,1.0,6/21,10.25%,ITGA5;COL5A1;CEACAM1;PDPN;CCN1;PLET1
prerank,GO_Biological_Process_2021__regulation of protein localization to membrane (GO:1905475),-0.4675510700413133,-0.9642533484280439,0.5217391304347826,1.0,1.0,6/28,15.23%,GBP1;PDZK1;GPC3;VAMP8;CLN3;CDK5
prerank,GO_Biological_Process_2021__regulation of protein targeting to membrane (GO:0090313),-0.45676234742130667,-0.96417219339325,0.5147058823529411,1.0,1.0,5/26,12.15%,KCNB1;PDZK1;SLC51B;CEMIP;FIS1
prerank,GO_Biological_Process_2021__adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.344379636408173,0.9637411816896977,0.5769230769230769,0.829082949053651,1.0,20/84,16.14%,NPY1R;ABCA1;ADGRB3;PRKACB;CNR1;ADCY1;ADGRL3;CALCB;ADRB2;LGR4;GNAI3;GNA13;LPAR3;GPR161;GABBR1;ADGRL2;GNAI1;GRM8;GNAQ;VIPR1
prerank,GO_Biological_Process_2021__glycerophospholipid catabolic process (GO:0046475),-0.4828014318004042,-0.9635848653582991,0.5483870967741935,1.0,1.0,1/18,2.28%,ENPP2
prerank,GO_Biological_Process_2021__regulation of microvillus organization (GO:0032530),-0.5865444062242362,-0.9633754384045901,0.603448275862069,1.0,1.0,4/7,20.15%,PODXL;FSCN1;CDHR2;ATP8B1
prerank,GO_Biological_Process_2021__sphingoid metabolic process (GO:0046519),0.47984923916120137,0.9633472869383627,0.5833333333333334,0.8295631178122865,1.0,3/12,11.98%,PLPP1;PLPP3;PLPP2
prerank,GO_Biological_Process_2021__monosaccharide transmembrane transport (GO:0015749),-0.5577647872618343,-0.9632553157769228,0.5614035087719298,1.0,1.0,1/10,2.33%,SLC5A10
prerank,PanglaoDB_Augmented_2021__Glomus Cells,0.3094398015690271,0.963129414072827,0.5769230769230769,0.8296436476116776,1.0,29/118,19.34%,TENM3;MPDZ;ABCC8;ANK2;MEIS3;PDZRN3;LIMCH1;CACNA2D1;FRZB;PKDCC;GFRA1;PRICKLE2;RBFOX2;HSPA12A;TLN2;GUCY1A2;PLPP3;SLIT2;ZNF423;ASIC3;ADGRL2;PLPPR4;BCAR1;LIFR;LRCH2;CHST3;LRP4;FAM13C;DRD2
prerank,GO_Biological_Process_2021__sensory organ morphogenesis (GO:0090596),-0.5440150140588458,-0.9631095969385859,0.5319148936170213,1.0,1.0,1/7,3.46%,COL5A1
prerank,GO_Biological_Process_2021__positive regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000343),0.6076132228587477,0.9630425380564308,0.5306122448979592,0.8294659313150967,1.0,2/5,9.68%,MBP;HMGB1
prerank,GO_Biological_Process_2021__negative regulation of response to cytokine stimulus (GO:0060761),-0.5863677081425003,-0.9630415953988588,0.5,1.0,1.0,2/8,10.93%,SIGIRR;KLF4
prerank,GO_Biological_Process_2021__digestive tract morphogenesis (GO:0048546),0.5659944738424779,0.9629223887327257,0.5952380952380952,0.8293587610092926,1.0,3/8,12.75%,RBPMS2;PDGFRA;NIPBL
prerank,GO_Biological_Process_2021__regulation of calcium ion transmembrane transport (GO:1903169),0.4511465580115509,0.9625367711416253,0.4583333333333333,0.8298456961530852,1.0,5/16,11.24%,ANK2;CACNA2D1;CASQ1;CBARP;CAMK2D
prerank,GO_Biological_Process_2021__response to reactive oxygen species (GO:0000302),0.3614704229108985,0.9623961242472208,0.4482758620689655,0.8297306347511256,1.0,17/49,20.37%,PTPRK;EGFR;PDGFRA;AKT1;APTX;PKD2;SIRT1;AGAP3;FER;MAPK1;PDK2;PXN;MAPK8;HIF1A;FYN;MAPK9;ADAM9
prerank,GO_Biological_Process_2021__carnitine transport (GO:0015879),-0.6447947814125037,-0.9620580126099898,0.576271186440678,1.0,1.0,1/5,3.29%,PDZK1
prerank,GO_Biological_Process_2021__regulation of bone mineralization (GO:0030500),0.3757311092629421,0.961588218785707,0.4838709677419355,0.8311383149682143,1.0,11/42,16.20%,BMP2;TRPM4;PKDCC;BMPR1B;ANKH;GPM6B;ACVR1;ACVR2A;BMPR1A;ECM1;BMP7
prerank,GO_Biological_Process_2021__atrial septum development (GO:0003283),0.5538839540210188,0.9615016146348102,0.4782608695652174,0.8309368955803907,1.0,2/8,4.56%,ANK2;NOTCH2
prerank,GO_Biological_Process_2021__very long-chain fatty acid metabolic process (GO:0000038),-0.4662399832494921,-0.9613384467212972,0.5294117647058824,1.0,1.0,2/28,1.74%,ACOT2;ACOT1
prerank,GO_Biological_Process_2021__tail-anchored membrane protein insertion into ER membrane (GO:0071816),-0.5013439584809534,-0.9611577785682776,0.47058823529411764,1.0,1.0,2/15,11.89%,EMC6;EMC4
prerank,GO_Biological_Process_2021__protein sialylation (GO:1990743),0.5912659681708599,0.9608784628275038,0.5510204081632653,0.831968213796909,1.0,1/5,10.43%,ST3GAL1
prerank,GO_Biological_Process_2021__peroxisomal membrane transport (GO:0015919),0.4385862407277001,0.9607598284054975,0.4117647058823529,0.8318055768664567,1.0,10/25,18.03%,GDAP1;RAB8B;PEX14;PEX16;PEX5;PEX2;ABCD3;PEX7;PEX6;PEX13
prerank,GO_Biological_Process_2021__cardiocyte differentiation (GO:0035051),0.512899886597086,0.9606787757677795,0.4418604651162791,0.8315963339746512,1.0,1/8,2.72%,BMP2
prerank,GO_Biological_Process_2021__regulation of cellular response to oxidative stress (GO:1900407),0.502581936474949,0.9606195129039571,0.5384615384615384,0.8313171823712603,1.0,3/9,16.20%,AIFM2;PRKN;BMP7
prerank,GO_Biological_Process_2021__regulation of histamine secretion by mast cell (GO:1903593),-0.6652744292975523,-0.9605091888838571,0.5636363636363636,1.0,1.0,2/5,18.93%,VAMP8;SNX6
prerank,GO_Biological_Process_2021__cholesterol metabolic process (GO:0008203),-0.4057868929597387,-0.9604652051946697,0.5714285714285714,1.0,1.0,16/53,21.38%,DHCR24;ANGPTL3;MVK;SQLE;MT3;APOE;DHCR7;SCARF1;HSD17B7;FDPS;ACAT2;ABCA5;TM7SF2;INSIG1;MSMO1;HMGCR
prerank,GO_Biological_Process_2021__positive regulation of protein localization to centrosome (GO:1904781),0.589856703683249,0.9604156229524763,0.56,0.8313730974701645,1.0,3/6,36.10%,GSK3B;PARD6A;BICD1
prerank,GO_Biological_Process_2021__protein tetramerization (GO:0051262),0.374632089785258,0.9602503241263423,0.5333333333333333,0.8312888767981729,1.0,10/52,9.50%,NUDT21;ACACB;SAMHD1;SNCA;GLS;GRIN1;CPSF6;TRPM4;HOMER1;PKD2
prerank,GO_Biological_Process_2021__positive regulation of exosomal secretion (GO:1903543),0.4698941935691629,0.9601405938865588,0.5116279069767442,0.8311658429001834,1.0,1/13,2.25%,SDC4
prerank,GO_Biological_Process_2021__negative regulation of axonogenesis (GO:0050771),0.4082419433823336,0.9600450158840407,0.5588235294117647,0.8310273760200401,1.0,11/25,29.08%,RNF6;KIAA0319;DCC;RUFY3;PTEN;LRP4;ARHGDIA;PTPRS;TRIM46;MCF2;FGF13
prerank,GO_Biological_Process_2021__mitotic DNA replication checkpoint signaling (GO:0033314),0.6032974749185407,0.9599017013720658,0.5952380952380952,0.8309589821631145,1.0,1/7,21.18%,TICRR
prerank,GO_Biological_Process_2021__natural killer cell mediated cytotoxicity (GO:0042267),-0.5732027779537823,-0.9596094513729283,0.6101694915254238,1.0,1.0,3/9,24.88%,TUBB;MICA;TUBB4B
prerank,GO_Biological_Process_2021__regulation of cell adhesion mediated by integrin (GO:0033628),-0.47841455337157396,-0.9594799321939351,0.5573770491803278,1.0,1.0,3/22,3.42%,SFRP2;EFNA1;P2RY12
prerank,GO_Biological_Process_2021__regulation of immune response (GO:0050776),-0.3815133214195945,-0.9592505770408759,0.5584415584415584,1.0,1.0,17/79,18.09%,IRF1;HLA-B;HLA-A;HLA-C;B2M;ERAP1;CASP8;RSAD2;KLRD1;HERC5;MADCAM1;CD160;SPINK5;MICA;ICAM1;PTPN22;ADCY7
prerank,GO_Biological_Process_2021__negative regulation of amyloid precursor protein catabolic process (GO:1902992),0.4369853370847635,0.9591143898960809,0.5,0.8321412342219596,1.0,3/19,6.44%,PICALM;BIN1;NTRK2
prerank,GO_Biological_Process_2021__histone H3-K27 demethylation (GO:0071557),0.6154128322470236,0.9590707255979077,0.6470588235294118,0.8319559181830964,1.0,3/5,32.04%,KDM7A;KDM6A;PHF8
prerank,GO_Biological_Process_2021__chromosome condensation (GO:0030261),-0.4322472806259967,-0.9590046451767954,0.5076923076923077,1.0,1.0,3/31,6.42%,H1-4;H1-2;TTN
prerank,GO_Biological_Process_2021__embryonic organ morphogenesis (GO:0048562),0.4340942534468711,0.9589359809950565,0.525,0.8318406198919516,1.0,4/18,12.75%,RBPMS2;PDGFRA;ACVR1;NIPBL
prerank,GO_Biological_Process_2021__regulation of calcium ion transport (GO:0051924),0.37165648351252917,0.9588824506912198,0.5555555555555556,0.8315625437169692,1.0,9/39,11.69%,ANK2;STIM2;CACNA2D1;CASQ1;CAMK2B;HOMER1;CAMK2A;PKD2;STIM1
prerank,GO_Biological_Process_2021__modulation by host of viral genome replication (GO:0044827),0.4842026875548845,0.9587680621372064,0.5111111111111111,0.8314010239965857,1.0,3/11,10.08%,VAPA;EIF2AK4;PRKN
prerank,GO_Biological_Process_2021__cell-matrix adhesion (GO:0007160),0.360594153047256,0.9585914185608835,0.56,0.8314101393894947,1.0,9/73,9.62%,ITGA1;PTPRK;NPNT;RCC2;ITGB8;ITGA10;PPFIA2;MKLN1;LYVE1
prerank,GO_Biological_Process_2021__positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),-0.5021737088293609,-0.9585450000848167,0.5081967213114754,1.0,1.0,3/19,12.58%,SRF;PSMC3;PSMC4
prerank,GO_Biological_Process_2021__Fc-epsilon receptor signaling pathway (GO:0038095),0.32274707216052545,0.9583680821946158,0.5,0.8315586654497515,1.0,27/95,19.87%,MAPK10;BTRC;TAB3;MAP2K4;NFKB1;PSMA1;TEC;PIK3CA;PIK3R1;PSMD11;MAP3K7;PSMD10;TAB1;PSMF1;PSMD14;SOS1;FER;MAPK1;CUL1;MAPK8;PPP3CB;PSME4;MAP3K1;NFATC3;BCL10;FBXW11;MAPK9
prerank,GO_Biological_Process_2021__adenine nucleotide transport (GO:0051503),0.5175439663341936,0.9580916234231026,0.5428571428571428,0.83185414609554,1.0,4/13,10.73%,SLC19A1;SLC25A41;ABCC5;SLC25A24
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",-0.5460925558876567,-0.9578846634673652,0.5454545454545454,1.0,1.0,5/9,24.61%,FOXM1;SP100;KAT5;TFAP4;RPS27L
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell apoptotic process (GO:2000353),-0.5273147711309295,-0.9578384134204075,0.5,1.0,1.0,4/11,17.91%,THBS1;CD160;CCL2;GPER1
prerank,GO_Biological_Process_2021__ribosomal subunit export from nucleus (GO:0000054),0.5320175646925168,0.9578006361283907,0.5652173913043478,0.8321570853836329,1.0,2/10,2.74%,XPO1;LTV1
prerank,GO_Biological_Process_2021__regulation of peptidyl-lysine acetylation (GO:2000756),0.5360979230050422,0.9576045954430693,0.5853658536585366,0.8322818440124261,1.0,4/9,24.39%,SIRT1;KLF15;SETD5;PRKAA1
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial growth factor production (GO:0010575),-0.5156579582323617,-0.9571636131515715,0.5862068965517241,1.0,1.0,5/17,12.47%,CCBE1;CXCL17;NODAL;NOX1;BRCA1
prerank,GO_Biological_Process_2021__pyrimidine deoxyribonucleotide catabolic process (GO:0009223),0.4903054449775776,0.9571425359341625,0.5,0.8328162210874828,1.0,4/13,21.36%,DUT;NEIL2;NT5M;SMUG1
prerank,GO_Biological_Process_2021__regulation of protein export from nucleus (GO:0046825),0.4174361523226602,0.9564469240325388,0.5227272727272727,0.8341923606275004,1.0,5/21,15.08%,RANGAP1;UHMK1;ANP32B;PTPN14;GSK3B
prerank,GO_Biological_Process_2021__tachykinin receptor signaling pathway (GO:0007217),-0.5768931082821805,-0.9563785135948728,0.5535714285714286,1.0,1.0,1/6,6.51%,TACR1
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction resulting in transcription (GO:0042772)",-0.5321279154087242,-0.9556990527816771,0.5789473684210527,1.0,1.0,5/10,24.61%,FOXM1;SP100;KAT5;TFAP4;RPS27L
prerank,GO_Biological_Process_2021__regulation of protein exit from endoplasmic reticulum (GO:0070861),-0.5346978020014874,-0.9556961694063815,0.5576923076923077,1.0,1.0,3/11,19.60%,SLC51B;GCC2;INSIG1
prerank,GO_Biological_Process_2021__phospholipid catabolic process (GO:0009395),-0.48659679556556434,-0.9555734199463807,0.5645161290322581,1.0,1.0,3/17,14.00%,ENPP2;ANGPTL3;ENPP6
prerank,GO_Biological_Process_2021__negative regulation of response to endoplasmic reticulum stress (GO:1903573),-0.470203625972601,-0.9553418012511816,0.5909090909090909,1.0,1.0,6/24,15.71%,SELENOS;CLU;AQP11;CREB3;XBP1;CREB3L1
prerank,GO_Biological_Process_2021__regulation of anoikis (GO:2000209),0.4478377647670792,0.954845423892149,0.5,0.8374208586144416,1.0,5/16,14.77%,PDK4;PIK3CA;PTK2;BCL2;ANKRD13C
prerank,GO_Biological_Process_2021__regulation of translational elongation (GO:0006448),0.6013686170894291,0.9546749379241688,0.5918367346938775,0.8374193787789954,1.0,1/5,23.57%,GRM5
prerank,GO_Biological_Process_2021__positive regulation of lipid kinase activity (GO:0090218),0.44494593150108375,0.9545012632966252,0.4838709677419355,0.8374950632222786,1.0,7/21,11.91%,FLT1;PDGFRA;IRS1;PIK3R4;PRKD1;DGKZ;PTK2
prerank,GO_Biological_Process_2021__cell junction organization (GO:0034330),0.36172093777790265,0.9544296529202457,0.64,0.8372853082405456,1.0,17/64,14.47%,SNCA;MARVELD3;RAB8B;PPFIA2;PPFIBP1;SDK1;PAK3;DVL1;NLGN3;FBLIM1;NLGN4X;OCLN;APBB2;ELFN1;TJP1;OPHN1;VASP
prerank,GO_Biological_Process_2021__muscle organ development (GO:0007517),0.38906032235458227,0.9543076252707237,0.5,0.8370449148919271,1.0,12/40,20.68%,ANKRD2;CHD2;SOX6;LARGE1;TCF12;CHODL;MRAS;SGCD;FXR1;IGF1;UTRN;NEB
prerank,GO_Biological_Process_2021__mesenchyme development (GO:0060485),-0.5234935873671052,-0.9538627139733792,0.5666666666666667,1.0,1.0,2/10,8.34%,SFRP2;MEOX1
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor production (GO:0010574),-0.5015307927277789,-0.9537251909318115,0.5932203389830508,1.0,1.0,5/18,12.47%,CCBE1;CXCL17;NODAL;NOX1;BRCA1
prerank,GO_Biological_Process_2021__positive regulation of regulated secretory pathway (GO:1903307),0.4595765065476706,0.9536586004598318,0.47058823529411764,0.8379605556720121,1.0,4/15,8.17%,CACNA1G;RAB27A;CACNA1I;DOC2B
prerank,GO_Biological_Process_2021__nuclear mRNA surveillance (GO:0071028),0.4914611479316835,0.9535690727287507,0.5,0.8377585795526232,1.0,2/10,17.08%,EXOSC6;PCID2
prerank,GO_Biological_Process_2021__establishment of protein localization to endoplasmic reticulum (GO:0072599),-0.47779571365911255,-0.9533122882509412,0.5714285714285714,1.0,1.0,2/17,11.28%,SRPRA;SPCS1
prerank,GO_Biological_Process_2021__regulation of p38MAPK cascade (GO:1900744),0.40722560473106506,0.9531402232279547,0.37037037037037035,0.8383112104931645,1.0,4/28,5.77%,SASH1;BMP2;PRMT1;DUSP10
prerank,GO_Biological_Process_2021__sequestering of extracellular ligand from receptor (GO:0035581),0.5020305090509679,0.9529712723499778,0.525,0.8383708728289121,1.0,2/10,13.21%,BMP2;NBL1
prerank,GO_Biological_Process_2021__regulation of cell junction assembly (GO:1901888),0.4224555941465758,0.9529471121244402,0.5161290322580645,0.8380843888434403,1.0,11/18,23.66%,RAPGEF2;OCLN;PDLIM5;RAP1A;TJP1;ROCK2;CBFB;RUNX1;ROCK1;SETD5;RAP1B
prerank,GO_Biological_Process_2021__very-low-density lipoprotein particle assembly (GO:0034379),0.5261218624472401,0.9529013586969418,0.5135135135135135,0.8378058613894979,1.0,2/8,20.19%,MTTP;ACSL3
prerank,GO_Biological_Process_2021__ammonium transport (GO:0015696),-0.6051599347249009,-0.952757354818604,0.5517241379310345,1.0,1.0,3/5,12.91%,AQP1;RHD;RHCE
prerank,GO_Biological_Process_2021__acidic amino acid transport (GO:0015800),0.45812692308198644,0.9525433196625114,0.5384615384615384,0.8382805951403564,1.0,2/16,5.19%,SLC6A13;SLC25A18
prerank,GO_Biological_Process_2021__negative regulation of cell-matrix adhesion (GO:0001953),0.39523554743927397,0.9521525582255455,0.4117647058823529,0.838731842947143,1.0,5/28,11.21%,SERPINE1;AJAP1;RCC2;FAM107A;MAP4K4
prerank,GO_Biological_Process_2021__protein retention in ER lumen (GO:0006621),-0.5924298417723498,-0.9517883261676074,0.5686274509803921,1.0,1.0,1/7,2.33%,KDELR3
prerank,GO_Biological_Process_2021__neuromuscular junction development (GO:0007528),0.39805001519386557,0.9517745209275544,0.475,0.8393361963976926,1.0,6/23,12.46%,CACNB4;PDZRN3;GPHN;PPFIBP1;DVL1;ZC4H2
prerank,GO_Biological_Process_2021__positive regulation of cardiac epithelial to mesenchymal transition (GO:0062043),0.5752424775972172,0.9516617741568139,0.5869565217391305,0.8391650243555663,1.0,3/7,13.12%,TGFBR2;ACVR1;TGFBR1
prerank,GO_Biological_Process_2021__positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),0.3210176084399271,0.9515342515874288,0.5263157894736842,0.8389940128123075,1.0,20/85,19.80%,EGLN3;SNCA;CRADD;BOK;CASP10;ROBO1;HMGB1;TRADD;CFLAR;MAP3K5;ANP32B;SIRT1;TNFRSF10B;VCP;HIP1;FAS;AIFM1;BCL10;PPM1F;REST
prerank,GO_Biological_Process_2021__regulation of calcium-mediated signaling (GO:0050848),-0.49946849912736435,-0.9512238248089419,0.5178571428571429,1.0,1.0,1/17,0.79%,GBP1
prerank,GO_Biological_Process_2021__positive regulation of endocytic recycling (GO:2001137),-0.5520987196094972,-0.9510657736063244,0.5538461538461539,1.0,1.0,4/7,23.93%,AKAP5;EHD2;EHD1;ACTN2
prerank,GO_Biological_Process_2021__macrophage chemotaxis (GO:0048246),-0.5837762214261857,-0.9508211176560227,0.5714285714285714,1.0,1.0,4/6,22.74%,CXCL17;CCL2;EDNRB;SFTPD
prerank,"GO_Biological_Process_2021__positive regulation of gene expression, epigenetic (GO:0045815)",-0.4131404856856903,-0.9507155670476722,0.5,1.0,1.0,4/51,8.55%,H1-4;H1-2;TAF1D;ATAD2
prerank,GO_Biological_Process_2021__positive regulation of leukocyte apoptotic process (GO:2000108),-0.585440592656403,-0.9505136898883041,0.5692307692307692,1.0,1.0,2/8,8.27%,ANXA1;PIK3CB
prerank,GO_Biological_Process_2021__embryonic appendage morphogenesis (GO:0035113),0.48273703919702915,0.9504622648820882,0.5227272727272727,0.8410615359978106,1.0,6/9,37.61%,MBNL1;FBXW4;TGFB2;MEGF8;SKI;MYH3
prerank,GO_Biological_Process_2021__telomere organization (GO:0032200),0.37959680827069764,0.9502169188788832,0.47058823529411764,0.8412882242811895,1.0,4/38,7.68%,DNA2;LTO1;POLD3;STN1
prerank,GO_Biological_Process_2021__regulation of protein localization (GO:0032880),0.3557202913675285,0.9499074431222839,0.6071428571428571,0.8416372361232813,1.0,16/52,19.25%,PICALM;MMD;TESK1;CEP290;CSNK1E;FBXW7;RAB9A;DVL1;AFDN;KIAA0586;DNAJB6;DLG1;MAPK8;RABGAP1L;KDM1A;PPM1F
prerank,GO_Biological_Process_2021__toll-like receptor 3 signaling pathway (GO:0034138),-0.5235695484302282,-0.9498537560146055,0.5254237288135594,1.0,1.0,7/11,27.36%,CASP8;TLR3;SCIMP;RFTN1;SCARA3;TNIP2;FADD
prerank,GO_Biological_Process_2021__cellular response to nitrogen levels (GO:0043562),0.5043790087826922,0.9497358488625497,0.4883720930232558,0.8411559764285655,1.0,2/9,18.61%,ATG7;ATG5
prerank,GO_Biological_Process_2021__cellular response to nitrogen starvation (GO:0006995),0.5043790087826922,0.9497358488625497,0.4883720930232558,0.8411559764285655,1.0,2/9,18.61%,ATG7;ATG5
prerank,GO_Biological_Process_2021__interleukin-12-mediated signaling pathway (GO:0035722),-0.39750516217241116,-0.9497004825640333,0.5135135135135135,1.0,1.0,8/36,22.85%,IL12A;CA1;RPLP0;AIP;TALDO1;GSTO1;ANXA2;IL12RB1
prerank,GO_Biological_Process_2021__adherens junction maintenance (GO:0034334),0.5693025970236357,0.9495819377248866,0.575,0.841168059725958,1.0,5/5,43.09%,TJP1;CAMSAP3;PLEKHA7;FERMT2;KIFC3
prerank,GO_Biological_Process_2021__positive regulation of protein kinase activity (GO:0045860),0.30626769193284936,0.9495602107024428,0.6,0.840805567232859,1.0,36/120,22.19%,CASS4;SNCA;CSF1R;EPHA4;MMD;TNIK;AGAP2;RAPGEF2;ADRB2;DLG3;SRCIN1;RALB;LRP8;DUSP19;PAK3;MAP4K4;STOX1;INCENP;TGFBR2;PTK2;RAP1A;RPTOR;TAOK2;STK11;PAK4;AXIN1;CAB39;CAMKK1;ALS2;MAP2K2;CIB1;PTPRC;ETAA1;IL6R;STK4;CACUL1
prerank,GO_Biological_Process_2021__microtubule anchoring (GO:0034453),0.4718556659460533,0.9491559867117337,0.6,0.8413068015038674,1.0,6/12,26.31%,PEX14;BICD2;CLASP1;PCM1;CLASP2;SAXO2
prerank,GO_Biological_Process_2021__negative regulation of type I interferon-mediated signaling pathway (GO:0060339),-0.4679618696602309,-0.9491108787598658,0.6065573770491803,1.0,1.0,4/14,12.07%,USP18;ISG15;STAT2;OAS3
prerank,GO_Biological_Process_2021__surfactant homeostasis (GO:0043129),0.5769781014175679,0.9489436565692789,0.5952380952380952,0.8409796425045246,1.0,1/6,1.16%,RCN3
prerank,GO_Biological_Process_2021__chemical homeostasis within a tissue (GO:0048875),0.5769781014175679,0.9489436565692789,0.5952380952380952,0.8409796425045246,1.0,1/6,1.16%,RCN3
prerank,GO_Biological_Process_2021__depyrimidination (GO:0045008),0.5177240566932633,0.9488970783670757,0.5681818181818182,0.8406713235678897,1.0,3/8,27.61%,NEIL2;SMUG1;TDG
prerank,GO_Biological_Process_2021__negative regulation of leukocyte chemotaxis (GO:0002689),0.525622540300606,0.9487399692774876,0.5,0.840538698269351,1.0,4/7,15.69%,RIN3;SLIT2;NBL1;PADI2
prerank,GO_Biological_Process_2021__positive regulation of cellular process (GO:0048522),0.28367513727809457,0.948703659281772,0.5,0.8402156265460718,1.0,91/413,18.44%,VEGFD;PRODH;ACACB;TNFSF4;TUB;SOX4;PARD3;MEIS3;ERBB4;CSF1R;PRMT1;EGFR;RAB27A;EPHA4;VHL;FLT1;CCKBR;ACER3;SOX9;CXCL12;MYRF;PDGFRA;FGF17;ADNP2;GRIN1;HCLS1;RPS6KA3;RAD18;AKT1;NTRK2;TRPM4;CNOT6L;CSNK2A1;BST1;PDGFA;IRS1;BMPR1B;HDAC2;TFE3;VEGFC;MARCHF7;PSMD10;ZNF268;EFNB2;PTPRJ;TGM1;NAP1L1;ANKRD17;MEIS2;STOX1;DERL2;CRKL;TGFBR2;PTK2;MERTK;HDAC4;SIRT1;TGFBR1;PDGFC;SMC6;FER;SIRT2;EPCAM;TJP1;RPTOR;DNAJA2;CCPG1;MLXIPL;BCL2;CDK13;FAF1;PHIP;USP47;MAPK8;VIPR1;CCAR1;AKT2;CNOT8;FXR1;CDKN2AIP;CUL3;ZNF703;ASH2L;IGF1;SLC6A6;CELF1;SRPK2;RPRD1B;LIFR;MDM2;PTEN
prerank,GO_Biological_Process_2021__positive regulation of transforming growth factor beta production (GO:0071636),-0.5937153852425028,-0.9486255313802612,0.5925925925925926,1.0,1.0,1/6,5.73%,THBS1
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell differentiation (GO:0030858),0.45145537200538355,0.9486044535400641,0.47368421052631576,0.8399766675315987,1.0,3/13,6.75%,VEZF1;SOX9;RFX3
prerank,GO_Biological_Process_2021__regulation of epithelial to mesenchymal transition involved in endocardial cushion formation (GO:1905005),0.5649619485619041,0.9484756417132126,0.5531914893617021,0.8398978607851072,1.0,3/7,13.12%,TGFBR2;ACVR1;TGFBR1
prerank,GO_Biological_Process_2021__mitotic cell cycle checkpoint signaling (GO:0007093),-0.4949844886852042,-0.9484303156345837,0.5806451612903226,1.0,1.0,3/16,12.01%,ZWILCH;WEE1;PLK3
prerank,GO_Biological_Process_2021__regulation of adherens junction organization (GO:1903391),-0.6093923660467163,-0.947844408501123,0.6326530612244898,1.0,1.0,1/5,6.91%,RDX
prerank,GO_Biological_Process_2021__I-kappaB phosphorylation (GO:0007252),-0.5874301090630006,-0.9478232626249719,0.6041666666666666,1.0,1.0,2/7,10.28%,PRDX4;TLR3
prerank,GO_Biological_Process_2021__positive regulation of nitric oxide metabolic process (GO:1904407),-0.4713633701743237,-0.9478117453940783,0.49333333333333335,1.0,1.0,3/16,11.22%,KLF2;KLF4;CLU
prerank,GO_Biological_Process_2021__pyrimidine-containing compound salvage (GO:0008655),0.5200006957366876,0.9475842250600383,0.5319148936170213,0.840866542848762,1.0,4/9,17.61%,PUDP;DCK;UCK2;UPP1
prerank,GO_Biological_Process_2021__pyrimidine nucleoside salvage (GO:0043097),0.5200006957366876,0.9475842250600383,0.5319148936170213,0.840866542848762,1.0,4/9,17.61%,PUDP;DCK;UCK2;UPP1
prerank,GO_Biological_Process_2021__sequestering of BMP from receptor via BMP binding (GO:0038098),0.5884198164250645,0.9474527680949605,0.6341463414634146,0.8407341967378155,1.0,2/6,13.21%,BMP2;NBL1
prerank,GO_Biological_Process_2021__myeloid cell development (GO:0061515),-0.5106419132146844,-0.9472385587655782,0.6,1.0,1.0,2/15,9.66%,GATA1;ZNF385A
prerank,GO_Biological_Process_2021__divalent inorganic cation homeostasis (GO:0072507),0.4656834435963617,0.9470431990211339,0.5,0.841217699006624,1.0,4/17,10.40%,SNCA;GRIN1;PRKN;TMTC2
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell proliferation (GO:0050680),-0.4115982368809955,-0.9470203510701488,0.5609756097560976,1.0,1.0,11/52,13.39%,SFRP2;SPARC;STAT1;B2M;CEACAM1;THBS1;CAV2;ATP5IF1;APOE;SFRP1;AQP11
prerank,GO_Biological_Process_2021__myofibril assembly (GO:0030239),-0.47094206054782173,-0.9469574622359135,0.582089552238806,1.0,1.0,3/28,6.42%,TNNT1;LMOD1;TTN
prerank,GO_Biological_Process_2021__neutrophil chemotaxis (GO:0030593),-0.48062960808096233,-0.9468314138415953,0.5238095238095238,1.0,1.0,4/17,14.31%,CXCL2;PPIB;CX3CL1;CCL2
prerank,GO_Biological_Process_2021__positive regulation of heart contraction (GO:0045823),-0.5326967750209807,-0.9465790928386059,0.5344827586206896,1.0,1.0,2/12,6.80%,ADM;KCNQ1
prerank,GO_Biological_Process_2021__response to cadmium ion (GO:0046686),-0.4753739782528284,-0.946385837455227,0.5068493150684932,1.0,1.0,9/22,19.84%,MT1H;MT1G;MT2A;MT3;MT1E;MT1F;MT1A;MT1M;FOS
prerank,GO_Biological_Process_2021__peptidyl-lysine methylation (GO:0018022),-0.47005271844690877,-0.9459632312938414,0.5166666666666667,1.0,1.0,5/23,14.40%,EEF1AKMT2;TRMT112;EEF2KMT;SUV39H1;CSKMT
prerank,GO_Biological_Process_2021__positive regulation of actin filament bundle assembly (GO:0032233),0.3879850882145323,0.945796972962738,0.5,0.8436230504950025,1.0,11/41,15.85%,PLEK;RGCC;TESK1;PPM1E;LIMCH1;CARMIL1;ARHGEF10L;TGFBR1;ROCK2;PXN;NRP1
prerank,GO_Biological_Process_2021__regulation of cell cycle phase transition (GO:1901987),-0.36872212976936714,-0.9457728647000418,0.578125,1.0,1.0,11/80,13.44%,PSMB6;ANAPC15;ANAPC11;PSMA8;PSMB9;PSMA7;PSMC3;PSME1;CDC26;PSMC4;PSMA3
prerank,GO_Biological_Process_2021__regulation of receptor signaling pathway via STAT (GO:1904892),-0.5363928923684527,-0.9456354170796191,0.5423728813559322,1.0,1.0,2/10,15.01%,HES1;CRLF2
prerank,GO_Biological_Process_2021__positive regulation of response to stimulus (GO:0048584),-0.44775003813649716,-0.9454122546919024,0.5423728813559322,1.0,1.0,3/29,8.15%,ARG2;B2M;RSAD2
prerank,GO_Biological_Process_2021__cellular response to amino acid stimulus (GO:0071230),0.3892852029462682,0.9453732808678872,0.5277777777777778,0.8443098138975357,1.0,13/33,26.63%,CPEB3;SESN1;CPEB4;RPTOR;SESN3;UBR1;FYN;CPEB1;IPO5;RRAGD;SESN2;SH3BP4;UBR2
prerank,GO_Biological_Process_2021__dopaminergic neuron differentiation (GO:0071542),0.4803472052785592,0.9452646574855795,0.5,0.8441153879092834,1.0,1/9,3.17%,NR4A2
prerank,GO_Biological_Process_2021__positive regulation of cell motility (GO:2000147),0.2983467001146808,0.9450104598839951,0.625,0.8443005145222168,1.0,38/157,18.12%,SEMA5B;CASS4;FAM110C;BMP2;CSF1R;EGFR;FLT1;CXCL12;PDGFRA;CARMIL1;PDGFA;FAM107A;ZNF268;TRADD;SEMA3C;MAP4K4;PTK2;ACVR1;TGFBR1;PDGFC;FER;MAPRE1;TJP1;SEMA6C;ROCK2;CPNE3;SMO;HGF;SEMA4D;SEMA3D;CCAR1;RUFY3;AKT2;CDH13;ITGA6;ZNF703;IGF1;BCAR1
prerank,GO_Biological_Process_2021__positive regulation of melanin biosynthetic process (GO:0048023),-0.5886949729191224,-0.9447448703342683,0.6379310344827587,1.0,1.0,2/6,13.87%,ASIP;GIPC1
prerank,GO_Biological_Process_2021__positive regulation of secondary metabolite biosynthetic process (GO:1900378),-0.5886949729191224,-0.9447448703342683,0.6379310344827587,1.0,1.0,2/6,13.87%,ASIP;GIPC1
prerank,GO_Biological_Process_2021__negative regulation of cell activation (GO:0050866),0.49537222117385155,0.9444335380759146,0.5581395348837209,0.8452438622103169,1.0,3/9,9.81%,PDGFRA;PDGFA;NR1D1
prerank,MSigDB_Hallmark_2020__p53 Pathway,0.29290859858652935,0.9442997560437301,0.631578947368421,0.8452160427625516,1.0,17/170,8.28%,TXNIP;ZMAT3;TPD52L1;AK1;RAP2B;BMP2;EPHA2;RRAD;RGS16;AEN;KIF13B;FOXO3;SESN1;SLC7A11;PDGFA;CYFIP2;ABCC5
prerank,GO_Biological_Process_2021__protein modification by small protein removal (GO:0070646),0.3170923949305465,0.9438335007176414,0.5,0.8457262091177836,1.0,65/231,20.74%,USP13;CDC25A;USP49;USP46;KAT2B;KEAP1;RHOT1;OTUB2;USP31;SMAD2;COPS7B;PSMA1;COPS2;USP38;ADRB2;SMAD7;UBE2D1;USP12;PSMD11;MAP3K7;CCNA2;INO80D;PSMD10;USP24;KAT2A;PRKN;TAB1;PSMF1;EP300;USP3;ZRANB1;PSMD14;VCPIP1;GPS1;TGFBR1;OGT;USP40;SMAD4;MDM4;VCP;USP25;OTUD4;USP35;USP22;USP9X;USP47;BIRC2;UIMC1;ABRAXAS2;USP2;BRCC3;PSME4;HIF1A;YY1;KDM1B;MDM2;RAD23B;PTEN;USP34;ASXL2;STAM2;MBD5;ATXN7;OTUD7A;WDR48
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte apoptotic process (GO:0070229),0.5297273347244595,0.9437694616410799,0.55,0.8454709902988515,1.0,1/6,2.08%,FOXP1
prerank,GO_Biological_Process_2021__calcium-mediated signaling using intracellular calcium source (GO:0035584),-0.5458310206571962,-0.9430148915006973,0.543859649122807,1.0,1.0,2/13,12.15%,SELP;FIS1
prerank,PanglaoDB_Augmented_2021__Ductal Cells,-0.4259765422529954,-0.9425120585743254,0.6515151515151515,1.0,1.0,15/45,15.20%,SLC3A1;CFTR;EFNA1;CXCL2;AQP1;S100A10;GPX2;TRIM29;B3GNT3;CTSH;ONECUT1;ERBB3;EPS8L2;CCL2;S100A16
prerank,"GO_Biological_Process_2021__RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",0.28487551369155195,0.9417665040765935,0.8,0.8496595327974542,1.0,41/231,19.83%,NUDT21;USP49;SNRPF;WDR33;PAPOLA;HNRNPH1;CSTF3;RAVER2;PSPC1;SART1;SNRPN;HNRNPU;DHX15;HNRNPC;SPEN;LSM8;RBM15B;CTNNBL1;SYNCRIP;HNRNPH3;ZMAT5;U2AF1;U2AF2;DHX9;SMNDC1;PRPF40B;PRCC;RBM17;RBM41;CCAR1;SF3B3;PRPF40A;RBM6;PTBP1;CWC27;TRA2A;SMU1;HNRNPD;NOVA1;RALY;GTF2F2
prerank,MSigDB_Hallmark_2020__TNF-alpha Signaling via NF-kB,-0.3551121920197481,-0.9416411346381521,0.6049382716049383,1.0,1.0,40/147,22.41%,GPR183;IRF1;KLF2;IER3;EFNA1;CXCL2;IFIT2;IFNGR2;HES1;IER2;CCN1;TNFAIP2;DUSP1;KLF4;CEBPD;IL18;ID2;IL15RA;RIPK2;TNC;CCL2;BTG1;TUBB2A;CCND1;ICAM1;SLC16A6;BTG3;TNIP1;SOCS3;EIF1;FOS;TRIP10;SQSTM1;GADD45A;ZFP36;GADD45B;EHD1;NFKB2;SPSB1;JUNB
prerank,GO_Biological_Process_2021__extracellular structure organization (GO:0043062),-0.366590939505108,-0.9415618656827814,0.6470588235294118,1.0,1.0,37/155,18.67%,THSD4;MMP21;SPARC;COL8A1;COL10A1;MMP25;ITGA5;COL5A1;COL6A2;ECM2;THBS1;MMP19;ELN;COL24A1;MMP24;COL4A4;TEX14;VWF;FBLN5;LAMB1;ADAMTS16;COL9A2;MATN3;MARCOL;MADCAM1;ITGA2;TNC;ADAMTS10;LAMA1;SPINK5;COL4A2;ICAM1;COL14A1;CDH1;MMP14;LAMA4;BGN
prerank,GO_Biological_Process_2021__Fc receptor signaling pathway (GO:0038093),0.3217678413750374,0.9412144192286702,0.5384615384615384,0.8504090603954497,1.0,27/95,19.87%,MAPK10;BTRC;TAB3;MAP2K4;NFKB1;PSMA1;TEC;PIK3CA;PIK3R1;PSMD11;MAP3K7;PSMD10;TAB1;PSMF1;PSMD14;SOS1;FER;MAPK1;CUL1;MAPK8;PPP3CB;PSME4;MAP3K1;NFATC3;BCL10;FBXW11;MAPK9
prerank,PanglaoDB_Augmented_2021__Fibroblasts,-0.3527188362166491,-0.9410305446366989,0.620253164556962,1.0,1.0,41/165,18.67%,LMOD1;IL1R1;SPARC;COL8A1;KLF2;SPON2;COX7A1;COL5A1;ANGPTL2;C1R;COL6A2;FBLN7;PI16;ELN;COL4A4;MEOX1;FMO2;MGP;P4HTM;FBLN5;KLF4;GSTM5;LAMB1;HHIP;SOD3;LRRK1;PAMR1;ADGRL4;C1S;SRPX2;IL34;ADAMTS10;CXCL14;EDNRA;COL4A2;C1QTNF1;COL14A1;MMP14;TAGLN;LAMA4;BGN
prerank,GO_Biological_Process_2021__lipoprotein catabolic process (GO:0042159),0.46729675718429936,0.9409145607393973,0.55,0.8506814328774107,1.0,6/10,25.83%,ABHD17B;ABHD17A;LYPLA2;LYPLAL1;ABHD17C;ABHD10
prerank,GO_Biological_Process_2021__phosphate-containing compound metabolic process (GO:0006796),0.2978419304311488,0.9406583819832822,0.5294117647058824,0.850877959677209,1.0,37/165,21.25%,EPHA7;LIMD1;PLPP1;ISYNA1;ITPKB;DUSP10;INPP5A;AKT1;PIK3CA;PLBD1;PPM1A;PANK2;PLCB1;ACP6;PLPP3;PLPP2;GK;PTPRB;MINPP1;IP6K2;PPA2;SYNJ1;ITPK1;GPD2;PPP3CB;LHPP;PLPPR4;AGK;IPPK;PTEN;ACYP1;PANK3;DUSP18;PLAAT3;PLCB3;DUSP12;PTPRC
prerank,GO_Biological_Process_2021__microtubule anchoring at microtubule organizing center (GO:0072393),0.47444455627131005,0.9406179032653872,0.5348837209302325,0.8505982830061591,1.0,7/11,36.10%,BICD2;PCM1;NINL;HOOK3;CEP19;CCDC120;BICD1
prerank,GO_Biological_Process_2021__blood vessel endothelial cell migration (GO:0043534),0.41040977811029095,0.940469903983456,0.5555555555555556,0.8505152273704533,1.0,7/17,22.98%,AKT1;ROBO1;EFNB2;SLIT2;NRP1;NR4A1;FGF2
prerank,GO_Biological_Process_2021__negative regulation of neural precursor cell proliferation (GO:2000178),0.5783147366652622,0.9404693221664353,0.574468085106383,0.8501227422632219,1.0,2/7,13.72%,NF1;SIRT2
prerank,PanglaoDB_Augmented_2021__Peritubular Myoid Cells,-0.37001066195794985,-0.9403292986272322,0.56,1.0,1.0,28/92,19.18%,LMOD1;COX7A1;AQP1;ANGPTL2;C1R;ELN;IGFBP5;MGP;WNT2B;SAT2;GSTM3;SOD3;PAMR1;ADGRL4;MATN2;C1S;RASD1;TNS2;EDNRA;COL4A2;CALD1;CRYAB;C1QTNF1;COL14A1;TAGLN;LAMA4;BGN;CPXM2
prerank,GO_Biological_Process_2021__regulation of toll-like receptor signaling pathway (GO:0034121),-0.469847466604233,-0.9403016577619298,0.5806451612903226,1.0,1.0,2/20,10.28%,IRF1;TLR3
prerank,GO_Biological_Process_2021__negative regulation of NF-kappaB transcription factor activity (GO:0032088),0.3490413116815398,0.9402925580879512,0.46153846153846156,0.8501229825197553,1.0,15/61,20.44%,IRAK2;ANXA4;ARRB1;ITCH;PSMD10;SIRT1;HAVCR2;MAP2K5;COMMD1;FAF1;BMP7;TAX1BP1;OTULIN;TCEAL7;NFKBIL1
prerank,GO_Biological_Process_2021__regulation of mitotic spindle assembly (GO:1901673),0.4521540401814252,0.9401841229814888,0.53125,0.8500251769555787,1.0,7/17,21.28%,HNRNPU;CHMP1A;CEP97;CHMP2B;EML3;PLK1;HSPA1A
prerank,GO_Biological_Process_2021__positive regulation of potassium ion transport (GO:0043268),0.41898447579079323,0.9398579668829513,0.5581395348837209,0.8502742322406248,1.0,5/30,14.81%,ANK2;KCNH2;KCNMA1;GABBR1;DLG1
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110),0.5592091185369412,0.9398308732416503,0.5714285714285714,0.8499730015364529,1.0,2/8,17.39%,RHOT1;ATF2
prerank,GO_Biological_Process_2021__RNA transport (GO:0050658),0.3447621154273162,0.9396482656024314,0.6296296296296297,0.8498904632190178,1.0,10/63,15.13%,NUP188;RBFOX1;EIF4E;KIF5C;NUP153;TGFBR2;CKAP5;U2AF1;U2AF2;THOC7
prerank,GO_Biological_Process_2021__negative regulation of glial cell proliferation (GO:0060253),-0.6189322657568377,-0.9395967835745673,0.5652173913043478,1.0,1.0,1/5,7.41%,HES1
prerank,GO_Biological_Process_2021__cellular protein catabolic process (GO:0044257),0.36920805607478546,0.939426358453909,0.6,0.8499585625910016,1.0,7/51,10.08%,UBE2G1;AP2B1;CTSK;AFG1L;CTSV;FAP;PRKN
prerank,GO_Biological_Process_2021__modulation by symbiont of entry into host (GO:0052372),-0.47983169073240806,-0.9394047755861368,0.5714285714285714,1.0,1.0,2/14,6.55%,TRIM22;TRIM21
prerank,GO_Biological_Process_2021__aggrephagy (GO:0035973),-0.45195091537791665,-0.9392021124607618,0.5079365079365079,1.0,1.0,3/26,9.49%,CFTR;RPS27A;UBC
prerank,GO_Biological_Process_2021__mitochondrion distribution (GO:0048311),0.46984584176814254,0.9390355786204901,0.5510204081632653,0.850523224453976,1.0,3/12,18.71%,TRAK1;TRAK2;MTM1
prerank,GO_Biological_Process_2021__regulation of cytokine production involved in inflammatory response (GO:1900015),0.42871756565672703,0.9383707964706888,0.5588235294117647,0.8518093988062102,1.0,3/25,8.76%,MACIR;IL17D;TICAM1
prerank,GO_Biological_Process_2021__fusion of virus membrane with host plasma membrane (GO:0019064),-0.5641204268723345,-0.9383466954562419,0.6111111111111112,1.0,1.0,2/7,17.27%,CTSL;CXCR4
prerank,GO_Biological_Process_2021__membrane fusion involved in viral entry into host cell (GO:0039663),-0.5641204268723345,-0.9383466954562419,0.6111111111111112,1.0,1.0,2/7,17.27%,CTSL;CXCR4
prerank,GO_Biological_Process_2021__mitochondrial cytochrome c oxidase assembly (GO:0033617),-0.5141594061619217,-0.9383422979691732,0.6101694915254238,1.0,1.0,5/14,26.64%,COX20;SURF1;OXA1L;COA3;TIMM21
prerank,GO_Biological_Process_2021__double-strand break repair via homologous recombination (GO:0000724),0.3153133395327125,0.9382748410529366,0.6363636363636364,0.8516585089151941,1.0,13/84,13.62%,RAD54B;SEM1;SAMHD1;UBE2N;RAD52;RFWD3;RAD51B;PSMD14;NSMCE2;NIPBL;EXD2;SMC6;REV3L
prerank,GO_Biological_Process_2021__regulation of spindle assembly (GO:0090169),0.41896859723228463,0.9381078758654704,0.48484848484848486,0.8515528431704912,1.0,7/22,21.28%,HNRNPU;CHMP1A;CEP97;CHMP2B;EML3;PLK1;HSPA1A
prerank,GO_Biological_Process_2021__regulation of platelet-derived growth factor receptor-beta signaling pathway (GO:2000586),0.5766731723718936,0.9380815452349119,0.6530612244897959,0.8512519935517182,1.0,2/5,25.37%,HIP1;PTPN2
prerank,GO_Biological_Process_2021__cellular respiration (GO:0045333),0.38165571872022863,0.9380174553809644,0.48717948717948717,0.8509589274255388,1.0,4/38,5.03%,PPARGC1A;SDHAF4;COX10;UQCRHL
prerank,GO_Biological_Process_2021__protein desumoylation (GO:0016926),0.5715761723578141,0.9378780395688863,0.5897435897435898,0.850831216261273,1.0,5/6,42.85%,SENP1;SENP6;SENP2;SENP7;SENP5
prerank,PanglaoDB_Augmented_2021__Embryonic Stem Cells,0.30506125287506475,0.9377386104933652,0.5238095238095238,0.850718623155043,1.0,59/137,26.57%,TENM3;PAWR;PARD3;PIWIL4;EPHA2;FZD5;SMAD2;CDK8;SPRY4;PCGF2;LYPD6;PUM2;LGR4;MID1;ROR1;SMAD5;RBFOX2;FBLIM1;PTK2;ALDH7A1;NCKAP1;ENAH;TAF8;EPCAM;TJP1;TRIM28;ADGRL2;SMAD4;PTPN14;SH3PXD2B;PTPRG;YAP1;ITGA6;FBLN1;LIFR;SHROOM3;LRP4;CD59;LEF1;ESRRB;NR6A1;FBXO15;DOCK1;ZFX;PLS3;TEAD2;FZD7;CTNNB1;TEAD1;RBPMS;GULP1;SMAD3;ADGRA3;SUMO2;SH3BP4;GNG12;SMAD1;MYO10;EPHB4
prerank,GO_Biological_Process_2021__positive regulation of RNA export from nucleus (GO:0046833),0.5775998623699653,0.9377206453520195,0.631578947368421,0.8499766879325547,1.0,2/5,13.28%,CPSF6;DHX9
prerank,GO_Biological_Process_2021__positive regulation of nucleobase-containing compound transport (GO:0032241),0.5775998623699653,0.9377206453520195,0.631578947368421,0.8499766879325547,1.0,2/5,13.28%,CPSF6;DHX9
prerank,GO_Biological_Process_2021__regulation of cAMP-dependent protein kinase activity (GO:2000479),0.4395409501373784,0.9376579549241832,0.5609756097560976,0.8497373078659516,1.0,6/13,15.57%,PRKAR1B;RAPGEF2;ADRB2;PKIA;SIRT1;ATP2B4
prerank,PanglaoDB_Augmented_2021__Vascular Smooth Muscle Cells,0.30929118957464274,0.9374860911802827,0.6206896551724138,0.8497751563630591,1.0,19/80,12.65%,POSTN;DCN;HMCN1;FAT4;ACTA2;CXCL12;PDGFRA;CDH11;VSTM4;MSRB3;CACNA2D1;PRKG1;PCDH18;PRRX1;SSC5D;FAP;RUNX1T1;SLIT2;SGCD
prerank,GO_Biological_Process_2021__negative regulation of vascular permeability (GO:0043116),0.4696971823071193,0.9371716600333634,0.5405405405405406,0.8500674030125945,1.0,4/10,15.68%,PDE3A;PTPRJ;SLIT2;DDAH1
prerank,GO_Biological_Process_2021__DNA unwinding involved in DNA replication (GO:0006268),-0.4988092787298151,-0.9366764218072253,0.5645161290322581,1.0,1.0,5/14,29.71%,BLM;MCMDC2;MCM4;RECQL;RAD51
prerank,GO_Biological_Process_2021__RNA polymerase II preinitiation complex assembly (GO:0051123),0.5262674610520159,0.9366707325787013,0.56,0.8507408570667963,1.0,4/8,26.77%,DR1;TAF1;TAF12;GTF2B
prerank,GO_Biological_Process_2021__regulation of neuron apoptotic process (GO:0043523),0.3253587120947934,0.9366594812152023,0.5882352941176471,0.8503894182178706,1.0,10/75,10.68%,EPHA7;PPARGC1A;EGLN3;LIG4;FOXO3;AGAP2;NTRK2;CPEB4;PRKN;NF1
prerank,GO_Biological_Process_2021__positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),0.4257262559103169,0.9365552391468877,0.52,0.8502624923024336,1.0,8/26,16.20%,BMP2;GDF10;ACVR1;TGFBR1;ACVR2A;BMPR1A;SMAD4;BMP7
prerank,GO_Biological_Process_2021__regulation of chromosome segregation (GO:0051983),0.4868617201299542,0.936524375688948,0.45161290322580644,0.8499489410782023,1.0,7/12,17.92%,ZNF207;RAD18;CSNK2A1;PUM2;SMC6;PUM1;CSNK2A2
prerank,GO_Biological_Process_2021__negative regulation of leukocyte activation (GO:0002695),0.5961193972508518,0.9364200480234579,0.65,0.8498148658235809,1.0,2/6,13.26%,LRFN5;HAVCR2
prerank,GO_Biological_Process_2021__urate metabolic process (GO:0046415),-0.5725517487485351,-0.9361622737215753,0.625,1.0,1.0,3/7,12.85%,PNP;ABCG2;PRPS1
prerank,GO_Biological_Process_2021__external encapsulating structure organization (GO:0045229),-0.36633321310301026,-0.9359355023953898,0.6904761904761905,1.0,1.0,37/155,18.67%,THSD4;MMP21;SPARC;COL8A1;COL10A1;MMP25;ITGA5;COL5A1;COL6A2;ECM2;THBS1;MMP19;ELN;COL24A1;MMP24;COL4A4;HRNR;VWF;FBLN5;LAMB1;ADAMTS16;COL9A2;MATN3;MARCOL;MADCAM1;ITGA2;TNC;ADAMTS10;LAMA1;SPINK5;COL4A2;ICAM1;COL14A1;CDH1;MMP14;LAMA4;BGN
prerank,GO_Biological_Process_2021__regulation of ERAD pathway (GO:1904292),0.46785668783551265,0.9357771569469011,0.5365853658536586,0.850710783929163,1.0,1/11,1.13%,USP13
prerank,GO_Biological_Process_2021__fatty acid derivative biosynthetic process (GO:1901570),-0.44335984110803284,-0.9356615470042944,0.5454545454545454,1.0,1.0,7/28,17.56%,HSD17B8;AWAT1;FAR2;GGTA1;SLC25A1;ALOX12;FASN
prerank,GO_Biological_Process_2021__neutrophil migration (GO:1990266),-0.47961895412570343,-0.9356249827654589,0.5483870967741935,1.0,1.0,4/19,14.31%,CXCL2;PPIB;CX3CL1;CCL2
prerank,GO_Biological_Process_2021__positive regulation of non-motile cilium assembly (GO:1902857),-0.5192619028705227,-0.9355897247304684,0.5,1.0,1.0,2/5,15.18%,CEP135;HAP1
prerank,GO_Biological_Process_2021__somite development (GO:0061053),-0.5415739436962089,-0.9355729450302418,0.6470588235294118,1.0,1.0,2/8,8.34%,SFRP2;MEOX1
prerank,GO_Biological_Process_2021__cell communication by electrical coupling involved in cardiac conduction (GO:0086064),-0.5026990135003736,-0.9355529503619748,0.6140350877192983,1.0,1.0,5/12,24.66%,PKP2;GJC1;ATP1A1;ATP1B1;TBX5
prerank,GO_Biological_Process_2021__protein localization to cell surface (GO:0034394),0.38366892169502254,0.9354403449382467,0.48148148148148145,0.8510389682446835,1.0,4/23,11.85%,PTPRK;ANK2;SMURF1;GGA2
prerank,GO_Biological_Process_2021__ribosomal small subunit export from nucleus (GO:0000056),0.550593535163105,0.9354095747661698,0.6078431372549019,0.8507107227026343,1.0,2/6,2.74%,XPO1;LTV1
prerank,GO_Biological_Process_2021__excitatory postsynaptic potential (GO:0060079),0.46242754918677353,0.935352388929482,0.5862068965517241,0.850420039414208,1.0,6/15,19.34%,GRIN1;MPP2;AKT1;RAB3GAP1;GSK3B;DRD2
prerank,GO_Biological_Process_2021__regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),0.35116916831611517,0.935351294882506,0.6,0.850032780744165,1.0,15/54,20.50%,CSF1R;SOX9;NFKB1;CDK8;ZNF451;MED13;TNRC6B;TRIM28;AGO3;CBFB;PTEN;PPM1D;MED27;LEF1;MED4
prerank,MSigDB_Hallmark_2020__DNA Repair,0.28153535963145526,0.935063438202451,0.6111111111111112,0.8502489884092846,1.0,11/134,9.38%,NUDT21;VPS37B;AK3;AK1;CSTF3;DUT;POLD3;HCLS1;SMAD5;CANT1;RAD52
prerank,GO_Biological_Process_2021__positive regulation of protein serine/threonine kinase activity (GO:0071902),0.3194063635809926,0.9350560990297164,0.47368421052631576,0.8498696023959609,1.0,21/82,15.57%,SNCA;TPD52L1;CSF1R;EGFR;FLT1;RGCC;AKT1;RAPGEF2;ADRB2;PDGFA;ROBO1;DIPK2A;PSMD10;PKD2;RALB;INCENP;SIRT1;PDGFC;RPTOR;TENM1;ATP2B4
prerank,GO_Biological_Process_2021__neuromuscular process (GO:0050905),0.5007625704059514,0.9348630108822764,0.6222222222222222,0.8500410531607967,1.0,3/10,15.95%,SHANK1;NRXN1;AGTPBP1
prerank,GO_Biological_Process_2021__response to endoplasmic reticulum stress (GO:0034976),0.3225877312652196,0.9346264747320621,0.55,0.8501751695814747,1.0,21/97,15.08%,RCN3;TMX1;PPP1R15B;TMEM33;RHBDD1;PDIA2;MARCHF6;ERP44;ATF6;PIK3R1;PRKN;MAP3K5;UBXN6;TNFRSF10B;TMEM117;NCK1;NIBAN1;UBQLN1;VCP;BCL2;GSK3B
prerank,GO_Biological_Process_2021__steroid hormone biosynthetic process (GO:0120178),-0.4635968256375319,-0.9345564123913422,0.5901639344262295,1.0,1.0,4/17,13.87%,HSD17B8;HSD17B14;DHCR7;HSD17B7
prerank,GO_Biological_Process_2021__positive regulation of nitric-oxide synthase activity (GO:0051000),-0.5417766859151115,-0.9340172216258836,0.5740740740740741,1.0,1.0,5/12,18.94%,HTR2B;PIK3CB;APOE;NOS1AP;S100A1
prerank,GO_Biological_Process_2021__TOR signaling (GO:0031929),0.4351686724517779,0.9339054758138248,0.5128205128205128,0.851357120920638,1.0,6/22,14.11%,RPS6KB2;AKT1;EIF4EBP2;RPS6KB1;SMG1;RPTOR
prerank,GO_Biological_Process_2021__negative regulation of cell population proliferation (GO:0008285),0.27871846177082477,0.9336940968210811,0.8,0.8514905178587538,1.0,58/270,18.47%,ITGA1;NCK2;PTPRK;KLF11;KAT2B;SOX4;BMP2;ERBB4;MARVELD3;VHL;RGCC;SOX9;PLPP1;DUSP10;FRZB;CHD5;PDS5B;RAPGEF2;DLG3;STRN;ZBTB7C;SMARCA2;BMPR1B;ADRA1A;RPS6KA2;MORC3;MAGED1;DNAJB2;MEN1;PKD2;ZNF268;FAP;CAMK2N1;PTPRJ;ADARB1;NF1;MTSS1;PEX2;DLG5;ABI1;MAGI2;PRKRA;SIRT2;MDM4;PTPN14;VGLL4;TENM1;DDAH1;RBBP4;STK11;ARID2;RNF41;CDH13;TNFRSF8;FBLN1;CELF1;PTEN;PPM1D
prerank,GO_Biological_Process_2021__cellular response to muramyl dipeptide (GO:0071225),-0.5438613565782382,-0.9336122961784146,0.6666666666666666,1.0,1.0,2/8,17.40%,RIPK2;PTPN22
prerank,GO_Biological_Process_2021__IMP biosynthetic process (GO:0006188),0.5589480855415511,0.9333116443390356,0.6122448979591837,0.8520099233418318,1.0,3/5,29.13%,ATIC;HPRT1;AMPD2
prerank,GO_Biological_Process_2021__positive regulation of necrotic cell death (GO:0010940),0.5764497977576136,0.9329892298540562,0.5813953488372093,0.852269080458171,1.0,1/5,1.84%,SLC6A13
prerank,GO_Biological_Process_2021__positive regulation of cell migration (GO:0030335),0.29094940781011713,0.9329524227286401,0.6153846153846154,0.8519493333831842,1.0,50/202,18.12%,SEMA5B;CASS4;FAM110C;BMP2;CSF1R;EGFR;FLT1;SOX9;CXCL12;PDGFRA;CARMIL1;RAPGEF2;PDGFA;FAM107A;ZNF268;TRADD;PRKCE;SEMA3C;MAP4K4;CRKL;PTK2;ACVR1;NIPBL;TGFBR1;RREB1;PDGFC;FER;MAPRE1;CLASP1;TJP1;SEMA6C;GAB1;FERMT1;ROCK2;ARHGEF7;CPNE3;NRP1;SMO;HGF;SEMA4D;SEMA3D;CCAR1;RUFY3;AKT2;CDH13;HIF1A;ITGA6;ZNF703;IGF1;BCAR1
prerank,GO_Biological_Process_2021__enzyme-directed rRNA pseudouridine synthesis (GO:0000455),0.5049259132415568,0.9329343555184275,0.5434782608695652,0.8515853833650463,1.0,1/6,11.50%,DKC1
prerank,GO_Biological_Process_2021__negative regulation of macromolecule biosynthetic process (GO:0010558),-0.5276972824311682,-0.9328582044586446,0.5370370370370371,1.0,1.0,2/9,8.49%,SELENOS;GSTP1
prerank,GO_Biological_Process_2021__negative regulation of DNA binding (GO:0043392),-0.45662178934926706,-0.9328432337337798,0.582089552238806,1.0,1.0,4/25,16.25%,GATA1;HEY2;MSX2;SP100
prerank,GO_Biological_Process_2021__potassium ion homeostasis (GO:0055075),0.432666668922188,0.932644674427759,0.5142857142857142,0.8516813141034555,1.0,6/18,19.37%,SLC12A2;KCNH2;KCNMA1;SLC12A8;ATP1A4;SLC12A9
prerank,GO_Biological_Process_2021__fatty acid alpha-oxidation (GO:0001561),0.5731956004585592,0.932406090059704,0.5957446808510638,0.8518438367434206,1.0,3/6,33.73%,PEX13;SLC25A17;HACL1
prerank,GO_Biological_Process_2021__positive regulation of endocytosis (GO:0045807),0.365137712048129,0.9323873578753552,0.4838709677419355,0.8514952395586649,1.0,8/38,12.15%,SNCA;SERPINE1;NEDD4L;CBL;RAB31;SGIP1;RAB21;CLIP3
prerank,GO_Biological_Process_2021__water-soluble vitamin metabolic process (GO:0006767),0.3465770859093197,0.9323129378097024,0.5263157894736842,0.8512431845001427,1.0,4/61,8.55%,MTHFS;SLC19A1;TPK1;PANK2
prerank,GO_Biological_Process_2021__cellular response to cadmium ion (GO:0071276),-0.47579559794363446,-0.932142741488469,0.5416666666666666,1.0,1.0,9/21,19.84%,MT1H;MT1G;MT2A;MT3;MT1E;MT1F;MT1A;MT1M;FOS
prerank,GO_Biological_Process_2021__regulation of hydrolase activity (GO:0051336),0.3367343337868855,0.9316419511999477,0.625,0.8522787316694017,1.0,13/62,12.74%,ADAP1;EFNA5;PLXNA2;EPHA4;PRKG1;NTRK2;EPHA5;PLXNA1;CAMK2A;FGD4;NF1;PTK2;RAB3GAP1
prerank,GO_Biological_Process_2021__white fat cell differentiation (GO:0050872),0.5680614383743402,0.9313576042420475,0.5957446808510638,0.852544225343546,1.0,3/5,28.39%,SIRT1;CTBP1;CTBP2
prerank,GO_Biological_Process_2021__positive regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901838),-0.5115332054642459,-0.9309974811803844,0.5272727272727272,1.0,1.0,1/10,5.54%,DDX11
prerank,GO_Biological_Process_2021__regulation of chaperone-mediated autophagy (GO:1904714),0.5021379420694325,0.9309328662595469,0.5652173913043478,0.8529129672998335,1.0,1/8,2.09%,SNCA
prerank,GO_Biological_Process_2021__acylglycerol catabolic process (GO:0046464),-0.4934976756642183,-0.9305334104008327,0.5,1.0,1.0,3/20,8.80%,LIPI;PNPLA3;FABP3
prerank,GO_Biological_Process_2021__visual perception (GO:0007601),0.35050770495572675,0.9304699320152332,0.6206896551724138,0.8535547572089938,1.0,14/57,15.09%,POU6F2;TYR;RGS16;CRYGS;ZIC2;ATF6;CRYBB3;DRAM2;SLC4A10;OPA1;EYA3;RP2;CRYBB2;GRM8
prerank,GO_Biological_Process_2021__regulation of anion transport (GO:0044070),-0.6117682384466132,-0.9302213592219114,0.6376811594202898,1.0,1.0,1/5,3.29%,PDZK1
prerank,GO_Biological_Process_2021__regulation of extracellular matrix assembly (GO:1901201),0.5597303264374258,0.9299697091947807,0.5675675675675675,0.8543806011580058,1.0,1/6,4.09%,RGCC
prerank,GO_Biological_Process_2021__cytoplasmic pattern recognition receptor signaling pathway in response to virus (GO:0039528),-0.5334397441182451,-0.9298653714644065,0.5535714285714286,1.0,1.0,5/8,28.90%,OAS3;TRIM25;IRF3;IFIH1;PHB2
prerank,GO_Biological_Process_2021__positive regulation of mononuclear cell migration (GO:0071677),0.41336442398109774,0.9294435918356041,0.47368421052631576,0.8550949696310466,1.0,4/15,11.68%,SERPINE1;CXCL12;HMGB1;JAM2
prerank,GO_Biological_Process_2021__aminoglycan metabolic process (GO:0006022),-0.5410487824528454,-0.9293366120091053,0.5740740740740741,1.0,1.0,2/9,19.87%,CHST9;XYLT2
prerank,GO_Biological_Process_2021__fatty acid metabolic process (GO:0006631),-0.37881366019002904,-0.9292685642172062,0.6125,1.0,1.0,10/95,9.81%,ACOT2;LIPI;ACOT1;HSD17B8;ACOT6;PNPLA3;ACSM6;ANGPTL3;ACSBG2;ACSM5
prerank,GO_Biological_Process_2021__positive regulation of MAPK cascade (GO:0043410),0.2830871616941919,0.9291268821338511,0.7857142857142857,0.855321700850545,1.0,32/170,15.85%,TPD52L1;NPNT;BMP2;ERBB4;CSF1R;EGFR;FLT1;HTR2C;NOTCH2;PDGFRA;ARRB1;NTRK2;RAPGEF2;ADRB2;MID1;PDGFA;ROBO1;ROR1;ADRA1A;HMGB1;PTPRJ;BRAF;FBXW7;DUSP19;CRKL;PDGFC;RAP1A;TAOK2;TENM1;ROCK2;PTPN11;NRP1
prerank,GO_Biological_Process_2021__mitotic spindle organization (GO:0007052),-0.35291051375413357,-0.9290931228251197,0.5897435897435898,1.0,1.0,19/127,16.21%,RPS27;ERCC6L;CENPE;SPC24;ZWILCH;KIF2C;RAB11A;NUF2;SPDL1;MIS12;ABRAXAS1;KIF4A;ITGB3BP;TPX2;CENPH;CENPN;TBCE;DCTN2;DSN1
prerank,GO_Biological_Process_2021__regulation of chemokine production (GO:0032642),0.4390211923485105,0.9288701088711677,0.5714285714285714,0.8554966001582741,1.0,4/22,3.05%,TNFSF4;FOXP1;ACKR1;CSF1R
prerank,GO_Biological_Process_2021__gonad development (GO:0008406),-0.4635271506905328,-0.9288499033905814,0.5873015873015873,1.0,1.0,4/27,4.02%,GATA1;SOX15;ADAM21;MEA1
prerank,GO_Biological_Process_2021__regulation of cell communication (GO:0010646),0.40979419559790586,0.9287649665957793,0.6060606060606061,0.8554280648893046,1.0,6/27,12.07%,ANK2;MGLL;GRK3;CDC42SE2;CAMK2D;GRK4
prerank,GO_Biological_Process_2021__regulation of axon extension (GO:0030516),0.35097237321101965,0.928664430602223,0.5806451612903226,0.8552343233326939,1.0,9/34,26.03%,CDKL5;RNF6;KIAA0319;GSK3B;RUFY3;DNM2;MACF1;PTPRS;TRIM46
prerank,GO_Biological_Process_2021__cytochrome complex assembly (GO:0017004),0.5843914394996824,0.9283730960780192,0.574468085106383,0.855526871977466,1.0,2/5,11.00%,COX10;HCCS
prerank,GO_Biological_Process_2021__positive regulation of protein exit from endoplasmic reticulum (GO:0070863),-0.5091182644195671,-0.9280867843778339,0.6551724137931034,1.0,1.0,1/11,4.61%,SLC51B
prerank,GO_Biological_Process_2021__nuclear cell cycle DNA replication initiation (GO:1902315),-0.6164643084418604,-0.9279981108054323,0.6428571428571429,1.0,1.0,4/5,27.37%,GINS3;MCMDC2;MCM3;MCM4
prerank,GO_Biological_Process_2021__mitotic DNA replication initiation (GO:1902975),-0.6164643084418604,-0.9279981108054323,0.6428571428571429,1.0,1.0,4/5,27.37%,GINS3;MCMDC2;MCM3;MCM4
prerank,GO_Biological_Process_2021__regulation of centriole elongation (GO:1903722),-0.5747029100499588,-0.9277664439055462,0.5319148936170213,1.0,1.0,1/5,8.99%,CHMP2A
prerank,GO_Biological_Process_2021__acylglycerol metabolic process (GO:0006639),0.40045650477298794,0.9276639116668951,0.5428571428571428,0.8566878821772765,1.0,12/28,21.98%,DGKB;MGLL;DGKH;DGKZ;GK;ABHD6;DGKG;LYPLA2;ABHD2;PLAAT3;DGKE;GK5
prerank,GO_Biological_Process_2021__sialylation (GO:0097503),-0.5619774860812946,-0.927090487678514,0.509090909090909,1.0,1.0,1/6,6.00%,ST6GAL1
prerank,GO_Biological_Process_2021__negative regulation of cAMP-mediated signaling (GO:0043951),0.5042081770499809,0.9262946545385258,0.48717948717948717,0.8594667757899492,1.0,2/9,2.44%,PDE3A;PDE3B
prerank,GO_Biological_Process_2021__negative regulation of cell projection organization (GO:0031345),0.3754041771051911,0.9260356257184881,0.5,0.8596540503636232,1.0,19/42,26.18%,EPHA4;KANK1;RAPGEF2;HDAC2;SPRY3;RTN4RL1;EFNB2;PTPN9;DCC;PTPRO;PTEN;FYN;CIB1;ADCY6;GRIN2B;CBFA2T2;FKBP4;PTPRS;BAG5
prerank,GO_Biological_Process_2021__positive regulation of protein localization to membrane (GO:1905477),0.2963868175596763,0.9256353370164612,0.782608695652174,0.8601425947022052,1.0,25/86,19.50%,MTCL1;ARHGEF16;EPHA2;EGFR;MFF;AKT1;PIK3R1;PRKN;PRKCE;PTPN9;TP53BP2;CLIP3;ZDHHC5;BCL2;DLG1;ATP2B4;TFDP2;MAPK8;YWHAG;AKT2;WNK3;MIEF2;FYN;ARF6;YWHAZ
prerank,"GO_Biological_Process_2021__CD4-positive, alpha-beta T cell activation (GO:0035710)",0.5705514643671351,0.925513424343086,0.6458333333333334,0.8600574901116235,1.0,2/5,9.68%,TNFSF4;HMGB1
prerank,GO_Biological_Process_2021__regulation of miRNA mediated inhibition of translation (GO:1905616),0.5617258929073663,0.9254507655728403,0.6153846153846154,0.8594249484200281,1.0,5/7,34.66%,TNRC6B;DDX6;EIF4E2;AGO2;EIF4G1
prerank,GO_Biological_Process_2021__positive regulation of miRNA mediated inhibition of translation (GO:1905618),0.5617258929073663,0.9254507655728403,0.6153846153846154,0.8594249484200281,1.0,5/7,34.66%,TNRC6B;DDX6;EIF4E2;AGO2;EIF4G1
prerank,GO_Biological_Process_2021__protein localization to perinuclear region of cytoplasm (GO:1905719),0.5681979148300353,0.9251702245176683,0.6170212765957447,0.8595971437618737,1.0,2/6,12.47%,RNF26;HOOK1
prerank,GO_Biological_Process_2021__snRNA transcription by RNA polymerase II (GO:0042795),0.35107145634877684,0.9251675541950548,0.5555555555555556,0.859219009854861,1.0,15/68,23.48%,INTS13;SNAPC1;INTS7;INTS6;INTS8;SNAPC3;TAF8;POU2F1;CCNT2;SNAPC5;RPRD1B;GTF2F2;CDK9;INTS14;RPRD2
prerank,GO_Biological_Process_2021__mitotic cell cycle phase transition (GO:0044772),0.29702794787923315,0.925027159395909,0.8125,0.8592078337353849,1.0,41/188,19.25%,CDC25A;BTRC;CEP152;TPD52L1;PHLDA1;EPS8;ANAPC1;FBXL17;CDC27;FBXL3;CCNG2;NEDD1;CEP290;CSNK1E;CAMK2A;PLCB1;RPS6KB1;CCNA2;EIF4E;ACVR1;CKAP5;CUL2;MAPRE1;CLASP1;ALMS1;CUL1;TUBG1;CDC34;LATS1;PPP2R2A;FBXL6;PPP1R12A;YWHAG;ARPP19;TAF2;CUL3;CDK14;DNM2;CCND3;FBXW11;PPP1CB
prerank,GO_Biological_Process_2021__amide biosynthetic process (GO:0043604),0.33734511515111937,0.9247971994243499,0.6428571428571429,0.8593066039954306,1.0,3/41,2.22%,CERS3;SGMS1;PCSK5
prerank,GO_Biological_Process_2021__negative regulation of platelet activation (GO:0010544),-0.47006802726063424,-0.9245274555511603,0.5737704918032787,1.0,1.0,5/12,17.43%,CD9;CEACAM1;APOE;ALOX12;C1QTNF1
prerank,GO_Biological_Process_2021__regulation of erythrocyte differentiation (GO:0045646),-0.4234687204057001,-0.924502180798922,0.6774193548387096,1.0,1.0,2/32,3.14%,GATA1;STAT1
prerank,"GO_Biological_Process_2021__negative regulation of retrograde protein transport, ER to cytosol (GO:1904153)",-0.5553793892206081,-0.9242836649676763,0.609375,1.0,1.0,2/8,10.11%,SVIP;ERLEC1
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte differentiation (GO:0045621),-0.4814212407451791,-0.9240062442626744,0.5483870967741935,1.0,1.0,4/14,18.44%,IL7;RHOH;XBP1;MMP14
prerank,GO_Biological_Process_2021__regulation of nuclear cell cycle DNA replication (GO:0033262),0.5428124847127057,0.9235572984038823,0.66,0.8618008252796134,1.0,2/7,30.23%,ATRX;INO80
prerank,GO_Biological_Process_2021__positive regulation of cell growth (GO:0030307),0.3146210710505752,0.9234546503555324,0.6111111111111112,0.8616567029438028,1.0,20/86,17.75%,SYT3;EGFR;CDKL5;ADNP2;NEDD4L;RPS6KA3;AKT1;CSNK2A1;PSMD10;SMURF1;DERL2;RASAL1;TGFBR1;RPTOR;BCL2;USP47;SEMA4D;RUFY3;CDKN2AIP;IGF1
prerank,GO_Biological_Process_2021__negative regulation of activated T cell proliferation (GO:0046007),-0.5586670983315284,-0.9234177916466576,0.6333333333333333,1.0,1.0,3/7,16.12%,PDCD1LG2;CD274;BTN2A2
prerank,GO_Biological_Process_2021__response to organic cyclic compound (GO:0014070),-0.41366188132768744,-0.9233372747552925,0.5294117647058824,1.0,1.0,11/34,24.41%,ANXA1;IGFBP5;TLR3;SFRP1;IL18;CCL2;WNT8B;ARL6IP5;TGFB1;ALPL;CYP1B1
prerank,GO_Biological_Process_2021__lipid homeostasis (GO:0055088),-0.40413379098382696,-0.9233015688431524,0.671875,1.0,1.0,10/48,14.20%,TLCD1;ORMDL2;PNPLA3;ANGPTL3;FABP3;APOE;ORMDL1;RBP1;XBP1;TLCD2
prerank,GO_Biological_Process_2021__IRE1-mediated unfolded protein response (GO:0036498),0.34851065237287415,0.9230509693696664,0.5581395348837209,0.8622007193866457,1.0,1/47,0.04%,VAPB
prerank,GO_Biological_Process_2021__homeostasis of number of cells (GO:0048872),-0.5170854091946097,-0.9230125774045923,0.5862068965517241,1.0,1.0,1/8,5.48%,LRRC19
prerank,GO_Biological_Process_2021__atrioventricular valve morphogenesis (GO:0003181),0.4622621171555065,0.9227721098057868,0.5833333333333334,0.8623126064157235,1.0,7/18,14.40%,SOX4;BMP2;TGFBR2;ACVR1;BMPR1A;SMAD4;MDM4
prerank,GO_Biological_Process_2021__peptidyl-lysine dimethylation (GO:0018027),-0.4848923218147404,-0.9224441528988762,0.5294117647058824,1.0,1.0,3/18,14.40%,EEF1AKMT2;SUV39H1;CSKMT
prerank,GO_Biological_Process_2021__translesion synthesis (GO:0019985),-0.4203413048319977,-0.9224377356355563,0.59375,1.0,1.0,4/39,9.49%,RPS27A;ISG15;RPA3;UBC
prerank,GO_Biological_Process_2021__negative regulation of myeloid cell differentiation (GO:0045638),0.44460712387155293,0.92242517844718,0.631578947368421,0.8626145238583713,1.0,5/16,23.22%,PRMT1;MEIS2;ZBTB16;CIB1;CDC73
prerank,GO_Biological_Process_2021__snRNA transcription (GO:0009301),0.3510570185171068,0.9223898561872385,0.631578947368421,0.8622948689237215,1.0,15/69,23.48%,INTS13;SNAPC1;INTS7;INTS6;INTS8;SNAPC3;TAF8;POU2F1;CCNT2;SNAPC5;RPRD1B;GTF2F2;CDK9;INTS14;RPRD2
prerank,GO_Biological_Process_2021__regulation of ERK1 and ERK2 cascade (GO:0070372),0.2830035342945505,0.9221073377957422,0.8333333333333334,0.8626476678404523,1.0,34/158,15.85%,EPHA7;NPNT;BMP2;ERBB4;CSF1R;EPHA2;EGFR;HTR2C;SPRED2;NOTCH2;PDGFRA;ARRB1;DUSP10;NTRK2;RAPGEF2;LMO3;PDGFA;SPRED1;ROR1;ADRA1A;SPRY3;HMGB1;STYX;CAMK2N1;BRAF;FBXW7;CRKL;PDGFC;RAP1A;SMAD4;DLG1;DUSP6;PTPN11;NRP1
prerank,GO_Biological_Process_2021__cellular response to gamma radiation (GO:0071480),0.44216973426795514,0.921870785321307,0.5277777777777778,0.8627518526250241,1.0,4/16,18.39%,MAP3K20;YAP1;KDM1A;MDM2
prerank,GO_Biological_Process_2021__respiratory electron transport chain (GO:0022904),0.4533060255894827,0.9218530870542854,0.5833333333333334,0.8624033657008799,1.0,2/13,5.19%,PPARGC1A;SLC25A18
prerank,GO_Biological_Process_2021__response to UV-A (GO:0070141),0.5423497793137397,0.9210530564918303,0.6,0.8639157719124925,1.0,3/7,6.29%,EGFR;MME;AKT1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle hypertrophy (GO:0010611),0.39059795254738466,0.9210069615426301,0.5625,0.8636545945862282,1.0,10/21,27.42%,CAMK2D;SMAD4;ROCK2;IGF1;ROCK1;PRKCA;PDE9A;MLIP;GLRX3;LMCD1
prerank,GO_Biological_Process_2021__acylglycerol biosynthetic process (GO:0046463),0.4534086343549726,0.9209162318948656,0.5789473684210527,0.8634155197323448,1.0,2/17,1.34%,LPIN3;AGMO
prerank,GO_Biological_Process_2021__regulation of B cell proliferation (GO:0030888),0.3911228757383248,0.9207263808204085,0.5833333333333334,0.8634826971977929,1.0,3/25,7.28%,TNFSF13B;CD22;BST1
prerank,GO_Biological_Process_2021__regulation of osteoblast proliferation (GO:0033688),0.4716220157050066,0.920695055963272,0.5581395348837209,0.8631492274830411,1.0,2/12,2.72%,SOX8;BMP2
prerank,GO_Biological_Process_2021__glycosaminoglycan metabolic process (GO:0030203),0.3562124588054704,0.9204364462965872,0.6129032258064516,0.8632383041610789,1.0,6/43,9.03%,SDC4;HS3ST5;GPC5;UGDH;EXT1;EXT2
prerank,GO_Biological_Process_2021__regulation of interleukin-8 production (GO:0032677),0.35723206881840996,0.9200312346909046,0.5,0.8636693171422543,1.0,8/45,9.75%,SERPINE1;ANXA4;ARRB1;IL17D;MAPKBP1;CD58;HMGB1;SSC5D
prerank,GO_Biological_Process_2021__intracellular protein transmembrane transport (GO:0065002),0.35678499202276326,0.9195976711100892,0.64,0.864245420651002,1.0,10/40,18.37%,DNAJC15;PEX14;PEX16;PEX5;PEX2;PEX7;PEX6;AKT2;SEC61A2;AIFM1
prerank,GO_Biological_Process_2021__protein localization to Golgi apparatus (GO:0034067),0.39874157471144345,0.9192072384034129,0.5714285714285714,0.8647628484015243,1.0,5/24,12.93%,ARL5A;RAB33B;ARFRP1;GOLPH3;BICD2
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell differentiation (GO:1905065),-0.5650550597038737,-0.9188704963351565,0.6666666666666666,1.0,1.0,2/7,18.33%,GPER1;ENG
prerank,PanglaoDB_Augmented_2021__Leydig Cells,0.2933757555623044,0.9187875306753035,0.6060606060606061,0.8652798164205936,1.0,13/101,8.44%,POSTN;DCN;SASH1;PDZRN3;EGFR;ESRRG;PARVA;CXCL12;PDGFRA;CDH11;FRZB;MAOA;PRICKLE2
prerank,GO_Biological_Process_2021__platelet degranulation (GO:0002576),-0.37159860074304135,-0.9187781683127988,0.6119402985074627,1.0,1.0,14/91,11.51%,F8;SELP;SPARC;CD63;CD9;F13A1;TIMP1;THBS1;TTN;VWF;A2M;F5;CLU;PCYOX1L
prerank,GO_Biological_Process_2021__regulation of histone H3-K9 methylation (GO:0051570),0.4970051747774282,0.9187552261479345,0.5333333333333333,0.8649682291625187,1.0,4/9,18.41%,SIRT1;KDM1A;JARID2;ATRX
prerank,GO_Biological_Process_2021__regulation of cellular component movement (GO:0051270),0.35757762900072004,0.9186355209342598,0.6,0.8648747418193238,1.0,9/47,13.12%,ZSWIM6;ERBB4;EGFR;ARAP1;ZSWIM5;ABL2;MEMO1;NRG2;TGFBR1
prerank,GO_Biological_Process_2021__protein alkylation (GO:0008213),-0.453316350568038,-0.9184081924183845,0.576271186440678,1.0,1.0,4/21,14.40%,BHMT;EEF1AKMT2;EEF2KMT;CSKMT
prerank,GO_Biological_Process_2021__keratan sulfate metabolic process (GO:0042339),0.42127845288382254,0.9181765516632983,0.575,0.8654054872406878,1.0,6/24,13.91%,B4GALT3;B4GALT6;ST3GAL1;B4GALT2;HEXB;B4GALT5
prerank,GO_Biological_Process_2021__positive regulation of insulin secretion (GO:0032024),0.3934424421712125,0.918071511459359,0.6470588235294118,0.8651740564940603,1.0,5/29,8.17%,SOX4;MCU;BAIAP3;TRPM4;DOC2B
prerank,GO_Biological_Process_2021__hexose transmembrane transport (GO:0008645),-0.49990038395751557,-0.9176107539667455,0.5483870967741935,1.0,1.0,1/16,2.33%,SLC5A10
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),0.42869965983593106,0.9173823695601855,0.5555555555555556,0.8663350463313091,1.0,5/17,20.13%,AKT1;PRKN;SIRT1;HIF1A;NFE2L2
prerank,GO_Biological_Process_2021__one-carbon compound transport (GO:0019755),-0.5626330821281723,-0.9173518842552172,0.6567164179104478,1.0,1.0,3/6,19.60%,AQP1;AQP11;SLC14A2
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol 3-kinase activity (GO:0043551),0.3583566104576764,0.9170790928751668,0.5945945945945946,0.8667484727279704,1.0,9/26,17.54%,FLT1;PDGFRA;PIK3R1;IRS1;PIK3R4;PRKD1;PTK2;WDR91;WDR81
prerank,GO_Biological_Process_2021__regulation of mitotic centrosome separation (GO:0046602),0.5076837909611973,0.9169272645184375,0.5,0.8666906274790043,1.0,3/7,31.46%,NSFL1C;UBXN2B;CEP85
prerank,GO_Biological_Process_2021__regulation of mitotic cell cycle phase transition (GO:1901990),-0.33074333915426546,-0.9167676574941237,0.6463414634146342,1.0,1.0,20/163,14.29%,PSMB6;CETN2;CENPE;RPS27A;ANAPC15;ANAPC11;PSMA8;PSMB9;PSMA7;PSMC3;UBC;PSME1;CDC26;CEP72;PSMC4;ID2;CEP135;PSMA3;TPX2;TUBB
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion mediated by cadherin (GO:2000047),0.44219995230179493,0.9165487579955472,0.5,0.8671759453662787,1.0,5/16,19.25%,RGCC;AFDN;EPCAM;TJP1;PPM1F
prerank,PanglaoDB_Augmented_2021__Endothelial Cells (Aorta),-0.36225513365122747,-0.9161179400801235,0.6753246753246753,1.0,1.0,32/134,19.49%,LMOD1;COX7A1;ITGA5;COL5A1;AQP1;ANGPTL2;C1R;PI16;AFAP1L1;COL4A4;IGFBP5;PROCR;CRACR2B;MMRN2;CALCRL;SOD3;ADGRL4;HEY2;C1S;SRPX2;S100A16;TNS2;EDNRA;COL4A2;CALD1;C1QTNF1;COL14A1;LAMA4;BGN;EHD2;AMOTL2;NXN
prerank,GO_Biological_Process_2021__sulfur compound catabolic process (GO:0044273),0.40727527488963006,0.9159689241791281,0.6216216216216216,0.8679576035811167,1.0,3/29,4.50%,DCN;CSPG5;ADO
prerank,GO_Biological_Process_2021__regulation of skeletal muscle cell differentiation (GO:2001014),0.5629338238950856,0.915965076997979,0.6458333333333334,0.8675809564902462,1.0,1/7,7.47%,NR1D2
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 2 signaling pathway (GO:0034135),0.5637334269678812,0.9158724582079883,0.6363636363636364,0.8673999034022583,1.0,4/6,43.10%,PJA2;TIRAP;TLR1;MFHAS1
prerank,GO_Biological_Process_2021__alpha-amino acid metabolic process (GO:1901605),-0.421448066441374,-0.9157178541048455,0.5757575757575758,1.0,1.0,1/35,0.82%,KMO
prerank,GO_Biological_Process_2021__cellular response to X-ray (GO:0071481),0.6085705284177214,0.9156867766977727,0.68,0.8673491267908058,1.0,1/5,12.75%,NIPBL
prerank,GO_Biological_Process_2021__O-glycan processing (GO:0016266),-0.42392176651142766,-0.9155212546832913,0.578125,1.0,1.0,6/37,10.57%,GCNT1;GALNT15;ST6GAL1;B3GNT5;B3GNT3;CHST4
prerank,GO_Biological_Process_2021__regulation of type I interferon-mediated signaling pathway (GO:0060338),-0.4175502001923771,-0.91537540985533,0.6440677966101694,1.0,1.0,5/24,13.44%,USP18;ISG15;STAT2;OAS3;CDC37
prerank,MSigDB_Hallmark_2020__Estrogen Response Early,-0.35631507100463605,-0.9153685745975824,0.6463414634146342,1.0,1.0,18/151,13.88%,THSD4;PRSS23;OVOL2;MYOF;PDZK1;SVIL;KAZN;SH3BP5;RASGRP1;PGR;HES1;ALDH3B1;FHL2;KLF4;BLVRB;PODXL;DHCR7;XBP1
prerank,GO_Biological_Process_2021__regulation of cellular response to growth factor stimulus (GO:0090287),-0.47462721036155137,-0.9153233960784846,0.6461538461538462,1.0,1.0,1/14,3.94%,SFRP4
prerank,GO_Biological_Process_2021__positive regulation of acute inflammatory response (GO:0002675),-0.5921536228257989,-0.9152852247588872,0.5961538461538461,1.0,1.0,2/5,21.34%,ADAM8;PARK7
prerank,PanglaoDB_Augmented_2021__Adipocytes,-0.3499749965741203,-0.914802509431036,0.6097560975609756,1.0,1.0,32/129,18.77%,LMOD1;IL1R1;PXMP2;HSD11B1;COX7A1;EPSTI1;AQP1;ANGPTL2;TIMP1;C1R;RSPO3;COL6A2;ECM2;FGF7;FMO2;MT2A;APOL6;FBLN5;SOD3;ADGRL4;SERPINF1;C1S;SRPX2;MAOB;CREB3L1;TNS2;CRYAB;C1QTNF1;COL14A1;TAGLN;BGN;F10
prerank,GO_Biological_Process_2021__nucleic acid transport (GO:0050657),0.5124354020696393,0.9145687320433941,0.5833333333333334,0.869531074415403,1.0,2/9,12.42%,RBFOX1;CKAP5
prerank,GO_Biological_Process_2021__regulation of stem cell differentiation (GO:2000736),-0.36503023971692017,-0.9144439870933184,0.6190476190476191,1.0,1.0,11/74,13.44%,PSMB6;GATA1;PSMA8;PSMB9;PSMA7;HES1;PSMC3;PSME1;EIF2AK2;PSMC4;PSMA3
prerank,GO_Biological_Process_2021__PERK-mediated unfolded protein response (GO:0036499),-0.5138326875416013,-0.9144362092687542,0.6333333333333333,1.0,1.0,2/9,14.31%,DDIT3;CCL2
prerank,GO_Biological_Process_2021__synaptic vesicle cycle (GO:0099504),0.3898900188029826,0.9143442973138761,0.5952380952380952,0.8697610717977828,1.0,6/22,17.41%,WNT7A;SNCA;PIP5K1C;SLC32A1;STX1A;PCLO
prerank,GO_Biological_Process_2021__positive regulation of macrophage migration (GO:1905523),-0.5095280039182559,-0.914289210324788,0.59375,1.0,1.0,5/15,14.90%,P2RY12;THBS1;CXCL17;CX3CL1;IL34
prerank,GO_Biological_Process_2021__regulation of actin filament depolymerization (GO:0030834),-0.474479395674669,-0.9139624124551364,0.5882352941176471,1.0,1.0,2/9,5.50%,VIL1;SEMA5A
prerank,GO_Biological_Process_2021__positive regulation of pinocytosis (GO:0048549),-0.5328053923276016,-0.9139040302793867,0.532258064516129,1.0,1.0,1/7,13.86%,CLN3
prerank,GO_Biological_Process_2021__regulation of embryonic development (GO:0045995),0.3999507963705443,0.9138889117313237,0.5405405405405406,0.8701713442390002,1.0,11/29,27.61%,PLCB1;NIPBL;TRIP12;SEPTIN7;B4GALT5;CLASP1;EHMT1;POGLUT1;BAG6;CLASP2;TDG
prerank,GO_Biological_Process_2021__arachidonic acid metabolic process (GO:0019369),-0.40292516624743346,-0.9136811447161967,0.6268656716417911,1.0,1.0,5/32,15.84%,CYP4Z1;AWAT1;CYP2D6;GPX4;ALOX12
prerank,GO_Biological_Process_2021__regulation of mitotic spindle organization (GO:0060236),-0.44451586015010375,-0.9136189911734309,0.6774193548387096,1.0,1.0,5/32,14.22%,ANKRD53;CHMP2A;BORA;DRG1;TPX2
prerank,GO_Biological_Process_2021__secretion (GO:0046903),-0.5334020236422131,-0.913580643260769,0.6774193548387096,1.0,1.0,4/10,22.71%,FBLN5;SLC22A4;RIMS1;VIP
prerank,GO_Biological_Process_2021__water homeostasis (GO:0030104),-0.5902574712947055,-0.9131100108734029,0.6666666666666666,1.0,1.0,3/5,13.86%,AQP1;AQP11;CLN3
prerank,GO_Biological_Process_2021__regulation of ubiquitin-dependent protein catabolic process (GO:2000058),-0.4219477718028125,-0.9131096444818353,0.6065573770491803,1.0,1.0,6/38,11.22%,RPL23;RPL11;RPS7;RPL5;CAV3;CLU
prerank,GO_Biological_Process_2021__carboxylic acid catabolic process (GO:0046395),-0.4963508033913211,-0.9130941512305678,0.5737704918032787,1.0,1.0,4/11,26.16%,GNPDA1;ACOT4;ACOT8;PON3
prerank,GO_Biological_Process_2021__glycosylceramide biosynthetic process (GO:0046476),0.5274814190860859,0.9129096000958665,0.6,0.8718873394806098,1.0,2/7,8.62%,B4GALT3;GAL3ST1
prerank,GO_Biological_Process_2021__cardiac atrium morphogenesis (GO:0003209),0.5243620033809425,0.9128380939088959,0.65,0.8716399518050666,1.0,2/11,4.56%,BMP2;NOTCH2
prerank,GO_Biological_Process_2021__positive regulation of neuron migration (GO:2001224),-0.48800785331807245,-0.912781472662367,0.5901639344262295,1.0,1.0,1/13,2.77%,KIF20B
prerank,GO_Biological_Process_2021__Golgi disassembly (GO:0090166),-0.577937264560051,-0.912462448644354,0.6909090909090909,1.0,1.0,1/6,12.01%,PLK3
prerank,GO_Biological_Process_2021__regulation of peptidyl-serine phosphorylation (GO:0033135),0.3142552221570252,0.9123726366754912,0.56,0.8722435123216502,1.0,23/77,19.25%,NCK2;SNCA;EGFR;HCLS1;CNOT9;AKT1;SMAD7;DOCK7;CAPRIN2;BRAF;PRKD1;STOX1;NCK1;RPTOR;MLXIPL;TENM1;LATS1;ATP2B4;TFRC;PDE4D;PTEN;AXIN1;PPM1F
prerank,GO_Biological_Process_2021__regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process (GO:1902959),0.5086671838051203,0.9122992927375272,0.675,0.8720250113099856,1.0,3/8,6.19%,PICALM;EPHA4;BIN1
prerank,GO_Biological_Process_2021__negative regulation of oxidoreductase activity (GO:0051354),0.5675726229491671,0.912233269112347,0.6410256410256411,0.8718067027254558,1.0,2/6,10.08%,SNCA;PRKN
prerank,GO_Biological_Process_2021__positive regulation of cell cycle G2/M phase transition (GO:1902751),0.42650183899830457,0.9120742345324311,0.5909090909090909,0.8717397875259458,1.0,4/20,11.30%,CDC25A;RCC2;RAD51B;STOX1
prerank,GO_Biological_Process_2021__maintenance of gastrointestinal epithelium (GO:0030277),0.5639145109342827,0.9118837217386282,0.5581395348837209,0.8717592938855566,1.0,1/6,4.24%,SOX9
prerank,GO_Biological_Process_2021__renal tubule development (GO:0061326),-0.5532625946283277,-0.9117115960945583,0.5714285714285714,1.0,1.0,1/5,3.14%,STAT1
prerank,GO_Biological_Process_2021__calcium-mediated signaling (GO:0019722),-0.3849504408931139,-0.911040952839457,0.59375,1.0,1.0,7/60,12.15%,SELP;ACKR4;P2RY12;HTR2B;PPP1R9A;RCAN3;FIS1
prerank,GO_Biological_Process_2021__mRNA cleavage involved in mRNA processing (GO:0098787),0.4181839349280957,0.9109573586361185,0.6,0.8735124708643712,1.0,2/13,6.26%,NUDT21;CPSF6
prerank,GO_Biological_Process_2021__regulation of macrophage activation (GO:0043030),-0.474314724974352,-0.9107715381439592,0.5373134328358209,1.0,1.0,7/16,25.75%,THBS1;CD74;WNT5A;HSPD1;MYO18A;SPHK1;TNIP2
prerank,GO_Biological_Process_2021__ventricular trabecula myocardium morphogenesis (GO:0003222),0.5548640068917072,0.9106441854250442,0.7105263157894737,0.8738475656518419,1.0,4/7,20.43%,TGFBR1;BMPR1A;RBPJ;NRG1
prerank,MSigDB_Hallmark_2020__Pperoxisome,0.29479892543479336,0.9105535435462443,0.6666666666666666,0.873700809923119,1.0,22/90,18.83%,ABCC8;CACNA1B;PEX11A;PEX14;ABCC5;CADM1;ISOC1;SEMA3C;NUDT19;PEX5;ELOVL5;PEX2;HSD17B4;ABCD3;CRAT;STS;MSH2;SMARCC1;PEX6;PEX13;IDE;BCL10
prerank,GO_Biological_Process_2021__transcription-coupled nucleotide-excision repair (GO:0006283),-0.3760149039737135,-0.9104152985610376,0.5972222222222222,1.0,1.0,15/69,22.54%,RPS27A;RPA3;UBC;POLR2I;COPS6;POLR2L;POLR2J;POLD2;COPS5;RBX1;UBA52;POLR2G;POLR2K;CDK7;UBB
prerank,GO_Biological_Process_2021__negative regulation of protein modification process (GO:0031400),0.32342627183960043,0.9103047109854608,0.72,0.8738918427206444,1.0,21/72,20.59%,PID1;PPP1R15B;PTPN13;MEN1;PRKN;CRKL;PLPP3;SLIT2;OCLN;SIRT1;NIBAN1;GSK3B;ATP2B4;IMPACT;ARPP19;CRTAP;FBLN1;PTEN;PPP1R8;FKBP8;CIB1
prerank,GO_Biological_Process_2021__Golgi ribbon formation (GO:0090161),0.45681894966084846,0.9102253351953976,0.5454545454545454,0.8736590232785351,1.0,4/13,10.61%,FHDC1;VTI1A;TRIP11;GOLPH3
prerank,PanglaoDB_Augmented_2021__Myocytes,-0.3589129612168973,-0.9100563399182701,0.6582278481012658,1.0,1.0,10/82,11.83%,TNNT1;LMOD1;COX7A1;ANGPTL2;TTN;PRKCQ;FABP3;FHL2;CAV3;LAMB1
prerank,GO_Biological_Process_2021__actin filament organization (GO:0007015),0.3172201805414935,0.9099118586272947,0.6875,0.8739360420762939,1.0,13/123,8.56%,TCAP;SPIRE2;GAS2;CASS4;MYO5B;EPS8;MCU;RHOBTB3;CGNL1;CARMIL1;WASL;SPIRE1;CORO6
prerank,GO_Biological_Process_2021__positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),-0.5214067724646734,-0.9098025987151048,0.6363636363636364,1.0,1.0,1/10,1.71%,CFTR
prerank,GO_Biological_Process_2021__regulation of fibroblast apoptotic process (GO:2000269),-0.5491988880801556,-0.909765776719219,0.6304347826086957,1.0,1.0,2/7,14.85%,SFRP1;BTG1
prerank,GO_Biological_Process_2021__mitotic DNA replication (GO:1902969),-0.526283716058487,-0.9097586825873747,0.6440677966101694,1.0,1.0,5/8,30.86%,GINS3;MCMDC2;MCM3;MCM4;LIG1
prerank,GO_Biological_Process_2021__negative regulation of multicellular organismal process (GO:0051241),0.2887250913814618,0.9096442420178736,0.7142857142857143,0.8741912934920504,1.0,25/147,9.98%,ELAPOR2;ZNF706;HDAC9;NPTN;BMP2;HS3ST5;EGFR;RPS6KA4;LOXL2;MARVELD3;RGCC;SOX9;SPRED2;NFIB;RHEB;IL17D;DUSP10;SPX;SMAD7;LGR4;SPRED1;ROBO1;TFE3;NR1D1;DOCK7
prerank,"GO_Biological_Process_2021__endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",-0.4950153085668727,-0.9095797625573883,0.5915492957746479,1.0,1.0,1/11,1.02%,RPS21
prerank,"GO_Biological_Process_2021__mRNA splicing, via spliceosome (GO:0000398)",0.2821563337025425,0.9092535891504427,1.0,0.8747475303546982,1.0,44/254,19.83%,NUDT21;USP49;SNRPF;WDR33;PAPOLA;HNRNPH1;CSTF3;RAVER2;PSPC1;SART1;SNRPN;HNRNPU;DHX15;HNRNPC;SPEN;LSM8;RBM15B;CTNNBL1;SYNCRIP;HNRNPH3;ZMAT5;CLNS1A;U2AF1;U2AF2;DHX9;SMNDC1;PRPF40B;PRCC;CDK13;RBM17;RBM41;CCAR1;SF3B3;PRPF40A;RBM6;PTBP1;SRPK2;CWC27;TRA2A;SMU1;HNRNPD;NOVA1;RALY;GTF2F2
prerank,GO_Biological_Process_2021__striated muscle contraction (GO:0006941),-0.4277860554544396,-0.9091681313307463,0.6119402985074627,1.0,1.0,4/30,6.89%,TNNT1;TTN;KCNQ1;STAC3
prerank,GO_Biological_Process_2021__copper ion transport (GO:0006825),-0.4816830209697093,-0.909047923541464,0.5967741935483871,1.0,1.0,4/10,22.79%,CUTC;STEAP2;ATOX1;SLC31A2
prerank,GO_Biological_Process_2021__negative regulation of developmental process (GO:0051093),0.34834315065450466,0.9090397414887414,0.6896551724137931,0.8748444953218002,1.0,13/60,12.40%,ELAPOR2;ZNF706;BMP2;LOXL2;SOX9;NFIB;KANK1;IL17D;SPRY3;PRKN;ANP32B;KIAA0319;DCC
prerank,GO_Biological_Process_2021__regulation of interferon-alpha production (GO:0032647),-0.4783608071719014,-0.9090367226132844,0.6029411764705882,1.0,1.0,3/17,14.02%,STAT1;TLR3;RIPK2
prerank,GO_Biological_Process_2021__ceramide metabolic process (GO:0006672),0.34402967705907894,0.9090036049889842,0.6538461538461539,0.8745329494680613,1.0,4/42,4.43%,CERS3;SGMS1;ACER3;PLPP1
prerank,GO_Biological_Process_2021__DNA modification (GO:0006304),0.41372121999583,0.9088590009772956,0.59375,0.874465192208854,1.0,2/21,6.44%,EXOSC6;NEIL2
prerank,GO_Biological_Process_2021__negative regulation of histone modification (GO:0031057),0.46628420062630915,0.9086756791212287,0.6388888888888888,0.8744619261070342,1.0,2/12,4.84%,SNCA;PRMT6
prerank,GO_Biological_Process_2021__regulation of cellular protein metabolic process (GO:0032268),0.3449562701619647,0.9083392421768895,0.5588235294117647,0.8747806811919013,1.0,9/41,16.22%,WNT7A;NFKB1;FOXO3;AKT1;EIF4E;SSH1;MAPKAPK5;CYFIP1;WDR91
prerank,GO_Biological_Process_2021__coenzyme A metabolic process (GO:0015936),0.44439166434936367,0.9082769057375772,0.6,0.8745126251432722,1.0,6/14,26.34%,PANK2;SLC25A16;PANK3;PANK1;ACAT1;ACOT7
prerank,GO_Biological_Process_2021__positive regulation of monooxygenase activity (GO:0032770),-0.5160988965894617,-0.9082083506018304,0.6610169491525424,1.0,1.0,6/15,21.34%,HTR2B;PIK3CB;APOE;NOS1AP;S100A1;PARK7
prerank,GO_Biological_Process_2021__negative regulation of immune response (GO:0050777),0.31421298414849796,0.9081626926021393,0.7083333333333334,0.8743305999012783,1.0,15/90,13.72%,PRKACB;ADCY1;MAPKBP1;CALCB;PRKAR1B;CD247;ADRB2;ITCH;RNF26;GPR176;ADRB1;HAVCR2;FER;SAMSN1;SIRT2
prerank,GO_Biological_Process_2021__negative regulation of insulin secretion (GO:0046676),-0.4841050846489554,-0.9080438934709003,0.6065573770491803,1.0,1.0,2/13,11.83%,KCNB1;SFRP1
prerank,GO_Biological_Process_2021__regulation of leukocyte activation (GO:0002694),-0.49721346000192135,-0.9079797066442585,0.5084745762711864,1.0,1.0,3/9,21.47%,CD74;GPER1;MYO18A
prerank,GO_Biological_Process_2021__lipoxygenase pathway (GO:0019372),0.4779236125547285,0.9079727973145374,0.5686274509803921,0.8742702256333275,1.0,2/8,7.18%,LTC4S;PON2
prerank,GO_Biological_Process_2021__B cell proliferation (GO:0042100),-0.5617248032444928,-0.9078963333259908,0.5862068965517241,1.0,1.0,1/8,5.26%,RASGRP1
prerank,GO_Biological_Process_2021__negative regulation of locomotion (GO:0040013),0.4963593929059098,0.9078817640012551,0.64,0.8741527563870132,1.0,7/10,25.82%,FBLN1;FRMD5;CRK;SPOCK3;CCDC125;PTPN2;DUSP3
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell migration (GO:0010634),-0.39453764933405167,-0.9076417913008679,0.7183098591549296,1.0,1.0,11/74,10.67%,SPARC;ENPP2;VIL1;THBS1;RAB11A;FGF7;PIK3CB;HYAL1;CTSH;RRAS;FGF1
prerank,GO_Biological_Process_2021__nucleotide-excision repair (GO:0006289),-0.35437892077553135,-0.9074286948614554,0.6081081081081081,1.0,1.0,22/97,23.00%,CETN2;RPS27A;RPA3;UBC;SLX4;PNKP;POLR2I;COPS6;POLR2L;POLR2J;POLD2;COPS5;RBX1;UBA52;POLR2G;RNF111;BRCA2;POLR2K;CDK7;UBB;BRIP1;USP45
prerank,GO_Biological_Process_2021__telomeric loop disassembly (GO:0090657),-0.5521940011740678,-0.9072245674842561,0.6041666666666666,1.0,1.0,2/8,11.65%,BLM;SLX4
prerank,GO_Biological_Process_2021__receptor-mediated endocytosis (GO:0006898),0.2960339726656074,0.9071433982174799,0.8421052631578947,0.8752135466666204,1.0,18/111,12.54%,COLEC11;SNCA;DNM3;SNAP91;PICALM;LRP1B;AP2B1;HSPH1;EPS15;GRK3;RAB31;ADRB2;PIP5K1C;DNAJC13;SGIP1;NLGN3;GRK4;PIKFYVE
prerank,GO_Biological_Process_2021__negative regulation of anoikis (GO:2000811),0.45925065037139423,0.9069607239340928,0.5882352941176471,0.8752028268026417,1.0,1/12,0.07%,PDK4
prerank,GO_Biological_Process_2021__epithelium development (GO:0060429),0.3407253156808003,0.9068858092674722,0.5652173913043478,0.874985226885084,1.0,13/74,14.31%,MEOX2;RCN3;SOX8;SALL1;BMP2;ANXA4;SOX9;BDH2;PKD2;HNRNPH3;DVL1;ACADVL;EHF
prerank,GO_Biological_Process_2021__regulation of epithelial cell apoptotic process (GO:1904035),0.486076422894956,0.906702760409526,0.5555555555555556,0.8750174019410054,1.0,2/8,15.63%,BOK;YAP1
prerank,GO_Biological_Process_2021__histone exchange (GO:0043486),-0.40848707651120775,-0.90668996206076,0.49206349206349204,1.0,1.0,11/32,27.40%,OIP5;ITGB3BP;CENPH;CENPN;CENPU;RNF8;NPM1;KNL1;SMARCA5;CENPX;MIS18A
prerank,GO_Biological_Process_2021__exonucleolytic catabolism of deadenylated mRNA (GO:0043928),0.37848572926035734,0.9064767450630357,0.5833333333333334,0.8751350837609232,1.0,6/28,20.05%,EXOSC6;DCP1B;EXOSC1;CNOT8;EDC3;DDX6
prerank,GO_Biological_Process_2021__respiratory chain complex III assembly (GO:0017062),-0.5433334364586941,-0.9063018692954521,0.6140350877192983,1.0,1.0,2/8,10.62%,UQCRFS1;SLC25A33
prerank,GO_Biological_Process_2021__mitochondrial respiratory chain complex III assembly (GO:0034551),-0.5433334364586941,-0.9063018692954521,0.6140350877192983,1.0,1.0,2/8,10.62%,UQCRFS1;SLC25A33
prerank,GO_Biological_Process_2021__intestinal epithelial cell differentiation (GO:0060575),0.5526664475871603,0.9058525443330651,0.725,0.8762501344805205,1.0,4/5,32.33%,YAP1;NPY;IL6ST;SRC
prerank,GO_Biological_Process_2021__pyrimidine nucleoside biosynthetic process (GO:0046134),0.44784943007318156,0.9054113719620478,0.5777777777777777,0.8768941825202758,1.0,4/12,17.61%,PUDP;DCK;UCK2;UPP1
prerank,GO_Biological_Process_2021__gastrulation (GO:0007369),0.4353744618299933,0.9053541929282032,0.5365853658536586,0.876654964260899,1.0,3/11,6.52%,SMAD2;TASOR;UGDH
prerank,GO_Biological_Process_2021__regulation of proteolysis (GO:0030162),0.3620637346446263,0.9052832310658454,0.7142857142857143,0.8764657625976002,1.0,13/36,20.85%,BTRC;AKT1;CYFIP2;ITCH;HDAC2;CAMK2N1;ASPH;OGT;SPOPL;TBC1D10A;FBXW11;PLK1;SERPINE2
prerank,GO_Biological_Process_2021__negative regulation of cell morphogenesis involved in differentiation (GO:0010771),0.4493426892067222,0.9047331723184557,0.6444444444444445,0.8768556585197333,1.0,4/12,6.06%,EFNA5;RCC2;KANK1;SPRY4
prerank,GO_Biological_Process_2021__negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),0.4493426892067222,0.9047331723184557,0.6444444444444445,0.8768556585197333,1.0,4/12,6.06%,EFNA5;RCC2;KANK1;SPRY4
prerank,GO_Biological_Process_2021__negative regulation of coagulation (GO:0050819),0.5579491295316805,0.9046364812011765,0.66,0.8766808286952611,1.0,2/6,2.99%,SERPINE1;HS3ST5
prerank,GO_Biological_Process_2021__establishment of Golgi localization (GO:0051683),0.4987343485826016,0.9044038150720958,0.6,0.876847101412509,1.0,5/7,39.85%,YWHAZ;STK25;CDC42;COPG1;PDCD10
prerank,GO_Biological_Process_2021__regulation of vasculature development (GO:1901342),-0.45856315671066805,-0.904295288639403,0.59375,1.0,1.0,6/20,19.76%,WARS1;SFRP1;SP100;EMP2;VASH2;RNH1
prerank,GO_Biological_Process_2021__NIK/NF-kappaB signaling (GO:0038061),-0.36698803807674346,-0.9041642889388463,0.676923076923077,1.0,1.0,10/65,15.13%,PSMB6;PSMA8;PSMB9;PSMA7;PSMC3;PSME1;TLR3;PSMC4;PSMA3;TNFRSF10A
prerank,GO_Biological_Process_2021__barbed-end actin filament capping (GO:0051016),-0.47930879554421313,-0.9040588901570018,0.6323529411764706,1.0,1.0,2/16,4.89%,SVIL;VIL1
prerank,GO_Biological_Process_2021__actin filament capping (GO:0051693),-0.47930879554421313,-0.9040588901570018,0.6323529411764706,1.0,1.0,2/16,4.89%,SVIL;VIL1
prerank,GO_Biological_Process_2021__dosage compensation by inactivation of X chromosome (GO:0009048),0.47581214992924536,0.9039930377438893,0.65,0.8772688318446072,1.0,2/12,8.69%,HNRNPU;RBM15B
prerank,GO_Biological_Process_2021__regulation of coagulation (GO:0050818),0.5344386862903826,0.903812143894959,0.509090909090909,0.8773282505421424,1.0,1/5,2.99%,HS3ST5
prerank,GO_Biological_Process_2021__spermidine metabolic process (GO:0008216),-0.5482647314059589,-0.9037200329031058,0.6037735849056604,1.0,1.0,1/6,10.44%,SAT2
prerank,GO_Biological_Process_2021__neural crest cell migration (GO:0001755),0.37858925727216225,0.9033525076744792,0.6153846153846154,0.8781324771020295,1.0,8/29,16.40%,SEMA5B;SOX8;ERBB4;SEMA3C;SEMA6C;NRP1;SEMA4D;SEMA3D
prerank,GO_Biological_Process_2021__regulation of macrophage chemotaxis (GO:0010758),-0.45488685604074086,-0.903131925367756,0.6086956521739131,1.0,1.0,4/16,14.90%,MST1;THBS1;CXCL17;IL34
prerank,GO_Biological_Process_2021__reelin-mediated signaling pathway (GO:0038026),0.6174454704036278,0.9030474200866999,0.6595744680851063,0.8784112854754117,1.0,3/5,31.02%,LRP8;RELN;PAFAH1B1
prerank,GO_Biological_Process_2021__response to dsRNA (GO:0043331),0.5281037071549316,0.9025953073239507,0.6521739130434783,0.8789804500703369,1.0,2/7,8.76%,PDE12;TICAM1
prerank,GO_Biological_Process_2021__neuromuscular process controlling balance (GO:0050885),0.5084529890369787,0.9025381910495692,0.5869565217391305,0.8787556372659406,1.0,2/9,7.38%,SHANK1;NRXN1
prerank,GO_Biological_Process_2021__renal water homeostasis (GO:0003091),0.41173807152917186,0.9024848548161306,0.6571428571428571,0.8784531213374097,1.0,4/21,6.50%,MYO5B;PRKACB;ADCY1;PRKAR1B
prerank,GO_Biological_Process_2021__protein localization to chromosome (GO:0034502),0.3722880890246959,0.902421759707571,0.7368421052631579,0.8781933385194797,1.0,18/32,39.66%,MSH2;ATRX;XRCC4;PLK1;WAPL;TNKS2;TNKS;TERF2IP;RAD21;LEMD2;TERF2;XRCC5;RB1;CHMP7;FAM47E;ATR;BOD1;RPA1
prerank,GO_Biological_Process_2021__receptor clustering (GO:0043113),-0.42368069175088935,-0.9023470239355073,0.5396825396825397,1.0,1.0,2/23,4.46%,MUSK;LRRC7
prerank,GO_Biological_Process_2021__negative regulation of heart rate (GO:0010459),-0.55130130288115,-0.9019395147204683,0.6226415094339622,1.0,1.0,1/5,4.39%,PLN
prerank,GO_Biological_Process_2021__regulation of secretion (GO:0051046),-0.5327523451101308,-0.9019323453703586,0.6,1.0,1.0,3/9,18.83%,KCNQ1;ERBB3;POFUT2
prerank,GO_Biological_Process_2021__regulation of tumor necrosis factor superfamily cytokine production (GO:1903555),0.5286368142636342,0.9018565752723714,0.5641025641025641,0.8789809528347371,1.0,2/7,12.58%,FOXP1;MAPKAPK2
prerank,GO_Biological_Process_2021__cellular response to potassium ion (GO:0035865),-0.5810033736286637,-0.9015785347861327,0.7169811320754716,1.0,1.0,1/5,4.56%,CACNA1H
prerank,GO_Biological_Process_2021__response to potassium ion (GO:0035864),-0.5810033736286637,-0.9015785347861327,0.7169811320754716,1.0,1.0,1/5,4.56%,CACNA1H
prerank,GO_Biological_Process_2021__negative regulation of protein tyrosine kinase activity (GO:0061099),0.41973625166379597,0.901522630764885,0.6585365853658537,0.8793152505825316,1.0,10/18,25.02%,CBL;SH3BP5L;SRCIN1;CBLB;DUSP22;CHMP6;PTPRC;TSG101;SOCS4;ERRFI1
prerank,GO_Biological_Process_2021__bone cell development (GO:0098751),0.4735351290864424,0.9015148046297019,0.5813953488372093,0.8789423220088676,1.0,1/8,2.08%,FOXP1
prerank,GO_Biological_Process_2021__positive regulation of actin filament depolymerization (GO:0030836),-0.498186314137143,-0.9015126816750809,0.6140350877192983,1.0,1.0,2/10,5.50%,VIL1;SEMA5A
prerank,GO_Biological_Process_2021__synaptic vesicle docking (GO:0016081),0.55246319478179,0.9014306606294632,0.6346153846153846,0.8787817052239096,1.0,1/6,21.54%,UNC13A
prerank,GO_Biological_Process_2021__cellular response to bacterial lipopeptide (GO:0071221),-0.5688705105972498,-0.9010329283716075,0.5813953488372093,1.0,1.0,2/5,24.73%,CD14;CD36
prerank,GO_Biological_Process_2021__negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),-0.46696008527695626,-0.9007915838008483,0.5901639344262295,1.0,1.0,4/14,15.71%,SELENOS;CREB3;XBP1;CREB3L1
prerank,GO_Biological_Process_2021__regulation of leukocyte chemotaxis (GO:0002688),-0.5267570443187404,-0.9004890684031875,0.625,1.0,1.0,1/12,2.92%,MST1
prerank,GO_Biological_Process_2021__protein import into peroxisome membrane (GO:0045046),0.4288503977087763,0.9004322977404192,0.48484848484848486,0.8806271955515049,1.0,7/20,14.41%,GDAP1;RAB8B;PEX14;PEX16;PEX5;PEX2;ABCD3
prerank,"GO_Biological_Process_2021__exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000467)",0.4879266002813779,0.9003548354937332,0.5675675675675675,0.8800438085312233,1.0,2/8,7.65%,ERI1;ERI3
prerank,GO_Biological_Process_2021__exonucleolytic trimming involved in rRNA processing (GO:0000459),0.4879266002813779,0.9003548354937332,0.5675675675675675,0.8800438085312233,1.0,2/8,7.65%,ERI1;ERI3
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial cell proliferation (GO:1905564),0.5027911231847539,0.9002329031621524,0.5238095238095238,0.8799182644656425,1.0,5/11,31.31%,HMGB1;AKT3;FGF2;MDK;PDPK1
prerank,GO_Biological_Process_2021__epithelial to mesenchymal transition involved in endocardial cushion formation (GO:0003198),-0.5377193558617124,-0.8999039518848383,0.5925925925925926,1.0,1.0,2/5,18.33%,HEY2;ENG
prerank,GO_Biological_Process_2021__anterior/posterior axis specification (GO:0009948),0.5212842166019712,0.8998165265083254,0.6190476190476191,0.8803780691808335,1.0,2/8,6.32%,FZD5;TASOR
prerank,GO_Biological_Process_2021__regulation of response to DNA damage stimulus (GO:2001020),0.37451431242003985,0.899750391901846,0.5714285714285714,0.8801326723786652,1.0,11/36,21.83%,FEM1B;UBE2N;RFWD3;NPAS2;NEK4;SMG1;FXR1;WRNIP1;CDK9;FMR1;ETAA1
prerank,GO_Biological_Process_2021__positive regulation of cellular catabolic process (GO:0031331),0.28478080294293745,0.8997217811377748,0.75,0.8798099917484371,1.0,30/119,20.97%,DCN;SNCA;FOXO1;ZBTB20;FOXO3;PLIN5;ABHD5;ATF6;IRS1;ITCH;TICAM1;HMGB1;PRKD1;TFEB;SLC4A4;TPCN1;VGLL4;MLXIPL;GSK3B;FAF1;STK11;AKT2;CNOT8;HIF1A;IGF1;TRIM8;ARNT;ROCK1;ADAM9;LIN28B
prerank,GO_Biological_Process_2021__purine nucleotide catabolic process (GO:0006195),-0.48384649548112846,-0.8993969634434306,0.6428571428571429,1.0,1.0,3/11,12.86%,PNP;HINT1;NT5C
prerank,GO_Biological_Process_2021__negative regulation of cyclin-dependent protein kinase activity (GO:1904030),0.38017725885826853,0.899319602584168,0.6176470588235294,0.880184745445586,1.0,8/20,26.73%,MEN1;CAMK2N1;LATS1;PTEN;IPO5;PLK1;IPO7;CDKN1B
prerank,GO_Biological_Process_2021__regulation of actin filament polymerization (GO:0030833),0.3499127868884375,0.8991415189355476,0.5588235294117647,0.8802072288916272,1.0,17/55,17.00%,NCK2;KANK1;HCLS1;BIN1;CARMIL1;PRKCE;PAK3;SLIT2;SSH1;NCKAP1;FER;NCK1;VASP;TENM1;LATS1;ARFGEF1;CYRIB
prerank,GO_Biological_Process_2021__regulation of histone modification (GO:0031056),0.47481909893709096,0.8990418820524374,0.6341463414634146,0.8800397229582149,1.0,4/11,20.95%,UBE2N;MTHFR;SETD5;CDK9
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transmembrane transporter activity (GO:1901021),0.37912481456985936,0.8989238775417641,0.5897435897435898,0.8798934597613622,1.0,4/20,9.50%,ANK2;CASQ1;GSTM2;PKD2
prerank,GO_Biological_Process_2021__extracellular matrix disassembly (GO:0022617),0.35380251552084296,0.8988636430703882,0.6571428571428571,0.8796629637123008,1.0,7/37,7.14%,TLL2;MMP16;CTSK;KLKB1;EXOC8;CTSV;ADAMTS4
prerank,GO_Biological_Process_2021__microtubule polymerization (GO:0046785),0.3864326760500587,0.8987252522788537,0.6,0.8796153640555556,1.0,6/27,15.55%,ZNF207;CKAP5;CLASP1;TUBG1;HDGFL3;SLAIN2
prerank,GO_Biological_Process_2021__regulation of membrane repolarization (GO:0060306),0.504748678039507,0.8986773116615074,0.6590909090909091,0.8793289946010907,1.0,3/10,6.86%,NEDD4L;CACNA2D1;KCNH2
prerank,GO_Biological_Process_2021__response to chemokine (GO:1990868),-0.5170858748012769,-0.8986580827582896,0.6307692307692307,1.0,1.0,1/11,0.34%,DOCK8
prerank,GO_Biological_Process_2021__chondroitin sulfate proteoglycan metabolic process (GO:0050654),0.5244732023995534,0.8984445920637532,0.6829268292682927,0.879309662452036,1.0,6/10,31.50%,CSGALNACT1;DSEL;PXYLP1;DSE;XYLT1;CSGALNACT2
prerank,GO_Biological_Process_2021__positive regulation of nuclear cell cycle DNA replication (GO:0010571),0.5570222171351813,0.8983935517543123,0.6481481481481481,0.8790657767501469,1.0,2/6,30.23%,ATRX;INO80
prerank,GO_Biological_Process_2021__mesoderm development (GO:0007498),0.47807731757861577,0.897862377101702,0.5641025641025641,0.8798392473022568,1.0,5/10,28.86%,MEST;MESP1;GDF11;JAK2;TBX6
prerank,GO_Biological_Process_2021__long-chain fatty acid biosynthetic process (GO:0042759),-0.4324815694903482,-0.8973971846971069,0.6190476190476191,1.0,1.0,8/20,18.73%,CYP2D6;GSTP1;ACSBG2;FADS1;GPX4;ALOX12;CYP3A4;ASAH2
prerank,GO_Biological_Process_2021__synapse organization (GO:0050808),0.3144019679391892,0.897280191406141,0.9444444444444444,0.8807382671981819,1.0,28/115,13.59%,SNCA;CACNB4;PCDHB2;DNM3;PDZRN3;CDH2;ADGRL3;FZD5;GPM6A;GPHN;SLITRK2;NRXN1;LRRC4C;PPFIA2;PPFIBP1;SDK1;LRFN5;PCDHB13;PAK3;SLITRK1;DVL1;NLGN3;SHANK3;NLGN4X;ZC4H2;APBB2;FARP1;ELFN1
prerank,GO_Biological_Process_2021__ERK1 and ERK2 cascade (GO:0070371),-0.46972105181238233,-0.8972007738037876,0.6129032258064516,1.0,1.0,3/14,10.41%,HTR2B;CTSH;MT3
prerank,GO_Biological_Process_2021__positive regulation of innate immune response (GO:0045089),-0.42590576637377514,-0.8968917123223391,0.6428571428571429,1.0,1.0,12/23,27.36%,IFI35;SPI1;RPS19;WNT5A;POLR3G;ADAM8;RIOK3;NLRC5;HLA-E;TRIM62;SLC15A4;FADD
prerank,GO_Biological_Process_2021__acetyl-CoA biosynthetic process (GO:0006085),0.48239691950489916,0.8966936090724429,0.5714285714285714,0.8814893319983969,1.0,2/9,23.24%,DLAT;ACAT1
prerank,GO_Biological_Process_2021__phospholipid homeostasis (GO:0055091),-0.532531829403499,-0.8966866300188048,0.6290322580645161,1.0,1.0,3/8,8.80%,TLCD1;ANGPTL3;FABP3
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-serine phosphorylation (GO:0033137),0.44826681857020795,0.8963655259892717,0.7073170731707317,0.8817563536392418,1.0,7/17,19.25%,NCK2;SMAD7;NCK1;MLXIPL;PDE4D;PTEN;PPM1F
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),-0.4644283888897619,-0.8962795926604062,0.6,1.0,1.0,5/21,16.96%,SFRP2;ZNF385A;CLU;CD74;DDIAS
prerank,GO_Biological_Process_2021__mRNA stabilization (GO:0048255),0.36681681916600223,0.8962406223978037,0.6341463414634146,0.8816870124644983,1.0,7/33,13.75%,RBM24;HNRNPU;HNRNPC;SYNCRIP;MAPKAPK2;DHX9;ANGEL2
prerank,GO_Biological_Process_2021__positive regulation of response to wounding (GO:1903036),-0.4725304337502221,-0.8962091962758977,0.6029411764705882,1.0,1.0,2/17,4.63%,DUOX1;ANXA1
prerank,GO_Biological_Process_2021__termination of RNA polymerase I transcription (GO:0006363),-0.43501512977472084,-0.8955476475637625,0.5833333333333334,1.0,1.0,7/29,21.52%,TAF1D;POLR2L;POLR1C;TTF1;POLR2K;TBP;CDK7
prerank,GO_Biological_Process_2021__pre-mRNA cleavage required for polyadenylation (GO:0098789),0.42755085431411183,0.8955403489780697,0.631578947368421,0.8829616921104999,1.0,2/12,6.26%,NUDT21;CPSF6
prerank,GO_Biological_Process_2021__positive regulation of mRNA binding (GO:1902416),0.5629246114320454,0.8954493304304424,0.6739130434782609,0.8827309681847022,1.0,3/6,21.70%,EIF3E;CDK9;FMR1
prerank,GO_Biological_Process_2021__positive regulation of acrosome reaction (GO:2000344),-0.5585601508942667,-0.8953744038532344,0.5666666666666667,1.0,1.0,3/5,20.26%,CACNA1H;ZP3;GLRA1
prerank,GO_Biological_Process_2021__chromatin assembly (GO:0031497),-0.42408194398839516,-0.8951340908347039,0.6865671641791045,1.0,1.0,2/43,1.35%,H1-4;H1-2
prerank,GO_Biological_Process_2021__positive regulation of phosphate metabolic process (GO:0045937),0.40133818791926684,0.8950881220212987,0.6,0.8832557734633513,1.0,8/20,23.24%,SNCA;EGFR;NRP1;PTGES3;ITGA6;BCL10;FZD7;BTBD10
prerank,PanglaoDB_Augmented_2021__Cholangiocytes,-0.4050990813849895,-0.8949961589809343,0.726027397260274,1.0,1.0,11/41,13.59%,CD24;CFTR;OVOL2;EFNA1;AQP1;TMC4;GPX2;B3GNT3;PPL;ERBB3;EPS8L2
prerank,GO_Biological_Process_2021__aminoglycan biosynthetic process (GO:0006023),0.34948298910122666,0.8946968043551294,0.6785714285714286,0.883808093491546,1.0,6/38,9.03%,SDC4;HS3ST5;GPC5;UGDH;EXT1;EXT2
prerank,GO_Biological_Process_2021__cellular response to pH (GO:0071467),-0.4710620297584075,-0.8945001449296865,0.5714285714285714,1.0,1.0,5/13,26.70%,HYAL1;GPR68;MCOLN1;RAB11FIP5;PKD1L3
prerank,GO_Biological_Process_2021__positive regulation of membrane potential (GO:0045838),-0.5145330380129206,-0.894062059241248,0.6065573770491803,1.0,1.0,2/8,8.75%,MTLN;GLRX
prerank,GO_Biological_Process_2021__sensory perception of sound (GO:0007605),-0.37534765756551147,-0.8939755165222448,0.6060606060606061,1.0,1.0,13/66,16.46%,OTOS;LHFPL5;TIMM10;MYO3A;MYO3B;KCNQ1;TIMM8B;SLC26A5;CEMIP;EPS8L2;TMC2;NDUFB9;CLRN1
prerank,GO_Biological_Process_2021__negative regulation of tubulin deacetylation (GO:1904428),-0.5712430432710196,-0.8937721504180964,0.6808510638297872,1.0,1.0,1/5,12.16%,BEX4
prerank,GO_Biological_Process_2021__regulation of actin polymerization or depolymerization (GO:0008064),0.400435286250437,0.8937054135895671,0.6285714285714286,0.8854989594117059,1.0,5/23,15.41%,CXCL12;ARHGAP35;HCLS1;PAK3;LATS1
prerank,GO_Biological_Process_2021__positive regulation of cell adhesion (GO:0045785),-0.37680666510420263,-0.8934514656501832,0.5897435897435898,1.0,1.0,6/53,9.68%,SFRP2;P2RY12;ECM2;IL12A;HYAL1;NODAL
prerank,GO_Biological_Process_2021__sensory perception of mechanical stimulus (GO:0050954),-0.3798914990564026,-0.8933701295787785,0.6190476190476191,1.0,1.0,9/63,11.11%,OTOS;LHFPL5;TIMM10;MYO3A;MYO3B;KCNQ1;TIMM8B;SLC26A5;CEMIP
prerank,GO_Biological_Process_2021__smooth muscle tissue development (GO:0048745),0.49065935898409796,0.8932169451455426,0.631578947368421,0.8862035167835022,1.0,2/7,15.98%,NF1;SMO
prerank,GO_Biological_Process_2021__hematopoietic stem cell migration (GO:0035701),0.5840616136047725,0.8929660219417597,0.6222222222222222,0.8863140134381621,1.0,2/5,25.15%,JAM2;GAS6
prerank,GO_Biological_Process_2021__glucan catabolic process (GO:0009251),0.4141164474125299,0.892834149843826,0.5789473684210527,0.886229006737545,1.0,3/14,18.44%,MGAM;PGM2;PYGB
prerank,PanglaoDB_Augmented_2021__Cardiomyocytes,0.31288698237955875,0.8927037370910452,0.7368421052631579,0.8861161688594892,1.0,13/96,8.56%,TCAP;ZFPM2;MITF;ADPRHL1;RRAD;ENO3;PNMT;ADIPOR2;RBM24;PRKG1;CASQ1;STRN;CORO6
prerank,GO_Biological_Process_2021__mitochondrial calcium ion transmembrane transport (GO:0006851),0.4105941444332972,0.8924581250928243,0.627906976744186,0.8862823450141275,1.0,2/19,4.36%,MAIP1;MCU
prerank,"GO_Biological_Process_2021__positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",0.5018945920511131,0.8922719830613096,0.627906976744186,0.886232310339136,1.0,2/8,11.72%,TNFSF4;TGFBR2
prerank,GO_Biological_Process_2021__bone marrow development (GO:0048539),0.5853099205392482,0.8922674731951085,0.7272727272727273,0.8858688029932708,1.0,1/5,21.25%,PTPRC
prerank,GO_Biological_Process_2021__neuron maturation (GO:0042551),0.4434683273859128,0.892156265176484,0.6129032258064516,0.8857145263619219,1.0,4/15,13.91%,ADGRB3;B4GALT6;ANKS1A;B4GALT5
prerank,GO_Biological_Process_2021__response to indole-3-methanol (GO:0071680),-0.5507053436675239,-0.8920822143628989,0.5818181818181818,1.0,1.0,3/5,25.46%,BRCA1;CDH1;JUP
prerank,GO_Biological_Process_2021__cellular response to indole-3-methanol (GO:0071681),-0.5507053436675239,-0.8920822143628989,0.5818181818181818,1.0,1.0,3/5,25.46%,BRCA1;CDH1;JUP
prerank,GO_Biological_Process_2021__nucleic acid phosphodiester bond hydrolysis (GO:0090305),0.33609141237101475,0.8920407252632334,0.7857142857142857,0.8855743031839818,1.0,5/58,4.20%,DNASE1L2;PDE12;DNA2;DCP1B;POLD3
prerank,GO_Biological_Process_2021__Golgi to lysosome transport (GO:0090160),0.45035675640781103,0.8912699013395642,0.6046511627906976,0.8868814874582173,1.0,3/10,14.69%,SORT1;AP1G1;CCDC91
prerank,GO_Biological_Process_2021__regulation of T cell cytokine production (GO:0002724),0.4538853768852443,0.8910844938267269,0.6176470588235294,0.8868730353587669,1.0,5/13,8.77%,TNFSF4;FZD5;TRPM4;SMAD7;MAP3K7
prerank,GO_Biological_Process_2021__regulation of pinocytosis (GO:0048548),-0.512730488788783,-0.8907940066447415,0.5932203389830508,1.0,1.0,2/8,23.45%,CLN3;PROM2
prerank,GO_Biological_Process_2021__alpha-amino acid catabolic process (GO:1901606),-0.42951718145745654,-0.8907938339151428,0.6119402985074627,1.0,1.0,2/24,1.59%,KMO;ACMSD
prerank,GO_Biological_Process_2021__regulation of chromatin binding (GO:0035561),-0.48675890820005885,-0.8906953582581908,0.6031746031746031,1.0,1.0,2/11,12.71%,DDX11;DTX3L
prerank,GO_Biological_Process_2021__striated muscle cell differentiation (GO:0051146),0.4296216051388376,0.8904872356135874,0.575,0.8878448509144914,1.0,2/14,3.91%,BMP2;SORT1
prerank,GO_Biological_Process_2021__response to glucose (GO:0009749),-0.38253837819410186,-0.8901488839588346,0.5606060606060606,1.0,1.0,7/36,18.47%,KCNB1;SELENOS;THBS1;XBP1;PCK2;GPER1;PDK3
prerank,GO_Biological_Process_2021__response to amino acid (GO:0043200),0.38002830893855677,0.8900548848422878,0.7352941176470589,0.8882668501618576,1.0,8/31,20.51%,CPEB3;GRIN1;CPEB4;GLRB;RPTOR;CPEB1;IPO5;RRAGD
prerank,GO_Biological_Process_2021__cellular response to fluid shear stress (GO:0071498),-0.47534054690250815,-0.8899787755916365,0.6031746031746031,1.0,1.0,2/11,10.93%,KLF2;KLF4
prerank,GO_Biological_Process_2021__second-messenger-mediated signaling (GO:0019932),-0.38064046460545997,-0.8897876343471063,0.6307692307692307,1.0,1.0,7/47,13.85%,ACKR4;P2RY12;HTR2B;PPP1R9A;RCAN3;APOE;NOS1
prerank,GO_Biological_Process_2021__positive regulation of inflammatory response (GO:0050729),0.3330429299486234,0.8895196236352703,0.65625,0.888994128123,1.0,3/53,2.21%,TNFSF4;SNCA;SERPINE1
prerank,GO_Biological_Process_2021__receptor internalization (GO:0031623),-0.38803417749649094,-0.889468854961106,0.5714285714285714,1.0,1.0,8/37,13.14%,CD9;MX1;ADM;CEACAM1;ARR3;CAV3;CALCRL;RAMP3
prerank,GO_Biological_Process_2021__negative regulation of bone resorption (GO:0045779),0.5909283362562483,0.8892639865133672,0.6595744680851063,0.8891792074493536,1.0,2/5,24.58%,UBASH3B;GPR137B
prerank,GO_Biological_Process_2021__galactolipid biosynthetic process (GO:0019375),0.5293789719012651,0.8889547047518832,0.6190476190476191,0.8891603973917638,1.0,2/6,8.62%,B4GALT3;GAL3ST1
prerank,GO_Biological_Process_2021__galactosylceramide biosynthetic process (GO:0006682),0.5293789719012651,0.8889547047518832,0.6190476190476191,0.8891603973917638,1.0,2/6,8.62%,B4GALT3;GAL3ST1
prerank,GO_Biological_Process_2021__negative regulation of cellular catabolic process (GO:0031330),0.33343721484591377,0.8887489790317271,0.5925925925925926,0.8892342185556645,1.0,10/53,16.14%,LEPR;TAB3;PLIN5;AKT1;EIF4E;SIRT2;EIF4G3;BCL2;MTMR2;HGF
prerank,GO_Biological_Process_2021__nucleoside salvage (GO:0043174),0.48084918544754707,0.8882825834516671,0.6,0.890098177391499,1.0,4/10,17.61%,PUDP;DCK;UCK2;UPP1
prerank,GO_Biological_Process_2021__response to ATP (GO:0033198),-0.5024048018902978,-0.8881386624831787,0.6111111111111112,1.0,1.0,1/15,3.42%,P2RY12
prerank,GO_Biological_Process_2021__base-excision repair (GO:0006284),0.3440888963857681,0.8879721667739877,0.6176470588235294,0.8904071127594977,1.0,4/43,6.44%,DNA2;POLD3;PRMT6;NEIL2
prerank,GO_Biological_Process_2021__regulation of steroid metabolic process (GO:0019218),0.42126447564670505,0.8875523325161281,0.75,0.890909706468193,1.0,6/17,13.58%,RORA;PANK2;TTC39B;ACADVL;ABCA2;ARV1
prerank,GO_Biological_Process_2021__translational termination (GO:0006415),-0.3594023801321934,-0.8874183402017524,0.6805555555555556,1.0,1.0,18/84,21.59%,MRPL20;MTRF1L;MRPL51;TRMT112;MRPL40;MRPL27;MRPS33;GADD45GIP1;MRPL36;MRPL34;AURKAIP1;MRPL54;MRPS21;MRPS34;MRPS26;MRPS22;MRPL21;OXA1L
prerank,GO_Biological_Process_2021__sterol transport (GO:0015918),0.4306262808044542,0.8874100325270058,0.5789473684210527,0.890781901734372,1.0,2/14,13.58%,STARD3;ARV1
prerank,GO_Biological_Process_2021__negative regulation of cytokine production involved in inflammatory response (GO:1900016),0.4862818458706515,0.8873824499685214,0.5588235294117647,0.8905019683731182,1.0,1/13,1.78%,MACIR
prerank,PanglaoDB_Augmented_2021__Pluripotent Stem Cells,-0.3690639561006825,-0.8872419513569999,0.6710526315789473,1.0,1.0,10/72,16.16%,PIF1;ERCC6L;DEPDC1B;ATAD5;BLM;WDHD1;HK2;CENPH;FANCI;TTF2
prerank,GO_Biological_Process_2021__iron ion transport (GO:0006826),-0.40283392162798837,-0.8872406994237587,0.6619718309859155,1.0,1.0,2/42,1.05%,FTH1;CP
prerank,GO_Biological_Process_2021__regulation of morphogenesis of an epithelium (GO:1905330),0.5725361062344048,0.8870394164590742,0.675,0.890782542786805,1.0,1/5,2.08%,FOXP1
prerank,GO_Biological_Process_2021__morphogenesis of an epithelial sheet (GO:0002011),0.5138192444276108,0.8867656379570659,0.6363636363636364,0.8911181920526309,1.0,3/7,26.99%,BMP7;LIN7C;PHACTR4
prerank,GO_Biological_Process_2021__regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),0.5258013832839541,0.8867629253768683,0.631578947368421,0.8907417162638465,1.0,4/8,11.24%,CACNA2D1;BIN1;SESTD1;CAMK2D
prerank,GO_Biological_Process_2021__mRNA 3'-end processing by stem-loop binding and cleavage (GO:0006398),-0.5872278355506004,-0.8867279590792922,0.717391304347826,1.0,1.0,2/5,24.28%,CPSF3;ZNF473
prerank,GO_Biological_Process_2021__nucleoside diphosphate metabolic process (GO:0009132),-0.46570506047591387,-0.8864199620405356,0.660377358490566,1.0,1.0,3/14,12.59%,ENTPD3;CMPK2;AK7
prerank,GO_Biological_Process_2021__positive regulation of voltage-gated potassium channel activity (GO:1903818),-0.5637171804807587,-0.8862200802219411,0.6666666666666666,1.0,1.0,3/6,22.99%,LRRC55;NOS1AP;AKAP6
prerank,GO_Biological_Process_2021__pyrimidine-containing compound metabolic process (GO:0072527),0.4826135937972395,0.8861439385496575,0.6666666666666666,0.891678109505916,1.0,5/11,23.14%,TPK1;DCK;SLC19A2;ERH;NT5C3A
prerank,GO_Biological_Process_2021__negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),-0.40296236329814306,-0.8860861718960081,0.7058823529411765,1.0,1.0,1/35,0.10%,EPN1
prerank,GO_Biological_Process_2021__regulation of chemotaxis (GO:0050920),-0.43849802540245486,-0.8860554315290493,0.6461538461538462,1.0,1.0,3/23,5.73%,GPR183;P2RY12;THBS1
prerank,GO_Biological_Process_2021__regulation of mitotic sister chromatid separation (GO:0010965),-0.497835049576517,-0.8859041733712083,0.5892857142857143,1.0,1.0,1/12,1.66%,CENPE
prerank,GO_Biological_Process_2021__purine nucleoside bisphosphate biosynthetic process (GO:0034033),0.48819223174878934,0.8852780028100963,0.7428571428571429,0.8923713266666554,1.0,6/11,26.34%,PANK2;SLC25A16;PANK3;PANK1;ACAT1;ACOT7
prerank,GO_Biological_Process_2021__coenzyme A biosynthetic process (GO:0015937),0.48819223174878934,0.8852780028100963,0.7428571428571429,0.8923713266666554,1.0,6/11,26.34%,PANK2;SLC25A16;PANK3;PANK1;ACAT1;ACOT7
prerank,GO_Biological_Process_2021__ribonucleoside bisphosphate biosynthetic process (GO:0034030),0.48819223174878934,0.8852780028100963,0.7428571428571429,0.8923713266666554,1.0,6/11,26.34%,PANK2;SLC25A16;PANK3;PANK1;ACAT1;ACOT7
prerank,GO_Biological_Process_2021__mitochondrial fission (GO:0000266),0.4637241765890677,0.8852558186957658,0.6571428571428571,0.892064081297587,1.0,5/16,13.68%,GDAP1;DNM3;MFF;PRKN;OPA1
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),0.38271894422474534,0.8851073647874497,0.65,0.8919845839343409,1.0,8/26,19.50%,BOK;TP53BP2;BCL2;GSK3B;TFDP2;MAPK8;YWHAG;YWHAZ
prerank,GO_Biological_Process_2021__DNA synthesis involved in DNA repair (GO:0000731),-0.40177494216606624,-0.8846170623359015,0.6521739130434783,1.0,1.0,4/39,9.49%,RPS27A;ISG15;RPA3;UBC
prerank,GO_Biological_Process_2021__Arp2/3 complex-mediated actin nucleation (GO:0034314),0.4970243340196553,0.8845780925505103,0.6666666666666666,0.8926631309764541,1.0,6/11,38.86%,JMY;ACTR3;WHAMM;ARPC5L;TRIM27;ACTR2
prerank,GO_Biological_Process_2021__regulation of vascular endothelial cell proliferation (GO:1905562),0.43310036767639526,0.8845096987993974,0.6341463414634146,0.8924181410650317,1.0,4/16,22.98%,FLT1;HMGB1;AKT3;FGF2
prerank,GO_Biological_Process_2021__cellular response to hydrogen peroxide (GO:0070301),-0.41537064145350755,-0.8843249113583385,0.6753246753246753,1.0,1.0,2/30,4.63%,AQP1;ANXA1
prerank,GO_Biological_Process_2021__cardiac ventricle morphogenesis (GO:0003208),-0.4072475949889529,-0.8842674132120376,0.6212121212121212,1.0,1.0,1/24,0.66%,SFRP2
prerank,GO_Biological_Process_2021__endochondral bone morphogenesis (GO:0060350),0.5697999628743843,0.8841379754852103,0.6538461538461539,0.892641530823739,1.0,1/6,8.44%,BMPR1B
prerank,GO_Biological_Process_2021__apical protein localization (GO:0045176),0.4592110548550178,0.8840866815588977,0.6071428571428571,0.8924242841619884,1.0,2/10,18.59%,INSC;SHROOM3
prerank,GO_Biological_Process_2021__regulation of centriole replication (GO:0046599),0.4216379271511718,0.8839772531550938,0.6382978723404256,0.892234736666688,1.0,3/14,14.15%,KAT2B;KAT2A;ALMS1
prerank,GO_Biological_Process_2021__nucleoside phosphate biosynthetic process (GO:1901293),0.44498041946293226,0.8837383550123138,0.6666666666666666,0.8923410260496156,1.0,3/13,4.07%,AK3;AK1;NMNAT2
prerank,GO_Biological_Process_2021__positive regulation of receptor internalization (GO:0002092),-0.45178637365479113,-0.8833185042927605,0.6842105263157895,1.0,1.0,2/17,3.94%,CD63;SFRP4
prerank,GO_Biological_Process_2021__regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),0.3398792109975339,0.8832041630525944,0.6551724137931034,0.8929970927061244,1.0,17/44,30.01%,PRKN;TRADD;CFLAR;CLIP3;SPPL2A;BIRC2;CPNE1;TAX1BP1;OTULIN;HSPA1A;GAS6;PTPN2;UBE2K;CYLD;IKBKB;SPATA2;HIPK1
prerank,GO_Biological_Process_2021__neutral amino acid transport (GO:0015804),0.3817751525043536,0.8831363296517564,0.65,0.8927457094501474,1.0,5/22,21.37%,SLC43A1;SLC38A6;SLC6A6;SLC7A9;SLC6A9
prerank,GO_Biological_Process_2021__regulation of relaxation of cardiac muscle (GO:1901897),-0.5669789726121143,-0.8829382712705448,0.6964285714285714,1.0,1.0,1/5,4.39%,PLN
prerank,GO_Biological_Process_2021__receptor signaling pathway via STAT (GO:0097696),-0.4232952146952143,-0.8827657930709698,0.5818181818181818,1.0,1.0,4/19,14.31%,STAT1;STAT2;CTR9;CCL2
prerank,GO_Biological_Process_2021__positive regulation of protein-containing complex assembly (GO:0031334),-0.36427153911891696,-0.8825983117235139,0.6842105263157895,1.0,1.0,14/92,17.75%,WARS1;IL5;ISG15;RPA3;MTLN;TPPP3;PSMC3;CLU;PSMC4;FSCN1;SKAP1;HRK;RBX1;USP50
prerank,GO_Biological_Process_2021__regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),-0.41694803623160476,-0.8825305437629329,0.6307692307692307,1.0,1.0,4/24,11.67%,EFNA1;PSME1;ATP5IF1;APOE
prerank,GO_Biological_Process_2021__negative regulation of signal transduction (GO:0009968),0.2825531272547461,0.8819728535487006,0.9,0.8947127595776445,1.0,36/189,14.89%,PID1;MOSMO;BTRC;DCN;SNCA;BMP2;NR4A2;EGFR;PLEK;KANK1;ARRB1;PLIN5;SPRY4;AKT1;FRZB;CSNK2A1;LGR4;IRS1;NLK;SPRY3;RPS6KB1;GLI3;DACT3;PTPRJ;FBXW7;HERC4;NLGN4X;PIP4K2C;ACVR1;DCC;WWOX;NCK1;VGLL4;VCP;BCL2;OTUD4
prerank,GO_Biological_Process_2021__positive regulation of potassium ion transmembrane transporter activity (GO:1901018),0.4806633930912608,0.8817684713171335,0.575,0.8947491838780383,1.0,1/8,2.35%,ANK2
prerank,GO_Biological_Process_2021__3'-UTR-mediated mRNA destabilization (GO:0061158),0.41883506607849474,0.8816148426746291,0.5789473684210527,0.8946140326219344,1.0,2/13,5.01%,CPEB3;RBM24
prerank,GO_Biological_Process_2021__protein localization to non-motile cilium (GO:0097499),-0.6182047057341644,-0.8811798485908563,0.7291666666666666,1.0,1.0,1/5,12.84%,ARL13A
prerank,GO_Biological_Process_2021__cyclooxygenase pathway (GO:0019371),0.5237071066391144,0.880758486821615,0.6578947368421053,0.8961251361969316,1.0,4/7,29.11%,PTGES3;TBXAS1;PTGIS;HPGDS
prerank,GO_Biological_Process_2021__positive regulation of interleukin-4 production (GO:0032753),0.4494234398129337,0.8805354633865453,0.6,0.8962500513837824,1.0,1/10,1.31%,TNFSF4
prerank,GO_Biological_Process_2021__negative regulation by host of viral transcription (GO:0043922),-0.509140112988873,-0.8803988441964276,0.6666666666666666,1.0,1.0,5/10,27.78%,PSMC3;POU2F3;TFAP4;JUN;TARDBP
prerank,GO_Biological_Process_2021__regulation of inflammatory response (GO:0050727),0.3089442610517953,0.880264746413056,0.6666666666666666,0.8965461913078414,1.0,13/119,10.37%,ACE2;TNFSF4;MACIR;FOXP1;SNCA;SERPINE1;MGLL;RORA;BST1;NR1D2;NR1D1;TRADD;LRFN5
prerank,GO_Biological_Process_2021__negative regulation of DNA biosynthetic process (GO:2000279),-0.4438941952221097,-0.8802453198114095,0.582089552238806,1.0,1.0,1/25,0.16%,PIF1
prerank,GO_Biological_Process_2021__muscle cell migration (GO:0014812),0.5073309511597239,0.880206869485548,0.6285714285714286,0.8962666574905981,1.0,2/7,19.93%,MEGF10;ROCK1
prerank,GO_Biological_Process_2021__peptide hormone secretion (GO:0030072),-0.4747877702051263,-0.8800463096460186,0.6176470588235294,1.0,1.0,1/13,4.63%,ANXA1
prerank,GO_Biological_Process_2021__regulation of cell growth (GO:0001558),0.27794738552169235,0.879965285370254,0.8421052631578947,0.8964598309630836,1.0,45/172,20.77%,NRG3;EGFR;RAB33B;ADNP2;RPS6KA3;AKT1;FRZB;CSNK2A1;GNG4;SMARCA2;ITCH;FAM107A;DNAJB2;PSMD10;DACT3;CAPRIN2;PTPRJ;CAMK2D;ST7L;NDRG3;DERL2;DCUN1D5;SLIT2;SGK3;SIRT1;TGFBR1;APBB2;IP6K2;RPTOR;SMAD4;TAOK2;VGLL4;BCL2;SERTAD2;USP47;STK11;TFRC;CDKN2AIP;BCAR1;PAK4;APBB1;NAIF1;ZNF639;CIB1;PPP2R1A
prerank,GO_Biological_Process_2021__regulation of Cdc42 protein signal transduction (GO:0032489),0.5345015540004064,0.8798459766942304,0.6470588235294118,0.8963243032469176,1.0,2/6,15.85%,ABCA1;NRP1
prerank,GO_Biological_Process_2021__regulation of RNA splicing (GO:0043484),0.29592414497242253,0.8797212988401586,0.7083333333333334,0.896257306006146,1.0,20/69,18.97%,HNRNPH1;RBM12B;MBNL2;QKI;DYRK1A;PIK3R1;HNRNPLL;HNRNPH3;MBNL1;KHDRBS3;U2AF2;CLK1;PTBP2;JMJD6;RBM20;PTBP1;CELF1;SRPK2;KHDRBS2;RBM38
prerank,GO_Biological_Process_2021__intermembrane lipid transfer (GO:0120009),0.5283458766913057,0.8796932675784124,0.7222222222222222,0.8959236496017713,1.0,3/6,21.35%,PLEKHA8;PLEKHA3;GLTP
prerank,GO_Biological_Process_2021__peptidyl-glutamic acid modification (GO:0018200),-0.43988446972461603,-0.8796803574230382,0.6865671641791045,1.0,1.0,2/18,6.30%,GGCX;TTLL6
prerank,GO_Biological_Process_2021__organelle assembly (GO:0070925),0.24264089991921253,0.879465142543443,1.0,0.8960687915640746,1.0,66/351,20.25%,LIMD1;VPS37B;SPAG16;MACIR;FHDC1;PARVA;CILK1;EXOC2;SEPTIN6;CYS1;UBAP2L;CHMP1A;EXOC8;EHD4;RFX3;RAB3IP;RAB23;RAB8B;VPS37A;EXOC5;SSX2IP;TTBK2;CEP290;G3BP1;ATG7;PIK3C3;ANLN;DZIP1;EXOC6;TTC8;DYNLL2;CHMP2B;PRRC2C;SEPTIN7;EXOC4;BBS9;MAPRE1;CEP20;UBQLN1;KIAA0586;RP2;SH3PXD2B;CDC14A;LZTFL1;MKKS;TMOD2;ATG2B;RAB1A;UBQLN2;POGZ;BBS2;VTA1;YTHDF2;ATG5;LSM14A;ATAT1;EDC3;NSFL1C;UBXN2B;CHMP6;STX12;STX7;PTPN23;DDX6;STAM2;TCTN1
prerank,GO_Biological_Process_2021__B cell receptor signaling pathway (GO:0050853),0.4125099000376123,0.879427218752196,0.7073170731707317,0.8957491589230657,1.0,7/20,21.27%,TEC;BCL2;BCAR1;PLEKHA1;NFATC2;PTPRC;PRKCB
prerank,GO_Biological_Process_2021__positive regulation of interleukin-2 production (GO:0032743),-0.4524875491591933,-0.8794025037226664,0.5915492957746479,1.0,1.0,2/18,7.28%,ANXA1;PNP
prerank,GO_Biological_Process_2021__positive regulation of receptor-mediated endocytosis (GO:0048260),0.34678098365102583,0.8790790513036404,0.6060606060606061,0.8959967068033682,1.0,10/33,14.97%,SERPINE1;TBC1D5;ARRB1;CBL;WASL;SGIP1;RAB21;MAGI2;SCYL2;HIP1
prerank,GO_Biological_Process_2021__positive regulation of receptor recycling (GO:0001921),0.5187772452661992,0.8788504138988465,0.6216216216216216,0.8961074993755604,1.0,3/9,15.37%,SNCA;NSF;SCRIB
prerank,GO_Biological_Process_2021__regulation of cell division (GO:0051302),-0.3687104030239104,-0.8786795819691974,0.7236842105263158,1.0,1.0,8/56,12.01%,SFRP2;CETN2;HTR2B;RAB11A;NLRP5;FGF1;BLM;PLK3
prerank,GO_Biological_Process_2021__regulation of cell motility (GO:2000145),0.30216807814420055,0.878670143034989,0.7586206896551724,0.8961158307245575,1.0,17/100,12.64%,AMOTL1;PRKX;RCC2;ERBB4;CSF1R;EGFR;PLXNA2;FGF17;AKT1;AMOT;PLXNA1;TTBK2;ABL2;SRCIN1;MEMO1;SGK3;NRG2
prerank,GO_Biological_Process_2021__positive regulation of protein maturation (GO:1903319),0.48846309282488987,0.8785503936564271,0.6590909090909091,0.8959877203366198,1.0,2/7,3.81%,SOX4;RHBDD1
prerank,GO_Biological_Process_2021__calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),0.3747817170449697,0.8781211551513257,0.6511627906976745,0.8964461417942032,1.0,15/29,24.61%,PCDHB2;CDH11;ATP2C1;CDH20;PCDHB13;CDH9;CDH13;CDH18;CDH6;CDH10;DCHS1;CDH8;NLGN1;CDH19;PCDHB6
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity (GO:2000116),0.4176625086518054,0.8779611757280871,0.6,0.8964475055733715,1.0,2/17,4.99%,EPHA7;GRIN1
prerank,GO_Biological_Process_2021__regulation of protein serine/threonine kinase activity (GO:0071900),0.2777454800249986,0.8778065948277254,0.875,0.896312603900632,1.0,25/95,22.35%,CDC25A;SNCA;CSF1R;TESK1;CDK5R2;AKT1;CCNG2;ADRB2;CDK12;CCNA2;RALB;DUSP19;INCENP;SIRT1;RPTOR;CCNT2;TRIB2;CAB39;CCND3;MAP2K2;CDK5R1;CIB1;TSG101;ETAA1;CCNJL
prerank,GO_Biological_Process_2021__detection of mechanical stimulus (GO:0050982),0.4238364745875811,0.8776710004475666,0.6595744680851063,0.8961846249316684,1.0,4/16,11.91%,TCAP;CDH2;PKD2;PTK2
prerank,GO_Biological_Process_2021__amyloid precursor protein catabolic process (GO:0042987),0.4720945373622711,0.877467674504164,0.6585365853658537,0.8963154391964269,1.0,2/12,7.40%,NCSTN;DYRK1A
prerank,GO_Biological_Process_2021__outer dynein arm assembly (GO:0036158),0.41799653923161395,0.8774385900014572,0.6875,0.896003838256708,1.0,3/15,11.09%,ZMYND10;DNAAF4;ODAD3
prerank,GO_Biological_Process_2021__positive regulation of cellular protein catabolic process (GO:1903364),-0.46131816228588074,-0.877229681420869,0.7142857142857143,1.0,1.0,3/16,11.67%,RDX;ATP5IF1;APOE
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte proliferation (GO:0050671),0.3536570750676324,0.877118238689829,0.6571428571428571,0.8962910622403806,1.0,3/40,1.31%,TNFSF13B;NCK2;TNFSF4
prerank,GO_Biological_Process_2021__positive regulation of protein localization to cell cortex (GO:1904778),0.5907571594842932,0.8768762091564196,0.7804878048780488,0.8963196833019152,1.0,3/5,33.69%,GNAI1;EPB41;EPB41L2
prerank,GO_Biological_Process_2021__regulation of release of cytochrome c from mitochondria (GO:0090199),0.3616097537623391,0.876754319477588,0.7333333333333333,0.8961308011486271,1.0,9/31,23.33%,MFF;AKT1;PSMD10;PRKN;OPA1;HGF;IGF1;MLLT11;BCL2L1
prerank,GO_Biological_Process_2021__positive regulation of vasculogenesis (GO:2001214),-0.5219338476615344,-0.8763151632329506,0.6545454545454545,1.0,1.0,3/8,14.55%,CEACAM1;RRAS;ASB4
prerank,GO_Biological_Process_2021__establishment of protein localization to mitochondrion (GO:0072655),-0.3904238090541774,-0.8761471799180585,0.6714285714285714,1.0,1.0,13/42,21.87%,TOMM7;TIMM10;TIMM8B;FIS1;HK2;ROMO1;AIP;HSPD1;TOMM34;TSPO;BCAP31;SLC25A6;GRPEL1
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced neuron death (GO:1903204),0.4661287274094772,0.8759977084329562,0.6341463414634146,0.8973958656003046,1.0,3/10,19.80%,PRKN;HIF1A;REST
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell proliferation (GO:0048661),-0.4191559616961573,-0.8759693682281977,0.640625,1.0,1.0,8/32,12.68%,STAT1;THBS1;IGFBP5;P2RY6;NOX1;IL18;CX3CL1;ID2
prerank,GO_Biological_Process_2021__negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),0.47848164751837113,0.8759174420688152,0.6,0.8971184158577268,1.0,3/9,19.25%,RGCC;EPCAM;PPM1F
prerank,GO_Biological_Process_2021__insulin secretion (GO:0030073),-0.4551625435261752,-0.8758559804375695,0.6,1.0,1.0,1/13,4.63%,ANXA1
prerank,GO_Biological_Process_2021__myeloid dendritic cell activation (GO:0001773),0.5310251843905334,0.8758276552698309,0.6222222222222222,0.8969226496309034,1.0,3/5,22.18%,HMGB1;TGFBR2;CAMK4
prerank,"GO_Biological_Process_2021__regulation of synaptic transmission, GABAergic (GO:0032228)",0.4329545392508537,0.875559605106203,0.65,0.8971544980839808,1.0,3/11,8.71%,USP46;BAIAP3;ADRA1A
prerank,GO_Biological_Process_2021__morphogenesis of an epithelium (GO:0002009),-0.4252180298225764,-0.8754630775277876,0.6,1.0,1.0,1/19,0.71%,FLG2
prerank,GO_Biological_Process_2021__B cell differentiation (GO:0030183),0.3852826617210791,0.8754227672916806,0.6470588235294118,0.8969995720880735,1.0,5/28,16.03%,HDAC9;PTPRJ;HDAC4;DCAF1;MSH2
prerank,GO_Biological_Process_2021__dorsal/ventral pattern formation (GO:0009953),0.4230456973243595,0.8753592848195708,0.6341463414634146,0.896722746503176,1.0,6/15,23.31%,BMPR1B;ACVR1;NBL1;BMPR1A;AIDA;FBXL15
prerank,GO_Biological_Process_2021__regulation of establishment of protein localization (GO:0070201),0.4712841936054417,0.8749028324632355,0.6046511627906976,0.8972457802073235,1.0,4/11,16.58%,CEP290;KIAA0586;GAPVD1;CEP120
prerank,GO_Biological_Process_2021__positive regulation of SMAD protein signal transduction (GO:0060391),0.4164266097624656,0.8749013540231879,0.6944444444444444,0.8968810235824441,1.0,4/11,14.34%,KIAA0319;TGFBR1;BMPR1A;SMAD4
prerank,GO_Biological_Process_2021__regulation of receptor-mediated endocytosis (GO:0048259),0.39328173610441935,0.8747238053447807,0.6451612903225806,0.8969702202268244,1.0,7/30,11.87%,SERPINE1;SNAP91;PICALM;CBL;MKLN1;SGIP1;RAB21
prerank,PanglaoDB_Augmented_2021__Enterochromaffin Cells,0.3237407803257815,0.8745907050320386,0.782608695652174,0.8968427634209587,1.0,11/69,6.53%,PPARGC1A;ITGA1;DCN;PDE3A;LSAMP;GIPC2;SLC26A3;PDGFRA;CDH11;PDE1C;FRZB
prerank,GO_Biological_Process_2021__regulation of protein localization to chromatin (GO:1905634),0.47797789341783425,0.874218724719776,0.6956521739130435,0.8972228106464752,1.0,4/6,20.24%,VCPIP1;VCP;SETD2;WAPL
prerank,GO_Biological_Process_2021__protection from non-homologous end joining at telomere (GO:0031848),0.49397731322501454,0.8741508925179878,0.5945945945945946,0.8970006795485308,1.0,4/7,31.95%,DCLRE1C;DCLRE1A;TERF2IP;TERF2
prerank,GO_Biological_Process_2021__positive regulation of ruffle assembly (GO:1900029),-0.4844093037915247,-0.8740313173121018,0.6122448979591837,1.0,1.0,3/11,14.19%,P2RY12;EPS8L2;PFN1
prerank,GO_Biological_Process_2021__endothelial cell morphogenesis (GO:0001886),0.5476007076339804,0.8739250592476694,0.6981132075471698,0.8970626404214078,1.0,1/5,15.25%,COL15A1
prerank,PanglaoDB_Augmented_2021__Airway Goblet Cells,-0.3913046859655446,-0.8737598435276257,0.6567164179104478,1.0,1.0,7/31,9.68%,OVOL2;CEACAM1;TMC4;GPX2;CXCL17;TRIM29;B3GNT3
prerank,GO_Biological_Process_2021__positive regulation of sodium ion transport (GO:0010765),-0.4810559113962559,-0.8736826384526531,0.6507936507936508,1.0,1.0,3/8,23.06%,NOS1;PKP2;SCN1B
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, deadenylation-independent decay (GO:0031086)",0.5118193715878073,0.8736493358515199,0.627906976744186,0.8972326610118524,1.0,3/7,24.81%,DCP1B;EDC3;DCP1A
prerank,"GO_Biological_Process_2021__negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",0.5216394288526142,0.8736287263555932,0.64,0.8968959805802282,1.0,3/7,17.52%,HMGB1;CBFB;RUNX1
prerank,GO_Biological_Process_2021__regulation of vesicle-mediated transport (GO:0060627),0.3135195220099471,0.873614461276908,0.8518518518518519,0.8965528266982283,1.0,19/83,21.25%,PICALM;STXBP5;RAB33B;CD22;RAB8B;ABL2;ATP9A;DNAJC13;RAB21;OPHN1;MAPK1;HIP1;NSF;NRP1;CDH13;RAB4A;MAP2K2;RAB10;PTPRC
prerank,GO_Biological_Process_2021__phosphatidic acid biosynthetic process (GO:0006654),0.35916342359625764,0.8735381095372946,0.6486486486486487,0.8962841902048932,1.0,7/37,10.92%,DGKB;PLD6;ABHD5;DGKH;ACP6;GPAM;DGKZ
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance via telomere lengthening (GO:1904357),-0.4732168828814031,-0.8731819589853632,0.7413793103448276,1.0,1.0,1/23,0.16%,PIF1
prerank,GO_Biological_Process_2021__cation transport (GO:0006812),-0.33526904982679046,-0.8731770616969711,0.7792207792207793,1.0,1.0,24/114,22.12%,SLC5A10;KCNJ13;SLC18A2;AQP1;KCNQ4;CNGB3;KCNG1;SLC8A3;CLN3;KCNJ8;SLC4A11;SLC8B1;SLC22A4;SCN7A;SLC5A9;TRPM1;SLC22A1;CNGA3;KCNV1;KCNH1;SLC36A1;RHCG;KCNK1;MCOLN1
prerank,GO_Biological_Process_2021__macrophage activation (GO:0042116),0.39478927022712923,0.8730717935223263,0.7368421052631579,0.896879235879314,1.0,2/22,2.09%,FOXP1;SNCA
prerank,PanglaoDB_Augmented_2021__Hepatoblasts,0.34368910353280163,0.8729370527730553,0.75,0.8967522894178838,1.0,8/35,14.01%,MYO5B;ARHGEF16;MAP2K4;FZD5;LGR4;SMAD5;EPCAM;HNF4G
prerank,GO_Biological_Process_2021__stress granule assembly (GO:0034063),-0.42924912047725694,-0.8726275723689616,0.696969696969697,1.0,1.0,1/19,1.04%,RPS23
prerank,GO_Biological_Process_2021__substantia nigra development (GO:0021762),0.33305207243046553,0.872381961052924,0.7916666666666666,0.8975758195865939,1.0,5/39,15.69%,MBP;NDRG2;ZNF148;SIRT2;PADI2
prerank,GO_Biological_Process_2021__spliceosomal tri-snRNP complex assembly (GO:0000244),-0.47877216346804247,-0.8721872409230249,0.696969696969697,1.0,1.0,5/13,23.20%,LSM2;PRPF8;DDX20;PRPF3;PRPF6
prerank,GO_Biological_Process_2021__marginal zone B cell differentiation (GO:0002315),0.5404487978676267,0.8720667125340954,0.7317073170731707,0.8977653509966732,1.0,1/6,4.56%,NOTCH2
prerank,"GO_Biological_Process_2021__retrograde protein transport, ER to cytosol (GO:0030970)",0.42844596931141016,0.8719509795272097,0.6176470588235294,0.8976651352263756,1.0,4/17,14.67%,RHBDD1;TMEM129;DERL2;VCP
prerank,GO_Biological_Process_2021__negative regulation of interleukin-8 production (GO:0032717),0.45368520552712477,0.8718438935716792,0.6046511627906976,0.8974976828800718,1.0,5/12,13.35%,ANXA4;ARRB1;MAPKBP1;SSC5D;MAP2K5
prerank,GO_Biological_Process_2021__regulation of axon extension involved in axon guidance (GO:0048841),0.3655865266321469,0.8713521255088046,0.6060606060606061,0.898184968648696,1.0,6/22,16.40%,SEMA5B;SEMA3C;SEMA6C;NRP1;SEMA4D;SEMA3D
prerank,GO_Biological_Process_2021__positive regulation of collagen metabolic process (GO:0010714),0.46576601549209484,0.8712421909239385,0.6842105263157895,0.8979838084140914,1.0,3/13,17.52%,RGCC;HDAC2;RUNX1
prerank,GO_Biological_Process_2021__regulation of membrane depolarization (GO:0003254),0.4183015898230801,0.8709158708561237,0.723404255319149,0.8982803603141416,1.0,3/14,11.24%,NEDD4L;SMAD7;CAMK2D
prerank,MSigDB_Hallmark_2020__Angiogenesis,0.38547308025183635,0.8708360342012952,0.6923076923076923,0.8980658844947204,1.0,5/24,16.66%,POSTN;PDGFA;PTK2;NRP1;VCAN
prerank,GO_Biological_Process_2021__negative regulation of potassium ion transport (GO:0043267),0.48671309061769946,0.8708309276017527,0.675,0.8977037870190032,1.0,3/10,6.86%,NEDD4L;BIN1;KCNH2
prerank,GO_Biological_Process_2021__tRNA transcription by RNA polymerase III (GO:0042797),-0.5387590063222547,-0.8707278512607288,0.6379310344827587,1.0,1.0,2/7,14.52%,GTF3C6;POLR2L
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),0.3037609675437725,0.8706477430511255,0.7619047619047619,0.8977113296938403,1.0,30/82,24.90%,SPRED2;ZEB2;SMAD2;SMAD7;SPRED1;PPM1A;MEN1;ZNF451;EP300;SMURF1;TGFBR2;SIRT1;HIPK2;TGFBR1;SMAD4;BCL9;LATS1;STK11;LEMD3;ZNF703;SNX25;SPRED3;CREBBP;HSPA1A;PMEPA1;SKIL;WFIKKN1;TRIM33;SMAD3;SLC2A10
prerank,GO_Biological_Process_2021__response to peptide hormone (GO:0043434),-0.3681699034827406,-0.8706403419332015,0.6060606060606061,1.0,1.0,6/40,13.88%,STAT1;ANXA1;IGFBP5;STAT2;CELA2A;XBP1
prerank,GO_Biological_Process_2021__positive regulation of proteolysis (GO:0045862),0.3480380939935869,0.8705471241292113,0.6216216216216216,0.8976517404866148,1.0,13/40,20.74%,RCN3;BTRC;RHBDD1;CYFIP2;HDAC2;ASPH;OGT;TBC1D10A;FBXW11;PLK1;BAG2;ADAM9;WDR48
prerank,GO_Biological_Process_2021__photoreceptor cell differentiation (GO:0046530),0.5137621692132401,0.8705026786194576,0.6571428571428571,0.8973841958706869,1.0,3/6,25.64%,AGTPBP1;RP1;ARL3
prerank,GO_Biological_Process_2021__positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001269),-0.5297156002992729,-0.8705001518988817,0.7166666666666667,1.0,1.0,2/7,16.67%,CASP8;HTRA2
prerank,GO_Biological_Process_2021__cilium assembly (GO:0060271),0.2608561827236321,0.8702359720741625,1.0,0.8975260015982485,1.0,48/273,16.86%,SPAG16;MACIR;ZMYND10;CEP152;FHDC1;PARVA;CILK1;EXOC2;SEPTIN6;CYS1;CEP97;EXOC8;EHD4;RFX3;RAB3IP;RAB23;RAB8B;EXOC5;NEDD1;SSX2IP;TTBK2;CEP290;CSNK1E;TRIP11;DZIP1;EXOC6;TTC8;C2CD3;BBS10;DYNLL2;CKAP5;SEPTIN7;EXOC4;BBS9;MAPRE1;CEP20;CLASP1;ALMS1;KIAA0586;RP2;TUBG1;TOGARAM1;CDC14A;LZTFL1;MKKS;RAB1A;YWHAG;TNPO1
prerank,PanglaoDB_Augmented_2021__Gastric Chief Cells,0.3333760567293782,0.8700242858834055,0.6153846153846154,0.8976408738274703,1.0,7/57,5.25%,ACE2;CAPN13;ARHGEF16;EGFR;HID1;PLEKHA6;ALS2CL
prerank,GO_Biological_Process_2021__regulation of response to stress (GO:0080134),0.44522575446730445,0.8698182063526444,0.6590909090909091,0.8977020393817853,1.0,7/10,34.66%,STOX1;MACROH2A1;MLC1;DYRK3;SLC38A2;CORO2B;EIF4G1
prerank,GO_Biological_Process_2021__regulation of protein kinase activity (GO:0045859),0.29692040771518574,0.8695459984717147,0.8214285714285714,0.8979038301705341,1.0,25/90,19.25%,SNCA;RAP2B;SMCR8;MMD;PPM1E;AKT1;AGAP2;GSKIP;RAPGEF2;SPRED1;TAB1;CAMK2N1;NF1;DUSP19;DVL1;PTK2;SIRT1;RAP2C;RAP1A;GNAQ;YWHAG;TRIB2;CAMKK1;ALS2;PPM1F
prerank,GO_Biological_Process_2021__positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),0.2937572344093236,0.8694186053505996,0.9375,0.8977974359354337,1.0,28/138,18.83%,C18ORF32;VAPA;TAB3;EEF1D;ATP2C1;TNFRSF19;CASP10;UBE2N;PPM1A;ROR1;TRAF3IP2;TICAM1;MAP3K7;CANT1;PRKN;TRADD;CFLAR;PRKD1;ANKRD17;LURAP1;TNFRSF10B;ECM1;BIRC2;TFG;TFRC;NDFIP1;TRIM8;BCL10
prerank,GO_Biological_Process_2021__proton-transporting V-type ATPase complex assembly (GO:0070070),-0.569502568998995,-0.8693898716534827,0.7551020408163265,1.0,1.0,1/5,4.93%,ALDOB
prerank,GO_Biological_Process_2021__galactosylceramide metabolic process (GO:0006681),0.48798630088470574,0.8693828737386744,0.6904761904761905,0.8975037151524649,1.0,2/8,8.62%,B4GALT3;GAL3ST1
prerank,GO_Biological_Process_2021__neurotransmitter secretion (GO:0007269),0.33261750068878976,0.8693269214964762,0.7272727272727273,0.8972570688723309,1.0,14/37,23.19%,SNCA;NRXN1;PIP5K1C;DVL1;SLC32A1;STX1A;LIN7C;PCLO;NRXN2;LIN7A;DNAJC5;UNC13A;PTPRN2;RIMS2
prerank,GO_Biological_Process_2021__nucleotide catabolic process (GO:0009166),0.4246890332105722,0.8692080386614165,0.5869565217391305,0.8971510695448364,1.0,2/14,4.71%,SAMHD1;NT5C1A
prerank,GO_Biological_Process_2021__Wnt signaling pathway (GO:0016055),-0.35928535394596384,-0.8688334914468605,0.675,1.0,1.0,10/79,12.07%,CD24;SFRP2;RPS27A;SFRP4;WNT2B;UBC;WNT9B;WNT3;SFRP1;FZD9
prerank,GO_Biological_Process_2021__SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),-0.3553307593267212,-0.8687638279749542,0.704225352112676,1.0,1.0,11/83,13.44%,PSMB6;FBXL22;PSMA8;PSMB9;PSMA7;PSMC3;FBXL18;PSME1;SKP2;PSMC4;PSMA3
prerank,PanglaoDB_Augmented_2021__Eosinophils,-0.39850651096796175,-0.8685533466105672,0.6363636363636364,1.0,1.0,11/34,13.63%,TAGAP;IL5;CLEC12A;DPEP2;ARHGAP9;GMFG;TRAF3IP3;ARHGAP30;SPI1;PGLYRP1;MYO1F
prerank,GO_Biological_Process_2021__regulation of ion transmembrane transport (GO:0034765),-0.417923252433374,-0.8685451498929804,0.6909090909090909,1.0,1.0,2/26,6.80%,KCNJ13;KCNQ1
prerank,GO_Biological_Process_2021__regulation of carbohydrate biosynthetic process (GO:0043255),-0.48803292026015493,-0.8681437032764118,0.7017543859649122,1.0,1.0,1/9,5.71%,SELENOS
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell apoptotic process (GO:1905459),0.5265816622947974,0.8681002854653926,0.6428571428571429,0.8989637912762417,1.0,4/7,41.42%,IGF1;PPARG;MFN2;E2F3
prerank,GO_Biological_Process_2021__glutamate receptor signaling pathway (GO:0007215),0.3560084337067527,0.8679501683508799,0.6842105263157895,0.8988839109849994,1.0,15/34,23.57%,GRIN1;HOMER1;PLCB1;CPEB4;GRM1;GRM8;GNAQ;CDK5R1;GRIK2;GRIA2;FMR1;HOMER2;GRIN2B;GRIK1;GRM5
prerank,GO_Biological_Process_2021__regulation of autophagy of mitochondrion (GO:1903146),0.40074881226240794,0.8678233722656394,0.7,0.8987506585057593,1.0,4/18,17.92%,FZD5;PRKN;FBXW7;CSNK2A2
prerank,GO_Biological_Process_2021__determination of bilateral symmetry (GO:0009855),-0.43050539657650183,-0.8677917469145293,0.6363636363636364,1.0,1.0,1/20,1.88%,MMP21
prerank,GO_Biological_Process_2021__cGMP metabolic process (GO:0046068),0.5283491547709598,0.8676318707686514,0.6136363636363636,0.8986909612703227,1.0,1/6,5.24%,GUCY1B1
prerank,GO_Biological_Process_2021__electron transport chain (GO:0022900),0.4408910253978987,0.867509324931374,0.627906976744186,0.8985912673836125,1.0,2/13,8.46%,PPARGC1A;ENOX2
prerank,GO_Biological_Process_2021__stabilization of membrane potential (GO:0030322),-0.5307408112708771,-0.8674310705003236,0.6851851851851852,1.0,1.0,3/6,24.50%,KCNK13;KCNK1;CHCHD10
prerank,GO_Biological_Process_2021__receptor signaling pathway via JAK-STAT (GO:0007259),-0.40948268953156175,-0.8672422317760085,0.6181818181818182,1.0,1.0,4/22,14.31%,STAT1;STAT2;CTR9;CCL2
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor production (GO:0032760),-0.39091151729377166,-0.867169605851841,0.676056338028169,1.0,1.0,7/43,12.42%,RASGRP1;THBS1;LY96;TLR3;CLU;OAS3;CD14
prerank,GO_Biological_Process_2021__cellular biogenic amine biosynthetic process (GO:0042401),0.44066391311188946,0.8671549306222657,0.6046511627906976,0.898838573091601,1.0,2/10,7.88%,PNMT;SMOX
prerank,GO_Biological_Process_2021__leukotriene transport (GO:0071716),0.4897475102830367,0.8671019795439681,0.6304347826086957,0.8985321679578956,1.0,2/7,12.53%,ABCC2;ABCC3
prerank,GO_Biological_Process_2021__interleukin-1-mediated signaling pathway (GO:0070498),-0.3457561389355476,-0.866994079374904,0.6986301369863014,1.0,1.0,12/83,14.02%,PSMB6;IL1R1;RPS27A;PSMA8;PSMB9;PSMA7;PSMC3;UBC;PSME1;PSMC4;PSMA3;RIPK2
prerank,GO_Biological_Process_2021__collagen-activated signaling pathway (GO:0038065),-0.4964939250256051,-0.8661626710761935,0.6610169491525424,1.0,1.0,2/7,16.62%,ITGA2;COL4A2
prerank,GO_Biological_Process_2021__regulation of actin filament-based movement (GO:1903115),-0.5220574254910888,-0.8659079843413261,0.6491228070175439,1.0,1.0,2/6,6.08%,PLN;PDPN
prerank,GO_Biological_Process_2021__cellular response to interleukin-12 (GO:0071349),-0.3744167266462595,-0.8657750765389484,0.6805555555555556,1.0,1.0,8/38,22.85%,IL12A;CA1;RPLP0;AIP;TALDO1;GSTO1;ANXA2;IL12RB1
prerank,GO_Biological_Process_2021__negative regulation of mitochondrion organization (GO:0010823),0.37739986904084094,0.8656711814206766,0.6571428571428571,0.9008724415798292,1.0,11/27,24.29%,AKT1;PSMD10;PRKN;OPA1;VAT1;HGF;TFRC;IGF1;HSPA1A;BCL2L1;HUWE1
prerank,GO_Biological_Process_2021__regulation of protein localization to cell surface (GO:2000008),0.35615636698904246,0.8655695012449263,0.6764705882352942,0.9007253780708673,1.0,7/30,15.16%,PICALM;NEDD4L;GPM6B;LEPROTL1;COMMD1;ABCA2;TM9SF4
prerank,GO_Biological_Process_2021__regulation of natural killer cell activation (GO:0032814),-0.5127794515695826,-0.865422500014563,0.6491228070175439,1.0,1.0,5/7,25.32%,IL12A;MICA;PTPN22;PRDM1;DCAF15
prerank,GO_Biological_Process_2021__negative regulation of biomineralization (GO:0110150),0.4728289521694137,0.8654150561340307,0.7272727272727273,0.9006117375190049,1.0,4/8,25.15%,SOX9;ROCK2;ROCK1;GAS6
prerank,GO_Biological_Process_2021__snoRNA localization (GO:0048254),0.5265180053451115,0.8652411545464731,0.625,0.9005847425453722,1.0,3/6,43.00%,PRPF31;FBL;ZNHIT6
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-threonine phosphorylation (GO:0010800),0.3797758852634612,0.8649646440045313,0.7317073170731707,0.9008040126822037,1.0,8/21,20.03%,STOX1;RPTOR;MAPK1;BMP7;WNK3;AXIN1;CAB39;PLK1
prerank,GO_Biological_Process_2021__phosphatidic acid metabolic process (GO:0046473),0.35871254608015807,0.8649526732076606,0.6666666666666666,0.9004576408158713,1.0,7/38,10.92%,DGKB;PLD6;ABHD5;DGKH;ACP6;GPAM;DGKZ
prerank,GO_Biological_Process_2021__positive regulation of translation (GO:0045727),-0.36461499927754126,-0.8649414905991002,0.6417910447761194,1.0,1.0,5/84,6.86%,EIF2S3B;RPS4X;THBS1;RPS9;RPL5
prerank,GO_Biological_Process_2021__positive regulation of intracellular protein transport (GO:0090316),-0.3355239187679774,-0.864876420019793,0.7894736842105263,1.0,1.0,12/124,12.15%,TOMM7;KIF20B;KCNB1;PDZK1;SLC51B;CASP8;UBL5;ARIH2;AKAP5;CEMIP;PLK3;FIS1
prerank,GO_Biological_Process_2021__Notch receptor processing (GO:0007220),0.5050206412649085,0.8646973933109782,0.66,0.9006435353046692,1.0,1/7,5.23%,NCSTN
prerank,PanglaoDB_Augmented_2021__Mesangial Cells,0.28742046746372224,0.8645340561290887,0.7142857142857143,0.9007162778966454,1.0,27/124,15.63%,POSTN;DCN;HMCN1;PDE3A;PAWR;FAT4;NR4A2;ACTA2;PARVA;CXCL12;PDGFRA;CDH11;PCDH18;DYRK1A;PRRX1;NCOA2;FAP;ADAMTSL4;MAP3K20;PLPP3;OGT;TPM2;MIB1;TRIP4;COL15A1;ECM1;YAP1
prerank,PanglaoDB_Augmented_2021__Langerhans Cells,-0.39852118146966875,-0.8643345945536799,0.6507936507936508,1.0,1.0,12/35,20.06%,TAGAP;IGSF6;CIITA;ARHGAP30;SPI1;MYO1F;CD74;NFAM1;WDFY4;HLA-F;HLA-DPB1;PTAFR
prerank,"GO_Biological_Process_2021__nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",0.3663807631957199,0.8643161974228958,0.6136363636363636,0.9007358061368047,1.0,6/22,10.13%,IRAK2;TAB3;UBE2N;ITCH;MAP3K7;TAB1
prerank,GO_Biological_Process_2021__protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043328),0.5336533191729054,0.864173088770629,0.72,0.9002702499812327,1.0,1/5,28.69%,STAM
prerank,GO_Biological_Process_2021__establishment of protein localization to vacuole (GO:0072666),0.5336533191729054,0.864173088770629,0.72,0.9002702499812327,1.0,1/5,28.69%,STAM
prerank,GO_Biological_Process_2021__nuclear body organization (GO:0030575),0.4463349304899187,0.863951705822793,0.7,0.9003629349295277,1.0,4/12,25.98%,HIPK2;SRPK2;ZPR1;DYRK3
prerank,GO_Biological_Process_2021__tRNA transcription (GO:0009304),-0.5375210429121349,-0.8639164641066313,0.6491228070175439,1.0,1.0,2/8,14.52%,GTF3C6;POLR2L
prerank,GO_Biological_Process_2021__positive regulation of nitrogen compound metabolic process (GO:0051173),-0.4281759462288838,-0.8638211274269672,0.6296296296296297,1.0,1.0,2/15,10.93%,KLF2;KLF4
prerank,GO_Biological_Process_2021__actin nucleation (GO:0045010),-0.43777179566954977,-0.863388213451989,0.639344262295082,1.0,1.0,1/14,0.81%,LMOD1
prerank,GO_Biological_Process_2021__urogenital system development (GO:0001655),0.5249651968655464,0.8630292431362648,0.7,0.9018220724494226,1.0,2/6,4.24%,AMH;SOX9
prerank,GO_Biological_Process_2021__establishment of vesicle localization (GO:0051650),0.3998350778057214,0.8630092135429723,0.6829268292682927,0.9015029348918288,1.0,7/17,18.91%,RAB27A;TESK1;KIF5A;KIF5C;SYNJ1;TMEM230;DNM2
prerank,GO_Biological_Process_2021__muscle cell differentiation (GO:0042692),0.38419541723874306,0.8630063113999669,0.6774193548387096,0.9011442864300102,1.0,7/23,20.68%,RORA;MEGF10;MRTFA;SYNE1;NEBL;KDM1A;NEB
prerank,GO_Biological_Process_2021__positive regulation of epidermis development (GO:0045684),0.5174132296325007,0.8629748676909195,0.6521739130434783,0.9008521841845383,1.0,1/5,1.01%,ELAPOR2
prerank,GO_Biological_Process_2021__negative regulation of blood vessel endothelial cell migration (GO:0043537),0.4206840611309975,0.8629145372631695,0.6333333333333333,0.9005669413461975,1.0,6/24,15.57%,MEOX2;STARD13;RGCC;HMGB1;MAP2K5;ATP2B4
prerank,GO_Biological_Process_2021__regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),0.49857532931975124,0.8628507520777847,0.775,0.9002885495870961,1.0,4/9,13.35%,FOXP1;MBP;HMGB1;MAP2K5
prerank,GO_Biological_Process_2021__positive regulation of peptidase activity (GO:0010952),0.39669686840767115,0.8627258966560026,0.6666666666666666,0.9001294985819362,1.0,2/17,5.23%,RCN3;NCSTN
prerank,GO_Biological_Process_2021__positive regulation of cellular component movement (GO:0051272),-0.43518177424328447,-0.8626183027089706,0.6515151515151515,1.0,1.0,2/20,6.08%,DUOX1;PDPN
prerank,GO_Biological_Process_2021__regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),0.50464383401892,0.862401556222811,0.6444444444444445,0.9003410079669631,1.0,4/8,17.75%,BMP2;MYORG;PHIP;IGF1
prerank,GO_Biological_Process_2021__positive regulation of defense response to virus by host (GO:0002230),-0.42312001358838514,-0.8621849775604613,0.7241379310344828,1.0,1.0,6/19,17.40%,STAT1;PQBP1;APOBEC3G;DTX3L;AIM2;PTPN22
prerank,GO_Biological_Process_2021__regulation of sequestering of calcium ion (GO:0051282),0.45552664138685084,0.8621759021850027,0.7380952380952381,0.900519285470669,1.0,2/9,6.27%,ANK2;CASQ1
prerank,GO_Biological_Process_2021__positive regulation of collagen biosynthetic process (GO:0032967),0.4682162807386128,0.8620896510678002,0.7297297297297297,0.9003669435355112,1.0,3/12,17.52%,RGCC;HDAC2;RUNX1
prerank,PanglaoDB_Augmented_2021__Hematopoietic Stem Cells,-0.33911430860989744,-0.8620439736563321,0.7662337662337663,1.0,1.0,21/95,18.42%,SELP;CLEC12A;F13A1;P2RY13;GPR171;FPR3;PROCR;VWF;ABCG2;FES;IL3RA;CD14;SPI1;GNL3;SCARF1;ARID3A;GFI1B;CXCR4;C1QB;ENG;WDFY4
prerank,GO_Biological_Process_2021__ventricular cardiac muscle cell action potential (GO:0086005),0.41973547322459576,0.862014548529693,0.5957446808510638,0.9001156220838011,1.0,3/14,6.86%,ANK2;NEDD4L;KCNH2
prerank,GO_Biological_Process_2021__negative regulation of T-helper cell differentiation (GO:0045623),0.5303901974863919,0.8616887423584771,0.75,0.9003730247093703,1.0,2/6,7.25%,TNFSF4;SMAD7
prerank,GO_Biological_Process_2021__histone methylation (GO:0016571),0.3468881298596924,0.8614921869429688,0.6666666666666666,0.900339753333854,1.0,3/23,9.82%,PRMT1;PRMT6;FBLL1
prerank,GO_Biological_Process_2021__regulation of MDA-5 signaling pathway (GO:0039533),-0.5452715730609818,-0.8614862233676042,0.7413793103448276,1.0,1.0,4/6,23.63%,DDX60;RIOK3;DHX58;TKFC
prerank,GO_Biological_Process_2021__extracellular matrix organization (GO:0030198),-0.31946245840053217,-0.8612523700300074,0.8064516129032258,1.0,1.0,31/217,12.95%,THSD4;MMP21;SPARC;COL8A1;COL10A1;MMP25;P4HA3;ITGA5;COL5A1;TIMP1;COL6A2;ECM2;THBS1;CTSL;MMP19;ELN;COL24A1;MMP24;COL4A4;PPIB;VWF;KIF9;A2M;SCUBE3;FBLN5;LAMB1;ADAMTS16;COL9A2;MATN3;MARCOL;MADCAM1
prerank,GO_Biological_Process_2021__negative regulation of cholesterol transport (GO:0032375),0.5820926059638304,0.8611586065156108,0.75,0.9006496486227905,1.0,2/5,13.55%,NFKB1;ABCA2
prerank,GO_Biological_Process_2021__maturation of 5.8S rRNA (GO:0000460),0.4199671825355185,0.8611360027574958,0.6363636363636364,0.9003260605333222,1.0,3/16,15.32%,MPHOSPH6;C1D;URB1
prerank,PanglaoDB_Augmented_2021__Osteoblasts,-0.34162351886118164,-0.8610703973587389,0.7215189873417721,1.0,1.0,34/118,19.09%,LMOD1;SPARC;ITGA5;COL5A1;SFRP4;ANGPTL2;C1R;COL6A2;RUNX2;IGFBP5;PHEX;CALB1;CX3CL1;SOD3;PAMR1;ADGRL4;ITGA2;TNC;C1S;SRPX2;TNFRSF10A;TNS2;EDNRA;COL4A2;CALD1;WNT5A;C1QTNF1;COL14A1;GPER1;SOCS3;MMP14;TAGLN;BGN;EHD2
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle cell differentiation (GO:2000727),0.5486707522047859,0.8604790591317862,0.6829268292682927,0.9015060565923265,1.0,1/5,9.93%,EFNB2
prerank,GO_Biological_Process_2021__nitrogen compound transport (GO:0071705),0.29622894682173945,0.8603075914700411,0.8571428571428571,0.9013669284704933,1.0,13/103,7.75%,TXNIP;RCN3;SLC6A13;SLC15A3;SLC43A1;LRP1B;ABCC2;SLC15A2;CMTM6;CHMP1A;SLC12A2;SLC7A11;CEP290
prerank,GO_Biological_Process_2021__response to hydroxyurea (GO:0072710),-0.5000450239385611,-0.860283038946012,0.6615384615384615,1.0,1.0,2/9,10.79%,DDX11;BLM
prerank,GO_Biological_Process_2021__response to forskolin (GO:1904321),-0.500002804540438,-0.8601410999364218,0.64,1.0,1.0,1/9,1.71%,CFTR
prerank,GO_Biological_Process_2021__cellular response to forskolin (GO:1904322),-0.500002804540438,-0.8601410999364218,0.64,1.0,1.0,1/9,1.71%,CFTR
prerank,GO_Biological_Process_2021__negative regulation of glial cell differentiation (GO:0045686),-0.5210864665947987,-0.8600932137022005,0.6491228070175439,1.0,1.0,1/6,7.41%,HES1
prerank,GO_Biological_Process_2021__negative regulation of oligodendrocyte differentiation (GO:0048715),-0.5210864665947987,-0.8600932137022005,0.6491228070175439,1.0,1.0,1/6,7.41%,HES1
prerank,GO_Biological_Process_2021__positive regulation of immunoglobulin production (GO:0002639),0.41446639944610053,0.8600248366746605,0.6666666666666666,0.9016363815753646,1.0,1/20,1.31%,TNFSF4
prerank,GO_Biological_Process_2021__positive regulation of microtubule polymerization (GO:0031116),-0.412850522282721,-0.8599840992446401,0.6190476190476191,1.0,1.0,4/27,13.54%,ANKRD53;CAV3;FES;DRG1
prerank,GO_Biological_Process_2021__regulation of nervous system development (GO:0051960),0.36260905170369695,0.8599561341100235,0.7073170731707317,0.9013787729265731,1.0,7/31,18.07%,ELAPOR2;ASCL1;DOCK7;SIRT2;PTPRZ1;YAP1;YTHDF2
prerank,GO_Biological_Process_2021__telomere maintenance via recombination (GO:0000722),0.5064420919952997,0.8596570829454844,0.6666666666666666,0.9016150898518535,1.0,2/9,13.49%,NSMCE2;SMC6
prerank,GO_Biological_Process_2021__regulation of superoxide anion generation (GO:0032928),-0.4945778752057434,-0.85955810769635,0.6296296296296297,1.0,1.0,1/8,8.49%,GSTP1
prerank,GO_Biological_Process_2021__nucleotide phosphorylation (GO:0046939),-0.4877684414810485,-0.8595568720515588,0.673469387755102,1.0,1.0,3/8,12.59%,CMPK2;PNKP;AK7
prerank,GO_Biological_Process_2021__ribonucleoside monophosphate biosynthetic process (GO:0009156),0.40834162834470467,0.8595551736606941,0.6136363636363636,0.9014761417297096,1.0,3/13,17.77%,GMPS;ATIC;LHPP
prerank,GO_Biological_Process_2021__positive regulation of neurotransmitter secretion (GO:0001956),0.5137459941044255,0.8594963276462406,0.625,0.9011991754099979,1.0,1/6,4.85%,BAIAP3
prerank,GO_Biological_Process_2021__positive regulation of transport (GO:0051050),0.30674289629891793,0.859415825504213,0.8076923076923077,0.9009816064828713,1.0,8/63,12.81%,TUB;SNCA;RAB27A;BOK;NEDD4L;DOC2B;CLIP3;MERTK
prerank,GO_Biological_Process_2021__positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),-0.42638725177867076,-0.8593516615964741,0.6486486486486487,1.0,1.0,7/20,19.28%,THBS1;LTBR;SFRP1;HTRA2;TNFRSF12A;GPER1;AGT
prerank,GO_Biological_Process_2021__regulation of reactive oxygen species biosynthetic process (GO:1903426),0.3980164858863503,0.859066883312412,0.6585365853658537,0.9013162881592952,1.0,3/18,4.99%,SNCA;RAB27A;GRIN1
prerank,GO_Biological_Process_2021__negative regulation of mitotic nuclear division (GO:0045839),-0.4974397659956658,-0.8583509803761429,0.7321428571428571,1.0,1.0,2/7,17.09%,AURKAIP1;TOM1L1
prerank,"GO_Biological_Process_2021__phagocytosis, engulfment (GO:0006911)",-0.41147735924230033,-0.858156496209182,0.6615384615384615,1.0,1.0,3/24,10.33%,RHOBTB2;THBS1;RHOH
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),0.42280704264479674,0.8579766019388699,0.7692307692307693,0.9031288815383124,1.0,4/15,20.13%,AKT1;SIRT1;UBQLN1;NFE2L2
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell membrane repolarization (GO:0099623),0.43163750426684594,0.8579554600620188,0.6444444444444445,0.9027991600505886,1.0,3/14,6.86%,ANK2;CACNA2D1;KCNH2
prerank,GO_Biological_Process_2021__negative regulation of mitochondrial membrane potential (GO:0010917),-0.5131576528675892,-0.8578344628259901,0.6481481481481481,1.0,1.0,2/6,22.21%,PRELID1;ARL6IP5
prerank,GO_Biological_Process_2021__macrophage differentiation (GO:0030225),0.44869019852545916,0.8578244299790876,0.6666666666666666,0.9026666357445193,1.0,2/10,13.01%,CSF1R;SIRT1
prerank,GO_Biological_Process_2021__positive regulation of apoptotic signaling pathway (GO:2001235),0.32483637531341336,0.8574787934911897,0.7307692307692307,0.90290167774071,1.0,8/44,18.83%,TPD52L1;CRADD;BOK;WWOX;TGFBR1;BCL2;FAS;BCL10
prerank,GO_Biological_Process_2021__regulation of fatty acid beta-oxidation (GO:0031998),0.44098952323327434,0.8573479963693456,0.6486486486486487,0.9027626594489945,1.0,3/13,7.80%,PLIN5;AKT1;IRS1
prerank,GO_Biological_Process_2021__cellular component disassembly (GO:0022411),0.3513033333090581,0.8571281974894003,0.75,0.9029253527678077,1.0,7/37,7.14%,TLL2;MMP16;CTSK;KLKB1;EXOC8;CTSV;ADAMTS4
prerank,GO_Biological_Process_2021__regulation of angiogenesis (GO:0045765),-0.32070926899879054,-0.857003586563712,0.7471264367816092,1.0,1.0,30/143,17.22%,SFRP2;WARS1;SPARC;STAT1;APLNR;CEACAM1;AQP1;SEMA5A;THBS1;ISM1;ANGPTL3;HYAL1;NODAL;CTSH;RRAS;FGF1;KLF4;SFRP1;BRCA1;CD160;XBP1;HK2;SERPINF1;BTG1;AGGF1;SP100;SPINK5;COL4A2;EMP2;WNT5A
prerank,GO_Biological_Process_2021__regulation of phospholipase activity (GO:0010517),-0.5013706003817578,-0.8567764566659989,0.6842105263157895,1.0,1.0,2/10,7.43%,RASGRP1;ANGPTL3
prerank,GO_Biological_Process_2021__response to retinoic acid (GO:0032526),0.32985309225521375,0.8566110388536301,0.7419354838709677,0.9034680418472506,1.0,5/41,7.84%,BRINP3;ASCL1;SOX9;ADNP2;ABL2
prerank,GO_Biological_Process_2021__positive regulation of heart rate (GO:0010460),-0.4694109985016081,-0.8566042699406213,0.6911764705882353,1.0,1.0,2/12,6.80%,ADM;KCNQ1
prerank,GO_Biological_Process_2021__innate immune response activating cell surface receptor signaling pathway (GO:0002220),0.2908036767172104,0.8563687137733526,0.9354838709677419,0.9028482145500253,1.0,15/82,12.47%,BTRC;TAB3;PRKACB;NFKB1;MUC20;PSMA1;PSMD11;MAP3K7;PSMD10;TAB1;PSMF1;EP300;PAK3;PSMD14;NRAS
prerank,GO_Biological_Process_2021__cellular response to lectin (GO:1990858),0.2908036767172104,0.8563687137733526,0.9354838709677419,0.9028482145500253,1.0,15/82,12.47%,BTRC;TAB3;PRKACB;NFKB1;MUC20;PSMA1;PSMD11;MAP3K7;PSMD10;TAB1;PSMF1;EP300;PAK3;PSMD14;NRAS
prerank,GO_Biological_Process_2021__stimulatory C-type lectin receptor signaling pathway (GO:0002223),0.2908036767172104,0.8563687137733526,0.9354838709677419,0.9028482145500253,1.0,15/82,12.47%,BTRC;TAB3;PRKACB;NFKB1;MUC20;PSMA1;PSMD11;MAP3K7;PSMD10;TAB1;PSMF1;EP300;PAK3;PSMD14;NRAS
prerank,GO_Biological_Process_2021__chloride transport (GO:0006821),0.3200326596492672,0.856319835909567,0.95,0.9025786830384973,1.0,10/58,13.61%,SLC26A7;CLIC5;ANO5;GABRG1;SLC12A2;GABRA4;GLRB;GABRA5;GABRB1;SLC4A10
prerank,GO_Biological_Process_2021__protein kinase A signaling (GO:0010737),-0.5570713018439204,-0.8560158332221446,0.711864406779661,1.0,1.0,2/6,6.91%,TTN;RDX
prerank,GO_Biological_Process_2021__regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),0.30085479866458964,0.8559933333511188,0.8148148148148148,0.9028522531448352,1.0,10/73,9.50%,CDC25A;EGFR;RGCC;CDK5R2;AKT1;CCNG2;CCNA2;PSMD10;MEN1;PKD2
prerank,GO_Biological_Process_2021__signal release from synapse (GO:0099643),0.32523911626522456,0.8557816688983898,0.6764705882352942,0.9028706154757801,1.0,13/36,23.13%,SNCA;NRXN1;PIP5K1C;DVL1;SLC32A1;STX1A;LIN7C;PCLO;NRXN2;LIN7A;DNAJC5;UNC13A;PTPRN2
prerank,GO_Biological_Process_2021__activation of phospholipase C activity (GO:0007202),-0.46932708140353985,-0.8556646548244671,0.6440677966101694,1.0,1.0,4/15,11.33%,P2RY12;HTR2B;BDNF;P2RY6
prerank,GO_Biological_Process_2021__cellular polysaccharide catabolic process (GO:0044247),0.3976690270142232,0.8554305352575279,0.6097560975609756,0.9032222771925188,1.0,3/15,18.44%,MGAM;PGM2;PYGB
prerank,MSigDB_Hallmark_2020__Glycolysis,-0.3190573549945516,-0.8554108889838982,0.7701149425287356,1.0,1.0,32/168,20.22%,LDHC;GAPDHS;GMPPB;KDELR3;IER3;COL5A1;SLC16A3;CACNA1H;ALDOB;GPC3;GPR87;GNE;GLRX;B3GNT3;CHST4;PSMC4;LDHA;PRPS1;HK2;GYS1;AKR1A1;SAP30;IDUA;PGLS;CXCR4;PGAM1;PDK3;NOL3;GNPDA1;PKP2;XYLT2;ENO1
prerank,GO_Biological_Process_2021__Golgi transport vesicle coating (GO:0048200),-0.5425326365179901,-0.855206714415991,0.6865671641791045,1.0,1.0,1/6,16.58%,TMED9
prerank,GO_Biological_Process_2021__COPI-coated vesicle budding (GO:0035964),-0.5425326365179901,-0.855206714415991,0.6865671641791045,1.0,1.0,1/6,16.58%,TMED9
prerank,GO_Biological_Process_2021__COPI coating of Golgi vesicle (GO:0048205),-0.5425326365179901,-0.855206714415991,0.6865671641791045,1.0,1.0,1/6,16.58%,TMED9
prerank,GO_Biological_Process_2021__negative regulation of cellular senescence (GO:2000773),0.45103229762201535,0.8551398144239103,0.6097560975609756,0.9034495317947278,1.0,4/11,32.71%,SIRT1;AKT3;TERF2;CDK6
prerank,GO_Biological_Process_2021__regulation of protein secretion (GO:0050708),0.3098369627871839,0.8550687850567373,0.5555555555555556,0.903160707168207,1.0,20/86,19.34%,ARFIP1;ABCC8;HADH;STXBP5;SLC12A2;RFX3;CLOCK;GOLPH3;DISP1;RAP1A;DPH3;STX1A;SYTL4;PPP3CB;KCNC2;IGF1;SERGEF;APBB1;ARF6;DRD2
prerank,GO_Biological_Process_2021__protein localization to ciliary membrane (GO:1903441),-0.55284025600651,-0.8548592142840985,0.746031746031746,1.0,1.0,1/7,12.84%,ARL13A
prerank,GO_Biological_Process_2021__keratan sulfate biosynthetic process (GO:0018146),0.40954399435714106,0.854815004288387,0.5714285714285714,0.9033421107500468,1.0,5/20,13.91%,B4GALT3;B4GALT6;ST3GAL1;B4GALT2;B4GALT5
prerank,"GO_Biological_Process_2021__mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",-0.49219012455086913,-0.8548083287357378,0.6666666666666666,1.0,1.0,3/11,12.92%,UQCRQ;UQCRFS1;UQCR10
prerank,GO_Biological_Process_2021__microglial cell activation (GO:0001774),0.46231616653025037,0.8546818553742546,0.6818181818181818,0.9032166879378009,1.0,1/11,2.09%,SNCA
prerank,GO_Biological_Process_2021__cellular response to ATP (GO:0071318),-0.5175809436589525,-0.8546649518139094,0.7358490566037735,1.0,1.0,1/11,3.42%,P2RY12
prerank,GO_Biological_Process_2021__positive regulation of angiogenesis (GO:0045766),-0.3378473996711585,-0.8545359723206064,0.7012987012987013,1.0,1.0,18/84,15.19%,SFRP2;ITGA5;APLNR;AQP1;SEMA5A;THBS1;ANGPTL3;HYAL1;NODAL;CTSH;RRAS;FGF1;KLF4;BRCA1;XBP1;HK2;BTG1;AGGF1
prerank,GO_Biological_Process_2021__protein N-linked glycosylation via asparagine (GO:0018279),0.3348718390818947,0.8544352214706604,0.7586206896551724,0.9032609511920773,1.0,4/26,13.53%,OSTC;STT3B;FUT8;UGGT1
prerank,GO_Biological_Process_2021__negative regulation of skeletal muscle cell differentiation (GO:2001015),0.4943841010707031,0.8539248370021137,0.7916666666666666,0.9040484523983595,1.0,2/5,34.70%,AKIRIN1;EPHB1
prerank,GO_Biological_Process_2021__cellular protein-containing complex assembly (GO:0034622),0.27543301849544677,0.8538660370568869,0.75,0.9038316552797623,1.0,35/135,19.12%,NCK2;SNCA;PICALM;PSMG3;STXBP6;EPS15;PDE4DIP;SMAD2;BIN1;CASQ1;TTC12;ADRB2;TCF4;PSMD11;ANLN;SGIP1;NUP153;SAMM50;BBS10;DHX9;NDC1;NCK1;SMAD4;HIP1;PXN;IMMP2L;MKKS;PTGES3;NUP205;HSPA4;POGZ;AIFM1;AXIN1;COX7A2L;PSMG2
prerank,GO_Biological_Process_2021__regulation of necrotic cell death (GO:0010939),0.5173258696208284,0.8538314807907403,0.7435897435897436,0.9035238243732346,1.0,1/6,1.84%,SLC6A13
prerank,GO_Biological_Process_2021__regulation of macrophage cytokine production (GO:0010935),-0.5100748762483828,-0.8537878757505595,0.7586206896551724,1.0,1.0,4/11,22.39%,CUEDC2;CD74;WNT5A;TGFB1
prerank,GO_Biological_Process_2021__cAMP biosynthetic process (GO:0006171),0.46061418260849873,0.8537582018789673,0.6818181818181818,0.9032813600961054,1.0,4/9,27.47%,ADCY1;ADCY6;ADCY9;ADCY2
prerank,GO_Biological_Process_2021__negative regulation of cellular biosynthetic process (GO:0031327),-0.39664704791733474,-0.8537318305077115,0.6764705882352942,1.0,1.0,5/33,12.47%,ACMSD;MST1;CEACAM1;PGP;BRCA1
prerank,GO_Biological_Process_2021__receptor metabolic process (GO:0043112),0.307891769793294,0.8536091417345829,0.7647058823529411,0.9032083374177697,1.0,8/46,12.07%,SNCA;DNM3;PICALM;GRK3;RAB31;PIK3R4;SMURF1;GRK4
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),0.369359634430041,0.8532759965843996,0.75,0.9035778470233488,1.0,5/24,14.73%,CRADD;SORT1;TRADD;TNFRSF10B;BCL2
prerank,GO_Biological_Process_2021__chromosome organization (GO:0051276),-0.3389297674027145,-0.8532648916503488,0.7160493827160493,1.0,1.0,14/84,18.52%,CETN2;SOX15;RPS27A;NUF2;UBC;CENPV;SUV39H1;COPS6;POLE3;CENPH;COPS5;RBX1;UBA52;PADI4
prerank,GO_Biological_Process_2021__regulation of sister chromatid cohesion (GO:0007063),-0.5212529973840334,-0.8531334380330843,0.6428571428571429,1.0,1.0,1/8,5.54%,DDX11
prerank,GO_Biological_Process_2021__T cell receptor signaling pathway (GO:0050852),-0.3293383851006098,-0.8529440564292223,0.7564102564102564,1.0,1.0,20/119,16.27%,PSMB6;HLA-A;PSMA8;BTN3A1;THEMIS;PSMB9;INPP5D;PSMA7;FYB2;HHLA2;PRKCQ;PIK3CB;PSMC3;PSME1;PSMC4;PSMA3;RIPK2;SKAP1;BTN2A2;TNFRSF21
prerank,GO_Biological_Process_2021__embryonic heart tube development (GO:0035050),-0.463646723458677,-0.852575936685538,0.6451612903225806,1.0,1.0,1/10,7.41%,HES1
prerank,GO_Biological_Process_2021__organic acid transport (GO:0015849),-0.35288363757179836,-0.8525708791733354,0.7105263157894737,1.0,1.0,11/73,11.61%,SLC3A1;AKR1C1;CEACAM1;SLC51B;SLC38A4;PDPN;SLC51A;SLC25A45;ABCG2;SLC10A1;SLC38A1
prerank,GO_Biological_Process_2021__regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),-0.43468711749288236,-0.8525448866520856,0.7333333333333333,1.0,1.0,2/21,3.11%,CFTR;ABCA12
prerank,GO_Biological_Process_2021__vascular transport (GO:0010232),-0.3664755823516992,-0.8520305899527645,0.7432432432432432,1.0,1.0,1/71,0.04%,SLC28A2
prerank,GO_Biological_Process_2021__tRNA 5'-leader removal (GO:0001682),-0.4849796597394122,-0.8520128456105448,0.7121212121212122,1.0,1.0,3/10,10.00%,RPP38;RPP25L;POP5
prerank,GO_Biological_Process_2021__negative regulation of transport (GO:0051051),0.3220808663703083,0.8517337583505733,0.7407407407407407,0.9060479795051553,1.0,13/41,24.88%,SNCA;PRKN;PIP4P2;PRKD1;MTMR2;NDFIP1;PTEN;PPM1F;NRG1;NDFIP2;LRSAM1;SIRPA;PXK
prerank,GO_Biological_Process_2021__post-translational protein modification (GO:0043687),0.2799644413412224,0.8513732360633713,1.0,0.9063315433373219,1.0,60/277,18.80%,SPSB4;FEM1B;BTRC;SPSB2;KEAP1;DCUN1D1;PRKCSH;STT3B;CDH2;RHBDD1;VHL;QSOX1;SOCS6;MGAT4A;KBTBD7;BTBD1;COPS7B;PSMA1;KBTBD6;FEM1C;FBXL3;COPS2;FBXO30;KLHL42;DCAF17;LMO7;PSMD11;ASB3;PSMD10;MEN1;FBXO11;PSMF1;DCAF5;FBXW7;COP1;FBXL14;FBXO21;PSMD14;ZBTB16;TULP4;GPS1;WSB2;COMMD1;CUL2;HIF3A;CUL1;PTP4A2;CHM;RAB1A;VCAN;PSME4;HIF1A;ANKRD9;FBXW2;CUL3;DCAF6;DCAF7;ATG5;UBXN7;KLHL2
prerank,GO_Biological_Process_2021__transport across blood-brain barrier (GO:0150104),-0.3649594592951497,-0.851341348427689,0.7567567567567568,1.0,1.0,1/73,0.04%,SLC28A2
prerank,GO_Biological_Process_2021__regulation of interleukin-12 production (GO:0032655),0.3742209100924018,0.8512644264641934,0.7222222222222222,0.9062314280022431,1.0,6/26,10.82%,TNFSF4;FOXP1;PLCB1;MAPK11;HMGB1;MAST2
prerank,GO_Biological_Process_2021__muscle tissue development (GO:0060537),0.4567677902465088,0.8512404847241862,0.7435897435897436,0.9058975132669344,1.0,5/9,31.78%,NF1;SMO;POGLUT1;SRPK3;CSRP2
prerank,GO_Biological_Process_2021__negative regulation of voltage-gated potassium channel activity (GO:1903817),0.5591325621082146,0.8511690898246274,0.7021276595744681,0.9053473254822834,1.0,3/5,38.08%,KCNE4;KCNE2;SUMO1
prerank,GO_Biological_Process_2021__negative regulation of delayed rectifier potassium channel activity (GO:1902260),0.5591325621082146,0.8511690898246274,0.7021276595744681,0.9053473254822834,1.0,3/5,38.08%,KCNE4;KCNE2;SUMO1
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell migration (GO:1904752),0.463153578805112,0.8509849012977438,0.7272727272727273,0.9052542483107584,1.0,3/10,11.94%,PRKG1;DOCK7;DOCK4
prerank,PanglaoDB_Augmented_2021__Pulmonary Vascular Smooth Muscle Cells,-0.3505887627738362,-0.8509249385862209,0.7534246575342466,1.0,1.0,9/73,6.39%,LMOD1;SPARC;GALNT15;COL5A1;AQP1;ANGPTL2;C1R;COL6A2;ELN
prerank,GO_Biological_Process_2021__positive regulation of B cell proliferation (GO:0030890),0.3992036821974071,0.8508195270993881,0.7209302325581395,0.9051288132878157,1.0,1/18,0.14%,TNFSF13B
prerank,GO_Biological_Process_2021__protein autoprocessing (GO:0016540),-0.48663996489848993,-0.8507428625463651,0.6851851851851852,1.0,1.0,5/10,21.42%,CTSL;HTRA2;SPRTN;KLK6;AFG3L2
prerank,GO_Biological_Process_2021__fibrinolysis (GO:0042730),0.5147679359657678,0.8503690000232482,0.6730769230769231,0.9055935000255921,1.0,1/6,2.21%,SERPINE1
prerank,GO_Biological_Process_2021__regulation of monocyte differentiation (GO:0045655),0.4202884406254533,0.8503529643033539,0.7021276595744681,0.9052606318102469,1.0,1/12,2.08%,FOXP1
prerank,GO_Biological_Process_2021__negative regulation of histone H3-K9 methylation (GO:0051573),-0.49518117600062816,-0.8499208914758416,0.6333333333333333,1.0,1.0,1/6,12.47%,BRCA1
prerank,GO_Biological_Process_2021__bone development (GO:0060348),-0.40494707648514155,-0.8499069453860377,0.6338028169014085,1.0,1.0,3/25,8.24%,SFRP4;RPL13;PPIB
prerank,GO_Biological_Process_2021__cardiac epithelial to mesenchymal transition (GO:0060317),0.44713920627656645,0.8498296987560743,0.6818181818181818,0.9058609494239036,1.0,3/13,18.40%,BMP2;TGFBR1;RBPJ
prerank,GO_Biological_Process_2021__reverse cholesterol transport (GO:0043691),-0.5019141370344746,-0.8498078309019304,0.6296296296296297,1.0,1.0,4/8,15.65%,APOM;CLU;APOE;ABCA5
prerank,GO_Biological_Process_2021__positive regulation of glycolytic process (GO:0045821),-0.44375213288556065,-0.849782045103034,0.7741935483870968,1.0,1.0,1/19,1.20%,GAPDHS
prerank,GO_Biological_Process_2021__positive regulation of purine nucleotide metabolic process (GO:1900544),-0.44375213288556065,-0.849782045103034,0.7741935483870968,1.0,1.0,1/19,1.20%,GAPDHS
prerank,GO_Biological_Process_2021__negative regulation of canonical Wnt signaling pathway (GO:0090090),0.2771065118649591,0.8493333010320282,0.9333333333333333,0.9063247944370758,1.0,32/129,19.04%,LIMD1;CCDC88C;BMP2;MLLT3;AMER2;SOX9;TLE2;INVS;FRZB;PSMA1;TMEM170B;PSMD11;PSMD10;GLI3;DACT3;PRKN;PSMF1;PSMD14;DVL1;SCYL2;TMEM131L;GSK3B;SOX13;BICC1;LATS1;STK11;PTPRO;PSME4;CUL3;AXIN1;LRP4;RBMS3
prerank,GO_Biological_Process_2021__neurotransmitter receptor transport to postsynaptic membrane (GO:0098969),-0.48561948115248454,-0.8491975173016364,0.65,1.0,1.0,1/9,5.81%,RAB11A
prerank,GO_Biological_Process_2021__positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),0.34820726618223496,0.8490377483265354,0.6944444444444444,0.9062030916184434,1.0,6/19,16.28%,ZEB2;MEN1;EP300;HIPK2;SMAD4;STK11
prerank,GO_Biological_Process_2021__positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),0.34820726618223496,0.8490377483265354,0.6944444444444444,0.9062030916184434,1.0,6/19,16.28%,ZEB2;MEN1;EP300;HIPK2;SMAD4;STK11
prerank,GO_Biological_Process_2021__negative regulation of MAP kinase activity (GO:0043407),-0.38576725913513216,-0.8489391125732694,0.7272727272727273,1.0,1.0,6/37,11.67%,PAQR3;PIK3CB;GSTP1;CAV3;DUSP1;APOE
prerank,GO_Biological_Process_2021__regulation of cation transmembrane transport (GO:1904062),-0.41195753207743013,-0.8489357362296228,0.6885245901639344,1.0,1.0,2/25,3.29%,CD63;PDZK1
prerank,GO_Biological_Process_2021__glycerolipid biosynthetic process (GO:0045017),0.4886093170943506,0.8489088357698218,0.6222222222222222,0.906097033738729,1.0,4/8,19.43%,CPNE3;AGK;CPNE1;FAR1
prerank,GO_Biological_Process_2021__positive regulation of protein polymerization (GO:0032273),-0.37576243188546804,-0.8487372855609785,0.6818181818181818,1.0,1.0,7/53,14.19%,ANKRD53;LMOD1;TPPP3;CAV3;FES;DRG1;PFN1
prerank,GO_Biological_Process_2021__cellular response to retinoic acid (GO:0071300),0.34795332551321745,0.8487151073804142,0.8275862068965517,0.906204431844326,1.0,4/28,7.84%,BRINP3;SOX9;ADNP2;ABL2
prerank,GO_Biological_Process_2021__regulation of non-motile cilium assembly (GO:1902855),-0.4725610387697521,-0.8483299505309249,0.6938775510204082,1.0,1.0,2/6,15.18%,CEP135;HAP1
prerank,GO_Biological_Process_2021__nucleobase-containing small molecule interconversion (GO:0015949),0.3577884505820439,0.8483109731702632,0.6388888888888888,0.9066219819442818,1.0,4/24,11.77%,AK1;DUT;GSR;AK6
prerank,GO_Biological_Process_2021__regulation of signal transduction (GO:0009966),0.28338894200876447,0.8481674961378303,0.9,0.9065288057176322,1.0,41/155,19.12%,NCK2;KCTD8;IRAK2;RGS5;RGS3;MGLL;RGS16;FBXL17;RGS6;GIT1;RORA;GRK3;YJEFN3;GSKIP;BST1;GNG4;HOMER1;CDC42SE2;PLCB1;RIC8B;ELF1;PRKD1;SIK2;GRK4;ACVR1;RGS12;SIRT1;OGT;NCK1;UBTF;DTX1;PXN;YWHAG;CDKN2AIP;CBFB;CSK;RUNX1;LIFR;AXIN1;GIT2;FYN
prerank,GO_Biological_Process_2021__cellular response to peptide (GO:1901653),-0.38845695561578436,-0.847813160724659,0.696969696969697,1.0,1.0,10/42,18.93%,RPL23;DDX11;CACNB1;XBP1;RIPK2;CDK5;ICAM1;PTPN22;GPER1;SNX6
prerank,PanglaoDB_Augmented_2021__Chondrocytes,-0.33739957123845354,-0.8477532090492875,0.7361111111111112,1.0,1.0,31/109,18.67%,LMOD1;SPARC;COL10A1;STAT1;COL5A1;ANGPTL2;C1R;COL6A2;SEMA5A;ELN;CHAD;RUNX2;IGFBP5;MGP;SFRP1;MATN3;SOD3;PAMR1;ADGRL4;TNC;C1S;EDNRA;COL4A2;CALD1;CRYAB;AEBP1;COL14A1;MMP14;TAGLN;LAMA4;BGN
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA gap filling (GO:0006297)",-0.4117058759508806,-0.8474370614234911,0.639344262295082,1.0,1.0,3/23,9.49%,RPS27A;RPA3;UBC
prerank,GO_Biological_Process_2021__inner dynein arm assembly (GO:0036159),-0.4912625836448791,-0.8472108434509679,0.68,1.0,1.0,4/11,12.69%,CCDC39;DNAAF1;CFAP73;CFAP100
prerank,GO_Biological_Process_2021__sarcomere organization (GO:0045214),-0.44120296695496675,-0.8472039084951194,0.6865671641791045,1.0,1.0,2/18,6.42%,TNNT1;TTN
prerank,GO_Biological_Process_2021__regulation of lipid catabolic process (GO:0050994),0.4507490959852591,0.847071283494623,0.7027027027027027,0.9081794075232866,1.0,1/10,2.44%,PDE3B
prerank,GO_Biological_Process_2021__histone H3-K36 demethylation (GO:0070544),0.43946440719187996,0.8470344034903199,0.627906976744186,0.9078920217438218,1.0,3/9,32.04%,KDM4C;KDM7A;PHF8
prerank,GO_Biological_Process_2021__regulation of ventricular cardiac muscle cell action potential (GO:0098911),0.43935061853765556,0.846984869855705,0.6521739130434783,0.9076435811155604,1.0,3/9,14.81%,BIN1;TRPM4;DLG1
prerank,GO_Biological_Process_2021__nucleosome organization (GO:0034728),-0.37187801368636114,-0.846979225044382,0.759493670886076,1.0,1.0,2/59,1.35%,H1-4;H1-2
prerank,GO_Biological_Process_2021__regulation of MyD88-independent toll-like receptor signaling pathway (GO:0034127),-0.522750857403601,-0.846932106758172,0.6666666666666666,1.0,1.0,3/6,12.42%,LY96;TLR3;CD14
prerank,GO_Biological_Process_2021__regulation of primary metabolic process (GO:0080090),-0.32143291164774485,-0.8466688429815663,0.7692307692307693,1.0,1.0,17/112,14.67%,PSMB6;ZFP69;PSMA8;PSMB9;PSMA7;HELZ2;MVK;PSMC3;PSME1;SQLE;APOE;PSMC4;ID2;EDF1;DHCR7;PSMA3;FDPS
prerank,MSigDB_Hallmark_2020__Oxidative Phosphorylation,-0.3217802306835331,-0.846576448428834,0.7948717948717948,1.0,1.0,32/179,16.83%,ETFB;COX7C;COX4I1;TIMM10;NDUFA6;PDHX;NDUFA2;NDUFC1;TIMM8B;SLC25A4;UQCRQ;UQCRFS1;ATP5ME;SURF1;ATP5F1E;ATP5MC3;LDHA;UQCR10;ATP5PD;ATP6V1D;ATP6V1F;COX7A2;COX5B;NDUFB3;NDUFA1;GPX4;GPI;MAOB;MRPL34;RETSAT;HTRA2;SLC25A5
prerank,GO_Biological_Process_2021__negative regulation of complement activation (GO:0045916),-0.5143656744463752,-0.8461682237132669,0.6545454545454545,1.0,1.0,6/9,30.51%,A2M;SUSD4;CR1;CR1L;SERPING1;CD46
prerank,GO_Biological_Process_2021__regulation of mammary gland epithelial cell proliferation (GO:0033599),-0.5129459685178465,-0.8461256847433575,0.7166666666666667,1.0,1.0,1/8,2.92%,MST1
prerank,GO_Biological_Process_2021__negative regulation of Wnt signaling pathway (GO:0030178),0.2702071386032765,0.8460140552467017,1.0,0.9091498791887486,1.0,37/147,19.04%,LIMD1;CCDC88C;BMP2;MLLT3;AMER2;SOX9;TLE2;INVS;FRZB;PSMA1;TMEM170B;NLK;PSMD11;PSMD10;GLI3;DACT3;PRKN;PSMF1;PSMD14;DVL1;WWOX;SCYL2;TMEM131L;VGLL4;GSK3B;SOX13;BICC1;LATS1;STK11;PTPRO;PSME4;CUL3;ALPK2;AXIN1;LRP4;CXXC4;RBMS3
prerank,GO_Biological_Process_2021__interleukin-7-mediated signaling pathway (GO:0038111),-0.45783812255741524,-0.8459108595839279,0.6333333333333333,1.0,1.0,1/11,2.51%,IL7
prerank,GO_Biological_Process_2021__cellular response to interleukin-7 (GO:0098761),-0.45783812255741524,-0.8459108595839279,0.6333333333333333,1.0,1.0,1/11,2.51%,IL7
prerank,GO_Biological_Process_2021__negative regulation of secretion by cell (GO:1903531),-0.427040066155851,-0.845872730069706,0.6716417910447762,1.0,1.0,7/26,14.18%,ANXA1;IL12A;RSAD2;VAMP8;APOE;ERP29;PNKD
prerank,GO_Biological_Process_2021__digestive tract development (GO:0048565),0.3644426281050082,0.8456852280953592,0.7352941176470589,0.9094234251764997,1.0,6/26,12.75%,RARB;PCSK5;SALL1;PKDCC;GLI3;NIPBL
prerank,GO_Biological_Process_2021__T cell activation involved in immune response (GO:0002286),-0.49719708604680934,-0.8448146745109685,0.6956521739130435,1.0,1.0,3/7,17.15%,SLC11A1;CD74;ICAM1
prerank,GO_Biological_Process_2021__negative regulation of dephosphorylation (GO:0035305),0.371568567291793,0.84468125424649,0.75,0.9109020532084341,1.0,6/18,25.33%,PPP1R36;GPATCH2;ARPP19;PPP1R8;ENSA;PPP1R26
prerank,GO_Biological_Process_2021__vesicle localization (GO:0051648),-0.5410681547602079,-0.8444327470445386,0.6470588235294118,1.0,1.0,1/5,5.81%,RAB11A
prerank,GO_Biological_Process_2021__regulation of cell cycle (GO:0051726),0.2584243655316096,0.8442246752055317,0.9,0.9114259668400707,1.0,56/238,18.54%,UHRF2;CDC25A;PTPRK;KAT2B;BMP2;INTS13;FBXL17;RGCC;SOX9;TTLL12;NOTCH2;TTC28;HNRNPU;CHMP1A;BIN1;CSNK2A1;FBXL3;UHMK1;RPS6KA2;MEN1;PKD2;ZNF268;CKS1B;FAP;CAMK2N1;MAP3K20;ADARB1;EP300;TP53BP2;TGM1;ANKRD17;SIRT1;HIPK2;TGFBR1;APBB2;MAGI2;SIRT2;CCPG1;PRCC;JMY;MLXIPL;CDC14A;BIRC2;BMP7;RBBP4;STK11;FBXL6;AKT2;PUM1;BOP1;ZNF703;CSNK2A2;SRPK2;RPRD1B;MDM2;LIN52
prerank,GO_Biological_Process_2021__negative regulation of inflammatory response (GO:0050728),0.2710401120471762,0.8440340371499141,0.8333333333333334,0.911517963380154,1.0,14/109,11.64%,MACIR;PRKACB;ADCY1;GIT1;RORA;CALCB;PRKAR1B;CD247;ADRB2;NR1D1;GPR176;LRFN5;ADRB1;TNFAIP6
prerank,GO_Biological_Process_2021__sulfur amino acid metabolic process (GO:0000096),0.3810696766154486,0.8437734598543136,0.7567567567567568,0.9116613901665613,1.0,5/21,16.73%,ADO;AHCY;GCLC;SMS;MTHFR
prerank,GO_Biological_Process_2021__pyrimidine-containing compound catabolic process (GO:0072529),0.3928905494706712,0.843770437470288,0.725,0.9113027507526484,1.0,6/15,23.14%,NT5C1A;NT5M;DPYSL4;UPP1;DPYSL5;NT5C3A
prerank,GO_Biological_Process_2021__cellular response to lipoteichoic acid (GO:0071223),-0.5184806955162049,-0.84333943853596,0.6956521739130435,1.0,1.0,1/5,12.42%,CD14
prerank,GO_Biological_Process_2021__response to lipoteichoic acid (GO:0070391),-0.5184806955162049,-0.84333943853596,0.6956521739130435,1.0,1.0,1/5,12.42%,CD14
prerank,GO_Biological_Process_2021__protein lipidation (GO:0006497),0.3087859890074981,0.8432154095324325,0.8857142857142857,0.91181924995912,1.0,19/55,29.14%,ZDHHC18;ATG7;PIK3C3;ZDHHC21;ZDHHC5;ZDHHC16;PIGP;ATG5;ZDHHC2;ZDHHC13;ZDHHC14;PORCN;PIGQ;PIGU;ZDHHC17;DPM1;GLUL;PGAP4;PIGZ
prerank,GO_Biological_Process_2021__negative regulation of protein exit from endoplasmic reticulum (GO:0070862),-0.4937127660291071,-0.8428528178051157,0.796875,1.0,1.0,3/9,19.60%,SVIP;ERLEC1;INSIG1
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell migration (GO:0010633),0.3776951851182073,0.8427441905087262,0.7272727272727273,0.9123932152747501,1.0,11/23,21.92%,DCN;MARVELD3;DUSP10;SLIT2;ADIPOR1;PTPRG;PTEN;PTPN23;MCC;ADGRB1;VASH1
prerank,MSigDB_Hallmark_2020__Fatty Acid Metabolism,0.29099799490686395,0.8426416473488859,0.8235294117647058,0.9122146870453539,1.0,31/129,17.05%,OSTC;HADH;MGLL;ENO3;HSPH1;ADIPOR2;PRDX6;UGDH;LTC4S;MAOA;CA2;BMPR1B;NSDHL;AUH;HCCS;SLC22A5;BCKDHB;ELOVL5;SDHC;HSD17B4;SMS;RAP1GDS1;ACADVL;ACADM;SUCLG2;PTPRG;NCAPH2;CRAT;GPD2;CPT1A;HSDL2
prerank,GO_Biological_Process_2021__positive regulation of deoxyribonuclease activity (GO:0032077),-0.540631231515651,-0.8426009597365154,0.6984126984126984,1.0,1.0,1/5,5.54%,DDX11
prerank,GO_Biological_Process_2021__fibroblast growth factor receptor signaling pathway (GO:0008543),0.33413887757651267,0.8425789389696878,0.8125,0.9119977479242516,1.0,11/54,15.44%,HNRNPH1;SPRED2;FLRT2;FGF17;CBL;SPRED1;SHOC2;RBFOX2;MAPK1;TIAL1;PTPN11
prerank,GO_Biological_Process_2021__synaptic vesicle transport along microtubule (GO:0099517),0.45962094809283727,0.8425120823889792,0.72,0.91138461644942,1.0,2/11,9.32%,AP3S1;AP3B1
prerank,GO_Biological_Process_2021__anterograde synaptic vesicle transport (GO:0048490),0.45962094809283727,0.8425120823889792,0.72,0.91138461644942,1.0,2/11,9.32%,AP3S1;AP3B1
prerank,GO_Biological_Process_2021__regulation of transcription by RNA polymerase III (GO:0006359),-0.41051118440395507,-0.842389595112092,0.7101449275362319,1.0,1.0,1/21,3.25%,PRDX5
prerank,GO_Biological_Process_2021__negative regulation of synaptic transmission (GO:0050805),0.3780348587378173,0.8421282410748941,0.65,0.9116559979455611,1.0,8/20,26.82%,NLGN4X;SLC30A1;MTMR2;PTEN;DRD2;PRRT1;PICK1;ATAD1
prerank,GO_Biological_Process_2021__regulation of fibroblast proliferation (GO:0048145),-0.37655676341203553,-0.8419678933399508,0.6891891891891891,1.0,1.0,8/37,17.22%,FTH1;AQP1;S100A6;GSTP1;SFRP1;CD74;EMD;WNT5A
prerank,GO_Biological_Process_2021__regulation of intracellular signal transduction (GO:1902531),0.2513376810927992,0.841855295091224,1.0,0.9117475435066225,1.0,79/373,18.48%,RCN3;SGMS1;STARD13;TIAM2;ARHGEF6;ARAP2;PIP5K1B;DNA2;ARHGEF16;EGFR;ARHGEF12;RHOT1;SLC15A2;ARAP1;RHOQ;ARHGAP35;DAPK2;ARHGEF26;ARHGAP24;TNIK;AKT1;NTRK2;PRKAR1B;ARHGAP5;CSNK2A1;PEX5L;BST1;PTPN13;ARHGAP26;SPRED1;TAF4;DIPK2A;HDAC2;FGD4;MAPK11;ITSN1;PIP5K1C;TTI1;ARHGAP32;EP300;TP53BP2;MOB3B;GNA13;PAK3;MAP4K4;SOS1;MBD3;PIP4K2C;HIPK2;PRKAB1;MAPKAPK5;OPHN1;MAPK1;MCF2L;MDM4;DYRK2;TAOK2;JMY;ZFAND6;DLG1;TP53RK;GNAI1;ARHGEF7;BIRC2;RBBP4;STK11;USP2;RNF41;BOP1;TAF2;CSNK2A2;TBCK;ARHGAP31;ARHGAP17;PAK4;TAF4B;MDM2;PTEN;CPNE1
prerank,GO_Biological_Process_2021__regulated exocytosis (GO:0045055),-0.32371841772266197,-0.841204071832219,0.7972972972972973,1.0,1.0,17/135,11.51%,F8;SELP;SPARC;CD63;CD9;ABCA12;F13A1;TIMP1;THBS1;TTN;SNAPIN;SYT2;VWF;A2M;F5;CLU;PCYOX1L
prerank,GO_Biological_Process_2021__positive regulation of gene expression (GO:0010628),0.25950355441623885,0.8411526042277818,1.0,0.912647004328543,1.0,73/332,18.07%,PPARGC1A;SLC24A3;PID1;TNFSF4;ZNF804A;AMH;MITF;KAT2B;ANK2;SOX4;BMP2;EGFR;SERPINB9;PASK;RAB27A;ACTA2;ZCCHC4;ITGB8;CPEB3;RGCC;SOX9;FGF17;RBM24;MBIP;PHF2;AKT1;NTRK2;GABPA;DYRK1A;PIK3R1;ROBO1;UBR5;TICAM1;RPS6KB1;TAF1B;MAPK11;CADM1;KAT2A;PRKN;CAMK2N1;BRAF;EP300;TNRC6B;HNRNPLL;STOX1;FUBP1;LURAP1;TENT4B;AFDN;OCLN;TGFBR1;PRKAB1;U2AF2;NIBAN1;MAPK1;AGO3;POU3F1;GSK3B;ROCK2;YAP1;MAPK8;SMO;BMP7;TFRC;EIF3E;FXR1;ATF2;HIF1A;RBM20;IGF1;LARP4;CELF1;SRPK2
prerank,GO_Biological_Process_2021__regulation of germinal center formation (GO:0002634),0.530129084018584,0.8408991121669865,0.6666666666666666,0.9127509099855066,1.0,3/5,46.67%,BCL6;RC3H1;MEF2C
prerank,GO_Biological_Process_2021__negative regulation of intracellular protein transport (GO:0090317),0.37226255228737154,0.8407354304630602,0.675,0.9127073600893337,1.0,2/20,7.26%,RANGAP1;RAB23
prerank,GO_Biological_Process_2021__long-term synaptic potentiation (GO:0060291),0.39192699857420166,0.8407029269011753,0.7105263157894737,0.9124076417729763,1.0,3/18,7.92%,NPTN;MPP2;TSHZ3
prerank,GO_Biological_Process_2021__regulation of intracellular pH (GO:0051453),-0.40077805639687375,-0.8405080392535864,0.6268656716417911,1.0,1.0,7/30,16.06%,CFTR;NOX1;SLC9A2;CLN3;SLC4A2;SLC9A7;SLC9B1
prerank,GO_Biological_Process_2021__body fluid secretion (GO:0007589),0.4395735607663238,0.840384567498159,0.7380952380952381,0.9125243242236117,1.0,1/12,2.79%,ERBB4
prerank,GO_Biological_Process_2021__tRNA 5'-end processing (GO:0099116),-0.45690469519783583,-0.8402481906794405,0.7352941176470589,1.0,1.0,4/12,15.95%,RPP38;RPP25L;POP5;TRMT10C
prerank,GO_Biological_Process_2021__immune response-activating cell surface receptor signaling pathway (GO:0002429),-0.5075690758392302,-0.8401450417919583,0.7,1.0,1.0,1/10,7.15%,FPR3
prerank,GO_Biological_Process_2021__membrane assembly (GO:0071709),-0.37893401947355,-0.8400687671517371,0.7714285714285715,1.0,1.0,9/36,22.08%,TLCD1;S100A10;CHMP2A;TLCD2;EMP2;FLOT1;DMKN;RFTN1;ANXA2
prerank,GO_Biological_Process_2021__regulation of platelet activation (GO:0010543),-0.4232090699402444,-0.8392328408859857,0.6491228070175439,1.0,1.0,4/13,11.67%,SELP;PRKCQ;CELA2A;APOE
prerank,GO_Biological_Process_2021__cellular response to low-density lipoprotein particle stimulus (GO:0071404),-0.44115151314958334,-0.8391787080657729,0.6451612903225806,1.0,1.0,1/11,3.03%,CD9
prerank,GO_Biological_Process_2021__DNA dealkylation involved in DNA repair (GO:0006307),0.47522258919739113,0.8390224355788148,0.6595744680851063,0.9142608391911097,1.0,4/10,20.82%,FTO;ASCC3;ASCC1;ALKBH5
prerank,GO_Biological_Process_2021__DNA dealkylation (GO:0035510),0.47522258919739113,0.8390224355788148,0.6595744680851063,0.9142608391911097,1.0,4/10,20.82%,FTO;ASCC3;ASCC1;ALKBH5
prerank,GO_Biological_Process_2021__positive regulation of protein kinase C signaling (GO:0090037),0.5112987380333135,0.838927195679213,0.7111111111111111,0.91406330300616,1.0,1/6,8.71%,ADRA1A
prerank,GO_Biological_Process_2021__transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery (GO:0000972),0.5064804330547286,0.8386821441125988,0.6739130434782609,0.9141024454941074,1.0,2/6,32.91%,PCID2;NUP107
prerank,GO_Biological_Process_2021__regulation of ion transport (GO:0043269),0.3428228767042666,0.8384768119661898,0.6521739130434783,0.9141351673507658,1.0,8/56,11.34%,CHRNA4;SYT3;SNCA;NEDD4L;CA2;PRKN;KCNA2;NKAIN2
prerank,GO_Biological_Process_2021__positive regulation of phospholipid biosynthetic process (GO:0071073),-0.5266656650495126,-0.8384332802483115,0.7166666666666667,1.0,1.0,2/6,8.80%,HTR2B;FABP3
prerank,GO_Biological_Process_2021__glycoside catabolic process (GO:0016139),-0.47691828629708866,-0.8381431243120225,0.6923076923076923,1.0,1.0,5/8,31.93%,FUCA2;FUCA1;GBA3;GBA2;NAGA
prerank,PanglaoDB_Augmented_2021__Sertoli Cells,-0.3107670518363044,-0.837859638652257,0.7901234567901234,1.0,1.0,30/122,20.33%,LMOD1;GATA1;SLC16A3;AQP1;C1R;IGFBP5;INHA;CST3;CLU;RXRB;SOD3;MATN2;LURAP1L;C1S;S100A16;BCAM;MAOB;TNS2;OBSL1;CTSA;FSHR;CRYAB;C1QTNF1;SEMA3B;BGN;F10;AMOTL2;AGT;SCX;AR
prerank,GO_Biological_Process_2021__microtubule polymerization or depolymerization (GO:0031109),0.3897003786949338,0.8377802398419227,0.625,0.9151834850703447,1.0,5/20,17.87%,NCKAP5;ZNF207;CKAP5;HDGFL3;KATNB1
prerank,GO_Biological_Process_2021__fructose 6-phosphate metabolic process (GO:0006002),-0.5032209241259247,-0.8376948904072102,0.7058823529411765,1.0,1.0,3/8,23.31%,HK2;FBP1;GFPT2
prerank,GO_Biological_Process_2021__positive regulation of alpha-beta T cell activation (GO:0046635),-0.45286536912580483,-0.837487346250343,0.6666666666666666,1.0,1.0,3/12,7.28%,HLA-A;IL12A;PNP
prerank,GO_Biological_Process_2021__nucleoside catabolic process (GO:0009164),0.45458752824391646,0.8374575695893425,0.7380952380952381,0.9153626158780388,1.0,4/10,23.14%,NT5C1A;NT5M;UPP1;NT5C3A
prerank,GO_Biological_Process_2021__negative regulation of cardiac muscle hypertrophy (GO:0010614),0.48224344815451337,0.8374490317905271,0.6444444444444445,0.9150118534571436,1.0,3/10,15.57%,FOXO1;SMAD4;ATP2B4
prerank,GO_Biological_Process_2021__negative regulation of peptide hormone secretion (GO:0090278),-0.47185341806618564,-0.8369223166806606,0.6885245901639344,1.0,1.0,2/12,11.83%,KCNB1;SFRP1
prerank,GO_Biological_Process_2021__inorganic ion transmembrane transport (GO:0098660),0.4916226296526608,0.8367670948306676,0.6486486486486487,0.9159118607808145,1.0,3/8,9.50%,ABCC8;TRPM4;PKD2
prerank,GO_Biological_Process_2021__negative regulation of cellular amide metabolic process (GO:0034249),-0.3346637684752107,-0.8366778268952814,0.7236842105263158,1.0,1.0,9/78,11.86%,PATL2;ORMDL2;TYMS;IGFBP5;RPL13A;CLU;APOE;ORMDL1;EIF2AK2
prerank,GO_Biological_Process_2021__ATP synthesis coupled electron transport (GO:0042773),-0.5223864613352632,-0.8365801529436343,0.7288135593220338,1.0,1.0,1/6,16.26%,NDUFA12
prerank,GO_Biological_Process_2021__regulation of histone methylation (GO:0031060),0.4105528938797057,0.8365708386367262,0.6976744186046512,0.9159183030471945,1.0,4/13,22.37%,TTLL12;MTHFR;JARID2;NSD1
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",0.3572509953235842,0.8365401865690397,0.7878787878787878,0.9155868594857942,1.0,9/30,25.79%,EXOSC6;DCP1B;EXOSC1;CNOT8;EDC3;DDX6;DIS3L2;DCP1A;DIS3
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),-0.36964120009454,-0.8364797459939871,0.7066666666666667,1.0,1.0,7/45,12.42%,RASGRP1;THBS1;LY96;TLR3;CLU;OAS3;CD14
prerank,"GO_Biological_Process_2021__regulation of retrograde protein transport, ER to cytosol (GO:1904152)",-0.44455989297406656,-0.8361573200175958,0.6825396825396826,1.0,1.0,2/12,10.11%,SVIP;ERLEC1
prerank,GO_Biological_Process_2021__positive regulation of spindle checkpoint (GO:0090232),0.5104648650513406,0.835711480044995,0.6792452830188679,0.9164599515928057,1.0,2/5,23.64%,PCID2;DYNC1LI1
prerank,GO_Biological_Process_2021__positive regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090267),0.5104648650513406,0.835711480044995,0.6792452830188679,0.9164599515928057,1.0,2/5,23.64%,PCID2;DYNC1LI1
prerank,GO_Biological_Process_2021__protein polyubiquitination (GO:0000209),0.25179250344420967,0.83569655470795,1.0,0.9161350519057778,1.0,93/285,24.47%,BTRC;SASH1;ANAPC1;FBXL17;UBE2G1;UBE2T;KBTBD7;RNF217;RNF146;NEDD4L;MARCHF6;CDC27;PSMA1;RNF144A;KBTBD6;UBE2E3;FBXL3;RNF6;FBXO30;KLHL42;UBE2D1;UBE2N;LMO7;UBR5;TRAF3IP2;PSMD11;RNF14;ITCH;TMEM129;RUSC1;RNF26;PSMD10;UBE3C;PRKN;RMND5A;FBXO11;PSMF1;FBXW7;FBXL14;FBXO21;PSMD14;SMURF1;MKRN3;TRIP12;FBXO28;UBE2E2;UBE2E1;ARIH1;CUL1;BLMH;BCL2;CDC34;HACE1;BIRC2;RNF166;RNF41;PSME4;CBFB;BFAR;FBXW2;CUL3;MDM2;LNPEP;FBXW11;FBXO38;MIB2;FBXO31;MKRN1;UBE2D3;ANAPC13;UBE3B;RBBP6;HECTD1;PSMD1;FBXO15;SHPRH;UBE2L5;PSMD13;TRIM36;TNKS2;LRSAM1;UBE2H;PELI1;TAF1;FBXL15;TRAF3;CTNNB1;UBE2G2;AMFR;FBXL7;PSMB5;HUWE1;FBXO10
prerank,GO_Biological_Process_2021__response to axon injury (GO:0048678),-0.42639928986714093,-0.8356949425495153,0.6666666666666666,1.0,1.0,2/14,14.24%,P2RY12;DPYSL3
prerank,"GO_Biological_Process_2021__mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",-0.448495540843871,-0.8356322747589886,0.671875,1.0,1.0,2/11,4.33%,COX7C;COX4I1
prerank,GO_Biological_Process_2021__positive regulation of extracellular matrix disassembly (GO:0090091),-0.495845137285254,-0.8352273372858032,0.6615384615384615,1.0,1.0,2/7,14.53%,PDPN;FSCN1
prerank,GO_Biological_Process_2021__regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),-0.47879142060025814,-0.8352208378875869,0.7090909090909091,1.0,1.0,2/10,12.58%,PSMC3;PSMC4
prerank,PanglaoDB_Augmented_2021__Clara Cells,-0.3575484480209981,-0.8351936331465876,0.7,1.0,1.0,9/36,9.68%,DUOX1;TEKT1;TMC4;FMO2;FOXM1;CXCL17;SYT2;TRIM29;B3GNT3
prerank,GO_Biological_Process_2021__protein methylation (GO:0006479),-0.37698229553332063,-0.8345057078853689,0.6911764705882353,1.0,1.0,4/36,8.89%,BHMT;EEF1AKMT2;TRMT112;EEF2KMT
prerank,GO_Biological_Process_2021__negative regulation of cell development (GO:0010721),0.407390343789731,0.8343231151293163,0.5833333333333334,0.918356479942024,1.0,6/16,20.86%,WNT7A;FBXW7;GSK3B;IGF1;REST;PCM1
prerank,GO_Biological_Process_2021__spliceosomal snRNP assembly (GO:0000387),0.323212803740526,0.8340668567459082,0.7096774193548387,0.918393769887462,1.0,2/36,4.49%,SNRPF;SART1
prerank,GO_Biological_Process_2021__positive regulation of ossification (GO:0045778),0.3685797320419649,0.8338269893691838,0.7878787878787878,0.9185836765386061,1.0,10/31,16.20%,BMP2;PKDCC;BMPR1B;GPM6B;ZBTB16;ACVR1;ACVR2A;BMPR1A;PTPN11;BMP7
prerank,GO_Biological_Process_2021__regulation of amyloid-beta formation (GO:1902003),0.3460577119223073,0.8338169542507575,0.71875,0.9182393832567206,1.0,9/31,20.20%,PICALM;EPHA4;BIN1;NTRK2;ABCA2;ROCK2;IGF1;ROCK1;CASP3
prerank,GO_Biological_Process_2021__negative regulation of neuron differentiation (GO:0045665),0.39542980752836826,0.8334897330502499,0.6857142857142857,0.9185118211735737,1.0,7/17,16.20%,ASCL1;SOX9;EIF2AK4;GSK3B;DTX1;CNTN4;BMP7
prerank,GO_Biological_Process_2021__negative regulation of MyD88-independent toll-like receptor signaling pathway (GO:0034128),-0.5240451819434354,-0.8331579864894317,0.7037037037037037,1.0,1.0,3/5,12.42%,LY96;TLR3;CD14
prerank,GO_Biological_Process_2021__regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),0.2629454377976276,0.8330009923786523,0.9473684210526315,0.9190889832139604,1.0,34/178,18.83%,C18ORF32;VAPA;TAB3;RORA;EEF1D;ATP2C1;MAPKBP1;TNFRSF19;CASP10;UBE2N;PPM1A;ROR1;TRAF3IP2;TICAM1;MAP3K7;CANT1;NR1D1;PRKN;TRADD;CFLAR;PRKD1;ANKRD17;LURAP1;SIRT1;TNFRSF10B;ZFAND6;ECM1;BIRC2;TFG;TFRC;NDFIP1;CPNE1;TRIM8;BCL10
prerank,GO_Biological_Process_2021__ceramide transport (GO:0035627),-0.457806082037859,-0.8329561127989286,0.6956521739130435,1.0,1.0,1/12,3.11%,ABCA12
prerank,GO_Biological_Process_2021__establishment of apical/basal cell polarity (GO:0035089),0.41685702619717085,0.8327161984745377,0.7045454545454546,0.9193418287126605,1.0,3/12,17.59%,OPHN1;SCRIB;RAP2A
prerank,GO_Biological_Process_2021__astral microtubule organization (GO:0030953),-0.5258594171885141,-0.8325608637352089,0.7169811320754716,1.0,1.0,1/8,5.81%,RAB11A
prerank,GO_Biological_Process_2021__purine nucleoside monophosphate biosynthetic process (GO:0009127),0.4331491570644185,0.8323522989554072,0.6904761904761905,0.9195944779789211,1.0,3/11,17.77%,GMPS;ATIC;LHPP
prerank,GO_Biological_Process_2021__positive regulation of type I interferon-mediated signaling pathway (GO:0060340),-0.5311377019078585,-0.8323115360985791,0.6666666666666666,1.0,1.0,3/5,27.36%,WNT5A;NLRC5;FADD
prerank,GO_Biological_Process_2021__peptidyl-asparagine modification (GO:0018196),0.3269244443249342,0.832242716656212,0.8076923076923077,0.9194027507994155,1.0,4/27,13.53%,OSTC;STT3B;FUT8;UGGT1
prerank,GO_Biological_Process_2021__negative regulation of protein maturation (GO:1903318),0.4756326424324696,0.8321692128804542,0.7254901960784313,0.9191604285076069,1.0,4/7,41.45%,SERPINE2;GAS1;LRRK2;PRNP
prerank,GO_Biological_Process_2021__sphingosine biosynthetic process (GO:0046512),0.4276959345189435,0.8321002680273891,0.6578947368421053,0.9185812763559525,1.0,2/12,13.55%,ACER3;ABCA2
prerank,GO_Biological_Process_2021__sphingoid biosynthetic process (GO:0046520),0.4276959345189435,0.8321002680273891,0.6578947368421053,0.9185812763559525,1.0,2/12,13.55%,ACER3;ABCA2
prerank,GO_Biological_Process_2021__branching morphogenesis of an epithelial tube (GO:0048754),0.37283401487047046,0.8319122612094154,0.7857142857142857,0.9185803067457922,1.0,7/26,12.05%,NPNT;SALL1;BMP2;EPHA2;PKD2;TGFBR2;SLIT2
prerank,GO_Biological_Process_2021__positive regulation of small GTPase mediated signal transduction (GO:0051057),0.3790633646388252,0.831852287873012,0.7575757575757576,0.9183006792067823,1.0,11/23,29.64%,NOTCH2;EPOR;SHOC2;CRKL;IGF1;LRRC59;IRS2;RELN;JAK2;GRB2;ERBIN
prerank,GO_Biological_Process_2021__glycogen biosynthetic process (GO:0005978),0.40796194340275777,0.8316837118361141,0.7,0.9179825467391806,1.0,4/11,17.67%,PGM2;NR1D1;UGP2;PGM1
prerank,GO_Biological_Process_2021__glucan biosynthetic process (GO:0009250),0.40796194340275777,0.8316837118361141,0.7,0.9179825467391806,1.0,4/11,17.67%,PGM2;NR1D1;UGP2;PGM1
prerank,GO_Biological_Process_2021__non-canonical Wnt signaling pathway (GO:0035567),-0.32821376096987975,-0.8314302737611632,0.8,1.0,1.0,15/108,14.19%,SFRP2;PSMB6;SFRP4;PDE6B;PSMA8;PSMB9;PSMA7;PSMC3;PSME1;WNT9B;SFRP1;FZD9;PSMC4;PSMA3;PFN1
prerank,GO_Biological_Process_2021__Notch signaling involved in heart development (GO:0061314),0.46055633930522877,0.8314207488491411,0.6956521739130435,0.9181526068847798,1.0,2/8,18.40%,NOTCH2;RBPJ
prerank,GO_Biological_Process_2021__glycosaminoglycan catabolic process (GO:0006027),0.3248333422067275,0.831115730771951,0.7142857142857143,0.9183478289956684,1.0,6/44,9.62%,DCN;SDC4;CSPG5;GPC5;HMMR;LYVE1
prerank,GO_Biological_Process_2021__positive regulation of T cell mediated immunity (GO:0002711),-0.42393116229076405,-0.8311108891899222,0.7746478873239436,1.0,1.0,4/24,5.79%,HLA-B;HLA-A;B2M;IL12A
prerank,PanglaoDB_Augmented_2021__Paneth Cells,-0.42077524963333945,-0.830940365945779,0.7377049180327869,1.0,1.0,5/18,14.02%,CEACAM1;GPX2;WNT9B;WNT3;RIPK2
prerank,GO_Biological_Process_2021__regulation of oligodendrocyte differentiation (GO:0048713),-0.43912954634491164,-0.8307279976223915,0.78125,1.0,1.0,4/15,17.27%,HES1;IL34;TNFRSF21;CXCR4
prerank,GO_Biological_Process_2021__regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),0.3851880867343942,0.8306989662404037,0.6363636363636364,0.9186440348985799,1.0,5/26,15.09%,EAF2;HNRNPU;CDK12;NELFA;CDK13
prerank,PanglaoDB_Augmented_2021__Myofibroblasts,-0.3384050110314972,-0.8305288909546058,0.7910447761194029,1.0,1.0,21/80,18.67%,LMOD1;SPARC;COL5A1;AQP1;ANGPTL2;C1R;ELN;IGFBP5;SOD3;PAMR1;ADGRL4;C1S;TNS2;EDNRA;COL4A2;CALD1;CRYAB;COL14A1;TAGLN;LAMA4;BGN
prerank,GO_Biological_Process_2021__dendritic cell chemotaxis (GO:0002407),-0.5684542338964845,-0.8304433572956624,0.7592592592592593,1.0,1.0,1/5,1.79%,GPR183
prerank,GO_Biological_Process_2021__cellular biogenic amine catabolic process (GO:0042402),-0.47396275268291443,-0.8304426000000237,0.6875,1.0,1.0,1/10,3.28%,BHMT
prerank,GO_Biological_Process_2021__positive regulation of leukocyte proliferation (GO:0070665),-0.4932710010156597,-0.8301708173351265,0.7230769230769231,1.0,1.0,2/9,5.79%,BST2;IL12A
prerank,GO_Biological_Process_2021__iron ion transmembrane transport (GO:0034755),0.4820001223681416,0.8298232623343373,0.7692307692307693,0.9198245984474934,1.0,2/8,22.82%,ABCC5;SLC39A8
prerank,GO_Biological_Process_2021__interstrand cross-link repair (GO:0036297),-0.3618592805460303,-0.8296588070965039,0.7534246575342466,1.0,1.0,13/46,24.54%,RPS27A;RPA3;UBC;SLX4;FANCI;RAD51AP1;UBA52;MUS81;RNF8;HROB;UBB;XRCC3;DCLRE1B
prerank,GO_Biological_Process_2021__regulation of interleukin-17 production (GO:0032660),-0.4419041942580877,-0.8295792676455123,0.6935483870967742,1.0,1.0,4/14,12.13%,IL12A;PRKCQ;DDIT3;IL18
prerank,GO_Biological_Process_2021__kidney epithelium development (GO:0072073),0.5308098218504333,0.8291278911452653,0.6730769230769231,0.920808453273654,1.0,1/5,2.67%,SALL1
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial calcium ion concentration (GO:0051561),0.491813566079916,0.8286843612645218,0.7906976744186046,0.921059171349529,1.0,2/7,13.29%,MCU;RAP1GDS1
prerank,GO_Biological_Process_2021__positive regulation of striated muscle contraction (GO:0045989),-0.5184403564743514,-0.828190047900253,0.6981132075471698,1.0,1.0,1/5,6.80%,KCNQ1
prerank,GO_Biological_Process_2021__positive regulation of protein acetylation (GO:1901985),-0.42862095873369005,-0.8278732567568208,0.734375,1.0,1.0,3/12,23.47%,FAM161A;KAT5;CAMK1
prerank,GO_Biological_Process_2021__lysosomal lumen acidification (GO:0007042),-0.5242738854051334,-0.827836886317244,0.7358490566037735,1.0,1.0,1/6,13.86%,CLN3
prerank,GO_Biological_Process_2021__regulation of Rho protein signal transduction (GO:0035023),0.3238333556643804,0.8277312245212305,0.7407407407407407,0.9224520162376031,1.0,9/54,7.91%,STARD13;KCTD13;ABCA1;EPS8;KANK1;ARHGAP35;ARRB1;ABL2;ROBO1
prerank,GO_Biological_Process_2021__regulation of necroptotic process (GO:0060544),-0.42350564541677,-0.8274955951795617,0.7246376811594203,1.0,1.0,5/21,17.83%,CASP8;SLC25A4;FZD9;CDC37;FLOT1
prerank,"GO_Biological_Process_2021__positive regulation of DNA-templated transcription, initiation (GO:2000144)",0.4229034655852818,0.827300260131973,0.7352941176470589,0.922847007825521,1.0,2/16,10.62%,MITF;MED13
prerank,GO_Biological_Process_2021__regulation of receptor recycling (GO:0001919),0.4245367925376242,0.8271124917736938,0.6842105263157895,0.922762416395486,1.0,3/14,15.37%,SNCA;NSF;SCRIB
prerank,GO_Biological_Process_2021__ceramide catabolic process (GO:0046514),0.41912340790469266,0.8270161676245382,0.7,0.9225581167155519,1.0,3/14,16.63%,ACER3;HEXB;NEU3
prerank,GO_Biological_Process_2021__endothelial cell chemotaxis (GO:0035767),0.4788922548345348,0.826701305823359,0.7777777777777778,0.9227005534805938,1.0,3/6,28.48%,NRP1;NR4A1;CORO1B
prerank,GO_Biological_Process_2021__epithelial cell differentiation (GO:0030855),-0.36146392783473363,-0.8265973995042067,0.7714285714285715,1.0,1.0,5/64,4.89%,AKR1C1;OVOL2;OVOL3;ANXA1;VIL1
prerank,PanglaoDB_Augmented_2021__Hepatic Stellate Cells,-0.3255070335812033,-0.8264530118232872,0.7916666666666666,1.0,1.0,28/100,18.67%,LMOD1;SPARC;COL5A1;ANGPTL2;TIMP1;C1R;COL6A2;PNPLA3;CCN1;IGFBP5;RBP1;SOD3;PAMR1;ADGRL4;CCL2;C1S;SRPX2;KCNJ8;TNS2;EDNRA;COL4A2;CALD1;CRYAB;C1QTNF1;COL14A1;TAGLN;LAMA4;BGN
prerank,GO_Biological_Process_2021__negative regulation of signaling (GO:0023057),-0.44909531965338656,-0.826244003802253,0.6774193548387096,1.0,1.0,6/12,26.84%,HHIP;ERBB3;GLRA1;OPRM1;BRAP;NLRP12
prerank,GO_Biological_Process_2021__positive regulation of canonical Wnt signaling pathway (GO:0090263),-0.32519717362726736,-0.8259877908749366,0.7777777777777778,1.0,1.0,16/113,13.44%,SFRP2;PSMB6;SFRP4;PSMA8;SEMA5A;GPC3;PSMB9;PSMA7;NRARP;PSMC3;PSME1;SFRP1;FZD9;PSMC4;LRRK1;PSMA3
prerank,GO_Biological_Process_2021__protein depolymerization (GO:0051261),0.3832604847933997,0.8259665679832727,0.7368421052631579,0.9237625361333971,1.0,2/23,2.37%,MICAL1;NCKAP5
prerank,GO_Biological_Process_2021__positive regulation of interleukin-8 production (GO:0032757),0.3297025682003063,0.8259048195307686,0.8285714285714286,0.9235203078901681,1.0,8/32,21.28%,SERPINE1;IL17D;CD58;HMGB1;RAB1A;BCL10;MYD88;HSPA1A
prerank,GO_Biological_Process_2021__regulation of leukocyte tethering or rolling (GO:1903236),-0.5182795864298474,-0.8257509544325552,0.7288135593220338,1.0,1.0,2/5,8.40%,SELP;CCL28
prerank,"GO_Biological_Process_2021__Notch receptor processing, ligand-dependent (GO:0035333)",0.5270316755830322,0.8255830064394423,0.7307692307692307,0.9236559158623694,1.0,1/5,5.23%,NCSTN
prerank,GO_Biological_Process_2021__negative regulation of endopeptidase activity (GO:0010951),0.33804436235277036,0.8252573991651749,0.8275862068965517,0.9238354617199246,1.0,4/31,6.29%,SERPINE1;SERPINB9;BIN1;AKT1
prerank,GO_Biological_Process_2021__positive regulation of endopeptidase activity (GO:0010950),0.3839411557805665,0.8251792470990822,0.7058823529411765,0.923618642120924,1.0,5/23,7.99%,PICALM;EPHA4;GRIN1;NCSTN;MBP
prerank,GO_Biological_Process_2021__regulation of viral release from host cell (GO:1902186),0.35373051601857847,0.8251457961480562,0.7435897435897436,0.9233265462981396,1.0,5/20,18.56%,VPS37B;CHMP2B;TRIM28;TRIM35;TRIM8
prerank,"GO_Biological_Process_2021__RNA splicing, via transesterification reactions (GO:0000375)",-0.4002972317443052,-0.8247524169713711,0.6818181818181818,1.0,1.0,10/25,28.20%,SLU7;PRPF4;DDX23;PRPF8;MPHOSPH10;PRPF3;PRPF6;SRSF4;SRSF10;GEMIN2
prerank,GO_Biological_Process_2021__positive regulation of sodium ion transmembrane transport (GO:1902307),-0.4600740329357887,-0.8238555938936083,0.6785714285714286,1.0,1.0,5/11,26.73%,GLRX;NOS1;WNK4;ATP1B1;WNK2
prerank,GO_Biological_Process_2021__heterotypic cell-cell adhesion (GO:0034113),-0.42386505034097005,-0.82368880941848,0.7910447761194029,1.0,1.0,3/17,12.95%,ITGA5;CTNNA3;MADCAM1
prerank,GO_Biological_Process_2021__negative regulation of gene expression (GO:0010629),0.2578624317299586,0.8235117308932332,1.0,0.9260323773050148,1.0,61/257,18.65%,SLC24A3;HDAC9;FOXP1;KAT2B;NPTN;EED;BMP2;PICALM;RPS6KA4;RIDA;ABCC2;ITGB8;VHL;CPEB3;AEBP2;RGCC;SMCR8;NOTCH2;NFKB1;CNOT9;TASOR;LGR4;IGF2BP2;ROBO1;SFMBT2;SYNCRIP;HELLS;PRKN;TNRC6B;ZNF148;FBXW7;STOX1;CRKL;OCLN;CAPRIN1;SIRT1;HAVCR2;BMPR1A;AGO3;PTBP2;ROCK2;ATP2B4;YAP1;ZC3H12D;SMO;RBBP4;CNOT8;FXR1;HIF1A;RUNX1;NDFIP1;IGF1;YY1;PTBP1;CELF1;YTHDF2;PPHLN1;JARID2;PPM1D;CPNE1;LSM14A
prerank,GO_Biological_Process_2021__positive regulation of cell cycle process (GO:0090068),-0.3499942899362545,-0.823415299828207,0.7714285714285715,1.0,1.0,7/65,13.87%,SOX15;KIF20B;SVIL;DDX11;CENPV;USP19;GIPC1
prerank,GO_Biological_Process_2021__DNA replication-independent nucleosome assembly (GO:0006336),-0.36348550657293155,-0.8233450978149629,0.7205882352941176,1.0,1.0,11/31,27.40%,OIP5;ITGB3BP;CENPH;CENPN;CENPU;NPM1;CABIN1;KNL1;SMARCA5;CENPX;MIS18A
prerank,GO_Biological_Process_2021__entry of bacterium into host cell (GO:0035635),0.44774109280510316,0.8233058024920641,0.7441860465116279,0.9261102214948087,1.0,5/8,32.33%,CBL;CTNNB1;CBLL1;GRB2;SRC
prerank,GO_Biological_Process_2021__amino-acid betaine biosynthetic process (GO:0006578),-0.4986428323503503,-0.823207550189274,0.74,1.0,1.0,1/5,7.17%,TMLHE
prerank,GO_Biological_Process_2021__carnitine biosynthetic process (GO:0045329),-0.4986428323503503,-0.823207550189274,0.74,1.0,1.0,1/5,7.17%,TMLHE
prerank,GO_Biological_Process_2021__smoothened signaling pathway (GO:0007224),0.31384219931355267,0.8232019945384484,0.8857142857142857,0.9259556582604365,1.0,7/29,15.98%,TTBK2;GLI3;HIPK2;MAP3K10;KIAA0586;DYRK2;SMO
prerank,GO_Biological_Process_2021__regulation of megakaryocyte differentiation (GO:0045652),-0.3573733548430803,-0.8217977617716288,0.746268656716418,1.0,1.0,4/45,8.20%,GATA1;RAB7B;THBS1;PRKCQ
prerank,GO_Biological_Process_2021__regulation of high voltage-gated calcium channel activity (GO:1901841),0.4729523427155218,0.8215635440663684,0.7441860465116279,0.9284753250280301,1.0,5/9,32.40%,CACNA2D1;CACNB3;PDE4B;SRI;CACNB2
prerank,GO_Biological_Process_2021__entrainment of circadian clock by photoperiod (GO:0043153),-0.41098125970268007,-0.8215346257082727,0.6935483870967742,1.0,1.0,4/24,13.30%,PDE6B;FBXL22;ID2;RBM4B
prerank,GO_Biological_Process_2021__regulation of cell-matrix adhesion (GO:0001952),0.2995429786350363,0.8211804373482822,0.8666666666666667,0.9289035341056758,1.0,17/56,21.71%,EFNA5;AJAP1;LIMCH1;PLEKHA2;BST1;NF1;MAP4K4;GPM6B;PTK2;CLASP1;GSK3B;ROCK2;CDH13;UTRN;ROCK1;CIB1;ADAM15
prerank,GO_Biological_Process_2021__negative regulation of mitotic cell cycle (GO:0045930),0.3133117716165304,0.8210890438062325,0.8421052631578947,0.9286477185243383,1.0,9/37,16.26%,BRINP3;RGCC;HECA;ANGEL2;PRCC;SCRIB;TRIM35;BMP7;FZD3
prerank,GO_Biological_Process_2021__glutamine metabolic process (GO:0006541),0.43527895168443953,0.820956513879999,0.7619047619047619,0.9285049597430728,1.0,1/8,3.18%,GLS
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell differentiation (GO:0051150),0.4626314477206187,0.8208179450037726,0.673469387755102,0.9284563249021967,1.0,1/6,2.63%,RBPMS2
prerank,GO_Biological_Process_2021__positive regulation by host of viral process (GO:0044794),-0.44873587277377125,-0.8204229226517312,0.6666666666666666,1.0,1.0,3/11,11.67%,PPIB;CAV2;APOE
prerank,GO_Biological_Process_2021__negative regulation of growth (GO:0045926),-0.3425759500424615,-0.820389127810642,0.8333333333333334,1.0,1.0,14/99,16.76%,SFRP2;MT1H;BST2;MT1G;HYAL1;CRLF3;MT2A;MT3;SFRP1;MT1E;BTG1;TCHP;MT1F;MT1A
prerank,GO_Biological_Process_2021__protein localization to phagophore assembly site (GO:0034497),0.45147557021979406,0.8203708517569215,0.7692307692307693,0.928883885249017,1.0,1/10,4.98%,TRAPPC8
prerank,GO_Biological_Process_2021__regulation of defense response to virus by host (GO:0050691),-0.3870640745596364,-0.820290332204772,0.7719298245614035,1.0,1.0,6/25,17.40%,STAT1;PQBP1;APOBEC3G;DTX3L;AIM2;PTPN22
prerank,GO_Biological_Process_2021__regulation of interleukin-1 production (GO:0032652),-0.4960428515261056,-0.8202764356067279,0.6666666666666666,1.0,1.0,2/9,4.63%,CEACAM1;ANXA1
prerank,GO_Biological_Process_2021__negative regulation of cell communication (GO:0010648),-0.4627020609458906,-0.8199814759363844,0.7,1.0,1.0,6/10,26.84%,HHIP;ERBB3;GLRA1;OPRM1;BRAP;NLRP12
prerank,"GO_Biological_Process_2021__retrograde transport, endosome to Golgi (GO:0042147)",0.30293549499079114,0.819777606956865,0.8,0.9296117344064191,1.0,24/79,27.77%,TBC1D5;VTI1A;BAIAP3;RHOBTB3;ARFRP1;RAB9A;PIKFYVE;TRAPPC10;SNX5;TBC1D10A;TBC1D23;PHETA1;GGA1;ERC1;VAMP3;VPS50;SNX1;TBC1D17;VPS54;VPS51;RIC1;VPS26B;TBC1D10B;STX5
prerank,GO_Biological_Process_2021__tubulin complex assembly (GO:0007021),-0.5344393290199919,-0.8197724424552136,0.7592592592592593,1.0,1.0,2/6,16.59%,TBCE;VBP1
prerank,GO_Biological_Process_2021__hexose metabolic process (GO:0019318),-0.38116601852457993,-0.8196641993879908,0.8095238095238095,1.0,1.0,9/29,24.97%,ALDOB;AKR1A1;SORD;FUCA2;PMM1;FBP1;KHK;FUCA1;DCXR
prerank,GO_Biological_Process_2021__regulation of inflammatory response to antigenic stimulus (GO:0002861),0.3050895298945221,0.8196404056702993,0.7777777777777778,0.9294312625874579,1.0,8/62,11.00%,PRKACB;ADCY1;CALCB;PRKAR1B;CD247;ADRB2;GPR176;ADRB1
prerank,GO_Biological_Process_2021__regulation of epithelial to mesenchymal transition (GO:0010717),-0.3537845177323529,-0.8194947112482247,0.75,1.0,1.0,4/58,6.08%,SFRP2;OVOL2;EFNA1;PDPN
prerank,GO_Biological_Process_2021__store-operated calcium entry (GO:0002115),0.521207489352606,0.8194043873373028,0.7619047619047619,0.929494992626744,1.0,2/6,11.69%,STIM2;STIM1
prerank,PanglaoDB_Augmented_2021__Satellite Cells,0.2712509102639599,0.8193911239522211,0.9583333333333334,0.9291583121681375,1.0,37/113,25.82%,SOX8;EPHA2;EGFR;PARVA;SOX9;LIMCH1;RBFOX2;HSPA12A;PLPP3;ZNF423;NCKAP1;ENAH;TJP1;SH3PXD2B;SCRIB;YAP1;DDAH1;PARD3B;RUNX1;BCAR1;LIFR;CHST3;CASKIN2;SNX7;NFATC2;DOCK1;NTN4;ADCY6;PLS3;FZD7;MESP1;TEAD1;TMEM47;HTRA1;ERRFI1;SH3BP4;GNG12
prerank,MSigDB_Hallmark_2020__IL-2/STAT5 Signaling,0.26124751536607316,0.8193569035315824,1.0,0.9288656619384233,1.0,31/142,17.64%,BMP2;PHLDA1;ENO3;RGS16;ANXA4;RORA;SPRED2;PLPP1;ALCAM;GUCY1B1;AHCY;SPRY4;PDCD2L;CA2;CDC42SE2;NCOA3;IKZF2;AHR;MAPKAPK2;HIPK2;TTC39B;BCL2;CYFIP1;ECM1;POU2F1;NRP1;SWAP70;RABGAP1L;UCK2;ITGA6;TNFRSF8
prerank,GO_Biological_Process_2021__vasculogenesis (GO:0001570),-0.4038250259832305,-0.8192077946889283,0.7384615384615385,1.0,1.0,7/22,22.39%,APLNR;ADM;HEY2;AGGF1;ENG;TGFBR3L;TGFB1
prerank,GO_Biological_Process_2021__resolution of meiotic recombination intermediates (GO:0000712),0.41017619609533434,0.8188758159750654,0.7727272727272727,0.9294358556504428,1.0,1/12,0.89%,MSH4
prerank,GO_Biological_Process_2021__gas transport (GO:0015669),-0.5515014993348423,-0.8185519029789423,0.782608695652174,1.0,1.0,1/5,4.59%,AQP1
prerank,GO_Biological_Process_2021__L-amino acid transport (GO:0015807),0.34780438471234093,0.8185353042214675,0.75,0.9296994380513541,1.0,8/23,31.76%,SLC25A18;SFXN1;SLC7A9;SLC25A13;SLC38A2;SLC7A2;SLC25A12;SLC1A2
prerank,GO_Biological_Process_2021__organic cation transport (GO:0015695),-0.44674455641671895,-0.8182151189025018,0.6875,1.0,1.0,4/16,18.07%,PDZK1;SLC25A26;SLC22A4;SLC22A1
prerank,GO_Biological_Process_2021__regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),0.4369425496073366,0.8181301198890428,0.7021276595744681,0.9299753113638523,1.0,3/12,6.86%,ANK2;CACNA2D1;KCNH2
prerank,GO_Biological_Process_2021__toll-like receptor 4 signaling pathway (GO:0034142),-0.44067489927880166,-0.8178892039630259,0.7647058823529411,1.0,1.0,3/11,14.25%,LY96;CD14;SCIMP
prerank,GO_Biological_Process_2021__nitric oxide metabolic process (GO:0046209),0.4057980394904429,0.8178277168522099,0.631578947368421,0.9300137129476014,1.0,2/12,6.29%,MTARC2;AKT1
prerank,GO_Biological_Process_2021__mitochondrion disassembly (GO:0061726),0.3230022153723567,0.8177576024878223,0.8214285714285714,0.9298149146130508,1.0,10/33,27.63%,CTSK;ATG7;PRKN;FUNDC2;ATG2B;ATG5;RB1CC1;MARK2;USP30;ATG3
prerank,GO_Biological_Process_2021__excitatory chemical synaptic transmission (GO:0098976),-0.5060270990491709,-0.8173277495833812,0.7346938775510204,1.0,1.0,1/7,4.95%,GRIN2D
prerank,GO_Biological_Process_2021__regulation of response to reactive oxygen species (GO:1901031),-0.5214720158331027,-0.8172589629868813,0.7647058823529411,1.0,1.0,1/5,10.75%,FBLN5
prerank,GO_Biological_Process_2021__positive regulation of MHC class II biosynthetic process (GO:0045348),-0.5313885783485742,-0.8171402012991692,0.6896551724137931,1.0,1.0,2/5,13.88%,CIITA;XBP1
prerank,PanglaoDB_Augmented_2021__Pulmonary Alveolar Type I Cells,-0.3143968569499772,-0.8169404696462148,0.8333333333333334,1.0,1.0,18/96,20.08%,THSD4;PDPN;GRAMD2A;COL4A4;AKAP5;TRIM29;PPL;IL20RA;S100A16;BCAM;EDNRA;EMP2;ICAM1;SEMA3B;AMOTL2;CLDN18;SEMA3E;PTPRF
prerank,GO_Biological_Process_2021__positive regulation of Wnt signaling pathway (GO:0030177),-0.3125180647195128,-0.8169249149233642,0.7848101265822784,1.0,1.0,19/133,14.17%,SFRP2;PSMB6;SFRP4;DEPDC1B;PSMA8;RSPO3;SEMA5A;GPC3;PSMB9;PSMA7;NRARP;PSMC3;PSME1;SFRP1;FZD9;PSMC4;LRRK1;PSMA3;RSPO4
prerank,GO_Biological_Process_2021__inner mitochondrial membrane organization (GO:0007007),-0.36920941451893946,-0.8165844776232686,0.7741935483870968,1.0,1.0,8/44,14.94%,MICOS10;TIMM10;TIMM8B;ATP5ME;ATP5F1E;ATP5MC3;ATP5PD;ROMO1
prerank,GO_Biological_Process_2021__regulation of MAPK cascade (GO:0043408),-0.3193387290583029,-0.8164627209978921,0.7325581395348837,1.0,1.0,10/123,10.30%,APIP;CD24;CEACAM1;RASGRP1;CCN1;GSTP1;CAV2;RRAS;CAV3;DUSP1
prerank,GO_Biological_Process_2021__replication fork protection (GO:0048478),-0.5117340019322962,-0.8161166079687056,0.7758620689655172,1.0,1.0,2/8,20.62%,BLM;DONSON
prerank,GO_Biological_Process_2021__regulation of chromatin assembly or disassembly (GO:0001672),0.492178982306349,0.8159542044769161,0.6808510638297872,0.9325797699323443,1.0,4/6,33.58%,PADI2;SPTY2D1;TLK1;TLK2
prerank,GO_Biological_Process_2021__cellular response to alcohol (GO:0097306),0.3228006641552095,0.8159069146894721,0.6944444444444444,0.9322928328650273,1.0,9/40,15.98%,TNFSF4;GRAMD1C;ADCY1;GOLPH3;AHR;OSBPL7;GNAI1;KLF9;SMO
prerank,GO_Biological_Process_2021__tRNA thio-modification (GO:0034227),0.48778789300127595,0.8157776373341801,0.7857142857142857,0.9321495010149272,1.0,1/5,8.86%,CTU1
prerank,GO_Biological_Process_2021__negative regulation of fatty acid biosynthetic process (GO:0045717),-0.45637028282276076,-0.8156952743267855,0.7580645161290323,1.0,1.0,2/11,12.47%,CEACAM1;BRCA1
prerank,GO_Biological_Process_2021__cellular response to organic substance (GO:0071310),0.2831287637850991,0.8154434503473253,0.9354838709677419,0.932523519544621,1.0,23/92,15.86%,PID1;PTPN4;CSF1R;MME;HCLS1;NFAT5;PTPN13;NCOA2;BMPR1B;RPS6KB1;NCOA3;PTPN9;TGFBR2;SLIT2;ACVR1;TGFBR1;MAP2K5;ACVR2A;BMPR1A;PTPN14;PTPN11;CPNE3;MAPK8
prerank,GO_Biological_Process_2021__positive regulation of cell-matrix adhesion (GO:0001954),-0.3538748178147949,-0.8149702364148343,0.7702702702702703,1.0,1.0,7/34,17.03%,S100A10;CCL28;RRAS;SFRP1;CX3CL1;SKAP1;EMP2
prerank,GO_Biological_Process_2021__phospholipid efflux (GO:0033700),-0.5137891247825849,-0.8147561689066157,0.7619047619047619,1.0,1.0,2/6,11.67%,ABCA12;APOE
prerank,GO_Biological_Process_2021__cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),0.35061580996762726,0.8138642396338258,0.7619047619047619,0.9349031355551757,1.0,6/23,10.13%,IRAK2;TAB3;UBE2N;ITCH;MAP3K7;TAB1
prerank,GO_Biological_Process_2021__peptidyl-cysteine modification (GO:0018198),-0.4755508506756867,-0.8134900570656657,0.7090909090909091,1.0,1.0,2/6,21.34%,NOS1;PARK7
prerank,GO_Biological_Process_2021__regulation of type I interferon production (GO:0032479),-0.3339235663018392,-0.8134265413718689,0.8208955223880597,1.0,1.0,15/79,20.74%,IRF1;ISG15;PQBP1;TRIM21;HERC5;CD14;POLR2L;DDX41;POLR1C;POLR3G;PTPN22;NLRX1;GAPDH;POLR2K;NLRC5
prerank,GO_Biological_Process_2021__positive regulation of potassium ion transmembrane transport (GO:1901381),0.3337913795193719,0.8131113267972246,0.7631578947368421,0.9358611663627603,1.0,7/37,21.72%,ANK2;KCNH2;KCNMA1;GABBR1;WNK3;WNK1;KCNN3
prerank,GO_Biological_Process_2021__cellular protein complex disassembly (GO:0043624),-0.4934191772843533,-0.812868853445389,0.7391304347826086,1.0,1.0,1/6,8.13%,TRMT112
prerank,GO_Biological_Process_2021__steroid biosynthetic process (GO:0006694),-0.35180102293530663,-0.812848391071883,0.75,1.0,1.0,9/42,23.44%,HSD11B1;SQLE;DHCR7;TM7SF2;INSIG1;MSMO1;HMGCR;ACOT8;ACOX2
prerank,GO_Biological_Process_2021__positive regulation of wound healing (GO:0090303),-0.3927521068401241,-0.8125400213394727,0.7272727272727273,1.0,1.0,3/24,5.73%,DUOX1;ANXA1;THBS1
prerank,GO_Biological_Process_2021__negative regulation of reactive oxygen species metabolic process (GO:2000378),-0.4141555821801929,-0.8125327171608331,0.625,1.0,1.0,3/17,12.47%,SLC18A2;MT3;BRCA1
prerank,GO_Biological_Process_2021__activation of protein kinase activity (GO:0032147),0.2656633108055653,0.8118955956643297,0.9411764705882353,0.9376401294559994,1.0,23/89,22.67%,PRKACB;ADCY1;TNIK;AKT1;PRKAR1B;ADRB2;MAP3K7;PRRC1;PAK3;MAP4K4;TGFBR2;TNFRSF10B;TAOK2;OSBPL8;STK11;IGF1;PAK4;AXIN1;NRG1;STK4;NTRK3;ADCY6;ADCY9
prerank,GO_Biological_Process_2021__lipoprotein transport (GO:0042953),0.4611291257399752,0.8118028055681968,0.7674418604651163,0.9374390351800901,1.0,5/8,36.27%,PRKCB;VMP1;ZDHHC17;UNC119B;PPARG
prerank,GO_Biological_Process_2021__actin filament depolymerization (GO:0030042),0.41522573948829544,0.8114748367542869,0.696969696969697,0.9376112922562597,1.0,1/10,1.48%,MICAL1
prerank,GO_Biological_Process_2021__regulation of adaptive immune response (GO:0002819),0.39420835733020854,0.8112205197317054,0.7222222222222222,0.9376466309748194,1.0,5/12,13.60%,TNFSF4;EIF2AK4;AHR;SIRT1;SAMSN1
prerank,GO_Biological_Process_2021__negative regulation of neuron apoptotic process (GO:0043524),-0.3410060312296057,-0.8112068512903942,0.7681159420289855,1.0,1.0,11/57,15.80%,POU4F1;BDNF;MT3;APOE;UNC5B;FZD9;CX3CL1;ERBB3;CLN3;CCL2;NRBP2
prerank,GO_Biological_Process_2021__response to acidic pH (GO:0010447),0.44299176101843435,0.8111705411316554,0.7391304347826086,0.9373401042339432,1.0,4/9,30.33%,IMPACT;CTSS;TRPV1;RAB11B
prerank,GO_Biological_Process_2021__regulation of regulatory T cell differentiation (GO:0045589),0.37938267065167025,0.8111606591871701,0.7142857142857143,0.936996533006451,1.0,5/14,17.52%,TNFSF4;DUSP10;KAT2A;CBFB;RUNX1
prerank,GO_Biological_Process_2021__negative regulation of binding (GO:0051100),-0.3400023177484542,-0.8109868332983479,0.8,1.0,1.0,12/70,16.25%,IFIT1;PLN;IFIT2;DDX11;CYP2D6;TMC8;LRPAP1;EFHB;ZFPM1;GTF2F1;ARHGAP28;SP100
prerank,GO_Biological_Process_2021__regulation of developmental growth (GO:0048638),-0.39288724413273857,-0.8109609119939564,0.6779661016949152,1.0,1.0,1/26,1.66%,MUSK
prerank,GO_Biological_Process_2021__cellular sodium ion homeostasis (GO:0006883),0.4214675258341487,0.8106628150513915,0.6923076923076923,0.9375537492335441,1.0,2/12,6.40%,NEDD4L;SLC12A2
prerank,GO_Biological_Process_2021__adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),0.40002359015908034,0.810589269152932,0.8947368421052632,0.9373407292967735,1.0,1/14,2.23%,BTN3A3
prerank,GO_Biological_Process_2021__regulation of cellular ketone metabolic process (GO:0010565),0.304942465676044,0.8103554783063801,0.8529411764705882,0.9373326629134748,1.0,8/51,13.01%,PDK4;PSMA1;PSMD11;PANK2;PSMD10;PSMF1;PSMD14;SIRT1
prerank,PanglaoDB_Augmented_2021__Macrophages,-0.32995362037453463,-0.8102262068612458,0.7808219178082192,1.0,1.0,16/80,14.31%,TAGAP;PARP14;CLEC12A;F13A1;IGSF6;CXCL2;RAB7B;GPR171;SLC11A1;P2RY6;CD14;SPI1;CLEC5A;MYO1F;SCIMP;CCL2
prerank,GO_Biological_Process_2021__activation of adenylate cyclase activity (GO:0007190),0.3640137575606498,0.8101552163801615,0.6666666666666666,0.937318399185331,1.0,4/23,11.00%,ADCY1;ADRB2;LGR4;ADRB1
prerank,GO_Biological_Process_2021__acyl-CoA biosynthetic process (GO:0071616),-0.44354102818046165,-0.8098191473338419,0.7571428571428571,1.0,1.0,5/15,23.58%,HSD17B8;SLC25A1;FASN;CBR4;GCDH
prerank,GO_Biological_Process_2021__regulation of neurotransmitter secretion (GO:0046928),0.3205152330313475,0.8097567139543287,0.8055555555555556,0.9376017996047948,1.0,8/29,23.27%,BAIAP3;CAMK2A;RIMS3;SLC30A1;GSK3B;FMR1;RIMS2;HCRT
prerank,GO_Biological_Process_2021__regulation of Wnt signaling pathway (GO:0030111),0.26752967134046207,0.8096394799939235,0.9230769230769231,0.9374758669984926,1.0,30/84,23.89%,BTRC;SALL1;BMP2;AMER2;KANK1;FRZB;GSKIP;CSNK2A1;NLK;DACT3;PRKN;ZRANB1;WWOX;VGLL4;GNAQ;CBFB;RUNX1;ZNF703;CDK14;CTNND2;AXIN1;CXXC4;OTULIN;PPP2R1A;FZD7;CDC73;NFATC1;FGFR2;CTNNB1;MACF1
prerank,GO_Biological_Process_2021__regulation of cell communication by electrical coupling (GO:0010649),0.4655523403922371,0.809542771536463,0.7021276595744681,0.9373562262089845,1.0,2/8,16.88%,CAMK2D;PDE4D
prerank,GO_Biological_Process_2021__leucine transport (GO:0015820),0.45779705495003853,0.809229703725517,0.6511627906976745,0.9375897378449304,1.0,3/6,40.30%,LLGL2;SLC6A17;SLC6A15
prerank,GO_Biological_Process_2021__negative regulation of macrophage activation (GO:0043031),0.42541305476660596,0.8090458860108994,0.6904761904761905,0.9375630203626086,1.0,2/9,10.37%,NR1D1;LRFN5
prerank,GO_Biological_Process_2021__response to epinephrine (GO:0071871),0.4530620130987339,0.8089909265145663,0.6976744186046512,0.9369404384393881,1.0,3/8,15.57%,SNCA;SIRT2;ATP2B4
prerank,GO_Biological_Process_2021__cellular response to epinephrine stimulus (GO:0071872),0.4530620130987339,0.8089909265145663,0.6976744186046512,0.9369404384393881,1.0,3/8,15.57%,SNCA;SIRT2;ATP2B4
prerank,GO_Biological_Process_2021__regulation of keratinocyte differentiation (GO:0045616),-0.3884965235894715,-0.808811896180962,0.7692307692307693,1.0,1.0,4/21,10.68%,ABCA12;CTSL;PLAAT4;ETV4
prerank,GO_Biological_Process_2021__regulation of RIG-I signaling pathway (GO:0039535),0.3734601193725111,0.8087729740213514,0.675,0.9368212262444005,1.0,5/15,17.09%,PUM2;ANKRD17;SEC14L1;BIRC2;PUM1
prerank,GO_Biological_Process_2021__positive regulation of cell-substrate junction organization (GO:0150117),0.35971875051635416,0.8087608336112255,0.7567567567567568,0.9364919038325523,1.0,7/21,19.93%,PIK3R1;PTPRJ;MAP4K4;NRP1;ARF6;PPM1F;ROCK1
prerank,GO_Biological_Process_2021__regulation of integrin activation (GO:0033623),-0.4483357357280874,-0.8086972369060818,0.7846153846153846,1.0,1.0,1/14,1.97%,SELP
prerank,GO_Biological_Process_2021__regulation of fibrinolysis (GO:0051917),0.4930044544597376,0.8082168420825453,0.75,0.9369167935256922,1.0,3/7,9.84%,SERPINE1;KLKB1;FAP
prerank,GO_Biological_Process_2021__negative regulation of heart contraction (GO:0045822),-0.464150807275555,-0.808072651358403,0.7333333333333333,1.0,1.0,1/8,4.39%,PLN
prerank,GO_Biological_Process_2021__ribonucleoprotein complex disassembly (GO:0032988),0.4958907059148202,0.808033981921829,0.7291666666666666,0.9368533245563885,1.0,4/7,25.98%,VCP;KLC1;ZFAND1;DYRK3
prerank,GO_Biological_Process_2021__regulation of adipose tissue development (GO:1904177),0.4881026798367393,0.8078409355884781,0.7021276595744681,0.9367466759797134,1.0,3/6,20.71%,TRPM4;SIRT1;PLAAT3
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),0.41815013142832136,0.8078063210106136,0.65625,0.936448743943537,1.0,6/14,18.39%,MARCHF7;PRKN;SIRT1;BCL2;KDM1A;MDM2
prerank,GO_Biological_Process_2021__positive regulation of protein catabolic process in the vacuole (GO:1904352),-0.5392223943149207,-0.8077364735840505,0.8214285714285714,1.0,1.0,3/5,31.84%,LDLR;RNF128;LRP2
prerank,GO_Biological_Process_2021__positive regulation of cation channel activity (GO:2001259),0.34201885668995147,0.8074526455239931,0.8275862068965517,0.9366508635426245,1.0,7/30,11.56%,ANK2;CASQ1;ADRB2;GSTM2;PKD2;NLGN3;SHANK3
prerank,GO_Biological_Process_2021__negative regulation of metabolic process (GO:0009892),0.3087856733697849,0.8073415484139477,0.8125,0.9365074017004901,1.0,14/41,21.30%,RHEB;LGR4;TFE3;NR1D1;DOCK7;ZNF423;ABHD6;STK11;RBPJ;LNPEP;NOVA1;PGAM5;PLCL1;NOVA2
prerank,GO_Biological_Process_2021__actomyosin structure organization (GO:0031032),-0.3461658972280069,-0.8072232949446354,0.7901234567901234,1.0,1.0,2/59,0.81%,TNNT1;LMOD1
prerank,GO_Biological_Process_2021__negative regulation of cellular protein catabolic process (GO:1903363),-0.4852888282929899,-0.8070529342413039,0.7192982456140351,1.0,1.0,1/9,3.19%,EFNA1
prerank,GO_Biological_Process_2021__regulation of cell differentiation (GO:0045595),-0.3155689911195666,-0.8069748880146862,0.9213483146067416,1.0,1.0,12/114,14.43%,CD24;PRAME;BDNF;RUNX2;SRF;FES;KLF4;CEBPD;EIF2AK2;ID2;FADS1;HEY2
prerank,GO_Biological_Process_2021__negative regulation of leukocyte apoptotic process (GO:2000107),0.45715147856527416,0.8069200138510713,0.7659574468085106,0.9368696641236478,1.0,3/7,12.81%,CXCL12;HCLS1;MERTK
prerank,GO_Biological_Process_2021__regulation of intracellular transport (GO:0032386),-0.35553825280636375,-0.8065367449520622,0.7313432835820896,1.0,1.0,6/31,20.96%,NEFH;HAP1;REEP5;CRYAB;ANTKMT;DNAJC30
prerank,GO_Biological_Process_2021__mitotic sister chromatid cohesion (GO:0007064),0.42592243082421555,0.8064416822134887,0.7441860465116279,0.9373672555444967,1.0,5/13,17.23%,PDS5B;NIPBL;PDS5A;NAA50;POGZ
prerank,MSigDB_Hallmark_2020__Complement,-0.3140352181994056,-0.8063609524594637,0.875,1.0,1.0,16/145,11.22%,CP;F8;IRF1;TIMP1;C1R;RASGRP1;PRSS3;CTSL;ERAP2;PSMB9;APOBEC3G;PHEX;CTSH;MT3;F5;CLU
prerank,GO_Biological_Process_2021__nucleotide metabolic process (GO:0009117),-0.3821431653911633,-0.8061826097721794,0.7627118644067796,1.0,1.0,4/22,12.59%,CMPK2;NMNAT3;PNP;AK7
prerank,GO_Biological_Process_2021__RIG-I signaling pathway (GO:0039529),-0.4968975491980485,-0.8061026112257794,0.7058823529411765,1.0,1.0,3/5,28.90%,OAS3;TRIM25;PHB2
prerank,GO_Biological_Process_2021__negative regulation of peptidase activity (GO:0010466),-0.36305158789473607,-0.8057070685124655,0.6835443037974683,1.0,1.0,12/33,21.34%,SPINK6;TIMP1;CSTB;CST3;SERPINF1;SERPIND1;SPINK5;AGT;GAPDH;SPOCK2;TIMP2;PARK7
prerank,GO_Biological_Process_2021__cellular response to interleukin-6 (GO:0071354),0.35806675330449567,0.8055823402320144,0.7,0.9383573845574538,1.0,7/24,15.63%,PID1;NFKB1;CBL;FER;SMAD4;PTPN11;YAP1
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),-0.323040384502025,-0.8050230601282413,0.8873239436619719,1.0,1.0,13/76,13.44%,PSMB6;KLF2;RPS27A;PSMA8;PSMB9;PSMA7;ELOB;PSMC3;UBC;PSME1;DDIT3;PSMC4;PSMA3
prerank,GO_Biological_Process_2021__protein sulfation (GO:0006477),0.5450410730278267,0.8048872049641973,0.7592592592592593,0.9391188818273387,1.0,1/5,2.99%,HS3ST5
prerank,GO_Biological_Process_2021__mitochondrial translational termination (GO:0070126),-0.336601111817416,-0.8039446606829468,0.8428571428571429,1.0,1.0,17/78,21.59%,MRPL20;MTRF1L;MRPL51;MRPL40;MRPL27;MRPS33;GADD45GIP1;MRPL36;MRPL34;AURKAIP1;MRPL54;MRPS21;MRPS34;MRPS26;MRPS22;MRPL21;OXA1L
prerank,GO_Biological_Process_2021__potassium ion transport (GO:0006813),-0.3068029528135261,-0.8037453453713232,0.8271604938271605,1.0,1.0,13/86,15.72%,KCNJ13;KCNB1;AQP1;CCDC51;KCNQ4;KCNQ1;KCNG1;LRRC55;KCNK13;SLC9A2;SLC24A1;SLC9A7;KCNJ8
prerank,GO_Biological_Process_2021__metallo-sulfur cluster assembly (GO:0031163),0.36334600175823795,0.8036197723015622,0.7222222222222222,0.9406986559677165,1.0,2/21,4.66%,IBA57;LYRM4
prerank,GO_Biological_Process_2021__pyrimidine nucleoside catabolic process (GO:0046135),0.45579556721399705,0.8033195672197592,0.7857142857142857,0.9408432542991851,1.0,4/9,23.14%,NT5C1A;NT5M;UPP1;NT5C3A
prerank,GO_Biological_Process_2021__chromatin organization involved in negative regulation of transcription (GO:0097549),0.4972162882886111,0.8031891749474659,0.7,0.9406862891775817,1.0,2/6,13.01%,BAHD1;SIRT1
prerank,GO_Biological_Process_2021__autophagosome assembly (GO:0000045),0.31453709662276774,0.8031377787474037,0.8888888888888888,0.9404187452477143,1.0,16/52,24.28%,TRAPPC8;RAB23;ATG7;PIK3C3;SMURF1;UBQLN1;ATG2B;RAB1A;UBQLN2;ATG5;NSFL1C;UBXN2B;STX12;RB1CC1;STX17;VMP1
prerank,GO_Biological_Process_2021__protein targeting to mitochondrion (GO:0006626),-0.35154989966061045,-0.8029506300874367,0.7837837837837838,1.0,1.0,12/48,21.87%,TOMM7;TIMM10;TIMM8B;FIS1;ROMO1;AIP;HSPD1;TOMM34;TSPO;BCAP31;SLC25A6;GRPEL1
prerank,GO_Biological_Process_2021__post-Golgi vesicle-mediated transport (GO:0006892),0.2798405677043174,0.8027253090832356,0.8636363636363636,0.940655498439228,1.0,27/81,23.77%,SORT1;STXBP6;EPS15;EXOC2;ARRB1;EXOC8;EXOC5;AP1S3;EXOC6;EXOC6B;RABIF;GOLGA7;EXOC4;COMMD1;AP1G1;RP2;PUM1;MYO5A;DNM2;SCAMP1;RAB10;SNAP23;CLVS2;AP1G2;OSBPL5;MON2;SCFD1
prerank,GO_Biological_Process_2021__negative regulation of cytokine production (GO:0001818),-0.3120739058484903,-0.8024949028125149,0.8421052631578947,1.0,1.0,16/120,12.24%,GBP1;ISG15;CEACAM1;ANXA1;SELENOS;THBS1;IL12A;SIGIRR;INHA;SLC11A1;CUEDC2;KLF4;DDIT3;PDCD1LG2;HERC5;CX3CL1
prerank,GO_Biological_Process_2021__transcription elongation from RNA polymerase II promoter (GO:0006368),0.28911890586261296,0.8022743895646484,0.9629629629629629,0.9409781066004439,1.0,14/62,23.56%,EAF2;MLLT3;IWS1;CDK12;NELFA;CDK13;CCNT2;SETD2;PCID2;GTF2F2;CDK9;ELP2;CDC73;TCEA1
prerank,MSigDB_Hallmark_2020__Androgen Response,0.2688081978828603,0.8021914170533009,0.95,0.9407783263418972,1.0,23/92,20.19%,VAPA;PLPP1;RPS6KA3;ZBTB10;AKT1;BMPR1B;GSR;FKBP5;GNAI3;ANKH;PIAS1;ELK4;ELOVL5;PDLIM5;SMS;MERTK;MAF;RAB4A;LIFR;CCND3;ABHD2;TSC22D1;ACSL3
prerank,GO_Biological_Process_2021__inflammatory response (GO:0006954),-0.3161694086215591,-0.8019696894368222,0.85,1.0,1.0,18/99,14.31%,MMP25;PRDX5;ADM;CXCL2;ANXA1;THBS1;TACR1;FPR3;HYAL1;CIITA;SLC11A1;NOX1;GPR68;IL18;CX3CL1;CD14;RIPK2;CCL2
prerank,GO_Biological_Process_2021__protein side chain deglutamylation (GO:0035610),0.48276368094242916,0.8019245043410173,0.6818181818181818,0.9407936167101683,1.0,1/5,15.95%,AGTPBP1
prerank,GO_Biological_Process_2021__hemostasis (GO:0007599),-0.494187555933199,-0.8019065226007532,0.7592592592592593,1.0,1.0,3/5,15.06%,P2RY12;VWF;GPI
prerank,GO_Biological_Process_2021__neuron projection fasciculation (GO:0106030),0.42141896663428924,0.8018534308861871,0.75,0.9406063321786962,1.0,2/10,5.05%,EPHA4;ARHGAP35
prerank,GO_Biological_Process_2021__regulation of protein-containing complex assembly (GO:0043254),-0.3245012687305697,-0.8016351869221832,0.7974683544303798,1.0,1.0,9/90,11.86%,WARS1;SELP;MTLN;TMC8;SVIP;KIF9;CLU;APOE;EIF2AK2
prerank,GO_Biological_Process_2021__epithelial cell apoptotic process (GO:1904019),0.4495700446469411,0.8013064492515808,0.6585365853658537,0.9412168659574761,1.0,5/8,45.47%,HIPK1;GSN;BMPR2;DAB2IP;RYR2
prerank,GO_Biological_Process_2021__heterocycle biosynthetic process (GO:0018130),0.4146881198272968,0.8011213102834794,0.7272727272727273,0.9412074399645867,1.0,1/12,6.33%,GPHN
prerank,GO_Biological_Process_2021__regulation of centrosome duplication (GO:0010824),0.3341100383104035,0.8010503035577097,0.7368421052631579,0.9409711598489134,1.0,5/26,16.58%,CHMP1A;CHMP2B;SIRT1;ALMS1;CEP120
prerank,GO_Biological_Process_2021__antigen receptor-mediated signaling pathway (GO:0050851),-0.30925457425728586,-0.8009773290666969,0.881578947368421,1.0,1.0,21/134,16.62%,PSMB6;HLA-A;PSMA8;BTN3A1;THEMIS;PSMB9;INPP5D;PSMA7;FYB2;HHLA2;PRKCQ;PIK3CB;PSMC3;PSME1;PSMC4;PSMA3;RIPK2;SKAP1;BTN2A2;TNFRSF21;BLNK
prerank,GO_Biological_Process_2021__heat acclimation (GO:0010286),0.49801187508155714,0.8009231630060747,0.813953488372093,0.9405052573748021,1.0,1/5,21.28%,HSPA1A
prerank,GO_Biological_Process_2021__cellular heat acclimation (GO:0070370),0.49801187508155714,0.8009231630060747,0.813953488372093,0.9405052573748021,1.0,1/5,21.28%,HSPA1A
prerank,GO_Biological_Process_2021__positive regulation of transcription of Notch receptor target (GO:0007221),0.41656607326594386,0.8008056469357453,0.7894736842105263,0.9403368749997865,1.0,7/16,21.25%,KAT2B;MAML2;PBX1;EP300;MAML1;RBPJ;CREBBP
prerank,GO_Biological_Process_2021__unsaturated fatty acid metabolic process (GO:0033559),-0.348612208406571,-0.8004637409182265,0.7538461538461538,1.0,1.0,8/41,15.84%,CYP4Z1;AWAT1;CYP2D6;GSTP1;FADS1;GPX4;PTGR1;ALOX12
prerank,PanglaoDB_Augmented_2021__Mammary Epithelial Cells,-0.3441008444254864,-0.8003344742010318,0.8026315789473685,1.0,1.0,13/48,18.44%,OVOL2;BTN3A1;RUNX2;TRIM29;B3GNT3;ABCG2;PPL;EPS8L2;RARRES1;S100A16;BTN2A2;CDH1;MMP14
prerank,GO_Biological_Process_2021__establishment of mitotic spindle localization (GO:0040001),0.3441467580718899,0.8000220142489454,0.8285714285714286,0.9414175484308954,1.0,12/24,31.35%,INSC;CLASP1;ESPL1;FBXW11;NSFL1C;UBXN2B;PLK1;CLASP2;HTT;GJA1;PAFAH1B1;CDK5RAP2
prerank,GO_Biological_Process_2021__protein processing (GO:0016485),-0.32558156898193197,-0.7999489044798387,0.8333333333333334,1.0,1.0,19/75,19.63%,TMEM208;C1R;PRSS3;CTSL;PCSK1;SEC11C;PHEX;CTSH;SPCS1;C1RL;CLN3;APH1A;ATP23;HTRA2;PCSK2;AEBP1;MMP14;CPXM2;SPRTN
prerank,GO_Biological_Process_2021__negative regulation of DNA recombination at telomere (GO:0048239),-0.41415289109138387,-0.7998794106162548,0.7794117647058824,1.0,1.0,5/20,20.46%,POLR2I;POLR2L;POLR2J;POLR2G;POLR2K
prerank,GO_Biological_Process_2021__regulation of DNA recombination at telomere (GO:0072695),-0.41415289109138387,-0.7998794106162548,0.7794117647058824,1.0,1.0,5/20,20.46%,POLR2I;POLR2L;POLR2J;POLR2G;POLR2K
prerank,GO_Biological_Process_2021__endodermal cell fate commitment (GO:0001711),-0.501782787409816,-0.7998420619545223,0.7321428571428571,1.0,1.0,4/5,29.86%,CTR9;RTF1;PAF1;LEO1
prerank,GO_Biological_Process_2021__cell fate commitment involved in formation of primary germ layer (GO:0060795),-0.501782787409816,-0.7998420619545223,0.7321428571428571,1.0,1.0,4/5,29.86%,CTR9;RTF1;PAF1;LEO1
prerank,GO_Biological_Process_2021__regulation of tissue remodeling (GO:0034103),0.39919147518844256,0.7997556175853444,0.7297297297297297,0.9414876274054922,1.0,1/13,0.74%,LEPR
prerank,GO_Biological_Process_2021__positive regulation of neural precursor cell proliferation (GO:2000179),0.35233682456957727,0.7997519940279874,0.6052631578947368,0.9411477730430547,1.0,6/19,23.61%,TOX;NAP1L1;FZD3;KDM1A;DRD2;CTNNB1
prerank,GO_Biological_Process_2021__desensitization of G protein-coupled receptor signaling pathway (GO:0002029),-0.47444256362414633,-0.7996585731125126,0.7272727272727273,1.0,1.0,2/8,5.70%,ADM;ARR3
prerank,GO_Biological_Process_2021__regulation of epithelial cell proliferation (GO:0050678),-0.3470270481581261,-0.7988790909104241,0.8481012658227848,1.0,1.0,10/63,15.16%,SFRP2;B2M;FGF7;HYAL1;NODAL;FGF1;SFRP1;LAMB1;AQP11;FUT2
prerank,GO_Biological_Process_2021__collagen fibril organization (GO:0030199),-0.3250110139485521,-0.7986423604383608,0.8518518518518519,1.0,1.0,8/74,8.24%,COL8A1;COL10A1;P4HA3;COL5A1;COL6A2;COL24A1;COL4A4;PPIB
prerank,GO_Biological_Process_2021__maintenance of protein localization in endoplasmic reticulum (GO:0035437),-0.45100326025278636,-0.7984731577739322,0.7241379310344828,1.0,1.0,1/11,2.33%,KDELR3
prerank,GO_Biological_Process_2021__positive regulation of catalytic activity (GO:0043085),0.372331418861824,0.7983550499044118,0.8292682926829268,0.9428751572707113,1.0,7/27,20.59%,NCSTN;ABL2;MAPK8;MSH2;POT1;XRCC4;CIB1
prerank,GO_Biological_Process_2021__death-inducing signaling complex assembly (GO:0071550),-0.5229640640531805,-0.7982666443989407,0.75,1.0,1.0,1/6,7.86%,CASP8
prerank,GO_Biological_Process_2021__regulation of secretion by cell (GO:1903530),0.3187997692397094,0.7981968638267214,0.9285714285714286,0.9427734474870031,1.0,15/50,26.48%,ARFIP1;STXBP5;RAB8B;CAMK2A;RAB21;DISP1;NSF;RAB10;FMR1;RIMS2;HCRT;VAMP3;RAB12;RIC1;LLGL1
prerank,GO_Biological_Process_2021__ganglioside catabolic process (GO:0006689),0.4719364960961926,0.797956038521362,0.6829268292682927,0.9427879183199986,1.0,2/5,16.63%,HEXB;NEU3
prerank,GO_Biological_Process_2021__cellular response to inorganic substance (GO:0071241),-0.43456719184046033,-0.7978996216261129,0.7627118644067796,1.0,1.0,4/16,10.79%,AQP1;DDX11;MT3;BLM
prerank,GO_Biological_Process_2021__transepithelial transport (GO:0070633),-0.4277844186655857,-0.7977817582193818,0.765625,1.0,1.0,2/14,9.85%,BEST1;ABCG2
prerank,"GO_Biological_Process_2021__base-excision repair, gap-filling (GO:0006287)",-0.3682793469396263,-0.7973697487781171,0.7647058823529411,1.0,1.0,5/32,20.46%,RPA3;PNKP;POLD2;PARG;APEX1
prerank,GO_Biological_Process_2021__zinc ion transmembrane transport (GO:0071577),0.38068028692670036,0.7971907758731568,0.723404255319149,0.9435415054055296,1.0,8/16,29.03%,SLC39A11;SLC30A4;SLC30A1;SLC39A12;SLC39A8;TRPM2;SLC30A3;SLC39A13
prerank,GO_Biological_Process_2021__protein localization to microtubule (GO:0035372),0.45356527573448696,0.7971758987177121,0.7111111111111111,0.9432259435097984,1.0,5/8,16.20%,CRIPT;HNRNPU;MID1;MAPRE1;CHAMP1
prerank,GO_Biological_Process_2021__negative regulation of membrane potential (GO:0045837),-0.4646024920366481,-0.7968836268217192,0.7592592592592593,1.0,1.0,2/7,22.21%,PRELID1;ARL6IP5
prerank,GO_Biological_Process_2021__negative regulation of protein kinase activity by regulation of protein phosphorylation (GO:0044387),0.5000647898224525,0.7964355879485475,0.7954545454545454,0.944192442308003,1.0,2/6,19.25%,ADARB1;PPM1F
prerank,GO_Biological_Process_2021__regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),0.4033754833757256,0.7962120840319498,0.7105263157894737,0.9442002606198211,1.0,3/16,8.82%,NPTN;SPRY4;SPRY3
prerank,GO_Biological_Process_2021__negative regulation of apoptotic signaling pathway (GO:2001234),0.2738623816319618,0.7962120634364307,0.96875,0.9438482098142209,1.0,17/64,17.92%,NR4A2;SH3RF1;AKT1;CSNK2A1;PSMD10;PRKN;CFLAR;CAAP1;ACVR1;TGFBR1;OPA1;BCL2;PHIP;HGF;ITGA6;IGF1;CSNK2A2
prerank,GO_Biological_Process_2021__negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),-0.35430565560073757,-0.796210781203612,0.6896551724137931,1.0,1.0,4/30,10.33%,STAT1;CASP8;GSTP1;RHOH
prerank,GO_Biological_Process_2021__protein localization to axon (GO:0099612),0.49872079669807295,0.7959497052167088,0.7608695652173914,0.9438317621817139,1.0,2/5,23.76%,CNTNAP2;CNTN2
prerank,GO_Biological_Process_2021__regulation of myotube differentiation (GO:0010830),0.3750903889074472,0.7959046119083311,0.6944444444444444,0.9435593438294133,1.0,5/17,19.68%,HDAC9;RBM24;HDAC4;MAML1;ATP11A
prerank,GO_Biological_Process_2021__negative regulation of ERAD pathway (GO:1904293),-0.5232849189407853,-0.7958429133517663,0.7627118644067796,1.0,1.0,2/6,13.39%,SVIP;AQP11
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway (GO:1903377),0.5119372493913671,0.7958253670352143,0.7777777777777778,0.9433175912098213,1.0,2/5,17.47%,PRKN;HIF1A
prerank,GO_Biological_Process_2021__regulation of delayed rectifier potassium channel activity (GO:1902259),-0.47174425026116,-0.7958095911581856,0.8235294117647058,1.0,1.0,3/9,22.99%,KCNG1;NOS1AP;AKAP6
prerank,GO_Biological_Process_2021__regulation of cellular respiration (GO:0043457),0.40590457749792286,0.7955363165359706,0.6944444444444444,0.9434414362717838,1.0,3/12,27.86%,VCP;IDE;PRDM16
prerank,GO_Biological_Process_2021__thiamine-containing compound metabolic process (GO:0042723),0.5098257788121363,0.795290568605973,0.7872340425531915,0.9434616926775403,1.0,2/5,18.41%,TPK1;SLC19A2
prerank,GO_Biological_Process_2021__positive regulation of cellular component biogenesis (GO:0044089),-0.3292939581620009,-0.7944741130447762,0.7972972972972973,1.0,1.0,12/69,18.04%,WARS1;VIL1;MTLN;HYAL1;CHMP2A;CLU;SLX4;CX3CL1;PFN1;HRK;FLOT1;PFN2
prerank,GO_Biological_Process_2021__positive regulation of aspartic-type peptidase activity (GO:1905247),0.4658403912648937,0.7939402983845294,0.6904761904761905,0.9451555188549408,1.0,2/7,3.59%,PICALM;EPHA4
prerank,GO_Biological_Process_2021__establishment of melanosome localization (GO:0032401),0.3984207942522654,0.7939386361726258,0.717948717948718,0.9444528009970561,1.0,4/13,17.73%,RAB27A;MKKS;MYO5A;BBS2
prerank,GO_Biological_Process_2021__melanosome localization (GO:0032400),0.3984207942522654,0.7939386361726258,0.717948717948718,0.9444528009970561,1.0,4/13,17.73%,RAB27A;MKKS;MYO5A;BBS2
prerank,GO_Biological_Process_2021__actin-myosin filament sliding (GO:0033275),-0.41786891458469666,-0.7938310431000649,0.7076923076923077,1.0,1.0,2/17,6.42%,TNNT1;TTN
prerank,GO_Biological_Process_2021__muscle filament sliding (GO:0030049),-0.41786891458469666,-0.7938310431000649,0.7076923076923077,1.0,1.0,2/17,6.42%,TNNT1;TTN
prerank,GO_Biological_Process_2021__proline transport (GO:0015824),0.534865575926503,0.7937499348968337,0.7674418604651163,0.9443997037187429,1.0,4/5,44.33%,SLC6A7;SLC6A17;SLC6A15;SLC36A4
prerank,GO_Biological_Process_2021__regulation of endopeptidase activity (GO:0052548),0.3141306484607594,0.7936206879966016,0.9166666666666666,0.944170420999112,1.0,6/43,9.43%,SERPINE1;PICALM;SERPINB9;NCSTN;AKT1;A2ML1
prerank,GO_Biological_Process_2021__positive regulation of RNA binding (GO:1905216),0.4866905522850528,0.7935961279466679,0.7083333333333334,0.9438623405300686,1.0,3/5,32.16%,EIF3E;FMR1;NCBP1
prerank,PanglaoDB_Augmented_2021__Undefined Placental Cells,-0.3433952810648062,-0.7935853777347549,0.821917808219178,1.0,1.0,13/70,18.74%,TLCD1;RPL8;CCDC86;PRDX4;DHCR7;MBNL3;GIPC1;SLC25A1;POLD2;TNFRSF12A;FASN;SLC52A2;LAS1L
prerank,GO_Biological_Process_2021__pyrimidine nucleoside metabolic process (GO:0006213),0.4213151538480463,0.7934305992830111,0.7567567567567568,0.9437852327201324,1.0,5/13,23.14%,NT5C1A;NT5M;UPP1;ERH;NT5C3A
prerank,GO_Biological_Process_2021__cellular response to molecule of bacterial origin (GO:0071219),0.2948854043915268,0.7933799300689931,0.9444444444444444,0.9435382233681402,1.0,8/58,9.81%,TNFSF4;SERPINE1;GIT1;NFKB1;FZD5;TICAM1;HMGB1;NR1D1
prerank,GO_Biological_Process_2021__positive regulation of histone deacetylation (GO:0031065),-0.454826111449065,-0.7932795195674075,0.7843137254901961,1.0,1.0,1/12,3.87%,APLNR
prerank,GO_Biological_Process_2021__cellular response to radiation (GO:0071478),0.32436013550891374,0.7931586164320036,0.9444444444444444,0.9434794960946109,1.0,5/33,13.01%,LIG4;INTS7;EEF1D;CLOCK;SIRT1
prerank,GO_Biological_Process_2021__positive regulation of type 2 immune response (GO:0002830),0.44647026917336863,0.7928981161826744,0.7333333333333333,0.9435178596451543,1.0,1/8,1.31%,TNFSF4
prerank,GO_Biological_Process_2021__oligosaccharide biosynthetic process (GO:0009312),0.39066036877081073,0.7927996203059376,0.7111111111111111,0.9433076032908911,1.0,2/14,2.74%,ST6GALNAC5;FUT9
prerank,GO_Biological_Process_2021__membrane invagination (GO:0010324),-0.5022897345324546,-0.7927553192355781,0.6885245901639344,1.0,1.0,1/6,8.99%,CHMP2A
prerank,GO_Biological_Process_2021__regulation of wound healing (GO:0061041),-0.38699242997122285,-0.7923252227301186,0.8333333333333334,1.0,1.0,3/27,4.89%,DUOX1;ANXA1;VIL1
prerank,GO_Biological_Process_2021__regulation of potassium ion transmembrane transporter activity (GO:1901016),0.3544717105024944,0.7922339885561157,0.7894736842105263,0.9438248179434974,1.0,2/21,5.40%,ANK2;NEDD4L
prerank,GO_Biological_Process_2021__cellular response to hypoxia (GO:0071456),-0.30668313722026364,-0.792194890914552,0.8873239436619719,1.0,1.0,17/106,13.44%,PSMB6;RPS27A;AQP1;PSMA8;PSMB9;PSMA7;ELOB;SLC8A3;PSMC3;UBC;PSME1;MT3;SUV39H1;SFRP1;PLK3;PSMC4;PSMA3
prerank,GO_Biological_Process_2021__ventricular cardiac muscle cell membrane repolarization (GO:0099625),-0.47851698840153856,-0.7919837259914708,0.7959183673469388,1.0,1.0,2/7,15.72%,KCNQ1;KCNJ8
prerank,GO_Biological_Process_2021__positive regulation of cellular amide metabolic process (GO:0034250),0.27794867486896035,0.791837127894926,0.8888888888888888,0.9441477705867479,1.0,6/72,3.84%,SOX4;PICALM;PASK;ZCCHC4;EPHA4;CPEB3
prerank,GO_Biological_Process_2021__negative regulation of blood coagulation (GO:0030195),-0.38837345359349096,-0.7913780145328754,0.7377049180327869,1.0,1.0,8/19,18.96%,F8;A2M;CPB2;APOE;C1QTNF1;PLAT;F10;F11
prerank,GO_Biological_Process_2021__negative regulation of protein catabolic process (GO:0042177),0.35041602545600914,0.7911608232736566,0.8214285714285714,0.9447127429781128,1.0,9/33,20.35%,SNCA;EGFR;AGAP2;SIRT2;MDM4;SF3B3;ROCK1;ADGRB1;FMN2
prerank,GO_Biological_Process_2021__positive regulation of bone mineralization (GO:0030501),0.3527690532049169,0.7911299525186526,0.7714285714285715,0.9444054879725197,1.0,8/27,16.20%,BMP2;PKDCC;BMPR1B;GPM6B;ACVR1;ACVR2A;BMPR1A;BMP7
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transmembrane transport (GO:1904427),0.39170781993626236,0.7911261355310568,0.868421052631579,0.9440560963750455,1.0,3/16,6.27%,SNCA;ANK2;CASQ1
prerank,GO_Biological_Process_2021__negative regulation of neuroinflammatory response (GO:0150079),0.4458444382168172,0.7909998167447975,0.7435897435897436,0.9439610528139569,1.0,4/9,21.25%,NR1D1;CD200R1;IGF1;PTPRC
prerank,MSigDB_Hallmark_2020__Epithelial Mesenchymal Transition,-0.2983111555506447,-0.7906494502448873,0.8674698795180723,1.0,1.0,34/156,18.67%,SPARC;ITGA5;COL5A1;SFRP4;TIMP1;COL6A2;ECM2;THBS1;BDNF;ELN;GLIPR1;EMP3;CCN1;PPIB;MGP;FBLN5;SFRP1;MATN3;ID2;MATN2;ITGA2;DPYSL3;TNC;SNTB1;LAMA1;COL4A2;TNFRSF12A;CALD1;WNT5A;GPX7;PFN2;MMP14;TAGLN;BGN
prerank,GO_Biological_Process_2021__nitric oxide biosynthetic process (GO:0006809),0.40637943433572876,0.7906455887562523,0.6857142857142857,0.9442591680736283,1.0,2/11,6.29%,MTARC2;AKT1
prerank,GO_Biological_Process_2021__axonemal dynein complex assembly (GO:0070286),-0.38700819794981073,-0.7905606426281551,0.8421052631578947,1.0,1.0,5/27,13.80%,CCDC39;DNAAF1;CFAP73;CFAP100;DRC1
prerank,GO_Biological_Process_2021__regulation of programmed cell death (GO:0043067),0.2538618565610622,0.7904940765522198,1.0,0.9441641197141005,1.0,24/135,18.70%,AIFM2;TRIM24;CRADD;ACER3;SOX9;DAPK2;AKT1;CASP10;MAGED1;PRKN;FBXO11;LRP8;TP53BP2;ANP32B;SIRT1;TNFRSF10B;VCP;HIP1;BIRC2;CHM;ALPK2;BCAR1;FAS;TNFRSF25
prerank,GO_Biological_Process_2021__mitophagy (GO:0000423),-0.45524184689943564,-0.7904890521726257,0.7307692307692307,1.0,1.0,2/8,20.07%,ATG14;SQSTM1
prerank,"GO_Biological_Process_2021__DNA-templated transcription, elongation (GO:0006354)",0.28310784075359896,0.7898510146023473,1.0,0.9449453835487512,1.0,14/64,23.56%,EAF2;MLLT3;IWS1;CDK12;NELFA;CDK13;CCNT2;SETD2;PCID2;GTF2F2;CDK9;ELP2;CDC73;TCEA1
prerank,GO_Biological_Process_2021__aspartate family amino acid catabolic process (GO:0009068),0.3741231201200147,0.7894684118261672,0.782608695652174,0.945297172406502,1.0,2/18,12.06%,DDO;ALDH7A1
prerank,GO_Biological_Process_2021__inner ear morphogenesis (GO:0042472),-0.4218449731046279,-0.7894325893884057,0.7777777777777778,1.0,1.0,2/14,6.10%,MYO3A;MYO3B
prerank,GO_Biological_Process_2021__SMAD protein complex assembly (GO:0007183),0.45017943815364375,0.7892315986569001,0.7291666666666666,0.9453588493884135,1.0,4/6,26.16%,SMAD2;SMAD4;SMAD3;SMAD1
prerank,GO_Biological_Process_2021__negative regulation of axon extension (GO:0030517),0.3434478437167553,0.7891694932532912,0.8571428571428571,0.9451186629348477,1.0,7/28,16.40%,SEMA5B;RNF6;SEMA3C;KIAA0319;SEMA6C;SEMA4D;SEMA3D
prerank,GO_Biological_Process_2021__negative regulation of alpha-beta T cell proliferation (GO:0046642),-0.5185617932729423,-0.7891560462834821,0.6923076923076923,1.0,1.0,1/5,16.07%,CD274
prerank,GO_Biological_Process_2021__regulation of ATP metabolic process (GO:1903578),0.32631188006891604,0.7889969524231205,0.7777777777777778,0.945071745890674,1.0,14/52,21.80%,NUP42;NUP37;NUP188;EP300;NUP153;OGT;NDC1;NUP205;HIF1A;NUP214;COX7A2L;AK4;BEND3;RANBP2
prerank,GO_Biological_Process_2021__medium-chain fatty acid metabolic process (GO:0051791),-0.4625698334229704,-0.7889765283142867,0.8307692307692308,1.0,1.0,1/12,3.50%,CYP4Z1
prerank,GO_Biological_Process_2021__negative regulation of cell-cell adhesion (GO:0022408),0.3362831026924224,0.7888126364175976,0.8571428571428571,0.944970576285282,1.0,10/31,19.25%,BMP2;RGCC;AKT1;MBP;PTK2;MAP2K5;EPCAM;ZNF703;WNK1;PPM1F
prerank,GO_Biological_Process_2021__positive regulation of blood coagulation (GO:0030194),0.41197543608290926,0.7887330557922425,0.74,0.9446946204420081,1.0,1/10,2.21%,SERPINE1
prerank,MSigDB_Hallmark_2020__Pancreas Beta Cells,0.3495627073333553,0.7886634904369683,0.7692307692307693,0.9444309228794763,1.0,2/22,2.45%,ABCC8;FOXO1
prerank,GO_Biological_Process_2021__regulation of cellular protein localization (GO:1903827),0.3075187847155668,0.7884071622149976,0.8125,0.9444325302026031,1.0,10/42,19.25%,GPC5;CSNK1E;RALB;DVL1;VCPIP1;ABCA2;VCP;SETD2;KDM1A;PPM1F
prerank,GO_Biological_Process_2021__regulation of telomerase activity (GO:0051972),-0.3667559276799363,-0.7883271495269887,0.8,1.0,1.0,4/40,12.32%,PIF1;PRKCQ;KLF4;PNKP
prerank,GO_Biological_Process_2021__negative regulation of calcium ion transmembrane transport (GO:1903170),0.4379485008496481,0.7883243212177666,0.7608695652173914,0.9442173075054442,1.0,3/7,9.77%,BIN1;SESTD1;CBARP
prerank,GO_Biological_Process_2021__cellular response to organonitrogen compound (GO:0071417),-0.31156489838301926,-0.7881258750204049,0.8611111111111112,1.0,1.0,12/87,13.88%,CFTR;P2RY12;AQP1;KCNQ1;TSHR;IGFBP5;RRAGC;P2RY6;SFRP1;BRCA1;LAMTOR2;XBP1
prerank,GO_Biological_Process_2021__nucleoside diphosphate phosphorylation (GO:0006165),-0.42811672463493755,-0.7879234609807275,0.7,1.0,1.0,2/8,12.59%,CMPK2;AK7
prerank,GO_Biological_Process_2021__regulation of T cell chemotaxis (GO:0010819),0.44813896319903274,0.7874707703733772,0.7058823529411765,0.944870683648445,1.0,3/7,26.51%,OXSR1;WNK1;ADAM10
prerank,GO_Biological_Process_2021__positive regulation of T cell chemotaxis (GO:0010820),0.44813896319903274,0.7874707703733772,0.7058823529411765,0.944870683648445,1.0,3/7,26.51%,OXSR1;WNK1;ADAM10
prerank,GO_Biological_Process_2021__positive regulation of adaptive immune response (GO:0002821),0.48528794849703394,0.7874002728238572,0.8,0.9446314717604627,1.0,2/6,13.01%,EIF2AK4;SIRT1
prerank,GO_Biological_Process_2021__regulation of endothelial cell proliferation (GO:0001936),0.3022222142346502,0.7873009030008994,0.8571428571428571,0.9444164924269918,1.0,11/64,13.12%,VEGFD;BMP2;RGCC;AKT1;NRP2;VEGFC;NF1;PRKD1;NRAS;SIRT1;TGFBR1
prerank,GO_Biological_Process_2021__replication-born double-strand break repair via sister chromatid exchange (GO:1990414),-0.48054908918242745,-0.7872964259602719,0.6875,1.0,1.0,2/5,14.73%,RAD21L1;REC8
prerank,GO_Biological_Process_2021__rDNA heterochromatin assembly (GO:0000183),0.4706384713111026,0.7872489408235024,0.7333333333333333,0.9441535754638544,1.0,4/8,21.74%,MBD2;SIRT1;SIRT2;BEND3
prerank,GO_Biological_Process_2021__nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),0.3492031261134781,0.7871928376507644,0.75,0.9439028711738154,1.0,6/24,10.13%,IRAK2;TAB3;UBE2N;ITCH;MAP3K7;TAB1
prerank,GO_Biological_Process_2021__carnitine metabolic process (GO:0009437),0.4345689955348727,0.7867712263919472,0.8292682926829268,0.9441329542133644,1.0,5/11,16.87%,CPT1C;ACADM;CRAT;BBOX1;CPT1A
prerank,GO_Biological_Process_2021__protein localization to cell-cell junction (GO:0150105),0.4266413567701108,0.7865719644497918,0.7368421052631579,0.9440445855951932,1.0,6/12,29.95%,CGNL1;TJP1;SCRIB;TJP2;JAK1;PAK2
prerank,GO_Biological_Process_2021__translational elongation (GO:0006414),-0.31783920483606043,-0.7864646873776177,0.8133333333333334,1.0,1.0,20/92,22.76%,MRPL20;EEF1B2;MRPL51;MRPL40;MRPL27;MRPS33;GADD45GIP1;MRPL36;GTPBP2;MRPL34;AURKAIP1;MRPL54;MRPS21;MRPS34;MRPS26;MRPS22;MRPL21;OXA1L;EEF1A1;MRPL23
prerank,GO_Biological_Process_2021__positive regulation of protein export from nucleus (GO:0046827),0.4035461455961133,0.7864458944586815,0.8421052631578947,0.9438902473971601,1.0,5/13,26.88%,ANP32B;GSK3B;BAG3;GAS6;TCF7L2
prerank,GO_Biological_Process_2021__homotypic cell-cell adhesion (GO:0034109),-0.3445694071269505,-0.7863556456797068,0.7777777777777778,1.0,1.0,4/36,9.35%,GATA1;P2RY12;PIK3CB;MYL12A
prerank,GO_Biological_Process_2021__nucleotide-sugar biosynthetic process (GO:0009226),-0.4096517357714875,-0.7862099455674011,0.8596491228070176,1.0,1.0,2/19,9.42%,GMPPB;UAP1
prerank,GO_Biological_Process_2021__negative regulation of androgen receptor signaling pathway (GO:0060766),0.41603326347583786,0.7860863807737997,0.782608695652174,0.9440480707159369,1.0,2/11,13.01%,FOXP1;SIRT1
prerank,GO_Biological_Process_2021__glycosphingolipid catabolic process (GO:0046479),0.3966333984500767,0.785604392429,0.6444444444444445,0.9444697223159021,1.0,2/8,16.63%,HEXB;NEU3
prerank,PanglaoDB_Augmented_2021__Trophoblast Stem Cells,-0.3428059312160348,-0.7855978454714588,0.875,1.0,1.0,11/45,20.08%,OVOL2;ABCA12;TRIM29;MSX2;SH2D4A;TUFT1;CCND1;EMP2;TOM1L1;AMOTL2;PTPRF
prerank,GO_Biological_Process_2021__positive regulation of protein deacetylation (GO:0090312),-0.43966097847620766,-0.7853639458471267,0.7551020408163265,1.0,1.0,1/12,3.87%,APLNR
prerank,GO_Biological_Process_2021__regulation of endoplasmic reticulum unfolded protein response (GO:1900101),-0.4569869576333913,-0.7853531394561388,0.7636363636363637,1.0,1.0,3/9,16.94%,FICD;XBP1;COPS5
prerank,GO_Biological_Process_2021__lipoprotein localization (GO:0044872),0.43546616139378447,0.7847869800947711,0.7857142857142857,0.9453288114044388,1.0,5/9,36.27%,PRKCB;VMP1;ZDHHC17;UNC119B;PPARG
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),-0.31280486785627926,-0.7846978146442845,0.875,1.0,1.0,11/65,13.44%,PSMB6;RPS27A;PSMA8;PSMB9;PSMA7;ELOB;PSMC3;UBC;PSME1;PSMC4;PSMA3
prerank,GO_Biological_Process_2021__somatic hypermutation of immunoglobulin genes (GO:0016446),0.47858000408543033,0.7846701445068912,0.7547169811320755,0.9451142855243782,1.0,1/7,1.79%,SAMHD1
prerank,GO_Biological_Process_2021__sister chromatid segregation (GO:0000819),0.3447757758657414,0.7846050036332218,0.8055555555555556,0.9448759482623638,1.0,6/23,16.25%,ZNF207;NSL1;TUBG1;LATS1;CHAMP1;ESPL1
prerank,GO_Biological_Process_2021__carbohydrate biosynthetic process (GO:0016051),0.390525716971707,0.784604318616519,0.7619047619047619,0.9445299665896203,1.0,2/15,2.74%,ST6GALNAC5;FUT9
prerank,GO_Biological_Process_2021__positive regulation of vasculature development (GO:1904018),-0.3176906055487914,-0.784593488760681,0.8441558441558441,1.0,1.0,16/72,15.19%,SFRP2;APLNR;AQP1;SEMA5A;THBS1;ANGPTL3;HYAL1;NODAL;CTSH;RRAS;FGF1;BRCA1;XBP1;HK2;BTG1;AGGF1
prerank,GO_Biological_Process_2021__fatty-acyl-CoA metabolic process (GO:0035337),-0.41616648929904293,-0.7844341441220077,0.8115942028985508,1.0,1.0,4/17,17.56%,HSD17B8;FAR2;SLC25A1;FASN
prerank,GO_Biological_Process_2021__regulation of antifungal innate immune response (GO:1905034),-0.5083449942810193,-0.7844282623785132,0.7636363636363637,1.0,1.0,1/5,12.68%,SPI1
prerank,GO_Biological_Process_2021__negative regulation of protein binding (GO:0032091),-0.33473617457378607,-0.7843006989722326,0.821917808219178,1.0,1.0,9/57,14.38%,IFIT1;B2M;IFIT2;DDX11;TMC8;LRPAP1;EFHB;ZFPM1;GTF2F1
prerank,"GO_Biological_Process_2021__neurotransmitter receptor transport, endosome to postsynaptic membrane (GO:0098887)",-0.49521064119104785,-0.784218450390597,0.7454545454545455,1.0,1.0,1/6,5.81%,RAB11A
prerank,GO_Biological_Process_2021__hydrogen sulfide metabolic process (GO:0070813),0.5107891425239909,0.7840310929502944,0.7804878048780488,0.9450285108509081,1.0,3/5,41.67%,SQOR;CBS;ETHE1
prerank,GO_Biological_Process_2021__negative regulation of T cell mediated immunity (GO:0002710),-0.4987137538875742,-0.783967106319275,0.7857142857142857,1.0,1.0,2/7,8.78%,CEACAM1;KLRD1
prerank,"GO_Biological_Process_2021__RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",0.39628172127800093,0.7839218987327892,0.8,0.9448443366209359,1.0,1/12,2.71%,RPP40
prerank,GO_Biological_Process_2021__negative regulation of toll-like receptor signaling pathway (GO:0034122),-0.3962440005169496,-0.783330004601837,0.7377049180327869,1.0,1.0,4/22,12.42%,RAB7B;LY96;TLR3;CD14
prerank,GO_Biological_Process_2021__positive regulation of keratinocyte migration (GO:0051549),-0.43647906410455345,-0.7832336449540276,0.7377049180327869,1.0,1.0,1/8,6.05%,FGF7
prerank,GO_Biological_Process_2021__myoblast migration (GO:0051451),-0.48398126766494454,-0.782834370520487,0.7246376811594203,1.0,1.0,1/7,4.63%,ANXA1
prerank,GO_Biological_Process_2021__positive regulation of phospholipase C activity (GO:0010863),0.3384654318197713,0.7823349145925234,0.8484848484848485,0.9467604596743744,1.0,6/25,8.71%,EGFR;FLT1;PDGFRA;NTRK2;ABL2;ADRA1A
prerank,GO_Biological_Process_2021__regulation of extracellular matrix disassembly (GO:0010715),-0.4404508420405494,-0.7820369808500948,0.7692307692307693,1.0,1.0,3/12,14.53%,PDPN;CST3;FSCN1
prerank,"GO_Biological_Process_2021__maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",-0.4124435510962132,-0.781919700321777,0.8088235294117647,1.0,1.0,3/19,13.62%,RPS21;ERI2;WDR12
prerank,GO_Biological_Process_2021__regulation of fibroblast migration (GO:0010762),0.36543547309231167,0.7818941494507242,0.75,0.9471200743774496,1.0,7/20,23.49%,MACIR;PRKCE;PTK2;ARHGEF7;FGF2;DDR2;GNA12
prerank,PanglaoDB_Augmented_2021__Myeloid-derived Suppressor Cells,-0.3866528528624759,-0.7816467311800906,0.75,1.0,1.0,7/23,13.63%,TAGAP;CLEC12A;IGSF6;DPEP2;ARHGAP30;SPI1;MYO1F
prerank,GO_Biological_Process_2021__axonal fasciculation (GO:0007413),0.40723704706235697,0.781590381746738,0.8055555555555556,0.9471864554348878,1.0,2/12,5.05%,EPHA4;ARHGAP35
prerank,GO_Biological_Process_2021__integrin activation (GO:0033622),0.445050982173061,0.7814064326250523,0.7441860465116279,0.9470973909054321,1.0,1/7,4.88%,CXCL12
prerank,GO_Biological_Process_2021__negative regulation of actin filament polymerization (GO:0030837),-0.370819466188666,-0.7812681868036704,0.7719298245614035,1.0,1.0,6/21,18.04%,VIL1;PFN4;KANK3;PFN1;TMSB10;PFN2
prerank,GO_Biological_Process_2021__ameboidal-type cell migration (GO:0001667),0.31231060517035214,0.7810852946617107,0.8333333333333334,0.9473250467114805,1.0,6/41,7.08%,SEMA5B;AMOTL1;SOX8;ERBB4;AKT1;AMOT
prerank,GO_Biological_Process_2021__positive regulation of T-helper cell differentiation (GO:0045624),0.4273976711669833,0.7810754618235917,0.75,0.9470030712013611,1.0,1/8,1.31%,TNFSF4
prerank,GO_Biological_Process_2021__positive regulation of vasoconstriction (GO:0045907),-0.49531112576014064,-0.7807451381493274,0.7619047619047619,1.0,1.0,1/7,3.73%,SMTNL1
prerank,GO_Biological_Process_2021__mitochondrial translation (GO:0032543),-0.31860521948791437,-0.7805764158386559,0.868421052631579,1.0,1.0,18/93,21.59%,MRPL20;MTRF1L;MRPL51;MRPL40;MTIF3;MRPL27;MRPS33;GADD45GIP1;MRPL36;MRPL34;AURKAIP1;MRPL54;MRPS21;MRPS34;MRPS26;MRPS22;MRPL21;OXA1L
prerank,GO_Biological_Process_2021__positive regulation of MAP kinase activity (GO:0043406),-0.3446570067502796,-0.7803639620994213,0.8611111111111112,1.0,1.0,3/48,5.26%,CD24;HTR2B;RASGRP1
prerank,GO_Biological_Process_2021__female gamete generation (GO:0007292),-0.3929191694660424,-0.78034865646263,0.7741935483870968,1.0,1.0,6/20,22.75%,IHO1;MEI4;FSHR;GDF9;HROB;M1AP
prerank,GO_Biological_Process_2021__organonitrogen compound catabolic process (GO:1901565),-0.35151693402900763,-0.7798999865786358,0.8032786885245902,1.0,1.0,5/46,7.19%,ENPP2;PDXDC1;ERAP2;ERAP1;CYP2D6
prerank,GO_Biological_Process_2021__positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),-0.3589996424680057,-0.7796938042169144,0.8235294117647058,1.0,1.0,7/31,23.06%,RPS7;DDIT3;FIS1;NUPR1;BCAP31;UBB;GSDME
prerank,GO_Biological_Process_2021__fatty acid beta-oxidation (GO:0006635),0.28431507759676655,0.7796651356265952,0.875,0.9487351025005626,1.0,10/48,15.81%,HADH;ECHDC1;BDH2;AUH;PEX2;HSD17B4;ACADVL;ABCD3;ACADM;CRAT
prerank,GO_Biological_Process_2021__malate metabolic process (GO:0006108),0.44746345125306275,0.7795283756954343,0.7555555555555555,0.9486456029514251,1.0,1/7,9.29%,ME2
prerank,"GO_Biological_Process_2021__G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",-0.37044560262004983,-0.7792494666073972,0.75,1.0,1.0,7/27,14.31%,ANXA1;HTR2B;CHRM2;TSHR;CHRM5;CALCRL;CCL2
prerank,GO_Biological_Process_2021__regulation of rRNA processing (GO:2000232),-0.4084775800503433,-0.7791241987220583,0.7413793103448276,1.0,1.0,2/16,8.13%,BUD23;TRMT112
prerank,GO_Biological_Process_2021__positive regulation of inositol phosphate biosynthetic process (GO:0060732),0.4697945518972866,0.7784621083481557,0.8367346938775511,0.949886567092901,1.0,1/5,2.09%,SNCA
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell action potential (GO:0098901),0.36765758229833,0.7782794181246799,0.7647058823529411,0.9498265317034879,1.0,4/19,14.81%,ANK2;TRPM4;CAMK2D;DLG1
prerank,GO_Biological_Process_2021__negative regulation of activin receptor signaling pathway (GO:0032926),-0.46706753695035563,-0.7782697961215466,0.7666666666666667,1.0,1.0,1/7,4.58%,IGSF1
prerank,GO_Biological_Process_2021__chemical homeostasis (GO:0048878),-0.31908599815627736,-0.778209789418475,0.8333333333333334,1.0,1.0,8/52,15.92%,TLCD1;PNPLA3;ANGPTL3;RBP1;AQP11;TLCD2;SLC4A2;SLC4A11
prerank,GO_Biological_Process_2021__wound healing (GO:0042060),0.2913818179945684,0.7781733637193287,0.96,0.9496413472314156,1.0,17/46,26.01%,WNT7A;PDGFRA;PDGFA;PRCP;NF1;CFLAR;TGFBR1;SYTL4;IGF1;NRG1;FZD7;FGF2;PPP3CA;MACF1;SMAD3;RAF1;EPB41L4B
prerank,GO_Biological_Process_2021__regulation of actin nucleation (GO:0051125),0.41041187283031855,0.7779214093831123,0.7105263157894737,0.9498079018140744,1.0,1/9,1.83%,ARFIP1
prerank,GO_Biological_Process_2021__serine family amino acid metabolic process (GO:0009069),-0.4088116834970954,-0.7777855046376468,0.7692307692307693,1.0,1.0,1/15,5.93%,GLYAT
prerank,GO_Biological_Process_2021__peptide catabolic process (GO:0043171),0.37136359787367473,0.7774612885836161,0.775,0.9500815650824795,1.0,1/18,0.39%,LVRN
prerank,GO_Biological_Process_2021__histone H4-K12 acetylation (GO:0043983),0.4605244603905199,0.7772248151539718,0.7333333333333333,0.9500572764460004,1.0,1/6,13.97%,KAT7
prerank,GO_Biological_Process_2021__I-kappaB kinase/NF-kappaB signaling (GO:0007249),0.2916612075771492,0.7770013793939514,0.92,0.9499972881699768,1.0,8/52,10.25%,IRAK2;TAB3;TBKBP1;AKT1;TICAM1;MAP3K7;TAB1;TRADD
prerank,GO_Biological_Process_2021__regulation of early endosome to late endosome transport (GO:2000641),0.3580223354836225,0.7765967283154634,0.7575757575757576,0.9502348795711928,1.0,6/17,19.73%,DNAJC13;RAB21;MAPK1;MTMR2;MAP2K2;PTPN23
prerank,GO_Biological_Process_2021__heterochromatin assembly (GO:0031507),0.3640782495808954,0.7764413211174069,0.868421052631579,0.9500618477613795,1.0,5/20,13.72%,BAHD1;MBD2;HELLS;SIRT1;SIRT2
prerank,GO_Biological_Process_2021__necroptotic process (GO:0070266),-0.43967560302844794,-0.7764154798729653,0.8035714285714286,1.0,1.0,3/12,12.42%,LY96;TLR3;CD14
prerank,GO_Biological_Process_2021__bicarbonate transport (GO:0015701),0.3267935307901574,0.7761591810895955,0.7837837837837838,0.9501803150750397,1.0,7/22,14.81%,SLC26A7;CA2;CA5B;SLC4A7;SLC4A4;SLC4A10;CA12
prerank,GO_Biological_Process_2021__negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),0.28359692774771283,0.7760364521388352,0.9333333333333333,0.9499717634401443,1.0,19/56,24.90%,SPRED2;SMAD2;SMAD7;SPRED1;PPM1A;ZNF451;SMURF1;TGFBR2;SIRT1;TGFBR1;LEMD3;SNX25;SPRED3;HSPA1A;PMEPA1;SKIL;WFIKKN1;SMAD3;SLC2A10
prerank,GO_Biological_Process_2021__glycerol metabolic process (GO:0006071),-0.45745188093049416,-0.7757377061851485,0.7741935483870968,1.0,1.0,2/9,9.32%,ANGPTL3;PGP
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway (GO:2001242),0.32512495060783775,0.7751572568251908,0.8666666666666667,0.9508982995451246,1.0,3/38,5.15%,SGMS1;DAPK2;BOK
prerank,GO_Biological_Process_2021__regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),-0.4060279554203594,-0.7751334465025731,0.8035714285714286,1.0,1.0,5/14,17.47%,SIGIRR;LY96;CX3CL1;SCIMP;TRIM5
prerank,GO_Biological_Process_2021__negative regulation of GTPase activity (GO:0034260),0.3654197652101778,0.7749114095593561,0.8125,0.9508678361645894,1.0,2/16,3.93%,RCC2;LRCH1
prerank,GO_Biological_Process_2021__regulation of calcium ion transmembrane transporter activity (GO:1901019),-0.3813064042090516,-0.774718304171331,0.8356164383561644,1.0,1.0,5/21,13.85%,JPH3;PLN;CAV3;CACNB1;NOS1
prerank,GO_Biological_Process_2021__cellular potassium ion homeostasis (GO:0030007),0.41668171065441817,0.7746655830628935,0.7777777777777778,0.9508967725074648,1.0,2/10,7.05%,SLC12A2;KCNMA1
prerank,GO_Biological_Process_2021__cell-cell adhesion mediated by cadherin (GO:0044331),0.43782124799437827,0.7746195334920999,0.7906976744186046,0.9506526499590592,1.0,3/7,13.58%,CDH2;AFDN;FER
prerank,GO_Biological_Process_2021__positive regulation of transcription by RNA polymerase I (GO:0045943),-0.356054351637873,-0.774528536482527,0.7536231884057971,1.0,1.0,1/21,5.54%,DDX11
prerank,GO_Biological_Process_2021__protein localization to microtubule organizing center (GO:1905508),0.3825852642019519,0.7743928705674332,0.7555555555555555,0.9507528448028426,1.0,6/15,26.88%,NEDD1;C2CD3;PCM1;STIL;CSNK1D;HOOK3
prerank,GO_Biological_Process_2021__response to hydrogen peroxide (GO:0042542),-0.340780198729704,-0.7739949393858936,0.8026315789473685,1.0,1.0,2/40,4.63%,AQP1;ANXA1
prerank,GO_Biological_Process_2021__programmed necrotic cell death (GO:0097300),-0.4318965677377837,-0.7739588825596853,0.7666666666666667,1.0,1.0,3/14,12.42%,LY96;TLR3;CD14
prerank,GO_Biological_Process_2021__peptidyl-lysine monomethylation (GO:0018026),-0.4278671635322875,-0.7737307488344831,0.72,1.0,1.0,2/11,14.40%,EEF1AKMT2;CSKMT
prerank,GO_Biological_Process_2021__monoacylglycerol metabolic process (GO:0046462),-0.4639928514211712,-0.7737160326917444,0.7454545454545455,1.0,1.0,1/8,2.67%,DGAT2L6
prerank,GO_Biological_Process_2021__regulation of lamellipodium organization (GO:1902743),-0.41853356755536014,-0.7737005052802697,0.71875,1.0,1.0,2/13,6.08%,VIL1;PDPN
prerank,GO_Biological_Process_2021__regulation of histone H4-K16 acetylation (GO:2000618),0.48204790191349833,0.7735000491770824,0.8,0.95180197532106,1.0,2/5,13.01%,AUTS2;SIRT1
prerank,GO_Biological_Process_2021__G protein-coupled serotonin receptor signaling pathway (GO:0098664),-0.4641975021725049,-0.773173734960563,0.7758620689655172,1.0,1.0,1/6,4.80%,HTR2B
prerank,GO_Biological_Process_2021__negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),-0.41762883087455527,-0.7731095159436745,0.7575757575757576,1.0,1.0,1/12,2.96%,PARP14
prerank,GO_Biological_Process_2021__regulation of endothelial cell migration (GO:0010594),0.28155546329104025,0.7729794646980057,0.8888888888888888,0.9522040677263709,1.0,11/64,12.05%,DCN;SASH1;FOXP1;EPHA2;AKT1;NRP2;PRCP;NF1;PRKD1;PTK2;SLIT2
prerank,GO_Biological_Process_2021__7-methylguanosine RNA capping (GO:0009452),-0.3670293269189223,-0.772498791757313,0.7014925373134329,1.0,1.0,8/30,21.52%,POLR2I;GTF2F1;POLR2L;POLR2J;NCBP2;POLR2G;POLR2K;CDK7
prerank,GO_Biological_Process_2021__7-methylguanosine mRNA capping (GO:0006370),-0.3670293269189223,-0.772498791757313,0.7014925373134329,1.0,1.0,8/30,21.52%,POLR2I;GTF2F1;POLR2L;POLR2J;NCBP2;POLR2G;POLR2K;CDK7
prerank,GO_Biological_Process_2021__positive regulation of biomineral tissue development (GO:0070169),0.339566740033703,0.7722817583215766,0.8,0.9528962919578579,1.0,8/30,16.20%,BMP2;PKDCC;BMPR1B;GPM6B;ACVR1;ACVR2A;BMPR1A;BMP7
prerank,GO_Biological_Process_2021__postsynaptic density protein 95 clustering (GO:0097119),0.46955800129211456,0.7721536489810703,0.7674418604651163,0.952711135872519,1.0,4/5,25.94%,NRXN1;NRXN2;NLGN1;NLGN2
prerank,GO_Biological_Process_2021__apoptotic process (GO:0006915),-0.29386550467005634,-0.7721403231449926,0.8809523809523809,1.0,1.0,22/175,15.44%,IFI6;IRF1;IER3;BCL2L14;DHCR24;MX1;IFI27L2;IFIT2;CASP8;NLRP1;ZNF385A;RRAGC;NUDT2;PLK3;CD14;ERBB3;IFI27L1;HK2;TCHP;TNFRSF10A;CDK5;DDX41
prerank,GO_Biological_Process_2021__regulation of protein binding (GO:0043393),-0.31192721352585817,-0.7715278259393079,0.8395061728395061,1.0,1.0,14/96,14.38%,IFIT1;RPL11;B2M;IFIT2;DDX11;TRIM21;TMC8;SNAPIN;LRPAP1;EFHB;DTX3L;ZFPM1;RIPK2;GTF2F1
prerank,GO_Biological_Process_2021__protein localization to membrane (GO:0072657),0.26371380513422005,0.7713509491598708,0.8333333333333334,0.9535033613757264,1.0,63/168,27.09%,ANK2;ARL5A;EPHA2;TSPAN14;PACS1;TSPAN17;DENND4C;TNIK;EHD4;RAPGEF2;RAB8B;NRXN1;DLG3;EFR3A;MRAP;BRAF;ABHD17A;DVL1;SMURF1;SHANK3;TTC7B;BSG;MAGI2;NDC1;TSPAN33;RAP1A;TM9SF3;DLG1;SH3PXD2B;TM9SF4;SCRIB;ROCK2;LIN7C;CACNB3;RAP2A;MYO5A;WNK3;NRXN2;LIN7A;FRMPD1;ROCK1;RAB10;TSPAN5;SLMAP;ZDHHC2;TTC7A;NLGN1;P2RY1;RAMP1;NUP54;SH3GLB1;RAB12;GAS6;CPE;RAPGEF6;ARL3;CLASP2;DPP6;NLGN2;PICK1;PACS2;SPTBN1;PPIL2
prerank,GO_Biological_Process_2021__5S class rRNA transcription by RNA polymerase III (GO:0042791),-0.49310537800170584,-0.7712141788381419,0.7962962962962963,1.0,1.0,1/6,9.10%,GTF3C6
prerank,GO_Biological_Process_2021__skeletal muscle tissue development (GO:0007519),-0.37829946899196665,-0.7709702830562135,0.746031746031746,1.0,1.0,3/17,14.01%,SVIL;CAV2;MYL6B
prerank,GO_Biological_Process_2021__negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),0.32570865244131286,0.7707088044705892,0.8285714285714286,0.9540759523865054,1.0,7/18,26.73%,MEN1;LATS1;PTEN;IPO5;PLK1;IPO7;CDKN1B
prerank,GO_Biological_Process_2021__negative regulation of actin filament depolymerization (GO:0030835),-0.495384766686978,-0.7706700020014456,0.8490566037735849,1.0,1.0,3/5,21.60%,VIL1;LIMA1;PLEKHH2
prerank,GO_Biological_Process_2021__polyamine biosynthetic process (GO:0006596),0.4184151116800543,0.7706155751437462,0.75,0.953860978338869,1.0,2/6,12.79%,SMOX;SMS
prerank,GO_Biological_Process_2021__microtubule nucleation (GO:0007020),0.37160272415812745,0.7703859876877661,0.7692307692307693,0.9538118157992094,1.0,9/19,33.09%,CLASP1;TUBG1;SLAIN2;CSNK1D;CLASP2;TUBGCP3;TPPP;RANBP9;TUBGCP6
prerank,GO_Biological_Process_2021__negative regulation of axon extension involved in axon guidance (GO:0048843),0.34993582989672756,0.770121229877464,0.8108108108108109,0.9538514010151296,1.0,5/18,16.40%,SEMA5B;SEMA3C;SEMA6C;SEMA4D;SEMA3D
prerank,GO_Biological_Process_2021__metanephros development (GO:0001656),0.4087257181058406,0.7700833837533434,0.717391304347826,0.9535717090893414,1.0,4/12,16.20%,PKD2;NF1;NIPBL;BMP7
prerank,GO_Biological_Process_2021__molybdopterin cofactor biosynthetic process (GO:0032324),0.4882037347316602,0.7696790451819842,0.7380952380952381,0.9538654770272965,1.0,1/6,6.33%,GPHN
prerank,GO_Biological_Process_2021__regulation of melanin biosynthetic process (GO:0048021),-0.45353850437531557,-0.7694346666605463,0.8253968253968254,1.0,1.0,1/9,2.51%,ASIP
prerank,GO_Biological_Process_2021__negative regulation of protein processing (GO:0010955),0.3947730678650464,0.7690478449387671,0.7547169811320755,0.9543244494923678,1.0,1/11,2.21%,SERPINE1
prerank,GO_Biological_Process_2021__regulation of NIK/NF-kappaB signaling (GO:1901222),0.29413724508916755,0.7689167539331843,1.0,0.9541925298789949,1.0,12/53,18.48%,SASH1;EGFR;NFAT5;PPM1A;TRADD;EP300;ADIPOR1;DLG1;BMP7;TRIM44;NR3C2;CPNE1
prerank,GO_Biological_Process_2021__cellular response to glucocorticoid stimulus (GO:0071385),-0.4313296550598543,-0.7689026159099658,0.8636363636363636,1.0,1.0,2/13,4.63%,AQP1;ANXA1
prerank,"GO_Biological_Process_2021__positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",0.3780000018281521,0.768800395025242,0.8205128205128205,0.9540784159071225,1.0,2/11,7.82%,SPRED2;SPRED1
prerank,GO_Biological_Process_2021__atrioventricular valve development (GO:0003171),0.41254465500288184,0.7687843460105704,0.7857142857142857,0.9537578371584167,1.0,5/13,14.40%,BMP2;TGFBR2;ACVR1;BMPR1A;MDM4
prerank,GO_Biological_Process_2021__positive regulation of carbohydrate metabolic process (GO:0045913),-0.38405070483899795,-0.7686410160672742,0.8095238095238095,1.0,1.0,1/21,1.20%,GAPDHS
prerank,GO_Biological_Process_2021__positive regulation of cell cycle G1/S phase transition (GO:1902808),0.3357779635410651,0.768355221823654,0.8421052631578947,0.9540156129743016,1.0,7/29,14.11%,EGFR;RGCC;AKT1;PLCB1;ANKRD17;UBE2E2;RPTOR
prerank,PanglaoDB_Augmented_2021__Trichocytes,-0.35287715645956347,-0.7681460199121428,0.8548387096774194,1.0,1.0,7/30,16.33%,ABCA12;GPR87;TRIM29;B3GNT3;EPS8L2;S100A16;TUFT1
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced neuron death (GO:1903203),0.45401566772000435,0.768053366861233,0.8043478260869565,0.954131672748875,1.0,2/5,22.48%,REST;LANCL1
prerank,GO_Biological_Process_2021__positive regulation of receptor signaling pathway via STAT (GO:1904894),-0.41787092945440113,-0.7679003906882816,0.7924528301886793,1.0,1.0,3/13,15.01%,HES1;CRLF3;CRLF2
prerank,GO_Biological_Process_2021__positive regulation of protein deubiquitination (GO:1903003),0.4606700972329284,0.7672314583967086,0.8297872340425532,0.9551024189715107,1.0,3/6,22.69%,VCP;WDR48;TANK
prerank,GO_Biological_Process_2021__response to vitamin (GO:0033273),0.4796290807437458,0.766616695039145,0.813953488372093,0.9555597885009915,1.0,1/5,12.26%,KYNU
prerank,GO_Biological_Process_2021__membrane repolarization during ventricular cardiac muscle cell action potential (GO:0098915),-0.4855593428717476,-0.7665866876902401,0.76,1.0,1.0,2/5,15.72%,KCNQ1;KCNJ8
prerank,GO_Biological_Process_2021__regulation of receptor signaling pathway via JAK-STAT (GO:0046425),0.3485870223097245,0.7665482257090227,0.8048780487804879,0.9552922699976085,1.0,3/25,8.41%,ERBB4;VHL;NLK
prerank,GO_Biological_Process_2021__aorta development (GO:0035904),-0.42433117444963375,-0.7664270255135781,0.7543859649122807,1.0,1.0,1/12,3.87%,APLNR
prerank,GO_Biological_Process_2021__photoperiodism (GO:0009648),-0.3723598919354758,-0.7663914301939218,0.7692307692307693,1.0,1.0,4/25,13.30%,PDE6B;FBXL22;ID2;RBM4B
prerank,GO_Biological_Process_2021__mitochondrial translational elongation (GO:0070125),-0.31668629509528523,-0.766385629255524,0.8918918918918919,1.0,1.0,17/78,22.76%,MRPL20;MRPL51;MRPL40;MRPL27;MRPS33;GADD45GIP1;MRPL36;MRPL34;AURKAIP1;MRPL54;MRPS21;MRPS34;MRPS26;MRPS22;MRPL21;OXA1L;MRPL23
prerank,GO_Biological_Process_2021__positive regulation of autophagy of mitochondrion (GO:1903599),-0.43698154355961016,-0.7663314364346344,0.7796610169491526,1.0,1.0,3/9,21.34%,SLC25A4;SLC25A5;PARK7
prerank,GO_Biological_Process_2021__positive regulation of cell population proliferation (GO:0008284),-0.27999347323523105,-0.7661953504483731,0.9787234042553191,1.0,1.0,38/311,13.39%,PRAME;RPL23;SFRP2;RPS4X;SOX15;COPS9;IL7;BST2;KIF20B;STAT1;RPS6;AQP1;HTR2B;TIMP1;THBS1;RPS9;S100A6;FGF7;TSHR;HES1;CCN1;HYAL1;FOXM1;NODAL;CTSH;SLC25A33;FGF1;NOX1;SFRP1;LAMB1;FZD9;IL18;CX3CL1;ID2;SPDYA;TMEM250;ERBB3;AQP11
prerank,GO_Biological_Process_2021__phosphatidylcholine metabolic process (GO:0046470),0.2924250353046461,0.7661095473854318,0.9310344827586207,0.9554783663011099,1.0,4/52,8.43%,LPIN3;CSNK2A1;PLBD1;SLC44A5
prerank,GO_Biological_Process_2021__organic anion transport (GO:0015711),0.28914805375400215,0.7659732440898541,0.8888888888888888,0.955328799248493,1.0,12/61,14.81%,SLC26A7;SLC19A1;SLC25A41;CA2;ABCC5;CA5B;SLC25A24;SLC2A8;SLC4A7;SLC4A4;SLC4A10;CA12
prerank,GO_Biological_Process_2021__positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process (GO:1902961),0.4659307321832193,0.7659459978490721,0.8095238095238095,0.9550322307052341,1.0,2/6,3.59%,PICALM;EPHA4
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor 9 signaling pathway (GO:0034165),-0.48153345775852574,-0.7657711916074361,0.7358490566037735,1.0,1.0,2/5,17.40%,RSAD2;PTPN22
prerank,GO_Biological_Process_2021__regulation of response to external stimulus (GO:0032101),-0.308393934031294,-0.7655683622010827,0.9066666666666666,1.0,1.0,13/81,12.24%,IL1R1;IRF1;USP18;P2RY12;PDE6B;ANXA1;LRRC19;ERAP1;CASP8;NLRP1;AKNA;HERC5;CX3CL1
prerank,GO_Biological_Process_2021__regulation of myeloid leukocyte mediated immunity (GO:0002886),-0.4397535995055453,-0.76542697055772,0.6833333333333333,1.0,1.0,1/7,10.87%,FES
prerank,GO_Biological_Process_2021__tumor necrosis factor-mediated signaling pathway (GO:0033209),-0.29238621946249593,-0.7653701357489472,0.8933333333333333,1.0,1.0,12/89,14.21%,PSMB6;STAT1;PSMA8;PSMB9;PSMA7;PSMC3;PSME1;LTBR;TXNDC17;PSMC4;PSMA3;AIM2
prerank,GO_Biological_Process_2021__positive regulation of intracellular transport (GO:0032388),-0.3659699073885452,-0.7650582214090623,0.8484848484848485,1.0,1.0,2/33,3.11%,KIF20B;ABCA12
prerank,GO_Biological_Process_2021__regulation of striated muscle contraction (GO:0006942),0.3532574930460691,0.7647186704866394,0.8571428571428571,0.9563240823491234,1.0,3/18,9.01%,ANK2;SMAD7;ASB3
prerank,GO_Biological_Process_2021__response to lipid (GO:0033993),0.28528844150737603,0.76445064831322,0.88,0.9563860573905252,1.0,12/74,14.77%,FOXP1;SNCA;FOXO1;ASCL1;SOX9;FOXO3;RPS6KA3;STRN3;MAPKAPK2;ABCA2;FER;TRIM16
prerank,GO_Biological_Process_2021__regulation of nitric oxide biosynthetic process (GO:0045428),-0.3810903094578578,-0.764415329552517,0.8194444444444444,1.0,1.0,3/24,11.22%,KLF2;KLF4;CLU
prerank,GO_Biological_Process_2021__response to glucocorticoid (GO:0051384),0.37886027382748566,0.7643164357251783,0.8484848484848485,0.956189354990489,1.0,6/16,20.37%,HNRNPU;FAM107A;NR3C1;SLIT2;REST;ADAM9
prerank,GO_Biological_Process_2021__negative regulation of defense response (GO:0031348),0.28244215983893434,0.7642166642329992,0.9,0.9559516625354726,1.0,9/58,13.72%,MACIR;RORA;MAPKBP1;ITCH;RNF26;NR1D1;LRFN5;TNFAIP6;SIRT2
prerank,GO_Biological_Process_2021__B cell activation involved in immune response (GO:0002312),0.4558790016716633,0.7641655508200259,0.8,0.9556612765812812,1.0,2/7,3.32%,LIG4;EXOSC6
prerank,GO_Biological_Process_2021__glutathione biosynthetic process (GO:0006750),0.4003512069697868,0.7637126603347774,0.8095238095238095,0.9560052417158398,1.0,2/9,12.62%,GCLC;GGCT
prerank,GO_Biological_Process_2021__lipoprotein biosynthetic process (GO:0042158),0.40899863789983404,0.7634243525516066,0.8461538461538461,0.9560730895582997,1.0,2/10,9.59%,ATG7;PIK3C3
prerank,GO_Biological_Process_2021__regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),-0.4080624747508655,-0.7630622221907806,0.7586206896551724,1.0,1.0,1/14,5.54%,DDX11
prerank,GO_Biological_Process_2021__negative regulation of macromolecule metabolic process (GO:0010605),-0.28660717363950267,-0.7630542648602958,0.9534883720930233,1.0,1.0,7/143,5.32%,POU4F1;SFRP2;PTRH2;OVOL2;PARP14;APLNR;PGR
prerank,GO_Biological_Process_2021__regulation of exit from mitosis (GO:0007096),-0.35612213660813696,-0.7625010679664185,0.7868852459016393,1.0,1.0,5/31,11.59%,RPS27A;ANAPC15;ANAPC11;UBC;CDC26
prerank,GO_Biological_Process_2021__regulation of leukocyte degranulation (GO:0043300),-0.46249193213662154,-0.7624492566895917,0.7142857142857143,1.0,1.0,1/6,10.87%,FES
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),0.3330561489181505,0.7622193508096402,0.9117647058823529,0.9574141316468635,1.0,6/26,18.23%,SERPINE1;TRADD;CFLAR;TNFRSF10B;GSK3B;FAS
prerank,GO_Biological_Process_2021__regulation of defense response (GO:0031347),-0.32643674878978146,-0.7622125377739368,0.8857142857142857,1.0,1.0,11/54,11.67%,IL1R1;IRF1;USP18;ANXA1;LRRC19;ERAP1;CASP8;NLRP1;AKNA;HERC5;APOE
prerank,GO_Biological_Process_2021__transcription initiation from RNA polymerase III promoter (GO:0006384),0.48553731157333624,0.762209598262679,0.8222222222222222,0.9570884455449358,1.0,4/5,49.88%,BDP1;CRCP;GTF3C1;BRF1
prerank,GO_Biological_Process_2021__monocyte activation (GO:0042117),0.43332233286527105,0.7619017957615302,0.78,0.957243781279689,1.0,1/8,2.08%,FOXP1
prerank,GO_Biological_Process_2021__epidermal cell differentiation (GO:0009913),-0.36872088049290014,-0.7617793821456801,0.8382352941176471,1.0,1.0,4/31,4.63%,OVOL2;OVOL3;FLG;ANXA1
prerank,GO_Biological_Process_2021__regulation of voltage-gated calcium channel activity (GO:1901385),0.3156842280476551,0.7616426417260533,0.8529411764705882,0.9572876434340701,1.0,8/19,24.95%,CACNB4;CBARP;CACNB3;DRD2;FMR1;GPR35;STAC;PDE4B
prerank,GO_Biological_Process_2021__hexose biosynthetic process (GO:0019319),-0.33551878019188297,-0.7614277863228339,0.765625,1.0,1.0,13/36,24.62%,GAPDHS;ALDOB;GPI;SLC25A1;SORD;PCK2;PGAM1;GAPDH;ENO1;FBP1;SLC39A14;SLC25A10;TPI1
prerank,GO_Biological_Process_2021__regulation of mast cell activation (GO:0033003),-0.4650727638793417,-0.7614090855846294,0.7678571428571429,1.0,1.0,1/5,15.01%,CRLF2
prerank,GO_Biological_Process_2021__cellular response to metal ion (GO:0071248),0.2703711422918863,0.7611630899424553,1.0,0.9576478640971784,1.0,13/103,11.24%,CPNE2;SYT3;SNCA;EGFR;ADCY1;ITPKB;AKT1;SLC12A2;PKD2;PRKN;BRAF;SLC25A24;CAMK2D
prerank,GO_Biological_Process_2021__peptidyl-lysine trimethylation (GO:0018023),-0.3554767526118194,-0.7611065084673485,0.8028169014084507,1.0,1.0,5/27,14.40%,PRDM7;EEF2KMT;SUV39H1;CTR9;CSKMT
prerank,GO_Biological_Process_2021__endoplasmic reticulum mannose trimming (GO:1904380),-0.3917009719429669,-0.7610080190644342,0.8064516129032258,1.0,1.0,2/18,9.49%,RPS27A;UBC
prerank,GO_Biological_Process_2021__regulation of mRNA catabolic process (GO:0061013),-0.29455026185582295,-0.7608885114909985,0.9027777777777778,1.0,1.0,9/111,9.95%,PSMB6;RPS27A;CSDC2;PSMA8;PSMB9;PSMA7;PSMC3;UBC;PSME1
prerank,GO_Biological_Process_2021__angiogenesis involved in wound healing (GO:0060055),0.478407061427587,0.7605568100400536,0.813953488372093,0.958177679089416,1.0,3/6,17.17%,ADIPOR2;PRCP;NDNF
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte chemotaxis (GO:0140131),0.4330702931883109,0.7602826582456939,0.6875,0.9581743208668245,1.0,3/8,26.51%,OXSR1;WNK1;ADAM10
prerank,GO_Biological_Process_2021__L-glutamate transmembrane transport (GO:0015813),0.38223629906847595,0.7597924234339238,0.75,0.9585513960036174,1.0,1/10,5.19%,SLC25A18
prerank,GO_Biological_Process_2021__positive regulation of keratinocyte differentiation (GO:0045618),-0.4463551370783978,-0.7594646052215224,0.8148148148148148,1.0,1.0,3/9,17.51%,PLAAT4;ETV4;MACROH2A2
prerank,GO_Biological_Process_2021__dosage compensation (GO:0007549),0.42362606739456676,0.7594585756985901,0.8636363636363636,0.9587585313861693,1.0,2/10,8.69%,HNRNPU;RBM15B
prerank,GO_Biological_Process_2021__hepatocyte growth factor receptor signaling pathway (GO:0048012),-0.4345452858590925,-0.7586924893642766,0.7959183673469388,1.0,1.0,1/10,2.92%,MST1
prerank,GO_Biological_Process_2021__positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),-0.34122641505312284,-0.7583314857936961,0.8656716417910447,1.0,1.0,4/31,12.13%,PARP14;IL12A;HES1;IL18
prerank,GO_Biological_Process_2021__membrane lipid metabolic process (GO:0006643),0.3631137332406377,0.7582666139792325,0.8333333333333334,0.9600124178593036,1.0,5/19,20.78%,AGMO;GAL3ST1;ARV1;AGK;TEX2
prerank,GO_Biological_Process_2021__regulation of peptidase activity (GO:0052547),-0.4036900647051326,-0.7582121394441799,0.8181818181818182,1.0,1.0,5/15,13.44%,SVBP;CTSH;CSTB;CST3;PSMA3
prerank,GO_Biological_Process_2021__atrial cardiac muscle cell action potential (GO:0086014),0.4126232179760848,0.7579456899363447,0.8,0.9600668737915931,1.0,1/9,2.35%,ANK2
prerank,GO_Biological_Process_2021__establishment of spindle orientation (GO:0051294),0.3176095503806453,0.7577568979803515,0.8571428571428571,0.9600044024161523,1.0,12/24,31.35%,INSC;CLASP1;FBXW11;NSFL1C;UBXN2B;PLK1;LLGL1;HTT;GJA1;MAP4;PAFAH1B1;CDK5RAP2
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte activation (GO:0051250),0.3618097134003369,0.7571474472420365,0.8205128205128205,0.9604444162619189,1.0,3/14,18.03%,PAG1;SAMSN1;FGL1
prerank,GO_Biological_Process_2021__response to magnesium ion (GO:0032026),0.44004710859557994,0.757142684133056,0.7441860465116279,0.9601073631076389,1.0,1/7,2.09%,SNCA
prerank,GO_Biological_Process_2021__inner ear auditory receptor cell differentiation (GO:0042491),0.4849399571870613,0.757119134533356,0.8076923076923077,0.9598055795083376,1.0,2/6,27.09%,SLC4A7;MYO6
prerank,GO_Biological_Process_2021__endothelial cell migration (GO:0043542),0.3212035901262443,0.756950397353589,0.8,0.9597432905017105,1.0,8/27,17.44%,STARD13;PRKX;LOXL2;PIK3CA;FAP;PXN;NRP1;CDH13
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor signaling pathway (GO:1900746),-0.4159690354150434,-0.75693131205063,0.8064516129032258,1.0,1.0,4/15,8.27%,CD63;CCBE1;IL12A;PIK3CB
prerank,GO_Biological_Process_2021__protein homooligomerization (GO:0051260),-0.29326791677846065,-0.7566308423876849,0.9493670886075949,1.0,1.0,9/86,14.42%,APIP;B2M;RNF213;CHMP2A;CLYBL;BLM;POLQ;AQP11;CBY1
prerank,GO_Biological_Process_2021__positive regulation of cellular respiration (GO:1901857),-0.44596588294485895,-0.7563090095136867,0.8059701492537313,1.0,1.0,5/8,26.30%,PRELID1;NUPR1;PARK7;PINK1;ISCU
prerank,GO_Biological_Process_2021__artery development (GO:0060840),-0.39610338697628156,-0.7562760440924328,0.85,1.0,1.0,3/18,7.43%,APLNR;HES1;ANGPTL3
prerank,GO_Biological_Process_2021__T-helper cell differentiation (GO:0042093),-0.4576669509964287,-0.7561298705668691,0.8333333333333334,1.0,1.0,1/6,1.79%,GPR183
prerank,GO_Biological_Process_2021__regulation of calcineurin-NFAT signaling cascade (GO:0070884),0.36549869879627894,0.7560947861002902,0.8378378378378378,0.9604452996959413,1.0,9/19,22.09%,CAMTA1;DYRK2;GSK3B;ATP2B4;SPPL3;IGF1;PTBP1;CIB1;HOMER2
prerank,GO_Biological_Process_2021__apoptotic DNA fragmentation (GO:0006309),0.39379163910547577,0.756043148330632,0.7692307692307693,0.9601787098937703,1.0,5/13,26.27%,DFFB;HMGB1;CASP3;EXOG;DICER1
prerank,GO_Biological_Process_2021__peptidyl-glutamine methylation (GO:0018364),-0.4639521753436169,-0.7560111480873896,0.75,1.0,1.0,1/5,8.13%,TRMT112
prerank,GO_Biological_Process_2021__positive regulation of cell killing (GO:0031343),-0.4266789148032445,-0.7556974667593753,0.8269230769230769,1.0,1.0,2/8,17.22%,NOX1;WNT5A
prerank,GO_Biological_Process_2021__cell chemotaxis (GO:0060326),0.2989159934369632,0.7555756253115179,0.8421052631578947,0.9605127836287827,1.0,5/38,4.93%,ARHGEF16;EPHA2;PARVA;CXCL12;PDGFRA
prerank,GO_Biological_Process_2021__cholesterol transport (GO:0030301),-0.34158953239658013,-0.7553031989361025,0.8055555555555556,1.0,1.0,6/32,16.98%,AKR1C1;APOM;CLU;APOE;ABCA5;LIMA1
prerank,GO_Biological_Process_2021__melanosome transport (GO:0032402),0.40004311274984833,0.7552735854383159,0.7948717948717948,0.9601956760410081,1.0,4/12,17.73%,RAB27A;MKKS;MYO5A;BBS2
prerank,GO_Biological_Process_2021__pigment granule transport (GO:0051904),0.40004311274984833,0.7552735854383159,0.7948717948717948,0.9601956760410081,1.0,4/12,17.73%,RAB27A;MKKS;MYO5A;BBS2
prerank,GO_Biological_Process_2021__regulation of cell morphogenesis (GO:0022604),-0.3618306745129538,-0.7552276972582094,0.8611111111111112,1.0,1.0,3/29,6.08%,SPARC;VIL1;PDPN
prerank,GO_Biological_Process_2021__carboxylic acid transport (GO:0046942),-0.32959842310185006,-0.7550404706921207,0.8767123287671232,1.0,1.0,7/41,17.53%,SLC16A3;SLC16A4;SLC38A1;SLC17A5;CLN3;SLC16A11;SLC16A6
prerank,GO_Biological_Process_2021__positive regulation by host of viral genome replication (GO:0044829),0.4634813358824493,0.7550221505359684,0.6739130434782609,0.9601916173472125,1.0,1/5,2.99%,VAPA
prerank,GO_Biological_Process_2021__negative regulation of cellular metabolic process (GO:0031324),0.33098822871594885,0.754986723836871,0.8181818181818182,0.9599023060172357,1.0,9/27,20.20%,NFKB1;PLIN5;RIN3;PRKN;ABCA2;SIRT2;MTMR2;AATF;SIRT5
prerank,GO_Biological_Process_2021__replication fork processing (GO:0031297),0.33578273369219375,0.7549469095223331,0.7777777777777778,0.9596364784108996,1.0,8/32,21.83%,SAMHD1;DNA2;RFWD3;EXD2;PRIMPOL;ATRX;CDK9;ETAA1
prerank,PanglaoDB_Augmented_2021__Myoblasts,-0.2980426043994785,-0.754893342518329,0.9459459459459459,1.0,1.0,23/90,20.41%,LMOD1;MUSK;COL5A1;ANGPTL2;TTN;AFAP1L1;IGFBP5;SYNC;LAMB1;CCL2;SRPX2;TNS2;EDNRA;COL4A2;TNFRSF12A;CALD1;CRYAB;C1QTNF1;BGN;EHD2;AMOTL2;MYOZ2;COL4A1
prerank,GO_Biological_Process_2021__regulation of DNA binding (GO:0051101),0.31013183076858714,0.7543626125852922,0.8333333333333334,0.9599758495570769,1.0,11/36,20.97%,HMGB1;PRKN;SIRT2;MAPK8;SMO;RSF1;IGF1;KDM1A;CPNE1;LEF1;IFI16
prerank,GO_Biological_Process_2021__cellular response to acid chemical (GO:0071229),-0.35492518882303664,-0.7542411664003826,0.9253731343283582,1.0,1.0,4/28,13.88%,KLF2;RRAGC;LAMTOR2;XBP1
prerank,GO_Biological_Process_2021__negative regulation of protein transport (GO:0051224),-0.3706086772698908,-0.7541263448621024,0.8064516129032258,1.0,1.0,4/19,14.15%,IL12A;RSAD2;APOE;ERP29
prerank,GO_Biological_Process_2021__negative regulation of ERK1 and ERK2 cascade (GO:0070373),0.28773645662965464,0.7540181489937974,0.9354838709677419,0.9601579654303677,1.0,14/41,21.25%,SPRED2;DUSP10;LMO3;SPRED1;SPRY3;CAMK2N1;SMAD4;DLG1;DUSP6;C3ORF33;FBLN1;PTEN;SPRED3;PTPRC
prerank,GO_Biological_Process_2021__regulation of synaptic vesicle exocytosis (GO:2000300),0.350821370738558,0.7539841956909556,0.8478260869565217,0.9598341977075322,1.0,9/18,26.56%,RIMS3;RAB3GAP1;RAP1A;GSK3B;FMR1;NLGN1;RIMS2;RAP1B;RAB5A
prerank,GO_Biological_Process_2021__intracellular estrogen receptor signaling pathway (GO:0030520),0.39343692090528537,0.7539837075362871,0.7619047619047619,0.9594932264117213,1.0,3/14,15.69%,RBFOX2;TRIP4;PADI2
prerank,GO_Biological_Process_2021__iron-sulfur cluster assembly (GO:0016226),0.35277611380599616,0.7530966434055006,0.9090909090909091,0.9604595532144197,1.0,2/22,4.66%,IBA57;LYRM4
prerank,"GO_Biological_Process_2021__retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",-0.31172314532840095,-0.7530898011398702,0.935064935064935,1.0,1.0,5/74,12.90%,CENPE;KDELR3;KIF2C;KIF4A;ARF5
prerank,GO_Biological_Process_2021__sensory perception of chemical stimulus (GO:0007606),0.3975021926567324,0.7530707935855832,0.75,0.9601418303075256,1.0,6/14,19.34%,OR9Q1;UBR3;OR3A2;MKKS;SLC24A4;DRD2
prerank,MSigDB_Hallmark_2020__Myc Targets V1,-0.27272905078327986,-0.7530214779829885,1.0,1.0,1.0,31/185,20.46%,RPL34;RPS6;EEF1B2;RPL18;TYMS;PRDX4;PSMA7;EIF2S2;DDX18;SNRPD2;RPL14;RPL6;LSM2;HDDC2;PSMC4;LDHA;GNL3;POLE3;RPS2;NCBP2;VBP1;POLD2;COPS5;IMPDH2;EIF3J;RPLP0;CBX3;NOP16;RAN;NPM1;APEX1
prerank,GO_Biological_Process_2021__positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),-0.3890585168752409,-0.7529518184383357,0.8181818181818182,1.0,1.0,2/15,9.04%,HES1;CRLF3
prerank,GO_Biological_Process_2021__organophosphate biosynthetic process (GO:0090407),0.29989842099989666,0.752873860835452,0.8333333333333334,0.9600391184359006,1.0,12/35,26.18%,ITPKB;TPK1;GPHN;GPAM;GK;IP6K2;IPPK;GK5;FGF2;AGPAT5;IPMK;LPCAT1
prerank,GO_Biological_Process_2021__positive regulation of fat cell differentiation (GO:0045600),-0.3518619884212061,-0.7527858999896153,0.8428571428571429,1.0,1.0,6/41,13.88%,SFRP2;ADIRF;ZNF385A;SFRP1;ID2;XBP1
prerank,GO_Biological_Process_2021__axonal transport (GO:0098930),0.32362723536159865,0.7527587848741406,0.9210526315789473,0.9598726469265966,1.0,7/31,19.18%,AP3S1;AP3B1;RAB21;KIF1B;OPA1;HIF1A;FBXW11
prerank,GO_Biological_Process_2021__proteolysis involved in cellular protein catabolic process (GO:0051603),-0.3227188695854806,-0.7525514055206136,0.9166666666666666,1.0,1.0,7/63,9.74%,RPS27A;ISG15;PSMA8;CTSL;CASP8;UBC;CTSH
prerank,GO_Biological_Process_2021__glucose metabolic process (GO:0006006),-0.32166538715997145,-0.7522110335523455,0.8309859154929577,1.0,1.0,15/47,24.97%,GAPDHS;ALDOB;GPI;AKR1A1;SLC25A1;SORD;PCK2;PGAM1;GAPDH;ENO1;FBP1;SLC39A14;SLC25A10;TPI1;DCXR
prerank,GO_Biological_Process_2021__positive regulation of lipopolysaccharide-mediated signaling pathway (GO:0031666),0.4835865469042304,0.7520524190842705,0.8793103448275862,0.9605300209359345,1.0,1/5,2.02%,SASH1
prerank,GO_Biological_Process_2021__mitochondrial proton-transporting ATP synthase complex assembly (GO:0033615),-0.4623794717056263,-0.7519984656776746,0.7407407407407407,1.0,1.0,2/5,21.59%,ATP23;OXA1L
prerank,GO_Biological_Process_2021__positive regulation of astrocyte differentiation (GO:0048711),0.45503443122840725,0.7518536952010062,0.875,0.9604330795273046,1.0,2/7,6.19%,BMP2;BIN1
prerank,GO_Biological_Process_2021__non-motile cilium assembly (GO:1905515),0.3606980835335354,0.7517205212568766,0.8285714285714286,0.9602608485999684,1.0,7/27,20.86%,CEP290;TTC8;C2CD3;BBS10;TOGARAM1;RPGRIP1L;PCM1
prerank,GO_Biological_Process_2021__regulation of endothelial cell apoptotic process (GO:2000351),-0.341600756803515,-0.7515268089626181,0.8095238095238095,1.0,1.0,6/25,17.91%,SEMA5A;THBS1;CD160;CCL2;ICAM1;GPER1
prerank,GO_Biological_Process_2021__response to estradiol (GO:0032355),-0.36329884891941017,-0.7509051610311835,0.875,1.0,1.0,2/25,4.63%,POU4F1;ANXA1
prerank,GO_Biological_Process_2021__base conversion or substitution editing (GO:0016553),-0.45801675678726456,-0.7508976781522458,0.803921568627451,1.0,1.0,2/9,8.33%,APOBEC3G;APOBEC2
prerank,GO_Biological_Process_2021__regulation of neuron migration (GO:2001222),-0.36887773541888524,-0.7508045933208324,0.8181818181818182,1.0,1.0,4/26,12.24%,KIF20B;IGSF10;NEXMIF;CX3CL1
prerank,GO_Biological_Process_2021__skeletal muscle contraction (GO:0003009),-0.4481710297644549,-0.7505495126557573,0.8245614035087719,1.0,1.0,2/10,6.89%,TNNT1;STAC3
prerank,GO_Biological_Process_2021__T-tubule organization (GO:0033292),-0.46899879018083557,-0.7504743976351954,0.7627118644067796,1.0,1.0,2/6,10.23%,MYOF;CAV3
prerank,PanglaoDB_Augmented_2021__Olfactory Epithelial Cells,-0.28364342049175795,-0.7502121844446453,0.9302325581395349,1.0,1.0,11/186,12.41%,PDE4A;ANO2;PPP1R14C;CIBAR2;CFAP52;ZBBX;KLHDC9;KIF9;CFAP126;LRRIQ1;FAM81A
prerank,GO_Biological_Process_2021__negative regulation of lipid metabolic process (GO:0045833),0.3857308650854002,0.7500986998026139,0.8205128205128205,0.9622791487482879,1.0,3/11,13.78%,PDE3B;PPP2R5A;ASXL3
prerank,GO_Biological_Process_2021__positive regulation of lipid metabolic process (GO:0045834),0.3393973295853606,0.7500634133360096,0.7894736842105263,0.9619673617464712,1.0,2/15,6.29%,ZBTB20;AKT1
prerank,GO_Biological_Process_2021__regulation of cholesterol efflux (GO:0010874),-0.35470984529948024,-0.7500431808069739,0.8769230769230769,1.0,1.0,3/25,15.65%,ABCA12;APOE;ABCA5
prerank,GO_Biological_Process_2021__chromatin organization involved in regulation of transcription (GO:0034401),0.369177974577943,0.7499358100732915,0.7959183673469388,0.9618237237629158,1.0,3/12,15.69%,ARID1B;SERTAD2;PADI2
prerank,GO_Biological_Process_2021__mRNA methylation (GO:0080009),0.4128734568490337,0.749920376150338,0.725,0.9615007414096278,1.0,4/15,25.49%,METTL8;ZC3H13;WTAP;CBLL1
prerank,GO_Biological_Process_2021__negative regulation of interleukin-6 production (GO:0032715),-0.3830678765451524,-0.7497400089806706,0.8596491228070176,1.0,1.0,3/15,17.40%,SELENOS;CX3CL1;PTPN22
prerank,GO_Biological_Process_2021__intermediate filament organization (GO:0045109),0.4374216515559614,0.7496813324962042,0.86,0.9614615277120747,1.0,3/7,18.71%,DNAJB6;KLHL24;MTM1
prerank,GO_Biological_Process_2021__vasoconstriction (GO:0042310),-0.43668528228405795,-0.7495674872566694,0.7755102040816326,1.0,1.0,3/7,20.54%,HTR2B;EDNRA;EDNRB
prerank,GO_Biological_Process_2021__positive regulation of calcium ion-dependent exocytosis (GO:0045956),0.4015620722509947,0.7495154607704159,0.8461538461538461,0.9613413589196366,1.0,3/10,8.17%,CACNA1G;CACNA1I;DOC2B
prerank,PanglaoDB_Augmented_2021__Urothelial Cells,0.26945508061602697,0.7490484289993585,0.9230769230769231,0.96168387051867,1.0,4/53,10.99%,ANXA11;RPS6KB2;TRADD;TGM1
prerank,GO_Biological_Process_2021__response to nutrient levels (GO:0031667),-0.45154709869019616,-0.7488157105498258,0.8235294117647058,1.0,1.0,1/11,3.26%,KCNB1
prerank,GO_Biological_Process_2021__regulation of microtubule polymerization (GO:0031113),-0.3322744282389693,-0.7487991308519533,0.8933333333333333,1.0,1.0,4/38,13.54%,ANKRD53;CAV3;FES;DRG1
prerank,GO_Biological_Process_2021__regulation of type B pancreatic cell proliferation (GO:0061469),0.430705581518235,0.7484150871487335,0.6730769230769231,0.9622168932498166,1.0,2/6,21.38%,NR1D1;NR4A1
prerank,GO_Biological_Process_2021__positive regulation of non-membrane spanning protein tyrosine kinase activity (GO:1903997),-0.4548101012513722,-0.7484052406587683,0.8113207547169812,1.0,1.0,1/5,5.93%,BDNF
prerank,GO_Biological_Process_2021__androgen metabolic process (GO:0008209),-0.41756752990092,-0.7483174279466784,0.7868852459016393,1.0,1.0,2/10,16.34%,HSD17B7;CYP3A4
prerank,GO_Biological_Process_2021__endothelial cell proliferation (GO:0001935),0.3989522811160104,0.7482829453891403,0.7346938775510204,0.9620445797596486,1.0,2/12,3.38%,PRKX;LOXL2
prerank,GO_Biological_Process_2021__positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),-0.49787265656479107,-0.748114379250572,0.8,1.0,1.0,1/5,14.31%,CCL2
prerank,GO_Biological_Process_2021__positive regulation of cell-cell adhesion mediated by cadherin (GO:2000049),0.43334295036263515,0.7479914090249663,0.7608695652173914,0.9621265459292332,1.0,3/7,25.06%,AFDN;TJP1;SERPINF2
prerank,GO_Biological_Process_2021__protein localization to endoplasmic reticulum exit site (GO:0070973),-0.4846331298133858,-0.7471569464328894,0.8490566037735849,1.0,1.0,1/5,21.70%,BCAP31
prerank,GO_Biological_Process_2021__positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),0.3852927559890141,0.7470749718915869,0.782608695652174,0.9629475618875512,1.0,4/12,22.18%,TICAM1;SIRT1;BCL10;CAMK4
prerank,GO_Biological_Process_2021__regulation of response to biotic stimulus (GO:0002831),-0.3593978789632335,-0.747041832439777,0.8245614035087719,1.0,1.0,7/25,17.47%,IRF1;ERAP1;CASP8;HERC5;CX3CL1;PTPN22;TRIM5
prerank,GO_Biological_Process_2021__negative regulation of cell-substrate junction organization (GO:0150118),0.35330395012338855,0.7467490055863905,0.8529411764705882,0.9627356204050949,1.0,4/15,18.44%,RCC2;FAM107A;DUSP22;PTEN
prerank,GO_Biological_Process_2021__negative regulation of focal adhesion assembly (GO:0051895),0.35330395012338855,0.7467490055863905,0.8529411764705882,0.9627356204050949,1.0,4/15,18.44%,RCC2;FAM107A;DUSP22;PTEN
prerank,GO_Biological_Process_2021__B cell activation (GO:0042113),0.29731479888933693,0.7467023686149448,0.9142857142857143,0.9624480643965291,1.0,8/45,16.03%,CHRNA4;HDAC9;CD22;PTPRJ;HDAC4;DCAF1;BCL2;MSH2
prerank,GO_Biological_Process_2021__regulation of phosphorylation (GO:0042325),0.27133191153577957,0.746615675327449,0.9473684210526315,0.9622126063407759,1.0,23/104,18.83%,CCDC88C;NUP42;NUP37;EGFR;NUP188;TESK1;EP300;NUP153;PTK2;SIRT1;OGT;NDC1;FER;SIRT2;PHIP;NRP1;PTGES3;NUP205;BMP7;HIF1A;ITGA6;NUP214;BCL10
prerank,GO_Biological_Process_2021__amide transport (GO:0042886),-0.37909973200563096,-0.7464138979119128,0.9014084507042254,1.0,1.0,6/20,19.60%,ABCA12;PDPN;ABCG2;AQP11;CPTP;SLC14A2
prerank,GO_Biological_Process_2021__fatty-acyl-CoA biosynthetic process (GO:0046949),0.3395011910450922,0.7463467223994613,0.7741935483870968,0.9622251707495847,1.0,7/26,16.92%,ELOVL7;HACD2;SCD5;ELOVL6;ELOVL5;HACD1;ACSBG1
prerank,GO_Biological_Process_2021__sodium ion homeostasis (GO:0055078),0.36338910625868354,0.746017464345522,0.7142857142857143,0.9623702540337103,1.0,4/15,19.39%,NEDD4L;SLC12A2;ATP1A4;CYP4F12
prerank,GO_Biological_Process_2021__pyrimidine-containing compound biosynthetic process (GO:0072528),0.4269416403428875,0.7458471820251431,0.8222222222222222,0.9622675531611871,1.0,1/7,5.62%,TPK1
prerank,GO_Biological_Process_2021__negative regulation of response to DNA damage stimulus (GO:2001021),-0.3717935376339221,-0.7454710033355324,0.7894736842105263,1.0,1.0,1/25,0.66%,SFRP2
prerank,GO_Biological_Process_2021__cellular glucan metabolic process (GO:0006073),0.4155966112425301,0.7453674326856226,0.7555555555555555,0.9624758575975055,1.0,2/10,15.08%,UGP2;GSK3B
prerank,GO_Biological_Process_2021__blood vessel morphogenesis (GO:0048514),-0.3358649120681687,-0.7451528376195293,0.8870967741935484,1.0,1.0,12/38,20.41%,APLNR;ADM;CCBE1;HES1;ANGPTL3;HEY2;AGGF1;LAMA1;ENG;ID1;TGFBR3L;COL4A1
prerank,GO_Biological_Process_2021__positive regulation of hemostasis (GO:1900048),0.4751692731536408,0.7451370118272869,0.8260869565217391,0.9620807173617902,1.0,1/6,2.21%,SERPINE1
prerank,GO_Biological_Process_2021__positive regulation of coagulation (GO:0050820),0.4751692731536408,0.7451370118272869,0.8260869565217391,0.9620807173617902,1.0,1/6,2.21%,SERPINE1
prerank,GO_Biological_Process_2021__histone H3-K4 methylation (GO:0051568),0.3389469130464535,0.7449584405984195,0.9428571428571428,0.9619897666307612,1.0,8/25,21.74%,MEN1;WDR5B;OGT;KMT2C;CXXC1;ASH2L;WDR82;BEND3
prerank,GO_Biological_Process_2021__regulation of glial cell apoptotic process (GO:0034350),-0.46054087881416716,-0.7448384477669681,0.7391304347826086,1.0,1.0,1/6,14.31%,CCL2
prerank,GO_Biological_Process_2021__T cell mediated immunity (GO:0002456),-0.41666797436496,-0.7446100573006389,0.8490566037735849,1.0,1.0,4/12,17.03%,HLA-A;CTSH;MICA;EMP2
prerank,GO_Biological_Process_2021__apoptotic nuclear changes (GO:0030262),0.3456307959116719,0.7444686999464363,0.8064516129032258,0.9622841246824186,1.0,7/18,28.25%,DFFB;HMGB1;BLCAP;CASP3;EXOG;DICER1;ACVR1C
prerank,GO_Biological_Process_2021__regulation of receptor internalization (GO:0002090),-0.35436261380240003,-0.7444633987803023,0.8405797101449275,1.0,1.0,3/28,8.20%,CD63;SFRP4;LRPAP1
prerank,GO_Biological_Process_2021__quaternary ammonium group transport (GO:0015697),-0.4358871740547542,-0.7443520410006214,0.7222222222222222,1.0,1.0,3/7,18.07%,SLC25A45;SLC22A4;SLC22A1
prerank,GO_Biological_Process_2021__zinc ion transport (GO:0006829),0.3492603984041821,0.7443229437063585,0.8409090909090909,0.962141435270444,1.0,4/16,14.10%,SLC39A11;SLC30A4;SLC30A9;SLC30A1
prerank,GO_Biological_Process_2021__regulation of chaperone-mediated protein folding (GO:1903644),0.44950774351593153,0.7442281314379278,0.7391304347826086,0.9619241496077552,1.0,1/5,9.31%,DNAJB2
prerank,GO_Biological_Process_2021__positive regulation of reproductive process (GO:2000243),0.3240041599158013,0.7441696436051624,0.8157894736842105,0.9616438340043943,1.0,5/22,16.79%,PDE3A;LHFPL2;PLCB1;SIRT2;TACR3
prerank,GO_Biological_Process_2021__negative regulation of stem cell differentiation (GO:2000737),0.4013088073724701,0.7440304506797085,0.8222222222222222,0.9614326173847786,1.0,5/11,20.47%,HNRNPU;YTHDF2;REST;N4BP2L2;ESRRB
prerank,GO_Biological_Process_2021__insulin secretion involved in cellular response to glucose stimulus (GO:0035773),0.45396497180977036,0.7438890520712469,0.84,0.9612904270131358,1.0,4/6,34.31%,RAB11FIP2;PTPRN2;RAB11B;SELENOT
prerank,GO_Biological_Process_2021__chloride transmembrane transport (GO:1902476),-0.33546712310114873,-0.7435871119610912,0.8405797101449275,1.0,1.0,3/42,7.00%,ANO2;CFTR;GABRE
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-serine phosphorylation (GO:0033138),0.28661127855911056,0.7433416397700454,0.9444444444444444,0.9616991673214679,1.0,15/59,16.74%,SNCA;EGFR;HCLS1;CNOT9;AKT1;DOCK7;CAPRIN2;BRAF;PRKD1;STOX1;RPTOR;TENM1;LATS1;ATP2B4;TFRC
prerank,PanglaoDB_Augmented_2021__Basophils,-0.3022594642616287,-0.7427134992183616,0.8636363636363636,1.0,1.0,11/69,13.63%,GPR183;CLEC12A;F13A1;P2RY13;FAR2;IL3RA;CD14;SPI1;CLEC5A;FADS1;MYO1F
prerank,GO_Biological_Process_2021__regulation of hemoglobin biosynthetic process (GO:0046984),0.4315395622661197,0.7425883342627073,0.7560975609756098,0.962365732461478,1.0,1/7,3.27%,PRMT1
prerank,GO_Biological_Process_2021__regulation of interleukin-5 production (GO:0032674),-0.4193347198043032,-0.7421419195170409,0.7647058823529411,1.0,1.0,2/6,16.27%,CRLF2;TNFRSF21
prerank,GO_Biological_Process_2021__regulation of potassium ion import (GO:1903286),0.4304426165939741,0.7416851632358633,0.8,0.9632726499242751,1.0,3/8,18.82%,DLG1;WNK3;WNK1
prerank,GO_Biological_Process_2021__mitotic G1/S transition checkpoint signaling (GO:0044819),0.39296240515539216,0.7414490806089964,0.8108108108108109,0.9631930638172808,1.0,4/12,20.33%,SDE2;RFWD3;WAC;FBXO31
prerank,GO_Biological_Process_2021__ciliary basal body-plasma membrane docking (GO:0097711),0.250671632171614,0.7411603171665803,1.0,0.9631937504276046,1.0,20/88,20.86%,CEP152;CEP97;RAB3IP;NEDD1;TTBK2;CEP290;CSNK1E;C2CD3;CKAP5;MAPRE1;CLASP1;ALMS1;TUBG1;YWHAG;RPGRIP1L;PLK1;TCTN1;NPHP4;PPP2R1A;PCM1
prerank,GO_Biological_Process_2021__maintenance of apical/basal cell polarity (GO:0035090),-0.43135731653988374,-0.7410614801487216,0.8214285714285714,1.0,1.0,4/8,23.33%,ANK1;PDZD11;WDR1;CRB2
prerank,GO_Biological_Process_2021__maintenance of epithelial cell apical/basal polarity (GO:0045199),-0.43135731653988374,-0.7410614801487216,0.8214285714285714,1.0,1.0,4/8,23.33%,ANK1;PDZD11;WDR1;CRB2
prerank,GO_Biological_Process_2021__cardiac ventricle development (GO:0003231),0.3658595098408989,0.740999043031233,0.88,0.9630512421320077,1.0,3/12,14.40%,SALL1;TMEM65;MDM4
prerank,GO_Biological_Process_2021__positive regulation of protein binding (GO:0032092),-0.3308661751029337,-0.7409611607969996,0.8082191780821918,1.0,1.0,7/46,14.02%,RPL11;B2M;BDNF;TRIM21;APOE;DTX3L;RIPK2
prerank,GO_Biological_Process_2021__positive regulation of fibroblast proliferation (GO:0048146),0.33555442717743134,0.7409533052212549,0.8,0.9628057696979319,1.0,5/20,13.28%,LIG4;PDGFRA;PDGFA;PDGFC;DHX9
prerank,MSigDB_Hallmark_2020__mTORC1 Signaling,-0.2788706773118993,-0.7403568188781199,0.9294117647058824,1.0,1.0,37/179,21.58%,WARS1;DHCR24;CD9;M6PR;PNP;EIF2S2;IGFBP5;GLRX;SQLE;DDIT3;RDH11;PSMC4;LDHA;DHCR7;ATP6V1D;PSMA3;FADS1;XBP1;HK2;NMT1;GPI;SORD;COPS5;CXCR4;POLR3G;PDK1;TM7SF2;SYTL2;INSIG1;GAPDH;SQSTM1;ENO1;NUPR1;DDIT4;HSPD1;HMGCR;GBE1
prerank,GO_Biological_Process_2021__placenta development (GO:0001890),-0.4471145250335169,-0.7403121924969743,0.7454545454545455,1.0,1.0,1/8,9.68%,NODAL
prerank,GO_Biological_Process_2021__regulation of collateral sprouting (GO:0048670),-0.4599523111954848,-0.7402408002270817,0.7692307692307693,1.0,1.0,1/8,5.93%,BDNF
prerank,GO_Biological_Process_2021__mitochondrial tRNA processing (GO:0090646),-0.4718647671787941,-0.7401381209037163,0.8545454545454545,1.0,1.0,4/7,19.92%,TRMT10B;TRMT10C;TRMT10A;TRNT1
prerank,GO_Biological_Process_2021__positive regulation of cellular extravasation (GO:0002693),-0.41411505480670724,-0.7400237067622853,0.8103448275862069,1.0,1.0,3/10,23.21%,ICAM1;ADAM8;PLVAP
prerank,GO_Biological_Process_2021__lymphocyte mediated immunity (GO:0002449),0.41861192954978066,0.7399395107311767,0.8571428571428571,0.9637567367144164,1.0,1/10,2.23%,BTN3A3
prerank,GO_Biological_Process_2021__rRNA modification (GO:0000154),-0.3932719405049643,-0.7399166637192325,0.8135593220338984,1.0,1.0,3/20,8.13%,NOP10;BUD23;TRMT112
prerank,GO_Biological_Process_2021__regulation of microtubule motor activity (GO:2000574),0.45984378699634987,0.7393482955034112,0.7777777777777778,0.9640890876779514,1.0,1/6,1.22%,MTCL1
prerank,GO_Biological_Process_2021__regulation of histone H3-K9 acetylation (GO:2000615),0.3655301398424335,0.7391700579961238,0.825,0.9639293063412919,1.0,2/11,14.34%,ZNF451;SMAD4
prerank,GO_Biological_Process_2021__negative regulation of mitotic metaphase/anaphase transition (GO:0045841),0.38153269738521434,0.7388786638249567,0.7941176470588235,0.9639754763094639,1.0,2/13,12.63%,ZNF207;BUB3
prerank,GO_Biological_Process_2021__axon development (GO:0061564),-0.30017308630607575,-0.7383961099075723,0.8918918918918919,1.0,1.0,5/71,7.75%,POU4F1;SEMA5A;S100A6;NEFH;SVBP
prerank,GO_Biological_Process_2021__transcription by RNA polymerase I (GO:0006360),-0.34774983470502363,-0.738389775541589,0.819672131147541,1.0,1.0,7/33,21.52%,TAF1D;POLR2L;POLR1C;TTF1;POLR2K;TBP;CDK7
prerank,GO_Biological_Process_2021__regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091),0.40773982381245055,0.7381310974213184,0.813953488372093,0.9645531805384879,1.0,2/11,8.49%,TASOR;APOBEC3F
prerank,GO_Biological_Process_2021__hyaluronan catabolic process (GO:0030214),-0.4110552200227111,-0.7378658652189412,0.8405797101449275,1.0,1.0,3/14,11.11%,STAB2;HYAL1;CEMIP
prerank,GO_Biological_Process_2021__regulation of lysosomal lumen pH (GO:0035751),-0.4464141044905588,-0.7377554984255221,0.8245614035087719,1.0,1.0,1/8,13.86%,CLN3
prerank,GO_Biological_Process_2021__negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),-0.45194665238371357,-0.7371028388526704,0.7741935483870968,1.0,1.0,2/7,8.27%,IL12A;PIK3CB
prerank,GO_Biological_Process_2021__negative regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045869),0.420834270880726,0.7368412211130984,0.9,0.9656847171498142,1.0,2/10,8.49%,TASOR;APOBEC3F
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),-0.32489670860628983,-0.7367184134283613,0.8615384615384616,1.0,1.0,1/32,0.33%,POU4F1
prerank,GO_Biological_Process_2021__negative regulation of chemotaxis (GO:0050922),0.30556713075074127,0.7365886120226293,0.9444444444444444,0.9656445491684167,1.0,7/27,16.40%,SEMA5B;ROBO1;SEMA3C;SLIT2;SEMA6C;SEMA4D;SEMA3D
prerank,GO_Biological_Process_2021__cellular senescence (GO:0090398),0.30983017934322105,0.7361077543544008,0.9047619047619048,0.9658385103709739,1.0,5/24,13.82%,NSMCE2;SIRT1;SMC6;OPA1;MAPKAPK5
prerank,GO_Biological_Process_2021__polyphosphate metabolic process (GO:0006797),0.4283522335896993,0.7357250327933214,0.7959183673469388,0.9659467193442015,1.0,1/6,13.10%,MINPP1
prerank,GO_Biological_Process_2021__membrane fusion (GO:0061025),-0.3688406626502364,-0.7357168181729056,0.9180327868852459,1.0,1.0,2/28,3.06%,MYOF;MX1
prerank,PanglaoDB_Augmented_2021__Microglia,-0.3187365483501732,-0.7356751324725004,0.8939393939393939,1.0,1.0,6/59,4.78%,TAGAP;GPR183;CLEC12A;P2RY12;IGSF6;P2RY13
prerank,GO_Biological_Process_2021__mitotic DNA damage checkpoint signaling (GO:0044773),0.2788462175823284,0.7355418635938088,1.0,0.9657923859910835,1.0,11/51,21.18%,SDE2;RFWD3;FOXN3;TAOK2;UIMC1;BRCC3;ATF2;PLK1;WAC;FBXO31;TICRR
prerank,GO_Biological_Process_2021__histone H3-K9 methylation (GO:0051567),-0.4600027014865791,-0.7355384493198807,0.8333333333333334,1.0,1.0,2/6,22.90%,SUV39H1;SETDB1
prerank,GO_Biological_Process_2021__retinal cone cell differentiation (GO:0042670),0.467443382079639,0.7352946976827814,0.8292682926829268,0.965409918342189,1.0,2/5,23.31%,RORB;RP1
prerank,GO_Biological_Process_2021__retinal cone cell development (GO:0046549),0.467443382079639,0.7352946976827814,0.8292682926829268,0.965409918342189,1.0,2/5,23.31%,RORB;RP1
prerank,GO_Biological_Process_2021__positive regulation of hemoglobin biosynthetic process (GO:0046985),0.4543220064846588,0.7351989544427975,0.8695652173913043,0.9651932351488975,1.0,3/6,21.37%,PRMT1;ABCB10;SLC6A9
prerank,GO_Biological_Process_2021__membrane protein ectodomain proteolysis (GO:0006509),-0.3634218114946193,-0.7351738440527805,0.8,1.0,1.0,3/18,15.82%,ERAP1;PRKCQ;APH1A
prerank,GO_Biological_Process_2021__leukocyte cell-cell adhesion (GO:0007159),-0.4009614358477509,-0.7351177850643464,0.8928571428571429,1.0,1.0,1/15,1.97%,SELP
prerank,GO_Biological_Process_2021__membrane organization (GO:0061024),-0.2789111975827887,-0.7350066457237133,0.9534883720930233,1.0,1.0,14/202,10.23%,EPN1;TLCD1;CFTR;RPS27A;MYOF;MX1;CHRM2;ATP10B;M6PR;CHMP2A;UBC;SYT2;VAMP8;CAV3
prerank,GO_Biological_Process_2021__negative regulation of hydrogen peroxide-induced cell death (GO:1903206),0.3935588884103043,0.7346114018595322,0.8055555555555556,0.965529394479248,1.0,2/12,20.13%,HGF;NFE2L2
prerank,MSigDB_Hallmark_2020__UV Response Up,0.2491694964560351,0.7345059309075604,1.0,0.9653583875182818,1.0,32/137,22.75%,BMP2;RRAD;GLS;STARD3;RAB27A;NPTXR;HNRNPU;KCNH2;CTSV;MAOA;CA2;ATP6V1C1;TGFBRAP1;BSG;EPCAM;CDC34;LHX2;TFRC;TACR3;STIP1;CCND3;SIGMAR1;CASP3;H2AX;NPTX2;PLCL1;NR4A1;SLC6A12;NTRK3;POLG2;CDC5L;CDO1
prerank,GO_Biological_Process_2021__regulation of sterol biosynthetic process (GO:0106118),-0.4092953258510801,-0.7343646649162604,0.851063829787234,1.0,1.0,4/9,23.35%,SREBF1;RAN;SEC14L2;SREBF2
prerank,GO_Biological_Process_2021__peptidyl-proline hydroxylation (GO:0019511),-0.4171424462324806,-0.7342539172697184,0.8793103448275862,1.0,1.0,3/9,13.46%,P4HA3;P4HTM;OGFOD1
prerank,GO_Biological_Process_2021__microtubule anchoring at centrosome (GO:0034454),0.4193730131978103,0.7341117476614987,0.7674418604651163,0.965546214345937,1.0,5/9,33.33%,PCM1;NINL;HOOK3;CEP19;CCDC120
prerank,GO_Biological_Process_2021__mitochondrial membrane organization (GO:0007006),0.31821041797926775,0.7338773423733034,0.8918918918918919,0.9655346938378295,1.0,6/31,14.73%,MAIP1;MTX2;CHCHD3;SAMM50;OPA1;BCL2
prerank,GO_Biological_Process_2021__regulation of epithelial cell migration (GO:0010632),-0.336911126811868,-0.7336780799124095,0.9285714285714286,1.0,1.0,6/45,9.74%,ENPP2;CEACAM1;VIL1;RAB11A;HYAL1;CTSH
prerank,GO_Biological_Process_2021__mitotic cytokinetic process (GO:1902410),0.32558305043388913,0.7336591519307474,0.8461538461538461,0.9654719720291669,1.0,3/15,19.53%,CHMP1A;CHMP2B;CHMP6
prerank,GO_Biological_Process_2021__positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),-0.36337728866511987,-0.7336528508130781,0.8611111111111112,1.0,1.0,4/23,8.30%,ANXA1;RDX;MTBP;HYAL1
prerank,GO_Biological_Process_2021__regulation of T-helper 2 cell differentiation (GO:0045628),0.4478278518854956,0.7331918643727203,0.8292682926829268,0.9657505705650917,1.0,1/5,1.31%,TNFSF4
prerank,GO_Biological_Process_2021__negative regulation of interleukin-1 production (GO:0032692),0.3598830079653126,0.7322917032426514,0.8536585365853658,0.9663530756275976,1.0,2/14,3.96%,CARD18;GIT1
prerank,GO_Biological_Process_2021__toll-like receptor signaling pathway (GO:0002224),0.278372736902996,0.7319493280529703,0.9565217391304348,0.9664833905951125,1.0,11/66,10.13%,IRAK2;TAB3;CTSK;RPS6KA3;UBE2D1;TICAM1;MAP3K7;PIK3C3;HMGB1;PIK3R4;TAB1
prerank,GO_Biological_Process_2021__negative regulation of hydrolase activity (GO:0051346),0.28166489839303704,0.7319112419258145,0.9333333333333333,0.966176099613877,1.0,5/38,8.03%,RCC2;PPP1R36;LRCH1;PLIN5;CAMK2A
prerank,GO_Biological_Process_2021__negative regulation of inflammatory response to antigenic stimulus (GO:0002862),0.272552264365376,0.7317335428185893,0.9285714285714286,0.966050783486085,1.0,8/61,11.00%,PRKACB;ADCY1;CALCB;PRKAR1B;CD247;ADRB2;GPR176;ADRB1
prerank,GO_Biological_Process_2021__neurotrophin TRK receptor signaling pathway (GO:0048011),0.35181604919017506,0.731522570866695,0.8863636363636364,0.9660561500546133,1.0,5/12,20.20%,SORT1;NTRK2;SOS1;BCAR1;CASP3
prerank,GO_Biological_Process_2021__lipid transport (GO:0006869),-0.2946172314561464,-0.7313355282377506,0.9240506329113924,1.0,1.0,11/88,15.67%,AKR1C1;ABCA12;CEACAM1;SLC51B;SLC51A;FABP3;SLC10A1;APOE;CLN3;ABCA5;SLCO3A1
prerank,GO_Biological_Process_2021__carbohydrate derivative biosynthetic process (GO:1901137),-0.37274894699629413,-0.7312993149080738,0.8615384615384616,1.0,1.0,2/23,9.23%,GCNT1;B3GNT5
prerank,GO_Biological_Process_2021__fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),0.3568433912189716,0.7312844625540472,0.9459459459459459,0.9659650191345093,1.0,4/14,22.89%,HSD17B4;CRAT;ACOX1;SCP2
prerank,PanglaoDB_Augmented_2021__Osteoclasts,-0.29751114213747243,-0.7311797391685623,0.922077922077922,1.0,1.0,15/87,14.31%,IL1R1;F13A1;MMP19;FPR3;TNFAIP2;VWF;CST3;ONECUT1;P2RY6;CEBPD;CD14;CLEC5A;ITGA2;SERPINF1;CCL2
prerank,MSigDB_Hallmark_2020__E2F Targets,-0.27114485200949245,-0.7311480275239383,0.987012987012987,1.0,1.0,25/169,16.91%,CENPE;SPC24;RPA3;KIF2C;CDCA3;PRDX4;POLE4;CCNB2;ATAD2;KIF4A;NAA38;WEE1;PNN;CDKN3;SUV39H1;BRCA1;PRPS1;WDR90;TUBB;UBE2S;RAD51AP1;TCF19;POLD2;GINS3;PMS2
prerank,GO_Biological_Process_2021__regulation of sodium ion transmembrane transport (GO:1902305),0.3347315674562582,0.7310726121279981,0.8604651162790697,0.9659023221087717,1.0,7/19,21.69%,NEDD4L;CAMK2D;COMMD1;DLG1;ATP2B4;UTRN;SLMAP
prerank,GO_Biological_Process_2021__mitotic spindle assembly checkpoint signaling (GO:0007094),0.38285173950235496,0.731063573351517,0.8181818181818182,0.9649039338775857,1.0,2/12,12.63%,ZNF207;BUB3
prerank,GO_Biological_Process_2021__mitotic spindle checkpoint signaling (GO:0071174),0.38285173950235496,0.731063573351517,0.8181818181818182,0.9649039338775857,1.0,2/12,12.63%,ZNF207;BUB3
prerank,GO_Biological_Process_2021__spindle assembly checkpoint signaling (GO:0071173),0.38285173950235496,0.731063573351517,0.8181818181818182,0.9649039338775857,1.0,2/12,12.63%,ZNF207;BUB3
prerank,GO_Biological_Process_2021__neural tube closure (GO:0001843),0.3124589703751826,0.7310145396932137,0.8571428571428571,0.9646263728721678,1.0,10/30,33.42%,DVL1;VASP;SCRIB;MTHFR;BCL10;STIL;PHACTR4;TGFB2;COBL;SKI
prerank,GO_Biological_Process_2021__negative regulation of heterotypic cell-cell adhesion (GO:0034115),0.4477332431095908,0.7309632326069583,0.8717948717948718,0.9640491779092856,1.0,3/6,18.82%,MBP;MAP2K5;WNK1
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion involved in gastrulation (GO:0070587),0.4477332431095908,0.7309632326069583,0.8717948717948718,0.9640491779092856,1.0,3/6,18.82%,MBP;MAP2K5;WNK1
prerank,GO_Biological_Process_2021__negative regulation of mRNA polyadenylation (GO:1900364),0.40762788136793904,0.7308936941200989,0.7555555555555555,0.9637948423583587,1.0,1/8,4.68%,ZC3H14
prerank,GO_Biological_Process_2021__sodium ion import across plasma membrane (GO:0098719),0.3769200577473588,0.7306219212973706,0.8108108108108109,0.9638122875632376,1.0,5/13,23.83%,SLC12A2;TRPM4;SLC9A9;SLC6A1;HCN2
prerank,GO_Biological_Process_2021__vasodilation (GO:0042311),-0.4223123070080563,-0.7303692389226109,0.8518518518518519,1.0,1.0,3/9,17.91%,KLF2;NOS1;GPER1
prerank,GO_Biological_Process_2021__mitochondrial transport (GO:0006839),-0.3164847770785221,-0.7301642409117649,0.9342105263157895,1.0,1.0,4/51,8.79%,TOMM7;TIMM10;TIMM8B;SLC25A4
prerank,GO_Biological_Process_2021__lipid droplet formation (GO:0140042),-0.42561847467161945,-0.7298386876536965,0.8301886792452831,1.0,1.0,1/7,10.37%,SQLE
prerank,GO_Biological_Process_2021__ncRNA transcription (GO:0098781),-0.40445909537349367,-0.7298069293949374,0.8163265306122449,1.0,1.0,2/13,17.22%,GTF3A;NIFK
prerank,GO_Biological_Process_2021__regulation of lysosomal protein catabolic process (GO:1905165),-0.44838731890055383,-0.7297724711856468,0.8363636363636363,1.0,1.0,3/6,31.84%,LAPTM4B;LDLR;LRP2
prerank,MSigDB_Hallmark_2020__Notch Signaling,0.33615612141790147,0.7295456582601167,0.7333333333333333,0.9647347570037204,1.0,12/29,22.95%,NOTCH2;ARRB1;FZD5;MAML2;DTX4;KAT2A;CUL1;DTX1;FBXW11;DTX2;PRKCA;FZD7
prerank,GO_Biological_Process_2021__positive regulation of viral transcription (GO:0050434),-0.3481659651868261,-0.7295313456430967,0.8676470588235294,1.0,1.0,8/25,22.57%,POLR2I;GTF2F1;POLR2L;POLR2J;POLR2G;POLR2K;NELFE;NELFCD
prerank,GO_Biological_Process_2021__skeletal system morphogenesis (GO:0048705),0.34301962342636605,0.7290597879693003,0.8666666666666667,0.9650685184677997,1.0,4/20,13.12%,RAB33B;PDGFRA;WWOX;TGFBR1
prerank,GO_Biological_Process_2021__positive regulation of cytokine production involved in immune response (GO:0002720),-0.3860546112063025,-0.7282929581969544,0.9090909090909091,1.0,1.0,6/20,19.17%,HLA-A;B2M;CD160;SCIMP;WNT5A;HLA-F
prerank,GO_Biological_Process_2021__regulation of apoptotic process (GO:0042981),-0.2593651226599401,-0.7279384054317428,1.0,1.0,1.0,63/545,17.48%,IFI6;APIP;PRAME;SFRP2;GATA1;RPL10;RPS27A;IL7;BCL2L14;DHCR24;STAT1;PRDX5;IFIT3;SFRP4;BCL2L2;RPS6;AQP1;ANXA1;HTR2B;IFIT2;THBS1;PDPN;RASGRF2;RPS3A;CASP8;GSTP1;UBC;CTSH;FHL2;SKP2;MT3;NAA38;ZNF420;CLU;SFRP1;PLK3;FZD9;CX3CL1;ITGB3BP;PTMA;CLEC5A;CLN3;XBP1;PLEKHG2;RIPK2;TP53I3;TNFRSF10A;CDK5;ARHGAP10;CD74;APH1A;ARHGEF3;MIEN1;ARHGEF18;BEX2;HRK;HTRA2;TNFRSF12A;COPS5;BAG1;WNT5A;CRYAB;DDX20
prerank,GO_Biological_Process_2021__regulation of establishment of protein localization to mitochondrion (GO:1903747),-0.42398207220789097,-0.7275623121569711,0.7735849056603774,1.0,1.0,4/7,23.96%,ATP5IF1;SREBF1;HAX1;PINK1
prerank,GO_Biological_Process_2021__positive regulation of growth (GO:0045927),0.285230772204107,0.7275426021315642,0.9130434782608695,0.9665777833702965,1.0,17/56,21.04%,EGFR;ADNP2;RPS6KA3;AKT1;CSNK2A1;PLCB1;PSMD10;DERL2;TGFBR1;RPTOR;BCL2;USP47;CDKN2AIP;PPM1F;ZNF639;CIB1;ZPR1
prerank,GO_Biological_Process_2021__peptidyl-proline hydroxylation to 4-hydroxy-L-proline (GO:0018401),-0.4469060757787535,-0.7273966805394151,0.86,1.0,1.0,2/6,10.61%,P4HA3;P4HTM
prerank,GO_Biological_Process_2021__cellular response to organic cyclic compound (GO:0071407),-0.28230711757190385,-0.7270690505940535,0.9178082191780822,1.0,1.0,13/112,13.14%,POU4F1;CFTR;P2RY12;AQP1;KCNQ1;IGFBP5;BLM;FES;P2RY6;SFRP1;IL18;BRCA1;RAMP3
prerank,GO_Biological_Process_2021__regulation of oxidative phosphorylation (GO:0002082),-0.3703602664288443,-0.7270187420013188,0.7936507936507936,1.0,1.0,3/14,13.93%,COX7A1;SLC25A33;COX7A2
prerank,GO_Biological_Process_2021__positive regulation of histone H3-K4 methylation (GO:0051571),-0.4016513142486578,-0.7268994430019307,0.875,1.0,1.0,3/12,14.92%,BRCA1;CTR9;SNW1
prerank,GO_Biological_Process_2021__phosphatidylcholine acyl-chain remodeling (GO:0036151),-0.34907850545636265,-0.7268790418543847,0.859375,1.0,1.0,1/19,6.24%,PLB1
prerank,GO_Biological_Process_2021__valine metabolic process (GO:0006573),0.45096985310271587,0.7268754645037859,0.7954545454545454,0.966984135630684,1.0,1/5,21.60%,HIBCH
prerank,GO_Biological_Process_2021__negative regulation of RIG-I signaling pathway (GO:0039536),0.44270390733106496,0.7267591829631126,0.7727272727272727,0.9668140435267315,1.0,1/6,11.30%,SEC14L1
prerank,GO_Biological_Process_2021__regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),0.41655066739732016,0.7261062041595886,0.7916666666666666,0.9671466264156023,1.0,2/7,16.88%,CAMK2D;PDE4D
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),-0.4004603580044822,-0.725795416609264,0.7142857142857143,1.0,1.0,2/11,15.71%,DDIT3;CREB3L1
prerank,GO_Biological_Process_2021__B cell homeostasis (GO:0001782),-0.44230432498686745,-0.725665323440409,0.8461538461538461,1.0,1.0,7/7,55.79%,CAMLG;PPP2R3C;DOCK11;TNFAIP3;LYN;MEF2C;DOCK10
prerank,GO_Biological_Process_2021__protein deglycosylation (GO:0006517),-0.4236489336144535,-0.7256148742975005,0.746268656716418,1.0,1.0,3/8,21.34%,AGA;MAN2A2;PARK7
prerank,GO_Biological_Process_2021__negative regulation of T cell differentiation (GO:0045581),-0.4593746590782244,-0.7255608389900627,0.8688524590163934,1.0,1.0,1/6,2.16%,IRF1
prerank,GO_Biological_Process_2021__regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),-0.3713978751951769,-0.7254211965982585,0.8448275862068966,1.0,1.0,5/19,15.71%,SELENOS;DDIT3;CREB3;XBP1;CREB3L1
prerank,GO_Biological_Process_2021__positive regulation of transcription by RNA polymerase III (GO:0045945),0.3952811210574898,0.7251683222374254,0.9090909090909091,0.9679813639298085,1.0,5/10,32.81%,RPTOR;ICE1;MTOR;ICE2;CHD8
prerank,GO_Biological_Process_2021__transcription initiation from RNA polymerase I promoter (GO:0006361),-0.34794549011079556,-0.7251037445404671,0.8524590163934426,1.0,1.0,6/31,21.52%,TAF1D;POLR2L;POLR1C;POLR2K;TBP;CDK7
prerank,GO_Biological_Process_2021__protein-containing complex disassembly (GO:0032984),-0.3197335121836176,-0.7248891848207013,0.9078947368421053,1.0,1.0,1/46,0.62%,RPL23
prerank,GO_Biological_Process_2021__positive regulation of macromolecule metabolic process (GO:0010604),-0.2648015274433231,-0.7247664006126276,0.9882352941176471,1.0,1.0,27/254,13.14%,POU4F1;RPL23;WARS1;MUSK;OVOL2;KLF2;RPL11;RPS7;CD63;SFRP4;FGF7;TTN;RPL5;RDX;PIK3CB;CTSH;SLC11A1;TLR3;WNT3;MT3;FGF1;KLF4;CLU;BRCA1;ID2;DTX3L;RAMP3
prerank,GO_Biological_Process_2021__positive regulation of mesenchymal cell proliferation (GO:0002053),-0.4108828232812621,-0.7246944702197186,0.8125,1.0,1.0,1/7,3.14%,STAT1
prerank,GO_Biological_Process_2021__response to UV-B (GO:0010224),-0.4629001317540432,-0.7246341716835873,0.7884615384615384,1.0,1.0,2/8,8.30%,IL12A;HYAL1
prerank,GO_Biological_Process_2021__regulation of ruffle assembly (GO:1900027),-0.37470433105614387,-0.7242790938374769,0.8333333333333334,1.0,1.0,5/17,18.04%,P2RY12;RDX;EPS8L2;PFN1;PFN2
prerank,"GO_Biological_Process_2021__wound healing, spreading of epidermal cells (GO:0035313)",-0.4390469814574422,-0.7242088815420715,0.7894736842105263,1.0,1.0,3/6,10.25%,ITGA5;COL5A1;PLET1
prerank,GO_Biological_Process_2021__negative regulation of protein metabolic process (GO:0051248),0.2777789880340095,0.7239259116191722,0.9736842105263158,0.9692218085036461,1.0,9/37,20.35%,EGFR;NFKB1;AGAP2;SIRT2;MDM4;SF3B3;ROCK1;ADGRB1;FMN2
prerank,GO_Biological_Process_2021__regulation of vesicle fusion (GO:0031338),-0.4443150298781789,-0.7238940313597144,0.8983050847457628,1.0,1.0,1/8,4.63%,ANXA1
prerank,GO_Biological_Process_2021__negative regulation of striated muscle cell differentiation (GO:0051154),0.37350967471662977,0.7238914814347148,0.7777777777777778,0.9689383619421318,1.0,3/12,12.84%,BMP2;SOX6;HDAC4
prerank,GO_Biological_Process_2021__gluconeogenesis (GO:0006094),-0.32801592283887154,-0.723850255282823,0.8870967741935484,1.0,1.0,12/33,24.62%,GAPDHS;ALDOB;GPI;SLC25A1;PCK2;PGAM1;GAPDH;ENO1;FBP1;SLC39A14;SLC25A10;TPI1
prerank,GO_Biological_Process_2021__nerve growth factor signaling pathway (GO:0038180),0.3875096647065854,0.723653238749002,0.8378378378378378,0.9689201404257513,1.0,3/7,13.90%,RAPGEF2;MAGI2;RAP1A
prerank,GO_Biological_Process_2021__positive regulation of activin receptor signaling pathway (GO:0032927),0.4471531482227257,0.7235467593954428,0.7692307692307693,0.9687159109548404,1.0,2/5,13.83%,SMAD2;ACVR2A
prerank,GO_Biological_Process_2021__aortic valve morphogenesis (GO:0003180),-0.37053883316302444,-0.7233268001623521,0.8208955223880597,1.0,1.0,2/20,6.39%,EFNA1;ELN
prerank,GO_Biological_Process_2021__negative regulation of response to stimulus (GO:0048585),-0.31659565879166685,-0.7226716489736983,0.8714285714285714,1.0,1.0,6/43,16.31%,KLF4;CLU;HHIP;ERBB3;AQP11;SPINK5
prerank,GO_Biological_Process_2021__purine nucleobase biosynthetic process (GO:0009113),0.43034850215229004,0.7225996893214421,0.8409090909090909,0.9694528744417608,1.0,1/6,7.91%,GMPS
prerank,GO_Biological_Process_2021__rRNA methylation (GO:0031167),-0.368093195218371,-0.7224637307490352,0.8360655737704918,1.0,1.0,3/19,8.13%,BUD23;EMG1;TRMT112
prerank,GO_Biological_Process_2021__positive regulation of production of molecular mediator of immune response (GO:0002702),0.35670216684937867,0.7223973773815969,0.8974358974358975,0.9693443649274709,1.0,1/16,1.31%,TNFSF4
prerank,GO_Biological_Process_2021__regulation of protein targeting (GO:1903533),-0.45984912203865114,-0.7223734046255393,0.7924528301886793,1.0,1.0,4/5,23.96%,ATP5IF1;SREBF1;HAX1;PINK1
prerank,MSigDB_Hallmark_2020__Myc Targets V2,-0.3060115719023126,-0.7218446169991152,0.95,1.0,1.0,15/50,23.49%,DDX18;GNL3;HK2;SORD;NIP7;LAS1L;IMP4;CBX3;NOP16;NPM1;MPHOSPH10;PLK4;HSPD1;TMEM97;AIMP2
prerank,GO_Biological_Process_2021__negative regulation of DNA-dependent DNA replication (GO:2000104),-0.38227489490752997,-0.7209987450001213,0.8461538461538461,1.0,1.0,2/12,20.62%,BLM;DONSON
prerank,GO_Biological_Process_2021__regulation of protein lipidation (GO:1903059),-0.47732458512782133,-0.7209852699488148,0.8108108108108109,1.0,1.0,2/5,21.14%,SVIP;DBI
prerank,GO_Biological_Process_2021__regulation of centrosome cycle (GO:0046605),0.32807261749965844,0.7206231704338288,0.8928571428571429,0.9711392635160403,1.0,3/19,13.01%,CHMP1A;CHMP2B;SIRT1
prerank,GO_Biological_Process_2021__cellular response to drug (GO:0035690),0.3543675741002927,0.7205224579860237,0.8461538461538461,0.970962697655044,1.0,8/17,25.15%,PPM1E;KCNH2;TFRC;RAP2A;PPM1F;REST;PDE4B;GAS6
prerank,GO_Biological_Process_2021__regulation of establishment of planar polarity (GO:0090175),-0.2863756961097978,-0.7196241097056261,0.971830985915493,1.0,1.0,9/77,14.19%,PSMB6;PSMA8;PSMB9;PSMA7;PSMC3;PSME1;PSMC4;PSMA3;PFN1
prerank,GO_Biological_Process_2021__negative regulation of protein serine/threonine kinase activity (GO:0071901),-0.3039258173516802,-0.7195863496985042,0.8690476190476191,1.0,1.0,8/66,11.67%,PAQR3;HEXIM1;PIK3CB;GSTP1;SLC8A3;CAV3;DUSP1;APOE
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair (GO:2000781),0.2949843797714133,0.7194073740570835,0.9428571428571428,0.9719285930770931,1.0,1/36,0.62%,SPIRE2
prerank,GO_Biological_Process_2021__negative regulation of cell death (GO:0060548),-0.29627148428879696,-0.7192684277887551,0.9714285714285714,1.0,1.0,8/70,11.22%,POU4F1;PM20D1;HTR2B;CCN1;LRPAP1;CHMP2A;MT3;CLU
prerank,GO_Biological_Process_2021__negative regulation of histone acetylation (GO:0035067),0.37736260083027523,0.7191797295793608,0.92,0.971864384308474,1.0,3/11,13.01%,SNCA;ZNF451;SIRT1
prerank,GO_Biological_Process_2021__negative regulation of MAPK cascade (GO:0043409),-0.3011335143116902,-0.7191470728885092,0.8974358974358975,1.0,1.0,8/72,11.67%,GBP1;PAQR3;PIK3CB;GSTP1;FOXM1;CAV3;DUSP1;APOE
prerank,GO_Biological_Process_2021__positive regulation of blood vessel endothelial cell migration (GO:0043536),0.30920919596674984,0.7190986421011996,1.0,0.9716033999565656,1.0,10/39,22.98%,HDAC9;AKT1;HMGB1;PRKD1;SIRT1;HIF1A;CIB1;AKT3;PRKCA;FGF2
prerank,GO_Biological_Process_2021__cardiolipin acyl-chain remodeling (GO:0035965),-0.4474744284902476,-0.7188906652483167,0.8181818181818182,1.0,1.0,2/6,24.46%,HADHA;PLA2G4A
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection morphogenesis (GO:0120039),0.28118751533065395,0.7185202502581293,0.9642857142857143,0.9719722016715119,1.0,16/45,26.27%,GPM6A;TNIK;MAP4K4;NCKAP1;NBL1;TAOK2;BMP7;WASF1;ALS2;DNM2;TRIO;CNTNAP2;SNX1;TAOK1;NYAP2;DICER1
prerank,GO_Biological_Process_2021__histone monoubiquitination (GO:0010390),-0.34850466219175025,-0.7183934510487225,0.8,1.0,1.0,3/24,13.65%,RAG1;DTX3L;CTR9
prerank,GO_Biological_Process_2021__regulation of transposition (GO:0010528),0.3695213043354706,0.718243326316955,0.8333333333333334,0.9719698592237691,1.0,2/13,8.49%,PIWIL4;APOBEC3F
prerank,GO_Biological_Process_2021__tricuspid valve development (GO:0003175),0.46728714165410834,0.7179122280810685,0.8367346938775511,0.9719619007574041,1.0,2/5,14.10%,TGFBR2;BMPR1A
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell differentiation (GO:1905063),0.44807297886536224,0.7174909003536705,0.8823529411764706,0.9721504972193807,1.0,4/6,28.45%,NFATC3;NFATC2;NFATC1;KIT
prerank,GO_Biological_Process_2021__response to X-ray (GO:0010165),0.3808075613771032,0.7173703712288158,0.9523809523809523,0.9719684552986936,1.0,5/13,18.51%,LIG4;NIPBL;MSH2;BRCC3;XRCC4
prerank,GO_Biological_Process_2021__histone H2A ubiquitination (GO:0033522),-0.36093294916449953,-0.717353178986146,0.8,1.0,1.0,2/17,19.58%,DTX3L;RNF8
prerank,GO_Biological_Process_2021__glycogen metabolic process (GO:0005977),0.3347428600324952,0.7170571515626452,0.92,0.9719156107363888,1.0,6/24,18.44%,PGM2;NR1D1;UGP2;GSK3B;PGM1;PYGB
prerank,GO_Biological_Process_2021__unsaturated fatty acid biosynthetic process (GO:0006636),0.3960359111944392,0.7169143025804036,0.8085106382978723,0.971767433752967,1.0,1/7,4.31%,SCD5
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle cell proliferation (GO:0048662),-0.33072275187668326,-0.7167287501589407,0.9014084507042254,1.0,1.0,7/24,24.25%,IL12A;IGFBP5;OGN;GPER1;VIP;TRIB1;APLN
prerank,GO_Biological_Process_2021__regulation of protein modification process (GO:0031399),-0.3149883677401571,-0.7165071451471915,0.8450704225352113,1.0,1.0,5/42,10.41%,WARS1;ATG14;PPIB;STAT2;MT3
prerank,GO_Biological_Process_2021__nucleotide biosynthetic process (GO:0009165),-0.3882550194620708,-0.7164691922760428,0.7846153846153846,1.0,1.0,5/15,18.88%,NMNAT3;PNP;PRPS1;PPAT;PRPSAP1
prerank,GO_Biological_Process_2021__negative regulation of mRNA 3'-end processing (GO:0031441),0.4016414265284719,0.7162482507066326,0.7727272727272727,0.9722081981894787,1.0,1/9,4.68%,ZC3H14
prerank,GO_Biological_Process_2021__lipopolysaccharide-mediated signaling pathway (GO:0031663),-0.4097405552652255,-0.7159621980203987,0.8709677419354839,1.0,1.0,5/12,17.73%,IL18;CD14;CCL2;PTPN22;CD6
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen (GO:0002478),-0.29367042132129917,-0.715500214516102,0.9027777777777778,1.0,1.0,4/78,5.85%,CENPE;HLA-A;KIF2C;CTSL
prerank,GO_Biological_Process_2021__oxidative DNA demethylation (GO:0035511),0.44750093415135317,0.7154156880784001,0.9148936170212766,0.9728336610489531,1.0,1/5,4.11%,FTO
prerank,GO_Biological_Process_2021__calcium ion transport into cytosol (GO:0060402),-0.3877471407894174,-0.7153334028553998,0.8571428571428571,1.0,1.0,2/19,4.95%,JPH3;GRIN2D
prerank,GO_Biological_Process_2021__protein modification process (GO:0036211),-0.30462264035380954,-0.7151542073473877,0.9,1.0,1.0,5/67,8.59%,USP6;GGCX;ST3GAL6;PHEX;UBL5
prerank,GO_Biological_Process_2021__N-acetylneuraminate catabolic process (GO:0019262),-0.4130032707546632,-0.7149341318435017,0.8360655737704918,1.0,1.0,1/6,19.10%,GNPDA1
prerank,GO_Biological_Process_2021__midbrain dopaminergic neuron differentiation (GO:1904948),0.42746117957746005,0.7147755642958049,0.851063829787234,0.9731728834106466,1.0,1/7,3.17%,NR4A2
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),-0.31312428196563546,-0.7145335754110552,0.8805970149253731,1.0,1.0,8/33,17.15%,THBS1;TMC8;CASP8;SFRP1;BRCA1;TNFRSF10A;SP100;ICAM1
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway (GO:2001236),-0.302186566249576,-0.7145025735892843,0.9315068493150684,1.0,1.0,14/55,21.34%,BCL2L14;THBS1;TMC8;CASP8;GSTP1;LTBR;TNFRSF10A;SP100;TNFRSF12A;GPER1;NOL3;AGT;AR;PARK7
prerank,GO_Biological_Process_2021__sodium-independent organic anion transport (GO:0043252),-0.41645756276662127,-0.7140205544226025,0.8679245283018868,1.0,1.0,2/8,26.32%,SLCO3A1;SLCO2B1
prerank,GO_Biological_Process_2021__regulation of granulocyte differentiation (GO:0030852),-0.44075777127455673,-0.7138398756624573,0.782608695652174,1.0,1.0,1/7,4.51%,CEACAM1
prerank,GO_Biological_Process_2021__cellular response to estradiol stimulus (GO:0071392),-0.381326319883172,-0.7137496500503248,0.9137931034482759,1.0,1.0,1/15,0.33%,POU4F1
prerank,GO_Biological_Process_2021__mitotic nuclear division (GO:0140014),0.27436547487085755,0.713382081644562,1.0,0.9744586514282185,1.0,4/58,4.31%,KIFC2;ZNF207;EPS8;NSL1
prerank,GO_Biological_Process_2021__triglyceride metabolic process (GO:0006641),-0.3415921079612386,-0.7132725620862881,0.8507462686567164,1.0,1.0,5/31,11.67%,LIPI;PNPLA3;FABP3;CAV3;APOE
prerank,GO_Biological_Process_2021__nucleic acid-templated transcription (GO:0097659),-0.31997398407352035,-0.7132589770840356,0.875,1.0,1.0,10/36,20.46%,RRAGC;PTMA;POLR2I;DRG1;POLR2L;POLR2J;PAX8;POLR2G;SCX;POLR2K
prerank,GO_Biological_Process_2021__cellular response to epidermal growth factor stimulus (GO:0071364),-0.33856954095288194,-0.7132128455556559,0.8852459016393442,1.0,1.0,2/25,5.76%,VIL1;KNSTRN
prerank,GO_Biological_Process_2021__sensory perception of smell (GO:0007608),0.39026869897935507,0.712991877431685,0.7948717948717948,0.9744722667237458,1.0,5/9,19.34%,OR9Q1;UBR3;MKKS;SLC24A4;DRD2
prerank,GO_Biological_Process_2021__positive regulation of leukocyte cell-cell adhesion (GO:1903039),-0.3616393304336947,-0.7128713208270082,0.890625,1.0,1.0,5/19,21.11%,PRKCQ;CCL2;SKAP1;HLA-DPB1;HSPD1
prerank,GO_Biological_Process_2021__histone H3-K4 trimethylation (GO:0080182),-0.3932385482159795,-0.7127568355814015,0.8548387096774194,1.0,1.0,2/12,13.65%,PRDM7;CTR9
prerank,GO_Biological_Process_2021__protein kinase C signaling (GO:0070528),-0.43421122865598993,-0.7123073356316014,0.8507462686567164,1.0,1.0,1/6,4.80%,HTR2B
prerank,PanglaoDB_Augmented_2021__Pinealocytes,-0.30690239636483674,-0.7120836167631494,0.9452054794520548,1.0,1.0,12/64,20.55%,KCNB1;PDE6B;PDE6C;SV2C;RNFT2;MYO15A;AIPL1;CABP4;SLC7A14;ASMT;OPRM1;MCF2L2
prerank,GO_Biological_Process_2021__negative regulation of cellular protein metabolic process (GO:0032269),-0.27882912147906974,-0.7119499584028799,1.0,1.0,1.0,11/76,16.08%,PATL2;TYMS;IGFBP5;RPL13A;CSTB;CST3;APOE;EIF2AK2;CLN3;CDK5;IGF2BP3
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell migration (GO:0014911),0.3622505759868107,0.7118945099341997,0.8611111111111112,0.9753816170463726,1.0,4/12,17.75%,DOCK7;DOCK4;NRP1;IGF1
prerank,GO_Biological_Process_2021__polyphosphate catabolic process (GO:0006798),-0.45330537252909453,-0.7118226496927497,0.8235294117647058,1.0,1.0,2/5,28.17%,BNIP2;PRUNE2
prerank,GO_Biological_Process_2021__regulation of anion channel activity (GO:0010359),0.44419198703310336,0.7117436108162845,0.7619047619047619,0.975204626712611,1.0,2/5,25.73%,GRM5;TCAF1
prerank,GO_Biological_Process_2021__negative regulation of neuron projection development (GO:0010977),0.27619480579461597,0.7112514298761137,0.9259259259259259,0.9753634318125303,1.0,21/50,26.85%,EPHA4;KANK1;HDAC2;RTN4RL1;EFNB2;PTPN9;KIAA0319;DCC;RUFY3;PTPRO;PTEN;LRP4;ARHGDIA;CIB1;NLGN1;ADCY6;CBFA2T2;FKBP4;PTPRS;BAG5;MCF2
prerank,GO_Biological_Process_2021__secondary alcohol metabolic process (GO:1902652),0.28526426974746905,0.7111934051329011,0.8484848484848485,0.9751306421128423,1.0,3/30,9.63%,ABCA1;STARD3;NSDHL
prerank,GO_Biological_Process_2021__cellular response to fibroblast growth factor stimulus (GO:0044344),0.26328381280190166,0.7110841558043315,0.967741935483871,0.9748756485358148,1.0,8/66,8.96%,HNRNPH1;SPRED2;FLRT2;FGF17;CBL;SPRED1;SHOC2;RBFOX2
prerank,GO_Biological_Process_2021__positive regulation of binding (GO:0051099),-0.2941869709137585,-0.71106848225541,0.9452054794520548,1.0,1.0,9/73,14.02%,RPL11;B2M;DDX11;TRIM21;HES1;APOE;DTX3L;EDF1;RIPK2
prerank,GO_Biological_Process_2021__postreplication repair (GO:0006301),-0.31543144208455487,-0.7108090348716958,0.9014084507042254,1.0,1.0,5/41,12.47%,RPS27A;ISG15;RPA3;UBC;BRCA1
prerank,GO_Biological_Process_2021__cGMP-mediated signaling (GO:0019934),0.3656886452889057,0.7107500396877253,0.8604651162790697,0.9749729260376876,1.0,3/11,5.24%,PDE3A;HTR2C;GUCY1B1
prerank,GO_Biological_Process_2021__integrin-mediated signaling pathway (GO:0007229),-0.2997413797906538,-0.7107422118780135,0.9367088607594937,1.0,1.0,5/61,7.43%,ITGA5;ISG15;CEACAM1;FYB2;ANGPTL3
prerank,GO_Biological_Process_2021__cellular response to mechanical stimulus (GO:0071260),-0.3225817359765318,-0.7107080814166329,0.8656716417910447,1.0,1.0,5/37,11.57%,IRF1;AQP1;CASP8;TLR3;LTBR
prerank,GO_Biological_Process_2021__oligosaccharide metabolic process (GO:0009311),0.28645752190014373,0.7105285879185278,0.8974358974358975,0.974896942262294,1.0,2/34,2.74%,ST6GALNAC5;FUT9
prerank,GO_Biological_Process_2021__negative regulation of calcium ion transmembrane transporter activity (GO:1901020),0.3295474253674091,0.7102142333132863,0.7804878048780488,0.9748824456189971,1.0,8/19,22.43%,GSTM2;PKD2;CBARP;UBQLN1;DRD2;FMR1;THADA;GPR35
prerank,GO_Biological_Process_2021__atrial cardiac muscle cell to AV node cell signaling (GO:0086026),0.4443630685417892,0.7101240079661524,0.8823529411764706,0.974655800446891,1.0,1/5,2.35%,ANK2
prerank,"GO_Biological_Process_2021__synaptic transmission, GABAergic (GO:0051932)",0.3715270401269438,0.7100141404213545,0.8297872340425532,0.9744237287170302,1.0,3/11,12.88%,GABRG1;GABRA4;GABRA5
prerank,GO_Biological_Process_2021__mitotic DNA integrity checkpoint signaling (GO:0044774),0.3836409792675994,0.7095788492702032,0.8947368421052632,0.9746158426996023,1.0,3/10,41.22%,TICRR;STK33;NAE1
prerank,GO_Biological_Process_2021__membrane repolarization during cardiac muscle cell action potential (GO:0086013),-0.38640382789267774,-0.7091765718957744,0.9019607843137255,1.0,1.0,5/13,25.77%,KCNQ1;KCNJ8;ATP1A1;ATP1B1;KCNN2
prerank,GO_Biological_Process_2021__response to progesterone (GO:0032570),-0.39520017507543725,-0.7091144221354053,0.875,1.0,1.0,1/15,5.73%,THBS1
prerank,GO_Biological_Process_2021__regulation of tyrosine phosphorylation of STAT protein (GO:0042509),-0.31791692246975645,-0.7091022580023193,0.9104477611940298,1.0,1.0,4/37,12.13%,PARP14;IL12A;HES1;IL18
prerank,GO_Biological_Process_2021__positive regulation of amyloid precursor protein catabolic process (GO:1902993),0.32150959173677857,0.709089835628716,0.8974358974358975,0.9748245578977919,1.0,4/18,15.41%,PICALM;EPHA4;ABCA2;ROCK2
prerank,GO_Biological_Process_2021__regulation of mitochondrial translation (GO:0070129),0.3284628036118772,0.7090654799219893,0.8604651162790697,0.9745201843796324,1.0,3/20,18.10%,NSUN3;MRPS27;FASTKD3
prerank,GO_Biological_Process_2021__response to lipopolysaccharide (GO:0032496),-0.2832200065434277,-0.7090441778935489,0.9571428571428572,1.0,1.0,17/87,17.73%,SELP;CXCL2;SELENOS;IL12A;GSTP1;LY96;SLC11A1;PDCD1LG2;CD14;CTR9;NOS1;XBP1;CCL2;CD274;WNT5A;PTPN22;CD6
prerank,GO_Biological_Process_2021__negative regulation of lipid biosynthetic process (GO:0051055),0.33709857589761416,0.7089174092084525,0.9024390243902439,0.9743943736359165,1.0,5/17,13.78%,BMP2;FBXW7;ACADVL;ABCA2;ASXL3
prerank,PanglaoDB_Augmented_2021__Salivary Mucous Cells,-0.3606745959508232,-0.7087914800006678,0.890625,1.0,1.0,7/19,17.03%,ADIRF;THBS1;MGP;TRIM29;IL20RA;DUOXA1;EMP2
prerank,GO_Biological_Process_2021__chemokine-mediated signaling pathway (GO:0070098),-0.3746841890096144,-0.708784648821053,0.8548387096774194,1.0,1.0,4/15,18.79%,CXCL2;CX3CL1;CCL2;THPO
prerank,GO_Biological_Process_2021__regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),0.3089018168780037,0.7085277576257244,0.8928571428571429,0.9745360905200684,1.0,11/31,24.64%,SOX9;NFIB;FOXO3;NR3C1;HIF1A;NFATC3;REST;ATOH8;FGF2;TEAD1;SMAD3
prerank,GO_Biological_Process_2021__chaperone-mediated protein complex assembly (GO:0051131),0.31874271848144814,0.7085079190649949,0.85,0.9742265563130457,1.0,8/19,23.37%,PSMG3;BBS10;MKKS;PTGES3;HSPA4;PSMG2;HSPA1A;PSMG1
prerank,GO_Biological_Process_2021__vasculature development (GO:0001944),0.3927615195792368,0.7084778007342155,0.825,0.9739395044725677,1.0,4/10,16.28%,PDGFRA;PIK3CA;FBXW7;STK11
prerank,GO_Biological_Process_2021__iron import into cell (GO:0033212),-0.4364487937945024,-0.7083227004924004,0.8360655737704918,1.0,1.0,2/5,23.42%,TFR2;SLC39A14
prerank,GO_Biological_Process_2021__regulation of smooth muscle contraction (GO:0006940),-0.38467821667231084,-0.7075666456327826,0.864406779661017,1.0,1.0,2/14,8.69%,CHRM2;SRF
prerank,GO_Biological_Process_2021__negative regulation of cellular component organization (GO:0051129),0.25914142933469586,0.7074328162650922,1.0,0.9746767955481918,1.0,17/65,22.99%,CARMIL1;WASL;DNAJB2;FAP;EP300;PRKD1;PEX5;SACS;DNAJB6;GSK3B;MTMR2;IMPACT;DNM2;TMEFF2;HSPA1A;AIDA;LRSAM1
prerank,GO_Biological_Process_2021__negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),-0.3450074824553393,-0.7072190932667942,0.9375,1.0,1.0,3/27,13.87%,RPL11;SVIP;GIPC1
prerank,GO_Biological_Process_2021__negative regulation of bone remodeling (GO:0046851),-0.43206957761131043,-0.7071795755415278,0.8846153846153846,1.0,1.0,1/7,11.83%,SFRP1
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte proliferation (GO:0050672),0.34898666657889343,0.7071783563161795,0.8387096774193549,0.9746234791402434,1.0,2/15,12.88%,SDC4;DLG5
prerank,GO_Biological_Process_2021__regulation of complement-dependent cytotoxicity (GO:1903659),0.47029081949887175,0.7071408832017227,0.8571428571428571,0.9743421473826686,1.0,3/5,36.65%,CD59;TGFB2;CD55
prerank,GO_Biological_Process_2021__amyloid fibril formation (GO:1990000),-0.31531681190950084,-0.7068602460074348,0.8985507246376812,1.0,1.0,5/38,11.74%,RPS27A;B2M;UBC;CST3;CALB1
prerank,GO_Biological_Process_2021__protein localization to plasma membrane (GO:0072659),0.2457432119948337,0.7068323592799746,1.0,0.9743557050924851,1.0,33/120,22.00%,ANK2;EPHA2;TSPAN14;PACS1;TSPAN17;NECTIN3;DENND4C;TNIK;EHD4;RAPGEF2;RAB8B;EFR3A;ASB3;MRAP;SMURF1;TTC7B;AFDN;BSG;TSPAN33;RAP1A;DLG1;ROCK2;CACNB3;RAP2A;MYO5A;WNK3;ROCK1;RAB10;TSPAN5;SLMAP;GORASP2;ZDHHC2;TTC7A
prerank,GO_Biological_Process_2021__covalent chromatin modification (GO:0016569),0.35667814242039925,0.706495776588008,0.9714285714285714,0.9743748120431119,1.0,5/12,20.76%,MBD2;HELLS;SIRT1;CHD1;SETD5
prerank,GO_Biological_Process_2021__icosanoid transport (GO:0071715),0.39676154502087735,0.7064085303444763,0.8913043478260869,0.9741494170972237,1.0,2/9,12.53%,ABCC2;ABCC3
prerank,GO_Biological_Process_2021__regulation of multicellular organism growth (GO:0040014),-0.3746982066635007,-0.7063064162261186,0.8518518518518519,1.0,1.0,1/14,8.24%,PPIB
prerank,MSigDB_Hallmark_2020__Myogenesis,-0.2769555620118583,-0.7055387835241144,1.0,1.0,1.0,19/141,17.39%,TNNT1;SPARC;COX7A1;APLNR;SVIL;CACNA1H;COL6A2;FABP3;CAV3;CLU;SOD3;ERBB3;NOS1;MYL6B;FDPS;COL4A2;BAG1;CRYAB;AEBP1
prerank,GO_Biological_Process_2021__nitric oxide mediated signal transduction (GO:0007263),0.3680503890843011,0.7055167364411095,0.7906976744186046,0.9746907209917258,1.0,4/10,17.44%,GUCY1B1;DDAH1;NDNF;KCNC2
prerank,"GO_Biological_Process_2021__posttranslational protein targeting to membrane, translocation (GO:0031204)",-0.4463136160900637,-0.7050395133638077,0.9193548387096774,1.0,1.0,1/7,12.36%,SEC62
prerank,"GO_Biological_Process_2021__neurotransmitter receptor transport, endosome to plasma membrane (GO:0099639)",-0.43768608230884254,-0.7049920759906104,0.8928571428571429,1.0,1.0,1/7,5.81%,RAB11A
prerank,GO_Biological_Process_2021__negative regulation of sequestering of calcium ion (GO:0051283),0.31227204114513457,0.7049906970593383,0.9642857142857143,0.9749762288782593,1.0,7/19,24.55%,HTR2C;PKD2;DRD2;PTPRC;FGF2;IBTK;TRPM2
prerank,GO_Biological_Process_2021__regulation of gluconeogenesis (GO:0006111),-0.3358612444815845,-0.7048921650583745,0.873015873015873,1.0,1.0,3/21,9.32%,MST1;SELENOS;PGP
prerank,GO_Biological_Process_2021__positive regulation of glycoprotein biosynthetic process (GO:0010560),-0.40149330253664994,-0.7046884534665794,0.8135593220338984,1.0,1.0,1/11,4.61%,SLC51B
prerank,GO_Biological_Process_2021__regulation of granulocyte chemotaxis (GO:0071622),0.31319834433655813,0.7045634719575827,0.8484848484848485,0.9751005666194392,1.0,4/16,14.21%,CSF1R;BST1;PTK2;MAPK1
prerank,GO_Biological_Process_2021__positive regulation of keratinocyte proliferation (GO:0010838),0.3974440295025104,0.704197036461621,0.8285714285714286,0.9751915258456176,1.0,2/6,10.99%,NOTCH2;TGM1
prerank,GO_Biological_Process_2021__regulation of neurotransmitter transport (GO:0051588),0.32374137408914605,0.7039098556933823,0.8529411764705882,0.9751492918993925,1.0,3/14,23.27%,CAMK2A;FMR1;HCRT
prerank,GO_Biological_Process_2021__macromolecule modification (GO:0043412),-0.4379604260755979,-0.7036339067632787,0.8448275862068966,1.0,1.0,1/8,6.00%,ST6GAL1
prerank,GO_Biological_Process_2021__cellular response to ketone (GO:1901655),0.3058302439712346,0.7035888149104489,0.8888888888888888,0.9751403581750769,1.0,8/32,15.41%,TNFSF4;ADCY1;NR3C1;GOLPH3;AHR;GNAI1;KLF9;ROCK2
prerank,PanglaoDB_Augmented_2021__Adipocyte Progenitor Cells,-0.276147522350096,-0.703039878770798,0.9868421052631579,1.0,1.0,12/74,20.41%,LMOD1;COL5A1;IGFBP5;LAMB1;EDNRA;COL4A2;CALD1;COL14A1;GLI1;EHD2;AMOTL2;COL4A1
prerank,GO_Biological_Process_2021__regulation of NLRP3 inflammasome complex assembly (GO:1900225),0.4050847085772786,0.7028383634231102,0.9,0.9756802256871849,1.0,1/9,2.98%,STMP1
prerank,GO_Biological_Process_2021__negative regulation of stress-activated protein kinase signaling cascade (GO:0070303),-0.44347494477577376,-0.7022887762189994,0.8541666666666666,1.0,1.0,2/6,9.02%,GSTP1;FOXM1
prerank,GO_Biological_Process_2021__G-quadruplex DNA unwinding (GO:0044806),-0.4345668970576769,-0.7022447198103903,0.8793103448275862,1.0,1.0,2/7,10.79%,DDX11;BLM
prerank,"GO_Biological_Process_2021__positive regulation of synaptic transmission, GABAergic (GO:0032230)",0.42168409624952563,0.7021786394449905,0.8333333333333334,0.975920486012403,1.0,3/5,25.94%,ADRA1A;NLGN1;NLGN2
prerank,GO_Biological_Process_2021__negative regulation of interleukin-17 production (GO:0032700),0.46108153307133404,0.7020747134342724,0.7954545454545454,0.9757063338510699,1.0,1/5,1.31%,TNFSF4
prerank,GO_Biological_Process_2021__purine nucleobase metabolic process (GO:0006144),0.38471948000865275,0.701783631262898,0.8235294117647058,0.9756418460921266,1.0,1/8,7.91%,GMPS
prerank,GO_Biological_Process_2021__negative regulation by symbiont of host programmed cell death (GO:0052041),0.39715094225030523,0.7016930027802962,0.8292682926829268,0.9754445408132348,1.0,2/7,14.21%,SERPINB9;MAPK1
prerank,GO_Biological_Process_2021__negative regulation of Arp2/3 complex-mediated actin nucleation (GO:0034316),-0.4489535829420892,-0.7015648042001945,0.7916666666666666,1.0,1.0,1/6,6.90%,GMFG
prerank,GO_Biological_Process_2021__negative regulation of actin nucleation (GO:0051126),-0.4489535829420892,-0.7015648042001945,0.7916666666666666,1.0,1.0,1/6,6.90%,GMFG
prerank,GO_Biological_Process_2021__negative regulation of cellular process (GO:0048523),-0.2514720338820184,-0.7015379808487506,1.0,1.0,1.0,35/418,12.26%,PRAME;FTH1;SFRP2;WARS1;IRF1;BST2;CD9;IFIT3;SFRP4;HTR2B;SEMA5A;PDPN;IFI35;APOBEC3G;NUDT6;CCN1;LRPAP1;HYAL1;FABP3;CHMP2A;FOXM1;CRLF3;VAMP8;INHA;SST;BTBD18;DUSP1;MT3;BLM;KLF4;CLU;CDKN3;SFRP1;EIF2AK2;PODXL
prerank,GO_Biological_Process_2021__cellular response to osmotic stress (GO:0071470),-0.35708254807685047,-0.7015228090121208,0.8596491228070176,1.0,1.0,3/17,15.92%,AQP1;RCSD1;SLC4A11
prerank,GO_Biological_Process_2021__pattern recognition receptor signaling pathway (GO:0002221),0.2933609008114207,0.7014902378377843,1.0,0.9753525152034586,1.0,8/38,12.58%,IRAK2;TAB3;CTSK;RPS6KA3;MAP3K7;HMGB1;TAB1;MAPKAPK2
prerank,GO_Biological_Process_2021__succinyl-CoA metabolic process (GO:0006104),0.44544088349565525,0.7014716249298273,0.8222222222222222,0.9750392663289802,1.0,3/5,30.64%,SUCLG2;SUCLA2;OGDH
prerank,"GO_Biological_Process_2021__alternative mRNA splicing, via spliceosome (GO:0000380)",-0.3709094520505981,-0.7012131414451538,0.8245614035087719,1.0,1.0,3/14,19.38%,PQBP1;SLU7;SCNM1
prerank,"GO_Biological_Process_2021__positive regulation of mRNA splicing, via spliceosome (GO:0048026)",0.365588440078329,0.7004502956985875,0.8648648648648649,0.9757603892658143,1.0,3/15,18.52%,PRDX6;CELF3;TRA2A
prerank,GO_Biological_Process_2021__regulation of myeloid cell differentiation (GO:0045637),-0.3080135638476324,-0.700401290125165,0.9701492537313433,1.0,1.0,7/54,13.65%,GATA1;THBS1;PRKCQ;FES;SPI1;ZFPM1;CTR9
prerank,GO_Biological_Process_2021__cellular response to corticosteroid stimulus (GO:0071384),0.3675633123788554,0.700154442171502,0.8,0.9756959922075741,1.0,3/12,9.32%,HNRNPU;FAM107A;NR3C1
prerank,GO_Biological_Process_2021__regulation of amyloid precursor protein biosynthetic process (GO:0042984),0.3727160245985725,0.698766395972326,0.926829268292683,0.9768198427796346,1.0,5/11,34.74%,ABCA2;BACE2;AGO2;SOAT1;NECAB2
prerank,GO_Biological_Process_2021__ATF6-mediated unfolded protein response (GO:0036500),-0.4121015893255685,-0.6987125292075893,0.8421052631578947,1.0,1.0,2/9,13.88%,DDIT3;XBP1
prerank,GO_Biological_Process_2021__negative regulation of blood vessel morphogenesis (GO:2000181),-0.2977607052473359,-0.6986108684525151,0.958904109589041,1.0,1.0,9/53,16.62%,SPARC;STAT1;THBS1;ISM1;KLF4;CD160;SERPINF1;SPINK5;COL4A2
prerank,GO_Biological_Process_2021__purine-containing compound catabolic process (GO:0072523),-0.3710722910973495,-0.6983901648844939,0.9,1.0,1.0,2/11,12.86%,PNP;NT5C
prerank,GO_Biological_Process_2021__regulation of mitotic cell cycle (GO:0007346),-0.2617616193072251,-0.6983669605205363,0.9746835443037974,1.0,1.0,19/143,16.27%,PSMB6;FBXO43;KIF20B;ANAPC15;ANAPC11;PSMA8;PSMB9;PSMA7;PSMC3;CAV2;PSME1;CDC26;BORA;PSMC4;PSMA3;BTG1;UBE2S;OBSL1;PTPN3
prerank,"GO_Biological_Process_2021__Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",-0.2784376635086608,-0.6982804122595866,0.9852941176470589,1.0,1.0,9/77,14.19%,PSMB6;PSMA8;PSMB9;PSMA7;PSMC3;PSME1;PSMC4;PSMA3;PFN1
prerank,GO_Biological_Process_2021__positive regulation of membrane protein ectodomain proteolysis (GO:0051044),-0.4108818489578829,-0.6977913405610167,0.8813559322033898,1.0,1.0,2/10,20.29%,APOE;ADAM8
prerank,GO_Biological_Process_2021__regulation of stress-activated MAPK cascade (GO:0032872),0.26507378744106547,0.6973130707933209,0.875,0.9779816069000646,1.0,10/41,20.06%,FOXO1;EGFR;MID1;MAP4K4;MAPK1;TAOK2;RAP2A;FAS;MAP2K2;PHLPP1
prerank,GO_Biological_Process_2021__cardiac muscle cell membrane repolarization (GO:0099622),-0.3950071655184557,-0.6972544300985336,0.8867924528301887,1.0,1.0,1/10,6.80%,KCNQ1
prerank,GO_Biological_Process_2021__negative regulation of neuron death (GO:1901215),-0.2860982051039567,-0.6972118881467978,0.9583333333333334,1.0,1.0,16/79,19.17%,POU4F1;PM20D1;BDNF;MT3;APOE;UNC5B;FZD9;ERBB3;CLN3;CCL2;CDK5;NRBP2;HTRA2;SNX6;VPS35;HLA-F
prerank,GO_Biological_Process_2021__positive regulation of myoblast fusion (GO:1901741),-0.4278998702831057,-0.697164888688679,0.8363636363636363,1.0,1.0,3/6,22.25%,FLOT1;EHD2;EHD1
prerank,GO_Biological_Process_2021__positive regulation of interleukin-10 production (GO:0032733),0.360341231513989,0.6970568800491318,0.85,0.9779330935578645,1.0,2/12,9.68%,TNFSF4;HMGB1
prerank,GO_Biological_Process_2021__intraciliary transport involved in cilium assembly (GO:0035735),-0.315046748104093,-0.6968996231799924,0.9,1.0,1.0,2/36,8.37%,DYNLRB1;DYNLRB2
prerank,GO_Biological_Process_2021__regulation of keratinocyte migration (GO:0051547),-0.3866679995645456,-0.6965486735934906,0.8135593220338984,1.0,1.0,1/9,6.05%,FGF7
prerank,GO_Biological_Process_2021__posttranscriptional regulation of gene expression (GO:0010608),0.27074358677588806,0.6965427309078006,0.9772727272727273,0.9781993062705853,1.0,9/40,19.35%,NUDT21;FOXO3;PUM2;EIF4E;MAPKAPK5;CYFIP1;PUM1;LARP4;ZC3H7A
prerank,GO_Biological_Process_2021__response to nitric oxide (GO:0071731),0.40771287017298175,0.6962759914677666,0.8409090909090909,0.9781728285059182,1.0,2/8,5.24%,FOXO1;GUCY1B1
prerank,GO_Biological_Process_2021__regulation of actin filament bundle assembly (GO:0032231),0.3097397141456719,0.6961147808427174,0.8333333333333334,0.9779698178439747,1.0,6/24,15.41%,SHANK1;PLEK;PRKN;SHANK3;ALMS1;ROCK2
prerank,GO_Biological_Process_2021__negative regulation of immune effector process (GO:0002698),0.35212555934395384,0.69588691793228,0.9,0.9778441589881854,1.0,2/11,13.58%,HAVCR2;FER
prerank,GO_Biological_Process_2021__positive regulation by host of viral transcription (GO:0043923),0.3512305409904784,0.695647732300063,0.9047619047619048,0.9777185848367143,1.0,4/16,20.10%,EP300;CHD1;LEF1;ZNF639
prerank,GO_Biological_Process_2021__regulation of G2/M transition of mitotic cell cycle (GO:0010389),-0.26571202777211356,-0.6956114577134667,1.0,1.0,1.0,21/132,19.79%,PSMB6;CETN2;PSMA8;RAB11A;PSMB9;PSMA7;PSMC3;PSME1;CEP72;PSMC4;CEP135;PSMA3;TPX2;TUBB;DCTN2;CCND1;RBX1;OFD1;CCNB1;SSNA1;CEP76
prerank,GO_Biological_Process_2021__nuclear envelope organization (GO:0006998),0.33307368432635587,0.6954785246596642,0.8095238095238095,0.9775600254970899,1.0,7/17,30.57%,REEP4;LEMD3;TOR1B;DMPK;TOR1AIP1;SUN2;LEMD2
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),0.30780711341978645,0.6952634122612662,0.9318181818181818,0.9774291218578016,1.0,7/17,23.33%,BOK;DCC;BCL2;GSK3B;FAS;CASP3;BCL2L1
prerank,GO_Biological_Process_2021__negative regulation of cell-substrate adhesion (GO:0010812),-0.3165403397737223,-0.6948776312628733,0.8923076923076924,1.0,1.0,5/35,12.24%,GBP1;THBS1;PLET1;NEXMIF;CX3CL1
prerank,GO_Biological_Process_2021__positive regulation of vesicle fusion (GO:0031340),0.39774607801770934,0.6948658325767956,0.7272727272727273,0.977485575748978,1.0,2/6,8.17%,SNCA;DOC2B
prerank,GO_Biological_Process_2021__positive regulation of extracellular matrix organization (GO:1903055),0.3513256252767399,0.6946720586401152,0.875,0.9773107367371004,1.0,2/16,4.09%,BMP2;RGCC
prerank,GO_Biological_Process_2021__regulation of cyclin-dependent protein kinase activity (GO:1904029),-0.28718795343338016,-0.69443965272187,0.9538461538461539,1.0,1.0,10/48,18.52%,CCNE2;CCNB3;CCNB2;BLM;CDKN3;HERC5;CDC37;CCND1;CCNJ;CCNB1
prerank,GO_Biological_Process_2021__modulation by symbiont of host apoptotic process (GO:0052150),0.41544685555117566,0.6943844443416418,0.825,0.9773561840384691,1.0,2/6,14.21%,SERPINB9;MAPK1
prerank,GO_Biological_Process_2021__positive regulation of integrin activation (GO:0033625),-0.39971812659153455,-0.694297277898974,0.8225806451612904,1.0,1.0,1/11,3.42%,P2RY12
prerank,GO_Biological_Process_2021__mitochondrial calcium ion homeostasis (GO:0051560),0.31542512492119057,0.6939984101432835,0.9428571428571428,0.9775391598912968,1.0,2/19,4.36%,MAIP1;MCU
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair via homologous recombination (GO:1905168),0.3489108693103524,0.6937795879860068,0.8958333333333334,0.9774029828332722,1.0,4/12,28.07%,ARID2;WDR48;ERCC6;TIMELESS
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),-0.37199241324725885,-0.6937462520320764,0.9272727272727272,1.0,1.0,2/16,11.33%,IGFBP5;P2RY6
prerank,GO_Biological_Process_2021__positive regulation of histone methylation (GO:0031062),0.3084966140575025,0.6937170677895803,0.8461538461538461,0.9771844173339912,1.0,5/22,18.20%,AUTS2;SIRT1;OGT;SMAD4;JARID2
prerank,GO_Biological_Process_2021__regulation of double-strand break repair via homologous recombination (GO:0010569),0.29422712272173207,0.6923024997149743,0.9655172413793104,0.9782302669185228,1.0,13/40,29.64%,KLHL15;UBQLN4;ARID2;SETD2;KDM1A;WDR48;ERCC6;PPP4R2;PARPBP;TIMELESS;PPP4C;TERF2IP;SMCHD1
prerank,GO_Biological_Process_2021__midbody abscission (GO:0061952),0.3439124230459071,0.6922699133006387,0.8974358974358975,0.9779346407578992,1.0,3/12,19.53%,CHMP1A;CHMP2B;CHMP6
prerank,GO_Biological_Process_2021__cellular response to hexose stimulus (GO:0071331),0.3110164069991114,0.6920726785310648,0.9285714285714286,0.9778095000630754,1.0,2/21,4.08%,SOX4;ZBTB20
prerank,GO_Biological_Process_2021__protein targeting (GO:0006605),-0.27646235881633835,-0.6918960276511341,0.9759036144578314,1.0,1.0,12/108,13.87%,TOMM7;SRPRA;RPL11;NACA;TIMM10;TIMM8B;SPCS1;FIS1;AP4M1;AQP11;CDC37;GIPC1
prerank,GO_Biological_Process_2021__regulation of mast cell degranulation (GO:0043304),-0.431887160487626,-0.6917588449570676,0.8703703703703703,1.0,1.0,1/8,10.87%,FES
prerank,GO_Biological_Process_2021__aminoglycan catabolic process (GO:0006026),0.3181649640865384,0.6915343235228112,0.8709677419354839,0.9779974464966289,1.0,3/25,9.94%,SDC4;GPC5;CTBS
prerank,GO_Biological_Process_2021__negative regulation of fatty acid metabolic process (GO:0045922),-0.379862896336276,-0.6914989412391062,0.8666666666666667,1.0,1.0,2/13,12.47%,CEACAM1;BRCA1
prerank,GO_Biological_Process_2021__positive regulation of pattern recognition receptor signaling pathway (GO:0062208),-0.38275706850524477,-0.6913828539395572,0.8793103448275862,1.0,1.0,2/10,10.28%,DDX60;TLR3
prerank,GO_Biological_Process_2021__microtubule depolymerization (GO:0007019),0.37170809989719444,0.6913222252522406,0.8372093023255814,0.9779437314327641,1.0,3/14,17.87%,NCKAP5;CKAP5;KATNB1
prerank,GO_Biological_Process_2021__glycoprotein biosynthetic process (GO:0009101),-0.2938867429331413,-0.6909958993392097,0.9516129032258065,1.0,1.0,8/64,10.62%,GCNT1;ALG1L2;B3GALT2;ST3GAL6;CHST9;B3GNT5;B3GNT3;CHST10
prerank,GO_Biological_Process_2021__negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),-0.4086213948864271,-0.6909555780805914,0.7727272727272727,1.0,1.0,2/9,8.27%,IL12A;PIK3CB
prerank,GO_Biological_Process_2021__telomere maintenance via telomere trimming (GO:0090737),0.38873236970022107,0.6907701020328161,0.8723404255319149,0.9775360259596433,1.0,1/9,2.95%,DNA2
prerank,GO_Biological_Process_2021__formation of extrachromosomal circular DNA (GO:0001325),0.38873236970022107,0.6907701020328161,0.8723404255319149,0.9775360259596433,1.0,1/9,2.95%,DNA2
prerank,GO_Biological_Process_2021__t-circle formation (GO:0090656),0.38873236970022107,0.6907701020328161,0.8723404255319149,0.9775360259596433,1.0,1/9,2.95%,DNA2
prerank,GO_Biological_Process_2021__supramolecular fiber organization (GO:0097435),-0.2550802101364503,-0.6902915220964293,1.0,1.0,1.0,25/268,12.39%,LMOD1;COL8A1;RPS27A;COL10A1;P4HA3;COL5A1;B2M;RHOBTB2;COL6A2;RND2;KIF2C;COL24A1;MYO1H;TPPP3;COL4A4;PPIB;PPP1R9A;UBC;NLRP5;RHOH;FBLN5;CST3;CALB1;PLK3;COL9A2
prerank,GO_Biological_Process_2021__negative regulation of secretion (GO:0051048),-0.4209721455129087,-0.6901274121487071,0.7962962962962963,1.0,1.0,3/8,15.74%,VAMP8;ERBB3;CD74
prerank,GO_Biological_Process_2021__positive regulation of cell cycle phase transition (GO:1901989),-0.38188668367837947,-0.6899776551177753,0.8225806451612904,1.0,1.0,7/14,29.13%,ATAD5;GLI1;NPM1;DDRGK1;PAF1;PHB2;ZNF16
prerank,GO_Biological_Process_2021__positive regulation of chemokine production (GO:0032722),-0.33153639864906526,-0.6898556856195184,0.9032258064516129,1.0,1.0,7/27,17.22%,IL7;TLR3;EIF2AK2;OAS3;IL18;CD74;WNT5A
prerank,GO_Biological_Process_2021__embryo development ending in birth or egg hatching (GO:0009792),0.370031702955158,0.6897271863985447,0.9047619047619048,0.9782171364491817,1.0,3/13,17.97%,UBR3;USP22;CELF1
prerank,GO_Biological_Process_2021__neuron remodeling (GO:0016322),0.41678942413232545,0.6897110531344017,0.85,0.977900386005563,1.0,2/8,11.76%,ADGRB3;ANKS1A
prerank,GO_Biological_Process_2021__neuron projection regeneration (GO:0031102),0.394539115361485,0.6894348724905616,0.8695652173913043,0.9778687250191829,1.0,1/8,9.87%,RTN4RL1
prerank,GO_Biological_Process_2021__regulation of alpha-beta T cell proliferation (GO:0046640),0.45241943704045917,0.6893175262880944,0.9090909090909091,0.9776892176925401,1.0,2/6,6.13%,TNFSF4;SH3RF1
prerank,GO_Biological_Process_2021__regulation of cell killing (GO:0031341),-0.3734105001120085,-0.6886443088222622,0.9056603773584906,1.0,1.0,3/13,17.22%,NOX1;ICAM1;WNT5A
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transport into cytosol (GO:0010524),0.35890496181353565,0.6885126332842241,0.9473684210526315,0.9781449006687725,1.0,3/18,6.27%,SNCA;GRIN1;CASQ1
prerank,GO_Biological_Process_2021__polyamine metabolic process (GO:0006595),0.35156316553291833,0.6883128184829317,0.8571428571428571,0.9779818397898965,1.0,2/10,12.79%,SMOX;SMS
prerank,GO_Biological_Process_2021__steroid hormone mediated signaling pathway (GO:0043401),0.33474738802598136,0.6879932030541202,0.8444444444444444,0.9779720782398559,1.0,5/13,19.52%,PLPP1;NR3C1;BMP7;NR3C2;ABHD2
prerank,GO_Biological_Process_2021__negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),-0.3167902969750852,-0.6873066024376729,0.921875,1.0,1.0,6/32,18.82%,WEE1;KLF4;PLK3;CCL2;GFI1B;PRMT2
prerank,GO_Biological_Process_2021__positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),-0.3338786459437909,-0.6872966889207108,0.8709677419354839,1.0,1.0,7/23,18.80%,APLNR;CEMIP;P2RY6;CX3CL1;HAP1;GPER1;TRDN
prerank,GO_Biological_Process_2021__artery morphogenesis (GO:0048844),0.3130196233268131,0.6870754244092679,0.8536585365853658,0.9785912871352566,1.0,6/20,15.85%,SMAD7;PKD2;NF1;TGFBR1;BMPR1A;NRP1
prerank,GO_Biological_Process_2021__mRNA splice site selection (GO:0006376),0.2789688987064577,0.6867909413355673,0.9259259259259259,0.9785649261475102,1.0,4/26,19.40%,CELF2;CELF3;CELF1;LUC7L
prerank,GO_Biological_Process_2021__negative regulation of lyase activity (GO:0051350),-0.35743823203280356,-0.6867751019943359,0.8421052631578947,1.0,1.0,3/11,20.54%,AKAP5;PHPT1;EDNRB
prerank,GO_Biological_Process_2021__nucleobase-containing compound biosynthetic process (GO:0034654),-0.35254862547887045,-0.6867111112595599,0.8688524590163934,1.0,1.0,4/16,16.74%,TYMS;PNP;GMPR2;POLD2
prerank,GO_Biological_Process_2021__exit from mitosis (GO:0010458),0.3551885604600746,0.6866313104414979,0.8055555555555556,0.9783527524847798,1.0,2/11,13.92%,EPS8;CLASP1
prerank,MSigDB_Hallmark_2020__Estrogen Response Late,-0.26414450091561825,-0.6864251573058688,0.9866666666666667,1.0,1.0,25/142,17.92%,PRSS23;OVOL2;MYOF;CD9;ETFB;PDZK1;IGSF1;PGR;ALDH3B1;TRIM29;KLF4;BLVRB;ID2;DHCR7;XBP1;SORD;CXCL14;CCND1;EMP2;BAG1;CDH1;BTG3;SNX10;GPER1;COX6C
prerank,GO_Biological_Process_2021__positive regulation of amyloid-beta formation (GO:1902004),0.3345104962444675,0.6863687046109498,0.9523809523809523,0.9783264887771356,1.0,4/15,15.41%,PICALM;EPHA4;ABCA2;ROCK2
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell proliferation (GO:1904705),0.2884809818425222,0.6863162724329441,0.8484848484848485,0.9780544549949851,1.0,5/30,18.44%,TAFA5;PRKG1;BMPR1A;IGF1;PTEN
prerank,GO_Biological_Process_2021__eye morphogenesis (GO:0048592),0.3341969672438713,0.6859950430787702,0.8974358974358975,0.9780228482612332,1.0,4/17,15.95%,TENM3;NF1;NIPBL;AGTPBP1
prerank,GO_Biological_Process_2021__oxaloacetate transport (GO:0015729),0.3777248902241477,0.6859402566280883,0.7804878048780488,0.977745639029285,1.0,2/5,33.07%,SLC25A14;SLC13A5
prerank,GO_Biological_Process_2021__hemopoiesis (GO:0030097),-0.28304620977249884,-0.685782883985918,0.9863013698630136,1.0,1.0,8/63,13.47%,SFRP2;GLRX5;RUNX2;ARIH2;WNT2B;RRAS;SFRP1;ZFPM1
prerank,GO_Biological_Process_2021__inorganic anion transmembrane transport (GO:0098661),-0.2944184837666502,-0.6857452261604767,0.9722222222222222,1.0,1.0,3/56,7.00%,ANO2;CFTR;GABRE
prerank,GO_Biological_Process_2021__amino sugar metabolic process (GO:0006040),-0.4159989734927573,-0.6854515247191135,0.875,1.0,1.0,2/8,8.53%,ST6GAL1;GNE
prerank,GO_Biological_Process_2021__astrocyte development (GO:0014002),-0.41645104407951,-0.6854263704337732,0.8148148148148148,1.0,1.0,1/5,10.41%,MT3
prerank,GO_Biological_Process_2021__positive regulation of response to external stimulus (GO:0032103),-0.273397848933278,-0.6852172592627002,0.9876543209876543,1.0,1.0,17/78,20.58%,P2RY12;DDX60;THBS1;IFI35;LY96;TLR3;IL18;CX3CL1;SCARF1;SCIMP;ZP3;WNT5A;POLR3G;TNIP1;AGT;ADAM8;RIOK3
prerank,GO_Biological_Process_2021__metal ion export (GO:0070839),-0.34337139621301443,-0.6849409838290208,0.9333333333333333,1.0,1.0,3/21,10.16%,KCNQ1;ATP12A;SLC11A1
prerank,GO_Biological_Process_2021__cellular response to nitric oxide (GO:0071732),0.4077159928532798,0.6849396023033061,0.84,0.978173614315852,1.0,2/7,5.24%,FOXO1;GUCY1B1
prerank,GO_Biological_Process_2021__cellular response to reactive nitrogen species (GO:1902170),0.4077159928532798,0.6849396023033061,0.84,0.978173614315852,1.0,2/7,5.24%,FOXO1;GUCY1B1
prerank,GO_Biological_Process_2021__response to laminar fluid shear stress (GO:0034616),-0.39360236983481633,-0.6846492517468016,0.8846153846153846,1.0,1.0,2/10,10.93%,KLF2;KLF4
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell migration (GO:0010595),-0.2925049811535642,-0.6840614803599065,0.9859154929577465,1.0,1.0,6/67,10.67%,SPARC;SEMA5A;THBS1;PIK3CB;RRAS;FGF1
prerank,GO_Biological_Process_2021__regulation of rhodopsin mediated signaling pathway (GO:0022400),-0.3627475295043484,-0.6839151076261629,0.8548387096774194,1.0,1.0,2/12,14.35%,PDE6B;NMT1
prerank,GO_Biological_Process_2021__glycogen catabolic process (GO:0005980),0.31026762778253997,0.6838959234562448,0.8717948717948718,0.9787581813436272,1.0,4/14,26.34%,PGM2;PYGB;RB1CC1;PHKA1
prerank,GO_Biological_Process_2021__lysine catabolic process (GO:0006554),0.35258353925606123,0.683600844042315,0.9183673469387755,0.9783458758828514,1.0,1/12,12.06%,ALDH7A1
prerank,GO_Biological_Process_2021__lysine metabolic process (GO:0006553),0.35258353925606123,0.683600844042315,0.9183673469387755,0.9783458758828514,1.0,1/12,12.06%,ALDH7A1
prerank,GO_Biological_Process_2021__regulation of neurotrophin TRK receptor signaling pathway (GO:0051386),0.42017242117861786,0.6831684178033309,0.8269230769230769,0.9784558780853175,1.0,4/5,28.67%,NTRK3;ZDHHC17;DOK5;TMEM108
prerank,GO_Biological_Process_2021__amyloid precursor protein metabolic process (GO:0042982),-0.3433999091330515,-0.682921538475395,0.9272727272727272,1.0,1.0,4/16,21.26%,APOE;CLN3;APH1A;KLK6
prerank,GO_Biological_Process_2021__negative regulation of T cell proliferation (GO:0042130),0.3091189318428138,0.6828373829908579,0.9487179487179487,0.9784623409749493,1.0,3/18,15.37%,SDC4;DLG5;SCRIB
prerank,GO_Biological_Process_2021__mitotic spindle assembly (GO:0090307),0.2896828852356388,0.6823698702492905,0.9117647058823529,0.9785940062905593,1.0,2/34,2.53%,KIFC2;ZNF207
prerank,GO_Biological_Process_2021__regulation of cellular amide metabolic process (GO:0034248),-0.30917717594908334,-0.68215973175943,0.8833333333333333,1.0,1.0,1/28,1.40%,RPL10
prerank,GO_Biological_Process_2021__regulation of cellular response to osmotic stress (GO:0106049),-0.42203535980128415,-0.682043170770646,0.8070175438596491,1.0,1.0,1/5,13.86%,CLN3
prerank,GO_Biological_Process_2021__positive regulation of focal adhesion assembly (GO:0051894),-0.3529329289776809,-0.6818400893767635,0.90625,1.0,1.0,2/16,11.83%,S100A10;SFRP1
prerank,GO_Biological_Process_2021__regulation of interleukin-6 production (GO:0032675),-0.29293441972039724,-0.6818110075699362,0.9558823529411765,1.0,1.0,11/57,18.41%,HLA-B;RAB7B;SELENOS;TLR3;CX3CL1;XBP1;SCIMP;CD74;WNT5A;PTPN22;C1QTNF4
prerank,GO_Biological_Process_2021__protein kinase B signaling (GO:0043491),0.3560674228019617,0.681797134882392,0.8285714285714286,0.9788670749589908,1.0,5/16,18.44%,EPHA2;AKT1;SIRT2;IGF1;PTEN
prerank,GO_Biological_Process_2021__glycoprotein catabolic process (GO:0006516),-0.36581769814142534,-0.6817144416615991,0.8888888888888888,1.0,1.0,1/15,5.85%,CTSL
prerank,GO_Biological_Process_2021__regulation of DNA-templated transcription in response to stress (GO:0043620),0.38959718845750313,0.6816270877836663,0.8260869565217391,0.9787428310536416,1.0,1/7,5.78%,RPS6KA3
prerank,GO_Biological_Process_2021__negative regulation by symbiont of host apoptotic process (GO:0033668),0.38000186381185097,0.6815684279045618,0.8837209302325582,0.9784663961962807,1.0,2/7,14.21%,SERPINB9;MAPK1
prerank,GO_Biological_Process_2021__regulation of mast cell activation involved in immune response (GO:0033006),-0.43317834927284155,-0.6814309829652231,0.8524590163934426,1.0,1.0,1/7,10.87%,FES
prerank,GO_Biological_Process_2021__positive regulation of T cell receptor signaling pathway (GO:0050862),0.34422257776962906,0.6812439814847702,0.8378378378378378,0.978429352578253,1.0,3/11,26.72%,BCL10;NECTIN2;RELA
prerank,GO_Biological_Process_2021__regulation of neuroinflammatory response (GO:0150077),0.3516619659059189,0.680974490622229,0.8378378378378378,0.9783108126547043,1.0,3/9,17.75%,NR1D1;CD200R1;IGF1
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway (GO:0097191),0.2553730390376382,0.6808718191650351,1.0,0.9781217234701928,1.0,18/59,23.33%,CRADD;SORT1;BOK;TRADD;DCC;TNFRSF10B;BCL2;GSK3B;RNF41;FAS;CASP3;BAG3;CIB1;MLLT11;IL6R;G0S2;SIVA1;BCL2L1
prerank,GO_Biological_Process_2021__negative regulation of muscle hypertrophy (GO:0014741),-0.4006366852554431,-0.6807787420636511,0.8431372549019608,1.0,1.0,1/7,10.23%,CAV3
prerank,"GO_Biological_Process_2021__mRNA cis splicing, via spliceosome (GO:0045292)",-0.35323435906830225,-0.6806063309059357,0.8382352941176471,1.0,1.0,3/15,15.87%,SNRNP200;DDX23;NCBP2
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),0.31634337965477555,0.6801503228074303,0.8387096774193549,0.9784378539313862,1.0,10/20,26.72%,BMP2;SMAD5;EP300;SMAD4;HIF1A;RBPJ;NFE2L2;SESN2;SMAD1;RELA
prerank,GO_Biological_Process_2021__copper ion homeostasis (GO:0055070),-0.36378996665597824,-0.6797691396336049,0.9122807017543859,1.0,1.0,2/14,9.72%,CUTC;MT2A
prerank,GO_Biological_Process_2021__response to interleukin-4 (GO:0070670),-0.441681981394199,-0.6797637288962208,0.8490566037735849,1.0,1.0,2/5,22.02%,XBP1;TCF7
prerank,GO_Biological_Process_2021__glucosamine-containing compound metabolic process (GO:1901071),0.32794446035618413,0.6795709521568062,0.9210526315789473,0.9786343295815471,1.0,5/13,26.70%,LARGE1;CHST3;CHST1;OGA;MGAT3
prerank,GO_Biological_Process_2021__cellular response to lipopolysaccharide (GO:0071222),-0.2807267458221806,-0.6794462108734788,0.9710144927536232,1.0,1.0,14/60,17.73%,CXCL2;SELENOS;GSTP1;LY96;PDCD1LG2;IL18;CD14;CTR9;XBP1;CCL2;CD274;WNT5A;PTPN22;CD6
prerank,GO_Biological_Process_2021__regulation of NMDA receptor activity (GO:2000310),0.2878809099239013,0.6791425986065026,0.967741935483871,0.9786461393360532,1.0,9/29,23.30%,GRIN1;CAMK2B;DLG3;CAMK2A;DLG1;GRIA2;SLC6A9;NLGN1;GRIN2B
prerank,GO_Biological_Process_2021__positive regulation of protein processing (GO:0010954),0.34920619040316747,0.6784203671322737,0.9444444444444444,0.9789672070190955,1.0,2/13,6.16%,RHBDD1;KLKB1
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial membrane potential (GO:0010918),-0.4217704411128932,-0.6781450837467644,0.8421052631578947,1.0,1.0,1/6,5.53%,MTLN
prerank,GO_Biological_Process_2021__synaptic vesicle exocytosis (GO:0016079),-0.3022646392818468,-0.6781364949766548,0.921875,1.0,1.0,3/31,9.54%,STX19;SNAPIN;SYT2
prerank,GO_Biological_Process_2021__receptor-mediated endocytosis of virus by host cell (GO:0019065),-0.45483267601835986,-0.6781192376118345,0.8627450980392157,1.0,1.0,2/6,9.70%,CTSL;CAV2
prerank,GO_Biological_Process_2021__positive regulation of early endosome to late endosome transport (GO:2000643),-0.4302920996751865,-0.6780484669123522,0.8867924528301887,1.0,1.0,1/7,6.91%,RDX
prerank,GO_Biological_Process_2021__positive regulation of heterotypic cell-cell adhesion (GO:0034116),-0.4295748724241546,-0.6774817414690987,0.896551724137931,1.0,1.0,4/7,26.87%,SKAP1;FLOT1;GCNT2;CD44
prerank,GO_Biological_Process_2021__positive regulation of small molecule metabolic process (GO:0062013),0.3472797628553881,0.6774282728676096,0.9444444444444444,0.9795484097679756,1.0,4/13,16.90%,AKT1;IRS1;PRKCE;AKT2
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-lysine acetylation (GO:2000757),0.3856235371333439,0.6772727361616776,0.9302325581395349,0.9793430200679263,1.0,4/9,21.94%,SNCA;SIRT1;KLF15;CTBP1
prerank,GO_Biological_Process_2021__P-body assembly (GO:0033962),0.3696616596614618,0.6771775734120382,0.9523809523809523,0.9791215055123531,1.0,1/12,0.72%,LIMD1
prerank,GO_Biological_Process_2021__membrane protein proteolysis (GO:0033619),0.28460500602321215,0.6765871408244442,0.975,0.9793661309719311,1.0,6/30,16.21%,RHBDD1;NFKB1;NCSTN;SPPL2A;NAPSA;SPPL3
prerank,"GO_Biological_Process_2021__protein localization to chromosome, telomeric region (GO:0070198)",0.3302674709383037,0.676294352587307,0.8947368421052632,0.9792368399088442,1.0,7/14,31.98%,POT1;ATRX;TNKS2;TNKS;TERF2IP;TERF2;XRCC5
prerank,GO_Biological_Process_2021__nuclear membrane disassembly (GO:0051081),-0.3681904647204206,-0.6761781537145696,0.8867924528301887,1.0,1.0,3/12,21.21%,CCNB2;CCNB1;DCTN1
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell apoptotic process (GO:0034391),-0.42499844629884326,-0.6756523214038375,0.8870967741935484,1.0,1.0,1/6,5.79%,IL12A
prerank,GO_Biological_Process_2021__thymus development (GO:0048538),0.448613244262252,0.6756510123383894,0.851063829787234,0.9794541905452069,1.0,2/6,13.12%,ZBTB1;TGFBR1
prerank,GO_Biological_Process_2021__neurotransmitter uptake (GO:0001504),-0.37132792503350137,-0.675466359454576,0.8888888888888888,1.0,1.0,1/11,11.61%,SLC38A1
prerank,GO_Biological_Process_2021__long-term synaptic depression (GO:0060292),-0.4048116823493546,-0.67544820175666,0.8571428571428571,1.0,1.0,1/7,14.28%,SLC24A1
prerank,MSigDB_Hallmark_2020__Apical Surface,0.2840784180425816,0.6754476930484383,1.0,0.9793033033199952,1.0,3/35,9.87%,EFNA5;ADIPOR2;RTN4RL1
prerank,GO_Biological_Process_2021__nicotinamide nucleotide biosynthetic process (GO:0019359),0.36393740855683687,0.675175662687321,0.8837209302325582,0.9792823884803,1.0,2/7,12.26%,NMNAT2;KYNU
prerank,GO_Biological_Process_2021__cellular response to nutrient (GO:0031670),-0.4136942308056525,-0.6749860163314303,0.8235294117647058,1.0,1.0,2/5,23.07%,XBP1;USF1
prerank,GO_Biological_Process_2021__histone ubiquitination (GO:0016574),0.31365244218138094,0.6746344143047647,0.9459459459459459,0.9794995084286731,1.0,9/20,26.63%,PHC1;UBE2N;UBE2E1;USP22;WAC;CDC73;HUWE1;RNF20;UBR2
prerank,GO_Biological_Process_2021__phosphatidylinositol 3-kinase signaling (GO:0014065),0.2912091939397847,0.6742444153408197,0.9310344827586207,0.9794298725458237,1.0,11/27,23.55%,AKT1;PIK3CA;PIK3R1;IRS1;NF1;SIRT2;IGF1;PTEN;PLEKHA1;PIK3C2B;TPTE2
prerank,GO_Biological_Process_2021__positive regulation of macrophage cytokine production (GO:0060907),-0.4309145499781055,-0.6741800667991767,0.8518518518518519,1.0,1.0,2/6,17.22%,CD74;WNT5A
prerank,GO_Biological_Process_2021__positive regulation of NIK/NF-kappaB signaling (GO:1901224),0.27514772332590787,0.6741610329290099,0.9428571428571428,0.9791926969428598,1.0,5/36,10.77%,SASH1;EGFR;NFAT5;TRADD;EP300
prerank,GO_Biological_Process_2021__negative regulation of plasminogen activation (GO:0010757),0.414408047645084,0.6741400220971842,0.875,0.9788854233704872,1.0,1/5,2.21%,SERPINE1
prerank,GO_Biological_Process_2021__release of sequestered calcium ion into cytosol (GO:0051209),0.3011944297370367,0.6737720623762109,1.0,0.9788592786506813,1.0,8/20,24.55%,HTR2C;PKD2;DRD2;LETM1;PTPRC;FGF2;IBTK;TRPM2
prerank,GO_Biological_Process_2021__potassium ion transmembrane transport (GO:0071805),-0.2673635215380157,-0.673592849051773,0.9871794871794872,1.0,1.0,13/95,15.72%,KCNJ13;KCNB1;CCDC51;KCNQ4;KCNQ1;KCNG1;LRRC55;ATP12A;KCNK13;SLC9A2;SLC24A1;SLC9A7;KCNJ8
prerank,GO_Biological_Process_2021__positive regulation of NF-kappaB transcription factor activity (GO:0051092),-0.2590225678285586,-0.6734492093095648,1.0,1.0,1.0,21/113,20.40%,TRIM22;RPS27A;RAB7B;TRIM21;PRKCQ;UBC;CLU;EIF2AK2;IL18;CX3CL1;RIPK2;AIM2;SLCO3A1;WNT5A;TRIM5;FLOT1;UBA52;AGT;ADAM8;AR;NPM1
prerank,GO_Biological_Process_2021__positive regulation of immune effector process (GO:0002699),0.33310063746828084,0.672964136029488,0.9428571428571428,0.979194993909324,1.0,3/16,11.20%,TNFSF4;PTPRJ;ANKRD17
prerank,GO_Biological_Process_2021__dynamin family protein polymerization involved in mitochondrial fission (GO:0003374),-0.4099275823338732,-0.6728905328726151,0.8727272727272727,1.0,1.0,1/7,3.06%,MX1
prerank,GO_Biological_Process_2021__dynamin family protein polymerization involved in membrane fission (GO:0003373),-0.4099275823338732,-0.6728905328726151,0.8727272727272727,1.0,1.0,1/7,3.06%,MX1
prerank,GO_Biological_Process_2021__regulation of translation (GO:0006417),-0.25394821858722616,-0.6721323684515875,1.0,1.0,1.0,15/163,16.08%,RPS4X;RPL10;PATL2;THBS1;TYMS;RPL5;IGFBP5;RPL13A;ZNF385A;EIF2AK2;RBM4B;OGFOD1;SHFL;NCBP2;IGF2BP3
prerank,GO_Biological_Process_2021__regulation of G1/S transition of mitotic cell cycle (GO:2000045),-0.28940388822281726,-0.67204855859809,0.9583333333333334,1.0,1.0,10/60,16.61%,ANXA1;RDX;HYAL1;PSME1;WEE1;KLF4;ID2;CCL2;GFI1B;CCND1
prerank,GO_Biological_Process_2021__depurination (GO:0045007),0.39016823587198796,0.6718189148444147,0.9069767441860465,0.9799192051449904,1.0,3/8,31.95%,POT1;TERF2IP;TERF2
prerank,GO_Biological_Process_2021__regulation of mRNA stability (GO:0043488),-0.25416924881328185,-0.6716075094152245,0.9868421052631579,1.0,1.0,11/134,10.16%,PSMB6;RPS27A;CSDC2;DND1;PSMA8;PSMB9;PSMA7;PSMC3;UBC;PSME1;SLC11A1
prerank,GO_Biological_Process_2021__protein insertion into ER membrane (GO:0045048),-0.3277762110772864,-0.6715326158579266,0.9242424242424242,1.0,1.0,5/32,15.99%,EMC6;TRAM1L1;EMC4;CCDC47;EMD
prerank,GO_Biological_Process_2021__regulation of transport (GO:0051049),0.2979263996804056,0.6714146895038886,0.9,0.979887348159022,1.0,2/30,2.09%,LEPR;SNCA
prerank,GO_Biological_Process_2021__DNA deamination (GO:0045006),0.43454722015719416,0.6712425906778142,0.851063829787234,0.979682862781898,1.0,2/7,8.49%,EXOSC6;APOBEC3F
prerank,GO_Biological_Process_2021__positive regulation of lipid catabolic process (GO:0050996),-0.3677996886943146,-0.6708956054756227,0.8852459016393442,1.0,1.0,2/13,7.43%,MTLN;ANGPTL3
prerank,GO_Biological_Process_2021__negative regulation of protein-containing complex assembly (GO:0031333),-0.30334436763827266,-0.6708914006789505,0.8656716417910447,1.0,1.0,8/38,21.34%,TMC8;RPL13A;SVIP;CLU;CRYAB;CPTP;RIOK3;PARK7
prerank,GO_Biological_Process_2021__canonical Wnt signaling pathway (GO:0060070),-0.29126813102052435,-0.6708646944639758,0.9436619718309859,1.0,1.0,7/53,12.07%,SFRP2;SFRP4;WNT2B;WNT9B;WNT3;SFRP1;FZD9
prerank,GO_Biological_Process_2021__cellular response to steroid hormone stimulus (GO:0071383),0.3209380644925038,0.6703818515578692,0.9767441860465116,0.9801527016254151,1.0,3/14,19.52%,NR3C1;BMP7;ABHD2
prerank,GO_Biological_Process_2021__regulation of activin receptor signaling pathway (GO:0032925),-0.37328114542206997,-0.670369450216053,0.9393939393939394,1.0,1.0,2/11,9.68%,IGSF1;NODAL
prerank,GO_Biological_Process_2021__negative regulation of cell adhesion (GO:0007162),0.2634804495712721,0.6698125360781327,0.9642857142857143,0.9803903860470464,1.0,25/59,31.05%,SERPINE1;PDE3B;PLXNA2;PLXNA1;PTK2;SEMA4D;PTPRO;CDH13;FBLN1;PLXNA4;ARHGDIA;PTPRC;FZD7;TBCD;CBLL1;PLXNA3;ADAM10;JAG1;LPXN;RIPOR2;SPOCK1;SEMA6A;RND1;CORO2B;MDK
prerank,GO_Biological_Process_2021__positive regulation of neuroblast proliferation (GO:0002052),0.35161596014831265,0.6690400588984478,0.8636363636363636,0.9806979833305437,1.0,4/10,23.61%,FZD3;KDM1A;DRD2;CTNNB1
prerank,GO_Biological_Process_2021__posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),-0.3880381477498116,-0.6689041354177673,0.8805970149253731,1.0,1.0,1/11,12.36%,SEC62
prerank,GO_Biological_Process_2021__regulation of interleukin-10 production (GO:0032653),-0.3223967980246135,-0.6687808116162806,0.8103448275862069,1.0,1.0,4/21,16.27%,ISG15;PDCD1LG2;CD274;TNFRSF21
prerank,GO_Biological_Process_2021__signal peptide processing (GO:0006465),0.36553476535951096,0.6686273193336969,0.8974358974358975,0.9807736860050549,1.0,1/9,2.22%,PCSK5
prerank,GO_Biological_Process_2021__regulation of establishment of cell polarity (GO:2000114),-0.3607322414312908,-0.6685518241478282,0.9180327868852459,1.0,1.0,1/14,2.77%,KIF20B
prerank,GO_Biological_Process_2021__DNA damage induced protein phosphorylation (GO:0006975),-0.41542959734336377,-0.6685368877061677,0.8852459016393442,1.0,1.0,1/8,14.80%,MAP2K6
prerank,GO_Biological_Process_2021__nuclear membrane organization (GO:0071763),-0.3422282652058752,-0.6682797086760413,0.9032258064516129,1.0,1.0,7/19,27.89%,CHMP2A;EMD;GPER1;DCTN1;VPS4A;TARDBP;TMEM43
prerank,GO_Biological_Process_2021__autophagosome organization (GO:1905037),0.2500974654345987,0.6679104389055033,1.0,0.9810809545119553,1.0,11/50,19.54%,RAB23;ATG7;PIK3C3;UBQLN1;ATG2B;RAB1A;UBQLN2;ATG5;NSFL1C;UBXN2B;STX12
prerank,GO_Biological_Process_2021__interleukin-6-mediated signaling pathway (GO:0070102),-0.3364819316131666,-0.6674121053769982,0.9375,1.0,1.0,4/17,17.99%,STAT1;SPI1;CTR9;SOCS3
prerank,GO_Biological_Process_2021__fatty acid homeostasis (GO:0055089),-0.3827601950820725,-0.6672705562587788,0.8363636363636363,1.0,1.0,2/8,13.88%,APOE;XBP1
prerank,GO_Biological_Process_2021__endoplasmic reticulum calcium ion homeostasis (GO:0032469),-0.322203101025516,-0.6672080267760389,0.9384615384615385,1.0,1.0,4/18,17.89%,SELENOK;FIS1;CCDC47;TMCO1
prerank,GO_Biological_Process_2021__sterol metabolic process (GO:0016125),0.24314290023511112,0.6668376107184523,0.9565217391304348,0.9817057143945234,1.0,8/46,18.35%,ABCA1;STARD3;NSDHL;ARV1;LBR;OSBPL1A;FDX1;INSIG2
prerank,GO_Biological_Process_2021__glycolipid biosynthetic process (GO:0009247),0.28579006373736116,0.6666041622574898,0.9428571428571428,0.9815710789469851,1.0,3/35,9.17%,ST6GALNAC5;B4GALT6;LARGE1
prerank,GO_Biological_Process_2021__regulation of cholesterol metabolic process (GO:0090181),-0.34737545165875416,-0.6664804680104722,0.9622641509433962,1.0,1.0,6/19,23.35%,FMO5;APOE;SREBF1;RAN;SEC14L2;SREBF2
prerank,GO_Biological_Process_2021__regulation of calcium ion import (GO:0090279),-0.3301131436695398,-0.6662938592489431,0.90625,1.0,1.0,3/17,14.31%,PLN;CAV3;CCL2
prerank,GO_Biological_Process_2021__phospholipid transport (GO:0015914),0.2803642409344925,0.6659608737140557,1.0,0.9817701600127885,1.0,12/49,23.07%,ABCA1;ATP11C;PRELID2;ATP9A;MTTP;ATP8A1;OSBPL8;ATP11A;PITPNM1;SCP2;OSBPL5;ATP10A
prerank,GO_Biological_Process_2021__regulation of T cell differentiation (GO:0045580),-0.3338155614498076,-0.6651698989874051,0.8873239436619719,1.0,1.0,8/21,24.04%,IL7;RHOH;XBP1;SPINK5;PRELID1;TCF7;PRDM1;CR1
prerank,GO_Biological_Process_2021__regulation of superoxide metabolic process (GO:0090322),0.38469519863735085,0.6648961355090519,0.8627450980392157,0.9824371115309504,1.0,2/6,16.20%,BST1;BMP7
prerank,GO_Biological_Process_2021__mitotic nuclear membrane disassembly (GO:0007077),-0.35692472714293744,-0.6643141604691226,0.95,1.0,1.0,2/10,18.52%,CCNB2;CCNB1
prerank,GO_Biological_Process_2021__skeletal muscle tissue regeneration (GO:0043403),-0.40346118623338295,-0.6642681463684762,0.859375,1.0,1.0,1/7,4.63%,ANXA1
prerank,GO_Biological_Process_2021__'de novo' posttranslational protein folding (GO:0051084),0.2834201588203621,0.6641010084193067,0.9142857142857143,0.9827056852693019,1.0,12/28,36.70%,DNAJB13;UGGT1;PTGES3;HSPA1A;CHCHD4;DNAJB14;DNAJB5;SDF2;SELENOF;GAK;HSPA8;DNAJC18
prerank,GO_Biological_Process_2021__negative regulation of interferon-gamma production (GO:0032689),0.34619969414247787,0.6640832250586884,0.8604651162790697,0.9823827455107514,1.0,3/15,13.26%,TNFSF4;HMGB1;HAVCR2
prerank,GO_Biological_Process_2021__lymphocyte proliferation (GO:0046651),-0.36488737779873537,-0.6638880937558616,0.9411764705882353,1.0,1.0,1/14,5.26%,RASGRP1
prerank,GO_Biological_Process_2021__negative regulation of protein polyubiquitination (GO:1902915),0.4042156093097614,0.6637524112020948,0.8679245283018868,0.9823448412413821,1.0,1/5,16.54%,TRIM44
prerank,GO_Biological_Process_2021__negative regulation of T cell activation (GO:0050868),0.28911768809131655,0.6635836252166446,0.9210526315789473,0.9821350495541421,1.0,4/22,13.26%,SDC4;PAG1;DLG5;HAVCR2
prerank,GO_Biological_Process_2021__positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),0.3398302011916394,0.6631737273821383,0.9411764705882353,0.9822583663741371,1.0,1/13,1.86%,HDAC9
prerank,GO_Biological_Process_2021__xenobiotic transport across blood-brain barrier (GO:1990962),0.4102915354784513,0.6627364140079103,0.8333333333333334,0.9823010712477934,1.0,1/6,3.70%,ABCC2
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),-0.3226334504315851,-0.6627094783534585,0.8852459016393442,1.0,1.0,2/23,11.06%,SELENOK;DDIT3
prerank,GO_Biological_Process_2021__positive regulation of mitotic sister chromatid separation (GO:1901970),0.3389866535011189,0.6626295148483395,0.9024390243902439,0.9813885080010697,1.0,4/11,17.56%,CDC27;NSMCE2;ESPL1;CUL3
prerank,GO_Biological_Process_2021__positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),0.3389866535011189,0.6626295148483395,0.9024390243902439,0.9813885080010697,1.0,4/11,17.56%,CDC27;NSMCE2;ESPL1;CUL3
prerank,GO_Biological_Process_2021__positive regulation of mitotic metaphase/anaphase transition (GO:0045842),0.3389866535011189,0.6626295148483395,0.9024390243902439,0.9813885080010697,1.0,4/11,17.56%,CDC27;NSMCE2;ESPL1;CUL3
prerank,GO_Biological_Process_2021__lipid droplet organization (GO:0034389),-0.31941230408812876,-0.6624604158564857,0.9166666666666666,1.0,1.0,2/14,10.37%,PNPLA3;SQLE
prerank,GO_Biological_Process_2021__cellular response to interleukin-4 (GO:0071353),-0.4206208570624039,-0.6617488691320342,0.8363636363636363,1.0,1.0,2/6,22.02%,XBP1;TCF7
prerank,GO_Biological_Process_2021__peptidyl-arginine modification (GO:0018195),-0.3728430821918837,-0.6615387769583926,0.8666666666666667,1.0,1.0,4/10,21.34%,ART4;ART3;PADI4;PARK7
prerank,GO_Biological_Process_2021__regulation of alcohol biosynthetic process (GO:1902930),-0.356010623354462,-0.6611480938615524,0.8909090909090909,1.0,1.0,4/12,23.35%,SREBF1;RAN;SEC14L2;SREBF2
prerank,GO_Biological_Process_2021__neuron apoptotic process (GO:0051402),0.30714130726769623,0.6604053657373306,0.9487179487179487,0.9829809718172364,1.0,1/18,1.18%,LIG4
prerank,GO_Biological_Process_2021__lysosome organization (GO:0007040),-0.29792043947107855,-0.660293234722246,0.90625,1.0,1.0,4/31,13.86%,ATP10B;SNAPIN;GNPTAB;CLN3
prerank,GO_Biological_Process_2021__RNA biosynthetic process (GO:0032774),0.27924034406394044,0.6602076672436066,0.9444444444444444,0.9828411320683456,1.0,8/28,26.77%,TAF4;MTERF1;RSF1;NAT14;NCOA6;TAF12;SETX;GTF2B
prerank,GO_Biological_Process_2021__phospholipid biosynthetic process (GO:0008654),-0.3188625889757927,-0.660134572300596,0.9565217391304348,1.0,1.0,6/32,17.60%,AGPAT4;DOLK;FADS1;CLN3;FDPS;DHDDS
prerank,GO_Biological_Process_2021__regulation of endodeoxyribonuclease activity (GO:0032071),0.3781413551734019,0.6600323845969988,0.9473684210526315,0.9826960257450605,1.0,3/7,13.01%,AKT1;HMGB1;SIRT1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction (GO:0055117),-0.33062401311992223,-0.6589639337938712,0.967741935483871,1.0,1.0,4/23,13.85%,PLN;KCNQ1;CAV3;NOS1
prerank,GO_Biological_Process_2021__pericardium morphogenesis (GO:0003344),0.41084907815186344,0.6589601076646052,0.851063829787234,0.9832955579413651,1.0,1/5,16.20%,BMP7
prerank,GO_Biological_Process_2021__purine nucleotide metabolic process (GO:0006163),-0.3195368091040256,-0.6588615891955784,0.9545454545454546,1.0,1.0,6/20,20.57%,PNP;PRPS1;NT5C;PPAT;PRPSAP1;DNPH1
prerank,GO_Biological_Process_2021__detection of mechanical stimulus involved in sensory perception of sound (GO:0050910),0.35510148796596597,0.6583193403792192,0.9069767441860465,0.9834556143221124,1.0,4/9,28.45%,WHRN;MKKS;COL11A1;KIT
prerank,GO_Biological_Process_2021__positive regulation of calcium ion import (GO:0090280),0.3845965862282758,0.6582968000494951,0.9387755102040817,0.9831391558524794,1.0,1/7,4.88%,CXCL12
prerank,GO_Biological_Process_2021__cellular response to platelet-derived growth factor stimulus (GO:0036120),-0.4294845141652585,-0.6575185523653241,0.8928571428571429,1.0,1.0,1/5,8.30%,HYAL1
prerank,GO_Biological_Process_2021__positive regulation of lamellipodium organization (GO:1902745),-0.31065478276466624,-0.6567819537839341,0.9655172413793104,1.0,1.0,2/29,4.89%,ENPP2;VIL1
prerank,GO_Biological_Process_2021__rRNA transcription (GO:0009303),-0.3457930979025531,-0.6565586739540731,0.8771929824561403,1.0,1.0,3/17,17.22%,GTF3C6;GTF3A;NIFK
prerank,GO_Biological_Process_2021__peptide antigen assembly with MHC protein complex (GO:0002501),0.44014730507359795,0.6565051885704941,0.9024390243902439,0.9842035066556069,1.0,1/5,19.32%,HLA-DRA
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell migration (GO:0010596),0.3059084302571117,0.6563449373969943,1.0,0.9840260955482429,1.0,10/24,24.32%,DCN;RGCC;HMGB1;SLIT2;ATP2B4;ADGRB1;VASH1;FGF2;MECP2;DNAJA4
prerank,GO_Biological_Process_2021__mitral valve development (GO:0003174),-0.41967446933657937,-0.6561789668190543,0.8727272727272727,1.0,1.0,1/6,3.19%,EFNA1
prerank,GO_Biological_Process_2021__catecholamine catabolic process (GO:0042424),0.4263554539136502,0.6559821663929942,0.86,0.9841375747654589,1.0,1/5,7.50%,MAOA
prerank,GO_Biological_Process_2021__protein polyglutamylation (GO:0018095),-0.37949270108325783,-0.6551709941970556,0.8653846153846154,1.0,1.0,1/10,6.30%,TTLL6
prerank,GO_Biological_Process_2021__positive regulation of receptor catabolic process (GO:2000646),-0.4118956275570663,-0.6551422644518573,0.851063829787234,1.0,1.0,2/5,12.71%,APOE;DTX3L
prerank,GO_Biological_Process_2021__response to ethanol (GO:0045471),-0.3580951404900735,-0.6550656747414362,0.875,1.0,1.0,3/11,20.26%,ADH6;ADCY7;GLRA1
prerank,GO_Biological_Process_2021__dendritic cell migration (GO:0036336),-0.4251158259080306,-0.6549963417859564,0.8833333333333333,1.0,1.0,1/7,1.79%,GPR183
prerank,GO_Biological_Process_2021__positive regulation of Golgi to plasma membrane protein transport (GO:0042998),0.41627915487007977,0.6547798405299823,0.9148936170212766,0.9847408062391901,1.0,1/5,5.88%,ATP2C1
prerank,GO_Biological_Process_2021__positive regulation of cytoplasmic transport (GO:1903651),0.3443683585525942,0.6545792711384083,0.9024390243902439,0.9846168352641278,1.0,4/10,19.73%,PRKN;RAB21;MTMR2;PTPN23
prerank,GO_Biological_Process_2021__hematopoietic stem cell differentiation (GO:0060218),-0.437287536810938,-0.653932936464725,0.896551724137931,1.0,1.0,2/6,11.83%,MEOX1;SFRP1
prerank,GO_Biological_Process_2021__regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),0.2988076867298589,0.6537152513699733,0.9777777777777777,0.9849043126360502,1.0,3/14,21.28%,BOK;GSK3B;HSPA1A
prerank,GO_Biological_Process_2021__regulation of establishment or maintenance of cell polarity (GO:0032878),-0.34746500852577655,-0.6536264551089901,0.9333333333333333,1.0,1.0,1/16,2.77%,KIF20B
prerank,GO_Biological_Process_2021__negative regulation of alpha-beta T cell activation (GO:0046636),0.4139547870819523,0.6534975469096526,0.8958333333333334,0.9847162809564727,1.0,1/6,9.57%,GLI3
prerank,GO_Biological_Process_2021__potassium ion export across plasma membrane (GO:0097623),-0.3929934138610839,-0.6534387690350996,0.8947368421052632,1.0,1.0,1/8,6.80%,KCNQ1
prerank,GO_Biological_Process_2021__protein O-linked glycosylation via serine (GO:0018242),0.36293051420512573,0.653341478035132,0.9148936170212766,0.9845070162282218,1.0,5/9,29.74%,GALNT1;MGAT5B;GALNT2;POGLUT1;GALNT3
prerank,GO_Biological_Process_2021__oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),0.3197153833284627,0.6531231011389627,0.8611111111111112,0.984345922889716,1.0,5/12,36.94%,ALG6;ALG13;MPDU1;ALG12;ALG2
prerank,GO_Biological_Process_2021__regulation of adenylate cyclase activity (GO:0045761),0.3185631020133605,0.6516853860000121,0.9487179487179487,0.9852466918735434,1.0,3/16,11.69%,GNAI3;NF1;STIM1
prerank,GO_Biological_Process_2021__purine ribonucleotide catabolic process (GO:0009154),-0.29998625607230434,-0.6516227419346496,0.9622641509433962,1.0,1.0,2/20,8.28%,PNP;HINT1
prerank,GO_Biological_Process_2021__hemidesmosome assembly (GO:0031581),0.3777163739050746,0.6514078457006138,0.85,0.9851494670986227,1.0,1/7,17.49%,ITGA6
prerank,GO_Biological_Process_2021__positive regulation of interleukin-1 beta production (GO:0032731),-0.2987878212738486,-0.6510866854183253,0.9857142857142858,1.0,1.0,7/29,20.27%,CASP8;NLRP1;RIPK2;AIM2;WNT5A;USP50;NLRP2
prerank,GO_Biological_Process_2021__regulation of long-chain fatty acid import across plasma membrane (GO:0010746),-0.43950280485430726,-0.650818079300182,0.9032258064516129,1.0,1.0,1/6,5.73%,THBS1
prerank,GO_Biological_Process_2021__positive regulation of hormone metabolic process (GO:0032352),0.39863974274368,0.6507689050477873,0.8367346938775511,0.9852815810746355,1.0,3/6,25.26%,HIF1A;ARNT;SLCO1C1
prerank,GO_Biological_Process_2021__leukotriene biosynthetic process (GO:0019370),0.3736008120454004,0.650551600749244,0.8909090909090909,0.9851577570506859,1.0,1/10,6.65%,LTC4S
prerank,GO_Biological_Process_2021__nucleus localization (GO:0051647),0.3929206517736101,0.6505399147905576,0.8809523809523809,0.9848421872702535,1.0,4/9,31.02%,FBXW11;SUN2;MTOR;PAFAH1B1
prerank,GO_Biological_Process_2021__negative regulation of JUN kinase activity (GO:0043508),0.344107244967608,0.6503530079899875,0.8666666666666667,0.9846493388689824,1.0,2/10,11.06%,DUSP10;DUSP19
prerank,GO_Biological_Process_2021__porphyrin-containing compound catabolic process (GO:0006787),-0.3864144120131543,-0.650312843142624,0.85,1.0,1.0,2/8,11.32%,ABCG2;BLVRB
prerank,GO_Biological_Process_2021__heme catabolic process (GO:0042167),-0.3864144120131543,-0.650312843142624,0.85,1.0,1.0,2/8,11.32%,ABCG2;BLVRB
prerank,GO_Biological_Process_2021__calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),0.33747358101920466,0.6496114442256586,0.9024390243902439,0.9849252197762006,1.0,4/11,23.19%,DOC2B;RIMS3;UNC13A;RIMS2
prerank,GO_Biological_Process_2021__negative regulation of cell aging (GO:0090344),-0.3430525972422453,-0.6493905597404569,0.8596491228070176,1.0,1.0,1/13,9.02%,FOXM1
prerank,GO_Biological_Process_2021__ESCRT complex disassembly (GO:1904896),0.36359112777779407,0.6493448774403237,0.8048780487804879,0.9844972727382669,1.0,3/9,17.79%,CHMP1A;CHMP2B;VTA1
prerank,GO_Biological_Process_2021__ESCRT III complex disassembly (GO:1904903),0.36359112777779407,0.6493448774403237,0.8048780487804879,0.9844972727382669,1.0,3/9,17.79%,CHMP1A;CHMP2B;VTA1
prerank,GO_Biological_Process_2021__regulation of IRE1-mediated unfolded protein response (GO:1903894),0.3009626981739033,0.6492243522657019,0.9375,0.9842409491937937,1.0,1/13,3.64%,TMEM33
prerank,GO_Biological_Process_2021__positive regulation of cell-cell adhesion (GO:0022409),0.2591728012757883,0.6490049146147708,0.9736842105263158,0.9840805184345331,1.0,6/31,16.20%,MEGF10;SMAD7;PLPP3;AFDN;TJP1;BMP7
prerank,GO_Biological_Process_2021__positive regulation of cytoskeleton organization (GO:0051495),-0.27954542896018225,-0.648454493043037,0.9846153846153847,1.0,1.0,7/58,15.23%,LMOD1;VIL1;SEMA5A;FES;CX3CL1;PFN1;CDK5
prerank,GO_Biological_Process_2021__mitochondrial tRNA modification (GO:0070900),0.3683676714168812,0.6479734924652194,0.85,0.9847708143055275,1.0,1/8,10.07%,TRIT1
prerank,GO_Biological_Process_2021__cellular response to nitrogen compound (GO:1901699),0.29453247043605524,0.647906255393392,0.9459459459459459,0.984504022394199,1.0,6/16,21.70%,PDE12;ROCK2;ATP2B4;ATRX;RTF2;FMR1
prerank,GO_Biological_Process_2021__regulation of cell aging (GO:0090342),-0.35632302559663404,-0.6478200010920316,0.9344262295081968,1.0,1.0,1/10,9.02%,FOXM1
prerank,GO_Biological_Process_2021__hyaluronan metabolic process (GO:0030212),-0.3596978815867484,-0.6475696136918832,0.9117647058823529,1.0,1.0,3/15,11.11%,STAB2;HYAL1;CEMIP
prerank,GO_Biological_Process_2021__protein localization to mitochondrion (GO:0070585),-0.35005128425438964,-0.6474698829064395,0.9655172413793104,1.0,1.0,1/12,3.26%,ISG15
prerank,GO_Biological_Process_2021__cellular lipid catabolic process (GO:0044242),-0.3273762162591506,-0.6473183943492963,0.9322033898305084,1.0,1.0,3/22,10.41%,ENPP2;ANGPTL3;MT3
prerank,GO_Biological_Process_2021__retrograde axonal transport (GO:0008090),0.3171210275147974,0.646918747371602,0.9574468085106383,0.98487495614661,1.0,2/15,19.18%,KIF5A;FBXW11
prerank,GO_Biological_Process_2021__short-chain fatty acid catabolic process (GO:0019626),-0.3774369564639718,-0.646428060956849,0.8620689655172413,1.0,1.0,2/7,25.17%,PCK2;MMAA
prerank,GO_Biological_Process_2021__MyD88-dependent toll-like receptor signaling pathway (GO:0002755),-0.31631003526458285,-0.6462016298719077,0.9047619047619048,1.0,1.0,6/23,17.95%,RPS27A;UBC;LY96;CD14;UBA52;TNIP1
prerank,GO_Biological_Process_2021__response to ketone (GO:1901654),-0.3438501078750731,-0.6459382969765842,0.8688524590163934,1.0,1.0,1/16,5.73%,THBS1
prerank,GO_Biological_Process_2021__protein localization to endosome (GO:0036010),0.33924123363524,0.645908206348021,0.9285714285714286,0.9854102965864651,1.0,4/10,33.80%,NRP1;ARF6;TOLLIP;TMEM30A
prerank,GO_Biological_Process_2021__regulation of alpha-beta T cell differentiation (GO:0046637),0.4266697136453241,0.6457585049805697,0.8958333333333334,0.9852072707468457,1.0,2/5,9.57%,SH3RF1;GLI3
prerank,GO_Biological_Process_2021__negative regulation of type I interferon production (GO:0032480),-0.2823392591274143,-0.6454508782052022,0.9428571428571428,1.0,1.0,8/35,25.55%,ISG15;HERC5;NLRX1;NLRC5;DHX58;TRIM25;IRF3;IFIH1
prerank,GO_Biological_Process_2021__retinoic acid metabolic process (GO:0042573),-0.3973499550212612,-0.6454045467742132,0.9464285714285714,1.0,1.0,4/8,18.65%,ADH6;SCPEP1;CYP3A4;CYP3A5
prerank,GO_Biological_Process_2021__negative regulation of response to biotic stimulus (GO:0002832),-0.3010121796086226,-0.645197418450791,0.9649122807017544,1.0,1.0,2/24,7.64%,TRIM21;SIGIRR
prerank,GO_Biological_Process_2021__regulation of double-strand break repair via nonhomologous end joining (GO:2001032),-0.30035480931962255,-0.6449471191333374,0.9538461538461539,1.0,1.0,3/28,13.34%,PNKP;DTX3L;USP51
prerank,GO_Biological_Process_2021__negative regulation of transmembrane transport (GO:0034763),-0.40184140561694764,-0.6443628830887993,0.9166666666666666,1.0,1.0,1/7,5.73%,THBS1
prerank,GO_Biological_Process_2021__G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),-0.34896546592152816,-0.6442115306108765,0.9285714285714286,1.0,1.0,2/14,12.76%,CHRM2;CHRM5
prerank,GO_Biological_Process_2021__actin filament-based transport (GO:0099515),0.3169020175240453,0.6441142638171907,0.9393939393939394,0.9861508538541366,1.0,2/17,7.64%,MYO5B;WASL
prerank,GO_Biological_Process_2021__protein glycosylation (GO:0006486),0.23335824888056828,0.6438799066433488,1.0,0.9859848618167477,1.0,31/112,26.80%,FUT9;STT3B;MGAT4A;TRAK1;GAL3ST1;GALNT7;LARGE1;PLOD2;ST3GAL1;POMK;ALG6;FUT8;OGT;B4GALT5;ALG10;B3GALT1;PLOD1;ALG5;C1GALT1C1;MGAT4C;GALNT1;SLC39A8;POFUT1;MGAT5B;GALNT2;POGLUT1;DPM1;COG3;OGA;MGAT3;GALNT9
prerank,GO_Biological_Process_2021__regulation of cyclase activity (GO:0031279),0.40602596386972967,0.643770668802062,0.8478260869565217,0.9857553255545184,1.0,4/5,40.33%,MAPK8;MAPK3;MAPK14;CAP2
prerank,GO_Biological_Process_2021__positive regulation of ATPase activity (GO:0032781),0.27899716326547913,0.6437135034915179,1.0,0.985483517273986,1.0,8/34,18.56%,HNRNPU;DNAJB2;DYNLL2;DHX9;MSH2;POT1;DNAJB11;TOR1AIP2
prerank,GO_Biological_Process_2021__positive regulation of sodium ion transmembrane transporter activity (GO:2000651),-0.3594479259286917,-0.6435141296714988,0.9074074074074074,1.0,1.0,4/13,26.73%,GLRX;WNK4;ATP1B1;WNK2
prerank,GO_Biological_Process_2021__relaxation of cardiac muscle (GO:0055119),-0.3522394955413909,-0.6434957500932916,0.9508196721311475,1.0,1.0,1/13,4.39%,PLN
prerank,GO_Biological_Process_2021__negative regulation of amyloid-beta formation (GO:1902430),0.30245386325578394,0.6434295521542756,0.9761904761904762,0.9853762125843133,1.0,2/17,6.44%,BIN1;NTRK2
prerank,GO_Biological_Process_2021__cellular nitrogen compound biosynthetic process (GO:0044271),-0.3285812378142501,-0.6429677421731863,0.8615384615384616,1.0,1.0,2/25,4.16%,ARG2;PM20D1
prerank,GO_Biological_Process_2021__neutrophil activation (GO:0042119),-0.3653554336407144,-0.6426173130244593,0.7872340425531915,1.0,1.0,6/6,63.48%,SYK;DNASE1;PRKCD;IL15;KMT2E;PREX1
prerank,GO_Biological_Process_2021__regulation of sodium ion transmembrane transporter activity (GO:2000649),0.2637162573632853,0.6419653995206133,1.0,0.9860691517589241,1.0,17/29,33.56%,NEDD4L;PRKCE;CAMK2D;WNK3;WNK1;FGF14;UTRN;SLMAP;NETO1;HECW1;NEDD4;FGF13;DMD;FGF12;YWHAH;FXYD7;SCN3B
prerank,GO_Biological_Process_2021__N-terminal protein amino acid modification (GO:0031365),0.3441194570984644,0.6418476631812804,0.8648648648648649,0.9858875625935922,1.0,4/10,30.41%,NAA50;NAA16;METAP1D;NAA35
prerank,GO_Biological_Process_2021__regulation of cGMP-mediated signaling (GO:0010752),-0.414294690610823,-0.6410773090007108,0.8979591836734694,1.0,1.0,1/5,5.73%,THBS1
prerank,GO_Biological_Process_2021__potassium ion import across plasma membrane (GO:1990573),-0.30815981028384465,-0.640788995453057,0.927536231884058,1.0,1.0,2/30,9.59%,KCNJ13;ATP12A
prerank,GO_Biological_Process_2021__protein monoubiquitination (GO:0006513),-0.28995718533022496,-0.640669528259175,0.9444444444444444,1.0,1.0,5/35,13.65%,OBI1;TRIM21;RAG1;DTX3L;CTR9
prerank,GO_Biological_Process_2021__striated muscle tissue development (GO:0014706),-0.32528862726587293,-0.6403422985569671,0.9259259259259259,1.0,1.0,4/18,22.09%,SVIL;MYL6B;MYOZ2;MYL6
prerank,GO_Biological_Process_2021__organic hydroxy compound biosynthetic process (GO:1901617),-0.28690292989819327,-0.6395037119382577,0.9324324324324325,1.0,1.0,10/38,23.44%,SQLE;DHCR7;ALOX12;TM7SF2;INSIG1;MSMO1;PARK7;HMGCR;ACOT8;ACOX2
prerank,GO_Biological_Process_2021__positive regulation of adenylate cyclase activity (GO:0045762),0.3717219631097093,0.6393256640166207,0.8636363636363636,0.9873583608963385,1.0,2/6,11.69%,NF1;STIM1
prerank,GO_Biological_Process_2021__regulation of mesenchymal cell proliferation (GO:0010464),-0.3745337454312818,-0.6391235103507426,0.9508196721311475,1.0,1.0,1/9,3.14%,STAT1
prerank,GO_Biological_Process_2021__negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),-0.34617279302872667,-0.6386468825187219,0.9666666666666667,1.0,1.0,6/12,24.60%,THBS1;CREB3L1;SPRY1;GPC1;APLN;SULF2
prerank,GO_Biological_Process_2021__Rho protein signal transduction (GO:0007266),0.2474632151945654,0.6384529844592676,1.0,0.9877005803233787,1.0,8/44,19.93%,EPS8;ARHGAP5;GNA13;ROCK2;CNKSR1;CDH13;ARHGDIA;ROCK1
prerank,GO_Biological_Process_2021__regulation of cell size (GO:0008361),-0.3246377386711977,-0.6382540727949759,0.9552238805970149,1.0,1.0,2/21,10.23%,RDX;CAV3
prerank,GO_Biological_Process_2021__regulation of attachment of spindle microtubules to kinetochore (GO:0051988),0.35361228423653396,0.6380367156898343,0.9318181818181818,0.9877885474266442,1.0,2/8,13.72%,RCC2;SIRT2
prerank,GO_Biological_Process_2021__positive regulation of protein sumoylation (GO:0033235),-0.3506997230747079,-0.6374382228129796,0.8888888888888888,1.0,1.0,2/9,13.12%,PIAS3;GNL3
prerank,GO_Biological_Process_2021__vesicle transport along actin filament (GO:0030050),0.32653299577770856,0.6373792536477884,0.9696969696969697,0.9879875602024161,1.0,2/15,7.64%,MYO5B;WASL
prerank,GO_Biological_Process_2021__protein localization to microtubule cytoskeleton (GO:0072698),0.3878090984043448,0.6373633514548467,0.8695652173913043,0.9876945776920428,1.0,4/7,16.20%,CRIPT;MID1;MAPRE1;CHAMP1
prerank,GO_Biological_Process_2021__regulation of blood coagulation (GO:0030193),0.3529255564284788,0.6370374766776279,0.9782608695652174,0.9875762614687089,1.0,2/12,9.84%,SERPINE1;FAP
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),0.34407751901763545,0.6367238023862102,0.9705882352941176,0.9871654941287145,1.0,4/10,17.81%,MARCHF7;SIRT1;BCL2;KDM1A
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),0.34407751901763545,0.6367238023862102,0.9705882352941176,0.9871654941287145,1.0,4/10,17.81%,MARCHF7;SIRT1;BCL2;KDM1A
prerank,GO_Biological_Process_2021__negative regulation of glycogen metabolic process (GO:0070874),-0.40675715019257064,-0.6363023717734522,0.9090909090909091,1.0,1.0,1/5,5.71%,SELENOS
prerank,GO_Biological_Process_2021__negative regulation of glycogen biosynthetic process (GO:0045719),-0.40675715019257064,-0.6363023717734522,0.9090909090909091,1.0,1.0,1/5,5.71%,SELENOS
prerank,GO_Biological_Process_2021__regulation of non-membrane spanning protein tyrosine kinase activity (GO:1903995),-0.38923501871982025,-0.6358694815807506,0.82,1.0,1.0,1/6,5.93%,BDNF
prerank,GO_Biological_Process_2021__regulation of protein metabolic process (GO:0051246),-0.2805499610051491,-0.635801903758979,0.9859154929577465,1.0,1.0,3/36,11.67%,KLF2;KLF4;APOE
prerank,GO_Biological_Process_2021__glucosamine-containing compound catabolic process (GO:1901072),-0.36160406307201176,-0.6357657113724577,0.8793103448275862,1.0,1.0,3/8,24.40%,CHI3L2;GNPDA1;CHI3L1
prerank,GO_Biological_Process_2021__negative regulation of NIK/NF-kappaB signaling (GO:1901223),-0.3223101491576052,-0.6357428773987973,0.9090909090909091,1.0,1.0,2/16,12.68%,IFI35;SPI1
prerank,GO_Biological_Process_2021__positive regulation of RIG-I signaling pathway (GO:1900246),-0.3829498528258083,-0.635660035102264,0.8421052631578947,1.0,1.0,1/7,5.15%,DDX60
prerank,GO_Biological_Process_2021__regulation of biosynthetic process (GO:0009889),0.3736248818963133,0.6354910455275381,0.8333333333333334,0.9876865922735397,1.0,2/7,12.54%,SNCA;PIKFYVE
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell activation (GO:0032816),0.3298747734045545,0.6354029870632668,0.8536585365853658,0.9874311422351957,1.0,3/10,14.63%,ZBTB1;TICAM1;AP1G1
prerank,GO_Biological_Process_2021__inner ear receptor cell stereocilium organization (GO:0060122),0.35911940414226895,0.6349864482483648,0.9130434782608695,0.987466182713752,1.0,1/7,14.52%,WHRN
prerank,GO_Biological_Process_2021__negative regulation of lipid kinase activity (GO:0090219),0.33691744202124807,0.6349168591759863,0.8723404255319149,0.9871793069085997,1.0,2/8,12.26%,PPP2R5A;PIP4K2C
prerank,GO_Biological_Process_2021__regulation of homophilic cell adhesion (GO:1903385),0.4086055592927271,0.6347661153015094,0.9148936170212766,0.9870033962454035,1.0,1/5,1.63%,TENM3
prerank,GO_Biological_Process_2021__regulation of systemic arterial blood pressure (GO:0003073),-0.3766055189585015,-0.634656435116874,0.9038461538461539,1.0,1.0,1/9,4.11%,ADM
prerank,GO_Biological_Process_2021__pyrimidine nucleotide metabolic process (GO:0006220),-0.3947924687968667,-0.6344963979090837,0.86,1.0,1.0,1/5,12.85%,PRPS1
prerank,GO_Biological_Process_2021__intracellular distribution of mitochondria (GO:0048312),-0.4029180040852057,-0.6343486520331204,0.8541666666666666,1.0,1.0,5/5,59.73%,ARMC1;DNM1L;MAPT;CLUH;LRRK2
prerank,GO_Biological_Process_2021__negative regulation of viral release from host cell (GO:1902187),-0.3513974761226576,-0.6329382175411951,0.9655172413793104,1.0,1.0,2/12,17.47%,TRIM21;TRIM5
prerank,GO_Biological_Process_2021__entry into host (GO:0044409),0.3246136066889666,0.6326173122796563,0.9767441860465116,0.9881828996118952,1.0,1/12,5.82%,CBL
prerank,GO_Biological_Process_2021__negative regulation of ion transmembrane transporter activity (GO:0032413),-0.3547667884626179,-0.6324900594750933,0.9259259259259259,1.0,1.0,2/13,10.23%,PLN;CAV3
prerank,GO_Biological_Process_2021__NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),-0.3541320469573848,-0.6320860656893776,0.9230769230769231,1.0,1.0,4/11,27.12%,NAXE;PARP9;PARP10;NNMT
prerank,"GO_Biological_Process_2021__regulation of Wnt signaling pathway, planar cell polarity pathway (GO:2000095)",-0.42539144566818726,-0.631675901754348,0.8888888888888888,1.0,1.0,1/5,5.28%,RSPO3
prerank,GO_Biological_Process_2021__regulation of histone deacetylation (GO:0031063),-0.36500649877589886,-0.6311013845096873,0.8518518518518519,1.0,1.0,1/11,3.87%,APLNR
prerank,GO_Biological_Process_2021__purine nucleotide biosynthetic process (GO:0006164),0.3249592224794572,0.6310303233098294,0.9555555555555556,0.9888713612764122,1.0,2/10,11.84%,PRPS2;ADA
prerank,GO_Biological_Process_2021__positive regulation of transcription elongation from RNA polymerase II promoter (GO:0032968),0.3354149172166206,0.6306095386943932,0.8648648648648649,0.9888373694334348,1.0,4/11,24.38%,CDK12;CDK13;CDC73;BRD4
prerank,GO_Biological_Process_2021__leucine catabolic process (GO:0006552),0.3786871118932027,0.6301755970441187,0.82,0.9888402786215527,1.0,2/5,35.32%,HMGCLL1;IVD
prerank,GO_Biological_Process_2021__protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan (GO:0018406),-0.4217281976765448,-0.6290177218391938,0.8596491228070176,1.0,1.0,2/5,20.30%,DPM3;DPY19L2
prerank,GO_Biological_Process_2021__protein C-linked glycosylation via tryptophan (GO:0018317),-0.4217281976765448,-0.6290177218391938,0.8596491228070176,1.0,1.0,2/5,20.30%,DPM3;DPY19L2
prerank,GO_Biological_Process_2021__C21-steroid hormone biosynthetic process (GO:0006700),-0.35346958125955663,-0.6287006346818924,0.9107142857142857,1.0,1.0,1/9,4.56%,CACNA1H
prerank,GO_Biological_Process_2021__cholesterol efflux (GO:0033344),-0.33061282953114224,-0.6286652433266763,0.9152542372881356,1.0,1.0,6/15,24.26%,APOM;APOE;ABCA5;ABCG5;NPC1;APOC1
prerank,GO_Biological_Process_2021__mitotic G2 DNA damage checkpoint signaling (GO:0007095),-0.30791247597621807,-0.6286202926789967,0.9538461538461539,1.0,1.0,3/27,12.47%,ABRAXAS1;BLM;BRCA1
prerank,GO_Biological_Process_2021__negative regulation of receptor internalization (GO:0002091),0.327777264788478,0.6284143116733684,0.9166666666666666,0.9897121999851433,1.0,3/11,16.48%,RIN3;MTMR2;UBQLN2
prerank,GO_Biological_Process_2021__endothelium development (GO:0003158),-0.3929399796913906,-0.6284074798896456,0.8833333333333333,1.0,1.0,1/6,13.17%,EDF1
prerank,GO_Biological_Process_2021__DNA strand elongation involved in DNA replication (GO:0006271),-0.33220431792740357,-0.6283826914141262,0.9344262295081968,1.0,1.0,4/17,17.68%,POLE3;POLD2;GINS3;MCMDC2
prerank,GO_Biological_Process_2021__substrate-dependent cell migration (GO:0006929),-0.3516662508348572,-0.6283506645573425,0.921875,1.0,1.0,1/13,3.42%,P2RY12
prerank,GO_Biological_Process_2021__regulation of collagen biosynthetic process (GO:0032965),0.33236517674688904,0.6282058594765373,0.9142857142857143,0.98952528369229,1.0,2/14,8.82%,RGCC;HDAC2
prerank,GO_Biological_Process_2021__miRNA mediated inhibition of translation (GO:0035278),0.3548063462550975,0.6281288195917989,1.0,0.9889308217050287,1.0,6/9,39.40%,AGO3;AGO1;AGO2;NOTCH4;TNRC6C;TNRC6A
prerank,"GO_Biological_Process_2021__negative regulation of translation, ncRNA-mediated (GO:0040033)",0.3548063462550975,0.6281288195917989,1.0,0.9889308217050287,1.0,6/9,39.40%,AGO3;AGO1;AGO2;NOTCH4;TNRC6C;TNRC6A
prerank,GO_Biological_Process_2021__protein localization to centrosome (GO:0071539),0.3010801833393994,0.6277369218393303,0.9565217391304348,0.9888179766542619,1.0,6/17,26.88%,NEDD1;C2CD3;PCM1;STIL;CSNK1D;HOOK3
prerank,GO_Biological_Process_2021__endoplasmic reticulum to cytosol transport (GO:1903513),-0.33640283600618226,-0.627731057503991,0.9545454545454546,1.0,1.0,1/15,5.71%,SELENOS
prerank,GO_Biological_Process_2021__positive regulation of mRNA processing (GO:0050685),0.29433884691228757,0.6269616305571732,0.96875,0.988999668226132,1.0,5/20,24.56%,PRDX6;CELF3;TRA2A;CDC73;NUP98
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell contraction (GO:0086004),-0.3151433541260602,-0.6263608494948402,0.9558823529411765,1.0,1.0,3/19,10.23%,PLN;CTNNA3;CAV3
prerank,GO_Biological_Process_2021__phosphatidylglycerol acyl-chain remodeling (GO:0036148),0.36207419805889524,0.6263145218066735,0.8837209302325582,0.9891549600426159,1.0,2/7,26.18%,SERAC1;LPCAT1
prerank,GO_Biological_Process_2021__protein localization to cell periphery (GO:1990778),-0.243223133212116,-0.6263007930882892,1.0,1.0,1.0,12/123,13.14%,ABCA12;KCNB1;PDZK1;RAB11A;S100A10;RDX;FYB2;TSPAN32;ANK1;CAV3;AP4M1;RAMP3
prerank,GO_Biological_Process_2021__positive regulation of macrophage chemotaxis (GO:0010759),-0.3547375368093761,-0.6262588612745362,0.9384615384615385,1.0,1.0,3/12,14.90%,THBS1;CXCL17;IL34
prerank,GO_Biological_Process_2021__icosanoid biosynthetic process (GO:0046456),0.35411200570823415,0.6258087306566692,0.92,0.9891630146425582,1.0,1/9,6.65%,LTC4S
prerank,GO_Biological_Process_2021__glycine metabolic process (GO:0006544),-0.35104212234719856,-0.625646308318175,0.9473684210526315,1.0,1.0,1/9,5.93%,GLYAT
prerank,GO_Biological_Process_2021__cristae formation (GO:0042407),-0.3162555422623623,-0.6255240605677616,0.9245283018867925,1.0,1.0,8/25,23.60%,ATP5ME;ATP5F1E;ATP5MC3;ATP5PD;MICOS13;AFG3L2;ATP5PF;SPG7
prerank,GO_Biological_Process_2021__positive regulation of interleukin-6 production (GO:0032755),0.2582366921975654,0.625450694736937,0.9230769230769231,0.989118531856362,1.0,6/38,15.44%,TNFSF4;IL17D;MBP;HMGB1;DHX9;PTPN11
prerank,GO_Biological_Process_2021__rRNA transport (GO:0051029),-0.4135095813183932,-0.6250294961613545,0.8909090909090909,1.0,1.0,1/5,20.40%,NPM1
prerank,GO_Biological_Process_2021__protein K69-linked ufmylation (GO:1990592),-0.4157816148768477,-0.6249407808849312,0.92,1.0,1.0,3/5,31.49%,UFC1;DDRGK1;UFL1
prerank,GO_Biological_Process_2021__protein polyufmylation (GO:1990564),-0.4157816148768477,-0.6249407808849312,0.92,1.0,1.0,3/5,31.49%,UFC1;DDRGK1;UFL1
prerank,GO_Biological_Process_2021__protein ufmylation (GO:0071569),-0.4157816148768477,-0.6249407808849312,0.92,1.0,1.0,3/5,31.49%,UFC1;DDRGK1;UFL1
prerank,GO_Biological_Process_2021__protein insertion into mitochondrial membrane (GO:0051204),-0.3220115924311345,-0.6244928850255382,0.9636363636363636,1.0,1.0,3/20,14.94%,TIMM10;TIMM8B;ROMO1
prerank,GO_Biological_Process_2021__dolichol-linked oligosaccharide biosynthetic process (GO:0006488),-0.31804650419772396,-0.6239942507436579,0.9558823529411765,1.0,1.0,5/16,27.65%,DOLK;DHDDS;ALG1;DPAGT1;ALG9
prerank,GO_Biological_Process_2021__positive regulation of histone H3-K9 acetylation (GO:2000617),-0.4213398187496272,-0.6238139140147184,0.9215686274509803,1.0,1.0,1/5,12.47%,BRCA1
prerank,GO_Biological_Process_2021__calcium ion transmembrane import into cytosol (GO:0097553),-0.295154139333083,-0.623801894256126,0.9558823529411765,1.0,1.0,3/32,8.70%,HTR2B;GRIN2D;SLC8A3
prerank,GO_Biological_Process_2021__magnesium ion transport (GO:0015693),0.3097013192859133,0.6234717136107779,0.9767441860465116,0.9900508631165742,1.0,1/11,14.18%,MMGT1
prerank,GO_Biological_Process_2021__histone H3-K4 dimethylation (GO:0044648),-0.3832486608758636,-0.6232036995407773,0.9333333333333333,1.0,1.0,3/6,31.54%,KMT2B;SETD1A;SETD1B
prerank,GO_Biological_Process_2021__positive regulation of oligodendrocyte differentiation (GO:0048714),-0.40045207559053314,-0.6231520484724131,0.9666666666666667,1.0,1.0,2/6,17.27%,IL34;CXCR4
prerank,"GO_Biological_Process_2021__protein alpha-1,2-demannosylation (GO:0036508)",-0.3012321946644252,-0.6229574983937773,0.9850746268656716,1.0,1.0,6/23,22.54%,RPS27A;UBC;MAN1C1;UBA52;MAN1B1;UBB
prerank,GO_Biological_Process_2021__regulation of cellular pH (GO:0030641),0.2676760525699853,0.6221663305844438,1.0,0.9906728548392982,1.0,7/25,20.90%,CA2;SLC4A7;SLC4A4;SLC4A10;TM9SF4;ATP1A4;SLC9A9
prerank,GO_Biological_Process_2021__proton transmembrane transport (GO:1902600),0.2759508055129069,0.6220465056883108,0.9772727272727273,0.9904652373541382,1.0,5/21,18.73%,ATP6V1A;NNT;ATP1A4;DMAC2L;SLC25A14
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell apoptotic process (GO:1904036),0.2810267023957084,0.6219819170927334,1.0,0.9902000417396039,1.0,5/22,20.13%,SERPINE1;YAP1;NDNF;PAK4;NFE2L2
prerank,GO_Biological_Process_2021__ATP transport (GO:0015867),0.3280177328785061,0.6217843814813588,0.9767441860465116,0.990008443376419,1.0,2/9,10.73%,SLC25A41;SLC25A24
prerank,GO_Biological_Process_2021__regulation of cell-substrate adhesion (GO:0010810),0.27144770230650794,0.6215263541118317,1.0,0.9898536696653472,1.0,8/34,19.25%,NPNT;RSU1;BST1;NF1;PTK2;PTPRO;NDNF;PPM1F
prerank,GO_Biological_Process_2021__positive regulation of cellular component organization (GO:0051130),-0.2550446412086227,-0.6209302693213926,1.0,1.0,1.0,12/86,17.83%,WARS1;MTLN;GPC3;HYAL1;CLU;NOX1;APOE;CALY;HRK;TMED9;TFR2;FLOT1
prerank,GO_Biological_Process_2021__regulation of vacuole organization (GO:0044088),0.29077639253078963,0.6208444960801287,0.9696969696969697,0.9899925157204859,1.0,5/21,18.71%,ENO3;TBC1D12;PIKFYVE;UBQLN2;MTM1
prerank,GO_Biological_Process_2021__relaxation of muscle (GO:0090075),-0.35306787384115745,-0.6205440644582759,0.9642857142857143,1.0,1.0,1/12,4.39%,PLN
prerank,PanglaoDB_Augmented_2021__Schwann Cells,-0.2283142464505706,-0.6199984377825092,1.0,1.0,1.0,22/124,20.54%,LMOD1;APLNR;AQP1;NRN1;IGFBP5;MT3;FGF1;ART3;MATN2;S100B;PCDHB4;TNS2;BCAS1;CRYAB;SCN7A;SEMA3B;TAGLN;AGT;CTHRC1;TCEAL6;LGI4;EDNRB
prerank,GO_Biological_Process_2021__protein homotrimerization (GO:0070207),-0.3459143654413803,-0.6199316513062075,0.9322033898305084,1.0,1.0,1/8,9.69%,CLYBL
prerank,GO_Biological_Process_2021__protein trimerization (GO:0070206),-0.3459143654413803,-0.6199316513062075,0.9322033898305084,1.0,1.0,1/8,9.69%,CLYBL
prerank,GO_Biological_Process_2021__renal absorption (GO:0070293),-0.349062822284361,-0.6195705205327527,0.9215686274509803,1.0,1.0,1/10,6.80%,KCNQ1
prerank,GO_Biological_Process_2021__renal filtration (GO:0097205),0.3353254215442162,0.6193510407613994,0.8666666666666667,0.9906971669227222,1.0,3/8,26.53%,TBC1D8B;TMEM63C;XPNPEP3
prerank,GO_Biological_Process_2021__myotube differentiation (GO:0014902),0.32093005885017145,0.6192854597535604,1.0,0.9904218454632492,1.0,5/14,17.75%,ADGRB3;SORT1;JAM2;ADAM12;IGF1
prerank,GO_Biological_Process_2021__phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092),0.3618991728547567,0.6181403344821276,0.8809523809523809,0.9907855417502547,1.0,2/7,9.59%,PIK3CA;PIK3C3
prerank,GO_Biological_Process_2021__DNA strand elongation (GO:0022616),0.34023626063371726,0.6177945063924674,0.9767441860465116,0.9906988184951149,1.0,1/15,4.20%,POLD3
prerank,GO_Biological_Process_2021__glucose 6-phosphate metabolic process (GO:0051156),-0.3181701701584867,-0.6177767854669565,0.95,1.0,1.0,5/18,21.27%,RBKS;HK2;GPI;PGLS;TALDO1
prerank,GO_Biological_Process_2021__regulation of I-kappaB phosphorylation (GO:1903719),0.3955452773071797,0.6174163122661783,0.9230769230769231,0.990617383780485,1.0,1/5,6.29%,AKT1
prerank,GO_Biological_Process_2021__positive regulation of macrophage derived foam cell differentiation (GO:0010744),0.31995948085162523,0.617300761285967,0.8837209302325582,0.9903633655488581,1.0,1/10,4.81%,NFKB1
prerank,GO_Biological_Process_2021__establishment of protein localization to chromosome (GO:0070199),0.34076493196613566,0.6171484198230103,0.975609756097561,0.9900938206046649,1.0,3/10,24.34%,NIPBL;POT1;MACROH2A1
prerank,GO_Biological_Process_2021__positive regulation of trophoblast cell migration (GO:1901165),0.38542235904717403,0.6170215013067599,0.95,0.9898349040248486,1.0,4/6,41.21%,AGO2;SYDE1;SMURF2;ACVR1B
prerank,GO_Biological_Process_2021__positive regulation of dendritic cell cytokine production (GO:0002732),0.3710656473212565,0.6168913678454795,0.8723404255319149,0.9896127374613343,1.0,3/6,28.45%,TICAM1;CAMK4;KIT
prerank,GO_Biological_Process_2021__L-alpha-amino acid transmembrane transport (GO:1902475),0.27077969652535694,0.616255984593323,1.0,0.9896571724374017,1.0,8/23,31.76%,SLC25A18;SLC47A1;SLC6A9;SLC22A2;SLC25A13;SLC7A2;SLC25A12;SLC1A2
prerank,GO_Biological_Process_2021__regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),0.29802858687633127,0.6158889715102356,0.975609756097561,0.9893073627775867,1.0,6/19,19.50%,TP53BP2;BCL2;TFDP2;MAPK8;YWHAG;YWHAZ
prerank,GO_Biological_Process_2021__positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),0.29802858687633127,0.6158889715102356,0.975609756097561,0.9893073627775867,1.0,6/19,19.50%,TP53BP2;BCL2;TFDP2;MAPK8;YWHAG;YWHAZ
prerank,GO_Biological_Process_2021__regulation of isotype switching (GO:0045191),0.31952284469424763,0.6149780401619894,0.9555555555555556,0.9895554208498815,1.0,2/13,29.82%,TFRC;KMT5B
prerank,GO_Biological_Process_2021__regulation of MHC class I biosynthetic process (GO:0045343),0.38856778545632137,0.6149487873998913,0.8913043478260869,0.98926586334901,1.0,1/5,4.44%,HSPH1
prerank,GO_Biological_Process_2021__phosphatidylethanolamine acyl-chain remodeling (GO:0036152),-0.3183001155493653,-0.6148954735837979,0.9830508474576272,1.0,1.0,1/14,9.14%,PLAAT4
prerank,GO_Biological_Process_2021__negative regulation of cellular carbohydrate metabolic process (GO:0010677),-0.3423002411311159,-0.614391700432745,0.9,1.0,1.0,2/15,9.32%,MST1;PGP
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell apoptotic process (GO:2000352),0.2964419068830552,0.6143145586978263,0.9555555555555556,0.9893259871938921,1.0,4/14,20.13%,SERPINE1;NDNF;PAK4;NFE2L2
prerank,GO_Biological_Process_2021__primary neural tube formation (GO:0014020),0.2635340760276125,0.6142075786764924,1.0,0.9887684242433958,1.0,9/27,33.42%,VASP;SCRIB;MTHFR;BCL10;STIL;PHACTR4;TGFB2;COBL;SKI
prerank,GO_Biological_Process_2021__tube closure (GO:0060606),0.2635340760276125,0.6142075786764924,1.0,0.9887684242433958,1.0,9/27,33.42%,VASP;SCRIB;MTHFR;BCL10;STIL;PHACTR4;TGFB2;COBL;SKI
prerank,GO_Biological_Process_2021__regulation of programmed necrotic cell death (GO:0062098),-0.33073766702593266,-0.614005330651348,0.9696969696969697,1.0,1.0,5/19,20.56%,CASP8;CDC37;FLOT1;ASAH1;NUPR1
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion mediated by integrin (GO:0033632),-0.3711870700566963,-0.6133355135606436,0.9347826086956522,1.0,1.0,2/7,15.28%,PODXL;SKAP1
prerank,GO_Biological_Process_2021__skeletal muscle organ development (GO:0060538),0.29289626629049087,0.6127125832379712,0.8958333333333334,0.989360210159695,1.0,6/15,18.28%,LARGE1;CFLAR;DISP1;MYH14;FXR1;ZBTB18
prerank,GO_Biological_Process_2021__positive regulation of DNA recombination (GO:0045911),-0.29217982297535416,-0.6121975343537721,0.9672131147540983,1.0,1.0,2/25,15.68%,PRDM7;RAD51AP1
prerank,GO_Biological_Process_2021__carbohydrate phosphorylation (GO:0046835),0.35115937440261813,0.6121170983633436,0.9574468085106383,0.9893108231778938,1.0,4/8,19.88%,POMK;ITPK1;IPPK;FGGY
prerank,GO_Biological_Process_2021__positive regulation of interleukin-1 production (GO:0032732),-0.27790790907399227,-0.6119109405380937,0.9859154929577465,1.0,1.0,8/32,20.27%,CASP8;NLRP1;RIPK2;AIM2;WNT5A;USP50;S100A13;NLRP2
prerank,GO_Biological_Process_2021__positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316),0.36805019660560456,0.6113928680380206,0.9523809523809523,0.9893760450654597,1.0,1/7,9.40%,GSTM2
prerank,GO_Biological_Process_2021__glomerular epithelial cell development (GO:0072310),-0.3690122721224235,-0.6112870629988205,0.9423076923076923,1.0,1.0,2/7,19.82%,PODXL;MYO1E
prerank,GO_Biological_Process_2021__establishment of protein localization to chromatin (GO:0071169),0.3790199898088509,0.6111050875342101,0.9333333333333333,0.9892485883739844,1.0,2/6,24.34%,NIPBL;MACROH2A1
prerank,GO_Biological_Process_2021__acetylcholine receptor signaling pathway (GO:0095500),-0.314446050137517,-0.611098229257407,0.9491525423728814,1.0,1.0,2/15,12.76%,CHRM2;CHRM5
prerank,GO_Biological_Process_2021__regulation of interleukin-4 production (GO:0032673),-0.33605742991566845,-0.6107994997349933,0.8870967741935484,1.0,1.0,4/14,14.75%,PRKCQ;DDIT3;ZFPM1;ZP3
prerank,"GO_Biological_Process_2021__regulation of CD4-positive, alpha-beta T cell proliferation (GO:2000561)",0.3638033591417939,0.6107394847291931,0.8958333333333334,0.9891316222888182,1.0,1/6,11.72%,TGFBR2
prerank,GO_Biological_Process_2021__positive regulation of protein transport (GO:0051222),-0.24616754827525306,-0.6100211793041967,1.0,1.0,1.0,4/55,13.86%,KIF20B;TTN;PLK3;CLN3
prerank,GO_Biological_Process_2021__regulation of cytokine production involved in immune response (GO:0002718),0.3652858830242755,0.6099364353724179,0.95,0.9892436667957669,1.0,1/7,6.66%,TRPM4
prerank,GO_Biological_Process_2021__pentose-phosphate shunt (GO:0006098),0.3139612833681865,0.609058939514983,0.9487179487179487,0.9894024530168962,1.0,2/11,9.18%,PGD;PGM2
prerank,GO_Biological_Process_2021__glomerular visceral epithelial cell development (GO:0072015),-0.3690914692110309,-0.6090090689137844,0.8846153846153846,1.0,1.0,2/6,19.82%,PODXL;MYO1E
prerank,GO_Biological_Process_2021__positive regulation of alpha-beta T cell proliferation (GO:0046641),-0.3533333846518187,-0.6084428599446023,0.9047619047619048,1.0,1.0,3/9,17.40%,HLA-A;IL18;PTPN22
prerank,GO_Biological_Process_2021__mitotic G2/M transition checkpoint (GO:0044818),-0.2898001692692279,-0.6079161043314808,1.0,1.0,1.0,3/35,12.47%,ABRAXAS1;BLM;BRCA1
prerank,GO_Biological_Process_2021__mitochondrial gene expression (GO:0140053),0.26022011001336776,0.6074382931787075,0.9142857142857143,0.9899355229851513,1.0,5/33,14.67%,FOXO3;MRPS2;GATB;GFM2;LARS2
prerank,GO_Biological_Process_2021__glycolipid metabolic process (GO:0006664),-0.2617964170168817,-0.6063982292285822,1.0,1.0,1.0,11/46,19.86%,ST3GAL6;B3GNT5;SUMF2;FUT2;NEU1;CTSA;B4GALNT1;CPTP;ESYT1;ASAH1;PIGW
prerank,GO_Biological_Process_2021__positive regulation of fibroblast migration (GO:0010763),-0.36530482303599426,-0.6062908508081971,0.9122807017543859,1.0,1.0,1/8,5.73%,THBS1
prerank,GO_Biological_Process_2021__positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),-0.34744026401400735,-0.6058465826164955,0.9629629629629629,1.0,1.0,4/9,23.47%,FLOT1;EHD2;EHD1;CAMK1
prerank,GO_Biological_Process_2021__regulation of protein localization to centrosome (GO:1904779),0.3345067401126049,0.6057843330815177,0.9545454545454546,0.99052543365961,1.0,3/9,19.45%,GSK3B;NSFL1C;UBXN2B
prerank,GO_Biological_Process_2021__pexophagy (GO:0000425),0.3479176563297985,0.6055705598166493,0.9318181818181818,0.9903354969738752,1.0,1/7,11.91%,PEX5
prerank,GO_Biological_Process_2021__protein localization to cilium (GO:0061512),0.24593400811519237,0.6055184607449283,1.0,0.9900469790820505,1.0,4/29,13.45%,TUB;INVS;ZNF423;BBS9
prerank,GO_Biological_Process_2021__mannose trimming involved in glycoprotein ERAD pathway (GO:1904382),0.40411747697060596,0.6053833681081132,0.9183673469387755,0.9891773339356306,1.0,2/5,23.71%,EDEM1;EDEM3
prerank,GO_Biological_Process_2021__ubiquitin-dependent glycoprotein ERAD pathway (GO:0097466),0.40411747697060596,0.6053833681081132,0.9183673469387755,0.9891773339356306,1.0,2/5,23.71%,EDEM1;EDEM3
prerank,GO_Biological_Process_2021__protein deglycosylation involved in glycoprotein catabolic process (GO:0035977),0.40411747697060596,0.6053833681081132,0.9183673469387755,0.9891773339356306,1.0,2/5,23.71%,EDEM1;EDEM3
prerank,GO_Biological_Process_2021__positive regulation of axon extension (GO:0045773),-0.30738102750817115,-0.6051320377194949,0.9701492537313433,1.0,1.0,1/20,5.50%,SEMA5A
prerank,GO_Biological_Process_2021__cellular response to UV-B (GO:0071493),0.3672548334770288,0.6050938255380865,0.8235294117647058,0.9890088789840051,1.0,2/5,16.28%,MME;STK11
prerank,GO_Biological_Process_2021__keratan sulfate catabolic process (GO:0042340),-0.36802300720934866,-0.6049916043463056,0.9107142857142857,1.0,1.0,2/7,20.36%,OGN;OMD
prerank,GO_Biological_Process_2021__respiratory chain complex IV assembly (GO:0008535),-0.3123218598734575,-0.6046275613425167,0.9672131147540983,1.0,1.0,2/16,10.77%,COX20;SURF1
prerank,GO_Biological_Process_2021__regulation of protein kinase A signaling (GO:0010738),0.31163999525401576,0.6041434995313831,0.9387755102040817,0.989151726751885,1.0,2/14,7.11%,PRKAR1B;ADRB2
prerank,GO_Biological_Process_2021__establishment of mitotic spindle orientation (GO:0000132),0.27825280895040977,0.6038899933370597,0.9705882352941176,0.9889678318394722,1.0,5/20,20.03%,INSC;FBXW11;NSFL1C;UBXN2B;PLK1
prerank,GO_Biological_Process_2021__lytic vacuole organization (GO:0080171),0.254063991070766,0.603389322016231,1.0,0.9889602860550785,1.0,4/29,15.33%,ABCA1;HOOK1;TFEB;TMEM106B
prerank,GO_Biological_Process_2021__regulation of hematopoietic stem cell proliferation (GO:1902033),-0.3771830281777145,-0.603290086151777,0.8392857142857143,1.0,1.0,2/5,18.79%,EIF2AK2;THPO
prerank,GO_Biological_Process_2021__purine-containing compound biosynthetic process (GO:0072522),0.2683136922593769,0.6032372420274623,0.9230769230769231,0.9887402965948853,1.0,5/22,16.56%,PRPS2;GMPS;ADA;DGUOK;DCK
prerank,GO_Biological_Process_2021__positive regulation of mast cell activation (GO:0033005),-0.3972289577140248,-0.6032182952468552,0.9607843137254902,1.0,1.0,1/5,15.01%,CRLF2
prerank,GO_Biological_Process_2021__regulation of release of sequestered calcium ion into cytosol (GO:0051279),-0.27436070968652737,-0.6023345336131785,0.9726027397260274,1.0,1.0,5/34,13.85%,JPH3;APLNR;CEMIP;CX3CL1;NOS1
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell apoptotic process (GO:1905461),0.4089160694236731,0.6016094786555164,0.9555555555555556,0.9893751512177555,1.0,3/5,41.42%,PPARG;MFN2;E2F3
prerank,GO_Biological_Process_2021__endothelial cell differentiation (GO:0045446),-0.35172099887926156,-0.6014023930041585,0.9629629629629629,1.0,1.0,1/8,13.17%,EDF1
prerank,GO_Biological_Process_2021__odontogenesis (GO:0042476),-0.3079754868690374,-0.6008774219309985,0.9393939393939394,1.0,1.0,3/19,16.33%,AQP1;LAMB1;TUFT1
prerank,GO_Biological_Process_2021__regulation of plasminogen activation (GO:0010755),0.3155661523743782,0.6007254116523179,1.0,0.989496943387165,1.0,1/10,2.21%,SERPINE1
prerank,GO_Biological_Process_2021__negative regulation of cytokine production involved in immune response (GO:0002719),-0.3567353855567806,-0.6006085092526371,0.8793103448275862,1.0,1.0,3/9,22.39%,CUEDC2;HLA-F;TGFB1
prerank,GO_Biological_Process_2021__positive regulation of lyase activity (GO:0051349),-0.34219568836050623,-0.6004130379903067,0.8870967741935484,1.0,1.0,2/9,13.85%,AKAP5;NOS1
prerank,GO_Biological_Process_2021__cadmium ion transport (GO:0015691),-0.3876823593880506,-0.6001043662580737,0.9607843137254902,1.0,1.0,1/5,10.16%,SLC11A1
prerank,GO_Biological_Process_2021__cadmium ion transmembrane transport (GO:0070574),-0.3876823593880506,-0.6001043662580737,0.9607843137254902,1.0,1.0,1/5,10.16%,SLC11A1
prerank,GO_Biological_Process_2021__membrane repolarization (GO:0086009),-0.32664173600067725,-0.5995251846248214,0.9661016949152542,1.0,1.0,1/13,6.80%,KCNQ1
prerank,GO_Biological_Process_2021__regulation of supramolecular fiber organization (GO:1902903),0.2553913714115894,0.5992300725643874,0.9696969696969697,0.989981030997813,1.0,2/22,11.81%,PIK3CA;CAMSAP2
prerank,GO_Biological_Process_2021__negative regulation of glial cell apoptotic process (GO:0034351),-0.35747314614241843,-0.5982954061964747,0.8837209302325582,1.0,1.0,1/7,14.31%,CCL2
prerank,GO_Biological_Process_2021__regulation of T cell activation (GO:0050863),-0.28657869055801205,-0.5981430467603528,0.9705882352941176,1.0,1.0,7/24,21.11%,PRKCQ;CCL2;SPINK5;PTPN22;PRELID1;HLA-DPB1;HSPD1
prerank,GO_Biological_Process_2021__positive regulation of glial cell differentiation (GO:0045687),0.30679086610513495,0.5979124566649469,0.9722222222222222,0.9903354345042814,1.0,2/14,6.19%,BMP2;BIN1
prerank,GO_Biological_Process_2021__histone lysine methylation (GO:0034968),0.2557431314162436,0.5975013195948968,0.9736842105263158,0.9902188275302753,1.0,6/28,18.75%,MEN1;WDR5B;SETD3;CXXC1;ASH2L;WDR82
prerank,GO_Biological_Process_2021__R-loop disassembly (GO:0062176),0.370678384696708,0.5970879818889443,0.9333333333333333,0.9901229816496748,1.0,2/5,18.07%,PRIMPOL;SRPK2
prerank,GO_Biological_Process_2021__establishment of monopolar cell polarity (GO:0061162),-0.38950597922402663,-0.595656583045373,0.8867924528301887,1.0,1.0,1/5,14.53%,FSCN1
prerank,GO_Biological_Process_2021__cellular response to glucose stimulus (GO:0071333),0.2581712727200738,0.5951508456991986,1.0,0.9907665357824867,1.0,2/27,4.08%,SOX4;ZBTB20
prerank,GO_Biological_Process_2021__purine ribonucleoside monophosphate catabolic process (GO:0009169),-0.35135066524224423,-0.5950388257440999,0.9310344827586207,1.0,1.0,1/7,7.28%,PNP
prerank,GO_Biological_Process_2021__negative regulation of cellular response to hypoxia (GO:1900038),-0.37821706855396103,-0.5949844985433731,0.9583333333333334,1.0,1.0,2/5,20.22%,NOL3;ENO1
prerank,GO_Biological_Process_2021__membrane repolarization during action potential (GO:0086011),-0.33489506947357817,-0.5946110938049953,0.9629629629629629,1.0,1.0,1/11,6.80%,KCNQ1
prerank,GO_Biological_Process_2021__negative regulation of ion transport (GO:0043271),-0.2987855088383987,-0.5944847048072023,0.9428571428571428,1.0,1.0,3/18,13.85%,PLN;CAV3;NOS1
prerank,GO_Biological_Process_2021__DNA biosynthetic process (GO:0071897),0.28447890448346397,0.5941220880168245,0.9767441860465116,0.990965186033815,1.0,3/15,17.77%,POLD3;SIRT1;WRNIP1
prerank,GO_Biological_Process_2021__purine-containing compound salvage (GO:0043101),-0.31952245116899763,-0.5937883934073324,0.9464285714285714,1.0,1.0,2/11,14.12%,PNP;GMPR2
prerank,GO_Biological_Process_2021__regulation of sodium ion transport (GO:0002028),0.2545516505182757,0.5933570431694947,0.9714285714285714,0.9910397042423547,1.0,8/29,21.69%,NKAIN2;DLG1;ATP2B4;WNK3;WNK1;DRD2;NKAIN3;SLMAP
prerank,GO_Biological_Process_2021__response to iron ion (GO:0010039),-0.3405660572407009,-0.5929933970969795,0.9333333333333333,1.0,1.0,1/10,3.99%,B2M
prerank,GO_Biological_Process_2021__alpha-linolenic acid metabolic process (GO:0036109),0.30143599646944297,0.5927034830262516,0.9473684210526315,0.9910470263848935,1.0,5/12,26.80%,ELOVL5;HSD17B4;ACOX1;SCP2;ELOVL1
prerank,GO_Biological_Process_2021__regulation of protein processing (GO:0070613),-0.31091774358440116,-0.5926322801539923,0.8823529411764706,1.0,1.0,2/15,13.86%,CCBE1;CLN3
prerank,GO_Biological_Process_2021__autophagy of mitochondrion (GO:0000422),0.22379415993037552,0.5924392397913586,0.9642857142857143,0.990868451505736,1.0,6/37,18.61%,CTSK;ATG7;PRKN;FUNDC2;ATG2B;ATG5
prerank,GO_Biological_Process_2021__regulation of ion transmembrane transporter activity (GO:0032412),0.27954503652803403,0.5918838774298669,1.0,0.990767420052458,1.0,3/30,8.02%,ANK2;NEDD4L;HOMER1
prerank,GO_Biological_Process_2021__mitral valve morphogenesis (GO:0003183),-0.35062062106896497,-0.5913082521638667,0.90625,1.0,1.0,2/9,13.47%,EFNA1;ZFPM1
prerank,GO_Biological_Process_2021__carboxylic acid metabolic process (GO:0019752),-0.2919001650361417,-0.5912139634775045,0.9722222222222222,1.0,1.0,3/28,8.53%,GLYAT;ST6GAL1;GNE
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance (GO:0032205),-0.3307001767167889,-0.5910160512279589,0.9545454545454546,1.0,1.0,1/13,11.65%,SLX4
prerank,GO_Biological_Process_2021__amino sugar catabolic process (GO:0046348),-0.32546566911806685,-0.5909492109305866,0.9016393442622951,1.0,1.0,1/7,19.10%,GNPDA1
prerank,GO_Biological_Process_2021__regulation of protein localization to nucleolus (GO:1904749),0.3603763538189237,0.5905721772651333,0.9743589743589743,0.9910483234149696,1.0,3/6,31.49%,NVL;GLUL;POLR1A
prerank,GO_Biological_Process_2021__ribosome disassembly (GO:0032790),-0.34673271513895176,-0.5902219917572715,0.9166666666666666,1.0,1.0,1/7,9.50%,MTIF3
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),-0.24198161787140188,-0.5900733339407034,1.0,1.0,1.0,4/74,10.04%,CENPE;KIF2C;CTSL;KIF4A
prerank,GO_Biological_Process_2021__establishment of planar polarity (GO:0001736),-0.3699311626531732,-0.5899064715513154,0.9152542372881356,1.0,1.0,3/6,34.12%,CELSR1;VANGL2;FUZ
prerank,GO_Biological_Process_2021__protein peptidyl-prolyl isomerization (GO:0000413),0.2770539245834211,0.5898663631345664,0.9743589743589743,0.9910349984328674,1.0,6/18,27.09%,FKBP5;CWC27;PPIL6;PPIG;FKBP4;PPIL2
prerank,GO_Biological_Process_2021__digestive system development (GO:0055123),0.3510605744994656,0.5898456068402813,0.9423076923076923,0.9907225662139415,1.0,5/8,32.81%,NIPBL;FGFR2;KIT;COBL;CHD8
prerank,GO_Biological_Process_2021__morphogenesis of a polarized epithelium (GO:0001738),0.292667681051517,0.5892626208287994,1.0,0.9906887301327756,1.0,2/12,20.55%,SCRIB;RAB10
prerank,GO_Biological_Process_2021__GPI anchor biosynthetic process (GO:0006506),0.26183139668927546,0.5892159595840804,0.972972972972973,0.9903869117118916,1.0,8/27,29.14%,PGAP1;PIGX;PIGP;PIGQ;PIGU;DPM1;PGAP4;PIGZ
prerank,GO_Biological_Process_2021__aortic valve development (GO:0003176),-0.301091889974535,-0.5891448948293695,0.9838709677419355,1.0,1.0,2/23,6.39%,EFNA1;ELN
prerank,GO_Biological_Process_2021__sphingosine-1-phosphate receptor signaling pathway (GO:0003376),-0.381608005144501,-0.5886128085199736,0.9122807017543859,1.0,1.0,1/5,8.27%,PIK3CB
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte activation (GO:0051251),0.28713461617971836,0.5884916476501904,0.9411764705882353,0.9903892687156169,1.0,2/17,8.76%,TNFSF4;TICAM1
prerank,GO_Biological_Process_2021__regulation of cellular protein catabolic process (GO:1903362),-0.30850576343182506,-0.5883860514612099,0.9701492537313433,1.0,1.0,1/16,6.91%,RDX
prerank,GO_Biological_Process_2021__response to testosterone (GO:0033574),0.3605059422786322,0.5876521017163465,0.9534883720930233,0.9901416748328948,1.0,1/5,15.41%,ROCK2
prerank,GO_Biological_Process_2021__cellular response to testosterone stimulus (GO:0071394),0.3605059422786322,0.5876521017163465,0.9534883720930233,0.9901416748328948,1.0,1/5,15.41%,ROCK2
prerank,GO_Biological_Process_2021__protein O-linked glycosylation (GO:0006493),-0.24416395869077642,-0.5865217382326328,1.0,1.0,1.0,6/78,10.57%,GCNT1;GALNT15;ST6GAL1;B3GNT5;B3GNT3;CHST4
prerank,GO_Biological_Process_2021__negative regulation of histone methylation (GO:0031061),0.2847325203242492,0.586052311294057,1.0,0.9905507537134711,1.0,3/12,24.34%,KDM1A;JARID2;MACROH2A1
prerank,GO_Biological_Process_2021__negative regulation of double-strand break repair via homologous recombination (GO:2000042),0.2818156251486369,0.5859172104160902,1.0,0.990275182453374,1.0,2/16,15.92%,KLHL15;UBQLN4
prerank,GO_Biological_Process_2021__histone H2B ubiquitination (GO:0033523),-0.34221429823493643,-0.5857104997909294,0.9344262295081968,1.0,1.0,3/10,19.58%,DTX3L;CTR9;RNF8
prerank,GO_Biological_Process_2021__regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),0.2550374108969372,0.585615584217738,1.0,0.9901283893129659,1.0,6/25,17.57%,SMAD2;SMAD7;SMAD4;BCL9;LATS1;ZNF703
prerank,GO_Biological_Process_2021__IMP metabolic process (GO:0046040),-0.3294969162461614,-0.5854812489475375,0.9310344827586207,1.0,1.0,1/8,7.28%,PNP
prerank,GO_Biological_Process_2021__negative regulation of cell cycle G1/S phase transition (GO:1902807),-0.2772841517581776,-0.5854598765911687,0.9682539682539683,1.0,1.0,5/29,18.82%,WEE1;KLF4;CCL2;GFI1B;PRMT2
prerank,GO_Biological_Process_2021__positive regulation of fatty acid beta-oxidation (GO:0032000),0.35021591487648096,0.5848560259023526,0.9545454545454546,0.9901822488918601,1.0,2/8,7.80%,PLIN5;IRS1
prerank,GO_Biological_Process_2021__telomere maintenance in response to DNA damage (GO:0043247),0.3128141238870058,0.5846592777479397,1.0,0.9899276170859104,1.0,4/9,31.95%,DCLRE1C;DCLRE1A;TERF2IP;TERF2
prerank,GO_Biological_Process_2021__alditol metabolic process (GO:0019400),-0.3881541173926464,-0.5839732086246644,0.875,1.0,1.0,1/5,7.43%,ANGPTL3
prerank,GO_Biological_Process_2021__regulation of potassium ion transmembrane transport (GO:1901379),-0.2499792635935944,-0.5837311781003264,1.0,1.0,1.0,5/46,17.06%,CD63;KCNQ1;CAV3;DPP10;NOS1AP
prerank,GO_Biological_Process_2021__regulation of cholesterol esterification (GO:0010872),0.3381381802279788,0.5836844730812533,0.9302325581395349,0.9899969239304156,1.0,2/7,13.55%,STARD4;ABCA2
prerank,GO_Biological_Process_2021__organelle disassembly (GO:1903008),-0.2716519941368529,-0.5833571754601978,0.9852941176470589,1.0,1.0,3/31,12.01%,MTIF3;KIF9;PLK3
prerank,GO_Biological_Process_2021__negative regulation of calcineurin-mediated signaling (GO:0106057),0.3231572234148808,0.5832472733177279,0.9130434782608695,0.9896320676378942,1.0,4/9,22.09%,DYRK2;GSK3B;ATP2B4;HOMER2
prerank,GO_Biological_Process_2021__negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),0.3231572234148808,0.5832472733177279,0.9130434782608695,0.9896320676378942,1.0,4/9,22.09%,DYRK2;GSK3B;ATP2B4;HOMER2
prerank,GO_Biological_Process_2021__regulation of histone H3-K4 methylation (GO:0051569),-0.3097315777916848,-0.5824850528497812,0.9375,1.0,1.0,3/16,14.92%,BRCA1;CTR9;SNW1
prerank,GO_Biological_Process_2021__glomerular filtration (GO:0003094),0.33684387175757896,0.5824035543587628,0.9512195121951219,0.9896397879335708,1.0,3/7,26.53%,TBC1D8B;TMEM63C;XPNPEP3
prerank,GO_Biological_Process_2021__prostanoid biosynthetic process (GO:0046457),0.32928193524268484,0.5823031934146483,0.8913043478260869,0.989375460036545,1.0,4/8,28.07%,PTGES3;PRXL2B;TBXAS1;PTGIS
prerank,GO_Biological_Process_2021__regulation of MHC class II biosynthetic process (GO:0045346),-0.3529413312171025,-0.5818734034785012,0.9016393442622951,1.0,1.0,2/7,13.88%,CIITA;XBP1
prerank,GO_Biological_Process_2021__antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),-0.24000422626701054,-0.5818383935088576,1.0,1.0,1.0,4/76,10.04%,CENPE;KIF2C;CTSL;KIF4A
prerank,GO_Biological_Process_2021__maintenance of synapse structure (GO:0099558),0.33947923298444355,0.5812599259612221,1.0,0.9895269319126705,1.0,2/6,22.55%,ERC2;ERC1
prerank,GO_Biological_Process_2021__natural killer cell activation (GO:0030101),-0.3274112791174578,-0.5805341929962324,0.9710144927536232,1.0,1.0,2/13,7.86%,RASGRP1;CASP8
prerank,GO_Biological_Process_2021__regulation of nitric-oxide synthase activity (GO:0050999),-0.29089789518190273,-0.5804917278166359,0.9714285714285714,1.0,1.0,4/25,11.67%,HTR2B;PIK3CB;CAV3;APOE
prerank,GO_Biological_Process_2021__regulation of skeletal muscle tissue development (GO:0048641),0.3609822976855118,0.5802942835089916,0.9791666666666666,0.9896424010727037,1.0,1/5,6.03%,MEGF10
prerank,GO_Biological_Process_2021__ribose phosphate biosynthetic process (GO:0046390),0.3604277671919146,0.5800912254613961,0.9473684210526315,0.9893885770731071,1.0,1/6,6.53%,PRPS2
prerank,GO_Biological_Process_2021__adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),-0.27052409043629655,-0.5786486376159165,1.0,1.0,1.0,4/37,12.76%,P2RY12;CHRM2;AKAP5;CHRM5
prerank,GO_Biological_Process_2021__positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),-0.29384304116003135,-0.5785819867341679,0.96875,1.0,1.0,4/23,13.12%,SRF;KLF4;SPI1;GNL3
prerank,GO_Biological_Process_2021__pharyngeal system development (GO:0060037),-0.3698100269494213,-0.5777801268065127,0.9423076923076923,1.0,1.0,1/8,7.41%,HES1
prerank,GO_Biological_Process_2021__myelin maintenance (GO:0043217),0.3234521181758614,0.5776617642554521,0.9782608695652174,0.9901909627442912,1.0,1/9,4.89%,MYRF
prerank,GO_Biological_Process_2021__N-acetylglucosamine metabolic process (GO:0006044),0.2659891819336234,0.5771433612870661,0.975609756097561,0.9901062460797218,1.0,5/15,26.70%,LARGE1;CHST3;CHST1;OGA;MGAT3
prerank,"GO_Biological_Process_2021__SRP-dependent cotranslational protein targeting to membrane, translocation (GO:0006616)",-0.3752015453287274,-0.5770369894475184,0.9272727272727272,1.0,1.0,2/5,21.19%,ZFAND2B;SRP54
prerank,GO_Biological_Process_2021__negative regulation of extracellular matrix organization (GO:1903054),-0.35797250501709943,-0.5769013946213274,0.9298245614035088,1.0,1.0,2/7,22.39%,CST3;TGFB1
prerank,GO_Biological_Process_2021__histone H3-K4 monomethylation (GO:0097692),0.3506054544687331,0.5766795575146472,0.9636363636363636,0.9899959662387385,1.0,1/7,14.25%,KMT2C
prerank,GO_Biological_Process_2021__regulation of store-operated calcium entry (GO:2001256),-0.3370565770544306,-0.5766300717917229,0.9333333333333333,1.0,1.0,3/9,16.10%,GRAMD2A;EFHB;SLC8B1
prerank,GO_Biological_Process_2021__heme biosynthetic process (GO:0006783),-0.28883848395478967,-0.5765785333369042,0.9324324324324325,1.0,1.0,5/17,22.03%,ABCG2;ATP5IF1;UROD;TSPO;ALAD
prerank,GO_Biological_Process_2021__glutamine transport (GO:0006868),-0.3549829038729849,-0.5762502485006777,0.8867924528301887,1.0,1.0,1/5,11.61%,SLC38A1
prerank,GO_Biological_Process_2021__ubiquitin-dependent ERAD pathway (GO:0030433),-0.2386913343312581,-0.5752316013403113,1.0,1.0,1.0,2/70,5.71%,SEL1L2;SELENOS
prerank,GO_Biological_Process_2021__regulation of lymphocyte proliferation (GO:0050670),-0.34359820469767904,-0.57520639422313,0.9636363636363636,1.0,1.0,1/8,5.79%,IL12A
prerank,GO_Biological_Process_2021__organic cyclic compound biosynthetic process (GO:1901362),0.24928776282061937,0.5745844612645554,1.0,0.9905771774000622,1.0,3/20,22.89%,GPHN;FDXR;SCP2
prerank,GO_Biological_Process_2021__nucleoside triphosphate catabolic process (GO:0009143),0.34430421072909334,0.5742467522266238,0.9166666666666666,0.9903746584567745,1.0,1/5,31.77%,ENPP3
prerank,GO_Biological_Process_2021__regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),-0.2827486227088656,-0.5739457616605536,0.9565217391304348,1.0,1.0,5/19,22.99%,JPH3;NOS1;TRDN;GSTO1;AKAP6
prerank,GO_Biological_Process_2021__poly(A)+ mRNA export from nucleus (GO:0016973),0.2974514237025444,0.5732334804966923,0.9318181818181818,0.9905356754170106,1.0,3/13,22.61%,IWS1;PCID2;THOC2
prerank,GO_Biological_Process_2021__negative regulation of p38MAPK cascade (GO:1903753),0.333166313699798,0.573191712548582,0.9487179487179487,0.99022584255013,1.0,2/6,14.81%,DUSP10;DLG1
prerank,GO_Biological_Process_2021__manganese ion transport (GO:0006828),-0.3075445993276404,-0.5729878326962482,0.984375,1.0,1.0,5/13,25.40%,SLC11A1;TRPC5;TRPC6;SLC39A14;ATP2C2
prerank,GO_Biological_Process_2021__leucine metabolic process (GO:0006551),0.31669876845853023,0.5729423522827243,0.925,0.9900491996378924,1.0,7/7,68.34%,HMGCLL1;IVD;MCCC1;BCAT2;HMGCL;BCAT1;MCCC2
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle contraction (GO:0045987),-0.37281086019231335,-0.5726487914285934,0.9333333333333333,1.0,1.0,2/7,17.91%,SRF;GPER1
prerank,GO_Biological_Process_2021__positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),-0.27637677197860766,-0.572530101032619,1.0,1.0,1.0,4/26,11.24%,PSMC3;CAV3;CLU;ATP5IF1
prerank,GO_Biological_Process_2021__regulation of stress-activated protein kinase signaling cascade (GO:0070302),-0.32587481213642794,-0.5724054214840687,0.953125,1.0,1.0,1/10,8.49%,GSTP1
prerank,GO_Biological_Process_2021__purine ribonucleoside monophosphate biosynthetic process (GO:0009168),0.2664905639194406,0.5719091462890922,0.975609756097561,0.9902408491691442,1.0,3/14,17.77%,GMPS;ATIC;LHPP
prerank,GO_Biological_Process_2021__cellular response to purine-containing compound (GO:0071415),0.2909648616235795,0.5711742814017177,0.9583333333333334,0.9903659223867496,1.0,3/9,24.55%,GSTM2;P2RY1;TRPM2
prerank,GO_Biological_Process_2021__regulation of mononuclear cell migration (GO:0071675),-0.3121381870225482,-0.5711463475331766,0.9661016949152542,1.0,1.0,3/17,14.90%,THBS1;CXCL17;IL34
prerank,GO_Biological_Process_2021__tricuspid valve morphogenesis (GO:0003186),-0.37549499517369334,-0.5710125444814235,0.9259259259259259,1.0,1.0,2/5,14.43%,ZFPM1;HEY2
prerank,GO_Biological_Process_2021__interleukin-15-mediated signaling pathway (GO:0035723),0.31775688860091883,0.5705759975756383,0.9555555555555556,0.990043643486186,1.0,1/11,8.66%,PLCB1
prerank,GO_Biological_Process_2021__cellular response to interleukin-15 (GO:0071350),0.31775688860091883,0.5705759975756383,0.9555555555555556,0.990043643486186,1.0,1/11,8.66%,PLCB1
prerank,GO_Biological_Process_2021__autophagosome maturation (GO:0097352),-0.26864175716593014,-0.5698169193120408,0.9846153846153847,1.0,1.0,3/29,13.86%,ATG14;VAMP8;CLN3
prerank,GO_Biological_Process_2021__peripheral nervous system development (GO:0007422),-0.2940078255509779,-0.5696352778881758,0.9666666666666667,1.0,1.0,3/17,13.38%,BDNF;GSTM3;ERBB3
prerank,GO_Biological_Process_2021__embryonic eye morphogenesis (GO:0048048),-0.3438977412011907,-0.5678524309768632,0.9137931034482759,1.0,1.0,7/7,65.63%,FBN2;KDM2B;RARG;TBX2;LRP6;FBN1;EFEMP1
prerank,GO_Biological_Process_2021__sodium ion export across plasma membrane (GO:0036376),-0.3243003693240528,-0.5675868100856952,0.9310344827586207,1.0,1.0,3/9,24.18%,ATP12A;ATP1A1;ATP1B1
prerank,GO_Biological_Process_2021__positive regulation of voltage-gated calcium channel activity (GO:1901387),-0.3633412907414481,-0.5674747086287665,0.9622641509433962,1.0,1.0,1/7,6.89%,STAC3
prerank,GO_Biological_Process_2021__positive regulation of response to biotic stimulus (GO:0002833),-0.26623023718197625,-0.5673313937090385,0.9838709677419355,1.0,1.0,7/26,20.58%,DDX60;IFI35;LY96;SCIMP;POLR3G;ADAM8;RIOK3
prerank,GO_Biological_Process_2021__cellular copper ion homeostasis (GO:0006878),-0.32906621613195897,-0.5669660759159867,1.0,1.0,1.0,4/11,26.51%,MT2A;ATOX1;SLC31A2;CCDC22
prerank,GO_Biological_Process_2021__positive regulation of release of cytochrome c from mitochondria (GO:0090200),0.25055459024154125,0.566922305869768,1.0,0.9912258624823164,1.0,1/18,5.86%,MFF
prerank,GO_Biological_Process_2021__inorganic cation import across plasma membrane (GO:0098659),-0.26407623382052176,-0.5658352556578318,1.0,1.0,1.0,8/55,17.64%,KCNJ13;SLC8A3;ATP12A;SLC9A2;SLC24A1;SLC9A7;KCNJ8;SLC39A6
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell action potential involved in regulation of contraction (GO:0098909),-0.3720828418028024,-0.5652418229767125,0.9298245614035088,1.0,1.0,1/6,10.23%,CAV3
prerank,"GO_Biological_Process_2021__negative regulation of DNA-templated transcription, elongation (GO:0032785)",-0.2972826205117529,-0.5651879258934127,0.9215686274509803,1.0,1.0,4/13,22.57%,HEXIM1;RNF8;NELFE;NELFCD
prerank,GO_Biological_Process_2021__spindle assembly (GO:0051225),-0.24825092049641315,-0.565027153805235,1.0,1.0,1.0,3/63,9.44%,GOLGA8B;RAB11A;ABRAXAS1
prerank,GO_Biological_Process_2021__regulation of collagen fibril organization (GO:1904026),-0.3611634966228706,-0.5645306942982155,0.9344262295081968,1.0,1.0,1/6,17.39%,AEBP1
prerank,GO_Biological_Process_2021__positive regulation of cyclase activity (GO:0031281),-0.31032144656869154,-0.5643687674847023,0.9384615384615385,1.0,1.0,2/10,13.85%,AKAP5;NOS1
prerank,GO_Biological_Process_2021__regulation of neutrophil migration (GO:1902622),0.33316901028489254,0.5638851105400297,0.9148936170212766,0.9920397360730498,1.0,1/6,7.28%,BST1
prerank,GO_Biological_Process_2021__negative regulation of potassium ion transmembrane transporter activity (GO:1901017),0.366895442707446,0.5630969663743718,0.9555555555555556,0.9920364512466358,1.0,2/5,18.57%,NEDD4L;CAB39
prerank,GO_Biological_Process_2021__autophagosome-lysosome fusion (GO:0061909),0.3147358166696991,0.563000117485389,0.9111111111111111,0.9917729423036744,1.0,5/8,33.50%,RUBCNL;VPS39;PIP4K2B;ARL8B;PIP4K2A
prerank,GO_Biological_Process_2021__neurotransmitter biosynthetic process (GO:0042136),-0.3221819775460481,-0.5628422615809032,0.9423076923076923,1.0,1.0,2/8,23.51%,NOS1;PAH
prerank,GO_Biological_Process_2021__regulation of heterotypic cell-cell adhesion (GO:0034114),0.27087028216278164,0.5620683814531673,0.9411764705882353,0.9918513568415883,1.0,4/14,18.82%,MBP;MAP2K5;BMP7;WNK1
prerank,GO_Biological_Process_2021__linoleic acid metabolic process (GO:0043651),-0.31154820170119824,-0.5607030348706675,0.9649122807017544,1.0,1.0,5/13,24.00%,GSTP1;FADS1;ALOX12;ALOX5;FADS2
prerank,GO_Biological_Process_2021__regulation of gastrulation (GO:0010470),0.3008304518112033,0.560514567241137,0.9487179487179487,0.9920164104692858,1.0,3/10,25.72%,CLASP1;POGLUT1;CLASP2
prerank,GO_Biological_Process_2021__positive regulation of steroid metabolic process (GO:0045940),-0.3796029263621624,-0.5601675980169633,0.9642857142857143,1.0,1.0,3/5,24.26%,APOE;AGT;APOC1
prerank,GO_Biological_Process_2021__myotube cell development (GO:0014904),0.33266445551377777,0.5601350088334827,0.9347826086956522,0.9917939357477625,1.0,2/6,17.75%,MYORG;IGF1
prerank,GO_Biological_Process_2021__nucleotide transport (GO:0006862),-0.354935409547811,-0.559879253129504,0.9310344827586207,1.0,1.0,1/6,10.62%,SLC25A33
prerank,GO_Biological_Process_2021__mitotic intra-S DNA damage checkpoint signaling (GO:0031573),0.27369175914144744,0.5591311161001232,0.9534883720930233,0.9918518859985886,1.0,2/13,24.24%,ATF2;EME2
prerank,GO_Biological_Process_2021__positive regulation of myeloid leukocyte mediated immunity (GO:0002888),0.32875297819973337,0.5588487809228453,0.9555555555555556,0.9916652627849379,1.0,2/6,22.18%,TICAM1;CAMK4
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),0.28144304047096225,0.558498150104312,0.9736842105263158,0.9915144063721256,1.0,2/9,18.23%,CAAP1;FAS
prerank,GO_Biological_Process_2021__SCF complex assembly (GO:0010265),0.35924906154017167,0.5579300901686048,0.95,0.9914654710098261,1.0,3/6,26.63%,CUL1;FBXL7;CAND2
prerank,GO_Biological_Process_2021__chaperone cofactor-dependent protein refolding (GO:0051085),0.23167707282715586,0.5575040301364791,1.0,0.9913249501809739,1.0,6/23,29.26%,DNAJB13;PTGES3;HSPA1A;DNAJB14;DNAJB5;SDF2
prerank,GO_Biological_Process_2021__positive regulation of non-canonical Wnt signaling pathway (GO:2000052),-0.34073425374111654,-0.5574051573727326,0.9090909090909091,1.0,1.0,2/8,11.83%,RSPO3;SFRP1
prerank,GO_Biological_Process_2021__positive regulation of telomere capping (GO:1904355),-0.3061658132313343,-0.5573812234117944,0.9682539682539683,1.0,1.0,2/13,12.32%,PRKCQ;PNKP
prerank,GO_Biological_Process_2021__negative regulation of cyclase activity (GO:0031280),-0.3104527414669851,-0.5563726466370755,0.9423076923076923,1.0,1.0,1/9,8.94%,AKAP5
prerank,GO_Biological_Process_2021__negative regulation of adenylate cyclase activity (GO:0007194),-0.3104527414669851,-0.5563726466370755,0.9423076923076923,1.0,1.0,1/9,8.94%,AKAP5
prerank,GO_Biological_Process_2021__regulation of acute inflammatory response (GO:0002673),-0.3533720272023197,-0.5560065502225076,0.9555555555555556,1.0,1.0,1/7,8.49%,GSTP1
prerank,GO_Biological_Process_2021__negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),-0.30381033434245225,-0.555788360202794,0.9574468085106383,1.0,1.0,4/12,22.57%,HEXIM1;RNF8;NELFE;NELFCD
prerank,GO_Biological_Process_2021__Golgi inheritance (GO:0048313),0.28190420698492125,0.5556072039407471,1.0,0.9916475420656226,1.0,4/10,27.77%,VCPIP1;YWHAZ;STK25;STX5
prerank,GO_Biological_Process_2021__neuromuscular synaptic transmission (GO:0007274),-0.2999095529377136,-0.5554394174262977,1.0,1.0,1.0,1/12,6.89%,STAC3
prerank,GO_Biological_Process_2021__aspartate family amino acid metabolic process (GO:0009066),0.27617806702415254,0.555185359280722,1.0,0.9915426582667665,1.0,7/15,30.95%,SMS;MTHFR;SLC25A13;MSRA;FOLH1;NAT8L;SLC25A12
prerank,GO_Biological_Process_2021__regulation of protein polymerization (GO:0032271),-0.26614860698286047,-0.554419171578811,1.0,1.0,1.0,7/30,21.93%,TPPP3;PLEKHG2;PFN1;ARHGAP28;PFN2;COTL1;HAX1
prerank,GO_Biological_Process_2021__regulation of intracellular protein transport (GO:0033157),-0.2729071159544976,-0.5541060407773841,0.9830508474576272,1.0,1.0,1/27,2.77%,KIF20B
prerank,GO_Biological_Process_2021__pentose metabolic process (GO:0019321),0.3391677732253008,0.5538690251832976,1.0,0.9916717509053622,1.0,3/6,30.65%,FGGY;RPE;RPIA
prerank,GO_Biological_Process_2021__regulation of pseudopodium assembly (GO:0031272),-0.34778802381230306,-0.5533218914122845,0.9423076923076923,1.0,1.0,6/6,65.24%,CDC42EP1;APC;CDC42EP3;CDC42EP4;WASHC1;CDC42
prerank,GO_Biological_Process_2021__positive regulation of pseudopodium assembly (GO:0031274),-0.34778802381230306,-0.5533218914122845,0.9423076923076923,1.0,1.0,6/6,65.24%,CDC42EP1;APC;CDC42EP3;CDC42EP4;WASHC1;CDC42
prerank,GO_Biological_Process_2021__growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),0.3035026269702278,0.5528555268688295,0.9722222222222222,0.9916330095749227,1.0,10/10,69.67%,JAK2;STAT5B;GHR;STAT3;LYN;PTPN1;STAT5A;JAK3;STAT6;PRLR
prerank,GO_Biological_Process_2021__UV protection (GO:0009650),-0.3334306058130034,-0.5528078386223576,0.9285714285714286,1.0,1.0,6/6,66.67%,SCARA3;XPA;GPX1;SDF4;ERCC2;CAT
prerank,GO_Biological_Process_2021__regulation of endocytic recycling (GO:2001135),0.2930818569536526,0.5525580609212766,0.972972972972973,0.9914418362932413,1.0,1/9,9.23%,ATP9A
prerank,GO_Biological_Process_2021__regulation of DNA-directed DNA polymerase activity (GO:1900262),-0.31042328793184726,-0.5523579614480673,0.9272727272727272,1.0,1.0,2/8,26.12%,DSCC1;RFC5
prerank,GO_Biological_Process_2021__positive regulation of DNA-directed DNA polymerase activity (GO:1900264),-0.31042328793184726,-0.5523579614480673,0.9272727272727272,1.0,1.0,2/8,26.12%,DSCC1;RFC5
prerank,GO_Biological_Process_2021__negative regulation of cell growth (GO:0030308),-0.22816608639240896,-0.5516145886612303,1.0,1.0,1.0,8/100,15.04%,SFRP2;BST2;HYAL1;CRLF3;MT3;SFRP1;BTG1;TCHP
prerank,GO_Biological_Process_2021__positive regulation of cysteine-type endopeptidase activity (GO:2001056),-0.24482600442238117,-0.5512322196087381,1.0,1.0,1.0,12/43,22.21%,CASP8;NODAL;FIS1;RIPK2;AIM2;HTRA2;USP50;GPER1;PDCD5;NLRP2;BCAP31;ARL6IP5
prerank,GO_Biological_Process_2021__negative regulation of blood pressure (GO:0045776),-0.3285931435535408,-0.5506985492593554,0.9807692307692307,1.0,1.0,2/8,15.10%,NOS1;SCPEP1
prerank,GO_Biological_Process_2021__early endosome to Golgi transport (GO:0034498),0.28665247540878996,0.5501765052027943,0.9772727272727273,0.9918654967421562,1.0,3/12,27.77%,TRAPPC10;SNX1;STX5
prerank,GO_Biological_Process_2021__regulation of glutamate receptor signaling pathway (GO:1900449),0.32878250460204445,0.549929226631953,0.9230769230769231,0.9916489764265655,1.0,2/6,19.12%,SHANK3;FYN
prerank,GO_Biological_Process_2021__skeletal muscle fiber development (GO:0048741),-0.36698468605654927,-0.5497477697241511,0.9615384615384616,1.0,1.0,1/5,9.70%,CAV2
prerank,GO_Biological_Process_2021__2-oxoglutarate metabolic process (GO:0006103),-0.3018856909335046,-0.5494456677394199,0.9473684210526315,1.0,1.0,11/11,69.84%,IDH2;GPT2;GOT1;AADAT;IDH1;PHYH;L2HGDH;DLST;GOT2;OGDH;D2HGDH
prerank,GO_Biological_Process_2021__activation of protein kinase B activity (GO:0032148),-0.2617459087789157,-0.5482203371499076,0.9846153846153847,1.0,1.0,4/23,17.22%,MT3;FGF1;IL18;WNT5A
prerank,GO_Biological_Process_2021__positive regulation of tissue remodeling (GO:0034105),-0.3720495581642608,-0.5479503948862404,0.94,1.0,1.0,1/5,12.13%,IL18
prerank,GO_Biological_Process_2021__activation of Janus kinase activity (GO:0042976),0.3597893253509361,0.5479361980673484,0.9555555555555556,0.9920418467923726,1.0,3/5,38.64%,JAK2;PIBF1;GHR
prerank,GO_Biological_Process_2021__dorsal aorta development (GO:0035907),-0.3496511823546313,-0.5472680542892969,0.9180327868852459,1.0,1.0,2/5,18.33%,HEY2;ENG
prerank,GO_Biological_Process_2021__dorsal aorta morphogenesis (GO:0035912),-0.3496511823546313,-0.5472680542892969,0.9180327868852459,1.0,1.0,2/5,18.33%,HEY2;ENG
prerank,GO_Biological_Process_2021__negative regulation of mRNA catabolic process (GO:1902373),-0.2694642901661745,-0.5472303766246671,1.0,1.0,1.0,2/23,10.16%,DND1;SLC11A1
prerank,GO_Biological_Process_2021__activation of cysteine-type endopeptidase activity (GO:0097202),-0.31187742774937066,-0.547170023422615,0.9649122807017544,1.0,1.0,2/12,14.02%,CASP8;RIPK2
prerank,GO_Biological_Process_2021__TORC2 signaling (GO:0038203),0.3209520180031713,0.5458754465837939,0.9791666666666666,0.9923583399606664,1.0,4/6,38.38%,MAPKAP1;RICTOR;SYAP1;PRR5
prerank,GO_Biological_Process_2021__NAD biosynthetic process (GO:0009435),0.23878987144307193,0.5448477955524781,1.0,0.9924513814057048,1.0,2/18,12.26%,NMNAT2;KYNU
prerank,GO_Biological_Process_2021__activation of NF-kappaB-inducing kinase activity (GO:0007250),-0.3018317576405344,-0.5431883333180691,0.9583333333333334,1.0,1.0,2/12,15.13%,TLR3;TNFRSF10A
prerank,GO_Biological_Process_2021__regulation of oxidoreductase activity (GO:0051341),-0.3093273327342119,-0.5430652832349143,0.9491525423728814,1.0,1.0,1/8,10.41%,MT3
prerank,GO_Biological_Process_2021__endothelial cell development (GO:0001885),-0.27859967811234254,-0.5426982589421389,0.9655172413793104,1.0,1.0,3/22,17.15%,RDX;GSTM3;ICAM1
prerank,GO_Biological_Process_2021__regulation of nitric oxide mediated signal transduction (GO:0010749),-0.356054902918695,-0.5400919976893995,0.95,1.0,1.0,1/5,5.73%,THBS1
prerank,GO_Biological_Process_2021__positive regulation of immune response (GO:0050778),-0.24664984496018866,-0.53996178647575,1.0,1.0,1.0,9/37,20.58%,IFI35;RSAD2;XBP1;ZP3;SKAP1;CD74;POLR3G;ADAM8;RIOK3
prerank,GO_Biological_Process_2021__calcium ion import across plasma membrane (GO:0098703),-0.31079167483444414,-0.5393311508483704,0.9444444444444444,1.0,1.0,2/10,14.28%,SLC8A3;SLC24A1
prerank,GO_Biological_Process_2021__calcium ion import into cytosol (GO:1902656),-0.31079167483444414,-0.5393311508483704,0.9444444444444444,1.0,1.0,2/10,14.28%,SLC8A3;SLC24A1
prerank,GO_Biological_Process_2021__vitamin K metabolic process (GO:0042373),0.32911279722388664,0.53910333273432,0.9534883720930233,0.9939342062445344,1.0,3/6,35.93%,CYP4F12;UBIAD1;CYP4F11
prerank,GO_Biological_Process_2021__peptidyl-proline modification (GO:0018208),-0.2524183889641375,-0.5390684660395011,1.0,1.0,1.0,5/23,24.94%,PPIB;OGFOD1;NTMT1;FKBP7;P3H2
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell migration (GO:1904754),0.32292931734280983,0.5373591208003745,0.9795918367346939,0.994178826730036,1.0,2/7,11.94%,DOCK7;DOCK4
prerank,GO_Biological_Process_2021__transcription by RNA polymerase III (GO:0006383),-0.25766503188523604,-0.5352200816811472,1.0,1.0,1.0,6/28,21.48%,GTF3C6;GTF3A;POLR2L;POLR3G;POLR2K;TBP
prerank,GO_Biological_Process_2021__mitochondrial protein processing (GO:0034982),-0.29925905747848075,-0.5349832959116827,0.9661016949152542,1.0,1.0,3/10,23.60%,ATP23;AFG3L2;SPG7
prerank,GO_Biological_Process_2021__negative regulation of proteasomal protein catabolic process (GO:1901799),-0.24743749448558616,-0.5345289362911443,1.0,1.0,1.0,3/32,13.87%,RPL11;AQP11;GIPC1
prerank,GO_Biological_Process_2021__telencephalon cell migration (GO:0022029),0.32782711862690617,0.534077881701013,0.9545454545454546,0.9948440449354905,1.0,2/5,29.08%,PEX13;FGF13
prerank,GO_Biological_Process_2021__pyrimidine ribonucleotide biosynthetic process (GO:0009220),-0.33245782991887,-0.5335913999130673,0.9824561403508771,1.0,1.0,7/7,66.77%,DHODH;CTPS1;AK5;UMPS;CMPK1;CAD;CTPS2
prerank,GO_Biological_Process_2021__tRNA threonylcarbamoyladenosine metabolic process (GO:0070525),0.342126793889745,0.5335173561951526,1.0,0.9947132223036411,1.0,2/5,14.96%,TRIT1;TP53RK
prerank,GO_Biological_Process_2021__heart process (GO:0003015),-0.2826783635073821,-0.5329352352846755,0.9629629629629629,1.0,1.0,2/10,18.80%,RAMP3;TRDN
prerank,GO_Biological_Process_2021__negative regulation of protein targeting to membrane (GO:0090315),-0.34905164867230815,-0.5319326542082157,0.92,1.0,1.0,5/5,65.11%,ITGB1BP1;KCNE1;GDI1;INPP5K;DMTN
prerank,GO_Biological_Process_2021__negative regulation of erythrocyte differentiation (GO:0045647),-0.3337981567447659,-0.5316767936900434,0.9056603773584906,1.0,1.0,1/5,20.81%,ZFP36
prerank,GO_Biological_Process_2021__sensory perception of taste (GO:0050909),0.3171479858516023,0.5312903448674784,0.9111111111111111,0.9950283000694817,1.0,1/6,14.09%,ASIC3
prerank,GO_Biological_Process_2021__protein import into mitochondrial matrix (GO:0030150),0.2503406532747075,0.5302481402182109,1.0,0.9949987926118127,1.0,1/16,7.98%,DNAJC15
prerank,GO_Biological_Process_2021__regulation of potassium ion transport (GO:0043266),-0.25386368809597387,-0.5289050765350666,1.0,1.0,1.0,3/24,15.25%,CD63;NOS1;DPP10
prerank,GO_Biological_Process_2021__positive regulation of cardiocyte differentiation (GO:1905209),0.2930060179418908,0.5288709518998997,0.9523809523809523,0.9950908152568614,1.0,1/9,9.93%,EFNB2
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial translation (GO:0070131),-0.2873623755115867,-0.5262724550463503,1.0,1.0,1.0,4/13,24.67%,TRMT10C;RPUSD3;COA3;RMND1
prerank,GO_Biological_Process_2021__regulation of protein deubiquitination (GO:0090085),-0.34246636600893504,-0.525915735047063,0.92,1.0,1.0,1/6,6.55%,TRIM21
prerank,GO_Biological_Process_2021__protein exit from endoplasmic reticulum (GO:0032527),-0.2616797467618364,-0.525114435518479,0.9850746268656716,1.0,1.0,1/23,5.71%,SELENOS
prerank,GO_Biological_Process_2021__cellular response to acidic pH (GO:0071468),-0.3121611206733835,-0.5245008714523518,0.9811320754716981,1.0,1.0,1/8,11.38%,NOX1
prerank,GO_Biological_Process_2021__regulation of dendritic spine maintenance (GO:1902950),0.3104541842203628,0.5241811144042751,0.9375,0.9960786534847034,1.0,3/6,23.30%,HOMER1;FYN;GRIN2B
prerank,GO_Biological_Process_2021__chromatin assembly or disassembly (GO:0006333),0.2759883443291755,0.5235694782057301,1.0,0.9959021125492654,1.0,3/10,33.48%,RBBP4;MTA2;CDAN1
prerank,GO_Biological_Process_2021__epithelial cell-cell adhesion (GO:0090136),-0.28461358860611724,-0.5235254257052783,0.9836065573770492,1.0,1.0,8/8,71.56%,JUP;VCL;THBS4;KIFC3;PLEKHA7;ITGB5;CAMSAP3;KIT
prerank,GO_Biological_Process_2021__negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),0.2722108697124393,0.5231062544046556,1.0,0.9957357973850451,1.0,1/9,11.30%,SEC14L1
prerank,GO_Biological_Process_2021__prostaglandin biosynthetic process (GO:0001516),0.2833145191547642,0.52231048346385,0.9743589743589743,0.9955948687079798,1.0,5/12,29.11%,PTGES3;PRXL2B;TBXAS1;PTGIS;HPGDS
prerank,GO_Biological_Process_2021__rescue of stalled ribosome (GO:0072344),-0.35920630288882405,-0.518620216978396,0.9433962264150944,1.0,1.0,5/5,64.10%,MTRES1;RACK1;LTN1;ZNF598;NEMF
prerank,GO_Biological_Process_2021__positive regulation of potassium ion import across plasma membrane (GO:1903288),0.30606613293172846,0.5184845598862443,1.0,0.9962577992107684,1.0,2/7,18.82%,WNK3;WNK1
prerank,GO_Biological_Process_2021__purine-containing compound metabolic process (GO:0072521),-0.322933348528095,-0.5182184825359913,0.9464285714285714,1.0,1.0,1/6,12.85%,PRPS1
prerank,GO_Biological_Process_2021__regulation of protein acetylation (GO:1901983),-0.29937406779024367,-0.5176780691040488,1.0,1.0,1.0,4/11,23.47%,FAM161A;KAT5;PARK7;CAMK1
prerank,GO_Biological_Process_2021__integrated stress response signaling (GO:0140467),-0.2714651621740325,-0.5176062765169085,0.9836065573770492,1.0,1.0,2/12,14.31%,DDIT3;CCL2
prerank,GO_Biological_Process_2021__collagen-activated tyrosine kinase receptor signaling pathway (GO:0038063),-0.31519396980102177,-0.514363688768008,0.9629629629629629,1.0,1.0,1/5,16.62%,COL4A2
prerank,GO_Biological_Process_2021__inhibitory synapse assembly (GO:1904862),-0.29784693948513913,-0.5143560651206921,0.9649122807017544,1.0,1.0,1/8,17.22%,WNT5A
prerank,GO_Biological_Process_2021__alanine transport (GO:0032328),0.29251146216995144,0.5117782414816553,0.9787234042553191,0.997582342847998,1.0,1/7,17.76%,SLC6A6
prerank,GO_Biological_Process_2021__protein localization to site of double-strand break (GO:1990166),-0.3273963560421041,-0.5105798363256225,1.0,1.0,1.0,1/5,17.89%,IFFO1
prerank,GO_Biological_Process_2021__cellular response to alkaloid (GO:0071312),0.26509820411390295,0.5098043986806396,1.0,0.9976733686713201,1.0,3/13,24.87%,GSTM2;CASP3;TRPV1
prerank,GO_Biological_Process_2021__negative regulation of microglial cell activation (GO:1903979),0.312312147446963,0.5093230375044075,1.0,0.9974865614401669,1.0,2/6,21.25%,NR1D1;PTPRC
prerank,GO_Biological_Process_2021__protein localization to lysosome (GO:0061462),-0.2493119972616786,-0.508893299445706,1.0,1.0,1.0,3/27,17.72%,M6PR;AP4M1;GCC2
prerank,GO_Biological_Process_2021__atrioventricular valve formation (GO:0003190),0.3108408234745067,0.5088448410268299,0.9545454545454546,0.9972544291578873,1.0,2/6,20.08%,SMAD4;DCHS1
prerank,GO_Biological_Process_2021__T-helper 1 type immune response (GO:0042088),-0.32227642472162843,-0.5082370634710784,0.9444444444444444,1.0,1.0,2/6,18.73%,IL18;IL18BP
prerank,GO_Biological_Process_2021__negative regulation of telomere capping (GO:1904354),-0.31954009571612,-0.507894154093481,0.9464285714285714,1.0,1.0,6/6,68.06%,ATM;NBN;SMG6;ERCC1;ERCC4;TERF2
prerank,GO_Biological_Process_2021__regulation of telomere capping (GO:1904353),-0.2712692421400697,-0.5074339146736928,0.984375,1.0,1.0,2/18,12.32%,PRKCQ;PNKP
prerank,GO_Biological_Process_2021__B cell mediated immunity (GO:0019724),-0.3379700716087943,-0.5066378483086511,0.9811320754716981,1.0,1.0,2/5,24.43%,CD74;SLA2
prerank,GO_Biological_Process_2021__positive regulation of leukocyte degranulation (GO:0043302),0.2745879371168317,0.506035135684427,0.9782608695652174,0.9975170825327125,1.0,1/8,14.63%,AP1G1
prerank,GO_Biological_Process_2021__regulation of cell cycle G2/M phase transition (GO:1902749),-0.20819023321257005,-0.5031794028201184,1.0,1.0,1.0,13/75,21.21%,CETN2;ATAD5;CEP72;CEP135;TPX2;TUBB;DCTN2;OFD1;SSNA1;CEP76;NPM1;PLK4;DCTN1
prerank,GO_Biological_Process_2021__pyrimidine nucleobase biosynthetic process (GO:0019856),-0.33241902538663554,-0.5030414993458008,0.9636363636363636,1.0,1.0,5/5,66.77%,DHODH;CTPS1;UMPS;CAD;CTPS2
prerank,GO_Biological_Process_2021__proton-transporting ATP synthase complex assembly (GO:0043461),-0.3051787739885787,-0.5020176651897341,0.9090909090909091,1.0,1.0,2/6,21.59%,ATP23;OXA1L
prerank,GO_Biological_Process_2021__positive regulation of histone ubiquitination (GO:0033184),0.3078733144929455,0.500910911655659,0.9782608695652174,0.9983547967469398,1.0,3/5,25.81%,KDM1A;CDK9;RNF20
prerank,GO_Biological_Process_2021__ventricular cardiac muscle tissue development (GO:0003229),-0.26494177246330164,-0.5005953329254769,0.9814814814814815,1.0,1.0,4/12,24.66%,ID2;PKP2;TGFB1;TBX5
prerank,GO_Biological_Process_2021__negative regulation of IRE1-mediated unfolded protein response (GO:1903895),-0.32380699940954627,-0.5002948777816877,0.9666666666666667,1.0,1.0,4/5,31.49%,DNAJB9;DDRGK1;HSPA5;UFL1
prerank,GO_Biological_Process_2021__cellular response to interleukin-2 (GO:0071352),0.29049203291892856,0.5002515947922729,0.9830508474576272,0.9979611672080819,1.0,7/7,70.96%,JAK1;STAT5B;SHC1;STAT5A;JAK3;PTK2B;SYK
prerank,GO_Biological_Process_2021__interleukin-2-mediated signaling pathway (GO:0038110),0.29049203291892856,0.5002515947922729,0.9830508474576272,0.9979611672080819,1.0,7/7,70.96%,JAK1;STAT5B;SHC1;STAT5A;JAK3;PTK2B;SYK
prerank,GO_Biological_Process_2021__histone H2A acetylation (GO:0043968),-0.2597730390725862,-0.49925811970715117,1.0,1.0,1.0,1/16,11.34%,BRD8
prerank,GO_Biological_Process_2021__pyrimidine nucleobase catabolic process (GO:0006208),-0.3073720882910222,-0.49864648571945525,0.9827586206896551,1.0,1.0,1/7,14.24%,DPYSL3
prerank,GO_Biological_Process_2021__cellular hypotonic response (GO:0071476),0.30437696681101023,0.49841499994067306,1.0,0.9980417976331386,1.0,3/5,27.92%,CAB39;SLC12A6;MYLK
prerank,GO_Biological_Process_2021__regulation of extent of cell growth (GO:0061387),-0.2853341668597391,-0.4979285679679289,0.9841269841269841,1.0,1.0,1/8,11.67%,APOE
prerank,GO_Biological_Process_2021__regulation of tubulin deacetylation (GO:0090043),-0.3026683149395443,-0.49670407963921753,1.0,1.0,1.0,1/7,12.16%,BEX4
prerank,GO_Biological_Process_2021__nucleobase catabolic process (GO:0046113),-0.3100055157887861,-0.49631166342382305,0.9821428571428571,1.0,1.0,1/6,14.24%,DPYSL3
prerank,GO_Biological_Process_2021__positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),0.2590587649722356,0.4956746503249867,1.0,0.9982282099105508,1.0,2/11,21.76%,MRAP;PRKCA
prerank,GO_Biological_Process_2021__nuclear polyadenylation-dependent ncRNA catabolic process (GO:0071046),-0.3112926758097461,-0.49458748667051217,0.9814814814814815,1.0,1.0,5/5,68.89%,EXOSC8;EXOSC7;EXOSC10;EXOSC2;EXOSC9
prerank,GO_Biological_Process_2021__tRNA surveillance (GO:0106354),-0.3112926758097461,-0.49458748667051217,0.9814814814814815,1.0,1.0,5/5,68.89%,EXOSC8;EXOSC7;EXOSC10;EXOSC2;EXOSC9
prerank,GO_Biological_Process_2021__nuclear polyadenylation-dependent rRNA catabolic process (GO:0071035),-0.3112926758097461,-0.49458748667051217,0.9814814814814815,1.0,1.0,5/5,68.89%,EXOSC8;EXOSC7;EXOSC10;EXOSC2;EXOSC9
prerank,GO_Biological_Process_2021__nuclear polyadenylation-dependent tRNA catabolic process (GO:0071038),-0.3112926758097461,-0.49458748667051217,0.9814814814814815,1.0,1.0,5/5,68.89%,EXOSC8;EXOSC7;EXOSC10;EXOSC2;EXOSC9
prerank,GO_Biological_Process_2021__regulation of protein localization to cilium (GO:1903564),0.34084428263479155,0.4940539937619847,0.9791666666666666,0.9982180236236342,1.0,1/5,15.71%,LZTFL1
prerank,GO_Biological_Process_2021__regulation of histone H2B ubiquitination (GO:2001166),-0.31192077378968475,-0.4927380654752875,0.9636363636363636,1.0,1.0,1/5,13.65%,CTR9
prerank,GO_Biological_Process_2021__regulation of extracellular matrix organization (GO:1903053),-0.27127316533546114,-0.4922749702066383,0.9672131147540983,1.0,1.0,3/13,19.28%,ANGPTL7;AEBP1;AGT
prerank,GO_Biological_Process_2021__negative regulation of vascular associated smooth muscle cell differentiation (GO:1905064),0.2939407361519073,0.48922507801075765,0.9411764705882353,0.9987316389406058,1.0,3/7,23.42%,NFATC3;NFATC2;NFATC1
prerank,GO_Biological_Process_2021__response to corticosteroid (GO:0031960),-0.3236866713081491,-0.4878898779706599,0.9811320754716981,1.0,1.0,1/5,18.69%,PDCD7
prerank,GO_Biological_Process_2021__negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),0.2749489027437374,0.4876013615512257,0.9761904761904762,0.9987011642015653,1.0,1/7,20.97%,LIN28B
prerank,GO_Biological_Process_2021__mast cell activation involved in immune response (GO:0002279),-0.3239479826507666,-0.4874634480501223,0.9523809523809523,1.0,1.0,1/5,19.82%,S100A13
prerank,GO_Biological_Process_2021__mast cell degranulation (GO:0043303),-0.3239479826507666,-0.4874634480501223,0.9523809523809523,1.0,1.0,1/5,19.82%,S100A13
prerank,GO_Biological_Process_2021__axo-dendritic transport (GO:0008088),0.3008113227660826,0.4867756294731662,0.9583333333333334,0.9985549401497972,1.0,1/6,18.05%,APBA1
prerank,GO_Biological_Process_2021__short-chain fatty acid metabolic process (GO:0046459),-0.2811410631979443,-0.4866944021741277,1.0,1.0,1.0,3/8,25.17%,OXSM;ACOT4;MMAA
prerank,GO_Biological_Process_2021__pyridine-containing compound metabolic process (GO:0072524),-0.2920922089290925,-0.48490482050702194,0.9833333333333333,1.0,1.0,5/5,70.81%,NNMT;HAAO;PNPO;PDXK;AOX1
prerank,GO_Biological_Process_2021__positive regulation of ligase activity (GO:0051351),0.2848499873973892,0.4829322628354361,1.0,0.9987761308073883,1.0,2/8,18.51%,ATPSCKMT;XRCC4
prerank,GO_Biological_Process_2021__cell migration involved in heart development (GO:0060973),-0.29892589978935713,-0.4821602532840023,0.9655172413793104,1.0,1.0,2/5,24.66%,FLRT3;TBX5
prerank,GO_Biological_Process_2021__cellular response to sterol depletion (GO:0071501),-0.2710330166140623,-0.4819498979835221,1.0,1.0,1.0,4/8,23.84%,SREBF1;INSIG1;SREBF2;ERLIN2
prerank,GO_Biological_Process_2021__SREBP signaling pathway (GO:0032933),-0.2710330166140623,-0.4819498979835221,1.0,1.0,1.0,4/8,23.84%,SREBF1;INSIG1;SREBF2;ERLIN2
prerank,GO_Biological_Process_2021__regulation of muscle system process (GO:0090257),-0.2987027620920125,-0.481106702688952,0.9545454545454546,1.0,1.0,2/7,23.79%,MYL5;PVALEF
prerank,GO_Biological_Process_2021__lipid transport across blood-brain barrier (GO:1990379),-0.2919171286839802,-0.4809873426320864,0.9696969696969697,1.0,1.0,5/5,70.82%,CD36;SLC27A4;MFSD2A;FABP5;SLC27A1
prerank,GO_Biological_Process_2021__positive regulation of embryonic development (GO:0040019),0.25844623177009196,0.4806955745982209,0.9761904761904762,0.9988714279657771,1.0,2/12,13.91%,PLCB1;B4GALT5
prerank,GO_Biological_Process_2021__chitin catabolic process (GO:0006032),-0.3127057432218181,-0.4797892677400704,0.9814814814814815,1.0,1.0,1/5,11.94%,CHI3L2
prerank,GO_Biological_Process_2021__chitin metabolic process (GO:0006030),-0.3127057432218181,-0.4797892677400704,0.9814814814814815,1.0,1.0,1/5,11.94%,CHI3L2
prerank,GO_Biological_Process_2021__lysosome localization (GO:0032418),0.19863948044031216,0.4792297561334272,1.0,0.9987906602045095,1.0,8/29,29.89%,TFEB;TMEM106B;SYTL4;KLC2;BORCS5;KIT;MAP6;ARL8B
prerank,GO_Biological_Process_2021__GPI anchor metabolic process (GO:0006505),0.21687740547361148,0.476655422943093,1.0,0.9989663296352597,1.0,7/24,29.14%,PGAP1;PIGP;PIGQ;PIGU;DPM1;PGAP4;PIGZ
prerank,GO_Biological_Process_2021__neuron projection organization (GO:0106027),0.24956356582276845,0.47639122216680824,1.0,0.9986845558490792,1.0,3/14,27.71%,GSK3B;PICK1;ABCD2
prerank,GO_Biological_Process_2021__porphyrin-containing compound biosynthetic process (GO:0006779),-0.24434658663302927,-0.47514565485014865,1.0,1.0,1.0,5/19,22.03%,ABCG2;ATP5IF1;UROD;TSPO;ALAD
prerank,GO_Biological_Process_2021__negative regulation of transcription by RNA polymerase I (GO:0016479),-0.32630641278382116,-0.4744398404875008,1.0,1.0,1.0,1/5,17.51%,MACROH2A2
prerank,GO_Biological_Process_2021__positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),0.22958763101394783,0.4740928352317151,1.0,0.9987244987519293,1.0,7/14,31.41%,MID1;TAOK2;STK25;TAOK1;RNF13;TGFB2;TAOK3
prerank,GO_Biological_Process_2021__regulation of DNA-dependent DNA replication (GO:0090329),0.27165644879922574,0.47311243848955126,1.0,0.9985584914976181,1.0,5/9,31.30%,KAT7;WRNIP1;TICRR;GMNN;METTL4
prerank,GO_Biological_Process_2021__platelet activating factor metabolic process (GO:0046469),0.28852271845934063,0.47251483975279995,1.0,0.9983172706299415,1.0,2/6,31.02%,CHPT1;PAFAH1B1
prerank,GO_Biological_Process_2021__gap junction assembly (GO:0016264),-0.2888240443536621,-0.4715761733925584,0.94,1.0,1.0,5/5,71.13%,GJC1;GJB2;GJB1;GJB6;GJA1
prerank,GO_Biological_Process_2021__regulation of cell cycle G1/S phase transition (GO:1902806),-0.2341478596735661,-0.4695015250599314,1.0,1.0,1.0,3/25,17.86%,PSME1;ID2;GLI1
prerank,GO_Biological_Process_2021__protein auto-ADP-ribosylation (GO:0070213),-0.25029133335434445,-0.4672905178022975,1.0,1.0,1.0,3/12,24.63%,PARP2;PARP12;PARP10
prerank,GO_Biological_Process_2021__reticulophagy (GO:0061709),0.23201394157294314,0.4672322591368647,1.0,0.998743790505184,1.0,2/12,22.32%,ATG2B;RB1CC1
prerank,GO_Biological_Process_2021__gland morphogenesis (GO:0022612),0.2807728039171187,0.46691566761808395,1.0,0.9984775710139214,1.0,3/6,36.61%,FGFR2;TGFB2;EZR
prerank,GO_Biological_Process_2021__positive regulation of smoothened signaling pathway (GO:0045880),0.21181779884373006,0.4663656312612362,1.0,0.9982666953685164,1.0,5/16,28.33%,DLG5;SMO;EVC;PDCL;KIF7
prerank,GO_Biological_Process_2021__positive regulation of isotype switching (GO:0045830),0.26209189197345517,0.4655300955275533,1.0,0.9980709936485137,1.0,2/12,29.82%,TFRC;KMT5B
prerank,GO_Biological_Process_2021__peptidyl-amino acid modification (GO:0018193),-0.295144157814871,-0.46408703826471415,0.9705882352941176,1.0,1.0,6/6,70.50%,FKBP7;METAP2;FKBP10;TTLL4;METAP1;METAP1D
prerank,GO_Biological_Process_2021__neuron projection maintenance (GO:1990535),-0.27720056035489143,-0.4624409779202603,1.0,1.0,1.0,8/8,72.30%,DCTN1;APP;INSR;PSEN1;MAP1A;PRNP;ABCD1;ABCD2
prerank,GO_Biological_Process_2021__medium-chain fatty acid biosynthetic process (GO:0051792),0.2677906960795148,0.46180076677642656,0.9722222222222222,0.9982764791468155,1.0,3/6,31.80%,ABHD2;ACOT7;ABHD3
prerank,GO_Biological_Process_2021__positive regulation of actin cytoskeleton reorganization (GO:2000251),0.2220897814462646,0.4615716983463124,0.9705882352941176,0.9980057172714228,1.0,3/14,22.16%,HCLS1;NRP1;NTRK3
prerank,GO_Biological_Process_2021__spliceosomal complex assembly (GO:0000245),-0.2022429406724372,-0.460267220408152,1.0,1.0,1.0,6/42,23.20%,SNRPD2;SNRNP200;DDX23;NOL3;SRSF5;PRPF6
prerank,GO_Biological_Process_2021__negative regulation of histone H4 acetylation (GO:0090241),-0.3028065583185461,-0.4602267208112923,0.95,1.0,1.0,1/5,12.68%,SPI1
prerank,GO_Biological_Process_2021__establishment of spindle localization (GO:0051293),-0.24951003969454683,-0.45967280527711674,1.0,1.0,1.0,1/12,10.11%,NLRP5
prerank,GO_Biological_Process_2021__creatine metabolic process (GO:0006600),0.27529272300866003,0.45903464443303976,1.0,0.9981058812235638,1.0,4/6,42.77%,GAMT;SLC6A8;CKB;GATM
prerank,GO_Biological_Process_2021__interleukin-23-mediated signaling pathway (GO:0038155),-0.2865647251079725,-0.4574704230019445,0.9821428571428571,1.0,1.0,6/6,71.36%,IL12RB1;STAT4;P4HB;TYK2;STAT3;JAK2
prerank,GO_Biological_Process_2021__response to steroid hormone (GO:0048545),-0.23113136110315885,-0.4564298749771992,1.0,1.0,1.0,1/23,5.73%,THBS1
prerank,GO_Biological_Process_2021__cardiolipin metabolic process (GO:0032048),-0.2551079976649153,-0.4558939076058897,1.0,1.0,1.0,10/10,74.51%,HADHA;PLA2G4A;PLA2G5;PNPLA8;PLA2G6;PGS1;LCLAT1;HADHB;SLC27A1;TAMM41
prerank,GO_Biological_Process_2021__DNA-dependent DNA replication maintenance of fidelity (GO:0045005),-0.22505149995937554,-0.45568981282087995,1.0,1.0,1.0,5/35,22.69%,DDX11;BLM;TONSL;DONSON;BOD1L1
prerank,GO_Biological_Process_2021__preassembly of GPI anchor in ER membrane (GO:0016254),0.23537776373446367,0.4553343681218558,1.0,0.9982210100457191,1.0,3/15,23.77%,PIGX;PIGP;PIGQ
prerank,GO_Biological_Process_2021__pyrimidine nucleobase metabolic process (GO:0006206),-0.26142585845581773,-0.45456088186441995,1.0,1.0,1.0,1/10,14.24%,DPYSL3
prerank,GO_Biological_Process_2021__regulation of microglial cell activation (GO:1903978),0.25000467320418013,0.4535690823662384,1.0,0.998175837902585,1.0,2/8,21.25%,NR1D1;PTPRC
prerank,GO_Biological_Process_2021__positive regulation of neutrophil extravasation (GO:2000391),-0.292850889991246,-0.4518720478915372,1.0,1.0,1.0,5/5,70.73%,ADAM8;XG;CD99;MDK;RIPOR2
prerank,GO_Biological_Process_2021__regulation of neutrophil extravasation (GO:2000389),-0.292850889991246,-0.4518720478915372,1.0,1.0,1.0,5/5,70.73%,ADAM8;XG;CD99;MDK;RIPOR2
prerank,GO_Biological_Process_2021__transmembrane receptor protein tyrosine phosphatase signaling pathway (GO:0007185),0.29124691764053495,0.45136991352857575,1.0,0.9981356990750602,1.0,4/6,35.55%,TRIO;FRS2;PTPRD;PTPRU
prerank,GO_Biological_Process_2021__negative regulation of response to reactive oxygen species (GO:1901032),0.26623882350313754,0.44908930540020503,1.0,0.9980405392733214,1.0,1/8,20.13%,NFE2L2
prerank,GO_Biological_Process_2021__hypotonic response (GO:0006971),-0.28836261827542947,-0.44855493030531524,0.9827586206896551,1.0,1.0,1/5,15.92%,SLC4A11
prerank,GO_Biological_Process_2021__tRNA metabolic process (GO:0006399),-0.23913319954147363,-0.4444429148208432,1.0,1.0,1.0,4/15,26.21%,POP5;TRPT1;SARS1;DTD1
prerank,GO_Biological_Process_2021__regulation of proton transport (GO:0010155),-0.27814311496196265,-0.4440600504677577,1.0,1.0,1.0,2/7,20.96%,ANTKMT;DNAJC30
prerank,GO_Biological_Process_2021__protein localization to basolateral plasma membrane (GO:1903361),0.2788666074075544,0.4426605667455264,0.9607843137254902,0.9983906698659571,1.0,3/6,20.55%,LIN7C;LIN7A;RAB10
prerank,GO_Biological_Process_2021__regulation of mitochondrial membrane permeability (GO:0046902),0.22892516002036617,0.4423524068332742,1.0,0.9981104503568626,1.0,4/16,23.33%,CAMK2A;BCL2;NAIF1;BCL2L1
prerank,GO_Biological_Process_2021__serine family amino acid catabolic process (GO:0009071),-0.26790480169091646,-0.4414909488274592,1.0,1.0,1.0,3/8,32.39%,SDS;THNSL2;DAO
prerank,GO_Biological_Process_2021__regulation of ER-associated ubiquitin-dependent protein catabolic process (GO:1903069),-0.2715137550586115,-0.44081132822528507,0.9821428571428571,1.0,1.0,1/8,9.60%,SVIP
prerank,GO_Biological_Process_2021__embryonic hemopoiesis (GO:0035162),-0.2592846775404676,-0.4394402582503967,0.9833333333333333,1.0,1.0,1/8,13.47%,ZFPM1
prerank,GO_Biological_Process_2021__positive regulation of protein localization to cell surface (GO:2000010),0.2382153687446488,0.43939753827292666,0.9743589743589743,0.9981353747467773,1.0,1/11,15.16%,TM9SF4
prerank,GO_Biological_Process_2021__aorta morphogenesis (GO:0035909),-0.23996497360728117,-0.4378529568218359,1.0,1.0,1.0,2/13,18.33%,HEY2;ENG
prerank,GO_Biological_Process_2021__protein O-linked glycosylation via threonine (GO:0018243),0.2567700484600656,0.4372454284708044,1.0,0.9980503273879907,1.0,5/8,36.83%,GALNT1;GALNT2;GALNT3;GALNTL6;GALNT11
prerank,GO_Biological_Process_2021__xenobiotic catabolic process (GO:0042178),-0.2699686806465757,-0.43682664495700513,0.9629629629629629,1.0,1.0,3/6,24.87%,GSTM3;GSTO1;ACAA1
prerank,GO_Biological_Process_2021__isoleucine metabolic process (GO:0006549),-0.2778517425284752,-0.435508672002035,1.0,1.0,1.0,2/5,25.15%,SDS;SDSL
prerank,GO_Biological_Process_2021__aerobic respiration (GO:0009060),-0.2217357975535989,-0.43396728245977934,1.0,1.0,1.0,6/20,24.86%,SURF1;UQCR10;SIRT3;OXA1L;MTFR1L;UQCRB
prerank,GO_Biological_Process_2021__plasma membrane tubulation (GO:0097320),-0.23760873372642888,-0.4316635074899379,1.0,1.0,1.0,11/11,76.26%,EHD2;PACSIN3;BIN2;PACSIN2;MICALL1;PACSIN1;SNX9;FNBP1L;SNX33;WHAMM;BIN3
prerank,GO_Biological_Process_2021__regulation of myoblast fusion (GO:1901739),0.2497003346558753,0.43093424631412225,0.9787234042553191,0.998315086771223,1.0,2/7,19.97%,CFLAR;ADGRB1
prerank,GO_Biological_Process_2021__negative regulation of nervous system process (GO:0031645),-0.29856249296206433,-0.4309257886220034,1.0,1.0,1.0,2/5,20.26%,TNFRSF21;GLRA1
prerank,GO_Biological_Process_2021__regulation of transmission of nerve impulse (GO:0051969),0.2860257575063901,0.43076730756683884,1.0,0.9980252426511008,1.0,3/5,32.07%,FMR1;HCRT;FGF12
prerank,GO_Biological_Process_2021__regulation of hydrogen peroxide-induced cell death (GO:1903205),0.2471932894543038,0.4304206843128433,1.0,0.9977605427140854,1.0,1/9,20.13%,NFE2L2
prerank,GO_Biological_Process_2021__L-ascorbic acid metabolic process (GO:0019852),-0.25974784029885595,-0.42946601054613964,0.9722222222222222,1.0,1.0,8/8,74.04%,GSTO1;CYB5R3;RGN;CYB5A;SLC2A3;SLC2A1;SLC23A2;GSTO2
prerank,GO_Biological_Process_2021__Cdc42 protein signal transduction (GO:0032488),-0.2590171588654138,-0.4225293109315201,1.0,1.0,1.0,6/6,74.11%,SHTN1;NTN1;WAS;RHOJ;CDC42;RHOU
prerank,GO_Biological_Process_2021__negative regulation of glycoprotein biosynthetic process (GO:0010561),-0.24908061409141322,-0.4223211466616178,1.0,1.0,1.0,9/9,75.11%,ACOT8;ITM2C;ITM2B;JAK3;ITM2A;ABCA7;AGO2;BACE2;SLC2A10
prerank,GO_Biological_Process_2021__glycosylceramide catabolic process (GO:0046477),-0.2637116563642825,-0.4141753348781451,0.9814814814814815,1.0,1.0,3/5,31.93%,GBA3;GBA2;NAGA
prerank,GO_Biological_Process_2021__negative regulation of osteoclast differentiation (GO:0045671),-0.23673395142243936,-0.4136200312380203,1.0,1.0,1.0,1/11,10.28%,TLR3
prerank,GO_Biological_Process_2021__hair cell differentiation (GO:0035315),-0.24832005876116892,-0.41052227311840933,1.0,1.0,1.0,1/7,16.31%,SPINK5
prerank,GO_Biological_Process_2021__biotin metabolic process (GO:0006768),0.22125981855892857,0.407802994219269,1.0,0.9990884277109434,1.0,4/9,33.90%,PCCA;SLC5A6;PC;HLCS
prerank,GO_Biological_Process_2021__box C/D snoRNP assembly (GO:0000492),-0.24426545263526528,-0.4075578961161852,1.0,1.0,1.0,7/7,75.59%,PIH1D2;RUVBL2;ZNHIT3;RUVBL1;PIH1D1;ZNHIT6;NUFIP1
prerank,GO_Biological_Process_2021__mRNA 5'-splice site recognition (GO:0000395),-0.2741173037642253,-0.40470041961297115,1.0,1.0,1.0,5/5,72.60%,SNRPC;SRSF12;PSIP1;PRPF39;SFSWAP
prerank,GO_Biological_Process_2021__regulation of peptidyl-cysteine S-nitrosylation (GO:2000169),0.2620052234164128,0.4035300682614842,1.0,0.9990680945341084,1.0,3/5,34.40%,ATP2B4;DMD;SNTA1
prerank,GO_Biological_Process_2021__oligosaccharide catabolic process (GO:0009313),-0.2350458695546621,-0.4019976119132166,0.9833333333333333,1.0,1.0,2/8,26.10%,NEU1;GBA3
prerank,GO_Biological_Process_2021__zinc ion import across plasma membrane (GO:0071578),-0.25925848923342915,-0.39266235456395127,1.0,1.0,1.0,2/5,23.42%,SLC39A6;SLC39A14
prerank,GO_Biological_Process_2021__glycine transport (GO:0015816),-0.2590906530330294,-0.39235019588555886,1.0,1.0,1.0,1/5,20.57%,SLC36A1
prerank,GO_Biological_Process_2021__regulation of transcription by RNA polymerase I (GO:0006356),-0.20231642782020823,-0.39090829273399547,1.0,1.0,1.0,2/16,20.46%,POLR2L;POLR2K
prerank,GO_Biological_Process_2021__neurotransmitter reuptake (GO:0098810),-0.25169081229875767,-0.38900772405709866,1.0,1.0,1.0,1/6,18.07%,SLC22A1
prerank,GO_Biological_Process_2021__negative regulation of amyloid precursor protein biosynthetic process (GO:0042985),-0.2561573479631143,-0.3882275827371656,0.9814814814814815,1.0,1.0,6/6,74.40%,ITM2C;ITM2B;ITM2A;ABCA7;AGO2;BACE2
prerank,GO_Biological_Process_2021__toxin transport (GO:1901998),0.2205948772295705,0.38254091828317566,1.0,0.9996264836130497,1.0,4/9,31.32%,ANTXR2;SLC22A2;ADAM10;RAB40B
prerank,GO_Biological_Process_2021__defense response to fungus (GO:0050832),0.2475304371442422,0.3797834416118787,1.0,0.9993915424399148,1.0,1/5,18.83%,BCL10
prerank,GO_Biological_Process_2021__peroxisome proliferator activated receptor signaling pathway (GO:0035357),-0.24243982290077973,-0.3777055281178535,0.9615384615384616,1.0,1.0,1/5,18.47%,PDK3
prerank,GO_Biological_Process_2021__positive regulation of bone resorption (GO:0045780),-0.21765014883558048,-0.3739313830440687,1.0,1.0,1.0,7/7,78.25%,ADAM8;SYK;SPP1;PLEKHM1;ATP6AP1;DEF8;PRKCA
prerank,GO_Biological_Process_2021__protein deglutamylation (GO:0035608),-0.22463997408220937,-0.3711567022360807,1.0,1.0,1.0,2/7,25.29%,AGBL5;AGBL3
prerank,GO_Biological_Process_2021__positive regulation of sphingolipid biosynthetic process (GO:0090154),-0.22841632128889147,-0.36830159454057876,1.0,0.9994416126942038,1.0,9/9,77.18%,SIRT3;RACK1;PRKCD;SMPD3;TNFRSF1A;SMPD2;PLA2G6;SPHK2;NSMAF
prerank,GO_Biological_Process_2021__positive regulation of ceramide biosynthetic process (GO:2000304),-0.22841632128889147,-0.36830159454057876,1.0,0.9994416126942038,1.0,9/9,77.18%,SIRT3;RACK1;PRKCD;SMPD3;TNFRSF1A;SMPD2;PLA2G6;SPHK2;NSMAF
